Citrus Sinensis ID: 048430
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 973 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.970 | 0.934 | 0.392 | 1e-171 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.958 | 0.904 | 0.369 | 1e-161 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.969 | 0.92 | 0.359 | 1e-141 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.899 | 0.745 | 0.348 | 1e-137 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.902 | 0.702 | 0.336 | 1e-131 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.928 | 0.721 | 0.332 | 1e-130 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.941 | 0.802 | 0.326 | 1e-124 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.865 | 0.859 | 0.343 | 1e-123 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.913 | 0.793 | 0.300 | 1e-113 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.948 | 0.926 | 0.313 | 1e-113 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 603 bits (1555), Expect = e-171, Method: Compositional matrix adjust.
Identities = 393/1001 (39%), Positives = 565/1001 (56%), Gaps = 57/1001 (5%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+Q K+++S D LS N S +CNW GVTC ++ RV L L L LGG
Sbjct: 28 ALLQFKSQVSEDKRVV------LSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+ P +GNLSFLVSL++ N F T+P E+ + RL+ +D N L G +P + N ++L
Sbjct: 82 ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNC-SRL 140
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
+ + SN++ G PS + ++++L + L N++ G PT L L L QL L NN+
Sbjct: 141 LNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSL-GNLTLLEQLALSHNNLE 199
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS- 239
G EIP+++ L + L L NN +G+ P ++N S++ + + NH SG L
Sbjct: 200 G-----EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDL 254
Query: 240 -IYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
I LPNL + + N +G IP ++ N S L ++ N +G +P TFGN L++L L
Sbjct: 255 GILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFL 313
Query: 299 GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQ 358
N L + SS + F +SL C L L + N L G +P SI NLS L G +
Sbjct: 314 HTNSLGSDSSRDLE-FLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTL 372
Query: 359 LSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL 418
+SG IP GNL NL L L N L+G +PT LGKL L+ L L SN+L G IP + +
Sbjct: 373 ISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNM 432
Query: 419 EKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478
L TL +NN +G +PT L N + L L N LN TIP ++ +L +D S NS
Sbjct: 433 TMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNS 492
Query: 479 LSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL 538
L GSLP +IG L+ LG L+L N+LSG +P ++GN ++ L L N F G IP G L
Sbjct: 493 LIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-L 551
Query: 539 ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYA 598
+ ++ +DLS N++SG IP+ S+L N+SFN LEG++P G F N T S N
Sbjct: 552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611
Query: 599 LCGS-SRLQVPPCKTSS-----THKSKATKIVLRYILPAIATTMVVVA-LFIILIRRRKR 651
LCG Q+ PC + + H S+ K+V+ + ++ +A + +I +R+RK+
Sbjct: 612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKK 671
Query: 652 NKSLPEENNSLNLATL----SRISYHELQQATNGFGESNLLGSGSFDNVYKA-TLANGVS 706
NK E N+ +TL +ISY +L+ ATNGF SN++GSGSF VYKA L
Sbjct: 672 NK----ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKV 727
Query: 707 VAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG-----FKALIMQYMPQG 761
VAVKV N+Q A+KSF ECE ++ IRHRNL+K++++CS+ F+ALI ++MP G
Sbjct: 728 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNG 787
Query: 762 SLEKWLYSHNY--------SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813
SL+ WL+ +LT+ +RL+I IDVAS L+YLH PI HCDLKP+NVLL
Sbjct: 788 SLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 847
Query: 814 DDDMVAHLGDFGIAKLLDGVDP------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
DDD+ AH+ DFG+A+LL D ++ TIGY APEYG G SI+GDVYSF
Sbjct: 848 DDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSF 907
Query: 868 GILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKK 927
GIL++E FT ++PTNE+F G +L + +LP + ++VD ++L F +
Sbjct: 908 GILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRV---GFPVVE 964
Query: 928 TCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968
C++ + + L+C E P R+ + +L I++ +A
Sbjct: 965 -CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKA 1004
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 568 bits (1465), Expect = e-161, Method: Compositional matrix adjust.
Identities = 367/993 (36%), Positives = 547/993 (55%), Gaps = 60/993 (6%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL++ K+++S + +WN S+ CNW+GVTC R RV +L+L L G
Sbjct: 34 ALLEFKSQVSENNKREVLASWN-----HSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+ P +GNLSFL LN++ NSF T+P ++ + RL+ ++ S N L G +P + N ++L
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNC-SRL 147
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
+ D+SSN + PS + ++S L + L N+L+G+FP L L SL +L N +
Sbjct: 148 STVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASL-GNLTSLQKLDFAYNQMR 206
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
G EIP+E+ L + + N+ +G P ++N S++ ++ L N SG+L +
Sbjct: 207 G-----EIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADF 261
Query: 241 --YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
LPNL L L N +G IP ++ N S ++SSN SG +P +FG R L L +
Sbjct: 262 GYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGI 321
Query: 299 GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQ 358
+N L SS+ + F ++A C L L + N L G +P SI NLST+L + + G +
Sbjct: 322 RNNSLGNNSSSGLE-FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNL 380
Query: 359 LSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL 418
+SG IP GNL +L LSL N L+G +P GKL LQ +DL SN + G IP+ +
Sbjct: 381 ISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNM 440
Query: 419 EKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478
+L L N+N+ G+IP L L L +N LN TIP + + +D S N
Sbjct: 441 TRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNF 500
Query: 479 LSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL 538
L+G P +G LE L GL + N+LSG +P +IG ++++L + N+F G IP L
Sbjct: 501 LTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRL 559
Query: 539 ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYA 598
+SL+++D S NN+SG IP+ L L L + N+S N EG +P+ G F N TA S N
Sbjct: 560 VSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTN 619
Query: 599 LCGSSR-LQVPPCKTSSTHKSKATKIVLRYILPAIATTMVVVALFIILI-------RRRK 650
+CG R +Q+ PC ++ + + V + ++ I + + L II+ R++K
Sbjct: 620 ICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKK 679
Query: 651 RNKSLPEENNSLNLATL-SRISYHELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVA 708
N S ++S L ++SY EL AT+ F +NL+GSG+F NV+K L VA
Sbjct: 680 NNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVA 739
Query: 709 VKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN-----PGFKALIMQYMPQGSL 763
VKV NL + A KSF ECE + IRHRNL+K+++ CS+ F+AL+ ++MP+GSL
Sbjct: 740 VKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSL 799
Query: 764 EKWLY--------SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815
+ WL H+ SLT ++L+I IDVASALEYLH P+ HCD+KP+N+LLDD
Sbjct: 800 DMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDD 859
Query: 816 DMVAHLGDFGIAKLLDGVD------PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGI 869
D+ AH+ DFG+A+LL D + TIGY APEYG G SI GDVYSFGI
Sbjct: 860 DLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGI 919
Query: 870 LMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTC 929
L++E F+ +KPT+E F G+ +L + L G + +A D +
Sbjct: 920 LLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTS----------SGGSNAIDEGLR--- 966
Query: 930 ISYIMSLALKCSAEIPEERINVKDALADLKKIK 962
++ + +KCS E P +R+ +A+ +L I+
Sbjct: 967 --LVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1298), Expect = e-141, Method: Compositional matrix adjust.
Identities = 358/995 (35%), Positives = 546/995 (54%), Gaps = 52/995 (5%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL++ K+++S + +WN S +C+W GV C ++H RV + L L L G
Sbjct: 43 ALLEFKSQVS-ETSRVVLGSWN-----DSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGV 96
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+ P VGNLSFL SLN++ N F+ +P+E+ ++ RL+ ++ S+N G +P + N +
Sbjct: 97 VSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLS 156
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
D+SSN + P ++S L + L N+L+G FP L L SL L + N I
Sbjct: 157 TL-DLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASL-GNLTSLQMLDFIYNQIE 214
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
G EIP +I L + + N G+ P I+N S+++ + + GN SG L
Sbjct: 215 G-----EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDF 269
Query: 241 --YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
LPNL+ L++ N+ +G IP+++ N S L++ SN +G +P +FG R +L L
Sbjct: 270 GSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFG--RLQNLLLL 327
Query: 299 GDNQLTTGSSAQGQI-FYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSS 357
G N + G+ + G + F +L C L+ L + N L G +P I NLST L G +
Sbjct: 328 GLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGN 387
Query: 358 QLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCK 417
+SG IP G GNL +L L L N L G +P LG+L +L+ + L SN L G IP+ L
Sbjct: 388 LISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGN 447
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLN 477
+ L L NN+ +G IP+ L + + L L+ +N LN +IP L ++ ++ S N
Sbjct: 448 ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFN 507
Query: 478 SLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGS 537
L G L +IG L+ L L+++ N+LSG IP ++ N +L++L L N+F GPIP G
Sbjct: 508 LLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG- 566
Query: 538 LISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNY 597
L L+ LDLS NN+SG IP+ + S+L + N+S N +G +P+ G F N +A S N
Sbjct: 567 LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNI 626
Query: 598 ALCGS-SRLQVPPCKTSSTHK-SKATKIVLRYILPAIATTMVVVALFIILIRRRKRNKSL 655
LCG LQ+ PC + S KI+ + +A +++ + L + R KS+
Sbjct: 627 NLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSV 686
Query: 656 PEENNSLNL------ATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVA 708
NN + + +ISY EL + T GF SNL+GSG+F V+K L + +VA
Sbjct: 687 RANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVA 746
Query: 709 VKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GFKALIMQYMPQGSL 763
+KV NL + A KSF ECE + IRHRNL+K+V+ CS+ F+AL+ ++MP G+L
Sbjct: 747 IKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNL 806
Query: 764 EKWLYSH--------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815
+ WL+ + +L + RL+I IDVASAL YLH PI HCD+KP+N+LLD
Sbjct: 807 DMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDK 866
Query: 816 DMVAHLGDFGIAKLLDGVDPVTQTMTLA------TIGYMAPEYGSEGIVSISGDVYSFGI 869
D+ AH+ DFG+A+LL D T + + TIGY APEYG G SI GDVYSFGI
Sbjct: 867 DLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGI 926
Query: 870 LMMETFTRRKPTNEMFTGEMSLKQWVAESLPG-AVTEVVDANLLSREDEEDADDFATKKT 928
+++E FT ++PTN++F ++L + +L ++ D +L + +
Sbjct: 927 VLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN----MVE 982
Query: 929 CISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
C++ + + + CS E P RI++ +A++ L I++
Sbjct: 983 CLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRE 1017
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 343/985 (34%), Positives = 516/985 (52%), Gaps = 110/985 (11%)
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDM--C 114
L G++P +G L+ L L++SGN +P + ++ L+ + + N L G +P ++ C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 115 NSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRL 174
+S QLE +D N++TG+ P+ + N+ L+++R+ N L+ S P+ L RL L L L
Sbjct: 264 SSLVQLELYD---NQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLF-RLTQLTHLGL 319
Query: 175 LGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG 234
N++ G I EIG L +L++L L NN G P I N N+ + + N++SG
Sbjct: 320 SENHLVG-----PISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISG 374
Query: 235 HLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG----- 288
LP+ + L NL NL N L+G IP SI N + +L+LS N +G +P FG
Sbjct: 375 ELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLT 434
Query: 289 ------------------NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330
NC L+ LS+ DN LT + K + LR+L +
Sbjct: 435 FISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTG-------TLKPLIGKLQKLRILQVS 487
Query: 331 TNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTV 390
N L G IP IGNL L Y S+ +G IP NL+ L L + +N+L G IP
Sbjct: 488 YNSLTGPIPREIGNLK-DLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEE 546
Query: 391 LGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450
+ ++ L LDL++NK G IP KLE L L N G IP L +L+ L D
Sbjct: 547 MFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDI 606
Query: 451 RSNSLNSTIPSTFW-SLKYI-LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP 508
N L TIP SLK + L ++FS N L+G++P +G LE + ++L+ N SG IP
Sbjct: 607 SDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIP 666
Query: 509 SSIGNLKN---LDW----------------------LALARNAFQGPIPQSFGSLISLQS 543
S+ KN LD+ L L+RN+F G IPQSFG++ L S
Sbjct: 667 RSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVS 726
Query: 544 LDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSS 603
LDLS NN++GEIP+SL LS L ++ N L+G +P G F N A N LCGS
Sbjct: 727 LDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSK 786
Query: 604 RLQVPPC--KTSSTHKSKATKIVLRYI-------LPAIATTMVVVALFIILIRRRKRNKS 654
+ + PC K S+H SK T+++L + L + ++ S
Sbjct: 787 K-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESS 845
Query: 655 LPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNL 714
LP+ +++L L R EL+QAT+ F +N++GS S VYK L +G +AVKV NL
Sbjct: 846 LPDLDSALK---LKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNL 902
Query: 715 QEDRAL--KSFDTECEVMRRIRHRNLIKIVSSCSNPG-FKALIMQYMPQGSLEKWLYSHN 771
+E A K F TE + + +++HRNL+KI+ G KAL++ +M G+LE ++
Sbjct: 903 KEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSA 962
Query: 772 YSL-TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830
+ ++ +++D+ + +AS ++YLH GY PI+HCDLKP N+LLD D VAH+ DFG A++L
Sbjct: 963 APIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL 1022
Query: 831 ----DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPT--NEM 884
DG + + TIGY+APE+ V+ DV+SFGI+MME T+++PT N+
Sbjct: 1023 GFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDE 1082
Query: 885 FTGEMSLKQWVAESLPG---AVTEVVDANL----LSREDEEDADDFATKKTCISYIMSLA 937
+ +M+L+Q V +S+ + V+D L +S + EE +DF + L
Sbjct: 1083 DSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIEDF----------LKLC 1132
Query: 938 LKCSAEIPEERINVKDALADLKKIK 962
L C++ PE+R ++ + L L K++
Sbjct: 1133 LFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1212), Expect = e-131, Method: Compositional matrix adjust.
Identities = 348/1033 (33%), Positives = 509/1033 (49%), Gaps = 155/1033 (15%)
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
L GT+P +G L L LN++ NS +P++L M +L+ + +N L G +P + +
Sbjct: 227 LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLAD- 285
Query: 117 FTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
L++ D+S+N +TGE P N+S L + L NN LSGS P +C+ +L QL L G
Sbjct: 286 LGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSG 345
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIF------------------- 217
++G EIP E+ +LK LDL N++AG IP +F
Sbjct: 346 TQLSG-----EIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTL 400
Query: 218 -----NNSNMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATI 271
N +N+ ++LY N+L G LP I L LE LFL++N SG IP I N + +
Sbjct: 401 SPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKM 460
Query: 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331
+++ N F G +P + G ++L +L L N+L G A SL C L +L L
Sbjct: 461 IDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPA-------SLGNCHQLNILDLAD 513
Query: 332 NPLKGVIPNSIGNL---------------------------------------------- 345
N L G IP+S G L
Sbjct: 514 NQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG 573
Query: 346 STSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405
S+S +F ++ IP+ GN NL L L N+L G IP LGK+++L LD++SN
Sbjct: 574 SSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSN 633
Query: 406 KLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWS 465
L G IP L +KL + NNN L G IP L L+ L L SN ++P+ ++
Sbjct: 634 ALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFN 693
Query: 466 LKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARN 525
+L + NSL+GS+P IGNL AL LNL NQ SG +P ++G L L L L+RN
Sbjct: 694 CTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRN 753
Query: 526 AFQGPIPQSFGSLISLQS-LDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS--- 581
+ G IP G L LQS LDLS NN +G+IP ++ LS+L ++S N L GE+P
Sbjct: 754 SLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVG 813
Query: 582 ---------------GGP----FVNFTADSFKQNYALCGSSRLQVPPCKTSSTHK--SKA 620
GG F + ADSF N LCGS + ++++ + S
Sbjct: 814 DMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSAR 873
Query: 621 TKIVLRYI--LPAIATTMVVVALFIILIRRRKRNKSLPEENNSL---------------- 662
+ +++ I L AI ++V+ALF +R K + + +
Sbjct: 874 SVVIISAISALTAIGLMILVIALF--FKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFR 931
Query: 663 NLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED-RALK 721
N A+ S I + ++ +AT+ E ++GSG VYKA L NG +VAVK ++D + K
Sbjct: 932 NGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNK 991
Query: 722 SFDTECEVMRRIRHRNLIKIVSSCS--NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQ- 778
SF E + + RIRHR+L+K++ CS + G LI +YM GS+ WL+ L ++
Sbjct: 992 SFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKK 1051
Query: 779 ------RLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-D 831
RL I + +A +EYLHH PI+H D+K +NVLLD +M AHLGDFG+AK+L +
Sbjct: 1052 LLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTE 1111
Query: 832 GVDPVTQTMTL--ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM 889
D T + T + GY+APEY + DVYS GI++ME T + PT+ +F EM
Sbjct: 1112 NCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM 1171
Query: 890 SLKQWVAESLP---GAVTEVVDANLLS-REDEEDADDFATKKTCISYIMSLALKCSAEIP 945
+ +WV L A +++D L EEDA C ++ +AL+C+ P
Sbjct: 1172 DMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDA-------AC--QVLEIALQCTKTSP 1222
Query: 946 EERINVKDALADL 958
+ER + + A L
Sbjct: 1223 QERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 466 bits (1199), Expect = e-130, Method: Compositional matrix adjust.
Identities = 337/1013 (33%), Positives = 510/1013 (50%), Gaps = 110/1013 (10%)
Query: 22 NLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSF 81
NL + S + + +G SI++ L+L L G +P + L+ L +L++S N+
Sbjct: 246 NLGDNSFSGEIPSQLGDLVSIQY-----LNLIGNQLQGLIPKRLTELANLQTLDLSSNNL 300
Query: 82 YDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNI 141
+ E W M +L+ + + N LSGSLP +C++ T L+ +S +++GE P+ I N
Sbjct: 301 TGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNC 360
Query: 142 SSLKSIRLDNNSLSGSFPTDL-----------------------CTRLPSLVQLRLLGNN 178
SLK + L NN+L+G P L + L +L + L NN
Sbjct: 361 QSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNN 420
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPS 238
+ G++P EIG L L+I+ L N +G +P I N + + I YGN LSG +PS
Sbjct: 421 LEGKVPK-----EIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPS 475
Query: 239 SI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILS 297
SI L +L L L +N L G IP S+ N + T+++L+ N SG +P++FG L++
Sbjct: 476 SIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFM 535
Query: 298 LGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSS 357
+ +N L QG + SL + L + +N G I G S+S +F +
Sbjct: 536 IYNNSL------QGNL-PDSLINLKNLTRINFSSNKFNGSISPLCG--SSSYLSFDVTEN 586
Query: 358 QLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCK 417
G IP+ G +NL L L N+ G IP GK+ +L LD++ N L G IP +L
Sbjct: 587 GFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGL 646
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLN 477
+KL + NNN L G IPT L L L L SN ++P+ +SL IL + N
Sbjct: 647 CKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGN 706
Query: 478 SLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGS 537
SL+GS+P IGNL+AL LNL NQLSG +PS+IG L L L L+RNA G IP G
Sbjct: 707 SLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQ 766
Query: 538 LISLQS-LDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS--------------- 581
L LQS LDLS NN +G IP ++ L +L ++S N L GE+P
Sbjct: 767 LQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSY 826
Query: 582 -------GGPFVNFTADSFKQNYALCGSSRLQVPPCKTSSTHKSKATKIVLRYILPAIAT 634
F + AD+F N LCGS + C + + ++ I+ AI++
Sbjct: 827 NNLEGKLKKQFSRWQADAFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAISS 883
Query: 635 TMVVVALFIILIRRRKRNKSLPEENNS-----------------LNLATLSRISYHELQQ 677
+ + +++I K+N L ++ N S I + ++ +
Sbjct: 884 LAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIME 943
Query: 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHR 736
AT+ E ++GSG VYKA L NG ++AVK ++D + KSF+ E + + IRHR
Sbjct: 944 ATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHR 1003
Query: 737 NLIKIVSSCSNP--GFKALIMQYMPQGSLEKWLYSHNYS-----LTIRQRLDIMIDVASA 789
+L+K++ CS+ G LI +YM GS+ WL+++ + L RL I + +A
Sbjct: 1004 HLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQG 1063
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG---VDPVTQTMTLATIG 846
+EYLH+ PI+H D+K +NVLLD ++ AHLGDFG+AK+L G + + TM + G
Sbjct: 1064 VEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYG 1123
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PG-- 901
Y+APEY + DVYS GI++ME T + PT MF E + +WV L PG
Sbjct: 1124 YIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSE 1183
Query: 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDA 954
A +++D+ L S E+ + ++ +AL+C+ P+ER + + A
Sbjct: 1184 AREKLIDSELKSLLPCEEEAAYQ--------VLEIALQCTKSYPQERPSSRQA 1228
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1151), Expect = e-124, Method: Compositional matrix adjust.
Identities = 339/1037 (32%), Positives = 510/1037 (49%), Gaps = 121/1037 (11%)
Query: 20 NWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGN 79
NWN S NT + NW +TCS G + + + ++ L +LP ++ L L ISG
Sbjct: 60 NWN-SIDNTPCN--NWTFITCS-SQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGA 115
Query: 80 SFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIV 139
+ TLP L LK++D SSN L G +P + + LE+ ++SN++TG+ P I
Sbjct: 116 NLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSL-SKLRNLETLILNSNQLTGKIPPDIS 174
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN-ITGRIPNR------------ 186
S LKS+ L +N L+GS PT+L +L L +R+ GN I+G+IP+
Sbjct: 175 KCSKLKSLILFDNLLTGSIPTEL-GKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGL 233
Query: 187 -------EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239
+P+ +G L L+ L + I+G IPS + N S +V + LY N LSG +P
Sbjct: 234 AETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPRE 293
Query: 240 I-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
I L LE LFLW+N+L G IP+ I N S +++LS NL SG +P++ G L+ +
Sbjct: 294 IGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMI 353
Query: 299 GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQ 358
DN+ + G I ++++ C L L LD N + G+IP+ +G L T L F+A S+Q
Sbjct: 354 SDNKFS------GSI-PTTISNCSSLVQLQLDKNQISGLIPSELGTL-TKLTLFFAWSNQ 405
Query: 359 LSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL 418
L G IP G + ++L L L N L G IP+ L L+ L L L SN L GFIP ++
Sbjct: 406 LEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNC 465
Query: 419 EKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478
L L N + G+IP+ + +L + LDF SN L+ +P S + +D S NS
Sbjct: 466 SSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNS 525
Query: 479 LSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL 538
L GSLP + +L L L+++ NQ SG IP+S+G L +L+ L L++N F G IP S G
Sbjct: 526 LEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMC 585
Query: 539 ISLQSLDLSGNNISGEIPK----------------------------SLEKLS------- 563
LQ LDL N +SGEIP SL KLS
Sbjct: 586 SGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHN 645
Query: 564 -------------RLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPC 610
LV N+S+N G +P F + + N LC S++ C
Sbjct: 646 MLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQ---DSC 702
Query: 611 -----------KTSSTHKSKATKIVLRYILPAIATTMVVVALFIILIRRRKRNKSLPE-- 657
+++ ++ L ++ M++ A+ +I RR N+ E
Sbjct: 703 FLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELG 762
Query: 658 ENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVK-----VF 712
E ++++ + Q E N++G G VY+A + NG +AVK +
Sbjct: 763 ETYKWQFTPFQKLNFS-VDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMV 821
Query: 713 NLQEDRALK----SFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY 768
N D K SF E + + IRH+N+++ + C N + L+ YMP GSL L+
Sbjct: 822 NGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH 881
Query: 769 SHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827
SL R I++ A L YLHH PI+H D+K NN+L+ D ++ DFG+A
Sbjct: 882 ERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLA 941
Query: 828 KLLDGVDPVTQTMTLA-TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFT 886
KL+D D + T+A + GY+APEYG ++ DVYS+G++++E T ++P +
Sbjct: 942 KLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVP 1001
Query: 887 GEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPE 946
+ L WV ++ EV+D+ L SR E +AD+ ++ AL C P+
Sbjct: 1002 EGIHLVDWVRQNR--GSLEVLDSTLRSRT-EAEADEMMQ-------VLGTALLCVNSSPD 1051
Query: 947 ERINVKDALADLKKIKK 963
ER +KD A LK+IK+
Sbjct: 1052 ERPTMKDVAAMLKEIKQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1142), Expect = e-123, Method: Compositional matrix adjust.
Identities = 315/916 (34%), Positives = 480/916 (52%), Gaps = 74/916 (8%)
Query: 111 GDMCN-SFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
G CN TQ+ D+S + GE +I N++ L + L N G P ++ + +L
Sbjct: 58 GVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETL 117
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN---SNMVAIL 226
QL L N + G IP E+G L+ L LDLG N + G IP +F N S++ I
Sbjct: 118 KQLSLSENLLHGNIPQ-----ELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYID 172
Query: 227 LYGNHLSGHLP--SSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP 284
L N L+G +P +L L L LW N L+G +P S+ N++ ++L SN+ SG +P
Sbjct: 173 LSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELP 232
Query: 285 N-TFGNCRQLQILSLGDNQLTTGSSAQG-QIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI 342
+ QLQ L L N + ++ + F++SLA L+ L L N L G I +S+
Sbjct: 233 SQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSV 292
Query: 343 GNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402
+LS +L + +++ G IP NL NL +L+L +N L+G IP L KL KL+ + L
Sbjct: 293 RHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYL 352
Query: 403 NSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPST 462
++N L G IP +L + +L L + N L G IP NL+ LR L N L+ T+P +
Sbjct: 353 SNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQS 412
Query: 463 FWSLKYILAVDFSLNSLSGS--------------------------LPLNIGNLEALGGL 496
+ +D S N+L+G+ +PL + ++ + +
Sbjct: 413 LGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSV 472
Query: 497 NLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIP 556
+L+ N+LSG IP +G+ L+ L L+RN F +P S G L L+ LD+S N ++G IP
Sbjct: 473 DLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIP 532
Query: 557 KSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCKTSSTH 616
S ++ S L N SFN L G + G F T +SF + LCGS + + CK
Sbjct: 533 PSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKK---- 587
Query: 617 KSKATKIVLRYILPAIATTMVVVALFIILIRRR--------KRNKSLPEENNSLNLATLS 668
K K ++L +L IAT ++ V + ++ R R + + EE + N
Sbjct: 588 KHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYP 647
Query: 669 RISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALK---SFDT 725
RISY +L AT GF S+L+GSG F +VYK L N VAVKV L AL+ SF
Sbjct: 648 RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKV--LDPKTALEFSGSFKR 705
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS---LTIRQRLDI 782
EC++++R RHRNLI+I+++CS PGF AL++ MP GSLE+ LY YS L + Q ++I
Sbjct: 706 ECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNI 765
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT--- 839
DVA + YLHH ++HCDLKP+N+LLDD+M A + DFGI++L+ GV+ T
Sbjct: 766 CSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDS 825
Query: 840 --------MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891
+ ++GY+APEYG S GDVYSFG+L++E + R+PT+ + SL
Sbjct: 826 VSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSL 885
Query: 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATK--KTCISYIMSLALKCSAEIPEERI 949
+++ P ++ +++ LSR + + K + I ++ L L C+ P R
Sbjct: 886 HEFMKSHYPDSLEGIIE-QALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRP 944
Query: 950 NVKDALADLKKIKKIL 965
++ D ++ ++K+ L
Sbjct: 945 DMLDVAHEMGRLKEYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1057), Expect = e-113, Method: Compositional matrix adjust.
Identities = 326/1085 (30%), Positives = 502/1085 (46%), Gaps = 196/1085 (18%)
Query: 26 TNTSASVCNWVGVTCSIRHGRVAALSLPNLS-------------------------LGGT 60
TNTS S +W GV+C+ R G + L+L N L GT
Sbjct: 59 TNTSFSCTSWYGVSCNSR-GSIEELNLTNTGIEGTFQDFPFISLSNLAYVDLSMNLLSGT 117
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+PP GNLS L+ ++S N + L +++ L ++ N L+ +P ++ N +
Sbjct: 118 IPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGN-MESM 176
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
+S NK+TG PS++ N+ +L + L N L+G P +L + S+ L L N +T
Sbjct: 177 TDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELG-NMESMTDLALSQNKLT 235
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
G IP+ +GNL NL +L L N + G+IP I N +M + L N L+G +PSS+
Sbjct: 236 G-----SIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSL 290
Query: 241 -YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299
L NL L L++N L+G IP + N LELS+N +G +P++ GN + L IL L
Sbjct: 291 GNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLY 350
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLST------------ 347
+N LT + L + L L+ N L G IP+S GNL
Sbjct: 351 ENYLT-------GVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLT 403
Query: 348 -----------SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK 396
S+ N ++L+G +P FGN + L L L N L+GAIP +
Sbjct: 404 GVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSH 463
Query: 397 LQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL----------- 445
L L L++N GF P +CK KL + + N L+G IP L + SL
Sbjct: 464 LTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFT 523
Query: 446 -------------RHLDFR------------------------SNSLNSTIPSTFWSLKY 468
+DF +N++ IP+ W++
Sbjct: 524 GDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQ 583
Query: 469 ILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528
++ +D S N+L G LP IGNL L L L GNQLSG +P+ + L NL+ L L+ N F
Sbjct: 584 LVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFS 643
Query: 529 GPIPQSFGSLI-----------------------------------------------SL 541
IPQ+F S + SL
Sbjct: 644 SEIPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSL 703
Query: 542 QSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCG 601
LDLS NN+SG IP + E + L + ++S N LEG +P F TAD+ ++N LC
Sbjct: 704 DKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCS 763
Query: 602 S-SRLQVPPCKTSSTHKSKATKIVLRYILPAIATTMVVVAL----FIILIRRRK----RN 652
+ + ++ PC+ K +V +IL I +V++++ F IR+RK RN
Sbjct: 764 NIPKQRLKPCRELKKPKKNGNLVV--WILVPILGVLVILSICANTFTYCIRKRKLQNGRN 821
Query: 653 KSLPEENNSLNLATLS-RISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKV 711
PE ++++ ++ + Y ++ ++TN F ++L+G+G + VY+A L + + +AVK
Sbjct: 822 TD-PETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKR 879
Query: 712 FNLQEDRAL------KSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
+ D + + F E + + IRHRN++K+ CS+ LI +YM +GSL K
Sbjct: 880 LHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNK 939
Query: 766 WLYSHNYS--LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823
L + + LT +R++++ VA AL Y+HH TPI+H D+ N+LLD+D A + D
Sbjct: 940 LLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISD 999
Query: 824 FGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
FG AKLL D + T GY+APE+ V+ DVYSFG+L++E + P +
Sbjct: 1000 FGTAKLLK-TDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGD- 1057
Query: 884 MFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAE 943
+ SL + E + +L S DE + + + ++ +AL C
Sbjct: 1058 -----------LVSSLSSSPGEAL--SLRSISDERVLEPRGQNREKLLKMVEMALLCLQA 1104
Query: 944 IPEER 948
PE R
Sbjct: 1105 NPESR 1109
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1055), Expect = e-113, Method: Compositional matrix adjust.
Identities = 310/989 (31%), Positives = 501/989 (50%), Gaps = 66/989 (6%)
Query: 6 KARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHV 65
+ ++SLD + + ++WN + AS C W GV+C+ V ++ L + +L G P +
Sbjct: 25 QVKLSLDDPDSYLSSWN----SNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFPSVI 80
Query: 66 GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125
LS L L++ NS TLP + + L+ +D S N L+G LP + + T L D+
Sbjct: 81 CRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPT-LVHLDL 139
Query: 126 SSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN 185
+ N +G+ P++ +L+ + L N L G+ P L ++ L++L + P+
Sbjct: 140 TGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPP----FLGNISTLKMLNLSYNPFSPS 195
Query: 186 REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY-LPN 244
R IP E GNL NL+++ L ++ G IP + S +V + L N L GH+P S+ L N
Sbjct: 196 R-IPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTN 254
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCR-QLQILSLGDNQL 303
+ + L+ N+L+G IP + N +L+ S N +G +P+ CR L+ L+L +N L
Sbjct: 255 VVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDEL--CRVPLESLNLYENNL 312
Query: 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI 363
+G++ +S+A L + + N L G +P +G L++ L ++ SG +
Sbjct: 313 ------EGEL-PASIALSPNLYEIRIFGNRLTGGLPKDLG-LNSPLRWLDVSENEFSGDL 364
Query: 364 PVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNT 423
P L L +++N +G IP L + L + L N+ G +PT L +N
Sbjct: 365 PADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNL 424
Query: 424 LLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSL 483
L NN+ G+I + ++L L +N ++P SL + + S N SGSL
Sbjct: 425 LELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSL 484
Query: 484 PLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQS 543
P ++ +L LG L+L GNQ SG + S I + K L+ L LA N F G IP GSL L
Sbjct: 485 PDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNY 544
Query: 544 LDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFV--NFTADSFKQNYALCG 601
LDLSGN SG+IP SL+ L +L N+S+N L G++P P + + +SF N LCG
Sbjct: 545 LDLSGNMFSGKIPVSLQSL-KLNQLNLSYNRLSGDLP---PSLAKDMYKNSFIGNPGLCG 600
Query: 602 SSRLQVPPCKTSSTHKSKATKIVLRYILPAIATTMVV-VALFIILIRRRKRNKSLPEENN 660
+ C + + K + +LR I A ++ VA F R K+ +++ E +
Sbjct: 601 DIKGL---CGSENEAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAM--ERS 655
Query: 661 SLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVF-------- 712
L + ++ + E + E N++G+G+ VYK L NG +VAVK
Sbjct: 656 KWTLMSFHKLGFSE-HEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKET 714
Query: 713 -NLQEDRALK------SFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
+ ++ K +F+ E E + +IRH+N++K+ CS K L+ +YMP GSL
Sbjct: 715 GDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGD 774
Query: 766 WLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824
L+S L + R I++D A L YLHH PI+H D+K NN+L+D D A + DF
Sbjct: 775 LLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADF 834
Query: 825 GIAKLLD--GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTN 882
G+AK +D G P + ++ + GY+APEY V+ D+YSFG++++E TR++P +
Sbjct: 835 GVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVD 894
Query: 883 EMFTGEMSLKQWVAESL-PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCS 941
GE L +WV +L + V+D L S EE IS I+++ L C+
Sbjct: 895 PEL-GEKDLVKWVCSTLDQKGIEHVIDPKLDSCFKEE-----------ISKILNVGLLCT 942
Query: 942 AEIPEERINVKDALADLKKIKKILTQALH 970
+ +P R +++ + L++I +LH
Sbjct: 943 SPLPINRPSMRRVVKMLQEIGGGDEDSLH 971
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 973 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.979 | 0.876 | 0.504 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.974 | 0.930 | 0.517 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.977 | 0.873 | 0.491 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.902 | 0.827 | 0.54 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.976 | 0.910 | 0.514 | 0.0 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.975 | 0.907 | 0.480 | 0.0 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.945 | 0.945 | 0.527 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.918 | 0.614 | 0.515 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.934 | 0.754 | 0.481 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.916 | 0.725 | 0.503 | 0.0 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2441), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/1057 (50%), Positives = 681/1057 (64%), Gaps = 104/1057 (9%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
+L+ LKA I+LDPH+ A NW+ T S C W+GV+C+ + RV AL L NL L GT
Sbjct: 35 SLLALKAHITLDPHHVLAGNWS-----TKTSFCEWIGVSCNAQQQRVIALDLSNLGLRGT 89
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCN----- 115
+PP +GNLSFLVSL++S N+F+ +P E+ + L ++ N LSG +P N
Sbjct: 90 IPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPPSFGNLNRLQ 149
Query: 116 -------SFT-----------------------------------QLESFDVSSNKITGE 133
SFT ++ D+ SN++ G
Sbjct: 150 SLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGA 209
Query: 134 FPSAIVNISSLKSIRLDNNSLSGSFPTDLCT-RLPSLVQLRLLGNNITGRIPNR------ 186
PSAI NISSL+ I L NSLSG P+ +C L +L +RL N TG IP+
Sbjct: 210 IPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGE 269
Query: 187 -------------------------------------EIPNEIGNLHNLKILDLGGNNIA 209
E+P EIG+L L +L++ N++
Sbjct: 270 LQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLT 329
Query: 210 GLIPSMIFNNSNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLSGIIPDSICNAS 267
G IP IFN S+MV+ L N+LSG+LP + YLPNLENL L N LSGIIP SI NAS
Sbjct: 330 GHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNAS 389
Query: 268 EATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVL 327
+ L+ N+ +G +P+ G+ R L+ L+LG N L S Q F +SL C+ LR+L
Sbjct: 390 KLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRIL 449
Query: 328 VLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAI 387
L NPL G++P SIGNLSTSL+ F A + +L G IP GNLSNL +LSL NN+L G I
Sbjct: 450 YLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTI 509
Query: 388 PTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRH 447
P +G+LQKLQGL L SNKL+G IP D+C+L L L NN L G IP CL LT LRH
Sbjct: 510 PPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRH 569
Query: 448 LDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYI 507
L SN LNSTIPST WSL +IL++D S N L G LP ++GNL+ L ++L+ NQLSG I
Sbjct: 570 LYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEI 629
Query: 508 PSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVD 567
PS+IG L++L L+LA N F+GPI SF +L SL+ +DLS N + GEIPKSLE L L
Sbjct: 630 PSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKY 689
Query: 568 FNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCKTSSTHKSKATKIVLRY 627
+VSFNGL GEIP GPF NF+A+SF N ALCGS RL++PPC+T + + + ++L+Y
Sbjct: 690 LDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISWLLLKY 749
Query: 628 ILPAIATTMVVVALFIILIRRRKRNKSLPEENNSLNLATLSRISYHELQQATNGFGESNL 687
ILPAI +T++ +AL + R RKRN LP ++ SL AT RISY E+ QATNGF NL
Sbjct: 750 ILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNL 809
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG GS +VY+ TL++G + A+KVFNLQE+ A KSFD ECEVM IRHRNLIKIVSSCSN
Sbjct: 810 LGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSN 869
Query: 748 P--GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
FKAL+++Y+P GSLE+WLYSHNY L I QRL+IMIDVA A+EYLHHG STP++HCD
Sbjct: 870 SYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCD 929
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
LKP+N+LLD+D H+GDFGIAKLL + + +T TLATIGYMAP+Y S GIV+ SGDVY
Sbjct: 930 LKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVY 989
Query: 866 SFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFAT 925
S+GI++METFTRR+PT+E+F+ EMS+K WV + L G++TEVVDANLL EDE+ F
Sbjct: 990 SYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQ----FMA 1045
Query: 926 KKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962
KK CIS I+ LA+ C A+ PEERI +KD + LKKIK
Sbjct: 1046 KKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2438), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/988 (51%), Positives = 667/988 (67%), Gaps = 40/988 (4%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+ K I+ DP N ++W+ + S CNW+GV+CS+R RV AL L ++ L GT
Sbjct: 34 ALLAFKDHITFDPQNMLTHSWS-----SKTSFCNWMGVSCSLRRQRVTALDLSSMGLLGT 88
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+PP +GNLSFL L + NSF+ LP+E+ ++RRL+++D SN LS + + + +L
Sbjct: 89 IPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRL 148
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
E N +TG PS I NISSLK + L N L GS P ++C LP L L L N ++
Sbjct: 149 EELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEMLLLSSNQLS 208
Query: 181 GRIPN-----RE--------------IPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSN 221
G+IP+ RE IP E+G L L++L+LG N ++G +P IFN ++
Sbjct: 209 GQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLSGDLPRSIFNMTS 268
Query: 222 MVAILLYGNHLSGHLPS--SIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLF 279
+ + + N+LSG +P SI LPNLE L L N ++G +P + N S IL+LS N
Sbjct: 269 LRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKM 328
Query: 280 SGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIP 339
+G V FGN R LQ+LSL N T S+Q F +SL R L+ L + NPL G++P
Sbjct: 329 TGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLP 388
Query: 340 NSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQG 399
NS+GNLS+ L FY +S+L G IP GNLSNL+VLSL N L G IPT +G L+K+Q
Sbjct: 389 NSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQV 448
Query: 400 LDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTI 459
L L+ N L G IP+D+C +L + NNN L G+IP+C+ NLTSLR+L N L+STI
Sbjct: 449 LYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTI 508
Query: 460 PSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDW 519
P WSLK +L ++ N L GSLP +G +EA G+ L+ NQLSG IPS+IG+L+NL
Sbjct: 509 PMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIR 568
Query: 520 LALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579
+L++N+FQG IP++FG L+SL+ LDLS NN+SGEIPKSLE L L F+VSFNGL+GEI
Sbjct: 569 FSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEI 628
Query: 580 PSGGPFVNFTADSFKQNYALCGSSRLQVPPCKTSSTHKSKATKIVLRYILPAIATTMVVV 639
P GGPF NFTA SF N LCG SRLQVPPC S SK +LR+ LP +A+ ++VV
Sbjct: 629 PRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVV 688
Query: 640 ALFIILI---RRRKRNKSLPEENNSLNLATLSR-ISYHELQQATNGFGESNLLGSGSFDN 695
A FI L+ RRR R +PE +L + + R ISY EL ATN F ESNLLG GSF +
Sbjct: 689 A-FIFLVMGCRRRYRKDPIPE---ALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGS 744
Query: 696 VYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755
VY+ L +G++VAVK+FNLQ RA +SFDTECE+MR IRHRNL+KI+ SCSN FKAL++
Sbjct: 745 VYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVL 804
Query: 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815
+YMP+GSLEKWLYSHNY L I QR++IMIDVASALEYLHHGY +P++HCDLKP+NVLLD+
Sbjct: 805 EYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDE 864
Query: 816 DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETF 875
DMVAH+ DFGIAKLL + QT TLATIGYMAPEYG +G+VS DVYSFGI++ME
Sbjct: 865 DMVAHVCDFGIAKLLGENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEML 924
Query: 876 TRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKT-CISYIM 934
TR++PT+EMF GEMSLK+ V ESLP +V ++VD+N+L+R D ++ KK C++ IM
Sbjct: 925 TRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNR-----GDGYSVKKEHCVTSIM 979
Query: 935 SLALKCSAEIPEERINVKDALADLKKIK 962
LAL+C E P ER+ + + LA LK IK
Sbjct: 980 ELALQCVNESPGERMAMVEILARLKNIK 1007
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2422), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/1056 (49%), Positives = 673/1056 (63%), Gaps = 105/1056 (9%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+ LK + DP F + NW+ ++ S C+W GVTCS RH RV AL+L N+ + G
Sbjct: 34 ALLVLKEHSNFDP--FMSKNWS-----SATSFCHWYGVTCSERHNRVVALTLSNMGIKGI 86
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMC------ 114
+PPH+GNLSFLV +++S NS+ LPNEL ++ RLK ++FS+NS G +P +
Sbjct: 87 VPPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQ 146
Query: 115 ------NSFT-----------------------------------QLESFDVSSNKITGE 133
NS T L+ ++ N+++G
Sbjct: 147 HLLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGS 206
Query: 134 FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR------- 186
FP I+++ SLK I L N+LSG+ LC + L L L GN + G+IP+
Sbjct: 207 FPPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKEL 266
Query: 187 ------------------------------------EIPNEIGNLHNLKILDLGGNNIAG 210
IP EIGNL NL+I+ L NN+ G
Sbjct: 267 RSLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNG 326
Query: 211 LIPSMIFNNSNMVAILLYGNHLSGHLPSS--IYLPNLENLFLWKNNLSGIIPDSICNASE 268
IP +FN S M I + N+L G+LP+S ++LPNL L+L N LSG IP I NAS+
Sbjct: 327 SIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASK 386
Query: 269 ATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLV 328
TILEL SN F+G +P++ G+ R LQ L LG N L++ ++Q +SSL C+ L+ L
Sbjct: 387 LTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLW 446
Query: 329 LDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIP 388
L NPL G +P+S+GNLS SLE+F A + G + GNLS+L L+L NN+L G IP
Sbjct: 447 LSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIP 506
Query: 389 TVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHL 448
T +G L+ LQGL L+ N L G IP++LC L L L N L G IPTC +NLTSLR+L
Sbjct: 507 TTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNL 566
Query: 449 DFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP 508
SN STI ST W+LK IL V+ + N L+GSLP I NL A+ +N++ NQLSG IP
Sbjct: 567 FLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIP 626
Query: 509 SSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDF 568
SIG L++L L L+ N QGPIPQS G + SL+ LDLS NN+SG IPKSL+ L L F
Sbjct: 627 ISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYF 686
Query: 569 NVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCK--TSSTHKSKATKIVLR 626
NVSFN L+GEIP GG F NF+A SF N ALCGS+RLQV PCK S ++ +KIVLR
Sbjct: 687 NVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLR 746
Query: 627 YILPAIATTMVVVALFIILIRRRKRNKSLPEENNSLNLATLSRISYHELQQATNGFGESN 686
Y+LPAI + V+A I+L R +R E++ L L T+ RISYHELQ ATNGF ESN
Sbjct: 747 YVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESN 806
Query: 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG GSF +VYK TL++G +A KVFNLQ +RA KSFDTECEV+R +RHRNL+KI++SCS
Sbjct: 807 FLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCS 866
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
P FKAL++++MP SLEKWLYS +Y L QRL+IM+DVAS LEYLHHGY+ P+ HCD+
Sbjct: 867 GPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDI 926
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
KP+NVLL++DMVA L DFGI+KLL V QTMTLATIGYMAPEYGSEGIVS+ GDVYS
Sbjct: 927 KPSNVLLNEDMVAFLADFGISKLLGEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYS 986
Query: 867 FGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATK 926
+G+L+METFT++KPT++MFT ++SLK WV +SL VT+V+DANLL E+ D A K
Sbjct: 987 YGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEE----DHLAAK 1042
Query: 927 KTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962
K CI I+ LAL+CSA++P +RI++K + L+KIK
Sbjct: 1043 KDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIK 1078
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 920 bits (2377), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/900 (54%), Positives = 640/900 (71%), Gaps = 22/900 (2%)
Query: 69 SFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSN 128
S L LN+ N + +P+ L L+++D SN +GS+P ++C + T+L+ + N
Sbjct: 163 STLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEIC-TLTKLKELYLGKN 221
Query: 129 KITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDL--CTRLPSLVQLRLLGNNITGRIPNR 186
+TG+ P I + SL+ + L+ N L+G+ P ++ CT L +++ + NN+TG IPN
Sbjct: 222 NLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYL---MEIHVENNNLTGVIPN- 277
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS--IYLPN 244
E+GNLH L+ LDLG NNI G IPS FN S + + + N+LSGHLPS+ + LPN
Sbjct: 278 ----EMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPN 333
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
LE L+L KN LSG IPDSI NAS+ +L+LS N FSG +P+ GN R LQ L+L +N LT
Sbjct: 334 LEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILT 393
Query: 305 TGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIP 364
+ S F SSL+ CR L L + NPL+G +P SIGNLS SLE YA ++ G IP
Sbjct: 394 SKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIP 453
Query: 365 VGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL 424
G GNLSNL+ L L NEL GAIP+ +G+L+ LQ L SNKL+G IP ++C LE+L+ L
Sbjct: 454 RGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYL 513
Query: 425 LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP 484
N G +P CL+N+TSLR L SN S IP+TFWSLK +L ++ S NSL+G+LP
Sbjct: 514 YLLENGFSGSLPACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLP 572
Query: 485 LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSL 544
L IGNL+ + ++ + NQLSG IP+SI +L+NL +L+ N QGPIP SFG L+SL+ L
Sbjct: 573 LEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFL 632
Query: 545 DLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSR 604
DLS N++SG IPKSLEKL L FNVSFN L+GEI GGPF NF+ SF N ALCG R
Sbjct: 633 DLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIR 692
Query: 605 LQVPPCKTSSTHKS--KATKIVLRYILPAIATTMVVVALFIILIRRRKRNKSLPEENNSL 662
+QVPPCK+ STH+ + + V+RYI+PAIA ++V+AL +I+ RR + K L + + L
Sbjct: 693 MQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRK-LSTQEDPL 751
Query: 663 NLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKS 722
AT +ISYHEL +AT GF E+NLLG+GS +VYK TL++G+ +AVKVF+LQ + L
Sbjct: 752 PPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMR 811
Query: 723 FDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI 782
FD+ECEV+R +RHRNL+KI+SSC N FKALI++++P GSLEKWLYSHNY L I QRL+I
Sbjct: 812 FDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNI 871
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL 842
MIDVASALEYLHHG + P++HCDLKP+NVL+++DMVAH+ DFGI++LL D VTQT+TL
Sbjct: 872 MIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEGDAVTQTLTL 931
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902
ATIGYMAPEYG EGIVS+ GDVYS+GI +METFTR+KPT++MF GEMSLK WV +SLP A
Sbjct: 932 ATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKA 991
Query: 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962
+TEV+DANLL E+ F KK CI+ I++LAL+CSA++P ERI ++D L L+KIK
Sbjct: 992 ITEVIDANLLIEEEH-----FVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIK 1046
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2344), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/1011 (51%), Positives = 666/1011 (65%), Gaps = 61/1011 (6%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+ LK RI DP+N A NW+++ SVC WVGVTC RHGRV AL L ++ L GT
Sbjct: 37 ALLALKVRIIRDPNNLLAANWSIT-----TSVCTWVGVTCGARHGRVTALDLSDMGLTGT 91
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+PPH+GNLSFL ++ N F+ +LP+EL +RR+K S+N SG +P SFTQL
Sbjct: 92 IPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIP-SWIGSFTQL 150
Query: 121 ESFDVSSNKITGEFPSAIVN--ISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
+ +SSNK TG P+ + N ISSL + N+L+G P ++ T L +L L L N
Sbjct: 151 QRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRALYLNSNL 210
Query: 179 ITGRIPNR-------------------EIPNEIGNLHNLKILDLGGNN------------ 207
G IP+ I +IGNL L+ L LGGNN
Sbjct: 211 FNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTIPDEIGDL 270
Query: 208 ------------IAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNL 255
++GL+PS I+N S M AI L N LSG+LPSS LPNLE + NN
Sbjct: 271 AHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYLPSSSNLPNLEFFIIEDNNF 330
Query: 256 SGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFY 315
+G IP S+ NAS+ ++L N F G +P+ GN + L++ S N LT SS+ G +
Sbjct: 331 TGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVKSSSSGLSLF 390
Query: 316 SSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLV 375
SSL KC++LR L NPL G +P S+GNLS+SLE ++G IP GNLS+L
Sbjct: 391 SSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIPKEIGNLSSLSW 450
Query: 376 LSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQI 435
L L N+L G IPT + KL KLQ L L+ N+L+G P +LC L+ L L NAL GQI
Sbjct: 451 LDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQI 510
Query: 436 PTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGG 495
P+CL N+ SLR L N +STIPST W L IL ++ S NSLSGSL ++IGNL+A+
Sbjct: 511 PSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDIGNLKAVTL 570
Query: 496 LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI 555
++L+GNQLSG+IPSSIG LK L L+LA N +G IPQ FG ISLQ LDLS NN+SGEI
Sbjct: 571 IDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEI 630
Query: 556 PKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCKTSST 615
PKSLE+L L FNVSFN L+GEIP+G F+N +A SF N LCG+++LQV PC+TS+
Sbjct: 631 PKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTH 690
Query: 616 HKSK-ATKIVLRYILPAIA-TTMVVVALFIILIRRRKRNKSLPEENNSLNLATLSRISYH 673
SK A+K+ LRY L A T + V A+ II IR RKRN + E L LATL RISY
Sbjct: 691 QGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMRITE--GLLPLATLKRISYR 748
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI 733
EL+QAT+ F E NLLG GSF +VYK T ++G SVAVKVFNLQ + A KSFD ECEV+R I
Sbjct: 749 ELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMI 808
Query: 734 RHRNLIKIVSSCS--NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
RHRNL+KI++SCS N FKAL++++MP SLEKWL S + L + +RL+IM+DVASA+E
Sbjct: 809 RHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVE 868
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
YLHHGY+ PI+HCDLKP+N+LLD++MVAH+ DFGIAKLL QT+TLAT+GYMAPE
Sbjct: 869 YLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGDEHSFIQTITLATVGYMAPE 928
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911
YGSEG+VS GD+YSFGIL+METFTR+KPT++MF E+S+KQWV ES+PG VT++ D +L
Sbjct: 929 YGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDL 988
Query: 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962
L E++ F+ KK CI +M +AL+CSA++PEER N++D L L K
Sbjct: 989 LRIEEQH----FSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNHTK 1035
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 906 bits (2341), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/1039 (48%), Positives = 665/1039 (64%), Gaps = 90/1039 (8%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+ LKA I+ D A NW+ T +S CNW G++C+ RV+A++L N+ L GT
Sbjct: 12 ALIALKAHITYDSQGILATNWS-----TKSSYCNWYGISCNAPQQRVSAINLSNMGLEGT 66
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDM------- 113
+ P VGNLSFLVSL+++ N F ++PN + ++ L+ + +NSL+G +P ++
Sbjct: 67 IAPQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELR 126
Query: 114 -----CNSFT-----------------------------------QLESFDVSSNKITGE 133
N FT L + SN I+G
Sbjct: 127 GLSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIPREIGNLSNLNILQLGSNGISGP 186
Query: 134 FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN-----RE- 187
P+ I +SSL+ I NNSLSGS P D+C LP+L L L N+++G++P RE
Sbjct: 187 IPAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCREL 246
Query: 188 -------------IPNEIGNLHNLKILDLGGNNIAGLIPS----------MIFNNSNMVA 224
IP EIGNL L+ +DL N++ G IP+ + FN S +
Sbjct: 247 LSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLSFNISKLQT 306
Query: 225 ILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGL 282
+ L NHLSG LPSSI +LP+LE L++ N SG IP SI N S+ T+L LS N F+G
Sbjct: 307 LGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSLSDNSFTGN 366
Query: 283 VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI 342
VP N +LQ L L NQLT A G F +SL C++LR L + NPL G +PNS+
Sbjct: 367 VPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPLTGTLPNSL 426
Query: 343 GNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402
GNL +LE F A + Q G IP G GNL+NL+ L L N+L G+IPT LG+LQKLQ L +
Sbjct: 427 GNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQALSI 486
Query: 403 NSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPST 462
N+++G IP DLC L+ L L + N L G IP+C +L +LR L SN L IP +
Sbjct: 487 VGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMS 546
Query: 463 FWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522
FWSL+ +L ++ S N L+G+LP +GN++++ L+L+ N +SGYIPS +G L+NL L+L
Sbjct: 547 FWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQNLITLSL 606
Query: 523 ARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
++N QGPIP FG L+SL+SLDLS NN+SG IPK+LE L L NVSFN L+GEIP+G
Sbjct: 607 SQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPNG 666
Query: 583 GPFVNFTADSFKQNYALCGSSRLQVPPC-KTSSTHKSKATKIVLRYILPAIATTMVVVAL 641
GPFV FTA+SF N ALCG+ QV C K + T K +L+YIL + +T+ +V +
Sbjct: 667 GPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLV-V 725
Query: 642 FIILIRRRKRNKSLPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATL 701
FI+L RR+ N +P +S T +IS+ +L ATN FGE NL+G GS VYK L
Sbjct: 726 FIVLWIRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVL 785
Query: 702 ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761
+NG++VA+KVFNL+ AL+SF++ECEVM+ IRHRNL++I++ CSN FKAL+++YMP G
Sbjct: 786 SNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNG 845
Query: 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHL 821
SLEK LYSH Y L + QRL+IMIDVASALEYLHH S+ ++HCDLKP+NVLLDDDMVAH+
Sbjct: 846 SLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHV 905
Query: 822 GDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPT 881
DFGIAKLL + + QT TL+TIGYMAPE+GS GIVS DVYS+GIL+ME F R+KP
Sbjct: 906 ADFGIAKLLTETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPM 965
Query: 882 NEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCS 941
+EMFTG+++LK WV ESL +V +VVD NLL REDE D ATK +C+S IM+LAL C+
Sbjct: 966 DEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDE----DLATKLSCLSSIMALALACT 1020
Query: 942 AEIPEERINVKDALADLKK 960
+ PEERI++KDA+ +LKK
Sbjct: 1021 TDSPEERIDMKDAVVELKK 1039
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/970 (52%), Positives = 650/970 (67%), Gaps = 50/970 (5%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+ LK RI DP++ NW+ T+ SVC W+GVTC RH RV AL+L ++ L GT
Sbjct: 38 ALLALKVRIVGDPNSLLTTNWS-----TATSVCTWIGVTCGARHNRVTALNLSHMGLAGT 92
Query: 61 LPPHVGNLSFLV--SLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
+PPH+GNLSFLV LN+ + +P L+++ +L I SSN+L G +P + N ++
Sbjct: 93 IPPHLGNLSFLVFGCLNMFAVLYIGVIPTSLFNLSKLSIFYLSSNNLQGYIPEAIGNLYS 152
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
L + N+ + PS+I NISSL+ I NN SG
Sbjct: 153 -LRLLSLEKNEFSDSIPSSIFNISSLEQIDFSNNRFSGI--------------------- 190
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPS 238
IP+EIGNL NL++++LG N +AG++PS I+N S M+ I L N LSGHLPS
Sbjct: 191 ---------IPDEIGNLANLELINLGVNRLAGVVPSGIYNASKMMVISLSSNQLSGHLPS 241
Query: 239 SIYLP--NLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQIL 296
S+ L NL LFL NN +G IP S+ NASE T++ L SN F G +P+ GN R LQ L
Sbjct: 242 SLGLLLPNLRRLFLGGNNFTGPIPISLSNASELTLIALPSNSFFGHIPDELGNLRSLQYL 301
Query: 297 SLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGS 356
L N LT S + G ++SL KC+ LR+L L NPL G +P S+GNLS+SLE A
Sbjct: 302 YLWGNHLTIKSLSSGLSLFNSLTKCKDLRILYLHDNPLNGTLPISVGNLSSSLEVLSAYR 361
Query: 357 SQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC 416
++G IP+ GNLSNL +LSL N+L G IP +GKL+KLQ L L+ NKL+G P +LC
Sbjct: 362 CGITGTIPIEIGNLSNLTLLSLYENDLRGTIPATIGKLRKLQALLLDHNKLEGVFPPELC 421
Query: 417 KLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSL 476
L+ L L N L G IP+CL N+ SLR+L + N NSTIPST W L+ IL V+ S
Sbjct: 422 DLQSLAILSLGVNTLSGSIPSCLGNVDSLRNLSMQMNKFNSTIPSTLWRLENILIVNLSF 481
Query: 477 NSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFG 536
NSLSG+L ++IGNL+ ++L+GNQLSG IP +G+LK+L L+LA N F+G IPQSFG
Sbjct: 482 NSLSGALAVDIGNLKVATIIDLSGNQLSGQIPPGLGSLKDLSSLSLADNRFEGSIPQSFG 541
Query: 537 SLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQN 596
ISLQ LDLS N +SGEIPK LE L L FNVSFN L+GEIP+GG F N +A SF N
Sbjct: 542 DAISLQFLDLSNNTLSGEIPKYLEILRYLTYFNVSFNELQGEIPNGGAFTNLSAQSFMGN 601
Query: 597 YALCGSSRLQVPPCKTSSTHKSKA-TKIVLRYILPAIA-TTMVVVALFIILIRRRKRNKS 654
CG+++ QV PCKT + SKA +K+ LRY L A T + V A+ II IR RKRN+
Sbjct: 602 KGFCGAAKFQVQPCKTRTDQGSKAGSKLALRYGLMATGLTILAVAAVVIIFIRSRKRNRR 661
Query: 655 LPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNL 714
E L LATL RISY EL+QAT+ F E NLLG GSF +VYK ++G SVAVKVFNL
Sbjct: 662 TTE--GLLPLATLERISYRELEQATDKFNEINLLGKGSFGSVYKGIFSDGRSVAVKVFNL 719
Query: 715 QEDRALKSFDTECEVMRRIRHRNLIKIVSSCS--NPGFKALIMQYMPQGSLEKWLYSHNY 772
Q + A KSFD E EV+R IRHRNL+KI++SCS N FKAL++++MP SLEKWLYS N+
Sbjct: 720 QAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVLEFMPNHSLEKWLYSPNH 779
Query: 773 SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832
L QRL+IM+DVASA+EYLHHGY+TPI+HCDLKPNN+LLD++M AH+ DFGIAKLL
Sbjct: 780 FLEFLQRLNIMLDVASAVEYLHHGYTTPIVHCDLKPNNILLDENMAAHVTDFGIAKLLGD 839
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+T+TLAT+GYMAPEYGSEG+VS GDVYSFGILM+ETFT RKPT++MF EM++K
Sbjct: 840 ERSFIRTITLATVGYMAPEYGSEGVVSTGGDVYSFGILMIETFTSRKPTDDMFNEEMNMK 899
Query: 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK 952
QWV ESL G VT++ D NLL EDE + KK CI +M LAL+CSA++PEER N++
Sbjct: 900 QWVQESLAGGVTQIADPNLLRIEDEH----LSAKKDCIISMMQLALQCSADLPEERPNIR 955
Query: 953 DALADLKKIK 962
D L+ L IK
Sbjct: 956 DVLSTLNHIK 965
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2301), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/909 (51%), Positives = 629/909 (69%), Gaps = 15/909 (1%)
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
L G +P +GNLS L L+ + +P E++++ L+I D + NSL GSLP D+
Sbjct: 553 LVGGIPREIGNLSNLNILDFGSSGISGPIPPEIFNISSLQIFDLTDNSLLGSLPMDIYKH 612
Query: 117 FTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
L+ +S NK++G+ PS + L+S+ L N +G+ P L +L L L
Sbjct: 613 LPNLQELYLSWNKLSGQLPSTLSLCGQLQSLSLWGNRFTGNIPPSF-GNLTALQDLELGD 671
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL 236
NNI G IPN E+GNL NL+ L L NN+ G+IP IFN S + ++ L NH SG L
Sbjct: 672 NNIQGNIPN-----ELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSL 726
Query: 237 PSSI--YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294
PSS+ LP+LE L + +N SGIIP SI N SE T L++ N F+G VP GN R+L+
Sbjct: 727 PSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLE 786
Query: 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYA 354
L+LG NQLT SA F +SL C +LR L ++ NPLKG++PNS+GNLS SLE+F A
Sbjct: 787 FLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDA 846
Query: 355 GSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTD 414
+ Q G IP G GNL++L+ L L +N+L G IPT LG+L+KLQ L + N+L+G IP D
Sbjct: 847 SACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPND 906
Query: 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDF 474
LC+L+ L L ++N L G IP+CL L LR L SN+L S IP + W+L+ +L ++
Sbjct: 907 LCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNL 966
Query: 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQS 534
S N L+G LP +GN++++ L+L+ NQ+SG+IP ++G L+NL+ L+L++N QGPIP
Sbjct: 967 SSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLE 1026
Query: 535 FGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFK 594
FG L+SL+ LDLS NN+SG IPKSL+ L+ L NVSFN L+GEIP GGPF+NFTA+SF
Sbjct: 1027 FGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFI 1086
Query: 595 QNYALCGSSRLQVPPCKTSSTHKSKATKI-VLRYILPAIATTMVVVALFIILIRRRKRNK 653
N ALCG+ QV C S+ +S TK+ +L+YILP + + + +V ++ IRRRK N
Sbjct: 1087 FNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRK-NL 1145
Query: 654 SLPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFN 713
+P +S + +IS+ +L ATN FGE NL+G GS VYK L+NG++VAVKVFN
Sbjct: 1146 EVPTPIDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFN 1205
Query: 714 LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS 773
L+ A +SFD+ECEVM+ IRHRNL+KI++ CSN FKAL+++YMP+GSL+KWLYSHNY
Sbjct: 1206 LEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYF 1265
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
L + QRL+IMIDVASALEYLHH + ++HCDLKPNN+LLDDDMVAH+GDFGIA+LL
Sbjct: 1266 LDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLTET 1325
Query: 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + QT TL TIGYMAPEYGS+GIVS GDV+S+GI++ME F R+KP +EMF G+++LK
Sbjct: 1326 ESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKS 1385
Query: 894 WVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKD 953
WV ESL ++ EVVDANLL REDE DFATK +C+S IM+LAL C+ + PEERI++KD
Sbjct: 1386 WV-ESLADSMIEVVDANLLRREDE----DFATKLSCLSSIMALALACTTDSPEERIDMKD 1440
Query: 954 ALADLKKIK 962
+ LKKIK
Sbjct: 1441 VVVGLKKIK 1449
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2236), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/984 (48%), Positives = 631/984 (64%), Gaps = 75/984 (7%)
Query: 46 RVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSL 105
++ +SL G++P +GNL L L++ NS +P+ L H R L+++ S N
Sbjct: 221 KLQVISLAYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRVLSSSFNQF 280
Query: 106 SGSLP---GDMCN--------------------SFTQLESFDVSSNKITGEFPSAIVNIS 142
+G +P G +CN + + L + SN I+G P+ I NIS
Sbjct: 281 TGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNIS 340
Query: 143 SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN----------------- 185
SL+ I NNSLSGS P +C LP+L L L N+++G++P
Sbjct: 341 SLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFLSLSFNK 400
Query: 186 ------REI--------------------PNEIGNLHNLKILDLGGNNIAGLIPSMIFNN 219
REI P GNL LK L+LG N + G +P IFN
Sbjct: 401 FRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVPEAIFNI 460
Query: 220 SNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSN 277
S + + L NHLSG LPSSI +LP+LE L++ N SG IP SI N S+ T+L LS N
Sbjct: 461 SELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDN 520
Query: 278 LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGV 337
F+G VP N +L+ L+L NQLT A G F +SL C++LR L + NPLKG
Sbjct: 521 SFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKGT 580
Query: 338 IPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKL 397
+PNS+GNL +LE+F A + Q G IP G GNL+NL+ L L N+L G+IPT LG+LQKL
Sbjct: 581 LPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKL 640
Query: 398 QGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS 457
Q L + N+++G IP DLC L+ L L ++N L G P+C +L +LR L SN+L
Sbjct: 641 QRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAF 700
Query: 458 TIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNL 517
IP++ WSL+ +L ++ S N L+G+LP +GN++++ L+L+ N +SGYIPS +G L+ L
Sbjct: 701 NIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYL 760
Query: 518 DWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577
L+L++N QGPI FG L+SL+SLDLS NN+SG IPKSLE L L NVSFN L+G
Sbjct: 761 ITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQG 820
Query: 578 EIPSGGPFVNFTADSFKQNYALCGSSRLQVPPC-KTSSTHKSKATKIVLRYILPAIATTM 636
EIP+GGPFV FTA+SF N ALCG+ QV C K + T K +L+YIL + +T+
Sbjct: 821 EIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTV 880
Query: 637 VVVALFIILIRRRKRNKSLPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNV 696
+V +FI+L RR+ N +P +S L T +IS+ +L ATN FGE NL+G GS V
Sbjct: 881 TLV-VFIVLWIRRRDNMEIPTPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGMV 939
Query: 697 YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756
YK L+NG++VA+KVFNL+ AL+SFD+ECEVM+ IRHRNL++I++ CSN FKAL+++
Sbjct: 940 YKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLE 999
Query: 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816
YMP GSLEKWLYSHNY L + QRL+IMIDVASALEYLHH S+ ++HCDLKP+NVLLDDD
Sbjct: 1000 YMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDD 1059
Query: 817 MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
MVAH+ DFGIAKLL + + QT TL TIGYMAPE+GS GIVS DVYS+GIL+ME F
Sbjct: 1060 MVAHVADFGIAKLLTETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFA 1119
Query: 877 RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSL 936
R+KP +EMFTG+++LK WV ESL +V +VVD NLL REDE D ATK +C+S IM+L
Sbjct: 1120 RKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDE----DLATKLSCLSSIMAL 1174
Query: 937 ALKCSAEIPEERINVKDALADLKK 960
AL C+ + P+ERI++KDA+ +LKK
Sbjct: 1175 ALACTTDSPKERIDMKDAVVELKK 1198
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2236), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/907 (50%), Positives = 616/907 (67%), Gaps = 15/907 (1%)
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
L G +P +GNLS L L +S N +P E++++ L++I F+ NSLSGSLP D+C
Sbjct: 328 LTGGIPREIGNLSNLNILQLSSNGISGPIPAEIFNVSSLQVIAFTDNSLSGSLPKDICKH 387
Query: 117 FTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
L+ +S N ++G+ P+ + L + L N GS P ++ L L ++ L
Sbjct: 388 LPNLQGLSLSQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEI-GNLSKLEKIYLGT 446
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL 236
N++ G IP GNL LK L+LG NN+ G +P IFN S + ++ + NHLSG L
Sbjct: 447 NSLIG-----SIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSL 501
Query: 237 PSSI--YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294
PSSI +L +LE LF+ N SGIIP SI N S+ T+L LS+N F+G VP GN +L+
Sbjct: 502 PSSIGTWLSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLK 561
Query: 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYA 354
+L L NQLT A F +SL C++L+ L + NP KG +PNS+GNL +LE+F A
Sbjct: 562 VLDLAGNQLTDEHVASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIA 621
Query: 355 GSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTD 414
+ Q G IP GNL+NL+ L L N+L G+IPT LG+L+KLQ L + N+L+G IP D
Sbjct: 622 SACQFRGTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPND 681
Query: 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDF 474
LC L+ L L ++N L G IP+C +L +L+ L SN L IP++ WSL+ +L ++
Sbjct: 682 LCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNL 741
Query: 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQS 534
S N L+G+LP +GN++++ L+L+ N +SG+IP +G +NL L+L++N QGPIP
Sbjct: 742 SSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIE 801
Query: 535 FGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFK 594
FG L+SL+SLDLS NN+SG IPKSLE L L NVS N L+GEIP+GGPF+NFTA+SF
Sbjct: 802 FGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFM 861
Query: 595 QNYALCGSSRLQVPPC-KTSSTHKSKATKIVLRYILPAIATTMVVVALFIILIRRRKRNK 653
N ALCG+ QV C K + T K +L+YIL + + +V + +FI+L RR+ N
Sbjct: 862 FNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGS-IVTLVVFIVLWIRRRDNM 920
Query: 654 SLPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFN 713
+P +S T +IS+ +L ATN FGE NL+G GS VYK L+NG++VA+KVFN
Sbjct: 921 EIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFN 980
Query: 714 LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS 773
L+ AL+SFD+ECEVM+ IRHRNL++I++ CSN FKAL+++YMP GSLEKWLYSHNY
Sbjct: 981 LEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYF 1040
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
L + QRL+IMIDVASALEYLHH S+ ++HCDLKPNNVLLDDDMVAH+ DFGI KLL
Sbjct: 1041 LDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKT 1100
Query: 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + QT TL TIGYMAPE+GS+GIVS DVYS+GIL+ME F+R+KP +EMFTG+++LK
Sbjct: 1101 ESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKT 1160
Query: 894 WVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKD 953
WV ESL +V +VVDANLL REDE D ATK +C+S IM+LAL C+ + PEER+N+KD
Sbjct: 1161 WV-ESLSNSVIQVVDANLLRREDE----DLATKLSCLSSIMALALACTTDSPEERLNMKD 1215
Query: 954 ALADLKK 960
A+ +LKK
Sbjct: 1216 AVVELKK 1222
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 973 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.771 | 0.732 | 0.337 | 3.3e-145 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.918 | 0.872 | 0.365 | 1.6e-143 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.895 | 0.742 | 0.334 | 1.1e-119 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.769 | 0.741 | 0.361 | 3.5e-114 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.931 | 0.896 | 0.319 | 7.6e-112 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.772 | 0.729 | 0.342 | 2e-111 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.729 | 0.567 | 0.306 | 3.9e-74 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.924 | 0.891 | 0.324 | 6.1e-110 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.668 | 0.520 | 0.317 | 2.4e-107 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.886 | 0.770 | 0.305 | 1.4e-103 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 3.3e-145, Sum P(2) = 3.3e-145
Identities = 265/786 (33%), Positives = 409/786 (52%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL++ K+++S + +WN S +C+W GV C ++H RV + L L L G
Sbjct: 43 ALLEFKSQVS-ETSRVVLGSWN-----DSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGV 96
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+ P VGNLSFL SLN++ N F+ +P+E+ ++ RL+ ++ S+N G +P + N + L
Sbjct: 97 VSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNC-SSL 155
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
+ D+SSN + P ++S L + L N+L+G FP L L SL L + N I
Sbjct: 156 STLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASL-GNLTSLQMLDFIYNQIE 214
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL-PS- 238
G EIP +I L + + N G+ P I+N S+++ + + GN SG L P
Sbjct: 215 G-----EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDF 269
Query: 239 SIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
LPNL+ L++ N+ +G IP+++ N S L++ SN +G +P +FG + L +L L
Sbjct: 270 GSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGL 329
Query: 299 GDNQLTTGSSAQGQI-FYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSS 357
+N L G+ + G + F +L C L+ L + N L G +P I NLST L G +
Sbjct: 330 NNNSL--GNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGN 387
Query: 358 QLSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCK 417
+SG IP G G L G +P L SN L G IP+ L
Sbjct: 388 LISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGN 447
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXX 477
+ L L NN+ +G IP+ L + + L L+ +N LN +IP L ++ ++
Sbjct: 448 ISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFN 507
Query: 478 XXXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGS 537
+ L L+++ N+LSG IP ++ N +L++L L N+F GPIP G
Sbjct: 508 LLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG- 566
Query: 538 LISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNY 597
L L+ LDLS NN+SG IP+ + S+L + N+S N +G +P+ G F N +A S N
Sbjct: 567 LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNI 626
Query: 598 ALCGS-SRLQVPPCXXXXXXXXXXXXIVLRYILPAIATTMVVVALFIILIRRRK-RNKSL 655
LCG LQ+ PC ++ + A+ ++++ L ++ + K R KS+
Sbjct: 627 NLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSV 686
Query: 656 PEENNSLNLATLS-------RISYHELQQATNGFGESNLLGSGSFDNVYKATLAN-GVSV 707
NN N + S +ISY EL + T GF SNL+GSG+F V+K L + +V
Sbjct: 687 RANNNE-NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAV 745
Query: 708 AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF-----KALIMQYMPQGS 762
A+KV NL + A KSF ECE + IRHRNL+K+V+ CS+ F +AL+ ++MP G+
Sbjct: 746 AIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGN 805
Query: 763 LEKWLY 768
L+ WL+
Sbjct: 806 LDMWLH 811
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1403 (498.9 bits), Expect = 1.6e-143, P = 1.6e-143
Identities = 343/938 (36%), Positives = 507/938 (54%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIR---HG-RVAALSLPNLS 56
AL+ K+ + A+ WN T+ C WVGV C R H RV L L + +
Sbjct: 35 ALLSFKSSLLYQGGQSLAS-WN---TSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSN 90
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
L G + P +GNLSFL L++ N +P EL + RL++++ S NS+ GS+P + +
Sbjct: 91 LSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAI-GA 149
Query: 117 FTQLESFDVSSNKITGEFPSAI-VNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL 175
T+L S D+S N++ G P I ++ L ++ L N LSG P+ L L SL + L
Sbjct: 150 CTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSAL-GNLTSLQEFDLS 208
Query: 176 GNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGH 235
N ++G IP+ +G L +L ++LG NN++G+IP+ I+N S++ A + N L G
Sbjct: 209 FNRLSGAIPS-----SLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGM 263
Query: 236 LPSSIY--LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQL 293
+P++ + L LE + + N G IP S+ NAS T++++ NLFSG++ + FG R L
Sbjct: 264 IPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNL 323
Query: 294 QILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
L L N T F S L C L+ L L N L GV+PNS NLSTSL
Sbjct: 324 TELYLWRNLFQTREQDDWG-FISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLA 382
Query: 354 AGSSQLSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPT 413
++++G IP G G++P+ N L G IP
Sbjct: 383 LELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPL 442
Query: 414 DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI-LAV 472
+ L +LN LL N G IP L+NLT+L L +N+L+ IPS ++++ + + +
Sbjct: 443 AIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMI 502
Query: 473 DFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIP 532
+ + L + N+LSG IP+++G+ + L +L L N G IP
Sbjct: 503 NVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIP 562
Query: 533 QSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADS 592
+ G L L++LDLS NN+SG+IP SL ++ L N+SFN GE+P+ G F + S
Sbjct: 563 SALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGIS 622
Query: 593 FKQNYALCGS-SRLQVPPCXXXXXXXXXXXXIVLRYILPAIATTMVVVALFIILIRRRKR 651
+ N LCG L +P C + + ++A + +++ +LI KR
Sbjct: 623 IQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISV---SLAAALAILSSLYLLITWHKR 679
Query: 652 NKSLPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKV 711
K S+ L +SY +L +AT+GF +NLLGSGSF +VYK L VAVKV
Sbjct: 680 TKKGAPSRTSMKGHPL--VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKV 737
Query: 712 FNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS---NPG--FKALIMQYMPQGSLEKW 766
L+ +ALKSF ECE +R +RHRNL+KIV+ CS N G FKA++ +MP GSLE W
Sbjct: 738 LKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDW 797
Query: 767 LYSHNYS------LTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVA 819
++ L + +R+ I++DVA AL+YLH HG P++HCD+K +NVLLD DMVA
Sbjct: 798 IHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHG-PEPVVHCDIKSSNVLLDSDMVA 856
Query: 820 HLGDFGIAKLL-DGVDPVTQTMT----LATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874
H+GDFG+A++L DG + Q+ + + TIGY APEYG I S GD+YS+GIL++E
Sbjct: 857 HVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEI 916
Query: 875 FTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
T ++PT+ F ++ L+Q+V L G VT+VVD L+
Sbjct: 917 VTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLI 954
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
Identities = 307/918 (33%), Positives = 470/918 (51%)
Query: 54 NLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDM 113
NL L G +P +GN S LV L + N +P EL ++ +L+ + N L+ S+P +
Sbjct: 250 NL-LEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSL 308
Query: 114 CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173
TQL +S N + G I + SL+ + L +N+ +G FP + T L +L L
Sbjct: 309 FR-LTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSI-TNLRNLTVLT 366
Query: 174 LLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS 233
+ NNI+G E+P ++G L NL+ L N + G IPS I N + + + L N ++
Sbjct: 367 VGFNNISG-----ELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMT 421
Query: 234 GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQL 293
G +P NL + + +N+ +G IPD I N S L ++ N +G + G ++L
Sbjct: 422 GEIPRGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKL 481
Query: 294 QILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
+IL + N LT G I + + L +L L +N G IP + NL T L+
Sbjct: 482 RILQVSYNSLT------GPI-PREIGNLKDLNILYLHSNGFTGRIPREMSNL-TLLQGLR 533
Query: 354 AGSSQLSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPT 413
S+ L G IP + +G IP + L NK G IP
Sbjct: 534 MYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPA 593
Query: 414 DLCKLEKLNTLLSNNNALQGQIP-TCLANLTSLR-HLDFRSNSLNSTIPSTFWSLKYILA 471
L L LNT ++N L G IP LA+L +++ +L+F +N L TIP L+ +
Sbjct: 594 SLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQE 653
Query: 472 VDFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDW---LALARNAFQ 528
+D + + L+ + N LSG+IP + + +D L L+RN+F
Sbjct: 654 IDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEV--FQGMDMIISLNLSRNSFS 711
Query: 529 GPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNF 588
G IPQSFG++ L SLDLS NN++GEIP+SL LS L ++ N L+G +P G F N
Sbjct: 712 GEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNI 771
Query: 589 TADSFKQNYALCGSSRLQVPPCXXXXXXXXXXXXI-VLRYILPAIATTMVVVALFIILIR 647
A N LCGS + + PC V+ IL + A ++V+ L +IL
Sbjct: 772 NASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTC 830
Query: 648 RRKRNKSLPEENNS----LNLAT-LSRISYHELQQATNGFGESNLLGSGSFDNVYKATLA 702
+K+ K + + S L+ A L R EL+QAT+ F +N++GS S VYK L
Sbjct: 831 CKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLE 890
Query: 703 NGVSVAVKVFNLQEDRAL--KSFDTECEVMRRIRHRNLIKIVSSCSNPG-FKALIMQYMP 759
+G +AVKV NL+E A K F TE + + +++HRNL+KI+ G KAL++ +M
Sbjct: 891 DGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFME 950
Query: 760 QGSLEKWLYSHNYSL-TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV 818
G+LE ++ + ++ +++D+ + +AS ++YLH GY PI+HCDLKP N+LLD D V
Sbjct: 951 NGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRV 1010
Query: 819 AHLGDFGIAKLL----DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874
AH+ DFG A++L DG + + TIGY+APE+ V+ DV+SFGI+MME
Sbjct: 1011 AHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMEL 1070
Query: 875 FTRRKPT--NEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKT--CI 930
T+++PT N+ + +M+L+Q V +S+ +V +L D E D + K I
Sbjct: 1071 MTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMV--RVL---DMELGDSIVSLKQEEAI 1125
Query: 931 SYIMSLALKCSAEIPEER 948
+ L L C++ PE+R
Sbjct: 1126 EDFLKLCLFCTSSRPEDR 1143
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 3.5e-114, P = 3.5e-114
Identities = 284/786 (36%), Positives = 414/786 (52%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+Q K+++S D ++WN S +CNW GVTC ++ RV L L L LGG
Sbjct: 28 ALLQFKSQVSEDKR-VVLSSWN-----HSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGV 81
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+ P +GNLSFLVSL++ N F T+P E+ + RL+ +D N L G +P + N ++L
Sbjct: 82 ISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNC-SRL 140
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
+ + SN++ G PS + ++++L + L N++ G PT L L L QL L NN+
Sbjct: 141 LNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSL-GNLTLLEQLALSHNNLE 199
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL-PS- 238
G EIP+++ L + L L NN +G+ P ++N S++ + + NH SG L P
Sbjct: 200 G-----EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDL 254
Query: 239 SIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
I LPNL + + N +G IP ++ N S L ++ N +G +P TFGN L++L L
Sbjct: 255 GILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFL 313
Query: 299 GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQ 358
N L + SS + F +SL C L L + N L G +P SI NLS L G +
Sbjct: 314 HTNSLGSDSSRDLE-FLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTL 372
Query: 359 LSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKL 418
+SG IP G L+G +PT L SN+L G IP + +
Sbjct: 373 ISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNM 432
Query: 419 EKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXX 478
L TL +NN +G +PT L N + L L N LN TIP ++ +L +D
Sbjct: 433 TMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNS 492
Query: 479 XXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL 538
+ LG L+L N+LSG +P ++GN ++ L L N F G IP G L
Sbjct: 493 LIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-L 551
Query: 539 ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYA 598
+ ++ +DLS N++SG IP+ S+L N+SFN LEG++P G F N T S N
Sbjct: 552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611
Query: 599 LCGSSR-LQVPPCXXXXXXXXXXXXIVLRYILPAIATTMVVVALF------IILIRRRKR 651
LCG Q+ PC L+ ++ ++ + ++ L +I +R+RK+
Sbjct: 612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKK 671
Query: 652 NKSLPEENNSL--NLATL-SRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSV- 707
NK E NN L L +ISY +L+ ATNGF SN++GSGSF VYKA L V
Sbjct: 672 NK---ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVV 728
Query: 708 AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN---PG--FKALIMQYMPQGS 762
AVKV N+Q A+KSF ECE ++ IRHRNL+K++++CS+ G F+ALI ++MP GS
Sbjct: 729 AVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGS 788
Query: 763 LEKWLY 768
L+ WL+
Sbjct: 789 LDMWLH 794
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
Identities = 320/1002 (31%), Positives = 492/1002 (49%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL++ K+++S + ++ WN S +CNW VTC +H RV L+L L LGG
Sbjct: 28 ALLEFKSQVSEGKRDVLSS-WN-----NSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGI 81
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCN----- 115
+ P +GN+SFL+SL++S N+F +P E+ ++ RL+ + + NSL G +P + N
Sbjct: 82 VSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLL 141
Query: 116 ------------------SFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGS 157
S T+L D+ N + G+ P ++ N++SLKS+ +N++ G
Sbjct: 142 NLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGE 201
Query: 158 FPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG-LIPSMI 216
P +L RL +V L L N G P P I NL L+ L L G+ +G L P
Sbjct: 202 VPDELA-RLSQMVGLGLSMNKFFGVFP----P-AIYNLSALEDLFLFGSGFSGSLKPD-- 253
Query: 217 FNN--SNMVAILLYGNHLSGHLPSSIY-LPNLENLFLWKNNLSGIIPDSICNASEATILE 273
F N N+ + L N L G +P+++ + L+ + KN ++G I + L+
Sbjct: 254 FGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLD 313
Query: 274 LSSN-----LFSGL-VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVL 327
LS N F L ++ NC LQ+LS+G +L G + I S L L
Sbjct: 314 LSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRL--GGALPTSIANMSTE----LISL 367
Query: 328 VLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGXXXXXXXXXXXXXELAGAI 387
L N G IP IGNL L+ G + L+G +P G ++G I
Sbjct: 368 NLIGNHFFGSIPQDIGNL-IGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEI 426
Query: 388 PTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRH 447
P+ L++N +G +P L K + L N L G IP + + +L +
Sbjct: 427 PSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVN 486
Query: 448 LDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYI 507
L NSL+ ++P+ SL+ ++ + A+ L L GN G I
Sbjct: 487 LSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAI 546
Query: 508 PSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVD 567
P+ I L + + L+ N G IP+ F + L+ L+LS NN +G++P + +
Sbjct: 547 PN-IRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIV 605
Query: 568 FNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCXXXXXXXXXXXXIVLRY 627
F L G I K L Q PP I++
Sbjct: 606 FVFGNKNLCGGIKD-----------LKLKPCLA-----QEPPVETKHSSHLKKVAILVSI 649
Query: 628 ILPAIATTMVVVALFIILIRRRKRNKSLPEENNSLNLATLSRISYHELQQATNGFGESNL 687
+ A+ +V+ ++ + R+R++N+ S +ISY +L+ ATNGF SN+
Sbjct: 650 GI-ALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNM 708
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+GSGSF V+KA L VAVKV N+Q A+KSF ECE ++ RHRNL+K++++C+
Sbjct: 709 VGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACA 768
Query: 747 NPGF-----KALIMQYMPQGSLEKWLYSHNY--------SLTIRQRLDIMIDVASALEYL 793
+ F +ALI +Y+P GS++ WL+ +LT+ +RL+I+IDVAS L+YL
Sbjct: 769 STDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYL 828
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA------TIGY 847
H PI HCDLKP+NVLL+DD+ AH+ DFG+A+LL D + L+ TIGY
Sbjct: 829 HVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGY 888
Query: 848 MAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907
APEYG G SI GDVYSFG+L++E FT ++PT+E+F G ++L + +LP V E+
Sbjct: 889 AAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIA 948
Query: 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI 949
D +L F T + C++ ++ + L+C E P R+
Sbjct: 949 DKAILHIGLRVG---FRTAE-CLTLVLEVGLRCCEEYPTNRL 986
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1100 (392.3 bits), Expect = 2.0e-111, P = 2.0e-111
Identities = 269/785 (34%), Positives = 411/785 (52%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL++ K+++S + +WN S+ CNW+GVTC R RV +L+L L G
Sbjct: 34 ALLEFKSQVSENNKREVLASWN-----HSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+ P +GNLSFL LN++ NSF T+P ++ + RL+ ++ S N L G +P + N ++L
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNC-SRL 147
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
+ D+SSN + PS + ++S L + L N+L+G+FP L L SL +L N +
Sbjct: 148 STVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASL-GNLTSLQKLDFAYNQMR 206
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
G EIP+E+ L + + N+ +G P ++N S++ ++ L N SG+L +
Sbjct: 207 G-----EIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADF 261
Query: 241 -YL-PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
YL PNL L L N +G IP ++ N S ++SSN SG +P +FG R L L +
Sbjct: 262 GYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGI 321
Query: 299 GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQ 358
+N L SS+ G F ++A C L L + N L G +P SI NLST+L + + G +
Sbjct: 322 RNNSLGNNSSS-GLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNL 380
Query: 359 LSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKL 418
+SG IP G L+G +P DL SN + G IP+ +
Sbjct: 381 ISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNM 440
Query: 419 EKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXX 478
+L L N+N+ G+IP L L L +N LN TIP + + +D
Sbjct: 441 TRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNF 500
Query: 479 XXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL 538
E L GL + N+LSG +P +IG ++++L + N+F G IP L
Sbjct: 501 LTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRL 559
Query: 539 ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYA 598
+SL+++D S NN+SG IP+ L L L + N+S N EG +P+ G F N TA S N
Sbjct: 560 VSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTN 619
Query: 599 LCGSSR-LQVPPCXXXXXXXXXXXXIVLRYILPAIATTMVVVALFIIL------IRRRKR 651
+CG R +Q+ PC V + ++ I + + L II+ ++R+K+
Sbjct: 620 ICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKK 679
Query: 652 NKSL---PEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSV 707
N + P ++ +L + ++SY EL AT+ F +NL+GSG+F NV+K L V
Sbjct: 680 NNASDGNPSDSTTLGMFH-EKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLV 738
Query: 708 AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN---PG--FKALIMQYMPQGS 762
AVKV NL + A KSF ECE + IRHRNL+K+++ CS+ G F+AL+ ++MP+GS
Sbjct: 739 AVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGS 798
Query: 763 LEKWL 767
L+ WL
Sbjct: 799 LDMWL 803
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 3.9e-74, P = 3.9e-74
Identities = 229/748 (30%), Positives = 364/748 (48%)
Query: 43 RHGRVAALSLPNLSLGGTLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFS 101
R ++ L L L G+LP + N + L L +S +P E+ + + LK++D S
Sbjct: 310 RMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLS 369
Query: 102 SNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTD 161
+N+L+G +P D +L + +++N + G S+I N+++L+ L +N+L G P +
Sbjct: 370 NNTLTGQIP-DSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKE 428
Query: 162 LCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSN 221
+ L L + L N +G E+P EIGN L+ +D GN ++G IPS I +
Sbjct: 429 IGF-LGKLEIMYLYENRFSG-----EMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKD 482
Query: 222 MVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFS 280
+ + L N L G++P+S+ + + L N LSG IP S + + + +N
Sbjct: 483 LTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQ 542
Query: 281 GLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPN 340
G +P++ N + L ++ N+ GS + + SS YL V + N +G IP
Sbjct: 543 GNLPDSLINLKNLTRINFSSNKFN-GSISP--LCGSS----SYLSFDVTE-NGFEGDIPL 594
Query: 341 SIGNLSTSLENFYAGSSQLSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXX 400
+G ST+L+ G +Q +G IP FG L+G IP
Sbjct: 595 ELGK-STNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHI 653
Query: 401 DLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIP 460
DLN+N L G IPT L KL L L ++N G +PT + +LT++ L NSLN +IP
Sbjct: 654 DLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIP 713
Query: 461 STFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDW- 519
+L+ + A++ L L L+ N L+G IP IG L++L
Sbjct: 714 QEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSA 773
Query: 520 LALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579
L L+ N F G IP + +L L+SLDLS N + GE+P + + L N+S+N LEG++
Sbjct: 774 LDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL 833
Query: 580 PSGGPFVNFTADSFKQNYALCGSSRLQVPPCXXXXXXXXXXXXIVLRYI---LPAIATTM 636
F + AD+F N LCGS +V+ L AIA +
Sbjct: 834 KK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMV 891
Query: 637 VVVALFII----LIRRRKRNKSLPEENNSLNLATL-------SRISYHELQQATNGFGES 685
+V+ LF L ++ + S N+S + A L S I + ++ +AT+ E
Sbjct: 892 LVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEE 951
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSS 744
++GSG VYKA L NG ++AVK ++D + KSF+ E + + IRHR+L+K++
Sbjct: 952 FMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGY 1011
Query: 745 CSNP--GFKALIMQYMPQGSLEKWLYSH 770
CS+ G LI +YM GS+ WL+++
Sbjct: 1012 CSSKADGLNLLIYEYMANGSVWDWLHAN 1039
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
Identities = 326/1006 (32%), Positives = 489/1006 (48%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
AL+++K+++S + LS N S +C+W V C +H RV L L L LGG
Sbjct: 28 ALLEIKSQVSESKRDA------LSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGV 81
Query: 61 LPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDM--CNSFT 118
+ P +GNLSFL+ L++S NSF T+P E+ ++ RLK + N L G +P + C+
Sbjct: 82 ISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLL 141
Query: 119 QLESFD------VSS---------------NKITGEFPSAIVNISSLKSIRLDNNSLSGS 157
L+ F V S N + G+FP I N++SL + L N L G
Sbjct: 142 YLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGE 201
Query: 158 FPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG-LIPSMI 216
P D+ L +V L L NN +G P P NL +L+ L L GN +G L P
Sbjct: 202 IPDDIAM-LSQMVSLTLTMNNFSGVFP----P-AFYNLSSLENLYLLGNGFSGNLKPD-- 253
Query: 217 FNN--SNMVAILLYGNHLSGHLPSSIY-LPNLENLFLWKNNLSGIIPDSICNASEATILE 273
F N N+ + L+GN L+G +P+++ + LE + KN ++G I + LE
Sbjct: 254 FGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLE 313
Query: 274 LSSNL-----FSGLV-PNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVL 327
L++N F L + NC L LS+ N+L G + I S L VL
Sbjct: 314 LANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRL--GGALPTSIVNMSTE----LTVL 367
Query: 328 VLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGXXXXXXXXXXXXXELAGAI 387
L N + G IP+ IGNL L++ + L+G +P G +G I
Sbjct: 368 NLKGNLIYGSIPHDIGNL-IGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEI 426
Query: 388 PTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRH 447
P+ L++N +G +P L + L N L G IP + + +L H
Sbjct: 427 PSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVH 486
Query: 448 LDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYI 507
L+ SNSL+ ++P+ L+ ++ + ++ + L N G I
Sbjct: 487 LNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTI 546
Query: 508 PSSIG--NLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIP-KSLEKLSR 564
P G +KN+D L+ N G I + F + L+ L+LS NN G +P + + + +
Sbjct: 547 PDIKGLMGVKNVD---LSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNAT 603
Query: 565 LVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCXXXXXXXXXXXXIV 624
LV + N L G I K + Q PP I
Sbjct: 604 LVSVFGNKN-LCGSIKE-----------LKLKPCIA-----QAPPVETRHPSLLKKVAIG 646
Query: 625 LRYILPAIATTMVVVALFIILIRRRKRNKSLPEENNSLNLATL-SRISYHELQQATNGFG 683
+ IA +++ + + ++RK N+ + + L ++SY +L+ AT+GF
Sbjct: 647 VSV---GIALLLLLFIVSLSWFKKRKNNQKI-NNSAPFTLEIFHEKLSYGDLRNATDGFS 702
Query: 684 ESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
SN++GSGSF V+KA L VAVKV N+Q A+KSF ECE ++ IRHRNL+K++
Sbjct: 703 SSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLL 762
Query: 743 SSCSN---PG--FKALIMQYMPQGSLEKWLYS------HNYS--LTIRQRLDIMIDVASA 789
++C++ G F+ALI ++MP GSL+KWL+ H S LT+ +RL+I IDVAS
Sbjct: 763 TACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASV 822
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP------VTQTMTLA 843
L+YLH PI HCDLKP+N+LLDDD+ AH+ DFG+A+LL D ++
Sbjct: 823 LDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRG 882
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV 903
TIGY APEYG G SI GDVYSFG+L++E FT ++PTNE+F G +L + +LP V
Sbjct: 883 TIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERV 942
Query: 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI 949
++ D ++L F + C+ I+ + L+C E P R+
Sbjct: 943 LDIADKSILHSGLRVG---FPVLE-CLKGILDVGLRCCEESPLNRL 984
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 2.4e-107, Sum P(2) = 2.4e-107
Identities = 219/689 (31%), Positives = 320/689 (46%)
Query: 50 LSLPNLSLGGTLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGS 108
L L N L G+LP + N + L L +SG +P EL + LK +D S+NSL+GS
Sbjct: 316 LVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGS 375
Query: 109 LPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPS 168
+P + +L + +N + G +I N+++L+ + L +N+L G P ++ + L
Sbjct: 376 IP-EALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEI-SALRK 433
Query: 169 LVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY 228
L L L N +G EIP EIGN +LK++D+ GN+ G IP I + + L
Sbjct: 434 LEVLFLYENRFSG-----EIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLR 488
Query: 229 GNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTF 287
N L G LP+S+ L L L N LSG IP S L L +N G +P++
Sbjct: 489 QNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSL 548
Query: 288 GNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLST 347
+ R L ++L N+L G I + YL V + N + IP +GN S
Sbjct: 549 ISLRNLTRINLSHNRLN------GTI-HPLCGSSSYLSFDVTN-NGFEDEIPLELGN-SQ 599
Query: 348 SLENFYAGSSQLSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKL 407
+L+ G +QL+G IP G L G IP DLN+N L
Sbjct: 600 NLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFL 659
Query: 408 KGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
G IP L KL +L L ++N +PT L N T L L NSLN +IP +L
Sbjct: 660 SGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLG 719
Query: 468 YILAVDFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDW-LALARNA 526
+ ++ L L L+ N L+G IP IG L++L L L+ N
Sbjct: 720 ALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNN 779
Query: 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFV 586
F G IP + G+L L++LDLS N ++GE+P S+ + L NVSFN L G++ F
Sbjct: 780 FTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFS 837
Query: 587 NFTADSFKQNYALCGS--SRLQVPPCXXXXXXXXXXXXIVLRYI--LPAIATTMVVVALF 642
+ ADSF N LCGS SR +++ I L AI ++V+ALF
Sbjct: 838 RWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALF 897
Query: 643 II----LIRRRKRNKSLPEENNSLNLAT---LSR-------ISYHELQQATNGFGESNLL 688
++ + ++S + AT L R I + ++ +AT+ E ++
Sbjct: 898 FKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMI 957
Query: 689 GSGSFDNVYKATLANGVSVAVKVFNLQED 717
GSG VYKA L NG +VAVK ++D
Sbjct: 958 GSGGSGKVYKAELENGETVAVKKILWKDD 986
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 1.4e-103, P = 1.4e-103
Identities = 284/929 (30%), Positives = 462/929 (49%)
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
L G +PP +GN+ + L +S N ++P+ L +++ L ++ N L+G +P ++ N
Sbjct: 210 LTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGN- 268
Query: 117 FTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
+ + +S NK+TG PS++ N+ +L + L N L+G P L + S++ L L
Sbjct: 269 MESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKL-GNIESMIDLELSN 327
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL 236
N +TG IP+ +GNL NL IL L N + G+IP + N +M+ + L N L+G +
Sbjct: 328 NKLTG-----SIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSI 382
Query: 237 PSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQI 295
PSS L NL L+L+ N L+G+IP + N L+LS N +G VP++FGN +L+
Sbjct: 383 PSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLES 442
Query: 296 LSLGDNQLT----TGSSAQGQI-------------FYSSLAKCRYLRVLVLDTNPLKGVI 338
L L N L+ G + + F ++ K R L+ + LD N L+G I
Sbjct: 443 LYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPI 502
Query: 339 PNSIGNLSTSLENFYAGSSQLSGGIPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXX 398
P S+ + + + + G+ + +G I FG + G I +
Sbjct: 503 PKSLRDCKSLIRARFLGN-KFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLG 561
Query: 399 XXDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS 457
+++N + G IPT++ + +L L LS NN L G++P + NLT+L L N L+
Sbjct: 562 ALIMSNNNITGAIPTEIWNMTQLVELDLSTNN-LFGELPEAIGNLTNLSRLRLNGNQLSG 620
Query: 458 TIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNL 517
+P+ L + ++D L +NL+ N+ G IP + L L
Sbjct: 621 RVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQL 679
Query: 518 DWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577
L L+ N G IP SL SL LDLS NN+SG IP + E + L + ++S N LEG
Sbjct: 680 TQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEG 739
Query: 578 EIPSGGPFVNFTADSFKQNYALCGS-SRLQVPPCXXXXXXXXXXXXIVLRYILPAIATTM 636
+P F TAD+ ++N LC + + ++ PC +V +IL I +
Sbjct: 740 PLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVV--WILVPILGVL 797
Query: 637 VVVAL----FIILIRRRK----RNKSLPEENNSLNLATLS-RISYHELQQATNGFGESNL 687
V++++ F IR+RK RN PE ++++ ++ + Y ++ ++TN F ++L
Sbjct: 798 VILSICANTFTYCIRKRKLQNGRNTD-PETGENMSIFSVDGKFKYQDIIESTNEFDPTHL 856
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRAL------KSFDTECEVMRRIRHRNLIKI 741
+G+G + VY+A L + + +AVK + D + + F E + + IRHRN++K+
Sbjct: 857 IGTGGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKL 915
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS--LTIRQRLDIMIDVASALEYLHHGYST 799
CS+ LI +YM +GSL K L + + LT +R++++ VA AL Y+HH T
Sbjct: 916 FGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRIT 975
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS 859
PI+H D+ N+LLD+D A + DFG AKLL D + T GY+APE+ V+
Sbjct: 976 PIVHRDISSGNILLDNDYTAKISDFGTAKLLK-TDSSNWSAVAGTYGYVAPEFAYTMKVT 1034
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919
DVYSFG+L++E + P G++ SL + E + +L S DE
Sbjct: 1035 EKCDVYSFGVLILELIIGKHP------GDL------VSSLSSSPGEAL--SLRSISDERV 1080
Query: 920 ADDFATKKTCISYIMSLALKCSAEIPEER 948
+ + + ++ +AL C PE R
Sbjct: 1081 LEPRGQNREKLLKMVEMALLCLQANPESR 1109
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3926 | 0.9701 | 0.9346 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00025217001 | SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (2202 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 973 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-114 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-06 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.003 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 373 bits (960), Expect = e-114
Identities = 299/967 (30%), Positives = 476/967 (49%), Gaps = 60/967 (6%)
Query: 2 LVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTL 61
L+ K+ I+ DP + +N WN +SA VC W G+TC+ RV ++ L ++ G +
Sbjct: 34 LLSFKSSIN-DPLKYLSN-WN-----SSADVCLWQGITCN-NSSRVVSIDLSGKNISGKI 85
Query: 62 PPHVGNLSFLVSLNISGNSFYDTLPNELWHM-RRLKIIDFSSNSLSGSLPGDMCNSFTQL 120
+ L ++ ++N+S N +P++++ L+ ++ S+N+ +GS+P S L
Sbjct: 86 SSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNL 142
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
E+ D+S+N ++GE P+ I + SSLK + L N L G P L T L SL L L N +
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL-TNLTSLEFLTLASNQLV 201
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
G +IP E+G + +LK + LG NN++G IP I +++ + L N+L+G +PSS+
Sbjct: 202 G-----QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
Query: 241 -YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299
L NL+ LFL++N LSG IP SI + + L+LS N SG +P + L+IL L
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLF 316
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359
N T G+I +L L+VL L +N G IP ++G +L ++ L
Sbjct: 317 SNNFT------GKI-PVALTSLPRLQVLQLWSNKFSGEIPKNLGK-HNNLTVLDLSTNNL 368
Query: 360 SGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLE 419
+G IP G + NL L L +N L G IP LG + L+ + L N G +P++ KL
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP 428
Query: 420 KLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSL 479
+ L +NN LQG+I + ++ SL+ L N +P +F S K + +D S N
Sbjct: 429 LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQF 487
Query: 480 SGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI 539
SG++P +G+L L L L+ N+LSG IP + + K L L L+ N G IP SF +
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP 547
Query: 540 SLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYAL 599
L LDLS N +SGEIPK+L + LV N+S N L G +PS G F+ A + N L
Sbjct: 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL 607
Query: 600 CGSSRLQ-VPPCKTSSTHKSKATKIVLRYILPAIATTMVVVALFIILIRRRKRN---KSL 655
CG +PPCK K+ + + L A ++ + F + R + N K +
Sbjct: 608 CGGDTTSGLPPCKR--VRKTPSWWFYITCTLGAF--LVLALVAFGFVFIRGRNNLELKRV 663
Query: 656 PEENNSLNLATL-SRISYH-ELQQATNGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVF 712
E+ + L S++S + + E N++ G YK ++ NG+ VK
Sbjct: 664 ENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 713 NLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNY 772
N + S + M +++H N++K++ C + LI +Y+ +L + L
Sbjct: 724 N-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----R 775
Query: 773 SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832
+L+ +R I I +A AL +LH S ++ +L P +++D HL + LL
Sbjct: 776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLL-- 832
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
T T + Y+APE ++ D+Y FG++++E T + P + F S+
Sbjct: 833 ---CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV 889
Query: 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK 952
+W D +L D D + + I +M+LAL C+A P R
Sbjct: 890 EWARYCYS-------DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942
Query: 953 DALADLK 959
D L L+
Sbjct: 943 DVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-47
Identities = 65/190 (34%), Positives = 101/190 (53%), Gaps = 8/190 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F VY A G VA+K+ + L+ E E+++++ H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ L+M+Y GSL+ L + L+ + L I++ + LEYLH S IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 806 LKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-YGSEGIVSISGD 863
LKP N+LLD D+ L DFG++KLL + +T+ + T YMAPE +G S D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176
Query: 864 VYSFGILMME 873
++S G+++ E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFNLQEDR--ALKSFDTECEVMRRIRHRNLIKIVSS 744
LGSGSF VYKA G VAVK+ + ++ ++ E ++RR+ H N+++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ L+M+Y G L +L L+ + I + + LEYLH S IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-------YGSEGI 857
DLKP N+LLD++ V + DFG+AK L T T YMAPE YG +
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK-- 179
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
DV+S G+++ E T + P
Sbjct: 180 ----VDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVS 743
LG GSF VY A G VA+KV ++ + + E +++++++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
+ L+M+Y G L L L+ + + + SALEYLH G I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKG----IV 119
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGSEG 856
H DLKP N+LLD+D L DFG+A+ LD T + T YMAPE YG
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVLLGKGYGK-- 175
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ D++S G+++ E T + P F G+ L +
Sbjct: 176 ----AVDIWSLGVILYELLTGKPP----FPGDDQLLE 204
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKI 741
LG G+F VYK L V VAVK ++ F E +MR++ H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ C+ ++M+YM G L +L + L++ L + +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH DL N L+ +++V + DFG+++ L D + I +MAPE EG +
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921
DV+SFG+L+ E FT E MS ++ + + + L +
Sbjct: 184 SDVWSFGVLLWEIFTL----GEQPYPGMSNEE--------VLEYLKNGYRLPQPPN---- 227
Query: 922 DFATKKTCISYIMSLALKCSAEIPEER 948
C + L L+C AE PE+R
Sbjct: 228 -------CPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F VYK TL VAVK + + F E +M+++ H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ C+ ++ +YMP G L +L H LT++ L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSI 860
+H DL N L+ +++V + DFG+++ + D + I +MAPE +G +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 861 SGDVYSFGILMMETFTR 877
DV+SFG+L+ E FT
Sbjct: 184 KSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 77/268 (28%), Positives = 120/268 (44%), Gaps = 33/268 (12%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F VYK TL V VAVK ++ ++ F E +MR++ H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ C+ ++M+YMP G L +L + L++ L + +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ +++V + DFG+++ L D I +MAPE EG +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920
DV+SFG+L+ E FT E MS + + + L +
Sbjct: 184 KSDVWSFGVLLWEIFTL----GEEPYPGMSNAE--------VLEYLKKGYRLPKP----- 226
Query: 921 DDFATKKTCISYIMSLALKCSAEIPEER 948
C + L L+C AE PE+R
Sbjct: 227 ------PNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIK 740
LG G+F VYK L VAVK + F E VM+++ H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSH--------NYSLTIRQRLDIMIDVASALEY 792
++ C+ L+++YM G L +L +L+++ L I +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-DGVDPVTQTMTLATIGYMAPE 851
L S +H DL N L+ +D+V + DFG+++ + D +T I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 852 YGSEGIVSISGDVYSFGILMMETFTR 877
+GI + DV+SFG+L+ E FT
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA--LKSFDTECEVMRRIRHRNLIKIV 742
LLG GSF +VY A G +AVK L D L++ + E ++ ++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 743 SSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYS----LTIRQRLDIMIDVASALEYLH-H 795
S + L ++Y+ GSL L + IR+ + L YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKY---TRQILEGLAYLHSN 120
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGS 854
G I+H D+K N+L+D D V L DFG AK L ++ T ++ T +MAPE
Sbjct: 121 G----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+ D++S G ++E T + P +E+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 16/194 (8%)
Query: 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G F +V G VAVK L++D A ++F E VM +RH NL++++
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
++ +YM +GSL +L S + +T+ Q+L +DV +EYL +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT--IGYMAPEYGSEGIVSISG 862
DL NVL+ +D+VA + DFG+AK +Q + + APE E S
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 863 DVYSFGILMMETFT 876
DV+SFGIL+ E ++
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 8/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LGSG F V++ N V VA+K+ + + F E + ++R+RH++LI + + CS
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I + M +GSL +L S L + +D+ VA + YL IH DL
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVY 865
N+L+ +D+V + DFG+A+L+ + V + + APE S G S DV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 866 SFGILMMETFTRRK-PTNEMFTGE 888
SFGIL+ E FT + P M E
Sbjct: 189 SFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNL----QEDR--ALKSFDTECEVMRRIRHRNL 738
+G GSF VY ++G +K +L +++R AL E ++++++ H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS---LTIRQRLDIMIDVASALEYLHH 795
IK S G ++M+Y G L + + Q LD + + AL+YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE---- 851
S I+H D+KP N+ L + + LGDFGI+K+L + +T+ + T Y++PE
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQN 177
Query: 852 --YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
Y D++S G ++ E T + P F GE
Sbjct: 178 KPYNY------KSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G F VYKA G VA+KV L+ + E +++++ +H N++K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCD 805
++M++ GSL+ L S N +LT Q + ++ LEYLH +G IIH D
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG----IIHRD 123
Query: 806 LKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPE------YGSEGIV 858
+K N+LL D L DFG++ L D TM T +MAPE Y +
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV-GTPYWMAPEVINGKPYDYK--- 177
Query: 859 SISGDVYSFGILMMETFTRRKP 880
D++S GI +E + P
Sbjct: 178 ---ADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 31/216 (14%)
Query: 685 SNLLGSGSFDNVYKATLAN-----GVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNL 738
LG G F V G VAVK N E++ F+ E E++R + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 739 IKIVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG 796
+K C PG ++ LIM+Y+P GSL +L H + +++ L + ++YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG-- 126
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----------DGVDPVTQTMTLATI 845
S IH DL N+L++ + + + DFG+AK+L G P I
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP---------I 176
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPT 881
+ APE S + DV+SFG+ + E FT P+
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 80/296 (27%), Positives = 125/296 (42%), Gaps = 51/296 (17%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F V+ + VAVK + A K F+ E E++ +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHN-------------YSLTIRQRLDIMIDVA 787
C+ ++ +YM G L K+L SH LT+ Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD--PVTQTMTLATI 845
S + YL S +H DL N L+ D+V +GDFG+++ + D V T+ I
Sbjct: 133 SGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH-TMLPI 188
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLPGAVT 904
+M PE + DV+SFG+++ E FT ++P + E V
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--------------VI 234
Query: 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960
E + L + TC S + + L C P++RIN+KD L+K
Sbjct: 235 ECITQGRLLQRPR----------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSVAVK---VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G G+F +VYK L VAVK + + F E E++++ H N++K++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIG 59
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
C ++M+ +P GSL +L LT+++ L + +D A+ +EYL S IH
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIH 116
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKL-LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
DL N L+ ++ V + DFG+++ G+ V+ + I + APE + G +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 863 DVYSFGILMMETFT 876
DV+S+GIL+ ETF+
Sbjct: 177 DVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 59/190 (31%), Positives = 100/190 (52%), Gaps = 5/190 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ T VAVK + ++F E ++M+++RH L+++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L S L + Q +D+ +A + YL S IH DL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
N+L+ +++V + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 190 FGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG GSF V G A+KV + + + ++ TE ++ RI H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
+ L+++Y P G L L R R ++ ALEYLH G II
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHSLG----II 115
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGSEGIVSIS 861
+ DLKP N+LLD D L DFG+AK + ++T T T Y+APE +
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 862 GDVYSFGILMMETFTRRKP-----TNEMF 885
D +S G+L+ E T + P E++
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (271), Expect = 2e-25
Identities = 85/286 (29%), Positives = 126/286 (44%), Gaps = 32/286 (11%)
Query: 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRH-RNLIKIV 742
LG GSF VY A + VA+KV + + + ++ F E +++ + H N++K+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ G L+M+Y+ GSLE L L+ + L I+ + SALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 801 IIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDG-----VDPVTQTMTLATIGYMAPEY-- 852
IIH D+KP N+LLD D V L DFG+AKLL P + ++ T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 853 -GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911
S S S D++S GI + E T P S + + T + + L
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPF--EGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
E + L K A+ P+ R++ L+
Sbjct: 240 SPSNPELISKA----------ASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 14/219 (6%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRR 732
E + + GE +LG G++ VY A L+ V +A+K ++ R ++ E +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI----DVAS 788
++HRN+++ + S S GF + M+ +P GSL L S L + +I +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILE 119
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
L+YLH I+H D+K +NVL++ V + DFG +K L G++P T+T T T+ Y
Sbjct: 120 GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQY 175
Query: 848 MAPEYGSEGI--VSISGDVYSFGILMMETFTRRKPTNEM 884
MAPE +G D++S G ++E T + P E+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFN---LQEDRALKSFDTECEVMRRI-RHR 736
FG+ ++G GSF V A A+K+ + L +++ +K E EV+ R+ H
Sbjct: 5 FGK--IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG 796
+IK+ + + +++Y P G L +++ SL + ++ ALEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH-- 119
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---------- 846
S IIH DLKP N+LLD DM + DFG AK+LD AT
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 847 ---------YMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
Y++PE +E S D+++ G ++ + T + P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 72/310 (23%)
Query: 687 LLGSGSFDNVYKATL------ANGVSVAVKVFNLQEDRA---LKSFDTECEVMRRI-RHR 736
LG G+F V KA +VAVK+ L++D L +E E+M+ I +H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYSLTIRQRL---DIM- 783
N+I ++ C+ G ++++Y G+L +L S + + L D++
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 784 --IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA----------KLLD 831
VA +E+L S IH DL NVL+ +D V + DFG+A K +
Sbjct: 137 FAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891
G PV +MAPE + + + DV+SFG+L+ E FT G
Sbjct: 194 GRLPVK---------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGG---- 232
Query: 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV 951
PG E + L E + C + L C E+P +R
Sbjct: 233 -----SPYPGIPVEELFKLLKEGYRMEKP------QNCTQELYHLMRDCWHEVPSQRPTF 281
Query: 952 KDALADLKKI 961
K + DL ++
Sbjct: 282 KQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 58/191 (30%), Positives = 97/191 (50%), Gaps = 4/191 (2%)
Query: 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIVSSC 745
LLG G+F V+K TL + VAVK + LK F +E ++++ H N++K++ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ ++M+ +P G +L L +Q + +D A+ + YL S IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L N L+ ++ V + DFG+++ D + + I + APE + G S DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 866 SFGILMMETFT 876
S+GIL+ ETF+
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 73/290 (25%), Positives = 118/290 (40%), Gaps = 38/290 (13%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQED------RALKSFDTECEVMRRIRHRNLIK 740
+G G++ VYKA G VA+K L+ + AL+ E ++++ + H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
++ + G L+ ++M L K + L + + L + H HG
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGI 857
I+H DLKP N+L++ + V L DFG+A+ G T + T Y APE G +G
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGDKG- 175
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW----------VAESLPGAVTEVV 907
S D++S G + E +RR +F G+ + Q E P T +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRP----LFPGKSEIDQLFKIFRTLGTPDPEVWPK-FTSLA 230
Query: 908 DANLLSREDEEDADDFATKKTCISY-IMSLALKCSAEIPEERINVKDALA 956
S + S + L + P +RI + ALA
Sbjct: 231 RNYKFSFPKKAGM-PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRAL-KSFDTECEVMRRIRHRNLIKIVSSC 745
LG GS VYK G A+K ++ D K E + +R ++K +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHHGYSTPIIH 803
G +++++YM GSL L I + + I + L+YLH IIH
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH--IIH 123
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGSEGI 857
D+KP+N+L++ + DFGI+K+L+ T + T+ YM+PE Y
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESYSY--- 179
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
+ D++S G+ ++E + P
Sbjct: 180 ---AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 685 SNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR--ALKSFDTECEVMRRIRHRNLIKI 741
+L+G G+F VYK L G VA+K +L++ + ALKS E ++++ ++H N++K
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ S +I++Y GSL + + SL + V L YLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV----YVYQVLQGLAYLH---E 117
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+IH D+K N+L D V L DFG+A L+ V ++ + T +MAPE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGA 176
Query: 859 SISGDVYSFGILMMETFTR------RKPTNEMF 885
S + D++S G ++E T P +F
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALF 209
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 70/212 (33%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 688 LGSGSFDNV--YKATLAN---GVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKI 741
LG G F V Y AN G VAVK + + S + E +++ + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 742 VSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
CS G K LIM+Y+P GSL +L H +L Q L + + YLH S
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQICEGMAYLH---SQ 126
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----------DGVDPVTQTMTLATIGYM 848
IH DL NVLLD+D + +GDFG+AK + DG PV +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---------WY 177
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
A E E S + DV+SFG+ + E T
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 17/219 (7%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI 733
LQ+ T G ++G G F V + G VAVK N++ D ++F E VM ++
Sbjct: 4 NLQKLTLG----EIIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKL 56
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL-TIRQRLDIMIDVASALEY 792
H+NL++++ + G ++M+ M +G+L +L + +L ++ Q L +DVA +EY
Sbjct: 57 HHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
L S ++H DL N+L+ +D VA + DFG+A+ V + + + + APE
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR----VGSMGVDNSKLPVKWTAPEA 168
Query: 853 GSEGIVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMS 890
S DV+S+G+L+ E F+ R P +M E+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VYKAT A G VA+K L++ + E +M+ +H N++ S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+YM GSL + + + Q + +V LEYLH S +IH D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGSEGIVSI 860
K +N+LL D L DFG A L ++ + T +MAPE YG + V
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEVIKRKDYGPK--V-- 197
Query: 861 SGDVYSFGILMME 873
D++S GI+ +E
Sbjct: 198 --DIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 9/192 (4%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG+G F V++ N VAVK L+ K F E ++M+++RH LI++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLH-HGYSTPIIHC 804
++ + M GSL ++L L + Q +D+ VAS + YL Y IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY----IHR 127
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL NVL+ ++ + + DFG+A+++ + I + APE SI DV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 865 YSFGILMMETFT 876
+SFGIL+ E T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 7/195 (3%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRAL-KSFDTECEVMRRIRHRNLIKIVSSC 745
LG+G+ V K G +AVK L+ + A+ K E +++ + ++ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
N G ++ M+YM GSL+K L + R I + V L YLH + IIH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
+KP+N+L++ L DFG++ L V+ + +T T YMAPE S+ D++
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDIW 183
Query: 866 SFGILMMETFTRRKP 880
S G+ ++E T R P
Sbjct: 184 SLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LGSG F V+ + VA+K+ + ED F E +VM ++ H NL+++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED----DFIEEAKVMMKLSHPNLVQLYGV 67
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIH 803
C+ ++ +YM G L +L L LD+ DV A+EYL +G+ IH
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF----IH 123
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTM-TLATIGYMAPEYGSEGIVSIS 861
DL N L+ +D V + DFG+A+ +LD D T + T + + PE S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 862 GDVYSFGILMMETFTRRKPTNEMFT 886
DV+SFG+LM E F+ K E F+
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 685 SNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR--ALKSFDTECEVMRRIRHRNLIKI 741
N +G G+F VY A L G +AVK +Q++ +K E +V+ ++H NL+K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 742 VSSCSNPGF-----KALI-MQYMPQGSLEKWL-YSHNYSLTIRQRLDIMIDVASALEYLH 794
G K I M+Y G+LE+ L + + + + + L YLH
Sbjct: 65 Y------GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH 116
Query: 795 -HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLA-TIGYMAP 850
HG I+H D+KP N+ LD + V LGDFG A L + + +LA T YMAP
Sbjct: 117 SHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 851 EYGSEGIVSISG---DVYSFGILMMETFTRRKPTNEM 884
E + G G D++S G +++E T ++P +E+
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 36/223 (16%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G G++ VYKA G VA+K ++ ++ A++ E ++++++RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 741 ---IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
IV+S ++ +YM L L S T Q M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--- 117
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------ 851
S I+H D+K +N+L+++D V L DFG+A+ + T + T+ Y PE
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 852 -YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
YG E V D++S G ++ E F + F G L+Q
Sbjct: 178 RYGPE--V----DMWSVGCILAELFLGKPI----FQGSTELEQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 687 LLGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRA--LKSFDTECEVMRRIRHRNLI 739
LG G+F +V Y N G VAVK LQ A L+ F+ E E+++ ++H N++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 740 KIVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
K C + G + L+M+Y+P GSL +L H L R+ L + +EYL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--- 125
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSE 855
S +H DL N+L++ + +GDFG+ K+L D + + I + APE +E
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 856 GIVSISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIK 740
++G G F V + L + VA+K D+ F TE +M + H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGY 797
+ V + S P +I +YM GSL+K+L ++ T+ Q + ++ +AS ++YL Y
Sbjct: 70 LEGVVTKSRPVM--IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG+++ L+ + T I + APE +
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLK 892
+ + DV+SFGI+M E + +P +M + + +K
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIK 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 748 -PGFKALIMQYMPQGSLEKWLYSHNYSLTIR--QRLDIMIDVASALEYLHHGYSTPIIHC 804
P + ++ +YM +GSL +L +R Q +D+ +AS + Y+ +H
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 865 YSFGILMMETFTR-RKPTNEMFTGEM 889
+SFGIL+ E T+ R P M E+
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 73/294 (24%), Positives = 125/294 (42%), Gaps = 47/294 (15%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK + A + F E E++ ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS--------------LTIRQRLDIMIDVA 787
C+ ++ +YM G L ++L SH LT+ Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIG 846
S + YL S +H DL N L+ +V +GDFG+++ + D T+ I
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906
+M PE + D++SFG+++ E FT K + W S TE
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQLS----NTEA 233
Query: 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960
++ RE E +TC + ++ C P++R+ +KD + L+
Sbjct: 234 IECITQGRELER-------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 686 NLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVS 743
+ LG G + VY+ ++VAVK L+ED ++ F E VM+ I+H NL++++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 744 SCS-NPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPI 801
C+ P F +I ++M G+L +L N + L + ++SA+EYL
Sbjct: 70 VCTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 862 GDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 186 SDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 58/192 (30%), Positives = 100/192 (52%), Gaps = 8/192 (4%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ T VAVK + +SF E ++M+++RH L+++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 748 -PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
P + ++ +YM +GSL +L +L + +D+ VA+ + Y+ IH D
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L+ N+L+ D +V + DFG+A+L++ + + I + APE G +I DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 866 SFGILMMETFTR 877
SFGIL+ E T+
Sbjct: 188 SFGILLTELVTK 199
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALK---SFDT--ECEVMRRIRHRNLI 739
LG G++ VYKA G VA+K L E + K +F E ++++ ++H N+I
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ + L+ ++M LEK + + LT M+ LEYLH +
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGI 857
I+H DLKPNN+L+ D V L DFG+A+ G T + T Y APE +G+
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELLFGAR-H 179
Query: 858 VSISGDVYSFGILMMETFTRR 878
+ D++S G + E R
Sbjct: 180 YGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 687 LLGSGSFDNVYKATLAN----GVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKI 741
+G G F +VY+ + ++VAVK +++ F E +MR+ H +++K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 742 VSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + NP + ++M+ P G L +L + YSL + + +++AL YL S
Sbjct: 73 IGVITENPVW--IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKR 127
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
+H D+ NVL+ LGDFG+++ L+ + I +MAPE + +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 861 SGDVYSFGILMMETFTR-RKP 880
+ DV+ FG+ M E KP
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-20
Identities = 81/320 (25%), Positives = 132/320 (41%), Gaps = 86/320 (26%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVK-VFNLQED-----RALKSFDTECEVMRRIRHRNL 738
+GSG++ V A G VA+K + N+ +D R L+ E +++R +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 739 IKIVS---SCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVA 787
I ++ S F + + + M + L K + S Q L + +
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKS-------PQPLTDDHIQYFLYQIL 113
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATI 845
L+YLH S +IH DLKP+N+L++ + + DFG+A+ +D + +T + T
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 846 GYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898
Y APE Y ++ I D++S G + E T RKP +F G + Q
Sbjct: 171 WYRAPELLLSSSRY-TKAI-----DIWSVGCIFAELLT-RKP---LFPGRDYIDQL---- 216
Query: 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSL----ALKCSAEIPE-------- 946
+V+ +L EED F T + +Y+ SL S P
Sbjct: 217 -----NLIVE--VLGTPSEED-LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDL 268
Query: 947 ----------ERINVKDALA 956
+RI +ALA
Sbjct: 269 LEKMLVFDPKKRITADEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 62/191 (32%), Positives = 94/191 (49%), Gaps = 12/191 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS-CS 746
+G G F +V G VAVK ++ D ++F E VM ++RH NL++++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL-DIMIDVASALEYLHHGYSTPIIHCD 805
G ++ +YM +GSL +L S S+ L +DV A+EYL + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L NVL+ +D VA + DFG+ K TQ + + APE E S DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 866 SFGILMMETFT 876
SFGIL+ E ++
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 73/271 (26%), Positives = 116/271 (42%), Gaps = 41/271 (15%)
Query: 688 LGSGSFDNVYKAT--LANGVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V K + +G V V V L+++ K F E VM ++ H +++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
C L+M+ P G L K+L + + ++ VA + YL S +
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFV 117
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGIVS 859
H DL NVLL + A + DFG+++ L G T A + + APE + G S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 860 ISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL-LSREDE 917
DV+S+G+ + E F+ KP EM E V ++++ L R +E
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------------VIAMLESGERLPRPEE 222
Query: 918 EDADDFATKKTCISYIMSLALKCSAEIPEER 948
C I S+ L C PE+R
Sbjct: 223 -----------CPQEIYSIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 8e-20
Identities = 70/211 (33%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 686 NLLGSGSFDNVYKAT----LANG---VSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRN 737
N LGSG+F VY+ T L G + VAVK D+ K F E +M H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS------LTIRQRLDIMIDVASALE 791
++K++ C + +IM+ M G L +L LT+++ LDI +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 792 YLHHGYSTPIIHCDLKPNNVLL-----DDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATI 845
YL IH DL N L+ D D V +GDFG+A+ + D + L +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+MAPE +G + DV+SFG+LM E T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM ++ H L+++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED----EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ ++ +YM G L +L H Q L++ DV + YL S IH
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTM-TLATIGYMAPEYGSEGIVSISG 862
DL N L+DD + DFG+++ +LD D T ++ + + + PE S
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 863 DVYSFGILMMETFTRRKPTNEMFT 886
DV++FG+LM E ++ K E F
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKV----FNLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+GSG F V+ VA+K +ED F E +VM ++ H L+++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED-----FIEEAQVMMKLSHPKLVQLYG 66
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
C+ L+ ++M G L +L + + L + +DV + YL S+ +IH
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIH 123
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL N L+ ++ V + DFG+ + + + T T + + +PE S S D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 864 VYSFGILMMETFTRRK 879
V+SFG+LM E F+ K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKI 741
LGSG+F VYK + VA+KV + A K E VM + H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL--HHGYST 799
+ C + LI Q MP G L ++ +H ++ + L+ + +A + YL
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---- 129
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD-GVDPVTQTMTLATIGYMAPEYGSEGIV 858
++H DL NVL+ + DFG+AKLLD I +MA E I
Sbjct: 130 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 859 SISGDVYSFGILMMETFT 876
+ DV+S+G+ + E T
Sbjct: 189 THKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 55/300 (18%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK A K F E E++ ++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRLDIMIDV 786
C + ++ +YM G L K+L +H L + Q L I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATI 845
AS + YL S +H DL N L+ +++ +GDFG+++ + D T+ I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905
+M PE + DV+SFG+++ E FT K + W S +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLSNTEVIEC 237
Query: 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965
+ +L R + C + + L C P++R+N+K+ I KIL
Sbjct: 238 ITQGRVLER-----------PRVCPKEVYDIMLGCWQREPQQRLNIKE-------IYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 687 LLGSGSFDNVYKATLA--NGVSVAVKVFNLQED----RALKSFDTECEVMRRIRHRNLIK 740
+LG G F +V + L+ +G + V V ++ D ++ F +E M+ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 741 IV------SSCSNPGFKALIMQYMPQGSLEKWLYSHN-----YSLTIRQRLDIMIDVASA 789
++ SS +I+ +M G L +L L ++ L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+EYL + IH DL N +L +DM + DFG++K + D Q + + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTR 877
A E ++ + + DV++FG+ M E TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATL--------ANGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
VA +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 141 SCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKI 741
++G G+F V A+K N Q E ++++ E +++ + H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
S + L++ + G L ++ S + Q + ++ ALEYLH S I
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGI 121
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH D+KP+N+LLD+ H+ DF IA + D +T + + T GYMAPE S++
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTP-DTLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 862 GDVYSFGILMMETFTRRKP 880
D +S G+ E ++P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 8/211 (3%)
Query: 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDT-ECEVMRRIRHRNLIKIV 742
N +G GSF V+K A+ A+K +L + +R + E V+ ++ +I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPI 801
S + G ++M+Y G L K L L Q I + L +LH S I
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKI 122
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+H D+K N+ LD +GD G+AKLL T+ + T Y++PE + +
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCEDKPYNEK 181
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
DV++ G+++ E T + P + G + LK
Sbjct: 182 SDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 45/295 (15%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK D A K F E E++ ++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHN------------YSLTIRQRLDIMIDVASA 789
C ++ +YM G L K+L +H LT Q L I +A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYM 848
+ YL S +H DL N L+ ++++ +GDFG+++ + D T+ I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
PE + DV+S G+++ E FT K + W S + +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLSNNEVIECITQ 237
Query: 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
+L R +TC + L L C P R+N+K+ + L+ + K
Sbjct: 238 GRVLQR-----------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 9e-19
Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 36/202 (17%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKIVS 743
LG+GSF V +G A+K+ + + LK + E +++ IRH L+ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGY 797
S + L+M+Y+P G L +SH L R + V ALEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSH---LRKSGRFPEPVARFYAAQVVLALEYLHS-- 119
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEG 856
I++ DLKP N+LLD D + DFG AK + G +T TL T Y+APE
Sbjct: 120 -LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPE----- 168
Query: 857 IVSISG-----DVYSFGILMME 873
I+ G D ++ GIL+ E
Sbjct: 169 IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-18
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL--------ANGVSVAVKVF-NLQEDRALKSFDTECEVMRRI-RHRN 737
LG G F V A V+VAVK+ + D+ L +E E+M+ I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSH------NYSLTIRQRLDI 782
+I ++ +C+ G ++++Y +G+L ++L YS LT + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+L+ E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKIVSSC 745
+G G+F V+ L A+ VAVK LK+ F E ++++ H N+++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ ++M+ + G +L + L +++ + ++ + A+ +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKL-LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
L N L+ + V + DFG+++ DGV T M + + APE + G S DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFA 924
+SFGIL+ E F+ GAV +N +RE E
Sbjct: 180 WSFGILLWEAFSL-----------------------GAVPYANLSNQQTREAIEQGVRLP 216
Query: 925 TKKTCISYIMSLALKCSAEIPEERIN 950
+ C + L +C P +R +
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K ++F E ++M+++RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 748 -PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
P + ++ ++M +GSL +L + L + Q +D+ +A + Y+ IH D
Sbjct: 73 EPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L+ N+L+ D++V + DFG+A+L++ + + I + APE G +I DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 866 SFGILMMETFTR-RKPTNEMFTGEM 889
SFGIL+ E T+ R P M E+
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+ V+KA G +VA+K L+ E E + ++ +H ++K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ L+M+YMP L + L L Q M + + Y+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGS----EGIV 858
DLKP N+L+ D V + DFG+A+L +P + +AT Y APE YG+ G+
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV- 182
Query: 859 SISGDVYSFGILMME 873
D+++ G + E
Sbjct: 183 ----DLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFN-----------LQEDRALKSFDTECEVM 730
LG GSF VY+ V VA+K N L E +K F+ V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH--------NYSLTIRQRLDI 782
R L+ +VS+ P ++M+ M +G L+ +L S Q+
Sbjct: 73 R------LLGVVST-GQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 783 M-IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD---PVTQ 838
M ++A + YL + +H DL N ++ +D+ +GDFG+ + + D +
Sbjct: 124 MAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ + +MAPE +G+ + DV+SFG+++ E T
Sbjct: 181 GLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 688 LGSGSFDNVYKATLANG---------VSVAVKVF-NLQEDRALKSFDTECEVMRRI-RHR 736
LG G F V +A A G V+VAVK+ + D+ L +E E+M+ I +H+
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY---------------SHNYSLTIRQRLD 781
N+I ++ C+ G +I++Y +G+L ++L L+ + +
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 842 -LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFGILM E FT
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 3e-18
Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 63/301 (20%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNL-QEDRALKSFDT---ECEVMRRIRHRNLIKIV 742
LG G++ VYKA G VA+K L E+ + S T E +++ ++H N++K++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS--TALREISLLKELKHPNIVKLL 64
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPI 801
L+ +Y L+K+L L+ IM + L Y H H I
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR----I 119
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-------YGS 854
+H DLKP N+L++ D V L DFG+A+ G+ T T + T+ Y APE Y
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVVTLWYRAPEILLGSKHY-- 176
Query: 855 EGIVSISGDVYSFGILMMETFTRR--------------------KPTNEMFTGEMSLKQW 894
S + D++S G + E T + PT E + G L +
Sbjct: 177 ----STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 895 VAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDA 954
+ P +L R D E D ++S L+ + P +RI+ K+A
Sbjct: 233 -KPTFP-KFPPKDLEKVLPRLDPEGID-----------LLSKMLQYN---PAKRISAKEA 276
Query: 955 L 955
L
Sbjct: 277 L 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 686 NLLGSGSFDNVYKATL---ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRI-RHRNLIK 740
+++G G+F V +A + ++ A+K+ + + F E EV+ ++ H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWL---------------YSHNYSLTIRQRLDIMID 785
++ +C N G+ + ++Y P G+L +L + +LT +Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLAT 844
VA+ ++YL IH DL NVL+ +++ + + DFG+++ G + V +TM
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMME 873
+ +MA E + + + DV+SFG+L+ E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 35/265 (13%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG+G F V+ VA+K +L++ + ++F E +M++++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 747 N-PGFKALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
P + +I +YM GSL +L LTI + +D+ +A + ++ IH
Sbjct: 72 QEPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHR 126
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL+ N+L+ + + + DFG+A+L++ + + I + APE + G +I DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 865 YSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923
+SFGIL+ E T R P PG V NL E
Sbjct: 187 WSFGILLTEIVTYGRIP------------------YPGMTNPEVIQNL------ERGYRM 222
Query: 924 ATKKTCISYIMSLALKCSAEIPEER 948
C + L C E PEER
Sbjct: 223 PRPDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 688 LGSGSFDNVYKA---TLANG---VSVAVKVFN------LQEDRALKSFDTECEVMRRIRH 735
LG G+F VYK SVA+K +Q++ F E E+M ++H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-----FRQEAELMSDLQH 67
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRL 780
N++ ++ C+ ++ +Y+ G L ++L ++ SL L
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 781 DIMIDVASALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-T 837
I I +A+ +EYL HH +H DL N L+ + + + DFG+++ + D
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
Q+ +L + +M PE G + D++SFG+++ E F+
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG GS+ +VYKA G VA+KV ++ED L+ E ++++ ++K S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
++M+Y GS+ + N +LT + I+ LEYLH S IH D
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRD 124
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT--IG---YMAPEYGSEGIVSI 860
+K N+LL+++ A L DFG++ L T TM IG +MAPE ++
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQL------TDTMAKRNTVIGTPFWMAPE-----VIQE 173
Query: 861 SG-----DVYSFGILMMETFTRRKP 880
G D++S GI +E + P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-18
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQ-EDRALKSFDTECEVMRRI-RHRN 737
LG G F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L Y +N + L+ + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 53/193 (27%), Positives = 97/193 (50%), Gaps = 5/193 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ N VAVK ++++F E +M+ ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM +GSL +L S + + + +D +A + Y+ IH DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ NVL+ + ++ + DFG+A++++ + + I + APE + G +I DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 867 FGILMMETFTRRK 879
FGIL+ E T K
Sbjct: 190 FGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 688 LGSGSFDNVYKATLANGVS-------VAVKVF----NLQEDRALKSFDTECEVMRRI-RH 735
LG+G+F V +AT A G+S VAVK+ + E AL S E ++M + H
Sbjct: 43 LGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELKIMSHLGNH 98
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLH 794
N++ ++ +C+ G +I +Y G L +L S LT+ L VA + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYG 853
S IH DL NVLL + + DFG+A+ +++ + V + + +MAPE
Sbjct: 159 ---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 854 SEGIVSISGDVYSFGILMMETFT 876
+ + DV+S+GIL+ E F+
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 53/211 (25%), Positives = 107/211 (50%), Gaps = 11/211 (5%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
++G+G F V++ L V+VA+K ++ + F +E +M + H N+I++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ +I +YM G+L+K+L H+ + Q + ++ +A+ ++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNY 128
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG--YMAPEYGSEGIVS 859
+H DL N+L++ ++ + DFG++++L+ T T + I + APE + +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 860 ISGDVYSFGILMMETFTR-RKPTNEMFTGEM 889
+ DV+SFGI+M E + +P +M E+
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 71/274 (25%), Positives = 107/274 (39%), Gaps = 42/274 (15%)
Query: 687 LLGSGSFDNVYKATLANG----VSVAVKVFNLQEDR---ALKSFDTECEVMRRIRHRNLI 739
LG GSF V + + + VAVK L+ D+ + F E +M + H NLI
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++ ++ + P GSL ++ I D + +A+ + YL S
Sbjct: 60 RLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---S 115
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLAT-IGYMAPEYGSEG 856
IH DL N+LL D +GDFG+ + L D L + APE
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFT-GEMSLKQWVAESLPGA-VTEVVDANLLSR 914
S + DV+ FG+ + EMFT GE W L G+ + + +D
Sbjct: 176 TFSHASDVWMFGVTLW----------EMFTYGEEP---WAG--LSGSQILKKIDKEGERL 220
Query: 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
E E C I ++ L+C A P +R
Sbjct: 221 ERPEA---------CPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNL-----QEDRALKSFDTECEVMRRIRHRNLIKI 741
+G GSF V K ++G + K + +E + L S E ++R ++H N+++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS---EVNILRELKHPNIVRY 64
Query: 742 VSSCSNPGFKAL--IMQYMPQGSLEKWL---YSHNYSLTIRQRLDIMIDVASALEYLHHG 796
+ + L +M+Y G L + + + I+ + AL H+
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 797 Y--STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
++H DLKP N+ LD + LGDFG+AK+L +T + T YM+PE +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQLN 183
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
D++S G L+ E P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G+ VY A L N VA+K +L++ + + E + M + H N++K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLH-HGYS 798
L+M Y+ GSL + +Y LD ++ +V LEYLH +G
Sbjct: 69 VVGDELWLVMPYLSGGSLLD-IMKSSYPRGG---LDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGI-AKLLDGVDPVTQTMTLATIG---YMAPEYGS 854
IH D+K N+LL +D + DFG+ A L DG D T+ + +G +MAPE
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGTPCWMAPEVME 179
Query: 855 EGI-VSISGDVYSFGILMMETFTRRKP 880
+ D++SFGI +E T P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIK 740
LLGSGSF +VY+ L +G AVK +L +D A+K + E ++ +++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLT-------IRQRLDIMIDVASALEYL 793
+ + + ++ +P GSL K L S RQ L LEYL
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILL-------GLEYL 118
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAP 850
H +H D+K N+L+D + V L DFG+AK + V + + G +MAP
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-----VEFSFAKSFKGSPYWMAP 170
Query: 851 EY-GSEGIVSISGDVYSFGILMMETFTRRKPTNEMF 885
E +G ++ D++S G ++E T + P +++
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 687 LLGSGSFDNVYKATLAN-GVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIK 740
LLG G+F VY + G +AVK D + + + + E ++++ ++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGY 797
+ ++ M+YMP GS++ L ++ ++T + I+ +EYLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLH--- 121
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD-------GVDPVTQTMTLATIGYMAP 850
S I+H D+K N+L D LGDFG +K L G+ VT T +M+P
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-----GTPYWMSP 176
Query: 851 E------YGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E YG + DV+S G ++E T + P E
Sbjct: 177 EVISGEGYGRK------ADVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA G+ A K+ ++ + L+ F E +++ +H N++ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+++++ G+L+ + LT Q + + AL +LH S +IH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGSEGIVSI 860
K N+LL D L DFG++ T + T +MAPE +
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYDYK 188
Query: 861 SGDVYSFGILMMETFTRRKPTNEM 884
+ D++S GI ++E P +E+
Sbjct: 189 A-DIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS- 746
LG+G F V+ AT VAVK ++++F E VM+ ++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID----VASALEYLHHGYSTPII 802
P + +I ++M +GSL +L S S +Q L +ID +A + ++ I
Sbjct: 73 EPIY--IITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DL+ N+L+ +V + DFG+A++++ + + I + APE + G +I
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 863 DVYSFGILMMETFTR-RKPTNEMFTGEM 889
DV+SFGIL+ME T R P M E+
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-16
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 27/175 (15%)
Query: 468 YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAF 527
+I + L G +P +I L L +NL+GN + G IP S+G++ +L+ L L+ N+F
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 528 QGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVN 587
G IP+S G L SL+ L+L+GN++SG +P +L G N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFN 521
Query: 588 FTADSFKQNYALCGSSRLQVPPCKTSSTHKSKATKIVLRYILPAIATTMVVVALF 642
FT N LCG +P + H S KI + + + +V+ A+
Sbjct: 522 FT-----DNAGLCG-----IPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG G F V + + + A+K + E + +E E++ H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNY--SLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ + + ++M+Y G L L T R + ++ A EYLH + I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLH---NRGI 114
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIV-- 858
I+ DLKP N+LLD + L DFG AK L +T T T Y+APE I+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKS---GQKTWTFCGTPEYVAPE-----IILN 166
Query: 859 ---SISGDVYSFGILMMETFTRRKPTNEMFTGE 888
S D +S GIL+ E T R P F +
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
++G+G F V L + VA+K ++ + F +E +M + H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 742 --VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYS 798
V + S P ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 71 EGVVTKSKPVM--IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY- 127
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP---VTQTMTLATIGYMAPEYGSE 855
+H DL N+L++ ++V + DFG++++L+ DP T I + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 856 GIVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI+M E + +P EM
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 15/209 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRAL-KSFDTECEVMRRIRHRN 737
E + LG G+ +V K L G+ A+K + L K E E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 738 LIKIVSSCSNP--GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA----SALE 791
++K + + + M+Y GSL+ +Y R ++ +A L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
YLH S IIH D+KP+N+LL L DFG++ L V+ + T T T YMAPE
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFT-GTSFYMAPE 173
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKP 880
SI+ DV+S G+ ++E R P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+GSG++ +VYKA +A G VA+KV L+ + E +++ RH N++ S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+Y GSL+ L+ Q + + L YLH T IH D+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDI 127
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-----LATIGYMAPEYGSEGIVSIS 861
K N+LL +D L DFG++ L T T+ + T +MAPE +
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAPEVAAVE--RKG 179
Query: 862 G-----DVYSFGILMME 873
G D+++ GI +E
Sbjct: 180 GYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT--ECEVMRRIRHRNLIKIVS 743
LG GS+ +VYK L++ A+K +L + D E ++ + H N+I
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYS---LTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + ++M+Y P G L K + + ++ I I + L+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPEYGSEGI 857
I+H DLK N+LL + + +GD GI+K+L + M IG YMAPE
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL------KKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
S D++S G L+ E T P ++ K
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 688 LGSGSFDNVYKATL---ANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIVS 743
LGSG+F V K + VA+KV + +++++ E E+M ++ + +++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
C L+M+ G L K+L +T+ +++M V+ ++YL +H
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT--IGYMAPEYGSEGIVSIS 861
DL NVLL + A + DFG++K L D + + + + APE + S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 862 GDVYSFGILMMETFTR-RKPTNEM 884
DV+S+GI M E F+ +KP +M
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 62/234 (26%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 659 NNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKV-FNLQE 716
+++ A + S EL++ N +GSG+ VYK G A+KV + E
Sbjct: 60 SSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE 112
Query: 717 DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTI 776
D + E E++R + H N++K + G +++++M GSLE + L
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA- 171
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
D+ + S + YLH I+H D+KP+N+L++ + DFG++++L
Sbjct: 172 ----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL------ 218
Query: 837 TQTM-----TLATIGYMAPEYGSEGIV-----SISGDVYSFGILMMETFTRRKP 880
QTM ++ TI YM+PE + + +GD++S G+ ++E + R P
Sbjct: 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVFNL------QEDRALKS----FDTECEVMRRIRH 735
L+G G++ VY A + G +AVK L + D K +E E ++ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN-------YSLTIRQRLDIMIDVAS 788
N+++ + + + ++ ++Y+P GS+ L ++ T Q L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT-EQVL-------E 119
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGY 847
L YLH S I+H DLK +N+L+D D + + DFGI+K D + Q M++ ++ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 848 MAPEYGSEGIVSISG--DVYSFGILMMETFTRRKPTNEM 884
MAPE S D++S G +++E F R+P ++
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 55/208 (26%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRAL---KSFDTECEVMRRI-RHRNLIK 740
+++G G+F V KA + +G+ + + ++E + + F E EV+ ++ H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWL---------------YSHNYSLTIRQRLDIMID 785
++ +C + G+ L ++Y P G+L +L S +L+ +Q L D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
VA ++YL IH DL N+L+ ++ VA + DFG+++ + V +TM +
Sbjct: 133 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPV 187
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMME 873
+MA E + + + + DV+S+G+L+ E
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 26/286 (9%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFD--TECEVMRRIRHRNLIK 740
LG G F V Y N G VAVK E D E E++R + H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 741 IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
C+ G LIM+++P GSL+++L + + ++Q+L + + ++YL S
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---S 127
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---GVDPVTQTMTLATIGYMAPEYGSE 855
+H DL NVL++ + +GDFG+ K ++ V + Y APE +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQ 186
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915
I+ DV+SFG+ + E T + T + LK VT +V +L
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVTRLV--RVL--- 239
Query: 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961
E+ C + L KC P +R ++ + + I
Sbjct: 240 --EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 687 LLGSGSFDNVYKATL----ANGVSVAVKVF--NLQEDRALKSFDTECEVMRRIRHRNLIK 740
+LG G F +V +A L + VAVK+ ++ ++ F E M+ H N+IK
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 741 I--VSSCSNPGFK----ALIMQYMPQGSLEKWLYSHN-----YSLTIRQRLDIMIDVASA 789
+ VS S + +I+ +M G L +L ++L ++ + MID+AS
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ-TMTLATIGYM 848
+EYL S IH DL N +L+++M + DFG++K + D Q + + ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTR 877
A E ++ + + DV++FG+ M E TR
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 55/208 (26%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIK 740
+++G G+F V KA + +G+ + + ++E + F E EV+ ++ H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWL---------------YSHNYSLTIRQRLDIMID 785
++ +C + G+ L ++Y P G+L +L S +L+ +Q L D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
VA ++YL IH DL N+L+ ++ VA + DFG+++ + V +TM +
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPV 175
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMME 873
+MA E + + + + DV+S+G+L+ E
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 84/319 (26%), Positives = 127/319 (39%), Gaps = 71/319 (22%)
Query: 686 NLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDT--------------ECEVM 730
LG G++ V KA G VA+K + E + D E ++M
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL 790
I+H N++ +V F L+M M L+K + LT Q I++ + + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT----------- 839
LH Y +H DL P N+ ++ + + DFG+A+ G P + T
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY-GYPPYSDTLSKDETMQRRE 188
Query: 840 -MT--LATIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ- 893
MT + T+ Y APE G+E + D++S G + E T KP +F GE + Q
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHF-AVDMWSVGCIFAELLTG-KP---LFPGENEIDQL 243
Query: 894 --------------W-VAESLPGAVTEVVDANLLSRED--EEDADDFATKKTCISYIMSL 936
W A+ LP TE + +DD I + SL
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLP-LYTEFTPRKPKDLKTIFPNASDD------AIDLLQSL 296
Query: 937 ALKCSAEIPEERINVKDAL 955
LK + P ERI+ K+AL
Sbjct: 297 -LKLN---PLERISAKEAL 311
|
Length = 335 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK---VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G G F VY+AT L +GV VA+K +F+L + +A E ++++++ H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTI---RQRLDIMIDVASALEYLHHGYSTP 800
S ++++ G L + + + + + + SALE++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
++H D+KP NV + V LGD G+ + ++ + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYNF 185
Query: 861 SGDVYSFGILMMETFTRRKP 880
D++S G L+ E + P
Sbjct: 186 KSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 64/226 (28%), Positives = 93/226 (41%), Gaps = 62/226 (27%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G GSF VYKA VA+KV +L+E + E E +++ I+ +S C
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA------EDEIEDIQQ-----EIQFLSQC 56
Query: 746 SNP-----------GFK-ALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVA 787
+P G K +IM+Y GS L +LD I+ +V
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSC--------LDLLKPGKLDETYIAFILREVL 108
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-----L 842
LEYLH IH D+K N+LL ++ L DFG++ L T TM+ +
Sbjct: 109 LGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL------TSTMSKRNTFV 159
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
T +MAPE + D++S GI E+ GE
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGI----------TAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 56/154 (36%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIM----IDVASALEYLHHGYSTPIIHCDLKPNN 810
M+ M SL+K Y Y + DI+ + + ALEYLH S +IH D+KP+N
Sbjct: 79 MEVM-DTSLDK-FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSN 134
Query: 811 VLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY----GSEGIVSISGDVYS 866
VL++ + L DFGI+ L VD V +T+ YMAPE ++ + DV+S
Sbjct: 135 VLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWS 192
Query: 867 FGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
GI M+E T R P + T LKQ V E P
Sbjct: 193 LGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-15
Identities = 41/114 (35%), Positives = 62/114 (54%), Gaps = 24/114 (21%)
Query: 399 GLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST 458
GL L++ L+GFIP D+ KL L ++ + N+++G IP L ++TSL L
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL---------- 471
Query: 459 IPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIG 512
D S NS +GS+P ++G L +L LNL GN LSG +P+++G
Sbjct: 472 --------------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 24/197 (12%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKIV 742
+G+G+F V+ + A+KV + E LK E V++ + H +I++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ + F ++M+Y+P G L +L + + L ++ ALEYLH S I+
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIV 123
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVSIS 861
+ DLKP N+LLD + L DFG AK L +T TL T Y+APE ++
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPE-----VIQSK 173
Query: 862 G-----DVYSFGILMME 873
G D ++ GIL+ E
Sbjct: 174 GHNKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG G+F VY+ + V + V V L E + + F E +M + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 739 IKIVSSC--SNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASAL 790
++++ P F L + M G L+ +L SLT++ L DVA
Sbjct: 72 VRLIGVSFERLPRFILL--ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQT-MTLATIG 846
+YL IH D+ N LL VA + DFG+A+ + + + I
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+M PE +GI + DV+SFG+L+ E F+
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 10/195 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LGSG F V+ + VA+K N + E+ F E +VM ++ H L+++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE----DFIEEAKVMMKLSHPKLVQLYGV 67
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ ++ ++M G L +L L+ L + DV +EYL IH
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHR 124
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L+ V + DFG+ + + + + + + + PE + S DV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 865 YSFGILMMETFTRRK 879
+SFG+LM E FT K
Sbjct: 185 WSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA G A KV + + L+ + E E++ H ++K++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
G +++++ P G+++ + + LT Q I + AL+YLH S IIH DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136
Query: 807 KPNNVLLDDDMVAHLGDFGIA----KLLDGVDPVTQTMTLATIGYMAPEY-----GSEGI 857
K NVLL D L DFG++ K L D + T +MAPE +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-----IGTPYWMAPEVVMCETMKDTP 191
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
D++S GI ++E P +E+ + LK +A+S P
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSEP 232
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 51/200 (25%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
++G+G F V + L + VA+K ++ + F +E +M + H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ +I ++M G+L+ +L ++ T+ Q + ++ +A+ ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG+++ L D DP T T +L I + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSSLGGKIPIRWTAPEAIAYR 186
Query: 857 IVSISGDVYSFGILMMETFT 876
+ + DV+S+GI+M E +
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 54/243 (22%), Positives = 102/243 (41%), Gaps = 26/243 (10%)
Query: 687 LLGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLI 739
LG G F V+ A V VK +D L+S F E ++ R++ H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWL--------YSHNYSLTIRQRLDIMIDVASALE 791
+++ C +I++Y G L+++L L+ +Q++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
+L + +H DL N L+ + ++K + + L + ++APE
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 852 YGSEGIVSISGDVYSFGILMMETFTR-----RKPTNEMF---TGEMSLKQWVAESLPGAV 903
E S DV+SFG+LM E FT+ ++E L+ V E P +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 904 TEV 906
++
Sbjct: 249 YKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 13/211 (6%)
Query: 688 LGSGSFDNVYKA---TLANGVSVAVKVF-NLQEDRALK-SFDTECEVMRRIRHRNLIKIV 742
LGSG+F V K + +VAVK+ N D ALK E VM+++ + +++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
C + L+M+ G L K+L N +T + +++ V+ ++YL T +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEE---TNFV 117
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT--IGYMAPEYGSEGIVSI 860
H DL NVLL A + DFG++K L + + T + + APE + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 861 SGDVYSFGILMMETFTR-RKPTNEMFTGEMS 890
DV+SFG+LM E F+ +KP M E++
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 35/217 (16%)
Query: 687 LLGSGSFDNVYKATLA-NGVSVAVKVFNL------QEDRALKSFDT---ECEVMRRIRHR 736
L+GSGSF +VY A +G +AVK L +DR D E +++ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNY-----SLT---IRQRLDIMIDVAS 788
N+++ + S + + ++Y+P GS+ L +NY +L +RQ L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQIL-------K 117
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-----LA 843
L YLH + IIH D+K N+L+D+ + DFGI+K L+ T+T
Sbjct: 118 GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
++ +MAPE + + D++S G L++E T + P
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D ++ F E +M+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ S ++ T++ + + VA +EYL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD-----PVTQTMTLATIGYMAPEYGS 854
+H DL N +LD+ + DFG+A+ D D T + +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK---VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G G F VY+AT L + VA+K +F + + +A + E ++++++ H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 744 SCSNPGFKALIMQYMPQGSLEKWL-YSHNYSLTIRQRL--DIMIDVASALEYLHHGYSTP 800
S ++++ G L + + Y I +R + + SA+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
++H D+KP NV + V LGD G+ + ++ + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYNF 185
Query: 861 SGDVYSFGILMMETFTRRKP 880
D++S G L+ E + P
Sbjct: 186 KSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 12/222 (5%)
Query: 687 LLGSGSFDNVYKAT-LANG----VSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIK 740
+LGSG+F VYK + G + VA+K+ N +A F E +M + H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
++ C +P + L+ Q MP G L +++ H ++ + L+ + +A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RR 129
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVS 859
++H DL NVL+ + DFG+A+LL+G + I +MA E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 860 ISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLP 900
DV+S+G+ + E T KP + + T E+ E LP
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVA---VKVFNLQEDRALKSFDTECEVMRRIR 734
F +G G F VYKA L +G VA V++F + + +A + E ++++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLE---KWLYSHNYSLTIRQRLDIMIDVASALE 791
H N+IK ++S ++++ G L K + R + + SALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT----LATIGY 847
++H S I+H D+KP NV + V LGD G+ + ++T + T Y
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-----SKTTAAHSLVGTPYY 172
Query: 848 MAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE-MSL 891
M+PE E + D++S G L+ E + P F G+ M+L
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 75/308 (24%), Positives = 126/308 (40%), Gaps = 63/308 (20%)
Query: 688 LGSGSFDNVYKAT------LANGVSVAVKVF----NLQEDRALKSFDTECEVMRRIRHRN 737
LG G F V KAT A +VAVK+ + E R L S E +++++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS---EFNLLKQVNHPH 64
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL--------------YSHNYS---------L 774
+IK+ +CS G LI++Y GSL +L + N S L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 775 TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834
T+ + ++ ++YL ++H DL NVL+ + + DFG+++ + D
Sbjct: 125 TMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 835 P-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
V ++ + +MA E + I + DV+SFG+L+ E T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG--------------- 226
Query: 894 WVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKD 953
PG E + NLL + + C + +L L C + P++R D
Sbjct: 227 --GNPYPGIAPERL-FNLLKTGYRMERPE-----NCSEEMYNLMLTCWKQEPDKRPTFAD 278
Query: 954 ALADLKKI 961
+L+K+
Sbjct: 279 ISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 684 ESNLLGSGSFDNVYKAT-LANGVSVAVK--VFNLQEDRALKSFDTECEVMRRIR---HRN 737
E +G G++ VYKA L G VA+K L E+ S E +++++ H N
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 738 LIKIVSSCSNPGFK-----ALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALE 791
+++++ C P L+ +++ Q L +L L D+M + ++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
+LH S I+H DLKP N+L+ D + DFG+A++ + T + T+ Y APE
Sbjct: 122 FLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPE 176
Query: 852 ------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
Y + D++S G + E F RR+P +F G Q
Sbjct: 177 VLLQSSYAT------PVDMWSVGCIFAELF-RRRP---LFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRAL--KSFDTECEVMRRIRHRNLIKIVS 743
++G G++ V K A G VA+K F ED K+ E +V+R++RH N++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ G L+ +Y+ + LE L + L + + A+ Y H S IIH
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-------YGSEG 856
D+KP N+L+ + V L DFG A+ L T +AT Y APE YG
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK-- 181
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
DV++ G +M E +F G+ + Q
Sbjct: 182 ----PVDVWAIGCIMAELLDGEP----LFPGDSDIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 688 LGSGSFDNVYKATLANG---VSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F +V + L + VAVK + ++ F +E M+ H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 743 SSC----SNPGFKA--LIMQYMPQGSLEKWL-YSH----NYSLTIRQRLDIMIDVASALE 791
C + G+ + +I+ +M G L +L YS L + + M D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ-TMTLATIGYMAP 850
YL S IH DL N +L+++M + DFG++K + D Q + + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTR 877
E ++ + + DV+SFG+ M E TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 46/221 (20%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTEC----EV--MRRI-RHRNLI 739
LG G+F +VY A G VA+K + S++ EC EV +R++ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL----TIRQRLDIMIDVASALEYLH- 794
K+ + +YM +G+L + + IR I+ + L ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR---SIIYQILQGLAHIHK 117
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--- 851
HG+ H DLKP N+L+ V + DFG+A+ + P T ++T Y APE
Sbjct: 118 HGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTRWYRAPEILL 171
Query: 852 ----YGSEGIVSISGDVYSFGILMMETFTRRKP----TNEM 884
Y S D+++ G +M E +T R P ++E+
Sbjct: 172 RSTSYSS------PVDIWALGCIMAELYTLR-PLFPGSSEI 205
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 687 LLGSGSFDNVYKATL---ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI---RHRNLIK 740
LLGSG F V+K + + + V + +Q+ ++F + M + H +++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
++ C + L+ Q P GSL + H SL ++ L+ + +A + YL H
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT-IGYMAPEYGSEGIV 858
++H +L N+LL D + + DFG+A LL D T I +MA E G
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 859 SISGDVYSFGILMMETFT 876
+ DV+S+G+ + E +
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 682 FGESNL-----LGSGSFDNVYKATLAN-GVSVAVK-----VFNLQEDRALKSFDTECEVM 730
F +L +G G+F V K G +AVK V ++ R L D VM
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV---VM 57
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMI 784
R ++K + G + M+ M SL+K Y + Y + + + I +
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVL-KSVIPEEILGKIAV 114
Query: 785 DVASALEYL---HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
AL YL IIH D+KP+N+LLD + L DFGI+ L VD + +T
Sbjct: 115 ATVKALNYLKEELK-----IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRD 167
Query: 842 LATIGYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKP 880
YMAPE +G + DV+S GI + E T + P
Sbjct: 168 AGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 687 LLGSGSFDNVYKATLAN-GVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIK 740
LLG G+F VY A+ G +AVK + + + + + E ++++ + H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 741 IVSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+P + L M++MP GS++ L S+ +LT + + YLH S
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---S 124
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA----PEYGS 854
I+H D+K N+L D LGDFG +K L QT+ L+ G + P + S
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRL-------QTICLSGTGMKSVTGTPYWMS 177
Query: 855 EGIVSISG-----DVYSFGILMMETFTRRKPTNE 883
++S G D++S G ++E T + P E
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 70/306 (22%), Positives = 129/306 (42%), Gaps = 57/306 (18%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV------SVAVKVFNLQEDRALKS-FDTE 726
E+ +T F E LG F VYK L +VA+K + + L+ F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 727 CEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY---------SHNYSLTIR 777
+ R++H N++ ++ + ++I Y L ++L S + T++
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 778 QRLD------IMIDVASALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
L+ I+ +A+ +E+L HH ++H DL NVL+ D + + D G+ +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 830 LDGVDPVTQTM--TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG 887
+ D + M +L I +M+PE G SI D++S+G+++ E F+
Sbjct: 174 VYAAD-YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS----------- 221
Query: 888 EMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE 947
L+ + S + + + +L D+ C +++ +L L+C E P
Sbjct: 222 -YGLQPYCGYSNQDVIEMIRNRQVLPCPDD-----------CPAWVYTLMLECWNEFPSR 269
Query: 948 RINVKD 953
R KD
Sbjct: 270 RPRFKD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 55/223 (24%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 688 LGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLI 739
LG GSF VY+ +A GV VA+K N R F E VM+ +++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYS------HNYSL---TIRQRLDIMIDVASAL 790
+++ S +IM+ M +G L+ +L S +N ++++ + + ++A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYMA 849
YL+ + +H DL N ++ +D +GDFG+ + + D + L + +M+
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRH---RNLIKI 741
L+G G++ VY+ + G VA+K+ NL D + E ++ ++R N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLHH 795
S +IM+Y GS+ +L + I+ +V AL+Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVR--------TLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
+IH D+K N+L+ + L DFG+A LL+ T T +MAPE +E
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 856 GIV-SISGDVYSFGILMMETFTRRKP 880
G D++S GI + E T P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 58/192 (30%), Positives = 88/192 (45%), Gaps = 17/192 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA+K NLQ+ + E VMR +H N++ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 747 NPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
++M+Y+ GSL E + + R+ L ALE+LH S +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH---SNQV 136
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH D+K +N+LL D L DFG + TM + T +MAPE +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 195
Query: 862 GDVYSFGILMME 873
D++S GI+ +E
Sbjct: 196 VDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT------ECEVMRRIRHRNLI 739
LG+G+F + Y+A + G +AVK + + + + E +M R+ H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNY-----SLTIRQRLDIMIDVASALEYLH 794
+++ + L +++M GS+ L Y ++ I ++ ++ YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLS----YLH 120
Query: 795 HGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLLD----GVDPVTQTMTLATIGYMA 849
IIH D+K N+L+D + DFG A L G Q L TI +MA
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF-QGQLLGTIAFMA 176
Query: 850 PE------YGSEGIVSISGDVYSFGILMMETFTRRKPTN 882
PE YG S DV+S G +++E T + P N
Sbjct: 177 PEVLRGEQYGR------SCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 10/198 (5%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG G F V + G A K + L++ + + E +++ ++ R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI-MIDVASALEYLHHGYSTPII 802
+ L+M M G L+ +Y+ R + LE+LH I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
+ DLKP NVLLDD + D G+A L G + T GYMAPE + S
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFSV 175
Query: 863 DVYSFGILMMETFTRRKP 880
D ++ G + E R P
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G GS+ V +G +K NL+ R K+ + E +++ +++H N++ S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 745 CSNP-GFKALIMQYMPQGSLEKWLYSHNYSLTI-RQRLDIMIDVASALEYLHHGYSTPII 802
G ++M + G L L L Q ++ + +A AL+YLH + I+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK NV L + +GD GIA++L+ + T+ + T YM+PE S +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPELFSNKPYNYKS 183
Query: 863 DVYSFGILMMETFTRRKPTN 882
DV++ G + E T + N
Sbjct: 184 DVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG +F +YK L + VA+K ++ + F E +M + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLY----------SHNYSLTIRQRLD------IMID 785
+ + ++ +Y+ QG L ++L S + T++ LD I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLAT 844
+A+ +EYL + +H DL N+L+ + + + D G+++ + D Q +L
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
I +M PE G S D++SFG+++ E F+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIK 740
LLG G+F VY + G +A K + + + + + E ++++ ++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 741 IVSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ K L M+YMP GS++ L ++ +LT + + YLH S
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---S 124
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---------YMA 849
I+H D+K N+L D LGDFG +K L QT+ ++ G +M+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL-------QTICMSGTGIRSVTGTPYWMS 177
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
PE S DV+S G ++E T + P E
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 62/213 (29%), Positives = 85/213 (39%), Gaps = 34/213 (15%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNL---QEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G GSF VY A + VA+K + Q + + E ++++RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE--- 79
Query: 744 SCSNPGFKA---------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
+K L+M+Y GS L H L + I L YLH
Sbjct: 80 ------YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY-- 852
S IH D+K N+LL + L DFG A L V P + T +MAPE
Sbjct: 133 ---SHERIHRDIKAGNILLTEPGTVKLADFGSASL---VSPANS--FVGTPYWMAPEVIL 184
Query: 853 -GSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
EG DV+S GI +E R+ P M
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECEVM-RRI-----RHRNLI 739
+LG GSF V A L V A+KV L++D L+ D +C + +RI +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYS 798
+ +M+Y+ G L + R R +V AL +LH HG
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG-- 116
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGI 857
+I+ DLK +N+LLD + L DFG+ K +G+ T T T Y+APE E
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
S D ++ G+LM E + P
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 43/163 (26%), Positives = 83/163 (50%), Gaps = 25/163 (15%)
Query: 722 SFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
+ EC+V++ + H N+I+ + ++M+Y P G+L ++ I++R +
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEY---------IQKRCN 95
Query: 782 IMIDVASALEY-------LHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGV 833
++D + L + LHH ++ I+H DLK N+LLD MV +GDFGI+K+L
Sbjct: 96 SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--- 152
Query: 834 DPVTQTMTLATIG---YMAPEYGSEGIVSISGDVYSFGILMME 873
+++ +G Y++PE + D+++ G ++ E
Sbjct: 153 --SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDT-ECEVMRRIRHRNLIKIVSSC 745
LG G++ VYK G VA+K +L + S E +M+ ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS----TPI 801
L+ +YM + L+K++ +H +R LD V S L G + +
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTH----GVRGALDPNT-VKSFTYQLLKGIAFCHENRV 121
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVS 859
+H DLKP N+L++ L DFG+A+ G+ T + + T+ Y AP+ GS S
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVVTLWYRAPDVLLGSR-TYS 179
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTG 887
S D++S G +M E T R +F G
Sbjct: 180 TSIDIWSVGCIMAEMITGRP----LFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 35/89 (39%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 327 LVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGA 386
L LD L+G IPN I L L++ + + G IP G++++L VL L N G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 387 IPTVLGKLQKLQGLDLNSNKLKGFIPTDL 415
IP LG+L L+ L+LN N L G +P L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 687 LLGSGSFDNVY---KATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRR-----IRHRN 737
+LG GSF V+ K T + G A+KV + LK D M R + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
++K+ + G LI+ ++ G L L S T + ++A AL++LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEG 856
S II+ DLKP N+LLD++ L DFG++K + +D + + T+ YMAPE +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ S D +SFG+LM E T P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 64/225 (28%), Positives = 91/225 (40%), Gaps = 60/225 (26%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVF----NLQE--------DRALKSFD--------- 724
+GSG+ VYK G +AVK N +E D LKS D
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 725 ---TECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
T+ +V I ++++S+C + I +P+ L K +
Sbjct: 82 YFITDSDV--FI----CMELMSTCLDK-LLKRIQGPIPEDILGKMTVA------------ 122
Query: 782 IMIDVASALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839
+ AL YL HG +IH D+KP+N+LLD L DFGI+ L VD +T
Sbjct: 123 ----IVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKT 172
Query: 840 MTLATIGYMAPEY----GSEGIVSISGDVYSFGILMMETFTRRKP 880
+ YMAPE I DV+S GI ++E T + P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTEC-EVMRRI-----RHRNLI 739
+LG GSF V A L + AVKV L++D L+ D EC +R+ +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYL 793
++ S +M+Y+ G L + + R D ++ L++L
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLM-------FHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 794 H-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYMAP 850
H G II+ DLK +NVLLD + + DFG+ K +L G VT + T Y+AP
Sbjct: 113 HERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYIAP 165
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKP 880
E S + D ++ G+L+ E + P
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 12/227 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 128 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLP 900
I + DV+S+G+ + E T KP + + E+S E LP
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 82/306 (26%), Positives = 132/306 (43%), Gaps = 64/306 (20%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT---------ECEVMRRIRHRN 737
+GSG++ V A +G VA+K + +FD E +++R +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 738 LIKIVSSCSNPG--FKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
+I I PG FK ++M M + L ++S + LT + + L+Y+
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYI 123
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT--MT--LATIGYMA 849
H S +IH DLKP+N+L+++D +GDFG+A+ L P MT +AT Y A
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS-SPTEHKYFMTEYVATRWYRA 179
Query: 850 PE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ-----WVAE 897
PE Y + I D++S G + E RR ++F G+ + Q V
Sbjct: 180 PELLLSLPEY-TTAI-----DMWSVGCIFAEMLGRR----QLFPGKNYVHQLKLILSVLG 229
Query: 898 SLPGAVTEVVDANL-------LSREDEEDADDFATKKTCISY-IMSLALKCSAEIPEERI 949
S V + ++ L R+ K + + ++S L+ PEERI
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD---PEERI 286
Query: 950 NVKDAL 955
V+ AL
Sbjct: 287 TVEQAL 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 48/194 (24%), Positives = 90/194 (46%), Gaps = 12/194 (6%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKI 741
+LG+G F + + L + VA+ D+ + F E + + H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYSTP 800
+ ++ +YM G+L+ +L H L Q + ++ +AS ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG-YMAPEYGSEGIVS 859
+H L + VL++ D+V + F + D + + TM+ + + APE S
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ-EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 860 ISGDVYSFGILMME 873
+ DV+SFGI+M E
Sbjct: 187 SASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H DL N ++ D +GDFG+ + + D + L + +M
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+ G++ V+ A + G A+KV + + TE +++ + + ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLH-HG 796
S L+M+Y+P G L L + LD + ++ ALEYLH +G
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGS-------LDEDVARIYIAEIVLALEYLHSNG 113
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-------LLDGVDPVTQTMTLATIGYMA 849
IIH DLKP+N+L+D + L DFG++K + D + T Y+A
Sbjct: 114 ----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 850 PE 851
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECE-----------VMRRIRH 735
+G G++ VYKA G VA+K L DTE E +++ + H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRL---------DTETEGVPSTAIREISLLKELNH 58
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLH 794
N++K++ L+ +++ Q L+K++ + S + + + + L + H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--Y 852
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE
Sbjct: 118 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 173
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
G + S + D++S G + E TRR +F G+ + Q
Sbjct: 174 GCK-YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-11
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 41/198 (20%)
Query: 704 GVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS-CSNPGFKALIMQYMP 759
G VA+K+ +E+ F E + R+ H N++ ++ S + PG + +Y+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 760 QGSLEKWLYSHNYSLTIRQRLD------------IMIDVASALEYLHHGYSTPIIHCDLK 807
T+R+ L +M+ V L+ L ++ I+H DLK
Sbjct: 63 -------------GRTLREVLAADGALPAGETGRLMLQV---LDALACAHNQGIVHRDLK 106
Query: 808 PNNVLL---DDDMVAHLGDFGIAKLLDGV-DPVTQTMTLAT--IG---YMAPEYGSEGIV 858
P N+++ A + DFGI LL GV D T+T T +G Y APE V
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 859 SISGDVYSFGILMMETFT 876
+ + D+Y++G++ +E T
Sbjct: 167 TPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR---ALKSFDTECEVMRRIRHRN 737
F + N +G G++ VY+A +G VA+K + +R + S E ++ +RH N
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPN 67
Query: 738 LIK----IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
+++ +V + F L+M+Y Q L L + + Q +M+ + L+YL
Sbjct: 68 IVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-- 851
H + IIH DLK +N+LL D + DFG+A+ G+ T + T+ Y APE
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTLWYRAPELL 180
Query: 852 YGSEGIVSISGDVYSFGILMMETFT 876
G + + D+++ G ++ E
Sbjct: 181 LGCTTYTT-AIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 687 LLGSGSFDNVYKATLAN-GVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIK 740
LLG G+F VY A+ G +AVK D + + + + E ++++ +RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 741 IVSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+P K L ++YMP GS++ L ++ +LT + + YLH S
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---S 124
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD-------GVDPVTQTMTLATIGYMAPE 851
I+H D+K N+L D LGDFG +K + G+ VT T +M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-----GTPYWMSPE 179
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
S DV+S ++E T + P E
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 32/253 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRAL-KSFDTECEVMRRIRHRNLIKIVSSC 745
LG+G+ +V K + G +A KV ++ ++ K E ++M R ++ +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL---HHGYSTPII 802
N + M++M GSL++ +Y + + I + V L YL H I+
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR-----IM 126
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H D+KP+N+L++ L DFG++ L ++ + T + T YM+PE G ++
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGEL--INSIADTF-VGTSTYMSPERIQGGKYTVKS 183
Query: 863 DVYSFGILMMETFTRRKP---TNEMFTGEMS-------LKQWVAE--------SLPGAVT 904
DV+S GI ++E + P +N G+ L+Q V E P +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 905 EVVDANLLSREDE 917
+ VDA LL E
Sbjct: 244 DFVDACLLKDPTE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA GV A KV + + + L+ + E +++ H N++K++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+++++ G+++ + LT Q + AL YLH IIH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-----LATIGYMAPEY-----GSEG 856
K N+L D L DFG++ T+T+ + T +MAPE +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
DV+S GI ++E P +E+ + LK +A+S P
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSEP 225
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 74/257 (28%), Positives = 113/257 (43%), Gaps = 40/257 (15%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM-RRI-----RHRNLI 739
+LG GSF V A L +G AVKV L++D L+ D EC + +RI H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYL 793
++ P +M+++ G L + + +R D ++ SAL +L
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLM-------FHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEY 852
H II+ DLK +NVLLD + L DFG+ K +G+ + T + T Y+APE
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEI 167
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV--TEVVDAN 910
E + S D ++ G+L+ EM G + + L A+ EVV
Sbjct: 168 LQEMLYGPSVDWWAMGVLLY----------EMLCGHAPFEAENEDDLFEAILNDEVVYPT 217
Query: 911 LLSREDEEDADDFATKK 927
LS++ + F TK
Sbjct: 218 WLSQDAVDILKAFMTKN 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIR---HRNLIKI 741
+G G++ VYKA +G VA+K +Q ED S E +++R+ H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 742 VSSCSNPGFK-----ALIMQYMPQ---GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
+ C+ L+ +++ Q L+K + TI+ D+M L++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK---DLMRQFLRGLDFL 124
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---GVDPVTQTMTLATIGYMAP 850
H + I+H DLKP N+L+ L DFG+A++ + PV + T+ Y AP
Sbjct: 125 H---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPV-----VVTLWYRAP 176
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
E + + D++S G + E F RRKP +F G Q
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQ------EDRALKSFDTECEVMRRIRHRNLI 739
+LG G++ VY G +AVK L ++ + E ++++ ++H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN------YSLTIRQRLDIMIDVASALEYL 793
+ + +C + ++ M+++P GS+ L + +Q LD + YL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------GVAYL 118
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD-PVTQTMTLATIG----YM 848
H + ++H D+K NNV+L + + L DFG A+ L V T + L ++ +M
Sbjct: 119 H---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
APE +E D++S G + E T + P M
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 688 LGSGSFDNVYKATLANGVS----VAVKVFNL-----QEDRALKSFDTECEVMRRIRHRNL 738
+G GSF +Y LA S +K +L +E A K E ++ +++H N+
Sbjct: 8 IGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNI 61
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ +S G ++M+Y G L K + + Q L + ++ L+++H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--- 118
Query: 798 STPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I+H D+K N+ L + MVA LGDFGIA+ L+ + T + T Y++PE
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNR 177
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ D++S G ++ E T + P
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+ VYKA L +AVKV L D E+ ++I ++I+ C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL---------DITVELQKQIMSE--LEILYKCD 57
Query: 747 NP---GFK---------ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
+P GF ++ ++M GSL+ + + L I + V L YL
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL- 111
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
+S I+H D+KP+N+L++ L DFG++ L V+ + +T + T YMAPE S
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTY-VGTNAYMAPERIS 166
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891
I DV+S GI ME R P ++ + SL
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 58/242 (23%), Positives = 96/242 (39%), Gaps = 42/242 (17%)
Query: 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRN 737
+G + + DN L VAVKV D A + F E +++ R+ N
Sbjct: 26 ADGLQDFSEKAFAENDNADAPVL-----VAVKVLRPDASDNAREDFLKEVKILSRLSDPN 80
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH--------NYSLTIRQR--LDIMIDVA 787
+ +++ C+ +IM+YM G L ++L H S ++ L + +A
Sbjct: 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--------DGVDPVTQT 839
S + YL S +H DL N L+ + + DFG+++ L G P
Sbjct: 141 SGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP---- 193
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT--RRKPTNEMFTGEMSLKQWVAE 897
I +MA E G + DV++FG+ + E T R +P + Q V E
Sbjct: 194 ---LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD------QQVIE 244
Query: 898 SL 899
+
Sbjct: 245 NA 246
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 6/178 (3%)
Query: 703 NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762
+G VAVK+ +L++ + + E +MR +H+N++++ S ++M+++ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 763 LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822
L + L Q + V AL YLH S +IH D+K +++LL D L
Sbjct: 105 LTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLS 159
Query: 823 DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
DFG + P +++ + T +MAPE S D++S GI+++E P
Sbjct: 160 DFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 688 LGSGSFDNVYKATLANGVSVA-VKVFNLQEDRALKS---FDTECEVMRRIRHRNLIKIVS 743
+G+G F V + +G + A V V L+ +++ F E + R ++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYS------LTIRQRLDIMIDVASALEYLH-HG 796
C+ L+M++ P G L+ +L S + T QR+ ++A L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKNN 120
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPE---- 851
+ IH DL N LL D+ +GD+G++ D VT + ++APE
Sbjct: 121 F----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 852 -YGSEGIV--SISGDVYSFGILMMETF 875
+G+ +V + +V+S G+ + E F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 69/228 (30%), Positives = 97/228 (42%), Gaps = 53/228 (23%)
Query: 687 LLGSGSFDNVYKATLANGVS----VAVKVFNL------QEDRALKSFDTECE--VMRRIR 734
+LG G + V++ G A+KV Q+D A T+ E ++ ++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA----HTKAERNILEAVK 58
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI-MIDVAS----- 788
H ++ ++ + G LI++Y+ G L + H +R I M D A
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMH------LEREGIFMEDTACFYLSE 108
Query: 789 ---ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
ALE+LH II+ DLKP N+LLD L DFG+ K VT T TI
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTI 164
Query: 846 GYMAPEYGSEGIVSISG-----DVYSFGILMMETFTRRKPTNEMFTGE 888
YMAPE I+ SG D +S G LM + T P FT E
Sbjct: 165 EYMAPE-----ILMRSGHGKAVDWWSLGALMYDMLTGAPP----FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 687 LLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRAL--KSFDTECEVMRRIRHRNLIKIVS 743
L+G GS+ V K G VA+K F ED + K E +++++RH NL+ ++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 744 SCSNPGFKALIMQYMPQ---GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
L+ +++ LEK+ + S + + + +E+ H S
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK----YLFQILRGIEFCH---SHN 120
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-------YG 853
IIH D+KP N+L+ V L DFG A+ L V T +AT Y APE YG
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVATRWYRAPELLVGDTKYG 179
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ D+++ G L+ E T +F G+ + Q
Sbjct: 180 R------AVDIWAVGCLVTEMLT----GEPLFPGDSDIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 687 LLGSGSFDNVYKATLANGVS--VAVKVFNL----------QEDRALKSFDTECEVMR-RI 733
LGSG+F VYK N +A+K N+ + D+++ +E +++ ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL-DIMIDVA 787
RH N+++ + ++M + L + S ++ +R+ +I + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMV 123
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
AL YLH I+H DL PNN++L +D + DFG+AK +T + TI Y
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILY 179
Query: 848 MAPE------YGSEGIVSISGDVYSFGILMMETFTRRKP--TNEMFTGEMSLKQWVAESL 899
PE YG + DV++FG ++ + T + P + M + + + V E L
Sbjct: 180 SCPEIVKNEPYGEK------ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233
Query: 900 P 900
P
Sbjct: 234 P 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 23/195 (11%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNL--QEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G GS V AT + G VAVK +L Q+ R L E +MR +H N++++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMYSS 84
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
++M+++ G+L + +H + Q + + V AL +LH + +IH
Sbjct: 85 YLVGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLAVLKALSFLH---AQGVIHR 139
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGSEGIV 858
D+K +++LL D L DFG + P +++ + T +MAPE YG+E
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPEVISRLPYGTE--- 195
Query: 859 SISGDVYSFGILMME 873
D++S GI+++E
Sbjct: 196 ---VDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA+K NLQ+ + E VMR ++ N++ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+Y+ GSL + + Q + + AL++LH S +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +N+LL D L DFG + TM + T +MAPE + D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 867 FGILMMETFTRRKP 880
GI+ +E P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 57/173 (32%), Positives = 79/173 (45%), Gaps = 18/173 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVM-------RRIRHRNLI 739
+G GSF V A A+G AVKV LQ+ LK + +M + ++H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKK-KEQKHIMAERNVLLKNVKHPFLV 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ S ++ Y+ G L L R R ++ASAL YLH S
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
II+ DLKP N+LLD L DFG+ K +G++ T T T Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 19/226 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVA-VKVFNLQEDRALKSFDT---ECEVMRRIRHRNLIKIVS 743
+G+G F V G+S A V V L+ E + R + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI----DVASALEYLHHGYST 799
C L++++ P G L+ +L S+ + + D++ +VAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPE----YGS 854
IH DL N L D+ +GD+G+A D +T+ + ++APE G
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 855 EGIV---SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897
+ + + +++S G+ M E FT + E LKQ V E
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 688 LGSGSFDNVYKATLANGV-------SVAVKVFNLQEDRAL---KSFDTECEVMRRIRHRN 737
+G G+F V++A A G+ VAVK+ L+E+ + F E +M H N
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPN 69
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL--------------------YSHNYS-LTI 776
++K++ C+ L+ +YM G L ++L N L+
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
++L I VA+ + YL +H DL N L+ ++MV + DFG+++ + D
Sbjct: 130 TEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 837 TQTMT-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ I +M PE + DV+++G+++ E F+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 46/234 (19%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNL 738
+G G++ VYKA G VA+K L ++ A++ E +++R++ HRN+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIKILRQLNHRNI 68
Query: 739 IK---IVSSCSNP-GFKA------LIMQYMPQ---GSLEKWLYS----HNYSLTIRQRLD 781
+ IV+ + FK L+ +YM G LE L H S ++Q L+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-MKQLLE 127
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
L Y H +H D+K +N+LL++ L DFG+A+L + + T
Sbjct: 128 -------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 842 LATIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ T+ Y PE G E + DV+S G ++ E FT++ +F L Q
Sbjct: 178 VITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKP----IFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 688 LGSGSFDN--VYKATLANGVSVAVKVFNLQEDRALKSFDT--ECEVMRRIRHRNLIKIVS 743
LG G+F +Y+ T + V K NL + D E ++ ++H N+I +
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 744 SCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ + M+Y G+L +K + L + + SA+ Y+H I+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H D+K N+ L + LGDFGI+K+L + +T+ + T YM+PE +
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFKS 182
Query: 863 DVYSFGILMMETFTRRK 879
D+++ G ++ E T ++
Sbjct: 183 DIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ V+ A +A G VA+K NLQ+ + E VM+ +++ N++ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+Y+ GSL + + Q + + ALE+LH + +IH D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +NVLL D L DFG + TM + T +MAPE + D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 867 FGILMMETFTRRKP 880
GI+ +E P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 34/86 (39%), Positives = 48/86 (55%)
Query: 376 LSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQI 435
L L N L G IP + KL+ LQ ++L+ N ++G IP L + L L + N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 436 PTCLANLTSLRHLDFRSNSLNSTIPS 461
P L LTSLR L+ NSL+ +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHRNLIKI 741
LLG G+F V A+G A+K+ + +D + TE V++ RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSL 60
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
S +M+Y+ G L L R R ++ SAL+YLH G I
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---KI 116
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYGSEGIVSI 860
++ DLK N++LD D + DFG+ K +G+ D T T Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 861 SGDVYSFGILMMETFTRRKP 880
+ D + G++M E R P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKIVS 743
LG G F V + A G A K N + + K ++ E ++ ++ R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ L+M M G L +Y+ N + + S LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMT---LATIGYMAPEYGSEG 856
II+ DLKP NVLLD+D + D G+A +L DG Q+ T T G+MAPE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTKGYAGTPGFMAPELLQGE 172
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
S D ++ G+ + E R P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT + G VAVK +L++ + + E +MR H N++ + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL YLH + +IH D+
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P +++ + T +MAPE S D++S
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL-VGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 867 FGILMMETFTRRKP 880
GI+++E P
Sbjct: 204 LGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNL---QEDRALKSFDTECEVMRRIRHRN 737
F + +G GSF VY A + N VA+K + Q + + E ++++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
I+ L+M+Y GS L H L Q ++I AL+ L + +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLH 132
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY---GS 854
S +IH D+K N+LL + + LGDFG A ++ + + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMD 187
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEM 884
EG DV+S GI +E R+ P M
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNL-QEDRALKSFDT---ECEVMRRIRHRNLIK-- 740
+G G++ VYKA G VA+K L ED + S T E +++ + H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS--TAIREISLLKELNHPNIVRLL 64
Query: 741 -IVSSCSNPGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYS 798
+V S + L+ +++ L+K++ S L + + + Y H S
Sbjct: 65 DVVHSENK---LYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---S 117
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPE--YGSE 855
++H DLKP N+L+D + L DFG+A+ GV PV T T + T+ Y APE GS
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF-GV-PVRTYTHEVVTLWYRAPEILLGSR 175
Query: 856 GIVSISGDVYSFGILMMETFTRR 878
S D++S G + E RR
Sbjct: 176 -QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 16/185 (8%)
Query: 705 VSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763
V VAVK+ + A F E ++M R+++ N+I+++ C + +I +YM G L
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 764 EKWL----------YSHNY-SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812
++L +++N S++I L + + +AS ++YL S +H DL N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161
Query: 813 LDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILM 871
+ + + DFG+++ L D Q + I +MA E G + + DV++FG+ +
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 872 METFT 876
E FT
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 688 LGSGSFDNVYKA-TLANGVS-VAVKVFNLQEDRALKSFDT--ECEVMRRIR---HRNLIK 740
+G G++ V+KA L NG VA+K +Q T E V+R + H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 741 IVSSCS-----NPGFKALIMQYMPQG---SLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
+ C+ L+ +++ Q L+K + TI+ D+M + L++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 125
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
LH S ++H DLKP N+L+ L DFG+A++ + T + T+ Y APE
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEV 180
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + D++S G + E F RRKP +F G + Q
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+Y+ GSL + + Q + + ALE+LH S +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +N+LL D L DFG + + ++ + T +MAPE + D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 867 FGILMMETFTRRKP 880
GI+ +E P
Sbjct: 202 LGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 54/234 (23%), Positives = 102/234 (43%), Gaps = 31/234 (13%)
Query: 688 LGSGSFDNVYKATLANG-----------VSVAVKVFNLQEDRALKSFDTECEVMRRIRHR 736
LG G+F N+YK L VSV +KV + R +F +M ++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG 796
+L+K+ C ++ +Y+ G L+ +L+ ++++ +LD+ +ASAL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 797 YSTPIIHCDLKPNNVLL---DDDM----VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
++H ++ N+L+ + L D GI + + + I ++A
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERIPWIA 172
Query: 850 PEYGSEGIVSIS--GDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLP 900
PE G S++ D +SFG ++E + +P + + + E LP
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 45/256 (17%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV---- 742
LG GS V+ A ++ VAVK L + +++K E +++RR+ H N++K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 743 -------SSCSNP-GFKAL--IMQYMP---QGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
+ ++ + +YM LE+ S ++ RL M +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQ-----TMTLA 843
L+Y+H S ++H DLKP NV ++ +D+V +GDFG+A++ VDP + L
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI---VDPHYSHKGYLSEGLV 180
Query: 844 TIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG--EMSLKQWVAESLP 900
T Y +P S + + D+++ G + E T + +F G E+ Q + ES+P
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILESVP 236
Query: 901 GAVTEVVDANLLSRED 916
V D N L
Sbjct: 237 --VVREEDRNELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 705 VSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761
V VAVK+ L+ED A F E ++M R++ N+I++++ C +I +YM G
Sbjct: 47 VLVAVKM--LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 762 SLEKWLYSHNY----------SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNV 811
L ++L H +++ + + +AS ++YL S +H DL N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161
Query: 812 LLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGIL 870
L+ + + DFG+++ L G Q + I +M+ E G + + DV++FG+
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 871 MMETFT 876
+ E T
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 51/227 (22%), Positives = 97/227 (42%), Gaps = 22/227 (9%)
Query: 683 GESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
+ N + G F+N V + K F+ + + E + +RRI N++KI
Sbjct: 31 NDQNSIYKGIFNN-------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83
Query: 742 ----VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ + +LI++Y +G L + L L+ + +LD+ ID L L+
Sbjct: 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY-MAPEYGSEG 856
+ P + +L + L+ ++ + G+ K+L P + Y M + SE
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLNDIFSE- 198
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE---MSLKQWVAESLP 900
+I D+YS G+++ E FT + P + T E + + + + LP
Sbjct: 199 -YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244
|
Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 41/149 (27%), Positives = 61/149 (40%), Gaps = 19/149 (12%)
Query: 687 LLGSGSFDN----VYKATLANGVSVAVKVFNL--QEDRALKSFDTECEVMRRIRHRNLIK 740
L+G D + K VAVK NL LK E R+++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS----LTIRQRLDIMIDVASALEYLHH- 795
V+S ++ M GS E L +H L I I+ DV +AL+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIHSK 120
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824
G+ IH +K +++LL D L
Sbjct: 121 GF----IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 14/196 (7%)
Query: 688 LGSGSFDNVYKATLA----NGVSVAVKVFNL--QEDRALKSFDTECEVMRRIRHRNLIKI 741
+G GSF KA L +G +K N+ + + E V+ ++H N+++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL-TIRQRLDIMIDVASALEYLHHGYSTP 800
S G ++M Y G L K + + L Q LD + + AL+++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
I+H D+K N+ L D LGDFGIA++L+ + +T + T Y++PE +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPYNN 180
Query: 861 SGDVYSFGILMMETFT 876
D+++ G ++ E T
Sbjct: 181 KSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT+ ++G VAVK +L++ + + E +MR +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL LH + +IH D+
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P +++ + T +MAPE S D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISRLPYGPEVDIWS 201
Query: 867 FGILMMETFTRRKP 880
GI+++E P
Sbjct: 202 LGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 8/205 (3%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQE-DRALKSFDTECEVMRRIRHRNLI 739
F + +G GSF V+K V A+K+ +L+E + ++ E V+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
K S +IM+Y+ GS L + + Q ++ ++ L+YLH S
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF--QIATMLKEILKGLDYLH---SE 120
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS 859
IH D+K NVLL + L DFG+A L T + T +MAPE +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSAYD 179
Query: 860 ISGDVYSFGILMMETFTRRKPTNEM 884
D++S GI +E P ++M
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 48/216 (22%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 685 SNLLGSGSFDNVYKATLAN---GVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNL 738
S+LL G+F ++ L + G V V +++ + E ++ + H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 739 IKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNY-------SLTIRQRLDIMIDVASAL 790
+ I+ C + ++ YM G+L+ +L +L+ +Q + + I +A +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD----------PVTQTM 840
YLH +IH D+ N ++D+++ + D +++ L +D PV
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK--- 184
Query: 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+MA E S + DV+SFG+L+ E T
Sbjct: 185 ------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVK-VFNLQEDR-----ALKSFDTECEVMRRIRHRNLIK 740
+G G+F V+KA VA+K V E AL+ E ++++ ++H N++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 741 IVSSCSNP-----GFKA---LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++ C +K L+ ++ L L + N T+ + +M + + L Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK---LLDGVDPVTQTMTLATIGYMA 849
+H I+H D+K N+L+ D + L DFG+A+ L P T + T+ Y
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191
Query: 850 PE-------YGSEGIVSISGDVYSFGILMMETFTR 877
PE YG I D++ G +M E +TR
Sbjct: 192 PELLLGERDYGP----PI--DMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 41/129 (31%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 753 LIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNV 811
L+M M G L+ +Y+ L + + + + + +LH S I++ D+KP NV
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126
Query: 812 LLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILM 871
LLDD L D G+A L +TQ T GYMAPE E S D ++ G +
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYSYPVDWFAMGCSI 184
Query: 872 METFTRRKP 880
E R P
Sbjct: 185 YEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECE-VMRRI-----RHRNLI 739
+LG GSF V A L A+K L++D L+ D EC V RR+ H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ + +M+Y+ G L + S + R R ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARF-YAAEIICGLQFLH---K 114
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
II+ DLK +NVLLD D + DFG+ K + T T Y+APE
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKY 173
Query: 859 SISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ S D +SFG+L+ E + P F GE
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 687 LLGSGSFDNVYKATLA-NG----VSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNL 738
+LGSG+F VYK +G + VA+KV L+E+ +A K E VM + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKV--LRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+++ C + L+ Q MP G L ++ + + + L+ + +A + YL
Sbjct: 72 CRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---E 127
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT-----IGYMAPEYG 853
++H DL NVL+ + DFG+A+LLD + +T A I +MA E
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD----IDETEYHADGGKVPIKWMALESI 183
Query: 854 SEGIVSISGDVYSFGILMMETFT 876
+ DV+S+G+ + E T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 9e-10
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVS--VAVKVFNLQE-DRALKSFDTECEVMRRIRHRNL 738
F + +G GSF V+K + N VA+K+ +L+E + ++ E V+ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
K S +IM+Y+ GS L T Q I+ ++ L+YLH S
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--QIATILREILKGLDYLH---S 119
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH D+K NVLL + L DFG+A L + + + T +MAPE +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAY 178
Query: 859 SISGDVYSFGILMMETFTRRKPTNEM 884
D++S GI +E P +E+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 5/108 (4%)
Query: 35 WVGVTC----SIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELW 90
W G C + + L L N L G +P + L L S+N+SGNS +P L
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 91 HMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAI 138
+ L+++D S NS +GS+P + T L +++ N ++G P+A+
Sbjct: 464 SITSLEVLDLSYNSFNGSIP-ESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQE-DRALKSFDTECEVMRRIRHRNLI 739
F + +G GSF VYK V A+K+ +L+E + ++ E V+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 740 KIVSSCSNPGFKALIMQYMPQGS----LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
+ S +IM+Y+ GS L+ Y TI + ++ L+YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATI------LREILKGLDYLH- 118
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
S IH D+K NVLL + L DFG+A L + + + T +MAPE +
Sbjct: 119 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ 175
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEM 884
D++S GI +E P +++
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 16/176 (9%)
Query: 687 LLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIK---- 740
++G G++ VYKA G VA+K+ ++ ED + E ++R+ H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 741 -IVSSCSNPGFKA-LIMQYMPQGS---LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
I + + L+M+ GS L K L L I+ + L YLH
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH- 130
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
+IH D+K N+LL + L DFG++ LD T T +MAPE
Sbjct: 131 --ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 688 LGSGSFDNVY---KATLAN-GVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHRN-- 737
LG+G++ V+ K + G A+KV +Q+ + + TE +V+ +R R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-RCPF 66
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
L+ + + LI+ Y+ G L LY + R+ I ++ AL++LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ-- 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-----TIGYMAPEY 852
II+ D+K N+LLD + L DFG++K + + A TI YMAPE
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-----LAEEEERAYSFCGTIEYMAPEV 177
Query: 853 --GSEGIVSISGDVYSFGILMMETFTRRKP 880
G G + D +S G+L E T P
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 77/290 (26%), Positives = 118/290 (40%), Gaps = 23/290 (7%)
Query: 94 RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNS 153
RL +D S S SL G + S ++ +++L S+ LDNN+
Sbjct: 68 RLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNN 127
Query: 154 LSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIP 213
++ P + +L +L L N I +P+ + NL NLK LDL N+++ L
Sbjct: 128 IT-DIPPLIGLLKSNLKELDLSDNKI------ESLPSPLRNLPNLKNLDLSFNDLSDLPK 180
Query: 214 SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILE 273
+ N SN+ + L GN +S LP I L + NN + S+ N + LE
Sbjct: 181 LLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLE 238
Query: 274 LSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNP 333
LS+N L P + GN L+ L L +NQ++ SSL LR L L N
Sbjct: 239 LSNNKLEDL-PESIGNLSNLETLDLSNNQIS---------SISSLGSLTNLRELDLSGNS 288
Query: 334 LKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL 383
L +P L + L + S LL ++++N
Sbjct: 289 LSNALPLIALLLLLLELL----LNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 685 SNLLGSGSFDNV-YKATLANGVSVAVKVFNLQ------EDRALKSFDT--ECEVMRRIR- 734
S +LGSG+ V +++G AVKV +++ ++RA C+ ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 735 HRNLIKIVSSCSNP---GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD-----IMIDV 786
H + K NP AL++ Y G L + + + + T R + + I V
Sbjct: 97 HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEI--KSRAKTNRTFREHEAGLLFIQV 152
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV--DPVTQTMTLAT 844
A+ HH +S +IH D+K N+LL + + LGDFG +K+ D V +T T
Sbjct: 153 LLAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GT 208
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
Y+APE S D++S G+L+ E T ++P F GE
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 7/166 (4%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIVSSC 745
LG GS+ VYK + NG VA+KV LQE+ + E +++ ++H N++ +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
L+ +Y+ L +++ H L + + L Y+H Y I+H D
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
LKP N+L+ D L DFG+A+ V T + + T+ Y P+
Sbjct: 129 LKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 41/290 (14%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN-----LQEDRALKSFDTECEVMRRIR-HRNLIK 740
+G G+F V KA + G A+K L++ L+ E + +RR+ H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR----EIQALRRLSPHPNILR 62
Query: 741 IVSSC--SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
++ G AL+ + M +L + + L ++ M + +L+++H +G
Sbjct: 63 LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-YGSEG 856
I H D+KP N+L+ DD++ L DFG + + P T+ ++T Y APE ++G
Sbjct: 121 ---IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTE--YISTRWYRAPECLLTDG 174
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVVDANLLSR 914
D+++ G + E + +F G L Q + + L EV+ SR
Sbjct: 175 YYGPKMDIWAVGCVFFEILS----LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230
Query: 915 EDEEDADDFATKK---------TCISYIMSLALKCSAEIPEERINVKDAL 955
+F +KK + + L K A P+ERI K AL
Sbjct: 231 HMNY---NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 74/318 (23%), Positives = 123/318 (38%), Gaps = 75/318 (23%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
LG G+F VYKA + G VA+K + ++ AL+ E +++++++H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 741 IVS--------SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++ S G ++ YM L L + + LT Q M+ + + Y
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ----------TMTL 842
LH I+H D+K N+L+D+ + + DFG+A+ DG P + T +
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 843 ATIGYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ-- 893
T Y PE Y + + D++ G + E FTRR + G+ + Q
Sbjct: 188 VTRWYRPPELLLGERRYTT------AVDIWGIGCVFAEMFTRRP----ILQGKSDIDQLH 237
Query: 894 -------------W-VAESLPGAVTEVVDANLLSREDEEDADDFATK-KTCISYIMSLAL 938
W SLPG N +E F + + L L
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER----FGKLGPEGLDLLSKL-L 292
Query: 939 KCSAEIPEERINVKDALA 956
P +R+ DAL
Sbjct: 293 SLD---PYKRLTASDALE 307
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 79/304 (25%), Positives = 126/304 (41%), Gaps = 67/304 (22%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNLIKIVSS 744
+G G++ VYK G VA+K L+ E+ + S E +++ ++H N++ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG----YSTP 800
LI +++ L+K+L S L Q +D + V S L + G +S
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDS----LPKGQYMDAEL-VKSYLYQILQGILFCHSRR 121
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIV 858
++H DLKP N+L+D+ V L DFG+A+ G+ T + T+ Y APE GS
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSP-RY 179
Query: 859 SISGDVYSFGILMMETFTRR--------------------KPTNEMFTGEMSLK------ 892
S D++S G + E T++ PT +++ G SL
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239
Query: 893 -QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV 951
+W SL AV + DE+ D L K P +RI+
Sbjct: 240 PKWKKGSLRSAVKNL---------DEDGLD--------------LLEKMLIYDPAKRISA 276
Query: 952 KDAL 955
K AL
Sbjct: 277 KKAL 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 60/173 (34%), Positives = 83/173 (47%), Gaps = 16/173 (9%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD-----TECEVM-RRIRHRNLI 739
++G GSF V A ++G AVKV LQ+ LK + E V+ + ++H L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ S ++ Y+ G L L L R R +VASA+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
II+ DLKP N+LLD L DFG+ K +GV+P T T T Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECE-VMRRI-----RHRNLI 739
+LG GSF V+ A L A+K L++D L D EC V +R+ H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ + +M+Y+ G L + S H + L + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP--RATFYAAEIICGLQFLH---S 114
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
I++ DLK +N+LLD D + DFG+ K D T T T Y+APE
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 859 SISGDVYSFGILMMETFTRRKP 880
+ S D +SFG+L+ E + P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD-----TECEVMRRIRH 735
F + +LG G F V + A G A K L++ R K E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM--IDVASALEYL 793
R ++ + + L++ M G L+ +Y H + + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE 851
H I++ DLKP N+LLDD + D G+A + P QT+ + T+GYMAPE
Sbjct: 119 HQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV----PEGQTIKGRVGTVGYMAPE 171
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKP 880
+ S D ++ G L+ E + P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 42/216 (19%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVK--------VFNLQEDRALKSFDTECEVMRRIRHR 736
+ +G G++ V AT GV VA+K F R L+ E +++RR +H
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ---RTLR----EIKILRRFKHE 63
Query: 737 NLIKIVSSCSNPGFKA-----LIMQYMPQGSLEKWLYSHNYS-----LTIRQRLDIMIDV 786
N+I I+ P F++ ++ + M L K + + + S + Q L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQIL------ 116
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LAT 844
L+Y+H S ++H DLKP+N+LL+ + + DFG+A++ D T +T +AT
Sbjct: 117 -RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 845 IGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRR 878
Y APE S+G + + D++S G ++ E + R
Sbjct: 173 RWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 31/81 (38%), Positives = 42/81 (51%)
Query: 359 LSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL 418
L G IP L +L ++L N + G IP LG + L+ LDL+ N G IP L +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 419 EKLNTLLSNNNALQGQIPTCL 439
L L N N+L G++P L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+GSG++ +VYKA + G A+KV L+ E +M+ +H N++ S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+ M++ GSL+ +Y L+ Q + + L YLH S +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS---EGIVSISGD 863
K N+LL D+ L DFG++ + ++ + T +MAPE + +G + D
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSF-IGTPYWMAPEVAAVERKGGYNQLCD 191
Query: 864 VYSFGILMMETFTRRKP 880
+++ GI +E + P
Sbjct: 192 IWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 52/196 (26%)
Query: 689 GSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVM--------------RRIR 734
G G++ VYKA NG ++ A+K F + E R ++
Sbjct: 9 GRGTYGRVYKAKRKNG--------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLD------IMIDV 786
H N++ +V K++ Y+ E L+ + R + ++ +
Sbjct: 61 HENVVSLVEVFLEHADKSV---YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLL----DDDMVAHLGDFGIA-------KLLDGVDP 835
+ + YLH S ++H DLKP N+L+ + V +GD G+A K L +DP
Sbjct: 118 LNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 836 VTQTMTLATIGYMAPE 851
V + TI Y APE
Sbjct: 175 V-----VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 21/218 (9%)
Query: 680 NGFGESNLLGSGSFDNVY----KATLANGVSVAVKVFN---LQEDRALKSFDTECEVMRR 732
F +L+G G F V KAT G A+KV L + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
+ ++ + + L+M+Y P G L L + + ++ A+
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 793 LHH-GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
+H GY +H D+KP NVL+D L DFG A L V + + T Y+APE
Sbjct: 118 VHQMGY----VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 852 Y------GSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
+G + D +S G++ E R P +E
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 687 LLGSGSFDNVY----KATLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHRNL 738
LLG G+F V KAT G A+K+ + +D + TE V++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFL 57
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ + +M+Y G L L R R ++ SALEYLH S
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---S 113
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYGSEGI 857
+++ D+K N++LD D + DFG+ K +G+ D T T Y+APE +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
+ D + G++M E R P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 149 LDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI 208
LDN L G P D+ ++L L + L GN+I G IP +G++ +L++LDL N+
Sbjct: 425 LDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRG-----NIPPSLGSITSLEVLDLSYNSF 478
Query: 209 AGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
G IP + +++ + L GN LSG +P+++
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G G + V+ A + G VA+K L + ++ TE +++ + L+K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYSTPII 802
+ + + L M+Y+P G L ++ L+ M ++ A++ LH GY I
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA--TIG---YMAPE--YGSE 855
H DLKP N L+D L DFG++K +T A +G YMAPE G
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK---------GIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 856 GIVSISGDVYSFGILMMETFTRRKP-----TNEMFTGEMSLKQW 894
+ D +S G ++ E P NE + +LK W
Sbjct: 175 --YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 16/210 (7%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSV-AVKVFNL---QEDRALKSFDTECEVMRRIRHRN 737
F + +G GSF VY A V A+K + Q + + E + ++RI+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
I+ L+M+Y GS L H L Q ++I AL+ L + +
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAITHGALQGLAYLH 142
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY---GS 854
S +IH D+K N+LL + L DFG A + P + T +MAPE
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASI---ASPANS--FVGTPYWMAPEVILAMD 197
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEM 884
EG DV+S GI +E R+ P M
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 29/232 (12%)
Query: 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
FGE L+ S VY L + + + D A F E ++M +++
Sbjct: 55 AFGEVQLVRHKSSQKVYAMKLLSKFEMIKR-----SDSAF--FWEERDIMAFANSPWVVQ 107
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + + + ++M+YMP G L + NY + + +V AL+ +H S
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMG 162
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY----GSEG 856
+IH D+KP+N+LLD L DFG +D V + T Y++PE G +G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
D +S G+ + E P + A+SL G ++++D
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTP-------------FYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+GSG++ +VYKA L G AVK+ L+ E +++ +H N++ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+ + M+Y GSL+ +Y L+ Q + + L YLH S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-----LATIGYMAPEYGS---EGIV 858
K N+LL D+ L DFG+A +T T+ + T +MAPE + G
Sbjct: 133 KGANILLTDNGDVKLADFGVAA------KITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 859 SISGDVYSFGILMMETFTRRKP 880
+ D+++ GI +E + P
Sbjct: 187 NQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 40/225 (17%)
Query: 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
F +LG GSF V A A+K+ L++D ++ D EC ++ + +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEK-------R 52
Query: 741 IVSSCSNPGFKA-------------LIMQYMPQGSLEKWLYSHNYSLTIR--QRLDIMID 785
+++ P F +M+Y+ G L +Y + Q + +
Sbjct: 53 VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAE 109
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLA 843
++ L +LH II+ DLK +NV+LD + + DFG+ K ++DGV T+T
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFC-G 163
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
T Y+APE + S D +++G+L+ E + P F GE
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP----FDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-08
Identities = 31/87 (35%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 98 IDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGS 157
+ + L G +P D+ + L+S ++S N I G P ++ +I+SL+ + L NS +GS
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 158 FPTDLCTRLPSLVQLRLLGNNITGRIP 184
P L +L SL L L GN+++GR+P
Sbjct: 482 IPESL-GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 26/74 (35%), Positives = 45/74 (60%), Gaps = 1/74 (1%)
Query: 232 LSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNC 290
L G +P+ I L +L+++ L N++ G IP S+ + + +L+LS N F+G +P + G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 291 RQLQILSLGDNQLT 304
L+IL+L N L+
Sbjct: 490 TSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 688 LGSGSFDNVYKATLA--NGVSVAVKVFNL---QEDRALKSFDTECEVMRRIRHRNLIKIV 742
+G GSF VY AT + N V VAVK + Q + + E + +++++H N I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
L+M+Y GS L H L Q ++I AL+ L + +S +I
Sbjct: 88 GCYLKEHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAITHGALQGLAYLHSHNMI 143
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY---GSEGIVS 859
H D+K N+LL + L DFG A P + T +MAPE EG
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK---SSPANS--FVGTPYWMAPEVILAMDEGQYD 198
Query: 860 ISGDVYSFGILMMETFTRRKPTNEM 884
DV+S GI +E R+ P M
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G++ +VYK GV++A+K L+ D + E +++ + ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA----LEYLHHGYSTPI 801
G + M+YM GSL+K LY+ T D++ + A L++L ++ I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPEYGSEG-- 856
IH D+KP NVL++ + L DFG++ L V + +T IG YMAPE G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKT----NIGCQSYMAPERIKSGGP 178
Query: 857 ----IVSISGDVYSFGILMMETFTRRKP 880
++ DV+S G+ ++E R P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD-----TECEVMRRIRH 735
F + +LG G F V + A G A K L++ R K E +++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLH 794
+ ++ + + L++ M G L+ +Y+ N + L ++ LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
++ DLKP N+LLDD + D G+A + + + + T+GYMAPE +
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG--RVGTVGYMAPEVLN 174
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
++S D + G L+ E + P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 688 LGSGSFDNVYKATLANG--VSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKIV 742
LG+GSF V AT N VA+K F + K D +E +++ I H + +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL----EYLHHGYS 798
S + + L+++++ G +L + R D+ A+ + EYL S
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQ---S 149
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGI 857
I++ DLKP N+LLD D + DFG AK++D T+T TL T Y+APE
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAPEILLNVG 204
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
+ D ++ GI + E P
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 42/207 (20%)
Query: 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKI 741
LG+GSF V A G A+K +E +K E ++ + H ++ +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS--------ALEYL 793
+ S + +++++ G L ++H +R+ DVA A EYL
Sbjct: 84 MCSFQDENRVYFLLEFVVGGEL----FTH-----LRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT-QTMTL-ATIGYMAPE 851
H S II+ DLKP N+LLD+ + DFG AK V +T TL T Y+APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAPE 185
Query: 852 YGSEGIVSISG-----DVYSFGILMME 873
++ G D ++ G+L+ E
Sbjct: 186 -----VIQSKGHGKAVDWWTMGVLLYE 207
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 687 LLGSGSFDNVY----KATLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHRNL 738
LLG G+F V KAT G A+K+ + +D + TE V++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ S +M+Y G L + S + + ++ SAL YLH S
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALGYLH---S 113
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGI 857
+++ DLK N++LD D + DFG+ K +G+ T T Y+APE +
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
+ D + G++M E R P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 687 LLGSGSFDNVYKATLANGVSV----AVKVFN----LQEDRALKSFDTECEVMRRIRHRNL 738
+LG+G++ V+ +G A+KV +Q+ + + TE +V+ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 739 IKIVSSCSNPGFKA-LIMQYMPQGSLEKWLYSHNYSLTIRQRL---DIMIDVASALEYLH 794
+ + K LI+ Y+ G L ++H L+ R+R ++ I + L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGEL----FTH---LSQRERFKEQEVQIYSGEIVLALE 119
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY-- 852
H + II+ D+K N+LLD + L DFG++K + TI YMAP+
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKP 880
G +G + D +S G+LM E T P
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 85/268 (31%)
Query: 688 LGSGSFDNVYKAT------LANGVSVAVKVFNL----QEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 71
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSH----------------------NYS 773
N++ ++ +C+ PG + I+++ G+L +L S + S
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDIS 131
Query: 774 LTIRQRLDIMIDVASA-------------------------------------------- 789
+++RLD + S+
Sbjct: 132 EDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKG 191
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYM 848
+E+L S IH DL N+LL ++ V + DFG+A+ + D V + + +M
Sbjct: 192 MEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 248
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
APE + + +I DV+SFG+L+ E F+
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 54/220 (24%)
Query: 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDT--ECEVMRRIRHRNLIKIV 742
+ +GSG++ V A G VA+K + A+ + T E +++ + H N+I
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI--- 77
Query: 743 SSCSNPGFKALIMQYMPQGSLEK----WLYSHN-----YSLTIRQRLD------IMIDVA 787
L+ + P SLE +L +H ++ Q+L ++ +
Sbjct: 78 ---------GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATI 845
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D MT +AT
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD------DEMTGYVATR 179
Query: 846 GYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRR 878
Y APE Y + + D++S G +M E T +
Sbjct: 180 WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 30/254 (11%)
Query: 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
FGE L+ S VY L + + + D A F E ++M +++
Sbjct: 55 AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----SDSAF--FWEERDIMAFANSPWVVQ 107
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + + + ++M+YMP G L + NY + + +V AL+ +H S
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 162
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY----GSEG 856
IH D+KP+N+LLD L DFG ++ V + T Y++PE G +G
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD-ANLLSRE 915
D +S G+ + E P + A+SL G +++++ N L+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP-------------FYADSLVGTYSKIMNHKNSLTFP 269
Query: 916 DEEDADDFATKKTC 929
D+ D A C
Sbjct: 270 DDNDISKEAKNLIC 283
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 61/234 (26%), Positives = 90/234 (38%), Gaps = 64/234 (27%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKV---FNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LLG G V+ L G A+KV + + +K TE E++ + H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQ---RLDIMI------DVASALEYL 793
+S + L+M Y P G L + L RQ L + +V ALEYL
Sbjct: 68 ASFQTETYLCLVMDYCPGGEL--------FRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 794 H-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT--------------- 837
H G I++ DLKP N+LL + L DF ++K D P
Sbjct: 120 HLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 838 -QTMTLATIG------------YMAPEYGSEGIVSISG-----DVYSFGILMME 873
+ T + Y+APE ++S G D ++ GIL+ E
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 70/318 (22%)
Query: 672 YHELQQATNGFGESNLLGSGSFDNV-YKATLANGVSVAVKVFN--LQEDRALKSFDTECE 728
Y +L+Q +GSG++ V G VA+K Q + K E
Sbjct: 17 YRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR 66
Query: 729 VMRRIRHRNLIKIVSSCSNPGFKA-----------LIMQYMPQGSLEKWLYSHNYSLTIR 777
+++ ++H N+I ++ F L+M +M L K + S
Sbjct: 67 LLKHMKHENVIGLLDV-----FTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLS---E 117
Query: 778 QRLDIMI-DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
R+ ++ + L+Y+H + IIH DLKP N+ +++D + DFG+A+ D
Sbjct: 118 DRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS---- 170
Query: 837 TQTMTLATIGYMAPEYGSEGIVSI-----SGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891
T + T Y APE I++ + D++S G +M E T + +F G L
Sbjct: 171 EMTGYVVTRWYRAPEV----ILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHL 222
Query: 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATK---------KTCISYIMSLALKCSA 942
Q + E + VT + + EDA ++ K ++ + LA+
Sbjct: 223 DQ-LMEIM--KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279
Query: 943 EI----PEERINVKDALA 956
++ E RI +ALA
Sbjct: 280 KMLVLDAESRITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNL-QEDRALKSFDT-ECEVMRRIRHRNLIKIVSS 744
+G G++ VYKA ++A+K L QED + S E +++ ++H N++++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 745 CSNPGFKALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ L+ +Y+ L+K + S +++ R + + + Y H S ++H
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125
Query: 804 CDLKPNNVLLDDDMVA-HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSI 860
DLKP N+L+D A L DFG+A+ G+ T T + T+ Y APE GS S
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAPEILLGSRH-YST 183
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
D++S G + E ++ +F G+ + +
Sbjct: 184 PVDIWSVGCIFAEMVNQKP----LFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKI-- 741
+GSG++ +V A G VA+K + Q + K E +++ ++H N+I +
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 742 --VSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
S+ S F+ L+M YM Q L+K + H S Q L + + L+Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYM-QTDLQK-IMGHPLSEDKVQYL--VYQMLCGLKYIH--- 134
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
S IIH DLKP N+ +++D + DFG+A+ D T + T Y APE I
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEV----I 186
Query: 858 VSI-----SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
++ + D++S G +M E T + +F G+ L Q
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKGKDYLDQ 223
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
LT+ + VA +E+L S IH DL N+LL ++ V + DFG+A+ +
Sbjct: 170 LTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D V + + +MAPE + + + DV+SFG+L+ E F+
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD--GVDPVTQT 839
IM + AL+Y+H S +IH DLKP+N+LL+ D L DFG+A+ L +P
Sbjct: 112 IMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 840 MT--LATIGYMAPEYGSEGIVSISGDVYSFGILM 871
+T +AT Y APE + + Y+ G+ M
Sbjct: 169 LTDYVATRWYRAPE------ILLGSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 687 LLGSGSFDNVYKATLANGVSV----AVKVFN----LQEDRALKSFDTECEVMRRIRHRNL 738
+LG+G++ V+ G A+KV +Q+ + ++ TE V+ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 739 IKIVSSCSNPGFKA-LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ + K LI+ Y+ G + LY + R ++ ALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
I++ D+K N+LLD + L DFG++K + TI YMAPE I
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI----I 178
Query: 858 VSISG-----DVYSFGILMMETFTRRKP 880
G D +S GIL+ E T P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD-----TECEVM-RRIRHRNLI 739
++G GSF V A A AVKV LQ+ LK + +E V+ + ++H L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ S ++ Y+ G L L L R R ++ASAL YLH S
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIV 858
I++ DLKP N+LLD L DFG+ K + ++ T T T Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 859 SISGDVYSFGILMMETFTRRKPTNEMFTGEM 889
+ D + G ++ E P T EM
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECE-VMRRI-----RHRNLI 739
+LG GSF V A L G AVK L++D L D EC V +R+ + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM------IDVASALEYL 793
+ + +M+++ G L + + + R D+ ++ L++L
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLM-------FHIQDKGRFDLYRATFYAAEIVCGLQFL 112
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEY 852
H S II+ DLK +NV+LD D + DFG+ K + V + T T Y+APE
Sbjct: 113 H---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEI 167
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKP 880
+ S D +SFG+L+ E + P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 46/232 (19%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR------ALKSFD-----TECEVMRRIRH 735
+G G++ VYKA G VA+K L+ D AL+ +E + R
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR--- 65
Query: 736 RNLIKIVSSCSNPGFKA---LIMQYMPQGSLEKWLYSHNYSL------TIRQRLDIMIDV 786
L+ + G K L+ +Y+ L+K++ S+ + M +
Sbjct: 66 --LLDVEHVEEKNG-KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF--MYQL 119
Query: 787 ASALEYLH-HGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLLDGVDPVTQ-TMTLA 843
+ + H HG ++H DLKP N+L+D + + D G+ + PV T +
Sbjct: 120 LKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--IPVKSYTHEIV 173
Query: 844 TIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
T+ Y APE GS S D++S G + E +R++P +F G+ L+Q
Sbjct: 174 TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQQ 220
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 687 LLGSGSFDNVY----KATLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHRNL 738
LLG G+F V KAT G A+K+ + +D + TE V++ RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 57
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ S +M+Y G L L R R ++ SAL+YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS--E 114
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYGSEGI 857
+++ DLK N++LD D + DFG+ K +G+ D T T Y+APE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
+ D + G++M E R P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 37/152 (24%), Positives = 68/152 (44%), Gaps = 12/152 (7%)
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID 785
E +++ + H ++I++ + + +++ + L +L + L I Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL--- 842
+ L YLH + IIH D+K N+ ++D +GD G A+ PV L
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-----PVVAPAFLGLA 217
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874
T+ APE + + D++S GI++ E
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 20/197 (10%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIVSSC 745
LG GS+ VYK + NG VA+KV +++ + + + E +++ ++H N++ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ +YM L +++ H L M + L Y+H + I+H D
Sbjct: 73 HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRD 128
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP-------EYGSEGIV 858
LKP N+L+ L DFG+A+ + T + + T+ Y P +Y S
Sbjct: 129 LKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA--- 184
Query: 859 SISGDVYSFGILMMETF 875
D++ G + +E
Sbjct: 185 ---LDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 707 VAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
VAVK+ ++ A F E +++ R++ N+I+++ C + +I +YM G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 766 WLYSHNY------------------SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
+L SH+ +++ L + + +AS ++YL S +H DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
N L+ +++ + DFG+++ L D Q + I +MA E G + + DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 867 FGILMMETFT--RRKPTNEM 884
FG+ + E + +P E+
Sbjct: 226 FGVTLWEILMLCKEQPYGEL 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 32/147 (21%), Positives = 66/147 (44%), Gaps = 13/147 (8%)
Query: 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLI--KIVSS 744
LL G + VY + +K+ +E A + E +++ + + L K+++S
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ G+ L+M+++ +L++ ++ ++ DI +A L LH + H
Sbjct: 62 GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLD 831
DL P N+L+DD + + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 39/208 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G GS+ V+K G VA+K F ED AL+ E ++++++H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 741 IVSSCSNPGFKA-----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ F+ L+ +Y L + L + + I+ A+ + H
Sbjct: 65 LIEV-----FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE---- 851
IH D+KP N+L+ L DFG A++L G T +AT Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVG 174
Query: 852 ---YGSEGIVSISGDVYSFGILMMETFT 876
YG DV++ G + E T
Sbjct: 175 DTQYGP------PVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 10/165 (6%)
Query: 718 RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNY----S 773
RA + E + R+ H N++KI + +I Q L ++Y +
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDR 263
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
++Q IM + A+EY+H +IH D+K N+ L+ D LGDFG A +
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 834 DPVTQTMTLATIGYMAPE-YGSEGIVSISGDVYSFGILMMETFTR 877
+ T+ +PE +G I+ D++S G+++++ +
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 28/77 (36%), Positives = 47/77 (61%), Gaps = 1/77 (1%)
Query: 316 SSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLV 375
+ ++K R+L+ + L N ++G IP S+G++ TSLE + +G IP G L++L +
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSI-TSLEVLDLSYNSFNGSIPESLGQLTSLRI 494
Query: 376 LSLVNNELAGAIPTVLG 392
L+L N L+G +P LG
Sbjct: 495 LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 66/189 (34%), Positives = 100/189 (52%), Gaps = 15/189 (7%)
Query: 61 LPPHVGNL-SFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQ 119
+PP +G L S L L++S N ++LP+ L ++ LK +D S N LS LP + N +
Sbjct: 131 IPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNL-SN 187
Query: 120 LESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179
L + D+S NKI+ + P I +S+L+ + L NNS+ + L + L +L L L N +
Sbjct: 188 LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL-SNLKNLSGLELSNNKL 244
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239
++P IGNL NL+ LDL N I+ S + + +N+ + L GN LS LP
Sbjct: 245 E------DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLI 296
Query: 240 IYLPNLENL 248
L L L
Sbjct: 297 ALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 42/179 (23%), Positives = 86/179 (48%), Gaps = 28/179 (15%)
Query: 726 ECEVMRRIRHRNLIKI----VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
E ++ +++H N++ + V S + + ++M+Y+ + L+ + + +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIY--MVMEYV-EHDLKSLMETMKQPFLQSEVKC 110
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
+M+ + S + +LH + I+H DLK +N+LL++ + + DFG+A+ G T
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQL 166
Query: 842 LATIGYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ T+ Y APE Y + I D++S G + E +KP +F G+ + Q
Sbjct: 167 VVTLWYRAPELLLGAKEYSTA-I-----DMWSVGCIFAE-LLTKKP---LFPGKSEIDQ 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
LT L VA +E+L S +H DL NVLL + + DFG+A+ ++
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ V++ T + +MAPE + + + DV+S+GIL+ E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+LG GSF V A + A+K+ L++D ++ D EC ++ + ++++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEK-------RVLALS 57
Query: 746 SNPGFKA-------------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM--IDVASAL 790
P F +M+Y+ G L +Y ++ + ++A L
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGL 114
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYM 848
+LH S II+ DLK +NV+LD + + DFG+ K + DGV T+T T Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFC-GTPDYI 168
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
APE + S D ++FG+L+ E + P F GE
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 77/276 (27%), Positives = 114/276 (41%), Gaps = 64/276 (23%)
Query: 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGN 344
N L L L N+L S L + L L LD N + IP IG
Sbjct: 87 ENLLNLLPLPSLDLNLNRLR--------SNISELLELTNLTSLDLDNNNITD-IPPLIGL 137
Query: 345 LSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNS 404
L ++L+ +++ +P NL NL L L N+L+ +P +L L L LDL+
Sbjct: 138 LKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSG 195
Query: 405 NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFW 464
NK+ +P ++ L L L +NN++ ++ + L+NL +L
Sbjct: 196 NKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS------------------ 235
Query: 465 SLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALAR 524
GL L+ N+L +P SIGNL NL+ L L+
Sbjct: 236 ------------------------------GLELSNNKLE-DLPESIGNLSNLETLDLSN 264
Query: 525 NAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLE 560
N Q S GSL +L+ LDLSGN++S +P
Sbjct: 265 N--QISSISSLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 87/319 (27%), Positives = 132/319 (41%), Gaps = 43/319 (13%)
Query: 164 TRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMV 223
SL +L L I + + + NL L LDL N + I + +N+
Sbjct: 61 LLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLT 119
Query: 224 AILLYGNHLS-----------------------GHLPSSI-YLPNLENLFLWKNNLSGII 259
++ L N+++ LPS + LPNL+NL L N+LS +
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DL 178
Query: 260 PDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLA 319
P + N S L+LS N S +P L+ L L +N + SSL+
Sbjct: 179 PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE--------LLSSLS 229
Query: 320 KCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLV 379
+ L L L N L+ +P SIGNLS +LE ++Q+S G+L+NL L L
Sbjct: 230 NLKNLSGLELSNNKLED-LPESIGNLS-NLETLDLSNNQIS--SISSLGSLTNLRELDLS 285
Query: 380 NNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCL 439
N L+ ++ L L L LN + L + N +LSN + P L
Sbjct: 286 GNSLSN-ALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNG---ETSSPEAL 341
Query: 440 ANLTSLRHLDFRSNSLNST 458
+ L SL +L N+L+ +
Sbjct: 342 SILESLNNLWTLDNALDES 360
|
Length = 394 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDT------ECEVMRRIRHRNLIK 740
++G GSF +A L V+ K + ++E R KS E ++ +++H N++
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQK-YAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQR-LDIMIDVASALEYLHHGYST 799
S G ++M+Y G L + + L L + + ++++H
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EK 119
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEGIV 858
++H D+K N+ L + LGDFG A+LL P T + T Y+ PE
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPY 177
Query: 859 SISGDVYSFGILMMETFTRRKP 880
+ D++S G ++ E T + P
Sbjct: 178 NNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-A 843
++ AL +LH II+ DLK +NVLLD D L D+G+ K +G+ P T T
Sbjct: 104 EICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCG 158
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
T Y+APE S D ++ G+LM E R P
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 8/162 (4%)
Query: 721 KSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY-SHNYSLTIRQR 779
K+ E ++++ I HR +I ++ + K+ + MP+ + + Y + L + Q
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 780 LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839
+ I + AL YLH IIH D+K N+ LD+ A LGDFG A LD Q
Sbjct: 188 ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 840 MTLA-TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
+ T+ +PE + D++S G+++ E +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-A 843
+++ AL +LH II+ DLK +NVLLD + L D+G+ K +G+ P T T
Sbjct: 104 EISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCG 158
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
T Y+APE S D ++ G+LM E R P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVY-----KATLANGVSV--AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG GSF VY KA + V + V L + +++ + E +++ ++ H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWL--YSHN-YSLTIRQRLDIMIDVASALEYLHHGY 797
+S +I +Y L+ L H +L+ Q + I + + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
I+H DLK N+ L ++++ +GDFG+++LL G + T T T YM+PE
Sbjct: 125 -RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSPEALKHQG 181
Query: 858 VSISGDVYSFGILMME 873
D++S G ++ E
Sbjct: 182 YDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 688 LGSGSFDNVYKATL--------ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLI 739
LG G+F ++K + V +KV + +SF +M ++ H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
C ++ +Y+ GSL+ +L + + I +L++ +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD-GVDPVTQT--MTLATIGYMAPEYGSEG 856
+ H ++ NVLL + G+ KL D G+ + L I ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 857 -IVSISGDVYSFGILMMETFT 876
+S++ D +SFG + E F+
Sbjct: 180 QNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSS 744
L+G+G++ VYK + G A+KV ++ D + E ++++ HRN+ +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 71
Query: 745 C---SNPGFKA---LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI--DVASALEYLHHG 796
+ PG L+M++ GS+ L + T+++ I ++ L +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 129
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY---- 852
+IH D+K NVLL ++ L DFG++ LD T + T +MAPE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACD 186
Query: 853 -GSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+ D++S GI +E P +M
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
LT+ + VA +E+L S IH DL N+LL ++ V + DFG+A+ +
Sbjct: 171 LTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D V + + +MAPE + + + DV+SFG+L+ E F+
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV 818
P+ + L + + +L+ + VA+ +E+L S +H DL NVL+ + +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 819 AHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT- 876
+ DFG+A+ ++ + +++ T + +MAPE + + DV+SFGIL+ E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
Query: 877 -----RRKPTNEMF 885
P NE F
Sbjct: 338 GGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD-----TECEVMRRIRH 735
F +LG G F V + A G A K L++ R K E ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQR-LDIMIDVASALEYLH 794
R ++ + + L++ M G L+ +Y+ QR + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM--TLATIGYMAPEY 852
I++ DLKP N+LLDD + D G+A + P +T+ + T+GYMAPE
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAPEV 172
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKP 880
+ + S D + G L+ E + P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLAT 844
VA +++L S IH D+ NVLL D VA + DFG+A+ +++ + V +
Sbjct: 221 VAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + ++ DV+S+GIL+ E F+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 79
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 80 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 133 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 185
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKIVSSC 745
LG+G+ V K +G+ +A K+ +L+ A+++ E +V+ ++ +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHHGYSTPIIH 803
+ G ++ M++M GSL++ L + I + + + I V L YL + I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMH 127
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
D+KP+N+L++ L DFG++ L +D + + + T YM+PE S+ D
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQGTHYSVQSD 184
Query: 864 VYSFGILMMETFTRRKP 880
++S G+ ++E R P
Sbjct: 185 IWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 21/234 (8%)
Query: 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD 724
+L I L+ F ++G+G++ VYK + G A+KV ++ ED +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIK 60
Query: 725 TECEVMRRI-RHRNLIKIVSSC---SNPGFKA---LIMQYMPQGSLEKWLYSHNYSLTIR 777
E ++++ HRN+ + S PG L+M++ GS+ L + ++
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALK 119
Query: 778 QRLDIMI--DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835
+ I ++ L +LH + +IH D+K NVLL ++ L DFG++ LD
Sbjct: 120 EDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176
Query: 836 VTQTMTLATIGYMAPEY-----GSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
T + T +MAPE + D++S GI +E P +M
Sbjct: 177 RRNTF-IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
++ LE LH I++ DLKP N+LLDD + D G+A + + + + T
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG--RVGT 164
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
+GYMAPE + S D + G L+ E + P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 8e-07
Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 51/196 (26%)
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP----VTQTMT--L 842
L+Y+H S ++H DLKP N+L++ D + DFG+A+ G MT +
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPGENAGFMTEYV 170
Query: 843 ATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901
AT Y APE S + + DV+S G ++ E RKP +F G+ + Q
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGKDYVDQ-------- 218
Query: 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLA---------------------LKC 940
+ +++ +L DEE + K +YI SL L+
Sbjct: 219 -LNQIL--QVLGTPDEETLSRIGSPKA-QNYIRSLPNIPKKPFESIFPNANPLALDLLEK 274
Query: 941 SAEI-PEERINVKDAL 955
P +RI+V++AL
Sbjct: 275 LLAFDPTKRISVEEAL 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 51/203 (25%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLI 739
F + + LG+G+ V+K + +G+ +A K+ +L+ A+++ E +V+ ++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHHGY 797
+ + G ++ M++M GSL++ L I +++ + I V L YL +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
I+H D+KP+N+L++ L DFG++ L +D + + + T YM+PE
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQGTH 178
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
S+ D++S G+ ++E R P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 25/80 (31%), Positives = 47/80 (58%)
Query: 49 ALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGS 108
+++L S+ G +PP +G+++ L L++S NSF ++P L + L+I++ + NSLSG
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 109 LPGDMCNSFTQLESFDVSSN 128
+P + SF+ + N
Sbjct: 506 VPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+YLH S I+H D+KP N+L++ + V + DFG+A++ + + T + T Y A
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 850 PE--YGSEGIVSISGDVYSFGILMMETFTRR 878
PE GS S + D++S G + E RR
Sbjct: 173 PEILMGSRHYTS-AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 27/213 (12%)
Query: 688 LGSGSFDNV----YKATLANGVSVAVKVFNLQ------EDRALKSFDTECEVMRRIRHRN 737
LG G F V YK T G A+K E +L E RH
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HG 796
L+ + + +M+Y G L ++ H + + + V L+YLH +
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSE 855
I++ DLK +N+LLD + + DFG+ K +G+ +T T T ++APE +E
Sbjct: 122 ----IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTE 175
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ + D + G+L+ E P F G+
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 34/167 (20%)
Query: 736 RNLI----KIVSSCSNP---GFK---------ALIMQYMPQGSLEKWLYSHNYSLTIRQR 779
RN I K++ C++P GF ++ M++M GSL++ L R
Sbjct: 43 RNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGR 95
Query: 780 L------DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
+ I I V L YL + I+H D+KP+N+L++ L DFG++ L +
Sbjct: 96 IPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--I 151
Query: 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
D + + + T YM+PE ++ D++S G+ ++E R P
Sbjct: 152 DSMANSF-VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
N++G+GSF VY+A + S V + + +D K + E +M+ + H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICID-TSEKVAIKKVLQDPQYK--NRELLIMKNLNHINIIFLKDYY 128
Query: 746 SNPGFKA--------LIMQYMPQGSLEKWL--YS-HNYSLTIRQRLDIMIDVASALEYLH 794
FK ++M+++PQ ++ K++ Y+ +N++L + + AL Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 795 HGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPE- 851
+ I H DLKP N+L+D + L DFG AK LL G V+ + + Y APE
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPEL 241
Query: 852 -YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
G+ + D++S G ++ E +F+G+ S+ Q V
Sbjct: 242 MLGATNYTT-HIDLWSLGCIIAEMIL----GYPIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 37/156 (23%)
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGY 847
L+Y+H S ++H DLKP+N+LL+ + + DFG+A+ MT + T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTEYVVTRWY 174
Query: 848 MAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
APE Y + +I DV+S G + E RKP +F G+ + Q
Sbjct: 175 RAPELLLNCSEYTT----AI--DVWSVGCIFAELLG-RKP---LFPGKDYVHQ------- 217
Query: 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSL 936
+ + LL EED +K YI SL
Sbjct: 218 --LKLIT--ELLGSPSEEDLGFIRNEKA-RRYIRSL 248
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 79
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 80 -------SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAP 187
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E R K +F G + QW
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGE-MVRHKI---LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-06
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVF--NLQEDRALKS-FDTECEVMRRIRHRNLIKIV 742
L+G G VY A VA+K +L E+ LK F E ++ + H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYS----------HNYSLTIRQRLDIMIDVASALEY 792
S CS+ M Y+ +L+ L S ++ L I + + +EY
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--------LLDGVDPVTQT----M 840
+H S ++H DLKP+N+LL + D+G A LLD M
Sbjct: 129 VH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 841 T-----LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
T + T YMAPE S S D+Y+ G+++ + T P
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-06
Identities = 48/187 (25%), Positives = 74/187 (39%), Gaps = 25/187 (13%)
Query: 707 VAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKW 766
V K L ++R +E + H ++K + LIM+Y G L K
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK- 154
Query: 767 LYSHNYSLTIRQRLD------------IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD 814
I+QRL + + AL+ +H S ++H DLK N+ L
Sbjct: 155 --------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLM 203
Query: 815 DDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMME 873
+ LGDFG +K D V + T Y+APE S D++S G+++ E
Sbjct: 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263
Query: 874 TFTRRKP 880
T +P
Sbjct: 264 LLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 704 GVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761
G++VAVK + Q K E +++ + H+N+I L+ + PQ
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIIS------------LLNVFTPQK 93
Query: 762 SLEKW--------LYSHNYSLTIRQRLD------IMIDVASALEYLHHGYSTPIIHCDLK 807
SLE++ L N I LD ++ + +++LH S IIH DLK
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLK 150
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
P+N+++ D + DFG+A+ T + T Y APE + D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208
Query: 868 GILMMETFTRRKPTNEMFTGEMSLKQW 894
G +M E + +F G + QW
Sbjct: 209 GCIMGELVK----GSVIFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 42/162 (25%), Positives = 63/162 (38%), Gaps = 58/162 (35%)
Query: 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLHH-GYSTPIIHCD 805
L+M+YMP G L L + + ++ AL+ +H G+ IH D
Sbjct: 78 LVMEYMPGGDLMNLLIRKD-------VFPEETARFYIAELVLALDSVHKLGF----IHRD 126
Query: 806 LKPNNVLLDDDMVAHLGDFGIAK-----------------------LLDGVDPVTQTMTL 842
+KP+N+L+D D L DFG+ K +L Q
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186
Query: 843 A--TIG---YMAPE------YGSEGIVSISGDVYSFGILMME 873
A T+G Y+APE YG E D +S G+++ E
Sbjct: 187 ANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 47/235 (20%)
Query: 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT---------ECE 728
TN + + +G G+F V A G +VA+K + +K F T E +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61
Query: 729 VMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS 788
+++ +RH N+I + +P + + L + L S Q + +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYF--LYQILR 119
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIG 846
L+Y+H S ++H DLKP+N+L++++ + DFG+A++ D MT ++T
Sbjct: 120 GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD------PQMTGYVSTRY 170
Query: 847 YMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
Y APE Y E D++S G + E KP +F G+ + Q+
Sbjct: 171 YRAPEIMLTWQKYDVE------VDIWSAGCIFAEML-EGKP---LFPGKDHVNQF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 30/151 (19%)
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-A 843
++A L +LH S II+ DLK +NV+LD + + DFG+ K + + T T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCG 163
Query: 844 TIGYMAPE------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897
T Y+APE YG S D ++FG+L+ E + P F GE +
Sbjct: 164 TPDYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPP----FDGEDE------D 207
Query: 898 SLPGAVTE--VVDANLLSREDEEDADDFATK 926
L ++ E V LS+E TK
Sbjct: 208 ELFQSIMEHNVSYPKSLSKEAVSICKGLLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 48/166 (28%), Positives = 61/166 (36%), Gaps = 48/166 (28%)
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLYSHNYSLTIRQRLDIMIDVAS 788
+ N IK+ S + LIM Y+ G L E L IRQ +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ-------LVE 120
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMV-AHLGDFGIAK------LLDGVDPVTQTMT 841
AL LH IIH D+K NVL D +L D+G+ K DG
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG--------- 168
Query: 842 LATIGYMAPEYGSEGIVSISGDVY--SF-----GILMMETFTRRKP 880
T+ Y +PE I G Y SF G+L E T + P
Sbjct: 169 --TLDYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 24/231 (10%)
Query: 691 GSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHR-----NLIKIVSS 744
G+F +VY A + G A+KV + D K+ T + R I + K+ S
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ + L+M+Y+ G + + L + +V +E LH IIH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLH---QRGIIHR 121
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS-GD 863
D+KP N+L+D L DFG+++ G++ + T Y+APE G+ D
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRN--GLEN---KKFVGTPDYLAPET-ILGVGDDKMSD 175
Query: 864 VYSFGILMMETFTRRKPTN-----EMFTGEMSLK-QWVAESLPGAVTEVVD 908
+S G ++ E P + +F +S + W E E VD
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLA 843
+++ AL YLH II+ DLK +NVLLD + L D+G+ K +G+ P T +
Sbjct: 104 EISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCG 158
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
T Y+APE S D ++ G+LM E R P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 23/182 (12%)
Query: 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812
++M+YMP G L + NY + + +V AL+ +H S IH D+KP+N+L
Sbjct: 120 MVMEYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNML 174
Query: 813 LDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY----GSEGIVSISGDVYSFG 868
LD L DFG +D V + T Y++PE G +G D +S G
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 869 ILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD-ANLLSREDEEDADDFATKK 927
+ + EM G+ + A+SL G ++++D N L+ D+ + A
Sbjct: 235 VFLY----------EMLVGDTP---FYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281
Query: 928 TC 929
C
Sbjct: 282 IC 283
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTE 905
E + D++S G +M E +F G + QW V E L E
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNKVIEQLGTPCPE 247
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 57/206 (27%), Positives = 85/206 (41%), Gaps = 37/206 (17%)
Query: 688 LGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+F VY+ + + A+KV + +E A K EV I RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 747 NP---GFK---------ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
+P G K L+ YM G L W + + + ++ ALE+LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFSEDRAKFYIAELVLALEHLH 113
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--- 851
I++ DLKP N+LLD L DFG++K + T T T Y+APE
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVLL 169
Query: 852 ----YGSEGIVSISGDVYSFGILMME 873
Y D +S G+L+ E
Sbjct: 170 DEKGYTKH------VDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 53/198 (26%)
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIR 777
E +M+ + H+N+I +++ + PQ SLE++ L N I+
Sbjct: 65 ELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQ 112
Query: 778 QRLD------IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
LD ++ + +++LH S IIH DLKP+N+++ D + DFG+A+
Sbjct: 113 MDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169
Query: 832 GVDPVTQTMT--LATIGYMAPE------YGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
+ MT + T Y APE Y E + D++S G +M E
Sbjct: 170 ----TSFMMTPYVVTRYYRAPEVILGMGY-KENV-----DIWSVGCIMGEMIRGTV---- 215
Query: 884 MFTGEMSLKQW--VAESL 899
+F G + QW + E L
Sbjct: 216 LFPGTDHIDQWNKIIEQL 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 52/247 (21%), Positives = 79/247 (31%), Gaps = 52/247 (21%)
Query: 242 LPNLENLFLWKNNLSGI----IPDSICNASEATILELSSN------LFSGLVPNTFGNCR 291
L L+ L L N L + ++ L LS N +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 292 QLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKG----VIPNSIGNLST 347
LQ L L DN L SL + L+ L L+ N L ++ + +L
Sbjct: 82 GLQELDLSDNALGPDGCG----VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP 137
Query: 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKL 407
+LE G ++L A+ L + L+ L+L +N +
Sbjct: 138 ALEKLVLGRNRL--------------------EGASCEALAKALRANRDLKELNLANNGI 177
Query: 408 KGF-IPT------DLCKLEKLNTLLSNNNALQ----GQIPTCLANLTSLRHLDFRSNSLN 456
I C LE L+ NNN L + LA+L SL L+ N+L
Sbjct: 178 GDAGIRALAEGLKANCNLEVLDL---NNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
Query: 457 STIPSTF 463
+
Sbjct: 235 DAGAAAL 241
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-06
Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 33/235 (14%)
Query: 327 LVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN-NELAG 385
L+LD N LK + N GN+ T YA S+QL+ IP + + LS+ EL
Sbjct: 204 LILDNNELKSLPENLQGNIKT----LYANSNQLTS-IPATLPDTIQEMELSINRITELPE 258
Query: 386 AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445
+P+ L Q LDL NK+ +L L+ ++ L +P+ +
Sbjct: 259 RLPSAL------QSLDLFHNKISCLPENLPEELRYLSVYDNSIRTLPAHLPS------GI 306
Query: 446 RHLDFRSNSLNSTIPSTF-WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS 504
HL+ +SNSL + +P T LK + A + +L SL SLP L L+++ NQ++
Sbjct: 307 THLNVQSNSL-TALPETLPPGLKTLEAGENALTSLPASLP------PELQVLDVSKNQIT 359
Query: 505 GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
+P ++ + L ++RNA +P++ + +LQ + S NN+ +P+SL
Sbjct: 360 -VLPETLP--PTITTLDVSRNALTN-LPENLPA--ALQIMQASRNNLV-RLPESL 407
|
Length = 754 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 680 NGFGESNLLGSGSFDNVYKATLANGVS-VAVKVFNLQEDRALKSFDT--ECEVMRRIRHR 736
N F ++G G++ V K VA+K F E+ T E +++R ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 737 NLIKIVSSCSNPGFKALIMQY-----------MPQGSLEKWLYSHNYSLTIRQRLDIMID 785
N++++ + G L+ +Y MP G + + S+ Y L
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
++ +H + I+H D+KP N+L+ + V L DFG A+ L T +AT
Sbjct: 110 ----IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
Y +PE + D++S G ++ E + +P +F GE + Q
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGE-LSDGQP---LFPGESEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 687 LLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS- 744
++G G F VY A+ G A+K + + + +K +T + R ++ +VS+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIMLSLVSTG 54
Query: 745 ------CSNPGFKA-----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
C F I+ M G L L H R ++ LE++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYG 853
H+ + +++ DLKP N+LLD+ + D G+A P ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVL 167
Query: 854 SEGIV-SISGDVYSFGILMMETFTRRKP 880
+G S D +S G ++ + P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G++ V+K + VA+K L+ E+ A + E +++ ++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
L+ +Y+ L+++L + +++ M + L Y H I+H D
Sbjct: 73 HTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRD 128
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISGD 863
LKP N+L+++ L DFG+A+ V T + + T+ Y P+ GS S D
Sbjct: 129 LKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTE-YSTPID 186
Query: 864 VYSFGILMMETFTRRKPTNEMFTG 887
++ G ++ E T R MF G
Sbjct: 187 MWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-06
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 201 LDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGII 259
L L + G IP+ I ++ +I L GN + G++P S+ + +LE L L N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 260 PDSICNASEATILELSSNLFSGLVPNTFG 288
P+S+ + IL L+ N SG VP G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 17/158 (10%)
Query: 725 TECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY-SHNYSLTIRQRLDIM 783
TE ++R I H ++I++ + + F LI+ P+ + + Y + ++ I L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-- 841
V A++YLH IIH D+K N+ ++ LGDFG A PV
Sbjct: 189 RSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF-----PVDINANKY 240
Query: 842 ---LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
TI APE + + D++S GI++ E T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 12/171 (7%)
Query: 687 LLGSGSFDNVYKATLA-NGVSVAVKVFN---LQEDRALKSFDTECEVM-RRIRHRNLIKI 741
++G GSF V A +G AVKV + + K E V+ + ++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
S ++ ++ G L L R R ++ASAL YLH S I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
++ DLKP N+LLD L DFG+ K +G+ T T T Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 48/206 (23%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 688 LGSGSFDNVYKATLANGVSVA-VKVFNLQEDRALK---SFDTECEVMRRIRHRNLIKIVS 743
+G+G F V + + VA V V L+ + + K F + + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSH-----NYSLTIRQRLDIMIDVASALEYLH-HGY 797
C L+ +Y G L+ +L N L + QR+ ++A+ + ++H H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKHNF 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSE- 855
+H DL N L D+ +GD+GI D + T+ + ++APE E
Sbjct: 121 ----LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 856 --GIVSIS----GDVYSFGILMMETF 875
G+++ +V++ G+ + E F
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 37/102 (36%), Positives = 49/102 (48%), Gaps = 9/102 (8%)
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYM 848
ALE LH +I+ DLKP N+LLD L DFG+ KL D T T T Y+
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYL 160
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
APE + + D ++ G+L+ E T P NEM+
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDR-----ALKSFDTECEVMRRIRHRNLIKI 741
LG GS+ VYK + G VA+K L+ + A++ E +++ ++H N++ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTL 68
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
L+ +Y+ L++++ L++ + + L Y H +
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---V 124
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAK 828
+H DLKP N+L+ + L DFG+A+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 18/60 (30%), Positives = 27/60 (45%)
Query: 244 NLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303
NL++L L N L+ I + +L+LS N + + P F L+ L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 33/122 (27%), Positives = 55/122 (45%), Gaps = 4/122 (3%)
Query: 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815
Y+ Q + L +L L VA + +L S IH DL N+LL
Sbjct: 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTH 249
Query: 816 DMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874
+ + DFG+A+ + + + V + + +MAPE + + DV+S+GIL+ E
Sbjct: 250 GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
Query: 875 FT 876
F+
Sbjct: 310 FS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
++ LE++H+ + +++ DLKP N+LLD+ + D G+A P ++ T
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGT 158
Query: 845 IGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFT 886
GYMAPE +G+ S D +S G ++ + P + T
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 23/56 (41%), Positives = 33/56 (58%)
Query: 496 LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNI 551
L+L+ N+L+ + L NL L L+ N P++F L SL+SLDLSGNN+
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 51/196 (26%), Positives = 95/196 (48%), Gaps = 21/196 (10%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFNLQED------RALKSFDTECEVMRRIRHRNLIK 740
+G G++ V+KA VA+K L +D AL+ E +++ ++H+N+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + L+ +Y Q L+K+ S N + M + L + H S
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ-TMTLATIGYMAPE--YGSEGI 857
++H DLKP N+L++ + L DFG+A+ G+ PV + + T+ Y P+ +G++
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF-GI-PVRCYSAEVVTLWYRPPDVLFGAKL- 176
Query: 858 VSISGDVYSFGILMME 873
S S D++S G + E
Sbjct: 177 YSTSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKI---- 741
+G G++ VYK T +G AVK+ + D + + E +++ + H N++K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 742 --VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD---IMIDVASALEYLHHG 796
G L+++ GS+ + + L QRLD I + AL L H
Sbjct: 89 YKADKLVG-GQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHL 144
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----- 851
++ IIH D+K NN+LL + L DFG++ L + + ++ T +MAPE
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACE 203
Query: 852 --YGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
Y DV+S GI +E P +M
Sbjct: 204 QQYDYS--YDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIRHRNLI 739
++G GS+ V A G VA+K VF D R L+ E +++R +RH +++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 740 KIVSSCSNPG---FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG 796
+I P FK + + + S + N LT + + AL+Y+H
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH-- 120
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYMAPEY-G 853
+ + H DLKP N+L + D + DFG+A+ D + T +AT Y APE G
Sbjct: 121 -TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 854 S-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + + D++S G + E T KP +F G+ + Q
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLT-GKP---LFPGKNVVHQ 216
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 29/78 (37%), Positives = 48/78 (61%), Gaps = 6/78 (7%)
Query: 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNV 811
L+M+Y+ G ++ L+ + Y + + +VA AL+YLH HG IIH DLKP+N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHG----IIHRDLKPDNM 135
Query: 812 LLDDDMVAHLGDFGIAKL 829
L+ ++ L DFG++K+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 26/203 (12%)
Query: 688 LGSGSFDNVYK--ATLANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G++ VYK + L + + VA+K L+ E+ A + E +++ ++H N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 745 CSNPGFKALIMQYMPQGSLEKWL-------YSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
L+ +Y+ + L+++L HN L + Q L L Y H
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLL-------RGLNYCHR-- 122
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
++H DLKP N+L+++ L DFG+A+ + T + + T+ Y P+ GS
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 856 GIVSISGDVYSFGILMMETFTRR 878
S D++ G + E T R
Sbjct: 181 D-YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 52/224 (23%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 688 LGSGSFDNVYKATL-------------ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRI 733
LG G+ +Y L + V +KV + D +L F+T +MR++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET-ASMMRQV 61
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
H++++ + C ++ +++ G L+ +++ + LT + + +ASAL YL
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL 121
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG-IAKLLDGVDPVT---QTMTLATIGYMA 849
++H ++ N+LL + + G+ G KL D P+T + + I ++A
Sbjct: 122 E---DKDLVHGNVCTKNILLAREGID--GECGPFIKLSDPGIPITVLSRQECVERIPWIA 176
Query: 850 PEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
PE + +SI+ D +SFG + E + GE+ LK
Sbjct: 177 PECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-05
Identities = 14/41 (34%), Positives = 23/41 (56%), Gaps = 5/41 (12%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCS 41
AL+ K+ ++ DP ++ WN S ++ C+W GVTC
Sbjct: 7 ALLAFKSSLNGDPSGALSS-WNPSSSD----PCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 1e-04
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 43/238 (18%)
Query: 683 GESNL--------LGSGSFDNVY----KATLANGVSVAVKVFNLQEDRALKSFDTECEVM 730
GES L +G+G F V+ K T A+ L+E R E VM
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVM 66
Query: 731 RRIRHRNLIKIVSSCSNPGFKAL--IMQYMPQGSLEKWL---YSHNYSLTIRQRLDIMID 785
R ++H+N+++ + N + L +M++ G L + + Y + +DI
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 786 VASALEYLHHGYSTP----IIHCDLKPNNVLLDDDM-----------------VAHLGDF 824
+ AL Y H+ P ++H DLKP N+ L + +A +GDF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 825 GIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI--SGDVYSFGILMMETFTRRKP 880
G++K + G++ + + + T Y +PE S D+++ G ++ E + + P
Sbjct: 187 GLSKNI-GIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 21/60 (35%), Positives = 31/60 (51%)
Query: 516 NLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGL 575
NL L L+ N +F L +L+ LDLSGNN++ P++ L L ++S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 22/59 (37%), Positives = 25/59 (42%), Gaps = 1/59 (1%)
Query: 372 NLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNN 429
NL L L NN L L L+ LDL+ N L P L L +L LS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLIK 740
++G G+F V L N V A+K+ N E LK +T C +V+ ++ +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDNQWITT 65
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---TIRQRLDIMIDVASALEYLHHGY 797
+ + + L+M Y G L L L R L M+ ++ LH+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY----- 852
+H D+KP+N+L+D + L DFG L V ++ + T Y++PE
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKP 880
+G D +S G+ M E P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 8/85 (9%)
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+NV +++D + DFG+A+ D T +AT Y A
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRA 183
Query: 850 PEYGSEGI-VSISGDVYSFGILMME 873
PE + + + D++S G +M E
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 23/61 (37%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 396 KLQGLDLNSNKLKGFIPTDLCK-LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNS 454
L+ LDL++N+L IP K L L L + N L P + L SLR LD N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 455 L 455
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 6/80 (7%)
Query: 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNV 811
LIM+Y+P G + L + + T + + + A++ +H GY IH D+KP+N+
Sbjct: 78 LIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGY----IHRDIKPDNL 132
Query: 812 LLDDDMVAHLGDFGIAKLLD 831
LLD L DFG+ L
Sbjct: 133 LLDAKGHIKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 38/167 (22%), Positives = 80/167 (47%), Gaps = 9/167 (5%)
Query: 688 LGSGSFDNVYK--ATLANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G++ V+K + L + VA+K L+ E+ A + E +++ ++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+ +Y+ + L++++ +++ + + L Y H ++H
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHR 128
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
DLKP N+L+++ L DFG+A+ V T + + T+ Y P+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPD 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 43/160 (26%), Positives = 62/160 (38%), Gaps = 39/160 (24%)
Query: 789 ALEYLHH-GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
A++ +H GY +H D+KP+NVLLD + L DFG L V + + T Y
Sbjct: 114 AIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169
Query: 848 MAPE-----------YGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMFTGEMSL 891
++PE YG E D +S G+ M E P E + M+
Sbjct: 170 ISPEILQAMEDGKGRYGPE------CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
Query: 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCIS 931
K+ P VT+V E+A D + C
Sbjct: 224 KEHF--QFPPDVTDV----------SEEAKDLIRRLICSP 251
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 781 DIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDG----V 833
+IM D+ + LEY+H HG S H D+KP N+++D + ++ D+GIA ++ G
Sbjct: 130 NIMKDMLTTLEYIHEHGIS----HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185
Query: 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
+ + T+ Y + + V+ GD+ S G M++ + P
Sbjct: 186 SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIM-QYMPQGSLEKWLYSHNYSLTIRQRLDIMI 784
E ++RR+ H ++ ++ G L++ +Y + L +L + L + Q +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV--DPVTQTMTL 842
+ SA++Y+H IIH D+K NVL++ LGDFG A G P +
Sbjct: 268 QLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA- 323
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874
T+ APE + + S D++S G+++ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 52/193 (26%), Positives = 77/193 (39%), Gaps = 28/193 (14%)
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLN 477
L L +L N N L+ I L LT+L LD +N++ P + +D S N
Sbjct: 92 LLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 478 SLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGS 537
+ SLP + NL L L+L+ N LS +P + NL NL
Sbjct: 151 KIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNL-------------------- 188
Query: 538 LISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNY 597
+LDLSGN IS ++P +E LS L + ++S N + + S N + N
Sbjct: 189 ----NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243
Query: 598 ALCGSSRLQVPPC 610
+
Sbjct: 244 LEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 21/60 (35%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 197 NLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY-LPNLENLFLWKNNL 255
NLK LDL N + + N+ + L GN+L+ P + LP+L +L L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 1/61 (1%)
Query: 94 RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNS 153
LK +D S+N L+ +P L+ D+S N +T P A + SL+S+ L N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 154 L 154
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 52/219 (23%), Positives = 84/219 (38%), Gaps = 44/219 (20%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
++G G+F V + + + A+K+ N E LK +T C R + + C
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWE--MLKRAETAC-----FREERNVLVNGDC 60
Query: 746 S----------NPGFKALIMQYMPQGSLEKWLYSHNYSL---TIRQRLDIMIDVASALEY 792
+ + L+M Y G L L L R + M+ ++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE- 851
LH+ +H D+KP+NVLLD + L DFG ++ V ++ + T Y++PE
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 852 ----------YGSEGIVSISGDVYSFGILMMETFTRRKP 880
YG E D +S G+ M E P
Sbjct: 175 LQAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 79/311 (25%), Positives = 120/311 (38%), Gaps = 64/311 (20%)
Query: 141 ISSLKSIRLDNNSLSGSFPTDLCTRL---PSLVQLRLLGNNITGRIPN--REIPNEIGNL 195
+ L+ +RL+ N+L L + L PSL +L L N TGRIP + + +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKEL-CLSLNETGRIPRGLQSLLQGLTKG 80
Query: 196 HNLKILDLGGNNI----AGLIPSMIFNNSNMVAILLY-------GNHLSGHLPSSIYLPN 244
L+ LDL N + G++ S++ ++S L L+ L P
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL--PPA 138
Query: 245 LENLFLWKNNLSGIIPDSICNASEAT----ILELSSN---------LFSGLVPNTFGNCR 291
LE L L +N L G +++ A A L L++N L GL N
Sbjct: 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANC----- 193
Query: 292 QLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLEN 351
L++L L +N LT +LA + L VL L N L
Sbjct: 194 NLEVLDLNNNGLT---DEGASALAETLASLKSLEVLNLGDNNLTD--------------- 235
Query: 352 FYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL----AGAIPTVLGKLQKLQGLDLNSNKL 407
AG++ L+ + +LL LSL N++ A + VL + + L LDL NK
Sbjct: 236 --AGAAALASALLSP---NISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
Query: 408 KGFIPTDLCKL 418
L +
Sbjct: 291 GEEGAQLLAES 301
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 22/61 (36%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
L+S D+S+N++T A + +LK + L N+L+ S + + LPSL L L GNN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 179 I 179
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 70/314 (22%), Positives = 114/314 (36%), Gaps = 66/314 (21%)
Query: 601 GSSRLQVPPCKTSSTHKSKATKIVLRYILPAIATTMVVVALFIILIRRRKRNKSLPEENN 660
GS R + T S TT V VA +++K +LP N
Sbjct: 55 GSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAP---PPKKKKVTYALP--NQ 109
Query: 661 SLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRA 719
S + ++ +T F +LLG G+F V +A AVK+ +
Sbjct: 110 SREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR-NVPKY 168
Query: 720 LKSFDTECEVMRRIRHRN------LIKIVSSCSN-PGFKALIM-QYMPQGSLEKWLYSHN 771
+ E + M ++R + L+KI N G ++M +Y P L W+ H
Sbjct: 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGP--CLLDWIMKHG 226
Query: 772 YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
+ R I+ AL+Y H ++H DLKP N+L++
Sbjct: 227 -PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTV------------ 271
Query: 832 GVDPVT-------------------------QTMTLATIGYMAPEYGSEGIVSI----SG 862
VDPVT +T ++T Y +PE ++ + S
Sbjct: 272 -VDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEV----VLGLGWMYST 326
Query: 863 DVYSFGILMMETFT 876
D++S G ++ E +T
Sbjct: 327 DMWSMGCIIYELYT 340
|
Length = 467 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 22/82 (26%)
Query: 754 IMQYMPQGSLEKWLYSHNYSLTIRQ--------RLDIMIDVASALEYLHH-GYSTPIIHC 804
+M Y+P G + SL IR R I ++ A+E +H G+ IH
Sbjct: 79 VMDYIPGGDM--------MSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMGF----IHR 125
Query: 805 DLKPNNVLLDDDMVAHLGDFGI 826
D+KP+N+L+D D L DFG+
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 64/174 (36%)
Query: 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYSTPIIHCDLKPNNV 811
LIM+++P G L L ++ R M + A+E +H G+ IH D+KP+N+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVHKLGF----IHRDIKPDNI 132
Query: 812 LLDDDMVAHLGDFGIA-------------KLLDG--------------VDPVTQTM---- 840
L+D L DFG++ KLL G VD + TM
Sbjct: 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKD 192
Query: 841 ---------------TLATIGYMAPE------YGSEGIVSISGDVYSFGILMME 873
T+ T Y+APE YG E D +S G +M E
Sbjct: 193 QIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE------CDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 17/92 (18%)
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
P ++M+Y+ G L K R D++ +V + LH I+H DL
Sbjct: 71 PDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKLHKA---GIVHGDLT 119
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLD-----GVD 834
+N++L + + DFG+ + D VD
Sbjct: 120 TSNIILSGGRI-YFIDFGLGEFSDEVEDKAVD 150
|
Length = 204 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 28/125 (22%), Positives = 37/125 (29%), Gaps = 31/125 (24%)
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-------HGYS 798
P + + L + L + +AL+ L
Sbjct: 144 ERPNALRRLE-WDILEPRAL----LRLDLVEPEDLRAAL--LAALDRLLARLPAHLPALG 196
Query: 799 TPIIHCDLKPNNVLLDDD-MVAHLGDFG----------IAKLL-----DGVDPVTQTMTL 842
IIH DL P+NVL DDD V+ DF +A L D DP
Sbjct: 197 DQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGYGWFIYDLAIALNAWNGDEADPRAAIAAF 256
Query: 843 ATIGY 847
GY
Sbjct: 257 LE-GY 260
|
Length = 331 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 973 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.87 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.78 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.71 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.5 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.46 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-114 Score=1096.22 Aligned_cols=908 Identities=32% Similarity=0.537 Sum_probs=774.5
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCC
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNS 80 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~ 80 (973)
||++||+++. ||.+.+++ |+. +.+||.|.||+|+. .++|+.|||++++++|.+|+.+..+++|+.|+|++|+
T Consensus 33 ~l~~~~~~~~-~~~~~~~~-w~~-----~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 33 LLLSFKSSIN-DPLKYLSN-WNS-----SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred HHHHHHHhCC-CCcccCCC-CCC-----CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 6999999995 78777765 864 57899999999985 5799999999999999999999999999999999999
Q ss_pred CCCCCCcccc-cccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCC
Q 048430 81 FYDTLPNELW-HMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFP 159 (973)
Q Consensus 81 ~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip 159 (973)
+.+.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 181 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence 9999998866 999999999999999999986 458999999999999999999999999999999999999998888
Q ss_pred ccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCC
Q 048430 160 TDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239 (973)
Q Consensus 160 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 239 (973)
..+ .++++|++|+|++|++++ .+|..++++++|++|+|++|++++.+|..+.++++|+.|++++|.+++.+|..
T Consensus 182 ~~~-~~l~~L~~L~L~~n~l~~-----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 255 (968)
T PLN00113 182 NSL-TNLTSLEFLTLASNQLVG-----QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255 (968)
T ss_pred hhh-hhCcCCCeeeccCCCCcC-----cCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh
Confidence 765 689999999999999985 46788999999999999999999999999999999999999999999888865
Q ss_pred C-CccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhh
Q 048430 240 I-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318 (973)
Q Consensus 240 ~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l 318 (973)
+ .+++|++|++++|++.+.+|..+..+++|++|+|++|.+.+.+|..+.++++|+.|++++|.+++. .+..+
T Consensus 256 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-------~~~~~ 328 (968)
T PLN00113 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK-------IPVAL 328 (968)
T ss_pred HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCc-------CChhH
Confidence 5 699999999999999999999999999999999999999999999999999999999999999763 34567
Q ss_pred ccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCC
Q 048430 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQ 398 (973)
Q Consensus 319 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 398 (973)
..+++|+.|++++|.+.+.+|..+..+ ..|+.+++++|++++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+
T Consensus 329 ~~l~~L~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~ 407 (968)
T PLN00113 329 TSLPRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR 407 (968)
T ss_pred hcCCCCCEEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCC
Confidence 889999999999999999999988776 6799999999999999999999999999999999999999999999999999
Q ss_pred EEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCc
Q 048430 399 GLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478 (973)
Q Consensus 399 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 478 (973)
.|+|++|++++.+|..+..+++|+.|++++|.+++.++..+..+++|+.|++++|++.+.+|..+ ..++|+.||+++|+
T Consensus 408 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~ 486 (968)
T PLN00113 408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQ 486 (968)
T ss_pred EEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCc
Confidence 99999999999999999999999999999999999999999999999999999999999888766 46899999999999
Q ss_pred ccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCcc
Q 048430 479 LSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKS 558 (973)
Q Consensus 479 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 558 (973)
+++.+|..+.++++|+.|+|++|++++.+|..++.+++|+.|+|++|.+++.+|..|+.+++|+.|||++|+++|.+|..
T Consensus 487 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 566 (968)
T PLN00113 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566 (968)
T ss_pred cCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCCCcccccCCCCCCCCccCccccccCcccccCCcc-CCCCccCCCccCcccceeEEEeehhhhHHH-H
Q 048430 559 LEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRL-QVPPCKTSSTHKSKATKIVLRYILPAIATT-M 636 (973)
Q Consensus 559 ~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~-~~~~c~~~s~~~~~~~~~~~~~i~~~~~~~-~ 636 (973)
+..++.|+.|++++|+++|.+|+.+.+.++...++.+|+.+||.+.. ..++|..... . ... +.+++.+++++ +
T Consensus 567 l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~--~~~-~~~~~~~~~~~~~ 641 (968)
T PLN00113 567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--T--PSW-WFYITCTLGAFLV 641 (968)
T ss_pred HhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--c--cee-eeehhHHHHHHHH
Confidence 99999999999999999999999999999999999999999986532 3456753211 1 111 11222222221 2
Q ss_pred HHHHhhhhhhhhhccCCCC---Cccccccccc-----ccCCCCHHHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEE
Q 048430 637 VVVALFIILIRRRKRNKSL---PEENNSLNLA-----TLSRISYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSV 707 (973)
Q Consensus 637 ~vv~~~~~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~v 707 (973)
+++++++++++++++.... ..+....... ....++++ .....|...+.||+|+||.||+|+. .+++.|
T Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~v 718 (968)
T PLN00113 642 LALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIN---DILSSLKEENVISRGKKGASYKGKSIKNGMQF 718 (968)
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHH---HHHhhCCcccEEccCCCeeEEEEEECCCCcEE
Confidence 2222222222222221111 1111111110 01112333 3345677889999999999999986 578999
Q ss_pred EEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHH
Q 048430 708 AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA 787 (973)
Q Consensus 708 avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~ 787 (973)
|||.++.... ...+|++.+++++||||++++++|.+++..++||||+++|+|.++++ .++|.++.+|+.|+|
T Consensus 719 avK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia 790 (968)
T PLN00113 719 VVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIA 790 (968)
T ss_pred EEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHH
Confidence 9998864332 12356889999999999999999999999999999999999999996 378999999999999
Q ss_pred HHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHH
Q 048430 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867 (973)
Q Consensus 788 ~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~ 867 (973)
+||+|||+.++++|+||||||+||+++.++.+++. ||.+..... .....+++.|+|||+..+..++.++|||||
T Consensus 791 ~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred HHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhH
Confidence 99999997667899999999999999999988875 665543321 122367899999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc-chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCC
Q 048430 868 GILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG-AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPE 946 (973)
Q Consensus 868 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~ 946 (973)
||++|||+||+.||+...........|+...... .....+|+.+..... .......++.+++.+||+.+|+
T Consensus 865 Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~~Cl~~~P~ 936 (968)
T PLN00113 865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS--------VNQNEIVEVMNLALHCTATDPT 936 (968)
T ss_pred HHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC--------ccHHHHHHHHHHHHhhCcCCch
Confidence 9999999999999977666666777787654432 244445544432111 1123456788999999999999
Q ss_pred CCCCHHHHHHHHHHHHHH
Q 048430 947 ERINVKDALADLKKIKKI 964 (973)
Q Consensus 947 ~Rpt~~evl~~L~~~~~~ 964 (973)
+||+|+||++.|+++.+.
T Consensus 937 ~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 937 ARPCANDVLKTLESASRS 954 (968)
T ss_pred hCcCHHHHHHHHHHhhcc
Confidence 999999999999998763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-60 Score=601.29 Aligned_cols=515 Identities=33% Similarity=0.508 Sum_probs=481.9
Q ss_pred CCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEE
Q 048430 69 SFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIR 148 (973)
Q Consensus 69 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 148 (973)
.+++.|+|++|++.+.+|..+..+++|+.|+|++|+++|.+|.+++..+++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 47899999999999999999999999999999999999999999988999999999999999998885 5689999999
Q ss_pred ccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEee
Q 048430 149 LDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY 228 (973)
Q Consensus 149 L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~ 228 (973)
|++|.+++.+|..+ ..+++|++|+|++|.+++ .+|..++++++|++|+|++|++.+.+|..+.++++|+.|+++
T Consensus 147 Ls~n~~~~~~p~~~-~~l~~L~~L~L~~n~l~~-----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (968)
T PLN00113 147 LSNNMLSGEIPNDI-GSFSSLKVLDLGGNVLVG-----KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220 (968)
T ss_pred CcCCcccccCChHH-hcCCCCCEEECccCcccc-----cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence 99999998888765 689999999999999985 567889999999999999999999999999999999999999
Q ss_pred cccccccCCCCC-CccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCC
Q 048430 229 GNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGS 307 (973)
Q Consensus 229 ~n~l~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 307 (973)
+|.+++.+|..+ .+++|++|++++|++.+.+|..++++++|+.|+|++|.+.+..|..+.++++|++|++++|++...
T Consensus 221 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~- 299 (968)
T PLN00113 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE- 299 (968)
T ss_pred CCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC-
Confidence 999998888655 699999999999999999999999999999999999999999999999999999999999999753
Q ss_pred CCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccccc
Q 048430 308 SAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAI 387 (973)
Q Consensus 308 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 387 (973)
.+..+.++++|+.|++++|.+.+.+|..+..+ ..|+.+++.+|.+++.+|..++.+++|+.|++++|++.+.+
T Consensus 300 ------~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~ 372 (968)
T PLN00113 300 ------IPELVIQLQNLEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372 (968)
T ss_pred ------CChhHcCCCCCcEEECCCCccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeC
Confidence 34567889999999999999999999988876 57899999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccc
Q 048430 388 PTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467 (973)
Q Consensus 388 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 467 (973)
|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+.++++|+.|++++|.+++.+|..++.++
T Consensus 373 p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 452 (968)
T PLN00113 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452 (968)
T ss_pred ChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccc
Q 048430 468 YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547 (973)
Q Consensus 468 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (973)
+|+.|++++|++.+.+|..+ ..++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..++.+++|++|+|+
T Consensus 453 ~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (968)
T PLN00113 453 SLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531 (968)
T ss_pred CCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence 99999999999999888866 45899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCCCcccccCCCC-CCCCccCccccccCcccc
Q 048430 548 GNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG-GPFVNFTADSFKQNYALC 600 (973)
Q Consensus 548 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c 600 (973)
+|+++|.+|..|..+++|+.|+|++|+++|.+|.. ..+..+....+.+|+..+
T Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 99999999999999999999999999999999974 445556666677777554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=439.02 Aligned_cols=288 Identities=40% Similarity=0.692 Sum_probs=247.2
Q ss_pred ccCCCCHHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeee
Q 048430 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745 (973)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 745 (973)
....|++.++..||++|...++||+|+||.||+|.+.+|+.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46678999999999999999999999999999999999999999987654432145699999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEee
Q 048430 746 SNPG-FKALIMQYMPQGSLEKWLYSHNY-SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823 (973)
Q Consensus 746 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 823 (973)
.+.+ +.+||||||++|+|.++++.... .++|.+|++||.++|+||+|||+.+..+||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999998766 899999999999999999999998888999999999999999999999999
Q ss_pred cccccccCC-CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc-cCcccHHHHHHhhC-C
Q 048430 824 FGIAKLLDG-VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMF-TGEMSLKQWVAESL-P 900 (973)
Q Consensus 824 fgla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~-~ 900 (973)
||+|+.... ........ .||.+|+||||...+..|.|+|||||||+++|++||+.|.+... .++..+..|+.... .
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976543 11111111 79999999999999999999999999999999999999887654 45556889986655 4
Q ss_pred cchhhhcccccCC-CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 901 GAVTEVVDANLLS-REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 901 ~~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
+.+.+++|+.+.. ..... .....+..++.+|++.+|++||+|.||++.|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~---------~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDE---------KEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChH---------HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 4788999998863 22110 345558899999999999999999999999966554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=381.21 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=215.0
Q ss_pred CCCHHHHHHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeee
Q 048430 669 RISYHELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCS 746 (973)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 746 (973)
.++..|++. .+.||+|..|+||+++++ +++.+|+|++.... +...+++.+|++++++.+||+||++||+|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355556654 578999999999999964 78999999996554 445688999999999999999999999999
Q ss_pred cCC-eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 747 NPG-FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 747 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
.++ ..+++||||++|||++++...+ .+++....+|+.++++||.|||+ +++||||||||+|||++..|++||||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 988 5999999999999999998764 79999999999999999999996 5999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
.++.+.+. .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+..............+..
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-- 299 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-- 299 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC--
Confidence 99887543 4566789999999999999999999999999999999999999986642222222222222111110
Q ss_pred hcccccCCCCchhhhhhHHhHH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKK-TCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+. .|. .|++++.+++..|++.||.+||+++|+++|
T Consensus 300 ---------------P~--lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 ---------------PR--LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---------------CC--CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 112 378889999999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=404.09 Aligned_cols=251 Identities=29% Similarity=0.472 Sum_probs=218.5
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHH
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 764 (973)
.+.||+|.||.||.|.++....||+|.++.. ....++|.+|+.+|++++|++||+++|+|..++..+||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 5789999999999999998889999999764 233478999999999999999999999999988999999999999999
Q ss_pred HHhhh-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccc
Q 048430 765 KWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843 (973)
Q Consensus 765 ~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 843 (973)
+|++. .+..+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+......+.......-
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf 366 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF 366 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC
Confidence 99997 5568999999999999999999999 8999999999999999999999999999999665544545555667
Q ss_pred cccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhh
Q 048430 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADD 922 (973)
Q Consensus 844 ~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 922 (973)
+..|+|||.+..+.++.|||||||||+||||+| |+.||..+.. .+.+. . .+.+.+
T Consensus 367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----~ev~~---------~----------le~GyR 422 (468)
T KOG0197|consen 367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----EEVLE---------L----------LERGYR 422 (468)
T ss_pred CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----HHHHH---------H----------HhccCc
Confidence 899999999999999999999999999999999 7778765322 22111 1 223446
Q ss_pred HHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 923 FATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 923 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
++.|..|+..+.++|..||+.+|++|||++.+...++.+..
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 67788899999999999999999999999988888887754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=395.40 Aligned_cols=256 Identities=31% Similarity=0.486 Sum_probs=212.3
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCC-eeEEEEEecCCC
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPG-FKALIMQYMPQG 761 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g 761 (973)
.+.+|+|+||+||+|.+.....||||++..... ...+.|.+|+.+|.+++|||||+++|+|.++. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 355999999999999998444499999976532 22569999999999999999999999999887 799999999999
Q ss_pred CHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eEEccCCCCcEEeCCCC-cEEEeecccccccCCCCCccc
Q 048430 762 SLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTP-IIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 762 sL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~~~ 838 (973)
+|.++++. ....+++..+..+|.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 99999998 3568999999999999999999999 677 99999999999999998 99999999998765322 233
Q ss_pred ccccccccccCccCCC--CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 839 TMTLATIGYMAPEYGS--EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~--~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
+...||+.|||||.+. ...++.|+|||||||++|||+||+.||..... . .....+.. ...
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-~~~~~v~~-----------~~~----- 263 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-QVASAVVV-----------GGL----- 263 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-HHHHHHHh-----------cCC-----
Confidence 3467999999999999 56999999999999999999999999977543 1 11111110 000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
+...+..|++.+..++.+||+.||++||++.|++..|+.+...+..
T Consensus 264 -----Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 264 -----RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -----CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 0111223778899999999999999999999999999999876553
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=413.07 Aligned_cols=259 Identities=26% Similarity=0.465 Sum_probs=222.6
Q ss_pred cCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
.+....+.||+|+||+||+|+. .+.+.||||.++...+. ..++|++|++.+..++|||||+++|+|.+++..|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 3444568899999999999984 24678999999877665 7889999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCC---------C----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 753 LIMQYMPQGSLEKWLYSHN---------Y----SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~---------~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
+|+|||..|||.+||+.+. . +++..+.+.||.|||.||+||. ++.+|||||.++|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999998643 2 3888999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCcccc-cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHh
Q 048430 820 HLGDFGIAKLLDGVDPVTQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 897 (973)
||+|||+++.....+++... ...-+.+|||||.+..+++|.+||||||||+|||+++ |+.||.+....+. +.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-----Ie- 716 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-----IE- 716 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-----HH-
Confidence 99999999988777776554 5567899999999999999999999999999999998 8889876443221 11
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
.+-+. .-+..|++|+.++++||..||+..|++||+++||-..|+...+.-
T Consensus 717 -------~i~~g-----------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 717 -------CIRAG-----------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -------HHHcC-----------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 11111 123456789999999999999999999999999999998876643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=386.17 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=213.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
..|...+.||+|||+.||.++. .+|+.||+|++... .....+...+|+++.++++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999996 89999999999754 3456678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|.|++++|.++++. +..+++.+++.+++||+.|+.||| +.+|+|||||..|++++++.++||+|||+|..+.. +.
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~-~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY-DG 172 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecC-cc
Confidence 99999999999984 458999999999999999999999 89999999999999999999999999999998764 33
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
..+...+|||.|.|||++.....++.+||||+|||+|-|+.|++||+... +.......
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~I----------------- 230 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKI----------------- 230 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHH-----------------
Confidence 55667789999999999999899999999999999999999999996521 11111110
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...++..|...+.+..+||.++|+.+|.+|||+++|+.|
T Consensus 231 ---k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 231 ---KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011122233456678899999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.73 Aligned_cols=200 Identities=28% Similarity=0.494 Sum_probs=181.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
..+|...+.||+|+||+||+|++ +++..||||.+... .....+....|+.+++.++|||||.+++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45788888899999999999995 46899999998766 3455677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC------CcEEEeecccccc
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD------MVAHLGDFGIAKL 829 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgla~~ 829 (973)
|||.||+|.+|++..+ .+++..++.++.|+|.||++|| +++||||||||.|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999886 7999999999999999999999 8999999999999999765 4689999999998
Q ss_pred cCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~ 884 (973)
+.+ .......+|++-|||||++...+|+.|+|+||.|+++||+++|+.||+..
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 863 33445578999999999999999999999999999999999999999753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=348.13 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=207.4
Q ss_pred CCCCCccccccCceEEEEEE-eCCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEe-eeecC-CeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVS-SCSNP-GFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~-~~~~lv~ 755 (973)
+|.+.++||+|.||+||+++ ..+|..||.|.++.. +..+.++...|+.++++++|||||++++ -+.+. ...++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45567899999999999998 678999999988754 3455678899999999999999999998 45444 4489999
Q ss_pred EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 756 QYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 756 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
|+|++|+|..+++. .+..+++..+++++.|+++||.++|... ++ |+||||||.||+++..|.||++|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999998864 3467999999999999999999999422 44 889999999999999999999999999988
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
... .......+|||.||+||.+....|++||||||+||++|||..-+.||.+. ++.+.......++...+
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~~~~---- 248 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDYPPL---- 248 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCCCCC----
Confidence 643 33445678999999999999999999999999999999999999999752 34433332222221111
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
+...++.++.+++..|+..||+.||+...+++.+.
T Consensus 249 --------------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 249 --------------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --------------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11457888999999999999999999665555543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=361.44 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=206.4
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchh-------hHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR-------ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
.+.|.+.+.+|+|+||.|-+|. .++|+.||||+++..... ......+|+++|++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456778999999999999998 668999999999754211 12345799999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC---CcEEEeecccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD---MVAHLGDFGIA 827 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla 827 (973)
.|+|||||+||+|.+.+-.++ .+.+..-+.+++|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999998876 6788888999999999999999 8999999999999999766 78999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGI---VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+... ........+||+.|.|||++.+.. +..++|+||+||++|-+++|.+||.+..... .+.+-+.. +.
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI~~---G~-- 398 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQILK---GR-- 398 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHHhc---Cc--
Confidence 9875 223344568999999999887654 3347899999999999999999997644332 22221111 10
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
+. .....+...+++..+++.+|+..||++||+++|+++|=
T Consensus 399 ------y~--------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 399 ------YA--------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred ------cc--------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 00 01122345677889999999999999999999999873
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=394.54 Aligned_cols=274 Identities=23% Similarity=0.416 Sum_probs=232.3
Q ss_pred ccCCCCHHHHHHHhcCC---------CCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHH
Q 048430 666 TLSRISYHELQQATNGF---------GESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMR 731 (973)
Q Consensus 666 ~~~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~ 731 (973)
.+...+|+|..+|...| .+.++||.|.||.||+|+++ ....||||.++... +.+..+|..|+.||.
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 34456777777666555 35689999999999999964 35679999998663 456789999999999
Q ss_pred hccCCceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcE
Q 048430 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNV 811 (973)
Q Consensus 732 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Ni 811 (973)
+++||||+++-|+.+.....++|+|||++|+|+.||+.+..++++.+...+.++||.||+||. ..++|||||.++||
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNI 762 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNI 762 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhe
Confidence 999999999999999999999999999999999999999888999999999999999999999 89999999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCCccc--ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCc
Q 048430 812 LLDDDMVAHLGDFGIAKLLDGVDPVTQ--TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGE 888 (973)
Q Consensus 812 ll~~~~~~kl~Dfgla~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~ 888 (973)
|++.+..+|++|||+++.+.......+ ....-+.+|.|||.+..+++|.+||||||||||||.++ |..||-++...+
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 999999999999999998744332222 22245789999999999999999999999999999887 889986644322
Q ss_pred ccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
. ... .+...+++.|.+|+..+.+||..||++|-.+||.+.|++..|+++.+.-+
T Consensus 843 V--------------Ika----------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 843 V--------------IKA----------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred H--------------HHH----------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1 111 12334567788999999999999999999999999999999999886543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=341.71 Aligned_cols=267 Identities=22% Similarity=0.296 Sum_probs=210.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
+.|....++|+|+||+||+++. .+|+.||||.+..+.+ ...+-.++|++++++++|+|+|.++.+|......++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4577788999999999999995 4799999999976543 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
||+. ++.+-+.......+.+.+.+++.|+++|+.|+| +.++|||||||+||+++.+|.+||||||+|+.+.. ...
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 9987 555556666668999999999999999999999 89999999999999999999999999999998864 344
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-----Ccchhhhcccc
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-----PGAVTEVVDAN 910 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~d~~ 910 (973)
.++.++.|.+|+|||.+.+ .+|...+||||.||++.||++|.+-| +++.++++...... ...-..++...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~----PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW----PGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC----CCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 5667889999999998776 67999999999999999999998765 45555555543211 11111222111
Q ss_pred --cC-----CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 --LL-----SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 --l~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+. .....+..++ .-......+.+++++|++.||.+|++.+|++.|
T Consensus 233 ~~F~Gv~lP~~~~~epLe~--k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLER--KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhh--hcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00 0011111110 111234568899999999999999999999876
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.07 Aligned_cols=476 Identities=26% Similarity=0.397 Sum_probs=313.7
Q ss_pred cEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEe
Q 048430 46 RVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125 (973)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~L 125 (973)
....+++++|+++ .+.+.+.+|..|+.|++++|++ ..+|++++.+..++.|+.|+|+++ .+|+++ +.+.+|..|++
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l-~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i-~s~~~l~~l~~ 121 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKL-SQLPAAIGELEALKSLNVSHNKLS-ELPEQI-GSLISLVKLDC 121 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchh-hhCCHHHHHHHHHHHhhcccchHh-hccHHH-hhhhhhhhhhc
Confidence 3566788888887 6666788889999999999988 578889999999999999999998 788887 66888999999
Q ss_pred eCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecC
Q 048430 126 SSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGG 205 (973)
Q Consensus 126 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~ 205 (973)
++|.+. ++|+.++.+..|..|+..+|+++ ++|.+++ .+.+|..|++.+|+++ ++|...-+++.|++||.-+
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~------~l~~~~i~m~~L~~ld~~~ 192 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLK------ALPENHIAMKRLKHLDCNS 192 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHH-HHHHHHHhhccccchh------hCCHHHHHHHHHHhcccch
Confidence 999988 77888888999999999999998 8887774 6788888999999986 5666666688899999999
Q ss_pred CcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhc-ccCcccEEEeccccccccCC
Q 048430 206 NNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSIC-NASEATILELSSNLFSGLVP 284 (973)
Q Consensus 206 N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~~N~i~~~~~ 284 (973)
|.++ .+|..++.+.+|..|+|.+|++.. +|+...+..|++|+++.|+|+ ++|...+ .+.++.+|||..|++... |
T Consensus 193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~-P 268 (565)
T KOG0472|consen 193 NLLE-TLPPELGGLESLELLYLRRNKIRF-LPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEV-P 268 (565)
T ss_pred hhhh-cCChhhcchhhhHHHHhhhccccc-CCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccC-c
Confidence 9887 667788888999999999999884 446667788899999999988 5666555 788899999999998854 6
Q ss_pred CcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCccccccc-ccceeec--cc---CC
Q 048430 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLST-SLENFYA--GS---SQ 358 (973)
Q Consensus 285 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-~l~~l~l--~~---n~ 358 (973)
+.+.-+++|++||+|+|.|++.+ .+++++ .|+.|.+.+|++..+--+-+..-.. -+.++.- .. ++
T Consensus 269 de~clLrsL~rLDlSNN~is~Lp--------~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~ 339 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDISSLP--------YSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQ 339 (565)
T ss_pred hHHHHhhhhhhhcccCCccccCC--------cccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCC
Confidence 77778888999999999988744 457777 8888889999886432221111110 0111100 00 00
Q ss_pred ccc------c-CC---CCCCCCCcccEEEeecCccccccCcccCCCCC---CCEEEccCCcCCCCCchhhhccCcCCeee
Q 048430 359 LSG------G-IP---VGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK---LQGLDLNSNKLKGFIPTDLCKLEKLNTLL 425 (973)
Q Consensus 359 l~~------~-~p---~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 425 (973)
-.| . .+ .+...+.+.+.|++++-+++ .+|+....... .+..+++.|++. .+|..+..++.+.+.
T Consensus 340 se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~- 416 (565)
T KOG0472|consen 340 SEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTD- 416 (565)
T ss_pred CcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHH-
Confidence 000 0 00 01122334445555555554 33332222222 444555555554 444444444433332
Q ss_pred cCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcc
Q 048430 426 SNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG 505 (973)
Q Consensus 426 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 505 (973)
+.+++|.+ +.+|..++.+++|+.|++++|-+. .+|.+++.+..|+.|++|.|+|.
T Consensus 417 ----------------------l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr- 471 (565)
T KOG0472|consen 417 ----------------------LVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR- 471 (565)
T ss_pred ----------------------HHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-
Confidence 22333332 344555555555555555555554 45555555555555666666555
Q ss_pred cCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCccc
Q 048430 506 YIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576 (973)
Q Consensus 506 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 576 (973)
.+|.++..+..|+.+-.++|++....|+.+.+|.+|.+|||.+|.|. .+|..+++|++|+.|++++|++.
T Consensus 472 ~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 472 MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 55555555555555555555555444444555666666666666655 45556666666666666666655
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=370.86 Aligned_cols=266 Identities=29% Similarity=0.451 Sum_probs=215.9
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 674 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
+++...+.+...+.||+|.||+||+|+|. ..||||+++... ++..+.|+.|+.++++-+|.||+-|+|||..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33334444556789999999999999986 369999998764 4567899999999999999999999999998887
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
.+|+.+|+|-+|+.+++..+..|+..+.+.||+|||+||.||| .++|||||+|..||++.+++.|||+|||++....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999998888999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCC-CcccccccccccccCccCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 832 GVD-PVTQTMTLATIGYMAPEYGSE---GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 832 ~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.-. ........|...|||||++.. .+|++.+||||||||+|||++|..||.. ...+. +--.+
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dq-------------IifmV 605 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQ-------------IIFMV 605 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhh-------------eEEEe
Confidence 221 112223357888999997653 4699999999999999999999999862 22221 11111
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
.+.+.. .+......+|+.++++|+..||..++++||.+.+++..|+.+....
T Consensus 606 GrG~l~------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 606 GRGYLM------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cccccC------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 111111 1122334578999999999999999999999999999998887754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=360.25 Aligned_cols=272 Identities=24% Similarity=0.317 Sum_probs=214.9
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 754 (973)
+.|..+++||+|.||.||+|+ ..+|+.||+|.+.... ++...-..+||.+|++++||||+++.+...+. +..|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345566789999999999998 6789999999987664 44556778999999999999999999998776 799999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||||++ ||.-++......|++.+++.+++|++.||+|+| .++|+|||||.+|||+|.+|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999987 999999988788999999999999999999999 8999999999999999999999999999999988777
Q ss_pred CcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhhccc--
Q 048430 835 PVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEVVDA-- 909 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~-- 909 (973)
....+..+.|.+|+|||.+.+. .|+.+.|+||.|||+.||++|++.|.+..+-+ .+...++... .+..+...+-
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccCCc
Confidence 7778888999999999977764 69999999999999999999999876532211 1111111111 1111111110
Q ss_pred -ccCC-CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 -NLLS-REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 -~l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... ....+ ..-.+.-..++....+|+..+|..||.+|.|+.+++++
T Consensus 352 ~~~~kp~~~y~-r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYK-RRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCccc-chHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0000 00000 00111223467788999999999999999999999875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=378.43 Aligned_cols=482 Identities=28% Similarity=0.386 Sum_probs=357.0
Q ss_pred ccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCC
Q 048430 88 ELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP 167 (973)
Q Consensus 88 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~ 167 (973)
..|.-..|+.|++++|.+. .+-+++ .++..|++|++++|+++ ..|++++.+.+++.|+.++|+++ .+|.++ ..+.
T Consensus 40 ~wW~qv~l~~lils~N~l~-~l~~dl-~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i-~s~~ 114 (565)
T KOG0472|consen 40 NWWEQVDLQKLILSHNDLE-VLREDL-KNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQI-GSLI 114 (565)
T ss_pred hhhhhcchhhhhhccCchh-hccHhh-hcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHH-hhhh
Confidence 4455566777788888776 344343 56777888888888877 67777888888888888888887 777776 3577
Q ss_pred CccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccce
Q 048430 168 SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLEN 247 (973)
Q Consensus 168 ~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~ 247 (973)
+|..|+++.|.+. ++|+.++.+..|+.|+..+|+++ ..|+.++++.++..+++.+|++...+|....++.|++
T Consensus 115 ~l~~l~~s~n~~~------el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ 187 (565)
T KOG0472|consen 115 SLVKLDCSSNELK------ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKH 187 (565)
T ss_pred hhhhhhcccccee------ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHh
Confidence 7888888888875 67777888888888888888887 4566777777888888888888877777777788888
Q ss_pred eeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEE
Q 048430 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVL 327 (973)
Q Consensus 248 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L 327 (973)
|+..+|-++ .+|..++.+.+|..|+|.+|+|...+ .|.++..|.+|+++.|+|...+. ..+.++.+|.+|
T Consensus 188 ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpa-------e~~~~L~~l~vL 257 (565)
T KOG0472|consen 188 LDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPA-------EHLKHLNSLLVL 257 (565)
T ss_pred cccchhhhh-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHH-------HHhcccccceee
Confidence 888888877 56777888888888888888887553 67888888888888888765332 235577788888
Q ss_pred EccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCC--CCEEE----
Q 048430 328 VLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK--LQGLD---- 401 (973)
Q Consensus 328 ~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~--L~~L~---- 401 (973)
||..|+++ ..|..++-+ ++++.+++++|.++ .+|..++++ .|+.|-+.+|.+..+-.+.+.+-+. |++|.
T Consensus 258 DLRdNklk-e~Pde~clL-rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~ 333 (565)
T KOG0472|consen 258 DLRDNKLK-EVPDEICLL-RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIK 333 (565)
T ss_pred eccccccc-cCchHHHHh-hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhc
Confidence 88888887 345554433 34555555555555 355566666 6777777777665322222221110 11111
Q ss_pred ---ccCCcC--------CCCCchhhhccCcCCeeecCCccccCcCcccccCcC--CCCeeeccCCCCCCCCccccccccc
Q 048430 402 ---LNSNKL--------KGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLT--SLRHLDFRSNSLNSTIPSTFWSLKY 468 (973)
Q Consensus 402 ---Ls~N~l--------~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~ 468 (973)
++...= ..........+.+.+.|+++.-+++.+..+.|..-. -...++++.|++. .+|..+..++.
T Consensus 334 ~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lke 412 (565)
T KOG0472|consen 334 DDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKE 412 (565)
T ss_pred cCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHH
Confidence 111100 001112233456788999999999965555554332 3789999999997 78888888877
Q ss_pred cc-EEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccc
Q 048430 469 IL-AVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547 (973)
Q Consensus 469 L~-~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (973)
+. .+++++|.+. .+|..+..+++|..|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|.....+..|+.+-.+
T Consensus 413 lvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas 489 (565)
T KOG0472|consen 413 LVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLAS 489 (565)
T ss_pred HHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhc
Confidence 64 5677777776 89999999999999999999998 89999999999999999999998 899999999999999999
Q ss_pred ccccCCCCCccccccccccccccCCCcccccCCCCCCCCccCccccccCccc
Q 048430 548 GNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYAL 599 (973)
Q Consensus 548 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 599 (973)
+|++....|..+..|.+|..|||.+|.+...+|..|.+.++...-..||+.-
T Consensus 490 ~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 490 NNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 9999977777799999999999999999988888899999998888888653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=362.44 Aligned_cols=270 Identities=22% Similarity=0.249 Sum_probs=211.6
Q ss_pred HhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhh-HHHHHHHHHHHHhcc-CCceeEEEeeeecCC-eeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIR-HRNLIKIVSSCSNPG-FKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 753 (973)
..++|...++||.|.||.||+|+ ..+|..||||.++.+-..+ ...=.+|+..++++. ||||+++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34678888999999999999998 5679999999887553322 233458999999998 999999999998877 9999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|||||+. +|+++++.++..+++..++.|+.||++||+|+| ++|+.|||+||+|||+.....+||+|||+|+.....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999976 999999998889999999999999999999999 899999999999999999999999999999987643
Q ss_pred CCcccccccccccccCccC-CCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh--hCCcchhhhccc-
Q 048430 834 DPVTQTMTLATIGYMAPEY-GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE--SLPGAVTEVVDA- 909 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~-~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~d~- 909 (973)
..++.++.|.+|+|||+ ++.+.|+.+.||||+|||++|+++-++-|.+ ...+++..+. .......+.+..
T Consensus 164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG----~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG----ASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC----CcHHHHHHHHHHHhCCCccccchhH
Confidence 34567889999999995 5667899999999999999999998886643 3344443321 111111111110
Q ss_pred -----ccCCCC-chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 -----NLLSRE-DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 -----~l~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+.-.. ......--..-..+..+..+++.+|+++||.+||||+|+++|
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 011000 011111111112378889999999999999999999999987
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=401.16 Aligned_cols=260 Identities=27% Similarity=0.490 Sum_probs=220.0
Q ss_pred CCCccccccCceEEEEEEeCC--C----eEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 683 GESNLLGSGSFDNVYKATLAN--G----VSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
...+.||+|+||.||.|...+ + ..||||.++.. +.+...+|.+|..+|+.++|||||+++|+|.+.+..++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 345789999999999998542 3 34899988655 3456789999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 756 QYMPQGSLEKWLYSH------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 756 e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
|||++|+|..|+++. ...++..+...++.|||+|+.||+ ++++|||||+++|+|+++...|||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999987 567999999999999999999999 89999999999999999999999999999996
Q ss_pred cCCCCCcccccc-cccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 830 LDGVDPVTQTMT-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 830 ~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+...+++..... .-+.+|||||.+.++.+|.|+|||||||++||++| |..||......+. +..+.
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~------------ 918 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVL------------ 918 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHH------------
Confidence 655565555444 56789999999999999999999999999999999 7778755322111 00010
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQAL 969 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~ 969 (973)
...++..|..|++.++++|..||+.+|++||++..+++.+.++...+..++
T Consensus 919 -----------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 919 -----------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred -----------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 111456677899999999999999999999999999999998887765443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=325.36 Aligned_cols=267 Identities=25% Similarity=0.341 Sum_probs=212.3
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.+|...+++|+|.||.||+|+ ..+|+.||||.++.... .......+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778899999999999998 57899999999976632 234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
||+. +|+..++.....++..+++.++.++++|++||| .+.|+||||||.|+|++++|.+||+|||+|+.+.+...
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~- 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR- 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-
Confidence 9976 999999998889999999999999999999999 89999999999999999999999999999999875443
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh---hC---Ccc---hhhh
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE---SL---PGA---VTEV 906 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~---~~~---~~~~ 906 (973)
..+..+.|.+|+|||.+.+ ..|+...||||.|||+.||+.|.+-| +++.++++.... .. ++. +..+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f----pG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF----PGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC----CCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 3444589999999997665 57999999999999999999987643 455555554321 11 111 2222
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.|..-..... ....+. .-..++.+..+++.+|+.+||.+|+++.|+++|
T Consensus 233 pdY~~~~~~P-~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFP-KPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCC-CCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 2211111010 001010 112356677999999999999999999999987
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=362.43 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=213.6
Q ss_pred ccCCCCHHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeee
Q 048430 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745 (973)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 745 (973)
....+.|++|-. .+-+|.|+.|.||.|+++ ++.||||.++. .=..+++.|++++||||+.|.|+|
T Consensus 117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeee
Confidence 455666666643 567999999999999997 78999998752 223578899999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
+....+|+|||||..|-|+.+++..+ .++....+.+.++||.||.||| .++|||||||+-||||..+..|||+|||
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecccc
Confidence 99999999999999999999999876 7889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
-++.... ...+...+||..|||||++...+.++|+||||||||||||+||..||....... .+ +.
T Consensus 258 TS~e~~~--~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----II--------wG 322 (904)
T KOG4721|consen 258 TSKELSD--KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----II--------WG 322 (904)
T ss_pred chHhhhh--hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eE--------Ee
Confidence 9987653 345567789999999999999999999999999999999999999985422110 00 00
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
+-. ..-.++.|..|++.|+-|++.||+-.|..||+|.+++.||+-..
T Consensus 323 VGs----------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 323 VGS----------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccC----------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 000 01124566789999999999999999999999999999997544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=344.41 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=203.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...++||+|+||.||.++. ++++.+|+|++++.. ....+...+|..++.+++||.||+++..|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46788899999999999999984 578999999997653 34567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+||+.||.|..+|+.++ .+++..+..++.+|+.||.||| +++|||||+||+|||+|++|.++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 99999999999999876 7999999999999999999999 899999999999999999999999999999864322
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......+||+.|||||++....++..+|.||+||++|||++|.+||.... ...++.....+. +
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k--------~--- 242 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK--------L--- 242 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc--------C---
Confidence 223344689999999999999999999999999999999999999997532 223332222111 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERI 949 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp 949 (973)
...+...+.+..+++.+.++.||++|.
T Consensus 243 --------~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 --------PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 001112356688999999999999996
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=368.84 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=216.2
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeCC--C---eEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeee
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATLAN--G---VSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 746 (973)
++...++....++||+|+||.||+|.+.. + ..||||..+.+ .....++|++|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34444555556899999999999998542 2 23899998853 3566789999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccc
Q 048430 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGI 826 (973)
Q Consensus 747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 826 (973)
.....++|||+|.||+|.++++..+..++..++..++.+.|+||+||| ++++|||||.++|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999999998877999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccc-cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 827 AKLLDGVDPVTQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 827 a~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++... ...... ....+..|+|||.+..+.+++++|||||||++||+++ |..||.+.... .+..++..
T Consensus 309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~------- 377 (474)
T KOG0194|consen 309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVK------- 377 (474)
T ss_pred ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHh-------
Confidence 87543 111111 2347889999999999999999999999999999999 88898664322 22333211
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
... +...+...+.++..++.+||..+|++||+|.++.+.++.+.+...
T Consensus 378 ----~~~----------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 ----NGY----------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----cCc----------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 000 111222456778899999999999999999999999999887644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.81 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=214.9
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
..|..-.+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467777899999999999997 6678999999998877766788999999999999999999999998889999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++|+|.+.+... .+++.++..|++++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 999999999876 4999999999999999999999 89999999999999999999999999999987765433 44
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...+||+.|||||+.....|.+|.||||||++++||+.|.+||-. +..+.........
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~n------------------ 484 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATN------------------ 484 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhc------------------
Confidence 556899999999999999999999999999999999999999843 2223322211111
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...++..++..+.++.+++.+|++.||++|++++|+|+|
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111223344567889999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.90 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=212.9
Q ss_pred HHhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEecc---chhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCee
Q 048430 677 QATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 751 (973)
....+|...+.||+|+|++||+|+ ..+++.+|||++.+. ++...+.+..|-.+|.++ .||.|++++..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 445678889999999999999998 567999999998644 334456778899999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
|+|+||+++|+|.++|...+ .+++...+.++.+|+.|++||| +.|||||||||+|||+|+||.+||+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999999886 8999999999999999999999 9999999999999999999999999999999875
Q ss_pred CCCCc------------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 832 GVDPV------------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 832 ~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
+.... .....+||..|.+||.+.....++.+|+|+|||++|+|+.|++||.+..+ +..+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yliF----- 296 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLIF----- 296 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHHH-----
Confidence 42211 11447899999999999999999999999999999999999999965221 1111
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
..+++- .+..++.+++.+.+|+++.+..||.+|++.+|+.+|-
T Consensus 297 ----qkI~~l------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 ----QKIQAL------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----HHHHHh------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111111 1223345567789999999999999999999998873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.42 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=205.5
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC--eeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG--FKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~ 757 (973)
++...+.||+|+||.||++... +|+..|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4556789999999999999964 59999999987664444677899999999999999999999854444 68999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeecccccccCC--CC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDG--VD 834 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~--~~ 834 (973)
+++|+|.+++...+..+++..++.+++||++||+||| +++||||||||+|||++. ++.+||+|||++..... ..
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999999999987657999999999999999999999 899999999999999999 79999999999987763 12
Q ss_pred CcccccccccccccCccCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGI-VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
........||+.|||||++..+. ...++||||+||++.||+||+.||.... . .....+.........
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~--~~~~~~~ig~~~~~P--------- 242 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-E--EAEALLLIGREDSLP--------- 242 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-c--hHHHHHHHhccCCCC---------
Confidence 22334568999999999988643 4469999999999999999999986531 1 011111111000000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..+...+.+..+++.+|+..+|++||||.|+++|-.-.
T Consensus 243 ----------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 243 ----------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ----------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 12234567789999999999999999999999986543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.36 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=214.7
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
....+.++||+|.||+|..+....+..||||+++..... ...+|.+|+++|.+++||||+.++|+|..++.+|+|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 344567899999999999999988899999999877543 4589999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-
Q 048430 759 PQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV- 836 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 836 (973)
++|+|.+|+..+..+ .......+|+.|||.||+||. +.++||||+.++|+|++.++++||+|||+++-+...+++
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999987533 355667789999999999999 899999999999999999999999999999966544444
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT--RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.+...+-+.+|||||.+.-+++|.+||||+|||++||+++ ...||....... .+. ...++.+..
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vve-----n~~~~~~~~---- 760 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVE-----NAGEFFRDQ---- 760 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHH-----hhhhhcCCC----
Confidence 3345567899999999999999999999999999999876 667876533211 111 111111111
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
....-...|..|+..++++|.+||..+.++||+++++..+|.+.
T Consensus 761 ---~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 ---GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11112334567899999999999999999999999999888653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.23 Aligned_cols=261 Identities=25% Similarity=0.320 Sum_probs=211.3
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.+.|...+.||.|..++||+|+ ...++.||||++..+.. ...+.+.+|+..|+.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3568888999999999999998 56789999999987753 336889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||.+||+.+++... ...+++..+..|.+++++||.||| .+|.||||||+.|||++.+|.|||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999864 346899999999999999999999 89999999999999999999999999998766543221
Q ss_pred c---ccccccccccccCccCCC-C-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 836 V---TQTMTLATIGYMAPEYGS-E-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 836 ~---~~~~~~~~~~y~aPE~~~-~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
. .....+||+.|||||.+. . ..|+.|+|||||||+..|+.+|..||....+..+-+... ....+.......
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~~~--- 257 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTSGL--- 257 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcccccC---
Confidence 1 114558999999999843 3 459999999999999999999999997755443222221 111111111111
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....+.+...+.+++..|++.||++|||++++++|
T Consensus 258 -----------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 258 -----------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -----------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 112233456689999999999999999999999986
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.81 Aligned_cols=366 Identities=24% Similarity=0.274 Sum_probs=202.7
Q ss_pred CccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCc
Q 048430 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNL 198 (973)
Q Consensus 119 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L 198 (973)
.-+.||+|+|++...-+..|.++++|+++++.+|.++ .||... +...+|+.|+|.+|.|+.. -.++++.++.|
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~-~~sghl~~L~L~~N~I~sv-----~se~L~~l~al 151 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG-HESGHLEKLDLRHNLISSV-----TSEELSALPAL 151 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc-ccccceeEEeeeccccccc-----cHHHHHhHhhh
Confidence 3456777777777766667777777777777777777 676543 3345566666666666522 12345666666
Q ss_pred cEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEecccc
Q 048430 199 KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNL 278 (973)
Q Consensus 199 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 278 (973)
+.||||.|.|+.+.-..|.. -.++++|+|+.|.|+...-+.|.++.+|..|.|++|+
T Consensus 152 rslDLSrN~is~i~~~sfp~-----------------------~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNr 208 (873)
T KOG4194|consen 152 RSLDLSRNLISEIPKPSFPA-----------------------KVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNR 208 (873)
T ss_pred hhhhhhhchhhcccCCCCCC-----------------------CCCceEEeeccccccccccccccccchheeeecccCc
Confidence 66666666666433333322 3567777777777776666677777777777777777
Q ss_pred ccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCC
Q 048430 279 FSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQ 358 (973)
Q Consensus 279 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~ 358 (973)
|+.+++..|.++++|+.|+|..|+|.-+ ....|.++++|+.|.|..|.+...
T Consensus 209 ittLp~r~Fk~L~~L~~LdLnrN~iriv-------e~ltFqgL~Sl~nlklqrN~I~kL--------------------- 260 (873)
T KOG4194|consen 209 ITTLPQRSFKRLPKLESLDLNRNRIRIV-------EGLTFQGLPSLQNLKLQRNDISKL--------------------- 260 (873)
T ss_pred ccccCHHHhhhcchhhhhhccccceeee-------hhhhhcCchhhhhhhhhhcCcccc---------------------
Confidence 7777777777777777777777776531 122344444444444444443311
Q ss_pred ccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCccc
Q 048430 359 LSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438 (973)
Q Consensus 359 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 438 (973)
--..|..+.++++|+|+.|++...-.+++.+|++|+.|+||+|.|..+.++...-.++|++|+|++|+|+...+..
T Consensus 261 ----~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~s 336 (873)
T KOG4194|consen 261 ----DDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGS 336 (873)
T ss_pred ----cCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhH
Confidence 1112444455555555555555444444555555555555555555444444444445555555555555444445
Q ss_pred ccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCc---CccCCCCCCeEEccCCcCcccCCcccccCC
Q 048430 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPL---NIGNLEALGGLNLTGNQLSGYIPSSIGNLK 515 (973)
Q Consensus 439 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 515 (973)
|..+..|++|+|++|++...-...|.++++|+.|||++|.++..+.+ .|.++++|+.|+|.+|+|....-..|.++.
T Consensus 337 f~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~ 416 (873)
T KOG4194|consen 337 FRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLE 416 (873)
T ss_pred HHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCc
Confidence 55555555555555555444444555555555555555554443322 244455555555555555532233455555
Q ss_pred cCCEEEcccCccccCCCCCccccccccccccc
Q 048430 516 NLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547 (973)
Q Consensus 516 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (973)
.|++|||.+|.|..+-|++|..+ .|+.|.++
T Consensus 417 ~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 417 ALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 55555555555554555555555 55555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=356.73 Aligned_cols=367 Identities=27% Similarity=0.311 Sum_probs=324.7
Q ss_pred CCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcce
Q 048430 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMV 223 (973)
Q Consensus 144 L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 223 (973)
-+.|++++|+|+ .+....|.++++|++++|..|.++ .+|.......+|+.|+|.+|.|+..-.+.+.
T Consensus 80 t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt------~IP~f~~~sghl~~L~L~~N~I~sv~se~L~------ 146 (873)
T KOG4194|consen 80 TQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT------RIPRFGHESGHLEKLDLRHNLISSVTSEELS------ 146 (873)
T ss_pred eeeeeccccccc-cCcHHHHhcCCcceeeeeccchhh------hcccccccccceeEEeeeccccccccHHHHH------
Confidence 467899999998 777777788889999999988886 6776666666788888888888865444443
Q ss_pred eEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcC
Q 048430 224 AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303 (973)
Q Consensus 224 ~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 303 (973)
+++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|.|+.+..+.|.++.+|..|.|+.|+|
T Consensus 147 -----------------~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNri 209 (873)
T KOG4194|consen 147 -----------------ALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRI 209 (873)
T ss_pred -----------------hHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcc
Confidence 378999999999999977667888888999999999999999999999999999999999999
Q ss_pred CCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcc
Q 048430 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 383 (973)
+.+| ...|..+++|+.|+|..|+|.-.- -..|.++++|+.|.|..|++
T Consensus 210 ttLp-------~r~Fk~L~~L~~LdLnrN~irive-------------------------~ltFqgL~Sl~nlklqrN~I 257 (873)
T KOG4194|consen 210 TTLP-------QRSFKRLPKLESLDLNRNRIRIVE-------------------------GLTFQGLPSLQNLKLQRNDI 257 (873)
T ss_pred cccC-------HHHhhhcchhhhhhccccceeeeh-------------------------hhhhcCchhhhhhhhhhcCc
Confidence 9865 456888999999999999997320 12388999999999999999
Q ss_pred ccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccc
Q 048430 384 AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF 463 (973)
Q Consensus 384 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 463 (973)
.....++|..+.++++|+|+.|++...-..++.+|+.|+.|+|++|.|..+.+......++|++|+|++|+|+...+..|
T Consensus 258 ~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf 337 (873)
T KOG4194|consen 258 SKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF 337 (873)
T ss_pred ccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH
Confidence 98888999999999999999999998888999999999999999999999999999999999999999999999999999
Q ss_pred cccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCc---ccccCCcCCEEEcccCccccCCCCCcccccc
Q 048430 464 WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPS---SIGNLKNLDWLALARNAFQGPIPQSFGSLIS 540 (973)
Q Consensus 464 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 540 (973)
..+..|+.|.|++|+++..-...|..+++|+.|||++|.|+..+.+ .|.+|+.|+.|.|.+|+|..+.-.+|.++.+
T Consensus 338 ~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~ 417 (873)
T KOG4194|consen 338 RVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEA 417 (873)
T ss_pred HHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcc
Confidence 9999999999999999977777899999999999999999976554 5788999999999999999666689999999
Q ss_pred cccccccccccCCCCCccccccccccccccCCC
Q 048430 541 LQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 541 L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
|+.|||.+|.|..+-|++|..| .|+.|-++.-
T Consensus 418 LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 418 LEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred cceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 9999999999999999999999 8998877643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.00 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=221.7
Q ss_pred CCCCCccccccCceEEEEEEeC---CC--eEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA---NG--VSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.....++||+|.||.||+|... .| -.||||+.+.+. ....+.|..|+.+|+.++||||++++|+|.+. ..++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3444679999999999999843 23 358899987653 34578899999999999999999999999754 57899
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||.++-|-|..|++.+...++......++.||+.||+||| +.++|||||.++|||+.....||++|||+++.+....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999989999999999999999999999 8999999999999999999999999999999988777
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
++..+...-+..|||||.+..+.+|.+||||.|||.+||++. |..||.+....+. +
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I------ 602 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------I------ 602 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------E------
Confidence 766666667899999999999999999999999999999887 9999976443321 0
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
...+.+++.+.|..|++.++.++.+||+++|.+||.+.|+...|+.+.+
T Consensus 603 -~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 -GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 0123455677788999999999999999999999999999999998876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.29 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=223.0
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeCC-CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
++++....+..+.++||-|.||.||.|.|+. .-.||||.++.+ ....++|.+|+.+|+.++|||+|+++|+|+.+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444444566777899999999999999864 567999998643 45578999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
|+|+|||..|+|.+|++++. ..++.-..+.+|.||+.||+||. ++.+||||+.++|+|+.++..||++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999865 45677778899999999999999 899999999999999999999999999999999
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
....+..+....-+..|.|||.+....++.|+|||+|||+|||+.| |-.||.+. ++.+ +.++++
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq---------VY~LLE- 480 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ---------VYGLLE- 480 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH---------HHHHHh-
Confidence 8766666666667889999999999999999999999999999998 66676442 2222 122222
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
...++..++.|++.+++||..||+++|.+||+++|+-+.+|.+.
T Consensus 481 ---------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 481 ---------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ---------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 23355677889999999999999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=335.30 Aligned_cols=272 Identities=24% Similarity=0.365 Sum_probs=206.7
Q ss_pred CCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHh--ccCCceeEEEeeeecCC----eeEEEEE
Q 048430 683 GESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR--IRHRNLIKIVSSCSNPG----FKALIMQ 756 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e 756 (973)
...++||+|+||.||+|++. ++.||||++.. +..+.|..|-++++. ++|+||++|+++-.... .+.||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34578999999999999987 59999999963 345788888888876 48999999999876554 8899999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhh------cCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH------GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
|.+.|+|.+|+..+ .++|....+|+..+++||+|||+ +.+++|+|||||++||||..|+++.|+|||+|..+
T Consensus 289 fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999999987 59999999999999999999995 35678999999999999999999999999999887
Q ss_pred CCCCCc-ccccccccccccCccCCCCCC------CCcchhHHHHHHHHHHHHhCCCCCCc--cccCcccHHHHHHhhCC-
Q 048430 831 DGVDPV-TQTMTLATIGYMAPEYGSEGI------VSISGDVYSFGILMMETFTRRKPTNE--MFTGEMSLKQWVAESLP- 900 (973)
Q Consensus 831 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~------~~~~sDvws~Gvvl~elltg~~p~~~--~~~~~~~~~~~~~~~~~- 900 (973)
.+.... .....+||.+|||||.+.+.. .-.+.||||+|.|+|||+++..-++. ..+-...+.+-+..+..
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 643332 223468999999999765532 22468999999999999998876532 11122222222222111
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
+++.+.+ + .+.........+.....+..+.+.+..||+.||+.|.|+.-|-+++.++...
T Consensus 447 e~mq~~V---V-~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 447 EEMQELV---V-RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHH---H-hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1122211 1 1112222233334445677899999999999999999999999988877643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=344.57 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=213.0
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|.||.||||+ ..+.+.||+|.+.+.. +.+.+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567778899999999999998 5578999999986553 3456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+.| +|..++.... .++++.+..|+.++..||.||| +.+|.|||+||+||+++.++.+|++|||+|+.+.. ...
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9977 9999998776 7999999999999999999999 89999999999999999999999999999998754 444
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
..+...||+-|||||...+..|+..+|+||+||++||+++|++||.. ..+.+.++....+.+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v------------- 217 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPV------------- 217 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCC-------------
Confidence 55667899999999999999999999999999999999999999854 123333333222211
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.+.+..+..+++..+..||.+|.+-.+++.|
T Consensus 218 -------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1223556779999999999999999999999887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=354.17 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=204.9
Q ss_pred HhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC-
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP- 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 748 (973)
..++|...++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788889999999999999973 235689999986543 23456789999999999 899999999988764
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC---------------------------------------------------------
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN--------------------------------------------------------- 771 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 771 (973)
+..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46789999999999999997532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-cccccccccc
Q 048430 772 ----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIG 846 (973)
Q Consensus 772 ----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~ 846 (973)
..+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 24778889999999999999999 899999999999999999999999999999865322221 2223346788
Q ss_pred ccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHh
Q 048430 847 YMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFAT 925 (973)
Q Consensus 847 y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 925 (973)
|+|||.+.+..++.++|||||||++|||++ |..||......+ .+......+. . ...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~--------~-----------~~~ 298 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGT--------R-----------MRA 298 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCC--------C-----------CCC
Confidence 999999988899999999999999999997 999986532211 1111110000 0 001
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 926 KKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 926 ~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
+..+++++.+++.+||+.||++||++.|+++.|+++.+
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 299 PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=346.21 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=207.8
Q ss_pred HHhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEecc----ch-hhHHHHHHHHHHHHhcc-CCceeEEEeeeecCC
Q 048430 677 QATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ----ED-RALKSFDTECEVMRRIR-HRNLIKIVSSCSNPG 749 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 749 (973)
...++|...+.||+|.||.|+.|. ..+++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345688889999999999999997 457899999977553 11 23456778999999999 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeeccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAK 828 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~ 828 (973)
..++||||+.+|+|.+++.. ..++.+.++.++++|++.|++|+| +++|+||||||+||+++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999999 448999999999999999999999 8999999999999999999 999999999999
Q ss_pred ccCCCCCcccccccccccccCccCCCCCC-CC-cchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGI-VS-ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
... .........+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.. ...........+
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~----- 238 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKG----- 238 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcC-----
Confidence 774 2333445678999999999988866 64 8899999999999999999999762 112221111111
Q ss_pred cccccCCCCchhhhhhHHhHHHH-HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTC-ISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..+..+ +.++..++.+|+..+|.+|+++.|+++|
T Consensus 239 ---------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 239 ---------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ---------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11112223 5668899999999999999999999954
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.32 Aligned_cols=271 Identities=21% Similarity=0.261 Sum_probs=206.6
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchh--hHHHHHHHHHHHHhccCCceeEEEeeee--cCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDR--ALKSFDTECEVMRRIRHRNLIKIVSSCS--NPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv 754 (973)
+.|...+.|++|.||.||+|+. ++++.||+|+++.+.+. ..-...+|+.++.+.+|||||.+-.+.. .-+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3456678999999999999994 57899999999876543 2345679999999999999999988764 34679999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||||+. +|.+.+..-++++...+++.++.|+++|++||| ...|+|||+|++|+|+...|.+||+|||+|+.++..
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999987 999999998889999999999999999999999 899999999999999999999999999999988643
Q ss_pred CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-C-cchh-hhcccc
Q 048430 835 PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-P-GAVT-EVVDAN 910 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~-~~~d~~ 910 (973)
....+..+.|.+|+|||.+.+ ..|+.+.||||+|||+.||+++++-|.+..+-+ .+...+.... + +.++ ......
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCccccc
Confidence 334566789999999997665 569999999999999999999998775532221 1222222111 1 1111 111111
Q ss_pred cCC-CCchh-----hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLS-REDEE-----DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~-~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ..... ...++... ...+.-.+++...+.+||++|.|+.|.++|
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000 00000 01111110 133667899999999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=339.06 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=207.9
Q ss_pred cccCCCCHHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccch---hhHHHHHHHHHHHHhccCCceeEE
Q 048430 665 ATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIKI 741 (973)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l 741 (973)
..+..++.++++ ......||+|++|.||+|.. +|+.||||+++.... ...+.+.+|+.++++++||||+++
T Consensus 10 ~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 344555666662 33346899999999999998 589999999865432 225778899999999999999999
Q ss_pred Eeeeec----CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC
Q 048430 742 VSSCSN----PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM 817 (973)
Q Consensus 742 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 817 (973)
++++.+ ....++||||+++|+|.+++.... .+++.....++.|++.|+.|||+ ..+++||||||+||+++.++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENY 160 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCC
Confidence 999866 356789999999999999998765 78999999999999999999993 25888999999999999999
Q ss_pred cEEEeecccccccCCCCCcccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHH
Q 048430 818 VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 818 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 895 (973)
.+||+|||+++...... ....++..|+|||.... ..++.++|||||||++|||++|+.||..... ....
T Consensus 161 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~ 231 (283)
T PHA02988 161 KLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIY 231 (283)
T ss_pred cEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence 99999999988654221 23457889999998865 6789999999999999999999999975321 1111
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
....... . +...+..+++.+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 232 ~~i~~~~--------~----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 232 DLIINKN--------N----------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHhcC--------C----------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1110000 0 00011235677999999999999999999999999998875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.93 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=211.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
...|+..+.||+|.||.||+|.. .+++.||+|++.... ....+++.+|+.++.+++++||.++|+.+..+..+.++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34577778999999999999984 578999999998764 3456889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
||.+|++.+.+.... .+++..+.-|++++..|+.||| ..+.+|||||+.||++..+|.+|++|||.+..+......
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999998875 4588888899999999999999 899999999999999999999999999999887654433
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
. ...+||+.|||||++....|+.|+||||+|++++||.+|.+|+....+... ...+ +.
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lflI----pk--------------- 225 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LFLI----PK--------------- 225 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EEec----cC---------------
Confidence 3 667899999999999988999999999999999999999999866443111 0000 00
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+.+. ..+++.+++++..|+..+|+.||+|+++++|
T Consensus 226 -~~PP~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 -SAPPRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -CCCCccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 0011111 1467779999999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=342.94 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=213.4
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.-|+..+.||+|+-|.|-.|+ ..+|+.+|||++.... +.....+.+|+-+|+.+.||||++++++++...++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 345667889999999999998 5689999999986552 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|-|.+++...+ .+++.++.+++.||+.|+.|+| ..+|+|||+||+|+|++..+++||+|||+|..-.+ .
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--G 165 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC--C
Confidence 9999999999999877 7999999999999999999999 89999999999999999999999999999986532 2
Q ss_pred cccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
..-...+|++.|.|||++.+..| ..++||||+|||+|.|+||+.||+ +.+++........|.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlKV~~G~------------ 228 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLKVQRGV------------ 228 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHHHHcCc------------
Confidence 23345689999999999999876 589999999999999999999997 355665554443332
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
+..|...+.+..+|+.+|+..||++|.|++||++|-
T Consensus 229 --------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 --------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 223345677899999999999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=336.14 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=205.1
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
..++|...++||+|+||.||.|+. .+|..+|+|+++++. ..+.+.+..|-.+|...++|.||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 357899999999999999999984 579999999998663 4557788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC-
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG- 832 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~- 832 (973)
||||++||++..+|...+ .+++..+..++.+++.|++-+| ..|+|||||||+|+|||..|.+||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999998876 8999999999999999999999 89999999999999999999999999999853211
Q ss_pred ---------------------CCCc-----cc-------------------ccccccccccCccCCCCCCCCcchhHHHH
Q 048430 833 ---------------------VDPV-----TQ-------------------TMTLATIGYMAPEYGSEGIVSISGDVYSF 867 (973)
Q Consensus 833 ---------------------~~~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~sDvws~ 867 (973)
.+.. .. ...+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 00 12469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccccCcc--cHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCC
Q 048430 868 GILMMETFTRRKPTNEMFTGEM--SLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIP 945 (973)
Q Consensus 868 Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P 945 (973)
|||+|||+.|.+||....+.+. .+..|..... ++....+..+..++|.+|+. ||
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----------------------fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----------------------FPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----------------------CCCcCcccHHHHHHHHHHhc-CH
Confidence 9999999999999976433221 1222211100 00111234668899999999 99
Q ss_pred CCCCC---HHHHHHH
Q 048430 946 EERIN---VKDALAD 957 (973)
Q Consensus 946 ~~Rpt---~~evl~~ 957 (973)
++|.. ++||.+|
T Consensus 431 ~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKH 445 (550)
T ss_pred HHhcCcccHHHHhcC
Confidence 99986 5565543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.78 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=205.6
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778899999999999999753 46789999987653 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++......+++.+++.++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876667899999999999999999999 8999999999999999999999999999876542221
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
........++..|+|||......++.++|||||||++||+++ |+.||...... .....+.. + .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~---~---------~-- 225 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED---G---------F-- 225 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC---C---------C--
Confidence 111122335678999999988899999999999999999875 99998653211 11111100 0 0
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
....+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 226 --------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 --------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011234567799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=319.68 Aligned_cols=271 Identities=24% Similarity=0.281 Sum_probs=206.3
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEe--ccchhhHHHHHHHHHHHHhccCCceeEEEeeeec-----CC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN-----PG 749 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 749 (973)
....|...+.||+|+||.|+.|.. .+|+.||||.+. .......+...+|+++++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345566678999999999999984 579999999886 3445556888999999999999999999998854 46
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..|+|+|+|+ .+|.+.++.+. .++...+..++.|+++||+|+| +.+|+|||+||+|++++.+..+||+|||+|+.
T Consensus 100 DvYiV~elMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 7899999994 59999998875 5999999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCC-CcccccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHH--HHhhCC---cc
Q 048430 830 LDGVD-PVTQTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLP---GA 902 (973)
Q Consensus 830 ~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~---~~ 902 (973)
..... ....+.++.|.+|+|||.+. ...||.+.||||.|||+.||++|+.-|.+ ...+.+. +..... ++
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG----~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG----KDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC----CchHHHHHHHHHhcCCCCHH
Confidence 75431 22335678999999999654 56799999999999999999999987754 2222222 111111 11
Q ss_pred -hhhhcccc----cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 -VTEVVDAN----LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 -~~~~~d~~----l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+..+-.+. +..........-...-....+...+++++|+..||.+|+|++|+++|
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111000 00000001111011112456778999999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.32 Aligned_cols=236 Identities=26% Similarity=0.340 Sum_probs=200.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.+|.|+||.|..++. .+|..+|+|+++... -.+.+....|.++++.+.||.++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4566788999999999999985 468999999997653 345677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||++||-|.++++..+ ++++..++.+|.||+.|++||| +.+|++||+||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 9999999999999876 8999999999999999999999 89999999999999999999999999999997643
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
..-..+||+.|+|||.+....+..++|-|||||++|||+.|..||....+ ..+ ......+
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~i---Y~KI~~~-------------- 256 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQI---YEKILEG-------------- 256 (355)
T ss_pred -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHH---HHHHHhC--------------
Confidence 23456899999999999999999999999999999999999999976433 111 1111111
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCC
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEER 948 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 948 (973)
+..-|..+..++.+|+.+.++.|-.+|
T Consensus 257 ------~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 ------KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 111223456678889999999998888
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=301.69 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=211.0
Q ss_pred HhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
+.++|.+.+.||+|.||.||.|+ .+++..||+|++.++. .....++.+|+++-+.++||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45678889999999999999998 4578899999986543 2335688999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 754 IMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
++||..+|.+...++..+ ..+++.....++.|+|.|+.|+| .++|+||||||+|+|++.++..||+|||-+...+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999654 46899999999999999999999 8999999999999999999999999999887542
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.......+||..|.|||...+...+.++|+|++||+.||++.|.+||..... +..+......
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~--------------- 237 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKV--------------- 237 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHc---------------
Confidence 3344567899999999999999999999999999999999999999976442 2222221110
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
+...|...+....+++.+|+..+|.+|.+..|+++|=
T Consensus 238 ---------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 ---------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ---------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1111234456688999999999999999999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=322.65 Aligned_cols=266 Identities=25% Similarity=0.302 Sum_probs=198.3
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecC---C--eeEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP---G--FKALI 754 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~--~~~lv 754 (973)
.|...+++|.|+||.||+|+. .+++.||||..-.+.. .-.+|+.+|+.++|||||++..+|... + ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 456678999999999999995 4579999998754433 234799999999999999999988532 2 34589
Q ss_pred EEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeeccccccc
Q 048430 755 MQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLL 830 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~ 830 (973)
||||+. +|.++++.. +..++...++-++.||++||+||| +.+|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 999998842 357888889999999999999999 8999999999999999987 89999999999987
Q ss_pred CCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--chhhhc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--AVTEVV 907 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 907 (973)
.... ....+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+. .+...++..+...... +-...+
T Consensus 177 ~~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHhhc
Confidence 5433 2355678999999997766 46999999999999999999999876541 1222233333322211 111112
Q ss_pred ccccCCCCchhhhhhH---HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDF---ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+...+.....-.... ......+++..+++.++++++|.+|.++.|+++|
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 2221111111000000 1223467889999999999999999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=333.55 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=201.3
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999985 579999999986442 22234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999998886533 36899999999999999999999 8999999999999999999999999999998653221
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ....... +....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~-------------~~~~~- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRR-------------VKEDQ- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHH-------------hhccc-
Confidence 22334689999999999999999999999999999999999999975322110 1111000 00000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
...+..++.++.+++.+||+.||++||+ ++|+++|
T Consensus 222 ------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 ------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011234567889999999999999997 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=334.92 Aligned_cols=274 Identities=22% Similarity=0.292 Sum_probs=204.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999964 789999999865432 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|++ ++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 995 6898888876667899999999999999999999 8999999999999999999999999999987543221 2
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC-c-c-hhhh-----c
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP-G-A-VTEV-----V 907 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~-~-~~~~-----~ 907 (973)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.........+......... . . +... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2234568899999997654 458899999999999999999999997643222222221111100 0 0 0000 0
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
++.-..................+..+.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000111111111234568899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=315.14 Aligned_cols=273 Identities=26% Similarity=0.318 Sum_probs=206.9
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCc-eeEEEeeeecCC------
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRN-LIKIVSSCSNPG------ 749 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 749 (973)
..|...++||+|+||+||+|+ ..+|+.||+|.++...+ .......+|+.+++.++|+| |+.+++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345556789999999999998 56789999999987644 34566789999999999999 999999997766
Q ss_pred eeEEEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGI 826 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 826 (973)
..++||||++. +|..++.... ..++...++.++.||++||+||| +++|+||||||.||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 88999999966 9999999866 35788899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh----hCCc
Q 048430 827 AKLLDGVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE----SLPG 901 (973)
Q Consensus 827 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~----~~~~ 901 (973)
|+...- .....+..++|..|+|||.+.+. .|+...||||+||+++||++++.-|.+.. .+.+.... ..+.
T Consensus 167 Ara~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s----e~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS----EIDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc----HHHHHHHHHHHcCCCC
Confidence 996541 22335667899999999987765 79999999999999999999988775533 23332211 1111
Q ss_pred --chhhhc-ccccCCCCchhh-hhh-HHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHH
Q 048430 902 --AVTEVV-DANLLSREDEED-ADD-FATKKTCISYIMSLALKCSAEIPEERINVKDALAD--LKKI 961 (973)
Q Consensus 902 --~~~~~~-d~~l~~~~~~~~-~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~--L~~~ 961 (973)
.+..+. -++......... ... ............+++.+|++++|.+|.+++.+++| +..+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111111 011111111110 000 01111112468899999999999999999999998 4443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.32 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=201.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-----------------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-----------------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKI 741 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 741 (973)
++|...++||+|+||.||+|..+ ++..||+|++.... ......+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 56788899999999999999753 23479999987643 3345679999999999999999999
Q ss_pred EeeeecCCeeEEEEEecCCCCHHHHhhhCC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEE
Q 048430 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHN------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803 (973)
Q Consensus 742 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 803 (973)
++++.+.+..++||||+++|+|.+++.... ..+++.++.+++.||+.||+||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999986532 24678889999999999999999 899999
Q ss_pred ccCCCCcEEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 048430 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT--RRKP 880 (973)
Q Consensus 804 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt--g~~p 880 (973)
|||||+||+++.++.+||+|||+++........ ......++..|+|||....+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865432221 1223346788999999888889999999999999999987 4566
Q ss_pred CCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 881 TNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
|...... .....+........... . ...+..++..+.+++.+||+.+|++||++.|+.+.|+
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~~~--------~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE--QVIENAGEFFRDQGRQV--------Y-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH--HHHHHHHHHhhhccccc--------c-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6543211 11111111100000000 0 0011235677899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.66 Aligned_cols=273 Identities=19% Similarity=0.233 Sum_probs=204.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999965 68899999987543 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|++++.+..+.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999876665543 3346899999999999999999999 899999999999999999999999999999876433322
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh--hCCcchhhhc--ccccC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE--SLPGAVTEVV--DANLL 912 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~--d~~l~ 912 (973)
......+++.|+|||...+..++.++|||||||++|||++|+.||......+ ........ ..+....... ++...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 3334568999999999888889999999999999999999999986532211 11111100 0000000000 00000
Q ss_pred CCCc----hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SRED----EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... ............++.++.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 00000011112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.94 Aligned_cols=265 Identities=23% Similarity=0.387 Sum_probs=208.1
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHh--ccCCceeEEEeeeecC----CeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR--IRHRNLIKIVSSCSNP----GFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~l 753 (973)
.+....+.||+|.||+||+|.+. |+.||||++...++ +.+.+|.++++. ++|+||+.|++.-..+ ..++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45566789999999999999998 99999999975543 567888888876 4999999999875332 47789
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-----GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
|++|.+.|||++|+... .++....++++..+|.||+|||. +.++.|.|||||++||||..++.+.|+|+|+|.
T Consensus 287 vTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999999985 69999999999999999999993 346789999999999999999999999999998
Q ss_pred ccCCCCC---cccccccccccccCccCCCCCC----C--CcchhHHHHHHHHHHHHhC----------CCCCCccccCcc
Q 048430 829 LLDGVDP---VTQTMTLATIGYMAPEYGSEGI----V--SISGDVYSFGILMMETFTR----------RKPTNEMFTGEM 889 (973)
Q Consensus 829 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~----~--~~~sDvws~Gvvl~elltg----------~~p~~~~~~~~~ 889 (973)
....... ......+||.+|||||++.... + -..+||||||.|+||+..+ +.||.+..+.+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 8754432 2345678999999999765432 1 2458999999999999864 366766666555
Q ss_pred cHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 890 SLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
++.++-.-.-.... ....+..+....+...+.++|+.||..+|..|.|+-.+.+.|.++.+
T Consensus 445 s~eeMrkVVCv~~~-------------RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKL-------------RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHhcceeeccc-------------CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 55443221111111 11122233344567789999999999999999999999999888875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=336.22 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=206.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999964 68899999987653 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++|+|.+++.... .+++..+..++.|++.|+.|||+ ..+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999999998755 68999999999999999999993 246999999999999999999999999998765321
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Ccc---hhhhc---cc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PGA---VTEVV---DA 909 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~---~~~~~---d~ 909 (973)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+...+.... .+. ..... .+
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCccccc
Confidence 22334689999999999888899999999999999999999999964321 11111111100 000 00000 00
Q ss_pred -------c-cCCCCch---hhhh-------hHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 910 -------N-LLSREDE---EDAD-------DFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 910 -------~-l~~~~~~---~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
. ....... .... .......++.++.+++.+||+.||++|||+.|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 0000000 0000 0000012467799999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.11 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=203.6
Q ss_pred hcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 750 (973)
.++|...+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45678889999999999999973 246689999986543 23456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC-----------------------------------------------------------
Q 048430 751 KALIMQYMPQGSLEKWLYSHN----------------------------------------------------------- 771 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 771 (973)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 772 ---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 772 ---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
..+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 14788899999999999999999 899999999999999999999999999999865432221
Q ss_pred -ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 837 -TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 837 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......++..|+|||......++.++|||||||++|||++ |..||....... ...+++... ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~------------~~~- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEG------------YRM- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhC------------ccC-
Confidence 1122345678999999998899999999999999999998 888886532211 111111110 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..+...+.++.+++.+||+.||++||+++|+++.|++.
T Consensus 337 ---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.46 Aligned_cols=247 Identities=32% Similarity=0.558 Sum_probs=194.9
Q ss_pred CccccccCceEEEEEEeC-----CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 685 SNLLGSGSFDNVYKATLA-----NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+.||.|.||.||+|.+. .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999966 367899999965433 34788999999999999999999999999888899999999
Q ss_pred CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-
Q 048430 759 PQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV- 836 (973)
Q Consensus 759 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 836 (973)
++|+|.+++... ...+++.++..|+.||++||+||| +.+++|+||+++||+++.++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence 999999999987 567999999999999999999999 789999999999999999999999999999876322222
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......+..|+|||.+....++.++||||||+++||+++ |+.||..... ..+......+..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~~~~~------------ 223 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLKQGQR------------ 223 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHHTTEE------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccccccc------------
Confidence 2233457789999999888889999999999999999999 6788755311 111111111100
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
...+..++..+.+++.+||+.+|++||++.|+++.|
T Consensus 224 -------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223566788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.41 Aligned_cols=272 Identities=19% Similarity=0.233 Sum_probs=203.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...++||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5688899999999999999985 478999999986543 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++ +|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 975 999999876666899999999999999999999 8999999999999999999999999999987643222 12
Q ss_pred cccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--C-cchhhhccc-ccC
Q 048430 838 QTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--P-GAVTEVVDA-NLL 912 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~d~-~l~ 912 (973)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+........ + +.+..+.+. ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchhhh
Confidence 233468899999998765 568999999999999999999999986532211 1111111110 0 111111100 000
Q ss_pred CCCch--hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDE--EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..... ............+.+..+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0000011112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.94 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=202.8
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||+|+++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999998888899999876432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999865556899999999999999999999 799999999999999999999999999998765332222222
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...++..|+|||......++.++||||||+++|||++ |+.||..... ...+.....+.. ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~~~~~--~~----------- 221 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMISRGFR--LY----------- 221 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCC--CC-----------
Confidence 3345678999999888889999999999999999999 8889854221 111111111100 00
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+...+.++.+++.+||+.+|++||+++|+++.|
T Consensus 222 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0011235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.70 Aligned_cols=246 Identities=25% Similarity=0.322 Sum_probs=202.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999864 68999999986542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999998765 6899999999999999999999 899999999999999999999999999998865321
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+. .
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~--------~---- 215 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGK--------L---- 215 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC--------c----
Confidence 1234689999999998888899999999999999999999999865321 11111111000 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALADL 958 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~L 958 (973)
..+..++..+.+++.+|++.||.+||+ ++|+++|-
T Consensus 216 --------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 216 --------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 011123456889999999999999995 89998873
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.37 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=209.0
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----CeeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GFKA 752 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 752 (973)
.++|++.+.+|+|||+.||.++ ..++..+|+|++.....+..+..++|++..++++|||+++++++...+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678999999999999999998 778999999999877777788999999999999999999999987443 4589
Q ss_pred EEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 753 LIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
++++|...|+|.+.+... +..+++.+++.|+.++++||++||+. ..+++||||||.||++.+.+.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999998763 35799999999999999999999932 33499999999999999999999999999875
Q ss_pred cCCCCCc--------ccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh
Q 048430 830 LDGVDPV--------TQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 830 ~~~~~~~--------~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 898 (973)
..-.-.. .+.....|..|+|||.+. ....++++|||||||++|+|+.|..||+.......++.-
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL----- 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL----- 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----
Confidence 4211100 112235788999999654 456789999999999999999999999765443222111
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
.+..+.+. ++....+++.+.++++.|++.||.+||++.|++.+++.+
T Consensus 254 ------Av~n~q~s----------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 ------AVQNAQIS----------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------eeeccccc----------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111111 111122678899999999999999999999999998765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.23 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 578999999987542 233466788999999999999999999999999999999999999
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 9999998765 7899999999999999999999 8999999999999999999999999999987532211 122345
Q ss_pred cccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhh
Q 048430 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921 (973)
Q Consensus 842 ~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 921 (973)
.||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .........+. .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~--------~---------- 212 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE--------I---------- 212 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC--------C----------
Confidence 699999999999888999999999999999999999999864211 11111111000 0
Q ss_pred hHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 922 DFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 922 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..++.++.+++.+||+.||++|| +++|+++|
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 01122456688999999999999999 79999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.05 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=204.2
Q ss_pred HhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG 749 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 749 (973)
..++|...+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+.+++.+ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345788889999999999999873 234579999987543 33456788999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---------------------------------------------------------- 771 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 771 (973)
..++||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-ccc
Q 048430 772 -----------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQT 839 (973)
Q Consensus 772 -----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~ 839 (973)
..+++.++.+++.||++||+||| +++|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 24788889999999999999999 899999999999999999999999999999765332211 112
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...++..|+|||++....++.++|||||||++|||++ |+.||....... .....+.. ....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~------------~~~~----- 334 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKR------------GYQM----- 334 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHc------------ccCc-----
Confidence 2335678999999988899999999999999999997 999986532211 11111110 0000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
..+...+.++.+++.+||+.+|++||++.|+++.|+++.
T Consensus 335 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 -----SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 000112466899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.70 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=206.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|...++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35678889999999999999998888899999876433 23578899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++... ...+++.++..++.|+++|++||| +.+++||||||+||+++.++.+||+|||++..........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999764 346889999999999999999999 7999999999999999999999999999998764322222
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....++..|+|||+.....++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~---------------- 222 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR---------------- 222 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC----------------
Confidence 223346778999999888889999999999999999998 89998542211 11111111000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
......++.++.+++.+|+..+|++||+++++.+.|++
T Consensus 223 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 ------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011245668899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.84 Aligned_cols=255 Identities=26% Similarity=0.450 Sum_probs=207.2
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|++. +...||||.++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888999999999999999864 24679999886543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++......+++.++..++.|++.|++||| +.+|+||||||+||++++++.++++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999876667899999999999999999999 8999999999999999999999999999998764222
Q ss_pred Cc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 835 PV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 835 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. ......++..|+|||......++.++||||||+++|||++ |..||...... .....+.. +. .
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~---~~---------~ 226 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVED---GY---------R 226 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHc---CC---------C
Confidence 11 1122345678999999988899999999999999999998 99998543211 11111110 00 0
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
.+.+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 227 ----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ----------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=339.18 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=204.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 58999999997542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999998655 6899999999999999999999 89999999999999999999999999999976532
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ .... +... .. .......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~-i~~~-~~----~~~~~~~--- 222 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWEN-LKYW-KE----TLQRPVY--- 222 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHH-HHhc-cc----cccCCCC---
Confidence 2234568999999999988899999999999999999999999986532111 0000 0000 00 0000000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......++.++.+++.+|++.+|++||+++|+++|
T Consensus 223 -------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 -------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00002345678899999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=344.47 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=217.8
Q ss_pred CCCccccccCceEEEEEEe-CCC----eEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 683 GESNLLGSGSFDNVYKATL-ANG----VSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
...++||+|+||+||+|.+ .+| -+||+|++... ..+..+++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468999999999999985 333 46899987644 3345678999999999999999999999998765 789999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
||+.|+|.+|++.++..+..+..+.+..|||+||.||| ++++|||||.++||||..-..+||+|||+|+...+....
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999989999999999999999999999 899999999999999999999999999999988654433
Q ss_pred -ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 837 -TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 837 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......++.|||-|.+....++.++|||||||++||++| |..||++....+. .+.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~dl-------- 912 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------PDL-------- 912 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------hHH--------
Confidence 2333456788999999999999999999999999999998 8899876433221 111
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
.+...++..|..|+-++..++.+||..|+..||+|+++...+.++.+..++
T Consensus 913 --le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 913 --LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred --HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 122334667788999999999999999999999999999999988776544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=320.65 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=200.0
Q ss_pred HHhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccch--------------hhHHHHHHHHHHHHhccCCceeEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED--------------RALKSFDTECEVMRRIRHRNLIKI 741 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l 741 (973)
...+.|...+.||+|.||.|-+|+ ..+++.||||++..... ...+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 455789999999999999999998 45799999999964311 124588999999999999999999
Q ss_pred Eeeeec--CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 742 VSSCSN--PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 742 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
+.+..+ .+..|||+|||..|.+... ......++..+++++++++..||+||| .++||||||||+|+|++++|.|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 999976 4688999999998876532 222223899999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCC----cccccccccccccCccCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccCcccH
Q 048430 820 HLGDFGIAKLLDGVDP----VTQTMTLATIGYMAPEYGSEGI----VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~ 891 (973)
||+|||.+........ ..-...+||+.|+|||....+. .+.+.||||+||+||.|+.|+.||-+.+. +
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~ 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----L 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----H
Confidence 9999999886632211 1223368999999999765532 46788999999999999999999865221 1
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
..+ ..++...+.- +...+..+++.++++++|++||++|.+..+|..|.+-
T Consensus 326 ~l~---------~KIvn~pL~f----------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 326 ELF---------DKIVNDPLEF----------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHH---------HHHhcCcccC----------CCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 111 1111111111 1111345678999999999999999999999988653
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.05 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=203.1
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3567788999999999999998777789999886432 234678999999999999999999999998889999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|+|.+++......+++.+++.++.||+.|++||| +.+++|+||||+||+++.++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999876557899999999999999999999 899999999999999999999999999998765432222222
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...++..|+|||......++.++|||||||++|||++ |+.||...... .....+.. +. ..
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~---~~---------~~----- 220 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQ---GL---------RL----- 220 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhc---CC---------CC-----
Confidence 2345678999999888889999999999999999998 99998643211 11111110 00 00
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
..+...++.+.+++.+||+.+|++||++.++++.|+
T Consensus 221 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000113466899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.01 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=207.3
Q ss_pred CccccccCceEEEEEEeC--C--CeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 685 SNLLGSGSFDNVYKATLA--N--GVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
.++||+|.||.|++|.|. . ...||||.++..... ...+|.+|+.+|-+++|||++++||+..+ ....+|||.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 478999999999999975 2 356899999766544 67899999999999999999999999987 66789999999
Q ss_pred CCCHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc--
Q 048430 760 QGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-- 836 (973)
Q Consensus 760 ~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-- 836 (973)
.|||.+.++. ....+-......++.|||.||.||. ++++||||+.++|+++...-.|||+|||+.+-+...+..
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999998 4466888899999999999999999 899999999999999999999999999999987643332
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......++.|+|||.+..+.++.+||||+|||++|||+| |..||-+... . .+.+.+|
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----~---------qIL~~iD------- 329 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----I---------QILKNID------- 329 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----H---------HHHHhcc-------
Confidence 2223356788999999999999999999999999999999 5666543111 0 1111222
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
..+++..++.|+++++++++.||...|++||+|..+.+.+-...
T Consensus 330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 23455677889999999999999999999999999986654443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=339.63 Aligned_cols=245 Identities=23% Similarity=0.281 Sum_probs=201.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56788899999999999999964 68999999987542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 9999999999998765 6889999999999999999999 899999999999999999999999999999865432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... . ........+. .
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~-~~~~~i~~~~--------~---- 232 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----F-RIYEKILAGR--------L---- 232 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----H-HHHHHHhcCC--------c----
Confidence 1234689999999999888899999999999999999999999854211 1 1111111110 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
..+..++..+.+++.+||+.||++||+ ++|+++|
T Consensus 233 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 001113455789999999999999997 6888876
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=331.65 Aligned_cols=271 Identities=21% Similarity=0.285 Sum_probs=205.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...++||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467889999999999999999865 68889999887553 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++|+|.+++.... .+++..+..++.|++.|+.|||+ ..+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999998754 68899999999999999999993 347999999999999999999999999998754321
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc-ccccCCC-
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV-DANLLSR- 914 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~- 914 (973)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .+.........+...... .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCcccCCccccccCcccCCcc
Confidence 123346889999999998888999999999999999999999998643211 111111110110000000 0000000
Q ss_pred -----Cchh-----hhhhH-----------HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 -----EDEE-----DADDF-----------ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 -----~~~~-----~~~~~-----------~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... ..... ......+.++.+++.+||+.||++||+++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000 00000 0000134678999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.85 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=197.3
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 578999999987542 234456788999999999999999999999999999999999999
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 9999887654 6899999999999999999999 8999999999999999999999999999987532211 122335
Q ss_pred cccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhh
Q 048430 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921 (973)
Q Consensus 842 ~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 921 (973)
.|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ........+. .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~--------~---------- 212 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEE--------I---------- 212 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC--------C----------
Confidence 6899999999998889999999999999999999999998642211 1111100000 0
Q ss_pred hHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 922 DFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 922 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|| ++.++++|
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 01123456688999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=338.66 Aligned_cols=268 Identities=22% Similarity=0.224 Sum_probs=202.0
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999985 578999999643 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+. ++|..++.... .+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.........
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 95 68998887654 6899999999999999999999 8899999999999999999999999999997543322223
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc--C----cccHHHHHHhhC--Ccc----hhh
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFT--G----EMSLKQWVAESL--PGA----VTE 905 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~--~----~~~~~~~~~~~~--~~~----~~~ 905 (973)
.....||+.|+|||++....++.++|||||||++|||++|+.||..... + ...+...+.... +.. ...
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 3345799999999999888999999999999999999999988643211 1 111111111110 000 000
Q ss_pred hccccc----CC-CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVDANL----LS-REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d~~l----~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+ .. ................+.++.+++.+|++.||++|||++|+++|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00 00000001111222356778999999999999999999999976
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=338.59 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=205.8
Q ss_pred HhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPG 749 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 749 (973)
..++|...++||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888899999999999999842 23579999986543 334567999999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---------------------------------------------------------- 771 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 771 (973)
..++||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886531
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC
Q 048430 772 -------------------------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD 814 (973)
Q Consensus 772 -------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 814 (973)
..+++.++..++.|+++|++||| +.+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 23778888999999999999999 89999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHH
Q 048430 815 DDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLK 892 (973)
Q Consensus 815 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~ 892 (973)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||........ ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH
Confidence 9999999999999865332221 2223456788999999888889999999999999999997 8899865322111 11
Q ss_pred HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
..+.. .. ....+..++.++.+++.+||+.+|++||++.++.+.|+++.
T Consensus 351 ~~~~~------------~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NKIKS------------GY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHhc------------CC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 10000 00 00111235677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=301.35 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=209.6
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.+.|...+.||+|.|+.||++. ..+|+.+|+|++.... ....+.+.+|+++-+.++||||+++...+.+.+..|+||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3456667899999999999987 4579999999886442 234678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~ 832 (973)
|+|+|++|..-+-.. ..+++..+..+++||++++.|+| ..+|||||+||+|+++.. .-.+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999997655443 35788888999999999999999 899999999999999954 3469999999999876
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
+.......+|||+|||||+....+++..+|||+.||++|-++.|+.||.+... .. .+.....+.. ++ +
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~r---lye~I~~g~y-d~-~---- 232 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HR---LYEQIKAGAY-DY-P---- 232 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HH---HHHHHhcccc-CC-C----
Confidence 44455667899999999999999999999999999999999999999965211 11 1111111110 00 0
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH-HHHhhccc
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK-ILTQALHL 971 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~-~~~~~~~~ 971 (973)
-+.+.+..++.++++.+|+..||.+|.|+.|++.|=+-..+ .+.-.+|+
T Consensus 233 ----------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~ 282 (355)
T KOG0033|consen 233 ----------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHR 282 (355)
T ss_pred ----------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhh
Confidence 01122456778999999999999999999999988543332 24444443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.18 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=208.3
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.+|.+.+.+|+|.||.|-+|. ...|+.||||.++.+ +++..-.+.+|+++|+.++||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 356667889999999999998 578999999998755 3444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||..+|.|++|+..++ .+++.+...|++||..|+.|+| +.++||||+|.+|||+|.++++||+|||++-.+.. .
T Consensus 133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--K 206 (668)
T ss_pred EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc--c
Confidence 9999999999999876 8999999999999999999999 89999999999999999999999999999987643 2
Q ss_pred cccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
..-...+|++-|.+||.+.+..| .+.+|-||+||++|-++.|..||++.. ....+++...++ +.+-
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs~Ga--------YrEP 273 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQISRGA--------YREP 273 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhhccc--------ccCC
Confidence 23355789999999999998876 588999999999999999999998732 233333333222 1110
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.-+.+..-+|+.|+..+|++|.|+.+|..|-
T Consensus 274 -------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 -------------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1133456699999999999999999998875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=333.23 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=206.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCe----EEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGV----SVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|...+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 333 48999986543 34456788999999999999999999999764 5679
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999987667899999999999999999999 899999999999999999999999999999876432
Q ss_pred CCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
.... .....++..|+|||......++.++|||||||++|||++ |+.||+..... .+........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~------------ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE------------ 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC------------
Confidence 2211 122334678999999998899999999999999999998 99998653211 1111111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
....+..++.++.+++.+||..+|.+||++.++++++.++.+.-.+
T Consensus 229 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 229 ----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 0001112455688999999999999999999999999888765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=322.11 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=206.1
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|...+.||+|++|.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998878899999986543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++.... ..+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997643 46899999999999999999999 7899999999999999999999999999998765322222
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......+..|+|||+.....++.++||||||+++|||++ |+.||...... .....+. ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~------------~~~~---- 222 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVD------------QGYR---- 222 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH------------cCCC----
Confidence 222233568999999988899999999999999999999 99898643211 0111100 0000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...+..++..+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111245678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=294.95 Aligned_cols=271 Identities=25% Similarity=0.340 Sum_probs=216.3
Q ss_pred HHHHhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--------hhhHHHHHHHHHHHHhc-cCCceeEEEee
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--------DRALKSFDTECEVMRRI-RHRNLIKIVSS 744 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 744 (973)
-+.-.+.|...+.+|.|..++|-++. ..+|..+|+|++.... ....++-.+|+.+++++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34455678888999999999999887 4578899999886432 12245667899999998 59999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 745 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
++.+...++|+|.|+.|-|.+++.+.- .+++++..+|++|+..|++||| .+.|||||+||+|||++++.++||+||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence 999999999999999999999998764 7999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh
Q 048430 825 GIAKLLDGVDPVTQTMTLATIGYMAPEYGS------EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 825 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 898 (973)
|+|+.+.+.. .-...+|||+|.|||.+. ...|+..+|+||+||++|-++.|++||... ...- +.+..
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQml---MLR~I 240 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQML---MLRMI 240 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHH---HHHHH
Confidence 9999875432 334568999999999543 345888999999999999999999998541 1111 11111
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhcccC
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQALHLT 972 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~~~~ 972 (973)
..+. + ....+.+.+.+...++++.+|++.||.+|.|++|+++|=.-+.-...++.+|+
T Consensus 241 meGk--------y--------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~ms 298 (411)
T KOG0599|consen 241 MEGK--------Y--------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMS 298 (411)
T ss_pred Hhcc--------c--------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccC
Confidence 1111 0 00112344567778999999999999999999999999666555556666654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.40 Aligned_cols=254 Identities=26% Similarity=0.504 Sum_probs=205.7
Q ss_pred cCCCCCccccccCceEEEEEEeCC------CeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
++|...+.||+|+||.||+|.... ...||+|.++.... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467778999999999999998532 26799998865433 34567899999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC
Q 048430 753 LIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM 817 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 817 (973)
++|||+++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999997642 35788999999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHH
Q 048430 818 VAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 818 ~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 895 (973)
.+||+|||++......+. .......+++.|+|||......++.++|||||||++|||++ |..||...... .+...+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999876533222 12233456889999999888889999999999999999998 99998653221 111111
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
.. +. . ...+..++.++.+++.+||+.+|.+||+++|++++|+.
T Consensus 240 ~~---~~--------~-----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RS---RQ--------L-----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred Hc---CC--------c-----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 10 00 0 01123467789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=334.75 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=203.2
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 752 (973)
..++|...++||+|.||.|++|.. .+++.+|||++++.. +.+.+..+.|.+++.... ||.++.++.+|+.+++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 456788899999999999999995 468899999998663 456788899999998874 999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
.||||+.||++..+.+. ..+++..+..+|..|+.||.||| +++|||||||.+|||+|.+|.+||+|||+++.--.
T Consensus 446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999995554443 36999999999999999999999 89999999999999999999999999999986432
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. ......+||+.|||||.+....|+.++|-|||||++|||+.|..||.+..+. +++|.-+.
T Consensus 521 ~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~FdsI~~ 582 (694)
T KOG0694|consen 521 QG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDSIVN 582 (694)
T ss_pred CC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHhc
Confidence 22 2456678999999999999999999999999999999999999999652211 11221111
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV 951 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 951 (973)
++ ...|..++.+..++++++++.+|++|..+
T Consensus 583 d~--------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DE--------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC--------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 11234567789999999999999999976
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.22 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=205.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+|...+.||+|+||.||+|... .++.||+|.+... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34667789999999999999854 5889999998644 333567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++.... ..+++..+..++.|+++|++||| +.+++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999997643 46899999999999999999999 7999999999999999999999999999998764332222
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......+..|+|||......++.++|||||||++|||++ |..||.... .......... ....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~---------~~~~--- 224 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK---------GYRM--- 224 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC---------CCCC---
Confidence 222234678999999888889999999999999999998 888875421 1111111100 0000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..+..++.++.+++.+||+.+|++||++.|+++.|+.+
T Consensus 225 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01123456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.20 Aligned_cols=242 Identities=25% Similarity=0.289 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999987542 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
+|..++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTF 155 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccc
Confidence 9999887654 6899999999999999999999 899999999999999999999999999998753221 1222345
Q ss_pred cccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhh
Q 048430 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921 (973)
Q Consensus 842 ~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 921 (973)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~------------------ 212 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDI------------------ 212 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCc------------------
Confidence 689999999999888899999999999999999999999864211 111111110000
Q ss_pred hHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 922 DFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 922 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..++.++.+++.+|++.||++|| +++|+++|
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 --KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 01112456688999999999999997 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.69 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=210.7
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++..+|...++||+|+||.||+|...+++.+|+|++..........+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34556888899999999999999988899999999876665556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|+++++|.+++.... ..+++.++..++.|++.|+.||| +.+|+||||+|+||+++.++.+||+|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 999999999998643 46899999999999999999999 7899999999999999999999999999997654322
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......++..|+|||......++.++||||||+++|+|++ |+.||......+ ....+.. ...
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~------------~~~-- 222 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITA------------GYR-- 222 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHh------------CCc--
Confidence 12223346778999999888889999999999999999998 888986432111 1111110 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
...+..++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 --------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001123456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=326.55 Aligned_cols=269 Identities=23% Similarity=0.316 Sum_probs=198.3
Q ss_pred cCCCCCccccccCceEEEEEEe-C-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhc---cCCceeEEEeeee-----c
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-A-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRI---RHRNLIKIVSSCS-----N 747 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~ 747 (973)
++|...+.||+|+||.||+|+. . +++.||+|+++... ......+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999985 3 47889999886543 22234566788777766 6999999999885 3
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccc
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGI 826 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 826 (973)
....++||||++ ++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 59999987643 45899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccch
Q 048430 827 AKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAV 903 (973)
Q Consensus 827 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~ 903 (973)
++..... .......+++.|+|||.+....++.++|||||||++|||++|+.||...... ..+...+.... +..+
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhc
Confidence 9865432 2233456899999999988888999999999999999999999998753221 11111111110 1111
Q ss_pred hhhc--ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 904 TEVV--DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 904 ~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... ............... ....++..+.+++.+|++.||++||++.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEK--FVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHH--HccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 000000000000011 112356778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.16 Aligned_cols=240 Identities=22% Similarity=0.250 Sum_probs=195.6
Q ss_pred ccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 688 LGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 688 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999864 68899999986532 23456788899999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 843 (973)
.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 99998754 6899999999999999999999 8999999999999999999999999999987543221 22334568
Q ss_pred cccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhH
Q 048430 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923 (973)
Q Consensus 844 ~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 923 (973)
|+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..........+. .
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~--------~------------ 210 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEP--------L------------ 210 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCC--------C------------
Confidence 999999999988889999999999999999999999986421 122222111110 0
Q ss_pred HhHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 048430 924 ATKKTCISYIMSLALKCSAEIPEERIN---VKDALAD 957 (973)
Q Consensus 924 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt---~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++||+ +.|++.|
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 011224566889999999999999985 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.93 Aligned_cols=255 Identities=26% Similarity=0.356 Sum_probs=206.0
Q ss_pred CCCCCccccccCceEEEEEEeCCC-eEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEee-eec------CCee
Q 048430 681 GFGESNLLGSGSFDNVYKATLANG-VSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSS-CSN------PGFK 751 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~~~~ 751 (973)
++++.++|.+|||+.||.|+...+ ..||+|++-..++.......+|+++|++++ |+|||.+++. ... ..+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 455678999999999999997655 999999988777788899999999999997 9999999993 211 2467
Q ss_pred EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
+|.||||.+|.|-+++...- ..|++.++++|+.|+++|+++||. +..+|||||||.+|||+..++..||||||.|.-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 89999999999999998532 359999999999999999999994 3677999999999999999999999999998643
Q ss_pred CCCC-Ccc-------cccccccccccCccC---CCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 831 DGVD-PVT-------QTMTLATIGYMAPEY---GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 831 ~~~~-~~~-------~~~~~~~~~y~aPE~---~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
-... ... ......|+.|+|||. ..+...++|+||||+||+||-|+....||+.... .
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--l---------- 264 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--L---------- 264 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--e----------
Confidence 2111 110 112357999999994 5567899999999999999999999999976311 1
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.+++..+ .++....++..+.+||..||++||.+||++.+|++++.++..
T Consensus 265 -----aIlng~Y----------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 -----AILNGNY----------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -----eEEeccc----------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1111111 112223578889999999999999999999999988877764
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.24 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=201.8
Q ss_pred CCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+|...+.||+|+||.||+|..+++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466788999999999999998877889999886432 2235688899999999999999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
++|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999876657899999999999999999999 8999999999999999999999999999987654222111222
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
..++..|+|||......++.++|||||||++||+++ |+.||+.....+ ....+.. + ..
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~---~---------~~------- 219 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSA---G---------YR------- 219 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHc---C---------Cc-------
Confidence 234567999999888889999999999999999999 788886432111 1111100 0 00
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
...+..++.++.+++.+||..+|++||++.|+++.|
T Consensus 220 ---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 ---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 001112466799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=324.90 Aligned_cols=259 Identities=28% Similarity=0.471 Sum_probs=209.1
Q ss_pred cCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|...+.||+|+||.||++.. .++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999974 2356789998876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEE
Q 048430 754 IMQYMPQGSLEKWLYSHN------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHL 821 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 821 (973)
||||+++++|.+++.... ..+++.++..++.|++.||+||| ..+++||||||+||++++++.+|+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999997543 24899999999999999999999 899999999999999999999999
Q ss_pred eecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhC
Q 048430 822 GDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 822 ~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++........ ......++..|+|||......++.++|||||||++|||++ |..||......+ ......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~~~~i~ 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----VIECIT 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH
Confidence 999999865332211 1223345778999999988889999999999999999998 888886432211 111111
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
.+.... .+..++.++.+++.+||+.+|.+||+++|+.+.|+++.+..
T Consensus 237 ~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 QGRVLQ-------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCCcCC-------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 110000 01123456899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.28 Aligned_cols=246 Identities=23% Similarity=0.283 Sum_probs=201.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-C-CeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-N-GVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.++|...+.||+|+||.||+|... + +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 346888899999999999999854 3 3689999986442 2335678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999998765 6899999999999999999999 899999999999999999999999999999865421
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . ........+. .
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~-~~~~~i~~~~--------~-- 245 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----L-LIYQKILEGI--------I-- 245 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----H-HHHHHHhcCC--------C--
Confidence 2234689999999999888899999999999999999999999864211 1 1111111100 0
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+...+..+.+++.+|++.+|++|+ +++|+++|
T Consensus 246 ----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00112345578899999999999995 89999887
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.33 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=207.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+++.||||.++.. .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688899999999999999985 47899999987542 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||+++++|.+++.. ....+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988863 2245889999999999999999999 89999999999999999999999999999886543
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. .......++..|+|||...+..++.++||||||+++|||++|+.||..... ....+......... +.
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~-----~~-- 227 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIEQCDY-----PP-- 227 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHhcCCC-----CC--
Confidence 22 122234588899999998888899999999999999999999999854221 11222111110000 00
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
.....++..+.+++.+||+.+|++||++.|+++.+++++
T Consensus 228 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 -----------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011234567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.45 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=212.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe-eEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF-KALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 755 (973)
++|...+++|+|+||.++..+. .++..+|+|.+.... +.......+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5677889999999999999984 467899999987654 2334578899999999999999999999999888 99999
Q ss_pred EecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+||+||++.+.+...+ ..++++.+..++.|++.|+.||| +.+|+|||||+.||+++.++.|||+|||+|+.+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998766 77999999999999999999999 8999999999999999999999999999999987544
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......+||+.||.||...+.+|..|+||||+||++|||++-+++|... +....+.....+.
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~------------ 222 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGL------------ 222 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhcc------------
Confidence 3445578999999999999999999999999999999999999998652 2222222211111
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
-.+.+..++.++..++..|++.+|+.||++.+++.+
T Consensus 223 -------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 012234567789999999999999999999999987
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=363.81 Aligned_cols=482 Identities=28% Similarity=0.344 Sum_probs=261.4
Q ss_pred EecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcc
Q 048430 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNK 129 (973)
Q Consensus 50 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~ 129 (973)
+|.++.+++ -||..+..-..++.|+++.|.+...--+.+.+.-+|+.||||+|+++ ..|..+ ..+.+|+.|.++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~i-t~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQI-TLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchh-hhHHHHhhcccchhh
Confidence 344444444 45555554455666666666553211122333444666666666665 566555 345666666666666
Q ss_pred cCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc
Q 048430 130 ITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209 (973)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~ 209 (973)
|. ..|.+.+++.+|++|+|.+|++. .+|.++ ..+.+|+.|+++.|++. .+|..+..++.++.+..++|...
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~-~~lknl~~LdlS~N~f~------~~Pl~i~~lt~~~~~~~s~N~~~ 150 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASI-SELKNLQYLDLSFNHFG------PIPLVIEVLTAEEELAASNNEKI 150 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhH-HhhhcccccccchhccC------CCchhHHhhhHHHHHhhhcchhh
Confidence 66 45566666666666666666665 555554 45566666666666664 44555556666666666666111
Q ss_pred CccccccccCCcceeEEeecccccccCCCCC-CccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCccc
Q 048430 210 GLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG 288 (973)
Q Consensus 210 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~ 288 (973)
...+ . ..++.+++..|.+.+.++... .+.. .|+|++|.+. . -.+..+.+|+.|....|+++.+. -
T Consensus 151 ~~lg----~-~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~ 216 (1081)
T KOG0618|consen 151 QRLG----Q-TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----I 216 (1081)
T ss_pred hhhc----c-ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----e
Confidence 1111 1 114555555555555444332 2222 3555555554 1 13444555555555555554332 1
Q ss_pred ccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCC
Q 048430 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFG 368 (973)
Q Consensus 289 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~ 368 (973)
..++|+.|+.++|.+++... -..-.+|+.++++.|++++ +|++++.+ ..++.+.+..|+++ .+|..+.
T Consensus 217 ~g~~l~~L~a~~n~l~~~~~---------~p~p~nl~~~dis~n~l~~-lp~wi~~~-~nle~l~~n~N~l~-~lp~ri~ 284 (1081)
T KOG0618|consen 217 SGPSLTALYADHNPLTTLDV---------HPVPLNLQYLDISHNNLSN-LPEWIGAC-ANLEALNANHNRLV-ALPLRIS 284 (1081)
T ss_pred cCcchheeeeccCcceeecc---------ccccccceeeecchhhhhc-chHHHHhc-ccceEecccchhHH-hhHHHHh
Confidence 22445555555555543111 0112345555555555553 23444443 34555555555553 4455555
Q ss_pred CCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhh-hccCc-CCeeecCCccccCcCcccccCcCCCC
Q 048430 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL-CKLEK-LNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 369 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
..++|+.|.+.+|.+. -+|.....++.|++|+|..|+|.. .|+.+ .-+.. |+.|..+.|.+.......=..++.|+
T Consensus 285 ~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq 362 (1081)
T KOG0618|consen 285 RITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQ 362 (1081)
T ss_pred hhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHH
Confidence 5555555555555555 444445555555555555555552 23322 22221 44455555555433222222345566
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
.|++.+|.++...-..+.+.++|+.|+|++|++.......+.++..|+.|+||+|+++ .+|.++..++.|+.|...+|+
T Consensus 363 ~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~ 441 (1081)
T KOG0618|consen 363 ELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQ 441 (1081)
T ss_pred HHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCc
Confidence 7777777776666566666777777777777776333334566677777777777776 666777777777777777777
Q ss_pred cccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCc
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNG 574 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~ 574 (973)
+. ..| .+..+++|+.+|||.|+|+...-..-...++|++|||++|.
T Consensus 442 l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 442 LL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred ee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 76 566 66777777777777777764433333333677777777775
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=334.37 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=193.6
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+|...++||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 344567899999999999985 468999999986543 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++|+|.+.. ..++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 225 (353)
T PLN00034 155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPC 225 (353)
T ss_pred CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccc
Confidence 999986532 3567788899999999999999 8999999999999999999999999999998654221 122
Q ss_pred ccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 839 TMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
....|+..|+|||.+.. ...+.++|||||||++|||++|+.||...... .............
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~----------- 292 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQ----------- 292 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccC-----------
Confidence 34568999999997643 23457899999999999999999999732211 1111111100000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ...+..++.++.+++.+||+.||++||+++|+++|
T Consensus 293 -~-------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 -P-------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -C-------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00112345678999999999999999999999987
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=342.37 Aligned_cols=370 Identities=28% Similarity=0.438 Sum_probs=237.2
Q ss_pred CCCCCCcEEEecCCCCC-CCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCC
Q 048430 66 GNLSFLVSLNISGNSFY-DTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSL 144 (973)
Q Consensus 66 ~~l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 144 (973)
|-|+..+-.|+++|.|+ +..|.....+++++-|.|...++. .+|+++ +.+.+|++|.+++|++. .+-..++.|+.|
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL-~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L 80 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEEL-SRLQKLEHLSMAHNQLI-SVHGELSDLPRL 80 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHH-HHHhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence 44556666677777776 466777777777777777777776 677665 56777777777777776 455667777777
Q ss_pred CeEEccCccccc-cCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcce
Q 048430 145 KSIRLDNNSLSG-SFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMV 223 (973)
Q Consensus 145 ~~L~L~~N~l~~-~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 223 (973)
+.+.+..|+++. -||.++| .+..|+.||||+|+++ ++|..+..-+++-+|+||+|+|..++...|-+
T Consensus 81 Rsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~------EvP~~LE~AKn~iVLNLS~N~IetIPn~lfin----- 148 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR------EVPTNLEYAKNSIVLNLSYNNIETIPNSLFIN----- 148 (1255)
T ss_pred HHHhhhccccccCCCCchhc-ccccceeeecchhhhh------hcchhhhhhcCcEEEEcccCccccCCchHHHh-----
Confidence 777777777762 3677776 4777777777777775 66777777777777777777776432232322
Q ss_pred eEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcC
Q 048430 224 AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303 (973)
Q Consensus 224 ~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 303 (973)
+..|-+||||+|++. .+|..+..+..|++|+|++|.+....-..+..++
T Consensus 149 ------------------LtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmt------------ 197 (1255)
T KOG0444|consen 149 ------------------LTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMT------------ 197 (1255)
T ss_pred ------------------hHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccch------------
Confidence 555666666666666 4555566666666666666665433222222333
Q ss_pred CCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcc
Q 048430 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL 383 (973)
Q Consensus 304 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 383 (973)
+|++|++++-+-+- ..+|.++..+.+|..+|+|.|.+
T Consensus 198 -------------------sL~vLhms~TqRTl------------------------~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 198 -------------------SLSVLHMSNTQRTL------------------------DNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred -------------------hhhhhhcccccchh------------------------hcCCCchhhhhhhhhccccccCC
Confidence 33333333322110 13555666777777777777777
Q ss_pred ccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccc
Q 048430 384 AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF 463 (973)
Q Consensus 384 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 463 (973)
. .+|+.+.++++|+.|+||+|+|+ .+......-.+|++|.++.|+++ .+|.++.+++.|+.|.+.+|+++
T Consensus 235 p-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~------- 304 (1255)
T KOG0444|consen 235 P-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT------- 304 (1255)
T ss_pred C-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc-------
Confidence 7 67777777777777777777777 33334444455556666666655 55555555555665555555554
Q ss_pred cccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccc
Q 048430 464 WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQS 543 (973)
Q Consensus 464 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 543 (973)
+. -+|..++.+.+|+.+..++|++. ..|+.++.+..|+.|.|++|++- .+|+++.-|+.|+.
T Consensus 305 ---------------Fe-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~v 366 (1255)
T KOG0444|consen 305 ---------------FE-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKV 366 (1255)
T ss_pred ---------------cc-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcce
Confidence 12 36666777777777777777776 67777777777777777777776 67777777777777
Q ss_pred ccccccccC
Q 048430 544 LDLSGNNIS 552 (973)
Q Consensus 544 L~Ls~N~l~ 552 (973)
|||.+|.--
T Consensus 367 LDlreNpnL 375 (1255)
T KOG0444|consen 367 LDLRENPNL 375 (1255)
T ss_pred eeccCCcCc
Confidence 777777544
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=332.26 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=200.2
Q ss_pred CCCCCccccccCceEEEEEEe----CCCeEEEEEEEeccc----hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCee
Q 048430 681 GFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQE----DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 751 (973)
+|...+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.+++++ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 368899999986432 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997754 6899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ........... ++.
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~~~ 229 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------DPP 229 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------CCC
Confidence 3333333345699999999987764 478899999999999999999999964322111 11111110000 000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
.+..++..+.+++.+|++.||++|| +++++++|
T Consensus 230 --------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 --------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0112345688999999999999999 77888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=331.62 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=203.5
Q ss_pred hcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeec-CC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSN-PG 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~ 749 (973)
.++|...+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34688889999999999999963 235789999986443 23346788899999999 79999999998854 45
Q ss_pred eeEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---------------------------------------------------------- 771 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 771 (973)
..++||||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7889999999999999986432
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-cccccccccccc
Q 048430 772 --YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYM 848 (973)
Q Consensus 772 --~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~ 848 (973)
..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.+...... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25789999999999999999999 899999999999999999999999999999875332221 222334677899
Q ss_pred CccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHH
Q 048430 849 APEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKK 927 (973)
Q Consensus 849 aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~ 927 (973)
|||+..+..++.++|||||||++|||++ |..||......+ .+...+.. + ... ..+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~---~---------~~~----------~~~~ 299 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKE---G---------TRM----------RAPE 299 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhc---c---------CCC----------CCCc
Confidence 9999999999999999999999999998 999986532211 11111100 0 000 0011
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 928 TCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 928 ~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.+..++.+++.+||+.+|++||++.|++++|+++.+
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234668999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.54 Aligned_cols=271 Identities=24% Similarity=0.401 Sum_probs=205.2
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 752 (973)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999974 3578999999876666666789999999999999999999998743 35688
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999876657899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCcc--cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 833 VDPVT--QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 833 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
..... .....++..|+|||...+..++.++|||||||++|||++|..|+..... .+................
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhcccccccccchHH
Confidence 22211 1122345569999998888899999999999999999998876532110 111110000000000000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
+... .........+..++.++.+++.+||+.+|++|||++|+++.|+++
T Consensus 235 ~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIEL--LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHH--HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000 000000111234567799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=344.05 Aligned_cols=250 Identities=21% Similarity=0.255 Sum_probs=203.2
Q ss_pred CCCCCccccccCceEEEEEEeC-C-CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-N-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999843 3 6789999876655555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 759 PQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 759 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
++|+|.+++... ...+++.++..++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 346889999999999999999999 89999999999999999999999999999987643222
Q ss_pred -cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 -VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+. ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~--------~~-- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGK--------YD-- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC--------CC--
Confidence 123345699999999999888999999999999999999999999864211 11111111100 00
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++.++.+++.+||+.+|++||++++++++
T Consensus 290 ---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 ---------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0011245668999999999999999999999865
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=339.18 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=198.0
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999984 568899999997542 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP- 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 835 (973)
|+++|+|.+++.... .+++..+..++.||+.||+||| ..+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999998765 6889999999999999999999 89999999999999999999999999999753310000
Q ss_pred ---------------------------------------------cccccccccccccCccCCCCCCCCcchhHHHHHHH
Q 048430 836 ---------------------------------------------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGIL 870 (973)
Q Consensus 836 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvv 870 (973)
......+||+.|+|||.+....++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999888889999999999999
Q ss_pred HHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHh--ccccCCCCC
Q 048430 871 MMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK--CSAEIPEER 948 (973)
Q Consensus 871 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~R 948 (973)
+|||++|+.||......+. ...... ... .+ ..+....++.++.+++.+ |+..+|..|
T Consensus 238 l~elltG~~Pf~~~~~~~~-~~~i~~--~~~--------~~----------~~~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET-QLKVIN--WEN--------TL----------HIPPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH-HHHHHc--ccc--------cc----------CCCCCCCCCHHHHHHHHHHccCcccccCC
Confidence 9999999999965322111 000000 000 00 000011234567788877 556677779
Q ss_pred CCHHHHHHH
Q 048430 949 INVKDALAD 957 (973)
Q Consensus 949 pt~~evl~~ 957 (973)
|+++|+++|
T Consensus 297 ~~~~~~l~h 305 (381)
T cd05626 297 NGADDIKAH 305 (381)
T ss_pred CCHHHHhcC
Confidence 999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.75 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=203.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999985 478999999997543 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999887567999999999999999999999 89999999999999999999999999999987654333
Q ss_pred cccccccccccccCccCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 836 VTQTMTLATIGYMAPEYGS------EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.......||+.|+|||.+. ...++.++|||||||++|||++|+.||..... .......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~-------~ 225 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNF-------Q 225 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcC-------C
Confidence 3333456899999999875 45678999999999999999999999864221 1111111000 0
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .+....++.++.+++.+|++ +|++||+++++++|
T Consensus 226 ~~~~---------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RFLK---------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CccC---------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000 00011235668889999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.47 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=197.6
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----CeeE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GFKA 752 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 752 (973)
+|...++||+|+||.||+|+. .+++.||||+++... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477789999999999999985 478999999886432 23345688999999999999999999987533 3579
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+. ++|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 69999987654 6899999999999999999999 89999999999999999999999999999975432
Q ss_pred CCC--cccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc----hh
Q 048430 833 VDP--VTQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA----VT 904 (973)
Q Consensus 833 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 904 (973)
... .......+++.|+|||.... ..++.++|||||||++|||++|+.||..... ......+....... ..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence 211 12234568999999998765 6789999999999999999999999865321 11111111111000 00
Q ss_pred hhccc-------ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVDA-------NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d~-------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+... .+...... ........++.++.+++.+||+.+|++||+++|+++|
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPV---PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCC---chHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 00000000 0000001235668899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=308.70 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=214.0
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
|.+..++|+|+||.||+|.+ .+|+.||||.+.... ..+++.+|+.+|++.+.|+||++||.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55578999999999999985 579999999876543 457899999999999999999999999888999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+..+.++..+..+++.++..+.+..++||+||| ..+-||||||+.|||++.+|.+|++|||.|..+.. .-.....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhhCc
Confidence 9999999998889999999999999999999999 67789999999999999999999999999986642 1223455
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|||||++..-.|..++||||+|++..||..|++||....+...-+ .....+.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------------MIPT~PP 246 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------------MIPTKPP 246 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------------eccCCCC
Confidence 689999999999999899999999999999999999999997654322100 0112333
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
..+..|+.++.++-+++++|+...|++|.|+-++++|-
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 44556778899999999999999999999999999874
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.15 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=203.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCe----EEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGV----SVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|...+.||+|+||.||+|.+. +++ .||+|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46777899999999999999853 344 47778775332 2334677888889999999999999999864 45688
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+||+++|+|.+++......+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||.++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999865432
Q ss_pred CC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
.. .......++..|+|||....+.++.++|||||||++||+++ |+.||.+.... ...+.+.. +.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~---~~--------- 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEK---GE--------- 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC---CC---------
Confidence 22 12233456788999999988889999999999999999998 99998653221 11111110 00
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
....+..++.++.+++.+||..+|++||++.|+++.|+.+.+.-+
T Consensus 229 ----------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 229 ----------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 000011234567889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.34 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=209.4
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|...+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35667789999999999999742 456789998876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc
Q 048430 754 IMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV 818 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~ 818 (973)
||||+++++|.+++.... ..+++..++.++.|++.|++||| +++|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999997542 24789999999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHH
Q 048430 819 AHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVA 896 (973)
Q Consensus 819 ~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 896 (973)
+||+|||++........ .......++..|+|||+.....++.++|||||||++|||++ |+.||...... ..+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----EVIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence 99999999976543221 12233456788999999988889999999999999999999 99998653221 1111
Q ss_pred hhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 897 ESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 897 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
....+.... .+..++..+.+++.+||+.+|++||+++++++.|+++.+..+
T Consensus 237 ~~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 237 CITQGRVLE-------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHhCCCCCC-------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 111110000 011245668899999999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.46 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=199.7
Q ss_pred ccccccCceEEEEEEeCCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHH
Q 048430 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 764 (973)
++||+|+||.||+|...+++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999886543 233457889999999999999999999999999999999999999999
Q ss_pred HHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccccccc
Q 048430 765 KWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844 (973)
Q Consensus 765 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~ 844 (973)
+++......+++..+..++.|++.|+.|+| ..+++||||||+||+++.++.+|++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999876667899999999999999999999 89999999999999999999999999999875432222122223446
Q ss_pred ccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhH
Q 048430 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923 (973)
Q Consensus 845 ~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 923 (973)
..|+|||+.....++.++|||||||++||+++ |..||...... .....+. .+ ...
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~---~~---------~~~---------- 213 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVE---KG---------YRM---------- 213 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHH---cC---------CCC----------
Confidence 78999999988889999999999999999998 89898643211 1111110 00 000
Q ss_pred HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 924 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
..+..++.++.+++.+|++.+|++||++.|+++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=330.66 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEe----CCCeEEEEEEEeccc----hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQE----DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++||+|+||.||+++. .+++.||||+++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 357899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++|+|.+++.... .+.+..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 99999999998765 6788899999999999999999 89999999999999999999999999999875432221 2
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....|++.|+|||.+....++.++|||||||++|||++|+.||..... ...+.....+. .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~--------~------ 217 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGK--------L------ 217 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------C------
Confidence 2334689999999999888899999999999999999999999865221 11111111110 0
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..++.++.+++.+|++.+|++|| +++++++|
T Consensus 218 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 ------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00112345688999999999999999 78888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.98 Aligned_cols=247 Identities=23% Similarity=0.407 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999986 478999999876443 33456789999999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc-ccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT-QTMTL 842 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~ 842 (973)
.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999876657899999999999999999999 8999999999999999999999999999987543211111 11122
Q ss_pred ccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhh
Q 048430 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921 (973)
Q Consensus 843 ~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 921 (973)
.+..|+|||.+..+.++.++|||||||++|||++ |..||...... .....+. ....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~------------~~~~--------- 214 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIE------------QGVR--------- 214 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHH------------cCCC---------
Confidence 3567999999988889999999999999999998 88887543211 1111110 0000
Q ss_pred hHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 922 DFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 922 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
...+..++..+.+++.+|++.+|++||++.|+.+.|+
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 -LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0011234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.43 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=203.2
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...++||+|+||.||+|+..+...||+|.++.... ..+.+.+|+.++++++||||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 56888999999999999999987777899999874332 23678999999999999999999998754 55789999999
Q ss_pred CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 760 QGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 760 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
+|+|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||.++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999999998643 35789999999999999999999 89999999999999999999999999999986643332222
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....++..|+|||+..+..++.++|||||||++|||++ |+.||......+ ........ ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~~~~~---------~~----- 221 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERG---------YR----- 221 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHHHhcC---------CC-----
Confidence 23446778999999888889999999999999999999 787875432111 11110000 00
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
...+..++..+.+++.+|++.+|++||+++++++.|++.
T Consensus 222 -----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001123466789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.17 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=204.0
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
++|...+.||+|+||.||+|... +++.||||.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999853 3578999998755433 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 753 LIMQYMPQGSLEKWLYSHN-------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
+||||+++++|.+++...+ ..+++.++..++.|++.|+.||| ..+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999997642 34788999999999999999999 8899999999999999999999
Q ss_pred EEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHh
Q 048430 820 HLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 897 (973)
||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||...... ..+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----~~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----EVIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHH
Confidence 9999999876532221 11233346788999999999999999999999999999998 99998543211 11111
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
...+... ..+..++..+.+++.+||+.+|++||+++|+++.|+
T Consensus 237 ~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLL-------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcC-------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1110000 001124566899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.61 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=202.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+|...+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999995 578999999987655445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++.... .+++..+..++.|++.|++||| +.+|+|||++|+||+++.++.+||+|||++....... ...
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06646 89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKR 163 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc-ccc
Confidence 9999999987654 6899999999999999999999 7899999999999999999999999999998653221 122
Q ss_pred ccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 839 TMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
....++..|+|||.+. ...++.++|||||||++|||++|+.||......+. ... ........
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~------------~~~~~~~~-- 228 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL------------MSKSNFQP-- 228 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-hee------------eecCCCCC--
Confidence 3346888999999764 34578899999999999999999999854221110 000 00000000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
........++..+.+++.+||+.+|++||+++++++++
T Consensus 229 -----~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 -----PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00001112456789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=338.43 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=200.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999985 468999999997542 234466888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999998765 6899999999999999999999 89999999999999999999999999999875422110
Q ss_pred c-------------------------------------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 048430 836 V-------------------------------------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRR 878 (973)
Q Consensus 836 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~ 878 (973)
. .....+||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 001235899999999998888999999999999999999999
Q ss_pred CCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC---HHHHH
Q 048430 879 KPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN---VKDAL 955 (973)
Q Consensus 879 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt---~~evl 955 (973)
.||...... .......... ..+. .+....+++++.+++.+|+. +|.+|++ ++|++
T Consensus 237 ~Pf~~~~~~-----~~~~~i~~~~------~~~~----------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 237 PPFCSDNPQ-----ETYRKIINWK------ETLQ----------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred CCCCCCCHH-----HHHHHHHcCC------CccC----------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 998653211 1111100000 0000 00001235568889999997 9999998 99998
Q ss_pred HH
Q 048430 956 AD 957 (973)
Q Consensus 956 ~~ 957 (973)
+|
T Consensus 295 ~h 296 (364)
T cd05599 295 SH 296 (364)
T ss_pred cC
Confidence 86
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.39 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=202.9
Q ss_pred CCCccccccCceEEEEEEe-----CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeEEE
Q 048430 683 GESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKALI 754 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 754 (973)
...+.||+|+||+||++.. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.. ....++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988652 4678899999875432 345678899999999999999999998865 3467899
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++... .+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999999865 5899999999999999999999 7899999999999999999999999999998654322
Q ss_pred Cc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh-hCCcchhhhccccc
Q 048430 835 PV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-SLPGAVTEVVDANL 911 (973)
Q Consensus 835 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~l 911 (973)
.. ......++..|+|||......++.++|||||||++|||++|+.||................ .......+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 11 1122345677999999888889999999999999999999999975432211100000000 00000111111100
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
....+..++.++.+++.+||+.+|++||+++++++.|+++.
T Consensus 242 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 ----------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 01112345678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.80 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=206.6
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHH
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 764 (973)
-++|+|.||+||-|+. .+...+|||.+........+-..+|+...++++|.|||+++|.|.+.++.-+.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 4799999999999994 567789999998777777788999999999999999999999999999999999999999999
Q ss_pred HHhhhCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC-CCCcEEEeecccccccCCCCCcccccc
Q 048430 765 KWLYSHNYSL--TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 765 ~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
+.++..-.++ .+.++-.+.+||++||.||| ...|||||||.+|||++ -.|.+||+|||-++.+...++... ..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE-TF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE-TF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc-cc
Confidence 9999865566 77888899999999999999 89999999999999995 578999999999998876555433 45
Q ss_pred cccccccCccCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 842 LATIGYMAPEYGSEGI--VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 842 ~~~~~y~aPE~~~~~~--~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
-||..|||||++..+. |..++|||||||++.||.||++||-+....... +.+- .+.+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---MFkV------------GmyKv----- 796 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---MFKV------------GMYKV----- 796 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---hhhh------------cceec-----
Confidence 6999999999988764 889999999999999999999999765433221 1110 01110
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.|+..+.+.+.++.+|+.+||.+||+++++++.
T Consensus 797 --HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 797 --HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred --CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 112445677889999999999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.37 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=197.0
Q ss_pred cccccCceEEEEEEeC---CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 687 LLGSGSFDNVYKATLA---NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 456799999865533 33467899999999999999999999886 457899999999999
Q ss_pred HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc--ccc
Q 048430 763 LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT--QTM 840 (973)
Q Consensus 763 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 840 (973)
|.+++......+++.++.+++.|++.|++||| +.+++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999876667999999999999999999999 7899999999999999999999999999987654322211 122
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
..++..|+|||......++.++|||||||++||+++ |+.||......+ ....+.. +. .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~---~~---------~------- 216 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQ---GK---------R------- 216 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHC---CC---------C-------
Confidence 234578999999888889999999999999999996 999986532211 1111110 00 0
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
...+..+++++.+++.+||+.+|++||++.++.+.|+.+
T Consensus 217 ---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 001123467789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.49 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=202.5
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46777899999999999999988888999999875433 2467899999999999999999999885 456789999999
Q ss_pred CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 760 QGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 760 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
+++|.+++.... ..+++.++..++.|++.|++||| +.+|+||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999999997643 45899999999999999999999 78999999999999999999999999999986543222222
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....++..|+|||......++.++||||||+++|||++ |..||...... .....+.. + ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~---~---------~~----- 221 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVER---G---------YR----- 221 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc---C---------CC-----
Confidence 22345678999999888889999999999999999999 88888642211 11111110 0 00
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...+..++..+.+++.+|++.+|++|||++++.+.|++
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 -----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00112345668999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=333.97 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=202.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
..++|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346788899999999999999985 468899999986432 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999998765 4788899999999999999999 899999999999999999999999999999876433
Q ss_pred CCcccccccccccccCccCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEG----IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.........||+.|+|||.+... .++.++|||||||++|||++|+.||..... ........... .
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~------~ 264 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHK------N 264 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC------C
Confidence 22233445799999999976543 478999999999999999999999865221 11111110000 0
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE--RINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~evl~~ 957 (973)
.+. .+....++.++.+++.+|++.+|++ |++++|+++|
T Consensus 265 ~~~----------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SLT----------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCC----------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0001124567889999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=333.28 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
+.||+|+||.||++.. .+++.||+|+++... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 578999999987542 233466788999999999999999999999999999999999999
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
+|..++.... .+++..+..++.||+.||+||| + .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 9999887654 6899999999999999999999 5 799999999999999999999999999987532211 12233
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~--------~--------- 213 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE--------I--------- 213 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCC--------C---------
Confidence 4699999999999888899999999999999999999999864211 11111110000 0
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..+++++.+++.+|++.||++|+ +++++++|
T Consensus 214 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 ---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00112355688999999999999997 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.13 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=204.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CC--eEEEEEEEecc-chhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NG--VSVAVKVFNLQ-EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|... ++ ..+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888899999999999999864 33 34788887643 233456789999999999 799999999999998999999
Q ss_pred EEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 755 MQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
+||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999997532 24788999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhh
Q 048430 820 HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 898 (973)
||+|||++..... .........+..|+|||+.....++.++|||||||++|||++ |..||...... ......
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYEKL 231 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH
Confidence 9999999864321 111122234567999999988889999999999999999997 99998653211 111111
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
. .... ...+..++.++.+++.+||+.+|.+||+++++++.|+.+.+....
T Consensus 232 ~---------~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 232 P---------QGYR----------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred h---------cCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 0000 001123456789999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.32 Aligned_cols=200 Identities=24% Similarity=0.354 Sum_probs=174.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||+||+|+. .+++.||+|+++... ......+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999985 468999999997542 233457788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999998765 7899999999999999999999 89999999999999999999999999999875432110
Q ss_pred ----------------------------------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 048430 836 ----------------------------------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPT 881 (973)
Q Consensus 836 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~ 881 (973)
......+||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346999999999998888999999999999999999999999
Q ss_pred Cc
Q 048430 882 NE 883 (973)
Q Consensus 882 ~~ 883 (973)
..
T Consensus 237 ~~ 238 (363)
T cd05628 237 CS 238 (363)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=329.59 Aligned_cols=242 Identities=24% Similarity=0.283 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999987542 23456677888888876 699999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 99999988765 6899999999999999999999 8999999999999999999999999999987532211 22233
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~--------~--------- 213 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDE--------V--------- 213 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCC--------C---------
Confidence 5689999999999888899999999999999999999999965321 11111111110 0
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINV------KDALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~------~evl~~ 957 (973)
..+..++.++.+++.+|++.||++||++ +++++|
T Consensus 214 ---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 ---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0011235568899999999999999998 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=328.38 Aligned_cols=242 Identities=24% Similarity=0.273 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 468899999987542 22344556677777654 899999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 99999998765 6899999999999999999999 7999999999999999999999999999997543222 22334
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+......... +
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~------~----------- 213 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILNDR------P----------- 213 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC------C-----------
Confidence 5689999999999888899999999999999999999999865321 11111110000 0
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVK-DALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-evl~~ 957 (973)
..+..++.++.+++.+||+.+|++||++. ++++|
T Consensus 214 ---~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 ---HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 00112355678999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.27 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=202.3
Q ss_pred HhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
+.++|+..+.||+|+||.||+|... .+..||||+++... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677899999999999999998743 35679999886432 2344678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEE
Q 048430 751 KALIMQYMPQGSLEKWLYSHN---------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHL 821 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 821 (973)
.++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999997632 23578889999999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhC
Q 048430 822 GDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 822 ~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++......... .....+++.|+|||.+....++.++|||||||++|||++ |..||..... ........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~~~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFVM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH
Confidence 9999987653322211 122345788999999988889999999999999999999 6788754321 11111110
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
... ... .+..++..+.+++.+||+.+|++||++.|++++|+
T Consensus 236 ~~~--------~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGG--------LLD-----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCC--------cCC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000 000 01123556899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.17 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=205.8
Q ss_pred cCCCCCccccccCceEEEEEEeCC----CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999998543 3568999887554 3456789999999999999999999999875 457899
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876667899999999999999999999 8999999999999999999999999999988664332
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
........++..|+|||......++.++|||||||++||+++ |+.||......+ ....+.. +.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~---~~----------- 225 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIEN---GE----------- 225 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHc---CC-----------
Confidence 222223345678999999888889999999999999999986 999986532211 1111110 00
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
....+..++..+.+++.+|+..+|++||++.|+++.|+++++
T Consensus 226 --------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000112345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.22 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+. .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 46889999998754 223445678899888877 799999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 99999887654 6899999999999999999999 8999999999999999999999999999987532211 12233
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc---ccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE---MSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .....++..... ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-------~~~~------ 222 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-------EKQI------ 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-------cCCC------
Confidence 568999999999998899999999999999999999999996432111 111111111100 0000
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERIN------VKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt------~~evl~~ 957 (973)
..+..++.++.+++.+||+.||++||+ ++++++|
T Consensus 223 ------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 011224556889999999999999998 4677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=329.87 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=195.2
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHH---HhccCCceeEEEeeeecCCeeEEE
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVM---RRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56678999999999999985 468999999997542 22345666776665 456799999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|..++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999988654 6899999999999999999999 8999999999999999999999999999987543222
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .........+ ..
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~--------~~--- 218 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFDSIVND--------EV--- 218 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC--------CC---
Confidence 222345689999999999888899999999999999999999999864321 1111111000 00
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..++..+.+++.+||+.||++|| +++++++|
T Consensus 219 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ---------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01112456688999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=337.74 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=204.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999964 78999999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC-
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD- 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 834 (973)
||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 37899999999999999999999 8999999999999999999999999999998654322
Q ss_pred ---------------------------CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccC
Q 048430 835 ---------------------------PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG 887 (973)
Q Consensus 835 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~ 887 (973)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223456899999999999889999999999999999999999998653211
Q ss_pred cccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 048430 888 EMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-VKDALAD 957 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~evl~~ 957 (973)
..+ ...... ...+.. +....+++++.+++.+|++ +|++||+ ++|+++|
T Consensus 237 ----~~~-~~i~~~------~~~~~~----------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ----ETY-NKIINW------KESLRF----------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----HHH-HHHhcc------CCcccC----------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 110000 000000 0001145678899999998 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.17 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=195.5
Q ss_pred ccccCceEEEEEEe-CCCeEEEEEEEeccch---hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 688 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
||+|+||+||++.. .+++.||+|.+..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 4789999999865422 2335677899999999999999999999999999999999999999
Q ss_pred HHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 764 EKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 764 ~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
..++.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988754 2246899999999999999999999 89999999999999999999999999999876543221 2233
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..|++.|+|||...+..++.++|||||||++|||++|+.||....... .............
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~------------------ 217 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS------------------ 217 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC------------------
Confidence 468999999999999999999999999999999999999986532111 1111111000000
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
...+..++.++.+++.+|++.||++|| +++|+++|
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 --VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 001123466788999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=326.85 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=196.9
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
++||+|+||.||+|+. .+++.||||+++... ....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 468899999997542 23345688899999988 699999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 99999887654 7999999999999999999999 8999999999999999999999999999987432111 12234
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc---ccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE---MSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||+.....+ .....+..... .....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~------ 222 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-------LEKQI------ 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-------HcCCC------
Confidence 568999999999998899999999999999999999999996432111 11111111110 00000
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERIN------VKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt------~~evl~~ 957 (973)
..+..++.++.+++.+|++.||++||+ ++|+++|
T Consensus 223 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 ------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 011124556889999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.59 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=202.4
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|+..+.||+|+||.||+|.. ..+..||+|.+.... ......+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567778999999999999984 356789999986433 3344678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC
Q 048430 754 IMQYMPQGSLEKWLYSHN----------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM 817 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 817 (973)
||||+++++|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999986321 24788899999999999999999 78999999999999999999
Q ss_pred cEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHH
Q 048430 818 VAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 818 ~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 895 (973)
.+||+|||+++....... .......++..|+|||+..+..++.++|||||||++|||++ |..||..... ..+...+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999976533221 12233345778999999888889999999999999999998 8888864221 1111211
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
.... . ...+..++.++.+++.+||+.+|++||++.++.++|.+
T Consensus 240 ~~~~---~-------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQ---L-------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC---c-------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1100 0 00112345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=340.18 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=204.8
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC--
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG-- 749 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 749 (973)
.....++|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++..++|+|++++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557899999999999999999984 579999999986542 344567889999999999999999988764332
Q ss_pred ------eeEEEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 750 ------FKALIMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 750 ------~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence 3679999999999999987532 46899999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 821 LGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 821 l~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
|+|||+++....... .......||+.|+|||.+....++.++|||||||++|||++|+.||... .....+....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHh
Confidence 999999986543221 1223456999999999999889999999999999999999999998642 1122222111
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+... ..+..+++++.+++.+||+.+|++||++.+++++
T Consensus 259 ~~~~~-------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYD-------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCC-------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11000 0112345678999999999999999999999876
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=329.64 Aligned_cols=242 Identities=24% Similarity=0.252 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 58899999987542 23345677888888866 799999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 99999987665 6899999999999999999999 8999999999999999999999999999987543222 22234
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..|++.|+|||.+....++.++|||||||++|||++|+.||..... .........+. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~~~--------~--------- 213 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILHDD--------V--------- 213 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------C---------
Confidence 5689999999999888899999999999999999999999965321 11111111100 0
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERI-------NVKDALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-------t~~evl~~ 957 (973)
..+..++.++.+++.+|++.||++|| +++++++|
T Consensus 214 ---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 ---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00112345688999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.02 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=202.3
Q ss_pred HhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
+.++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467888899999999999999864 46789999876443 3334678999999999999999999999998889
Q ss_pred eEEEEEecCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC---cEEE
Q 048430 751 KALIMQYMPQGSLEKWLYSHN------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---VAHL 821 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl 821 (973)
.++||||+++++|.+++...+ ..+++.++..++.||+.|++||| +.+++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997653 25899999999999999999999 78999999999999998754 6999
Q ss_pred eecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhC
Q 048430 822 GDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 822 ~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++......... ......+..|+|||+..+..++.++|||||||++|||++ |+.||......+ ....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence 9999998663322211 112234578999999988889999999999999999997 999986532211 111111000
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
. ...+..++..+.+++.+|++.+|++||++.+|+++|.
T Consensus 239 ~----------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 R----------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred c----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0011224567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=318.33 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=200.9
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.|+..++||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367788999999999999985 468999999986432 2223567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|+++|+|.+++.... ..+++..+..++.|++.|+.||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999886543 46899999999999999999999 7899999999999999999999999999988653221
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......|+..|+|||.+.+..++.++||||+||++|||++|+.||...... ......... +....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~---------~~~~~---- 221 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERR---------VKEDQ---- 221 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHH---------hhhcc----
Confidence 122346899999999998888999999999999999999999999652211 111111100 00000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
...+..++..+.+++.+||+.||++|| +++++++|
T Consensus 222 -------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001122456688999999999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=314.41 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=207.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999994 578999999876432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||+++++|.+++.. ....+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864 2246899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
... ......++..|+|||...+..++.++||||||+++|||++|..||...... ...+....... ..+..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-----~~~~~- 228 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQC-----DYPPL- 228 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhhcC-----CCCCC-
Confidence 221 222346888999999998888999999999999999999999998542211 11111110000 00000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
.+..+++++.+++.+||+.+|++|||+.+|++.++++.
T Consensus 229 ------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 ------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11235667999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=324.47 Aligned_cols=247 Identities=23% Similarity=0.249 Sum_probs=197.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccC-CceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH-RNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 755 (973)
+|...+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999854 57899999987542 2345678889999999976 56888999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999997765 6899999999999999999999 8999999999999999999999999999987432111
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .....+. .. ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~---~~--------~~---- 218 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIM---EH--------NV---- 218 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH---cC--------CC----
Confidence 1223456899999999999888999999999999999999999999653211 1111110 00 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINV-----KDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~-----~evl~~ 957 (973)
..+...+.++.+++.+|++.+|++|++. +++.+|
T Consensus 219 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 --------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0011234568899999999999999976 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=313.30 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=203.7
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++.+++.+.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344566677778999999999999984 4678899999876665566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeeccccccc
Q 048430 754 IMQYMPQGSLEKWLYSHNYSL--TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLL 830 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~ 830 (973)
|+||+++++|.+++......+ ++..+..++.|++.|++||| ..+|+||||||+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998754445 88889999999999999999 899999999999999976 679999999998765
Q ss_pred CCCCCcccccccccccccCccCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEG--IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
..... ......++..|+|||+.... .++.++|||||||++|||++|+.||........ ..+.....
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~--------- 227 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMF--------- 227 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhh---------
Confidence 43222 12233578999999987654 378999999999999999999999864321111 01100000
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ...+..+.+++.+++.+||+.+|++||++.|+++|
T Consensus 228 ----~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ----KIH-------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----ccC-------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000 00112345668899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=315.08 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=193.0
Q ss_pred ccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 688 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
||+|+||.||+++. .+|+.||+|.+.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 468999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccccc
Q 048430 764 EKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL 842 (973)
Q Consensus 764 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 842 (973)
.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 98886543 45889999999999999999999 899999999999999999999999999998765432 1223346
Q ss_pred ccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhh
Q 048430 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADD 922 (973)
Q Consensus 843 ~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 922 (973)
++..|+|||+..+..++.++||||+||++|||++|+.||...... ............. ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~--------~~~~--------- 217 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLED--------EVKF--------- 217 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhcc--------cccc---------
Confidence 899999999988888999999999999999999999998643211 1111111111100 0000
Q ss_pred HHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 923 FATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 923 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++.++.+++.+||+.||++||+++|++++
T Consensus 218 --~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 218 --EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred --ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 001245668999999999999999999665533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.22 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=197.2
Q ss_pred cccccCceEEEEEEe---CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 687 LLGSGSFDNVYKATL---ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 367899999986443 234567899999999999999999999886 45678999999999
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc--cc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT--QT 839 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~ 839 (973)
+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997654 6899999999999999999999 8999999999999999999999999999998764332211 12
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...++..|+|||......++.++|||||||++|||++ |+.||...... .....+. .+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~---~~~~--------------- 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIE---SGER--------------- 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---CCCC---------------
Confidence 2234678999999888889999999999999999998 99998653221 1111111 1000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
...+..++.++.+++.+||+.||++||++++|.+.|+.+
T Consensus 217 ----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 ----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 001123566789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=332.01 Aligned_cols=271 Identities=22% Similarity=0.266 Sum_probs=200.7
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCC-----eeE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG-----FKA 752 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 752 (973)
+|...++||+|+||.||+|.. .+++.||||.+... .....+.+.+|+++++.++||||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477789999999999999985 57899999988543 2234567889999999999999999999997766 789
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+|+||+. ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 58888886654 7899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc----
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV---- 907 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 907 (973)
..........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.............+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhH
Confidence 33333334568899999998766 457899999999999999999999996532211 111111110000000000
Q ss_pred --ccccCCC-Cc-hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 --DANLLSR-ED-EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 --d~~l~~~-~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+... .. .............++++.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 00 00000001111235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.85 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=206.4
Q ss_pred cCCCCCccccccCceEEEEEEeCC-CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
++|...++||+|+||.||+|+..+ ++.||+|.+..... .+.+.+|++++++++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999764 78999999865533 578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++......+++..+..++.|+++|+.||| ..+++||||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 999999999876668999999999999999999999 78999999999999999999999999999887643221 22
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
....++..|+|||...+..++.++|||||||++|||++|+.||....... ..... .. ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~~~-~~---------~~------- 215 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIFMI-PN---------KP------- 215 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhhhh-cc---------CC-------
Confidence 33457889999999888889999999999999999999999986532211 00000 00 00
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......+..++..+.+++.+||+.+|++||++.|++++
T Consensus 216 -~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 216 -PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00011122345678999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=331.02 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=204.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPG 749 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 749 (973)
..++|...+.||+|+||.||+|++. .+..||||+++... ....+.+.+|++++.++. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3445667899999999999999853 34689999997543 233457889999999997 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---------------------------------------------------------- 771 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 771 (973)
..++||||+++|+|.++++..+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999996532
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEE
Q 048430 772 ---------------------------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812 (973)
Q Consensus 772 ---------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 812 (973)
..+++..+..++.|+++||+||| +.+|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence 23677788999999999999999 899999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCccc
Q 048430 813 LDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMS 890 (973)
Q Consensus 813 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~ 890 (973)
+++++.+|++|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986532211 11223357789999999888889999999999999999998 8888864321111
Q ss_pred HHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
....+ ..+ .. ...+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus 351 ~~~~~---~~~---------~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAI---KRG---------YR----------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHH---HcC---------CC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11100 000 00 0011234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.36 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=200.9
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
....++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334568999999999999999999964 68899999986432 22345678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999999765 4889999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEG----IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...........||+.|+|||.+... .++.++||||+||++|||++|+.||..... ...... +.
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~--------i~ 260 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSK--------IM 260 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHH--------HH
Confidence 3333233455799999999977543 378899999999999999999999964221 111111 11
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE--RINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~evl~~ 957 (973)
+....- ..+.....+..+.+++.+|++.+|.+ |++++|+++|
T Consensus 261 ~~~~~~--------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNSL--------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCccc--------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 100000 00001123456788999999865544 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.88 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=209.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999965 7999999988643 2334578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||+++++|.+++... ...+++.++..++.|+++|++||| +.+|+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 345899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. .......++..|+|||...+..++.++|||||||++|||++|+.||.... ............+....
T Consensus 159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~------- 227 (267)
T cd08224 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYPP------- 227 (267)
T ss_pred CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCCC-------
Confidence 22 12233458889999999888889999999999999999999999985421 22222211111100000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
.....++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 228 -----------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 -----------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001234567899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.60 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=204.2
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|...++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356788899999999999999988899999999865432 3467899999999999999999999874 45689999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 9999999987543 46899999999999999999999 8999999999999999999999999999987654322222
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....++..|+|||......++.++|||||||++||+++ |+.||...... .....+... ..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~------------~~---- 221 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERG------------YR---- 221 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcC------------CC----
Confidence 233346778999999988889999999999999999999 99998643211 111111100 00
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...+..++.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00111235668999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.40 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=203.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-----hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++|...+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 5689999998864421 234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+||+++++|.+++.... .+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999998764 6889999999999999999999 899999999999999999999999999998765432
Q ss_pred CCccc--ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPVTQ--TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
..... ....++..|+|||...+..++.++||||+||++|||++|+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~--------- 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPT--------- 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHHhccCC---------
Confidence 22111 234578899999999888899999999999999999999999864211 111111000000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ...+..++..+.+++.+||..+|++||++.|++++
T Consensus 225 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 N----------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C----------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 00112345668899999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.30 Aligned_cols=194 Identities=25% Similarity=0.359 Sum_probs=169.4
Q ss_pred CCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-C-----CceeEEEeeeecCCeeEE
Q 048430 681 GFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-H-----RNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 753 (973)
+|.+.+.||+|.||.|.+|. .++++.||||+++.... ...+...|+.+|+.++ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78889999999999999998 56799999999975543 3356678999999996 4 389999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC--CcEEEeeccccccc
Q 048430 754 IMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD--MVAHLGDFGIAKLL 830 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~~ 830 (973)
|+|.+.. +|+++++.+. ..++...++.|+.||+.||.+|| +.+|||+||||+|||+.+. ..+||+|||.|+..
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999955 9999999876 56899999999999999999999 8999999999999999654 47999999999875
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~ 883 (973)
... .. .++-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 342 ~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 432 22 45678899999999999999999999999999999999766543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.24 Aligned_cols=253 Identities=26% Similarity=0.469 Sum_probs=203.2
Q ss_pred cCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|...++||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 3566678999999999999963 2467899998876655666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 754 IMQYMPQGSLEKWLYSHN--------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
||||+++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999997653 24789999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHh
Q 048430 820 HLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 897 (973)
||+|||++......... ......+++.|+|||......++.++|||||||++|||++ |+.||......+ ....+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECIT- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHH-
Confidence 99999998765322211 1222345788999999988889999999999999999998 888875432211 111000
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.+. . ...+..++..+.+++.+||+.||++||+++|+++.|+
T Consensus 239 --~~~--------~-----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 --QGR--------E-----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --cCc--------c-----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 0 0011134566889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=314.60 Aligned_cols=255 Identities=24% Similarity=0.432 Sum_probs=204.7
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.+|...+.||+|+||.||+|+.. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777899999999999999853 34479999886543 33456889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876667899999999999999999999 8999999999999999999999999999998764322
Q ss_pred Ccccc--cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 835 PVTQT--MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 835 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
..... ...++..|+|||+.....++.++|||||||++||+++ |+.||...... .....+....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~------------ 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY------------ 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC------------
Confidence 22111 1223568999999988889999999999999999887 99998653211 1111111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..+.+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0001122456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=321.15 Aligned_cols=272 Identities=17% Similarity=0.232 Sum_probs=203.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999854 68889999987543 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 975 899988876667899999999999999999999 8999999999999999999999999999987643222 12
Q ss_pred cccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccc-hhhhccccc-C
Q 048430 838 QTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGA-VTEVVDANL-L 912 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~~d~~l-~ 912 (973)
.....+++.|+|||...+ ..++.++|||||||++|||++|+.||......+ .......... ... +..+..... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 233457899999997654 568999999999999999999999986532211 1111111110 000 101000000 0
Q ss_pred C--CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 S--REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ...............++.++.+++.+|++.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0 00000000011112356678999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.86 Aligned_cols=242 Identities=25% Similarity=0.303 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999987542 23345667788888764 899999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 99999998654 6899999999999999999999 8999999999999999999999999999987532211 12234
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...+.+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~---------~~~---------- 214 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD---------NPC---------- 214 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CCC----------
Confidence 56899999999998888999999999999999999999998653211 111111100 000
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVK-DALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-evl~~ 957 (973)
.+..+..++.+++.+||+.+|++||++. ++.+|
T Consensus 215 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 215 ----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 0112345678999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=320.96 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=209.6
Q ss_pred HhcCCCCCccccccCceEEEEEEe--------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeec
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL--------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSN 747 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 747 (973)
..++|...+.||+|+||.||+|+. .++..||+|.++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 345677889999999999999973 134579999886442 34457789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEE
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 812 (973)
....++||||+++|+|.+++.... ..+++.++..++.||++||.||| +.+|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 999999999999999999997642 24788899999999999999999 899999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCccc
Q 048430 813 LDDDMVAHLGDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMS 890 (973)
Q Consensus 813 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~ 890 (973)
++.++.+||+|||.++......... .....++..|+|||...+..++.++|||||||++||+++ |..||....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----- 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----
Confidence 9999999999999998764332221 222345678999999888889999999999999999998 777775421
Q ss_pred HHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
...+......+. . ...+..++..+.+++.+||+.+|++||++.|+++.|+++...-+++
T Consensus 245 ~~~~~~~~~~~~---------~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~~ 303 (304)
T cd05101 245 VEELFKLLKEGH---------R----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303 (304)
T ss_pred HHHHHHHHHcCC---------c----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhcC
Confidence 122221111000 0 0011235677899999999999999999999999999988765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=316.17 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=204.6
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCe----EEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGV----SVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
.++|...++||+|+||+||+|++ .+++ .||+|+++... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 35677889999999999999984 3444 58999886543 33456788999999999999999999999754 567
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+++||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876667999999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 833 VDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 833 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.... ......++..|+|||......++.++|||||||++|||++ |..||+.... ..+..++.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~---------- 229 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGER---------- 229 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc----------
Confidence 2221 1122235678999999888889999999999999999998 8888864321 112222211000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
...+..++.++.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 230 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 ------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 000112456688999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=313.18 Aligned_cols=239 Identities=21% Similarity=0.357 Sum_probs=190.3
Q ss_pred ccccccCceEEEEEEeCC-------------CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 686 NLLGSGSFDNVYKATLAN-------------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
+.||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc-------EEEeecc
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV-------AHLGDFG 825 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Dfg 825 (973)
+||||+++|+|..++......+++..+..++.||++||+||| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998876667999999999999999999999 899999999999999987664 8999999
Q ss_pred cccccCCCCCcccccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHH-hCCCCCCccccCcccHHHHHHhhCCcch
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETF-TRRKPTNEMFTGEMSLKQWVAESLPGAV 903 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
++..... .....++..|+|||... ...++.++|||||||++|||+ +|+.||......+ ......
T Consensus 158 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~------- 223 (262)
T cd05077 158 IPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYE------- 223 (262)
T ss_pred CCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHh-------
Confidence 9875432 12345788899999876 467899999999999999998 5777765421110 000000
Q ss_pred hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
..... ......++.+++.+||+.||++||++.++++++
T Consensus 224 -----~~~~~------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -----GQCML------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----cCccC------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000 001235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=314.42 Aligned_cols=255 Identities=25% Similarity=0.438 Sum_probs=204.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CC---eEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NG---VSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++|+..+.||+|+||.||+|... ++ ..+|+|.++... ....+.+..|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999864 23 379999886542 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999876567899999999999999999999 8899999999999999999999999999987654322
Q ss_pred Ccccc--cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 835 PVTQT--MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 835 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
..... ....+..|+|||+.....++.++|||||||++||+++ |+.||..... ..+........
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~~~~--------- 227 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGF--------- 227 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHhcCC---------
Confidence 21111 1223567999999888889999999999999999998 9999854321 11111111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..+.+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=344.81 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=203.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...++||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999854 68999999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhC----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 756 QYMPQGSLEKWLYSH----------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 756 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
||+++|+|.+++... ....++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642 124567788999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCC-----------------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc
Q 048430 826 IAKLLDGVDP-----------------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888 (973)
Q Consensus 826 la~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~ 888 (973)
+++....... ......+||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 00112468999999999998899999999999999999999999986522111
Q ss_pred ccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-NVKDALADLKKIKK 963 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~evl~~L~~~~~ 963 (973)
... .... .++ ........++..+.+++.+|++.||++|| +++++.+.|+.+.+
T Consensus 239 i~~----~~~i-------~~P-----------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISY----RDVI-------LSP-----------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh----hhhc-------cCh-----------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 100 0000 000 00001123456688999999999999997 56677777777654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.96 Aligned_cols=242 Identities=24% Similarity=0.273 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|... +++.||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 58899999997542 23345677888998887 699999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|..++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 99999988764 6999999999999999999999 8999999999999999999999999999987532111 12233
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .......... ..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~--------~~--------- 213 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILED--------EV--------- 213 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcC--------CC---------
Confidence 4689999999999988999999999999999999999999864221 1111111000 00
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINV-----KDALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~-----~evl~~ 957 (973)
..+..++.++.+++.+||+.||++||++ .+++++
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 ---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0011235668899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=336.20 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=196.2
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.|...++||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999985 568899999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC--
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD-- 834 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-- 834 (973)
|+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997764 6889999999999999999999 8999999999999999999999999999975321000
Q ss_pred --------------------------------------------CcccccccccccccCccCCCCCCCCcchhHHHHHHH
Q 048430 835 --------------------------------------------PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGIL 870 (973)
Q Consensus 835 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvv 870 (973)
.......+||+.|+|||.+.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112468999999999988889999999999999
Q ss_pred HHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC
Q 048430 871 MMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN 950 (973)
Q Consensus 871 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 950 (973)
+|||++|+.||......+ ....... .. .... .+.....+++..+++.+|+ .+|++|++
T Consensus 238 l~elltG~~Pf~~~~~~~-~~~~i~~--~~--------~~~~----------~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLE-TQMKVIN--WQ--------TSLH----------IPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHhCCCCCCCCCHHH-HHHHHHc--cC--------CCcC----------CCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 999999999996532111 0000000 00 0000 0001123455677777765 49999997
Q ss_pred ---HHHHHHH
Q 048430 951 ---VKDALAD 957 (973)
Q Consensus 951 ---~~evl~~ 957 (973)
++|+++|
T Consensus 296 ~~~~~ei~~h 305 (382)
T cd05625 296 KNGADEIKAH 305 (382)
T ss_pred CCCHHHHhcC
Confidence 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=322.23 Aligned_cols=242 Identities=22% Similarity=0.259 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999864 68899999987542 23345667788888764 899999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.+++.... .+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 99999987754 6899999999999999999999 899999999999999999999999999998743211 122334
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .......... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~------~~~---------- 214 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVD------TPH---------- 214 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC------CCC----------
Confidence 5689999999999988999999999999999999999999864221 1111111000 000
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVK-DALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-evl~~ 957 (973)
.+..++.++.+++.+|++.||++||++. ++.+|
T Consensus 215 ----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 215 ----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred ----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0111345688999999999999999985 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.50 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=204.1
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|++|.||+|.. .+++.||+|.+... .....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467788999999999999986 46899999998654 234467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++... ...+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999875 357899999999999999999999 79999999999999999999999999999886643222
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......+++.|+|||+..+..++.++|||||||++|||++|+.||...... ........+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~------------ 219 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILKIIRGVFP------------ 219 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCCCC------------
Confidence 223346888999999998888999999999999999999999998653211 111110000000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++..+.+++.+||+.+|++||++.|++++
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011345668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=323.29 Aligned_cols=254 Identities=21% Similarity=0.250 Sum_probs=199.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999985 468999999987432 233466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999875557899999999999999999999 89999999999999999999999999999876543333
Q ss_pred cccccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC-cchhhhccc
Q 048430 836 VTQTMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP-GAVTEVVDA 909 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~ 909 (973)
.......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.... ..+....... ......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~--- 229 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKEHFQF--- 229 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCCcccC---
Confidence 23333568999999998752 457889999999999999999999986421 1111111100 000000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCC--CCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIP--EERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P--~~Rpt~~evl~~ 957 (973)
. .....++.++.+++.+|+..++ ..||+++++++|
T Consensus 230 -----~--------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 -----P--------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----C--------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0001245667888888775533 348899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.81 Aligned_cols=268 Identities=24% Similarity=0.406 Sum_probs=203.2
Q ss_pred CCCCCccccccCceEEEEEEe-----CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKA 752 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 752 (973)
-|...+.||+|+||.||.++. .++..||+|.++... ....+.+.+|+.++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356788999999999999973 357889999986543 33456799999999999999999999998764 5688
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999776556899999999999999999999 89999999999999999999999999999886543
Q ss_pred CCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Ccchhhhccc
Q 048430 833 VDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PGAVTEVVDA 909 (973)
Q Consensus 833 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~ 909 (973)
.... ......++..|+|||...+..++.++|||||||++|||++++.|+....... ........ .......++
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhcccccccccHHHHHH-
Confidence 2211 1123346778999999888889999999999999999999887643211100 00000000 000000000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
.+.. ....+.+..++..+.+++.+|++.+|++||+++++++.++++
T Consensus 238 ~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEE------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHc------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 000111123567799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=314.74 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=201.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566678999999999999985 568999999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++...+ .+++.++..++.|++.|+.||| ..+++|+||||+||+++.++.+||+|||++...... ....
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~ 163 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKR 163 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccc
Confidence 9999999987665 7899999999999999999999 789999999999999999999999999998765422 2222
Q ss_pred ccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 839 TMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
....|+..|+|||.+. ...++.++|||||||++|||++|+.||....+... ...... .. ...+..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~----~~---~~~~~~---- 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTK----SN---FQPPKL---- 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhc----cC---CCCCcc----
Confidence 3456899999999764 45688999999999999999999999854322111 000000 00 000000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....++..+.+++.+|++.+|++||+++++++|
T Consensus 232 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 --------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0001234568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.05 Aligned_cols=253 Identities=25% Similarity=0.451 Sum_probs=200.1
Q ss_pred CCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe-----
Q 048430 682 FGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF----- 750 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 750 (973)
|...+.||+|+||.||+|... .+..||+|.++... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999854 24779999987542 2345678999999999999999999998865543
Q ss_pred -eEEEEEecCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 751 -KALIMQYMPQGSLEKWLYSHN-----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 751 -~~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
.++|+||+++|+|..++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 36899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcc
Q 048430 825 GIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 825 gla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|+++......... .....++..|+|||......++.++|||||||++|||++ |..||...... ....++. .+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~---~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLR---HGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---cCC
Confidence 9998664332221 122335678999999988889999999999999999999 88887543211 1111111 000
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
. ...+..++.++.+++.+||+.||++||++.|++++|+++
T Consensus 233 --------~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 --------R-----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------C-----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 001123566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.64 Aligned_cols=369 Identities=27% Similarity=0.388 Sum_probs=256.0
Q ss_pred CccEEEeeCcccC-CCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCC
Q 048430 119 QLESFDVSSNKIT-GEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHN 197 (973)
Q Consensus 119 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~ 197 (973)
-.+-.|+|+|.++ +.+|.....+++++.|.|+..++. .+|.++ +.+.+|++|.+++|++. .+..+++.|+.
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL-~~lqkLEHLs~~HN~L~------~vhGELs~Lp~ 79 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEEL-SRLQKLEHLSMAHNQLI------SVHGELSDLPR 79 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHH-HHHhhhhhhhhhhhhhH------hhhhhhccchh
Confidence 3444555666665 356666666666666666666665 555554 34555666666666654 33445556666
Q ss_pred ccEEEecCCcccC-ccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEecc
Q 048430 198 LKILDLGGNNIAG-LIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSS 276 (973)
Q Consensus 198 L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 276 (973)
|+.+++.+|++.. -+|..++ .+..|+.||||+|++. ..|..+...+++-+|+||+
T Consensus 80 LRsv~~R~N~LKnsGiP~diF-----------------------~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~ 135 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIF-----------------------RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSY 135 (1255)
T ss_pred hHHHhhhccccccCCCCchhc-----------------------ccccceeeecchhhhh-hcchhhhhhcCcEEEEccc
Confidence 6666666666642 2233333 3666667777777776 5666777777777777777
Q ss_pred ccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeeccc
Q 048430 277 NLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGS 356 (973)
Q Consensus 277 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~ 356 (973)
|+|..++-..|-+++.|-.|+||+|++...|+
T Consensus 136 N~IetIPn~lfinLtDLLfLDLS~NrLe~LPP------------------------------------------------ 167 (1255)
T KOG0444|consen 136 NNIETIPNSLFINLTDLLFLDLSNNRLEMLPP------------------------------------------------ 167 (1255)
T ss_pred CccccCCchHHHhhHhHhhhccccchhhhcCH------------------------------------------------
Confidence 77776666666677777777777777654332
Q ss_pred CCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCC-CCCchhhhccCcCCeeecCCccccCcC
Q 048430 357 SQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLK-GFIPTDLCKLEKLNTLLSNNNALQGQI 435 (973)
Q Consensus 357 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~ 435 (973)
.+..+..|+.|.|++|.+...--..+..+++|+.|.+++.+-+ .-+|..+..+.+|..++++.|.+. ..
T Consensus 168 ---------Q~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 168 ---------QIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred ---------HHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 2233344444444444444332233444555555666554432 235666666666777777777666 66
Q ss_pred cccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCc-ccCCcccccC
Q 048430 436 PTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS-GYIPSSIGNL 514 (973)
Q Consensus 436 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l 514 (973)
|+++.++.+|+.|+||+|+|+ .+........+|++|+||.|+++ .+|.++..++.|+.|++.+|+++ .-+|+.++.+
T Consensus 238 Pecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred hHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 777777777777777777776 34555666778888888888888 89999999999999999999987 3489999999
Q ss_pred CcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCC
Q 048430 515 KNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 515 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
.+|+.+..++|++. ..|+.+..+..|+.|.|++|++. ..|+.+.-++.|+.|||..|+=--.+|.
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 99999999999998 99999999999999999999998 7899999999999999999975555554
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.26 Aligned_cols=252 Identities=26% Similarity=0.432 Sum_probs=201.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|++|.||+|....+..||+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577788999999999999998777789999876433 23467889999999999999999999875 456789999999
Q ss_pred CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 760 QGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 760 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
+++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999997643 45889999999999999999999 78999999999999999999999999999976543222222
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....++..|+|||...+..++.++|||||||++|||++ |+.||......+ ...++.....
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~----------------- 221 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR----------------- 221 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-----------------
Confidence 23346778999999988889999999999999999999 888886532211 1111110000
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -----MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.85 Aligned_cols=259 Identities=27% Similarity=0.477 Sum_probs=205.5
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
...++|...+.||+|+||.||+|... ....||+|.+.... ......+.+|+.+++++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34456888899999999999999853 34689999887543 33456788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 749 GFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+..++||||+++|+|.+++... ...+++..++.++.|++.|++||| +.+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 9999999999999999999642 246889999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
+.++.+|++|||.++......... .....++..|+|||......++.++|||||||++||+++ |..||...... ..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HH
Confidence 999999999999998664322211 122235678999999888889999999999999999998 88887542211 11
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
..... .... ...+..++..+.+++.+||+.+|++|||++|++++|+.+.
T Consensus 244 ~~~~~------------~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLK------------EGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHH------------cCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11110 0000 0011123566889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=335.39 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=198.1
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...++||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 578999999986532 233567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999998754 6899999999999999999999 89999999999999999999999999999863311000
Q ss_pred c----------------------------------------------ccccccccccccCccCCCCCCCCcchhHHHHHH
Q 048430 836 V----------------------------------------------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGI 869 (973)
Q Consensus 836 ~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gv 869 (973)
. .....+||+.|+|||.+....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246899999999998888999999999999
Q ss_pred HHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCC-
Q 048430 870 LMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER- 948 (973)
Q Consensus 870 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R- 948 (973)
++|||++|+.||...... ..+..... .... +. ++....++.++.+++.+|+. +|.+|
T Consensus 237 il~elltG~~Pf~~~~~~-~~~~~i~~--~~~~--------~~----------~p~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-ETYRKIIN--WRET--------LY----------FPDDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-HHHHHHHc--cCCc--------cC----------CCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999998643211 11111000 0000 00 00001234568889999997 67765
Q ss_pred --CCHHHHHHH
Q 048430 949 --INVKDALAD 957 (973)
Q Consensus 949 --pt~~evl~~ 957 (973)
+++.|+++|
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=317.99 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=204.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999985 578999999987665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++... .+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~ 173 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-ccc
Confidence 999999998754 5889999999999999999999 8999999999999999999999999999987654322 122
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
....+++.|+|||......++.++|||||||++|||++|+.||..... ...+......+ . +..
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~~~~~-~-----~~~------- 236 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNG-T-----PEL------- 236 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHHhcCC-C-----CCC-------
Confidence 334688999999998888899999999999999999999999864322 11111100000 0 000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+...+..+.+++.+||..+|++||++.|++++
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0012234568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.65 Aligned_cols=261 Identities=27% Similarity=0.464 Sum_probs=206.9
Q ss_pred hcCCCCCccccccCceEEEEEEeC--------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
.++|...+.||+|+||.||+|+.. ++..||+|.++... ......+.+|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356888999999999999999742 23579999987543 33456788899999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 99999999999999999997642 24888999999999999999999 7999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
+.++.+||+|||.+.......... .....++..|+|||...+..++.++|||||||++|||++ |..||.... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----H
Confidence 999999999999987653222111 112234568999999888889999999999999999998 888875421 1
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
........... ....+..++.++.+++.+||..+|++||++.|+++.|+++.+...
T Consensus 249 ~~~~~~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 EELFKLLKEGH-------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHHHcCC-------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111111000 001112345678899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=322.71 Aligned_cols=247 Identities=24% Similarity=0.255 Sum_probs=197.2
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 755 (973)
+|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999854 67899999987542 22344567788888777 5899999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-G 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-C
Confidence 9999999999987664 6899999999999999999999 899999999999999999999999999998754321 1
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......||+.|+|||.+....++.++|||||||++|||++|+.||..... ......+.. .. .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~---~~--------~---- 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIME---HN--------V---- 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHHHh---CC--------C----
Confidence 222345689999999999999999999999999999999999999965321 111111110 00 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINV-----KDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~-----~evl~~ 957 (973)
..+...+.++.+++.+|++.+|++|++. .++.+|
T Consensus 219 --------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0111235568899999999999999984 566554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=317.12 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=203.6
Q ss_pred CCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
+|...+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667889999999999999842 235789998865432 345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 048430 754 IMQYMPQGSLEKWLYSHN-----------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNN 810 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 810 (973)
|+||+.+++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999986421 24788999999999999999999 8999999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCc
Q 048430 811 VLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGE 888 (973)
Q Consensus 811 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~ 888 (973)
|++++++.+||+|||+++........ ......++..|+|||...+..++.++||||||+++|||++ |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999765332222 1222345778999999888889999999999999999998 99888543211
Q ss_pred ccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.+..++. ..... ..+..++.++.+++.+||+.+|++||+++|+++.|+++..
T Consensus 237 -~~~~~~~------------~~~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 -RLFNLLK------------TGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHh------------CCCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111111 10000 0112345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.97 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=205.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG 749 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 749 (973)
..++|...+.||+|+||.||+|.. ..+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345688889999999999999973 235679999886543 33456789999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
..++||||+.+|+|.++++... ..+++.++..++.|++.|++||| +.+|+|+||||+||+++.++.+|++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997644 34899999999999999999999 8899999999999999999999999999988
Q ss_pred ccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 829 LLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 829 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... .......++..|+|||......++.++|||||||++|||++ |+.||......+ .....+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~--------- 259 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKE--------- 259 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHc---------
Confidence 6543221 11222346778999999988889999999999999999998 999986532211 11111110
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
.... ..+...+.++.+++.+|+..+|++||++.|+++.|++.
T Consensus 260 ---~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 ---GYRM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---CCcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000 00011245688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=313.35 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=206.3
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..++|...++||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3467888999999999999999988888999999875432 346789999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... ..+++.++..++.|++.|+.||| +.+++|+||||+||+++.++.+|++|||.+.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999998754 46899999999999999999999 789999999999999999999999999998765432222
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......+..|+|||...+..++.++|||||||++||+++ |+.||...... ..+.. +.. + ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~-~~~---~---------~~--- 222 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQ-VER---G---------YR--- 222 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-HHc---C---------CC---
Confidence 2222335678999999988889999999999999999998 99998543211 11111 000 0 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...+..++.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus 223 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.74 Aligned_cols=239 Identities=21% Similarity=0.338 Sum_probs=189.0
Q ss_pred cccccCceEEEEEEeC-------------------------CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEE
Q 048430 687 LLGSGSFDNVYKATLA-------------------------NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 741 (973)
+||+|+||.||+|... ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999742 124588998866555455678899999999999999999
Q ss_pred EeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC----
Q 048430 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---- 817 (973)
Q Consensus 742 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---- 817 (973)
+++|.+....++||||+++|+|..++......+++..+..++.|+++||+||| +++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999876667899999999999999999999 89999999999999997644
Q ss_pred ---cEEEeecccccccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHH-hCCCCCCccccCcccHH
Q 048430 818 ---VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETF-TRRKPTNEMFTGEMSLK 892 (973)
Q Consensus 818 ---~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~ell-tg~~p~~~~~~~~~~~~ 892 (973)
.+|++|||.+...... ....++..|+|||.+.. ..++.++|||||||++||++ +|+.||......+ ..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~ 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KE 231 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HH
Confidence 4899999987643211 22357788999997765 56899999999999999985 6888886532211 11
Q ss_pred HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.+.... .. .+.....++.+++.+||+.+|++||++++++++|.
T Consensus 232 ~~~~~~------------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 RFYEKK------------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHhc------------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111100 00 00011245888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=315.91 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=208.1
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-----CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeec-CCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLAN-----GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 751 (973)
.++|...+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999765 7889999886442 3445778899999999999999999998765 5778
Q ss_pred EEEEEecCCCCHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 752 ALIMQYMPQGSLEKWLYSHN-------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
++++||+++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999997642 35899999999999999999999 799999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcc
Q 048430 825 GIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 825 gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|+++.+...... ......++..|+|||......++.++|||||||++||+++ |+.||..... ..+..++....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~--- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGY--- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCC---
Confidence 999865432221 1122345778999999888889999999999999999999 9999865321 11222211100
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
. ...+..+++++.+++.+||+.+|++||++.|+++.|+.+.++
T Consensus 237 ---------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 ---------R----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---------C----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0 001112456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.56 Aligned_cols=252 Identities=19% Similarity=0.252 Sum_probs=197.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999985 468999999986432 223466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC-
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD- 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 834 (973)
||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|.......
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999998765 6888999999999999999999 8999999999999999999999999999975321000
Q ss_pred -----------------------------------------CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHH
Q 048430 835 -----------------------------------------PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMME 873 (973)
Q Consensus 835 -----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~e 873 (973)
.......+||+.|+|||.+.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999998889999999999999999
Q ss_pred HHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC---C
Q 048430 874 TFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI---N 950 (973)
Q Consensus 874 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp---t 950 (973)
|++|+.||......+ ......... .... ......++.++.+++.+|+ .+|++|+ +
T Consensus 237 ll~G~~Pf~~~~~~~-----~~~~i~~~~------~~~~----------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 237 MLVGQPPFLADTPAE-----TQLKVINWE------TTLH----------IPSQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred hhhCCCCCCCCCHHH-----HHHHHhccC------cccc----------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 999999996532211 111000000 0000 0000123455777888876 4999999 8
Q ss_pred HHHHHHH
Q 048430 951 VKDALAD 957 (973)
Q Consensus 951 ~~evl~~ 957 (973)
+.|+++|
T Consensus 295 ~~ell~h 301 (376)
T cd05598 295 ADEIKAH 301 (376)
T ss_pred HHHHhCC
Confidence 9999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.45 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=196.4
Q ss_pred CCCccccccCceEEEEEEeCC-C--eEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------Cee
Q 048430 683 GESNLLGSGSFDNVYKATLAN-G--VSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------GFK 751 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 751 (973)
...+.||+|+||.||+|+... + ..||+|.++.. .....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998653 3 36899988654 234467889999999999999999999987432 356
Q ss_pred EEEEEecCCCCHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccc
Q 048430 752 ALIMQYMPQGSLEKWLYSH-----NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGI 826 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 826 (973)
++||||+++|+|.+++... ...+++..+..++.|++.|++||| .++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999987532 235889999999999999999999 79999999999999999999999999999
Q ss_pred ccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 827 AKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 827 a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++......... .....+++.|+|||......++.++|||||||++|||++ |+.||...... ........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~~~~- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----EIYDYLRQGNR- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHcCCC-
Confidence 98764322211 122346778999999988889999999999999999999 78888542211 11111111100
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
. ..+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 233 ------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 ------L------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------C------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00112455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=316.22 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=200.6
Q ss_pred CCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
|...+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999964 5788999998766555667889999999999999999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
++|..++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+|++|||++....... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence 9999988765557999999999999999999999 7999999999999999999999999999987653221 22233
Q ss_pred ccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 841 TLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 841 ~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
..++..|+|||.+. ...++.++|||||||++|||++|+.||......+ .... ..... .+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~-~~~~~-----~~------ 226 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR----VLLK-IAKSE-----PP------ 226 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH----HHHH-HhhcC-----CC------
Confidence 46889999999863 3457889999999999999999999986532111 1111 00000 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 ------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112245678899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=314.25 Aligned_cols=254 Identities=22% Similarity=0.430 Sum_probs=203.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CC---eEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NG---VSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
+|...+.||+|+||.||+|... ++ ..||||.++.. .....+.|..|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667889999999999999864 23 46999998654 3344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999876667899999999999999999999 79999999999999999999999999999876543221
Q ss_pred c-ccccc---cccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 836 V-TQTMT---LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 836 ~-~~~~~---~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
. ..... ..+..|+|||+.....++.++|||||||++||+++ |..||...... ....++....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~----------- 228 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY----------- 228 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence 1 11111 12457999999988899999999999999999886 99998643211 1122211100
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
....+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 229 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011123456788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=319.76 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=202.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCe--EEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGV--SVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|... ++. .+|+|.++... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777899999999999999864 444 45777765432 33456788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 755 MQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
|||+++++|.+++.... ..+++.+++.++.|++.|++||| +.+|+||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999997542 25789999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhh
Q 048430 820 HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 898 (973)
||+|||++..... .........+..|+|||+.....++.++|||||||++|||+| |..||...... ......
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL 236 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHHHH
Confidence 9999999864321 111122234678999999888889999999999999999998 99998542211 111111
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
..+ .. ...+..++.++.+++.+||+.+|++||++++++++++++.+.-.
T Consensus 237 ~~~---------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 PQG---------YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred hcC---------Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 000 00 00011234568899999999999999999999999988765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.21 Aligned_cols=272 Identities=21% Similarity=0.255 Sum_probs=205.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+++. .++..||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999985 468889999886542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++.... .+++..+..++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 99999999998764 68999999999999999999993 368999999999999999999999999998754321 1
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc-chhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG-AVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~ 916 (973)
.....++..|+|||...+..++.++|||||||++|||++|+.||.... ......+....... ...............
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCC
Confidence 233468899999999888889999999999999999999999986432 11122211111000 000000000000000
Q ss_pred hhh-h-------------hhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 917 EED-A-------------DDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 917 ~~~-~-------------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
... . ........++.++.+++.+||+.+|++||+++|++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000 0 000000124567899999999999999999999999843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=302.32 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=203.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.|+..+.||.|.-|+||+++.. ++..+|+|++.... .....+...|.+||+.++||.++.+|+.++.+...|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 3445678999999999999965 46899999997553 3345677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC--
Q 048430 757 YMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-- 833 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~-- 833 (973)
||+||+|....+.+. ..+++..++.++.+++-||+||| ..|||+|||||+||||.++|.+.|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998765 67999999999999999999999 899999999999999999999999999987543100
Q ss_pred -------------------------------CC----------------------cccccccccccccCccCCCCCCCCc
Q 048430 834 -------------------------------DP----------------------VTQTMTLATIGYMAPEYGSEGIVSI 860 (973)
Q Consensus 834 -------------------------------~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 860 (973)
.. ......+||-.|.|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 00 0112347999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhc
Q 048430 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKC 940 (973)
Q Consensus 861 ~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 940 (973)
++|-|+|||++|||+.|+.||-+....+ .+...+. +.+. ++.....+..+++||++.
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~------------~~l~----------Fp~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVG------------QPLK----------FPEEPEVSSAAKDLIRKL 371 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhc------------CCCc----------CCCCCcchhHHHHHHHHH
Confidence 9999999999999999999997643322 2222211 1110 011113456689999999
Q ss_pred cccCCCCCCC----HHHHHHH
Q 048430 941 SAEIPEERIN----VKDALAD 957 (973)
Q Consensus 941 l~~~P~~Rpt----~~evl~~ 957 (973)
|.+||++|.. +.||.+|
T Consensus 372 LvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hccChhhhhccccchHHhhcC
Confidence 9999999998 8887765
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=333.83 Aligned_cols=268 Identities=23% Similarity=0.263 Sum_probs=194.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec--------CC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN--------PG 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~ 749 (973)
..+|...++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45788999999999999999985 468999999885432 234579999999999999999887632 12
Q ss_pred eeEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecc
Q 048430 750 FKALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFG 825 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg 825 (973)
..++||||+++ ++.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 78777653 2346899999999999999999999 89999999999999998665 79999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--c
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--A 902 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~ 902 (973)
+|+...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ..+...+...... .
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHH
Confidence 998654322 2233568999999998765 46899999999999999999999998653221 1122222111110 0
Q ss_pred hhhhcccccCCCCchh---hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 VTEVVDANLLSREDEE---DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......+.+....... ..-....+...+.++.+++.+||++||++|||+.|+++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0011111111100000 000011122345789999999999999999999999977
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.00 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=204.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|...+.||+|+||.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 346778899999999999999876 78999999876544 4578999999999999999999999999899999999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++.... ..+++..+..++.|++.|+.||| ..+++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999997654 36899999999999999999999 8999999999999999999999999999998653211
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....+..|+|||+.....++.++||||||+++||+++ |+.||...... .+...+.. + ...
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~---~---------~~~--- 218 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEK---G---------YRM--- 218 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhc---C---------CCC---
Confidence 12335678999999988889999999999999999997 99998643211 11111110 0 000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
..+..+++++.+++.+||..+|++||++.|+++.|+.
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 -------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.81 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=201.4
Q ss_pred hcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC-C
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP-G 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 749 (973)
.++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788899999999999999973 357899999987543 23356788999999999 689999999988654 5
Q ss_pred eeEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---------------------------------------------------------- 771 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 771 (973)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999987531
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-cccccc
Q 048430 772 --------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTL 842 (973)
Q Consensus 772 --------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~ 842 (973)
..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 13678888999999999999999 899999999999999999999999999998765322211 112234
Q ss_pred ccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhh
Q 048430 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921 (973)
Q Consensus 843 ~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 921 (973)
++..|+|||......++.++|||||||++|||++ |..||....... ........+. .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~---------~--------- 300 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGT---------R--------- 300 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHHhccC---------C---------
Confidence 5678999999888889999999999999999997 888875432111 1111100000 0
Q ss_pred hHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 922 DFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 922 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
...+..+++++.+++.+||+.+|++||++.|++++|+.+.+
T Consensus 301 -~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 301 -MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00011134568899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.10 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=200.4
Q ss_pred CCCCccccccCceEEEEEEeC------CCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 682 FGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
|...+.||+|+||.||+|... .++.||+|+++..... ..+.+.+|+.+++.++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 555678999999999999853 3578999998755432 346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 755 MQYMPQGSLEKWLYSH---------------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
+||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 9999999999998532 134788889999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHh
Q 048430 820 HLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 897 (973)
||+|||+++........ ......+++.|+|||......++.++|||||||++|||++ |..||..... ..+...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~ 238 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVIEM 238 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 99999998865332211 1223346789999999888889999999999999999998 7778754221 111111
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
....... ..+..++..+.+++.+||+.+|++||+++|+++.|+.
T Consensus 239 i~~~~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVL-------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCcC-------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111000 0112356678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=344.36 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=213.8
Q ss_pred cCCCCCccccccCceEEEEEEeC--------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG 749 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 749 (973)
++....+.+|+|.||.|++|... ....||||..+... ..+.+.+..|+.+|+.+ +|+||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34445569999999999999732 14679999987553 34578899999999998 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD 814 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 814 (973)
..++|+||+..|+|.++++..+ ..++..+...++.|||.||+||+ +.++||||+.++||+++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence 9999999999999999999876 45899999999999999999999 89999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccccccc--ccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 815 DDMVAHLGDFGIAKLLDGVDPVTQTMTL--ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 815 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
++..+||+|||+|+.....+.+...... -+..|||||.+....++.|||||||||++||++| |..||.+.. ....+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHH
Confidence 9999999999999976655555433222 4677999999999999999999999999999999 777875421 11111
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.+++ ..+.++..|..|..+++++|+.||+.+|++||++.|+.+.++...+
T Consensus 532 ~~~l----------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 LEFL----------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHH----------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1111 1223445667889999999999999999999999999999999644
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=310.95 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=202.8
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
.+|...+.||+|+||.||+|...+++.+|+|.+..... ..+.+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677889999999999999987788999998864322 23578899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+++|.+++......++++.+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999876657899999999999999999999 789999999999999999999999999998765332222222
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...++.+|+|||......++.++|||||||++|||++ |+.||..... .........+. ...
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~--~~~----------- 221 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINAGF--RLY----------- 221 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHhCCC--CCC-----------
Confidence 3345678999999888889999999999999999998 8999864221 11111111000 000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+...+..+.+++.+||+.+|++||+++|++++|
T Consensus 222 ------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 ------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0011245688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=316.23 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=205.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|.. .++..||+|++........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35677888999999999999986 46899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++......+++.++..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||.+....... ..
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QK 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cc
Confidence 9999999999876667999999999999999999999 8999999999999999999999999999887543221 22
Q ss_pred cccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 838 QTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.....++..|+|||... ...++.++|||||||++|||++|+.||...... ..+........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--------- 225 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKILKSEP--------- 225 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHHHhcCCC---------
Confidence 23446889999999764 345788999999999999999999998653211 11111000000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....+..++.++.+++.+||+.+|++||++.+++++
T Consensus 226 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0001112345678899999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=330.53 Aligned_cols=260 Identities=20% Similarity=0.263 Sum_probs=203.3
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
.++....++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555689999999999999999999864 68899999986432 22345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
+..++||||+++|+|.+++... .++...+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999999765 4888899999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEG----IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
..............||+.|+|||.+... .++.++|||||||++|||++|+.||..... ...........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~-- 263 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHK-- 263 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC--
Confidence 7643332233455799999999987643 378999999999999999999999964211 11111110000
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE--RINVKDALADL 958 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~evl~~L 958 (973)
..+ .++....++..+.+++.+|++..+.+ |++++|+++|.
T Consensus 264 ----~~~----------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 ----NSL----------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----Ccc----------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 00011134566888999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.19 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=206.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
++|...+.||+|+||.||+|.. .+++.+|+|++........+.+.+|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788889999999999999985 467889999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++......+++.++..++.|++.|++||| ..+|+||||+|+||+++.++.+||+|||.+....... ...
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hcc
Confidence 999999999876557999999999999999999999 8999999999999999999999999999987654321 122
Q ss_pred ccccccccccCccCCCCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 839 TMTLATIGYMAPEYGSEG---IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~---~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
....++..|+|||..... .++.++|||||||++|||++|+.||........ .... . ... +..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~-~---~~~--------~~~-- 223 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLI-S---KSN--------FPP-- 223 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-H---hcc--------CCC--
Confidence 334678899999988766 789999999999999999999999865322111 0000 0 000 000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.........+.++.+++.+||..+|.+||++.+++.+
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 -----PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -----ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001122346678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.65 Aligned_cols=249 Identities=26% Similarity=0.314 Sum_probs=198.8
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+|...++||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999984 578999999986542 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|..+. .+++..+..++.|++.|++||| +.+|+|+||||+||+++.++.++|+|||++...... ..
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999997652 4678889999999999999999 899999999999999999999999999998765322 22
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccH--HHHHHhhCCcchhhhcccccCCCCc
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL--KQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
....++..|+|||...+..++.++|||||||++|||++|+.||.......... ..+... ..+......
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-- 220 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDPPVL-- 220 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH--------HhccCCCCC--
Confidence 33568999999999988889999999999999999999999986533221110 011100 000000000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.....+.++.+++.+|++.+|++||+++|++++-
T Consensus 221 --------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 --------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0011345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.28 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=203.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+.|.+.++||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46778899999999999999864 58999999987766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|..++......+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+...... ....
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence 999999988766567899999999999999999999 899999999999999999999999999998754321 1222
Q ss_pred ccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 839 TMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... . ..+........ +
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~-~~~~~~~~~~~-----~---- 233 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----M-RVLLKIAKSEP-----P---- 233 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----H-HHHHHHhcCCC-----c----
Confidence 3345788999999864 34578899999999999999999999854221 1 11111000000 0
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+..++.++.+++.+||+.+|++||++.|++++
T Consensus 234 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 --------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000112344568899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=319.60 Aligned_cols=245 Identities=28% Similarity=0.381 Sum_probs=203.6
Q ss_pred CCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
|...+-||.|+||.||-|+ ..+.+.||||.+.... .+.+.++.+|++++.+++|||++.+.|||......++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4556789999999999998 4678899999986553 34578899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
|- ||-.+++..++.++.+-++..|..+.+.||+||| +.+.||||||+.|||+++.|.||++|||.|....+.
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 95 5899999888888999999999999999999999 899999999999999999999999999999877543
Q ss_pred cccccccccccCccCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 838 QTMTLATIGYMAPEYG---SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
...+|||.|||||++ ..+.|+-|+||||+||+..|+..+++|+-.+. ....+ +.....+ .+.+
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-AMSAL---YHIAQNe------sPtL--- 245 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSAL---YHIAQNE------SPTL--- 245 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-HHHHH---HHHHhcC------CCCC---
Confidence 346899999999964 46789999999999999999999999963321 11111 1111100 0011
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
....++..|.+++..|++.-|.+|||.+++++|-
T Consensus 246 ----------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 246 ----------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ----------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1234677899999999999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.71 Aligned_cols=269 Identities=23% Similarity=0.294 Sum_probs=222.5
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeee
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSC 745 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 745 (973)
.++.....+++....+.+|.||.||.|.|. +.+.|-||.++... +-+...+..|...+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445555567777889999999999999764 34557778776543 33456788899999999999999999988
Q ss_pred e-cCCeeEEEEEecCCCCHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC
Q 048430 746 S-NPGFKALIMQYMPQGSLEKWLYSHN-------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM 817 (973)
Q Consensus 746 ~-~~~~~~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~ 817 (973)
. +.+..+++|.++.-|+|..|+..++ +.++..+...++.|++.|++||| +.+|||.||.++|+++++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 5 4567889999999999999998332 56788889999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHH
Q 048430 818 VAHLGDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 818 ~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 895 (973)
++||+|=.+++.+.+.++.. ......+..||+||.+....|+.++|||||||++|||+| |+.||.+..+-++ ..+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~y- 510 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHY- 510 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHH-
Confidence 99999999999887766553 234457889999999999999999999999999999998 8889865433221 111
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
.+++.++..|.+|++++..+|..||+.+|++||+++|++.-|.++..+++++
T Consensus 511 ---------------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~Y 562 (563)
T KOG1024|consen 511 ---------------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRY 562 (563)
T ss_pred ---------------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhc
Confidence 1223455677889999999999999999999999999999999999988765
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.77 Aligned_cols=238 Identities=27% Similarity=0.321 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEe----CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
+.||+|+||.||+++. .+|+.||+|+++.... .....+..|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3689999999975432 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 999999997654 6899999999999999999999 8999999999999999999999999999987653221 1223
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
...|++.|+|||......++.++|||||||++|||++|+.||..... .......... ..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~--------~~-------- 215 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKA--------KL-------- 215 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcC--------CC--------
Confidence 35689999999998888889999999999999999999999864221 1111111000 00
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKD 953 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~e 953 (973)
..+..++..+.+++.+||+.||++||++.+
T Consensus 216 ----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ----GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001123556889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.05 Aligned_cols=248 Identities=24% Similarity=0.302 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 467899999997542 23456688899999888 699999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 99999887654 6999999999999999999999 8999999999999999999999999999987532211 12234
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc-ccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE-MSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||+...... .....++..... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~--------- 219 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-------EKP--------- 219 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-------hCC---------
Confidence 568999999999988899999999999999999999999996432211 111111111100 000
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINV------KDALAD 957 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~------~evl~~ 957 (973)
...+...+..+.+++.+|++.||++|+++ .++++|
T Consensus 220 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 ---IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 00111234567899999999999999984 566665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.87 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=210.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch---hhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED---RALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 753 (973)
...|...+.||+|.||.||+++.+ +|+.+|+|++..... ...+.+.+|+.+|+++. ||||+.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456777799999999999999965 599999999976543 23468999999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC----CcEEEeecccccc
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKL 829 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~ 829 (973)
|||++.||.|.+.+... .+++..+..++.|++.++.||| +.+|+|||+||+|+++... +.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999876 3999999999999999999999 8999999999999999543 4799999999998
Q ss_pred cCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
..+ .......+||+.|+|||.+....++..+||||+||++|.|++|..||.+....+... .+...
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------~i~~~ 253 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------AILRG 253 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------HHHcC
Confidence 765 445566789999999999999999999999999999999999999997643222111 11111
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+. ...+.....+..+.+++.+|+..||.+|++++++++|-
T Consensus 254 ~~~--------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 254 DFD--------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred CCC--------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 110 00112234567789999999999999999999999983
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=305.83 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=208.9
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.-|...+.||+|.|+.|-.|+ .-+|..||||++.+.. +-....+.+|+++|+.++|||||++|.+.......|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346667889999999999998 4579999999997653 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC-CCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~ 835 (973)
.-++|+|++|+..+...+.+....+++.||+.|+.|+| ...+||||+||+||++- .-|-||++|||++-.+.+..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence 99999999999998888999999999999999999999 78999999999998775 56889999999997765432
Q ss_pred cccccccccccccCccCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVS-ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.-...+|+..|-|||.+.+..|+ +++||||+|||+|-+++|+.||+.....+ .+..++|=.
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCK---- 235 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCK---- 235 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhccc----
Confidence 33456899999999998888775 78999999999999999999997643322 122333321
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+..|...+.+..++|..|+..||++|.+.+|++.+
T Consensus 236 --------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 --------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 23345567788999999999999999999998754
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.91 Aligned_cols=463 Identities=27% Similarity=0.315 Sum_probs=304.6
Q ss_pred EEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEee
Q 048430 47 VAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126 (973)
Q Consensus 47 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls 126 (973)
..+||++++.+. ..|..+..+.+|+.|+++.|.+ ...|.+..++++|++|.|.+|.+. .+|.++ ..+++|++||+|
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i-~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~-~~lknl~~LdlS 122 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI-RSVPSSCSNMRNLQYLNLKNNRLQ-SLPASI-SELKNLQYLDLS 122 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhH-hhCchhhhhhhcchhheeccchhh-cCchhH-Hhhhcccccccc
Confidence 445555544433 5555555555666666665555 345555555566666666655555 555544 445555666666
Q ss_pred CcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCC
Q 048430 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGN 206 (973)
Q Consensus 127 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N 206 (973)
+|++. .+|..+..++.+..+..++|.....++ .. .++.++|..|.+.+. ++..+.+++. .|||++|
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg-----~~-~ik~~~l~~n~l~~~-----~~~~i~~l~~--~ldLr~N 188 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG-----QT-SIKKLDLRLNVLGGS-----FLIDIYNLTH--QLDLRYN 188 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhhhc-----cc-cchhhhhhhhhcccc-----hhcchhhhhe--eeecccc
Confidence 66555 555555555555555555552111111 11 155555555555432 2334444444 4666666
Q ss_pred cccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCc
Q 048430 207 NIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286 (973)
Q Consensus 207 ~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~ 286 (973)
.+. ...+.++.+|+.+....|+++...- ..++|+.|+.++|.+....+ -..-.+|+++++++|++++++ ..
T Consensus 189 ~~~---~~dls~~~~l~~l~c~rn~ls~l~~---~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~lp-~w 259 (1081)
T KOG0618|consen 189 EME---VLDLSNLANLEVLHCERNQLSELEI---SGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSNLP-EW 259 (1081)
T ss_pred hhh---hhhhhhccchhhhhhhhcccceEEe---cCcchheeeeccCcceeecc--ccccccceeeecchhhhhcch-HH
Confidence 654 2334455555555555555543221 13556666666666652211 122345666666666666543 55
Q ss_pred ccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCC
Q 048430 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG 366 (973)
Q Consensus 287 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~ 366 (973)
++.+.+|+.|...+|+++. .+..+...++|+.|....|.+. -+|..
T Consensus 260 i~~~~nle~l~~n~N~l~~--------lp~ri~~~~~L~~l~~~~nel~--------------------------yip~~ 305 (1081)
T KOG0618|consen 260 IGACANLEALNANHNRLVA--------LPLRISRITSLVSLSAAYNELE--------------------------YIPPF 305 (1081)
T ss_pred HHhcccceEecccchhHHh--------hHHHHhhhhhHHHHHhhhhhhh--------------------------hCCCc
Confidence 6666666666666666643 2333445555555555555555 34555
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCC-CCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQK-LQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 445 (973)
...++.|++|+|..|+|....+..|..+.. |..|+.+.|++.......-..++.|+.|++.+|.++...-..+.++..|
T Consensus 306 le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hL 385 (1081)
T KOG0618|consen 306 LEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHL 385 (1081)
T ss_pred ccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccce
Confidence 677899999999999999544445555544 8889999999984432233356789999999999999888889999999
Q ss_pred CeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccC
Q 048430 446 RHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARN 525 (973)
Q Consensus 446 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 525 (973)
+.|+|++|+|.......+..+..|+.|+||+|+++ .+|..+.++..|++|...+|++. ..| ++..++.|+.+|+|.|
T Consensus 386 KVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 386 KVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCN 462 (1081)
T ss_pred eeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccc
Confidence 99999999998666677889999999999999999 89999999999999999999999 788 8999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCC
Q 048430 526 AFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
+|+...-..-...++|++|||++|.=....-..|..+.++..+++.-|
T Consensus 463 ~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 463 NLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 998544333333389999999999744455667777888888888776
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.39 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEeC----CCeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeee-cCCeeEEEEEecC
Q 048430 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMP 759 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 759 (973)
+.||+|+||.||+|... +...||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 3467999987543 2344578889999999999999999999775 4566889999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc---
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--- 836 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--- 836 (973)
+|+|.+++.......++..+..++.|+++|++||| ..+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876656788889999999999999999 789999999999999999999999999998755321111
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRK-PTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......++..|+|||......++.++|||||||++|||++|+. ||.... ..........+. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~~~------------~ 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLLQGR------------R 220 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhcCC------------C
Confidence 1122345778999999888889999999999999999999654 453321 111111110000 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
...+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 221 -------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 -------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00011234568899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.88 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=205.0
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788899999999999999985 57999999998766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++... .+++.++..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||++........ .
T Consensus 98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 9999999998764 5889999999999999999999 78999999999999999999999999999876543222 2
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....+++.|+|||...+..++.++|||||||++|++++|+.||............ .... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-----~~~~-----------~--- 232 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNG-----------T--- 232 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-----ccCC-----------C---
Confidence 23346888999999988888999999999999999999999998642211100000 0000 0
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....+...+..+.+++.+||+.+|++||++++++++
T Consensus 233 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 ---PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000112345568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.04 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=203.3
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-----------------CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLAN-----------------GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIK 740 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 740 (973)
..+|...+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578888999999999999987532 3568999987553 334678899999999999999999
Q ss_pred EEeeeecCCeeEEEEEecCCCCHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 048430 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHN----------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNN 810 (973)
Q Consensus 741 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 810 (973)
+++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999997654 25899999999999999999999 7999999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccC
Q 048430 811 VLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT--RRKPTNEMFTG 887 (973)
Q Consensus 811 ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt--g~~p~~~~~~~ 887 (973)
|+++.++.++++|||+++....... .......++..|+|||......++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876533221 12233456788999999888889999999999999999998 66777543211
Q ss_pred cccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 888 EMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
+ ....+....... +... ....+..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 241 ~--~~~~~~~~~~~~-----~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q--VIENAGHFFRDD-----GRQI----------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H--HHHHHHhccccc-----cccc----------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 111111100000 0000 00011234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.76 Aligned_cols=242 Identities=25% Similarity=0.269 Sum_probs=191.0
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHH-HHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECE-VMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||+||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999996 478999999987542 122344555544 56789999999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++...... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 99999998754 6899999999999999999999 899999999999999999999999999998753221 122234
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.......+. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~--------~~-------- 214 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKP--------LR-------- 214 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCC--------CC--------
Confidence 468999999999998899999999999999999999999986421 111111111100 00
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHH----HHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVK----DALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~----evl~~ 957 (973)
.+...+..+.+++.+|++.||++||++. |+++|
T Consensus 215 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 215 ----LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 0012345688999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.27 Aligned_cols=257 Identities=24% Similarity=0.399 Sum_probs=202.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
..++|.+.++||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999743 356899998764432 234568889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEE
Q 048430 751 KALIMQYMPQGSLEKWLYSHN---------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHL 821 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 821 (973)
.++||||+++|+|.+++.... ...++..+..++.|++.||.||| +++|+||||||+||+++.++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 34567788999999999999999 899999999999999999999999
Q ss_pred eecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhC
Q 048430 822 GDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 822 ~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+++......... .....++..|+|||......++.++|||||||++|||++ |..||..... .+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence 9999988653322211 122245678999999988889999999999999999998 7778754221 11111111
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
.+ .... .+..+++.+.+++.+|++.+|++||++.|+++.|++.
T Consensus 236 ~~--------~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 DG--------GYLD-----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred cC--------CCCC-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00 0000 0112346799999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=306.41 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=199.9
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeee-ecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC-SNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~ 758 (973)
.+|...+.||+|+||.||+|... +..||+|.++... ..+.+.+|+.++++++|+|++++++++ ......++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999875 7889999886433 346789999999999999999999976 4556789999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998654 34889999999999999999999 8999999999999999999999999999987543211
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
....++..|+|||+.....++.++|||||||++|||++ |+.||... ...........+...
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~~------------ 218 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGYKM------------ 218 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCCCC------------
Confidence 22335678999999888889999999999999999998 88887532 122222111110000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..+..++..+.+++.+||+.+|++||++.+++++|+++
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00113456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.38 Aligned_cols=248 Identities=27% Similarity=0.481 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEeC-CCe--EEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA-NGV--SVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999864 343 57888876432 34456788999999999 799999999999999999999999999
Q ss_pred CCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 761 GSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 761 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997542 24789999999999999999999 7999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
++..... .........+..|+|||+.....++.++|||||||++|||++ |..||..... .........+
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~~~--- 227 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKLPQG--- 227 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHHhCC---
Confidence 9863221 111122234667999999888889999999999999999997 9999854221 1111111000
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
... ..+..++.++.+++.+||+.+|.+||++.|+++.|+++.
T Consensus 228 ------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 001124556889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.50 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=207.7
Q ss_pred CCccccccCceEEEEEEeCC-CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 684 ESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
++.-||.|+||.||+|..++ +-..|-|++.....+..++|.-|++++...+||+||++++.|...+.++++.|||.||.
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 35679999999999998653 45567788887788888999999999999999999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccccc
Q 048430 763 LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL 842 (973)
Q Consensus 763 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 842 (973)
.+.++-.-+..+++.++.-+++|++.||.||| +..|||||+|+.|||++-+|.++++|||.+..... .........
T Consensus 116 VDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFI 191 (1187)
T KOG0579|consen 116 VDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFI 191 (1187)
T ss_pred HhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhcccc
Confidence 99999887778999999999999999999999 89999999999999999999999999998765432 233456678
Q ss_pred ccccccCccC-----CCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 843 ATIGYMAPEY-----GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 843 ~~~~y~aPE~-----~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
|||+|||||+ ....+|+.++||||||+++.||..+.+|-....+ .+..+....
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKiaK------------------ 249 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAK------------------ 249 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHHhh------------------
Confidence 9999999995 4567899999999999999999999998543221 111111111
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+.+..|..+...+.+++.+|+..||..||+++++++|
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1122334556778889999999999999999999999987
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.74 Aligned_cols=255 Identities=20% Similarity=0.231 Sum_probs=199.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...++||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999864 57889999986432 223455888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999875557899999999999999999999 89999999999999999999999999999876543333
Q ss_pred cccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 836 VTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ............. .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~------~ 226 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKE------R 226 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCc------c
Confidence 2333457999999999875 3467899999999999999999999986421 1111111110000 0
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE--RINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~evl~~ 957 (973)
.. . ......++.++.+++.+|+..+|.+ |++++|+++|
T Consensus 227 ~~--~-------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQ--F-------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc--C-------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0 0001234566888999988654444 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.68 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEeC----CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
++||+|+||.||+|... .+..||+|.+..... ...+.+.+|+.++++++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999742 236899999875543 34567899999999999999999999876 4567999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc--
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ-- 838 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-- 838 (973)
|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998765 7899999999999999999999 78999999999999999999999999999986643322211
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....++..|+|||......++.++|||||||++|||++ |+.||+.... .....++....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER----------------- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-----------------
Confidence 11223567999999888889999999999999999998 9999865322 112222211100
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
...+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus 217 -----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 001123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.29 Aligned_cols=268 Identities=24% Similarity=0.304 Sum_probs=196.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhc---cCCceeEEEeeeec-----CC
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRI---RHRNLIKIVSSCSN-----PG 749 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 749 (973)
+|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999854 68999999886542 22234566777777665 69999999998754 34
Q ss_pred eeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
..++||||+.+ +|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 67899999975 8988887643 35899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-C--cchhh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-P--GAVTE 905 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 905 (973)
..... .......++..|+|||.+.+..++.++||||+||++|||++|+.||...... ..+........ + ..+..
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCcc
Confidence 65422 1223346889999999998888999999999999999999999998643221 11112111110 0 00000
Q ss_pred hcccccCCCCc--hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVDANLLSRED--EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d~~l~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ....... ............++.++.+++.+|++.||++||++.|+++|
T Consensus 234 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DV--TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cc--cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000000 00000001112355678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.37 Aligned_cols=265 Identities=19% Similarity=0.267 Sum_probs=196.4
Q ss_pred Ccccccc--CceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 685 SNLLGSG--SFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 685 ~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
.++||+| +|++||++.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 6889999985 578999999987542 3344677889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc--
Q 048430 760 QGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-- 836 (973)
Q Consensus 760 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-- 836 (973)
+|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999997542 35899999999999999999999 899999999999999999999999999865433211110
Q ss_pred ----ccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc--
Q 048430 837 ----TQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD-- 908 (973)
Q Consensus 837 ----~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 908 (973)
......++..|+|||++.. ..++.++|||||||++|||++|+.||........ .... ..+......+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~----~~~~~~~~~~~~ 234 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEK----LNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHH----hcCCcccccccc
Confidence 1122356778999998765 4588999999999999999999999975322111 1111 1111100000
Q ss_pred -----------------cccCCCCc-------hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 -----------------ANLLSRED-------EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 -----------------~~l~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........ ............+++.+.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 00000011122356779999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.62 Aligned_cols=265 Identities=25% Similarity=0.416 Sum_probs=207.2
Q ss_pred CCCCCccccccCceEEEEEEeC-----CCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-----NGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKA 752 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 752 (973)
.|...+.||+|+||.||+|+.. ++..||||++...... ..+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999853 4789999998765443 46789999999999999999999999877 56789
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999887667999999999999999999999 79999999999999999999999999999987652
Q ss_pred CCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc----chhhh
Q 048430 833 VDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG----AVTEV 906 (973)
Q Consensus 833 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 906 (973)
.... ......++..|+|||......++.++||||||+++|||++|+.|+......... +....... .+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLEL 238 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHHH
Confidence 2211 111234566799999988888999999999999999999999997553221111 00000000 00111
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..... ....+..++.++.+++.+||+.+|++||++.|+++.|+++
T Consensus 239 ~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11000 0111223557799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.29 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=200.0
Q ss_pred ccccccCceEEEEEEeCCCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHH
Q 048430 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 764 (973)
++||+|+||.||+|...+++.||+|.+...... ..+.+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999776999999988755433 4578999999999999999999999999999999999999999999
Q ss_pred HHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc-ccccc
Q 048430 765 KWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ-TMTLA 843 (973)
Q Consensus 765 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~~ 843 (973)
+++......+++..+..++.+++.|++||| +.+++||||+|+||+++.++.+||+|||.+........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999876557899999999999999999999 89999999999999999999999999999876532111111 12234
Q ss_pred cccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhh
Q 048430 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADD 922 (973)
Q Consensus 844 ~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 922 (973)
+..|+|||...+..++.++|||||||++|||++ |..||...... .....+.... .
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~----------------------~ 213 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY----------------------R 213 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC----------------------C
Confidence 667999999888889999999999999999999 78887543211 1111111000 0
Q ss_pred HHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 923 FATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 923 ~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
...+..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0011234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.69 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=205.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC--------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
.++|...++||+|+||.||+|+.. ....||+|.++... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999742 34579999887543 33456788999999999 699999999999998
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+..++||||+++|+|.+++.... ..+++.++..++.|++.|+.||| +.+|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 99999999999999999997632 34889999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
+.++.+||+|||.++......... .....++..|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999998654322211 112234567999999888889999999999999999999 8888754211
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
.........+.. ...+..++.++.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 243 ~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 243 EELFKLLREGHR-------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHHHHHcCCC-------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 111111000000 00112345668899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.00 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=199.9
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++|++++++++++...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678999999999999985 478999999886442 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999886543 45899999999999999999999 8999999999999999999999999999987643221
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ..... .. ..+. ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~--------~~~~-~~---- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ER--------LVKE-VQ---- 221 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hh--------hhhh-hh----
Confidence 1223468999999999988889999999999999999999999997532211 00110 00 0000 00
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
...+..++.++.+++.+||+.||++||+ ++|+++|
T Consensus 222 ------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 ------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0011234566889999999999999999 8899986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.83 Aligned_cols=271 Identities=19% Similarity=0.245 Sum_probs=202.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999854 68899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++ ++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cc
Confidence 97 5999998876667899999999999999999999 8999999999999999999999999999987543221 12
Q ss_pred cccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC----cchhhhcccccC
Q 048430 838 QTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP----GAVTEVVDANLL 912 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~d~~l~ 912 (973)
.....+++.|+|||...+ ..++.++|||||||++|||++|+.||...... .....+..... ..+....+....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccccc
Confidence 223457889999997654 45788999999999999999999998653211 11111111111 111111111000
Q ss_pred CCCc-hhhhh--hHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SRED-EEDAD--DFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~-~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... ..... .......++..+.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 00000 001112345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.87 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=204.1
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|...+.||+|+||.||+|...++..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999877888999988644 2345678999999999999999999999887 7789999999
Q ss_pred CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++... ...+++.++..++.|++.|+.||| ..+++||||+|+||+++.++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999764 345788999999999999999999 7899999999999999999999999999987654322222
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....++..|+|||++....++.++|||||||++||+++ |+.||..... .....++..... .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~------------~--- 222 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR------------M--- 222 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCC------------C---
Confidence 223345678999999988889999999999999999999 8888864221 111111111000 0
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
..+...+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.81 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=204.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+|...+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588889999999999999984 578999999987665555678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 999999998764 5899999999999999999999 89999999999999999999999999999876543222 22
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
....++..|+|||...+..++.++|||||||++|++++|+.||........ . ..+......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~~~~~~~~----------------- 233 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIATNGTP----------------- 233 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHhcCCc-----------------
Confidence 234688899999998888899999999999999999999999865322110 0 001000000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+..++..+.+++.+||..+|++||++.+++++
T Consensus 234 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 ---ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000112345668899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.28 Aligned_cols=241 Identities=22% Similarity=0.260 Sum_probs=193.3
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 755 (973)
+|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366788999999999999985 468999999987542 233456778889988885 577888999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999997754 6999999999999999999999 8999999999999999999999999999987543211
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......||+.|+|||.+....++.++||||+||++|||++|+.||..... ...+...... ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~~--------~~---- 218 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQSIMEH--------NV---- 218 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC--------CC----
Confidence 122334689999999999888899999999999999999999999865321 1111111100 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINV 951 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 951 (973)
..+..++.++.+++.+|++.+|++|++.
T Consensus 219 --------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111234567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.22 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=200.2
Q ss_pred CCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhH--HHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRAL--KSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
|+..+.||+|+||+||+++.. +++.||+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999964 577999999987654332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++.... .+++..+..++.|+++||+||| +.+|+|+||||+||+++.++.++|+|||.+.... ......
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred ccccccccccccc-cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccccc
Confidence 9999999998433 6899999999999999999999 7899999999999999999999999999987642 122344
Q ss_pred ccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....++..|+|||... ...++.++||||+|+++|+|++|+.||..... .................. .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~----~------ 223 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRPLPSS----S------ 223 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTHHHHH----T------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhccccccccc----c------
Confidence 4567899999999988 78899999999999999999999999876411 011111111000000000 0
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........++.+++.+||+.||++||++.|++++
T Consensus 224 ------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 ------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112679999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.62 Aligned_cols=271 Identities=23% Similarity=0.212 Sum_probs=199.1
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------ 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 748 (973)
..++|...+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 46899999998643 233456788999999999999999999988543
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 357999999975 67766643 4788999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--c----
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--A---- 902 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~---- 902 (973)
.... ........+|+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+.......... .
T Consensus 172 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHHH
Confidence 5432 12223456899999999999889999999999999999999999999653211 1111111110000 0
Q ss_pred ----hhhhccc--ccCCCCchhh------hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 903 ----VTEVVDA--NLLSREDEED------ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 903 ----~~~~~d~--~l~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
....... ........+. ..........++++.+++.+|++.||++|||++|+++|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000 0000000000 000001112346689999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.87 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=199.5
Q ss_pred cCCCCCccccccCceEEEEEEeCC---------------CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN---------------GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVS 743 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~ 743 (973)
++|...+.||+|+||.||++.... ...||+|.++... ......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987532 2358999887543 334567899999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhhhCC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEE
Q 048430 744 SCSNPGFKALIMQYMPQGSLEKWLYSHN-----------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812 (973)
Q Consensus 744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 812 (973)
++......++||||+++++|.+++.... ..+++..+..++.|+++|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986532 23688899999999999999999 899999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccCcc
Q 048430 813 LDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT--RRKPTNEMFTGEM 889 (973)
Q Consensus 813 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt--g~~p~~~~~~~~~ 889 (973)
++.++.+|++|||++......... ......++..|+|||....+.++.++|||||||++|||++ |..||...... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-Q 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-H
Confidence 999999999999998765322211 1222345778999999888889999999999999999998 55676543211 1
Q ss_pred cHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 890 SLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.... +....... +..... ..+..++..+.+++.+||+.+|++||++++|++.|+
T Consensus 241 ~~~~-~~~~~~~~-----~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIEN-TGEFFRNQ-----GRQIYL----------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH-HHHhhhhc-----cccccC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 11000000 000000 001123567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.91 Aligned_cols=194 Identities=22% Similarity=0.301 Sum_probs=160.0
Q ss_pred CccccccCceEEEEEEeC---CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeEEEEEecC
Q 048430 685 SNLLGSGSFDNVYKATLA---NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKALIMQYMP 759 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 759 (973)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 56889999886442 22457789999999999999999998853 467889999986
Q ss_pred CCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe----CCCCcEEEeecccc
Q 048430 760 QGSLEKWLYSHN--------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL----DDDMVAHLGDFGIA 827 (973)
Q Consensus 760 ~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla 827 (973)
+ +|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 8888876421 35889999999999999999999 8999999999999999 45678999999999
Q ss_pred cccCCCCCc--ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 048430 828 KLLDGVDPV--TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEM 884 (973)
Q Consensus 828 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~ 884 (973)
+........ ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876432211 2234568999999998766 45899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.24 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++.||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999864 68999999987543 344578899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++... .+++.++..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........ ..
T Consensus 85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 999999998764 5889999999999999999999 89999999999999999999999999999976543221 22
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
....++..|+|||...+..++.++|||||||++|||++|..||........ ... ......
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~---------~~~~~~------ 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFL---------IPKNNP------ 218 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhh---------hhcCCC------
Confidence 334578899999998888899999999999999999999999865322110 000 000000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+..++..+.+++.+||+.+|++||++++++++
T Consensus 219 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 ----PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 01122456778999999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.31 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=199.4
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999985 478999999986442 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999998887543 46999999999999999999999 8999999999999999999999999999987653221
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......|+..|+|||...+..++.++|||||||++|||++|+.||....... ....+........ .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~~------~------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLETE------E------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhccc------c-------
Confidence 1233468999999999988889999999999999999999999986532111 0111111000000 0
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
..+..++.++.+++.+|++.+|++||+ +.++++|
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 001123556789999999999999999 7788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=328.02 Aligned_cols=268 Identities=20% Similarity=0.216 Sum_probs=198.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+|...+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46888899999999999999864 57899999642 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-c
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-T 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~ 837 (973)
. ++|.+++......+++.++..++.|+++||.||| +.+||||||||+|||++.++.+||+|||+++........ .
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 5 6999998776557999999999999999999999 899999999999999999999999999999865432211 1
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccC------cccHHHHHHhhCC--cchhh----
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG------EMSLKQWVAESLP--GAVTE---- 905 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~------~~~~~~~~~~~~~--~~~~~---- 905 (973)
.....||..|+|||++.+..++.++|||||||++|||++|..|+...... ...+...+..... .....
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 22346999999999999889999999999999999999988765322111 1112222221100 00000
Q ss_pred -hcc---cccCCCCc-hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 -VVD---ANLLSRED-EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 -~~d---~~l~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ........ ...............++.+++.+||+.||++|||+.|+++|
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000000 00000000001233468899999999999999999999987
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.25 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=199.1
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeec------C
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSN------P 748 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~ 748 (973)
.+.+.|...+.||+|+||.||+|.. .+++.||+|++..... ....+..|+.+++++ +|+||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3556788889999999999999985 4688999999865432 345788999999998 69999999999864 2
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
...++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46889999999999999998743 46899999999999999999999 789999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ....... ..
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~~-~~- 231 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIP-RN- 231 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHHh-cC-
Confidence 7653221 2223456889999999865 345788999999999999999999998643211 1111000 00
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.. ....++.++.+++.+||..+|.+||+++|+++|
T Consensus 232 ----~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 ----PAPRL-------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----CCCCC-------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000 011245568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.87 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=201.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-----------------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-----------------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIK 740 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 740 (973)
.++|...++||+|+||.||++... ++..||+|+++... ....+.+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 24569999987543 334568999999999999999999
Q ss_pred EEeeeecCCeeEEEEEecCCCCHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 048430 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHN----------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNN 810 (973)
Q Consensus 741 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 810 (973)
+++++...+..++||||+++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999997643 24678899999999999999999 8899999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccC
Q 048430 811 VLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT--RRKPTNEMFTG 887 (973)
Q Consensus 811 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt--g~~p~~~~~~~ 887 (973)
|+++.++.++++|||+++........ ......++..|+|||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998765332211 1222345678999998888889999999999999999998 66777542211
Q ss_pred cccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 888 EMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
+.+... .+.......... .+.+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus 241 -----~~~~~~-----~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 -----QVIENT-----GEFFRDQGRQVY-------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred -----HHHHHH-----HHHHhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111100 000000000000 0111234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.14 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=199.2
Q ss_pred ccccccCceEEEEEEeCC--C--eEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLAN--G--VSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3699999876654 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc--c
Q 048430 761 GSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--T 837 (973)
Q Consensus 761 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~ 837 (973)
++|.+++.... ..+++..+..++.|++.||+||| ..+++||||+|+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765 46899999999999999999999 899999999999999999999999999999876432211 1
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....++..|+|||+.....++.++|||||||++|||++ |+.||......+ ....+.. .. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~--~~-------~~------ 219 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDK--EG-------ER------ 219 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh--cC-------Cc------
Confidence 123457789999999988889999999999999999999 999986432111 1111110 00 00
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
...+..++..+.+++.+|++.+|++||+++|+++.|.
T Consensus 220 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 ------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011123566889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.25 Aligned_cols=247 Identities=29% Similarity=0.520 Sum_probs=203.0
Q ss_pred ccccccCceEEEEEEeCC----CeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLAN----GVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|.... +..||+|.++..... ..+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 888999998765443 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 761 GSLEKWLYSH--------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 761 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
++|.+++... ...+++.++..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 357999999999999999999999 89999999999999999999999999999987653
Q ss_pred CCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 833 VDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 833 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
... .......++..|+|||......++.++||||+||+++||++ |..||..... ..+...+.. +.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~---~~-------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK---GY-------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc---CC--------
Confidence 321 12233457889999999888889999999999999999999 5888865411 111111110 00
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
....+..++.++.+++.+||+.+|++||++.|++++|+
T Consensus 225 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -----------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00112234677999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=306.84 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=201.7
Q ss_pred CCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc------hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE------DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477788999999999999998889999999886432 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+||+++++|.+++.... .+++..+..++.|++.|++||| +.+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997754 6889999999999999999999 7899999999999999999999999999987643211
Q ss_pred -----CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 835 -----PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 835 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
........++..|+|||...+..++.++|||||||++|||++|+.||...... ........... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~----~~~ 228 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFYIGAHRG----LMP 228 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHHhhhccC----CCC
Confidence 11122345889999999998888999999999999999999999998643211 11100000000 000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. .+..++.++.+++.+||+.+|++||++.|++++
T Consensus 229 ~--------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 229 R--------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred C--------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 011245668899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.07 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=199.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999854 68899999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875557899999999999999999999 89999999999999999999999999999987654333
Q ss_pred cccccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 836 VTQTMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.......|++.|+|||.+.. ..++.++|||||||++|||++|+.||..... ........... ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~------~~ 226 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHE------ER 226 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCC------Cc
Confidence 23334569999999997765 4678899999999999999999999864211 11111110000 00
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE--RINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~evl~~ 957 (973)
.. . . ......++++.+++.+|+...+++ |++++++++|
T Consensus 227 ~~--~-p------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 FQ--F-P------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cc--C-C------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0 0 000123566888999998876544 5688888877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.71 Aligned_cols=255 Identities=24% Similarity=0.416 Sum_probs=203.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999853 468899999875432 3456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN---------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNN 810 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 810 (973)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999997432 24778889999999999999999 7899999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCc
Q 048430 811 VLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGE 888 (973)
Q Consensus 811 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~ 888 (973)
|+++.++.++++|||++......... .......+..|+|||......++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999998765322211 1222345678999999888889999999999999999998 7788754321
Q ss_pred ccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
.........+.. . ..+..++.++.+++.+||+.+|++||++.|+++.|++
T Consensus 239 ---~~~~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---EEVIYYVRDGNV--------L-----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHHHHhcCCC--------C-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112111111110 0 0112245678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.73 Aligned_cols=254 Identities=23% Similarity=0.403 Sum_probs=204.1
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
++|...+.||+|+||.||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999853 3567999988654433 4578999999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 753 LIMQYMPQGSLEKWLYSHN--------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997644 15899999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcch
Q 048430 825 GIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAV 903 (973)
Q Consensus 825 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
|++...............++..|+|||......++.++|||||||++||+++ |..||...... ..+.....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQAGKL 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HHHHHHHcCCc
Confidence 9987543333333334456788999999888888999999999999999999 77787543211 11111110000
Q ss_pred hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.. ..+..++..+.+++.+||+.+|++||++.|++++|.
T Consensus 237 ~~------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 EL------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 001124567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=303.27 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=204.8
Q ss_pred CCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|+..+.||+|+||.||.++ ..+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999998 4568899999886542 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999875 356899999999999999999999 78999999999999999999999999999886643322
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......+++.|+|||...+..++.++||||||+++|||++|+.||..... ...+.....+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~----------- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGNYTP----------- 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCC-----------
Confidence 22345688999999998888889999999999999999999999864221 11111111111000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+..++.++.+++.+||+.+|++||+++|+++++
T Consensus 221 --------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0123456688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.31 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=207.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CC----eEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NG----VSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|...+.||+|+||.||+|... +| ..||+|...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45777899999999999999854 23 358999876553 3345678899999999999999999999987 78899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999887667999999999999999999999 799999999999999999999999999999876432
Q ss_pred CCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
.... .....++..|+|||......++.++|||||||++||+++ |+.||+.... ..+.+.+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~----------- 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGER----------- 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCCC-----------
Confidence 2211 112224568999999888889999999999999999998 9999865321 112222111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
...+..++..+.+++.+||..+|.+||++.++++.|+++.+..++.
T Consensus 230 -----------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05057 230 -----------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY 275 (279)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence 0011123456889999999999999999999999999987755443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.48 Aligned_cols=266 Identities=21% Similarity=0.277 Sum_probs=206.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|+..+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4566778999999999999985 468899999886543 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++...+ .+++..+..++.+++.|+.|||+ ..+++||||+|+||+++.++.++|+|||++...... .
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---I 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---c
Confidence 99999999987754 68999999999999999999994 368999999999999999999999999998654221 1
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....++..|+|||.+.+..++.++|||||||++||+++|+.||......+... ..+..+.+..........
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~-- 230 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMGILDLLQQIVQEPP-- 230 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhHHHHHHHHHhhccC--
Confidence 223468999999999888889999999999999999999999997543221100 000000000000000000
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
... ....++.++.+++.+|++.||++||+++|++++..-+..
T Consensus 231 ---~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 231 ---PRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ---CCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000 011245678999999999999999999999998544443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=333.04 Aligned_cols=274 Identities=21% Similarity=0.281 Sum_probs=196.8
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC------CceeEEEeee
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH------RNLIKIVSSC 745 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~ 745 (973)
+++....++|.+.++||+|+||+||+|.. ..++.||||+++... .....+..|+.+++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34455678899999999999999999985 468899999986432 223455667777777754 4588999988
Q ss_pred ecC-CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEeCCCC------
Q 048430 746 SNP-GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLLDDDM------ 817 (973)
Q Consensus 746 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~------ 817 (973)
... ++.|+|||++ +++|.+++...+ .+++..+..|+.||+.||+||| . .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccc
Confidence 654 5789999988 678999887664 6999999999999999999999 5 5999999999999998765
Q ss_pred ----------cEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccC
Q 048430 818 ----------VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG 887 (973)
Q Consensus 818 ----------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~ 887 (973)
.+||+|||.+.... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||+.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999876432 2233457999999999999999999999999999999999999999753221
Q ss_pred cccHHHHHHh--hCCcchh---------hhcccc--cCCCCchhhhhhH-----HhHHHHHHHHHHHHHhccccCCCCCC
Q 048430 888 EMSLKQWVAE--SLPGAVT---------EVVDAN--LLSREDEEDADDF-----ATKKTCISYIMSLALKCSAEIPEERI 949 (973)
Q Consensus 888 ~~~~~~~~~~--~~~~~~~---------~~~d~~--l~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~Rp 949 (973)
..+...... ..+..+. ++++.. +............ .........+.+|+.+||++||++||
T Consensus 352 -~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 -EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred -HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 111111110 0011110 111100 0000000000000 00011235678999999999999999
Q ss_pred CHHHHHHH
Q 048430 950 NVKDALAD 957 (973)
Q Consensus 950 t~~evl~~ 957 (973)
|++|+++|
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=320.84 Aligned_cols=267 Identities=19% Similarity=0.211 Sum_probs=197.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
...+|...+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4467999999999999999999864 5788999975322 23568999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
++. ++|.+++......+++.++..++.||+.||.||| +.+||||||||+||+++.++.+||+|||.++..... .
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 995 5999998876667999999999999999999999 899999999999999999999999999998753221 1
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCC-CccccCcc--------cHHHHHHhhC--Ccch--
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPT-NEMFTGEM--------SLKQWVAESL--PGAV-- 903 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~-~~~~~~~~--------~~~~~~~~~~--~~~~-- 903 (973)
......||..|+|||.+.+..++.++|||||||++|||+++..|+ +....... .+...+.... +...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 223346899999999999889999999999999999999966654 32211100 0111111000 0000
Q ss_pred -------hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 904 -------TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 904 -------~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...++........ ...........++.++.+++.+||+.||++|||++|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQP-YTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCc-ccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000000000 0000001112345567789999999999999999999986
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.98 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=198.1
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEecc--chhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 756 (973)
..|.+.++||+||.+.||++...+.+.+|+|.+... +......|..|+..|.+++ |.+|+++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 346677899999999999999888888998866433 4566789999999999995 9999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|=+ .+|.+++...........++.+..||+.++.++| ..||||.||||.|+++-.+ .+||+|||.|.-+.+....
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEee-eEEeeeechhcccCccccc
Confidence 864 4999999987655554488999999999999999 7999999999999998654 8999999999877554333
Q ss_pred -ccccccccccccCccCCCCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 837 -TQTMTLATIGYMAPEYGSEG-----------IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 837 -~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
.....+||+.||+||.+... +.+.++||||+|||+|+|+.|+.||..... .|.+ +.
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK------l~ 583 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK------LH 583 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH------HH
Confidence 44567899999999964432 256889999999999999999999965321 1111 12
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+.|+...-.+. .... ..++.++|+.||+.||++||++.|+++|
T Consensus 584 aI~~P~~~Iefp-----~~~~----~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 AITDPNHEIEFP-----DIPE----NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hhcCCCcccccc-----CCCC----chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222332111000 0000 1228899999999999999999999986
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=304.62 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=202.1
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+|...+.||+|+||.||+++. .+++.||+|.++... ....+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467789999999999999985 468999999986432 344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++... ...+++..+..++.|++.||.||| +.+|+|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988753 345889999999999999999999 89999999999999999999999999999876543221 2
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....++..|+|||......++.++||||||+++|+|++|+.||.... ..........+...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~------------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGSYK------------- 218 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCCCC-------------
Confidence 233468889999999888889999999999999999999999986421 11111111111000
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++..+.+++.+||+.+|++||++.|++..
T Consensus 219 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=314.30 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=205.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCe----EEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGV----SVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++|...+.||+|+||.||+|+.. ++. .||+|.+..... .....+.+|+.++++++||||++++++|..+ ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777889999999999999853 443 578888765432 3345788999999999999999999998754 4679
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999999877667899999999999999999999 899999999999999999999999999999865432
Q ss_pred CCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... ......++..|+|||...+..++.++|||||||++||+++ |+.||..... .....++... . ..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~---~-------~~ 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKG---E-------RL 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC---C-------CC
Confidence 221 1222345778999999888889999999999999999997 8899865321 1112221110 0 00
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
..+..++..+.+++.+||..+|++||+++|+++.|+++.+.-.+.
T Consensus 231 ------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (303)
T cd05110 231 ------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275 (303)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhh
Confidence 001123456889999999999999999999999999887665443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=310.22 Aligned_cols=272 Identities=21% Similarity=0.234 Sum_probs=204.6
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477789999999999999985 478999999987654 33456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+ +++|.+++......+++.++..++.|+++||+||| +.+++|+||||+||+++.++.++++|||.+..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999999876667999999999999999999999 7999999999999999999999999999988765433222
Q ss_pred cccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc---chhhhcc---cc
Q 048430 838 QTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG---AVTEVVD---AN 910 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d---~~ 910 (973)
.....++..|+|||..... .++.++||||+||+++||++|+.||..... ...+.......... .+.+..+ ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 3345688999999987544 468999999999999999999877754221 11111111111000 0000000 00
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...................+.++.+++.+|++.+|++||+++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000111345778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.85 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=202.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 356778899999999999999853 34789999986443 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEe
Q 048430 752 ALIMQYMPQGSLEKWLYSHN---------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 822 (973)
++||||+++|+|.+++.... ..+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999997532 24688899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCC
Q 048430 823 DFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 823 Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
|||+++........ ......++..|+|||......++.++|||||||++||+++ |..||..... .....++. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~---~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVI---D 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHh---c
Confidence 99998765433221 1223346789999999888889999999999999999998 8888854221 11111111 0
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
+. .. ..+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 237 ~~--------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GG--------HL-----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC--------CC-----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00 00 011123567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.58 Aligned_cols=271 Identities=21% Similarity=0.260 Sum_probs=201.1
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477788999999999999986 4689999999865422 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++ ++|.+++......+++..+..++.||++||.||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RC 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CC
Confidence 97 5898888765557999999999999999999999 7999999999999999999999999999988653221 12
Q ss_pred cccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc------hhhhcccc
Q 048430 838 QTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA------VTEVVDAN 910 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~~ 910 (973)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+.........+........... ..+..+..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2334578899999977654 4789999999999999999999986432222211211111111000 00111100
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..... .............++++.+++.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 236 PYPMY-PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccCCC-CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 00000011112356778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=327.65 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=197.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++..++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688889999999999999985 468999999987532 233567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999998755 6899999999999999999999 89999999999999999999999999999875421100
Q ss_pred ----------------------------------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 048430 836 ----------------------------------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPT 881 (973)
Q Consensus 836 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~ 881 (973)
......+||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011346999999999998889999999999999999999999999
Q ss_pred CccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 048430 882 NEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN---VKDALAD 957 (973)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt---~~evl~~ 957 (973)
......+ ........ ...+. ++.....++++.+++.+|+. +|++|++ +.|+++|
T Consensus 237 ~~~~~~~-----~~~~i~~~------~~~~~----------~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQE-----TYRKVMNW------KETLV----------FPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHH-----HHHHHHcC------CCcee----------cCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 6532211 11110000 00000 00001134567788888764 9999985 6788776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=325.24 Aligned_cols=269 Identities=21% Similarity=0.192 Sum_probs=201.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC---CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA---NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
..+|...+.||+|+||.||+|... .++.||+|.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357889999999999999999743 4678999987543 24568999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|++. ++|.+++... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9995 5899988544 47999999999999999999999 89999999999999999999999999999976543222
Q ss_pred c-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc--ccHHHHHHhhCCcchh--------
Q 048430 836 V-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE--MSLKQWVAESLPGAVT-------- 904 (973)
Q Consensus 836 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~-------- 904 (973)
. ......||+.|+|||++....++.++|||||||++|||++|+.||.+..... ..+...+.........
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 1 2234569999999999998899999999999999999999999986543221 1122222111100000
Q ss_pred --hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 --EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 --~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.....................+..++.+++.+|++.||++||++.|++.|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000000001111235678899999999999999999999987
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=322.53 Aligned_cols=239 Identities=25% Similarity=0.271 Sum_probs=188.1
Q ss_pred ccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHH-HHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECE-VMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 67889999987542 122234444444 56778999999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 99999998754 6788889999999999999999 8999999999999999999999999999987542211 22334
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ........... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~--------~~-------- 214 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKP--------LQ-------- 214 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCC--------cC--------
Confidence 5699999999999888999999999999999999999999864221 11111110000 00
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVKDA 954 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ev 954 (973)
.+...+..+.+++.+|++.+|.+||++.+.
T Consensus 215 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 215 ----LKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 001235568899999999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.85 Aligned_cols=268 Identities=22% Similarity=0.264 Sum_probs=199.8
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|++|.||+|+. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477789999999999999986 468999999886542 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
++ ++|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-V 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-c
Confidence 97 58988886533 46899999999999999999999 899999999999999999999999999998765322 1
Q ss_pred cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cch---hhhcc
Q 048430 836 VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAV---TEVVD 908 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~---~~~~d 908 (973)
.......+++.|+|||...+ ..++.++|||||||++|||++|+.||......+ ........... ..+ ....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhHH
Confidence 22233457889999997654 457899999999999999999999986532111 11111111000 000 00000
Q ss_pred --cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 --ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 --~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...... ...........+++++.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKW---KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhcccc---CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0000001112356778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=306.52 Aligned_cols=249 Identities=25% Similarity=0.316 Sum_probs=203.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777889999999999999854 68999999987553 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++++|||.++...... ..
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 9999999999875 6899999999999999999999 8999999999999999999999999999998765332 12
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....++..|+|||+..+..++.++|||||||++|||++|+.||...... .......... .+.+..
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~-----~~~~~~---- 220 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFLIPKNN-----PPSLEG---- 220 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHHhhhcC-----CCCCcc----
Confidence 23346788999999998888999999999999999999999998653211 1111100000 000000
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..++.++.+++.+||..+|++||++++++++
T Consensus 221 ---------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 ---------NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---------cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0145568899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.00 Aligned_cols=253 Identities=25% Similarity=0.305 Sum_probs=205.3
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677889999999999999865 68999999887653 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++++|.+++......+++..+..++.|++.|++||| + .+++||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999876557899999999999999999999 7 8999999999999999999999999999875532111
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....++..|+|||...+..++.++||||||+++|+|++|+.||.............+......... .+
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~------ 224 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP-----RL------ 224 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-----CC------
Confidence 115688899999998888999999999999999999999999865432222222222211111000 00
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++.++.+++.+||..+|++||++.|++++
T Consensus 225 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 -------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 001146678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.94 Aligned_cols=237 Identities=24% Similarity=0.270 Sum_probs=188.1
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHH-HHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECE-VMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 478999999986542 223345555555 46778999999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|..++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 99999887654 7899999999999999999999 899999999999999999999999999998753221 112234
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .......... .+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~--------~~~~------- 215 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHK--------PLVL------- 215 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcC--------CccC-------
Confidence 5689999999999988999999999999999999999999864211 1111111110 0000
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVK 952 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 952 (973)
+...+..+.+++.+|++.+|++||++.
T Consensus 216 -----~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 216 -----RPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred -----CCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 011345578899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=305.66 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEeC---CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 686 NLLGSGSFDNVYKATLA---NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
+.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999854 346799998865532 33457889999999999999999999999999999999999999
Q ss_pred CHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-
Q 048430 762 SLEKWLYSHN----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV- 836 (973)
Q Consensus 762 sL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 836 (973)
+|.+++.... ...++..+..++.|+++|++||| +.+++||||||+||+++.++.+|++|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 24567788899999999999999 899999999999999999999999999998754322221
Q ss_pred ccccccccccccCccCCCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 837 TQTMTLATIGYMAPEYGSEG-------IVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~-------~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
......++..|+|||+.... .++.++|||||||++|||++ |+.||......+ ...+. ..+......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~---~~~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT---VREQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---hhcccCCCCC
Confidence 12234577889999976532 35789999999999999996 999986532211 11110 0000001111
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
+... ..+++.+.+++..|| .+|++||+++||++.|+
T Consensus 233 ~~~~--------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLK--------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccC--------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1100 112445788999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=307.28 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=200.0
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch---------hhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED---------RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
+|.....||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999985 4688999998864321 123578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999998764 6889999999999999999999 789999999999999999999999999998866
Q ss_pred CCCCCc-----ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 831 DGVDPV-----TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 831 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
...... ......++..|+|||......++.++|||||||++|||++|+.||..... .... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~----- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAI-FKIGE----- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHH-HHHhc-----
Confidence 421111 11123578899999999888899999999999999999999999865321 1111 00000
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+ ..+..++..+.+++.+||+.+|.+||++.|++++
T Consensus 227 ~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 NASP--------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCCC--------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000 0112345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.91 Aligned_cols=240 Identities=23% Similarity=0.356 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEeCC--------CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 686 NLLGSGSFDNVYKATLAN--------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 334888887655445567889999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc--------EEEeecccccc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV--------AHLGDFGIAKL 829 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfgla~~ 829 (973)
+++|+|.+++......+++..+..++.||+.|++||| +++|+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999877667899999999999999999999 899999999999999987765 69999998865
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCC-CCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRR-KPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|. .||....... ......
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~----------- 219 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYE----------- 219 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHH-----------
Confidence 432 223457889999998876 45799999999999999999995 4543211110 000000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
... ..+.....++.+++.+||+.+|++||+++++++.|+
T Consensus 220 -~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -DRH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -ccc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000112355889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=304.81 Aligned_cols=238 Identities=24% Similarity=0.430 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEeCCC-----------eEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 686 NLLGSGSFDNVYKATLANG-----------VSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~-----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++||+|+||.||+|...+. ..|++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4699999999999996532 25788877644433 5788999999999999999999999987 778999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-------cEEEeecccc
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-------VAHLGDFGIA 827 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfgla 827 (973)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876657899999999999999999999 89999999999999999888 7999999998
Q ss_pred cccCCCCCcccccccccccccCccCCCCC--CCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEG--IVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
..... .....++..|+|||+.... .++.++|||||||++|||++ |..||...... ....+...
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~------- 221 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD------- 221 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc-------
Confidence 86542 2234467789999988776 78999999999999999999 46666543211 11111110
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
...... .....+.+++.+||..+|.+||++.|+++.|+
T Consensus 222 ----~~~~~~-------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 ----QHRLPM-------------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----CCCCCC-------------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 00156889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.84 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=204.0
Q ss_pred cCCCCCccccccCceEEEEEEeC--------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG 749 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 749 (973)
.+|.+.+.||+|+||.||+|+.. .+..||+|.++... ....+.+.+|+.+++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999742 23468999887543 33457889999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD 814 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 814 (973)
..++|+||+++|+|.+++.... ..+++.++..++.|+++||+||| +.+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999997532 34788999999999999999999 89999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHH
Q 048430 815 DDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLK 892 (973)
Q Consensus 815 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~ 892 (973)
.++.+||+|||+++........ ......++..|+|||......++.++|||||||++|||++ |..||.... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence 9999999999999865432211 1122234568999999988889999999999999999998 788875421 12
Q ss_pred HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.+......+... ..+..++.++.+++.+||+.+|++||++.|++++|+++..
T Consensus 244 ~~~~~~~~~~~~-------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 ELFKLLKEGHRM-------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHcCCCC-------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 222111110000 0111345668899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=321.41 Aligned_cols=270 Identities=22% Similarity=0.204 Sum_probs=199.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------ 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 748 (973)
..++|...+.||+|+||.||+|.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999985 46889999988643 223356788899999999999999999988543
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
...++||||+++ ++.+++.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999965 67777654 4788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC--------
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP-------- 900 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 900 (973)
..... .......+|..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+...+.....
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence 65322 22234568999999999988889999999999999999999999986532111 11111111000
Q ss_pred --cchhhhccccc--CCCCchhh------hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 --GAVTEVVDANL--LSREDEED------ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 --~~~~~~~d~~l--~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+...++... ........ ............++.+++.+|++.||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00001110000 00000000 00000111234568899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.28 Aligned_cols=237 Identities=24% Similarity=0.271 Sum_probs=187.3
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHH-HHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECE-VMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
++||+|+||.||+|+. .+++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999996 468899999986442 222344555554 57889999999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|..++.... .+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST 155 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence 99999887654 6889999999999999999999 899999999999999999999999999998753221 122234
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~--------~--------- 213 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKP--------L--------- 213 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCC--------C---------
Confidence 568999999999988889999999999999999999999986421 111111111100 0
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVK 952 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 952 (973)
..+.....++.+++.+|++.+|++||++.
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 ---QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00112245588999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=310.35 Aligned_cols=272 Identities=22% Similarity=0.255 Sum_probs=202.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999865 689999998864432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|++++.+..++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999988888776543 6899999999999999999999 79999999999999999999999999999987643221
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhhcccc-cC
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEVVDAN-LL 912 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~-l~ 912 (973)
......++..|+|||...+ ..++.++|||||||++|||++|+.||......+ .......... ........+.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhccccccc
Confidence 2223457889999998765 557899999999999999999999986533221 1111111100 00000111110 00
Q ss_pred -CCCchhh---hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 -SREDEED---ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 -~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....... ..........+..+.+++.+||+.+|++||++.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000 00000111245778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.90 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=200.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+|...+.||+|+||.||+|... +++.||+|.++.. .+.....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999965 7899999988754 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 759 PQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 759 ~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
++++|.+++... ...+++..+..++.|++.|+.|||+ +.+|+||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999999998764 2368999999999999999999994 368999999999999999999999999998755321
Q ss_pred ccccccccccccCccCCCCC------CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 837 TQTMTLATIGYMAPEYGSEG------IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~------~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
......++..|+|||..... .++.++|||||||++|||++|+.||....... ....+.. ..+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~--------~~~~~ 226 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSA--------IVDGD 226 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHH--------HhhcC
Confidence 22234578899999987543 35889999999999999999999986422111 1110000 00000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
. ...+..++.++.+++.+||+.+|++||++++++++-
T Consensus 227 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 227 P-----------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred C-----------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 0 001123567788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=309.41 Aligned_cols=275 Identities=21% Similarity=0.274 Sum_probs=201.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++.+|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457888999999999999999985 4689999999865432 22346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+. +++.+++......+++.++..++.|+++||+||| ..+|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9995 6888877665556888899999999999999999 7899999999999999999999999999987643221
Q ss_pred cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh-CCcc-hh-hhc----
Q 048430 836 VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES-LPGA-VT-EVV---- 907 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-~~-~~~---- 907 (973)
.......++..|+|||...+ ..++.++|||||||++|||++|+.||+........+...+... .+.. .. ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 11233457889999998765 3578899999999999999999999975432211111111100 0000 00 000
Q ss_pred -ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 -DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 -d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+.......................+.+++.+|++.||++|||++|++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000001124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.30 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=196.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-----hhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCee
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-----DRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFK 751 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 751 (973)
.+|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999985 468999999886432 2334678899999999999999999998865 4677
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++++||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999998755 5889999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCC--cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 832 GVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 832 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.... .......++..|+|||+..+..++.++|||||||++||+++|+.||..... ... +........ .+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~-~~~~~~~~~----~~ 228 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAA-IFKIATQPT----NP 228 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHH-HHHHhcCCC----CC
Confidence 2111 111224578899999999888899999999999999999999999865321 111 111000000 00
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+.+.+.+++ +||..+|++||+++|+++|
T Consensus 229 --------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 229 --------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01122345567777 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.90 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=200.4
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 45567899999999999985 468899999887543 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+++|.+++... .+++..+..++.|++.|+.||| ..+++|+||+|+||++++++.++++|||++....... ....
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06642 86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence 99999998754 5899999999999999999999 8999999999999999999999999999987654322 1222
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
...++..|+|||+..+..++.++|||||||++|||++|+.||....... ...++.. .. .+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~---~~-----~~~--------- 220 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPK---NS-----PPT--------- 220 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhc---CC-----CCC---------
Confidence 3457889999999988889999999999999999999999986432211 0110000 00 000
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
....++..+.+++.+||+.+|++||++.|+++|-
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 221 -----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred -----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0112355688999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=311.76 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=202.3
Q ss_pred HHHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeee---
Q 048430 672 YHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCS--- 746 (973)
Q Consensus 672 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--- 746 (973)
++.+..+.++|...+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 455667788999999999999999999985 468899999875432 2235678899999999 6999999999873
Q ss_pred --cCCeeEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEE
Q 048430 747 --NPGFKALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHL 821 (973)
Q Consensus 747 --~~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 821 (973)
..+..++||||+++++|.+++.. ....+++..+..++.|+++|+.||| +.+|+||||||+||+++.++.+|+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEE
Confidence 34578999999999999998763 2246888999999999999999999 899999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHH
Q 048430 822 GDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA 896 (973)
Q Consensus 822 ~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 896 (973)
+|||++....... .......|+..|+|||++. ...++.++||||+||++|||++|+.||..... ......
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~----~~~~~~ 240 (286)
T cd06638 166 VDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----MRALFK 240 (286)
T ss_pred ccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----hHHHhh
Confidence 9999987654322 2223446899999999764 34578899999999999999999999864321 111110
Q ss_pred hhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 897 ESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 897 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
. ....... ...+..++.++.+++.+||+.+|++||++.|++++.
T Consensus 241 ~-~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 I-PRNPPPT-----------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c-cccCCCc-----------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0000000 001112345688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=338.33 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=198.8
Q ss_pred HHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCe
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGF 750 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 750 (973)
....++|.+.+.||+|+||.||+|.. .++..||+|++... .......+..|+.++++++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34557899999999999999999985 46788999988654 23345678999999999999999999998854 457
Q ss_pred eEEEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcC----CCCeEEccCCCCcEEeCC--------
Q 048430 751 KALIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGY----STPIIHCDLKPNNVLLDD-------- 815 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~dlk~~Nill~~-------- 815 (973)
.++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999753 246899999999999999999999421 145999999999999964
Q ss_pred ---------CCcEEEeecccccccCCCCCcccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 048430 816 ---------DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEM 884 (973)
Q Consensus 816 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~ 884 (973)
.+.+||+|||++...... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 235899999999865422 12234568999999998753 45889999999999999999999998642
Q ss_pred ccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 885 FTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ....++....... .+ ....++.++.+|+..||+.+|++||++.|++++
T Consensus 247 ~----~~~qli~~lk~~p-------~l-------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 N----NFSQLISELKRGP-------DL-------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred C----cHHHHHHHHhcCC-------CC-------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 1 2222222111100 00 001134568899999999999999999999965
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=304.09 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=201.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-----hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-----DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
+|...+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+.+++.++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999965 78999999886543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+||+++++|.+++.... .+++..+..++.|+++|++||| +.+|+|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999998764 6899999999999999999999 8999999999999999999999999999987654322
Q ss_pred CcccccccccccccCccCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGI-VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
......++..|+|||...... ++.++|+|||||++|+|++|+.||...... .............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~--------- 221 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAVFKIGRSKELP--------- 221 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHHHHHHhcccCC---------
Confidence 223456888999999877666 899999999999999999999998653211 1111000000000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.+|.+||++.+++++
T Consensus 222 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ----------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0011235668889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.18 Aligned_cols=193 Identities=22% Similarity=0.304 Sum_probs=159.0
Q ss_pred CccccccCceEEEEEEeC---CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeee--cCCeeEEEEEecC
Q 048430 685 SNLLGSGSFDNVYKATLA---NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS--NPGFKALIMQYMP 759 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~ 759 (973)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++. .....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999854 45789999886442 2346788999999999999999999884 3567899999986
Q ss_pred CCCHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe----CCCCcEEEeecccc
Q 048430 760 QGSLEKWLYSH--------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL----DDDMVAHLGDFGIA 827 (973)
Q Consensus 760 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla 827 (973)
+ +|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 888877532 135888999999999999999999 8999999999999999 56679999999999
Q ss_pred cccCCCCCc--ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 048430 828 KLLDGVDPV--TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNE 883 (973)
Q Consensus 828 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~ 883 (973)
+........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876432211 1233468999999998765 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=321.77 Aligned_cols=270 Identities=21% Similarity=0.185 Sum_probs=198.9
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------ 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 748 (973)
..++|...+.||+|+||.||+|.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 456899999999999999999985 46889999998643 233456788999999999999999999987543
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
...++||||+++ ++.+++.. .+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 78777754 4788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--chhh-
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--AVTE- 905 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~- 905 (973)
..... .......+|..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+...+...... ....
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHh
Confidence 65322 2223456899999999998889999999999999999999999999653211 1111111110000 0000
Q ss_pred -------hcccc--cCCCCchhh------hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 -------VVDAN--LLSREDEED------ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 -------~~d~~--l~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..... ......... ............++.+++.+|++.||++|||+.|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000000000 00000011124568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.92 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=200.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec-CCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 756 (973)
+|...+.||+|++|.||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999854 57899999986542 2345678899999999999999999998764 456789999
Q ss_pred ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|+++++|.+++.... ..+++.++..++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999998643 45899999999999999999999 8999999999999999999999999999988664322
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......+++.|+|||...+..++.++|||||||+++||++|+.||+... ..........+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~----------- 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEGKLP----------- 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcCCC-----------
Confidence 22233458889999999988889999999999999999999999986421 11111111111100
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+|++.+|++||++.|+++|
T Consensus 221 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0012245668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.58 Aligned_cols=273 Identities=22% Similarity=0.276 Sum_probs=200.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999864 689999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+.+ +|.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 975 999999876667899999999999999999999 8999999999999999999999999999987543211 11
Q ss_pred cccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhhccc-ccC
Q 048430 838 QTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEVVDA-NLL 912 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~-~l~ 912 (973)
.....++..|+|||...+ ..++.++||||+||++|||++|+.||.........+........ +.......+. ...
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 222346889999998764 45789999999999999999999998653321111111111110 0000000000 000
Q ss_pred C----CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 S----REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ..................++.+++.+|++.+|++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00000000000000112567899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=308.85 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=203.7
Q ss_pred CCHHHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeec
Q 048430 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSN 747 (973)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 747 (973)
.+..++..+.+.|...+.||+|+||.||+|.. .+++.||+|++..... ....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45556666778899999999999999999985 5688999999865432 345688899999998 69999999999842
Q ss_pred ------CCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 748 ------PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 748 ------~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
....++||||+++|+|.+++.... ..+++..+..++.|+++|++||| +.+|+||||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 467899999999999999997643 45788889999999999999999 89999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHH
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 895 (973)
|+|||++....... .......++..|+|||.+. ...++.++|||||||++|||++|+.||....... ...
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----~~~ 236 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----ALF 236 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----hhh
Confidence 99999987553211 1223356889999999765 3467889999999999999999999986432111 000
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ....... .....++.++.+++.+||+.||++||++.|++++
T Consensus 237 ~~------~~~~~~~-------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 LI------PRNPPPK-------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hH------hhCCCCC-------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 0000000 0112356679999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.93 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=203.0
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 468999999986542 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... ..+++.++..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999997643 35789999999999999999999 79999999999999999999999999999976543221
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......++..|+|||...+..++.++|||||||++++|++|+.||.... ....+.....+...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~------------ 219 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGSYP------------ 219 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCCCC------------
Confidence 1223457889999999888889999999999999999999999985421 11111111111100
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++.++.+++.+||+.+|++||++.|+++|
T Consensus 220 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112345668999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.30 Aligned_cols=249 Identities=31% Similarity=0.513 Sum_probs=201.2
Q ss_pred CCCccccccCceEEEEEEeCC-----CeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 683 GESNLLGSGSFDNVYKATLAN-----GVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
...+.||.|+||.||+|+... +..||+|+++..... ..+.+..|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998653 488999998755433 56789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|+++++|.+++...... +++.++..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999876534 899999999999999999999 89999999999999999999999999999987654322
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......+++.|+|||......++.++||||+|++++||++ |+.||+... .............
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~----------- 222 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEYLKKGYR----------- 222 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCCC-----------
Confidence 22222347789999999888889999999999999999998 777775421 1111111110000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
...+..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus 223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000112466789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=300.29 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=200.3
Q ss_pred CCCCCccccccCceEEEEEEeCC--CeEEEEEEEecc----------chhhHHHHHHHHHHHHh-ccCCceeEEEeeeec
Q 048430 681 GFGESNLLGSGSFDNVYKATLAN--GVSVAVKVFNLQ----------EDRALKSFDTECEVMRR-IRHRNLIKIVSSCSN 747 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 747 (973)
+|...+.||+|+||.||+|.... ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999654 788999987532 22334567788888865 799999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 748 PGFKALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
.+..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+ ..+++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998753 34568999999999999999999993 368999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 825 GIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 825 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
|.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||.... ............
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~-- 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATKIVEAV-- 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHHHhhcc--
Confidence 9998754332 3344568899999999988889999999999999999999999985421 111111110000
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.... ....++..+.+++.+||+.||++||++.|+.++++
T Consensus 230 ------~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 ------YEPL----------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------CCcC----------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000 00123466889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=316.79 Aligned_cols=270 Identities=21% Similarity=0.236 Sum_probs=197.9
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP----- 748 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 748 (973)
...++|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 578899999986432 22345677899999999999999999987532
Q ss_pred -CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 749 -GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 749 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
...++++|++ +++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 4578999988 77999888654 5899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--c-h
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--A-V 903 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~-~ 903 (973)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..+....... . .
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 865421 233468999999998766 56899999999999999999999998642211 1111111111000 0 0
Q ss_pred hhhccc---ccCCCCchhhhhh-HHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 904 TEVVDA---NLLSREDEEDADD-FATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 904 ~~~~d~---~l~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+... ............. ........+.+.+++.+|++.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000000 00001134457899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.38 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=187.7
Q ss_pred cccccCceEEEEEEeC---CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 687 LLGSGSFDNVYKATLA---NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
.||+|+||.||+|... ....+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999754 34578888775443 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc-c
Q 048430 763 LEKWLYSHN----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-T 837 (973)
Q Consensus 763 L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~ 837 (973)
|.+++.... ...++.....++.||+.|++||| +.+|+||||||+||+++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999998653 23467788899999999999999 899999999999999999999999999998754322211 1
Q ss_pred cccccccccccCccCCC-------CCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 838 QTMTLATIGYMAPEYGS-------EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~-------~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.....++..|+|||+.. ...++.++|||||||++|||++ |..||...... ..+...+.. ......++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~----~~~~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVRE----QDIKLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhc----cCccCCCC
Confidence 22334677899999753 3456889999999999999999 77777543211 111111111 00011111
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
. .+..++..+.+++..|| .||++||+++||++.|
T Consensus 234 ~--------------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 Q--------------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred c--------------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0 11234566778999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.38 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=205.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
..+.|+.-++||+|+||.||-++. .+|+-+|.|.+..+. .........|-.++++++.+.||.+-..|+.++.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346778889999999999999985 479999999775442 2233556789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 754 IMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
|+..|.||+|.-+|...+ ..++++.++.+|.+|+.||++|| ..+||+||+||+|||+|+.|.++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999998888755 57999999999999999999999 89999999999999999999999999999998764
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. .....+||.+|||||++.++.|+...|-||+||++|||+.|+.||....... -.+.+|++..
T Consensus 340 g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~~ 403 (591)
T KOG0986|consen 340 GK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRTL 403 (591)
T ss_pred CC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHHh
Confidence 33 3334489999999999999999999999999999999999999985432211 1223343333
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN 950 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 950 (973)
... ...+..++++..++.+..++.||++|..
T Consensus 404 ~~~-------~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 404 EDP-------EEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cch-------hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 221 1233567888999999999999999984
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=309.91 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=202.6
Q ss_pred CHHHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 671 SYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 671 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
...++..+.++|...+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 4456666788999999999999999999986 568899999986432 2235678899999998 799999999998643
Q ss_pred -----CeeEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 749 -----GFKALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 749 -----~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
+..++||||+++++|.++++. ....+++..++.++.|++.||+||| ..+++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 468999999999999998863 2346899999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHH
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG-----IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 895 (973)
|+|||++....... .......++..|+|||..... .++.++|||||||++|||++|+.||...... ..+..+.
T Consensus 169 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~ 246 (291)
T cd06639 169 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP 246 (291)
T ss_pred Eeecccchhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh
Confidence 99999987654322 122334688899999976543 3689999999999999999999998653211 1111110
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...... + ..+......+.+++.+||+.+|++||++.|+++|
T Consensus 247 ----~~~~~~-----~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 ----RNPPPT-----L------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----cCCCCC-----C------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000 0 0111234568899999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.62 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=204.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999985 468899999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++... .+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 999999999765 4789999999999999999999 89999999999999999999999999998876543222 22
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
....+++.|+|||......++.++|||||||++||+++|+.||......+... .. ....
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~----~~~~---------------- 231 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI----ATNG---------------- 231 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-eh----hcCC----------------
Confidence 33468889999999888889999999999999999999999986532211100 00 0000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......+...+..+.+++.+||+.+|++||++.+++.|
T Consensus 232 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 -TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001112234568899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=282.92 Aligned_cols=247 Identities=24% Similarity=0.275 Sum_probs=197.9
Q ss_pred CccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 685 SNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
..-+|.|..|.||+++. .+|...|||.+.... .++.+.+...++++..-+ .|.||+.+|||.......+.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 46799999999999995 468999999987654 345677888888776654 89999999999998888999999854
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
.++.++..-..++++.-+-++...+.+||.||.+ +++|+|||+||+|||+|+.|++|+||||.+..+. ++..++..
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSkAhtrs 251 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSKAHTRS 251 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee--cccccccc
Confidence 6777777666678888888999999999999997 8999999999999999999999999999998764 33445556
Q ss_pred cccccccCccCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 842 LATIGYMAPEYGSE---GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 842 ~~~~~y~aPE~~~~---~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
.|-+.|||||.+.. ..|+.++|||||||.++|+.||+.||..-...-+.+...... .
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-e------------------- 311 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-E------------------- 311 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-C-------------------
Confidence 78999999997764 468999999999999999999999986532221111111110 0
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+...+.++.++.+++..|++.|+.+||...++++|
T Consensus 312 -PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 01112222367889999999999999999999999886
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.67 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=205.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||.|+||.||+|.. .++..+|+|++.... ....+.+.+|+.+++.++|+|++++++.+......++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999985 468899999986543 23567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997642 36899999999999999999999 89999999999999999999999999999876643322
Q ss_pred c---ccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 836 V---TQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 836 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
. ......++..|+|||.+... .++.++|||||||++|||++|+.||....... ......... + +.+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~-~--------~~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND-P--------PSL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-C--------CCc
Confidence 2 12334688999999987776 78999999999999999999999986532211 111111100 0 000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ......+++++.+++.+||+.+|++||+++|+++|
T Consensus 228 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ET---------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CC---------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00012346778999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=309.10 Aligned_cols=245 Identities=23% Similarity=0.298 Sum_probs=198.4
Q ss_pred CccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 685 SNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
...||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 46799999999999985 46889999998766555567789999999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 843 (973)
.+++... .+++.++..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||++........ ......+
T Consensus 107 ~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 180 (292)
T cd06658 107 TDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG 180 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence 9988654 5899999999999999999999 78999999999999999999999999999876532221 2233468
Q ss_pred cccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhH
Q 048430 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923 (973)
Q Consensus 844 ~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 923 (973)
+..|+|||......++.++|||||||++|||++|+.||...... .....+.. .....+.
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~--------~~~~~~~----------- 239 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRD--------NLPPRVK----------- 239 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh--------cCCCccc-----------
Confidence 89999999988888999999999999999999999998642110 00000000 0010000
Q ss_pred HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 924 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....+..+.+++.+||+.+|++|||++|++++
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011234568889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.08 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=202.7
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477789999999999999985 4789999999876544 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++.... .+++..+..++.|+++|++||| +.+|+|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998754 5889999999999999999999 8999999999999999999999999999988764333221
Q ss_pred c---ccccccccccCccCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 838 Q---TMTLATIGYMAPEYGSEGI---VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 838 ~---~~~~~~~~y~aPE~~~~~~---~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
. ....++..|+|||...... .+.++||||||+++||+++|+.||...... ......+.. +. .+.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~---~~-----~~~- 226 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGA---GH-----KPP- 226 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhc---CC-----CCC-
Confidence 1 1345788999999887766 889999999999999999999998643211 111111110 00 000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+....++..+.+++.+||+.+|++||++.|++.+
T Consensus 227 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 227 -----------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -----------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00111235567899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.41 Aligned_cols=247 Identities=32% Similarity=0.497 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEeCC-------CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 686 NLLGSGSFDNVYKATLAN-------GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+.||+|+||.||+|+..+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998542 3579999875443 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-----cEEEeeccc
Q 048430 758 MPQGSLEKWLYSH------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-----VAHLGDFGI 826 (973)
Q Consensus 758 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl 826 (973)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753 234788999999999999999999 78999999999999999887 899999999
Q ss_pred ccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 827 AKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 827 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+......... ......++..|+|||+..++.++.++|||||||++|||++ |+.||..... ......+.. +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~---~~-- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTA---GG-- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhc---CC--
Confidence 8765322211 1122345678999999998899999999999999999998 9999854221 111111100 00
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
....+..++..+.+++.+||+.+|++||+++++++.|+
T Consensus 231 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -----------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111234567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=302.88 Aligned_cols=257 Identities=24% Similarity=0.279 Sum_probs=200.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 755 (973)
++|...+.||.|++|.||+|.. .+++.||+|.+..... .....+.+|++++++++||||++++++|.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3677889999999999999996 4689999999875433 345678999999999999999999998854 44789999
Q ss_pred EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||+++++|.+++.. ....++...+..++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 2346889999999999999999999 89999999999999999999999999999875432
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccC---cccHHHHHHhhCCcchhhhccc
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG---EMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.. .....++..|+|||...+..++.++||||+||++|||++|+.||+..... ......++..... ...
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 228 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN---PEL--- 228 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---hhh---
Confidence 11 12335788899999998889999999999999999999999998754221 1111122111000 000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.... .....+++.+.+++.+||+.+|++|||+.|++++-
T Consensus 229 --~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 229 --KDEP--------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred --ccCC--------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0000 00012356789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=310.73 Aligned_cols=269 Identities=24% Similarity=0.297 Sum_probs=202.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...++||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999975 589999998754322 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|++++++.++..... .+++.++..++.|+++|++||| +.+++|||++|+||++++++.++++|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 999999988776543 5899999999999999999999 7899999999999999999999999999988654322 2
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh-----hCCcchhhhcccc
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-----SLPGAVTEVVDAN 910 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~d~~ 910 (973)
......++..|+|||+..+ ..++.++|||||||++|||++|+.||..... ...+... ..........+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhHHHhccc
Confidence 2233457889999998764 4578899999999999999999988854221 1111110 0000011111100
Q ss_pred -----cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 -----LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 -----l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..................++..+.+++.+||+.+|++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000111122456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.82 Aligned_cols=250 Identities=18% Similarity=0.321 Sum_probs=186.3
Q ss_pred cccccCceEEEEEEeCCC---eEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 687 LLGSGSFDNVYKATLANG---VSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 345667665443 3345789999999999999999999999999999999999999999
Q ss_pred HHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-ccc
Q 048430 763 LEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQ 838 (973)
Q Consensus 763 L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~ 838 (973)
|.+++.... ...++..+..++.||++||+||| +.+++||||||+||+++.++.+||+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998642 34567778899999999999999 78999999999999999999999999999864321111 112
Q ss_pred ccccccccccCccCCCC-------CCCCcchhHHHHHHHHHHHHhC-CCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 839 TMTLATIGYMAPEYGSE-------GIVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~-------~~~~~~sDvws~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
....++..|+|||+... ..++.++|||||||++|||+++ ..||..... ...+.....+......++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhhcccccCCCc
Confidence 33467889999997643 2457899999999999999974 567653221 1111111111111112211
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
+.. .+.+.+.+++..|| .+|++||+++|+++.|.
T Consensus 234 ~~~--------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LEL--------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCC--------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 13456788999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.39 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=200.7
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477789999999999999985 478899999986542 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~~~ 835 (973)
+++++|.+++.... ..+++..+..++.|+++|++||| +.+++||||+|+||+++.+ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998753 45899999999999999999999 8999999999999999865 468999999998664322
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......++..|+|||......++.++||||||+++|+|++|+.||+.... ...+..........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~---------- 220 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGTFAP---------- 220 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcCCCC----------
Confidence 22234578899999999888899999999999999999999999865321 11111111000000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..++.++.+++.+||+.+|++|||+.|++++
T Consensus 221 ---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011245668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=316.91 Aligned_cols=241 Identities=23% Similarity=0.248 Sum_probs=187.9
Q ss_pred ccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc---cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI---RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 688 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
||+|+||.||+|+. .+++.||||++.... ......+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 468999999986432 12234455667776655 699999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 99999987654 6899999999999999999999 8999999999999999999999999999987542211 22234
Q ss_pred ccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 841 TLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+.......+.. .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~------~~~------- 217 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGKV------RFP------- 217 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCCC------CCC-------
Confidence 5689999999987654 47999999999999999999999986421 1111111111100 000
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERI----NVKDALAD 957 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp----t~~evl~~ 957 (973)
...++.++.+++.+||+.||++|| ++.|+++|
T Consensus 218 ------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 ------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 011345678899999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.56 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=197.5
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4577889999999999999975 57889999986543 236788999999999999999999998754 4799999999
Q ss_pred CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 760 QGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 760 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
+++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||.+...... .
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~ 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----V 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc----C
Confidence 999999998654 35889999999999999999999 899999999999999999999999999998754321 1
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....+..|+|||......++.++|||||||++|||++ |+.||..... .........+ ..
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~---------~~----- 215 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVEKG---------YR----- 215 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHhCC---------CC-----
Confidence 12234678999999888889999999999999999998 8888864321 1111111000 00
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus 216 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 -----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00112345678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.56 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=201.6
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc------hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE------DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
+|+..+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999984 678999999986443 1235678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecccccccCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDG 832 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~ 832 (973)
|+||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++ .+||+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999998654 6889999999999999999999 89999999999999998776 699999999877643
Q ss_pred CCCc---ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 833 VDPV---TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 833 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.... ......++..|+|||......++.++||||+|+++|+|++|+.||...... .....+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~------ 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASATT------ 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccCC------
Confidence 2111 122345788999999988888999999999999999999999998542211 11111111000000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+...+.++.+++.+|++.+|++||++.|+++|
T Consensus 229 ------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 ------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000112345678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=297.55 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=207.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|+..+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36778899999999999999865 599999999876643 4467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... .+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999998763 7899999999999999999999 7 99999999999999999999999999998866432222
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....++..|+|||......++.++||||||+++|||++|+.||...... ...+.+.........
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~------------ 221 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGPPP------------ 221 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCCCC------------
Confidence 22345788999999998889999999999999999999999998664321 111111111110000
Q ss_pred hhhhhhHHhHHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 917 EEDADDFATKKT-CISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 917 ~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.. ++..+.+++.+|++.+|++||++.|++++
T Consensus 222 -------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 -------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00112 45678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.45 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=196.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-----hhhHHHHHHHHHHHHhccCCceeEEEeeeecC--Cee
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-----DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFK 751 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 751 (973)
.+|...++||+|+||.||.|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999985 468999999875431 23356788999999999999999999998663 567
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999998654 5888999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCC--cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 832 GVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 832 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.... .......++..|+|||...+..++.++|||||||++|||++|+.||..... ....... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~-~~~~~------ 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKI-ATQPT------ 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHHH-hcCCC------
Confidence 2111 112234588899999998888899999999999999999999999864211 1111110 00000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+......+.+++.+|+. +|++||+++|++++
T Consensus 227 ------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 000122345567889999985 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=303.95 Aligned_cols=250 Identities=28% Similarity=0.354 Sum_probs=193.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-hhHHHHHHHHHH-HHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-RALKSFDTECEV-MRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|+||.||+|+.. +|+.||+|+++.... .....+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999864 699999999875432 223455556665 566789999999999999999999999
Q ss_pred ecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 757 YMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYST-PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 757 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
|++ |+|.+++... ...+++..+..++.|++.||+||| +. +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887642 246899999999999999999999 65 899999999999999999999999999876532
Q ss_pred CCCcccccccccccccCccCCCC----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSE----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
. .......++..|+|||.... ..++.++|||||||++|||++|+.||.........+...... . .
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~-----~ 225 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE----P-----S 225 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----C-----C
Confidence 1 12233457889999997654 456889999999999999999999986432211111111100 0 0
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.+ ....++.++.+++.+||..+|++||++++++++
T Consensus 226 ~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 PQL-------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCC-------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 001245678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.17 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=198.3
Q ss_pred CccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 685 SNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
...||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999985 46899999998765545556788999999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 843 (973)
.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||++....... .......+
T Consensus 106 ~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~ 179 (297)
T cd06659 106 TDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVG 179 (297)
T ss_pred HHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceec
Confidence 9988653 5899999999999999999999 8999999999999999999999999999987553221 22234568
Q ss_pred cccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhH
Q 048430 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923 (973)
Q Consensus 844 ~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 923 (973)
+..|+|||+.....++.++|||||||++|||++|+.||...... ..+ ..+....... .
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~-~~~~~~~~~~--------~------------ 237 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAM-KRLRDSPPPK--------L------------ 237 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHhccCCCC--------c------------
Confidence 89999999988888999999999999999999999998642111 111 1111000000 0
Q ss_pred HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 924 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......+..+.+++.+||+.+|++||+++|++++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0001234568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=301.40 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=198.8
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch----------hhHHHHHHHHHHHHhccCCceeEEEeeeecCC
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED----------RALKSFDTECEVMRRIRHRNLIKIVSSCSNPG 749 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 749 (973)
+|...+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999984 4689999998754211 12356788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++||||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999998764 6899999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCCCc-ccccccccccccCccCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 830 LDGVDPV-TQTMTLATIGYMAPEYGSEGI--VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 830 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
....... ......++..|+|||...... ++.++||||||+++||+++|..||..... ....... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKL-GNKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHh-hccccCCc
Confidence 5322111 122345788999999876544 78999999999999999999999853211 1111110 00000000
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.. .....++.++.+++.+||..+|++||+++|+++|
T Consensus 233 ~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP--------------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc--------------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0011245678999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=305.20 Aligned_cols=271 Identities=24% Similarity=0.284 Sum_probs=200.9
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-----hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
+|...+.||+|+||.||+|.. .+++.||||.+..... .....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 467788999999999999985 4689999999875532 2345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+ +|+|.+++......+++..+..++.|+++||+||| +.+|+||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999999876546999999999999999999999 8999999999999999999999999999998764322
Q ss_pred CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc-cc-
Q 048430 835 PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA-NL- 911 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~l- 911 (973)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||..... ...+................+. .+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccccc
Confidence 1 2223356788999997754 4678999999999999999999777654221 1111111111100000000000 00
Q ss_pred --CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 --LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..................+..+.+++.+||+.+|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000011112345778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.77 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=201.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC-----
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG----- 749 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 749 (973)
.++++|...+.||+|++|.||+|... +++.+|+|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999964 678999999875543 346789999999999 6999999999996544
Q ss_pred -eeEEEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 750 -FKALIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 750 -~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+|++|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 589999999999999988753 257899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
.+....... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||....... ...+. ..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~----~~ 232 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKI----PR 232 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHh----hc
Confidence 987654322 22234568899999997643 346889999999999999999999986422111 11110 00
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... .....+..++.++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~-----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NPP-----------------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cCC-----------------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 0011122356678999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.11 Aligned_cols=273 Identities=25% Similarity=0.296 Sum_probs=203.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999865 68899999886542 2335788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|++++.+..+... ...+++.++..++.|++.|++||| ..+++|||++|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9998766665544 346899999999999999999999 789999999999999999999999999998876544332
Q ss_pred ccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh--hCCcchhhhc--cccc
Q 048430 837 TQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE--SLPGAVTEVV--DANL 911 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~--d~~l 911 (973)
......++..|+|||+.... .++.++||||||+++|||++|+.||......+ .+...... .......... ++..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCccc
Confidence 33345678899999998887 88999999999999999999999986432111 11110000 0000000000 0101
Q ss_pred CCCCchhh--h--hhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEED--A--DDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~--~--~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........ . .....+..++.++.+++++||..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 0 0001112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=301.95 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=197.6
Q ss_pred CCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC------
Q 048430 682 FGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG------ 749 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 749 (973)
|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999853 46899999886542 344567889999999999999999999885432
Q ss_pred eeEEEEEecCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN-----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
..++++||+.+|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875321 35788999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcc
Q 048430 825 GIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 825 gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
|.++........ ......+++.|++||......++.++|||||||++|||++ |+.||..... .....++.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~---~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIK---GN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHc---CC
Confidence 998865432211 1222345678999999888889999999999999999999 8888754321 111111111 00
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
... .+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 -------~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 -------RLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -------cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0012345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=304.62 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=197.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999854 67899999886543 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999998765 6899999999999999999999 78999999999999999999999999999864211000
Q ss_pred --------------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc
Q 048430 836 --------------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901 (973)
Q Consensus 836 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 901 (973)
.......++..|+|||.+....++.++|||||||++||+++|+.||.+... .++......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhc
Confidence 011123578899999998888899999999999999999999999864211 1111111111
Q ss_pred chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 902 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
... .+. ....++.++.+++.+||+.+|++||++.++.+.|
T Consensus 232 ~~~---~~~--------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 232 DIE---WPE--------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ccC---CCC--------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 000 000 0012456689999999999999999854444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.40 Aligned_cols=245 Identities=27% Similarity=0.309 Sum_probs=201.3
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999854 68999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999998764 7899999999999999999999 799999999999999999999999999998865432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....+++.|+|||.......+.++||||||+++|+|++|+.||..... .........+. .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~--------~---- 215 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEKILEGK--------V---- 215 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC--------c----
Confidence 2234588999999998888889999999999999999999999864321 01011000000 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+...+..+.+++.+||+.+|.+|+ +++|+++|
T Consensus 216 --------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 --------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 00112245688999999999999999 77888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=303.27 Aligned_cols=254 Identities=25% Similarity=0.313 Sum_probs=206.8
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
...+.|...+.||+|++|.||+|... +++.||+|++..... ..+.+.+|++.+++++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45567888899999999999999965 688999999876544 4567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++......+++..+..++.|++.||+||| ..+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999999886557999999999999999999999 8999999999999999999999999999887654222
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......++..|+|||...+..++.++|||||||++|+|++|+.||...... .....+. ... ..
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~----~~~--------~~--- 234 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLIT----TKG--------IP--- 234 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----hcC--------CC---
Confidence 1223345788999999988888999999999999999999999998642111 0011100 000 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......++..+.+++.+||+.+|.+||++.+++++
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 ------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 001112245678999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=297.01 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=202.2
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 755 (973)
+|...+.||.|+||.||+|.. .+++.||+|++.... ....+.+..|+.++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999984 578899999886542 3345678899999999999999999998753 45678999
Q ss_pred EecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 756 QYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGY--STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 756 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
||+++++|.+++... ...+++..++.++.|++.|++|||..+ +.+++|+||+|+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764 357899999999999999999999443 578999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
..... ......++..|+|||......++.++||||||+++|+|++|+.||.... ...+......+...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~------ 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKIKEGKFR------ 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHHhcCCCC------
Confidence 53322 1233468899999999988889999999999999999999999986532 11111111111000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++.++.+++.+|++.+|++||+++|++++
T Consensus 229 -------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.44 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=200.7
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
|...+.||+|++|.||+|.. .+++.||+|+++.......+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 57899999998765555556788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
++|.+++... .+++.++..++.|++.|++||| +.+|+||||+|+||+++.++.++++|||.+....... .....
T Consensus 101 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 101 GALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 9999999873 6899999999999999999999 8999999999999999999999999999887553222 12233
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..++..|+|||...+..++.++|||||||++|||++|+.||..... ........... .+..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~-----~~~~--------- 235 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNL-----PPKL--------- 235 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcC-----CCCC---------
Confidence 4688999999998888899999999999999999999999854211 11111111000 0000
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++..+.+++.+||+.+|++||++.+++++
T Consensus 236 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 ---KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ---cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0011234568999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=306.18 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=198.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
..|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999864 68999999886432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||++ |++.+++......+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 5888887765557999999999999999999999 899999999999999999999999999998765322
Q ss_pred cccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 VTQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...... ........... +.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~-----~~-- 233 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNDS-----PT-- 233 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcCCC-----CC--
Confidence 2345788999999763 456889999999999999999999998542111 00000000000 00
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.....++..+.+++.+||+.+|++||++.+++++.
T Consensus 234 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 234 -----------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -----------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00123566789999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.75 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=205.5
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
+|...+.||+|++|.||++... +++.|++|++........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999965 789999999976655456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+++|.+++......+++..+..++.|+++|++||| ..+++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999999876557999999999999999999999 79999999999999999999999999999887654322 33
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
...++..|+|||......++.++||||||+++++|++|+.||...... ..............
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~------------- 217 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIATNGPPGL------------- 217 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhcCCCCc-------------
Confidence 456888999999988888999999999999999999999998642111 11100000000000
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....++..+.+++.+||+.+|++||++.|+++|
T Consensus 218 ----~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 ----RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011135568899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=299.16 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=199.7
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhcc---CCceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIR---HRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 755 (973)
.|...+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999995 578999999986542 344567889999999996 999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++... .+++..+..++.|++.|+.||| ..+|+||||+|+||+++.++.++++|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999998764 6899999999999999999999 8999999999999999999999999999998765333
Q ss_pred cccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......|+..|+|||....+ .++.++|||||||++|+|++|+.||..... ...+...... ..+.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~~- 224 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLIPKS-----KPPRLED- 224 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhccccC-----CCCCCCc-
Confidence 222334688899999987654 468999999999999999999999865321 1111100000 0000000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..++.++.+++.+||+.+|++||++.|++++
T Consensus 225 ------------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 ------------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ------------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0135568899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=310.12 Aligned_cols=240 Identities=28% Similarity=0.448 Sum_probs=194.6
Q ss_pred CccccccCceEEEEEEe-CCCeEEEEEEEec----cchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC--eeEEEEEe
Q 048430 685 SNLLGSGSFDNVYKATL-ANGVSVAVKVFNL----QEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG--FKALIMQY 757 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~ 757 (973)
..+||+|+|-+||+|.. .+|..||=-.++. ..+...+.|..|+++|+.++||||++++.++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 46899999999999985 3576776322221 13445689999999999999999999999987654 47789999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|..|+|..|....+ ..+...++.+++||++||.|||.. .++|||||||-+||+|+. .|.|||+|.|+|......
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 99999999999887 799999999999999999999965 689999999999999975 589999999999987532
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC----CcchhhhcccccC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLL 912 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~d~~l~ 912 (973)
.....+|||.|||||... ..|.+.+||||||+.++||+|+..||..=. +-++.++... |..+..+-
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIYKKV~SGiKP~sl~kV~----- 269 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIYKKVTSGIKPAALSKVK----- 269 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHHHHHHcCCCHHHhhccC-----
Confidence 223378999999999655 789999999999999999999999986522 2333333332 33332222
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.++++++|.+|+.. .++||++.|++++
T Consensus 270 -----------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -----------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 24578899999999 9999999999975
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=303.06 Aligned_cols=271 Identities=23% Similarity=0.263 Sum_probs=199.1
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|++|.||+|+. .+++.||||.++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477889999999999999985 468999999886543 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+. ++|.+++.... ..+++..+..++.|+++|++||| ..+++||||+|+||+++.++.+|++|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 96 58999887543 46899999999999999999999 7899999999999999999999999999987653221 1
Q ss_pred ccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--chhhhccc--cc
Q 048430 837 TQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--AVTEVVDA--NL 911 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~--~l 911 (973)
......++..|+|||...+. .++.++|||||||++|||+||+.||...... ....+.+...... ........ ..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 22334578899999976654 4688999999999999999999998642211 1112211111100 00000000 00
Q ss_pred CCCCc-hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSRED-EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..... ...............++.+++.+|++.||++||+++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000 00000000112245668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=306.88 Aligned_cols=252 Identities=26% Similarity=0.329 Sum_probs=201.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch---hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999864 589999999875432 24567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||+.+++|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999987643 46899999999999999999999 8999999999999999999999999999987543211
Q ss_pred Cc----------------------------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 048430 835 PV----------------------------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFT 886 (973)
Q Consensus 835 ~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~ 886 (973)
.. ......|+..|+|||...+..++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01123578899999999888899999999999999999999999865322
Q ss_pred CcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC----HHHHHHH
Q 048430 887 GEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN----VKDALAD 957 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt----~~evl~~ 957 (973)
. ..+.. +.+..... ......+.++.+++.+||+.+|++||+ ++|+++|
T Consensus 238 ~----~~~~~---------~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 D----ETFSN---------ILKKEVTF----------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred H----HHHHH---------HhcCCccC----------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1 11111 11110000 000114567899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=299.96 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=201.0
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
-|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999985 468899999876443 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++... .+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++++|||++....... ...
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999999998754 5899999999999999999999 8999999999999999999999999999987654322 122
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
....++..|+|||......++.++|||||||++|||++|..||...... .+......... +.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-----~~-------- 220 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLIPKNNP-----PT-------- 220 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHHhcCCC-----CC--------
Confidence 3345788999999988888899999999999999999999998643211 11111000000 00
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++.++.+++.+||+.+|++||+++++++|
T Consensus 221 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011235668899999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=302.36 Aligned_cols=272 Identities=19% Similarity=0.217 Sum_probs=200.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 754 (973)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778899999999999999965 688999999875432 2234677899999999999999999998776 899999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++ +|.+++......+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999974 999998876657999999999999999999999 7899999999999999999999999999988664322
Q ss_pred CcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhhcccc
Q 048430 835 PVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEVVDAN 910 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~ 910 (973)
.......++..|+|||...+. .++.++||||+||++|||++|+.||...... ........... ...+....+-.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhccc
Confidence 122334578899999987654 4689999999999999999999998653211 11111111100 00000000000
Q ss_pred cCC-CCchhh-hhh--HHhHHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLS-REDEED-ADD--FATKKT-CISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~-~~~~~~-~~~--~~~~~~-~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ...... ... ...+.. +.+.+.+++.+||+.+|++||+++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000000 000 000011 35678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.00 Aligned_cols=271 Identities=23% Similarity=0.291 Sum_probs=202.3
Q ss_pred CCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeEEEEE
Q 048430 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKALIMQ 756 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 756 (973)
|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999865 58999999997663 33456788999999999999999999999887 89999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++ +|.+++......+++.++..++.|+++|++||| ..+++|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 899988776557999999999999999999999 789999999999999999999999999999876544322
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhhcc----
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD---- 908 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d---- 908 (973)
......++..|+|||...+ ..++.++||||||+++|||++|+.||...... ........... ...+....+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchhh
Confidence 3334457888999997654 45789999999999999999999998653221 11111111110 000000000
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....................++.++.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000000000111136789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.87 Aligned_cols=275 Identities=27% Similarity=0.376 Sum_probs=206.8
Q ss_pred CCCccccccCceEEEEEE-eCCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecC------CeeEEE
Q 048430 683 GESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------GFKALI 754 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 754 (973)
...+.||+|+||.||+|+ ..+|+.||||.++... ....+...+|++++++++|+|||++++.-.+. ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 345789999999999999 6689999999987643 23457788999999999999999999876443 467899
Q ss_pred EEecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC--CCC--cEEEeeccccc
Q 048430 755 MQYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD--DDM--VAHLGDFGIAK 828 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgla~ 828 (973)
||||.+|||+..+.... ..+++.+.+.+..+++.||.||| +.+||||||||.||++- ++| ..||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999998643 67999999999999999999999 89999999999999983 333 47999999999
Q ss_pred ccCCCCCcccccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccH-HHHHHh-hCCcchhh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL-KQWVAE-SLPGAVTE 905 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~ 905 (973)
..+. .......+||..|.+||... .+.|+..+|.|||||++||.+||..||.......-.. ..|... ..+..+.-
T Consensus 173 el~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 173 ELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 8763 33556778999999999877 5889999999999999999999999997654332111 112111 12222222
Q ss_pred hcccccCCCCchhhhhhHHh----HHHHHHHHHHHHHhccccCCCCCC--CHHHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFAT----KKTCISYIMSLALKCSAEIPEERI--NVKDALADLKKIKKI 964 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~Rp--t~~evl~~L~~~~~~ 964 (973)
..++...+.. +-...++. .......+..++..++..+|++|. .+.+....+..|...
T Consensus 251 ~~~~~eNgpv--~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 251 GAQEEENGPV--EWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeecccCCce--eeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 2222111110 00011111 122345567788999999999999 888887777776643
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.87 Aligned_cols=267 Identities=21% Similarity=0.261 Sum_probs=196.8
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecC--CeeEEEEE
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNP--GFKALIMQ 756 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 756 (973)
|...+.||+|+||.||+|.. .+++.||+|.++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 55678899999999999985 468999999886542 222234557888998885 99999999999877 88999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|++ |++.+++......+++.++..++.|++.||+||| ..+++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 996 5888888876557899999999999999999999 789999999999999999 999999999998654322
Q ss_pred ccccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc---chhhhccccc-
Q 048430 837 TQTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG---AVTEVVDANL- 911 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~l- 911 (973)
......++..|+|||... ...++.++|||||||++|||++|+.||..... .....+....... .+.......-
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 122345788999999654 45678999999999999999999999865321 1111222111111 1111100000
Q ss_pred CCCCchh--hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEE--DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....... ...-......++.++.+++.+||+++|++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000 000011122457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.08 Aligned_cols=268 Identities=19% Similarity=0.310 Sum_probs=206.7
Q ss_pred CHHHHHHHhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecC
Q 048430 671 SYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNP 748 (973)
Q Consensus 671 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 748 (973)
.++++-..+ .++||+|+|+.|--+. ..+|..+|||++.+......+.+.+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 355665555 3689999999999887 7889999999998877777889999999999985 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC---cEEEeecc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---VAHLGDFG 825 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg 825 (973)
+..|+|||.|.||+|...++.+. .+++.++..+.++|+.||.||| .++|.|||+||+|||-.... -+||+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999999999876 7999999999999999999999 89999999999999997654 58999999
Q ss_pred cccccC------CCCCcccccccccccccCccCC-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHH
Q 048430 826 IAKLLD------GVDPVTQTMTLATIGYMAPEYG-----SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894 (973)
Q Consensus 826 la~~~~------~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~ 894 (973)
++.-.. +.....-...+|+..|||||+. ....|+.++|.||+|||+|-|++|.+||.+.-..+-. |
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---W 301 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---W 301 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---c
Confidence 875331 1111122345789999999942 2345889999999999999999999999764322111 1
Q ss_pred HHhhC----CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 895 VAESL----PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 895 ~~~~~----~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
-+... .....+-+.+...+.. -..+...+.+.++++...+..+|.+|.++.+++.|
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFP-------dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFP-------DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCC-------hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 10000 0000111111111110 12234677888999999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.69 Aligned_cols=273 Identities=22% Similarity=0.260 Sum_probs=199.1
Q ss_pred CCCCCccccccCceEEEEEEeC---CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA---NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKA 752 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 752 (973)
+|...++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999964 47999999987633 33346778899999999999999999999887 8899
Q ss_pred EEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC----CCcEEEeec
Q 048430 753 LIMQYMPQGSLEKWLYSHN----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD----DMVAHLGDF 824 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 824 (973)
+||||+++ ++.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7777665332 36889999999999999999999 899999999999999999 999999999
Q ss_pred ccccccCCCCC--cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc--------cHHH
Q 048430 825 GIAKLLDGVDP--VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM--------SLKQ 893 (973)
Q Consensus 825 gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~--------~~~~ 893 (973)
|++........ .......++..|+|||...+ ..++.++|||||||+++||++|+.||........ .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543222 12233467889999997655 4578999999999999999999999975433220 1111
Q ss_pred HHHhhCCc------------chhhhcccccCCCCc-hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 894 WVAESLPG------------AVTEVVDANLLSRED-EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 894 ~~~~~~~~------------~~~~~~d~~l~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+...... ......+........ ...............++.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111000 000000000000000 00001111111345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=301.87 Aligned_cols=246 Identities=27% Similarity=0.368 Sum_probs=197.1
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
|...+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999985 468899999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+. |++.+++......+++.++..++.|++.|+.||| +.+|+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 96 4888888765667999999999999999999999 89999999999999999999999999999875432
Q ss_pred cccccccccccCccCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 838 QTMTLATIGYMAPEYG---SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.....++..|+|||++ ..+.++.++|||||||++|||++|+.||...... .....+.....+ .
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~------------~- 243 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP------------T- 243 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCC------------C-
Confidence 1234578899999986 3456899999999999999999999998642111 111111110000 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.....++..+.+++.+||+.+|++||++.+++++..
T Consensus 244 ---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 ---------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ---------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 001124556889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=293.48 Aligned_cols=249 Identities=23% Similarity=0.251 Sum_probs=195.0
Q ss_pred HHHHHhcCCCCCccc--cccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC
Q 048430 674 ELQQATNGFGESNLL--GSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG 749 (973)
Q Consensus 674 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 749 (973)
+...-.++|...+.+ |+|+||.||++.. .++..+|+|.+....... .|+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 444445677777776 9999999999984 568889999986442211 122222222 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeeccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAK 828 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~ 828 (973)
..++||||+++++|.+++.... .+++.++..++.|+++|+.||| +.+++||||||+||+++.++ .++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999999998765 7999999999999999999999 78999999999999999998 99999999987
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
..... ....++..|+|||...+..++.++|||||||++|||++|+.||......+.....+.... ...
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~------ 226 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK------ 226 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc------
Confidence 65422 223578899999999888899999999999999999999999975433332233322211 000
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-VKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~evl~~ 957 (973)
...+..++..+.+++.+|++.+|++||+ ++|+++|
T Consensus 227 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 227 --------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0011134567899999999999999996 6998865
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.52 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=201.2
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999864 68899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~ 835 (973)
+++++|.+++.... ..+++..+..++.|+++|+.||| +.+++|+||+|+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997643 35799999999999999999999 78999999999999999885 469999999886643221
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......|++.|+|||......++.++|||||||++|||++|+.||.... ..+++.....+.....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~--------- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI--------- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC---------
Confidence 2223458889999999888889999999999999999999999986422 2222222211111000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+.++.+++.+||+.+|++||++.|++++
T Consensus 223 ----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.59 Aligned_cols=242 Identities=19% Similarity=0.265 Sum_probs=188.2
Q ss_pred cccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHh---ccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRR---IRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
.||+|+||.||++.. .+++.||+|.+.... ......+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 468999999886432 1222334455444443 479999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.++++|||++...... ...
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH 153 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Ccc
Confidence 999999988665 6999999999999999999999 899999999999999999999999999998755322 122
Q ss_pred cccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...++..|+|||.... ..++.++|||||||++|||++|+.||........ . .+..... ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~-~~~~~~~-----~~~---------- 215 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--H-EIDRMTL-----TVN---------- 215 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--H-HHHHHhh-----cCC----------
Confidence 3468999999998764 5578999999999999999999999965432211 1 1110000 000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
...+..++.++.+++.+|++.||++|| +++|+++|
T Consensus 216 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 ----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001123456789999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=281.45 Aligned_cols=275 Identities=22% Similarity=0.241 Sum_probs=200.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC---C--CeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeec-CCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA---N--GVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 750 (973)
...|..+..||+|.||.||+|.-+ + ...+|+|.++...+ .......+|+..++.++|||++.++.++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356888899999999999999632 2 33789999876533 234567899999999999999999999866 888
Q ss_pred eEEEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC----CcEEEe
Q 048430 751 KALIMQYMPQGSLEKWLYSHN----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD----MVAHLG 822 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 822 (973)
.++++||++. +|.+.++-++ ..++...+++|+.||+.|+.||| +.=|+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 9999987543 56888999999999999999999 7889999999999999887 899999
Q ss_pred ecccccccCCCCCc--ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccC-----cccHHHH
Q 048430 823 DFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTG-----EMSLKQW 894 (973)
Q Consensus 823 Dfgla~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~-----~~~~~~~ 894 (973)
|||+++.+...-.. .....+.|..|+|||.+.+ ..||.+.||||.|||+.||+|-++-|.+.... .....+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999987543322 3345678999999997766 56999999999999999999988777543211 0111111
Q ss_pred HH---hhC-Cc--chh----------hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 895 VA---ESL-PG--AVT----------EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 895 ~~---~~~-~~--~~~----------~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+ -.. +. .+. .+.|-+............+.....-++...+++.+++++||.+|.|++++++|
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11 100 00 011 11110000000000001111111122337889999999999999999999987
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.91 Aligned_cols=270 Identities=23% Similarity=0.270 Sum_probs=199.2
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
|...+.||.|++|.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999985 479999999987543 223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+ ++|.+++.... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RT 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cc
Confidence 5 69999987654 46899999999999999999999 7899999999999999999999999999987653221 12
Q ss_pred cccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Ccc-hhhhc--ccccC
Q 048430 838 QTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PGA-VTEVV--DANLL 912 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~~--d~~l~ 912 (973)
.....++..|+|||...+. .++.++|||||||++|||++|+.||...... ........... +.. ..... .+...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2333568899999977654 5789999999999999999999998643211 11111111110 100 00000 00000
Q ss_pred CCCch-hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDE-EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..... ............+.++.+++.+|++.+|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0000001112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.79 Aligned_cols=272 Identities=22% Similarity=0.256 Sum_probs=199.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 753 (973)
.++|...+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46788899999999999999996 4689999999875432 2234567899999999999999999998654 56899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+.+ +|.+++......+++.++..++.|+++|++||| ..+++||||||+||+++.++.+||+|||.+......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999964 899988876567999999999999999999999 899999999999999999999999999999876432
Q ss_pred CCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc---chhhhccc
Q 048430 834 DPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG---AVTEVVDA 909 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~ 909 (973)
. .......++..|+|||...+ ..++.++||||+||++|||++|+.||...... ..+.... ..... ......+.
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLII-QLLGTPNESIWPGFSD 238 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HhcCCCChhhchhhhc
Confidence 2 12223346788999998765 45789999999999999999999998653211 1111111 11110 00000000
Q ss_pred -ccCCCCch--hhhhhH-HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 -NLLSREDE--EDADDF-ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 -~l~~~~~~--~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........ ...... ......++++.+++.+|++.||++||+++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000000 0011235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.34 Aligned_cols=276 Identities=21% Similarity=0.273 Sum_probs=202.5
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG---- 749 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 749 (973)
...++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678899999999999999999964 68899999987543 223456788999999999999999999986654
Q ss_pred ------eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEee
Q 048430 750 ------FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823 (973)
Q Consensus 750 ------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 823 (973)
..++|+||+++ ++...+......+++..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 788877766557999999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---
Q 048430 824 FGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--- 899 (973)
Q Consensus 824 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--- 899 (973)
||.+...............++..|+|||.... ..++.++|||||||++|||++|+.||..... ...+........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Confidence 99998764333222233356788999997654 4578999999999999999999999864221 111111111110
Q ss_pred CcchhhhcccccCCCCchhh---hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEED---ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.....+............. .........++..+.+++.+||+.+|.+||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111110000000000000 00001111246778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=297.02 Aligned_cols=271 Identities=22% Similarity=0.276 Sum_probs=201.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+|...+.||+|++|.||+|+.. +|+.||||.++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999964 689999999876532 23466778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 759 PQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 759 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
++ +|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.++++|||++....... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-N 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-c
Confidence 85 8999887644 46899999999999999999999 7899999999999999999999999999987653221 1
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhhccc-cc
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEVVDA-NL 911 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~-~l 911 (973)
......++..|+|||.... ..++.++|||||||++|||++|+.||...... ........... ...+..+.+. .+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 2233457889999997655 45789999999999999999999998653221 11111111110 0011111100 00
Q ss_pred CCCC-chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSRE-DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .............++.++.+++.+|++.+|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000001111112346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=322.48 Aligned_cols=275 Identities=19% Similarity=0.202 Sum_probs=192.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC--CCeEEEEEEE--------------e---ccchhhHHHHHHHHHHHHhccCCce
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA--NGVSVAVKVF--------------N---LQEDRALKSFDTECEVMRRIRHRNL 738 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~--------------~---~~~~~~~~~~~~e~~~l~~l~h~ni 738 (973)
..++|...+.||+|+||.||++..+ .+..+++|.+ . .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998743 2222222211 0 0112234568899999999999999
Q ss_pred eEEEeeeecCCeeEEEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC
Q 048430 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD 814 (973)
Q Consensus 739 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~ 814 (973)
+++++++...+..++|+|++. +++.+++.... ......++..++.|++.||+||| +++||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999985 57888776432 22345677889999999999999 89999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCC-CCccccC-cccHH
Q 048430 815 DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP-TNEMFTG-EMSLK 892 (973)
Q Consensus 815 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p-~~~~~~~-~~~~~ 892 (973)
.++.+||+|||+++.+............||..|+|||.+.+..++.++|||||||++|||++|..+ +...... ...+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987654333333345799999999999988999999999999999999998864 3322111 11111
Q ss_pred HHHHhh------CCcch---hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 893 QWVAES------LPGAV---TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 893 ~~~~~~------~~~~~---~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+... ++... .+.++..... ...............+.++.+++.+|++.||++||++.|+++|
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEID-HAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcc-cCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 211110 11110 0111100000 0000011111112245667889999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=296.88 Aligned_cols=248 Identities=26% Similarity=0.317 Sum_probs=202.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
+|...+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999865 68999999987542 2345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++++|.+++... ..+++.++..++.|+++|+.||| ..+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999876 37899999999999999999999 7899999999999999999999999999987654322
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......++..|+|||...+..++.++||||||+++|+|++|+.||...... ........ ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~-------------- 217 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK-QETA-------------- 217 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH-hccc--------------
Confidence 223345888999999988888999999999999999999999998753321 11111111 0000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH--HHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINV--KDALA 956 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~--~evl~ 956 (973)
....+...+.++.+++.+||+.+|.+||++ +|+++
T Consensus 218 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 218 -----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 000112245678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.16 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=197.6
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHH
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 764 (973)
.+||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 578999999986555555677899999999999999999999999999999999999999999
Q ss_pred HHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccccccc
Q 048430 765 KWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844 (973)
Q Consensus 765 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~ 844 (973)
+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++....... .......++
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 179 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGT 179 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccC
Confidence 987654 5899999999999999999999 7899999999999999999999999999987654322 122334688
Q ss_pred ccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHH
Q 048430 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFA 924 (973)
Q Consensus 845 ~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 924 (973)
..|+|||......++.++|||||||++|||++|..||..... ......+....+.. ..
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~--------~~------------ 237 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPK--------LK------------ 237 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcc--------cC------------
Confidence 999999998888889999999999999999999999864211 11111111111100 00
Q ss_pred hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 925 TKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 925 ~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++..+.+++.+||+.+|.+||++.++++|
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 001234557889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.57 Aligned_cols=243 Identities=26% Similarity=0.303 Sum_probs=196.5
Q ss_pred ccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 688 LGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 688 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
||.|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 58999999986543 23456789999999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 843 (973)
.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 99998764 6899999999999999999999 8999999999999999999999999999998764322 2223467
Q ss_pred cccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhH
Q 048430 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923 (973)
Q Consensus 844 ~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 923 (973)
+..|+|||......++.++|+||+|+++|||++|..||....... .........+. . ..
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~--------~----------~~ 213 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGN--------G----------KL 213 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccC--------C----------CC
Confidence 889999999888889999999999999999999999986533211 11111111000 0 00
Q ss_pred HhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 924 ATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 924 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
..+..++.++.+++.+||+.+|++||+ ++|+++|
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 011122566899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.27 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=193.5
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 344567899999999999985 468999999886543 234567889999999996 99999999999989999999999
Q ss_pred cCCCCHHHHh---hh-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 758 MPQGSLEKWL---YS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 758 ~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
+.. ++.++. .. ....+++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 655543 22 22468999999999999999999994 358999999999999999999999999998765322
Q ss_pred CCcccccccccccccCccCCCCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEG---IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
. ......++..|+|||.+... .++.++|||||||++|||++|+.||.... .....+.....+.. +.
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~-----~~ 230 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP-----PI 230 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC-----Cc
Confidence 1 22233578899999987765 68999999999999999999999986422 11111111111100 00
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.. ..+..++.++.+++.+||+.+|++||+++|++++
T Consensus 231 ~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSN----------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCC----------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0012356678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=299.02 Aligned_cols=272 Identities=20% Similarity=0.227 Sum_probs=196.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCe-----
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGF----- 750 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 750 (973)
++|...+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688889999999999999995 4689999998765432 23457888999999995 6999999999876555
Q ss_pred eEEEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeecc
Q 048430 751 KALIMQYMPQGSLEKWLYSHN----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFG 825 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 825 (973)
.++||||+++ +|.+++.... ..+++..+..++.||++||.||| +.+|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 8988886532 35899999999999999999999 899999999999999998 8899999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-C-cc
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-P-GA 902 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~ 902 (973)
.+...... ........+++.|+|||...+ ..++.++|||||||++|||++|..||........ ......... + ..
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIP-VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCC-ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCChh
Confidence 98765321 112223356888999997754 4578999999999999999999999864221111 111111100 0 00
Q ss_pred h-hhhccccc-CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 V-TEVVDANL-LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 ~-~~~~d~~l-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ....+... ..................+.++.+++.+|++++|++||+++|++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000000 0000000000001112356778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=296.09 Aligned_cols=244 Identities=23% Similarity=0.310 Sum_probs=193.7
Q ss_pred ccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 688 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
||+|+||+||+|.. .+|+.||+|.+.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468999999986532 22345667899999999999999999999999999999999999999
Q ss_pred HHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccccc
Q 048430 764 EKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL 842 (973)
Q Consensus 764 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 842 (973)
.+++.... ..+++.++..++.|++.|+.||| ..+++||||+|+||+++.++.+||+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99997654 36899999999999999999999 89999999999999999999999999999876532 11223345
Q ss_pred ccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhh
Q 048430 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADD 922 (973)
Q Consensus 843 ~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 922 (973)
++..|+|||...+..++.++|||||||++|+|++|+.||...... ............. .
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~--------------------~ 214 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEM--------------------A 214 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccc--------------------c
Confidence 788999999988888999999999999999999999998653221 1111111000000 0
Q ss_pred HHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 923 FATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 923 ~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
...+..+++.+.+++.+||+.+|++|| ++.++++|
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 001122456688999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=289.17 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=205.5
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 755 (973)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++++... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999965 789999999876542 4567899999999999999999999999887 8999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++.... .+++.++..++.|++.|++||| +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998765 7999999999999999999999 79999999999999999999999999999887654332
Q ss_pred c-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 V-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
. ......++..|+|||.......+.++||||||+++++|++|+.||.... ...............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~----------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKIGSSGEP----------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhccccCCC-----------
Confidence 1 1233568889999999888889999999999999999999999986533 111111000000000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+...+..+.+++.+|++.+|++||++.|+++|
T Consensus 223 --------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 --------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00112235678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=302.09 Aligned_cols=269 Identities=22% Similarity=0.320 Sum_probs=195.5
Q ss_pred cccccc--CceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSG--SFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
..||+| +||+||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356766 8999999985 479999999987543 33457888999999999999999999999999999999999999
Q ss_pred CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc--
Q 048430 761 GSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT-- 837 (973)
Q Consensus 761 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-- 837 (973)
+++.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999988643 35889999999999999999999 8999999999999999999999999998654332111110
Q ss_pred ----cccccccccccCccCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---------Ccc
Q 048430 838 ----QTMTLATIGYMAPEYGSEG--IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---------PGA 902 (973)
Q Consensus 838 ----~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~ 902 (973)
.....++..|+|||+..+. .++.++|||||||++|||++|+.||........ ......... +..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence 0112345679999987653 478999999999999999999999975432211 111100000 000
Q ss_pred hhhh------cc----cccCC----CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 903 VTEV------VD----ANLLS----REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 903 ~~~~------~d----~~l~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.... .+ ..... ...............++..+.+++.+||+.||++|||++|+++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000 00 00000 000000011122345778899999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=300.89 Aligned_cols=273 Identities=20% Similarity=0.283 Sum_probs=196.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCC------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPG------ 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 749 (973)
.++|...+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45788899999999999999985 4689999998864432 22345678999999999999999999986543
Q ss_pred --eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 750 --FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 750 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
..++||||+.+ ++.+++......+++.++..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999964 898888776557899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---C
Q 048430 828 KLLDGVDPV---TQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---P 900 (973)
Q Consensus 828 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~ 900 (973)
......... ......++..|+|||...+. .++.++||||||+++|||++|+.||...... .....+.... +
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~~ 244 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSIT 244 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 765432211 11234578899999976554 4788999999999999999999998653211 1111111111 1
Q ss_pred cchh-hhcccccCCC-----CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 GAVT-EVVDANLLSR-----EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~~~~-~~~d~~l~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+. ...+...... ...........+......+.+++.+||+.||++||+++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1100 0000000000 0000000000001123557899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=296.10 Aligned_cols=270 Identities=23% Similarity=0.265 Sum_probs=203.4
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
|...+.||+|++|.||+|.. .+++.+|+|.+..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 55678899999999999986 4789999998865432 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++ ++.+++......+++.++..++.|++.|+.||| ..+|+|+||+|+||+++.++.+||+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 899888876567999999999999999999999 7999999999999999999999999999988765432 122
Q ss_pred ccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cchhhhcc---ccc
Q 048430 839 TMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAVTEVVD---ANL 911 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d---~~l 911 (973)
....++..|+|||..... .++.++||||+|+++|+|++|+.||..... ...+......... ..+....+ ...
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 334578899999987766 789999999999999999999999854321 1111111111000 00001000 000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.................++.++.+++.+||+.+|.+||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000111223467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.80 Aligned_cols=271 Identities=23% Similarity=0.279 Sum_probs=198.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----Cee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 751 (973)
.++|...++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46789999999999999999984 578999999986432 33456788899999999999999999886543 357
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++|+||+++ ++.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999965 888888654 5899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCc--ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC----cchh
Q 048430 832 GVDPV--TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP----GAVT 904 (973)
Q Consensus 832 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~ 904 (973)
..... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+..... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHH
Confidence 32211 1123468899999997654 5689999999999999999999999854211 111111111111 1111
Q ss_pred hhcccccCC----CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVDANLLS----REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d~~l~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+.+..... ................+.++.+++.+||+.+|++||+++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111110000 00000000000111235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=252.06 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=202.7
Q ss_pred CCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...++||+|.||+||+|+ ..+++.||+|.++.++ +.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999 5678999999987664 34467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
|+. +|..|..+....++.+....++.|+++|+.|+| ++.+.|||+||.|.+++.+|+.|++|||+++.++- ....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgi-pvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRC 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCC-ceEe
Confidence 966 999999887778999999999999999999999 89999999999999999999999999999987652 2224
Q ss_pred cccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCccc---HHHHHHhhC---Ccc---hhhhc
Q 048430 838 QTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS---LKQWVAESL---PGA---VTEVV 907 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~---~~~---~~~~~ 907 (973)
.+..+.|..|++|.++.+. -|+...|+||.||++.|+.....|. +++... +....+... ++. +..+.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl---fpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL---FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC---CCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 4556789999999987765 4888999999999999999855552 233322 222222211 111 22222
Q ss_pred ccccCCCCchhhhhhHHhHHH----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKT----CISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~----~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
|....-.+ .......+ ....-.+++++.+.-+|.+|.+++++++|
T Consensus 235 dyk~yp~y-----pattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIY-----PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCc-----cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 22111110 00011111 22233678888888899999999999876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=306.97 Aligned_cols=270 Identities=23% Similarity=0.223 Sum_probs=199.1
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------ 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 748 (973)
..++|...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999985 47899999988543 233345677899999999999999999988543
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
...++||||+. ++|.+++... ++...+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999996 4888887653 889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEV 906 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 906 (973)
...... ......++..|+|||...+..++.++|||||||++|+|++|+.||...... ..+...+.... +..+.+.
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHH
Confidence 654321 223345788999999988888999999999999999999999998643211 11111111000 0001111
Q ss_pred ccccc----CCCC------chh-------hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANL----LSRE------DEE-------DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l----~~~~------~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+... .... ... .......+...+.++.+++.+|++.||++||++.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000 000 000000012245678899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=298.63 Aligned_cols=267 Identities=22% Similarity=0.253 Sum_probs=193.0
Q ss_pred cccccCceEEEEEEeCCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHH
Q 048430 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 764 (973)
.+|.|+++.||++.. +++.||||+++.. .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344444444444444 6899999998755 3345678999999999999999999999999999999999999999999
Q ss_pred HHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc------c
Q 048430 765 KWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV------T 837 (973)
Q Consensus 765 ~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~------~ 837 (973)
+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+|++|||.+......... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 999864 245889999999999999999999 899999999999999999999999999988755322111 1
Q ss_pred cccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc----hhhhccccc
Q 048430 838 QTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA----VTEVVDANL 911 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~d~~l 911 (973)
.....++..|+|||.+.. ..++.++|||||||++|||++|+.||.......... +.+....+.. .....+...
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhhcCCc
Confidence 123357788999998765 357889999999999999999999997532221111 1111000000 000000000
Q ss_pred CC------CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 912 LS------REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 912 ~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.. ..................++.+++.+||+.+|++||+++|+++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00 000011111222334567899999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=298.41 Aligned_cols=254 Identities=24% Similarity=0.276 Sum_probs=196.4
Q ss_pred hcCCCCCccccccCceEEEEEEeCC-CeEEEEEEEeccc-hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQE-DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||.||+|.... ++.||||.++... ......+.+|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567788999999999999999764 8999999987543 233456677787776665 999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+. +++.+++......+++..+..++.|+++|++|||+ ..+|+||||+|+||+++.++.+||+|||++.......
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 9985 47888777655578999999999999999999993 2589999999999999999999999999987653222
Q ss_pred cccccccccccccCccCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 836 VTQTMTLATIGYMAPEYGSEGI----VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
......++..|+|||.+.... ++.++||||||+++|||++|+.||.........+..... ...
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------~~~ 236 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ------------EEP 236 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc------------CCC
Confidence 122335788999999876543 789999999999999999999998642211111111110 000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.. ......++.++.+++.+||+.+|++||++++++++-
T Consensus 237 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 PS---------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CC---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00 000012456689999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=300.83 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=208.5
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.....|.+.+.||+|.|+.|..|+. .++..||||.+++..- .....+.+|+++|+.++|||||+++.+...+...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456788899999999999999984 5799999999876532 233558999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+.+|.+.+|+..++ ...+..+..++.|+.+|++|+| .+.|||||||++||+++.+.++||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc-
Confidence 999999999999999887 5555888999999999999999 89999999999999999999999999999988762
Q ss_pred CCcccccccccccccCccCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGI-VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
...-...+|++.|.|||...+.. .++++|+||+||++|-|+.|..||++..-.+. -++-+.
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------------r~rvl~ 269 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------------RPRVLR 269 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------------cchhee
Confidence 22334568999999999888765 47899999999999999999999986321111 111111
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
. .+..+..+..+..+++.+++..+|.+|++++++.++-+
T Consensus 270 g--------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 270 G--------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred e--------eecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 1 11222334566788999999999999999999988754
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.64 Aligned_cols=273 Identities=23% Similarity=0.249 Sum_probs=199.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc--chhhHHHHHHHHHHHHhc-cCCceeEEEeeeec--CCee
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ--EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSN--PGFK 751 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--~~~~ 751 (973)
..++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||++++++|.. ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999864 6889999987542 223345677899999999 99999999999864 3468
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||++ ++|..++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999988765 6889999999999999999999 7999999999999999999999999999998654
Q ss_pred CCCC----cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccc-h
Q 048430 832 GVDP----VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGA-V 903 (973)
Q Consensus 832 ~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~-~ 903 (973)
.... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ .......... ... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence 3221 12223468899999997654 567899999999999999999999986432211 1111111100 000 0
Q ss_pred hhh----cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 904 TEV----VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 904 ~~~----~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+ .+.-+.................++.++.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 000000000000000001111256779999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=288.81 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=204.6
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999964 689999999876532 4567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 758 MPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 758 ~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+++++|.+++.... ..+++.++..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998752 57999999999999999999999 7899999999999999999999999999998764332
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......+++.|+|||......++.++||||+|+++++|++|+.||+... ............ ...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~--------~~~- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ--------YPP- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC--------CCC-
Confidence 12233468889999999888889999999999999999999999986432 111111111100 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..++.++.+++.+||..+|++||++.|++++
T Consensus 223 ----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ----------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011245668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=279.54 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=205.4
Q ss_pred HhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
..++|...+++|+|.||.|..++ ..+++.+|+|++++. ...+.+.-..|-++++..+||.+..+...|+..+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 45788889999999999999998 568999999998765 23455677889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+.||.|.-++...+ .+++.....+-.+|..||.||| +++||+||+|.+|.|+|.||.+||+|||+++.--.
T Consensus 246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 999999999998887765 7899999999999999999999 89999999999999999999999999999985321
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
........+|||.|.|||++....|..++|-|.+|||+|||++|+.||...... .+-..+-
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kLFeLIl----------------- 381 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KLFELIL----------------- 381 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--HHHHHHH-----------------
Confidence 112334568999999999999999999999999999999999999999652211 1111110
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..-|....++.+.++...+..||.+|. .++||.+|
T Consensus 382 ------~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 382 ------MEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ------hhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 011112234456678899999999999998 45566554
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=296.63 Aligned_cols=257 Identities=18% Similarity=0.232 Sum_probs=184.4
Q ss_pred cCCCCCccccccCceEEEEEEeCC----CeEEEEEEEeccchhhH-----------HHHHHHHHHHHhccCCceeEEEee
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVFNLQEDRAL-----------KSFDTECEVMRRIRHRNLIKIVSS 744 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~~ 744 (973)
++|...++||+|+||.||+|+..+ +..+|+|+......... .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578889999999999999998653 45667776443321110 112223344556689999999997
Q ss_pred eecCC----eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 745 CSNPG----FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 745 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+||+++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence 65433 44677887643 6766665432 4678889999999999999999 88999999999999999999999
Q ss_pred EeecccccccCCCCC------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHH
Q 048430 821 LGDFGIAKLLDGVDP------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894 (973)
Q Consensus 821 l~Dfgla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~ 894 (973)
|+|||+|+....... .......||+.|+|||...+..++.++|||||||++|||++|+.||........ ....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHHH
Confidence 999999986532211 112234699999999999988999999999999999999999999976422111 1110
Q ss_pred HHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 895 VAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 895 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
... +....+.... .....++..+.+++..|++.+|++||+++++++.+
T Consensus 246 ~~~---~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKC---DFIKRLHEGK-------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHH---HHHHHhhhhh-------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000 0000000000 01123467799999999999999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=292.53 Aligned_cols=269 Identities=24% Similarity=0.301 Sum_probs=197.5
Q ss_pred CCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhc---cCCceeEEEeeeecCCe-----
Q 048430 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRI---RHRNLIKIVSSCSNPGF----- 750 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 750 (973)
|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999976 489999999875422 2234566788877766 59999999999987766
Q ss_pred eEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
.+++|||+.+ +|.+++.... ..+++..+..++.|+++||+||| +.+++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8999887644 36899999999999999999999 78999999999999999999999999999887
Q ss_pred cCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Ccchhhhcc
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PGAVTEVVD 908 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~d 908 (973)
..... ......++..|+|||...+..++.++|||||||++|||++|+.||..... ...+..+..... +........
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCC
Confidence 64322 11223478899999999888899999999999999999999988865322 112222222111 110000000
Q ss_pred ccc-CCCCch-hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANL-LSREDE-EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l-~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ...... ...............+.+++.+||+.||++||+++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 000000 0000011112345778899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=294.42 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=198.1
Q ss_pred CCCCCccccccCceEEEEEEe----CCCeEEEEEEEeccc----hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCee
Q 048430 681 GFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQE----DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 751 (973)
+|...+.||+|+||.||.|.. .+|+.||+|++.... ....+.+.+|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999985 368999999986532 12346778899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+++++|.+++.... .+++..+..++.|+++||.||| +.+++||||+|+||+++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999998764 6889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
...........++..|+|||.... ...+.++||||||+++|+|++|+.||..... ......+........ +
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~------~ 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE------P 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC------C
Confidence 322222233458899999998765 3467899999999999999999999864211 111111111111000 0
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..+...+.+++.+||+.+|++|| ++.+++.+
T Consensus 230 --------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 --------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01122456688999999999999997 77888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=289.28 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=203.1
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999854 678999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++.... .+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 99999999998764 7899999999999999999999 899999999999999999999999999999876543322
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....++..|+|||......++.++||||+|+++|+|++|+.||.... .......... ...
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~~-~~~-------------- 216 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIVQ-DDH-------------- 216 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhc-cCC--------------
Confidence 223457889999998887778999999999999999999999986432 1111111100 000
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+...+..+.+++.+|++.+|++||++.|++.+
T Consensus 217 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 217 -----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 00111235668899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=289.00 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=198.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc-----chhhHHHHHHHHHHHHhccCCceeEEEeeeecC--Cee
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ-----EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFK 751 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 751 (973)
.+|...+.||+|+||.||+|.. .++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999985 56899999987532 123456788999999999999999999998653 567
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++|+||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999998754 5889999999999999999999 8999999999999999999999999999997653
Q ss_pred CCC--CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 832 GVD--PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 832 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
... ........++..|+|||...+..++.++|||||||++||+++|+.||..... ....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~---- 228 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKI-ATQPTKP---- 228 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHH-HcCCCCC----
Confidence 211 1112234588999999998888899999999999999999999999864311 1111111 0000000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+....+++.+++.+|++ +|..||++.+++.|
T Consensus 229 --------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 --------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0112345668899999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=329.92 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=202.6
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
-++.....||.|.||.||-|. ..+|+..|+|-++... ....+...+|..++..++|||+|+++|+-.+.+..++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 355667899999999999998 6789999999776553 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP- 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 835 (973)
||++|+|.+.++-.+ ..++.....+..|++.|++||| +.|||||||||.||+++.+|.+|++|||.|..+.+...
T Consensus 1315 yC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999999988654 5666777789999999999999 89999999999999999999999999999988754321
Q ss_pred --cccccccccccccCccCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 836 --VTQTMTLATIGYMAPEYGSEGI---VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 836 --~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
..-...+||+.|||||.+.+.. -..+.||||+|||+.||+||+.||.... .+..+...|.....
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy~V~~gh~---------- 1459 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMYHVAAGHK---------- 1459 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-chhHHHhHHhccCC----------
Confidence 1223567999999999876533 4567899999999999999999986532 22222222221111
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...|+..+.+-.+++..|+..||++|+++.|++++
T Consensus 1460 ------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11223356678899999999999999999998876
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=291.03 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=202.4
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.||+|+||.||+++. .+++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477789999999999999974 478899999987542 33456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 758 MPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 758 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+++++|.+++... ...+++..++.++.|+++|++||| +.+++||||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998762 246899999999999999999999 899999999999999999999999999999876533
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......++..|+|||...+..++.++|+||+|+++|||++|+.||..... ..+...+.. ....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~---~~~~---------- 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQR---GKYP---------- 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhc---CCCC----------
Confidence 22234578899999999888899999999999999999999999865321 111111110 0000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++.++.+++.+|++.+|++||++.|++++
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=303.27 Aligned_cols=273 Identities=24% Similarity=0.265 Sum_probs=200.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec----CCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN----PGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 751 (973)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788889999999999999985 469999999986542 2335677889999999999999999988753 3568
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+. ++|.+++.... .+++..+..++.|+++||+||| ..+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 59999987654 5899999999999999999999 7899999999999999999999999999987653
Q ss_pred CCCCc---ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 832 GVDPV---TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 832 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
..... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .....+.........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhh
Confidence 32211 1123468889999998655 46889999999999999999999998653211 111111111111111110
Q ss_pred c----cccCC---CCc-hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 908 D----ANLLS---RED-EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 908 d----~~l~~---~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
+ ..... ... .............+.++.+++.+|++.+|++||++++++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0 00000 000 000000001123467799999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=303.61 Aligned_cols=276 Identities=21% Similarity=0.221 Sum_probs=202.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----Ce
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 750 (973)
.++|...+.||+|+||+||+|+. .+++.||||.++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999985 57899999988643 223345677899999999999999999987543 35
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++|+||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 68999887654 6999999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhh
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEV 906 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 906 (973)
.... .......++..|+|||.... ..++.++|||||||++|+|++|+.||..... ............ +......
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhc
Confidence 4322 12233457889999997654 4688999999999999999999999864311 111111111100 0011011
Q ss_pred cccccCC----CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHH
Q 048430 907 VDANLLS----REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD--LKKI 961 (973)
Q Consensus 907 ~d~~l~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~--L~~~ 961 (973)
.+..... ...............++.++.+++.+||+.+|++||+++|+++| ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 1110000 00000000011122466788999999999999999999999998 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=289.46 Aligned_cols=242 Identities=20% Similarity=0.267 Sum_probs=187.5
Q ss_pred cccccCceEEEEEEe-CCCeEEEEEEEeccch---hhHHHHHHHHHH---HHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQED---RALKSFDTECEV---MRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|..+ ++...||+|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 5689999998865321 112233444443 444579999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|+|.+++.... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 999999987654 6999999999999999999999 7999999999999999999999999999987553221 22
Q ss_pred cccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...|+..|+|||...++ .++.++||||+||++|||++|+.||......... ........ .+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~------~~---------- 215 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT------MA---------- 215 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhc------cC----------
Confidence 34689999999987754 5889999999999999999999998754221110 00000000 00
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
...+..++.++.+++.+|+..+|++|| +++|++++
T Consensus 216 ----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 001112356788999999999999999 99999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=294.94 Aligned_cols=271 Identities=21% Similarity=0.264 Sum_probs=197.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999864 78999999886442 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeecccccccCCCC
Q 048430 757 YMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~ 834 (973)
|++ +++.+++.... ..+++..+..++.||+.||+||| +++++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 996 58888876543 33678888899999999999999 789999999999999985 567999999999765322
Q ss_pred CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc----
Q 048430 835 PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA---- 909 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---- 909 (973)
........+++.|+|||...+ ..++.++||||+||++|+|+||+.||......+ .+....... .......++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRIL-GTPNEETWPGVTSL 234 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CCCChhhccccccc
Confidence 112233457889999997755 457899999999999999999999986532211 111111110 0000110000
Q ss_pred -ccCCCCch-hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 -NLLSREDE-EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 -~l~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+...... ............+.++.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0000001112345668899999999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=293.88 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=193.5
Q ss_pred ccccCceEEEEEEeC-CCeEEEEEEEeccch---hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 688 LGSGSFDNVYKATLA-NGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 688 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999999865432 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-------c
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-------V 836 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-------~ 836 (973)
.+++.... .+++..+..++.|+++||+||| ..+++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998765 7899999999999999999999 89999999999999999999999999999875432211 1
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......++..|+|||.......+.++||||||+++||+++|+.||..... .........+..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~------------- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQNILNGKI------------- 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCc-------------
Confidence 22334578899999998888899999999999999999999999864321 111111100000
Q ss_pred hhhhhhHHhHHH--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 048430 917 EEDADDFATKKT--CISYIMSLALKCSAEIPEERINVKDALA 956 (973)
Q Consensus 917 ~~~~~~~~~~~~--~~~~l~~l~~~cl~~~P~~Rpt~~evl~ 956 (973)
..+.. .+..+.+++.+||+.+|++||++.++.+
T Consensus 219 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 219 -------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred -------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 00011 2566889999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=298.05 Aligned_cols=247 Identities=27% Similarity=0.350 Sum_probs=196.4
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.|...+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 355678899999999999995 46788999988642 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+. |++.+++......+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.+|++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 5888888765557899999999999999999999 789999999999999999999999999998765432
Q ss_pred ccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 837 TQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
....++..|+|||... ...++.++|||||||++|||++|+.||......+ ....+.. +.. +.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~----~~~-----~~--- 233 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ----NES-----PA--- 233 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhh----cCC-----CC---
Confidence 2345788999999763 4567889999999999999999999975421110 0111100 000 00
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.....++..+.+++.+||+.+|++||++++++++-.
T Consensus 234 ----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 ----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 001134566889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=293.15 Aligned_cols=244 Identities=27% Similarity=0.330 Sum_probs=194.2
Q ss_pred CCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
|...+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999985 468899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+. |++.+++......+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 5888888766667899999999999999999999 78999999999999999999999999999864321
Q ss_pred cccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 838 QTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||....... ...... ...... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~~~---~~~~~~-----~--- 240 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA---QNDSPT-----L--- 240 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH---hcCCCC-----C---
Confidence 22346888999999863 4568899999999999999999999985432111 011100 000000 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++..+.+++.+||+.+|++||++.+++++
T Consensus 241 ----------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ----------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001234458889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=318.31 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=187.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeee---------
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCS--------- 746 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------- 746 (973)
-..+|.+.+.||+||||.||+++.+ ||+.||||++.... +.....+.+|+.++++++|||||+++..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456677789999999999999955 89999999987663 344567889999999999999999882110
Q ss_pred --------------------------------------------------------------------------------
Q 048430 747 -------------------------------------------------------------------------------- 746 (973)
Q Consensus 747 -------------------------------------------------------------------------------- 746 (973)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------c-------CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 048430 747 -----------------------N-------PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG 796 (973)
Q Consensus 747 -----------------------~-------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 796 (973)
+ +...|+=||||+...++++++.+...-.....++++++|++|++|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-- 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-- 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH--
Confidence 0 01346789999997788887776522257788999999999999999
Q ss_pred CCCCeEEccCCCCcEEeCCCCcEEEeecccccccC-----------------CCCCcccccccccccccCccCCCCC---
Q 048430 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD-----------------GVDPVTQTMTLATIGYMAPEYGSEG--- 856 (973)
Q Consensus 797 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~--- 856 (973)
+++||||||||.||+++++..|||+|||+|.... .......+..+||.-|+|||...+.
T Consensus 715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8999999999999999999999999999998721 1112234567899999999976654
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHH
Q 048430 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSL 936 (973)
Q Consensus 857 ~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l 936 (973)
.|+.|+|+||+|||++||+. ||+..++... .+.....+.+..- +.+.. ...+.=.++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~----iL~~LR~g~iP~~--~~f~~--------------~~~~~e~sl 850 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERAS----ILTNLRKGSIPEP--ADFFD--------------PEHPEEASL 850 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHH----HHHhcccCCCCCC--ccccc--------------ccchHHHHH
Confidence 49999999999999999985 5654332221 1111111111110 00000 011223579
Q ss_pred HHhccccCCCCCCCHHHHHHH
Q 048430 937 ALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 937 ~~~cl~~~P~~Rpt~~evl~~ 957 (973)
++.|++.||.+||||.|++..
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhc
Confidence 999999999999999999863
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=294.08 Aligned_cols=254 Identities=24% Similarity=0.277 Sum_probs=198.1
Q ss_pred CCCCCccccccCceEEEEEEe----CCCeEEEEEEEeccc----hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCee
Q 048430 681 GFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQE----DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 751 (973)
+|...+.||+|++|.||+++. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999974 357889999986432 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+++|+|.+++.... .+++..+..++.|+++||+||| ..+++||||+|+||+++.++.++++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987654 6889999999999999999999 7999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccCccCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGI--VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
...........++..|+|||...+.. .+.++||||||+++|||++|..||...... .....+.......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-------- 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKS-------- 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHcc--------
Confidence 33322233345889999999876654 788999999999999999999998532111 1111111110000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
. ...+..++..+.+++.+||+.+|++|||++++.+.|+
T Consensus 228 ----~--------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 ----K--------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ----C--------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 0 0011224456889999999999999999877765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=272.86 Aligned_cols=253 Identities=25% Similarity=0.298 Sum_probs=200.0
Q ss_pred HhcCCCCC-ccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeec----CCe
Q 048430 678 ATNGFGES-NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSN----PGF 750 (973)
Q Consensus 678 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 750 (973)
.+++|.+. ++||-|-.|.|-.+.. .+++++|+|++... ....+|++..-.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46677654 6899999999999874 57999999988532 3456888876655 59999999998743 456
Q ss_pred eEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeeccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGI 826 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl 826 (973)
+.+|||.|+||.|.+.+++++ ..+++.++..|++||+.|+.||| +..|.|||+||+|+|.+. +..+|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence 778999999999999999876 56999999999999999999999 899999999999999964 45799999999
Q ss_pred ccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 827 AKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 827 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
|+.... ...-...+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........+ ++.
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---------pgM---- 275 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------PGM---- 275 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---------hhH----
Confidence 997542 33344567899999999999999999999999999999999999999765432110 010
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..++....... ..+.+...+++.+++++.++..+|++|.|+.|++.|
T Consensus 276 -k~rI~~gqy~F---P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 276 -KRRIRTGQYEF---PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -HhHhhccCccC---CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 01111100000 112334567889999999999999999999999876
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-34 Score=274.85 Aligned_cols=274 Identities=20% Similarity=0.289 Sum_probs=200.8
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeec--------CC
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSN--------PG 749 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~ 749 (973)
.|....+||+|.||.||+|+. ++|+.||+|++-.. .+.......+|++++..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 344557899999999999984 56888999865332 23334667899999999999999999998832 34
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..|+||++|+. +|.-.+.....+++..++.++++++..||.|+| ...|+|||+||.|+|++.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 68999999987 999999887778999999999999999999999 88999999999999999999999999999976
Q ss_pred cCCCC---CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc--cHHHHHHhhCCcch
Q 048430 830 LDGVD---PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM--SLKQWVAESLPGAV 903 (973)
Q Consensus 830 ~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 903 (973)
+...+ ...++..+.|..|++||.+.+ ..++++.|||+.|||+.||+||.+-+.+..+... .+.+......++.+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 54322 223556678999999996554 6799999999999999999999887654322110 11111111222222
Q ss_pred hhhcccccCCCCchh--------hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 904 TEVVDANLLSREDEE--------DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
..+..-.+......+ ...+...+..-.++..+++.+++..||.+|+++++++.|-
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 222111111111111 0011111111134678999999999999999999999874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=287.87 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=187.6
Q ss_pred ccccccCceEEEEEEe-CCCeEEEEEEEeccch---hhHHHHHHHHHHH-HhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED---RALKSFDTECEVM-RRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999985 4689999999865421 2223344555544 445899999999999999999999999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 99999998754 6899999999999999999999 78999999999999999999999999999875432 223
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..++..|+|||...+..++.++||||||+++|||++|..||..... ........... ... .
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~--------~~~-~----- 213 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRR--------INW-P----- 213 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcc--------cCC-C-----
Confidence 4578899999998887889999999999999999999999864321 11111110000 000 0
Q ss_pred hhHHhHHHHHHHHHHHHHhccccCCCCCCCHH---HHHHH
Q 048430 921 DDFATKKTCISYIMSLALKCSAEIPEERINVK---DALAD 957 (973)
Q Consensus 921 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~---evl~~ 957 (973)
......++..+.+++.+||+.+|++||++. |++.|
T Consensus 214 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 214 --EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred --CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 000113466789999999999999999664 55544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=297.78 Aligned_cols=272 Identities=22% Similarity=0.249 Sum_probs=196.9
Q ss_pred cCCCC-CccccccCceEEEEEEe-CCCeEEEEEEEeccchhh--------------HHHHHHHHHHHHhccCCceeEEEe
Q 048430 680 NGFGE-SNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRA--------------LKSFDTECEVMRRIRHRNLIKIVS 743 (973)
Q Consensus 680 ~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 743 (973)
++|.. .+.||+|+||.||+|.. .+++.||||.+....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 46799999999999985 468999999886432211 124778999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEee
Q 048430 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823 (973)
Q Consensus 744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 823 (973)
++...+..++||||+. |+|.+++.... .+++.....++.|++.||+||| +.+|+||||+|+||+++.++.+|++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 59999987654 6899999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCC-------------CcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcc
Q 048430 824 FGIAKLLDGVD-------------PVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEM 889 (973)
Q Consensus 824 fgla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~ 889 (973)
||.+....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99987654111 1111223467889999987654 46899999999999999999999986532211
Q ss_pred cHHHHHHhhC-C--cchhhhcc-cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 890 SLKQWVAESL-P--GAVTEVVD-ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 890 ~~~~~~~~~~-~--~~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+........ + ..+.+..+ +...................++.++.+++.+|++.+|++||+++|++.+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111111110 0 00000000 0000000000000001112346778899999999999999999999976
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=299.98 Aligned_cols=275 Identities=24% Similarity=0.267 Sum_probs=205.3
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC-----eeE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG-----FKA 752 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 752 (973)
+|...+.||+|++|.||+|+.. +++.||||.+.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 58999999886543 334578899999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||++ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 48999987665 7999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCC--cccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc----hhh
Q 048430 833 VDP--VTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA----VTE 905 (973)
Q Consensus 833 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~ 905 (973)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+ .... +....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNL-IVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHH-HHHhcCCCChhHhhh
Confidence 321 122334578899999988877 78999999999999999999999986532211 0111 11111000 000
Q ss_pred hcccccCC----CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHH
Q 048430 906 VVDANLLS----REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD--LKKIK 962 (973)
Q Consensus 906 ~~d~~l~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~--L~~~~ 962 (973)
........ ................+..+.+++.+||+.+|++||++++++++ ++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000 00000000000112246778999999999999999999999987 44444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=301.94 Aligned_cols=271 Identities=21% Similarity=0.278 Sum_probs=196.6
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecC----------
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP---------- 748 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------- 748 (973)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788899999999999999985 56899999998776655667889999999999999999999776543
Q ss_pred ----CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC-CCCcEEEee
Q 048430 749 ----GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGD 823 (973)
Q Consensus 749 ----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D 823 (973)
...++||||++ ++|.+++... .+++..+..++.||+.|+.||| +.+|+||||||+||+++ +++.+|++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 5999888654 5889999999999999999999 78999999999999997 456789999
Q ss_pred cccccccCCCCCc--ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC
Q 048430 824 FGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 824 fgla~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
||.+......... ......++..|+|||.... ..++.++|||||||++|||++|+.||......+ ...........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 9999765432111 1122357889999996543 568889999999999999999999996532211 11111111000
Q ss_pred c---chhhh---cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 G---AVTEV---VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~---~~~~~---~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ..... .........................++.+++.+|++.||++||++.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 00000 000000000000000000112345678899999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=296.69 Aligned_cols=271 Identities=23% Similarity=0.297 Sum_probs=196.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecC-------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNP------- 748 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 748 (973)
.++|...++||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999854 689999998864432 2234677899999999999999999987443
Q ss_pred -CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 749 -GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 749 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
...++|+||+.+ ++...+......+++.++..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999965 788877765567999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCc----------ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHH
Q 048430 828 KLLDGVDPV----------TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA 896 (973)
Q Consensus 828 ~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 896 (973)
+........ ......+++.|+|||...+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 765322211 1123356788999997654 45789999999999999999999998643221 11111111
Q ss_pred hhC-C--cchh------hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 897 ESL-P--GAVT------EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 897 ~~~-~--~~~~------~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... + ..+. ...+......... .. ........+.+.+++.+|++.+|++|||+.|++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TL--EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCc-cH--HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 100 0 0000 0000000000000 00 00111234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.53 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=202.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc---chhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999864 7999999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998765 6999999999999999999999 8999999999999999999999999999988654322
Q ss_pred C-------------------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHH
Q 048430 835 P-------------------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 835 ~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 895 (973)
. .......++..|+|||......++.++||||||++++++++|+.||..... ....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~ 234 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTFQKI 234 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHH
Confidence 1 122234578899999988888899999999999999999999999865321 0000000
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV----KDALAD 957 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~----~evl~~ 957 (973)
. +... ..+...++.+.+++.+||+.+|++||++ .|+++|
T Consensus 235 ~-----------~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 L-----------KLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H-----------hcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 0000 0111225568899999999999999999 887765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.17 Aligned_cols=267 Identities=25% Similarity=0.274 Sum_probs=200.9
Q ss_pred CCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
|...+.||+|++|.||+|+.. +++.||+|++.... ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999965 59999999987653 333467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
+ ++|.+++......+++..+..++.|+++|++||| +.+|+||||+|+||+++.++.+||+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 5999999886457999999999999999999999 78999999999999999999999999999876543221 22
Q ss_pred ccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhhcc-----c
Q 048430 839 TMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-----A 909 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d-----~ 909 (973)
....++..|+|||..... .++.++|||||||++||+++|+.||...... ..+........ +..+....+ .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 233467789999987666 7899999999999999999999998552211 11111111100 000111100 0
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......... .......+..+.+++.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDL---EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccch---HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 01111235679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=299.55 Aligned_cols=273 Identities=22% Similarity=0.265 Sum_probs=198.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC------C
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------G 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 749 (973)
.++|...+.||+|+||.||+|+. .+++.||||+++... ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37888899999999999999985 478999999886432 22345688999999999999999999988643 3
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++|+||+.. ++.++.. ..+++..+..++.|+++||+||| ..+|+||||||+||+++.++.+|++|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 56899999964 7777653 25899999999999999999999 78999999999999999999999999999876
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh-CC-cchhhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES-LP-GAVTEV 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~ 906 (973)
... ......++..|+|||...+ ..++.++|||||||++|||++|+.||...... ..+....... .+ ....+.
T Consensus 167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 167 ADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHH
Confidence 432 1223457889999998765 46889999999999999999999999652211 1111111100 00 001111
Q ss_pred ccccc-C---C-CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHHHH
Q 048430 907 VDANL-L---S-REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD--LKKIKK 963 (973)
Q Consensus 907 ~d~~l-~---~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~--L~~~~~ 963 (973)
.+... . . ................+.++.+++.+||+.||++||+++|+++| ++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 10000 0 0 00000000000111245668899999999999999999999987 666554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=289.32 Aligned_cols=269 Identities=21% Similarity=0.230 Sum_probs=196.6
Q ss_pred CCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-hhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEec
Q 048430 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-RALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
|...+.||+|++|.||+|+.. +++.||||.+..... .......+|+..+++++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999965 578999998864422 22234567899999999 999999999999999999999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+|+|.+++.... ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 789999887754 56899999999999999999999 7899999999999999999999999999998654322 2
Q ss_pred cccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhh--ccccc
Q 048430 838 QTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEV--VDANL 911 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~--~d~~l 911 (973)
.....++..|+|||... ...++.++||||||+++|||++|+.||......+ .+........ ...+.+. .+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 23345788999999764 4557899999999999999999999985432111 1111111000 0000000 00000
Q ss_pred CCCCchhh-hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEED-ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........ ..........+.++.+++.+||+.+|++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00000001124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=294.99 Aligned_cols=272 Identities=23% Similarity=0.267 Sum_probs=200.1
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeec-CCe
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGF 750 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 750 (973)
+..++++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345678899999999999999999984 47899999987543 22334678899999999999999999998865 567
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++|+||+ +++|.+++... .+++..+..++.|+++||+||| ..+|+||||+|+||++++++.+||+|||.+...
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 89999998 56899888754 4788889999999999999999 899999999999999999999999999998754
Q ss_pred CCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh--CCcch-hhh
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES--LPGAV-TEV 906 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~-~~~ 906 (973)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+.... .++++ ...
T Consensus 159 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhc
Confidence 32 1123457889999998765 56899999999999999999999998643211 1111111100 01111 111
Q ss_pred cccccC----CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLL----SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+.... ................++.++.+++.+|++.+|++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111000 000000000000111245779999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=273.27 Aligned_cols=262 Identities=25% Similarity=0.273 Sum_probs=199.7
Q ss_pred ccCCCCHHHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-hhHHHHHHHHHHHH-hccCCceeEEE
Q 048430 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-RALKSFDTECEVMR-RIRHRNLIKIV 742 (973)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~-~l~h~niv~l~ 742 (973)
....|+.+.++. ...||.|+||+|++-.. +.|+..|||+++.... .+.+++..|.++.. .-+.||||+++
T Consensus 57 ~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 344555555554 35799999999999875 5799999999976643 55678888888654 45799999999
Q ss_pred eeeecCCeeEEEEEecCCCCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc
Q 048430 743 SSCSNPGFKALIMQYMPQGSLEKWLYS----HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV 818 (973)
Q Consensus 743 ~~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~ 818 (973)
|.+..++..++.||.|+- |++.+... ....+++.-.-+|..-...||.||.+ +..|||||+||+|||++..|.
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 999889999999999954 77665432 23468888888999999999999997 788999999999999999999
Q ss_pred EEEeecccccccCCCCCcccccccccccccCccCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHH
Q 048430 819 AHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG--IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA 896 (973)
Q Consensus 819 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 896 (973)
+|+||||.+..+. ++..++..+|-..|||||.+... .|+.+|||||+|++++|+.||..||..+..--+.+.+.+.
T Consensus 207 vKLCDFGIcGqLv--~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 207 VKLCDFGICGQLV--DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred EeeecccchHhHH--HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 9999999987653 44556667899999999977643 4899999999999999999999998764331111222111
Q ss_pred hhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 897 ESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 897 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+....+. ... ....+...+..++..|+..|-.+||.++++.++
T Consensus 285 ----gdpp~l~-----~~~---------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 ----GDPPILL-----FDK---------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----CCCCeec-----Ccc---------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111000 000 001245668999999999999999999998764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=295.25 Aligned_cols=270 Identities=21% Similarity=0.256 Sum_probs=198.2
Q ss_pred HHhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----
Q 048430 677 QATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG---- 749 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 749 (973)
...++|...+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 346789999999999999999998 4578999999885432 223456889999999999999999999886543
Q ss_pred --eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 750 --FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 750 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
..++||||+ +++|.+++... .+++..+..++.|+++|++||| ..+|+||||||+||+++.++.+|++|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 67999888753 5899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchh
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVT 904 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 904 (973)
...... .....++..|+|||...+ ..++.++||||+||++|++++|+.||....... .......... +....
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence 765321 123357889999997765 458899999999999999999999986432110 1111111000 00000
Q ss_pred hhcccc----cCC-CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVDAN----LLS-REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d~~----l~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+... +.. ...............+..++.+++.+|++.||++||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000 00000000001112355678999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=295.43 Aligned_cols=274 Identities=23% Similarity=0.257 Sum_probs=200.6
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC-
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP- 748 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 748 (973)
.++....++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 46667789999999999999999999984 578999999886432 22346688899999999999999999987532
Q ss_pred -----CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEee
Q 048430 749 -----GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823 (973)
Q Consensus 749 -----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 823 (973)
...+++++++ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEec
Confidence 3467888887 77999888654 5899999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--C
Q 048430 824 FGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--P 900 (973)
Q Consensus 824 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~ 900 (973)
||++..... ......++..|+|||...+ ..++.++|||||||++|||++|+.||..... ...+........ +
T Consensus 164 fg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~ 238 (345)
T cd07877 164 FGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPG 238 (345)
T ss_pred ccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Confidence 999875432 1223467889999997655 5688999999999999999999999854221 111111111110 0
Q ss_pred cchhhhcccc----cCCCCchhhhhhH-HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 GAVTEVVDAN----LLSREDEEDADDF-ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~~~~~~~d~~----l~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......+... +............ .....++.++.+++.+|++.+|++||++.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0111000000 0000000000000 0001235668899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=283.09 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=193.4
Q ss_pred CCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc-----chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ-----EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
+|...+.||+|+||.||++... .+..+++|+++.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777899999999999999854 3455666655431 122334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 755 MQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
|||+++++|.+++.. ....+++.+++.++.|+++|+.||| +.+++|+||+|+||+++. +.+|++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 2346899999999999999999999 899999999999999976 569999999987654
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... .......++..|+|||......++.++||||||+++|+|++|..||.... ..........+. .+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~-----~~-- 223 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGP-----TP-- 223 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCC-----CC--
Confidence 322 22233457889999998888888999999999999999999999985321 111111110000 00
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++.++.+++.+||+.+|++||++.|+++|
T Consensus 224 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 ------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=281.82 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=199.4
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccch-------hhHHHHHHHHHHHHhccCCceeEEEeeee-cCCe
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED-------RALKSFDTECEVMRRIRHRNLIKIVSSCS-NPGF 750 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~ 750 (973)
++|-..++||+|||+.||+|. +...+.||||+-..... ...+...+|.++.+.++||.||++|+|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456677899999999999997 56789999998754421 22456789999999999999999999995 5577
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIA 827 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla 827 (973)
.|-|+|||+|.+|+-|+..++ .+++.++..|+.||+.||.||.+. +.+|||-|+||.|||+.. -|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 899999999999999998876 789999999999999999999954 789999999999999954 478999999999
Q ss_pred cccCCCCCc------ccccccccccccCccCCCC----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh
Q 048430 828 KLLDGVDPV------TQTMTLATIGYMAPEYGSE----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 828 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 897 (973)
++++...+. ......||.+|++||.+.- ...+.|+||||.|||+|+.+.|+.||+....... ...+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd----ILqe 696 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD----ILQE 696 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH----HHhh
Confidence 998654332 1234579999999996443 3578899999999999999999999976332211 1111
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ++...- ..++.......+...+|++|+++.-++|....++..+
T Consensus 697 NT------IlkAtE---------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 697 NT------ILKATE---------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hc------hhccee---------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 00 000000 0111122345667889999999999999998887643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=313.82 Aligned_cols=259 Identities=24% Similarity=0.325 Sum_probs=210.2
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
.++....++|.+.++||+|+||.|..++. .+++.||+|++... .....+-|..|-.+|..-+.+-|+.++..|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34555567899999999999999999985 56889999998752 234457789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
.++|+|||||+||+|...+.... .+++..++.++..|.-||.-|| +.|+|||||||+|||+|..|.+||+|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999999887 8999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCC----C-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcch
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGS----E-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV 903 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
.+...........+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||+. .+++.-+.......
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-----dslveTY~KIm~hk- 297 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-----DSLVETYGKIMNHK- 297 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-----HHHHHHHHHHhchh-
Confidence 88776777778889999999999643 3 6789999999999999999999999965 22222222211100
Q ss_pred hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 048430 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN---VKDALAD 957 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt---~~evl~~ 957 (973)
.... ++.....+++..+||.+.+.. |+.|.. +.++-.|
T Consensus 298 ------~~l~---------FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 ------ESLS---------FPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNH 338 (1317)
T ss_pred ------hhcC---------CCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhC
Confidence 0000 000112456677888877764 778876 8777665
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=291.61 Aligned_cols=271 Identities=23% Similarity=0.215 Sum_probs=193.3
Q ss_pred CCCCCccccccCceEEEEEEeC-C--CeEEEEEEEeccc--hhhHHHHHHHHHHHHhc-cCCceeEEEeeeec----CCe
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-N--GVSVAVKVFNLQE--DRALKSFDTECEVMRRI-RHRNLIKIVSSCSN----PGF 750 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 750 (973)
+|...+.||+|+||.||+++.. + +..||+|.+.... ....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999954 4 7889999886432 22346788899999999 59999999987532 245
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++++||+. ++|.+++.... .+++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899886 59999987654 6899999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCc---ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Cc-ch
Q 048430 831 DGVDPV---TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PG-AV 903 (973)
Q Consensus 831 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~-~~ 903 (973)
...... ......|+..|+|||...+ ..++.++||||+||++|++++|+.||...... ..+...+.... .. ..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 422111 1223468899999997655 46899999999999999999999998652211 11111111000 00 00
Q ss_pred hhhcccccC---CCCchhhhhhH-HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 904 TEVVDANLL---SREDEEDADDF-ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 904 ~~~~d~~l~---~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++... ..........+ .....+...+.+++.+|++.+|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 00000000000 0011235678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=286.70 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=197.0
Q ss_pred CccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCC
Q 048430 685 SNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
.+++|+|.||+||-|+. ++|+.||||++.+-+ ........+|+.+++.++||.||.+-..|+.++..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999984 589999999986542 233478899999999999999999999999999999999999664
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC---CcEEEeecccccccCCCCCccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
-|+-.+.....++++..-+.++.||+.||.||| -++|||+|+||+|||+... .++||+|||+|++.+. ....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksFR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSFR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch--hhhh
Confidence 444455555578999999999999999999999 7999999999999999654 4799999999999864 3334
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...+||+.|.|||++....|...-|+||.|||+|--++|..||++. +++.+-+.. ..+..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQN-----------AaFMy----- 783 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQN-----------AAFMY----- 783 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhc-----------ccccc-----
Confidence 5578999999999999999999999999999999999999999752 222211111 11110
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+.+......++|...++..=++|.+.++.+.|
T Consensus 784 ---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 784 ---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 001223445667889999999988999998877665
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=296.52 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=198.4
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe---
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF--- 750 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 750 (973)
...++|...+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678989999999999999999864 6889999988643 22334567789999999999999999988765544
Q ss_pred ---eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 751 ---KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 751 ---~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
.++|+||+ +++|.+++... .+++.++..++.|+++|++||| +.+|+||||+|+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 56999998764 5899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
...... .....++..|+|||.... ..++.++|||||||++||+++|+.||...... ..+...... ........
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~-~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNL-VGTPDEEL 239 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHh-cCCCCHHH
Confidence 865321 223457888999997654 46789999999999999999999998643211 111111111 10000000
Q ss_pred cccccCC--------CCchhhhhhH-HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLS--------REDEEDADDF-ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~--------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+ .... .......... .....++.++.+++.+|++.+|++|||+.|+++|
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQ-KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred Hh-hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 0000 0000000000 0111246779999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=274.02 Aligned_cols=271 Identities=21% Similarity=0.271 Sum_probs=201.6
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-C-C----ceeEEEeeeecCCe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-H-R----NLIKIVSSCSNPGF 750 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~~~ 750 (973)
.+++|.+...+|+|.||.|-.+.. ..+..||||+++.- ....++.+-|++++.++. + | -++.+.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 367899999999999999999874 35789999998633 334567788999999993 2 2 37788889999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC--------------
Q 048430 751 KALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-------------- 815 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------------- 815 (973)
.|+|+|.+ |.|+.+++..+. .+++...+..|+.|++++++||| +.+++|.|+||+||++..
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999998 669999999865 67899999999999999999999 899999999999999832
Q ss_pred ------CCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc-
Q 048430 816 ------DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE- 888 (973)
Q Consensus 816 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~- 888 (973)
...+|++|||.|.... ..+...+.|..|+|||++.+..++.++||||+||||.|++||...|......+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2358999999998643 23356678999999999999999999999999999999999999886533211
Q ss_pred ccHHHHHHhhCCcchhhhc------ccc-c------CCC------Cchhhhhh-HHhHHHHHHHHHHHHHhccccCCCCC
Q 048430 889 MSLKQWVAESLPGAVTEVV------DAN-L------LSR------EDEEDADD-FATKKTCISYIMSLALKCSAEIPEER 948 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~------d~~-l------~~~------~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~R 948 (973)
..+.+.+-...|..+..-. ... + ... ....+... +......-.++.+|+++|+..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 1122222222222211111 000 0 000 00000000 11112234569999999999999999
Q ss_pred CCHHHHHHH
Q 048430 949 INVKDALAD 957 (973)
Q Consensus 949 pt~~evl~~ 957 (973)
+|+.|++.|
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999976
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.58 Aligned_cols=239 Identities=28% Similarity=0.324 Sum_probs=194.1
Q ss_pred ccccCceEEEEEEeC-CCeEEEEEEEeccch---hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 688 LGSGSFDNVYKATLA-NGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 688 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
||+|+||.||++... +++.||+|++..... ...+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999864 589999999865432 2456788999999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 843 (973)
.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+....... .......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99998765 6899999999999999999999 7999999999999999999999999999987654322 22334567
Q ss_pred cccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhH
Q 048430 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923 (973)
Q Consensus 844 ~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 923 (973)
+..|+|||...+...+.++|+||||+++||+++|+.||..... .......... ..
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~--------~~------------ 210 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKD--------PL------------ 210 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC--------CC------------
Confidence 8899999998888889999999999999999999999864321 1111111100 00
Q ss_pred HhHHHHHHHHHHHHHhccccCCCCCCCH---HHHHH
Q 048430 924 ATKKTCISYIMSLALKCSAEIPEERINV---KDALA 956 (973)
Q Consensus 924 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~---~evl~ 956 (973)
..+...+..+.+++.+||..||++||++ +++++
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 0111124568899999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=294.35 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=215.0
Q ss_pred CHHHHHHHhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeee--
Q 048430 671 SYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCS-- 746 (973)
Q Consensus 671 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-- 746 (973)
.++.+...++.|.+.+.||.|.+|.||+++ .++++.+|+|+.....+. .+++..|+++++.. +|||++.++|++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344445566778889999999999999998 568999999998766543 35778899999887 5999999999984
Q ss_pred ---cCCeeEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEe
Q 048430 747 ---NPGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822 (973)
Q Consensus 747 ---~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 822 (973)
.++.++||||||.+||..+++..- +..+.|..+..|++.++.|+.||| ...++|||||-.|||++.++.||++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence 367899999999999999998753 357899999999999999999999 8899999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh
Q 048430 823 DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 823 Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 897 (973)
|||.+..++. ........+||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+-++.+... .+
T Consensus 166 DFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----LF-- 238 (953)
T KOG0587|consen 166 DFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----LF-- 238 (953)
T ss_pred eeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh----hc--
Confidence 9999887754 3345556789999999997543 3478899999999999999999999866543211 00
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....+...+..++.+..++-++|..|+..|-++||++.++++|
T Consensus 239 ----------------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 ----------------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11223444556678889999999999999999999999999876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=310.76 Aligned_cols=145 Identities=26% Similarity=0.404 Sum_probs=131.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|.+.++||+|+||.||+|... +++.||||+++... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 78999999986542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
||+.+++|.+++.... .+++..++.|+.||+.||+||| ..+||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998654 6889999999999999999999 7899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=288.12 Aligned_cols=242 Identities=22% Similarity=0.262 Sum_probs=195.2
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++.|.....+|.|+|+.|-.+. ..+++..+||++.... .+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4456666779999999998887 5678999999986552 2345677666665 69999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe-CCCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL-DDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
.+.++-+.+.+...+ .+. .++..|+.+|+.|+.||| .+||||||+||+|||+ +..+.++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999998877777654 233 778889999999999999 8999999999999999 69999999999999876543
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
....+-|..|.|||......+++++|+||||++||+|++|+.||.....+ ..+.. ....+...
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~---~i~~~~~s----------- 532 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT---RIQMPKFS----------- 532 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH---hhcCCccc-----------
Confidence 33346788999999999999999999999999999999999999765443 11111 11111100
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
...+...++|+.+|++.||.+||+|+|+..|=.
T Consensus 533 -----------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 533 -----------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred -----------cccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 234566889999999999999999999987743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=246.78 Aligned_cols=217 Identities=28% Similarity=0.363 Sum_probs=178.0
Q ss_pred HhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc-hhhHHHHHHHHHHHHh-ccCCceeEEEeeeecCCeeEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE-DRALKSFDTECEVMRR-IRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv 754 (973)
..++......||+|++|.|-+.+ ..+|+..|+|.+...- .+..+....|+.+..+ ..+|.+|+|+|...+.+..++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 33444445779999999998887 4689999999987553 3445677778887544 5799999999999999999999
Q ss_pred EEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 755 MQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
||.|+. ||+.+... .+..+++.-+-+||..+.+||.|||+ +..++|||+||+|||++.+|++|+||||.+..+.
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 999965 88876653 44578889999999999999999997 6789999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccCCC----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGS----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
++...+...|-..|||||.+. ...|+.|+||||+|+.+.||.+++.||+.....-..+.+.+.+..
T Consensus 201 --dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 201 --DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred --hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 344555567888999999654 346899999999999999999999999887776666666655433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=274.01 Aligned_cols=219 Identities=19% Similarity=0.163 Sum_probs=176.3
Q ss_pred cCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHHHHhhh
Q 048430 691 GSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS 769 (973)
Q Consensus 691 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 769 (973)
|.+|.||+++. .+++.||+|.++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999985 578999999986542 234455555566799999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccC
Q 048430 770 HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849 (973)
Q Consensus 770 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~a 849 (973)
.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 54 6899999999999999999999 899999999999999999999999999987655321 122345678999
Q ss_pred ccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHH
Q 048430 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTC 929 (973)
Q Consensus 850 PE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~ 929 (973)
||......++.++||||+||++|||++|+.|+....... .... ....+..+
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~--------------~~~~~~~~ 201 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHT--------------TLNIPEWV 201 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------cccc--------------ccCCcccC
Confidence 999888888999999999999999999998864321100 0000 00011224
Q ss_pred HHHHHHHHHhccccCCCCCCCH
Q 048430 930 ISYIMSLALKCSAEIPEERINV 951 (973)
Q Consensus 930 ~~~l~~l~~~cl~~~P~~Rpt~ 951 (973)
++.+.+++.+|++.||++||++
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCC
Confidence 5668899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=272.39 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=195.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 753 (973)
..+|....+||+|+||.|..|.. .+.+.+|||+++.+. +...+--+.|-++++.. +-|.+++++.+|+.-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 34788899999999999999974 467889999987552 23334456677777766 57899999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+.||+|--.++.-+ .+-+..+..+|.+||-||-+|| +++||+||+|.+|||++.+|.+||+|||+++.---
T Consensus 428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 999999999998888766 6888899999999999999999 89999999999999999999999999999975321
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
+.......+||+.|+|||.+...+|+.++|-|||||++|||+.|++||++.. +..+-+-+ .+..+
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--E~elF~aI-----------~ehnv-- 567 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQAI-----------MEHNV-- 567 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHH-----------HHccC--
Confidence 2223445689999999999999999999999999999999999999998632 22222211 11111
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN 950 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 950 (973)
..|+..+.+..+++...+...|.+|..
T Consensus 568 ----------syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 ----------SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----------cCcccccHHHHHHHHHHhhcCCccccC
Confidence 123445667788999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=300.77 Aligned_cols=263 Identities=22% Similarity=0.205 Sum_probs=171.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-C----CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEee------ee
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-N----GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS------CS 746 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 746 (973)
..++|...+.||+|+||.||+|... + +..||||++...... +....| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999964 4 689999987543221 111111 1111122222222211 24
Q ss_pred cCCeeEEEEEecCCCCHHHHhhhCCCCC-------------------CHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCC
Q 048430 747 NPGFKALIMQYMPQGSLEKWLYSHNYSL-------------------TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807 (973)
Q Consensus 747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 807 (973)
.....++||||+.+++|.+++....... ....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5678899999999999999987643111 12345679999999999999 8999999999
Q ss_pred CCcEEeCC-CCcEEEeecccccccCCCCCcccccccccccccCccCCCCC----------------------CCCcchhH
Q 048430 808 PNNVLLDD-DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG----------------------IVSISGDV 864 (973)
Q Consensus 808 ~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sDv 864 (973)
|+|||++. ++.+||+|||+|+..............+++.|+|||..... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986543333334456789999999943211 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC--c---chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHh
Q 048430 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP--G---AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK 939 (973)
Q Consensus 865 ws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 939 (973)
|||||++|||+++..|++. ...++...... . .+.....+. ...+....+...........+|+.+
T Consensus 363 wSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPR----ASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred HHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccc----cchhhhhhhhhccccchHHHHHHHH
Confidence 9999999999997766432 11222111100 0 011111110 0000000000001112345689999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 048430 940 CSAEIPEERINVKDALAD 957 (973)
Q Consensus 940 cl~~~P~~Rpt~~evl~~ 957 (973)
|++.||++|||++|+++|
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=286.30 Aligned_cols=258 Identities=20% Similarity=0.228 Sum_probs=181.6
Q ss_pred HhcCCCCCccccccCceEEEEEEe-----------------CCCeEEEEEEEeccchhhHHH--------------HHHH
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-----------------ANGVSVAVKVFNLQEDRALKS--------------FDTE 726 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 726 (973)
..++|.+.++||+|+||.||+|.. ..++.||||.++.......++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235689999987543332223 3346
Q ss_pred HHHHHhccCCce-----eEEEeeeec--------CCeeEEEEEecCCCCHHHHhhhCC----------------------
Q 048430 727 CEVMRRIRHRNL-----IKIVSSCSN--------PGFKALIMQYMPQGSLEKWLYSHN---------------------- 771 (973)
Q Consensus 727 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------- 771 (973)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777743 356899999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCc
Q 048430 772 -YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850 (973)
Q Consensus 772 -~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aP 850 (973)
..+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 13467788899999999999999 78999999999999999999999999999976543222222223457899999
Q ss_pred cCCCCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCccccCcc-------cHHHHHHhhCC
Q 048430 851 EYGSEGIV----------------------SISGDVYSFGILMMETFTRRK-PTNEMFTGEM-------SLKQWVAESLP 900 (973)
Q Consensus 851 E~~~~~~~----------------------~~~sDvws~Gvvl~elltg~~-p~~~~~~~~~-------~~~~~~~~~~~ 900 (973)
|.+..... ..+.||||+||+++||++|.. ||.....-.. ....|...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--- 456 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--- 456 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh---
Confidence 97643221 234799999999999999876 6543211110 11111100
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIP---EERINVKDALAD 957 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~Rpt~~evl~~ 957 (973)
.... ..+.......+...+++.+++..+| .+|+|++|+++|
T Consensus 457 ------~~~~----------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 ------KGQK----------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ------cccC----------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000 0011112235668889999999766 689999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=263.09 Aligned_cols=239 Identities=29% Similarity=0.367 Sum_probs=193.4
Q ss_pred CceEEEEEEeC-CCeEEEEEEEeccchhh-HHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHHHHhhh
Q 048430 692 SFDNVYKATLA-NGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS 769 (973)
Q Consensus 692 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 769 (973)
+||.||+|+.. +++.||+|++....... .+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999987664433 67899999999999999999999999988999999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccC
Q 048430 770 HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849 (973)
Q Consensus 770 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~a 849 (973)
.. .+++..+..++.++++++.||| ..+++|+||+|+||+++.++.++++|||.+....... ......++..|+|
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 65 3899999999999999999999 7899999999999999999999999999998765332 2334467889999
Q ss_pred ccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHH
Q 048430 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTC 929 (973)
Q Consensus 850 PE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~ 929 (973)
||......++.++||||||++++++++|..||...... .....+... .. .... .....+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~---~~---------~~~~--------~~~~~~ 213 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGK---PK---------PPFP--------PPEWKI 213 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhc---cC---------CCCc--------cccccC
Confidence 99988888899999999999999999999998652111 111111110 00 0000 000004
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 930 ISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 930 ~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.++.+++.+|+..+|++||++.+++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 5668899999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=241.99 Aligned_cols=263 Identities=22% Similarity=0.366 Sum_probs=200.7
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecC--CeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNP--GFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 755 (973)
++|.+.+++|+|.+++||.|. ..+.++++||+++.- ..+.+.+|+.++..+. ||||+++++...++ ....+|+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 467778899999999999998 567899999999743 3467899999999997 99999999998664 5678999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~~ 834 (973)
||+.+.+...... .++...+..++.++++||.|+| +.||+|||+||.|+|++.. -..+++|+|+|.++-+..
T Consensus 115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999987776554 5778889999999999999999 9999999999999999865 469999999999875322
Q ss_pred CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhh----
Q 048430 835 PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEV---- 906 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~---- 906 (973)
.....+.+..|.-||.+.. ..++..-|+|||||++..|+..+.|| +.+..+.++.++... ..+...-
T Consensus 188 --eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF---FhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 188 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF---FHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred --eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc---cCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 2344567788999997654 56889999999999999999999998 445555565554321 2211111
Q ss_pred ---cccccCC---CCchhhhhhHHhH---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 ---VDANLLS---REDEEDADDFATK---KTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ---~d~~l~~---~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.|+++.+ ......-.++..+ .-..++..+++.+.+.+|-.+|+|++|+++|
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 2222211 1111111111111 1134778999999999999999999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=274.12 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=202.8
Q ss_pred CCCCCccccccCceEEEEEEeCCCe-EEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLANGV-SVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++..+..||-|+||.|-.++.+... .+|+|++++. +..+.+.+..|-.+|...+.|.||++|-.|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4444567999999999999866433 4888877544 45566788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
-|-||.++..++..+ .++......++..+.+|++||| .++||+||+||+|.+++.+|-+||.|||+|+.+....
T Consensus 501 aClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-- 574 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-- 574 (732)
T ss_pred hhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence 999999999999876 7999999999999999999999 8999999999999999999999999999999886432
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
..-..+||+.|.|||.+.+...+.++|.||+|++++||++|.+||.+..+. ..+ ....+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktY-n~ILk---------------- 633 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTY-NLILK---------------- 633 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHH-HHHHh----------------
Confidence 223468999999999999999999999999999999999999999763221 111 10011
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALADL 958 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~L 958 (973)
....+..|........+++++....+|.+|.. +.++-+|-
T Consensus 634 --Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 634 --GIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred --hhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11122233445566778999999999999985 66666653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=286.94 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=189.6
Q ss_pred CCCCccccccCce-EEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecC
Q 048430 682 FGESNLLGSGSFD-NVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 682 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
|...+++|.|+-| .||+|... |+.||||++- .+..+-..+|+..++.- +|||||++++.-.++.+.|++.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3445789999987 46899886 8899999874 23335667999999887 59999999999999999999999997
Q ss_pred CCCHHHHhhhCCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---C--CcEEEeecccccccC
Q 048430 760 QGSLEKWLYSHNYS---LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---D--MVAHLGDFGIAKLLD 831 (973)
Q Consensus 760 ~gsL~~~l~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgla~~~~ 831 (973)
. +|.+++...... ......+.+..|+++|++||| +.+|||||+||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6 999999874211 111345778999999999999 899999999999999976 3 479999999999886
Q ss_pred CCCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 832 GVDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 832 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
..... ......||.+|+|||.+....-+.++||||+|||+|+.++| .+||+.....+.++.. +.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~------ 729 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GN------ 729 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cc------
Confidence 54333 23455799999999999988888899999999999999996 8999875444333211 00
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ....+....+| +..+||.+|+.++|..||++.+|+.|
T Consensus 730 ------~---~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 730 ------Y---TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ------c---ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 00001111122 57899999999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=256.10 Aligned_cols=271 Identities=24% Similarity=0.291 Sum_probs=199.5
Q ss_pred CCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----CeeEEE
Q 048430 683 GESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GFKALI 754 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 754 (973)
...+.||.|+||.||.... ++|+.||+|.+..- .-...+.+.+|+.++..++|.|++..++...-+ .+.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3467899999999999884 57999999987432 223467899999999999999999988876433 356788
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+|.|. .+|++.+-+. ..++...++-+.+||++||+||| +.+|.||||||.|.+++.+...||+|||+|+.....+
T Consensus 136 TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 89884 4888877654 47888899999999999999999 8999999999999999999999999999999876555
Q ss_pred CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC------------Cc
Q 048430 835 PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL------------PG 901 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~ 901 (973)
....+..+.|..|+|||.+.+ +.|+.+.||||.||++.|++.++..|....+- ..-+.+.+.. ++
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555566688999999998776 56999999999999999999999887653221 1122222211 11
Q ss_pred chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 902 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
.-..+.....+. ........+..+.+-..+...+...++..||.+|.+..++++++..=
T Consensus 289 Ak~H~LR~~~k~-Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 289 AKNHVLRAGLRA-PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hHHHhhccCCCC-CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 111111111110 00000011111122334566788899999999999999999886543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=250.38 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=200.6
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (973)
..++|...++||+|+|+.|..+++ ++.+.+|+|++++. +++.....+.|-.++.+. +||.+|.+..+|+.+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 346788899999999999999984 57889999998754 455567778888888876 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+|.||++||+|--+++.++ .++++.+..+..+|.-||.||| ++|||+||+|.+||+++..|.+|++|+|+++.--.
T Consensus 328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999988888776 7999999999999999999999 89999999999999999999999999999986322
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc--cCcccHHHHHHhhCCcchhhhcccc
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMF--TGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.....+..+||+.|.|||.+.+..|.+.+|-|++||+++||+.|+.||+-.. ..+++...+.-+.+ .++.
T Consensus 404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-------lekq 475 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-------LEKQ 475 (593)
T ss_pred -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-------hhhc
Confidence 1223456789999999999999999999999999999999999999997532 23333333322111 1111
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN 950 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 950 (973)
+ ..|...+.....+++.-+..||.+|..
T Consensus 476 i------------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 I------------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c------------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1 111122334566888889999999873
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=268.17 Aligned_cols=206 Identities=21% Similarity=0.319 Sum_probs=176.9
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.-|..++.||-|+||+|.+++ .++...+|.|.+++.+ .........|-.||..-+.+-||++|..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 346678899999999999997 5567789999887553 345677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC----
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---- 831 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~---- 831 (973)
||++||++-++|-.-+ .|.+..++.++.++.+|+++.| +.|+|||||||+|||||.+|.+||+|||++.-+.
T Consensus 709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999988766 6888999999999999999999 8999999999999999999999999999985331
Q ss_pred -----CCCCc--------------------------------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHH
Q 048430 832 -----GVDPV--------------------------------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874 (973)
Q Consensus 832 -----~~~~~--------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~el 874 (973)
..+.. .....+||+.|+|||++....++..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00000 00123699999999999999999999999999999999
Q ss_pred HhCCCCCCccccCcc
Q 048430 875 FTRRKPTNEMFTGEM 889 (973)
Q Consensus 875 ltg~~p~~~~~~~~~ 889 (973)
+.|+.||-...+++.
T Consensus 865 ~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGET 879 (1034)
T ss_pred hhCCCCccCCCCCcc
Confidence 999999977665554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=250.83 Aligned_cols=270 Identities=21% Similarity=0.211 Sum_probs=196.6
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-----C---CceeEEEeeee----
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-----H---RNLIKIVSSCS---- 746 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~---- 746 (973)
.+|...++||-|.|++||+|- ....+.||+|+.+.. ....+....|+++|++++ | ..||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 578889999999999999997 567889999998644 344567889999999984 3 47999999985
Q ss_pred cCCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC---------
Q 048430 747 NPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD--------- 816 (973)
Q Consensus 747 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--------- 816 (973)
.+.+.|+|+|+. |.+|..+|.... ..++...++.|++||+.||.|||. +.+|||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhhhh
Confidence 456999999999 569999988755 468999999999999999999998 6799999999999998311
Q ss_pred --C-----------------------------------------------------------------------------
Q 048430 817 --M----------------------------------------------------------------------------- 817 (973)
Q Consensus 817 --~----------------------------------------------------------------------------- 817 (973)
+
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------cE
Q 048430 818 ------------------------------------------------------------------------------VA 819 (973)
Q Consensus 818 ------------------------------------------------------------------------------~~ 819 (973)
.+
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 01
Q ss_pred EEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc-----CcccHHHH
Q 048430 820 HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFT-----GEMSLKQW 894 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~-----~~~~~~~~ 894 (973)
||+|||-|+-.. ...+..+.|..|+|||++.+..|+..+|||||+|++|||+||...|+.... ++..++..
T Consensus 394 KIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 122222211100 011122356689999999999999999999999999999999998876422 33445554
Q ss_pred HHhhC--------Cc-chhhhcccccCCC--Cch-------hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 048430 895 VAESL--------PG-AVTEVVDANLLSR--EDE-------EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALA 956 (973)
Q Consensus 895 ~~~~~--------~~-~~~~~~d~~l~~~--~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~ 956 (973)
+.-.. .+ ...+.++++-.-+ ... .....+..++.-..++.+++.-|++.+|++||||++.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 43211 11 2334444331111 100 112334455666788999999999999999999999997
Q ss_pred H
Q 048430 957 D 957 (973)
Q Consensus 957 ~ 957 (973)
|
T Consensus 550 h 550 (590)
T KOG1290|consen 550 H 550 (590)
T ss_pred C
Confidence 6
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=245.30 Aligned_cols=264 Identities=25% Similarity=0.258 Sum_probs=197.2
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC------Ce
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------GF 750 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 750 (973)
.+|.....+|.|+- .|..|. .-.++.||+|...... ....+...+|..++..+.|+||++++.+|+-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666778888888 566554 2358899999764332 23457788999999999999999999998532 46
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.|+|||+|.. +|...+.. .++-..+..|..|+++|++||| +.+|+|||+||+||++..+..+||.|||+|+.-
T Consensus 96 ~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence 7899999955 99998884 4788889999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC----Ccc-hh-
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGA-VT- 904 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~-~~- 904 (973)
... ...+.++.+..|.|||.+.+..+.+.+||||.||++.||++|+.-| +++..+.+|.+... ++. ..
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf----~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF----PGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe----cCchHHHHHHHHHHHhcCCCHHHHH
Confidence 432 3556678999999999998888999999999999999999999875 46667777754311 110 00
Q ss_pred hh---------cccccCCCCchhh------hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EV---------VDANLLSREDEED------ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~---------~d~~l~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
++ ..++.......+. ........--.....+++.+|+..+|++|.+++++++|
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0000000000000 00001111123447889999999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=236.28 Aligned_cols=211 Identities=33% Similarity=0.528 Sum_probs=184.1
Q ss_pred ccccCceEEEEEEeC-CCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHHH
Q 048430 688 LGSGSFDNVYKATLA-NGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765 (973)
Q Consensus 688 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 765 (973)
||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4899999998765432 35789999999999999999999999999899999999999999999
Q ss_pred HhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeecccccccCCCCCccccccccc
Q 048430 766 WLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844 (973)
Q Consensus 766 ~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~ 844 (973)
++......+++..+..++.+++++++||| +.+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 99876446899999999999999999999 789999999999999999 89999999999986643221 12334578
Q ss_pred ccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhH
Q 048430 845 IGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923 (973)
Q Consensus 845 ~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 923 (973)
..|++||..... ..+.++|+|++|++++++
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 889999988777 888999999999999998
Q ss_pred HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 924 ~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2367899999999999999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-28 Score=256.61 Aligned_cols=197 Identities=22% Similarity=0.338 Sum_probs=170.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---h-----hhHHHHHHHHHHHHhcc---CCceeEEEeeee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---D-----RALKSFDTECEVMRRIR---HRNLIKIVSSCS 746 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 746 (973)
..+|...+.+|+|+||.|+.|..+ +...|+||.+.+.+ + ...-.+..|+.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999965 46778999886542 1 11223557999999997 999999999999
Q ss_pred cCCeeEEEEEec-CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 747 NPGFKALIMQYM-PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 747 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
+.+.+|++||.. ++-+|.+++..++ .+++.++..|++|++.|+++|| ..+|||||||-+||.++.+|-+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 999999999986 4569999998766 8999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTN 882 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~ 882 (973)
.|.... .......+||.+|.|||.+.+..| ...-|||++||++|-++....||.
T Consensus 716 saa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 987653 345566789999999999888776 456799999999999999988875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=267.73 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=207.2
Q ss_pred HhcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
..++|.....+|.|.||.||+|+ ..+++..|||+++.......+...+|+-+++..+||||+.++|.+...+...++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34567778899999999999999 45799999999998887778888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
||.+|+|.+..+... .+++.++..+.++..+|++||| +.+=+|||||-.||++++.|.+|++|||.+..++.. -.
T Consensus 93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~ 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IA 167 (829)
T ss_pred ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh-hh
Confidence 999999999887765 7899999999999999999999 899999999999999999999999999998766532 22
Q ss_pred ccccccccccccCccC---CCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 837 TQTMTLATIGYMAPEY---GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~---~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
......||+.|||||. ...+.|..++|||+.|+...|+-.-+.|.....+.. . ..++-...
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr----~----------l~LmTkS~-- 231 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR----A----------LFLMTKSG-- 231 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH----H----------HHHhhccC--
Confidence 3445679999999995 456678999999999999999988887743222110 0 00110000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+......+..+.+.+.++++.|+..+|++||++..+++|
T Consensus 232 ----~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 232 ----FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ----CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 0011112223457779999999999999999999987764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=241.86 Aligned_cols=275 Identities=24% Similarity=0.336 Sum_probs=202.9
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecC
Q 048430 674 ELQQATNGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNP 748 (973)
Q Consensus 674 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 748 (973)
.+....+.|..+++||+|.|++||+|... ..+.||+|.+..... ...+..|++++..+. +.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678899999999999999999843 478899998865433 366889999999995 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeecccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIA 827 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla 827 (973)
+..++|+||++.....++... ++..++..+++.+.+||+|+| ..|||||||||.|++++. .+.-.|.|||+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhH
Confidence 999999999999888888874 678899999999999999999 899999999999999975 467899999999
Q ss_pred cccCCCC-------------------------------------------CcccccccccccccCccCCCC-CCCCcchh
Q 048430 828 KLLDGVD-------------------------------------------PVTQTMTLATIGYMAPEYGSE-GIVSISGD 863 (973)
Q Consensus 828 ~~~~~~~-------------------------------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sD 863 (973)
....... ........||+||+|||++.. ...+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7221000 000112359999999997655 45789999
Q ss_pred HHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh---hccc-------------ccC----C-----CCchh
Q 048430 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE---VVDA-------------NLL----S-----REDEE 918 (973)
Q Consensus 864 vws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~-------------~l~----~-----~~~~~ 918 (973)
|||.|||+.-+++++.||-....+-..+.+.+....+.++.. ..+. .+. . ....+
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999998654444444444432221111110 0000 000 0 00000
Q ss_pred h--hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 D--ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ..........+..+++++.+|+..||.+|.|++|+++|
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00111112234578999999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=253.25 Aligned_cols=271 Identities=21% Similarity=0.277 Sum_probs=202.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc------CCceeEEEeeeecCCe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR------HRNLIKIVSSCSNPGF 750 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~ 750 (973)
.-.+|.+....|+|-|++|..|.. ..|+.||||++...... .+.=.+|+++|+++. .-|+++++..|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 456788889999999999999984 45889999999765432 345568999999995 3588899999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeecccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIA 827 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla 827 (973)
+|||||.+. .+|.+++...+ ..+....+..++.|+.-||..|- ..+|+|.||||.||||++. ..+||||||.|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 999999984 49999998765 45788899999999999999999 8999999999999999875 56899999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHH--hhC------
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA--ESL------ 899 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--~~~------ 899 (973)
...... .-+.+..+..|.|||++.+..|+..-|+||.||+|||++||+..|.+.....+ +..+.. ..+
T Consensus 585 ~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M-Lrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 585 SFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM-LRLFMELKGKFPNKMLR 660 (752)
T ss_pred cccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH-HHHHHHhcCCCcHHHhh
Confidence 876432 22345677889999999999999999999999999999999998866433221 111110 000
Q ss_pred Ccc-hhhhcccccCC-------------------CCc-hhhhhhH-------HhHHHHHHHHHHHHHhccccCCCCCCCH
Q 048430 900 PGA-VTEVVDANLLS-------------------RED-EEDADDF-------ATKKTCISYIMSLALKCSAEIPEERINV 951 (973)
Q Consensus 900 ~~~-~~~~~d~~l~~-------------------~~~-~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 951 (973)
.++ ..+-+|..+.- ... ......+ .........+.+|+.+|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 011 11111111100 000 0000000 1112356778999999999999999999
Q ss_pred HHHHHH
Q 048430 952 KDALAD 957 (973)
Q Consensus 952 ~evl~~ 957 (973)
.++++|
T Consensus 741 nqAL~H 746 (752)
T KOG0670|consen 741 NQALKH 746 (752)
T ss_pred HHHhcC
Confidence 999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=233.28 Aligned_cols=199 Identities=29% Similarity=0.443 Sum_probs=173.2
Q ss_pred CCCCccccccCceEEEEEEeCC-CeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 899999999766544 56789999999999999999999999998899999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+++|.+++......+++..+..++.+++.++.||| ..+++|+|++|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999999876533899999999999999999999 789999999999999999999999999998876533211223
Q ss_pred cccccccccCccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 048430 840 MTLATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRRKPTNE 883 (973)
Q Consensus 840 ~~~~~~~y~aPE~~-~~~~~~~~sDvws~Gvvl~elltg~~p~~~ 883 (973)
...++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34577889999987 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-27 Score=245.72 Aligned_cols=176 Identities=25% Similarity=0.317 Sum_probs=100.1
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCC-chhhhccCcCCeeecCCccccCcCcccccCcCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFI-PTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 445 (973)
|.+++.|+.|+|.+|+|+...|.+|..+.+|.+|.|-.|.+..-- -.|++. .|..+...+ .|.+ ++-..+
T Consensus 318 f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~-~~~C-q~p~~~ 388 (498)
T KOG4237|consen 318 FQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVG-NPRC-QSPGFV 388 (498)
T ss_pred hhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCC-CCCC-CCCchh
Confidence 778888999999999999888999999999999999988876321 111211 122233222 2222 223456
Q ss_pred CeeeccCCCCCC---CCcccccccccccEEEecCCcccCCcCcCccCCCCCCe-EEccCCcCcccCCcccccCCcCCEEE
Q 048430 446 RHLDFRSNSLNS---TIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGG-LNLTGNQLSGYIPSSIGNLKNLDWLA 521 (973)
Q Consensus 446 ~~L~L~~N~l~~---~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~ 521 (973)
+.+.++.+.+.. ..|+..+-. ..+..-..++-+.+ -.-|++.++ .+|..+- ..-++|+
T Consensus 389 ~~~~~~dv~~~~~~c~~~ee~~~~---------------~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~tely 450 (498)
T KOG4237|consen 389 RQIPISDVAFGDFRCGGPEELGCL---------------TSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELY 450 (498)
T ss_pred ccccchhccccccccCCccccCCC---------------CCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHh
Confidence 677777665532 122211100 00111112222322 223333443 4444332 2345667
Q ss_pred cccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCC
Q 048430 522 LARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 522 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
+.+|.++ .+|.+ .+.+| .+||++|+++..-...|.+|++|.+|-+|+|
T Consensus 451 l~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 451 LDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 7777777 66655 55666 7777777777666666777777777777765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-27 Score=245.02 Aligned_cols=392 Identities=24% Similarity=0.245 Sum_probs=210.1
Q ss_pred CeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecC-CcccCccccccccCCcce
Q 048430 145 KSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGG-NNIAGLIPSMIFNNSNMV 223 (973)
Q Consensus 145 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~L~ 223 (973)
..++|..|+|+ .||.++|+.+++|+.|||++|+|+. .-|++|.++.+|..|-+-+ |+|+.+....|.++..++
T Consensus 70 veirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~-----I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slq 143 (498)
T KOG4237|consen 70 VEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISF-----IAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQ 143 (498)
T ss_pred eEEEeccCCcc-cCChhhccchhhhceecccccchhh-----cChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHH
Confidence 34444444444 4444444444444444444444442 1234444444443333322 444443334444433332
Q ss_pred eEEeecccccccCCCCC-CccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCc
Q 048430 224 AILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302 (973)
Q Consensus 224 ~L~l~~n~l~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 302 (973)
.|.+.-|++.-.....+ .+++|..|.+.+|.+..+--.+|..+..++.+.+..|.+-.. .+++.|.. ++.-|
T Consensus 144 rLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd-----CnL~wla~-~~a~~- 216 (498)
T KOG4237|consen 144 RLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD-----CNLPWLAD-DLAMN- 216 (498)
T ss_pred HHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc-----cccchhhh-HHhhc-
Confidence 22222222221111111 156666666666666643333666666666666666652110 11111110 00001
Q ss_pred CCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCC-CCCCCCcccEEEeecC
Q 048430 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPV-GFGNLSNLLVLSLVNN 381 (973)
Q Consensus 303 l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~-~~~~l~~L~~L~Ls~n 381 (973)
+.+++..+-..-..+.++++..+-+..+......+..-..+.+...+..|. .|..+++|+.|+|++|
T Consensus 217 ------------~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN 284 (498)
T KOG4237|consen 217 ------------PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNN 284 (498)
T ss_pred ------------hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCC
Confidence 111122222222223333333333333222222222222333333334443 3888999999999999
Q ss_pred ccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCc-
Q 048430 382 ELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIP- 460 (973)
Q Consensus 382 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p- 460 (973)
+++.+-+.+|.++..+++|.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+...--
T Consensus 285 ~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 285 KITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred ccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence 9998888899999999999999999997777788899999999999999998889999999999999998888752100
Q ss_pred ccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcc---cCCccc---------ccCCcCCEEE-cccCcc
Q 048430 461 STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG---YIPSSI---------GNLKNLDWLA-LARNAF 527 (973)
Q Consensus 461 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~~---------~~l~~L~~L~-Ls~N~l 527 (973)
.++... |..+.-.|..| -+.-..++.+.++.+.+.. ..|++. ...+-+...- -|++.+
T Consensus 365 ~wl~~W-------lr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~l 435 (498)
T KOG4237|consen 365 AWLGEW-------LRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLL 435 (498)
T ss_pred HHHHHH-------HhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccch
Confidence 111110 11222222221 1222344455555544331 122222 2234455433 344444
Q ss_pred ccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccc
Q 048430 528 QGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 528 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
+ .+|..+- ..-..|++.+|.++ .+|.+ .+.+| .+|+|+|+++.
T Consensus 436 k-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~ 478 (498)
T KOG4237|consen 436 K-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISS 478 (498)
T ss_pred h-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceeh
Confidence 4 7776554 35789999999999 77877 77778 89999999873
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=220.10 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=187.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEee-eecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSS-CSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 755 (973)
.+.|.+.+.+|+|.||.+-.++++ +.+.+|+|.+... ....++|.+|...--.+ .|.||+.-|+. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 456888899999999999999864 6788999987543 23457899988765445 58999988764 67778888999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC--CCCcEEEeecccccccCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD--DDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~ 833 (973)
||++.|+|.+-+...+ +-+....+++.|++.|+.|+| ++.+||||||.+|||+- +...+|+||||..+..+..
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999887754 778888999999999999999 89999999999999993 3458999999998865422
Q ss_pred CCcccccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 834 DPVTQTMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
-.. .--+..|.|||.... -...+.+|||.||++++.++||+.||......+..+..|..-......
T Consensus 177 V~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~----- 247 (378)
T KOG1345|consen 177 VKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP----- 247 (378)
T ss_pred ehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-----
Confidence 111 123456889984332 235788999999999999999999998655556665555432111100
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+-+. + ..+++.+..+.++-+.++|++|-...++.+..
T Consensus 248 -~~P~~--------F---~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 -ALPKK--------F---NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -cCchh--------h---cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 00000 0 12345678899999999999995555554443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=264.58 Aligned_cols=285 Identities=24% Similarity=0.265 Sum_probs=133.8
Q ss_pred CCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEec
Q 048430 196 HNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELS 275 (973)
Q Consensus 196 ~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 275 (973)
.+|++|+|++|++. .++..+..+++|+.|+|++|.....+|....+++|++|+|++|..-..+|..+..+++|+.|+++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 34444444444443 22333333444444444443333333433345666666666665444566666777777777777
Q ss_pred cccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecc
Q 048430 276 SNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAG 355 (973)
Q Consensus 276 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~ 355 (973)
+|.....+|..+ ++++|+.|++++|..... ++ ...++|+.|++++|.+.. +|..
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~-------~p---~~~~nL~~L~L~~n~i~~-lP~~-------------- 743 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKS-------FP---DISTNISWLDLDETAIEE-FPSN-------------- 743 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccc-------cc---cccCCcCeeecCCCcccc-cccc--------------
Confidence 654433444433 566666666666542210 00 012345555555555431 2211
Q ss_pred cCCccccCCCCCCCCCcccEEEeecCccc-------cccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCC
Q 048430 356 SSQLSGGIPVGFGNLSNLLVLSLVNNELA-------GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428 (973)
Q Consensus 356 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~-------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 428 (973)
+ .+++|+.|++.++... ...+..+...++|+.|+|++|...+.+|..++++++|+.|++++
T Consensus 744 -----------~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~ 811 (1153)
T PLN03210 744 -----------L-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIEN 811 (1153)
T ss_pred -----------c-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCC
Confidence 1 2344444444432211 01111122234555555555554445555555555555555555
Q ss_pred ccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCC
Q 048430 429 NALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP 508 (973)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 508 (973)
|...+.+|..+ ++++|+.|++++|.....+|.. ..+|+.|+|++|.++ .+|
T Consensus 812 C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---------------------------~~nL~~L~Ls~n~i~-~iP 862 (1153)
T PLN03210 812 CINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---------------------------STNISDLNLSRTGIE-EVP 862 (1153)
T ss_pred CCCcCeeCCCC-CccccCEEECCCCCcccccccc---------------------------ccccCEeECCCCCCc-cCh
Confidence 44333444433 4555555555554432222221 134555555555554 445
Q ss_pred cccccCCcCCEEEccc-CccccCCCCCccccccccccccccc
Q 048430 509 SSIGNLKNLDWLALAR-NAFQGPIPQSFGSLISLQSLDLSGN 549 (973)
Q Consensus 509 ~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (973)
.++..+++|+.|+|++ |+++ .+|..+..+++|+.|++++|
T Consensus 863 ~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 863 WWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred HHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 5555555555555555 2333 34445555555555555555
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=265.73 Aligned_cols=352 Identities=21% Similarity=0.256 Sum_probs=252.0
Q ss_pred CCccccCCCCCccEEEcccccccccC-CCCCCCccccCCC-CccEEEecCCcccCccccccccCCcceeEEeeccccccc
Q 048430 158 FPTDLCTRLPSLVQLRLLGNNITGRI-PNREIPNEIGNLH-NLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGH 235 (973)
Q Consensus 158 ip~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 235 (973)
+....|.++++|+.|.+..+...... ....+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|++.+|++...
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L 626 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKL 626 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccccc
Confidence 34455667777777777655432100 0014566677664 6999999999987 557666 578999999999999865
Q ss_pred CCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCc-CCCCCCCcchhh
Q 048430 236 LPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ-LTTGSSAQGQIF 314 (973)
Q Consensus 236 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~ 314 (973)
......+++|+.|+|++|.....+|+ ++.+++|+.|+|++|.....+|..+.++++|+.|++++|. ++.+|..
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~----- 700 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG----- 700 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc-----
Confidence 55555799999999998865556664 8889999999999998777889999999999999999864 4443221
Q ss_pred hhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCC
Q 048430 315 YSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKL 394 (973)
Q Consensus 315 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l 394 (973)
+ ++++|+.|++++|...+.+|. ...+|++|++++|.+. .+|..+ .+
T Consensus 701 ---i-~l~sL~~L~Lsgc~~L~~~p~----------------------------~~~nL~~L~L~~n~i~-~lP~~~-~l 746 (1153)
T PLN03210 701 ---I-NLKSLYRLNLSGCSRLKSFPD----------------------------ISTNISWLDLDETAIE-EFPSNL-RL 746 (1153)
T ss_pred ---C-CCCCCCEEeCCCCCCcccccc----------------------------ccCCcCeeecCCCccc-cccccc-cc
Confidence 1 456666666666643322221 1235666666666665 444443 35
Q ss_pred CCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEe
Q 048430 395 QKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDF 474 (973)
Q Consensus 395 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 474 (973)
++|++|++.++... .+... +....+..+...++|+.|+|++|...+.+|..+..+++|+.|++
T Consensus 747 ~~L~~L~l~~~~~~-~l~~~----------------~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L 809 (1153)
T PLN03210 747 ENLDELILCEMKSE-KLWER----------------VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI 809 (1153)
T ss_pred cccccccccccchh-hcccc----------------ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence 66666666554332 11111 11111222233467888888888877788888888889999999
Q ss_pred cCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccccc-ccCC
Q 048430 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN-NISG 553 (973)
Q Consensus 475 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~ 553 (973)
++|...+.+|..+ ++++|+.|+|++|..-..+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++| ++.
T Consensus 810 s~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~- 883 (1153)
T PLN03210 810 ENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ- 883 (1153)
T ss_pred CCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-
Confidence 8876555777766 7899999999998655466653 368999999999998 78999999999999999995 555
Q ss_pred CCCccccccccccccccCCCc
Q 048430 554 EIPKSLEKLSRLVDFNVSFNG 574 (973)
Q Consensus 554 ~~p~~~~~l~~L~~l~ls~N~ 574 (973)
.+|..+..+++|+.++++++.
T Consensus 884 ~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 884 RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccCcccccccCCCeeecCCCc
Confidence 688889999999999999884
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=213.56 Aligned_cols=171 Identities=20% Similarity=0.207 Sum_probs=131.0
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccccc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 840 (973)
|+|.++++..+..+++.+++.++.|+++||+||| +.+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999876667999999999999999999999 555 999999999999999 99988654321
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 920 (973)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||.........+..+.....+... .
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~--- 127 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP-------------R--- 127 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-------------c---
Confidence 258899999999999999999999999999999999999986533222222222221111000 0
Q ss_pred hhHHhHHHHH--HHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 921 DDFATKKTCI--SYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 921 ~~~~~~~~~~--~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
....+.... .++.+++.+||+.+|++||++.|+++++..+....
T Consensus 128 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 128 -DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred -ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 000111222 26899999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=268.30 Aligned_cols=197 Identities=16% Similarity=0.246 Sum_probs=140.0
Q ss_pred hccC-CceeEEEeee-------ecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEE
Q 048430 732 RIRH-RNLIKIVSSC-------SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803 (973)
Q Consensus 732 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 803 (973)
.++| +||++++++| .+.+..+.++||+ +++|.+++......+++.+++.++.||++||+||| +++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 3445 5788888877 2334567788987 55999999865557999999999999999999999 899999
Q ss_pred ccCCCCcEEeCC-------------------CCcEEEeecccccccCCCC---------------CcccccccccccccC
Q 048430 804 CDLKPNNVLLDD-------------------DMVAHLGDFGIAKLLDGVD---------------PVTQTMTLATIGYMA 849 (973)
Q Consensus 804 ~dlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~---------------~~~~~~~~~~~~y~a 849 (973)
|||||+|||++. ++.+|++|||+++...... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999965 4455666666665321100 000112357889999
Q ss_pred ccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHH
Q 048430 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTC 929 (973)
Q Consensus 850 PE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~ 929 (973)
||++....++.++|||||||++|||++|..|+.... .....+.... ..+.. ...
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~--------~~~~~---------------~~~ 237 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRV--------LPPQI---------------LLN 237 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhh--------cChhh---------------hhc
Confidence 999998899999999999999999999888754211 0111110000 00000 001
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 930 ISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 930 ~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.....+++.+||+++|.+||++.|+++|-
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 22345788899999999999999998763
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=242.97 Aligned_cols=85 Identities=24% Similarity=0.361 Sum_probs=52.4
Q ss_pred cccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeecc
Q 048430 372 NLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFR 451 (973)
Q Consensus 372 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 451 (973)
+|+.|++++|++++ +|.. .++|+.|++++|++++ +|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 45566666666652 3332 2456666777776663 4432 235566777777776 566667777777777777
Q ss_pred CCCCCCCCcccccc
Q 048430 452 SNSLNSTIPSTFWS 465 (973)
Q Consensus 452 ~N~l~~~~p~~~~~ 465 (973)
+|+|++..+..+..
T Consensus 454 ~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 454 GNPLSERTLQALRE 467 (788)
T ss_pred CCCCCchHHHHHHH
Confidence 77777766665533
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=209.59 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=187.9
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
..+|.+...|+.|+|+++ |..+++|++...+ .....+|.+|.-.++-+.||||+.++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 357899999999999997 5567778775443 2223678999999999999999999999999999999999999999
Q ss_pred HHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccc
Q 048430 763 LEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 763 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
|+..++... ...+..++++++.+||+|++|||+- ++-|.---+.++.+++|++.+++|+- +-+++. ......
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~gr 346 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEVGR 346 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee-----eecccc
Confidence 999999865 4467789999999999999999952 33344456899999999999988751 111111 111122
Q ss_pred cccccccCccCCCCCCC---CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 842 LATIGYMAPEYGSEGIV---SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 842 ~~~~~y~aPE~~~~~~~---~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
.-.+.||+||.++..+- -.++|+|||++++||+.|+..||.+..+.+-..+.....
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg--------------------- 405 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG--------------------- 405 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc---------------------
Confidence 34678999998776553 467999999999999999999998765544322211100
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
-+...|......+.+++.-|...||.+||.++.++-.||++.
T Consensus 406 --lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 --LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 011222344556788999999999999999999999998874
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=241.19 Aligned_cols=264 Identities=27% Similarity=0.393 Sum_probs=148.0
Q ss_pred CcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEcc
Q 048430 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLD 150 (973)
Q Consensus 71 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 150 (973)
-..|+|++|+++ .+|+.+.. +|+.|++++|+++ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 345555555553 45555542 5566666666665 4553 1355666666666666 34432 2456666666
Q ss_pred CccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecc
Q 048430 151 NNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGN 230 (973)
Q Consensus 151 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n 230 (973)
+|.|+ .+|. ...+|+.|+|++|+|+ .+|.. +++|++|+|++|+|++. |... .+|+.|++++|
T Consensus 271 ~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt------~LP~~---p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N 332 (788)
T PRK15387 271 SNPLT-HLPA----LPSGLCKLWIFGNQLT------SLPVL---PPGLQELSVSDNQLASL-PALP---SELCKLWAYNN 332 (788)
T ss_pred CCchh-hhhh----chhhcCEEECcCCccc------ccccc---ccccceeECCCCccccC-CCCc---ccccccccccC
Confidence 66665 4443 1245666666666665 23321 24566666666666642 3321 24556666666
Q ss_pred cccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCc
Q 048430 231 HLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQ 310 (973)
Q Consensus 231 ~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 310 (973)
++++ +|. ...+|++|+|++|+|++ +|.. ..+|+.|++++|+|+.+ |.. ..+|+.|++++|+|+.++..
T Consensus 333 ~L~~-LP~--lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~LP~l- 400 (788)
T PRK15387 333 QLTS-LPT--LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTSLPVL- 400 (788)
T ss_pred cccc-ccc--cccccceEecCCCccCC-CCCC---CcccceehhhccccccC-ccc---ccccceEEecCCcccCCCCc-
Confidence 6654 232 13578888888888885 4443 35677888888888864 332 24677777777777643210
Q ss_pred chhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcc
Q 048430 311 GQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTV 390 (973)
Q Consensus 311 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~ 390 (973)
.++|+.|++++|++++ +|..
T Consensus 401 -----------------------------------------------------------~s~L~~LdLS~N~Lss-IP~l 420 (788)
T PRK15387 401 -----------------------------------------------------------PSELKELMVSGNRLTS-LPML 420 (788)
T ss_pred -----------------------------------------------------------ccCCCEEEccCCcCCC-CCcc
Confidence 1234555555555542 3332
Q ss_pred cCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCccccc
Q 048430 391 LGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA 440 (973)
Q Consensus 391 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 440 (973)
+ .+|+.|+|++|+|+ .+|..++++++|+.|+|++|++++..+..+.
T Consensus 421 ~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~ 466 (788)
T PRK15387 421 P---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 466 (788)
T ss_pred h---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence 2 24555666666665 4566666666666666666666655555443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-22 Score=215.03 Aligned_cols=167 Identities=22% Similarity=0.234 Sum_probs=130.1
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC--CCeEEEEEEEecc-----chhhHHHHHHHHHHHHhccCCceeE-EEeeeec
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATLA--NGVSVAVKVFNLQ-----EDRALKSFDTECEVMRRIRHRNLIK-IVSSCSN 747 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~ 747 (973)
....++|...+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999864 5788899986532 1223567899999999999999985 4432
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC-CCCcEEeCCCCcEEEeeccc
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL-KPNNVLLDDDMVAHLGDFGI 826 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl 826 (973)
+..++||||+++++|... ... . ...++.|+++||.||| +.+|+|||| ||+||+++.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999732 111 1 1467899999999999 899999999 99999999999999999999
Q ss_pred ccccCCCCCccc-------ccccccccccCccCCCCCC
Q 048430 827 AKLLDGVDPVTQ-------TMTLATIGYMAPEYGSEGI 857 (973)
Q Consensus 827 a~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~ 857 (973)
|+.......... ....+++.|+|||++....
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 987643321111 3456888899999766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=194.14 Aligned_cols=263 Identities=16% Similarity=0.156 Sum_probs=204.0
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
-.|.+.++||+|.||+++.|+ +-+++.||||.-....+ ..+...|.+.++.+. .+.|...+.+..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999998 66899999997543322 356788999999885 69999999998999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-----cEEEeecccccccCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-----VAHLGDFGIAKLLDG 832 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgla~~~~~ 832 (973)
. |-||+++..-++..|+.+++..+|.|++.-++|+| ++..|+|||||+|+||...+ .+.++|||+|+.+..
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 77999999988889999999999999999999999 89999999999999997543 689999999998754
Q ss_pred CCCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 833 VDPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 833 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
.... .+....||.+||+-....+.+-+.+.|+=|+|=|+++.+.|..||.+.... ..++......
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~--tnK~kYeKIG------- 252 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD--TNKEKYEKIG------- 252 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc--chHHHHHHhc-------
Confidence 4332 223446999999999999999999999999999999999999999875322 1222211110
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
|. ...-. -...-+.+++++..-+.-.-..+-.+-|..+-+...+..+.+..
T Consensus 253 -e~-----Kr~T~--i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 253 -ET-----KRSTP--IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -cc-----cccCC--HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 00 00000 01112345666777777666777888888877776666665543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=187.85 Aligned_cols=260 Identities=20% Similarity=0.205 Sum_probs=200.3
Q ss_pred hcCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC-CceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH-RNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 756 (973)
..+|..+++||.|+||.+|.|. ..+|..||||+-...... .+...|.++.+.+++ ..|..+..|..+.....+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678999999999999999998 678999999987654433 467788999999975 678888888999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC---CcEEEeecccccccCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD---MVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~~~ 833 (973)
.. |.||++...-+...++..+++-.|-|++.-++|+| .+++|||||||+|+|+.-+ ..+.++|||+|+.+...
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 98 77999999888778999999999999999999999 8999999999999999654 47899999999987543
Q ss_pred CCccc------ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc-cHHHHHHhhC-Ccchhh
Q 048430 834 DPVTQ------TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM-SLKQWVAESL-PGAVTE 905 (973)
Q Consensus 834 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~ 905 (973)
....+ ....||.+|.+-....+...+.+.|+=|+|.++..+-.|..||.+...... .-.+.+.+.. .-.+..
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence 33221 234699999998877777788899999999999999999999987543211 1111111111 101100
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.-+.++.++.-.+.-|-..--++-|...-+-+.+.-+..
T Consensus 248 -------------------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 248 -------------------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred -------------------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 112346677778888888888888887666655554443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-22 Score=233.84 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=143.0
Q ss_pred CcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEE
Q 048430 45 GRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFD 124 (973)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~ 124 (973)
..++.|++++++++ .+|..+. +.|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+ .++|+.|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l---~~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATL---PDTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhh---hccccEEE
Confidence 34567777777776 4565443 46777777777774 4565543 46777777777776 566543 24567777
Q ss_pred eeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEec
Q 048430 125 VSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLG 204 (973)
Q Consensus 125 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~ 204 (973)
|++|+++ .+|..+. ++|+.|+|++|+|+ .+|..++ ++|+.|+|++|+|+ .+|..+. ++|+.|+++
T Consensus 248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt------~LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 248 LSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIR------TLPAHLP--SGITHLNVQ 312 (754)
T ss_pred CcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCccc------cCcccch--hhHHHHHhc
Confidence 7777766 5565553 46677777777776 5665442 35666666666665 2333222 356666666
Q ss_pred CCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCC
Q 048430 205 GNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP 284 (973)
Q Consensus 205 ~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~ 284 (973)
+|+++. +|..+ .++|++|++++|.+++ +|..+. ++|+.|+|++|+|+.+ |
T Consensus 313 ~N~Lt~-LP~~l-------------------------~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~L-P 362 (754)
T PRK15370 313 SNSLTA-LPETL-------------------------PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVL-P 362 (754)
T ss_pred CCcccc-CCccc-------------------------cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcC-C
Confidence 666653 23222 2455555666665553 343332 4566666666666532 3
Q ss_pred CcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCC
Q 048430 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIP 364 (973)
Q Consensus 285 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p 364 (973)
..+ .++|+.|++++|+|+.+|.. +. ..|+.|++++|++. .+|..+..
T Consensus 363 ~~l--p~~L~~LdLs~N~Lt~LP~~--------l~--~sL~~LdLs~N~L~-~LP~sl~~-------------------- 409 (754)
T PRK15370 363 ETL--PPTITTLDVSRNALTNLPEN--------LP--AALQIMQASRNNLV-RLPESLPH-------------------- 409 (754)
T ss_pred hhh--cCCcCEEECCCCcCCCCCHh--------HH--HHHHHHhhccCCcc-cCchhHHH--------------------
Confidence 322 24566666666666654332 11 24666666666665 33443222
Q ss_pred CCCCCCCcccEEEeecCccc
Q 048430 365 VGFGNLSNLLVLSLVNNELA 384 (973)
Q Consensus 365 ~~~~~l~~L~~L~Ls~n~l~ 384 (973)
.+..++++..|++.+|.+.
T Consensus 410 -~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 410 -FRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -HhhcCCCccEEEeeCCCcc
Confidence 2344566777777777776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=207.51 Aligned_cols=260 Identities=18% Similarity=0.202 Sum_probs=196.0
Q ss_pred CCCCCccccccCceEEEEEEeCC--CeEEEEEEEeccchhhHHHHHHHHHHHHhccC----CceeEEEeee-ecCCeeEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLAN--GVSVAVKVFNLQEDRALKSFDTECEVMRRIRH----RNLIKIVSSC-SNPGFKAL 753 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 753 (973)
+|...++||+|+||.||.+.... ...+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78999999999999999999654 35899998765433322367788899888863 6899999988 57888999
Q ss_pred EEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-----CcEEEeecccc
Q 048430 754 IMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-----MVAHLGDFGIA 827 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgla 827 (973)
||+.+ |.+|.++..... ..++..+...|+.|++.+|+++| +.|++||||||.|++++.. -.+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 779999886655 68999999999999999999999 8999999999999999865 36999999999
Q ss_pred c--ccCCCCC-----c-c-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh
Q 048430 828 K--LLDGVDP-----V-T-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 828 ~--~~~~~~~-----~-~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 898 (973)
+ .+..... . . .....||..|+++....+...+.+.|+||++.++.|+..|..||........ ........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 3321111 1 1 2234699999999999999999999999999999999999999855332211 11110000
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.. ..... .....+.++.++...+-..+..++|....+...+++....
T Consensus 254 ~~----~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RK----LLTDR---------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hh----hcccc---------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00 00000 0011245566677777778999999999999887766544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=228.54 Aligned_cols=76 Identities=20% Similarity=0.373 Sum_probs=38.8
Q ss_pred CCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEE
Q 048430 94 RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173 (973)
Q Consensus 94 ~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~ 173 (973)
+.+.|+++++.++ .+|..+ .++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~I---p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~ 247 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACI---PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEME 247 (754)
T ss_pred CceEEEeCCCCcC-cCCccc---ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEE
Confidence 3455666666665 455433 235556666666655 3444332 35555555555555 4554331 2445555
Q ss_pred ccccccc
Q 048430 174 LLGNNIT 180 (973)
Q Consensus 174 L~~N~l~ 180 (973)
|++|+++
T Consensus 248 Ls~N~L~ 254 (754)
T PRK15370 248 LSINRIT 254 (754)
T ss_pred CcCCccC
Confidence 5555543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-21 Score=223.97 Aligned_cols=253 Identities=21% Similarity=0.221 Sum_probs=185.5
Q ss_pred CCccccccCceEEEEEEe-CCCeEEEEEEEe----cc-chh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 684 ESNLLGSGSFDNVYKATL-ANGVSVAVKVFN----LQ-EDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~-~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
..+++|.|++|.|+.+.. .....++.|.+. .. ... ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 357899999998887763 333334444332 11 111 12226677778888899999888887776666666699
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP- 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 835 (973)
||++ +|..++.... .++..++-.+++|+..|++|+| ..||.|||+|++|++++.+|.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 9999998763 6888999999999999999999 89999999999999999999999999999876532221
Q ss_pred --cccccccccccccCccCCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 --VTQTMTLATIGYMAPEYGSEGIVSI-SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 --~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
......+|+..|+|||......|.+ ..||||.||++..|.+|+.||-.....+..+.+ ....
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---------------~~~~ 541 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---------------NNYS 541 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---------------hccc
Confidence 3445668999999999999888764 589999999999999999998654333222100 0000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ...............+..-..++.+|++++|.+|.|+++|++.
T Consensus 542 ~-~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 542 D-QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred c-ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 0000111112223455667889999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-19 Score=199.08 Aligned_cols=257 Identities=32% Similarity=0.419 Sum_probs=197.7
Q ss_pred CCCCccccccCceEEEEEEeCCCeEEEEEEEeccchh---hHHHHHHHHHHHHhccCC-ceeEEEeeeecCCeeEEEEEe
Q 048430 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR---ALKSFDTECEVMRRIRHR-NLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 757 (973)
|...+.+|.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999977 78899988655332 467899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecccccccCCCC
Q 048430 758 MPQGSLEKWLYSHNY--SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 834 (973)
+.++++.+++..... .++......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977776542 6889999999999999999999 78899999999999999998 79999999998654333
Q ss_pred Cc-----ccccccccccccCccCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccC--cccHHHHHHhhCCcchh
Q 048430 835 PV-----TQTMTLATIGYMAPEYGSE---GIVSISGDVYSFGILMMETFTRRKPTNEMFTG--EMSLKQWVAESLPGAVT 904 (973)
Q Consensus 835 ~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 904 (973)
.. ......++..|+|||.... .......|+||+|++++++++|..||...... .......+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 22 2355679999999998877 57899999999999999999999996543321 11111111111111000
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ...... ......+.+++..|+..+|..|.++.+...+
T Consensus 237 ~~----~~~~~~----------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SP----LSPSNP----------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc----cCcccc----------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000 2233567889999999999999999887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=215.86 Aligned_cols=249 Identities=23% Similarity=0.237 Sum_probs=181.8
Q ss_pred CCCCCccccccCceEEEEEEeCCCeEEEEEEEeccch-hhHHHHHHHHHH--HHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED-RALKSFDTECEV--MRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+|...+.+|.+.|=.|.+|+.++|. |+||++-..++ -....|.++++- ...++|||++++.-+-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998887 99999865542 233444443332 4556899999998887777788899899
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc--CCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~--~~~~~ 835 (973)
..+ +|++.+..++ .+...+.+.|+.|+++|+..+| +.+|+|||||.+|||++.-.=+.|+||..-+.. +..++
T Consensus 103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 866 9999998765 6888889999999999999999 899999999999999999999999999876532 22222
Q ss_pred ccccc----ccccccccCccCCCC----------CC-CCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhC
Q 048430 836 VTQTM----TLATIGYMAPEYGSE----------GI-VSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 836 ~~~~~----~~~~~~y~aPE~~~~----------~~-~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
...+. ......|.|||.+.. .. .+++.||||+||+++|+++ |++||+. .+......
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~aYr~ 249 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLAYRS 249 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHhHhc
Confidence 22222 234457999995432 11 6788999999999999998 6777743 23322221
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
.+. ......+.. -....+.+++..|++.||++|.++++.++.-.
T Consensus 250 ~~~--~~~e~~Le~--------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 250 GNA--DDPEQLLEK--------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred cCc--cCHHHHHHh--------------CcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 110 000000000 01224778999999999999999999998743
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=199.14 Aligned_cols=218 Identities=27% Similarity=0.392 Sum_probs=164.7
Q ss_pred HHhccCCceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCC
Q 048430 730 MRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPN 809 (973)
Q Consensus 730 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 809 (973)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....++++|++||+|+|+ +.-..|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 356789999999999999999999999999999999999988889999999999999999999995 333389999999
Q ss_pred cEEeCCCCcEEEeecccccccCC-CCCcccccccccccccCccCCCCC-------CCCcchhHHHHHHHHHHHHhCCCCC
Q 048430 810 NVLLDDDMVAHLGDFGIAKLLDG-VDPVTQTMTLATIGYMAPEYGSEG-------IVSISGDVYSFGILMMETFTRRKPT 881 (973)
Q Consensus 810 Nill~~~~~~kl~Dfgla~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~sDvws~Gvvl~elltg~~p~ 881 (973)
|++++..+.+|++|||+...... .............-|.|||.+... ..+.++||||||++++|+++++.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999877642 111122223345669999976553 2577899999999999999999999
Q ss_pred CccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 882 NEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
+........ ...+..... .....+.+.+ .......+++..++.+||..+|++||+++++-..++.+
T Consensus 159 ~~~~~~~~~-~eii~~~~~-~~~~~~rP~i------------~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRVKK-GGSNPFRPSI------------ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccCCh-HHHHHHHHh-cCCCCcCcch------------hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 875443332 122111111 0000011111 10113345788999999999999999999998888776
Q ss_pred HH
Q 048430 962 KK 963 (973)
Q Consensus 962 ~~ 963 (973)
.+
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 65
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=179.75 Aligned_cols=139 Identities=18% Similarity=0.208 Sum_probs=108.4
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchh--h------------------------HHHHHHHHHHHHhccCCce
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR--A------------------------LKSFDTECEVMRRIRHRNL 738 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 738 (973)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999878999999998754211 0 1122359999999987776
Q ss_pred eEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeEEccCCCCcEEeCCCC
Q 048430 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTPIIHCDLKPNNVLLDDDM 817 (973)
Q Consensus 739 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk~~Nill~~~~ 817 (973)
.....+.. ...++||||++++++....... ..++..+...++.|++.+|.|+ | ..+|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 43332222 2238999999988776553333 3688999999999999999999 6 78999999999999998 47
Q ss_pred cEEEeeccccccc
Q 048430 818 VAHLGDFGIAKLL 830 (973)
Q Consensus 818 ~~kl~Dfgla~~~ 830 (973)
.++++|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=183.42 Aligned_cols=171 Identities=12% Similarity=0.137 Sum_probs=132.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhH---H------HHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRAL---K------SFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~------~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
..++|...+++|.|+||.||.+.. ++..+|||+++....... + .+.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999766 577899999975432221 2 268999999999999999998886432
Q ss_pred --------CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 749 --------GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 749 --------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
+..++||||++|.+|.++.. ++. ....+++.++..+| ..+++|||++|.||+++.++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988732 232 24669999999999 89999999999999999988 99
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHH
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETF 875 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ell 875 (973)
++|||......... .. ..+.....+..++|+|||||.+.-..
T Consensus 175 liDfg~~~~~~e~~--a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRK--AK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchh--hH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999876542111 00 01334445667899999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=173.89 Aligned_cols=139 Identities=19% Similarity=0.243 Sum_probs=110.8
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchh--------------------------hHHHHHHHHHHHHhccCCce
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR--------------------------ALKSFDTECEVMRRIRHRNL 738 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 738 (973)
...||+|++|.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998754210 01234578999999999987
Q ss_pred eEEEeeeecCCeeEEEEEecCCCCHHHH-hhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEeCCC
Q 048430 739 IKIVSSCSNPGFKALIMQYMPQGSLEKW-LYSHNYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLLDDD 816 (973)
Q Consensus 739 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~ 816 (973)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++| . .+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 544443332 24899999998755433 333 25788899999999999999999 6 8999999999999999 8
Q ss_pred CcEEEeecccccccC
Q 048430 817 MVAHLGDFGIAKLLD 831 (973)
Q Consensus 817 ~~~kl~Dfgla~~~~ 831 (973)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9e-21 Score=173.06 Aligned_cols=176 Identities=30% Similarity=0.531 Sum_probs=113.1
Q ss_pred CCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEE
Q 048430 394 LQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473 (973)
Q Consensus 394 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 473 (973)
+.+++.|.||+|+++ .+|+.+..+.+|+.|.+++|+|. ..|.+++.++.|+.|+++-|++. ..|..|++++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 334445555555555 44555555555555555555555 45555555566666666666554 4555666666666666
Q ss_pred ecCCcccC-CcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccC
Q 048430 474 FSLNSLSG-SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 474 ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (973)
+++|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.++.|+.|++.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 66655543 56777777777888888888887 77777888888888888888877 77888888888888888888887
Q ss_pred CCCCccccccccc---cccccCCCcc
Q 048430 553 GEIPKSLEKLSRL---VDFNVSFNGL 575 (973)
Q Consensus 553 ~~~p~~~~~l~~L---~~l~ls~N~l 575 (973)
.+|.+++.+.-+ +.+.+.+|++
T Consensus 187 -vlppel~~l~l~~~k~v~r~E~NPw 211 (264)
T KOG0617|consen 187 -VLPPELANLDLVGNKQVMRMEENPW 211 (264)
T ss_pred -ecChhhhhhhhhhhHHHHhhhhCCC
Confidence 666666554322 3344455544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=167.34 Aligned_cols=185 Identities=16% Similarity=0.085 Sum_probs=138.5
Q ss_pred CCCccccccCceEEEEEEeCCCeEEEEEEEeccch----hhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEe
Q 048430 683 GESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED----RALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.....|++|+||+||.+.. .+.+++.+.+..... -....+.+|+++|++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997766 578888777754432 11235789999999995 5889999886 346899999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC-CCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL-KPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
++|.+|.+.... ....++.|++.++.++| ..+|+|||| ||.||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754321 12357889999999999 899999999 799999999999999999999865432210
Q ss_pred ----c--------cccccccccccCccCC--CCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 048430 837 ----T--------QTMTLATIGYMAPEYG--SEGIVSISGDVYSFGILMMETFTRRKPTNE 883 (973)
Q Consensus 837 ----~--------~~~~~~~~~y~aPE~~--~~~~~~~~sDvws~Gvvl~elltg~~p~~~ 883 (973)
. +.....++.|++|+.. .....-...+-++-|.-+|.++||+.|.-.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 1112356777888732 222223567899999999999999998643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-18 Score=179.24 Aligned_cols=229 Identities=22% Similarity=0.306 Sum_probs=145.9
Q ss_pred CCCccccccCceEEEEEEe-CCCeEEEEEEEeccch---hhHHHHHHHHHHHHhcc----------CCceeEEEeee---
Q 048430 683 GESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED---RALKSFDTECEVMRRIR----------HRNLIKIVSSC--- 745 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~----------h~niv~l~~~~--- 745 (973)
...+.||.|+++.||.++. .+++.+|||++....+ ...+++.+|.-....+. |-.++..++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3457899999999999996 4699999999865432 34566777765554432 21222222211
Q ss_pred ---------ecCC-----eeEEEEEecCCCCHHHHhhh---CCC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEcc
Q 048430 746 ---------SNPG-----FKALIMQYMPQGSLEKWLYS---HNY---SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805 (973)
Q Consensus 746 ---------~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~d 805 (973)
.+.. ..+++|+-+ .+||.+++.. ... .+....+..+..|+++.+++|| ..|+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 1111 235788877 4588887652 221 2334556677899999999999 89999999
Q ss_pred CCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCCCC--------CCCCcchhHHHHHHHHHHHHhC
Q 048430 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE--------GIVSISGDVYSFGILMMETFTR 877 (973)
Q Consensus 806 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvws~Gvvl~elltg 877 (973)
|+|+|++++.+|.++|+||+.....+.. . .....+..|.+||.... -.+|++.|.|++|+++|.|++|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~--~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR--Y--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE--E--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce--e--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999987754321 1 11345678999995432 3578999999999999999999
Q ss_pred CCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCC
Q 048430 878 RKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948 (973)
Q Consensus 878 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 948 (973)
+.||+......... ..+.. .. +.++.+..++..+++++|++|
T Consensus 247 ~lPf~~~~~~~~~~-----------------~~f~~-----------C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE-----------------WDFSR-----------CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG-----------------GGGTT-----------SS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc-----------------ccchh-----------cC-CcCHHHHHHHHHHccCCcccC
Confidence 99997643221100 01111 11 467789999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-18 Score=176.53 Aligned_cols=194 Identities=25% Similarity=0.318 Sum_probs=139.9
Q ss_pred cCCceeEEEeeeec---------------------------CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHH
Q 048430 734 RHRNLIKIVSSCSN---------------------------PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786 (973)
Q Consensus 734 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 786 (973)
+|||||++.++|.+ +...|+||...+. +|+.|+..+. .+...+.-|..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 49999999987632 2467899998866 9999998764 5666777899999
Q ss_pred HHHHHHhhhcCCCCeEEccCCCCcEEeC--CCC--cEEEeecccccccCCC----CCcc-cccccccccccCccCCCCCC
Q 048430 787 ASALEYLHHGYSTPIIHCDLKPNNVLLD--DDM--VAHLGDFGIAKLLDGV----DPVT-QTMTLATIGYMAPEYGSEGI 857 (973)
Q Consensus 787 ~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgla~~~~~~----~~~~-~~~~~~~~~y~aPE~~~~~~ 857 (973)
++|+.||| .++|.|||+|++||++. +|+ ...++|||.+---... .+.. ....-|...-||||.....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 89999999999999993 333 5789999976432110 1111 11224677899999765433
Q ss_pred ------CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH--HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHH
Q 048430 858 ------VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK--QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTC 929 (973)
Q Consensus 858 ------~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~ 929 (973)
...|+|.|+.|-+.||+++...||+. .+++.+. .+-.. . --..+..+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe~---------------------q--LPalp~~v 482 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQES---------------------Q--LPALPSRV 482 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhhh---------------------h--CCCCcccC
Confidence 24689999999999999999999976 3332221 11000 0 01123456
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 930 ISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 930 ~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
++.+.+++...++.||.+|++..-+...|
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 78899999999999999999876554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-20 Score=168.45 Aligned_cols=167 Identities=28% Similarity=0.451 Sum_probs=155.0
Q ss_pred hhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCC
Q 048430 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALG 494 (973)
Q Consensus 415 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 494 (973)
+..+.+++.|.|++|+++ .+|..++.+.+|+.|++++|+++ .+|..++++++|+.|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456788899999999999 67777999999999999999998 68999999999999999999999 8999999999999
Q ss_pred eEEccCCcCc-ccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCC
Q 048430 495 GLNLTGNQLS-GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 495 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
.|||+.|++. ..+|..|..+..|..|+|+.|.+. .+|..++++++|+.|.+.+|.+- ..|.+++.+.+|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 9999999997 468999999999999999999999 89999999999999999999998 78999999999999999999
Q ss_pred cccccCCCCCCCC
Q 048430 574 GLEGEIPSGGPFV 586 (973)
Q Consensus 574 ~l~~~~p~~~~~~ 586 (973)
+++-.+|..+.+.
T Consensus 184 rl~vlppel~~l~ 196 (264)
T KOG0617|consen 184 RLTVLPPELANLD 196 (264)
T ss_pred eeeecChhhhhhh
Confidence 9998888765543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.9e-20 Score=201.99 Aligned_cols=286 Identities=23% Similarity=0.209 Sum_probs=152.0
Q ss_pred eeeecccccc-ccCcchhcccCcccEEEecccccccc----CCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccC
Q 048430 247 NLFLWKNNLS-GIIPDSICNASEATILELSSNLFSGL----VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKC 321 (973)
Q Consensus 247 ~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l 321 (973)
.|+|..+.++ ......+..+.+|+.|++++|.++.. ++..+...++|++|+++++.+...+.. .......+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~-~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRG-LQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchH-HHHHHHHHHhc
Confidence 4677777776 33445566677788888888877432 334455566677777777766531111 12233445556
Q ss_pred CcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccc----ccCcccCCC-CC
Q 048430 322 RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAG----AIPTVLGKL-QK 396 (973)
Q Consensus 322 ~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l-~~ 396 (973)
++|+.|++++|.+.+..+..+..+ ... ++|++|++++|.+++ .+...+..+ ++
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l---------------------~~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~ 138 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESL---------------------LRS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPA 138 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHH---------------------hcc-CcccEEEeeCCccchHHHHHHHHHHHhCCCC
Confidence 666666666666654333222111 112 346666666666652 222334444 56
Q ss_pred CCEEEccCCcCCCC----CchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEE
Q 048430 397 LQGLDLNSNKLKGF----IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAV 472 (973)
Q Consensus 397 L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 472 (973)
|++|+|++|.+++. ++..+..+++|+.|++++|.+++.... .++..+..+++|+.|
T Consensus 139 L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L 198 (319)
T cd00116 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR--------------------ALAEGLKANCNLEVL 198 (319)
T ss_pred ceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH--------------------HHHHHHHhCCCCCEE
Confidence 66666666666532 122333344455555555544421100 111122233344444
Q ss_pred EecCCcccCC----cCcCccCCCCCCeEEccCCcCcccCCcccc-----cCCcCCEEEcccCccc----cCCCCCccccc
Q 048430 473 DFSLNSLSGS----LPLNIGNLEALGGLNLTGNQLSGYIPSSIG-----NLKNLDWLALARNAFQ----GPIPQSFGSLI 539 (973)
Q Consensus 473 ~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~----~~~p~~~~~l~ 539 (973)
++++|.+++. ++..+..+++|+.|++++|.+++.....+. ..+.|+.|++++|.++ ..+...+..++
T Consensus 199 ~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~ 278 (319)
T cd00116 199 DLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKE 278 (319)
T ss_pred eccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCC
Confidence 4444444322 223345566677777777776643222222 1367777777777775 12334455557
Q ss_pred ccccccccccccCCC----CCcccccc-ccccccccCCCcc
Q 048430 540 SLQSLDLSGNNISGE----IPKSLEKL-SRLVDFNVSFNGL 575 (973)
Q Consensus 540 ~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~l~ls~N~l 575 (973)
+|+++++++|.++.. ....+... +.|+.+++.+|++
T Consensus 279 ~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 279 SLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 778888888888744 33344444 6777888877754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-19 Score=197.92 Aligned_cols=206 Identities=27% Similarity=0.249 Sum_probs=145.1
Q ss_pred eEEeecccccc-cCCCCC-Cccccceeeecccccccc----CcchhcccCcccEEEeccccccc------cCCCcccccc
Q 048430 224 AILLYGNHLSG-HLPSSI-YLPNLENLFLWKNNLSGI----IPDSICNASEATILELSSNLFSG------LVPNTFGNCR 291 (973)
Q Consensus 224 ~L~l~~n~l~~-~~~~~~-~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~i~~------~~~~~~~~l~ 291 (973)
.|+|.++.+++ .....+ .+.+|++|+++++.++.. ++..+...++++.|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 46777787763 222222 367899999999998543 45566777889999999998873 2345677889
Q ss_pred cceEEEccCCcCCCCCCCcchhhhhhhccC---CcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCC
Q 048430 292 QLQILSLGDNQLTTGSSAQGQIFYSSLAKC---RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFG 368 (973)
Q Consensus 292 ~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~ 368 (973)
+|+.|++++|.+.... ...+..+ ++|+.|++++|.+.+..... +...+.
T Consensus 82 ~L~~L~l~~~~~~~~~-------~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~---------------------l~~~l~ 133 (319)
T cd00116 82 GLQELDLSDNALGPDG-------CGVLESLLRSSSLQELKLNNNGLGDRGLRL---------------------LAKGLK 133 (319)
T ss_pred ceeEEEccCCCCChhH-------HHHHHHHhccCcccEEEeeCCccchHHHHH---------------------HHHHHH
Confidence 9999999999997421 2222333 55999999999887421111 112244
Q ss_pred CC-CcccEEEeecCcccc----ccCcccCCCCCCCEEEccCCcCCCC----CchhhhccCcCCeeecCCccccCcC----
Q 048430 369 NL-SNLLVLSLVNNELAG----AIPTVLGKLQKLQGLDLNSNKLKGF----IPTDLCKLEKLNTLLSNNNALQGQI---- 435 (973)
Q Consensus 369 ~l-~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~---- 435 (973)
.+ ++|+.|++++|.+++ .++..+..+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++..
T Consensus 134 ~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l 213 (319)
T cd00116 134 DLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASAL 213 (319)
T ss_pred hCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHH
Confidence 55 789999999999984 3445677788999999999999853 2334455668888888888876433
Q ss_pred cccccCcCCCCeeeccCCCCCC
Q 048430 436 PTCLANLTSLRHLDFRSNSLNS 457 (973)
Q Consensus 436 ~~~~~~l~~L~~L~L~~N~l~~ 457 (973)
...+..+++|++|++++|.+++
T Consensus 214 ~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 214 AETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhcccCCCCEEecCCCcCch
Confidence 3345566777788887777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-18 Score=191.52 Aligned_cols=225 Identities=24% Similarity=0.256 Sum_probs=177.6
Q ss_pred cccccCceEEEEEE----eCCCeEEEEEEEeccchh--hHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEecC
Q 048430 687 LLGSGSFDNVYKAT----LANGVSVAVKVFNLQEDR--ALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
.+|+|.||.|+.++ .+.|..+|+|+.+..... .......|..++..++ ||.++++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 345777898887654221 1125566888888887 9999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|.+...+.... .++......+...++-+++++| +.+|+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 999998887665 6777888889999999999999 89999999999999999999999999999986532221
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
.+||..|||||.+. ....++|-||||++++||+||..||.. ........
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~----------------------- 201 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILK----------------------- 201 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhh-----------------------
Confidence 27999999999887 457788999999999999999999865 11111110
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINV 951 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~ 951 (973)
.....|........+++..++..+|..|...
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 0112233455667788888888888888754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-17 Score=162.76 Aligned_cols=137 Identities=16% Similarity=0.269 Sum_probs=107.4
Q ss_pred CCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-----cCCceeEEEeeeecCC---eeE-
Q 048430 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-----RHRNLIKIVSSCSNPG---FKA- 752 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 752 (973)
+...+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ +||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 3334444 79988765444557899999999999 5799999999997753 333
Q ss_pred EEEEe--cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeEEccCCCCcEEeCC----CCcEEEeecc
Q 048430 753 LIMQY--MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL-EYLHHGYSTPIIHCDLKPNNVLLDD----DMVAHLGDFG 825 (973)
Q Consensus 753 lv~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg 825 (973)
+|+|| +.+|+|.+++... .+++. ..++.+++.++ +||| +.+||||||||+||+++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5579999999764 35555 35678888777 9999 899999999999999974 3479999954
Q ss_pred cc
Q 048430 826 IA 827 (973)
Q Consensus 826 la 827 (973)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-17 Score=196.40 Aligned_cols=199 Identities=23% Similarity=0.251 Sum_probs=159.8
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc---CCceeEEEeeeecCCe
Q 048430 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR---HRNLIKIVSSCSNPGF 750 (973)
Q Consensus 674 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~ 750 (973)
+.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+.... .+|.--.+++.+++ -+-|+++..++...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 44445567888899999999999999988899999998765433 23333344555555 2334455555556677
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-------CCcEEEee
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-------DMVAHLGD 823 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~D 823 (973)
-++|+||.+.|+|.+++...+ .+++.-.+.++.|+++.+++|| ..+|||+||||+|+|+.. ...++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 789999999999999998554 7999999999999999999999 899999999999999942 34689999
Q ss_pred cccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 048430 824 FGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRK 879 (973)
Q Consensus 824 fgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~ 879 (973)
||.+..+.--.. ......++|-.+-.+|...++.++++.|.|.++-+++-|+.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999876543222 24455678999999999999999999999999999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=163.23 Aligned_cols=142 Identities=18% Similarity=0.196 Sum_probs=111.8
Q ss_pred CCCCCccccccCceEEEEEE--eCCCeEEEEEEEeccchh------------------------hHHHHHHHHHHHHhcc
Q 048430 681 GFGESNLLGSGSFDNVYKAT--LANGVSVAVKVFNLQEDR------------------------ALKSFDTECEVMRRIR 734 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 734 (973)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46678899999999999998 568999999998743210 1123568999999997
Q ss_pred CC--ceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eEEccCCCCcE
Q 048430 735 HR--NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP-IIHCDLKPNNV 811 (973)
Q Consensus 735 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~Ni 811 (973)
+. .+.+++++ ...++||||++++++..+..... .....+...++.|++.++.+|| ..+ |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 53 34455543 23489999999988876653332 4566677899999999999999 788 99999999999
Q ss_pred EeCCCCcEEEeecccccccC
Q 048430 812 LLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 812 ll~~~~~~kl~Dfgla~~~~ 831 (973)
+++ ++.++++|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.8e-16 Score=158.41 Aligned_cols=134 Identities=22% Similarity=0.344 Sum_probs=113.7
Q ss_pred ccccccCceEEEEEEeCCCeEEEEEEEeccch--------hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQED--------RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
+.||+|++|.||+|.. .|..|++|+...... .....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 578899997653321 1234678899999999999988777777677788999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
++|++|.+++.... + .+..++.+++.++.++| ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987543 2 78899999999999999 89999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=155.51 Aligned_cols=138 Identities=21% Similarity=0.221 Sum_probs=109.9
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchh----------------------hHHHHHHHHHHHHhccCC-
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR----------------------ALKSFDTECEVMRRIRHR- 736 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~- 736 (973)
.-|...+.||+|+||.||+|...+|+.||||++...... ....+..|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 347778999999999999999888999999987643210 112366788999999887
Q ss_pred -ceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC
Q 048430 737 -NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815 (973)
Q Consensus 737 -niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~ 815 (973)
.+...++. ...++||||+++++|...... .....++.+++.++.++| ..+|+||||+|+||++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcC
Confidence 44444442 345899999999998765431 235678999999999999 799999999999999999
Q ss_pred CCcEEEeecccccccC
Q 048430 816 DMVAHLGDFGIAKLLD 831 (973)
Q Consensus 816 ~~~~kl~Dfgla~~~~ 831 (973)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=177.95 Aligned_cols=141 Identities=20% Similarity=0.267 Sum_probs=113.9
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEecc--c------hhhHHHHHHHHHHHHhccCCceeEEEeeeec
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQ--E------DRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 747 (973)
......|...+.||+|+||.||+|.+... .+++|+.... . ....+.+.+|+++++.++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33344556789999999999999987543 4444432211 1 1123568899999999999999988888877
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
+...++||||+++++|.+++. ....++.++++++.||| ..+++|||+||+||++ .++.++|+|||++
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 778899999999999999885 35679999999999999 8999999999999999 6779999999998
Q ss_pred ccc
Q 048430 828 KLL 830 (973)
Q Consensus 828 ~~~ 830 (973)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=153.21 Aligned_cols=130 Identities=22% Similarity=0.344 Sum_probs=106.7
Q ss_pred cccccCceEEEEEEeCCCeEEEEEEEeccc--h------hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 687 LLGSGSFDNVYKATLANGVSVAVKVFNLQE--D------RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.||+|+||.||+|.+ ++..|++|+..... . ...+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 47889999864321 1 12356778999999999887665555555666778999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
++++|.+++..... .++.+++++|.++| ..+++|||++|+||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998765321 78999999999999 89999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=179.44 Aligned_cols=146 Identities=29% Similarity=0.515 Sum_probs=107.1
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCcceEEEEEeeC--CC--CcEEEEecCCCCCCCcCCCCCCCCCCCcEEEe
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSI--RH--GRVAALSLPNLSLGGTLPPHVGNLSFLVSLNI 76 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~c~w~gv~C~~--~~--~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L 76 (973)
||++||+++. +|.. . +|++. .+...+|.|.||.|+. .. .+|+.|+|+++++.|.+|+.++.|++|+.|+|
T Consensus 376 aL~~~k~~~~-~~~~--~-~W~g~--~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~L 449 (623)
T PLN03150 376 ALQTLKSSLG-LPLR--F-GWNGD--PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINL 449 (623)
T ss_pred HHHHHHHhcC-Cccc--C-CCCCC--CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEEC
Confidence 6899999985 4422 2 48642 1111224799999963 22 25889999999999999988888888999999
Q ss_pred cCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCC-CCCCeEEccCcc
Q 048430 77 SGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNI-SSLKSIRLDNNS 153 (973)
Q Consensus 77 ~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~ 153 (973)
++|++.|.+|..++.+++|+.|||++|+++|.+|..+ +.+++|++|+|++|+++|.+|..++.+ .++..+++.+|.
T Consensus 450 s~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l-~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 450 SGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL-GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHH-hcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 8888888888888888888888888888887777654 567777777777777777777776543 244555555554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.2e-16 Score=170.96 Aligned_cols=122 Identities=30% Similarity=0.519 Sum_probs=106.5
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGI 826 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 826 (973)
...|+.|++|+..+|.+|+...+ ...++.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 35789999999999999996433 567788889999999999999 5789999999999999999999999999
Q ss_pred ccccCCCC-----CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh
Q 048430 827 AKLLDGVD-----PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876 (973)
Q Consensus 827 a~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt 876 (973)
........ ...++..+||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665433 224456689999999999999999999999999999999997
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.4e-14 Score=142.31 Aligned_cols=136 Identities=21% Similarity=0.295 Sum_probs=98.7
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchh--hHHH----------------------HHHHHHHHHhccCC--ce
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR--ALKS----------------------FDTECEVMRRIRHR--NL 738 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--ni 738 (973)
.+.||+|+||.||+|...+++.||||+++..... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653211 1111 13456666666443 34
Q ss_pred eEEEeeeecCCeeEEEEEecCCCCHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEeCCC
Q 048430 739 IKIVSSCSNPGFKALIMQYMPQGSLEK-WLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLLDDD 816 (973)
Q Consensus 739 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~ 816 (973)
.+.+++ ...++||||++++.+.. .+.... .. .+...++.+++.++.++| . .+|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 445543 23589999999854321 111111 11 567889999999999999 6 9999999999999999 8
Q ss_pred CcEEEeecccccccC
Q 048430 817 MVAHLGDFGIAKLLD 831 (973)
Q Consensus 817 ~~~kl~Dfgla~~~~ 831 (973)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.7e-14 Score=171.42 Aligned_cols=117 Identities=38% Similarity=0.684 Sum_probs=88.1
Q ss_pred CCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCC
Q 048430 493 LGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSF 572 (973)
Q Consensus 493 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~ 572 (973)
++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56777888888777887788888888888888888878887788888888888888888888888888888888888888
Q ss_pred CcccccCCCC--CCCCccCccccccCcccccCCccCCCCcc
Q 048430 573 NGLEGEIPSG--GPFVNFTADSFKQNYALCGSSRLQVPPCK 611 (973)
Q Consensus 573 N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~c~ 611 (973)
|+++|.+|.. ..........+.+|+.+||.|. .+.|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 8888888763 1122334556788999998764 34664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=134.83 Aligned_cols=135 Identities=22% Similarity=0.321 Sum_probs=114.1
Q ss_pred CCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC--CceeEEEeeeecCCeeEEEEEecCCC
Q 048430 684 ESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH--RNLIKIVSSCSNPGFKALIMQYMPQG 761 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 761 (973)
+.+.+|+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| ..++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999864 7899998865433 4678899999999976 58999999988888899999999887
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4567778999999999999943335799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-14 Score=166.60 Aligned_cols=212 Identities=23% Similarity=0.266 Sum_probs=144.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..+|..++.|..|+||.||..+++ ..+.+|+|+=+ +. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence 357888999999999999999865 46778885322 11 11111 22222233322
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC--
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-- 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-- 835 (973)
|+-...+..-+ .++. +++.+++|+| ..+|+|||+||+|.+|+.-|.+|++|||+++.......
T Consensus 136 ---gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444444432 2332 2278899999 89999999999999999999999999999875421110
Q ss_pred ------------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcch
Q 048430 836 ------------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV 903 (973)
Q Consensus 836 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
......+||+.|+|||++....|...+|.|++|+|+||.+.|+.||.+..+ ++-+.+.+.+... +
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~--w 277 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIE--W 277 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhcc--c
Confidence 011234799999999999999999999999999999999999999976322 2223333332110 0
Q ss_pred hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 048430 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKD 953 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~e 953 (973)
.+- | +..+.+..+++.+.++.+|..|--...
T Consensus 278 pE~-d------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 278 PEE-D------------------EALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred ccc-C------------------cCCCHHHHHHHHHHHHhChHhhcccch
Confidence 000 0 123566888999999999999985443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.9e-15 Score=174.91 Aligned_cols=256 Identities=22% Similarity=0.286 Sum_probs=193.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC--CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA--NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 753 (973)
...|...+.||+|+|+.|-.+... ....+|+|.+.... ....+....|..+-+... |+|++++++...++...++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345667778999999999888753 34556666554432 233445556777777776 9999999999999999999
Q ss_pred EEEecCCCCHHHHh-hhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecccccccC
Q 048430 754 IMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLD 831 (973)
Q Consensus 754 v~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~ 831 (973)
+.||.+++++.+-+ .......+......+..|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999888 5443356677788899999999999995 57899999999999999999 99999999998775
Q ss_pred C--CCCcccccccc-cccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 832 G--VDPVTQTMTLA-TIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 832 ~--~~~~~~~~~~~-~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
. .........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++........+..|......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------- 249 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR------- 249 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc-------
Confidence 4 22223344567 999999998777 456778999999999999999999987765555444444332110
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALA 956 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~ 956 (973)
..............++..+++..+|..|.+.+++..
T Consensus 250 -------------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -------------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000111122344677888999999999999887654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=4e-13 Score=140.11 Aligned_cols=136 Identities=16% Similarity=0.228 Sum_probs=106.5
Q ss_pred Ccccc-ccCceEEEEEEeCCCeEEEEEEEeccc-------------hhhHHHHHHHHHHHHhccCCce--eEEEeeeecC
Q 048430 685 SNLLG-SGSFDNVYKATLANGVSVAVKVFNLQE-------------DRALKSFDTECEVMRRIRHRNL--IKIVSSCSNP 748 (973)
Q Consensus 685 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 748 (973)
...|| .|+.|+||.+... +..+|||.+.... ......+.+|++++.+++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999886 7789999875311 1223567889999999998774 6677764332
Q ss_pred -C---eeEEEEEecCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEee
Q 048430 749 -G---FKALIMQYMPQ-GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823 (973)
Q Consensus 749 -~---~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 823 (973)
. ..++|||++++ .+|.+++... .++.. .+.+++.++.+|| ..||+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6999888653 34443 3678999999999 89999999999999999999999999
Q ss_pred ccccccc
Q 048430 824 FGIAKLL 830 (973)
Q Consensus 824 fgla~~~ 830 (973)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-15 Score=162.66 Aligned_cols=176 Identities=32% Similarity=0.517 Sum_probs=122.2
Q ss_pred CCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEE
Q 048430 393 KLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAV 472 (973)
Q Consensus 393 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 472 (973)
.++.-...||+.|++. .+|..++.+..|+.+.|..|.+. .+|.++.++..|.+|||+.|+++ .+|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3444556677777777 66777777777777777777776 66677777777777777777775 4565555554 6667
Q ss_pred EecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccC
Q 048430 473 DFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 473 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (973)
-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|.++..| .|..||+|.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 77777776 67777776677777777777776 66777777777777777777776 566666643 4677777777776
Q ss_pred CCCCccccccccccccccCCCcccc
Q 048430 553 GEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 553 ~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
.+|..|.+|..|++|-|.+|+|+.
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCC
Confidence 667777777777777777777764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-12 Score=147.98 Aligned_cols=141 Identities=21% Similarity=0.256 Sum_probs=102.6
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchhh----------------------------------------HHHHH
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRA----------------------------------------LKSFD 724 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 724 (973)
.+.||.|++|.||+|++.+|+.||||+.+...... .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 47899999999999999999999999986542110 01355
Q ss_pred HHHHHHHhcc----CCceeEEEeee-ecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH-HHHHhhhcCC
Q 048430 725 TECEVMRRIR----HRNLIKIVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS-ALEYLHHGYS 798 (973)
Q Consensus 725 ~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~ 798 (973)
+|++.+.+++ |.+-+.+-.++ ...+..++||||++|++|.++........ .+..++..++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence 5666666653 33223332222 23455799999999999988765432122 24457777666 467888 7
Q ss_pred CCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 799 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
.|++|+|++|.||+++.++.++++|||++..++
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.7e-15 Score=159.05 Aligned_cols=195 Identities=27% Similarity=0.417 Sum_probs=172.4
Q ss_pred CCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCee
Q 048430 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHL 448 (973)
Q Consensus 369 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 448 (973)
.+..-...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|+.|+|+.|+++ ..|..+..++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4555677899999998 89999999999999999999999 78999999999999999999998 6777777777 9999
Q ss_pred eccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc
Q 048430 449 DFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528 (973)
Q Consensus 449 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (973)
-+++|+++ .+|..++.+..|..||.+.|++. .+|..++++.+|+.|++..|++. .+|.+++.| .|..||+|.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 99999997 68888899999999999999999 78889999999999999999999 788888855 5889999999999
Q ss_pred cCCCCCcccccccccccccccccCCCCCcccccccc---ccccccCCC
Q 048430 529 GPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSR---LVDFNVSFN 573 (973)
Q Consensus 529 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~l~ls~N 573 (973)
.+|-.|..|..|++|-|.+|.++ ..|..++..-+ .++|+..-+
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 89999999999999999999998 77887765544 356666555
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.6e-13 Score=133.78 Aligned_cols=202 Identities=21% Similarity=0.326 Sum_probs=140.2
Q ss_pred HHHhccCCceeEEEeeeecC-----CeeEEEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 048430 729 VMRRIRHRNLIKIVSSCSNP-----GFKALIMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTP 800 (973)
Q Consensus 729 ~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 800 (973)
-+-++.|.|+++++.|+.+. ....++.|||.-|++..+++... ..+....-.+++.||..||.||| .|..+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCc
Confidence 34455799999999998543 35678999999999999998633 45777778899999999999999 56899
Q ss_pred eEEccCCCCcEEeCCCCcEEEeecccccccCC---CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhC
Q 048430 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG---VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTR 877 (973)
Q Consensus 801 ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg 877 (973)
|+|+++.-+-|++..+|-+|+.--.-...... .....+....+-++|.|||+......+-++|||+||+...||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888752211111000 001112223467899999999988889999999999999999988
Q ss_pred CCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 878 RKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 878 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..--........ +.. ....++ .. .+... =..++.+|++..|..||+|.+++.|
T Consensus 279 Eiq~tnseS~~~-----~ee----~ia~~i----~~---len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVE-----VEE----NIANVI----IG---LENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceee-----hhh----hhhhhe----ee---ccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 764211111000 000 000000 00 00000 1237789999999999999999877
Q ss_pred H
Q 048430 958 L 958 (973)
Q Consensus 958 L 958 (973)
.
T Consensus 332 p 332 (458)
T KOG1266|consen 332 P 332 (458)
T ss_pred c
Confidence 5
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.2e-13 Score=151.02 Aligned_cols=199 Identities=36% Similarity=0.502 Sum_probs=148.0
Q ss_pred EEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccC-cCCeeecCCccccCcCcccccCcCCCCeeeccCC
Q 048430 375 VLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLE-KLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453 (973)
Q Consensus 375 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 453 (973)
.++++.|.+. .....+..++.++.|++.+|+++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5677777764 23344455577888888888887 5666666664 7888888888877 45566777888888888888
Q ss_pred CCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCC
Q 048430 454 SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ 533 (973)
Q Consensus 454 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 533 (973)
+++ .+|.....++.|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+..+.++..|.+++|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 886 45555557778888888888888 66766556667888888888654 57777888888888888888887 4577
Q ss_pred CcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCC
Q 048430 534 SFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582 (973)
Q Consensus 534 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 582 (973)
.++.+.+|++|++++|+++. ++. +..+.+++.|++++|.+...+|..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 78888888888888888884 443 888888888888888888777753
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2e-12 Score=147.35 Aligned_cols=133 Identities=35% Similarity=0.561 Sum_probs=57.4
Q ss_pred CCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeee
Q 048430 370 LSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLD 449 (973)
Q Consensus 370 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 449 (973)
+++|+.|++++|++. .+|...+.++.|+.|++++|++. .+|........|++|.+++|.+. ..+..+.++.++..+.
T Consensus 162 l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~ 238 (394)
T COG4886 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238 (394)
T ss_pred cccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccc
Confidence 333344444444433 22322223344444444444444 23333333333444444444322 2333344444444444
Q ss_pred ccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCC
Q 048430 450 FRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP 508 (973)
Q Consensus 450 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 508 (973)
+.+|++.. ++..+..+..++.|++++|+++ .++. ++.+.+++.|++++|.++..+|
T Consensus 239 l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 239 LSNNKLED-LPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred cCCceeee-ccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccch
Confidence 44444431 2444444444555555555555 2222 5555555555665555554333
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.3e-11 Score=132.56 Aligned_cols=168 Identities=17% Similarity=0.258 Sum_probs=133.6
Q ss_pred EeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHH
Q 048430 700 TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQR 779 (973)
Q Consensus 700 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~ 779 (973)
+..++.+|.|...+.......+...+.++.++.++||+|++++..+...+..|+|+|.+. .|..++... .....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v 106 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEV 106 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHH
Confidence 355788999998876655555677888999999999999999999999999999999974 677777753 35667
Q ss_pred HHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCC
Q 048430 780 LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS 859 (973)
Q Consensus 780 ~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 859 (973)
...+.||+.||.|||+ ..+++|+++.-..|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 7789999999999997 78899999999999999999999999999876543222 111222334567777554433
Q ss_pred cchhHHHHHHHHHHHHhCC
Q 048430 860 ISGDVYSFGILMMETFTRR 878 (973)
Q Consensus 860 ~~sDvws~Gvvl~elltg~ 878 (973)
-..|.|-||+++||++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.7e-12 Score=129.57 Aligned_cols=209 Identities=21% Similarity=0.240 Sum_probs=151.8
Q ss_pred CCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCC-ccccCcCcccccC
Q 048430 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN-NALQGQIPTCLAN 441 (973)
Q Consensus 363 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~ 441 (973)
+|-.+.-..+|..+.+|.+.-..+ .+....-+.|+++...+.-+.. .| .+-....+....-+. .-..|.....+..
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dT 282 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADT 282 (490)
T ss_pred cccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecch
Confidence 444455667788888888876632 2323334678888887766652 22 122222332222221 1223334445556
Q ss_pred cCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEE
Q 048430 442 LTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLA 521 (973)
Q Consensus 442 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 521 (973)
+..|+++|||+|.|+ .+..+..-++.++.|++|+|.|+. +- .+..+++|+.||||+|.++ .+..+-..+-+.+.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 778999999999997 567778888999999999999984 32 3788999999999999998 6677777888999999
Q ss_pred cccCccccCCCCCcccccccccccccccccCCC-CCccccccccccccccCCCcccccCC
Q 048430 522 LARNAFQGPIPQSFGSLISLQSLDLSGNNISGE-IPKSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 522 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
|+.|.|.. + ..++.|.+|..||+++|+|... --..++++|-|+.+.|-+|++.+.+-
T Consensus 359 La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 359 LAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999973 3 4588899999999999999843 22568899999999999999987554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-11 Score=137.67 Aligned_cols=248 Identities=22% Similarity=0.223 Sum_probs=180.3
Q ss_pred CCCCCccccc--cCceEEEEEEe---CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeE
Q 048430 681 GFGESNLLGS--GSFDNVYKATL---ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 681 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 752 (973)
.|.....+|. |.+|.||.+.. .++..+|+|.-+... ......=.+|+...+.++ |++.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3566788999 99999999985 468889999744332 222333456666666664 999999888999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeecccc
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS----ALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIA 827 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla 827 (973)
+-+|.+. .++.++.+.....++....+.+..+... |+.++| +..++|-|+||.||+...+ ...+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence 9999985 6888888876556778888888888888 999999 8999999999999999999 89999999998
Q ss_pred cccCCCCCccc----ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcch
Q 048430 828 KLLDGVDPVTQ----TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV 903 (973)
Q Consensus 828 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
..+........ ....+...|++||... +-++.++|+|++|.+..+..++..+.-..... .|...
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~W~~~------ 338 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-----SWSQL------ 338 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-----Ccccc------
Confidence 87754332211 1125778899999654 56789999999999999999987764221100 11110
Q ss_pred hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+..+...+.. .....++...+..|++.+|..|++++++..+
T Consensus 339 ----r~~~ip~e~~---------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 339 ----RQGYIPLEFC---------EGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ----ccccCchhhh---------cCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1101000000 0112334558889999999999998877653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.9e-13 Score=138.87 Aligned_cols=211 Identities=20% Similarity=0.228 Sum_probs=138.3
Q ss_pred ccccCCcEEEccCCCCCCCCCc-cccCCCCCccEEEeeCcccCCCCC--ccccCCCCCCeEEccCccccccCCccccCCC
Q 048430 90 WHMRRLKIIDFSSNSLSGSLPG-DMCNSFTQLESFDVSSNKITGEFP--SAIVNISSLKSIRLDNNSLSGSFPTDLCTRL 166 (973)
Q Consensus 90 ~~l~~L~~L~Ls~n~l~~~~p~-~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l 166 (973)
.++.+|+...|.+.... ..+. +....+++++.||||.|-|..-.| .-...|++|+.|+|+.|++.--+....-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46777888888888875 3332 345678888888888888775222 3345788888888888888633333333456
Q ss_pred CCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccC--CCCCCccc
Q 048430 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL--PSSIYLPN 244 (973)
Q Consensus 167 ~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~~l~~ 244 (973)
++|+.|.|+.|.++- +.+-.-+..+++|+.|+|..|.....-......++.|++|+|++|++.... +....++.
T Consensus 197 ~~lK~L~l~~CGls~----k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~ 272 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSW----KDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPG 272 (505)
T ss_pred hhhheEEeccCCCCH----HHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccc
Confidence 788888888888762 233334556778888888888543343444455677788888888776543 44456788
Q ss_pred cceeeeccccccccC-cch-----hcccCcccEEEeccccccccC-CCcccccccceEEEccCCcCCC
Q 048430 245 LENLFLWKNNLSGII-PDS-----ICNASEATILELSSNLFSGLV-PNTFGNCRQLQILSLGDNQLTT 305 (973)
Q Consensus 245 L~~L~L~~N~l~~~~-~~~-----l~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~ 305 (973)
|+.|+++.+.+..+- |+. ...+++|++|+++.|+|.... -+.+..+++|+.|.+..|.++.
T Consensus 273 L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 273 LNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888888888776532 332 345567777777777775332 2445556677777777777765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-10 Score=132.27 Aligned_cols=146 Identities=18% Similarity=0.177 Sum_probs=95.7
Q ss_pred cCCCCCccccccCceEEEEEEeCC-CeEEEEEEEeccchh------------------------------h----H----
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDR------------------------------A----L---- 720 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------------------------------~----~---- 720 (973)
..|.. +.||+|++|.||+|++++ |+.||||+.+..... . .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 799999999999999877 999999999744210 0 0
Q ss_pred --HHHHHHHHHHHhcc----CCceeEEEeeeec-CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH-HHHH
Q 048430 721 --KSFDTECEVMRRIR----HRNLIKIVSSCSN-PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS-ALEY 792 (973)
Q Consensus 721 --~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~ 792 (973)
-+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+++.++-.-.....+.. .++...++ -+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHH
Confidence 12445555555553 4443443333322 456789999999999987532111122222 12222221 1222
Q ss_pred hhhcCCCCeEEccCCCCcEEeCCCC----cEEEeecccccccCC
Q 048430 793 LHHGYSTPIIHCDLKPNNVLLDDDM----VAHLGDFGIAKLLDG 832 (973)
Q Consensus 793 LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~~~~~ 832 (973)
+. ..|++|+|++|.||+++.++ .++++|||++..++.
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 57899999999999999988 999999999987753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-10 Score=116.17 Aligned_cols=128 Identities=23% Similarity=0.234 Sum_probs=96.5
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCcee-EEEeeeecCCeeEEEEEecCCCCH
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLI-KIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467899999999999876 78899998754432 224567899999998655544 4554433 345799999999877
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-----eEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP-----IIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
...- .....++.+++++++.|| ..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~---------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED---------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc---------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 112346789999999999 555 59999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.9e-10 Score=110.66 Aligned_cols=136 Identities=18% Similarity=0.199 Sum_probs=99.7
Q ss_pred ccccccCceEEEEEEeCC-------CeEEEEEEEeccc----------------------hhhHHHH----HHHHHHHHh
Q 048430 686 NLLGSGSFDNVYKATLAN-------GVSVAVKVFNLQE----------------------DRALKSF----DTECEVMRR 732 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~l~~ 732 (973)
..||.|.-+.||.|...+ +..+|||+.+... ....+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998543 5799999885320 0112233 389999999
Q ss_pred ccC--CceeEEEeeeecCCeeEEEEEecCCCCHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeEEccCCC
Q 048430 733 IRH--RNLIKIVSSCSNPGFKALIMQYMPQGSLEK-WLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTPIIHCDLKP 808 (973)
Q Consensus 733 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk~ 808 (973)
+.. -++...+++ ...++||||+.+..+.. .+.. ..++..+...+..+++.+|..+ | ..++||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 853 456666664 45689999997653322 2222 1345566778889999999999 7 78999999999
Q ss_pred CcEEeCCCCcEEEeecccccccC
Q 048430 809 NNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 809 ~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
.||++. ++.+.++|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.7e-12 Score=131.91 Aligned_cols=67 Identities=22% Similarity=0.291 Sum_probs=35.8
Q ss_pred CccCCCCCCeEEccCCcCcccCCccc-----ccCCcCCEEEcccCcccc----CCCCCcccccccccccccccccC
Q 048430 486 NIGNLEALGGLNLTGNQLSGYIPSSI-----GNLKNLDWLALARNAFQG----PIPQSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 486 ~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 552 (973)
.+..+++|+.|++++|.++..-...| ...++|+.|.|.+|.++. .+-..+...+.|..|+|++|++.
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 34445556666666666553222222 124566666666666652 12233444666777777777773
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.7e-12 Score=131.85 Aligned_cols=144 Identities=19% Similarity=0.310 Sum_probs=96.9
Q ss_pred cccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCC
Q 048430 288 GNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGF 367 (973)
Q Consensus 288 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~ 367 (973)
..-++|+++..+.|++...+.. .+...+..++.|+.+.+..|.|... .+. .+-..|
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~---~~A~~~~~~~~leevr~~qN~I~~e---G~~------------------al~eal 209 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGAT---ALAEAFQSHPTLEEVRLSQNGIRPE---GVT------------------ALAEAL 209 (382)
T ss_pred CCCcceEEEEeeccccccccHH---HHHHHHHhccccceEEEecccccCc---hhH------------------HHHHHH
Confidence 3446788888888888765443 3445566677888888888877522 110 122346
Q ss_pred CCCCcccEEEeecCcccc----ccCcccCCCCCCCEEEccCCcCCCCCchhhh-----ccCcCCeeecCCccccCc----
Q 048430 368 GNLSNLLVLSLVNNELAG----AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC-----KLEKLNTLLSNNNALQGQ---- 434 (973)
Q Consensus 368 ~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~---- 434 (973)
..+++|+.|||.+|-++. .+...+..+++|++|++++|.+...-...|. ..++|++|.+.+|.|+..
T Consensus 210 ~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~ 289 (382)
T KOG1909|consen 210 EHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALA 289 (382)
T ss_pred HhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHH
Confidence 778888888888888863 3455677788888888888888755444433 356788888888877642
Q ss_pred CcccccCcCCCCeeeccCCCC
Q 048430 435 IPTCLANLTSLRHLDFRSNSL 455 (973)
Q Consensus 435 ~~~~~~~l~~L~~L~L~~N~l 455 (973)
+..++...+.|+.|+|++|++
T Consensus 290 la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 290 LAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHhcchhhHHhcCCcccc
Confidence 233455667788888888887
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.6e-11 Score=116.07 Aligned_cols=81 Identities=28% Similarity=0.553 Sum_probs=14.9
Q ss_pred CCCcEEEecCCCCCCCCCcccc-cccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccc-cCCCCCCe
Q 048430 69 SFLVSLNISGNSFYDTLPNELW-HMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAI-VNISSLKS 146 (973)
Q Consensus 69 ~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 146 (973)
..+++|+|++|.|.. | +.++ .+.+|+.||||+|.|+ .++. +..++.|++|++++|+|+. +++.+ ..+++|++
T Consensus 19 ~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 19 VKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQE 92 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCc-cccchHHhCCcCCE
Confidence 344555555555522 2 2233 3444555555555554 3332 2334445555555555442 22222 23444444
Q ss_pred EEccCcccc
Q 048430 147 IRLDNNSLS 155 (973)
Q Consensus 147 L~L~~N~l~ 155 (973)
|+|++|+|.
T Consensus 93 L~L~~N~I~ 101 (175)
T PF14580_consen 93 LYLSNNKIS 101 (175)
T ss_dssp EE-TTS---
T ss_pred EECcCCcCC
Confidence 444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=9e-11 Score=114.07 Aligned_cols=83 Identities=29% Similarity=0.303 Sum_probs=27.4
Q ss_pred ccccceeeeccccccccCcchh-cccCcccEEEeccccccccCC-CcccccccceEEEccCCcCCCCCCCcchhhhhhhc
Q 048430 242 LPNLENLFLWKNNLSGIIPDSI-CNASEATILELSSNLFSGLVP-NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLA 319 (973)
Q Consensus 242 l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~ 319 (973)
+++|++|++++|+|+.+ .+.+ ..+++|++|+|++|+|..... ..++.+++|+.|+|.+|.++..+. .-...+.
T Consensus 63 L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~----YR~~vi~ 137 (175)
T PF14580_consen 63 LPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKN----YRLFVIY 137 (175)
T ss_dssp -TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTT----HHHHHHH
T ss_pred hhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhh----HHHHHHH
Confidence 34444444444444432 1122 234444444444444443221 344556666666666666654321 1223456
Q ss_pred cCCcCcEEEc
Q 048430 320 KCRYLRVLVL 329 (973)
Q Consensus 320 ~l~~L~~L~L 329 (973)
.+++|+.||-
T Consensus 138 ~lP~Lk~LD~ 147 (175)
T PF14580_consen 138 KLPSLKVLDG 147 (175)
T ss_dssp H-TT-SEETT
T ss_pred HcChhheeCC
Confidence 6777776654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-11 Score=128.70 Aligned_cols=158 Identities=22% Similarity=0.252 Sum_probs=89.8
Q ss_pred CCCcccEEEeecCccccccC--cccCCCCCCCEEEccCCcCCCCCc--hhhhccCcCCeeecCCccccCcCcccc-cCcC
Q 048430 369 NLSNLLVLSLVNNELAGAIP--TVLGKLQKLQGLDLNSNKLKGFIP--TDLCKLEKLNTLLSNNNALQGQIPTCL-ANLT 443 (973)
Q Consensus 369 ~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~ 443 (973)
++.+|++..|.+..+. ..+ +....+++++.||||.|-+....+ .....+++|+.|.++.|++..-..... ..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4567788888877776 333 356677888888888887764322 334467777777777777763332221 1355
Q ss_pred CCCeeeccCCCCCC-CCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCC--cccccCCcCCEE
Q 048430 444 SLRHLDFRSNSLNS-TIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP--SSIGNLKNLDWL 520 (973)
Q Consensus 444 ~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L 520 (973)
.|+.|.|+.|.++- .+-.....+++|+.|+|..|............+..|+.|||++|++- ..+ ...+.++.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhh
Confidence 67777777777652 12223334556666666666422233333344555666666666554 233 234455555555
Q ss_pred EcccCccc
Q 048430 521 ALARNAFQ 528 (973)
Q Consensus 521 ~Ls~N~l~ 528 (973)
+++.+.+.
T Consensus 277 nls~tgi~ 284 (505)
T KOG3207|consen 277 NLSSTGIA 284 (505)
T ss_pred hccccCcc
Confidence 55555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.8e-11 Score=120.20 Aligned_cols=132 Identities=27% Similarity=0.299 Sum_probs=77.8
Q ss_pred CCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccc
Q 048430 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE 246 (973)
Q Consensus 167 ~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~ 246 (973)
..|++|||++|.|+ .+.++..-++.++.|++|+|.|... ..+..+.+|+.|+|++|.++....-...+.+++
T Consensus 284 q~LtelDLS~N~I~------~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 284 QELTELDLSGNLIT------QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIK 355 (490)
T ss_pred hhhhhccccccchh------hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhhhcCEe
Confidence 44566666666664 3444555555666666666666522 224444555555555555543332223466777
Q ss_pred eeeeccccccccCcchhcccCcccEEEeccccccccCC-CcccccccceEEEccCCcCCCCCC
Q 048430 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP-NTFGNCRQLQILSLGDNQLTTGSS 308 (973)
Q Consensus 247 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 308 (973)
.|.|+.|.|... ..++.+-+|..||+++|+|..... ..+++++.|+.+.|.+|.+...+.
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 777777777643 456666777777777777764432 456777777777777777765443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-11 Score=140.13 Aligned_cols=82 Identities=29% Similarity=0.366 Sum_probs=45.4
Q ss_pred ccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCc---Cccc-ccCcCCCCee
Q 048430 373 LLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQ---IPTC-LANLTSLRHL 448 (973)
Q Consensus 373 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~~~~-~~~l~~L~~L 448 (973)
|+.+++++|++. ..+..+..+..+..|++.+|++... ..+.....+..+.+..|.+... .... ......++.+
T Consensus 234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (414)
T KOG0531|consen 234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL 310 (414)
T ss_pred HHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence 667777777776 3335566666777777777776632 2233445555556666655421 1111 3344555556
Q ss_pred eccCCCCCC
Q 048430 449 DFRSNSLNS 457 (973)
Q Consensus 449 ~L~~N~l~~ 457 (973)
.+..|.+..
T Consensus 311 ~~~~~~~~~ 319 (414)
T KOG0531|consen 311 TLELNPIRK 319 (414)
T ss_pred ccccCcccc
Confidence 666665543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.1e-09 Score=102.27 Aligned_cols=131 Identities=21% Similarity=0.333 Sum_probs=102.9
Q ss_pred ccccccCceEEEEEEeCCCeEEEEEEEecc--chh------hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDR------ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..+++|+-+.+|.+.+. |..+++|.-..+ ... ......+|++++.+.+--.|...+-+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999875 445777743222 111 134567899999998766666666666778888899999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
++|..|.+++... ...++..+-+-+.-|| ..+|||+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998898888765 2457778888889999 89999999999999998885 99999999874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-11 Score=138.11 Aligned_cols=85 Identities=27% Similarity=0.323 Sum_probs=49.7
Q ss_pred CCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCC---CCcc-cccccccccc
Q 048430 493 LGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGE---IPKS-LEKLSRLVDF 568 (973)
Q Consensus 493 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~l 568 (973)
|+.+++++|++. ..+..+..+..+..|++++|++...- .+.....+..+.++.|++... .... ....+.+..+
T Consensus 234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (414)
T KOG0531|consen 234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL 310 (414)
T ss_pred HHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence 566666666665 34355556666666666666665321 244455666666666666521 1121 4556677777
Q ss_pred ccCCCcccccCC
Q 048430 569 NVSFNGLEGEIP 580 (973)
Q Consensus 569 ~ls~N~l~~~~p 580 (973)
.+.+|+.....+
T Consensus 311 ~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 311 TLELNPIRKISS 322 (414)
T ss_pred ccccCccccccc
Confidence 777777766554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-08 Score=107.62 Aligned_cols=267 Identities=14% Similarity=0.118 Sum_probs=167.9
Q ss_pred CCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEee------eec-CCeeEEEE
Q 048430 684 ESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSS------CSN-PGFKALIM 755 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~-~~~~~lv~ 755 (973)
..+.+|+|+-+.+|-.- +-...+-|+++........ +.+..|... .||-+-.-+.+ ..+ .....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35789999999998532 1112345776544332211 223333333 45533221111 111 22255677
Q ss_pred EecCCC-CHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 756 QYMPQG-SLEKWLYSH-----NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 756 e~~~~g-sL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..+.+. ....++... -...+|...++.++.+|.+.+.|| ..|.+-+|+.++|+|+.+++.+.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 776553 222222211 145789999999999999999999 89999999999999999999999998665444
Q ss_pred cCCCCCcccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCccccCcc---cHHHHHHhhCC
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTR-RKPTNEMFTGEM---SLKQWVAESLP 900 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg-~~p~~~~~~~~~---~~~~~~~~~~~ 900 (973)
.. +...+...+|...|.+||... +-..+...|-|.+||++++++.| ++||.+...... .+.. ....
T Consensus 167 ~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~ 241 (637)
T COG4248 167 NA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAH 241 (637)
T ss_pred cc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhc
Confidence 32 223344567889999999543 33457789999999999999986 999987543211 1110 0011
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccC--CCCCCCHHHHHHHHHHHHHHHHh
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEI--PEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~--P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
+......|.+. ........+.....++++..+..+|+... |.-||+++..+..|.+++++++.
T Consensus 242 g~f~ya~~~~~----g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 242 GRFAYASDQRR----GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred ceeeechhccC----CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 11222222111 11222223333456677888999999874 56899999999999999988764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=3e-09 Score=110.84 Aligned_cols=143 Identities=21% Similarity=0.278 Sum_probs=111.9
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccC--CceeEEEeeeecC---CeeEEEEEec
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRH--RNLIKIVSSCSNP---GFKALIMQYM 758 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~ 758 (973)
.+.++.|..+.||++...+|+.+++|....... .....+.+|+++++.+++ ..+.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999987778999998754432 134578899999999975 3467777777654 3668999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG------------------------------------------ 796 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------ 796 (973)
++.++.+.+.. ..++..++..++.++++++.+||+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775532 2467788888999999999999841
Q ss_pred -----------CCCCeEEccCCCCcEEeCC--CCcEEEeecccccc
Q 048430 797 -----------YSTPIIHCDLKPNNVLLDD--DMVAHLGDFGIAKL 829 (973)
Q Consensus 797 -----------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~ 829 (973)
....++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.6e-09 Score=98.07 Aligned_cols=142 Identities=18% Similarity=0.238 Sum_probs=105.9
Q ss_pred CCccccccCceEEEEEEeCCCeEEEEEEEecc--c------hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 684 ESNLLGSGSFDNVYKATLANGVSVAVKVFNLQ--E------DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
....+.+|+-+.|+++.+. |+...||.--.+ + .-..+...+|++.+.+++--.|.-..-++.+...-+++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999987 777777743211 1 112456778999999887545554444566666678999
Q ss_pred EecCC-CCHHHHhhhCCCCCCH-HHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC---cEEEeecccccc
Q 048430 756 QYMPQ-GSLEKWLYSHNYSLTI-RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---VAHLGDFGIAKL 829 (973)
Q Consensus 756 e~~~~-gsL~~~l~~~~~~l~~-~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~ 829 (973)
||+++ .++.+++...-..-.. +....+++.|-+.+.-|| ..+|||+|+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 4788888765422233 333789999999999999 89999999999999996654 468999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5e-10 Score=124.74 Aligned_cols=249 Identities=18% Similarity=0.142 Sum_probs=174.2
Q ss_pred HhcCCCCCccccccCceEEEEEEe--CCCeEEEEEEEeccchhhHH--HHHHHHHHHHhc-cCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL--ANGVSVAVKVFNLQEDRALK--SFDTECEVMRRI-RHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (973)
...+|..+..||.|.|+.|+.... .++..+++|........... .-..|+.+...+ .|.+++..+..+..-+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 445788899999999999999874 46788899876544322212 223455555555 4888888777777777778
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeecccccccC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLLD 831 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~ 831 (973)
+=-||++++++...... ...+++..++++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..+.
T Consensus 343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999988766632 235778889999999999999999 8999999999999999886 788999999986432
Q ss_pred CCCCccccccccccccc--CccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 832 GVDPVTQTMTLATIGYM--APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
- . .......-+++ +++......+-.+.|+||||.-+.|..++..--.. . .+|.. +...
T Consensus 419 ~---~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~------~~~~~---------i~~~ 478 (524)
T KOG0601|consen 419 F---S-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-G------VQSLT---------IRSG 478 (524)
T ss_pred e---e-cccccccccccccchhhccccccccccccccccccccccccCcccCcc-c------cccee---------eecc
Confidence 1 1 11112233344 55566667788999999999999999998653111 0 11110 0000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
.+ ........++..+.+.+...++..||.+.+...+.+-..
T Consensus 479 ~~------------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 479 DT------------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cc------------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00 000111245677888999999999999999887765443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.2e-09 Score=130.42 Aligned_cols=105 Identities=26% Similarity=0.354 Sum_probs=48.4
Q ss_pred CCcEEEecCCC--CCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeE
Q 048430 70 FLVSLNISGNS--FYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSI 147 (973)
Q Consensus 70 ~L~~L~L~~n~--~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 147 (973)
.|++|-+..|. +....++.|..++.|+.||||+|.--+.+|.++ +.|-+|++|+|++..++ .+|..+++|.+|.+|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I-~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSI-GELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHH-hhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 34555555443 322222234445555555555544434455444 44555555555555555 455555555555555
Q ss_pred EccCccccccCCccccCCCCCccEEEcccc
Q 048430 148 RLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177 (973)
Q Consensus 148 ~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N 177 (973)
++..+.-...+ ..+...+++|++|.+..-
T Consensus 624 nl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 624 NLEVTGRLESI-PGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccccccccc-cchhhhcccccEEEeecc
Confidence 55544433222 233333455555544443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.6e-09 Score=126.87 Aligned_cols=39 Identities=23% Similarity=0.240 Sum_probs=18.9
Q ss_pred CCCCeeeccCCCCCCCCcccccccccccEEEecCCcccC
Q 048430 443 TSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481 (973)
Q Consensus 443 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 481 (973)
++|+.|.+..++....+.+....+..+..+-+..+.+.+
T Consensus 770 ~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 770 PHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred CcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 456666666555444444444444444444444444443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.6e-08 Score=98.72 Aligned_cols=125 Identities=23% Similarity=0.302 Sum_probs=85.1
Q ss_pred EEEEEEeCCCeEEEEEEEeccc--------------------------hhhHHHHHHHHHHHHhccCC--ceeEEEeeee
Q 048430 695 NVYKATLANGVSVAVKVFNLQE--------------------------DRALKSFDTECEVMRRIRHR--NLIKIVSSCS 746 (973)
Q Consensus 695 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 746 (973)
.||.|...+|..+|||+.+... ........+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999885320 01234567899999999755 566666553
Q ss_pred cCCeeEEEEEecC--CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeEEccCCCCcEEeCCCCcEEEee
Q 048430 747 NPGFKALIMQYMP--QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY-LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823 (973)
Q Consensus 747 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 823 (973)
..++||||++ |..+..+.... ++......++.+++..+.. +| ..+|||+|+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 65555443322 2234556778888886666 46 8999999999999999988 999999
Q ss_pred ccccccc
Q 048430 824 FGIAKLL 830 (973)
Q Consensus 824 fgla~~~ 830 (973)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.4e-09 Score=84.01 Aligned_cols=61 Identities=41% Similarity=0.618 Sum_probs=53.8
Q ss_pred cccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcC
Q 048430 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303 (973)
Q Consensus 243 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 303 (973)
|+|++|++++|+++.+.++.|..+++|++|++++|.++.+.+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5788899999999988778899999999999999999988888999999999999998875
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.2e-09 Score=84.81 Aligned_cols=59 Identities=34% Similarity=0.594 Sum_probs=26.9
Q ss_pred CCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCcc
Q 048430 94 RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNS 153 (973)
Q Consensus 94 ~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 153 (973)
+|++|++++|++. .+|.+.|..+++|++|++++|+++...|.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444444444444 4444444444444444444444444333444444444444444443
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.4e-07 Score=100.79 Aligned_cols=166 Identities=17% Similarity=0.231 Sum_probs=128.4
Q ss_pred ceEEEEEE-eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeee----cCCeeEEEEEecCC-CCHHHH
Q 048430 693 FDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS----NPGFKALIMQYMPQ-GSLEKW 766 (973)
Q Consensus 693 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 766 (973)
-.+.|++. ..+|..|++|+++..+.........-++.++++.|+|+|++..++. .+...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35788887 4589999999997665544434456688899999999999998875 35678899999875 477765
Q ss_pred hhhCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 767 LYSHN--------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 767 l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
..... ...++..++.++.|+..||.++| +.|..-+=+.+++|+++.+.+++|+.-|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 34677899999999999999999 88999999999999999999999988887665543
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRK 879 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~ 879 (973)
.. . |.+. --.+-|.-.||.++..|.||..
T Consensus 446 d~-------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP-------------T--EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC-------------C--cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 22 0 1111 1235699999999999999965
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-09 Score=127.30 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=168.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
..+++.+.+.+.+|.++.++.+.- ..|...+.|+..... ....+....+-.+.-..+||-++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 345566677888999999998863 234344444332211 1111222223333333456777766666666778899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|++|..+++|..-++..+ ..+..........+..+.+||| ...+.|||++|.|.+...++..+++|||......-.
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999998766 4555566667778889999999 677999999999999999999999999843322100
Q ss_pred ----------C--------------------CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 048430 834 ----------D--------------------PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883 (973)
Q Consensus 834 ----------~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~ 883 (973)
. ........+|+.|.+||...+......+|.|++|++++|.++|..||+.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0012234689999999999999999999999999999999999999876
Q ss_pred cccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 048430 884 MFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK 952 (973)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 952 (973)
..+... +....... . .....+........+++...+..+|.+|..+.
T Consensus 1038 ~tpq~~-----f~ni~~~~------------~-----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI-----FENILNRD------------I-----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh-----hhccccCC------------C-----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 433211 01000000 0 00011122344567788888899999998776
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.2e-10 Score=125.39 Aligned_cols=200 Identities=27% Similarity=0.312 Sum_probs=132.3
Q ss_pred CCcccEEEeecCcccccc-CcccCCCCCCCEEEccCCcCCCCCchhhhcc-CcCCeeecCCcc--ccCcCcccccC----
Q 048430 370 LSNLLVLSLVNNELAGAI-PTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL-EKLNTLLSNNNA--LQGQIPTCLAN---- 441 (973)
Q Consensus 370 l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~--l~~~~~~~~~~---- 441 (973)
+++++.|.+-.-.-.+.. |-.+..+.+|+.|.|.++.|.. ...+..+ ..|+.|...+-- +...+..+.+.
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns 160 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNS 160 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccc
Confidence 344555555444333322 5556677788888888888774 2222222 234444433211 11112222221
Q ss_pred --cCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCc-ccccCCcCC
Q 048430 442 --LTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPS-SIGNLKNLD 518 (973)
Q Consensus 442 --l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~ 518 (973)
+..|...+.+.|++. .+..++.-++.|+.|||++|+++... .+..++.|+.|||+.|.+. .+|. ...++. |+
T Consensus 161 ~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~ 235 (1096)
T KOG1859|consen 161 PVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQ 235 (1096)
T ss_pred hhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-he
Confidence 235778888899886 56677777888999999999998543 6788899999999999998 5554 344444 89
Q ss_pred EEEcccCccccCCCCCcccccccccccccccccCCCCC-ccccccccccccccCCCccccc
Q 048430 519 WLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIP-KSLEKLSRLVDFNVSFNGLEGE 578 (973)
Q Consensus 519 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~~ 578 (973)
.|+|++|.++. + ..+.+|++|+.|||++|-|++.-- ..+..|..|+.|+|.+|++...
T Consensus 236 ~L~lrnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 236 LLNLRNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred eeeecccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 99999999873 2 347888999999999998886422 3456778888999999998863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.7e-07 Score=97.32 Aligned_cols=140 Identities=17% Similarity=0.121 Sum_probs=100.3
Q ss_pred ccccccCceEEEEEEeCCCeEEEEEEEeccchh-----------hHHHHHHHHHHHHhccCCc--eeEEEeeeec-----
Q 048430 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR-----------ALKSFDTECEVMRRIRHRN--LIKIVSSCSN----- 747 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----- 747 (973)
+.+-+.....|++..+ +|+.|.||......-. ....+.+|++.+.++...+ .+..+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 4788999976433211 1124789999998885332 3344555432
Q ss_pred CCeeEEEEEecCCC-CHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-------CCc
Q 048430 748 PGFKALIMQYMPQG-SLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-------DMV 818 (973)
Q Consensus 748 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 818 (973)
...-++|+|++++. +|.+++... ....+...+..++.+++..+.-|| ..||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999876 899988642 224566777899999999999999 899999999999999975 568
Q ss_pred EEEeecccccc
Q 048430 819 AHLGDFGIAKL 829 (973)
Q Consensus 819 ~kl~Dfgla~~ 829 (973)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.2e-09 Score=75.86 Aligned_cols=37 Identities=38% Similarity=0.888 Sum_probs=26.0
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCcceEEEEEee
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCS 41 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~c~w~gv~C~ 41 (973)
||++||++|..||.+.+.+ |+.+. ..+||+|.||+|+
T Consensus 7 aLl~~k~~l~~~~~~~l~~-W~~~~---~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 7 ALLAFKKSLNNDPSGVLSS-WNPSS---DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHCTT-SC-CCCTT---TT-----S-CCCSTTEEE-
T ss_pred HHHHHHHhcccccCccccc-CCCcC---CCCCeeeccEEeC
Confidence 7999999998888888886 98631 3799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.5e-07 Score=95.18 Aligned_cols=133 Identities=23% Similarity=0.264 Sum_probs=96.9
Q ss_pred CCccccccCceEEEEEEeCCCeEEEEEEEeccch----------------------hhHHHHHHHHHHHHhccCC--cee
Q 048430 684 ESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED----------------------RALKSFDTECEVMRRIRHR--NLI 739 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--niv 739 (973)
+.++||.|.-+.||.|....|.++|||.-+.... -......+|.++|.++... .|.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 3578999999999999999999999996532211 1234567899999988654 566
Q ss_pred EEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 740 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
+.+++ +...+|||+++|--|...- ++.+..-.++..|++-+.-.- ..||||+|+++-||+++++|.+
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCE
Confidence 65554 4467999999986655422 123334445555555555555 5789999999999999999999
Q ss_pred EEeecccccc
Q 048430 820 HLGDFGIAKL 829 (973)
Q Consensus 820 kl~Dfgla~~ 829 (973)
.++||--+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999976553
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.8e-08 Score=113.67 Aligned_cols=151 Identities=21% Similarity=0.290 Sum_probs=103.6
Q ss_pred HHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc---c-----ccccccccccCccCCCC
Q 048430 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---Q-----TMTLATIGYMAPEYGSE 855 (973)
Q Consensus 784 ~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~---~-----~~~~~~~~y~aPE~~~~ 855 (973)
.+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+.+....+...+. + ........|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999997 7899999999999999999999999999876554311111 1 11234567999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHH
Q 048430 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMS 935 (973)
Q Consensus 856 ~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~ 935 (973)
...+.++|+||+||++|-+..|..+.-........ ..... .. ............+.++.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~-------------~~------~~~~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSR-------------NL------LNAGAFGYSNNLPSELRE 243 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhh-------------cc------cccccccccccCcHHHHH
Confidence 99999999999999999999655542111111111 00000 00 000111112345677889
Q ss_pred HHHhccccCCCCCCCHHHHHH
Q 048430 936 LALKCSAEIPEERINVKDALA 956 (973)
Q Consensus 936 l~~~cl~~~P~~Rpt~~evl~ 956 (973)
=+.+++..++..||++.++..
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHhcCCcccCcchhhhhc
Confidence 999999999999997776653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=8.9e-09 Score=91.83 Aligned_cols=134 Identities=24% Similarity=0.238 Sum_probs=92.8
Q ss_pred CCeeeccCCCCCCCCcccc---cccccccEEEecCCcccCCcCcCccC-CCCCCeEEccCCcCcccCCcccccCCcCCEE
Q 048430 445 LRHLDFRSNSLNSTIPSTF---WSLKYILAVDFSLNSLSGSLPLNIGN-LEALGGLNLTGNQLSGYIPSSIGNLKNLDWL 520 (973)
Q Consensus 445 L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 520 (973)
+..++|+++++- .+++.. .....|+.+++++|.+. .+|..|.. .+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445566666553 233332 33345566677777777 45555543 457888888888888 688888888888888
Q ss_pred EcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCCC
Q 048430 521 ALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGG 583 (973)
Q Consensus 521 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~ 583 (973)
+++.|.|. ..|..+..|.+|..||..+|.+. .+|-.+---......++.++++.+..|...
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 88888888 77788888888888888888887 566554444444556777888887777543
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.3e-08 Score=101.21 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=155.4
Q ss_pred CCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc---CccccccccCCcceeEEeecccccccCCCCCCc
Q 048430 166 LPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA---GLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYL 242 (973)
Q Consensus 166 l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~---~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l 242 (973)
+..+..++||+|.|... ..+.+...+.+-.+|++.+++.--.. ..+++.+ .-.++....+
T Consensus 29 ~d~~~evdLSGNtigtE-A~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L----------------~~Ll~aLlkc 91 (388)
T COG5238 29 MDELVEVDLSGNTIGTE-AMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNL----------------VMLLKALLKC 91 (388)
T ss_pred hcceeEEeccCCcccHH-HHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHH----------------HHHHHHHhcC
Confidence 55666777777766411 01123334555566666666543221 1111111 1123333447
Q ss_pred cccceeeeccccccccCcch----hcccCcccEEEeccccccccCCCcc-------------cccccceEEEccCCcCCC
Q 048430 243 PNLENLFLWKNNLSGIIPDS----ICNASEATILELSSNLFSGLVPNTF-------------GNCRQLQILSLGDNQLTT 305 (973)
Q Consensus 243 ~~L~~L~L~~N~l~~~~~~~----l~~l~~L~~L~L~~N~i~~~~~~~~-------------~~l~~L~~L~L~~N~l~~ 305 (973)
|+|+..+||+|.+....|.. ++..+.|.+|.|++|.+.-+--..+ .+-+.|++..++.|++..
T Consensus 92 p~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlen 171 (388)
T COG5238 92 PRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLEN 171 (388)
T ss_pred CcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhcc
Confidence 88888888888887665544 4556788888888888763322222 234789999999999987
Q ss_pred CCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccc
Q 048430 306 GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAG 385 (973)
Q Consensus 306 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 385 (973)
.+.. .+...|.....|+++.+..|.|. |..+..+ +-..+..+.+|+.|||.+|-++.
T Consensus 172 gs~~---~~a~~l~sh~~lk~vki~qNgIr---pegv~~L-----------------~~~gl~y~~~LevLDlqDNtft~ 228 (388)
T COG5238 172 GSKE---LSAALLESHENLKEVKIQQNGIR---PEGVTML-----------------AFLGLFYSHSLEVLDLQDNTFTL 228 (388)
T ss_pred CcHH---HHHHHHHhhcCceeEEeeecCcC---cchhHHH-----------------HHHHHHHhCcceeeeccccchhh
Confidence 6654 23334555578888988888776 3332221 11124567889999999998874
Q ss_pred ----ccCcccCCCCCCCEEEccCCcCCCCCchhhh------ccCcCCeeecCCccccCcCcccc-------cCcCCCCee
Q 048430 386 ----AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC------KLEKLNTLLSNNNALQGQIPTCL-------ANLTSLRHL 448 (973)
Q Consensus 386 ----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------~l~~L~~L~l~~N~l~~~~~~~~-------~~l~~L~~L 448 (973)
.+..++...+.|++|.+.+|-++..-...+- ..++|..|...+|.+.+.+-..+ .+++-|..|
T Consensus 229 ~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~l 308 (388)
T COG5238 229 EGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDL 308 (388)
T ss_pred hhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHH
Confidence 3345667777889999999988755443322 25778888888888765433221 245667777
Q ss_pred eccCCCCC
Q 048430 449 DFRSNSLN 456 (973)
Q Consensus 449 ~L~~N~l~ 456 (973)
-+.+|++.
T Consensus 309 e~ngNr~~ 316 (388)
T COG5238 309 ERNGNRIK 316 (388)
T ss_pred HHccCcch
Confidence 77777775
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6e-07 Score=102.47 Aligned_cols=141 Identities=23% Similarity=0.242 Sum_probs=97.0
Q ss_pred ccccccCceEEEEEEeCCCeEEEEEEEeccchh----------------------------------------hHHHHHH
Q 048430 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDR----------------------------------------ALKSFDT 725 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~ 725 (973)
+.|+.++-|.||+|++++|+.||||+.+..-.. ..-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 789999999999999999999999998543110 1113456
Q ss_pred HHHHHHhcc-----CCceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHH-HHHhhhcCCC
Q 048430 726 ECEVMRRIR-----HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA-LEYLHHGYST 799 (973)
Q Consensus 726 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~~~ 799 (973)
|+..+.+++ .+++.-..-|.+..+...++|||++|-.+.+...-.....+... ++..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence 666666653 34333222233335677899999999988887433333455333 33333332 22222 46
Q ss_pred CeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 800 ~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
|++|.|..|.||++..+|.+.+.|||+....++
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999877653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.8e-09 Score=93.49 Aligned_cols=104 Identities=21% Similarity=0.370 Sum_probs=63.2
Q ss_pred CcEEEecCCCCCCCCCccccccc---CCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeE
Q 048430 71 LVSLNISGNSFYDTLPNELWHMR---RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSI 147 (973)
Q Consensus 71 L~~L~L~~n~~~~~~p~~~~~l~---~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 147 (973)
+..++|+++++ +.+++....+. .|+..+|++|.+. .+|+.+-..++.++.|+|++|+|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~l-m~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQL-MYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchh-hHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 45667777766 55666555443 3444577777776 666666555666666777777766 556666666666666
Q ss_pred EccCccccccCCccccCCCCCccEEEcccccc
Q 048430 148 RLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179 (973)
Q Consensus 148 ~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l 179 (973)
+++.|.+. ..|.-++. |.+|..|+..+|.+
T Consensus 106 Nl~~N~l~-~~p~vi~~-L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAP-LIKLDMLDSPENAR 135 (177)
T ss_pred ccccCccc-cchHHHHH-HHhHHHhcCCCCcc
Confidence 66666665 44444432 55555555555554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.4e-08 Score=99.45 Aligned_cols=218 Identities=22% Similarity=0.323 Sum_probs=124.6
Q ss_pred CCCCCCCcEEEecCCCCCCCCCc--ccc-cccCCcEEEccCCCCCC--CCCccccCCCCCccEEEeeCcccCCCCCccc-
Q 048430 65 VGNLSFLVSLNISGNSFYDTLPN--ELW-HMRRLKIIDFSSNSLSG--SLPGDMCNSFTQLESFDVSSNKITGEFPSAI- 138 (973)
Q Consensus 65 l~~l~~L~~L~L~~n~~~~~~p~--~~~-~l~~L~~L~Ls~n~l~~--~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~- 138 (973)
+..+..++-|.+.++.+. ..-+ .|+ ..+.++.|||.+|.|+. .| ..++.++|.|+.|+||.|.+...| +++
T Consensus 41 v~s~ra~ellvln~~~id-~~gd~~~~~~~~~~v~elDL~~N~iSdWseI-~~ile~lP~l~~LNls~N~L~s~I-~~lp 117 (418)
T KOG2982|consen 41 VSSLRALELLVLNGSIID-NEGDVMLFGSSVTDVKELDLTGNLISDWSEI-GAILEQLPALTTLNLSCNSLSSDI-KSLP 117 (418)
T ss_pred eccccchhhheecCCCCC-cchhHHHHHHHhhhhhhhhcccchhccHHHH-HHHHhcCccceEeeccCCcCCCcc-ccCc
Confidence 444445556666665552 2211 232 34677778888887762 11 134466777788888887777433 223
Q ss_pred cCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCcccccccc
Q 048430 139 VNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFN 218 (973)
Q Consensus 139 ~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 218 (973)
..+.+|+.|.|++..+.-.-.......+|.+++|.++.|.+ +.+++..|.++..-|
T Consensus 118 ~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~-------------------rq~n~Dd~c~e~~s~----- 173 (418)
T KOG2982|consen 118 LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL-------------------RQLNLDDNCIEDWST----- 173 (418)
T ss_pred ccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh-------------------hhhccccccccccch-----
Confidence 34567777777777765333334445566666666665543 223344444432111
Q ss_pred CCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccC-CCcccccccceEEE
Q 048430 219 NSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV-PNTFGNCRQLQILS 297 (973)
Q Consensus 219 ~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~ 297 (973)
.+++|. +++.+..++++-|++..+ ++++..+-+..|.+.... ...+..++.+--|+
T Consensus 174 --~v~tlh--------------~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~Ln 230 (418)
T KOG2982|consen 174 --EVLTLH--------------QLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLN 230 (418)
T ss_pred --hhhhhh--------------cCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhh
Confidence 111111 244555555555655533 235556666666665333 24556667777888
Q ss_pred ccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCC
Q 048430 298 LGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVI 338 (973)
Q Consensus 298 L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 338 (973)
|+.|+|.+.. -.+.+.+++.|+.|.+.+|++...+
T Consensus 231 L~~~~idswa------svD~Ln~f~~l~dlRv~~~Pl~d~l 265 (418)
T KOG2982|consen 231 LGANNIDSWA------SVDALNGFPQLVDLRVSENPLSDPL 265 (418)
T ss_pred hcccccccHH------HHHHHcCCchhheeeccCCcccccc
Confidence 8888887632 2467888899999999999887543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 973 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-44 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-44 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 6e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 6e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 2e-04 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 4e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 7e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 973 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-159 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-139 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-25 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-09 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-90 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-63 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-35 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-84 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-81 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-38 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-06 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-82 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-73 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-70 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-57 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-46 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-25 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-79 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-68 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-76 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-11 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-72 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-67 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-50 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-23 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-72 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-72 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-68 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-59 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-43 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-27 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-60 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 7e-58 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-57 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-57 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-57 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-56 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-48 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-40 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-16 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-55 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-55 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-55 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-55 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-52 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-50 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-37 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-33 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-20 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 8e-50 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-49 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-47 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-20 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-48 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-48 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-48 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-42 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-41 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-46 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-38 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-09 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-37 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-37 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-20 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-40 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-34 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-37 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-32 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-30 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-11 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-38 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-38 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 9e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-33 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-37 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-37 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-37 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-37 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-37 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-37 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-37 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-37 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-37 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-37 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-37 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 8e-37 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-36 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-08 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-36 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-10 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-36 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-36 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-36 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-36 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-35 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-35 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-35 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-35 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-35 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-35 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-35 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-35 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-35 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-35 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-34 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-34 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-34 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-34 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-21 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-21 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-33 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-25 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-19 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-04 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-33 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-33 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-29 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-28 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-24 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-19 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-31 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-29 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-32 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-17 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-31 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-31 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-31 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-31 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-18 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-31 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-31 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-30 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-30 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-30 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-30 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-30 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-30 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-30 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-30 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-30 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 9e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-30 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-30 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-29 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-29 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-29 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-29 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-29 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-27 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-27 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-12 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-07 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-09 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-06 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-05 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-27 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-14 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 5e-08 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-26 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-26 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-25 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-25 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-25 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-25 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-24 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-24 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-24 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-24 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-14 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-24 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-24 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-23 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-23 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-23 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-22 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-19 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-14 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 8e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-23 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-22 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-22 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-18 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-09 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-22 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-22 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-22 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-22 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 8e-22 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-22 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 9e-22 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-21 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-21 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-21 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-20 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-20 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-20 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-20 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-20 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-08 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-19 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-19 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-18 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-18 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-17 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-05 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-18 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 8e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 8e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 8e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-13 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-17 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 9e-10 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-06 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-17 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-17 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-17 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-17 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 8e-17 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 8e-17 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-16 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-16 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-16 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-05 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-16 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-16 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-16 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-16 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-16 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-14 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-15 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-15 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-15 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-15 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-15 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-15 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-15 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 9e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-07 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-06 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-14 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-14 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-14 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-14 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-14 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-14 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-14 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-11 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 8e-14 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-13 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-13 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-13 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-13 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-13 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-12 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-12 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-12 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-06 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-11 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 7e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-07 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 9e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 9e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-04 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 7e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 9e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 9e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 9e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-04 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 7e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 7e-07 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 9e-07 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 7e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 7e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-159
Identities = 169/577 (29%), Positives = 255/577 (44%), Gaps = 31/577 (5%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L + + + +P +G+ S L L+ISGN + LK+++ SSN G +
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIV-NISSLKSIRLDNNSLSGSFPTDLCTRLPS 168
P L+ ++ NK TGE P + +L + L N G+ P
Sbjct: 264 PPLPL---KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG-SCSL 319
Query: 169 LVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNS-NMVAILL 227
L L L NN +G +P + + + LK+LDL N +G +P + N S +++ + L
Sbjct: 320 LESLALSSNNFSGELP----MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 228 YGNHLSGHLPSSI---YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP 284
N+ SG + ++ L+ L+L N +G IP ++ N SE L LS N SG +P
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGN 344
++ G+ +L+ L L N L G+I L + L L+LD N L G IP+ + N
Sbjct: 436 SSLGSLSKLRDLKLWLNMLE------GEIP-QELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 345 LSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNS 404
T+L +++L+G IP G L NL +L L NN +G IP LG + L LDLN+
Sbjct: 489 C-TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 405 NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN--SLNSTIPST 462
N G IP + K + N + G+ + N + N
Sbjct: 548 NLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
Query: 463 FWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522
L + + G N ++ L+++ N LSGYIP IG++ L L L
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663
Query: 523 ARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
N G IP G L L LDLS N + G IP+++ L+ L + ++S N L G IP
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
Query: 583 GPFVNFTADSFKQNYALCGSSRLQVPPCKTSSTHKSK 619
G F F F N LCG +P C S+
Sbjct: 724 GQFETFPPAKFLNNPGLCG---YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-139
Identities = 169/614 (27%), Positives = 253/614 (41%), Gaps = 86/614 (14%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT 60
L+ K L N + W+ ++ + C + GVTC +V ++ L + L
Sbjct: 16 QLISFKD--VLPDKNLLPD-WS-----SNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVG 65
Query: 61 L--------------------------PPHVGNLSFLVSLNISGNSFYDTLP--NELWHM 92
+ L SL++S NS + L
Sbjct: 66 FSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIV---NISSLKSIRL 149
LK ++ SSN+L LE D+S+N I+G V LK + +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 150 DNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209
N +SG +R +L L + NN + IP +G+ L+ LD+ GN ++
Sbjct: 186 SGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIP------FLGDCSALQHLDISGNKLS 236
Query: 210 GLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSIC-NASE 268
G I + + + + N G +P L +L+ L L +N +G IPD +
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 269 ATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLV 328
T L+LS N F G VP FG+C L+ L+L N + G++ +L K R L+VL
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS------GELPMDTLLKMRGLKVLD 349
Query: 329 LDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIP 388
L N G +P S+ NLS SL S+ SG I
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP----------------- 392
Query: 389 TVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRH 447
LQ L L +N G IP L +L +L LS N L G IP+ L +L+ LR
Sbjct: 393 -----KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY-LSGTIPSSLGSLSKLRD 446
Query: 448 LDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYI 507
L N L IP +K + + N L+G +P + N L ++L+ N+L+G I
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 508 PSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVD 567
P IG L+NL L L+ N+F G IP G SL LDL+ N +G IP ++ K S
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS---- 562
Query: 568 FNVSFNGLEGEIPS 581
++ N + G+
Sbjct: 563 GKIAANFIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-25
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 12/155 (7%)
Query: 437 TCLANLTSLRHLDFRSNSLN---STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEAL 493
TC + +D S LN S + S+ SL + ++ S + ++GS+ +L
Sbjct: 46 TC--RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASL 102
Query: 494 GGLNLTGNQLSGYIPS--SIGNLKNLDWLALARNAFQGPIPQS-FGSLISLQSLDLSGNN 550
L+L+ N LSG + + S+G+ L +L ++ N P S L SL+ LDLS N+
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162
Query: 551 ISGEIPKSLE---KLSRLVDFNVSFNGLEGEIPSG 582
ISG L +S N + G++
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS 197
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-09
Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 512 GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVS 571
+ ++D + N + S SL L+SL LS ++I+G + + + L ++S
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 572 FNGLEGEIPSGGPFVNFT 589
N L G + + + +
Sbjct: 109 RNSLSGPVTTLTSLGSCS 126
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 9e-90
Identities = 92/604 (15%), Positives = 185/604 (30%), Gaps = 80/604 (13%)
Query: 18 ANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNIS 77
NW+ T NW G +SL + + L++
Sbjct: 44 GKNWSQQGFGTQPG-ANWNFNKELDMWGAQPGVSL-------------NSNGRVTGLSLE 89
Query: 78 GNSFYDTLPNELWHMRRLKIIDFSSNSLSG----SLPGDMCNSFTQLESFDVSSNKITGE 133
G +P+ + + L+++ S+ P + + E
Sbjct: 90 GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISAN-MSDEQKQKMRMHYQKT 148
Query: 134 FPSAI--VNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNE 191
F + S L ++++ S Q+ L NNIT +
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSR-ITLKDTQIGQLSNNITF------VSKA 201
Query: 192 IGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-YLPNLENLFL 250
+ L L+ +G + + N N L +L ++ +
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 251 WKNNLSGIIPDSICNASEATILELSSNLFSGL--------VPNTFGNCRQLQILSLGDNQ 302
+ +P + E ++ ++ N ++QI+ +G N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
L T +SL K + L +L N L+G +P + G+ L + +Q++
Sbjct: 317 LKTFPVE------TSLQKMKKLGMLECLYNQLEGKLP-AFGSE-IKLASLNLAYNQITEI 368
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVL--GKLQKLQGLDLNSNKLKGF-------IPT 413
G + LS +N+L IP + + + +D + N++ +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 414 DLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS-------TIPSTFWS 465
K ++++ LSNN + + + L ++ N L F +
Sbjct: 428 TPFKGINVSSINLSNNQ-ISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 466 LKYILAVDFSLNSLSGSLP-LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNL------D 518
+ ++D N L+ L L G++L+ N S P+ N L +
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 519 WLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGE 578
N P+ SL L + N+I + + + + ++ N
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISI 602
Query: 579 IPSG 582
S
Sbjct: 603 DLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 2e-89
Identities = 93/588 (15%), Positives = 180/588 (30%), Gaps = 68/588 (11%)
Query: 27 NTSASVCNWV---GVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFY- 82
N + + W GV+ + +GRV LSL G +P +G L+ L L + +
Sbjct: 61 NFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV 119
Query: 83 ---DTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCN-SFTQLESFDVSSNKITGEFPSAI 138
P + + + F+ L ++S+ +
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 139 VNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNL 198
I +N+++ + RL L Q + + E E N
Sbjct: 180 RITLKDTQIGQLSNNIT-FVSKAVM-RLTKLRQFYMGNSPFVA-----ENICEAWENENS 232
Query: 199 KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY-LPNLENLFLWKNNLSG 257
+ N ++ + +Y LP+ + LP ++ + + N
Sbjct: 233 EYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
Query: 258 I--------IPDSICNASEATILELSSN-LFSGLVPNTFGNCRQLQILSLGDNQLTTGSS 308
+ I+ + N L + V + ++L +L NQL
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG--- 344
Query: 309 AQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIP--VG 366
+ L L L N + IP + + +EN ++L IP
Sbjct: 345 -----KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397
Query: 367 FGNLSNLLVLSLVNNELAG-------AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLE 419
++S + + NE+ + K + ++L++N++ F
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 420 KLNTL-LSNNN------ALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS-TFWSLKYILA 471
L+++ L N N L +D R N L +L Y++
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517
Query: 472 VDFSLNSLSGSLPLNIGNLEALGGL------NLTGNQLSGYIPSSIGNLKNLDWLALARN 525
+D S NS S P N L G + GN+ P I +L L + N
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576
Query: 526 AFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
+ + + ++ LD+ N + + + ++
Sbjct: 577 DIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-63
Identities = 69/505 (13%), Positives = 144/505 (28%), Gaps = 92/505 (18%)
Query: 39 TCSIRHGRVAALSLPNLSLGG----TLPPHVGNLSFLVSLNISGNSF------------- 81
SI+ L + + V L+ L + + F
Sbjct: 172 QKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231
Query: 82 ------YDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKIT---- 131
Y T + +++ L ++ + LP + +++ +V+ N+
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA-LPEMQLINVACNRGISGEQ 290
Query: 132 ----GEFPSAIVNISSLKSIRLDNNSL-SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
+ + ++ I + N+L + T L ++ L L L N + G
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEG----- 344
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI---YLP 243
G+ L L+L N I + + + + N L +P+ +
Sbjct: 345 -KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVS 402
Query: 244 NLENLFLWKNNLSGI-------IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQIL 296
+ + N + + + + + + LS+N S F L +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 297 SLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGS 356
+L N LT + + L + L N L + +
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDF-------------- 507
Query: 357 SQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN------SNKLKGF 410
L L+ + L N + PT L+G + N+
Sbjct: 508 ---------RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557
Query: 411 IPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI 469
P + L L + +N+ ++ + + ++ LD + N S S
Sbjct: 558 WPEGITLCPSLTQLQIGSND-IRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEA 613
Query: 470 LAVDFSLNSLSGSLPLNIGNLEALG 494
+ +I +AL
Sbjct: 614 GMYMLFYDKTQ-----DIRGCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-35
Identities = 34/263 (12%), Positives = 73/263 (27%), Gaps = 12/263 (4%)
Query: 340 NSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQG 399
G + NF V + + LSL +G +P +G+L +L+
Sbjct: 50 QGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEV 109
Query: 400 LDLNSNKLKG----FIPTDLCKLEKLNTLLSNNNALQGQIPTCLA--NLTSLRHLDFRSN 453
L L S+ K F P + Q + + L S+
Sbjct: 110 LALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169
Query: 454 SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGN 513
+I + + N+++ + + L L + +
Sbjct: 170 PQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
Query: 514 LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
+N ++ + +L L +++ ++P L+ L + NV+ N
Sbjct: 229 NENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 574 GLEGEIPSGGPFVNFTADSFKQN 596
+ +
Sbjct: 284 RGISGEQLKDDWQALADAPVGEK 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 9e-89
Identities = 121/580 (20%), Positives = 200/580 (34%), Gaps = 46/580 (7%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L L + S+ L++L++S N T + L+ + S+N +
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161
Query: 110 PGDMCNSF-TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCT--RL 166
++ + L+ ++SSN+I P I L + L+N L S LC
Sbjct: 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN 221
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLH--NLKILDLGGNNIAGLIPSMIFNNSNMVA 224
S+ L L + ++ L NL +LDL NN+ + +
Sbjct: 222 TSIRNLSLSNSQLST-----TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276
Query: 225 ILLYGNHLSGHLPSSIY-LPNLENLFLWKN---------NLSGIIPDSICNASEATILEL 274
L N++ S++ L N+ L L ++ +L I S L +
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336
Query: 275 SSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
N G+ N F L+ LSL ++ + + + F S L +L L N +
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFT-SLRTLTNETFVSL--AHSPLHILNLTKNKI 393
Query: 335 KGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGK 393
+ ++ L LE G +++ + + L N+ + L N+
Sbjct: 394 SKIESDAFSWL-GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452
Query: 394 LQKLQGLDLNSNKLKGF--IPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDF 450
+ LQ L L LK P+ L L L LSNNN + L L L LD
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN-IANINDDMLEGLEKLEILDL 511
Query: 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSS 510
+ N+L ++ G + L L LNL N
Sbjct: 512 QHNNLAR----------------LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 511 IGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEK-LSRLVDFN 569
+L L + L N F + +SL+SL+L N I+ K L + +
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615
Query: 570 VSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPP 609
+ FN + S FVN+ ++ L PP
Sbjct: 616 MRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-84
Identities = 119/556 (21%), Positives = 191/556 (34%), Gaps = 55/556 (9%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L+L + L + S L SL++ N+ P + LK+++ N LS
Sbjct: 30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
T L + SN I + V +L ++ L +N LS S +L +L
Sbjct: 90 DKTFAFC-TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENL 147
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYG 229
+L L N I +I +LK L+L N I P + + L
Sbjct: 148 QELLLSNNKIQALKSE---ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 230 NHLSGHLPSSI----YLPNLENLFLWKNNLSGIIPDSI--CNASEATILELSSNLFSGLV 283
L L + ++ NL L + LS + + T+L+LS N + +
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 284 PNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG 343
++F QL+ L N + +F SL +R L L + K I
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQH-------LFSHSLHGLFNVRYLNLKRSFTKQSISL--- 314
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+ L F L L L++ +N++ G + L L+ L L+
Sbjct: 315 -------------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 404 SNKLKG-------FIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
++ F+ L LN L+ N + + L L LD N +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILN--LTKNK-ISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 457 STIP-STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG--YIPSSIGN 513
+ + L+ I + S N + + +L L L L PS
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 514 LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS--------GEIPKSLEKLSRL 565
L+NL L L+ N L L+ LDL NN++ G L+ LS L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 566 VDFNVSFNGLEGEIPS 581
N+ NG +
Sbjct: 539 HILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 5e-81
Identities = 108/508 (21%), Positives = 185/508 (36%), Gaps = 34/508 (6%)
Query: 94 RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNS 153
++ D S L+ +P D+ T + +++ N++ + S L S+ + N+
Sbjct: 5 SHEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 154 LSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIP 213
+S P +LC +LP L L L N ++ NL L L N+I +
Sbjct: 61 ISKLEP-ELCQKLPMLKVLNLQHNELSQ-----LSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 214 SMIFNNSNMVAILLYGNHLSGHLPSSIY-LPNLENLFLWKNNLSGIIPD--SICNASEAT 270
+ N++ + L N LS + L NL+ L L N + + + I S
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 271 ILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330
LELSSN P F +L L L + QL + + + + +R L L
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA----NTSIRNLSLS 230
Query: 331 TNPLKGVIPNSIGNLS-TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPT 389
+ L + L T+L + L+ F L L L N +
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 390 VLGKLQKLQGLDLNSN---------KLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA 440
L L ++ L+L + L L+ L L +N + G
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
Query: 441 NLTSLRHLDFRSN--SLNSTIPSTFWSL--KYILAVDFSLNSLSGSLPLNIGNLEALGGL 496
L +L++L ++ SL + TF SL + ++ + N +S L L L
Sbjct: 351 GLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL 410
Query: 497 NLTGNQLSGYIP-SSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG-- 553
+L N++ + L+N+ + L+ N + SF + SLQ L L +
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470
Query: 554 EIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
P + L L ++S N +
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 8e-66
Identities = 97/460 (21%), Positives = 159/460 (34%), Gaps = 60/460 (13%)
Query: 143 SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILD 202
S + + L+ P DL ++ L L N + L LD
Sbjct: 5 SHEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRR-----LPAANFTRYSQLTSLD 55
Query: 203 LGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS 262
+G N I+ L P + LP L+ L L N LS + +
Sbjct: 56 VGFNTISKLEPELCQK-----------------------LPMLKVLNLQHNELSQLSDKT 92
Query: 263 ICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322
+ T L L SN + N F + L L L N L++ + +
Sbjct: 93 FAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-------TKLGTQVQLE 145
Query: 323 YLRVLVLDTNPLKGVIPNSIGNLS-TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNN 381
L+ L+L N ++ + + + +SL+ S+Q+ P F + L L L N
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 382 ELAGAIPTVLG---KLQKLQGLDLNSNKLKGFIPTDL--CKLEKLNTL-LSNNNALQGQI 435
+L ++ L ++ L L++++L T K L L LS NN L
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN-LNVVG 264
Query: 436 PTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKY---------ILAVDFSLNSLSGSLPLN 486
A L L + N++ + L SL SL +
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 487 IGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ--GPIPQSFGSLI--SLQ 542
L+ L LN+ N + G + L NL +L+L+ + ++F SL L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 543 SLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
L+L+ N IS + L L ++ N + E+
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-38
Identities = 58/270 (21%), Positives = 97/270 (35%), Gaps = 12/270 (4%)
Query: 320 KCR-YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
KC V L V + L T++ +QL F S L L +
Sbjct: 1 KCTVSHEVADCSHLKLTQVPDD----LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDV 56
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
N ++ P + KL L+ L+L N+L L L +N++Q
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP--LNIGNLEALGGL 496
+L LD N L+ST T L+ + + S N + L+I +L L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 497 NLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFG---SLISLQSLDLSGNNISG 553
L+ NQ+ + P + L L L + + + S+++L LS + +S
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 554 EIPKSLE--KLSRLVDFNVSFNGLEGEIPS 581
+ K + L ++S+N L
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-06
Identities = 18/120 (15%), Positives = 38/120 (31%), Gaps = 3/120 (2%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L+L + +L L +++ N+ + + LK ++ N ++
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
+F L D+ N S ++ + + LS + LC P
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY---LCNTPPHY 657
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 5e-82
Identities = 105/547 (19%), Positives = 190/547 (34%), Gaps = 38/547 (6%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
+L++S N + L+++D S + G + + L + ++ N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPI 88
Query: 131 TGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPN 190
A +SSL+ + +L+ + L +L +L + N I ++P
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPI-GHLKTLKELNVAHNLIQSF----KLPE 143
Query: 191 EIGNLHNLKILDLGGNNIAGLIPSMIFNNSNM----VAILLYGNHLSGHLPSSIYLPNLE 246
NL NL+ LDL N I + + + M +++ L N ++ P + L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 247 NLFLWKNNLSGIIPDSICNA-SEATILELSSNLFSG---LVPNTFGNCRQLQILSLGDNQ 302
L L N S + + + + L F L L L++ + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNS----------IGNLSTSLENF 352
L I + L + ++ V S +
Sbjct: 264 LAYLDYYLDDII-DLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL 322
Query: 353 YAGS------SQLSGGIPVGFGNLSNLLVLSLVNNELA--GAIPTVLGKLQKLQGLDLNS 404
S + GG +L +L L L N L+ G L+ LDL+
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 405 NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPSTF 463
N + + ++ LE+L L ++ L+ +L +L +LD F
Sbjct: 383 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441
Query: 464 WSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522
L + + + NS + +I L L L+L+ QL P++ +L +L L +
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 523 ARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKL-SRLVDFNVSFNGLEGEIPS 581
+ N F + L SLQ LD S N+I + L+ S L N++ N
Sbjct: 502 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
Query: 582 GGPFVNF 588
F+ +
Sbjct: 562 -QSFLQW 567
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-73
Identities = 98/579 (16%), Positives = 175/579 (30%), Gaps = 68/579 (11%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L L L + L L++S + L + + N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
G + L+ + I ++ +LK + + +N + + + L +L
Sbjct: 93 LGAFSGL-SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKI----LDLGGNNIAGLIPSMIFNNSNMVAI 225
L L N I ++ LH + + LDL N + + P F + +
Sbjct: 152 EHLDLSSNKIQS-----IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKL 205
Query: 226 LLYGNHLSGHLPSSIY--LPNLE------NLFLWKNNLSGIIPDSICNASEATILELSSN 277
L N S ++ + L LE F + NL ++ TI E
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 278 ---LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQG----------QIFYSSLAKCRYL 324
+ + + F + SL + + +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 325 RVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLS--GGIPVGFGNLSNLLVLSLVNNE 382
+ L KG S +L SLE + LS G ++L L L N
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 383 LAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTD-LCKLEKLNTL-LSNNNALQGQIPTCLA 440
+ + + L++L+ LD + LK L L L +S+ + +
Sbjct: 385 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH-TRVAFNGIFN 442
Query: 441 NLTSLRHLDFRSNSLNSTI-PSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLT 499
L+SL L NS P F L+ + +D S L P +L +L LN++
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 500 GNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI-SLQSLDLSGNNISG----- 553
N L +L L + N Q SL L+L+ N+ +
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 554 ---------------------EIPKSLEKLSRLVDFNVS 571
P + + ++ N++
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 5e-70
Identities = 101/504 (20%), Positives = 176/504 (34%), Gaps = 43/504 (8%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
+ +P ++ ++ D+S N + + + L+ + L +
Sbjct: 10 ITYQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSM 215
+ L L L L GN I L +L+ L N+A L
Sbjct: 66 TIEDGAYQS-LSHLSTLILTGNPIQS-----LALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 216 IFNNSNMVAILLYGNHL-SGHLPSSIY-LPNLENLFLWKNNLSGIIPDSICNASE----A 269
I + + + + N + S LP L NLE+L L N + I + +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 270 TILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVL 329
L+LS N + + P F R L L+L +N + + + + L V L
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDS------LNVMKTCIQGLAGLEVHRL 232
Query: 330 ------DTNPLKGVIPNSIGNLSTS--LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNN 381
+ L+ +++ L E A I F L+N+ SLV+
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292
Query: 382 ELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLAN 441
+ Q L+L + K F L L++L + +G +
Sbjct: 293 TIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVD 345
Query: 442 LTSLRHLDFRSNSLN--STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLT 499
L SL LD N L+ + + + +D S N + + N LE L L+
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQ 404
Query: 500 GNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI-PK 557
+ L S+ +L+NL +L ++ + F L SL+ L ++GN+ P
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 558 SLEKLSRLVDFNVSFNGLEGEIPS 581
+L L ++S LE P+
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-57
Identities = 72/426 (16%), Positives = 143/426 (33%), Gaps = 41/426 (9%)
Query: 174 LLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS 233
+ N +IP+ + + K LDL N + L F+ + + L +
Sbjct: 14 CMELNFY------KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 234 GHLPSSIY-LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQ 292
+ L +L L L N + + + S L + L G+ +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 293 LQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG---NLSTSL 349
L+ L++ N + + + L L L +N ++ + + +
Sbjct: 126 LKELNVAHNLIQSFKLP------EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 350 ENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIP-TVLGKLQKLQGLDLNSNKLK 408
+ + ++ P F + L L+L NN + + T + L L+ L + +
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 409 GFIP---------TDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTI 459
LC L L+ + I LT++ S ++
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 460 PSTF-WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLD 518
++ + +++ + L + +L LT G S +L +L+
Sbjct: 299 DFSYNFGWQHL---ELVNCKFGQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLE 350
Query: 519 WLALARNA--FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
+L L+RN F+G QS SL+ LDLS N + + + L +L + + L+
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 577 GEIPSG 582
Sbjct: 410 QMSEFS 415
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 9e-46
Identities = 81/401 (20%), Positives = 135/401 (33%), Gaps = 52/401 (12%)
Query: 218 NNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSN 277
N+ + N +P ++ + +NL L N L + S + E +L+LS
Sbjct: 6 VVPNITYQCMELNFYK--IPDNL-PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 278 LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGV 337
+ + + L L L N + + + + + L+ LV L +
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLAL-------GAFSGLSSLQKLVAVETNLASL 115
Query: 338 IPNSIGNLSTSLENFYAGSSQLSGG-IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK 396
IG+L +L+ + + +P F NL+NL L L +N++ T L L +
Sbjct: 116 ENFPIGHL-KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 397 LQ----GLDLNSNKLKGFIPTDL--CKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450
+ LDL+ N + P +L KL L NN + TC+ L L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT--LRNNFDSLNVMKTCIQGLAGLEVHRL 232
Query: 451 RSNSLNST------IPSTFWSLKYILAVDFSLNSLSGS---LPLNIGNLEALGGLNLTGN 501
+ S L + +F L L + L + +L
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292
Query: 502 QLSGYIPSSIGNLKNLDWLALARNAF-------------------QGPIPQSFGSLISLQ 542
+ S L L F +G S L SL+
Sbjct: 293 TIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE 350
Query: 543 SLDLSGNNIS--GEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
LDLS N +S G +S + L ++SFNG+ +
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN 391
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 35/168 (20%), Positives = 64/168 (38%), Gaps = 5/168 (2%)
Query: 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDF 474
+ + + N + IP L S ++LD N L +F+S + +D
Sbjct: 4 VEVVPNITYQCMELNFYK--IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQS 534
S + +L L L LTGN + + L +L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 535 FGSLISLQSLDLSGNNI-SGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
G L +L+ L+++ N I S ++P+ L+ L ++S N ++ +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 3e-79
Identities = 89/339 (26%), Positives = 136/339 (40%), Gaps = 61/339 (17%)
Query: 274 LSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNP 333
+ + G++ +T ++ L L L
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP-KP-------------------------- 65
Query: 334 LKGVIPNSIGNLSTSLENFY-AGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLG 392
IP+S+ NL L Y G + L G IP L+ L L + + ++GAIP L
Sbjct: 66 --YPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 393 KLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRS 452
+++ L LD + N L G +P +++L +L + F
Sbjct: 123 QIKTLVTLDFSYNA------------------------LSGTLPPSISSLPNLVGITFDG 158
Query: 453 NSLNSTIPSTFWSLKYILAV-DFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI 511
N ++ IP ++ S + S N L+G +P NL L ++L+ N L G
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLF 217
Query: 512 GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVS 571
G+ KN + LA+N+ + G +L LDL N I G +P+ L +L L NVS
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 572 FNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPC 610
FN L GEIP GG F ++ N LCGS +P C
Sbjct: 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-68
Identities = 80/313 (25%), Positives = 132/313 (42%), Gaps = 21/313 (6%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRH--GRVAALSLPNLSLG 58
AL+Q+K + ++W T W+GV C RV L L L+L
Sbjct: 10 ALLQIKKDLGNPTT---LSSWL---PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 59 GT--LPPHVGNLSFLVSLNISG-NSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCN 115
+P + NL +L L I G N+ +P + + +L + + ++SG++P +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 116 SFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQ-LRL 174
L + D S N ++G P +I ++ +L I D N +SG+ P L + +
Sbjct: 124 -IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG-SFSKLFTSMTI 181
Query: 175 LGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG 234
N +TG +IP NL NL +DL N + G + ++ N I L N L+
Sbjct: 182 SRNRLTG-----KIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 235 HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294
L NL L L N + G +P + L +S N G +P GN ++
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFD 294
Query: 295 ILSLGDNQLTTGS 307
+ + +N+ GS
Sbjct: 295 VSAYANNKCLCGS 307
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 9e-76
Identities = 100/651 (15%), Positives = 204/651 (31%), Gaps = 91/651 (13%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPT----NTSASVCNWVGVTCSI--RHGRVAALSLPN 54
AL + + +++ N + N + + W +GRV LSL
Sbjct: 273 ALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAG 332
Query: 55 LSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMC 114
G +P +G L+ L L+ +S + + + + +
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392
Query: 115 NSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRL 174
+ +L D+ + I + I I L + +
Sbjct: 393 DYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIG------------------N 432
Query: 175 LGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG 234
L N IT I I L L+I+ + ++ + +
Sbjct: 433 LTNRITF------ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAKQYE 481
Query: 235 HLPSSIY-LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGL---------VP 284
+ S L +L ++ L+ +PD + + E L ++ N +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541
Query: 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGN 344
+ ++QI +G N L + +SL K L +L N ++ + G
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPA------SASLQKMVKLGLLDCVHNKVR--HLEAFGT 593
Query: 345 LSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTV--LGKLQKLQGLD 401
L + +Q+ IP + L +N+L IP + + + +D
Sbjct: 594 N-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVD 650
Query: 402 LNSNKLKGFIPTDLCKLEKLNTL------LSNNNALQGQIPTCLANLTSLRHLDFRSNSL 455
+ NK+ C ++ + LS N +Q A + + + +N +
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE-IQKFPTELFATGSPISTIILSNNLM 709
Query: 456 NS-------TIPSTFWSLKYILAVDFSLNSLSGSLPLNI--GNLEALGGLNLTGNQLSGY 506
S + + + +D N L+ SL + L L ++++ N S
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS- 767
Query: 507 IPSSIGNLKNLDWLALAR------NAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLE 560
P+ N L + N P + SL L + N+I ++ + L
Sbjct: 768 FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL- 825
Query: 561 KLSRLVDFNVSFNGL-EGEIPSGGPFVNFTADSFK--QNYALCGSSRLQVP 608
+L +++ N ++ S P++ + + G L +
Sbjct: 826 -TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 4e-11
Identities = 36/215 (16%), Positives = 68/215 (31%), Gaps = 4/215 (1%)
Query: 396 KLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSL 455
K L+ S + + F D KL K + I A LD ++
Sbjct: 230 KRSELETQSVRGESFTVID-NKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRY 288
Query: 456 NSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLK 515
S + + L+ +++ N + GL+L G G +P +IG L
Sbjct: 289 YSGTINNTIHSL-NWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347
Query: 516 NLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK-SLEKLSRLVDFNVSFNG 574
L L+ ++ ++ + + I K L+ RL ++ +
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 575 LEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPP 609
+ P P + S K ++R+
Sbjct: 408 IN-RNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-72
Identities = 105/529 (19%), Positives = 186/529 (35%), Gaps = 33/529 (6%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
T+ L L L+++ Y + RL + ++N L + +
Sbjct: 47 TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI-FMAETALSGPK 105
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
L+ I+ + N +L+S+ L +N +S S L L N
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNA 164
Query: 179 ITGRIPNREIPNEIGNLHNLKI--LDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL 236
I + ++ +L L+L GN+IAG I F+++ ++ G +
Sbjct: 165 IHY-LS----KEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVI 218
Query: 237 PSSIY---LPNLENLFLWKNNLSGIIPDSICNASEATI--LELSSNLFSGLVPNTFGNCR 291
+ + +L + I P E ++ + L + F + NTF
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 292 QLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLEN 351
LQ L L L+ S L L+ LVL N + + S N SL +
Sbjct: 279 GLQELDLTATHLSELPSG--------LVGLSTLKKLVLSANKFENLCQISASNF-PSLTH 329
Query: 352 FYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELA--GAIPTVLGKLQKLQGLDLNSNKLK 408
+ + G NL NL L L ++++ L L LQ L+L+ N+
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 409 GFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
+ +L L L+ + NL L+ L+ + L+ + F L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 468 YILAVDFSLNSLSGSLPLNIG---NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALAR 524
+ ++ N L L L L+ LS + +LK ++ + L+
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 525 NAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
N ++ L + L+L+ N+IS +P L LS+ N+ N
Sbjct: 510 NRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 3e-67
Identities = 100/497 (20%), Positives = 169/497 (34%), Gaps = 28/497 (5%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
K + + L+ +PG + E + S N + + + +L + L +
Sbjct: 15 KTYNCENLGLN-EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSM 215
D L L L N + + LK L I+ +
Sbjct: 71 -WIHEDTFQSQHRLDTLVLTANPLIF-----MAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 216 IFNNSNMVAILLYGNHLSG-HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILEL 274
+ N + ++ L NH+S LP L+ L N + + + + + +AT L L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 275 --SSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTN 332
+ N +G+ P F + Q L+ G Q + + L + +
Sbjct: 185 NLNGNDIAGIEPGAF-DSAVFQSLNFGGTQNLLVI-----FKGLKNSTIQSLWLGTFEDM 238
Query: 333 PLKGVIPNSIGNLS-TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL 391
+ + P L S+E+ F S L L L L+ +P+ L
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 392 GKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDF 450
L L+ L L++NK + L L + N CL NL +LR LD
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 451 RSNSLNST--IPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP 508
+ + ++ +L ++ +++ S N L L+L +L
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 509 -SSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI---PKSLEKLSR 564
S NL L L L+ + Q F L +LQ L+L GN+ SL+ L R
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 565 LVDFNVSFNGLEGEIPS 581
L +SF L
Sbjct: 478 LEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-64
Identities = 98/532 (18%), Positives = 168/532 (31%), Gaps = 42/532 (7%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L L L + L L L + + L+ + SN +S S+
Sbjct: 86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SI 144
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
+L+ D +N I + ++ ++ L+ N +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLH-----------------------NLKILDLGGN 206
L G I + I +L +++ ++L +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 207 NIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY-LPNLENLFLWKNNLSGIIPDSICN 265
+ + S + + L HLS LPS + L L+ L L N + S N
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 266 ASEATILELSSN-LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYL 324
T L + N L N L+ L L + + T L +L
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL-----QLRNLSHL 378
Query: 325 RVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNEL 383
+ L L N + + LE ++L F NL L VL+L ++ L
Sbjct: 379 QSLNLSYNEPLSLKTEAFKEC-PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
Query: 384 AGAIPTVLGKLQKLQGLDLNSNKLKGFI---PTDLCKLEKLNTLLSNNNALQGQIPTCLA 440
+ + L LQ L+L N L L +L L+ + L
Sbjct: 438 DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497
Query: 441 NLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTG 500
+L + H+D N L S+ LK + ++ + N +S LP + L +NL
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILPSLLPILSQQRTINLRQ 556
Query: 501 NQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
N L + N+ L+W + + L+ + LS +S
Sbjct: 557 NPLDC----TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 6e-55
Identities = 79/453 (17%), Positives = 144/453 (31%), Gaps = 50/453 (11%)
Query: 145 KSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLG 204
K+ +N L+ P L S L N + L NL LDL
Sbjct: 15 KTYNCENLGLN-EIPGTL---PNSTECLEFSFNVLPT-----IQNTTFSRLINLTFLDLT 65
Query: 205 GNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSIC 264
I + + L+ L L N L + ++
Sbjct: 66 RCQIYWIHEDTFQS-----------------------QHRLDTLVLTANPLIFMAETALS 102
Query: 265 NASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYL 324
L S + N + L+ L LG N +++ I L
Sbjct: 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS-------IKLPKGFPTEKL 155
Query: 325 RVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLS-GGIPVGFGNLSNLLVLSLVNNEL 383
+VL N + + + +L N + GI G + + L+ +
Sbjct: 156 KVLDFQNNAIHYLSKEDMSSL-QQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214
Query: 384 AGAIPTVLG--KLQKLQGLDLNSNKLKGFIPTDLCKLEKLN--TLLSNNNALQGQIPTCL 439
I L +Q L + P L +++ ++ +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274
Query: 440 ANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLT 499
+ L+ LD + L+ +PS L + + S N ++ N +L L++
Sbjct: 275 HCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333
Query: 500 GNQLSGYIPS-SIGNLKNLDWLALARNAFQ--GPIPQSFGSLISLQSLDLSGNNISGEIP 556
GN + + + NL+NL L L+ + + +L LQSL+LS N
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393
Query: 557 KSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFT 589
++ ++ +L +++F L+ + PF N
Sbjct: 394 EAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-50
Identities = 73/427 (17%), Positives = 138/427 (32%), Gaps = 50/427 (11%)
Query: 163 CTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNM 222
C + EIP + ++ + L+ N + + +
Sbjct: 8 CIEKEVNKTYNCENLGLN------EIPGTL--PNSTECLEFSFNVLPTIQNTTFSR---- 55
Query: 223 VAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGL 282
L NL L L + + I D+ + L L++N +
Sbjct: 56 -------------------LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96
Query: 283 VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI 342
+ L+ L +++ I + L + L L L +N + +
Sbjct: 97 AETALSGPKALKHLFFIQTGISS-------IDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
Query: 343 GNLSTSLENFYAGSSQLSGGIPVGFGNLSNL--LVLSLVNNELAGAIPTVLGKLQKLQGL 400
L+ ++ + +L L L+L N++AG I Q L
Sbjct: 150 FPT-EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSL 207
Query: 401 DLNSNKLKGFIPTDL--CKLEKLNTLLSNNNALQGQIPTCLANL--TSLRHLDFRSNSLN 456
+ + I L ++ L + + P L S+ ++ + +
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
Query: 457 STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKN 516
+ +TF + +D + LS LP + L L L L+ N+ S N +
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326
Query: 517 LDWLALARNAFQGPI-PQSFGSLISLQSLDLSGNNI--SGEIPKSLEKLSRLVDFNVSFN 573
L L++ N + + +L +L+ LDLS ++I S L LS L N+S+N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 574 GLEGEIP 580
Sbjct: 387 EPLSLKT 393
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-23
Identities = 41/201 (20%), Positives = 64/201 (31%), Gaps = 7/201 (3%)
Query: 400 LDLNSNKLKGFIPTDL-CKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST 458
+ + L IP L E L S N L T + L +L LD +
Sbjct: 17 YNCENLGLNE-IPGTLPNSTECLE--FSFNV-LPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 459 IPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLD 518
TF S + + + N L + +AL L +S + N K L+
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 519 WLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL--VDFNVSFNGLE 576
L L N L+ LD N I + + L + + N++ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 577 GEIPSGGPFVNFTADSFKQNY 597
G P F + +F
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQ 213
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-72
Identities = 100/301 (33%), Positives = 148/301 (49%), Gaps = 20/301 (6%)
Query: 657 EENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE 716
EE+ ++L L R S ELQ A++ F N+LG G F VYK LA+G VAVK +
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 717 DRALKS-FDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY---SHNY 772
+ + F TE E++ HRNL+++ C P + L+ YM GS+ L
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 773 SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD- 831
L +R I + A L YLH IIH D+K N+LLD++ A +GDFG+AKL+D
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE--- 888
VT T TIG++APEY S G S DV+ +G++++E T ++ +
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 889 MSLKQWVAESLP-GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE 947
+ L WV L + +VD +L +E+ ++ +AL C+ P E
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV----------EQLIQVALLCTQSSPME 295
Query: 948 R 948
R
Sbjct: 296 R 296
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 4e-72
Identities = 101/322 (31%), Positives = 160/322 (49%), Gaps = 23/322 (7%)
Query: 647 RRRKRNKSLPEENNSLNLATLS--RISYHELQQATNGFGESNLLGSGSFDNVYKATLANG 704
+ K S+ + +S L R+ +L++ATN F L+G G F VYK L +G
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 705 VSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764
VA+K + + ++ F+TE E + RH +L+ ++ C LI +YM G+L+
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 765 KWLY---SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHL 821
+ LY S++ QRL+I I A L YLH IIH D+K N+LLD++ V +
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI 180
Query: 822 GDFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRK 879
DFGI+K +D ++ T+ T+GY+ PEY +G ++ DVYSFG+++ E R
Sbjct: 181 TDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 880 PTNEMF-TGEMSLKQWVAESLP-GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLA 937
+ ++L +W ES G + ++VD NL + E F A
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFG----------DTA 289
Query: 938 LKCSAEIPEERINVKDALADLK 959
+KC A E+R ++ D L L+
Sbjct: 290 VKCLALSSEDRPSMGDVLWKLE 311
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 2e-68
Identities = 99/531 (18%), Positives = 164/531 (30%), Gaps = 38/531 (7%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
L + N S L L++S + L + + N + S + T
Sbjct: 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ-SFSPGSFSGLT 104
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
LE+ K+ I + +LK + + +N + + L +LV + L N
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPS 238
I I ++ N LD+ N I I F + + L GN S ++
Sbjct: 165 IQT-ITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 239 SIY--LPNLENLFLWKNNLSGIIPDSICNAS--------EATILELSSNLFSGLVPNTFG 288
+ L L L I S L+ F
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLST- 347
+ +SL + + K + L + LK + L +
Sbjct: 283 CLANVSAMSLAGVSIKY---------LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL 333
Query: 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL--GKLQKLQGLDLNSN 405
+L + G I L +L L L N L+ + L+ LDL+ N
Sbjct: 334 TL-------TMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 406 KLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPSTF 463
+ + LE+L L ++ L+ +L L +LD + F
Sbjct: 387 GAII-MSANFMGLEELQHLDFQHST-LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 464 WSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522
L + + + NS + N+ N L L+L+ QL L L L +
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 523 ARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
+ N + L SL +LD S N I L FN++ N
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-59
Identities = 93/516 (18%), Positives = 152/516 (29%), Gaps = 63/516 (12%)
Query: 66 GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125
L L +L ++GN P + L+ + L+ SL L+ +V
Sbjct: 77 HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNV 135
Query: 126 SSNKITG-EFPSAIVNISSLKSIRLDNNSLSGSFPTD---LCTRLPSLVQLRLLGNNITG 181
+ N I + P+ N+++L + L N + D L + L + N I
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194
Query: 182 RIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL-LYGNHLSGHLPSSI 240
I ++ L L L GN + I N + + L I
Sbjct: 195 -----FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 241 YLPN---------LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCR 291
+ P+ ++ L N + + + L+ L
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK--HF 307
Query: 292 QLQILSLGDNQLTTGSSAQGQ------------IFYSSLAKCRYLRVLVLDTNPLKGVIP 339
+ Q LS+ QL + L L L N L
Sbjct: 308 KWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGC 367
Query: 340 NSIGNLS-TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPT-VLGKLQKL 397
S +L SL + + + F L L L ++ L L+KL
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 398 QGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
LD++ K L LNTL ++ N+ + AN T+L LD L
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 457 STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKN 516
F L L LN++ N L S L +
Sbjct: 487 QISWGVF------------------------DTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522
Query: 517 LDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
L L + N + SL +L+ N+++
Sbjct: 523 LSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-56
Identities = 107/530 (20%), Positives = 183/530 (34%), Gaps = 70/530 (13%)
Query: 59 GTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
G+L P + + + + +P+++ K ID S N L N F+
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSN-FS 56
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
+L+ D+S +I A + L ++ L N + SF + L SL L +
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ-SFSPGSFSGLTSLENLVAVETK 115
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPS 238
+ IG L LK L++ N I F+N
Sbjct: 116 LAS-----LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN------------------- 151
Query: 239 SIYLPNLENLFLWKNNLSGIIPDSICNASEATI----LELSSNLFSGLVPNTFGNCRQLQ 294
L NL ++ L N + I + + E L++S N + F + L
Sbjct: 152 ---LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LH 207
Query: 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNL-STSLENFY 353
L+L N ++ + L R + D L+ P+ + L +++ F
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 354 AGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPT 413
+ V F L+N+ +SL + + K K Q L + +LK F
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLKQFPTL 325
Query: 414 DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473
DL L+ L L+ N +G I L SL +LD N+L+ + ++ L
Sbjct: 326 DLPFLKSLT--LTMN---KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL------- 373
Query: 474 FSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ 533
+L L+L+ N + ++ L+ L L + +
Sbjct: 374 ---------------GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 534 S-FGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
S F SL L LD+S N + L+ L ++ N + S
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-43
Identities = 71/399 (17%), Positives = 130/399 (32%), Gaps = 32/399 (8%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
+SL++S N D + ++ + +L + N S ++ + L + +
Sbjct: 183 NLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241
Query: 131 TGEFPSAIVNISSLKS--------IRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGR 182
E I S ++ RL + L ++ + L G +I
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH-CLANVSAMSLAGVSIKY- 299
Query: 183 IPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYL 242
++ + L + + + + ++ L N S + L
Sbjct: 300 ------LEDVPKHFKWQSLSIIRCQLKQFPT---LDLPFLKSLTLTMNKGS-ISFKKVAL 349
Query: 243 PNLENLFLWKNNLSGIIPDSICNASEA--TILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
P+L L L +N LS S + L+LS N ++ F +LQ L
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408
Query: 301 NQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLS 360
+ L + +S+ L L + K L TSL +
Sbjct: 409 STLKRVTE------FSAFLSLEKLLYLDISYTNTKIDFDGIFLGL-TSLNTLKMAGNSFK 461
Query: 361 GGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLE 419
F N +NL L L +L V L +LQ L+++ N L + +L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 420 KLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST 458
L+TL + N ++ SL + +NS+
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-27
Identities = 50/258 (19%), Positives = 83/258 (32%), Gaps = 13/258 (5%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
++ +S +N + L F N S L L L E+ L L L L
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS-TIPST 462
N ++ F P L L L++ L + L +L+ L+ N ++S +P+
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
Query: 463 FWSLKYILAVDFSLNSLSGSLPLNIGNLEALGG----LNLTGNQLSGYIPSSIGNLKNLD 518
F +L ++ VD S N + ++ L L+++ N + +I L
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLH 207
Query: 519 WLALARNAFQGPIPQ-SFGSLISLQSLDLSGNNISGEI------PKSLEKLSRLVDFNVS 571
L L N I + +L L L E P +E L +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 572 FNGLEGEIPSGGPFVNFT 589
F
Sbjct: 268 LTYTNDFSDDIVKFHCLA 285
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-60
Identities = 67/319 (21%), Positives = 128/319 (40%), Gaps = 30/319 (9%)
Query: 668 SRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTEC 727
+ L + + G F V+KA L VAVK+F +Q+ + S+ E
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ---SWQNEY 67
Query: 728 EV--MRRIRHRNLIKIVSSCSNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
EV + ++H N+++ + + LI + +GSL +L ++ +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCH 125
Query: 782 IMIDVASALEYLH------HGYSTP-IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834
I +A L YLH P I H D+K NVLL +++ A + DFG+A +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 835 PVTQTMTLA-TIGYMAPEYGSEGI-----VSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
T T YMAPE I + D+Y+ G+++ E +R +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
M + P ++ ++ + + ++ D + K ++ + +C E R
Sbjct: 246 MLPFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYW-QKHAGMAMLCETIEECWDHDAEAR 303
Query: 949 IN---VKDALADLKKIKKI 964
++ V + + ++++ I
Sbjct: 304 LSAGCVGERITQMQRLTNI 322
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-58
Identities = 85/322 (26%), Positives = 141/322 (43%), Gaps = 36/322 (11%)
Query: 658 ENNSLNLAT--LSRISYHELQQATNGF------GESNLLGSGSFDNVYKATLANGVSVAV 709
EN SL ++ S++EL+ TN F N +G G F VYK + N +VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 710 KVFNLQEDRA----LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
K D + FD E +VM + +H NL++++ S+ L+ YMP GSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 766 WLYSHNYSLTI--RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823
L + + + R I A+ + +LH IH D+K N+LLD+ A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 824 FGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPT 881
FG+A+ + +T + + T YMAPE G ++ D+YSFG++++E T
Sbjct: 177 FGLARASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 882 NEMFTGEMSLKQWVAESL--PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK 939
+E L E + + +D ++ D + S+A +
Sbjct: 235 DEHR-EPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMY----------SVASQ 282
Query: 940 CSAEIPEERINVKDALADLKKI 961
C E +R ++K L+++
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEM 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-57
Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 14/219 (6%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTEC 727
I + +L E +G+GSF V++A +G VAVK+ Q+ + F E
Sbjct: 34 IPWCDLN-----IKE--KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREV 85
Query: 728 EVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN--YSLTIRQRLDIMID 785
+M+R+RH N++ + + + P +++ +Y+ +GSL + L+ L R+RL + D
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
VA + YLH+ + PI+H +LK N+L+D + DFG+++L ++ T
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS-TFLSSKSAAGTP 203
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+MAPE + + DVYSFG+++ E T ++P +
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 79/300 (26%), Positives = 137/300 (45%), Gaps = 38/300 (12%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTEC 727
I ++ G+ +GSGSF VYK +G VAVK+ N+ + L++F E
Sbjct: 21 IPDGQIT-----VGQ--RIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEV 71
Query: 728 EVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA 787
V+R+ RH N++ + + P A++ Q+ SL L++ +++ +DI A
Sbjct: 72 GVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIG 846
++YLH + IIH DLK NN+ L +D +GDFG+A Q L+ +I
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 847 YMAPE---YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV 903
+MAPE S DVY+FGI++ E T + P + + + +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------------NNRDQI 234
Query: 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
E+V LS + + + C + L +C + +ER + LA+++++ +
Sbjct: 235 IEMVGRGSLSPDLSKVRSN------CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-57
Identities = 55/259 (21%), Positives = 111/259 (42%), Gaps = 33/259 (12%)
Query: 656 PEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNL 714
+ + L ++ +E++ + + +G G F V+K + + VA+K L
Sbjct: 2 AMGGSEFPKSRLPTLADNEIE-----YEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54
Query: 715 QEDRA-------LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL 767
+ + F E +M + H N++K+ NP ++M+++P G L L
Sbjct: 55 GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL 112
Query: 768 YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-----DDMVAHLG 822
+ + +L +M+D+A +EY+ + + PI+H DL+ N+ L + A +
Sbjct: 113 LDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 823 DFGIAKLLDGVDPVTQTMTLA--TIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRR 878
DFG+++ +++ +MAPE E + D YSF +++ T
Sbjct: 172 DFGLSQQ------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 879 KPTNEMFTGEMSLKQWVAE 897
P +E G++ + E
Sbjct: 226 GPFDEYSYGKIKFINMIRE 244
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-57
Identities = 78/308 (25%), Positives = 125/308 (40%), Gaps = 53/308 (17%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEV 729
I Y E++ E ++G G+F V KA VA+K + +R K+F E
Sbjct: 5 IDYKEIE-----VEE--VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQ 54
Query: 730 MRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVA 787
+ R+ H N++K+ +C NP L+M+Y GSL L+ T + + +
Sbjct: 55 LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLA--T 844
+ YLH +IH DLKP N+LL V + DFG A + MT +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------IQTHMTNNKGS 166
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE----SLP 900
+MAPE S DV+S+GI++ E TRRKP +E+ + V L
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226
Query: 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960
K I SL +C ++ P +R ++++ + +
Sbjct: 227 --------------------------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 961 IKKILTQA 968
+ + A
Sbjct: 261 LMRYFPGA 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-56
Identities = 107/533 (20%), Positives = 184/533 (34%), Gaps = 34/533 (6%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
+L++S N + L+++D S + ++ S + L + ++ N I
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 131 TGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPN 190
A +SSL+ + +L+ S L +L +L + N I +P
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK---LPE 143
Query: 191 EIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL----LYGNHLSGHLPSSIYLPNLE 246
NL NL+ LDL N I + + + M + L N ++ P + L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 247 NLFLWKNNLSGIIPDSICNA-SEATILELSSNLFSG------LVPNTFGNCRQLQILSLG 299
L L N S + + + + L F + L I
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359
L +F + L + ++ V S LE Q
Sbjct: 264 LAYLDYYLDDIIDLFN----CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 360 SGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKL--KGFIPTDLCK 417
L +L L+ +N+ A V L L+ LDL+ N L KG
Sbjct: 320 P------TLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSL 476
L L + N + + + L L HLDF+ ++L S F SL+ ++ +D S
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 477 NSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSF 535
+ L +L L + GN I L+NL +L L++ + P +F
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 536 GSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNF 588
SL SLQ L+++ N + ++L+ L + N + P +
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-48
Identities = 109/509 (21%), Positives = 183/509 (35%), Gaps = 47/509 (9%)
Query: 99 DFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSF 158
+ +P ++ ++ D+S N + + + L+ + L + +
Sbjct: 13 QCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TI 67
Query: 159 PTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIF 217
L L L L GN I + L +L+ L N+A L I
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQ------SLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 218 NNSNMVAILLYGNHL-SGHLPSSIY-LPNLENLFLWKNNLSGIIPDSICNASEATI---- 271
+ + + + N + S LP L NLE+L L N + I + + +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331
L+LS N + + P F R L L+L +N + + L R + +
Sbjct: 182 LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 332 NPLKGVIPNSIGNLSTS--LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPT 389
L+ +++ L E A I F L+N+ SLV+ +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300
Query: 390 VL-------------------GKLQKLQGLDLNSNKLKGFIP-TDLCKLEKLNTLLSNNN 429
KL+ L+ L SNK DL LE L+ LS N
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD--LSRNG 358
Query: 430 -ALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI- 487
+ +G TSL++LD N + T+ S F L+ + +DF ++L ++
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 488 GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ-SFGSLISLQSLDL 546
+L L L+++ L +L+ L +A N+FQ F L +L LDL
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 547 SGNNISGEIPKSLEKLSRLVDFNVSFNGL 575
S + P + LS L N++ N L
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 74/422 (17%), Positives = 149/422 (35%), Gaps = 38/422 (9%)
Query: 186 REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY--LP 243
+IP+ + + K LDL N + L F+ + + L + + Y L
Sbjct: 20 YKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 244 NLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303
+L L L N + + + S L + L G+ + L+ L++ N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI---GNLSTSLENFYAGSSQLS 360
+ + L L L +N ++ + + + + + ++
Sbjct: 137 QSFKLP------EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 361 GGIPVGFGNLSNLLVLSLVNNELAGAIP-TVLGKLQKLQGLDLNSNKLKGF--------- 410
I G L L+L NN + + T + L L+ L + +
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF-WSLKYI 469
LC L L+ + I LT++ S ++ ++ + +++
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 470 LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARN--AF 527
V+ L++L L T N+ S +L +L++L L+RN +F
Sbjct: 310 ELVNCKFGQFPT------LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSF 361
Query: 528 QGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVN 587
+G QS SL+ LDLS N + + + L +L + + L+ ++ F++
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419
Query: 588 FT 589
Sbjct: 420 LR 421
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 85/446 (19%), Positives = 140/446 (31%), Gaps = 51/446 (11%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYD-TLPNELWHMRRLKIIDFSSNSLSGSLPGD---MC 114
+L G+L L LN++ N LP ++ L+ +D SSN + D +
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 115 NSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRL 174
S D+S N + P A I L + L NN S + L L RL
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232
Query: 175 LGNNITG----------------------------RIPNREIPNEIGNLHNLKILDLGGN 206
+ +I + L N+ L
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292
Query: 207 NIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNA 266
I + L + ++ L +L+ L N + +
Sbjct: 293 TIERVKDFSYNFGWQ----HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DL 346
Query: 267 SEATILELSSNL--FSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYL 324
L+LS N F G + L+ L L N + T S+ L
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT--------MSSNFLGLEQL 398
Query: 325 RVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELA 384
L + LK + S+ +L + F LS+L VL + N
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 385 GAIPT-VLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLT 443
+ +L+ L LDL+ +L+ PT L L L +N L+ LT
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
Query: 444 SLRHLDFRSNSLNSTIPSTFWSLKYI 469
SL+ + +N + + P + +++
Sbjct: 519 SLQKIWLHTNPWDCSCPRIDYLSRWL 544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-19
Identities = 43/212 (20%), Positives = 80/212 (37%), Gaps = 14/212 (6%)
Query: 54 NLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDM 113
LS G + L L++S N T+ + + +L+ +DF ++L +
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 114 CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173
S L D+S F +SSL+ +++ NS +F D+ T L +L L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 174 LLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHL 232
L + ++ +L +L++L++ N + + + +++ I L+ N
Sbjct: 477 LSQCQLE------QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
Query: 233 SGHLPSSIYLPNLENLFLWKNNLSGIIPDSIC 264
P YL W N S S
Sbjct: 531 DCSCPRIDYLSR------WLNKNSQKEQGSAK 556
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 5/163 (3%)
Query: 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDF 474
+ + + N +IP L S ++LD N L +F+S + +D
Sbjct: 4 VEVVPNITYQCMELN-FY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQS 534
S + +L L L LTGN + + L +L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 535 FGSLISLQSLDLSGNNI-SGEIPKSLEKLSRLVDFNVSFNGLE 576
G L +L+ L+++ N I S ++P+ L+ L ++S N ++
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 69/322 (21%), Positives = 120/322 (37%), Gaps = 54/322 (16%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTEC 727
I + +L+ GE L+G G F VY +G VA+++ +++ D LK+F E
Sbjct: 30 IPFEQLE-----IGE--LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREV 80
Query: 728 EVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA 787
R+ RH N++ + +C +P A+I +L + L + + I ++
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT--MTLA-- 843
+ YLH + I+H DLK NV D+ V + DFG+ + + + + +
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 844 TIGYMAPE---------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
+ ++APE + S DV++ G + E R P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---------- 246
Query: 895 VAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER---INV 951
A+ + + + I + L C A EER +
Sbjct: 247 ----PAEAIIWQMGTGMKPNLSQIG---------MGKEISDILLFCWAFEQEERPTFTKL 293
Query: 952 KDALADLKKIKKILTQALHLTK 973
D L L K + L+ H K
Sbjct: 294 MDMLEKLPKRNRRLSHPGHFWK 315
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-55
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED----RALKSFDT 725
I + EL E ++G G F VY+A G VAVK D + +++
Sbjct: 4 IDFAELT-----LEE--IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID 785
E ++ ++H N+I + C L+M++ G L + L + ++ +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ 113
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH--------LGDFGIAKLLDGVDPVT 837
+A + YLH PIIH DLK +N+L+ + + DFG+A+ T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----T 169
Query: 838 QTMTLA-TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
M+ A +MAPE + S DV+S+G+L+ E T P +
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 7e-55
Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 26/229 (11%)
Query: 667 LSR---ISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALK 721
+++ I + +L F L ++K G + VKV +++ R +
Sbjct: 1 MNKHSGIDFKQLN-----FLT--KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR 52
Query: 722 SFDTECEVMRRIRHRNLIKIVSSCSNPGFK--ALIMQYMPQGSLEKWLYSH-NYSLTIRQ 778
F+ EC +R H N++ ++ +C +P LI +MP GSL L+ N+ + Q
Sbjct: 53 DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQ 112
Query: 779 RLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838
+ +D+A + +LH I L +V++D+DM A + +
Sbjct: 113 AVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QS 165
Query: 839 TMTLATIGYMAPE---YGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+ ++APE E S D++SF +L+ E TR P ++
Sbjct: 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-53
Identities = 104/476 (21%), Positives = 183/476 (38%), Gaps = 48/476 (10%)
Query: 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQ 119
T +L + +L + + ++ L I+FS+N L+ P + T+
Sbjct: 37 TDTVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP---LKNLTK 91
Query: 120 LESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179
L +++N+I + + N+++L + L NN ++ P L +L +L L N I
Sbjct: 92 LVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP---LKNLTNLNRLELSSNTI 146
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239
+ + + L +L+ L G N + L P + N + + + + N +S +
Sbjct: 147 SD-------ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD-ISVL 195
Query: 240 IYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299
L NLE+L N +S I P + + L L+ N + + L L L
Sbjct: 196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLA 251
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359
+NQ++ + L+ L L L N + + P + L T+L N +QL
Sbjct: 252 NNQISN---------LAPLSGLTKLTELKLGANQISNISP--LAGL-TALTNLELNENQL 299
Query: 360 SGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLE 419
P NL NL L+L N ++ P + L KLQ L +NK+ L L
Sbjct: 300 EDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLT 353
Query: 420 KLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSL 479
+N L + +N + P LANLT + L + + P + + I ++
Sbjct: 354 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW-TNAPVNYKANVSIPNTVKNVTGA 410
Query: 480 SGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSF 535
P I + + ++T N S Y + F G + Q
Sbjct: 411 L-IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 9e-52
Identities = 106/511 (20%), Positives = 195/511 (38%), Gaps = 53/511 (10%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
L S I+ ++ + + + +++ ++ Q+ + I
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGI 58
Query: 131 TGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPN 190
+ +++L I NN L+ P L LV + + N I P
Sbjct: 59 KS--IDGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP------ 107
Query: 191 EIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFL 250
+ NL NL L L N I + P + N +N+ + L N +S + + L +L+ L
Sbjct: 108 -LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSF 163
Query: 251 WKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQ 310
N ++ + P + N + L++SSN S + + L+ L +NQ++
Sbjct: 164 -GNQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD----- 213
Query: 311 GQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNL 370
+ L L L L+ N LK + ++ +L T+L + ++Q+S P L
Sbjct: 214 ----ITPLGILTNLDELSLNGNQLKDI--GTLASL-TNLTDLDLANNQISNLAP--LSGL 264
Query: 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNA 430
+ L L L N+++ P L L L L+LN N+L+ P + L+ L L N
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320
Query: 431 LQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNL 490
+ P +++LT L+ L F +N ++ S+ +L I + N +S P + NL
Sbjct: 321 ISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANL 374
Query: 491 EALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPI-PQSFGSLISLQSLDLSGN 549
+ L L + + N+ + +N I P + S D++ N
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPN---TVKNVTGALIAPATISDGGSYTEPDITWN 431
Query: 550 NISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580
S + S+ V G +
Sbjct: 432 LPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-50
Identities = 96/504 (19%), Positives = 182/504 (36%), Gaps = 35/504 (6%)
Query: 66 GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125
G + + SL++S N +L L+++ S+ ++ ++ GD S LE D+
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDL 81
Query: 126 SSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN 185
S N ++ S +SSLK + L N T L L +L LR+ I
Sbjct: 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR- 140
Query: 186 REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-YLPN 244
+ L +L L++ ++ + + ++ + L+ + + L L +
Sbjct: 141 ---RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQL----------Q 294
+ L L NL+ + ++ ++ + S L +F +L +
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 295 ILSLGDNQLTTGSSAQGQIFYS-SLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
N L + ++ + + +R L + L + L ++
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL-EKVKRIT 316
Query: 354 AGSSQLSGGIPVGFGNLSNLLVLSLVNN---ELAGAIPTVLGKLQKLQGLDLNSNKLK-- 408
+S++ +L +L L L N E G LQ L L+ N L+
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376
Query: 409 GFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
L L+ L +L +S N +P +R L+ S + +L+
Sbjct: 377 QKTGEILLTLKNLTSLDISRNT-FH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE 434
Query: 468 YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAF 527
+ D S N+L S L + L+ L ++ N+L +P + L + ++RN
Sbjct: 435 VL---DVSNNNLD-SFSLFLPRLQEL---YISRNKLK-TLPDA-SLFPVLLVMKISRNQL 485
Query: 528 QGPIPQSFGSLISLQSLDLSGNNI 551
+ F L SLQ + L N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-39
Identities = 87/512 (16%), Positives = 162/512 (31%), Gaps = 90/512 (17%)
Query: 73 SLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITG 132
+ SF ++P+ L +K +D S N ++ + + L+ + S++I
Sbjct: 9 VCDGRSRSF-TSIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT 64
Query: 133 EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI 192
A ++ SL+ + L +N LS S + L SL L L+GN + + +
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLG---VTSLF 119
Query: 193 GNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWK 252
NL NL+ L +G I + F L +L L +
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAG----------------------LTSLNELEIKA 157
Query: 253 NNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQ 312
+L S+ + + L L + + L+ ++ L L D L
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR------- 210
Query: 313 IFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSN 372
+S L + + S L L + S++ F + +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL-LKLLRYILELSEVE------FDDCTL 263
Query: 373 LLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQ 432
+ +E + ++ L + L + T LEK+ + N+ +
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 433 GQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEA 492
+ +L SL LD N + G +
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKN---------------------SACKGAWPS 362
Query: 493 LGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
L L L+ N L S+ + +L +L SLD+S N
Sbjct: 363 LQTLVLSQNHLR-----SMQK-----------------TGEILLTLKNLTSLDISRNTFH 400
Query: 553 GEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGP 584
+P S + ++ N+S G+ + + P
Sbjct: 401 -PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP 430
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-37
Identities = 70/385 (18%), Positives = 133/385 (34%), Gaps = 31/385 (8%)
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
+ +PS + +++L L N ++ I + + +L L S+ + + +
Sbjct: 12 GRSRSFT-SIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
F + L+ L L DN L++ + S L+ L L NP + + S+
Sbjct: 70 FYSLGSLEHLDLSDNHLSS-------LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 347 TSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405
T+L+ G+ + I F L++L L + L L ++ + L L+ +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 406 KLKGFIPTDLCKLEKLNTL-LSNNN--ALQGQIPTCLANLTSLRHLDFRSNSL------- 455
+ + L + L L + N Q + ++ L FR + L
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 456 NSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALG--------GLNLTGNQLSGYI 507
+ L + D +LN L P + LG L++ L +
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 508 PSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKS---LEKLSR 564
+ L+ + + + + L SL+ LDLS N + E K+
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 565 LVDFNVSFNGLEGEIPSGGPFVNFT 589
L +S N L +G +
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-33
Identities = 61/444 (13%), Positives = 136/444 (30%), Gaps = 52/444 (11%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYD-TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSF 117
+L G LS L LN+ GN + + + ++ L+ + + +
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
T L ++ + + ++ +I + + L + + L S+ L L
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDT 206
Query: 178 NITG------RIPNREIPNEIGNLHNLKILDLGGNNIAGLIP--------SMIFNNSNMV 223
N+ + P + + D N + L+ N +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 224 AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV 283
+ + L + + L + + + + ++ +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 284 PNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG 343
+ + + L+ L L +N + L+ LVL N L+ + +
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACK----GAWPSLQTLVLSQNHLR-SMQKTGE 381
Query: 344 NLS--TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLD 401
L +L + + +P + L+L + + + T Q L+ LD
Sbjct: 382 ILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLD 437
Query: 402 LNSNKLKGFIPTDLCKLEKLNTLLSNN---------------------NALQGQIPTCLA 440
+++N L L +L++L +S N N L+
Sbjct: 438 VSNNNLD-SFSLFLPRLQELY--ISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFD 494
Query: 441 NLTSLRHLDFRSNSLNSTIPSTFW 464
LTSL+ + +N + + P +
Sbjct: 495 RLTSLQKIWLHTNPWDCSCPRIDY 518
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-21
Identities = 53/267 (19%), Positives = 96/267 (35%), Gaps = 15/267 (5%)
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTS 348
+C + T I A ++ L L N + + + +
Sbjct: 3 SCDASGVCDGRSRSFT-------SIPSGLTAA---MKSLDLSFNKITYIGHGDLRAC-AN 51
Query: 349 LENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKL 407
L+ SS+++ I F +L +L L L +N L+ + G L L+ L+L N
Sbjct: 52 LQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
Query: 408 KGFIPTDLC-KLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWS 465
+ T L L L TL + N A LTSL L+ ++ SL + + S
Sbjct: 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170
Query: 466 LKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARN 525
++ I + L+ + L + L ++ L L L+ + S + + +
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
Query: 526 AFQGPIPQSFGSLISLQSLDLSGNNIS 552
+SF L+ L L + +
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-20
Identities = 47/306 (15%), Positives = 102/306 (33%), Gaps = 43/306 (14%)
Query: 2 LVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTL 61
L++L I F + + + S + V + + L +P L L
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 62 PPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMC--NSFTQ 119
L + + + + + + H++ L+ +D S N + + ++
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 120 LESFDVSSNKIT--GEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
L++ +S N + + ++ + +L S+ + N+ + C + L L
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDS--CQWPEKMRFLNLSST 420
Query: 178 NITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLP 237
I + I L++LD+ NN+
Sbjct: 421 GIR------VVKTCI--PQTLEVLDVSNNNLDSF-------------------------- 446
Query: 238 SSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILS 297
S++LP L+ L++ +N L + S ++++S N + F LQ +
Sbjct: 447 -SLFLPRLQELYISRNKLKTLPDAS--LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 298 LGDNQL 303
L N
Sbjct: 504 LHTNPW 509
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-50
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G F K T G + +K ++ ++F E +VMR + H N++K +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
I +Y+ G+L + S + QR+ D+AS + YLH S IIH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-------------TIGYMAPEYG 853
+N L+ ++ + DFG+A+L+ + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+ DV+SFGI++ E R +
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-49
Identities = 100/539 (18%), Positives = 180/539 (33%), Gaps = 66/539 (12%)
Query: 50 LSLPNLSLGGTLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS-G 107
L L + T+ NL L L++ + Y P+ + L + LS
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 108 SLPGDMCNSFTQLESFDVSSNKITG-EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCT-R 165
L + L D+S N+I + ++SLKSI +N + +L +
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 166 LPSLVQLRLLGNNITGRIPNREIPNEIGNLHN--LKILDLGGNNIAGLIPSMIFNNSNMV 223
+L L N++ + + + N L+ILD+ GN I N +
Sbjct: 173 GKTLSFFSLAANSLYS-RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 224 AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATI--LELSSNLFSG 281
S I ++ +N+ ++ + +++ L+LS
Sbjct: 232 QAF-----------SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280
Query: 282 LVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNS 341
L F + L++L+L N++ +I + L+VL L N L + ++
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKIN-------KIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 342 IGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLD 401
L + + ++ F L L L L +N L T + + + +
Sbjct: 334 FYGL-PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIF 387
Query: 402 LNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS 461
L+ NKL +P ++ LS N I L + L+ L N +S
Sbjct: 388 LSGNKLVT-LPKINLTANLIH--LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD 444
Query: 462 TFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI-----GNLKN 516
+L L L N L + + L +
Sbjct: 445 QT-----------------------PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 517 LDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGL 575
L L L N P F L +L+ L L+ N ++ + + + L ++S N L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-47
Identities = 103/578 (17%), Positives = 186/578 (32%), Gaps = 114/578 (19%)
Query: 39 TCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKII 98
+CS GR+A NL+ +P L+ L +S N + + +L+++
Sbjct: 1 SCSF-DGRIAFYRFCNLT---QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 99 DFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSF 158
+ S ++ + + L D+ S+KI P A + L +RL LS +
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 159 -PTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIF 217
L +L +L L N I + + G L++LK +D N I + +
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIR-SLY---LHPSFGKLNSLKSIDFSSNQIFLVCEHEL- 168
Query: 218 NNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEA------TI 271
+ L L N+L + I
Sbjct: 169 --------------------EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208
Query: 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331
L++S N ++ + F N + SL ++
Sbjct: 209 LDVSGNGWTVDITGNFSNAIS-------------------KSQAFSLILAHHIMGAGFGF 249
Query: 332 NPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL 391
+ +K N+ L+ S++ L L + + V
Sbjct: 250 HNIKDPDQNTFAGLA-----------------------RSSVRHLDLSHGFVFSLNSRVF 286
Query: 392 GKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFR 451
L+ L+ L+L NK+ L+ L L + N L + L + ++D +
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346
Query: 452 SNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGY----- 506
N + TF L+ + +D N+L+ I + ++ + L+GN+L
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL 401
Query: 507 ----------------IPSSIGNLKNLDWLALARNAFQG-PIPQSFGSLISLQSLDLSGN 549
I + + +L L L +N F Q+ SL+ L L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 550 NISGEIPKSLEK-----LSRLVDFNVSFNGLEGEIPSG 582
+ L LS L ++ N L +P G
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPG 498
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-20
Identities = 41/218 (18%), Positives = 77/218 (35%), Gaps = 17/218 (7%)
Query: 51 SLPNLSLGG----TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSL 105
+ + L + L L +L++ N+ + + + I S N L
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL 393
Query: 106 SGSLPGDMCNSFTQLESFDVSSNKITGEFPSAI-VNISSLKSIRLDNNSLSGSFPTDLCT 164
++ +S N++ + + L+ + L+ N S +
Sbjct: 394 VTLPKINL-----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 165 RLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVA 224
PSL QL L N + + L +L++L L N + L P + + + +
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 225 ILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS 262
+ L N L+ L + NLE L + +N L PD
Sbjct: 509 LSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDV 545
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 54/239 (22%), Positives = 98/239 (41%), Gaps = 33/239 (13%)
Query: 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDT 725
++ R ++ E +G G + V++ + G +VAVK+F+ ++++ S+
Sbjct: 1 SMQRTVARDIT-----LLE--CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFR 49
Query: 726 ECEV--MRRIRHRNLIKIVSSCSNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQR 779
E E+ +RH N++ ++S + LI Y GSL +L +L
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSC 107
Query: 780 LDIMIDVASALEYLH-----HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834
L I++ +AS L +LH I H DLK N+L+ + + D G+A +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 835 PVTQTMTLATIG---YMAPE------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+G YMAPE D+++FG+++ E R +
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-48
Identities = 69/328 (21%), Positives = 120/328 (36%), Gaps = 38/328 (11%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEV 729
+ E + L+G G + VYK +L + VAVKVF+ + +F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 730 MR--RIRHRNLIKIVSSCSNPGFKA-----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI 782
R + H N+ + + L+M+Y P GSL K+L ++ +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 783 MIDVASALEYLH------HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
V L YLH Y I H DL NVL+ +D + DFG++ L G V
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 837 TQ-------TMTLATIGYMAPEYGSEGI-------VSISGDVYSFGILMMETFTRRKPTN 882
+ TI YMAPE + D+Y+ G++ E F R T+
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TD 234
Query: 883 EMFTGEMSLKQWVAESLPGA---VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK 939
+ Q ++ G ++ ++ + + + + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 940 CSAEIPEERINVKDALADLKKIKKILTQ 967
C + E R+ + A + ++ I +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-48
Identities = 68/317 (21%), Positives = 110/317 (34%), Gaps = 40/317 (12%)
Query: 669 RISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECE 728
R ++Q + +G G + V+ G VAVKVF E+ S+ E E
Sbjct: 33 RTIAKQIQ-----MVK--QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETE 81
Query: 729 V--MRRIRHRNLIKIVSSCSNPGFK----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI 782
+ +RH N++ +++ LI Y GSL +L + +L + L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKL 139
Query: 783 MIDVASALEYLH-----HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837
S L +LH I H DLK N+L+ + + D G+A
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 838 QTMTLATIG---YMAPE--YGSEGIVSISG----DVYSFGILMMETFTRRKPTNEMFTGE 888
+G YM PE S D+YSFG+++ E R + +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 889 MSLKQWVAE--SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPE 946
+ V S V L R + + C+ + L +C A P
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKL--RPSFPNRW---SSDECLRQMGKLMTECWAHNPA 314
Query: 947 ERINVKDALADLKKIKK 963
R+ L K+ +
Sbjct: 315 SRLTALRVKKTLAKMSE 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-47
Identities = 90/408 (22%), Positives = 155/408 (37%), Gaps = 63/408 (15%)
Query: 169 LVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY 228
L L I P +L L ++ ++ ++ +++
Sbjct: 2 AATLATLPAPINQIFP-------DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVA 52
Query: 229 GNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG 288
G ++ + YL NLE L L N ++ I P + N + T L + +N + +
Sbjct: 53 GEKVA-SIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQ 107
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTS 348
N L+ L L ++ ++ S LA + L L N + + N+ T
Sbjct: 108 NLTNLRELYLNEDNISD---------ISPLANLTKMYSLNLGANHNLSDLSP-LSNM-TG 156
Query: 349 LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLK 408
L S++ P NL++L LSL N++ P L L L N++
Sbjct: 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212
Query: 409 GFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKY 468
P + + +LN+L NN + P LANL+ L L+ +N + S I +
Sbjct: 213 DITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI-SDINA------- 260
Query: 469 ILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528
+ +L L LN+ NQ+S S + NL L+ L L N
Sbjct: 261 ------------------VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG 300
Query: 529 GPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
+ G L +L +L LS N+I+ P L LS++ + + ++
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-42
Identities = 69/349 (19%), Positives = 146/349 (41%), Gaps = 37/349 (10%)
Query: 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQ 119
T L + L ++G + ++ L+ ++ + N ++ P ++ +
Sbjct: 35 TDVVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISPL---SNLVK 89
Query: 120 LESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179
L + + +NKIT SA+ N+++L+ + L+ +++S P L + L L N+
Sbjct: 90 LTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLA---NLTKMYSLNLGANHN 144
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239
+ + N+ L L + + + + P I N +++ ++ L N + +
Sbjct: 145 LS------DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPL 195
Query: 240 IYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299
L +L + N ++ I P + N + L++ +N + L P N QL L +G
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIG 251
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359
NQ++ +++ L++L + +N + + + NL + L + + ++QL
Sbjct: 252 TNQISD---------INAVKDLTKLKMLNVGSNQISDISV--LNNL-SQLNSLFLNNNQL 299
Query: 360 SGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLK 408
G L+NL L L N + P L L K+ D + +K
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-41
Identities = 80/389 (20%), Positives = 158/389 (40%), Gaps = 63/389 (16%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
+L+ + + S D + E + + + + ++ S+ G T LE +++
Sbjct: 20 DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA-SIQGI--EYLTNLEYLNLN 74
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
N+IT S + N+ L ++ + N ++ + L L +L +L L +NI+ P
Sbjct: 75 GNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQN-LTNLRELYLNEDNISDISP-- 127
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE 246
+ NL + L+LG N+ + + N + L
Sbjct: 128 -----LANLTKMYSLNLGANHNLSDLSP-LSN-----------------------MTGLN 158
Query: 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTG 306
L + ++ + + P I N ++ L L+ N + P + L + NQ+T
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD- 213
Query: 307 SSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG 366
+ +A L L + N + + P + NL + L G++Q+S I
Sbjct: 214 --------ITPVANMTRLNSLKIGNNKITDLSP--LANL-SQLTWLEIGTNQIS-DIN-A 260
Query: 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426
+L+ L +L++ +N+++ +VL L +L L LN+N+L + L L TL
Sbjct: 261 VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 427 NNNALQGQIPTCLANLTSLRHLDFRSNSL 455
+ N + P LA+L+ + DF + +
Sbjct: 319 SQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-46
Identities = 106/506 (20%), Positives = 177/506 (34%), Gaps = 90/506 (17%)
Query: 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNELWH-------------MRRLKIIDFSSNSLS 106
+P N+ + + + P R+ ++ ++ LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 107 GSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRL 166
SLP LES S N +T E P SLKS+ +DNN+L L
Sbjct: 85 -SLP----ELPPHLESLVASCNSLT-ELPE---LPQSLKSLLVDNNNL-----KALSDLP 130
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL 226
P L L + N + ++P E+ N LKI+D+ N++ L ++ I
Sbjct: 131 PLLEYLGVSNNQLE------KLP-ELQNSSFLKIIDVDNNSLKKLPDLP----PSLEFIA 179
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
N L LP LP L ++ N+L +PD + + +N+ L
Sbjct: 180 AGNNQLE-ELPELQNLPFLTAIYADNNSLKK-LPDLPLSLES---IVAGNNILEEL--PE 232
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
N L + +N L T L L + N L +P +L
Sbjct: 233 LQNLPFLTTIYADNNLLKTLPDLPPS-----------LEALNVRDNYLTD-LPELPQSL- 279
Query: 347 TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK 406
T L+ S LS P NL L+ +NE I ++ L+ L++++NK
Sbjct: 280 TFLDVSENIFSGLSELPP-------NLYYLNASSNE----IRSLCDLPPSLEELNVSNNK 328
Query: 407 LKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSL 466
L +P +LE+L S N + +L+ L N L P S+
Sbjct: 329 LI-ELPALPPRLERLI--ASFN-----HLAEVPELPQNLKQLHVEYNPLRE-FPDIPESV 379
Query: 467 KYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526
+ D +NS +P NL+ L++ N L P ++++L +
Sbjct: 380 E-----DLRMNSHLAEVPELPQNLKQ---LHVETNPLR-EFPDIPESVEDLR---MNSER 427
Query: 527 FQGPIPQSFGSLISLQSLDLSGNNIS 552
P + + L+ ++
Sbjct: 428 VVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-38
Identities = 91/430 (21%), Positives = 159/430 (36%), Gaps = 79/430 (18%)
Query: 166 LPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAI 225
L + +N+T E+P E N+ + + P M
Sbjct: 10 NTFLQEPLRHSSNLT------EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 226 L-------------LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATIL 272
L LS LP P+LE+L N+L+ +P+ + +
Sbjct: 64 RLRDCLDRQAHELELNNLGLS-SLPELP--PHLESLVASCNSLT-ELPELPQSLKSLLVD 119
Query: 273 ELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTN 332
+ S L P L+ L + +NQL L +L+++ +D N
Sbjct: 120 NNNLKALSDLPPL-------LEYLGVSNNQLEK---------LPELQNSSFLKIIDVDNN 163
Query: 333 PLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLG 392
LK +P+ + LE AG++QL +P NL L + NN L +P +
Sbjct: 164 SLK-KLPDLPPS----LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPL 215
Query: 393 KLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRS 452
L+ + +N L+ +L L L T+ ++NN L+ +P +L + L+ R
Sbjct: 216 SLES---IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNVRD 266
Query: 453 NSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP----LNIGN---------LEALGGLNLT 499
N L +P SL ++ + + LS P LN + +L LN++
Sbjct: 267 NYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 325
Query: 500 GNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
N+L +P+ L+ L + N +P+ +L+ L + N + E P
Sbjct: 326 NNKLI-ELPALPPRLERLI---ASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIP 376
Query: 560 EKLSRLVDFN 569
E + L +
Sbjct: 377 ESVEDLRMNS 386
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 20/129 (15%), Positives = 46/129 (35%), Gaps = 17/129 (13%)
Query: 465 SLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALAR 524
S ++ ++L+ +P+ N+++ ++ P G + + L
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 525 NAFQG------------PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSF 572
+ +P+ L+SL S N+++ E+P+ + L L+ N +
Sbjct: 68 CLDRQAHELELNNLGLSSLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 573 NGLEGEIPS 581
L P
Sbjct: 124 KALSDLPPL 132
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-45
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEV--MRRIRHRNLIKIVS 743
+G G F V++ G VAVK+F+ +E+R S+ E E+ +RH N++ ++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 744 SCSNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH----- 794
+ + L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPE 851
I H DLK N+L+ + + D G+A D +G YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 852 YGSEGIVSISG------DVYSFGILMMETFTRRKPTNEM 884
+ I D+Y+ G++ E R
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-42
Identities = 76/442 (17%), Positives = 147/442 (33%), Gaps = 34/442 (7%)
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLK 199
N + K ++ ++SL L ++ +L L GN ++ +I ++ L+
Sbjct: 8 NGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLS-QIS----AADLAPFTKLE 61
Query: 200 ILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGII 259
+L+L N + + + + S + + L N++ L P++E L NN+S +
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNNISRVS 115
Query: 260 PDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLA 319
+ L++N + L G ++Q L L N++ T + A A
Sbjct: 116 CSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA------ELAA 166
Query: 320 KCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLV 379
L L L N + + + L+ S++L+ + F + + + +SL
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVVF--AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR 222
Query: 380 NNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL-CKLEKLNTLLSNNNALQGQIPTC 438
NN+L I L Q L+ DL N D K +++ T+ ++
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQN 279
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGS----LPLNIGNLEALG 494
T + + L + + +L S GS L N
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
Query: 495 GLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGE 554
++ Q I + L + A + + L E
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIE 398
Query: 555 IPKSLEKLSRLVDFNVSFNGLE 576
+ + E+ S L E
Sbjct: 399 LQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 74/499 (14%), Positives = 157/499 (31%), Gaps = 34/499 (6%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
+ + SL L + + L++SGN +L +L++++ SSN L +L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
S + L + D+++N + ++ S++++ NN++S
Sbjct: 75 D---LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR---GQGK 122
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL-LY 228
+ L N IT + + G ++ LDL N I + + + +S+ + L L
Sbjct: 123 KNIYLANNKIT-MLR----DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 229 GNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG 288
N + + + L+ L L N L+ + +A+ T + L +N +
Sbjct: 178 YNFIY-DVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLI-EKALR 234
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTS 348
+ L+ L N G+ + RV + +K + + T
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRD--------FFSKNQRVQTVAKQTVKKLTGQNEEEC-TV 285
Query: 349 LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGK----LQKLQGLDLNS 404
+ G+ L L G+ L + + +D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 405 NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFW 464
+ + I + + TL AL Q+ L ++ +T
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 465 SLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALAR 524
L + A+ ++ ++ + + K LA
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLAL 465
Query: 525 NAFQGPIPQSFGSLISLQS 543
+ + + +L S
Sbjct: 466 ASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-37
Identities = 72/494 (14%), Positives = 155/494 (31%), Gaps = 62/494 (12%)
Query: 66 GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125
N + ++ +S L + +K +D S N LS + FT+LE ++
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNL 65
Query: 126 SSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN 185
SSN + + ++S+L+++ L+NN + PS+ L NNI+
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNIS----- 112
Query: 186 REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY--LP 243
+ K + L N I L S + + L N + + +
Sbjct: 113 -RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 244 NLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303
LE+L L N + + + ++ L+LSSN + + F + + +SL +N+L
Sbjct: 170 TLEHLNLQYNFIYDVKGQVVF--AKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKL 226
Query: 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI 363
+L + L L N +L +F++ + ++
Sbjct: 227 VL--------IEKALRFSQNLEHFDLRGNGFH----------CGTLRDFFSKNQRV---- 264
Query: 364 PVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKL-- 421
++ + + + + +L L
Sbjct: 265 ------------QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR 312
Query: 422 --NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSL 479
+ LLS + ++ N R +D + I + + ++ +L
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL 372
Query: 480 SGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAF-QGPIPQSFGSL 538
+ L G + + L L + + + Q
Sbjct: 373 DEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQN 431
Query: 539 ISLQSLDLSGNNIS 552
+++ D+ + +
Sbjct: 432 NAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-35
Identities = 64/399 (16%), Positives = 128/399 (32%), Gaps = 29/399 (7%)
Query: 188 IPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY-LPNLE 246
I N + KI + +++ + S+ + N+ + L GN LS + + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTG 306
L L N L + + + S L+L++N L+ ++ L +N ++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGP-----SIETLHAANNNISRV 114
Query: 307 SSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSG-GIPV 365
S ++GQ + + L N + + G + ++ +++
Sbjct: 115 SCSRGQ----------GKKNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFAE 163
Query: 366 GFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLL 425
+ L L+L N + + + KL+ LDL+SNKL F+ + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 426 SNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPL 485
NN L I L +L H D R N + K + ++
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 486 NIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG----PIPQSFGSLISL 541
N + L L A + QG + +
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338
Query: 542 QSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580
+ +D I + + + L+ ++
Sbjct: 339 REIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-31
Identities = 56/352 (15%), Positives = 104/352 (29%), Gaps = 24/352 (6%)
Query: 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301
+ + ++L + +A L+LS N S + +L++L+L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 302 QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSG 361
L L LR L L+ N ++ + S+E +A ++ +S
Sbjct: 69 VLYE---------TLDLESLSTLRTLDLNNNYVQ-----ELLVG-PSIETLHAANNNISR 113
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGF-IPTDLCKLEK 420
V + L NN++ G ++Q LDL N++ +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480
L L N + + L+ LD SN L + + F S + + N L
Sbjct: 171 LEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLIS 540
+ + + L +L GN KN +A+ + Q+
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 541 LQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADS 592
++L L + +G
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 49/245 (20%), Positives = 86/245 (35%), Gaps = 17/245 (6%)
Query: 340 NSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQG 399
+ I + S L + + N+ L L N L+ L KL+
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 400 LDLNSNKLKGFIP-TDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST 458
L+L+SN L + L L L+ L+NN L S+ L +N+++
Sbjct: 63 LNLSSNVLYETLDLESLSTLRTLD--LNNNY------VQELLVGPSIETLHAANNNISRV 114
Query: 459 IPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG-YIPSSIGNLKNL 517
S K I + N ++ L+ G + L+L N++ + L
Sbjct: 115 SCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 518 DWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577
+ L L N Q L++LDLS N ++ + + + + ++ N L
Sbjct: 172 EHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 578 EIPSG 582
I
Sbjct: 228 LIEKA 232
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 9e-20
Identities = 36/198 (18%), Positives = 65/198 (32%), Gaps = 12/198 (6%)
Query: 386 AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445
AI + + + + + LK + + + L + N L LA T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 446 RHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG 505
L+ SN L SL + +D + N + + ++ L+ N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 506 YIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG-EIPKSLEKLSR 564
+ S + + LA N G +Q LDL N I +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 565 LVDFNVSFNGLEGEIPSG 582
L N+ +N + ++
Sbjct: 171 LEHLNLQYNFIY-DVKGQ 187
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-40
Identities = 74/402 (18%), Positives = 135/402 (33%), Gaps = 56/402 (13%)
Query: 156 GSFPTDL---CTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLI 212
P C +I + + E L+N KI+ + + L
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 61
Query: 213 PSMIFNNSNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLSGIIPDSICNASEAT 270
+++ + + + L + + + Y ++ L++ N + + P N T
Sbjct: 62 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120
Query: 271 ILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330
+L L N S L F N +L LS+ +N L I + L+ L L
Sbjct: 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-------IEDDTFQATTSLQNLQLS 173
Query: 331 TNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTV 390
+N L V + +L ++ N L +
Sbjct: 174 SNRLTH----------------------------VDLSLIPSLFHANVSYNLL-----ST 200
Query: 391 LGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450
L ++ LD + N + +L L L +NN L L N L +D
Sbjct: 201 LAIPIAVEELDASHNSINVVRGPVNVELTILK--LQHNN-LT-DTAW-LLNYPGLVEVDL 255
Query: 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSS 510
N L + F ++ + + S N L +L L + L L+L+ N L ++ +
Sbjct: 256 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 313
Query: 511 IGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
L+ L L N+ + + +L++L LS N+
Sbjct: 314 QPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 71/383 (18%), Positives = 131/383 (34%), Gaps = 55/383 (14%)
Query: 207 NIAGLIPSMIFNNSNM-VAILLYGNHLS------GHLPSSIYLPNLENLFLWKNNLSGII 259
N+ P +SN+ + Y H+ I L N + + + + +
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 61
Query: 260 PDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLA 319
+ + + +L L+ + F +Q L +G N + +
Sbjct: 62 AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-------LPPHVFQ 114
Query: 320 KCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLV 379
L VLVL+ N L +P I F N L LS+
Sbjct: 115 NVPLLTVLVLERNDLS-SLPRGI------------------------FHNTPKLTTLSMS 149
Query: 380 NNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCL 439
NN L LQ L L+SN+L + + L N +S N + L
Sbjct: 150 NNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHAN--VSYNL------LSTL 201
Query: 440 ANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLT 499
A ++ LD NS+N L + N+L+ + N L ++L+
Sbjct: 202 AIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT-DTA-WLLNYPGLVEVDLS 256
Query: 500 GNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
N+L + ++ L+ L ++ N + + +L+ LDLS N++ + ++
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
Query: 560 EKLSRLVDFNVSFNGLEGEIPSG 582
+ RL + + N + +
Sbjct: 315 PQFDRLENLYLDHNSIV-TLKLS 336
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-36
Identities = 66/381 (17%), Positives = 128/381 (33%), Gaps = 57/381 (14%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
+ + + L+ + ++ L R++++++ + + +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
++ + N I P N+ L + L+ N LS S P + P L
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 143
Query: 170 VQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY 228
L + NN+ I ++ +L+ L L N + + S+I ++ +
Sbjct: 144 TTLSMSNNNLE------RIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---PSLFHANVS 194
Query: 229 GNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG 288
N LS L +E L N+++ ++ + E TIL+L N +
Sbjct: 195 YNLLS-TLAI---PIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLTDT--AWLL 245
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTS 348
N L + L N+L I Y K + L L + N L
Sbjct: 246 NYPGLVEVDLSYNELEK-------IMYHPFVKMQRLERLYISNNRLV------------- 285
Query: 349 LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLK 408
+ + + L VL L +N L + + +L+ L L+ N +
Sbjct: 286 -------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
Query: 409 GFIPTDLCKLEKLNTLLSNNN 429
+ L+ L LS+N+
Sbjct: 332 TLKLSTHHTLKNLT--LSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 79/393 (20%), Positives = 135/393 (34%), Gaps = 59/393 (15%)
Query: 115 NSFTQLESFDVSSNKITGEFPSAI--VNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQL 172
N +DV + T + + +++ K + N+++ P L + L
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74
Query: 173 RLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNH 231
L I EI H ++ L +G N I L P +F N
Sbjct: 75 NLNDLQIE------EIDTYAFAYAHTIQKLYMGFNAIRYL-PPHVFQN------------ 115
Query: 232 LSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCR 291
+P L L L +N+LS + N + T L +S+N + +TF
Sbjct: 116 ----------VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165
Query: 292 QLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLEN 351
LQ L L N+LT + S + L + N L + ++E
Sbjct: 166 SLQNLQLSSNRLTH-------VDLSLIPS---LFHANVSYNLLSTLAIP------IAVEE 209
Query: 352 FYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFI 411
A + ++ V L +L L +N L L L +DL+ N+L+ +
Sbjct: 210 LDASHNSINV---VRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIM 264
Query: 412 PTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILA 471
K+++L L +NN L + + +L+ LD N L + +
Sbjct: 265 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLEN 322
Query: 472 VDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS 504
+ NS+ L + L L L+ N
Sbjct: 323 LYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 352
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 58/390 (14%), Positives = 115/390 (29%), Gaps = 67/390 (17%)
Query: 59 GTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
G+ H + S +L G++ + L +R D + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----N 56
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLD--NNSLSGSFPTDLCTRLPSLVQLRLLG 176
+ + + + + + + L+ + L FP RL L + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDA 113
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL 236
+ E+P+ + L+ L L N + L
Sbjct: 114 AGLM------ELPDTMQQFAGLETLTLARNPLR-------------------------AL 142
Query: 237 PSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQI 295
P+SI L L L + +P+ + + LQ
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTD---------------ASGEHQGLVNLQS 187
Query: 296 LSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAG 355
L L + + +S+A + L+ L + +PL + +I +L LE
Sbjct: 188 LRLEWTGIRS--------LPASIANLQNLKSLKIRNSPLSA-LGPAIHHL-PKLEELDLR 237
Query: 356 SSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL 415
P FG + L L L + +P + +L +L+ LDL +P+ +
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297
Query: 416 CKLEKLNTLLSNNNALQGQIPTCLANLTSL 445
+L +L + +
Sbjct: 298 AQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 52/324 (16%), Positives = 99/324 (30%), Gaps = 27/324 (8%)
Query: 260 PDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLA 319
++S L + + ++ A
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAW-----------RQA 53
Query: 320 KCRYLRVLVLDTNPLKGVIPNSIGNL-STSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
++ LK + + + S L P LS+L +++
Sbjct: 54 NSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTI 111
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNAL------ 431
L +P + + L+ L L N L+ +P + L +L L + L
Sbjct: 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEP 169
Query: 432 --QGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGN 489
L +L+ L + ++P++ +L+ + ++ + LS +L I +
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
Query: 490 LEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
L L L+L G P G L L L + +P L L+ LDL G
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 550 NISGEIPKSLEKLSRLVDFNVSFN 573
+P + +L V +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 57/329 (17%), Positives = 109/329 (33%), Gaps = 28/329 (8%)
Query: 241 YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
+ ENL+ + D + + + N QI +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65
Query: 301 NQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLS 360
L + A L L + PL P+ L + L++ ++ L
Sbjct: 66 RALKATADLLED------ATQPGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM 117
Query: 361 GGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNS-NKLKGF--------I 411
+P + L L+L N L A+P + L +L+ L + + +L
Sbjct: 118 E-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 412 PTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILA 471
+ L L +L ++ +P +ANL +L+ L R++ L S + L +
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEE 233
Query: 472 VDFSLNSLSGSLPLNIGNLEALGGLNLTG-NQLSGYIPSSIGNLKNLDWLALARNAFQGP 530
+D + + P G L L L + L +P I L L+ L L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 531 IPQSFGSLISLQSLDLSGNNISGEIPKSL 559
+P L + + + ++ ++ +
Sbjct: 293 LPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 55/376 (14%), Positives = 110/376 (29%), Gaps = 72/376 (19%)
Query: 41 SIRHGRVAALSLPNLSLGG-----TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRL 95
S H + NL G + + + + N
Sbjct: 3 SSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNP 58
Query: 96 KIIDFSSNSLSGSLPGDMCN-SFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
+I + +L + + + + + ++ S + +FP +S L+ + +D L
Sbjct: 59 QIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPS 214
P + + L L L N + +P I +L+ L+ L + +P
Sbjct: 117 M-ELPDTMQ-QFAGLETLTLARNPLR------ALPASIASLNRLRELSIRACPELTELPE 168
Query: 215 MIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILEL 274
+ + L NL++L L + +P SI N L++
Sbjct: 169 PLASTDA--------------SGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKI 213
Query: 275 SSNLFSGLVPNTFGNCRQLQILSL-GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNP 333
++ S L + +L+ L L G L
Sbjct: 214 RNSPLSAL-GPAIHHLPKLEELDLRGCTALRN---------------------------- 244
Query: 334 LKGVIPNSIGNLSTSLENFY-AGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLG 392
P G L+ S L +P+ L+ L L L +P+++
Sbjct: 245 ----YPPIFGGR-APLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298
Query: 393 KLQKLQGLDLNSNKLK 408
+L + + +
Sbjct: 299 QLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 47/273 (17%), Positives = 83/273 (30%), Gaps = 24/273 (8%)
Query: 321 CRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN 380
L + + + N + N +N + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQW-QRHYNADRNRWHSAWRQA----NSNNPQIETRTG 65
Query: 381 NELAGAIPTVLGKLQ--KLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
L A +L L+L S L P +L L + + L ++P
Sbjct: 66 RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGG--- 495
+ L L N L +P++ SL + + LP + + +A G
Sbjct: 123 MQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
Query: 496 ------LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
L L + +P+SI NL+NL L + + + + L L+ LDL G
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239
Query: 550 NISGEIPKSLEKLSRLVDFNVS-FNGLEGEIPS 581
P + L + + L +P
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLL-TLPL 271
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 44/266 (16%), Positives = 88/266 (33%), Gaps = 46/266 (17%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L L ++ L P LS L + I LP+ + L+ + + N L +L
Sbjct: 86 LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-AL 142
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNIS---------SLKSIRLDNNSLSGSFPT 160
P + + +L + + E P + + +L+S+RL+ + S P
Sbjct: 143 PASIAS-LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 161 DLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNS 220
+ L +L L++ + ++ + I +L L+ LDL G
Sbjct: 201 SIA-NLQNLKSLKIRNSPLS------ALGPAIHHLPKLEELDLRGCT------------- 240
Query: 221 NMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLF 279
+ P L+ L L + +P I ++ L+L +
Sbjct: 241 -----------ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 280 SGLVPNTFGNCRQLQILSLGDNQLTT 305
+P+ I+ + +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 26/123 (21%), Positives = 43/123 (34%), Gaps = 6/123 (4%)
Query: 51 SLPNLSLGG----TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS 106
+L +L + L P + +L L L++ G + P LK + S
Sbjct: 207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 107 GSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRL 166
+LP D+ TQLE D+ PS I + + I + + L
Sbjct: 267 LTLPLDIHR-LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPVAR 324
Query: 167 PSL 169
P+
Sbjct: 325 PAE 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKI--VS 743
+G G+F V+ L A+ VAVK F E ++++ H N++++ V
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ P + ++M+ + G +L + L ++ L ++ D A+ +EYL S IH
Sbjct: 182 TQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLL-DGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
DL N L+ + V + DFG+++ DGV + + + + APE + G S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 863 DVYSFGILMMETFTR-RKP 880
DV+SFGIL+ ETF+ P
Sbjct: 297 DVWSFGILLWETFSLGASP 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
LG G+F +V G VAVK LQ L+ F+ E E+++ ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 741 IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 132
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT---IGYMAPEYGSE 855
IH DL N+L++++ +GDFG+ K+L D + I + APE +E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 856 GIVSISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 688 LGSGSFDNVYKATLA-----NGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLI 739
LG G F V G VAVK L+ + + E E++R + H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 740 KIVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
K C+ G LIM+++P GSL+++L + + ++Q+L + + ++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSE 855
S +H DL NVL++ + +GDFG+ K ++ + + + + APE +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 856 GIVSISGDVYSFGILMMETFT 876
I+ DV+SFG+ + E T
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 5e-38
Identities = 75/402 (18%), Positives = 139/402 (34%), Gaps = 49/402 (12%)
Query: 151 NNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG 210
++ P C +I + + E L+N KI+ + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 211 LIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEAT 270
+P+ + ++ +E L L + I + A
Sbjct: 66 -LPAALLDS----------------------FRQVELLNLNDLQIEEIDTYAFAYAHTIQ 102
Query: 271 ILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330
L + N L P+ F N L +L L N L++ + L L +
Sbjct: 103 KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-------LPRGIFHNTPKLTTLSMS 155
Query: 331 TNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTV 390
N L+ + ++ TSL+N S++L+ V + +L ++ N L +
Sbjct: 156 NNNLERIEDDTFQAT-TSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL-----ST 206
Query: 391 LGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450
L ++ LD + N + +L L L +NN L L N L +D
Sbjct: 207 LAIPIAVEELDASHNSINVVRGPVNVELTILK--LQHNN-LT-DTAW-LLNYPGLVEVDL 261
Query: 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSS 510
N L + F ++ + + S N L +L L + L L+L+ N L ++ +
Sbjct: 262 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 319
Query: 511 IGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
L+ L L N+ + + +L++L LS N+
Sbjct: 320 QPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-37
Identities = 73/384 (19%), Positives = 132/384 (34%), Gaps = 55/384 (14%)
Query: 206 NNIAGLIPSMIFNNSNM-VAILLYGNHLSG------HLPSSIYLPNLENLFLWKNNLSGI 258
N+ P +SN+ + Y H+ I L N + + + + +
Sbjct: 7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 66
Query: 259 IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318
+ + + +L L+ + F +Q L +G N + +
Sbjct: 67 PAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-------LPPHVF 119
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
L VLVL+ N L S L GI F N L LS+
Sbjct: 120 QNVPLLTVLVLERNDL----------------------SSLPRGI---FHNTPKLTTLSM 154
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
NN L LQ L L+SN+L + + L N +S N +
Sbjct: 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHAN--VSYNL------LST 206
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNL 498
LA ++ LD NS+N L + N+L+ + N L ++L
Sbjct: 207 LAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT-DTA-WLLNYPGLVEVDL 261
Query: 499 TGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKS 558
+ N+L + ++ L+ L ++ N + + +L+ LDLS N++ + ++
Sbjct: 262 SYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 319
Query: 559 LEKLSRLVDFNVSFNGLEGEIPSG 582
+ RL + + N + +
Sbjct: 320 QPQFDRLENLYLDHNSIV-TLKLS 342
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 67/407 (16%), Positives = 134/407 (32%), Gaps = 80/407 (19%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
+ + + L+ + ++ L R++++++ + + +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
++ + N I P N+ L + L+ N LS S P + P L
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYG 229
L + NN+ RI + +L+ L L N +
Sbjct: 150 TTLSMSNNNLE-RIE----DDTFQATTSLQNLQLSSNRLT-------------------- 184
Query: 230 NHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGN 289
H+ S+ +P+L + + N LS ++ L+ S N + +
Sbjct: 185 -----HVDLSL-IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE 233
Query: 290 CRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSL 349
L IL L N LT + L L + L N L+ ++ +
Sbjct: 234 ---LTILKLQHNNLTD---------TAWLLNYPGLVEVDLSYNELEKIMYHP-------- 273
Query: 350 ENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKG 409
F + L L + NN L A+ + L+ LDL+ N L
Sbjct: 274 -----------------FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL- 314
Query: 410 FIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
+ + + ++L L ++N++ + L+ +L++L N +
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
LG G+F +V G VAVK LQ L+ F+ E E+++ ++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 741 IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 163
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT---IGYMAPEYGSE 855
IH DL N+L++++ +GDFG+ K+L D + I + APE +E
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 856 GIVSISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 24/236 (10%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
LG G+F +V G VAVK LQ + F E ++++ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 741 IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
PG ++ L+M+Y+P G L +L H L + L + +EYL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSE 855
+H DL N+L++ + + DFG+AKLL V + + I + APE S+
Sbjct: 149 ----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 856 GIVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLPG-AVTEVVDA 909
I S DV+SFG+++ E FT K + + + A++ +++
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLEL 256
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 9/196 (4%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+GSG F V+ N VA+K ++E + + F E EVM ++ H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTPIIHCD 805
L+ ++M G L +L + L + +DV + YL IH D
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV----IHRD 129
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L N L+ ++ V + DFG+ + + + T T + + +PE S S DV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 866 SFGILMMETFTR-RKP 880
SFG+LM E F+ + P
Sbjct: 190 SFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-37
Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 26/255 (10%)
Query: 646 IRRRKRNKSLPE-----ENNSLNLATLSRISYHELQQATNGFGE------------SNLL 688
I R + SL + ++ L + T G + L
Sbjct: 133 ITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKL 192
Query: 689 GSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748
G G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 749 GFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ Y +H DL
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHRDL 306
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 867 FGILMMETFTR-RKP 880
FGIL+ E T+ R P
Sbjct: 367 FGILLTELTTKGRVP 381
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 13/229 (5%)
Query: 662 LNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANG----VSVAVKVFN-LQE 716
L+ A L+ + + ++G G F VY + + A+K + + E
Sbjct: 3 LDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE 62
Query: 717 DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-GFKALIMQYMPQGSLEKWLYSHNYSLT 775
+ +++F E +MR + H N++ ++ P G +++ YM G L +++ S + T
Sbjct: 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 776 IRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835
++ + + VA +EYL +H DL N +LD+ + DFG+A+ + +
Sbjct: 123 VKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179
Query: 836 VTQTMTLAT---IGYMAPEYGSEGIVSISGDVYSFGILMMETFTR-RKP 880
+ + + A E + DV+SFG+L+ E TR P
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 688 LGSGSFDNVYKATLANG----VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIK 740
+G G F +V++ + ++VA+K + D + F E MR+ H +++K
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 741 IVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYS 798
++ + NP + +IM+ G L +L YSL + + +++AL YL +
Sbjct: 81 LIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF- 137
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H D+ NVL+ + LGDFG+++ ++ + I +MAPE +
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 859 SISGDVYSFGILMMETFTR-RKP 880
+ + DV+ FG+ M E KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-37
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG+G F V+ AT VAVK ++++F E VM+ ++H L+K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYL-HHGYSTPIIH 803
+ +I ++M +GSL +L S S + + +D +A + ++ Y IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IH 307
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL+ N+L+ +V + DFG+A++++ + + I + APE + G +I D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 864 VYSFGILMMETFTR-RKP 880
V+SFGIL+ME T R P
Sbjct: 368 VWSFGILLMEIVTYGRIP 385
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 59/205 (28%), Positives = 84/205 (40%), Gaps = 18/205 (8%)
Query: 688 LGSGSFDNVYKATL----ANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIK 740
LG GSF V + VSVAVK L + A+ F E M + HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYST 799
+ P K ++ + P GSL L H + + VA + YL +
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT---IGYMAPEYGSEG 856
IH DL N+LL + +GDFG+ + L D M + APE
Sbjct: 143 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPESLKTR 199
Query: 857 IVSISGDVYSFGILMMETFTR-RKP 880
S + D + FG+ + E FT ++P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG+G F V VA+K+ ++E + F E +VM + H L+++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTPIIHCD 805
+I +YM G L +L + +Q L++ DV A+EYL + +H D
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF----LHRD 145
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L N L++D V + DFG+++ + + + + + + PE S D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 866 SFGILMMETFTR-RKP 880
+FG+LM E ++ + P
Sbjct: 206 AFGVLMWEIYSLGKMP 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS- 746
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYL-HHGYSTPIIHC 804
P + +I +YM GSL +L + + LTI + LD+ +A + ++ Y IH
Sbjct: 80 EPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY----IHR 133
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 865 YSFGILMMETFTR-RKP 880
+SFGIL+ E T R P
Sbjct: 194 WSFGILLTEIVTHGRIP 210
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-37
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 663 NLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANG-----VSVAVKVFNLQED 717
N A L + E + + +LGSG+F VYK + VA+K L+E
Sbjct: 5 NQALLRILKETEFK-----KIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREA 55
Query: 718 ---RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL 774
+A K E VM + + ++ +++ C + LI Q MP G L ++ H ++
Sbjct: 56 TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI 114
Query: 775 TIRQRLDIMIDVASALEYL-HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
+ L+ + +A + YL +H DL NVL+ + DFG+AKLL
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 834 DPVTQTMTLAT-IGYMAPEYGSEGIVSISGDVYSFGILMMETFTR-RKP 880
+ I +MA E I + DV+S+G+ + E T KP
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKI--VSS 744
LGSG F V VAVK+ ++E + F E + M ++ H L+K V S
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKM--IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTPIIH 803
P + ++ +Y+ G L +L SH L Q L++ DV + +L H + IH
Sbjct: 74 KEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF----IH 127
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL N L+D D+ + DFG+ + + V+ T + + APE S D
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 864 VYSFGILMMETFTR-RKP 880
V++FGILM E F+ + P
Sbjct: 188 VWAFGILMWEVFSLGKMP 205
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 92/469 (19%), Positives = 160/469 (34%), Gaps = 25/469 (5%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
I++ S N +S L S ++L +S N+I S L+ + L +N L
Sbjct: 23 TTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPS 214
C +L L L N +P I E GN+ LK L L ++
Sbjct: 82 V-KIS---CHPTVNLKHLDLSFNAFD-ALP---ICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 215 MIFNNSNMVAILLYGNHLSGHLP----SSIYLPNLENLFLWKNNLSGIIPDSICNASEAT 270
I + + +L+ G +L +F I+ S+ +
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 271 ILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRV--LV 328
+ + L +LQ N F L + V
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 329 LDTNPLKGVIPNSIGNLS-TSLENFYA---GSSQLSGGIPVGFGNLSNLLVLSLVNNELA 384
+ L+G + + S TSL+ S + SN+ + + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 385 GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQ--GQIPTCLANL 442
K+ LD ++N L + + L +L TL+ N L+ +I +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 443 TSLRHLDFRSNSLNSTIPS-TFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGN 501
SL+ LD NS++ K +L+++ S N L+ ++ + + L+L N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431
Query: 502 QLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNN 550
++ IP + L+ L L +A N + F L SLQ + L N
Sbjct: 432 KIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 81/490 (16%), Positives = 156/490 (31%), Gaps = 58/490 (11%)
Query: 97 IIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSG 156
++D S N L +P D+ T L ++S N I+ + S I+++S L+ + + +N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 157 SFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMI 216
+ L L L N + +I NLK LDL N L
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLV------KIS--CHPTVNLKHLDLSFNAFDALPICKE 110
Query: 217 FNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSS 276
F N + L+ L L +L I + + + +L +
Sbjct: 111 FGN----------------------MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 277 NLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKG 336
+ + SL T I S+ L + +
Sbjct: 149 ETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHF--ILDVSVKTVANLELSNIKCVLEDN 204
Query: 337 VIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK 396
+ L+ N + L+ + + ++ +
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLN------NIETTWNSFIRILQLVWHTTVWYF-----S 253
Query: 397 LQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
+ + L L+ L+ ++ +++ +F +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 457 STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIG---N 513
+ L +DFS N L+ ++ N G+L L L L NQL +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQ 372
Query: 514 LKNLDWLALARNAFQ-GPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSF 572
+K+L L +++N+ SL SL++S N ++ I + L R+ ++
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430
Query: 573 NGLEGEIPSG 582
N ++ IP
Sbjct: 431 NKIK-SIPKQ 439
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 69/436 (15%), Positives = 138/436 (31%), Gaps = 30/436 (6%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
L V L L++S N + LK +D S N+ + +
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLK-SIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
QL+ +S+ + I +++ K + L P L + + N
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 178 NITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS---- 233
I + + + L N + + + +N L N++
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 234 --GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNAS-----EATILELSSNLFSGLVPNT 286
+ ++ + + L G + + S +I ++ S++F
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
+ + I + + + +K L N L + + G+L
Sbjct: 296 YEIFSNMNIKNFTVSGTR-------MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL- 347
Query: 347 TSLENFYAGSSQLS--GGIPVGFGNLSNLLVLSLVNNELAGAIPT-VLGKLQKLQGLDLN 403
T LE +QL I + +L L + N ++ + L L+++
Sbjct: 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF 463
SN L I L ++ L ++N ++ IP + L +L+ L+ SN L S F
Sbjct: 408 SNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF 464
Query: 464 WSLKYILAVDFSLNSL 479
L + + N
Sbjct: 465 DRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 76/407 (18%), Positives = 131/407 (32%), Gaps = 28/407 (6%)
Query: 66 GNLSFLVSLNISGNSFYDTLP--NELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESF 123
L L++S N+F D LP E +M +LK + S+ L S + +
Sbjct: 87 HPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145
Query: 124 DVSSNKITGEFPSAIVNISSLK-SIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN-NITG 181
+ E P + + ++ I N + +L +
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 182 RIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL---LYGNHLSGHLPS 238
I ++ L L L I + + L G L
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 239 ---SIYLPNLENLFLW--KNNLSGIIPDSICNA-SEATILELSSNLFSGLVPNTFGNCRQ 292
+L+ L + +++ G I S I + + +
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325
Query: 293 LQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS--TSLE 350
L +N LT + + L L+L N LK + + SL+
Sbjct: 326 FLHLDFSNNLLTD-------TVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQ 377
Query: 351 NFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKG 409
+ +S G +LL L++ +N L I L +++ LDL+SNK+K
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK- 434
Query: 410 FIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
IP + KLE L L +N L+ LTSL+ + +N +
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 32/120 (26%), Positives = 48/120 (40%), Gaps = 7/120 (5%)
Query: 470 LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529
VD S N L +P ++ LN++ N +S S I +L L L ++ N Q
Sbjct: 3 FLVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 530 PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFT 589
F L+ LDLS N + L L ++SFN + +P F N +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFD-ALPICKEFGNMS 115
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 72/365 (19%), Positives = 135/365 (36%), Gaps = 64/365 (17%)
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152
+++D N + +L D SF LE +++ N ++ P A N+ +L+++ L +N
Sbjct: 32 TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGL 211
L P + T L +L +L + N I + + + +L+NLK L++G N++
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIV------ILLDYMFQDLYNLKSLEVGDNDLV-Y 142
Query: 212 IPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATI 271
I F+ L +LE L L K NL+ I +++ + +
Sbjct: 143 ISHRAFSG----------------------LNSLEQLTLEKCNLTSIPTEALSHLHGLIV 180
Query: 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331
L L + + +F +L++L + + + L L +
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP-------NCLYGLNLTSLSITH 233
Query: 332 NPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL 391
L V + +L L L+L N ++ ++L
Sbjct: 234 CNLTAVPYLA-------------------------VRHLVYLRFLNLSYNPISTIEGSML 268
Query: 392 GKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFR 451
+L +LQ + L +L P L L L + N L + ++ +L L
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328
Query: 452 SNSLN 456
SN L
Sbjct: 329 SNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 68/358 (18%), Positives = 122/358 (34%), Gaps = 42/358 (11%)
Query: 199 KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLS 256
+ + +P I + + L N + L P+LE L L +N +S
Sbjct: 14 RAVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS 69
Query: 257 GIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYS 316
+ P + N L L SN + F L L + +N++ +
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI-------LLDY 122
Query: 317 SLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLV 375
L+ L + N L + + L SLE L+ IP +L L+V
Sbjct: 123 MFQDLYNLKSLEVGDNDLVYISHRAFSGL-NSLEQLTLEKCNLT-SIPTEALSHLHGLIV 180
Query: 376 LSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQI 435
L L + + +L +L+ L+++ + + L +L + L +
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AV 239
Query: 436 PTC-LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALG 494
P + +L LR L+ N +++ S L L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSML------------------------HELLRLQ 275
Query: 495 GLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
+ L G QL+ P + L L L ++ N F S+ +L++L L N ++
Sbjct: 276 EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-33
Identities = 69/335 (20%), Positives = 121/335 (36%), Gaps = 36/335 (10%)
Query: 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGS 307
+ + + P+ I +E +L+L N L + F + L+ L L +N ++
Sbjct: 16 VLCHRKRFVAV-PEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-- 70
Query: 308 SAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGF 367
+ + LR L L +N LK +IP + F
Sbjct: 71 -----VEPGAFNNLFNLRTLGLRSNRLK-LIPLGV------------------------F 100
Query: 368 GNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSN 427
LSNL L + N++ + + L L+ L++ N L L L L
Sbjct: 101 TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE 160
Query: 428 NNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI 487
L L++L L L R ++N+ +F L + ++ S ++ N
Sbjct: 161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220
Query: 488 GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547
L L++T L+ ++ +L L +L L+ N L+ LQ + L
Sbjct: 221 LYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280
Query: 548 GNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
G ++ P + L+ L NVS N L +
Sbjct: 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEES 314
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 18/296 (6%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
+ L L ++ N P ++ L+ + SN L +P + + L D+S
Sbjct: 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDIS 112
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
NKI ++ +LKS+ + +N L + L SL QL L N+T IP
Sbjct: 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIP-- 168
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILL--YGNHLSGHLPSSIYLPN 244
+ +LH L +L L NI I F + +L + +L P+ +Y N
Sbjct: 169 --TEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
L +L + NL+ + ++ + L LS N S + + +LQ + L QL
Sbjct: 226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285
Query: 305 TGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLS 360
+ + YLRVL + N L + + ++ +LE S+ L+
Sbjct: 286 V-------VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV-GNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 25/131 (19%), Positives = 58/131 (44%), Gaps = 4/131 (3%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNE-LWHMRRLKIIDFSSNSLSGS 108
L + + T+ P+ L SL+I+ + +P + H+ L+ ++ S N +S +
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 109 LPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPS 168
+ G M + +L+ + ++ P A ++ L+ + + N L+ + + + +
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGN 321
Query: 169 LVQLRLLGNNI 179
L L L N +
Sbjct: 322 LETLILDSNPL 332
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 688 LGSGSFDNVYKATLAN-----GVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLI 739
LG G F V G VAVK L+ D + + E +++R + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 740 KIVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
K C + G + L+M+Y+P GSL +L H S+ + Q L + + YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH--- 151
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-DGVDP-VTQTMTLATIGYMAPEYGSE 855
+ IH DL NVLLD+D + +GDFG+AK + +G + + + + + APE E
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 856 GIVSISGDVYSFGILMMETFT 876
+ DV+SFG+ + E T
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-36
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F V+ T VA+K + ++F E +VM+++RH L+++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLH-HGYSTPIIH 803
S ++ +YM +GSL +L L + Q +D+ +AS + Y+ Y +H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 386
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL+ N+L+ +++V + DFG+A+L++ + + I + APE G +I D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 864 VYSFGILMMETFTR-RKP 880
V+SFGIL+ E T+ R P
Sbjct: 447 VWSFGILLTELTTKGRVP 464
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-36
Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 688 LGSGSFDNVYKATLANG---VSVAVKVFNLQEDRALKS---FDTECEVMRRIRHRNLIKI 741
LG G+F +V + + VA+KV L++ E ++M ++ + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTP 800
+ C L+M+ G L K+L + + +++ V+ ++YL +
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSEGIV 858
+H DL NVLL + A + DFG++K L D ++ + + APE +
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 859 SISGDVYSFGILMMETFTR-RKP 880
S DV+S+G+ M E + +KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-36
Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 686 NLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVS 743
+ LG G + VY+ ++VAVK L+ED ++ F E VM+ I+H NL++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
C+ +I ++M G+L +L N ++ L + ++SA+EYL I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H +L N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 863 DVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G F +V G VAVK ++ D ++F E VM ++RH NL++++
Sbjct: 27 QTIGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 746 S-NPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYL-HHGYSTPII 802
G ++ +YM +GSL +L S L L +DV A+EYL + + +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----V 139
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DL NVL+ +D VA + DFG+ K TQ + + APE E S
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 863 DVYSFGILMMETFTR-RKP 880
DV+SFGIL+ E ++ R P
Sbjct: 196 DVWSFGILLWEIYSFGRVP 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 686 NLLGSGSFDNVYKATLANG----VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNL 738
++G G F VY TL + + AVK L + F TE +M+ H N+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 739 IKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ ++ C L ++ YM G L ++ + ++ T++ + + VA ++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--- 145
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT---IGYMAPEYGS 854
S +H DL N +LD+ + DFG+A+ + + + + +MA E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 855 EGIVSISGDVYSFGILMMETFTR 877
+ DV+SFG+L+ E TR
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTR 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 688 LGSGSFDNVYKATL-----ANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLI 739
LGSG F V+K + + V +KV +++ ++ ++ + + H +++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYS 798
+++ C + L+ QY+P GSL + H +L + L+ + +A + YL HG
Sbjct: 79 RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM- 136
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT---IGYMAPEYGSE 855
+H +L NVLL + DFG+A LL D Q + I +MA E
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESIHF 191
Query: 856 GIVSISGDVYSFGILMMETFTR-RKP 880
G + DV+S+G+ + E T +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 65/198 (32%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI--VSSC 745
+G G F +V G VAVK ++ D ++F E VM ++RH NL+++ V
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYL-HHGYSTPIIH 803
G ++ +YM +GSL +L S L L +DV A+EYL + + +H
Sbjct: 258 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VH 312
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL NVL+ +D VA + DFG+ K TQ + + APE E S D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 864 VYSFGILMMETFTR-RKP 880
V+SFGIL+ E ++ R P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 688 LGSGSFDNVYKATLANG----VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIK 740
LG G F VY+ N ++VAVK ++ + F +E +M+ + H +++K
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 741 IVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYS 798
++ P + +IM+ P G L +L + SL + + + + A+ YL
Sbjct: 78 LIGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 134
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H D+ N+L+ LGDFG+++ ++ D ++T I +M+PE +
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 859 SISGDVYSFGILMMETFTR-RKP 880
+ + DV+ F + M E + ++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 19/277 (6%)
Query: 617 KSKATKIVLRYILPAIATTMVVVALFIILIRRRKRNKSLPEENNS--LNLATLSRISYHE 674
S A I++ P + + L L ++ + N+ ++L+ L+
Sbjct: 19 ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78
Query: 675 LQQATNGFGESNL-----LGSGSFDNVYKATLANG----VSVAVKVFN-LQEDRALKSFD 724
+Q G + +G G F VY TL + + AVK N + + + F
Sbjct: 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 138
Query: 725 TECEVMRRIRHRNLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYSLTIRQRLDIM 783
TE +M+ H N++ ++ C L ++ YM G L ++ + ++ T++ +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV---TQTM 840
+ VA +++L S +H DL N +LD+ + DFG+A+ + + +T
Sbjct: 199 LQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTR 877
+ +MA E + DV+SFG+L+ E TR
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 688 LGSGSFDNVYKATL----ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIK 740
+GSG V L V VA+K L+ +R + F +E +M + H N+I+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGY 797
+ V + ++ +YM GSL+ +L +H+ TI Q + ++ V + + YL GY
Sbjct: 115 LEGVVTRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT---IGYMAPEYGS 854
+H DL NVL+D ++V + DFG++++L+ DP T I + APE +
Sbjct: 173 ----VHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 855 EGIVSISGDVYSFGILMMETFTR-RKP 880
S + DV+SFG++M E +P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 688 LGSGSFDNVYKATLANG-VSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G + VY+ ++VAVK L+ED ++ F E VM+ I+H NL++++ C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYL-HHGYSTPIIH 803
+ +I ++M G+L +L N ++ L + ++SA+EYL + IH
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IH 134
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL N L+ ++ + + DFG+++L+ G I + APE + SI D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 864 VYSFGILMMETFTR-RKP 880
V++FG+L+ E T P
Sbjct: 195 VWAFGVLLWEIATYGMSP 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 688 LGSGSFDNVYKATLANG-----VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLI 739
+G+G F VYK L V VA+K L+ ++ F E +M + H N+I
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 740 KI--VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHG 796
++ V S P +I +YM G+L+K+L + ++ Q + ++ +A+ ++YL +
Sbjct: 110 RLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-DGVDPVTQTM-TLATIGYMAPEYGS 854
Y +H DL N+L++ ++V + DFG++++L D + T I + APE S
Sbjct: 168 Y----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 855 EGIVSISGDVYSFGILMMETFTR-RKP 880
+ + DV+SFGI+M E T +P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-35
Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 688 LGSGSFDNVYKATLANG----VSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIV 742
+G G F +V++ + ++VA+K D + F E MR+ H +++K++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 743 SSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTP 800
+ NP + +IM+ G L +L +SL + + +++AL YL +
Sbjct: 458 GVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF--- 512
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
+H D+ NVL+ + LGDFG+++ ++ + I +MAPE + +
Sbjct: 513 -VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 861 SGDVYSFGILMMETFTR-RKP 880
+ DV+ FG+ M E KP
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP 592
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-35
Identities = 47/203 (23%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 688 LGSGSFDNVYKATLANG---VSVAVKVFNLQEDRALKS---FDTECEVMRRIRHRNLIKI 741
LG G+F +V + + VA+KV L++ E ++M ++ + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTP 800
+ C L+M+ G L K+L + + +++ V+ ++YL +
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSEGIV 858
+H +L NVLL + A + DFG++K L D ++ + + APE +
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 859 SISGDVYSFGILMMETFTR-RKP 880
S DV+S+G+ M E + +KP
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 688 LGSGSFDNVYKATLANG-----VSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLI 739
LGSG+F VYK + VA+K L+E +A K E VM + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYS 798
+++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT-IGYMAPEYGSEGI 857
+H DL NVL+ + DFG+AKLL + I +MA E I
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 858 VSISGDVYSFGILMMETFTR-RKP 880
+ DV+S+G+ + E T KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVS 743
+G GSF VYK V VA ++ + F E E+++ ++H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 744 SCSNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
S + L+ + M G+L+ +L + I+ + L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 800 PIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPEYGSE 855
PIIH DLK +N+ + +GD G+A L + A IG +MAPE E
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK------RASFAKAVIGTPEFMAPEMYEE 204
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEM 884
S DVY+FG+ M+E T P +E
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSEC 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 688 LGSGSFDNVYKATL----ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIK 740
+G+G F V L +SVA+K L+ ++ + F E +M + H N+I+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGY 797
+ V + S P ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-DGVDPV-TQTMTLATIGYMAPEYGSE 855
+H DL N+L++ ++V + DFG+ ++L D + T I + +PE +
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 856 GIVSISGDVYSFGILMMETFTR-RKP 880
+ + DV+S+GI++ E + +P
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKV--FNLQEDRALKS-FDTECEVMRRIRHRNLIKIV 742
L+G G +VY+A VA+K+ L D ++ E R++ +++ I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPI 801
G + M+ + L L L + + I+ + SAL+ H G
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG----A 155
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYMAPEYGSEGIVSI 860
H D+KP N+L+ D A+L DFGIA +TQ T+ T+ YMAPE SE +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGE 888
D+Y+ ++ E T P + G+
Sbjct: 215 RADIYALTCVLYECLTGSPP----YQGD 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 41/286 (14%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKV--FNLQEDRA-LKSFDTECEVMRRIRHRNLIKIV 742
LG G VY A + VA+K +E LK F+ E ++ H+N++ ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPI 801
L+M+Y+ +L +++ SH L++ ++ + +++ H I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR----I 132
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYMAPEYGSEGIVSI 860
+H D+KP N+L+D + + DFGIAK L +TQT L T+ Y +PE
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGE----MSLKQWVAESLPGAVTEVVDANLLSRED 916
D+YS GI++ E P F GE +++K + +S+P T+V + +
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKD--IPQSL 244
Query: 917 EEDADDFATKKTCISYIMSLALKCSAEIPEER-INVKDALADLKKI 961
+ L+ + + R +++ DL +
Sbjct: 245 SN-----------------VILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 688 LGSGSFDNVYKATLANG----VSVAVKVF--NLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G F +V +A L V VAVK+ ++ ++ F E M+ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 742 VSSCSNPGFKA------LIMQYMPQGSLEKWLYSH-----NYSLTIRQRLDIMIDVASAL 790
V K +I+ +M G L +L + ++L ++ + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMA 849
EYL S IH DL N +L +DM + DFG+++ + D + + ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTR 877
E ++ + ++ DV++FG+ M E TR
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 688 LGSGSFDNVYKATLANG----VSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKI 741
LG G F +V + L + VAVK L R ++ F +E M+ H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 742 VSSCSNPGFKA-----LIMQYMPQGSLEKWLYSH-----NYSLTIRQRLDIMIDVASALE 791
+ C + +I+ +M G L +L + ++ L M+D+A +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ-TMTLATIGYMAP 850
YL + +H DL N +L DDM + DFG++K + D Q + + ++A
Sbjct: 162 YLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTR 877
E ++ + + DV++FG+ M E TR
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 688 LGSGSFDNVYKATLANG---VSVAVKVF--NLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LGSG+F V K +VAVK+ + E VM+++ + +++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTPI 801
C + L+M+ G L K+L + + + ++++ V+ ++YL +
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNF---- 138
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSEGIVS 859
+H DL NVLL A + DFG++K L + QT + + APE + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 860 ISGDVYSFGILMMETFTR-RKP 880
DV+SFG+LM E F+ +KP
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 53/314 (16%), Positives = 113/314 (35%), Gaps = 26/314 (8%)
Query: 259 IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318
I + N + I +++ + + + + ++ L L N L+ QI + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-------QISAADL 54
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
A L +L L +N L + + +L ++L ++ + ++ L
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESL-STLRTLDLNNNYVQ-----ELLVGPSIETLHA 106
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPT 437
NN ++ + + Q + + L +NK+ D ++ L L N
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 438 CLANLTSLRHLDFRSNSLNSTIPSTFW-SLKYILAVDFSLNSLSGSLPLNIGNLEALGGL 496
A+ +L HL+ + N + + LK + D S N L+ + + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTL---DLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 497 NLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ-GPIPQSFGSLISLQSLDLSGNNISGEI 555
+L N+L I ++ +NL+ L N F G + F +Q++
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 556 PKSLEKLSRLVDFN 569
+ + L +
Sbjct: 279 NEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 59/380 (15%), Positives = 119/380 (31%), Gaps = 73/380 (19%)
Query: 188 IPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLEN 247
I N + KI + +++ + S+ + N++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQS-----------------------AWNVKE 38
Query: 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGS 307
L L N LS I + ++ +L LSSN+ + + L+ L L +N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ--- 93
Query: 308 SAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGF 367
L + L N + + S G +N Y +++++ +
Sbjct: 94 ---------ELLVGPSIETLHAANNNIS-RVSCSRG---QGKKNIYLANNKITMLRDLDE 140
Query: 368 GNLSNLLVLSLVNNELAG-AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426
G S + L L NE+ + L+ L+L N + + + KL TL
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDL 198
Query: 427 NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLN 486
++N L + + + + R+N L +
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-------------------------LIEKA 232
Query: 487 IGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDL 546
+ + L +L GN KN +A+ + + ++ +L
Sbjct: 233 LRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGH 290
Query: 547 SGNNISGEIPK-SLEKLSRL 565
G ++P ++L L
Sbjct: 291 YGAYCCEDLPAPFADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 60/315 (19%), Positives = 117/315 (37%), Gaps = 27/315 (8%)
Query: 135 PSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGN 194
N + K ++ ++SL L ++ +L L GN ++ +I ++
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLS-QIS----AADLAP 56
Query: 195 LHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNN 254
L++L+L N + + + + S + + L N++ L P++E L NN
Sbjct: 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNN 110
Query: 255 LSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIF 314
+S + + L++N + L G ++Q L L N++ T + A
Sbjct: 111 ISRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA----- 162
Query: 315 YSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLL 374
A L L L N + + + L+ S++L+ + F + + +
Sbjct: 163 -ELAASSDTLEHLNLQYNFIY-DVKGQVVF--AKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 375 VLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL-CKLEKLNTLLSNNNALQG 433
+SL NN+L I L Q L+ DL N D K +++ T+
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 434 QIPTCLANLTSLRHL 448
+ +L H
Sbjct: 277 GQNEEECTVPTLGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 56/362 (15%), Positives = 110/362 (30%), Gaps = 56/362 (15%)
Query: 91 HMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLD 150
+ R KI + +SL + S ++ D+S N ++ + + + L+ + L
Sbjct: 8 NGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 151 NNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG 210
+N L + + L +L L L N + E+ +++ L NNI+
Sbjct: 67 SNVLYETLDLE---SLSTLRTLDLNNNYVQ----------ELLVGPSIETLHAANNNIS- 112
Query: 211 LIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEAT 270
+ S +N++L N ++ + S
Sbjct: 113 ------------------------RVSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 271 ILELSSNLFSGL-VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVL 329
L+L N + + L+ L+L N + L+ L L
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD---------VKGQVVFAKLKTLDL 198
Query: 330 DTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELA-GAIP 388
+N L + + + +++L I NL L N G +
Sbjct: 199 SSNKLA-FMGPEFQSA-AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 389 TVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHL 448
K Q++Q + + K + C + L + L +L H
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL--GHYGAYCCEDLPAPFADRLIALGHH 313
Query: 449 DF 450
Sbjct: 314 HH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 47/259 (18%), Positives = 99/259 (38%), Gaps = 21/259 (8%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
+ + SL L + + L++SGN +L +L++++ SSN L +L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
S + L + D+++N + ++ S++++ NN++S
Sbjct: 75 D---LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR---GQGK 122
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAILLY 228
+ L N IT + + G ++ LDL N I + + + + + + L
Sbjct: 123 KNIYLANNKIT-MLR----DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 229 GNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG 288
N + + + L+ L L N L+ + +A+ T + L +N +
Sbjct: 178 YNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI-EKALR 234
Query: 289 NCRQLQILSLGDNQLTTGS 307
+ L+ L N G+
Sbjct: 235 FSQNLEHFDLRGNGFHCGT 253
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 41/211 (19%), Positives = 84/211 (39%), Gaps = 13/211 (6%)
Query: 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426
N + + + ++ L A+ ++ ++ LDL+ N L DL KL L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 427 NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLN 486
++N L + L +L++LR LD +N + I + + N++S + +
Sbjct: 66 SSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS 117
Query: 487 IGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG-PIPQSFGSLISLQSLD 545
+ + L N+++ G + +L L N + S +L+ L+
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 546 LSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
L N I ++ + ++L ++S N L
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 41/244 (16%), Positives = 86/244 (35%), Gaps = 20/244 (8%)
Query: 62 PPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLE 121
+ +LS L +L+++ N EL ++ + ++N++S + + +
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC---SRGQGKK 123
Query: 122 SFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITG 181
+ +++NKIT S ++ + L N + +L +L L L N I
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 182 RIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI- 240
++ ++ LK LDL N +A + + + + I L N L + ++
Sbjct: 183 -----DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 241 YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
+ NLE+ L N + + ++ L C + G
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 301 NQLT 304
Sbjct: 294 YCCE 297
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 36/198 (18%), Positives = 65/198 (32%), Gaps = 12/198 (6%)
Query: 386 AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445
AI + + + + + LK + + + L + N L LA T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 446 RHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG 505
L+ SN L SL + +D + N + + ++ L+ N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 506 YIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG-EIPKSLEKLSR 564
+ S + + LA N G +Q LDL N I +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 565 LVDFNVSFNGLEGEIPSG 582
L N+ +N + ++
Sbjct: 171 LEHLNLQYNFIY-DVKGQ 187
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 58/317 (18%), Positives = 120/317 (37%), Gaps = 45/317 (14%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
++D +N ++ + + L + + +NKI+ P A + L+ + L N L
Sbjct: 54 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNI-AGLI 212
P + +L +LR+ N IT ++ + L+ + +++LG N + + I
Sbjct: 113 K-ELPEKM---PKTLQELRVHENEIT------KVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 213 PSMIFNN-SNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATI 271
+ F + I + +++ +P + P+L L L N ++ + S+ +
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAK 220
Query: 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331
L LS N S + + N L+ L L +N+L LA +Y++V+ L
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG--------LADHKYIQVVYLHN 272
Query: 332 NPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAI--PT 389
N + + N P ++ +SL +N + P+
Sbjct: 273 NNISAIGSNDFCP-------------------PGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 390 VLGKLQKLQGLDLNSNK 406
+ + L + K
Sbjct: 314 TFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 67/331 (20%), Positives = 111/331 (33%), Gaps = 47/331 (14%)
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
L +P + P+ L L N ++ I N L L +N S + P
Sbjct: 38 CSDLGLE-KVPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
F +L+ L L NQL ++ + L+ L + N + V + L
Sbjct: 96 FAPLVKLERLYLSKNQLK---ELPEKMP-------KTLQELRVHENEITKVRKSVFNGL- 144
Query: 347 TSLENFYAGSSQL-SGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNS 404
+ G++ L S GI G F + L + + + + IP L L L L+
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 405 NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFW 464
NK+ L L L L + N++ LAN LR L +N L +P
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLA 260
Query: 465 SLKYILAVDFSLNSLSG------SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLD 518
KYI V N++S P + G++L N +
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-------------- 306
Query: 519 WLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
+ + + F+ + ++ L
Sbjct: 307 YWEIQPSTFRC--------VYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/318 (19%), Positives = 105/318 (33%), Gaps = 65/318 (20%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
NL L +L + N P + +L+ + S N L LP M L+ V
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVH 129
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSL-SGSFPTDLCTRLPSLVQLRLLGNNITGRIPN 185
N+IT S ++ + + L N L S + L +R+ NIT IP
Sbjct: 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188
Query: 186 REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNL 245
G +L L L GN I + + L NL
Sbjct: 189 -------GLPPSLTELHLDGNKITK-VDAASLKG----------------------LNNL 218
Query: 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305
L L N++S + S+ N L L++N VP + + +Q++ L +N ++
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277
Query: 306 --GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI 363
+ + + A + L +NP++ ++
Sbjct: 278 IGSNDFCPPGYNTKKAS---YSGVSLFSNPVQ----------YWEIQ------------- 311
Query: 364 PVGFGNLSNLLVLSLVNN 381
P F + + L N
Sbjct: 312 PSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 52/270 (19%), Positives = 95/270 (35%), Gaps = 21/270 (7%)
Query: 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL 383
+L L N + + NL +L ++++S P F L L L L N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 384 AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIP-TCLAN 441
+P + + LQ L ++ N++ + L ++ + L N I
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 442 LTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTG 500
+ L ++ ++ + SL + N ++ + L L L L+
Sbjct: 170 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKIT-KVDAASLKGLNNLAKLGLSF 225
Query: 501 NQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKS-- 558
N +S S+ N +L L L N +P +Q + L NNIS I +
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDF 283
Query: 559 -----LEKLSRLVDFNVSFNGLE-GEIPSG 582
K + ++ N ++ EI
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 11/215 (5%)
Query: 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNA 430
+ +L L NN++ L+ L L L +NK+ P L KL L + N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 431 LQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIG-- 488
L+ ++P + +L+ L N + S F L ++ V+ N L S + G
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-SSGIENGAF 167
Query: 489 -NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547
++ L + + ++ IP G +L L L N S L +L L LS
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 548 GNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
N+IS SL L + +++ N L ++P G
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 23/90 (25%), Positives = 36/90 (40%), Gaps = 6/90 (6%)
Query: 496 LNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGE 554
+ + L +P + + LD L N F +L +L +L L N IS
Sbjct: 36 VQCSDLGLE-KVPKDLPPDTALLD---LQNNKITEIKDGDFKNLKNLHTLILINNKISKI 91
Query: 555 IPKSLEKLSRLVDFNVSFNGLEGEIPSGGP 584
P + L +L +S N L+ E+P P
Sbjct: 92 SPGAFAPLVKLERLYLSKNQLK-ELPEKMP 120
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 10/200 (5%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+LG G++ VY L+N V +A+K ++ R + E + + ++H+N+++ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHHGYSTPIIH 803
S GF + M+ +P GSL L S L ++ + L+YLH I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 804 CDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSI 860
D+K +NVL++ V + DFG +K L G++P T+T T T+ YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204
Query: 861 SGDVYSFGILMMETFTRRKP 880
+ D++S G ++E T + P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 45/216 (20%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 688 LGSGSFDNVYKATL--------ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLI 739
LG G+F ++K + V +KV + +SF +M ++ H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 740 KI--VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHG 796
V C + L+ +++ GSL+ +L + + I +L++ +A+A+ +L +
Sbjct: 76 LNYGVCVCGDENI--LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 797 YSTPIIHCDLKPNNVLLD--------DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYM 848
IH ++ N+LL + L D GI+ + D + I ++
Sbjct: 134 L----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----ILQERIPWV 184
Query: 849 APE---YGSEGIVSISGDVYSFGILMMETFTR-RKP 880
PE ++++ D +SFG + E + KP
Sbjct: 185 PPECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-33
Identities = 45/259 (17%), Positives = 93/259 (35%), Gaps = 44/259 (16%)
Query: 687 LLGSGSFDNVYKA--TLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKI-- 741
+ G +Y A NG V +K D A E + + + H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 742 -----VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-H 795
G+ ++M+Y+ SL++ L + + + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI 201
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYMAPEYGS 854
G +++ DLKP N++L ++ + L D G + T G+ APE
Sbjct: 202 G----LVYNDLKPENIMLTEEQLK-LIDLGAVS------RINSFGYLYGTPGFQAPEIVR 250
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-----SLPGAVTEVVDA 909
G + D+Y+ G + G + E + ++
Sbjct: 251 TGPTVAT-DIYTVGRTLAALTLDLPT----RNGR--YVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 910 NLLSREDEE---DADDFAT 925
+ + + A++ +
Sbjct: 304 -AIDPDPRQRFTTAEEMSA 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 76/415 (18%), Positives = 132/415 (31%), Gaps = 88/415 (21%)
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
+V + +T P + + ++ + +N+L T L P L L + GN
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNL-----TSLPALPPELRTLEVSGN 91
Query: 178 NITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLP 237
+T +P L L I ++ L S + + ++GN L+ LP
Sbjct: 92 QLT------SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLP 137
Query: 238 SSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILS 297
P L+ L + N L+ +P L +N + L P LQ LS
Sbjct: 138 VLP--PGLQELSVSDNQLAS-LPALPSE---LCKLWAYNNQLTSL-PMLPSG---LQELS 187
Query: 298 LGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSS 357
+ DNQL + +P L L + +
Sbjct: 188 VSDNQLAS--------------------------------LPTLPSEL-YKLWAYNNRLT 214
Query: 358 QLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCK 417
L S L L + N L ++P + +L++ L ++ N+L +P
Sbjct: 215 SLP-------ALPSGLKELIVSGNRL-TSLPVLPSELKE---LMVSGNRLTS-LPMLPSG 262
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLN 477
L L+ + N L ++P L +L+S ++ N L+ + +
Sbjct: 263 LLSLS--VYRNQ-LT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318
Query: 478 S---LSGSLPLNIGNLEALGGLNLTGNQLSGYIP----SSIGNLKNLDWLALARN 525
S P L L + P G N D +L +
Sbjct: 319 RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLD 373
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-32
Identities = 76/355 (21%), Positives = 130/355 (36%), Gaps = 75/355 (21%)
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
+ + L+ LP + ++ L + NNL+ +P LE+S N + L P
Sbjct: 47 VGESGLT-TLPDCL-PAHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLTSL-PVL 99
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
+L I S L S L L + N L +P L
Sbjct: 100 PPGLLELSIFSNPLTHLPALPSG--------------LCKLWIFGNQLT-SLPVLPPGL- 143
Query: 347 TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK 406
+ +QL+ +P L L NN+L ++P + LQ+L ++ N+
Sbjct: 144 ---QELSVSDNQLAS-LPALPSELCKLWAY---NNQLT-SLPMLPSGLQEL---SVSDNQ 192
Query: 407 LKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSL 466
L +PT +L KL NN L +P A + L+ L N L S
Sbjct: 193 LA-SLPTLPSELYKLWAY---NNRLT-SLP---ALPSGLKELIVSGNRLTS--------- 235
Query: 467 KYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526
LP+ L+ L ++GN+L+ +P L +L + RN
Sbjct: 236 ----------------LPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSLS---VYRNQ 272
Query: 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
+P+S L S +++L GN +S ++L +++ ++ + S
Sbjct: 273 LTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 76/389 (19%), Positives = 145/389 (37%), Gaps = 58/389 (14%)
Query: 195 LHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNN 254
+ +L++G + + L P + + + +++ N+L+ LP+ P L L + N
Sbjct: 39 NNGNAVLNVGESGLTTL-PDCLPAH--ITTLVIPDNNLT-SLPALP--PELRTLEVSGNQ 92
Query: 255 LSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIF 314
L+ +P E +I L L L + NQLT+
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTSLPVLPPG-- 142
Query: 315 YSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLL 374
L+ L + N L +P L L +A ++QL+ +P+ L L
Sbjct: 143 ---------LQELSVSDNQLA-SLPALPSEL-CKL---WAYNNQLTS-LPMLPSGLQEL- 186
Query: 375 VLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQ 434
S+ +N+LA ++PT+ +L KL +N+L +P L++L + N L
Sbjct: 187 --SVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPSGLKELIV---SGNRLT-S 235
Query: 435 IPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALG 494
+P + L+ L N L +++P L + N L+ LP ++ +L +
Sbjct: 236 LP---VLPSELKELMVSGNRL-TSLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSET 287
Query: 495 GLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ---GPIPQSFGSLISLQSLDLSGNNI 551
+NL GN LS ++ + + + F P+ +L + L
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347
Query: 552 SG----EIPKSLEKLSRLVDFNVSFNGLE 576
+ + F++ + L
Sbjct: 348 GEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 79/406 (19%), Positives = 128/406 (31%), Gaps = 65/406 (16%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L +P+ +L +LP L +L +SGN +LP + L I L
Sbjct: 66 LVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP 120
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
+ L + N++T P L+ + + +N L+ S P L
Sbjct: 121 --------SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLA-SLPALPS----EL 163
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYG 229
+L N +T +P L+ L + N +A L P++ S + + Y
Sbjct: 164 CKLWAYNNQLT------SLPMLPS---GLQELSVSDNQLASL-PTLP---SELYKLWAYN 210
Query: 230 NHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGN 289
N L+ LP+ L+ L + N L+ +P L +S N + L P
Sbjct: 211 NRLT-SLPALP--SGLKELIVSGNRLTS-LPVLPSE---LKELMVSGNRLTSL-PMLPSG 262
Query: 290 CRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSL 349
L LS+ NQLT SL + L+ NPL TS
Sbjct: 263 ---LLSLSVYRNQLTR--------LPESLIHLSSETTVNLEGNPLS-ERTLQALREITSA 310
Query: 350 ENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKG 409
+ + + + + L A + N
Sbjct: 311 PGY--SGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAF 368
Query: 410 F-IPTDLCKLEKLNTLLSNNNALQGQIPTCLANL---TSLRHLDFR 451
L + E + + QI + LA L +LR F
Sbjct: 369 SLFLDRLSETEN----FIKDAGFKAQISSWLAQLAEDEALRANTFA 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 72/398 (18%), Positives = 140/398 (35%), Gaps = 33/398 (8%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
+ +++S NS + ++ L+ + + + + + L + N+
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 131 TGEFPSAIVNISSLKSIRLDNNSLSGSF-PTDLCTRLPSLVQLRLLGNNITGRIPNREIP 189
A +++L+ + L +L G+ + L SL L L NNI +I
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFF 150
Query: 190 NEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLF 249
N+ +LDL N + I N G H + + L ++
Sbjct: 151 L---NMRRFHVLDLTFNKVK-SICEEDLLN-------FQGKHF-----TLLRLSSITLQD 194
Query: 250 LWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTF---GNCRQLQILSLGDNQLTTG 306
+ + L + + T L+LS N F + F ++Q L L ++
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 307 SSAQGQIFYSSLAKCRY-------LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359
S + ++ L + + ++ + + T LE +++
Sbjct: 255 SFGHTNF--KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF-TDLEQLTLAQNEI 311
Query: 360 SGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL 418
+ I F L++LL L+L N L + L KL+ LDL+ N ++ L
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL 370
Query: 419 EKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
L L + N L+ LTSL+ + +N +
Sbjct: 371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 83/454 (18%), Positives = 136/454 (29%), Gaps = 79/454 (17%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
+ L +P + D+S N I ++ + L+ ++++ +
Sbjct: 13 YNAICINRGLH-QVP----ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG 67
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNI-AGLIP 213
+ L SL+ L+L N ++ L NL++L L N+ ++
Sbjct: 68 LVIRNNTFRGLSSLIILKLDYNQFL------QLETGAFNGLANLEVLTLTQCNLDGAVLS 121
Query: 214 SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSI-CNASEATIL 272
F L +LE L L NN+ I P S N +L
Sbjct: 122 GNFFKP----------------------LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 273 ELSSNLFSGLVPNTFGNC--RQLQILSLGDNQLTTGSSAQ-GQIFYSSLAKCRYLRVLVL 329
+L+ N + N + +L L L + G + K + L L
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219
Query: 330 DTNPLKGVIPNSIGNL-------STSLENFYAGSSQLSGGI-----PVGFGNL--SNLLV 375
N K + + S L N Y S F L S +
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT 279
Query: 376 LSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQI 435
L +++ + +V L+ L L N++ L L L + N L
Sbjct: 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID 339
Query: 436 PTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGG 495
NL L LD N + + +F L L
Sbjct: 340 SRMFENLDKLEVLDLSYNHIRALGDQSF------------------------LGLPNLKE 375
Query: 496 LNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQ 528
L L NQL +P I L +L + L N +
Sbjct: 376 LALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 67/342 (19%), Positives = 120/342 (35%), Gaps = 38/342 (11%)
Query: 270 TILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVL 329
++LS N + L +F + LQ L + I ++ L +L L
Sbjct: 33 NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL------VIRNNTFRGLSSLIILKL 86
Query: 330 DTNPLKGVIPNSIGNLSTSLENFYAGSSQL-SGGIPVG-FGNLSNLLVLSLVNNELAGAI 387
D N + + L +LE L + F L++L +L L +N +
Sbjct: 87 DYNQFLQLETGAFNGL-ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145
Query: 388 P-TVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKL---------NTLLS-NNNALQGQIP 436
P + +++ LDL NK+K DL + TL N L +
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 437 TCLANLTSLRHLDFRSNSLNSTIPSTFWSL-------------KYILAVDFSLNSLSGSL 483
TS+ LD N ++ F+ Y + F +
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 484 PLNIGNLEA--LGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSLIS 540
LEA + +L+ +++ + S+ + +L+ L LA+N +F L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 541 LQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
L L+LS N + + E L +L ++S+N + +
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 70/354 (19%), Positives = 118/354 (33%), Gaps = 61/354 (17%)
Query: 50 LSLPNLSLGGTLPPHV-GNLSFLVSLNISGNSFYDTLPNE-LWHMRRLKIIDFSSNSL-S 106
L + + G + + LS L+ L + N F L + L+++ + +L
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDG 117
Query: 107 GSLPGDMCNSFTQLESFDVSSNKITGEFPSAI-VNISSLKSIRLDNNSLSGSFPTDLCTR 165
L G+ T LE + N I P++ +N+ + L N + S +
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLN 176
Query: 166 LPS--LVQLRLLGNNITGRIPNREIPNEIGN---LHNLKILDLGGNNIAGLIPSMIF--- 217
LRL + + GN ++ LDL GN + F
Sbjct: 177 FQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI 236
Query: 218 -----------NNSNMVAIL-------------------------LYGNHLSGHLPSSI- 240
N+ NM + L + + L S+
Sbjct: 237 AGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVF 295
Query: 241 -YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299
+ +LE L L +N ++ I ++ + L LS N + F N +L++L L
Sbjct: 296 SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
N + + S L+ L LDTN LK V L TSL+ +
Sbjct: 356 YNHIRA-------LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL-TSLQKIW 401
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 44/260 (16%), Positives = 80/260 (30%), Gaps = 21/260 (8%)
Query: 341 SIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPT-VLGKLQKLQG 399
+ L + + ++ F L +L L + I L L
Sbjct: 24 QVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83
Query: 400 LDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQI--PTCLANLTSLRHLDFRSNSLNS 457
L L+ N+ L L L L G + LTSL L R N++
Sbjct: 84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK 143
Query: 458 TIPST-FWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKN 516
P++ F +++ +D + N + S+ L G + T L +
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVK-SICEED--LLNFQGKHFTLL-----------RLSS 189
Query: 517 LDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK---SLEKLSRLVDFNVSFN 573
+ + + S+ +LDLSGN + K +++ +S +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 574 GLEGEIPSGGPFVNFTADSF 593
G F + +F
Sbjct: 250 YNMGSSFGHTNFKDPDNFTF 269
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK---- 740
L+GSG F V+KA +G + +K ++A + E + + ++ H N++
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 72
Query: 741 ------------IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVA 787
SS S + M++ +G+LE+W+ L L++ +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT-IG 846
++Y+H S +I+ DLKP+N+ L D +GDFG+ L G
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK------NDGKRTRSKG 183
Query: 847 ---YMAPE------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
YM+PE YG E D+Y+ G+++ E E
Sbjct: 184 TLRYMSPEQISSQDYGKE------VDLYALGLILAELLHVCDTAFET 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVS 743
+G+GS+ K ++G + K + + + +E ++R ++H N+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 744 SCSNPGFKAL--IMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLH--HG 796
+ L +M+Y G L + L L +M + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----- 851
++H DLKP NV LD LGDFG+A++L+ +T + T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNRM 191
Query: 852 -YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
Y + D++S G L+ E P FT
Sbjct: 192 SYNEK------SDIWSLGCLLYELCALMPP----FTAF 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKV--FNLQEDRA-LKSFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L + VAVKV +L D + F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 743 SSCSNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
+ ++M+Y+ +L +++ +T ++ ++++ D AL + H +G
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG- 136
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT-MTLATIGYMAPEYGSE 855
IIH D+KP N+++ + DFGIA+ + D + VTQT + T Y++PE
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
V DVYS G ++ E T P FTG+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 44/181 (24%), Positives = 71/181 (39%), Gaps = 19/181 (10%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F V L +G A+K E + + E ++ R H N++++V+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYS 798
L++ + +G+L + LT Q L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA--------TIGYMAP 850
H DLKP N+LL D+ L D G ++ TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 851 E 851
E
Sbjct: 213 E 213
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 20/204 (9%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVS 743
+G GSF +G +K N+ + + E V+ ++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPII 802
S G ++M Y G L K + + Q LD + + AL+++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGSEG 856
H D+K N+ L D LGDFGIA++L+ + + T Y++PE Y +
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN-- 204
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
D+++ G ++ E T +
Sbjct: 205 ----KSDIWALGCVLYELCTLKHA 224
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNL 738
LG G+F VY+ ++ + VAVK L E ++ F E ++ + H+N+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH------NYSLTIRQRLDIMIDVASALEY 792
++ + + ++M+ M G L+ +L SL + L + D+A +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 793 L--HHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIG 846
L +H IH D+ N LL VA +GDFG+A+ + + +
Sbjct: 156 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+M PE EGI + D +SFG+L+ E F+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 36/217 (16%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNL 738
LG F VYK L +VA+K L++ + F E + R++H N+
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 739 IKI--VSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRLD 781
+ + V + P +I Y G L ++L +L +
Sbjct: 75 VCLLGVVTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 782 IMIDVASALEYL-HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQT 839
++ +A+ +EYL H +H DL NVL+ D + + D G+ + + D
Sbjct: 133 LVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+L I +MAPE G SI D++S+G+++ E F+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 58/295 (19%), Positives = 110/295 (37%), Gaps = 28/295 (9%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
++D +N +S L D L + + +NKI+ A + L+ + + N L
Sbjct: 56 TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGL-IP 213
P +L SLV+LR+ N I ++P L N+ +++GGN +
Sbjct: 115 V-EIPPNL---PSSLVELRIHDNRIR-KVP----KGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 214 SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILE 273
F+ + + + L+ +P + L L L N + I + + S+ L
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDL-PETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223
Query: 274 LSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNP 333
L N + + L+ L L +N+L+ + L + L+V+ L TN
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAG--------LPDLKLLQVVYLHTNN 275
Query: 334 LKGVIPNSIGNLSTSLENFYAGSSQLSG------GIPVG-FGNLSNLLVLSLVNN 381
+ V N + ++ Y L + F +++ L + N
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 28/309 (9%)
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
L +P I P+ L L N++S + D L L +N S +
Sbjct: 40 CSDLGLK-AVPKEI-SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA 97
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
F R+LQ L + N L + L L + N ++ V L
Sbjct: 98 FSPLRKLQKLYISKNHLV---EIPPNLP-------SSLVELRIHDNRIRKVPKGVFSGL- 146
Query: 347 TSLENFYAGSSQL-SGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405
++ G + L + G G + L L + +L IP L + L L L+ N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 406 KLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWS 465
K++ DL + KL L +N ++ L+ L +LR L +N L S +P+
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPD 262
Query: 466 LKYILAVDFSLNSLSGSLPLNI-------GNLEALGGLNLTGNQLSGYI--PSSIGNLKN 516
LK + V N+++ + +N G++L N + + P++ + +
Sbjct: 263 LKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321
Query: 517 LDWLALARN 525
+
Sbjct: 322 RLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 70/312 (22%), Positives = 109/312 (34%), Gaps = 71/312 (22%)
Query: 244 NLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303
+L + L + P I + + T+L+L +N S L + F + L L L +N++
Sbjct: 34 HLRVVQCSDLGLKAV-PKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI 363
+ I + + R L+ L + N L IP NL +SL +++ +
Sbjct: 91 SK-------IHEKAFSPLRKLQKLYISKNHLV-EIPP---NLPSSLVELRIHDNRIRK-V 138
Query: 364 PVG-FGNLSNLLVLSLVNNELA-GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKL 421
P G F L N+ + + N L KL L ++ KL G IP DL E L
Sbjct: 139 PKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETL 195
Query: 422 NTLLSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480
N L ++N +Q I L + L L N + +
Sbjct: 196 NELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS---------------- 238
Query: 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLIS 540
L L L+L N+LS +P L
Sbjct: 239 --------FLPTLRELHLDNNKLSR-------------------------VPAGLPDLKL 265
Query: 541 LQSLDLSGNNIS 552
LQ + L NNI+
Sbjct: 266 LQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 34/218 (15%)
Query: 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426
F L +L L LVNN+++ L+KLQ L ++ N L IP +L L L
Sbjct: 74 FKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRI 130
Query: 427 NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTI--PSTFWSLKYILAVDFSLNSLSGSLP 484
++N ++ + L ++ ++ N L ++ P F LK
Sbjct: 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK----------------- 173
Query: 485 LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSL 544
L L ++ +L+ IP + L+ L L N Q + L L
Sbjct: 174 --------LNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRL 222
Query: 545 DLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
L N I SL L L + ++ N L +P+G
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK A K F E E++ ++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRLDIMIDV 786
C + ++ +YM G L K+L +H L + Q L I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 787 ASALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLA 843
AS + YL H +H DL N L+ +++ +GDFG+++ + D T+
Sbjct: 143 ASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
I +M PE + DV+SFG+++ E FT
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNL 738
LG GSF VY+ VA+K + E R F E VM+ ++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH---------NYSLTIRQRLDIMIDVASA 789
++++ S +IM+ M +G L+ +L S ++ + + + ++A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYM 848
+ YL+ + +H DL N ++ +D +GDFG+ + + D L + +M
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTR 877
+PE +G+ + DV+SFG+++ E T
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNL 738
LG G F V KAT + +VAVK+ L+E L+ +E V++++ H ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH-----------------------NYSLT 775
IK+ +CS G LI++Y GSL +L +LT
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 776 IRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835
+ + ++ ++YL ++H DL N+L+ + + DFG+++ + D
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 836 -VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
V ++ + +MA E + I + DV+SFG+L+ E T
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G F V++A + + A+K L + A + E + + ++ H +++ ++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 745 C------------SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQR--LDIMIDVASAL 790
S + + MQ + +L+ W+ + L I + +A A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT------ 844
E+LH S ++H DLKP+N+ D V +GDFG+ +D + +T
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 845 --IG---YMAPE------YGSEGIVSISGDVYSFGILMME 873
+G YM+PE Y + D++S G+++ E
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHK------VDIFSLGLILFE 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 65/301 (21%), Positives = 117/301 (38%), Gaps = 33/301 (10%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKI--V 742
+LG G+ NV++ G A+KVFN R + E EV++++ H+N++K+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ K LIM++ P GSL L Y L + L ++ DV + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 800 PIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGS 854
I+H ++KP N++ D V L DFG A+ L + Q ++L T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPDMYE 188
Query: 855 EGIVSISG--------DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906
++ D++S G+ T P K+ + + + G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKIITGKPSGA 247
Query: 907 VDANLLSREDEEDADDFATKKTCISYIMSLALK-----CSAEIPEERINVKDALADLKKI 961
+ + D +S + + L E+ A+ I
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 962 K 962
Sbjct: 308 L 308
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRN 737
LG G+F V +A +VAVK+ L+E ++ +E +++ I H N
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 738 LIKIVSSCSNPGFKA-LIMQYMPQGSLEKWLYSH---------------NYSLTIRQRLD 781
++ ++ +C+ PG +I+++ G+L +L S LT+ +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTM 840
VA +E+L S IH DL N+LL + V + DFG+A+ + V +
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK + A + F E E++ ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSH--------------NYSLTIRQRLDIMIDVA 787
C+ ++ +YM G L ++L SH L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 788 SALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLAT 844
+ + YL H +H DL N L+ +V +GDFG+++ + D T+
Sbjct: 169 AGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
I +M PE + DV+SFG+++ E FT
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 688 LGSGSFDNVYKATLANG-------VSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHR 736
LG+G+F V +AT A G ++VAVK+ L+ ++ +E +V+ + H
Sbjct: 31 LGAGAFGKVVEAT-AYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH-----------------NYSLTIRQR 779
N++ ++ +C+ G +I +Y G L +L +L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 780 LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQ 838
L VA + +L S IH DL N+LL + + DFG+A+ + V +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + DV+S+GI + E F+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-30
Identities = 50/275 (18%), Positives = 89/275 (32%), Gaps = 56/275 (20%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIR-------- 734
+LG +AT G S V V E A+K E +R +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 735 --HRNLIKIVSSCSNPGFKALIMQY----------------MPQGSLE---KWLYSH--- 770
H I +P K +I Q +L+ + L SH
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 771 NYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
+ SL RL + + V L LH +G ++H L+P +++LD L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 830 LDGVDPVTQTMTLATIGYMAPE-----YGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
A A +++ + D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 885 FTGE--MSLKQWV---AESLPGAVTEVVDANLLSR 914
T + + +W+ +++P V +++ L
Sbjct: 317 NTDDAALGGSEWIFRSCKNIPQPVRALLEG-FLRY 350
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNL--IKI 741
+GSG V++ A+K NL+ +++ L S+ E + +++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTP 800
+ ++M+ L WL S+ +R ++ A+ +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE-------- 851
I+H DLKP N L+ D M+ L DFGIA + + T+ YM PE
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 852 ---YGSEGIVSISGDVYSFGILMMETFTRRKP 880
S+ +S DV+S G ++ + P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNL 738
LG G+F VY+ ++ + VAVK L E ++ F E ++ + H+N+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH------NYSLTIRQRLDIMIDVASALEY 792
++ + + ++++ M G L+ +L SL + L + D+A +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 793 L--HHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIG 846
L +H IH D+ N LL VA +GDFG+A+ + + +
Sbjct: 197 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+M PE EGI + D +SFG+L+ E F+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 46/222 (20%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI---- 741
+LG G+F V KA + A+K E++ L + +E ++ + H+ +++
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 742 ---------VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
+++ + M+Y G+L ++S N + + + + AL Y
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 793 LH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG----- 846
+H G IIH DLKP N+ +D+ +GDFG+AK + + + + G
Sbjct: 132 IHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 847 --------YMAPE-------YGSEGIVSISGDVYSFGILMME 873
Y+A E Y + D+YS GI+ E
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFE 223
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 94/473 (19%), Positives = 164/473 (34%), Gaps = 35/473 (7%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
K + S NS+S L + ++L +S N+I + L+ + + +N L
Sbjct: 54 TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPS 214
+ C + SL L L N+ +P + E GNL L L L L
Sbjct: 113 Q-NIS---CCPMASLRHLDLSFNDFD-VLP---VCKEFGNLTKLTFLGLSAAKFRQLDLL 164
Query: 215 MIFNNSNMVAIL-LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILE 273
+ + +L L H+ G S+ +PN L L + S + + L+
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 274 LSSNLFSGLVPNTFGN-----CRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLV 328
LS+ + R +L++ + T ++F R + L
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPVEYLN 282
Query: 329 LDTNPLKGVIPNSIGNLST----SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELA 384
+ + I S SL + + + + + + L ++
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342
Query: 385 GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQ--GQIPTCLANL 442
L+ N + L++L TL+ N L+ ++ N+
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM 402
Query: 443 TSLRHLDFRSNSLNSTIPSTFWSLKYILAV-DFSLNSLSG----SLPLNIGNLEALGGLN 497
+SL LD NSLNS + + V + S N L+G LP + L+
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK------VKVLD 456
Query: 498 LTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNN 550
L N++ IP + +L+ L L +A N + F L SLQ + L N
Sbjct: 457 LHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-29
Identities = 85/487 (17%), Positives = 166/487 (34%), Gaps = 35/487 (7%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
++D+S+ +L+ +P D+ L +S N I+ I +S L+ +RL +N +
Sbjct: 34 SMVDYSNRNLT-HVPKDLPPRTKAL---SLSQNSISELRMPDISFLSELRVLRLSHNRIR 89
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSM 215
S + L L + N + I + +L+ LDL N+ L
Sbjct: 90 -SLDFHVFLFNQDLEYLDVSHNRLQ------NIS--CCPMASLRHLDLSFNDFDVLPVCK 140
Query: 216 IFNN-SNMVAILLYGNHLSGHLPSSIYLPNLENLFL--WKNNLSGIIPDSICNASEATIL 272
F N + + + L + +L + L ++ G +S+ + T+L
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVL 199
Query: 273 ELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTN 332
L + S + L L L + +L + + F S L + L + L
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 333 PLKGVIPNSIGNL--STSLENFYAGSSQLSGGIPVGFGN-----LSNLLVLSLVNNELAG 385
+ +E + ++ I L +L++ + N
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319
Query: 386 AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445
+ + ++ L+ + L N + + L L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 446 RHLDFRSNSLNSTIPSTFW---SLKYILAVDFSLNSL-SGSLPLNIGNLEALGGLNLTGN 501
+ L + N L ++ + +D SLNSL S + E++ LNL+ N
Sbjct: 380 QTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
Query: 502 QLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNN---ISGEIPKS 558
L+G + + + L L N IP+ L +LQ L+++ N + +
Sbjct: 439 MLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDR 495
Query: 559 LEKLSRL 565
L L +
Sbjct: 496 LTSLQYI 502
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 73/426 (17%), Positives = 135/426 (31%), Gaps = 36/426 (8%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
+L HV L L++S N + M L+ +D S N + T
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRL-QNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLT 146
Query: 119 QLESFDVSSNKIT-GEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
+L +S+ K + S + L + + G L +++ L N
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206
Query: 178 NITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG--- 234
++ + N +G+L L + L N L+ + + + H+
Sbjct: 207 SLF-SVQVNMSVNALGHLQ-LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 235 ---HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEAT-----ILELSSNLFSGLVPNT 286
L + +E L ++ ++ I SE I + + +F
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
+ ++ I L + S L N + L
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSS-------FTFLNFTQNVFTDSVFQGCSTL- 376
Query: 347 TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL----AGAIPTVLGKLQKLQGLDL 402
L+ + L N+ L ++ L + A + + L+L
Sbjct: 377 KRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 403 NSNKLKGFIPTDL-CKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS 461
+SN L G + L K++ L+ L NN + IP + +L +L+ L+ SN L S
Sbjct: 436 SSNMLTGSVFRCLPPKVKVLD--LHNNR-IM-SIPKDVTHLQALQELNVASNQLKSVPDG 491
Query: 462 TFWSLK 467
F L
Sbjct: 492 VFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-20
Identities = 64/371 (17%), Positives = 122/371 (32%), Gaps = 28/371 (7%)
Query: 235 HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294
H+P + P + L L +N++S + I SE +L LS N L + F + L+
Sbjct: 45 HVPKDL-PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103
Query: 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI-GNLSTSLENFY 353
L + N+L I +A LR L L N + GNL T L
Sbjct: 104 YLDVSHNRLQN-------ISCCPMAS---LRHLDLSFNDFDVLPVCKEFGNL-TKLTFLG 152
Query: 354 AGSSQLSGGIPVGFGNLS-NLLVLSLVNNELAGAIPTVLGKLQ-KLQGLDLNSNKLKGFI 411
+++ + +L + ++L LV+ + G L + L + N L
Sbjct: 153 LSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 412 PTD-LCKLEKL----NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST----IPST 462
+ L L L N + L +L ++ + +
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 463 FW--SLKYILAVDFSLNSL--SGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLD 518
FW ++Y+ + ++ + L++L ++ + ++
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 519 WLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGE 578
L+ + S S L+ + N + + + L RL + NGL+
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392
Query: 579 IPSGGPFVNFT 589
N +
Sbjct: 393 FKVALMTKNMS 403
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 38/252 (15%), Positives = 75/252 (29%), Gaps = 30/252 (11%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L++ L L+ ++ F + + I S + +
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-FI 344
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169
S + + + N T + L+++ L N L F L ++
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL--MTKNM 402
Query: 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYG 229
L L ++ + + ++ +L+L N + G +
Sbjct: 403 SSLETLDVSLNS-LNSHAYDRTCAWAESILVLNLSSNMLTGSVFR--------------- 446
Query: 230 NHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGN 289
LP P ++ L L N + IP + + L ++SN + F
Sbjct: 447 -----CLP-----PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDR 495
Query: 290 CRQLQILSLGDN 301
LQ + L DN
Sbjct: 496 LTSLQYIWLHDN 507
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 686 NLLGSGSFDNVYKATLANG---VSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNL 738
+++G G+F V KA + + A+K ++E + F E EV+ ++ H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRLDIM 783
I ++ +C + G+ L ++Y P G+L +L +L+ +Q L
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843
DVA ++YL IH DL N+L+ ++ VA + DFG+++ + V +TM
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRL 203
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MA E + + + + DV+S+G+L+ E +
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 686 NLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RH 735
LG+G+F V +AT + VAVK+ L+ ++ +E ++M + +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LKSTAHADEKEALMSELKIMSHLGQH 109
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH-------------NYSLTIRQRLDI 782
N++ ++ +C++ G +I +Y G L +L N + + R L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMT 841
VA + +L S IH D+ NVLL + VA +GDFG+A+ + + +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + ++ DV+S+GIL+ E F+
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 66/292 (22%), Positives = 118/292 (40%), Gaps = 36/292 (12%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVK---VFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
+G G F VY+A L +GV VA+K +F+L + +A E ++++++ H N+IK
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYST 799
+S ++++ G L + + + R + + SALE++H S
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS 859
++H D+KP NV + V LGD G+ + ++ T YM+PE E +
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919
D++S G L+ E + P F G+ +L ++
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP----FYGD-------KMNLYSLCKKIEQ----------- 252
Query: 920 ADDFA-TKKTCISYIM-SLALKCSAEIPEERINVKDALADLKKIKKILTQAL 969
D+ S + L C PE+R +V K++ +L
Sbjct: 253 -CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATL--------ANGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A VAVK+ L+ D + L +E E+M+ I +H
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L + L+ + +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQT 839
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D T
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATL--------ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++ ++ L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L + +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQT 839
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 24/212 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNL--IKI 741
+GSG V++ A+K NL+ +++ L S+ E + +++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTP 800
+ ++M+ L WL S+ +R ++ A+ +H HG
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE-------- 851
I+H DLKP N L+ D M+ L DFGIA + + + YM PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 852 ---YGSEGIVSISGDVYSFGILMMETFTRRKP 880
S+ +S DV+S G ++ + P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNL--IKI 741
+GSG V++ A+K NL+ +++ L S+ E + +++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTP 800
+ ++M+ L WL S+ +R ++ A+ +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE-------- 851
I+H DLKP N L+ D M+ L DFGIA + + T+ YM PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 852 ---YGSEGIVSISGDVYSFGILMMETFTRRKP 880
S+ +S DV+S G ++ + P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 56/245 (22%), Positives = 92/245 (37%), Gaps = 25/245 (10%)
Query: 647 RRRKRNKSLPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGV 705
+ +R E+N + L + +E ++ + +G GSF V++ G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 706 SVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
AVK L+ R E + ++ + + + + M+ + GSL +
Sbjct: 85 QCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 766 WLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDF 824
L L + L + LEYLH + I+H D+K +NVLL D A L DF
Sbjct: 140 -LIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 825 GIAKLLDGVDPVTQTMTLAT-IG---YMAPEYGSEGIVSISG-----DVYSFGILMMETF 875
G A L +T G +MAPE +V D++S +M+
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHML 250
Query: 876 TRRKP 880
P
Sbjct: 251 NGCHP 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 43/210 (20%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIK 740
F ++LG G+ + + + VAVK + D E +++R H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + F+ + ++ +L++++ +++ + + ++ S L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 801 IIHCDLKPNNVLL-----DDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPEY- 852
I+H DLKP+N+L+ + A + DFG+ K L + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 853 --GSEGIVSISGDVYSFGILMMETFTRRKP 880
+ + + D++S G + +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 33/302 (10%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKI--V 742
+LG G+ NV++ G A+KVFN + R + E EV++++ H+N++K+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ K LIM++ P GSL L Y L + L ++ DV + +L +G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 800 PIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGS 854
I+H ++KP N++ D V L DFG A+ L + Q ++L T Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPDMYE 188
Query: 855 EGIVSISG--------DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906
++ D++S G+ T P K+ + + + G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKIITGKPSGA 247
Query: 907 VDANLLSREDEEDADDFATKKTCISYIMSLALK-----CSAEIPEERINVKDALADLKKI 961
+ + D +S + + L E+ A+ I
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 962 KK 963
Sbjct: 308 LH 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATL--------ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RH 735
LG G F V A V+VAVK+ L++ ++ L +E E+M+ I +H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L + +T + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQT 839
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D T
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNL 738
+G G+F V++A VAVK+ L+E F E +M + N+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDNPNI 112
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH-----------------------NYSLT 775
+K++ C+ L+ +YM G L ++L S L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 776 IRQRLDIMIDVASALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
++L I VA+ + YL +H DL N L+ ++MV + DFG+++ +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 834 DP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D I +M PE + DV+++G+++ E F+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-29
Identities = 72/446 (16%), Positives = 140/446 (31%), Gaps = 79/446 (17%)
Query: 120 LESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179
S ++ ++ + +++L S+ N+S++ +L L +L NNI
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD---MTGIEKLTGLTKLICTSNNI 76
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239
T + + NL L N + L + + + + N L+ L S
Sbjct: 77 T------TLD--LSQNTNLTYLACDSNKLTNLDVT---PLTKLTYLNCDTNKLT-KLDVS 124
Query: 240 IYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299
P L L +N L+ I + + ++ T L+ N + QL L
Sbjct: 125 Q-NPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCS 178
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359
N++T +++ + L L DTN + + + L S++L
Sbjct: 179 FNKITE----------LDVSQNKLLNRLNCDTNNITKL---DLNQN-IQLTFLDCSSNKL 224
Query: 360 SGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLE 419
+ + L+ L N L + + L KL L L T +L
Sbjct: 225 TE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278
Query: 420 KLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSL 479
++ + + T L LD ++ +
Sbjct: 279 YFQ--AEGCRKIK---ELDVTHNTQLYLLDCQAAGITE---------------------- 311
Query: 480 SGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI 539
L++ L L L +L+ + + + L L+ Q S G +
Sbjct: 312 -----LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIP 361
Query: 540 SLQSLDLSGNNISGEIPKSLEKLSRL 565
+L + + +PK + L
Sbjct: 362 ALNNNFEAEGQTI-TMPKETLTNNSL 386
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 80/474 (16%), Positives = 155/474 (32%), Gaps = 58/474 (12%)
Query: 48 AALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSG 107
A+ + T L+ L SL+ +S D + + L + +SN+++
Sbjct: 21 ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT- 77
Query: 108 SLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP 167
+L + T L SNK+T + ++ L + D N L+ + P
Sbjct: 78 TLD---LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQ----NP 127
Query: 168 SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILL 227
L L N +T EI + + L LD N + + + + +
Sbjct: 128 LLTYLNCARNTLT------EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 228 YGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTF 287
N ++ L S L L NN++ + + + T L+ SSN + +
Sbjct: 178 SFNKIT-ELDVS-QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI---DV 229
Query: 288 GNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLST 347
QL N LT ++ L L L + + + +
Sbjct: 230 TPLTQLTYFDCSVNPLTE----------LDVSTLSKLTTLHCIQTDLLEI---DLTHNTQ 276
Query: 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKL 407
+ G ++ + + + L +L + + L + KL L LN+ +L
Sbjct: 277 LIYFQAEGCRKIK---ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330
Query: 408 KGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
D+ KL +L N +Q + + + +L + + T +
Sbjct: 331 TEL---DVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNS 385
Query: 468 YILAVDFSLNSLSG---SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLD 518
+AV L G ++ G + +T LS P+ + +
Sbjct: 386 LTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSEN 439
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 65/425 (15%), Positives = 126/425 (29%), Gaps = 53/425 (12%)
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL 226
+ + L L LD ++I + I + + ++
Sbjct: 18 DNFASEVAAAFEM-----QATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLI 70
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
N+++ L S NL L N L+ + + ++ T L +N + L
Sbjct: 71 CTSNNIT-TLDLSQ-NTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL---D 122
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
L L+ N LT ++ L L N + +
Sbjct: 123 VSQNPLLTYLNCARNTLTE----------IDVSHNTQLTELDCHLNKKITKLD--VTPQ- 169
Query: 347 TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK 406
T L ++++ + L L+ N + + L + +L LD +SNK
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK 223
Query: 407 LKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSL 466
L D+ L +L + N L ++ ++ L+ L L L + L
Sbjct: 224 LTEI---DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQL 277
Query: 467 KYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526
Y F L++ + L L+ ++ + L +L L
Sbjct: 278 IY-----FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTE 329
Query: 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFV 586
+ L+SL +I + S+ K+ L + +
Sbjct: 330 LTE-LD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNN 384
Query: 587 NFTAD 591
+ T
Sbjct: 385 SLTIA 389
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 75/470 (15%), Positives = 150/470 (31%), Gaps = 85/470 (18%)
Query: 117 FTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
L S D ++ IT + I ++ L + +N+++ + ++ +L L
Sbjct: 41 LATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLDL---SQNTNLTYLACDS 94
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL 236
N +T + + L L L+ N + L S
Sbjct: 95 NKLT------NLD--VTPLTKLTYLNCDTNKLTKLDVSQ--------------------- 125
Query: 237 PSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQIL 296
P L L +N L+ I + + ++ T L+ N + QL L
Sbjct: 126 -----NPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTL 175
Query: 297 SLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGS 356
N++T +++ + L L DTN + + + L S
Sbjct: 176 DCSFNKITE----------LDVSQNKLLNRLNCDTNNITKL---DLNQN-IQLTFLDCSS 221
Query: 357 SQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC 416
++L+ + L+ L N L + + L KL L L T
Sbjct: 222 NKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNT 275
Query: 417 KLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSL 476
+L ++ + + T L LD ++ + S L Y+ +
Sbjct: 276 QLIYFQ--AEGCRKIK---ELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYL---YLNN 327
Query: 477 NSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFG 536
L+ L++ + L L+ + + SS+G + L+ A ++
Sbjct: 328 TELTE---LDVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLT 382
Query: 537 SL-----ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
+ +S LD GN ++ I + +++ L + P+
Sbjct: 383 NNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 688 LGSGSFDNVYKATLANG------VSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRN 737
LGSG+F V AT + VAVK+ L+E ++ +E ++M ++ H N
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH----------------------NYSLT 775
++ ++ +C+ G LI +Y G L +L S LT
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 776 IRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835
L VA +E+L +H DL NVL+ V + DFG+A+ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 836 -VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
V + + +MAPE EGI +I DV+S+GIL+ E F+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 55/244 (22%), Positives = 93/244 (38%), Gaps = 18/244 (7%)
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152
++++ N + + + LE +S N I A +++L ++ L +N
Sbjct: 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGL 211
L+ + P L L +L L N I IP+ + +L+ LDLG
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE------SIPSYAFNRIPSLRRLDLGELKRLSY 175
Query: 212 IPSMIFNN-SNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEAT 270
I F SN+ + L +L +P+ L L+ L L N+LS I P S
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234
Query: 271 ILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330
L + + + N F N + L ++L N LT + + +L + L
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-------LPHDLFTPLHHLERIHLH 287
Query: 331 TNPL 334
NP
Sbjct: 288 HNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 64/316 (20%), Positives = 95/316 (30%), Gaps = 67/316 (21%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKIL 201
+ + +L P + + L L N I I N +L +L+IL
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI---STNTRLLNLHENQIQ-IIK----VNSFKHLRHLEIL 93
Query: 202 DLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPD 261
L N+I I FN L NL L L+ N L+ I
Sbjct: 94 QLSRNHIR-TIEIGAFNG----------------------LANLNTLELFDNRLTTIPNG 130
Query: 262 SICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD-NQLTTGSSAQGQIFYSSLAK 320
+ S+ L L +N + F L+ L LG+ +L+ S +
Sbjct: 131 AFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE-------GAFEG 183
Query: 321 CRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN 380
LR L L L+ IPN L L L L
Sbjct: 184 LSNLRYLNLAMCNLR-EIPN--------------------------LTPLIKLDELDLSG 216
Query: 381 NELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA 440
N L+ P L LQ L + ++++ L+ L + +N L
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 441 NLTSLRHLDFRSNSLN 456
L L + N N
Sbjct: 277 PLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 61/286 (21%), Positives = 99/286 (34%), Gaps = 39/286 (13%)
Query: 196 HNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKN 253
+ + N+ +P I +N + L+ N + + + +L +LE L L +N
Sbjct: 43 NQFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 254 NLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQI 313
++ I + + LEL N + + F +L+ L L +N + + I
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-------I 151
Query: 314 FYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNL 373
+ + LR L L + +S F LSNL
Sbjct: 152 PSYAFNRIPSLRRLDLGEL-------KRLSYISEGA-----------------FEGLSNL 187
Query: 374 LVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQG 433
L+L L IP L L KL LDL+ N L P L L L + +Q
Sbjct: 188 RYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245
Query: 434 QIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSL 479
NL SL ++ N+L F L ++ + N
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 65/315 (20%), Positives = 105/315 (33%), Gaps = 70/315 (22%)
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152
+ + +L +P + T ++ N+I ++ ++ L+ ++L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGL 211
+ + L +L L L N +T IPN L LK L L N I
Sbjct: 99 HIR-TIEIGAFNGLANLNTLELFDNRLT------TIPNGAFVYLSKLKELWLRNNPIE-S 150
Query: 212 IPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATI 271
IPS FN +P+L L L + +
Sbjct: 151 IPSYAFNR----------------------IPSLRRLDLGELKR---------------L 173
Query: 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331
+S F GL L+ L+L L +L L L L
Sbjct: 174 SYISEGAFEGL--------SNLRYLNLAMCNLRE---------IPNLTPLIKLDELDLSG 216
Query: 332 NPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTV 390
N L + P S L L+ + SQ+ I F NL +L+ ++L +N L +
Sbjct: 217 NHLSAIRPGSFQGL-MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 391 LGKLQKLQGLDLNSN 405
L L+ + L+ N
Sbjct: 275 FTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 62/288 (21%), Positives = 102/288 (35%), Gaps = 40/288 (13%)
Query: 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302
+ + NL + PD I ++ +L L N + N+F + R L+IL L N
Sbjct: 43 NQFSKVICVRKNLREV-PDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
+ T I + L L L N L + + L + L+ + ++ +
Sbjct: 100 IRT-------IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYL-SKLKELWLRNNPIES- 150
Query: 363 IPVG-FGNLSNLLVLSLV-NNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEK 420
IP F + +L L L L+ L L+ L+L L+ IP L L K
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIK 208
Query: 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480
L+ L + N L P L L+ L + + + F
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD---------------- 252
Query: 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528
NL++L +NL N L+ L +L+ + L N +
Sbjct: 253 --------NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 6/228 (2%)
Query: 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNE 382
R+L L N ++ + NS +L LE + + I +G F L+NL L L +N
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHL-RHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNR 123
Query: 383 LAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLAN 441
L L KL+ L L +N ++ ++ L L L L
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 442 LTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGN 501
L++LR+L+ +L IP L + +D S N LS P + L L L + +
Sbjct: 184 LSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 502 QLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
Q+ ++ NL++L + LA N F L L+ + L N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 6/214 (2%)
Query: 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNA 430
+N +L+L N++ L+ L+ L L+ N ++ L LNTL +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 431 LQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFS-LNSLSGSLPLNI-G 488
L L+ L+ L R+N + S F + + +D L LS +
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFE 182
Query: 489 NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSG 548
L L LNL L IP+ + L LD L L+ N P SF L+ LQ L +
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 549 NNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
+ I + + L LV+ N++ N L +P
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 49/221 (22%), Positives = 84/221 (38%), Gaps = 9/221 (4%)
Query: 364 PVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNT 423
P + + V L +P + + L+L+ N+++ L L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 424 LLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSL 483
L + N ++ L +L L+ N L + F L + + N + S+
Sbjct: 93 LQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 484 PLNI-GNLEALGGLNLTG-NQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISL 541
P + +L L+L +LS + L NL +L LA + IP + LI L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKL 209
Query: 542 QSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
LDLSGN++S P S + L L + + ++ I
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERN 249
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 32/173 (18%), Positives = 65/173 (37%), Gaps = 11/173 (6%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWH-MRRLKIIDFSSNSLSGSLPGDMCNSF 117
T+P LS L L + N +++P+ ++ + L+ +D +
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
+ L +++ + + + L + L N LS + L L +L ++ +
Sbjct: 185 SNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQS 241
Query: 178 NITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGN 230
I I N NL +L ++L NN+ L + ++ I L+ N
Sbjct: 242 QIQ-VIE----RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 19/107 (17%), Positives = 41/107 (38%), Gaps = 4/107 (3%)
Query: 51 SLPNLSLGG---TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSG 107
+L L+L P++ L L L++SGN P + L+ + + +
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ- 244
Query: 108 SLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
+ + ++ L +++ N +T + L+ I L +N
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNL--QEDRALKSFDTECEVMRRI-RHRN 737
F + LG GS+ V+K +G AVK + + E ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+++ + G L + SL++ + SL Q + D AL +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-----Y 852
S ++H D+KP N+ L LGDFG+ L + YMAPE Y
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQE-GDPRYMAPELLQGSY 232
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKP 880
G+ + DV+S G+ ++E +
Sbjct: 233 GT------AADVFSLGLTILEVACNMEL 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 62/316 (19%), Positives = 94/316 (29%), Gaps = 67/316 (21%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKIL 201
+ + LS P + + L L+ NNI I + +LH+L++L
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQ-MIQ----ADTFRHLHHLEVL 104
Query: 202 DLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPD 261
LG N+I I FN L +L L L+ N L+ I
Sbjct: 105 QLGRNSIR-QIEVGAFNG----------------------LASLNTLELFDNWLTVIPSG 141
Query: 262 SICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD-NQLTTGSSAQGQIFYSSLAK 320
+ S+ L L +N + F L L LG+ +L S +
Sbjct: 142 AFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE-------GAFEG 194
Query: 321 CRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN 380
L+ L L +K +PN L L L +
Sbjct: 195 LFNLKYLNLGMCNIK-DMPN--------------------------LTPLVGLEELEMSG 227
Query: 381 NELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA 440
N P L L+ L + ++++ L L L +N L
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 441 NLTSLRHLDFRSNSLN 456
L L L N N
Sbjct: 288 PLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 61/317 (19%), Positives = 105/317 (33%), Gaps = 64/317 (20%)
Query: 163 CTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNM 222
C+ ++ ++ +P + IP N + L+L NNI I + F +
Sbjct: 50 CSCSNQFSKVVCTRRGLS-EVP-QGIP------SNTRYLNLMENNIQM-IQADTFRH--- 97
Query: 223 VAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGL 282
L +LE L L +N++ I + + LEL N + +
Sbjct: 98 -------------------LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVI 138
Query: 283 VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI 342
F +L+ L L +N + + I + + L L L +
Sbjct: 139 PSGAFEYLSKLRELWLRNNPIES-------IPSYAFNRVPSLMRLDLGEL-------KKL 184
Query: 343 GNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402
+S F L NL L+L + +P L L L+ L++
Sbjct: 185 EYISEGA-----------------FEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225
Query: 403 NSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPST 462
+ N P L L L N+ + L SL L+ N+L+S
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 463 FWSLKYILAVDFSLNSL 479
F L+Y++ + N
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 58/266 (21%), Positives = 90/266 (33%), Gaps = 42/266 (15%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
LN+ N+ + D LE + N I
Sbjct: 77 TRYLNLMENNI-------------------------QMIQADTFRHLHHLEVLQLGRNSI 111
Query: 131 TGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPN 190
A ++SL ++ L +N L+ P+ L L +L L N I IP+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE------SIPS 164
Query: 191 EI-GNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAILLYGNHLSGHLPSSIYLPNLENL 248
+ +L LDLG I F N+ + L ++ +P+ L LE L
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEEL 223
Query: 249 FLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSS 308
+ N+ I P S S L + ++ S + N F L L+L N L++
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS--- 280
Query: 309 AQGQIFYSSLAKCRYLRVLVLDTNPL 334
+ + RYL L L NP
Sbjct: 281 ----LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 64/315 (20%), Positives = 104/315 (33%), Gaps = 70/315 (22%)
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152
+ + + LS +P + + ++ N I ++ L+ ++L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGL 211
S+ L SL L L N +T IP+ L L+ L L N I
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT------VIPSGAFEYLSKLRELWLRNNPIE-S 161
Query: 212 IPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATI 271
IPS FN +P+L L L + I
Sbjct: 162 IPSYAFNR----------------------VPSLMRLDLGELKKLEYIS----------- 188
Query: 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331
F L+ L+LG + +L L L +
Sbjct: 189 ------------EGAFEGLFNLKYLNLGMCNIKD---------MPNLTPLVGLEELEMSG 227
Query: 332 NPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTV 390
N + P S L +SL+ + +SQ+S I F L++L+ L+L +N L+ +
Sbjct: 228 NHFPEIRPGSFHGL-SSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 391 LGKLQKLQGLDLNSN 405
L+ L L L+ N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 61/287 (21%), Positives = 89/287 (31%), Gaps = 38/287 (13%)
Query: 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302
+ + LS + P I S L L N + +TF + L++L LG N
Sbjct: 54 NQFSKVVCTRRGLSEV-PQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
+ I + L L L N L + +
Sbjct: 111 IRQ-------IEVGAFNGLASLNTLELFDNWLTVIPSGA--------------------- 142
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL-NSNKLKGFIPTDLCKLEKL 421
F LS L L L NN + ++ L LDL KL+ L L
Sbjct: 143 ----FEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL 198
Query: 422 NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
L ++ +P L L L L+ N P +F L + + + +S
Sbjct: 199 KYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 482 SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528
L +L LNL N LS L+ L L L N +
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 8/229 (3%)
Query: 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNE 382
R L L N ++ + ++ +L LE G + + I VG F L++L L L +N
Sbjct: 77 TRYLNLMENNIQMIQADTFRHL-HHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNW 134
Query: 383 LAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLAN 441
L L KL+ L L +N ++ ++ L L L L+
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 442 LTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLN-IGNLEALGGLNLTG 500
L +L++L+ ++ +P L + ++ S N + L +L L +
Sbjct: 195 LFNLKYLNLGMCNI-KDMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMN 251
Query: 501 NQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
+Q+S ++ L +L L LA N F L L L L N
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-21
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 6/214 (2%)
Query: 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNA 430
SN L+L+ N + L L+ L L N ++ L LNTL +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 431 LQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFS-LNSLSGSLPLNI-G 488
L L+ LR L R+N + S F + ++ +D L L +
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFE 193
Query: 489 NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSG 548
L L LNL + +P+ + L L+ L ++ N F P SF L SL+ L +
Sbjct: 194 GLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 549 NNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
+ +S + + L+ LV+ N++ N L +P
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD 284
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 28/172 (16%), Positives = 55/172 (31%), Gaps = 9/172 (5%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
+P LS L L + N + L +D +
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
L+ ++ I + + L+ + + N L SL +L ++ +
Sbjct: 197 NLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQ 253
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGN 230
++ I N L +L L+L NN++ L + +V + L+ N
Sbjct: 254 VS-LIE----RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 33/133 (24%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 51 SLPNLSLGG-----TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNS 104
SL L LG + L L LN+ + L + L+ ++ S N
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNH 229
Query: 105 LSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCT 164
+ + + L+ V +++++ +A ++SL + L +N+LS S P DL T
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
Query: 165 RLPSLVQLRLLGN 177
L LV+L L N
Sbjct: 288 PLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 4/107 (3%)
Query: 51 SLPNLSLGG---TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSG 107
+L L+LG P++ L L L +SGN F + P + LK + ++ +S
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS- 255
Query: 108 SLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
+ + + L +++ N ++ + L + L +N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 62/308 (20%), Positives = 92/308 (29%), Gaps = 61/308 (19%)
Query: 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGS 307
+ L+ + P I S AT LEL SN L F QL LSL N L+
Sbjct: 12 IRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 308 SAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGF 367
S L+ L L N + + F
Sbjct: 69 CCSQ-----SDFGTTSLKYLDLSFNGVIT--------------------------MSSNF 97
Query: 368 GNLSNLLVLSLVNNELAGAIPT-VLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-L 425
L L L ++ L V L+ L LD++ + L L L +
Sbjct: 98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157
Query: 426 SNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPL 485
+ N+ + +P L +L LD L P+ F
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN--------------------- 196
Query: 486 NIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI-SLQSL 544
+L +L LN++ N L +L L + N Q SL L
Sbjct: 197 ---SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253
Query: 545 DLSGNNIS 552
+L+ N+ +
Sbjct: 254 NLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 51/266 (19%), Positives = 87/266 (32%), Gaps = 37/266 (13%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS-GSLPGDMCNSFTQLESFDVSSNK 129
L + N + +L + SSN LS T L+ D+S N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 130 ITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIP 189
+ S + + L+ + +++L + L +L+ L + +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR------VAF 142
Query: 190 NEI-GNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENL 248
N I L +L++L + GN+ IF L NL L
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTE----------------------LRNLTFL 180
Query: 249 FLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSS 308
L + L + P + + S +L +S N F L + LQ+L N + T
Sbjct: 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT--- 237
Query: 309 AQGQIFYSSLAKCRYLRVLVLDTNPL 334
++ Q + L L L N
Sbjct: 238 SKKQELQHFPSS---LAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/258 (19%), Positives = 94/258 (36%), Gaps = 23/258 (8%)
Query: 101 SSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS-GSFP 159
+S L+ S+P + + ++ SNK+ ++ L + L +N LS
Sbjct: 15 NSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70
Query: 160 TDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN 219
+ SL L L N + + + L L+ LD +N+ + +F +
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVI------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 220 -SNMVAILLYGNHLSGHLPSSIY--LPNLENLFLWKNN-LSGIIPDSICNASEATILELS 275
N++ + + H + I+ L +LE L + N+ +PD T L+LS
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 276 SNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLK 335
L P F + LQ+L++ N + + L+VL N +
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFS-------LDTFPYKCLNSLQVLDYSLNHIM 236
Query: 336 GVIPNSIGNLSTSLENFY 353
+ + +SL
Sbjct: 237 TSKKQELQHFPSSLAFLN 254
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 10/225 (4%)
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKL--KGFIPTDLCKLEK 420
+P G S+ L L +N+L V KL +L L L+SN L KG
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSL 479
L L + N + + + L L HLDF+ ++L S F SL+ ++ +D S
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 480 SGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGS 537
I L +L L + GN I L+NL +L L++ + P +F S
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 538 LISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
L SLQ L++S NN + L+ L + S N +
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/250 (22%), Positives = 87/250 (34%), Gaps = 15/250 (6%)
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNL--FSGLVP 284
L+ +P+ I + L L N L + ++ T L LSSN F G
Sbjct: 14 CNSKGLT-SVPTGI-PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGN 344
+ L+ L L N + T SS L L + LK + S+
Sbjct: 72 QSDFGTTSLKYLDLSFNGVITMSSN--------FLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 345 LSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAI-PTVLGKLQKLQGLDL 402
+L + G F LS+L VL + N P + +L+ L LDL
Sbjct: 124 SLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 403 NSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPST 462
+ +L+ PT L L L ++N L SL+ LD+ N + ++
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 463 FWSLKYILAV 472
LA
Sbjct: 243 LQHFPSSLAF 252
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 42/229 (18%), Positives = 84/229 (36%), Gaps = 32/229 (13%)
Query: 54 NLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDM 113
LS G + L L++S N T+ + + +L+ +DF ++L +
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 121
Query: 114 CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173
S L D+S F +SSL+ +++ NS +F D+ T L +L L
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 174 LLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHL 232
L + ++ +L +L++L++ NN + + +
Sbjct: 182 LSQCQLE------QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKC------------- 221
Query: 233 SGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEA-TILELSSNLFS 280
L +L+ L N++ + + + L L+ N F+
Sbjct: 222 ---------LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 23/108 (21%), Positives = 38/108 (35%), Gaps = 3/108 (2%)
Query: 50 LSLPNLSLGGTLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGS 108
L + S P + L L L++S P + L++++ S N+ S
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-S 213
Query: 109 LPGDMCNSFTQLESFDVSSNKITGEFPSAIVNI-SSLKSIRLDNNSLS 155
L L+ D S N I + + SSL + L N +
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 51/231 (22%), Positives = 91/231 (39%), Gaps = 30/231 (12%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSS 744
+L G F VY+A + +G A+K E+ ++ E M+++ H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 745 CS-------NPGFKALIMQYMPQGSLEKWL--YSHNYSLTIRQRLDIMIDVASALEYLHH 795
S + L++ + +G L ++L L+ L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-----------T 844
PIIH DLK N+LL + L DFG A + + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 845 IGYMAPE---YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
Y PE S + D+++ G ++ R+ P F L+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 59/317 (18%), Positives = 108/317 (34%), Gaps = 52/317 (16%)
Query: 236 LPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQI 295
+PS + +++L L N ++ I + L L+SN + + ++F + L+
Sbjct: 46 IPSGL-TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104
Query: 296 LSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAG 355
L L N L+ + S L L L NP K + S+ + T L+ G
Sbjct: 105 LDLSYNYLSN-------LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVG 157
Query: 356 SSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTD 414
+ I F L+ L L + ++L P L +Q + L L+ + +
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEI 216
Query: 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDF 474
+ +S+ L+ R L++ F
Sbjct: 217 F-----------------------VDVTSSVECLELRDTDLDT----------------F 237
Query: 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQS 534
+ LS ++ + +T L + + + L L +RN + +P
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295
Query: 535 -FGSLISLQSLDLSGNN 550
F L SLQ + L N
Sbjct: 296 IFDRLTSLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 62/334 (18%), Positives = 117/334 (35%), Gaps = 65/334 (19%)
Query: 101 SSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPT 160
SS SL+ S+P + ++S D+S+N+IT S + +L+++ L +N ++ +
Sbjct: 39 SSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE 93
Query: 161 DLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNN 219
D + L SL L L N ++ + + L +L L+L GN L + +F++
Sbjct: 94 DSFSSLGSLEHLDLSYNYLS------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSH 147
Query: 220 -SNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLSGIIPDSICNASEATILELSS 276
+ + + + + L LE L + ++L P S+ + + L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 277 NLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKG 336
L+ ++ L L D L DT
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDL--------------------------DTFHF-- 239
Query: 337 VIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK 396
S+LS G + + + L + +L ++
Sbjct: 240 --------------------SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 397 LQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNN 429
L L+ + N+LK +L L + L N
Sbjct: 279 LLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 51/275 (18%), Positives = 100/275 (36%), Gaps = 26/275 (9%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
+ SL++S N ++L L+ + +SN ++ ++ D +S LE D+S N +
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 131 TGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPN 190
+ S +SSL + L N T L + L L LR+ + +I
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ----RK 168
Query: 191 EIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY--LPNLENL 248
+ L L+ L++ +++ P + + N+ ++L+ L ++E L
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 249 FLWKNNLSG--------IIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
L +L +S+ ++++ + L L
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQV-MKLLNQISGLLELEFSR 286
Query: 301 NQLTT-GSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
NQL + + L L+ + L TNP
Sbjct: 287 NQLKSVPDGI-----FDRLTS---LQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 48/257 (18%), Positives = 91/257 (35%), Gaps = 19/257 (7%)
Query: 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNE 382
++ L L N + + + + +L+ S+ ++ I F +L +L L L N
Sbjct: 54 VKSLDLSNNRITYISNSDLQRC-VNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNY 111
Query: 383 LAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL-CKLEKLNTLLSNNNALQGQIPT-CLA 440
L+ + L L L+L N K T L L KL L N +I A
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 441 NLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTG 500
LT L L+ ++ L S P + S++ + + + L + + ++ L L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 501 NQLSGYIPSSI--------GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
L + S + + + + + + + L L+ S N +
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK 290
Query: 553 GEIPK----SLEKLSRL 565
+P L L ++
Sbjct: 291 S-VPDGIFDRLTSLQKI 306
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 42/215 (19%), Positives = 72/215 (33%), Gaps = 10/215 (4%)
Query: 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNA 430
+ L L NN + + L + LQ L L SN + L L L + N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 431 LQGQIPTCLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNI-G 488
L + L+SL L+ N + S F L + + +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 489 NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSG 548
L L L + + L Y P S+ +++N+ L L + S++ L+L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 549 NNISG----EIPK----SLEKLSRLVDFNVSFNGL 575
++ E+ SL K + ++ L
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 32/204 (15%), Positives = 73/204 (35%), Gaps = 12/204 (5%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNEL-WHMRRLKIIDFSSNSLSGSLPGDMCNSF 117
L LS L LN+ GN + L H+ +L+I+ + +
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
T LE ++ ++ + P ++ +I ++ + L S+ L L
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDT 232
Query: 178 NITGRIPNREIP----NEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS 233
++ E+ N + + + + ++ + ++ S ++ + N L
Sbjct: 233 DLDT-FHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLK 290
Query: 234 GHLPSSIY--LPNLENLFLWKNNL 255
+P I+ L +L+ ++L N
Sbjct: 291 S-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 14/142 (9%)
Query: 51 SLPNLSLGG----TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSL 105
L L + + P ++ + L + L + ++ ++ L
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234
Query: 106 SG----SLPGDMCNSFTQLESF---DVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSF 158
L NS + +F ++ + + + IS L + N L S
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SV 292
Query: 159 PTDLCTRLPSLVQLRLLGNNIT 180
P + RL SL ++ L N
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPWD 314
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 57/229 (24%), Positives = 88/229 (38%), Gaps = 38/229 (16%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIV--- 742
LG+G F V + G VA+K + + + + E ++M+++ H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 743 ---SSCSNPGFKALIMQYMPQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLHHGY 797
+ L M+Y G L K+L L ++ D++SAL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 798 STPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----GYMAP 850
IIH DLKP N++L ++ + D G AK LD Q Y+AP
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD------QGELCTEFVGTLQYLAP 192
Query: 851 E------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
E Y D +SFG L E T +P + +
Sbjct: 193 ELLEQKKYTVT------VDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 42/324 (12%), Positives = 88/324 (27%), Gaps = 66/324 (20%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIK-- 740
L G V+ + A+KVF L+ R+ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 741 ----------IVSSCSNPGFKA--------------LIMQYMPQGSLE------KWLYSH 770
V+ S P F L+M LE ++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 771 NYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
I + + L G ++H P+N+ + D LGD
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 830 LDGVDPVTQTMTLATIGYMAPEY--GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG 887
+ P + + Y E+ S + + + + G+ + + P F
Sbjct: 244 VGTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGL 295
Query: 888 EMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE 947
+ + R D+ F + ++ +L +
Sbjct: 296 VTPGIKGSWK------------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343
Query: 948 RINVKDALAD--LKKIKKILTQAL 969
R+ +A+ +++ ++ +L
Sbjct: 344 RLLPLEAMETPEFLQLQNEISSSL 367
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 35/204 (17%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G F NVY A + +A+KV L++ E E+ +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLHH 795
+ LI++Y P G++ Y L + D + ++A+AL Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTV----YRE---LQKLSKFDEQRTATYITELANALSYCH- 126
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +IH D+KP N+LL + DFG + ++ L T+ Y+ PE
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPE--- 177
Query: 855 EGIVSISG-----DVYSFGILMME 873
++ D++S G+L E
Sbjct: 178 --MIEGRMHDEKVDLWSLGVLCYE 199
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 47/197 (23%), Positives = 94/197 (47%), Gaps = 24/197 (12%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LLG GSF VY+A + G+ VA+K+ + + + ++ E ++ +++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ + + L+++ G + ++L + + + M + + + YLH S I+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM--TLATIGYMAPE------YGS 854
H DL +N+LL +M + DFG+A L T+ T Y++PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN---YISPEIATRSAHGL 191
Query: 855 EGIVSISGDVYSFGILM 871
E DV+S G +
Sbjct: 192 E------SDVWSLGCMF 202
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 42/250 (16%), Positives = 79/250 (31%), Gaps = 61/250 (24%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQED----------------RALKSFDTECEV 729
+LG +AT G S V V E R L+ + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 730 MRRIRHRNLIKIVSSCSNPGFKAL-------------IMQYMPQGSLE---KWLYSH--- 770
+R +V + + Q +L+ + L SH
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 771 NYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
+ SL RL + + V L LH +G ++H L+P +++LD L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 830 LDGVDPVTQTMTLATIGYMAPEY-----------GSEGIVSISGDVYSFGILMMETFTRR 878
+ ++ + G+ PE +++ S D ++ G+++ +
Sbjct: 256 DG-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 879 KPTNEMFTGE 888
P T +
Sbjct: 311 LP----ITKD 316
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 42/204 (20%), Positives = 81/204 (39%), Gaps = 39/204 (19%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A K+ L + + E + R + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLH-H 795
+ F ++++ + SL + R+ L + + +YLH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKR-------RKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM--TLATIGYMAPE-- 851
+IH DLK N+ L++D+ +GDFG+A ++ + + T Y+APE
Sbjct: 135 R----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPEVL 187
Query: 852 ----YGSEGIVSISGDVYSFGILM 871
+ E DV+S G +M
Sbjct: 188 SKKGHSFE------VDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 42/204 (20%), Positives = 81/204 (39%), Gaps = 39/204 (19%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A K+ L + + E + R + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLH-H 795
+ F ++++ + SL + R+ L + + +YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR-------RKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM--TLATIGYMAPE-- 851
+IH DLK N+ L++D+ +GDFG+A ++ + + T Y+APE
Sbjct: 161 R----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAPEVL 213
Query: 852 ----YGSEGIVSISGDVYSFGILM 871
+ E DV+S G +M
Sbjct: 214 SKKGHSFE------VDVWSIGCIM 231
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 35/203 (17%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F NVY A N +A+KV L+++ E E+ +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLHHG 796
+ + L++++ P+G L Y L R D M ++A AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGEL----YKE---LQKHGRFDEQRSATFMEELADALHYCH-- 131
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSE 855
+IH D+KP N+L+ + DFG + + T+ T+ Y+ PE
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPPE---- 182
Query: 856 GIVSISG-----DVYSFGILMME 873
++ D++ G+L E
Sbjct: 183 -MIEGKTHDEKVDLWCAGVLCYE 204
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 34/205 (16%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKV-----FNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
+G G F V + G AVK+ F + + E + ++H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 742 VSSCSNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-H 795
+ + S+ G ++ ++M L ++ YS M + AL Y H +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--AVASHYMRQILEALRYCHDN 149
Query: 796 GYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE- 851
IIH D+KP+ VLL ++ LG FG+A L V + T +MAPE
Sbjct: 150 N----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEV 204
Query: 852 -----YGSEGIVSISGDVYSFGILM 871
YG DV+ G+++
Sbjct: 205 VKREPYGKP------VDVWGCGVIL 223
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+LGSG+F V+ G A+K S + E V+++I+H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 746 SNPGFKALIMQYMPQGSL-----EKWLYSHNY-SLTIRQRLDIMIDVASALEYLH-HGYS 798
+ L+MQ + G L E+ +Y+ SL I+Q V SA++YLH +G
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ-------VLSAVKYLHENG-- 126
Query: 799 TPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE---- 851
I+H DLKP N+L +++ + DFG++K+ + + T T GY+APE
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTA-CGTPGYVAPEVLAQ 181
Query: 852 --YGSEGIVSISGDVYSFGILM 871
Y D +S G++
Sbjct: 182 KPYSKA------VDCWSIGVIT 197
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 49/217 (22%), Positives = 82/217 (37%), Gaps = 39/217 (17%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSS 744
+LG GS V G VAVK + E +++ H N+I+ S
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYS------LTIRQRLDIMIDVASALEYLH-HGY 797
+ F + ++ +L+ + S N S + ++ +AS + +LH
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 798 STPIIHCDLKPNNVLLD-------------DDMVAHLGDFGIAKLLD-GVDPVTQTMTLA 843
IIH DLKP N+L+ +++ + DFG+ K LD G +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 844 --TIGYMAPEYGSEGIVSISG-------DVYSFGILM 871
T G+ APE E + D++S G +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+Y+ GSL + + Q + + ALE+LH S +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPE------YGSEGI 857
K +N+LL D L DFG + TM +G +MAPE YG +
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----VGTPYWMAPEVVTRKAYGPK-- 196
Query: 858 VSISGDVYSFGILMME 873
D++S GI+ +E
Sbjct: 197 ----VDIWSLGIMAIE 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA G A KV + + L+ + E E++ H ++K++ +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+ G +++++ P G+++ + + LT Q + + AL +LH S IIH DL
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 143
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPEYGSEGIVSISG- 862
K NVL+ + L DFG++ + IG +MAPE + +
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF----IGTPYWMAPEVVMCETMKDTPY 199
Query: 863 ----DVYSFGILMME 873
D++S GI ++E
Sbjct: 200 DYKADIWSLGITLIE 214
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 39/230 (16%), Positives = 71/230 (30%), Gaps = 25/230 (10%)
Query: 686 NLLGSGSFDNVYKAT------LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLI 739
+LLG G+F VY+AT N +KV E ++ +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 740 KIVSSCSNPGFKALIMQYMPQGSL----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
K S+ L+ + G+L + + + + + + +E +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH- 189
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAH-----------LGDFGIAKLLDGVDPVTQTMTLA- 843
IIH D+KP+N +L + + L D G + + T
Sbjct: 190 --DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
T G+ E S + D + + + GE +
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG 297
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 20/199 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA-LKSFDTECEV-MRRIRHRNLIKIVSS 744
+G G++ +V K +G +AVK D K + +V MR +++ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLHHGYS 798
G + M+ M S +K Y + YS+ + I + AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDK-FYKYVYSVL-DDVIPEEILGKITLATVKALNHLKENLK 146
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----YGS 854
IIH D+KP+N+LLD L DFGI+ L VD + +T YMAPE S
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 855 EGIVSISGDVYSFGILMME 873
+ DV+S GI + E
Sbjct: 203 RQGYDVRSDVWSLGITLYE 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVSSC 745
LG+G+ V+K + +G+ +A K+ +L+ A E +V+ ++ +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ G ++ M++M GSL++ + + + + I V L YL + I+H D
Sbjct: 101 YSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRD 157
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
+KP+N+L++ L DFG++ L +D + + T YM+PE S+ D++
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIW 214
Query: 866 SFGILMMETFTRRKP 880
S G+ ++E R P
Sbjct: 215 SMGLSLVEMAVGRYP 229
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 12/224 (5%)
Query: 235 HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294
+P I + +FL N +S + S TIL L SN+ + + F L+
Sbjct: 25 AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 295 ILSLGDN-QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
L L DN QL + + ++ L L LD L+ + P L +L+ Y
Sbjct: 84 QLDLSDNAQLRS-------VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL-AALQYLY 135
Query: 354 AGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIP 412
+ L +P F +L NL L L N ++ L L L L+ N++ P
Sbjct: 136 LQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 413 TDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
L +L TL N L LA L +L++L N
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 52/237 (21%), Positives = 86/237 (36%), Gaps = 21/237 (8%)
Query: 101 SSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPT 160
L ++P + + + N+I+ ++ +L + L +N L+
Sbjct: 19 PQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA 73
Query: 161 DLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN- 219
T L L QL L N + P L L L L + + +F
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVD----PATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL 128
Query: 220 SNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSN 277
+ + + L N L LP L NL +LFL N +S + + L L N
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 278 LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
+ + P+ F + +L L L N L+ + +LA R L+ L L+ NP
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSA-------LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 58/247 (23%), Positives = 79/247 (31%), Gaps = 37/247 (14%)
Query: 259 IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318
+P I + + + L N S + +F CR L IL L N L I ++
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-------IDAAAF 76
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
L L L N + + F L L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPAT------------------------FHGLGRLHTLHL 112
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTD-LCKLEKLNTLLSNNNALQGQIPT 437
L P + L LQ L L N L+ +P D L L L + N +
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 438 CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGL 496
L SL L N + P F L ++ + N+LS +LP L AL L
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYL 230
Query: 497 NLTGNQL 503
L N
Sbjct: 231 RLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 56/213 (26%), Positives = 83/213 (38%), Gaps = 5/213 (2%)
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLN 422
+PVG + + L N ++ + L L L+SN L L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 423 TL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
L LS+N L+ P L L L L P F L + + N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ- 142
Query: 482 SLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLIS 540
+LP + +L L L L GN++S + L +LD L L +N P +F L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 541 LQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
L +L L NN+S ++L L L ++ N
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 43/191 (22%), Positives = 76/191 (39%), Gaps = 9/191 (4%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
L L + N + L+ +D S N+ S+ + +L + +
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
+ P +++L+ + L +N+L + P D L +L L L GN I+ +P
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVP-- 169
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY--LPN 244
LH+L L L N +A + P + ++ + L+ N+LS LP+ L
Sbjct: 170 --ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRA 226
Query: 245 LENLFLWKNNL 255
L+ L L N
Sbjct: 227 LQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 39/186 (20%), Positives = 63/186 (33%), Gaps = 9/186 (4%)
Query: 400 LDLNSNKLKGFIPTDL-CKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST 458
L+ +P + +++ L N + +L L SN L
Sbjct: 16 TSCPQQGLQ-AVPVGIPAASQRIF--LHGNR-ISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 459 IPSTFWSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSI-GNLKN 516
+ F L + +D S N+ S+ L L L+L L + + L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA 130
Query: 517 LDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
L +L L NA Q +F L +L L L GN IS ++ L L + N +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 577 GEIPSG 582
+
Sbjct: 191 -HVHPH 195
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 25/196 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V A +G VAVK+ +L++ + + E +MR +H N++++ S
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + S L Q + V AL YLH + +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQV-RLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPE------YGSEGI 857
K +++LL D L DFG + P +++ +G +MAPE Y +E
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----VGTPYWMAPEVISRSLYATE-- 221
Query: 858 VSISGDVYSFGILMME 873
D++S GI+++E
Sbjct: 222 ----VDIWSLGIMVIE 233
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---------TECEVMRRI-RHR 736
LG G V + AVK+ ++ + + + E +++R++ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-H 795
N+I++ + F L+ M +G L +L L+ ++ IM + + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKL 143
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE 851
I+H DLKP N+LLDDDM L DFG + +DP + + T Y+APE
Sbjct: 144 N----IVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPE 193
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
F LG GS+ +VYKA G VA+K ++ D L+ E +M++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
S ++M+Y GS+ + N +LT + I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPEYGSEGI 857
IH D+K N+LL+ + A L DFG+A L T+ IG +MAPE E
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV----IGTPFWMAPEVIQEIG 201
Query: 858 VSISGDVYSFGILMME 873
+ D++S GI +E
Sbjct: 202 YNCVADIWSLGITAIE 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 43/206 (20%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT-----ECEVMRRIRHRNLIKI 741
LG G+F V + + G A + N + L + D E + R ++H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINT---KKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 742 VSSCSNPGFKALIMQYMPQGSL-----EKWLYSHNY-SLTIRQRLDIMIDVASALEYLH- 794
S S G LI + G L + YS S I+Q + A+ + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ-------ILEAVLHCHQ 128
Query: 795 HGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
G ++H +LKP N+LL L DFG+A ++G T GY++PE
Sbjct: 129 MG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLSPE 183
Query: 852 ------YGSEGIVSISGDVYSFGILM 871
YG D+++ G+++
Sbjct: 184 VLRKDPYGKP------VDLWACGVIL 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 46/188 (24%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LGSG+F V++ A G K N + E +M ++ H LI + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCD 805
+ LI++++ G L + + +Y ++ + ++ M L+++H H I+H D
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLD 174
Query: 806 LKPNNVLLDDDMVAHL--GDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
+KP N++ + + + DFG+A L+ + V T AT + APE V D
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTD 232
Query: 864 VYSFGILM 871
+++ G+L
Sbjct: 233 MWAIGVLG 240
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 16/186 (8%)
Query: 712 FNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN 771
+ L + + + M +N + + S + + MQ + +L+ W+
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156
Query: 772 YSLTIRQR--LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
L I I +A A+E+LH S ++H DLKP+N+ D V +GDFG+
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 830 LDGVDPVTQTMTLA-----------TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRR 878
+D + +T T YM+PE S D++S G+++ E
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273
Query: 879 KPTNEM 884
E
Sbjct: 274 STQMER 279
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 50/256 (19%)
Query: 651 RNKSLPEENN---SLNLATLSRISYHELQQATNGFGESNL---------LGSGSFDNVYK 698
+ K P NN +L+L+ + +L L LGSG+ V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 699 AT-LANGVSVAVKVFN--------LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG 749
A VA+++ + +E + +TE E+++++ H +IKI +
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213
Query: 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKP 808
+ ++++ M G L + + L + A++YLH +G IIH DLKP
Sbjct: 214 Y-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENG----IIHRDLKP 267
Query: 809 NNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---------YGSE 855
NVLL ++D + + DFG +K+ + + TL T Y+APE Y
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 324
Query: 856 GIVSISGDVYSFGILM 871
V D +S G+++
Sbjct: 325 --V----DCWSLGVIL 334
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 40/204 (19%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + G+ A K+ N R + + E + R+++H N++++ S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 745 CSNPGFKALIMQYMPQGSL-----EKWLYSHNY-SLTIRQRLDIMIDVASALEYLH-HGY 797
F L+ + G L + YS S I+Q + ++ Y H +G
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-------ILESIAYCHSNG- 148
Query: 798 STPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE-- 851
I+H +LKP N+LL L DFG+A V+ A T GY++PE
Sbjct: 149 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVL 202
Query: 852 ----YGSEGIVSISGDVYSFGILM 871
Y D+++ G+++
Sbjct: 203 KKDPYSKP------VDIWACGVIL 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 26/197 (13%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG GSF V G AVKV + +++ +S E ++++++ H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
+ G+ L+ + G L + S + I+ V S + Y+H + I+
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNK----IV 148
Query: 803 HCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-----YGS 854
H DLKP N+LL D + DFG++ + + + T Y+APE Y
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVLHGTYDE 206
Query: 855 EGIVSISGDVYSFGILM 871
+ DV+S G+++
Sbjct: 207 K------CDVWSTGVIL 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 25/196 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LGSG++ V V A+K+ + E V++ + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIH 803
+ L+M+ G L + I+ V S + YLH H I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHN----IVH 159
Query: 804 CDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-----YGSE 855
DLKP N+LL + D + + DFG++ + + + + L T Y+APE Y +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLRKKYDEK 217
Query: 856 GIVSISGDVYSFGILM 871
DV+S G+++
Sbjct: 218 ------CDVWSIGVIL 227
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
++ +LG G F V+K A G+ +A K+ + + + E VM ++ H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ + + L+M+Y+ G L + +Y+LT + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--- 207
Query: 800 PIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I+H DLKP N+L D + + DFG+A+ + + T ++APE +
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVNFG--TPEFLAPEVVNYD 263
Query: 857 IVSISGDVYSFGILM 871
VS D++S G++
Sbjct: 264 FVSFPTDMWSVGVIA 278
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 49/198 (24%), Positives = 83/198 (41%), Gaps = 29/198 (14%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG GSF V K AVKV N +++ + E E+++++ H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIH 803
+ ++ + G L + + I+ V S + Y+H H I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN----IVH 144
Query: 804 CDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE-----YG 853
DLKP N+LL + D + DFG++ M + T Y+APE Y
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ----NTKMKDRIGTAYYIAPEVLRGTYD 200
Query: 854 SEGIVSISGDVYSFGILM 871
+ DV+S G+++
Sbjct: 201 EK------CDVWSAGVIL 212
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-23
Identities = 58/295 (19%), Positives = 105/295 (35%), Gaps = 32/295 (10%)
Query: 290 CRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSL 349
SL N S ++S+ K + + N ++ L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC---LINQF 61
Query: 350 ENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKG 409
LS +P + VL + N L ++P + L+ L D N+L
Sbjct: 62 SELQLNRLNLSS-LPDNLP--PQITVLEITQNAL-ISLPELPASLEYL---DACDNRLS- 113
Query: 410 FIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI 469
+P L+ L+ + NN L +P A L +++ +N L + +P SL+ +
Sbjct: 114 TLPELPASLKHLD--VDNNQ-LT-MLPELPALL---EYINADNNQL-TMLPELPTSLEVL 165
Query: 470 LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNL----DWLALARN 525
N L+ LP +LEAL +++ N L +P+ + + N
Sbjct: 166 ---SVRNNQLT-FLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCREN 217
Query: 526 AFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580
IP++ SL ++ L N +S I +SL + + D++
Sbjct: 218 RITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 67/425 (15%), Positives = 136/425 (32%), Gaps = 47/425 (11%)
Query: 166 LPSLVQLRLLGNNITGRIPN--REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMV 223
LP L N+ I + + + N L+ + N + +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 224 AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV 283
L +LS LP ++ P + L + +N L +P+ + L+ N S L
Sbjct: 65 --QLNRLNLS-SLPDNL-PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLSTL- 115
Query: 284 PNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG 343
P + L+ L + +NQLT L + D N L ++P
Sbjct: 116 PELPAS---LKHLDVDNNQLTMLPELPAL-----------LEYINADNNQLT-MLPELPT 160
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQ----G 399
+ LE ++QL+ +P +L L + N L ++P V + +
Sbjct: 161 S----LEVLSVRNNQLT-FLP---ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF 211
Query: 400 LDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTI 459
N++ IP ++ L+ T++ +N L +I L+ T+ + +
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSD 270
Query: 460 PSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDW 519
+ + D + ++ + N S ++ + + +
Sbjct: 271 G--QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-DRLSDTVSARN 327
Query: 520 LALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579
+ R + L + L ++ + +S E L N+ L +
Sbjct: 328 TSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQA 383
Query: 580 PSGGP 584
G
Sbjct: 384 SEGLF 388
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 7e-22
Identities = 70/378 (18%), Positives = 122/378 (32%), Gaps = 53/378 (14%)
Query: 239 SIYLPNLENLFLWK----NNLSGIIPDSICNASEATILELSSNLFSGLVPN-TFGNCRQL 293
SI LP N L + N +SG D + L + V Q
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61
Query: 294 QILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
L L L++ + VL + N L +P +L E
Sbjct: 62 SELQLNRLNLSSLPDNLPP----------QITVLEITQNALI-SLPELPASL----EYLD 106
Query: 354 AGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPT 413
A ++LS +P +L +L + NN+L +P + L+ + + ++N+L +P
Sbjct: 107 ACDNRLST-LPELPASLKHL---DVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPE 157
Query: 414 DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473
LE L+ + NN Q+ SL LD +N L ++P+ + +
Sbjct: 158 LPTSLEVLS--VRNN-----QLTFLPELPESLEALDVSTNLL-ESLPAVPVRNHHSEETE 209
Query: 474 FSL----NSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529
N ++ +P NI +L+ + L N LS I S+ R F
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF-- 266
Query: 530 PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFT 589
+ + + D + ++ ++ E E +
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI---------WHAFEHEEHANTFSAFLD 317
Query: 590 ADSFKQNYALCGSSRLQV 607
S + R QV
Sbjct: 318 RLSDTVSARNTSGFREQV 335
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-19
Identities = 67/447 (14%), Positives = 138/447 (30%), Gaps = 110/447 (24%)
Query: 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQ 119
+L ++ L ++ + +LP+ L ++ +++ + N+L SLP
Sbjct: 51 SLLKE-CLINQFSELQLNRLNL-SSLPDNLP--PQITVLEITQNALI-SLP----ELPAS 101
Query: 120 LESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179
LE D N+++ P +SLK + +DNN L+ P L + N +
Sbjct: 102 LEYLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELPA----LLEYINADNNQL 152
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239
T +P +L++L + N + LP
Sbjct: 153 T------MLPELPT---SLEVLSVRNNQL-------------------------TFLPEL 178
Query: 240 IYLPNLENLFLWKNNLSGIIPDSICN----ASEATILELSSNLFSGLVPNTFGNCRQLQI 295
+LE L + N L +P N + + P +
Sbjct: 179 --PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCT 234
Query: 296 LSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAG 355
+ L DN L++ + T+ +++
Sbjct: 235 IILEDNPLSS--------------------------------RIRESLSQQTAQPDYHGP 262
Query: 356 SSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL 415
S G N + + V + + ++ + ++N F L
Sbjct: 263 RIYFSMSD--GQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAF----L 316
Query: 416 CKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPST--------FWSLK 467
+L + N + + Q+ L L++ L +S ++ + + + +L+
Sbjct: 317 DRLSDTVS-ARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLR 375
Query: 468 YILAVDFSLNSLSGSLPLNIGNLEALG 494
L V + G + G L +LG
Sbjct: 376 KTLLV---HQASEGLFDNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-14
Identities = 47/262 (17%), Positives = 74/262 (28%), Gaps = 32/262 (12%)
Query: 51 SLPNLSLGG----TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS 106
SL L TLP +L L++ N LP L+ I+ +N L+
Sbjct: 101 SLEYLDACDNRLSTLPELPASL---KHLDVDNNQL-TMLPELP---ALLEYINADNNQLT 153
Query: 107 GSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDL--CT 164
LP T LE V +N++T P SL+++ + N L S P
Sbjct: 154 -MLP----ELPTSLEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLE-SLPAVPVRNH 203
Query: 165 RLPSL-VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMV 223
+ R N IT IP I +L + L N ++ +
Sbjct: 204 HSEETEIFFRCRENRIT------HIPENILSLDPTCTIILEDNPLSSR-IRESLSQQTAQ 256
Query: 224 AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV 283
+ + A E +N FS
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA-F 315
Query: 284 PNTFGNCRQLQILSLGDNQLTT 305
+ + + S Q+
Sbjct: 316 LDRLSDTVSARNTSGFREQVAA 337
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 37/201 (18%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSC 745
LG GSF K + + AVK+ + R + E ++ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 746 SNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ L+M+ + G L +K +S + IM + SA+ ++H G
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSE------TEASYIMRKLVSAVSHMHDVG--- 126
Query: 800 PIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----- 851
++H DLKP N+L +D++ + DFG A+L + +T T+ Y APE
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQN 184
Query: 852 -YGSEGIVSISGDVYSFGILM 871
Y D++S G+++
Sbjct: 185 GYDES------CDLWSLGVIL 199
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 48/196 (24%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG GSF V K AVKV N +++ + E E+++++ H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIH 803
+ ++ + G L + + I+ V S + Y+H H I+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN----IVH 144
Query: 804 CDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-----YGSE 855
DLKP N+LL + D + DFG++ + + T Y+APE Y +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLRGTYDEK 202
Query: 856 GIVSISGDVYSFGILM 871
DV+S G+++
Sbjct: 203 ------CDVWSAGVIL 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA-LKSFDTECEV-MRRIRHRNLIKIVSS 744
LG G++ V K + +G +AVK + K + ++ MR + + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 745 CSNPGFKALIMQYMPQGSLE---KWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
G + M+ M SL+ K + ++ I + + ALE+LH S +
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----YGSEGI 857
IH D+KP+NVL++ + DFGI+ L VD V + + YMAPE ++
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 858 VSISGDVYSFGILMME 873
S+ D++S GI M+E
Sbjct: 190 YSVKSDIWSLGITMIE 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 38/203 (18%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + G+ A K+ N + R + + E + R+++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 745 CSNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYS 798
F L+ + G L + YS + + ++ Y H +G
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSE------ADASHCIQQILESIAYCHSNG-- 125
Query: 799 TPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE--- 851
I+H +LKP N+LL L DFG+A V+ A T GY++PE
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLK 180
Query: 852 ---YGSEGIVSISGDVYSFGILM 871
Y V D+++ G+++
Sbjct: 181 KDPYSKP--V----DIWACGVIL 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 647 RRRKRNKSLPEENNSLNLATLSRISYHELQQATNGFGE----SNLLGSGSFDNVYKAT-L 701
+K N + P+ +L ++ A F + +++G G V +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 702 ANGVSVAVKVFNL--------QEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKA 752
A G AVK+ + Q + ++ E ++R++ H ++I ++ S + F
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNV 811
L+ M +G L +L L+ ++ IM + A+ +LH + I+H DLKP N+
Sbjct: 177 LVFDLMRKGELFDYLTEKVA-LSEKETRSIMRSLLEAVSFLHANN----IVHRDLKPENI 231
Query: 812 LLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE 851
LLDD+M L DFG + ++P + L T GY+APE
Sbjct: 232 LLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAPE 269
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSG+ V A VA+K NL++ + + E + M + H N++ +S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 746 SNPGFKALIMQYMPQGSLEKWL-YSHNYSLTIRQRLD------IMIDVASALEYLHHGYS 798
L+M+ + GS+ + + LD I+ +V LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGI-AKLLDGVDPVTQTMTLATIG---YMAPEYGS 854
IH D+K N+LL +D + DFG+ A L G D + +G +MAPE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV-- 197
Query: 855 EGIVSISG-----DVYSFGILMME 873
+ + G D++SFGI +E
Sbjct: 198 --MEQVRGYDFKADIWSFGITAIE 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 44/209 (21%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+ VY+ A+KV D+ K TE V+ R+ H N+IK
Sbjct: 57 VES--ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 741 IVSSCSNPGFKALIMQYMPQGSL-----EKWLYS-HNYSLTIRQRLDIMIDVASALEYLH 794
+ P +L+++ + G L EK YS + + ++Q + A+ YLH
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ-------ILEAVAYLH 165
Query: 795 -HGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA--TIGYM 848
+G I+H DLKP N+L D + DFG++K+++ M T GY
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH----QVLMKTVCGTPGYC 217
Query: 849 APE------YGSEGIVSISGDVYSFGILM 871
APE YG E V D++S GI+
Sbjct: 218 APEILRGCAYGPE--V----DMWSVGIIT 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 46/234 (19%), Positives = 90/234 (38%), Gaps = 40/234 (17%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFN---LQEDRALKSFDT--------------ECEVM 730
L G F+ + + A+K + L++ R + E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH-------NYSLTIRQRLDIM 783
I++ + +N +I +YM S+ K+ + I+ I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM--T 841
V ++ Y+H+ + I H D+KP+N+L+D + L DFG ++ + D + T
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGT 213
Query: 842 LATIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+M PE D++S GI + F P F+ ++SL +
Sbjct: 214 YE---FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 54/293 (18%), Positives = 106/293 (36%), Gaps = 32/293 (10%)
Query: 166 LPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAI 225
L + +++ +N+T + +L + L G + + + +N++ +
Sbjct: 18 LANAIKIAAGKSNVTDTVT-------QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68
Query: 226 LLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPN 285
L N ++ L L + L L N L + I L+L+S + + P
Sbjct: 69 ELKDNQIT-DLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP- 124
Query: 286 TFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNL 345
LQ+L L NQ+T S LA L+ L + + + P + NL
Sbjct: 125 -LAGLSNLQVLYLDLNQITN---------ISPLAGLTNLQYLSIGNAQVSDLTP--LANL 172
Query: 346 STSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405
+ L A +++S I +L NL+ + L NN+++ P L L + L +
Sbjct: 173 -SKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQ 227
Query: 406 KLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST 458
+ L N + + A P +++ + + N +
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 68/311 (21%), Positives = 113/311 (36%), Gaps = 51/311 (16%)
Query: 194 NLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253
L N + G +N+ + + + + +G ++ + YL NL L L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73
Query: 254 NLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQI 313
++ + P + N ++ T LELS N + + ++ L L Q+T
Sbjct: 74 QITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD-------- 121
Query: 314 FYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNL 373
+ LA L+VL LD N + + P L+NL
Sbjct: 122 -VTPLAGLSNLQVLYLDLNQITNISP---------------------------LAGLTNL 153
Query: 374 LVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQG 433
LS+ N +++ P L L KL L + NK+ P L L L + NN +
Sbjct: 154 QYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209
Query: 434 QIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEAL 493
P LAN ++L + + ++ + +L V S + P I +
Sbjct: 210 VSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV--KGPSGAPIAPATISDNGTY 265
Query: 494 GGLNLTGNQLS 504
NLT N S
Sbjct: 266 ASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 71/336 (21%), Positives = 120/336 (35%), Gaps = 56/336 (16%)
Query: 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301
L N + K+N++ + + T L + + L L L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDN 73
Query: 302 QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSG 361
Q+T + L + L L NPLK V I L S++ S+Q++
Sbjct: 74 QITD---------LAPLKNLTKITELELSGNPLKNVSA--IAGL-QSIKTLDLTSTQITD 121
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKL 421
LSNL VL L N++ P L L LQ L + + ++ P L L KL
Sbjct: 122 --VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKL 175
Query: 422 NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
TL +++N + I LA+L +L + ++N ++ P
Sbjct: 176 TTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--------------------- 212
Query: 482 SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPI-PQSFGSLIS 540
+ N L + LT ++ NL + + + PI P + +
Sbjct: 213 -----LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN---VVKGPSGAPIAPATISDNGT 264
Query: 541 LQSLDLSGNNIS--GEIPKSLEKLSRLVDFNVSFNG 574
S +L+ N S + + + + V F+G
Sbjct: 265 YASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSG 300
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 51/277 (18%), Positives = 91/277 (32%), Gaps = 50/277 (18%)
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTS 348
++ G + +T + A + L + + + L +
Sbjct: 17 ALANAIKIAAGKSNVTD---------TVTQADLDGITTLSAFGTGVTTIEG--VQYL-NN 64
Query: 349 LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLK 408
L +Q++ P NL+ + L L N L + LQ ++ LDL S ++
Sbjct: 65 LIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT 120
Query: 409 GFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKY 468
P L L L L + N + P LA LT+L++L + ++ P
Sbjct: 121 DVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-------- 168
Query: 469 ILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528
+ NL L L N++S S + +L NL + L N
Sbjct: 169 ------------------LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS 208
Query: 529 GPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565
P + +L + L+ I+ + L
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 45/238 (18%), Positives = 90/238 (37%), Gaps = 24/238 (10%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
L+ + + ++ DT+ + + + ++ ++ G L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELK 71
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
N+IT + + N++ + + L N L L S+ L L IT
Sbjct: 72 DNQITD--LAPLKNLTKITELELSGNPLKNVSAIA---GLQSIKTLDLTSTQIT------ 120
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE 246
++ + L NL++L L N I + P + +N+ + + +S L L L
Sbjct: 121 DVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTPLANLSKLT 176
Query: 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
L N +S I P + + + L +N S + P N L I++L + +T
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 47/223 (21%), Positives = 92/223 (41%), Gaps = 26/223 (11%)
Query: 63 PHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLES 122
+ NL+ + L +SGN + + + ++ +K +D +S ++ P + L+
Sbjct: 79 APLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP---LAGLSNLQV 133
Query: 123 FDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC--TRLPSLVQLRLLGNNIT 180
+ N+IT S + +++L+ + + N + +DL L L L+ N I+
Sbjct: 134 LYLDLNQITNI--SPLAGLTNLQYLSIGNAQV-----SDLTPLANLSKLTTLKADDNKIS 186
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
+I + +L NL + L N I+ + P + N SN+ + L ++
Sbjct: 187 ------DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT--NQPVF 235
Query: 241 YLPNLENLFLWKNNLSGII-PDSICNASEATILELSSNLFSGL 282
Y NL + K I P +I + L+ NL S +
Sbjct: 236 YNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 43/220 (19%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 65 VGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFD 124
+ L + +L+++ D P L + L+++ N ++ ++ T L+
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLS 157
Query: 125 VSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIP 184
+ + +++ + + N+S L +++ D+N +S P LP+L+++ L N I+ P
Sbjct: 158 IGNAQVSDL--TPLANLSKLTTLKADDNKISDISP---LASLPNLIEVHLKNNQISDVSP 212
Query: 185 NREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY-LP 243
+ N NL I+ L I +NN+ +V ++ G + P++I
Sbjct: 213 -------LANTSNLFIVTLTNQTITNQPV--FYNNNLVVPNVVKGPSGAPIAPATISDNG 263
Query: 244 NLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV 283
+ L NL+ I + +++ + ++ FSG V
Sbjct: 264 TYASPNL-TWNLTSFINNVSYTFNQSVTFKNTTVPFSGTV 302
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 38/207 (18%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN--------LQEDRALKSFDTECEVMRRIRHRNL 738
LGSG+ V A VA+K+ + +E + +TE E+++++ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
IKI + + ++++ M G L + + L + A++YLH +G
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENG- 134
Query: 798 STPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE-- 851
IIH DLKP NVLL ++D + + DFG +K+ + + TL T Y+APE
Sbjct: 135 ---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVL 188
Query: 852 -------YGSEGIVSISGDVYSFGILM 871
Y V D +S G+++
Sbjct: 189 VSVGTAGYNRA--V----DCWSLGVIL 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 10/188 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG+G+F V++ T A G + A K + ++ E + M +RH L+ + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCD 805
+ +I ++M G L + + + ++ + ++ M V L ++H + +H D
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLD 280
Query: 806 LKPNNVLLDDDMVAHL--GDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
LKP N++ L DFG+ LD V T T + APE V D
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEGKPVGYYTD 338
Query: 864 VYSFGILM 871
++S G+L
Sbjct: 339 MWSVGVLS 346
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 50/196 (25%), Positives = 77/196 (39%), Gaps = 27/196 (13%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS+ V A + A K + F E E+M+ + H N+I++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCD 805
+ L+M+ G L + + IM DV SA+ Y H + H D
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLN----VAHRD 131
Query: 806 LKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE-----YGSE 855
LKP N L D L DFG+A + M + T Y++P+ YG E
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKP----GKMMRTKVGTPYYVSPQVLEGLYGPE 187
Query: 856 GIVSISGDVYSFGILM 871
D +S G++M
Sbjct: 188 ------CDEWSAGVMM 197
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 51/216 (23%), Positives = 83/216 (38%), Gaps = 14/216 (6%)
Query: 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302
+ +NL L N L + S + E +L+LS + + + L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
+ S F + L+ LV L + IG+L +L+ + +
Sbjct: 88 IQ---SLALGAF----SGLSSLQKLVAVETNLASLENFPIGHL-KTLKELNVAHNLIQSF 139
Query: 363 IPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQG----LDLNSNKLKGFIPTDLCK 417
F NL+NL L L +N++ T L L ++ LDL+ N + FI K
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453
+L L + N L+ LTSL+ + +N
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 63/293 (21%), Positives = 102/293 (34%), Gaps = 82/293 (27%)
Query: 259 IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318
IPD++ L+LS N L +F + +LQ+L L ++ + + + SL
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI---QTIEDGAY-QSL 75
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLS 377
+ L L+L NP++ + +G F LS+L L
Sbjct: 76 SH---LSTLILTGNPIQS--------------------------LALGAFSGLSSLQKLV 106
Query: 378 LVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPT 437
V LA +G L+ L+ L++ N ++ F +
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF--------------------- 145
Query: 438 CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGG-L 496
+NLT+L HLD SN + S + L + L L
Sbjct: 146 --SNLTNLEHLDLSSNKIQSIYCTDLRVLH---------------------QMPLLNLSL 182
Query: 497 NLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
+L+ N ++ +I L LAL N + F L SLQ + L N
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 45/226 (19%), Positives = 81/226 (35%), Gaps = 26/226 (11%)
Query: 117 FTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
++ D+S N + + + L+ + L + + L L L L G
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 177 NNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAILLYGNHLSG 234
N I + L +L+ L N+A L + + + + + N +
Sbjct: 86 NPIQ------SLALGAFSGLSSLQKLVAVETNLASL-ENFPIGHLKTLKELNVAHNLIQ- 137
Query: 235 HLPSSIY---LPNLENLFLWKNNLSGIIPDSICNASEATI----LELSSNLFSGLVPNTF 287
Y L NLE+L L N + I + + + L+LS N + + P F
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 288 GNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNP 333
+L+ L+L NQL + + + L+ + L TNP
Sbjct: 198 KEI-RLKELALDTNQLKS-------VPDGIFDRLTSLQKIWLHTNP 235
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 16/219 (7%)
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC-KLEK 420
+P + L L N L +LQ LDL+ +++ I L
Sbjct: 25 NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480
L+TL+ N +Q + L+SL+ L +L S LK + ++ + N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 481 GSLPLN--IGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDW----LALARNAFQGPIPQS 534
S L NL L L+L+ N++ + + L + L L+ N P +
Sbjct: 138 -SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 535 FGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
F + L+ L L N + ++L+ L + N
Sbjct: 197 FKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 14/191 (7%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G GSF V+K VA+K+ +L + + ++ E V+ + + K S
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+IM+Y+ GS L L Q I+ ++ L+YLH S IH D
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SEKKIHRD 144
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPEYGSEGIVSISG 862
+K NVLL + L DFG+A L T +G +MAPE +
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDSKA 200
Query: 863 DVYSFGILMME 873
D++S GI +E
Sbjct: 201 DIWSLGITAIE 211
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 46/202 (22%), Positives = 85/202 (42%), Gaps = 39/202 (19%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRR-IRHRNLIKIVSSC 745
+G GS+ + A + AVK+ + + E E++ R +H N+I +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTE-EIEILLRYGQHPNIITLKDVY 85
Query: 746 SNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ + ++ + M G L + +S R+ ++ + +EYLH G
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSE------REASAVLFTITKTVEYLHAQG--- 136
Query: 800 PIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE---- 851
++H DLKP+N+L + + DFG AK L + + T T ++APE
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-CYTANFVAPEVLER 194
Query: 852 --YGSEGIVSISGDVYSFGILM 871
Y + D++S G+L+
Sbjct: 195 QGYDAA--C----DIWSLGVLL 210
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-22
Identities = 43/189 (22%), Positives = 84/189 (44%), Gaps = 13/189 (6%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F V++ ++ + K ++ D+ E ++ RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNILHLHESF 70
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHC 804
+ +I +++ + + + + + L R+ + + V AL++LH H I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN----IGHF 126
Query: 805 DLKPNNVLLDDDMVAHL--GDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
D++P N++ + + +FG A+ L D T Y APE +VS +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVVSTAT 184
Query: 863 DVYSFGILM 871
D++S G L+
Sbjct: 185 DMWSLGTLV 193
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 9e-22
Identities = 37/209 (17%), Positives = 70/209 (33%), Gaps = 39/209 (18%)
Query: 689 GSGSFDNVYKAT-LANGVSVAVKVFNL--QEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
G V A G V V+ NL + + E V + H N++ ++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEYLH-HGYS 798
++ +M GS ++ I+ V AL+Y+H GY
Sbjct: 96 IADNELWVVTSFMAYGSA-----KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY- 149
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT---IG---YMAPE- 851
+H +K +++L+ D +L + + + + +++PE
Sbjct: 150 ---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 852 -------YGSEGIVSISGDVYSFGILMME 873
Y ++ D+YS GI E
Sbjct: 207 LQQNLQGYDAK------SDIYSVGITACE 229
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 42/249 (16%)
Query: 650 KRNKSLPEENNSLNLATLSRISYHELQQATNGFGE----SNLLGSGSFDNVYKAT-LANG 704
+ S EN ++ Y +++ GE LGSG++ V
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 705 VSVAVKV-------------FNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751
A+KV N ++ + E +++ + H N+IK+ + +
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNN 810
L+ ++ G L + + + + +IM + S + YLH H I+H D+KP N
Sbjct: 122 YLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLHKHN----IVHRDIKPEN 176
Query: 811 VLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-----YGSEGIVSISG 862
+LL + + + DFG++ + L T Y+APE Y +
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYYIAPEVLKKKYNEK------C 228
Query: 863 DVYSFGILM 871
DV+S G++M
Sbjct: 229 DVWSCGVIM 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LGSG+F +V+ ++G+ +K N Q + + E EV++ + H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHPNIIKIFE 87
Query: 744 SCSNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
+ ++M+ G L S ++M + +AL Y H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE--GYVAELMKQMMNALAYFHSQH- 144
Query: 798 STPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA--TIGYMAPE- 851
++H DLKP N+L + DFG+A+L + T A T YMAPE
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS----DEHSTNAAGTALYMAPEV 197
Query: 852 ----YGSEGIVSISGDVYSFGILM 871
+ D++S G++M
Sbjct: 198 FKRDVTFK------CDIWSAGVVM 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 51/243 (20%), Positives = 87/243 (35%), Gaps = 69/243 (28%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT-----ECEVMRRIRHRNLIKI 741
+G GS+ V A A+K+ N + R + D E +M+++ H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 742 VSSCSNPGFKALIMQYMPQGSL-------------------------------------- 763
+ + L+M+ G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 764 -EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHL 821
+ S ++ + +IM + SAL YLH G I H D+KP N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209
Query: 822 --GDFGIAKLLDGVDPVTQTM--TLA-TIGYMAPE--------YGSEGIVSISGDVYSFG 868
DFG++K ++ T A T ++APE YG + D +S G
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAG 263
Query: 869 ILM 871
+L+
Sbjct: 264 VLL 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 52/204 (25%), Positives = 82/204 (40%), Gaps = 33/204 (16%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKIV 742
+LG GSF V A A A+K+ + E +VM R+ H +K+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVASALEYLHHG 796
+ + + Y G L + + D ++ SALEYLH
Sbjct: 97 FTFQDDEKLYFGLSYAKNGEL----LKY---IRKIGSFDETCTRFYTAEIVSALEYLH-- 147
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE---- 851
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 852 --YGSEGIVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 207 KSACK------SSDLWALGCIIYQ 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 13/223 (5%)
Query: 659 NNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED 717
+S I Q N +GSG+ V+K G +AVK +
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63
Query: 718 RA-LKSFDTECEV-MRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLT 775
+ K + +V ++ +++ + + M+ M EK +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP 122
Query: 776 IRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835
R + + + AL YL + +IH D+KP+N+LLD+ L DFGI+ L VD
Sbjct: 123 ERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDD 178
Query: 836 VTQTMTLATIGYMAPE-----YGSEGIVSISGDVYSFGILMME 873
+ + YMAPE ++ I DV+S GI ++E
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 35/230 (15%)
Query: 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD 724
+L I L+ F L+G+G++ VYK + G A+KV ++ D +
Sbjct: 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIK 68
Query: 725 TECEVMRRI-RHRNLIK-----IVSSCSNPGFKA-LIMQYMPQGSLEKWLYSHNYSLTIR 777
E ++++ HRN+ I + + L+M++ GS+ + T
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-----TDLIKNTKG 123
Query: 778 QRLD------IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
L I ++ L +LH +IH D+K NVLL ++ L DFG++ LD
Sbjct: 124 NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 832 GVDPVTQTMTLATIG---YMAPEYGSEGIVSISG-----DVYSFGILMME 873
T IG +MAPE + + D++S GI +E
Sbjct: 181 RTVGRRNTF----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 27/182 (14%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSS 744
+LG G+ V L AVK+ Q E E++ + + HRN+++++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 745 CSNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYS 798
L+ + M GS+ ++ ++ + ++ DVASAL++LH G
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE------LEASVVVQDVASALDFLHNKG-- 131
Query: 799 TPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLL----DGVDPVTQTMTLA--TIGYMA 849
I H DLKP N+L + + DF + + D T + + YMA
Sbjct: 132 --IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 850 PE 851
PE
Sbjct: 190 PE 191
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 39/236 (16%), Positives = 83/236 (35%), Gaps = 55/236 (23%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ------EDRALKSFDTECEVMRRI- 733
F E +GSG F +V+K +G A+K E AL+ E +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR----EVYAHAVLG 68
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTI---RQRLDIMIDVASAL 790
+H ++++ S+ + + +Y GSL + + ++ + D+++ V L
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDD-------------------MVAHLGDFGIAKLLD 831
Y+H S ++H D+KP+N+ + ++ +GD G +
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 832 GVDPVTQTMTLATIGYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKP 880
Q ++A E + D+++ + ++
Sbjct: 186 S----PQVEE-GDSRFLANEVLQENYTHLP------KADIFALALTVVCAAGAEPL 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 34/202 (16%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA---LKSFDTECEVMRRIRHRNLIKIVS 743
+G GSF VY A + N VA+K + ++ + E ++++RH N I+
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
L+M+Y GS L H L + + L YLH S +IH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 177
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPE--------- 851
D+K N+LL + + LGDFG A ++ + +G +MAPE
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIM------APANSF--VGTPYWMAPEVILAMDEGQ 229
Query: 852 YGSEGIVSISGDVYSFGILMME 873
Y + DV+S GI +E
Sbjct: 230 YDGK------VDVWSLGITCIE 245
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 45/196 (22%), Positives = 79/196 (40%), Gaps = 19/196 (9%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN------LQEDRALKSFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + + + E ++R++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ N LI++ + G L +L L+ + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKK--- 135
Query: 800 PIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
I H DLKP N++L L DFG+A ++ T ++APE +
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNY 192
Query: 856 GIVSISGDVYSFGILM 871
+ + D++S G++
Sbjct: 193 EPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 19/196 (9%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN------LQEDRALKSFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + + + + E ++R++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ N LI++ + G L +L L+ + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKK--- 135
Query: 800 PIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
I H DLKP N++L L DFG+A ++ T ++APE +
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPEIVNY 192
Query: 856 GIVSISGDVYSFGILM 871
+ + D++S G++
Sbjct: 193 EPLGLEADMWSIGVIT 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G G++ V+KA VA+K L +D AL+ E +++ ++H+N+++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + L+ ++ Q L+K+ S N L + + L + H
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIV 858
++H DLKP N+L++ + L +FG+A+ G+ + + T+ Y P+ +G++ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAK-LY 179
Query: 859 SISGDVYSFGILMMETFTRRKPTNEMFTGE 888
S S D++S G + E +P +F G
Sbjct: 180 STSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 51/202 (25%), Positives = 79/202 (39%), Gaps = 31/202 (15%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN------LQEDRALKSFDTECEVMRRIRHRNLIK 740
LGSG F V K G A K + + + + E ++R IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ N LI++ + G L +L LT + + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILDGVHYLHSKR--- 128
Query: 800 PIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE---- 851
I H DLKP N++L + L DFGIA ++ + T ++APE
Sbjct: 129 -IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAPEIVNY 185
Query: 852 --YGSEGIVSISGDVYSFGILM 871
G E D++S G++
Sbjct: 186 EPLGLE------ADMWSIGVIT 201
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 52/247 (21%), Positives = 82/247 (33%), Gaps = 26/247 (10%)
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPS-AIVNISSLKSIRLDN 151
R + F L + + F LE ++S N + + N+ L IR++
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 152 -NSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIA 209
N+L + LP+L L + I +P+ + +LD+ N
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIK------HLPDVHKIHSLQKVLLDIQDNINI 141
Query: 210 GLIPSMIFNN--SNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNN-LSGIIPDSICNA 266
I F V + L N + S+ L+ L L NN L + D A
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201
Query: 267 SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRV 326
S IL++S L N ++L+ S L +L K L
Sbjct: 202 SGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK---------LPTLEKLVALME 250
Query: 327 LVLDTNP 333
L T P
Sbjct: 251 ASL-TYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 49/338 (14%), Positives = 97/338 (28%), Gaps = 92/338 (27%)
Query: 143 SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILD 202
S + + ++ P+DL + ++LR + + I +L+ ++
Sbjct: 10 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLR-VIQ----KGAFSGFGDLEKIE 60
Query: 203 LGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS 262
+ N++ +I + +F+N LP L + + K N
Sbjct: 61 ISQNDVLEVIEADVFSN----------------------LPKLHEIRIEKANN------- 91
Query: 263 ICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322
+L ++ F L LQ L + + + SL
Sbjct: 92 --------LLYINPEAFQNL--------PNLQYLLISNTGIK---HLPDVHKIHSLQ--- 129
Query: 323 YLRVLVLDTNP-LKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVN 380
+L + N + + NS LS + + + I F + N
Sbjct: 130 -KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDN 187
Query: 381 NELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA 440
N L V LD++ ++ +P+ L
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-----------------------LE 223
Query: 441 NLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478
NL LR S +P+ L ++ + S
Sbjct: 224 NLKKLRAR---STYNLKKLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 38/254 (14%), Positives = 70/254 (27%), Gaps = 33/254 (12%)
Query: 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVN-N 381
L L+ + + LE + + I F NL L + + N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGF-GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 382 ELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNNNALQGQIPTCLA 440
L P L LQ L +++ +K + L + +N +
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 441 NLTS-LRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLT 499
L+ L N + S F L+ L
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGT----------------------QLDEL--NLSD 186
Query: 500 GNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
N L L ++R +L L++ ++P +L
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TL 242
Query: 560 EKLSRLVDFNVSFN 573
EKL L++ ++++
Sbjct: 243 EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 34/166 (20%), Positives = 59/166 (35%), Gaps = 10/166 (6%)
Query: 422 NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
L + + +IP+ L + L F L F + ++ S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 482 SLPLNI-GNLEALGGLNLT-GNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSL 538
+ ++ NL L + + N L YI NL NL +L ++ +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 539 ISLQSLDLSGNNISGEIP-KSLEKLS-RLVDFNVSFNGLEGEIPSG 582
+ LD+ N I S LS V ++ NG++ EI +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNS 172
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 31/202 (15%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFD---TECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + R S + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
+ N LI++ + G L +L LT + + + + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 800 PIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE---- 851
I H DLKP N++L + DFG+A +D + T ++APE
Sbjct: 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNY 191
Query: 852 --YGSEGIVSISGDVYSFGILM 871
G E D++S G++
Sbjct: 192 EPLGLE------ADMWSIGVIT 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN--------LQEDRALKSFDTECEVMRRIRHRNL 738
LGSG+F V+ A V VK ED L E ++ R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALEY 792
IK++ N GF L+M+ G L+ L++ + RLD I + SA+ Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAF---IDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
L IIH D+K N+++ +D L DFG A L+ + T TI Y APE
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYT-FCGTIEYCAPE- 199
Query: 853 GSEGIVSISG--------DVYSFGILM 871
+ G +++S G+ +
Sbjct: 200 ------VLMGNPYRGPELEMWSLGVTL 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 37/205 (18%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT----ECEVMRRIRHRNLIKI 741
LLG GS+ V + AVK+ ++ R + + + E +++RR+RH+N+I++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 742 --VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALE 791
V ++M+Y G E + +R + A LE
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDS----VPEKRFPV--CQAHGYFCQLIDGLE 123
Query: 792 YLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----G 846
YLH G I+H D+KP N+LL + G+A+ L P T T
Sbjct: 124 YLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAADDTCRTSQGSPA 176
Query: 847 YMAPE--YGSEGIVSISGDVYSFGI 869
+ PE G + D++S G+
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGV 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 37/203 (18%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSS 744
+LG G V + G A+K+ D E + + +++ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKAR--QEVDHHWQASGGPHIVCILDV 90
Query: 745 CSNPGFKA----LIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYS 798
N +IM+ M G L + + + T R+ +IM D+ +A+++LH H
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-- 148
Query: 799 TPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE--- 851
I H D+KP N+L + D V L DFG AK T T Y+APE
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLG 202
Query: 852 ---YGSEGIVSISGDVYSFGILM 871
Y D++S G++M
Sbjct: 203 PEKYDKS------CDMWSLGVIM 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 29/199 (14%), Positives = 59/199 (29%), Gaps = 40/199 (20%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIV 742
G ++A A VA+ + Q D L+ + + RI + +++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPI 801
++ +++ GSL++ + + + M +A+A + H G +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG----V 150
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
P+ V + D G LA M +
Sbjct: 151 ALSIDHPSRVRVSID--------GDVV-------------LAYPATMPD-------ANPQ 182
Query: 862 GDVYSFGILMMETFTRRKP 880
D+ G + R P
Sbjct: 183 DDIRGIGASLYALLVNRWP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIKI 741
+G G++ VYKA + G VA+K L + A++ E +++ + H N++ +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ + L+ ++M + L+K L + L Q + + + + H I
Sbjct: 85 IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---I 140
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGI 857
+H DLKP N+L++ D L DFG+A+ PV ++ T + T+ Y AP+ GS+
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFG--IPV-RSYTHEVVTLWYRAPDVLMGSK-K 196
Query: 858 VSISGDVYSFGILMMETFTRR 878
S S D++S G + E T +
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
+G GSF V A+K N E +++ E ++M+ + H L+ +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALEYLH 794
S + +++ + G L H ++Q + + AL+YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDL----RYH-----LQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE-Y 852
+ IIH D+KP+N+LLD+ H+ DF IA + + TQ T+A T YMAPE +
Sbjct: 133 ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM---LPRETQITTMAGTKPYMAPEMF 186
Query: 853 GSEGIV--SISGDVYSFGILMMETFTRRKP 880
S S + D +S G+ E R+P
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 44/201 (21%), Positives = 77/201 (38%), Gaps = 31/201 (15%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHR-NLIKI 741
LG G F V + + G A K Q+ RA E V+ + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA--EILHEIAVLELAKSCPRVINL 94
Query: 742 VSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
N LI++Y G + L ++ + ++ + + YLH +
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--- 151
Query: 800 PIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----- 851
I+H DLKP N+LL + DFG+++ + + + M T Y+APE
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILNYD 208
Query: 852 -YGSEGIVSISGDVYSFGILM 871
+ D+++ GI+
Sbjct: 209 PITTA------TDMWNIGIIA 223
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 2e-18
Identities = 52/254 (20%), Positives = 93/254 (36%), Gaps = 26/254 (10%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
+ + N+ S D + + + I +++ + S+ G + ++
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLN 73
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC--TRLPSLVQLRLLGNNITGRIP 184
NK+T P + N+ +L + LD N + DL L L L L N I+
Sbjct: 74 GNKLTDIKP--LTNLKNLGWLFLDENKI-----KDLSSLKDLKKLKSLSLEHNGIS---- 122
Query: 185 NREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPN 244
+I + +L L+ L LG N I + + + + + L N +S + L
Sbjct: 123 --DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVPLAGLTK 176
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
L+NL+L KN++S + ++ +LEL S N N + D L
Sbjct: 177 LQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
Query: 305 TGSSAQGQIFYSSL 318
T Y
Sbjct: 235 TPEIISDDGDYEKP 248
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 2e-18
Identities = 54/327 (16%), Positives = 108/327 (33%), Gaps = 35/327 (10%)
Query: 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDL 203
+ + + FP D ++ L ++T + L+++ +
Sbjct: 1 MGETITVSTPIKQIFPDD---AFAETIKDNLKKKSVTDAVT-------QNELNSIDQIIA 50
Query: 204 GGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSI 263
++I + I N+ + L GN L+ + L NL LFL +N + + +
Sbjct: 51 NNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIKDLSS--L 105
Query: 264 CNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY 323
+ + L L N S + + QL+ L LG+N++T + L++
Sbjct: 106 KDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD---------ITVLSRLTK 154
Query: 324 LRVLVLDTNPLKGVIPNSIGNLS--TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNN 381
L L L+ N + I L+ T L+N Y + +S L NL VL L +
Sbjct: 155 LDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQ 207
Query: 382 ELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLAN 441
E L + L + + + ++
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQ 267
Query: 442 LTSLRHLDFRSNSLNSTIPSTFWSLKY 468
++ R + + +++ Y
Sbjct: 268 PVTIGKAKARFHGRVTQPLKEVYTVSY 294
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 9e-17
Identities = 64/380 (16%), Positives = 111/380 (29%), Gaps = 52/380 (13%)
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
+ + I PD +E L + V + + ++ +
Sbjct: 1 MGETITVSTPIKQIFPDDAF--AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 305 TGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIP 364
+ + + L L+ N L I L+
Sbjct: 57 S---------VQGIQYLPNVTKLFLNGNKLT-----DIKPLT------------------ 84
Query: 365 VGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL 424
NL NL L L N++ L L+KL+ L L N + L L +L +L
Sbjct: 85 ----NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESL 136
Query: 425 -LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSL 483
L NN + T L+ LT L L N + S I L + + S N +S
Sbjct: 137 YLGNN---KITDITVLSRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYLSKNHISDLR 191
Query: 484 PLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQS 543
L L+ L L L + + NL + + + P S +
Sbjct: 192 ALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 249
Query: 544 LDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSS 603
+ + E+ + + F+G + V++ D + +
Sbjct: 250 VKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGT 309
Query: 604 RLQVPPCKTSSTHKSKATKI 623
R+ P T + K
Sbjct: 310 RITAPKPPTKQGYVFKGWYT 329
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 6e-05
Identities = 25/161 (15%), Positives = 56/161 (34%), Gaps = 18/161 (11%)
Query: 51 SLPNLSLGG---TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSG 107
L +LSL + + +L L SL + N D L + +L + N +S
Sbjct: 110 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS- 166
Query: 108 SLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP 167
+ T+L++ +S N I+ A+ + +L + L + + L
Sbjct: 167 DIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQ-SNLV 221
Query: 168 SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI 208
++ ++ P I + + + ++ +
Sbjct: 222 VPNTVKNTDGSL-------VTPEIISDDGDYEKPNVKWHLP 255
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 40/216 (18%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN--------------------------LQEDRA 719
+G GS+ V A + A+KV + +Q
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 720 LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIR 777
++ E +++++ H N++K+V +P L + + + QG + L+
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLKPLSED 137
Query: 778 QRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
Q D+ +EYLH IIH D+KP+N+L+ +D + DFG++ G D +
Sbjct: 138 QARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 837 TQTMTLATIGYMAPEYGSEGIVSISG---DVYSFGI 869
T+ T +MAPE SE SG DV++ G+
Sbjct: 194 LSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 58/303 (19%), Positives = 98/303 (32%), Gaps = 65/303 (21%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G GS+ V+K G VA+K F ED AL+ E ++++++H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
++ L+ +Y ++ L + + I A+ + H H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-------Y 852
IH D+KP N+L+ V L DFG A+LL +AT Y +PE Y
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 853 GSEGIVSISGDVYSFGILMMETFTRR--------------------KPTNEMFTGEMSLK 892
G + DV++ G + E + + +
Sbjct: 181 GP----PV--DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234
Query: 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK 952
+ +P A C+ P ER+ +
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPNIS-YPALGLLKG--CLHM-----------DPTERLTCE 280
Query: 953 DAL 955
L
Sbjct: 281 QLL 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIKI 741
+G G++ VYKA G + A+K L+++ ++ E +++ ++H N++K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
L+ +++ Q L+K L L ++ + + + Y H +
Sbjct: 66 YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---V 121
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVS 859
+H DLKP N+L++ + + DFG+A+ G+ T + T+ Y AP+ GS+ S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSK-KYS 179
Query: 860 ISGDVYSFGILMMETFTRR 878
+ D++S G + E
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-18
Identities = 63/258 (24%), Positives = 97/258 (37%), Gaps = 40/258 (15%)
Query: 651 RNKSLPEENNSLNLATLSRISYHELQQAT-NGFGESNLLGSGSFDNVYKATL-ANGVSVA 708
E +SL + + E Q + F + +LG G F V+ + A G A
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA 214
Query: 709 VKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763
K L + R K + +++ ++ R ++ + + L+M M G +
Sbjct: 215 CKK--LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI 272
Query: 764 EKWLYSHNYSLTIRQRL---DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816
H Y++ I + S LE+LH II+ DLKP NVLLDDD
Sbjct: 273 ----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDD 325
Query: 817 MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGSEGIVSISGDVYSFGIL 870
+ D G+A L T+ T G+MAPE Y S D ++ G+
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDF------SVDYFALGVT 378
Query: 871 MMETFTRRKPTNEMFTGE 888
+ E R P F
Sbjct: 379 LYEMIAARGP----FRAR 392
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 46/228 (20%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
+GSG+ V A +VA+K F Q RA + E +M+ + H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 741 IV----SSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVAS 788
++ S F+ ++M+ M +L + I+ LD ++ +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELM-DANLCQ---------VIQMELDHERMSYLLYQMLC 138
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIG 846
+++LH S IIH DLKP+N+++ D + DFG+A+ + MT + T
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG----TSFMMTPYVVTRY 191
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
Y APE + D++S G +M E +F G + QW
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGV---LFPGTDHIDQW 235
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 49/229 (21%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK----IVS 743
+G+GSF V++A L VA+K + + E ++MR ++H N++ S
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS 103
Query: 744 SCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVASALEYLH- 794
+ L+++Y+P+ ++ + + +Q + + M + +L Y+H
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 795 HGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE 851
G I H D+KP N+LLD V L DFG AK+L +P + + Y APE
Sbjct: 160 IG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP----NVSYICSRYYRAPE 211
Query: 852 -------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
Y + +I D++S G +M E +P +F GE + Q
Sbjct: 212 LIFGATNYTT----NI--DIWSTGCVMAELMQ-GQP---LFPGESGIDQ 250
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 88/510 (17%), Positives = 156/510 (30%), Gaps = 106/510 (20%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGE----FPSAIVNISSLKSIRLD 150
++ +D LS + ++ Q + + +T SA+ +L + L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 151 NNSLSGSFPTDLCTRL----PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGN 206
+N L + L + +L L +TG + + + L L+ L L N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA-GCGVLSSTLRTLPTLQELHLSDN 123
Query: 207 NI-----AGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-----YLPNLENLFLWKNNLS 256
+ L ++ + + L LS + P+ + L + N+++
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
Query: 257 GIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYS 316
EA + L L + QL+ L L +T S +
Sbjct: 184 -----------EAGVRVLCQGLKD--------SPCQLEALKLESCGVT---SDNCRDLCG 221
Query: 317 SLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVL 376
+A LR L L +N L G ++L G+ S L L
Sbjct: 222 IVASKASLRELALGSNKLGD-----------------VGMAELCPGL---LHPSSRLRTL 261
Query: 377 SLVNNEL----AGAIPTVLGKLQKLQGLDLNSNKLKG--------FIPTDLCKLEKLNTL 424
+ + G + VL + L+ L L N+L + C+LE L
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW-- 319
Query: 425 LSNNN---ALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
+ + + A + LA L L +N L D + L
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE----------------DAGVRELCQ 363
Query: 482 SLPLNIGNLEALGGLNLTGNQLS----GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGS 537
L L L L +S + +++ +L L L+ N
Sbjct: 364 GLGQPGSVLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 420
Query: 538 LI-----SLQSLDLSGNNISGEIPKSLEKL 562
+ L+ L L S E+ L+ L
Sbjct: 421 SVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 84/471 (17%), Positives = 151/471 (32%), Gaps = 98/471 (20%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKIL 201
++S+ + LS + +L L +RL +T ++I + + L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC-KDISSALRVNPALAEL 61
Query: 202 DLGGNNI-----AGLIPSMIFNNSNMVAILLYGNHLS----GHLPSSI-YLPNLENLFLW 251
+L N + ++ + + + + L L+ G L S++ LP L+ L L
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 252 KNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQG 311
N L +A + L L L P +L+ L L L+ +A
Sbjct: 122 DNLL-----------GDAGLQLLCEGL---LDPQC-----RLEKLQLEYCSLS---AASC 159
Query: 312 QIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLS 371
+ S L + L + N I AG L G+ +
Sbjct: 160 EPLASVLRAKPDFKELTVSN--------NDINE---------AGVRVLCQGLKD---SPC 199
Query: 372 NLLVLSLVNNEL----AGAIPTVLGKLQKLQGLDLNSNKL-----KGFIPTDLCKLEKLN 422
L L L + + + ++ L+ L L SNKL P L +L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 423 TLLSNNNALQGQ----IPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478
TL + + + L SL+ L N L D
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG----------------DEGARL 303
Query: 479 LSGSLPLNIGNLEALGGLNLTGNQLSG----YIPSSIGNLKNLDWLALARNAFQGPIPQS 534
L +L LE+ L + + + S + + L L ++ N + +
Sbjct: 304 LCETLLEPGCQLES---LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE 360
Query: 535 FGSLI-----SLQSLDLSGNNISGE----IPKSLEKLSRLVDFNVSFNGLE 576
+ L+ L L+ ++S + +L L + ++S N L
Sbjct: 361 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 74/397 (18%), Positives = 134/397 (33%), Gaps = 68/397 (17%)
Query: 71 LVSLNISGNSFYDT----LPNELWHMRRLKIIDFSSNSLSGS----LPGDMCNSFTQLES 122
+ L++ L + L + L+ + S N L + L + + +LE
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 123 FDVSSNKITGE----FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP----SLVQLRL 174
+ ++ S + K + + NN ++ + LC L L L+L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206
Query: 175 LGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI-----AGLIPSMIFNNSNMVAILLYG 229
+T R++ + + +L+ L LG N + A L P ++ +S + + ++
Sbjct: 207 ESCGVTSDN-CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265
Query: 230 NHLS----GHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP 284
++ G L + +L+ L L N L + L L
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELG-----------DEGARLLCETLLE---- 310
Query: 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL--KGVIP--N 340
QL+ L + T +A F S LA+ R+L L + N L GV
Sbjct: 311 ----PGCQLESLWVKSCSFT---AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363
Query: 341 SIGNLSTSLENFYAGSSQLSGGIPVGFGNLS-------NLLVLSLVNNEL----AGAIPT 389
+G + L + +S +L+ +L L L NN L +
Sbjct: 364 GLGQPGSVLRVLWLADCDVS---DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 420
Query: 390 VLGKLQ-KLQGLDLNSNKLKGFIPTDLCKLEKLNTLL 425
+ + L+ L L + L LEK L
Sbjct: 421 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 457
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 55/230 (23%), Positives = 75/230 (32%), Gaps = 46/230 (20%)
Query: 242 LPNLENLFLWKNNLSGI---IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298
+ + + K NL+ + +P + TIL LS NL T +L L+L
Sbjct: 9 VASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 299 GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQ 358
+LT L L L N L+
Sbjct: 63 DRAELTK---------LQVDGTLPVLGTLDLSHNQLQS---------------------- 91
Query: 359 LSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC-K 417
+P+ L L VL + N L L L +LQ L L N+LK +P L
Sbjct: 92 ----LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
KL L NN L L L +L L + NSL + F S
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 50/190 (26%), Positives = 73/190 (38%), Gaps = 14/190 (7%)
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKL 421
+P + +L L N L L +L L+L+ +L L L
Sbjct: 28 DLPK------DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVL 79
Query: 422 NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
TL ++N LQ +P L +L LD N L S L + + N L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 482 SLPLNI-GNLEALGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSLI 539
+LP + L L+L N L+ +P+ + L+NLD L L N+ IP+ F
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195
Query: 540 SLQSLDLSGN 549
L L GN
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 48/191 (25%), Positives = 72/191 (37%), Gaps = 17/191 (8%)
Query: 397 LQGLDLNSNKLKGF---IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453
++ + L +P D L + N L L T L L+
Sbjct: 12 HLEVNCDKRNLTALPPDLPKDTTILH------LSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 454 SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI-G 512
L + + +L + +D S N L SLPL L AL L+++ N+L+ +P
Sbjct: 66 EL-TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 513 NLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL-EKLSRLVDFNVS 571
L L L L N + P L+ L L+ NN++ E+P L L L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 572 FNGLEGEIPSG 582
N L IP G
Sbjct: 181 ENSLYT-IPKG 190
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 44/209 (21%), Positives = 70/209 (33%), Gaps = 22/209 (10%)
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLK 199
++S + D +L+ + P DL L L N + + L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLY-TFS----LATLMPYTRLT 58
Query: 200 ILDLGGNNIAGLIPSMIFNN-SNMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSG 257
L+L + L + + + L N L LP LP L L + N L+
Sbjct: 59 QLNLDRAELTKL---QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS 114
Query: 258 IIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSS 317
+ ++ E L L N L P +L+ LSL +N LT + +
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT---ELPAGLL-NG 170
Query: 318 LAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
L L L+L N L + G+
Sbjct: 171 LEN---LDTLLLQENSLYTIPKGFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 57/218 (26%), Positives = 83/218 (38%), Gaps = 26/218 (11%)
Query: 25 PTNTSASVCNWVGVTCSIRHGRVAAL------SLPNLSLGG----TLPPHV-GNLSFLVS 73
P + V + + V C R + AL L L T + L
Sbjct: 2 PICEVSKVASHLEVNCDKR--NLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 74 LNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGE 133
LN+ T + L +D S N L SLP + + L DVS N++T
Sbjct: 60 LNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPL-LGQTLPALTVLDVSFNRLTSL 115
Query: 134 FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI- 192
A+ + L+ + L N L + P L T P L +L L NN+T E+P +
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT------ELPAGLL 168
Query: 193 GNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGN 230
L NL L L N++ IP F + + L+GN
Sbjct: 169 NGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 48/229 (20%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK----IV 742
+G+GSF VY+A L +G VA+K + + E ++MR++ H N+++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117
Query: 743 SSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVASALEYLH 794
SS L ++ Y+P+ ++ + ++ + +Q L + M + +L Y+H
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 795 HGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE 851
S I H D+KP N+LLD D V L DFG AK L +P + + Y APE
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRAPE 226
Query: 852 -------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
Y S SI DV+S G ++ E + P +F G+ + Q
Sbjct: 227 LIFGATDYTS----SI--DVWSAGCVLAELLLGQ-P---IFPGDSGVDQ 265
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 36/202 (17%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSC 745
LG G V + A+K+ E E+ R + ++++IV
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVY 124
Query: 746 SNPGFKA----LIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST 799
N ++M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 181
Query: 800 PIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---- 851
I H D+KP N+L + + L DFG AK + + T T Y+APE
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGP 237
Query: 852 --YGSEGIVSISGDVYSFGILM 871
Y D++S G++M
Sbjct: 238 EKYDKS------CDMWSLGVIM 253
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 53/225 (23%)
Query: 687 LLGSGSFDNVY----KATLANGVSVAVKVFNLQEDRALKSFDTEC-----EVMRRIRHRN 737
++G G+F V K+T A+K+ L + +K D+ ++M
Sbjct: 76 VIGRGAFGEVQLVRHKST---RKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SA 789
++++ + + + ++M+YMP G L + + D+ A A
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLA 180
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTLATIGY 847
L+ +H S IH D+KP+N+LLD H L DFG ++ V + T Y
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 848 MAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
++PE G +G D +S G+ + EM G+
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLY----------EMLVGD 270
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNL-QEDRALKSFDT----ECEVMRRIRHRNLIKI 741
LG G F VYKA VA+K L A + E ++++ + H N+I +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ + + +L+ +M LE + ++ LT M+ LEYLH + I
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 133
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGI 857
+H DLKPNN+LLD++ V L DFG+AK P + T + T Y APE +G+ +
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPN-RAYTHQVVTRWYRAPELLFGAR-M 189
Query: 858 VSISGDVYSFGILMMETFTRR 878
+ D+++ G ++ E R
Sbjct: 190 YGVGVDMWAVGCILAELLLRV 210
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 43/286 (15%), Positives = 81/286 (28%), Gaps = 31/286 (10%)
Query: 66 GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDM--CNSFTQLESF 123
G S L ++ LK + + + + + L+
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 124 DVSSNKITGEFPSAIVNIS--SLKSIRLDNNSLSG--SFPTDLCTRLPSLVQLRLLGNNI 179
+ + ++TG P ++ + L + L N S + ++ +L L +++ +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY-------GNHL 232
+ ++ L LDL N G + L
Sbjct: 161 SLNFS----CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 233 SGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEA-TILELSSNLFSGLVPNTFGNC 290
SG + L+ L L N+L C+ L LS +
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--- 273
Query: 291 RQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKG 336
+L +L L N+L S + + L L NP
Sbjct: 274 AKLSVLDLSYNRLDRN---------PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 46/280 (16%), Positives = 81/280 (28%), Gaps = 24/280 (8%)
Query: 265 NASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYL 324
S +L+ L+ L++ ++ + + L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG----ALRVLGISGL 97
Query: 325 RVLVLDTNPLKGVIPNSIGNLS-TSLENFYAGSSQLSGGIP----VGFGNLSNLLVLSLV 379
+ L L+ + G P + + L + + + L VLS+
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 380 NNELAGAIPTVLGKLQKLQGLDLNSNKLKG-------FIPTDLCKLEKLNTLLSNNNALQ 432
+ L LDL+ N G P L+ L +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 433 GQIPTCLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNIG-NL 490
G A L+ LD NSL + + +++ S L +P + L
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKL 276
Query: 491 EALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGP 530
L+L+ N+L P S L + L+L N F
Sbjct: 277 SV---LDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 48/296 (16%), Positives = 79/296 (26%), Gaps = 39/296 (13%)
Query: 168 SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILL 227
SL L + +I + +L L + + + S + + L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSL-SLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 228 YGNHLSGHLPSSI---YLPNLENLFLWKNNLSGIIPD----SICNASEATILELSSNLFS 280
++G P + P+L L L + + +L ++
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 281 GLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPN 340
L L L DN + L+VL L ++
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT---LQVLALRNAGME----- 214
Query: 341 SIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL-GKLQKLQG 399
SG L L L +N L A +L
Sbjct: 215 -----------------TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 400 LDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSL 455
L+L+ LK KL L+ LS N L P+ L + +L + N
Sbjct: 258 LNLSFTGLKQVPKGLPAKLSVLD--LSYNR-LDR-NPSPD-ELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 50/269 (18%), Positives = 79/269 (29%), Gaps = 36/269 (13%)
Query: 322 RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG---FGNLSNLLVLSL 378
R L L+ + + + S SL+ ++++ I G +S L L+L
Sbjct: 43 RSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 379 VNNELAGAIPTVLGKLQ--KLQGLDLNSNKLKGFIPTDL----CKLEKLNTLLSNNNALQ 432
N E+ G P L + L L+L + L L
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 433 GQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEA 492
+ +L LD N S PL L+
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLI-----------------SALCPLKFPTLQV 205
Query: 493 LGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG-PIPQSFGSLISLQSLDLSGNNI 551
L N SG + L L L+ N+ + S L SL+LS +
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
Query: 552 S---GEIPKSLEKLSRLVDFNVSFNGLEG 577
+P L L ++S+N L+
Sbjct: 266 KQVPKGLPAKLSVL------DLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 48/232 (20%), Positives = 81/232 (34%), Gaps = 18/232 (7%)
Query: 368 GNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS- 426
G S +L V+ E T + K L+ L + + ++ I ++ ++ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 427 --NNNALQGQIPTCLANLT--SLRHLDFRSNSLNSTIPST----FWSLKYILAVDFSLNS 478
N + G P L T L L+ R+ S + W + + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 479 LSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI----GNLKNLDWLALARNAFQ---GPI 531
+ AL L+L+ N G L LAL + G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 532 PQSFGSLISLQSLDLSGNNISGEIPKSL-EKLSRLVDFNVSFNGLEGEIPSG 582
+ + LQ LDLS N++ + S+L N+SF GL+ ++P G
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 37/234 (15%), Positives = 62/234 (26%), Gaps = 57/234 (24%)
Query: 27 NTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLP 86
+ A+ W+ + LS+ V L +L++S N
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE----- 185
Query: 87 NELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKIT---GEFPSAIVNISS 143
L +L F L+ + + + G +
Sbjct: 186 -------------LGERGLISALCP---LKFPTLQVLALRNAGMETPSGVCSALAAARVQ 229
Query: 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDL 203
L+ + L +NSL + C L L L + ++P + L +LDL
Sbjct: 230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK------QVPKGL--PAKLSVLDL 281
Query: 204 GGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSG 257
N + PS LP + NL L N
Sbjct: 282 SYNRLD-------------------------RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 20/103 (19%), Positives = 35/103 (33%), Gaps = 7/103 (6%)
Query: 56 SLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNEL-WHMRRLKIIDFSSNSLSGSLPGDMC 114
+ G L L++S NS D +L ++ S L +P
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--- 270
Query: 115 NSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGS 157
+L D+S N++ PS + + ++ L N S
Sbjct: 271 GLPAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 41/220 (18%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKIV 742
LG+GSF V +G A+K+ + Q+ LK + E +++ + L+K+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHG 796
S + ++M+Y+ G + +SH L R + EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEM----FSH---LRRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSE 855
S +I+ DLKP N+L+D + DFG AK + G T TL T +APE
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPE---- 208
Query: 856 GIVSISG-----DVYSFGILMMETFTRRKP-----TNEMF 885
I+ G D ++ G+L+ E P +++
Sbjct: 209 -IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 63/305 (20%), Positives = 106/305 (34%), Gaps = 65/305 (21%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNL 738
L+G GS+ V K G VA+K F +D A++ E ++++++RH NL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENL 86
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
+ ++ C L+ +++ ++ L L + + + + + + H H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN- 144
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------ 851
IIH D+KP N+L+ V L DFG A+ L +AT Y APE
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 852 -YGSEGIVSISGDVYSFGILMMETFTRR--------------------KPTNEMFTGEMS 890
YG ++ DV++ G L+ E F
Sbjct: 201 KYGK----AV--DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN 950
+ LP + E D A K C+ P++R
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLS-EVVIDLAKK--CLHI-----------DPDKRPF 300
Query: 951 VKDAL 955
+ L
Sbjct: 301 CAELL 305
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 68/226 (30%), Positives = 98/226 (43%), Gaps = 53/226 (23%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLIK 740
LG+GSF V+ NG A+KV L+++ ++ E ++ + H +I+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALEY 792
+ + + +IM Y+ G L +S L QR VA ALEY
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGEL----FSL---LRKSQRFPN--PVAKFYAAEVCLALEY 121
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
LH S II+ DLKP N+LLD + H + DFG AK + T TL T Y+A
Sbjct: 122 LH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP-----DVTYTLCGTPDYIA 171
Query: 850 PEYGSEGIVSISG-----DVYSFGILMMETFTRRKP-----TNEMF 885
PE +VS D +SFGIL+ E P T + +
Sbjct: 172 PE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-17
Identities = 49/227 (21%), Positives = 87/227 (38%), Gaps = 45/227 (19%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLIK 740
++G G+F V L A+K+ L + LK +T C +V+ + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID----------VASAL 790
+ + + L+M Y G L LT+ + + + + A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTLATIGYM 848
+ +H +H D+KP+N+L+D + H L DFG L V ++ + T Y+
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 849 APE-----YGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
+PE G +G D +S G+ M E P E +
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 43/232 (18%)
Query: 688 LGSGSFDNVYKATLANGVSVAVK-VFNLQEDRALKS-FDT---------ECEVMRRIRHR 736
+ SGS+ V + G+ VA+K VFN D + E ++ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 737 NLIK---IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
N++ I P L+ + M + L + ++ ++ + M + L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMA 849
LH ++H DL P N+LL D+ + DF +A+ D T + Y A
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR----EDTADANKTHYVTHRWYRA 201
Query: 850 PE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
PE + ++ + D++S G +M E F RK +F G Q
Sbjct: 202 PELVMQFKGF-TKLV-----DMWSAGCVMAEMFN-RKA---LFRGSTFYNQL 243
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 8e-17
Identities = 58/254 (22%), Positives = 96/254 (37%), Gaps = 35/254 (13%)
Query: 651 RNKSLPEENNSLNLATLSRISYHELQQAT-NGFGESNLLGSGSFDNVYKATL-ANGVSVA 708
+ +S+ + + E Q T N F + +LG G F V + A G A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 709 VKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763
K L++ R K +++ ++ R ++ + + L++ M G L
Sbjct: 214 CKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271
Query: 764 EKWLYSHNYSLTIRQRLDIMI-DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822
+ +Y + R ++ LE LH I++ DLKP N+LLDD +
Sbjct: 272 KFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRIS 328
Query: 823 DFGIAK-LLDGVDPVTQTMTLA-TIGYMAPE------YGSEGIVSISGDVYSFGILMMET 874
D G+A + +G T+GYMAPE Y S D ++ G L+ E
Sbjct: 329 DLGLAVHVPEG----QTIKGRVGTVGYMAPEVVKNERYTF------SPDWWALGCLLYEM 378
Query: 875 FTRRKPTNEMFTGE 888
+ P F
Sbjct: 379 IAGQSP----FQQR 388
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 78/318 (24%), Positives = 130/318 (40%), Gaps = 86/318 (27%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK---VFNLQED--RALKSFDTECEVMRRIRHRNLIK- 740
+G G++ V A N V VA+K F Q R L+ E +++ R RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 741 --IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASAL 790
I+ + + K ++ M + L K L + Q L + + L
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT--------QHLSNDHICYFLYQILRGL 141
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYM 848
+Y+H S ++H DLKP+N+LL+ + DFG+A++ D T +T +AT Y
Sbjct: 142 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 849 APE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901
APE Y ++ I D++S G ++ E + R +F G+ L Q
Sbjct: 199 APEIMLNSKGY-TKSI-----DIWSVGCILAEMLSNR----PIFPGKHYLDQL------- 241
Query: 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK-----------CSAEI------ 944
++ +L +ED + K +Y++SL K ++
Sbjct: 242 --NHILG--ILGSPSQEDLNCIINLKA-RNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 296
Query: 945 -----PEERINVKDALAD 957
P +RI V+ ALA
Sbjct: 297 MLTFNPHKRIEVEQALAH 314
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 29/179 (16%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT---ECEVMRRIRHRNLIKIV 742
LG G++ V A +VAVK+ ++ RA+ + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALEYLH 794
+ L ++Y G L + + + A + + YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL------FDR-IEPDIGMPE--PDAQRFFHQLMAGVVYLH 122
Query: 795 -HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
G I H D+KP N+LLD+ + DFG+A + + + T+ Y+APE
Sbjct: 123 GIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 53/232 (22%)
Query: 687 LLGSGSFDNVY----KATLANGVSVAVKVFNLQEDRALKSFDTEC-----EVMRRIRHRN 737
++G G+F V K T G A+K+ + + LK + C +V+ R
Sbjct: 68 VIGRGAFSEVAVVKMKQT---GQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID----------VA 787
+ ++ + + + L+M+Y G L L + I +
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIV 172
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTLATI 845
A++ +H +H D+KP+N+LLD H L DFG L V + + T
Sbjct: 173 MAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 846 GYMAPE-YGSEGIVSISG------DVYSFGILMMETFTRRKP-----TNEMF 885
Y++PE + G +G D ++ G+ E F + P T E +
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 70/319 (21%), Positives = 123/319 (38%), Gaps = 95/319 (29%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
+GSG++ +V A +G VA+K F + RA + E +++ ++H N+I
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 741 IV----SSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVAS 788
++ + S F L+M +M Q L+K + + ++ +
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFM-QTDLQK---------IMGLKFSEEKIQYLVYQMLK 137
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIG 846
L+Y+H S ++H DLKP N+ +++D + DFG+A+ D MT + T
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD------AEMTGYVVTRW 188
Query: 847 YMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899
Y APE Y ++ + D++S G +M E T K +F G+ L Q
Sbjct: 189 YRAPEVILSWMHY-NQTV-----DIWSVGCIMAEMLT-GKT---LFKGKDYLDQL----- 233
Query: 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEI--------------- 944
T+++ + E K SYI SL +
Sbjct: 234 ----TQILK--VTGVPGTEFVQKLNDKAA-KSYIQSLPQTPRKDFTQLFPRASPQAADLL 286
Query: 945 -------PEERINVKDALA 956
++R+ AL
Sbjct: 287 EKMLELDVDKRLTAAQALT 305
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 49/210 (23%), Positives = 80/210 (38%), Gaps = 47/210 (22%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN------LQEDRALKSFDTECEVMRRIRHR--N 737
LLGSG F +VY +++ + VA+K E E +++++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALE 791
+I+++ P LI++ P+ + L+ +T R L V A+
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LFDF---ITERGALQEELARSFFWQVLEAVR 163
Query: 792 YLH-HGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYM 848
+ H G ++H D+K N+L+D + L DFG LL T T Y
Sbjct: 164 HCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYS 215
Query: 849 APEYGSEGIVSISG--------DVYSFGIL 870
PE+ I V+S GIL
Sbjct: 216 PPEW-------IRYHRYHGRSAAVWSLGIL 238
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 236 LPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQI 295
+PS+I + + L L N LS + + ++ +L L+ N L F + L+
Sbjct: 31 IPSNI-PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89
Query: 296 LSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAG 355
L + DN+L + +F L L L LD N L SL
Sbjct: 90 LWVTDNKLQ---ALPIGVF-DQLVN---LAELRLDRNQL------------KSLPP---- 126
Query: 356 SSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPT-VLGKLQKLQGLDLNSNKLKGFIPTD 414
+ F +L+ L LSL NEL ++P V KL L+ L L +N+LK
Sbjct: 127 ------RV---FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGA 176
Query: 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453
KL +L TL +NN L+ +L L+ L + N
Sbjct: 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 101 SSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPT 160
SS L+ ++P N + D+ SNK++ A ++ L+ + L++N L + P
Sbjct: 24 SSKKLT-AIPS---NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA 78
Query: 161 DLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNN 219
+ L +L L + N + +P + L NL L L N + L P +F++
Sbjct: 79 GIFKELKNLETLWVTDNKLQ------ALPIGVFDQLVNLAELRLDRNQLKSL-PPRVFDS 131
Query: 220 -SNMVAILLYGNHLSGHLPSSIY--LPNLENLFLWKNNLSGIIPDSICNASEATILELSS 276
+ + + L N L LP ++ L +L+ L L+ N L + + +E L+L +
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 277 NLFSGLVPNTFGNCRQLQILSLGDN 301
N + F + +L++L L +N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 58/191 (30%), Positives = 81/191 (42%), Gaps = 12/191 (6%)
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC-KLEK 420
IP + L L +N+L+ +L KL+ L LN NKL+ +P + +L+
Sbjct: 34 NIPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 421 LNTLLSNNNALQGQIPTCL-ANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSL 479
L TL +N LQ +P + L +L L N L S P F SL + + N L
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145
Query: 480 SGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL 538
SLP + L +L L L NQL + L L L L N + +F SL
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 539 ISLQSLDLSGN 549
L+ L L N
Sbjct: 205 EKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 50/174 (28%), Positives = 72/174 (41%), Gaps = 11/174 (6%)
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYIL 470
IP D KL+ L +N L LT LR L N L + F LK +
Sbjct: 35 IPADTKKLD-----L-QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 471 AVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQ 528
+ + N L +LP+ + L L L L NQL +P + +L L +L+L N Q
Sbjct: 89 TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 529 GPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
F L SL+ L L N + + +KL+ L + N L+ +P G
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 5/120 (4%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNELWH-MRRLKIIDFSSNSLSGSLPGDMCNSF 117
LP V L L L + N +LP ++ + +L + N L SLP + +
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
T L+ + +N++ A ++ LK+++LDNN L P L L L+L N
Sbjct: 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 47/224 (20%), Positives = 79/224 (35%), Gaps = 41/224 (18%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTEC--------EVMRRIRHRN 737
++G G F VY G A+K L + R ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
++ + + P + I+ M G L L H R ++ LE++H
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH--- 309
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE----- 851
+ +++ DLKP N+LLD+ + D G+A + T GYMAPE
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKG 365
Query: 852 --YGSEGIVSISGDVYSFGILMMETFT--------RRKPTNEMF 885
Y S S D +S G ++ + + K +E+
Sbjct: 366 VAYDS------SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 49/209 (23%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F V G VAVK+ N ++ + E + ++ RH ++IK+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALEYLH 794
S P ++M+Y+ G L +Y + R++ A SA++Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGEL------FDY-ICKHGRVEE--MEARRLFQQILSAVDYCH 128
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----GYMAP 850
++H DLKP NVLLD M A + DFG++ ++ + L T Y AP
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM------SDGEFLRTSCGSPNYAAP 179
Query: 851 EYGSEGIVSISG--------DVYSFGILM 871
E ISG D++S G+++
Sbjct: 180 E-------VISGRLYAGPEVDIWSCGVIL 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 4e-16
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 5/145 (3%)
Query: 734 RHRNLIKIVSSCSNPGFKALIMQ-YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
R L I SS S+ + + E + LT+ + VA +E+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPE 851
L S IH DL N+LL + V + DFG+A+ + V + + +MAPE
Sbjct: 209 LA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 852 YGSEGIVSISGDVYSFGILMMETFT 876
+ + +I DV+SFG+L+ E F+
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIKI 741
LG G++ VYK VA+K L+ + A++ E +++ ++H N++ +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 65
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
L+ +Y+ + L+++L + + + + L Y H +
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---V 121
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGI 857
+H DLKP N+L+++ L DFG+A+ P +T + T+ Y P+ GS
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKS--IPT-KTYDNEVVTLWYRPPDILLGST-D 177
Query: 858 VSISGDVYSFGILMMETFTRR 878
S D++ G + E T R
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRN--- 737
+G G+F V+KA G VA+K ++ ++ AL+ E ++++ ++H N
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80
Query: 738 LIKIVSSCSNPGFKA-----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
LI+I + ++P + L+ + L L + T+ + +M + + L Y
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD-GVDPVTQTMT--LATIGYMA 849
+H I+H D+K NVL+ D V L DFG+A+ + T + T+ Y
Sbjct: 140 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196
Query: 850 PE-------YGSEGIVSISGDVYSFGILMMETFTRR 878
PE YG I D++ G +M E +TR
Sbjct: 197 PELLLGERDYG----PPI--DLWGAGCIMAEMWTRS 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLIK 740
LLG G+F V A G A+K+ L+++ + + V++ RH L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ S +M+Y G L L R R ++ SAL+YLH +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSEKN-- 269
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE------YGS 854
+++ DLK N++LD D + DFG+ K +T T Y+APE YG
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPEVLEDNDYGR 328
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
+ D + G++M E R P ++F
Sbjct: 329 ------AVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 29/179 (16%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT---ECEVMRRIRHRNLIKIV 742
LG G++ V A +VAVK+ ++ RA+ + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALEYLH 794
+ L ++Y G L + + + A + + YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL------FDR-IEPDIGMPE--PDAQRFFHQLMAGVVYLH 122
Query: 795 -HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
G I H D+KP N+LLD+ + DFG+A + + + T+ Y+APE
Sbjct: 123 GIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 32/199 (16%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VA+K+ + + +L+ E +M+ + H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
LIM+Y G + +L +H + ++ + SA++Y H I+H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKRIVHR 138
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----GYMAPEYGSEGIVSI 860
DLK N+LLD DM + DFG + T L Y APE
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNE------FTVGGKLDAFCGAPPYAAPEL-------F 185
Query: 861 SG--------DVYSFGILM 871
G DV+S G+++
Sbjct: 186 QGKKYDGPEVDVWSLGVIL 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 49/209 (23%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F V G VAVK+ N ++ + E + ++ RH ++IK+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALEYLH 794
S P ++M+Y+ G L +Y + RLD + S ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGEL------FDY-ICKNGRLDE--KESRRLFQQILSGVDYCH 133
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----GYMAP 850
++H DLKP NVLLD M A + DFG++ ++ + L T Y AP
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM------SDGEFLRTSCGSPNYAAP 184
Query: 851 EYGSEGIVSISG--------DVYSFGILM 871
E ISG D++S G+++
Sbjct: 185 E-------VISGRLYAGPEVDIWSSGVIL 206
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 51/265 (19%), Positives = 94/265 (35%), Gaps = 25/265 (9%)
Query: 194 NLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253
+L ++ + +++ I+ + + + YLPN+ LFL N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGN 78
Query: 254 NLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQI 313
L+ I P + N L L N L + ++L+ LSL N ++
Sbjct: 79 KLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISD-------- 126
Query: 314 FYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNL 373
+ L L L L N + + + L T L+ +Q+S I L+ L
Sbjct: 127 -INGLVHLPQLESLYLGNNKITDITV--LSRL-TKLDTLSLEDNQISD-IV-PLAGLTKL 180
Query: 374 LVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQG 433
L L N ++ L L+ L L+L S + L NT+ + + +L
Sbjct: 181 QNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
Query: 434 QIPTCLANLTSLRHLDFRSNSLNST 458
P +++ + + + T
Sbjct: 239 --PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 51/241 (21%), Positives = 92/241 (38%), Gaps = 26/241 (10%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
+ + N+ S D + + + I +++ + S+ G + ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLN 76
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC--TRLPSLVQLRLLGNNITGRIP 184
NK+T P + N+ +L + LD N + DL L L L L N I+
Sbjct: 77 GNKLTDIKP--LANLKNLGWLFLDENKV-----KDLSSLKDLKKLKSLSLEHNGIS---- 125
Query: 185 NREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPN 244
+I + +L L+ L LG N I + + + + + L N +S + L
Sbjct: 126 --DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVPLAGLTK 179
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
L+NL+L KN++S + ++ +LEL S N N + D L
Sbjct: 180 LQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
Query: 305 T 305
T
Sbjct: 238 T 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 60/335 (17%), Positives = 98/335 (29%), Gaps = 78/335 (23%)
Query: 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302
P + I D +E L + V + + ++
Sbjct: 2 PLGSETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 57
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
+ + + + L L+ N L I L+
Sbjct: 58 IKS---------VQGIQYLPNVTKLFLNGNKLT-----DIKPLA---------------- 87
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIP-TDLCKLEKL 421
NL NL L L N++ L L+KL+ L L N + L +LE L
Sbjct: 88 ------NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 422 NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
L NN + T L+ LT L L N + S I
Sbjct: 140 Y--LGNN---KITDITVLSRLTKLDTLSLEDNQI-SDIV--------------------- 172
Query: 482 SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISL 541
+ L L L L+ N +S ++ LKNLD L L +L+
Sbjct: 173 ----PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
Query: 542 QSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
++ + ++ P+ + NV ++ E
Sbjct: 227 NTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 68/320 (21%), Positives = 123/320 (38%), Gaps = 84/320 (26%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK--VFNLQED--RALKSFDTECEVMRRIRHRNLIKI- 741
LG G V+ A VA+K V + AL+ E +++RR+ H N++K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 742 -----------VSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS 788
S + ++ +YM + L L L M +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP--LLEEHARLFMYQLLR 131
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMT--LATI 845
L+Y+H S ++H DLKP N+ ++ +D+V +GDFG+A+++D ++ L T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 846 GYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898
Y +P Y ++ I D+++ G + E T K +F G L+Q
Sbjct: 189 WYRSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLT-GKT---LFAGAHELEQM---- 234
Query: 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK-----------CSAEI--- 944
+++ + EED + + YI + + S E
Sbjct: 235 -----QLILE--SIPVVHEEDRQELLSVIP--VYIRNDMTEPHKPLTQLLPGISREAVDF 285
Query: 945 --------PEERINVKDALA 956
P +R+ ++AL+
Sbjct: 286 LEQILTFSPMDRLTAEEALS 305
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 48/180 (26%), Positives = 67/180 (37%), Gaps = 34/180 (18%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
+GSG+F VAVK ++ + E R +RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA--------SALEYLH 794
P A+IM+Y G L + + R D A S + Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGEL------YER-ICNAGRFSE--DEARFFFQQLLSGVSYCH 133
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHL--GDFGIAKL-LDGVDPVTQTMTLATIGYMAPE 851
S I H DLK N LLD L DFG +K + P + T+ T Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPE 187
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 38/184 (20%), Positives = 73/184 (39%), Gaps = 28/184 (15%)
Query: 656 PEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNL 714
P + L + + I +++ + +LG G V + A+K+
Sbjct: 2 PHVKSGLQIKKNAIIDDYKV------TSQ--VLGLGINGKVLQIFNKRTQEKFALKMLQD 53
Query: 715 QEDRALKSFDTECEVMRRI-RHRNLIKIV----SSCSNPGFKALIMQYMPQGSL-EKWLY 768
E E+ R + ++++IV + + ++M+ + G L +
Sbjct: 54 CPK-----ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 108
Query: 769 SHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLL---DDDMVAHLGDF 824
+ + T R+ +IM + A++YLH I H D+KP N+L + + L DF
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 825 GIAK 828
G AK
Sbjct: 165 GFAK 168
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 58/234 (24%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
+GSG+ V A +VA+K F Q RA + E +M+ + H+N+I
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125
Query: 741 IV----SSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVAS 788
++ + F+ L+M+ M +L + I+ LD ++ +
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQ---------VIQMELDHERMSYLLYQMLC 175
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIG 846
+++LH S IIH DLKP+N+++ D + DFG+A+ + MT + T
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRY 228
Query: 847 YMAPE------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
Y APE Y E + D++S G +M E K +F G + QW
Sbjct: 229 YRAPEVILGMGY-KENV-----DIWSVGCIMGEMVR-HKI---LFPGRDYIDQW 272
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 36/210 (17%), Positives = 73/210 (34%), Gaps = 12/210 (5%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSN-KITGEFPSAIVNISSLKSIRLDNNS 153
+ + L ++P ++ + VS + + + N+S + I + N
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 154 LSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIP 213
D LP L L + + P+ ++ + IL++ N IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL---TKVYSTDIFFILEITDNPYMTSIP 147
Query: 214 SMIFNN-SNMVAIL-LYGNHLSGHLPSSI-YLPNLENLFLWKNN-LSGIIPDSICNASEA 269
F N L LY N + + L+ ++L KN L+ I D+
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 270 -TILELSSNLFSGLVPNTFGNCRQLQILSL 298
++L++S + L + ++L +
Sbjct: 207 PSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 43/209 (20%), Positives = 78/209 (37%), Gaps = 12/209 (5%)
Query: 370 LSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL-CKLEKLNTL-LSN 427
+ L L+ L L + + ++ + + + L K+ + + N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 428 NNALQGQIPTCLANLTSLRHLDFRSNSLNSTIP--STFWSLKYILAVDFSLNSLSGSLPL 485
L P L L L+ L + L P + +S ++ + N S+P+
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 486 NI--GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ-SFGSLIS-L 541
N G L L N + + N LD + L +N + I + +FG + S
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 542 QSLDLSGNNISGEIP-KSLEKLSRLVDFN 569
LD+S +++ +P K LE L L+ N
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 39/290 (13%), Positives = 79/290 (27%), Gaps = 66/290 (22%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKIL 201
+ R+ + P+ PS L+L+ ++ IP + NL N+ +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPS----LPPSTQTLKLIETHLR-TIP----SHAFSNLPNISRI 60
Query: 202 DLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPD 261
+ + + S F N L + ++ + I
Sbjct: 61 YVSIDVTLQQLESHSFYN----------------------LSKVTHIEIRNTRNLTYID- 97
Query: 262 SICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKC 321
P+ L+ L + + L S
Sbjct: 98 ----------------------PDALKELPLLKFLGIFNTGLK---MFPDLTKVYSTDIF 132
Query: 322 RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNN 381
L + D + + N+ L ++ + + N + L + L N
Sbjct: 133 FIL--EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189
Query: 382 ELAGAIPTVL--GKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNN 429
+ I G LD++ + +P+ LE L L++ N
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 40/216 (18%), Positives = 78/216 (36%), Gaps = 18/216 (8%)
Query: 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNL-FSGLVPNTFGNCRQLQILSLGD 300
P+ + L L + +L I + N + + +S ++ L ++F N ++ + + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 301 NQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLS 360
+ T I +L + L+ L + LK + + +
Sbjct: 90 TRNLT------YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYM 143
Query: 361 GGIPVG-FGNLSNLLV-LSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL 418
IPV F L N + L L NN ++ KL + LN NK I D
Sbjct: 144 TSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA--F 200
Query: 419 EKLNTLLS----NNNALQGQIPT-CLANLTSLRHLD 449
+ + S + ++ +P+ L +L L +
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 36/211 (17%), Positives = 72/211 (34%), Gaps = 18/211 (8%)
Query: 50 LSLPNLSLGGTLPPHV-GNLSFLVSLNISGNSFYDTLPNEL-WHMRRLKIIDFSSNSLSG 107
L L L T+P H NL + + +S + L + +++ ++ I+ +
Sbjct: 36 LKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 108 SLPGDMCNSFTQLESFDVSSNKITGEFP--SAIVNISSLKSIRLDNNSLSGSFPTDLCTR 165
+ D L+ + + + FP + + + + + +N S P +
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 166 LPS-LVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN--SNM 222
L + + L+L N T + N L + L N +I F S
Sbjct: 154 LCNETLTLKLYNNGFT------SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 223 VAILLYGNHLSGHLPSSI--YLPNLENLFLW 251
+ + ++ LPS +L L W
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 43/267 (16%), Positives = 80/267 (29%), Gaps = 54/267 (20%)
Query: 244 NLENLFLWKNNLSGI--IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301
E+ + ++ I +P L+L + + F N + + + +
Sbjct: 12 QEEDFRVTCKDIQRIPSLP------PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 302 QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSG 361
L+ + +S NL + + + +++
Sbjct: 66 ------------------------------VTLQQLESHSFYNL-SKVTHIEIRNTRNLT 94
Query: 362 GIPVG-FGNLSNLLVLSLVNNELAGAIP--TVLGKLQKLQGLDLNSNKLKGFIPTD---- 414
I L L L + N L P T + L++ N IP +
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
Query: 415 LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS-TFWSLKYILAV- 472
LC TL NN + N T L + N + I F + ++
Sbjct: 154 LCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 473 DFSLNSLSGSLPLNI-GNLEALGGLNL 498
D S S++ +LP +L+ L N
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 94/319 (29%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
+GSG++ +V A G+ VAVK F R + E +++ ++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 741 IV----SSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVAS 788
++ + S F L+ M L + Q+L ++ +
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILR 143
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIG 846
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ MT +AT
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTADEMTGYVATRW 194
Query: 847 YMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899
Y APE Y ++ + D++S G +M E T + +F G + Q
Sbjct: 195 YRAPEIMLNWMHY-NQTV-----DIWSVGCIMAELLT-GRT---LFPGTDHIDQL----- 239
Query: 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCS---AEI------------ 944
++ L+ E +++ +YI SL A +
Sbjct: 240 ----KLILR--LVGTPGAELLKKISSESA-RNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 945 -------PEERINVKDALA 956
++RI ALA
Sbjct: 293 EKMLVLDSDKRITAAQALA 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 46/212 (21%), Positives = 78/212 (36%), Gaps = 49/212 (23%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN------LQEDRALKSFDTECEVMRRIR----H 735
LLG G F V+ L + + VA+KV + E ++ ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASA 789
+I+++ L+++ + L+ + +T + L V +A
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ-D--LFDY---ITEKGPLGEGPSRCFFGQVVAA 151
Query: 790 LEYLH-HGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLA-TIG 846
+++ H G ++H D+K N+L+D A L DFG LL T
Sbjct: 152 IQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRV 203
Query: 847 YMAPEYGSEGIVSISG--------DVYSFGIL 870
Y PE+ IS V+S GIL
Sbjct: 204 YSPPEW-------ISRHQYHALPATVWSLGIL 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 60/260 (23%)
Query: 671 SYHELQQATNGFGESN----------LLGSGSFDNVYKATLA-NGVSVAVK-VFNLQED- 717
S L A S + G G+F V G+SVA+K V
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR 63
Query: 718 -RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA-------LIMQYMPQGSLEKWLYS 769
R L+ + + + H N++++ S G + ++M+Y+P +L + +
Sbjct: 64 NRELQ----IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN 118
Query: 770 HNYSLTIRQRLDI------MIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLG 822
+ + + + ++ LH S + H D+KP+NVL++ D L
Sbjct: 119 YYRR---QVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 823 DFGIAKLLDGVDPVTQTMT--LATIGYMAPE-------YGSEGIVSISGDVYSFGILMME 873
DFG AK L +P + + Y APE Y + ++ D++S G + E
Sbjct: 175 DFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTT----AV--DIWSVGCIFAE 224
Query: 874 TFTRRKPTNEMFTGEMSLKQ 893
+P +F G+ S Q
Sbjct: 225 MML-GEP---IFRGDNSAGQ 240
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNL-QEDRALKSFDT----ECEVMRRIR---HR 736
+G G++ VYKA +G VA+K + E ++RR+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 737 N---LIKIVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASAL 790
N L+ + ++ L+ +++ Q L +L L D+M L
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH I+H DLKP N+L+ L DFG+A++ + T + T+ Y AP
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVVTLWYRAP 188
Query: 851 E--YGSEGIVSISGDVYSFGILMMETFTRR 878
E S + D++S G + E F R+
Sbjct: 189 EVLLQSTYATPV--DMWSVGCIFAEMFRRK 216
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 70/319 (21%), Positives = 119/319 (37%), Gaps = 94/319 (29%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
+GSG++ V A G VA+K F + RA + E +++ +RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 741 IV----SSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVAS 788
++ + F L+M +M L K + ++L ++ +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLK 139
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIG 846
L Y+H + IIH DLKP N+ +++D + DFG+A+ D MT + T
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD------SEMTGYVVTRW 190
Query: 847 YMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899
Y APE Y ++ + D++S G +M E T K +F G L Q
Sbjct: 191 YRAPEVILNWMRY-TQTV-----DIWSVGCIMAEMIT-GKT---LFKGSDHLDQL----- 235
Query: 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK-----------CSAEI---- 944
E++ + E + + +Y+ L S
Sbjct: 236 ----KEIMK--VTGTPPAEFVQRLQSDEA-KNYMKGLPELEKKDFASILTNASPLAVNLL 288
Query: 945 -------PEERINVKDALA 956
E+R+ +ALA
Sbjct: 289 EKMLVLDAEQRVTAGEALA 307
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR-----ALKSFDTECEVMRRIRHRNLIKI 741
LG+G++ VYK GV VA+K L + A++ E +M+ ++H N++++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-----LTIRQRLDIMIDVASALEYLHHG 796
L+ ++M L+K++ S L + + L + H
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--Y 852
I+H DLKP N+L++ LGDFG+A+ PV T + + T+ Y AP+
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG--IPV-NTFSSEVVTLWYRAPDVLM 181
Query: 853 GSEGIVSISGDVYSFGILMMETFTRR 878
GS S S D++S G ++ E T +
Sbjct: 182 GSR-TYSTSIDIWSCGCILAEMITGK 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-15
Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 36/219 (16%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLIK 740
LLG G+F V A G A+K+ L+++ + + V++ RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + +M+Y G L L R R ++ SALEYLH S
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH---SRD 125
Query: 801 IIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE------ 851
+++ D+K N++LD D H + DFG+ K +G+ T T Y+APE
Sbjct: 126 VVYRDIKLENLMLDKD--GHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
YG + D + G++M E R P +F
Sbjct: 182 YGR------AVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 31/190 (16%), Positives = 59/190 (31%), Gaps = 35/190 (18%)
Query: 340 NSIGNLS----TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQ 395
+S N++ SL + ++ + G N+ L++ N P + L
Sbjct: 33 SSTANITEAQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNYNP--ISGLS 88
Query: 396 KLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSL 455
L+ L + + +L L L L +++A I T + L + +D N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 456 NSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLK 515
+ I + L L LN+ + + Y I +
Sbjct: 149 ITDIM-------------------------PLKTLPELKSLNIQFDGVHDY--RGIEDFP 181
Query: 516 NLDWLALARN 525
L+ L
Sbjct: 182 KLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 22/169 (13%), Positives = 61/169 (36%), Gaps = 14/169 (8%)
Query: 66 GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125
++ L + ++ + D + + +K + ++ + P + + LE +
Sbjct: 41 AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP---ISGLSNLERLRI 95
Query: 126 SSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN 185
+T + + ++SL + + +++ S T + LP + + L N I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI-NTLPKVNSIDLSYNGAITDIMP 154
Query: 186 REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG 234
+ L LK L++ + + I + + + + + G
Sbjct: 155 ------LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 32/184 (17%), Positives = 60/184 (32%), Gaps = 36/184 (19%)
Query: 394 LQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNN--ALQGQIPTCLANLTSLRHLDFR 451
+ L + + L + L+N N L G + +++ L
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYIT--LANINVTDLTG-----IEYAHNIKDLTIN 74
Query: 452 SNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI 511
+ + P I L L L + G ++ ++
Sbjct: 75 NIHATNYNP--------------------------ISGLSNLERLRIMGKDVTSDKIPNL 108
Query: 512 GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVS 571
L +L L ++ +A I +L + S+DLS N +I L+ L L N+
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQ 167
Query: 572 FNGL 575
F+G+
Sbjct: 168 FDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 37/241 (15%), Positives = 76/241 (31%), Gaps = 49/241 (20%)
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
E + +++ P + + + L +S + + SL + L N+T
Sbjct: 4 EQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQM----NSLTYITLANINVT 57
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
++ I HN+K L + + P +SG
Sbjct: 58 ------DLTG-IEYAHNIKDLTINNIHATNYNP------------------ISG------ 86
Query: 241 YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
L NLE L + +++ ++ + T+L++S + + ++ + L
Sbjct: 87 -LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145
Query: 301 NQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLS 360
N T L L+ L + + + I + L YA S +
Sbjct: 146 NGAITD--------IMPLKTLPELKSLNIQFDGVHDYRG--IEDF-PKLNQLYAFSQTIG 194
Query: 361 G 361
G
Sbjct: 195 G 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 21/130 (16%), Positives = 49/130 (37%), Gaps = 9/130 (6%)
Query: 453 NSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIG 512
+ N IP + + K L +S + + + +L + L ++ + I
Sbjct: 11 SQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIE 63
Query: 513 NLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSF 572
N+ L + P L +L+ L + G +++ + +L L+ L ++S
Sbjct: 64 YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 573 NGLEGEIPSG 582
+ + I +
Sbjct: 122 SAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 17/107 (15%), Positives = 45/107 (42%), Gaps = 4/107 (3%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L + + P++ L+ L L+IS ++ D++ ++ + ++ ID S N +
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSG 156
+ +L+S ++ + + I + L + + ++ G
Sbjct: 153 MP--LKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
LG G++ VYKA +VA+K L+ + A++ E +++ ++HRN+I+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ S + LI +Y L+K++ + +++R + + + + + H
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR--- 152
Query: 801 IIHCDLKPNNVLLDDDMVAH-----LGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YG 853
+H DLKP N+LL + +GDFG+A+ G+ T + T+ Y PE G
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLWYRPPEILLG 211
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
S S S D++S + E + P +F G+
Sbjct: 212 SR-HYSTSVDIWSIACIWAEMLM-KTP---LFPGD 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 1e-14
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM-RRI-----RHRNLI 739
+LG GSF V + AVK+ L++D ++ D EC ++ +R+ + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ S +M+Y+ G L + ++A L +L S
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAAEIAIGLFFLQ---SK 461
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE------Y 852
II+ DLK +NV+LD + + DFG+ K + + T T T Y+APE Y
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
G S D ++FG+L+ E + P +E+F
Sbjct: 520 GK------SVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 37/215 (17%)
Query: 686 NLLGSGSFDNVYKA--TLANGVSVAVKVFNLQEDR------------ALKSFDTECEVMR 731
+G G++ V+KA G VA+K +Q L+ +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-------LE 69
Query: 732 RIRHRN---LIKIVSSCSNPGFKA--LIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMID 785
H N L + + L+ +++ Q L +L + D+M
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
+ L++LH ++H DLKP N+L+ L DFG+A++ + T + T+
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTL 183
Query: 846 GYMAPE--YGSEGIVSISGDVYSFGILMMETFTRR 878
Y APE S + D++S G + E F R+
Sbjct: 184 WYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRK 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 34/201 (16%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG GSF V AT VA+K + L++ + E ++ +RH ++IK+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ P ++++Y G L ++ +T + + A+EY H I+
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCH---RHKIV 130
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----GYMAPEYGSEGIV 858
H DLKP N+LLDD++ + DFG++ ++ T L T Y APE
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIM------TDGNFLKTSCGSPNYAAPE------- 177
Query: 859 SISG--------DVYSFGILM 871
I+G DV+S GI++
Sbjct: 178 VINGKLYAGPEVDVWSCGIVL 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 4e-14
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 54/229 (23%)
Query: 687 LLGSGSFDNVYKATLANGVSV----AVKVFN----LQEDRALKSFDTECE--VMRRIRHR 736
+LG GSF V+ +G A+KV DR T+ E ++ + H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV----RTKMERDILVEVNHP 86
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVASAL 790
++K+ + G LI+ ++ G L ++ L+ + ++A AL
Sbjct: 87 FIVKLHYAFQTEGKLYLILDFLRGGDL----FTR---LSKEVMFTEEDVKFYLAELALAL 139
Query: 791 EYLH-HGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTL-ATIG 846
++LH G II+ DLKP N+LLD++ H L DFG++K +D + + T+
Sbjct: 140 DHLHSLG----IIYRDLKPENILLDEE--GHIKLTDFGLSKE--SIDHEKKAYSFCGTVE 191
Query: 847 YMAPEYGSEGIVSISG-----DVYSFGILMMETFTRRKP-----TNEMF 885
YMAPE +V+ G D +SFG+LM E T P E
Sbjct: 192 YMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 73/325 (22%), Positives = 123/325 (37%), Gaps = 92/325 (28%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK---VFNLQED--RALKSFDTECEVMRRIRHRNLIK- 740
LG G++ V AT G VA+K F+ R L+ E ++++ +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 741 --IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASAL 790
I S F +I + M Q L + + + Q L + A+
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-QTDLHRVIST--------QMLSDDHIQYFIYQTLRAV 125
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD-------GVDPVTQTMT-- 841
+ LH + +IH DLKP+N+L++ + + DFG+A+++D M
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 842 LATIGYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
+AT Y APE Y S + DV+S G ++ E F RR +F G Q
Sbjct: 183 VATRWYRAPEVMLTSAKY-SRAM-----DVWSCGCILAELFLRRP----IFPGRDYRHQL 232
Query: 895 VAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALK-----------CSAE 943
+ + + + + + D + + YI SL + + +
Sbjct: 233 L------LIFGI----IGTPHSDNDLRCIESPRA-REYIKSLPMYPAAPLEKMFPRVNPK 281
Query: 944 I-----------PEERINVKDALAD 957
P +RI K+AL
Sbjct: 282 GIDLLQRMLVFDPAKRITAKEALEH 306
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM--RRI-----RHRNL 738
+LG GSF V+ A A+K L++D L D EC M +R+ H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFL 80
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
+ + +M+Y+ G L + + + + ++ L++LH G
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKG- 138
Query: 798 STPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE--- 851
I++ DLK +N+LLD D H + DFG+ K + + +T T T Y+APE
Sbjct: 139 ---IVYRDLKLDNILLDKD--GHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 852 ---YGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
Y S D +SFG+L+ E + P E+F
Sbjct: 192 GQKYNH------SVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-14
Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM-RRI-----RHRNLI 739
++G GSF V A A V AVKV LQ+ LK + + + R + +H L+
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ S ++ Y+ G L L L R R ++ASAL YLH S
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH---SL 158
Query: 800 PIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEG 856
I++ DLKP N+LLD H L DFG+ K + ++ + T T T Y+APE
Sbjct: 159 NIVYRDLKPENILLDSQ--GHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPE----- 209
Query: 857 IVSISG-----DVYSFGILMMETFTRRKP-----TNEMF 885
++ D + G ++ E P T EM+
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 31/156 (19%), Positives = 48/156 (30%), Gaps = 21/156 (13%)
Query: 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426
L+NL L L +N L + L+ LDL+SN L L+ L LL
Sbjct: 60 PTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119
Query: 427 NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLN 486
NN + ++ L+ L N ++
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGN------------------- 160
Query: 487 IGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522
L L L+L+ N+L + + L L
Sbjct: 161 --KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 38/189 (20%), Positives = 62/189 (32%), Gaps = 33/189 (17%)
Query: 197 NLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLS 256
+LDL NN++ L L NL +L L N+L+
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTR----------------------LTNLHSLLLSHNHLN 77
Query: 257 GIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYS 316
I ++ L+LSSN L F + + L++L L +N + + +
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-------VDRN 130
Query: 317 SLAKCRYLRVLVLDTNPLKGVIPNSIGNLS--TSLENFYAGSSQLSGGIPVGFGNLSNL- 373
+ L+ L L N + I + + L S++L L
Sbjct: 131 AFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 374 -LVLSLVNN 381
L L NN
Sbjct: 191 KNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 15/171 (8%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKI 200
S + L +N+LS TRL +L L L N++ I +E + NL+
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN------FISSEAFVPVPNLRY 92
Query: 201 LDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNNLSGI 258
LDL N++ L + + + +LLY NH+ + + + L+ L+L +N +S
Sbjct: 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRF 151
Query: 259 IPDSICNASEATILE---LSSNLFSGLVPNTFGNCRQL--QILSLGDNQLT 304
+ I + ++ L LSSN L L L +N L
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 41/188 (21%), Positives = 65/188 (34%), Gaps = 30/188 (15%)
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152
++D S N+LS T L S +S N + A V + +L+ + L +N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGL 211
L + L + L +L L L N+I + ++ L+ L L N I+
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV------VVDRNAFEDMAQLQKLYLSQNQIS-R 150
Query: 212 IPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICN--ASEA 269
P + + N LP L L L N L + + A
Sbjct: 151 FPVELIKDGN-------------------KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 270 TILELSSN 277
L L +N
Sbjct: 192 NGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 14/170 (8%)
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS-TFWSLKYI 469
+P+ L+ LS+NN + + LT+L L N L + I S F + +
Sbjct: 37 LPSYTALLD-----LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNL 90
Query: 470 LAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAF 527
+D S N L +L + +L+AL L L N + + + ++ L L L++N
Sbjct: 91 RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148
Query: 528 QGPIPQSFG---SLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNG 574
+ L L LDLS N + L+KL V + +
Sbjct: 149 SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 44/220 (20%), Positives = 87/220 (39%), Gaps = 44/220 (20%)
Query: 688 LGSGSFDNVYKA---TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G++ +VYKA + A+K ++ + E ++R ++H N+I +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSAC-REIALLRELKHPNVISLQKV 86
Query: 745 CSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI--------MIDVASALEYLH 794
+ + L+ Y L + H S ++ + + + + + YLH
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAH----LGDFGIAKLLDGVDPVTQTMTLA-----TI 845
+ ++H DLKP N+L+ + + D G A+L + P+ + + T
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--SPL-KPLADLDPVVVTF 199
Query: 846 GYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRR 878
Y APE Y +I D+++ G + E T
Sbjct: 200 WYRAPELLLGARHYTK----AI--DIWAIGCIFAELLTSE 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 48/227 (21%)
Query: 687 LLGSGSFDNVYKATLANGVSV----AVKVFN----LQEDRALKSFDTECEVMRRIRHRNL 738
+LG G + V++ G + A+KV ++ + E ++ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVASALEY 792
+ ++ + G LI++Y+ G L + L + +++ AL +
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGEL----FMQ---LEREGIFMEDTACFYLAEISMALGH 136
Query: 793 LH-HGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTLA-TIGYM 848
LH G II+ DLKP N++L+ H L DFG+ K + T T T TI YM
Sbjct: 137 LHQKG----IIYRDLKPENIMLNHQ--GHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYM 188
Query: 849 APEYGSEGIVSISG-----DVYSFGILMMETFTRRKP-----TNEMF 885
APE I+ SG D +S G LM + T P +
Sbjct: 189 APE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 72/355 (20%), Positives = 124/355 (34%), Gaps = 105/355 (29%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK-VFNLQED-----RALKSFDTECEVMRRIRHRNLIK 740
+G+GS+ +V +A VA+K + + ED R L+ E ++ R+ H +++K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 741 ---IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
IV F ++++ +K + Y LT ++ ++ ++Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY-LTELHIKTLLYNLLVGVKYVH- 173
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD------------------------ 831
S I+H DLKP N L++ D + DFG+A+ +D
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 832 GVDPVTQTMT--LATIGYMAPE-------YGSEGIVSISGDVYSFGILMME--------- 873
+ + +T + T Y APE Y +E I DV+S G + E
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENY-TEAI-----DVWSIGCIFAELLNMIKENV 285
Query: 874 -TFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA---------NLLSREDEEDADDF 923
R P +F G + N+L EED +
Sbjct: 286 AYHADRGP---LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342
Query: 924 ATKKTCISYIMSLALK-----------CSAEI-----------PEERINVKDALA 956
+ YI + SA+ P +RI + + LA
Sbjct: 343 EKEDA-KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM--RRI-----RHRNL 738
+LG GSF V A + G AVKV L++D L+ D EC M +RI H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVEC-TMTEKRILSLARNHPFL 86
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++ P +M+++ G L + R R ++ SAL +LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---D 142
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE------ 851
II+ DLK +NVLLD + L DFG+ K +G+ T T T Y+APE
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
YG + D ++ G+L+ E P +++F
Sbjct: 201 YG------PAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM-RRI-----RHRNLI 739
+LG GSF V + AVK+ L++D ++ D EC ++ +R+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ S +M+Y+ G L + ++A L +L S
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAAEIAIGLFFLQ---SK 140
Query: 800 PIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE----- 851
II+ DLK +NV+LD + H + DFG+ K + + T T T Y+APE
Sbjct: 141 GIIYRDLKLDNVMLDSE--GHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 852 -YGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMF 885
YG S D ++FG+L+ E + P +E+F
Sbjct: 197 PYGK------SVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 43/212 (20%)
Query: 687 LLGSGSFDNVYKATLANGVSV----AVKVFN----LQEDRALKSFDTECEVMRRIRHRN- 737
+LG+G++ V+ +G A+KV +Q+ + + TE +V+ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVASALE 791
L+ + + LI+ Y+ G L ++H L+ R+R + ++ ALE
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGEL----FTH---LSQRERFTEHEVQIYVGEIVLALE 173
Query: 792 YLH-HGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTLA-TIGY 847
+LH G II+ D+K N+LLD + H L DFG++K D + TI Y
Sbjct: 174 HLHKLG----IIYRDIKLENILLDSN--GHVVLTDFGLSK-EFVADETERAYDFCGTIEY 226
Query: 848 MAPE------YGSEGIVSISGDVYSFGILMME 873
MAP+ G + V D +S G+LM E
Sbjct: 227 MAPDIVRGGDSGHDKAV----DWWSLGVLMYE 254
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 69/347 (19%), Positives = 119/347 (34%), Gaps = 97/347 (27%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIRHRNLIK 740
+G GS+ VY A +VA+K +F D R L+ E ++ R++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 741 ---IVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ F ++++ L+K + + LT I+ ++ ++H
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF-LTEEHIKTILYNLLLGENFIH- 146
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT---------------- 839
+ IIH DLKP N LL+ D + DFG+A+ ++
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 840 ---MT--LATIGYMAPE-------YGSEGIVSISGDVYSFGILMME----------TFTR 877
+T + T Y APE Y ++ I D++S G + E T
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENY-TKSI-----DIWSTGCIFAELLNMLQSHINDPTN 258
Query: 878 RKPTNEMFTGEMSLKQWVAESLPGAVTE-VVD-----ANLLSREDEEDADDFATKKTCIS 931
R P +F G + + D N++ E+D K I
Sbjct: 259 RFP---LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL-KNINKPEVIK 314
Query: 932 YIMSLALK-----------CSAEI-----------PEERINVKDALA 956
YI + S + P +RI + AL
Sbjct: 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 76/259 (29%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI----- 741
LG+GSF V + + +G A+K + E ++M+ + H N+IK+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 742 -------------------------------VSSCSNPGFKA--LIMQYMPQGSLEKWLY 768
+ K +IM+Y+P +L K L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLK 129
Query: 769 SHNYSLTIRQRLDI------MIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHL 821
S S + + + + + A+ ++H S I H D+KP N+L++ D L
Sbjct: 130 SFIRS---GRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183
Query: 822 GDFGIAKLLDGVDPVTQTMTLATIGYMAPE-------YGSEGIVSISGDVYSFGILMMET 874
DFG AK L +P + + Y APE Y + I D++S G + E
Sbjct: 184 CDFGSAKKLIPSEPSVA--YICSRFYRAPELMLGATEY-TPSI-----DLWSIGCVFGEL 235
Query: 875 FTRRKPTNEMFTGEMSLKQ 893
KP +F+GE S+ Q
Sbjct: 236 IL-GKP---LFSGETSIDQ 250
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 52/246 (21%), Positives = 100/246 (40%), Gaps = 59/246 (23%)
Query: 671 SYHELQQATNGFGES------NLLGSGSFDNVYKAT-LANGVSVAVKVFNL-QEDRALKS 722
Y + + +G LG G + V++A + N V VK+ ++ + +
Sbjct: 21 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR- 79
Query: 723 FDTECEVMRRIR-HRNLIKIVSSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLT---- 775
E +++ +R N+I + +P + AL+ +++ ++ + LT
Sbjct: 80 ---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDI 132
Query: 776 ---IRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLD 831
+ + L AL+Y H S I+H D+KP+NV++D + L D+G+A +
Sbjct: 133 RFYMYEIL-------KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---E 179
Query: 832 GVDPVTQTMTL--ATIGYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTN 882
P Q + A+ + PE Y S D++S G ++ R++P
Sbjct: 180 FYHP-GQEYNVRVASRYFKGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP-- 230
Query: 883 EMFTGE 888
F G
Sbjct: 231 -FFHGH 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM--RRI-----RHRNL 738
++G GS+ V L A+KV ++++ D + V + + H L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDW-VQTEKHVFEQASNHPFL 72
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ + S +++Y+ G L + R +++ AL YLH
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---E 128
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE------ 851
II+ DLK +NVLLD + L D+G+ K +G+ P T T T Y+APE
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGED 186
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKP 880
YG S D ++ G+LM E R P
Sbjct: 187 YGF------SVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 687 LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM-RRI-----RHRNLI 739
++G GS+ V L A++V ++++ D + + + H L+
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ S +++Y+ G L + R +++ AL YLH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ER 172
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE------Y 852
II+ DLK +NVLLD + L D+G+ K +G+ P T T T Y+APE Y
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKP 880
G S D ++ G+LM E R P
Sbjct: 231 GF------SVDWWALGVLMFEMMAGRSP 252
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 55/250 (22%), Positives = 102/250 (40%), Gaps = 69/250 (27%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK----VFNLQED--RALKSFDTECEVMRRIR-HRNLI 739
LG G++ V+K+ G VAVK F D R + E ++ + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 740 KIVSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLD------IMIDVASALE 791
+++ + L+ YM + L + + L+ ++ + ++
Sbjct: 73 NLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA--------NILEPVHKQYVVYQLIKVIK 123
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA------------------KLLDGV 833
YLH S ++H D+KP+N+LL+ + + DFG++ + +
Sbjct: 124 YLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 834 DPVTQTMT--LATIGYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
D +T +AT Y APE Y ++GI D++S G ++ E KP +
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILC-GKP---I 230
Query: 885 FTGEMSLKQW 894
F G ++ Q
Sbjct: 231 FPGSSTMNQL 240
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 49/240 (20%), Positives = 80/240 (33%), Gaps = 46/240 (19%)
Query: 192 IGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLW 251
L N +LG ++ L+ S + +++ L + NL+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLS 71
Query: 252 KNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQG 311
N +S + P + + ++ L ++ N L L L L +N+L
Sbjct: 72 HNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNELRD------ 120
Query: 312 QIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLS 371
SL + L +L + N LK SI L LS
Sbjct: 121 ---TDSLIHLKNLEILSIRNNKLK-----SIVMLG----------------------FLS 150
Query: 372 NLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNAL 431
L VL L NE+ L +L+K+ +DL K +L NT+ +
Sbjct: 151 KLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 54/286 (18%), Positives = 92/286 (32%), Gaps = 75/286 (26%)
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTS 348
+LG +T S + ++ D + ++ S+ +
Sbjct: 17 GLANAVKQNLGKQSVTD---------LVSQKELSGVQNFNGDNSNIQ-----SLAGMQ-- 60
Query: 349 LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLK 408
+NL L L +N+++ P L L KL+ L +N N+LK
Sbjct: 61 --------------------FFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98
Query: 409 GFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKY 468
L +L L NN + L +L +L L R+N L S +
Sbjct: 99 NLNGIPSACLSRLF--LDNNEL---RDTDSLIHLKNLEILSIRNNKLKSIVM-------- 145
Query: 469 ILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528
+G L L L+L GN+++ + LK ++W+ L
Sbjct: 146 ------------------LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185
Query: 529 GPIPQSFGSLISLQSL-DLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
+ L ++ D G IS P + VD V +
Sbjct: 186 NEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 36/222 (16%), Positives = 72/222 (32%), Gaps = 55/222 (24%)
Query: 116 SFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC--TRLPSLVQLR 173
++ +T + +S +++ DN+++ L +L +L
Sbjct: 17 GLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNI-----QSLAGMQFFTNLKELH 69
Query: 174 LLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS 233
L N I+ ++ + +L L+ L + N + L
Sbjct: 70 LSHNQIS------DLSP-LKDLTKLEELSVNRNRLKNL---------------------- 100
Query: 234 GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQL 293
+ I L LFL N L DS+ + IL + +N +V G +L
Sbjct: 101 ----NGIPSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIVM--LGFLSKL 152
Query: 294 QILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLK 335
++L L N++T L + + + + L
Sbjct: 153 EVLDLHGNEITN---------TGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 37/221 (16%), Positives = 86/221 (38%), Gaps = 24/221 (10%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
L+ V N+ S D + + + ++ + ++++ SL G FT L+ +S
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAG--MQFFTNLKELHLS 71
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
N+I+ S + +++ L+ + ++ N L L +L L N +
Sbjct: 72 HNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNNELR------ 119
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE 246
+ + + +L NL+IL + N + + M+ S + + L+GN ++ + L +
Sbjct: 120 DTDS-LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVN 175
Query: 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTF 287
+ L + + + E I + + +
Sbjct: 176 WIDLTGQK---CVNEPVKYQPELYITNTVKDPDGRWISPYY 213
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 28/153 (18%), Positives = 55/153 (35%), Gaps = 13/153 (8%)
Query: 424 LLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSL 483
+ + Q+ L + + S+ + L + + +++ SL
Sbjct: 2 SIQRPTPIN-QV-FPDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL 56
Query: 484 PLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQS 543
+ L L+L+ NQ+S S + +L L+ L++ RN + + L
Sbjct: 57 A-GMQFFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSR 110
Query: 544 LDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
L L N + SL L L ++ N L+
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305
L K +++ + + + + +++ + ++ L+LG N+L
Sbjct: 22 IKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD 77
Query: 306 GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPV 365
S+ L L L+L N L+ + PN + + T+L+ +QL +P
Sbjct: 78 ISA------LKELTN---LTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQS-LPD 126
Query: 366 G-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPT---DLCKLEKL 421
G F L+NL L+L +N+L V KL L LDL+ N+L+ +P D KL +L
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFD--KLTQL 183
Query: 422 NTLLSNNNALQGQIPT-CLANLTSLRHLDFRSN 453
L N L+ +P LTSL+++ N
Sbjct: 184 KDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 55/237 (23%), Positives = 89/237 (37%), Gaps = 49/237 (20%)
Query: 199 KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGI 258
+L ++ + N N + ++ N + YLPN+ L L N L I
Sbjct: 22 IKANLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI 78
Query: 259 -IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSS 317
+ + T L L+ N L F L+ L L +NQL +
Sbjct: 79 SALKEL---TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS------------ 123
Query: 318 LAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVL 376
+P+ + + T+L +QL +P G F L+NL L
Sbjct: 124 --------------------LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTEL 162
Query: 377 SLVNNELAGAIPT-VLGKLQKLQGLDLNSNKLKGFIPT---DLCKLEKLNTLLSNNN 429
L N+L ++P V KL +L+ L L N+LK +P D +L L + ++N
Sbjct: 163 DLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFD--RLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 13/186 (6%)
Query: 400 LDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTI 459
+L + + + +L ++ +++NN+ ++ + L ++R+L N L+
Sbjct: 24 ANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHDI- 78
Query: 460 PSTFWSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGN-LKNL 517
S L + + + N L SLP + L L L L NQL +P + + L NL
Sbjct: 79 -SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNL 135
Query: 518 DWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL-EKLSRLVDFNVSFNGLE 576
+L LA N Q F L +L LDLS N + +P+ + +KL++L D + N L+
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK 194
Query: 577 GEIPSG 582
+P G
Sbjct: 195 S-VPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 54/263 (20%), Positives = 86/263 (32%), Gaps = 50/263 (19%)
Query: 121 ESFDVSSNKITGEFPSAIVNIS-SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179
E+ VS+ FP + L S++ + + + + + N+
Sbjct: 1 ETITVSTPIKQI-FPD---DAFAETIKANLKKKSVTDAVTQNELNSIDQI----IANNSD 52
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS 239
+ I L N++ L LGGN + +
Sbjct: 53 IKSVQG------IQYLPNVRYLALGGNKLHDI---SALKE-------------------- 83
Query: 240 IYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299
L NL L L N L + + L L N L F L L+L
Sbjct: 84 --LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA 141
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359
NQL S +F L L L L N L+ +P + + T L++ +QL
Sbjct: 142 HNQLQ---SLPKGVF-DKLTN---LTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
Query: 360 SGGIPVG-FGNLSNLLVLSLVNN 381
+P G F L++L + L +N
Sbjct: 194 K-SVPDGVFDRLTSLQYIWLHDN 215
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 7e-12
Identities = 42/213 (19%), Positives = 67/213 (31%), Gaps = 14/213 (6%)
Query: 356 SSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL 415
S + S + + L L N I ++ L L D
Sbjct: 357 SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP 416
Query: 416 CKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIP--STFWSLKYILAVD 473
+ L+ L S + +R L L + + + ++ D
Sbjct: 417 MRAAYLDDLRSKFL---LENSVLKMEYADVRVLHLAHKDL-TVLCHLEQLLLVTHL---D 469
Query: 474 FSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG-PIP 532
S N L +LP + L L L + N L + NL L L L N Q
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAI 526
Query: 533 QSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565
Q S L L+L GN++ + E+L+ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 1e-11
Identities = 29/189 (15%), Positives = 63/189 (33%), Gaps = 9/189 (4%)
Query: 388 PTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRH 447
++L +L+ K + ++L ++L L N I + L L +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 448 LDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYI 507
++ +D + + + L+L L+ +
Sbjct: 401 EKETLQYFST---LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--V 455
Query: 508 PSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVD 567
+ L + L L+ N + +P + +L L+ L S N + + + L RL +
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512
Query: 568 FNVSFNGLE 576
+ N L+
Sbjct: 513 LLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 42/300 (14%), Positives = 83/300 (27%), Gaps = 47/300 (15%)
Query: 10 SLDPHNFFANNWNL-SPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNL 68
+ D N ++ W P + +
Sbjct: 289 TPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATD 348
Query: 69 SFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSN 128
L +S L +EL + L+ ++ + ++ M + L +
Sbjct: 349 EQLFRCELSVEKS-TVLQSELESCKELQELEPENKWCLLTIILLM-RALDPLLYEKETLQ 406
Query: 129 KITGEFPSAIVNISSLKSIRLDNNSLSGSF----PTDLCTRLPSLVQLRLLGNNITGRIP 184
+ + ++ +R S + L + L L ++T +
Sbjct: 407 YFS--------TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC 457
Query: 185 NREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPN 244
+ + L + LDL N + +P + + + N L ++ LP
Sbjct: 458 H------LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDGVANLPR 509
Query: 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
L+ L L N L A I L +C +L +L+L N L
Sbjct: 510 LQELLLCNNRLQQS----------AAIQPL-------------VSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 52/347 (14%), Positives = 92/347 (26%), Gaps = 47/347 (13%)
Query: 114 CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQL- 172
+ ++ F + S + ++ L + S +
Sbjct: 241 PHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVW 300
Query: 173 --RLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGN 230
L ++ ++P + K L +
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-----------DSATDE 349
Query: 231 HLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNC 290
L S L++ L + P++ IL + + T
Sbjct: 350 QLFRCELSVEKSTVLQSELESCKELQELEPENK-WCLLTIILLMRALDPLLYEKETLQYF 408
Query: 291 RQLQIL-SLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSL 349
L+ + + L S + +RVL L L T L
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL------------TVL 456
Query: 350 ENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKG 409
+ L + L L +N L A+P L L+ L+ L + N L+
Sbjct: 457 CHL---------------EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500
Query: 410 FIPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSL 455
+ L +L L L NN Q L + L L+ + NSL
Sbjct: 501 V--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 47/161 (29%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305
E L L L+ + + ++ T L L N L F + +L L L +NQL +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 306 GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPV 365
+F L + L L L N LK +P+ + + T L+ ++QL IP
Sbjct: 98 LPLG---VF-DHLTQ---LDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
Query: 366 G-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405
G F L+NL LSL N+L +L KLQ + L N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 49/154 (31%), Positives = 62/154 (40%), Gaps = 4/154 (2%)
Query: 398 QGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS 457
+ LDL S L L KL L + N LQ +LT L L +N L S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 458 TIPSTFWSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSI-GNLK 515
F L + + N L SLP + L L L L NQL IP+ L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLT 155
Query: 516 NLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
NL L+L+ N Q +F L LQ++ L GN
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 41/182 (22%), Positives = 59/182 (32%), Gaps = 24/182 (13%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+ E S+ L+ F L+ L L+L N+L V L +L L L
Sbjct: 32 GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91
Query: 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF 463
+N+L L +L+ L N L+ LT L+ L +N L S F
Sbjct: 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151
Query: 464 WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALA 523
L L L+L+ NQL + L L + L
Sbjct: 152 ------------------------DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 524 RN 525
N
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 51/166 (30%), Positives = 68/166 (40%), Gaps = 17/166 (10%)
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYIL 470
IP D KL+ + L LT L L+ N L + F L +
Sbjct: 33 IPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86
Query: 471 AVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQ 528
+ + N L+ SLPL + +L L L L GNQL +PS + L L L L N Q
Sbjct: 87 TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ 144
Query: 529 GPIPQS-FGSLISLQSLDLSGNNISGEIPK----SLEKLSRLVDFN 569
IP F L +LQ+L LS N + +P L KL + F
Sbjct: 145 S-IPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 11/160 (6%)
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
E D+ S + + ++ L + LD N L + + L L L L N +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAILLYGNHLSGHLPSS 239
+P + + +L L L LGGN + L PS +F+ + + + L N L +P+
Sbjct: 97 -SLPLG-VFD---HLTQLDKLYLGGNQLKSL-PSGVFDRLTKLKELRLNTNQLQS-IPAG 149
Query: 240 IY--LPNLENLFLWKNNLSGIIPDSICNASEATILELSSN 277
+ L NL+ L L N L + + + + L N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 35/160 (21%), Positives = 65/160 (40%), Gaps = 11/160 (6%)
Query: 73 SLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITG 132
L++ + +L ++ N L +L + + T+L + +++N++
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS 97
Query: 133 EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI 192
+++ L + L N L S P+ + RL L +LRL N + IP
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ------SIPAGA 150
Query: 193 -GNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAILLYGN 230
L NL+ L L N + +P F+ + I L+GN
Sbjct: 151 FDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 34/127 (26%), Positives = 50/127 (39%), Gaps = 9/127 (7%)
Query: 457 STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI-GNLK 515
S IP+ L D L+ L L LNL NQL + + + +L
Sbjct: 31 SGIPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLT 83
Query: 516 NLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGL 575
L L LA N F L L L L GN + ++L++L + ++ N L
Sbjct: 84 ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
Query: 576 EGEIPSG 582
+ IP+G
Sbjct: 144 Q-SIPAG 149
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 56/357 (15%), Positives = 113/357 (31%), Gaps = 70/357 (19%)
Query: 120 LESFDVSSNKITGE----FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR-- 173
+E + + IT E + ++ S+K I L N++ L + S L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 174 LLGNNITGRIPN------REIPNEIGNLHNLKILDLGGNNI----AGLIPSMIFNNSNMV 223
+ TGR+ + R + + L + L N + + ++ +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 224 AILLYGNHLS--------------GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEA 269
+ L+ N L + P L ++ +N L ++
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 270 ----TILELSSNLF-----SGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAK 320
+++ N L+ C++L++L L DN T +L
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT---HLGSSALAIALKS 242
Query: 321 CRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN 380
LR L L+ + G++ + N+ L L L
Sbjct: 243 WPNLRELGLND--------CLLSA---------RGAAAVVDAFSKL-ENIG-LQTLRLQY 283
Query: 381 NEL----AGAIPTVLG-KLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQ 432
NE+ + TV+ K+ L L+LN N+ + ++++ + S +
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNR----FSEEDDVVDEIREVFSTRGRGE 336
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 57/338 (16%), Positives = 94/338 (27%), Gaps = 77/338 (22%)
Query: 168 SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI----AGLIPSMIFNNSNMV 223
S+ L + IT + + + ++K + L GN I A + I + ++
Sbjct: 5 SIEGKSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 224 AILLYGNHLSGHLPSSIY------------LPNLENLFLWKNNLSGIIPDSICNASEA-- 269
G + I P L + L N + + +
Sbjct: 64 IAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122
Query: 270 --TILELSSN-------------LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIF 314
L L +N L V N L+ + G N+L GS + +
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS---MKEW 179
Query: 315 YSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLL 374
+ R L + + N I G L + G L
Sbjct: 180 AKTFQSHRLLHTVKMVQ--------NGIRP---------EGIEHL---LLEGLAYCQELK 219
Query: 375 VLSLVNNEL----AGAIPTVLGKLQKLQGLDLNSNKL---------KGFIPTDLCKLEKL 421
VL L +N + A+ L L+ L LN L F + L+ L
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279
Query: 422 NTLLSNNN----ALQGQIPTCLANLTSLRHLDFRSNSL 455
L N A++ + L L+ N
Sbjct: 280 R--LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 62/417 (14%), Positives = 116/417 (27%), Gaps = 108/417 (25%)
Query: 198 LKILDLGGNNI----AGLIPSMIFNNSNMVAILLYGNHLSG----HLPSSI-YLPNLENL 248
++ L + I + +++ + ++ I+L GN + L +I +LE
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 249 FLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSS 308
+ I E L L+ +L + L DN
Sbjct: 66 EFSDIFT---------GRVKDEIPEALRLLLQALLKCP-----KLHTVRLSDNAF---GP 108
Query: 309 AQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFG 368
+ L+K L L L N L P + ++ +L+
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAK--------- 156
Query: 369 NLSNLLVLSLVNNEL----AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL 424
N L + N L + L + + N + L
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI-----RPEGIEHLLLEG 211
Query: 425 LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP 484
L+ L+ LD + N+ ++L+ +L
Sbjct: 212 LAYC--------------QELKVLDLQDNTFT----------------HLGSSALAIALK 241
Query: 485 LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSL 544
NL L L LS +++ + A ++ LQ+L
Sbjct: 242 SWP-NLREL---GLNDCLLSARGAAAVVD-------AFSKLENI-----------GLQTL 279
Query: 545 DLSGNNISGEIPKSL-----EKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQN 596
L N I + ++L EK+ L+ ++ N E V+ + F
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE----DDVVDEIREVFSTR 332
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 36/237 (15%), Positives = 69/237 (29%), Gaps = 39/237 (16%)
Query: 368 GNLSNLLVLSLVNNEL----AGAIPTVLGKLQKLQGLDLNSNKLK-------GFIPTDLC 416
S + SL + + ++ VL + ++ + L+ N +
Sbjct: 2 ARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 417 KLEKLNTLLSNN--NALQGQIPTC-------LANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
LE S+ ++ +IP L L + N+ P+ L
Sbjct: 61 DLEIAE--FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPLI 115
Query: 468 YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAF 527
L+ L L L+ L G + + N L + RN
Sbjct: 116 DFLSKHTPLEHLY----LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 528 QGP----IPQSFGSLISLQSLDLSGNNISGE-----IPKSLEKLSRLVDFNVSFNGL 575
+ ++F S L ++ + N I E + + L L ++ N
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 34/149 (22%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLI-KIVSSC 745
+G G+F + L VA+K+ E +++ + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 746 SNPGFKALIMQYMPQG-SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ A++++ + G SLE + + +++ L I I + S +EY+H S +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 805 DLKPNNVLL-----DDDMVAHLGDFGIAK 828
D+KP N L+ V H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 29/134 (21%), Positives = 50/134 (37%), Gaps = 4/134 (2%)
Query: 325 RVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNEL 383
L L+ N + I L +++++ I G F S + + L +N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRL 93
Query: 384 AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDL-CKLEKLNTLLSNNNALQGQIPTCLANL 442
+ L+ L+ L L SN++ + D L + L +N + P L
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152
Query: 443 TSLRHLDFRSNSLN 456
SL L+ +N N
Sbjct: 153 HSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 24/126 (19%), Positives = 47/126 (37%), Gaps = 3/126 (2%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402
++ +++ + G F L L ++ NN++ + + L
Sbjct: 29 HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88
Query: 403 NSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPS 461
SN+L+ LE L TL+ +N + + L+S+R L N + + P
Sbjct: 89 TSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPG 147
Query: 462 TFWSLK 467
F +L
Sbjct: 148 AFDTLH 153
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 32/162 (19%), Positives = 53/162 (32%), Gaps = 28/162 (17%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKIL 201
+RL+NN + T + +LP L ++ N IT I + +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIE----EGAFEGASGVNEI 86
Query: 202 DLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPD 261
L N + + +F L +L+ L L N ++ + D
Sbjct: 87 LLTSNRLENV-QHKMFKG----------------------LESLKTLMLRSNRITCVGND 123
Query: 262 SICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303
S S +L L N + + P F L L+L N
Sbjct: 124 SFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 7/140 (5%)
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYIL 470
IP +L L+NN + L LR ++F +N + F +
Sbjct: 30 IPQYTAELR-----LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84
Query: 471 AVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529
+ + N L ++ + LE+L L L N+++ S L ++ L+L N
Sbjct: 85 EILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143
Query: 530 PIPQSFGSLISLQSLDLSGN 549
P +F +L SL +L+L N
Sbjct: 144 VAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 10/137 (7%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
+ ++N + + QL + S+NKIT A S + I L +N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPS 214
+ + L SL L L N IT + N+ L ++++L L N I +
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRIT------CVGNDSFIGLSSVRLLSLYDNQITT-VAP 146
Query: 215 MIFNN-SNMVAILLYGN 230
F+ ++ + L N
Sbjct: 147 GAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 32/157 (20%), Positives = 48/157 (30%), Gaps = 30/157 (19%)
Query: 197 NLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLS 256
L L N L + IF LP L + N ++
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKK----------------------LPQLRKINFSNNKIT 70
Query: 257 GIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYS 316
I + AS + L+SN + F L+ L L N++T +
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC-------VGND 123
Query: 317 SLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
S +R+L L N + V P + L SL
Sbjct: 124 SFIGLSSVRLLSLYDNQITTVAPGAFDTL-HSLSTLN 159
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 2/88 (2%)
Query: 496 LNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGE 554
L L N+ + + I L L + + N +F + + L+ N +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 555 IPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
K + L L + N + + +
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGND 123
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALK--SFDTECEVMRRIRHRNLI-KIVS 743
+GSGSF ++Y T +A G VA+K E K E ++ + ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 72
Query: 744 SCSNPGFKALIMQYMPQG-SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ + ++M+ + G SLE + +++ L + + S +EY+H S I
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 127
Query: 803 HCDLKPNNVLL---DDDMVAHLGDFGIAK 828
H D+KP+N L+ + ++ DFG+AK
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 29/150 (19%), Positives = 58/150 (38%), Gaps = 17/150 (11%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALK--SFDTECEVMRRIRHRNLI-KIVS 743
+G GSF +++ T L N VA+K E R E + + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
L++ + SLE L +++ + + ++ +H +++
Sbjct: 74 FGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 129
Query: 804 CDLKPNNVLLDDDM-----VAHLGDFGIAK 828
D+KP+N L+ + ++ DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 26/102 (25%), Positives = 39/102 (38%), Gaps = 2/102 (1%)
Query: 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426
F L + L NN+++ P L+ L L L NK+ + L L LL
Sbjct: 52 FSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111
Query: 427 NNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
N N + + +L +L L N L + TF L+
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 35/163 (21%), Positives = 56/163 (34%), Gaps = 33/163 (20%)
Query: 267 SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRV 326
T + L N + P F ++L+ + L +NQ++ + F L L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD---AFQG-LRS---LNS 84
Query: 327 LVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGA 386
LVL N + +P S+ F L +L +L L N++
Sbjct: 85 LVLYGNKIT-ELPKSL------------------------FEGLFSLQLLLLNANKINCL 119
Query: 387 IPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-LSNN 428
L L L L NKL+ L + T+ L+ N
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 30/140 (21%), Positives = 62/140 (44%), Gaps = 8/140 (5%)
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYIL 470
+P + + N ++ P + LR +D +N ++ P F L+ +
Sbjct: 30 LPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 471 AVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529
++ N ++ LP ++ L +L L L N+++ + +L NL+ L+L N Q
Sbjct: 84 SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 530 PIPQSFGSLISLQSLDLSGN 549
+F L ++Q++ L+ N
Sbjct: 143 IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 37/164 (22%), Positives = 63/164 (38%), Gaps = 34/164 (20%)
Query: 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302
+ + L +N + I P + + ++LS+N S L P+ F R L L L N+
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
+T +F L L++L+L+ N +
Sbjct: 92 IT---ELPKSLFE-GLFS---LQLLLLNANKIN--------------------------C 118
Query: 363 IPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405
+ V F +L NL +LSL +N+L L+ +Q + L N
Sbjct: 119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 36/138 (26%), Positives = 63/138 (45%), Gaps = 10/138 (7%)
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAI 225
++ ++RL N I IP P L+ +DL N I+ L F ++ ++
Sbjct: 32 ETITEIRLEQNTIK-VIP----PGAFSPYKKLRRIDLSNNQISEL-APDAFQGLRSLNSL 85
Query: 226 LLYGNHLSGHLPSSIY--LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV 283
+LYGN ++ LP S++ L +L+ L L N ++ + D+ + +L L N +
Sbjct: 86 VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 284 PNTFGNCRQLQILSLGDN 301
TF R +Q + L N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 33/167 (19%), Positives = 60/167 (35%), Gaps = 32/167 (19%)
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC-KLEK 420
+P + + L N + P +KL+ +DL++N++ + D L
Sbjct: 29 NLP------ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480
LN+L+ N + + L SL+ L +N +N F
Sbjct: 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAF----------------- 124
Query: 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAF 527
+L L L+L N+L + L+ + + LA+N F
Sbjct: 125 -------QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 37/140 (26%), Positives = 55/140 (39%), Gaps = 13/140 (9%)
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
+ + N I P A L+ I L NN +S D L SL L L GN
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 178 NITGRIPNREIPNEI-GNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAILLYGNHLSGH 235
IT E+P + L +L++L L N I + F + N+ + LY N L
Sbjct: 91 KIT------ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-T 142
Query: 236 LPSSI--YLPNLENLFLWKN 253
+ L ++ + L +N
Sbjct: 143 IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 7/128 (5%)
Query: 443 TSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGN 501
++ + N++ P F K + +D S N +S L + L +L L L GN
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 502 QLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNN---ISGEIPK 557
+++ +P S+ L +L L L N +F L +L L L N I+
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 558 SLEKLSRL 565
L + +
Sbjct: 150 PLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 23/120 (19%), Positives = 47/120 (39%), Gaps = 5/120 (4%)
Query: 60 TLPPHV-GNLSFLVSLNISGNSFYDTLPNEL-WHMRRLKIIDFSSNSLSGSLPGDMCNSF 117
+PP L +++S N L + +R L + N ++ LP +
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL 103
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
L+ +++NKI A ++ +L + L +N L + + L ++ + L N
Sbjct: 104 FSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 74 LNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGE 133
+ + N+ P ++L+ ID S+N +S L D L S + NKIT
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 134 FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI- 192
S + SL+ + L+ N ++ D L +L L L N + + I
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL------QTIAKGTF 148
Query: 193 GNLHNLKILDLGGN 206
L ++ + L N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 496 LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI 555
+ L N + P + K L + L+ N P +F L SL SL L GN I+ E+
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 556 PKSL-EKLSRLVDFNVSFNGLEGEIPSG 582
PKSL E L L ++ N + +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVD 122
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 48/235 (20%), Positives = 87/235 (37%), Gaps = 55/235 (23%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSF----DTECEVMRRIR------- 734
LG G F V+ A + N VA+K+ R K + + E ++++R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 735 ----HRNLIKIVSS--CSNPGFKALIMQYMPQG-SLEKWLYSHNYS-LTIRQRLDIMIDV 786
+++K++ P ++M + G +L + + + + + I +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH------LGDFGIAKLLDG-VDPVTQT 839
L+Y+H IIH D+KP NVL++ + D G A D QT
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 840 MTLATIGYMAPE------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
Y +PE +G D++S L+ E T +F +
Sbjct: 199 RE-----YRSPEVLLGAPWGC------GADIWSTACLIFELITGDF----LFEPD 238
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 32/166 (19%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI---- 741
+GSG F +Y A A V + E + +E + +R+ ++ IK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKV-EYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 742 ---------------VSSCSNPGFKALIMQYMPQG-SLEKWLYSHNYSLTIRQRLDIMID 785
++ ++ ++M+ + G L+K + N + L + I
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIR 159
Query: 786 VASALEYLH-HGYSTPIIHCDLKPNNVLLD--DDMVAHLGDFGIAK 828
+ LEY+H + Y +H D+K N+LL + +L D+G++
Sbjct: 160 MLDVLEYIHENEY----VHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 41/139 (29%), Positives = 63/139 (45%), Gaps = 9/139 (6%)
Query: 267 SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRV 326
+ A IL L N + L P F + L+ L LG NQL +F SL + L V
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG---VF-DSLTQ---LTV 92
Query: 327 LVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGA 386
L L TN L V+P+++ + L+ + ++L+ +P G L++L L+L N+L
Sbjct: 93 LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSI 150
Query: 387 IPTVLGKLQKLQGLDLNSN 405
+L L L N
Sbjct: 151 PHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 36/124 (29%), Positives = 51/124 (41%), Gaps = 1/124 (0%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+ T+ + Y +Q++ P F +L NL L L +N+L V L +L LDL
Sbjct: 37 GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96
Query: 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF 463
+N+L +L L L N L +P + LT L HL N L S F
Sbjct: 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAF 155
Query: 464 WSLK 467
L
Sbjct: 156 DRLS 159
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 40/140 (28%), Positives = 60/140 (42%), Gaps = 9/140 (6%)
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYIL 470
IPT+ L ++N + P +L +L+ L SN L + F SL +
Sbjct: 38 IPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 471 AVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529
+D N L+ LP + L L L + N+L+ +P I L +L LAL +N +
Sbjct: 92 VLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS 149
Query: 530 PIPQSFGSLISLQSLDLSGN 549
+F L SL L GN
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/137 (29%), Positives = 56/137 (40%), Gaps = 11/137 (8%)
Query: 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305
+ L+L N ++ + P + L L SN L F + QL +L LG NQLT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 306 GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPV 365
+F L L+ L + N L +P I L T L + +QL IP
Sbjct: 102 --VLPSAVF-DRLVH---LKELFMCCNKLTE-LPRGIERL-THLTHLALDQNQLK-SIPH 152
Query: 366 G-FGNLSNLLVLSLVNN 381
G F LS+L L N
Sbjct: 153 GAFDRLSSLTHAYLFGN 169
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 15/148 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALK--SFDTECEVMRRIRHRNLI-KIVS 743
+GSGSF +Y T + VA+K E+ K E ++ R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ L+M + SLE + L+++ L + + + +E++H S +H
Sbjct: 71 FGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLH 126
Query: 804 CDLKPNNVLLDDDMVAH---LGDFGIAK 828
D+KP+N L+ A+ + DFG+AK
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 33/170 (19%), Positives = 64/170 (37%), Gaps = 37/170 (21%)
Query: 687 LLGSGSFDNVYKATLANGVSVAVKV-----FNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
+G G F +Y A + + SV ++ L + E + +R I+
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT---ELKFYQRAAKPEQIQK 98
Query: 742 VSSCSNPG-------------------FKALIMQYMPQG-SLEKWLYSHNYSLTIRQRLD 781
++ +IM G L+K ++ + + L
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQ 156
Query: 782 IMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLD--DDMVAHLGDFGIAK 828
+ + + LEY+H H Y +H D+K +N+LL+ + +L D+G+A
Sbjct: 157 LSLRILDILEYIHEHEY----VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 3e-09
Identities = 36/263 (13%), Positives = 72/263 (27%), Gaps = 72/263 (27%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKV--------FNLQEDRALKSFDTECEV 729
T +G G F V++ A+ VA+K+ N + + E +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 730 MRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS-----LEKWLYSHNY------------ 772
+ + + GF L + QGS L+ W + ++
Sbjct: 77 SKELSL---LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133
Query: 773 -----------------------SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPN 809
++ I+ + ++L H DL
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 810 NVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGI 869
NVLL + L K + T+ + G ++S +
Sbjct: 192 NVLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDY----TLSRLERDGIV 237
Query: 870 LMMETFTRRKPTNEMFTGEMSLK 892
+ + ++FTG+ +
Sbjct: 238 VFCDVSMDE----DLFTGDGDYQ 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 29/166 (17%), Positives = 58/166 (34%), Gaps = 31/166 (18%)
Query: 688 LGSGSFDNVYKAT---------LANGVSVAVKV-------FNLQE--DRALKSFDTECEV 729
+ +Y+A ++K+ FN Q RA K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 730 -MRRIRHRNLIKIVSSCSNPG-FKALIMQYMPQG-SLEK-WLYSHNYSLTIRQRLDIMID 785
+ + + + ++ L++ + G SL+ S + L+ R L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 786 VASALEYLH-HGYSTPIIHCDLKPNNVLL--DDDMVAHLGDFGIAK 828
+ ALE+LH + Y +H ++ N+ + +D L +G A
Sbjct: 168 LLDALEFLHENEY----VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 43/212 (20%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSF----DTECEVMRRIRHR----- 736
++G GSF V KA VA+K+ R K F E ++ +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 737 -NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLH 794
N+I ++ + + + + + +L + + + + ++ + L+ LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMT--LATIGYMAP 850
IIHCDLKP N+LL + + DFG + Q + + + Y AP
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH------QRVYTYIQSRFYRAP 268
Query: 851 E------YGSEGIVSISGDVYSFGILMMETFT 876
E YG I D++S G ++ E T
Sbjct: 269 EVILGARYGM----PI--DMWSLGCILAELLT 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 3e-08
Identities = 80/515 (15%), Positives = 151/515 (29%), Gaps = 149/515 (28%)
Query: 135 PSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGN 194
PS + + + RL N++ F +RL ++LR + P + +
Sbjct: 105 PSMMTRMYIEQRDRLYNDN--QVFAKYNVSRLQPYLKLR---QALLELRPAKNV-----L 154
Query: 195 LHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNN 254
+ + G +G + + + + + I+ W
Sbjct: 155 IDGV-----LG---SG--------KTWVALDVCLSYKVQCKMDFKIF---------W--- 186
Query: 255 LSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSA--QGQ 312
+ CN S T+LE+ L + PN + L + + + +
Sbjct: 187 ----LNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 313 IFYSSL----------------AKCRYLRVLVLDTNPLKGVIPNSIGNLST---SLENFY 353
+ + L C ++L+ K V + + +T SL++
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSC---KILLTTRF--KQVT-DFLSAATTTHISLDHH- 294
Query: 354 AGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPT 413
+ +L + +P + L + + I
Sbjct: 295 ----------SMTLTPDEVKSLLLKYLDCRPQDLP-----REVLTTNPRRLSIIAESIRD 339
Query: 414 DLCKLEKLNTLLSNNNALQGQIPTCLANLTS--LRHLDFRSNSL---NSTIP----STFW 464
L + N N + L I + L L R + F S+ ++ IP S W
Sbjct: 340 GLATWD--NWKHVNCDKLTTIIESSLNVLEPAEYRKM-FDRLSVFPPSAHIPTILLSLIW 396
Query: 465 S--------------LKYILAVD------FSLNSLSGSLPLNIGNLEAL----------- 493
KY L S+ S+ L + + N AL
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP 456
Query: 494 ---GGLNLTGNQLSGYIPSSIG----NLKNLDWLALARNAFQ------------GPIPQS 534
+L L Y S IG N+++ + + L R F +
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 535 FGSLIS-LQSLDLSGNNISGEIPKSLEKLSRLVDF 568
GS+++ LQ L I PK ++ ++DF
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 53/298 (17%), Positives = 93/298 (31%), Gaps = 85/298 (28%)
Query: 8 RISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGN 67
ISLD H+ L+P + + ++ LP L P +
Sbjct: 288 HISLDHHS-----MTLTPDEVKSLLLKYLDCRPQ---------DLPREVLTT-NPRRLSI 332
Query: 68 LSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSS 127
++ + ++ + + + + II+ S N L P + F +L F S+
Sbjct: 333 IAESIRDGLATWDNWKHVNCD----KLTTIIESSLNVLE---PAEYRKMFDRLSVFPPSA 385
Query: 128 N-----------KITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
+ + +VN +L SL P + +PS+ L L
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVN-------KLHKYSLVEKQPKESTISIPSI-YLELK- 436
Query: 177 NNITGRIPNREIPNEIGNLHNLKILD----LGGNNIAGLIPSMIFNNSNMVAILLYG-NH 231
++ NE LH I+D + LIP + Y +H
Sbjct: 437 ---------VKLENEY-ALHR-SIVDHYNIPKTFDSDDLIPPYLDQ---------YFYSH 476
Query: 232 LSGHLP-----------SSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNL 278
+ HL ++L + FL + I DS + +IL L
Sbjct: 477 IGHHLKNIEHPERMTLFRMVFL-DFR--FLEQK----IRHDSTAWNASGSILNTLQQL 527
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-05
Identities = 54/392 (13%), Positives = 109/392 (27%), Gaps = 118/392 (30%)
Query: 515 KNLDWLALA-RNAFQGPIPQSFGSLISLQSLDLSGN--------NIS-----GEIPKSLE 560
N +L + + P S + + ++ D N N+S ++ ++L
Sbjct: 89 INYKFLMSPIKTEQRQP---SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL 145
Query: 561 KLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCKTSSTHKSKA 620
+L NV +G+ G G + + + C +
Sbjct: 146 ELRP--AKNVLIDGVLG----------------------SGKTWVALDVCLSYKVQCKMD 181
Query: 621 TKIVLRYILPAIATTMVVVALFIILIRRRKRNKSLPEENNSL------NLATLSRISY-- 672
KI F + ++ +++ E L N + S S
Sbjct: 182 FKI------------------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 673 -HELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVF-NLQEDRALKSFDTECEVM 730
+ LL Y+ L V N+Q +A +F+ C+++
Sbjct: 224 KLRIHSIQAEL--RRLL----KSKPYENCLL--------VLLNVQNAKAWNAFNLSCKIL 269
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQG-----SLE---KWLYSHNYSLTIRQRLDI 782
R + + + S + + + K+L L R+ L
Sbjct: 270 LTTRFKQVTDFL---SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-REVLTT 325
Query: 783 M---IDVASAL---------EYLHHGYS--TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828
+ + + + H T II L NVL + +
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSV-- 380
Query: 829 LLDGVD-PVTQTMTLATIGYMAPEYGSEGIVS 859
P T+ L+ I + + +V+
Sbjct: 381 FPPSAHIP---TILLSLIWFDVIKSDVMVVVN 409
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 6e-04
Identities = 28/184 (15%), Positives = 59/184 (32%), Gaps = 38/184 (20%)
Query: 794 HHGYSTPIIHCDLKPNNVLLD--DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
HH + ++L D V +F + D + + I M+ +
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFEDAFVD---NFDCKDVQDMPKSILSKEEIDHI-IMSKD 59
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKPTN--EMFTGEMSLKQ---WVAESLPGAVTEV 906
++SG + F L K + F E L+ ++ + TE
Sbjct: 60 -------AVSGTLRLFWTL------LSKQEEMVQKFVEE-VLRINYKFLMSPIK---TEQ 102
Query: 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966
++++R E D + K + + + ++ AL +L+ K +L
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFA-------KYNVSRLQPYLKLRQALLELRPAKNVL- 154
Query: 967 QALH 970
+
Sbjct: 155 --ID 156
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 42/168 (25%)
Query: 267 SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRV 326
++ T L+L +N L F L L LG N+L +
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS--------------------- 66
Query: 327 LVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAG 385
+PN + N TSL ++QL +P G F L+ L L+L N+L
Sbjct: 67 -----------LPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ- 113
Query: 386 AIPT-VLGKLQKLQGLDLNSNKLKGFIPT---DLCKLEKLNTLLSNNN 429
++P V KL +L+ L L N+LK +P D +L L + ++N
Sbjct: 114 SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFD--RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 34/125 (27%), Positives = 48/125 (38%), Gaps = 2/125 (1%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+ ++ L F L++L L L N+L V KL L L+L+
Sbjct: 25 GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84
Query: 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPST 462
+N+L+ KL +L L N N LQ +P LT L+ L N L S
Sbjct: 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGV 143
Query: 463 FWSLK 467
F L
Sbjct: 144 FDRLT 148
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 10/137 (7%)
Query: 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305
L L N+L + + T L L N L F L L+L NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 306 GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPV 365
S +F L + L+ L L+TN L+ +P+ + + T L++ +QL +P
Sbjct: 90 --SLPNGVF-DKLTQ---LKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPD 141
Query: 366 G-FGNLSNLLVLSLVNN 381
G F L++L + L +N
Sbjct: 142 GVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 37/110 (33%), Positives = 49/110 (44%), Gaps = 6/110 (5%)
Query: 443 TSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGN-LEALGGLNLTGN 501
+LD +NSL S F L + + N L SLP + N L +L LNL+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 502 QLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQ-SFGSLISLQSLDLSGN 549
QL +P+ + L L LAL N Q +P F L L+ L L N
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 36/130 (27%), Positives = 55/130 (42%), Gaps = 9/130 (6%)
Query: 454 SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGN 513
S+ + IP+ L D NSL L +L L L GN+L
Sbjct: 21 SVPTGIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74
Query: 514 LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL-EKLSRLVDFNVSF 572
L +L +L L+ N Q F L L+ L L+ N + +P + +KL++L D +
Sbjct: 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
Query: 573 NGLEGEIPSG 582
N L+ +P G
Sbjct: 134 NQLKS-VPDG 142
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 30/158 (18%), Positives = 50/158 (31%), Gaps = 29/158 (18%)
Query: 366 GFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLL 425
+ N L L ++ I + L + +D + N+++ L +L TLL
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70
Query: 426 SNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPL 485
NNN + L L L +NSL L L
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLV------------------ELGDLD----- 107
Query: 486 NIGNLEALGGLNLTGN---QLSGYIPSSIGNLKNLDWL 520
+ +L++L L + N Y I + + L
Sbjct: 108 PLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 25/163 (15%), Positives = 43/163 (26%), Gaps = 39/163 (23%)
Query: 172 LRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNH 231
++L I + N + LDL G I + +
Sbjct: 2 VKLTAELIE-QAAQYT------NAVRDRELDLRGYKIPVI------------------EN 36
Query: 232 LSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCR 291
L L + + N + + D L +++N +
Sbjct: 37 LGATLD------QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88
Query: 292 QLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
L L L +N L LA + L L + NP+
Sbjct: 89 DLTELILTNNSLVELGDL------DPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 34/145 (23%), Positives = 49/145 (33%), Gaps = 18/145 (12%)
Query: 316 SSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSG-GIPV--GFGNLSN 372
+ R L L + I NL +L+ F A S I GF L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAID--FSDNEIRKLDGFPLLRR 65
Query: 373 LLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL----LSNN 428
L L + NN + + L L L L +N L DL L L +L + N
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL--GDLDPLASLKSLTYLCILRN 123
Query: 429 NALQGQ--IPTCLANLTSLRHLDFR 451
+ + + +R LDF+
Sbjct: 124 PVTNKKHYRLYVIYKVPQVRVLDFQ 148
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 33/137 (24%), Positives = 54/137 (39%), Gaps = 8/137 (5%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
N L++ G + N + + IDFS N + L G +L++ V+
Sbjct: 17 NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVN 72
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN- 185
+N+I + L + L NNSL D L SL L +L N +T +
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHY 131
Query: 186 REIPNEIGNLHNLKILD 202
R I + +++LD
Sbjct: 132 RLYV--IYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 21/125 (16%), Positives = 49/125 (39%), Gaps = 15/125 (12%)
Query: 88 ELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSI 147
+ + R + +D + + ++ + Q ++ D S N+I + L+ +
Sbjct: 14 QYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRL 66
Query: 148 R---LDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLG 204
+ ++NN + L LP L +L L N++ + + +L +L L +
Sbjct: 67 KTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCIL 121
Query: 205 GNNIA 209
N +
Sbjct: 122 RNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 21/130 (16%), Positives = 40/130 (30%), Gaps = 35/130 (26%)
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNL 498
N R LD R + + +L +L +A+ +
Sbjct: 15 YTNAVRDRELDLRGYKIPV------------------IENLGATLD----QFDAI---DF 49
Query: 499 TGNQLSGYIPSSIGN---LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI 555
+ N++ + L+ L L + N +L L L L+ N++
Sbjct: 50 SDNEIR-----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-- 102
Query: 556 PKSLEKLSRL 565
L+ L+ L
Sbjct: 103 LGDLDPLASL 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 21/116 (18%), Positives = 38/116 (32%), Gaps = 11/116 (9%)
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLK 199
N + + L + +L L + N I ++ L LK
Sbjct: 17 NAVRDRELDLRGYKIPV--IENLGATLDQFDAIDFSDNEIR-KLDG------FPLLRRLK 67
Query: 200 ILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS--GHLPSSIYLPNLENLFLWKN 253
L + N I + + ++ ++L N L G L L +L L + +N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 33/113 (29%), Positives = 49/113 (43%), Gaps = 6/113 (5%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+ +S S++L F L+ L LSL N++ V KL KL L L+
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84
Query: 404 SNKLKGFIPT---DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453
NKL+ +P D KL +L L + N L+ LTSL+ + +N
Sbjct: 85 ENKLQS-LPNGVFD--KLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 33/107 (30%), Positives = 45/107 (42%), Gaps = 8/107 (7%)
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKL 421
GIP S+ L L +N+L V KL +L L L+ N+++ KL KL
Sbjct: 25 GIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 422 NTLLSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
L + N LQ +P LT L+ L +N L S F L
Sbjct: 79 TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLT 124
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 38/116 (32%), Positives = 53/116 (45%), Gaps = 10/116 (8%)
Query: 267 SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRV 326
S AT LEL SN L F QL LSL NQ+ + +F L K L +
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG---VF-DKLTK---LTI 80
Query: 327 LVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNN 381
L L N L+ +PN + + T L+ ++QL +P G F L++L + L N
Sbjct: 81 LYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 33/109 (30%), Positives = 45/109 (41%), Gaps = 4/109 (3%)
Query: 443 TSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI-GNLEALGGLNLTGN 501
+S L+ SN L S F L + + S N + SLP + L L L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 502 QLSGYIPSSI-GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
+L +P+ + L L LAL N + F L SLQ + L N
Sbjct: 87 KLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 8e-08
Identities = 16/119 (13%), Positives = 37/119 (31%), Gaps = 10/119 (8%)
Query: 114 CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173
+ + L + + + +L + ++N L L L
Sbjct: 7 PHGSSGLRC----TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 174 LLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHL 232
++ + + + P+ L L+L N + L ++ ++L GN L
Sbjct: 63 IVKSGLR-FVA----PDAFHFTPRLSRLNLSFNALESL-SWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 20/104 (19%), Positives = 33/104 (31%), Gaps = 9/104 (8%)
Query: 232 LSGHLPSSIYLPNLENLFLWKNNLSGIIPD-SICNASEATILELSSNLFSGLVPNTFGNC 290
L NL L++ + + E L + + + P+ F
Sbjct: 20 ALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT 79
Query: 291 RQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
+L L+L N L + + L+ LVL NPL
Sbjct: 80 PRLSRLNLSFNALES---LSWKTVQGL-----SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 17/89 (19%), Positives = 34/89 (38%), Gaps = 1/89 (1%)
Query: 476 LNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPS-SIGNLKNLDWLALARNAFQGPIPQS 534
+ ++ E L L + Q ++ + L L L + ++ + P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 535 FGSLISLQSLDLSGNNISGEIPKSLEKLS 563
F L L+LS N + K+++ LS
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 8e-06
Identities = 26/94 (27%), Positives = 35/94 (37%), Gaps = 2/94 (2%)
Query: 411 IPTDLCKLEKLNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI 469
L E L L + N LQ L L LR+L + L P F +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 470 LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQL 503
++ S N+L SL +L L L+GN L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 15/105 (14%), Positives = 33/105 (31%), Gaps = 5/105 (4%)
Query: 151 NNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG 210
+ L +L +L + + ++ L L+ L + + +
Sbjct: 16 TRDGALDSLHHL-PGAENLTELYIENQQHLQHLE----LRDLRGLGELRNLTIVKSGLRF 70
Query: 211 LIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNL 255
+ P + + L N L ++ +L+ L L N L
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 19/89 (21%), Positives = 30/89 (33%), Gaps = 1/89 (1%)
Query: 380 NNELAGAIPTVLGKLQKLQGLDLNSNK-LKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
+ A L + L L + + + L+ DL L +L L + L+ P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
L L+ N+L S T L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 3/96 (3%)
Query: 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNE-LWHMRRLKIIDFSSNSLSGSLPGDMCNSFT 118
H+ L L I L L + L+ + + L + D +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154
+L ++S N + V SL+ + L N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 24/128 (18%), Positives = 36/128 (28%), Gaps = 24/128 (18%)
Query: 422 NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSG 481
++ L L +L L + + D
Sbjct: 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELR----------DLR------ 53
Query: 482 SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISL 541
L L L + + L P + L L L+ NA + ++ L SL
Sbjct: 54 -------GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SL 105
Query: 542 QSLDLSGN 549
Q L LSGN
Sbjct: 106 QELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 21/128 (16%), Positives = 40/128 (31%), Gaps = 8/128 (6%)
Query: 338 IPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQK 396
+ + +L Y + Q + + L L L++V + L P +
Sbjct: 23 SLHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 397 LQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
L L+L+ N L+ + + L L+ + N L C L L+ +
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL-----HCSCALRWLQRWEEEGLGGV 135
Query: 457 STIPSTFW 464
Sbjct: 136 PEQKLQCH 143
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 2/97 (2%)
Query: 84 TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISS 143
+ L L + + L +L + + + + P A
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
L + L N+L S L SL +L L GN +
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 1/70 (1%)
Query: 507 IPSSIGNLKNLDWLALARNAFQGPIP-QSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565
+ +NL L + + + L L++L + + + P + RL
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 566 VDFNVSFNGL 575
N+SFN L
Sbjct: 83 SRLNLSFNAL 92
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 32/115 (27%), Positives = 48/115 (41%), Gaps = 3/115 (2%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402
++ ++L G FG L +L+ L L N+L G P +Q L L
Sbjct: 26 DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85
Query: 403 NSNKLKGFIPTDLC-KLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
NK+K I + L +L TL +N + +P +L SL L+ SN N
Sbjct: 86 GENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 9/108 (8%)
Query: 362 GIPVGFGNLSNLLVLSLVNNELAGAIPT-VLGKLQKLQGLDLNSNKLKGFIPTDLCKLEK 420
IP + L L +NEL + G+L L L+L N+L G P
Sbjct: 26 DIP------LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 421 LNTLLSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467
+ L N ++ +I L L+ L+ N ++ +P +F L
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 227 LYGNHLSGHLPSSIY--LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP 284
L N L ++ LP+L L L +N L+GI P++ AS L+L N +
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISN 95
Query: 285 NTFGNCRQLQILSLGDNQLTT 305
F QL+ L+L DNQ++
Sbjct: 96 KMFLGLHQLKTLNLYDNQISC 116
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 20/117 (17%)
Query: 145 KSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEI-GNLHNLKILDL 203
+ L++N L L RLP LV+L L N +T I +++ L L
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT------GIEPNAFEGASHIQELQL 85
Query: 204 GGNNIAGLIPSMIFNN-SNMVAILLYGNHLSGHLPSSI------YLPNLENLFLWKN 253
G N I + + +F + + LY N + S + +L +L +L L N
Sbjct: 86 GENKIKEI-SNKMFLGLHQLKTLNLYDNQI-----SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 9/109 (8%)
Query: 246 ENLFLWKNNLSGIIPDSICNA-SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304
L L N L I D + LEL N +G+ PN F +Q L LG+N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 305 TGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353
++F L + L+ L L N + V+P S +L SL +
Sbjct: 92 ---EISNKMF-LGLHQ---LKTLNLYDNQISCVMPGSFEHL-NSLTSLN 132
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 44/153 (28%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSF----DTECEVMRRIR------- 734
+G G+F V + N AVKV R +K + E +++++I+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 735 ----------HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIM 783
+ + + ++ F+ L SL + + +NY+ I
Sbjct: 97 NIVKYHGKFMYYDHMCLI-------FEPLGP------SLYEIITRNNYNGFHIEDIKLYC 143
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816
I++ AL YL + H DLKP N+LLDD
Sbjct: 144 IEILKALNYLR---KMSLTHTDLKPENILLDDP 173
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 23/93 (24%), Positives = 36/93 (38%), Gaps = 8/93 (8%)
Query: 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301
LE L L+ I ++ ++ LELS N SG + C L L+L N
Sbjct: 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 302 QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
++ S+ + L K L+ L L +
Sbjct: 99 KIKDLSTIE------PLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 9/116 (7%)
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLK 199
S +K + LDN+ + L L L + +T I N + L+ LK
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN------LPKLNKLK 67
Query: 200 ILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS--GHLPSSIYLPNLENLFLWKN 253
L+L N ++G + + N+ + L GN + + L NL++L L+
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 34/156 (21%), Positives = 56/156 (35%), Gaps = 29/156 (18%)
Query: 369 NLSNLLVLSLVNNEL-AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSN 427
S++ L L N+ G + + + ++L+ L + L +L KL KL L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 428 NNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI 487
+N + G + +L HL+ N + ST LK
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLK-------------------- 110
Query: 488 GNLEALGGLNLTGN---QLSGYIPSSIGNLKNLDWL 520
LE L L+L L+ Y + L L +L
Sbjct: 111 -KLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 27/139 (19%)
Query: 414 DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473
+++L L N+ + +G++ L L + L S + L + ++
Sbjct: 15 TPSDVKELV--LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLE 70
Query: 474 FSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ 533
S N +SG L + L LNL+GN+ I +L ++ L
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEPLK------------ 110
Query: 534 SFGSLISLQSLDLSGNNIS 552
L +L+SLDL ++
Sbjct: 111 ---KLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 24/140 (17%), Positives = 50/140 (35%), Gaps = 12/140 (8%)
Query: 67 NLSFLVSLNISGNSFYD-TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125
S + L + + + L L+ + + L+ S+ +L+ ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN--LPKLNKLKKLEL 71
Query: 126 SSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC--TRLPSLVQLRLLGNNITGRI 183
S N+++G +L + L N + + + +L +L L L +T +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEVT-NL 128
Query: 184 PN-REIPNEIGNLHNLKILD 202
+ RE L L LD
Sbjct: 129 NDYRENV--FKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 26/93 (27%), Positives = 35/93 (37%), Gaps = 10/93 (10%)
Query: 476 LNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNL---KNLDWLALARNAFQGPIP 532
S G L E L L+ L+ SI NL L L L+ N G +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELSDNRVSGGLE 81
Query: 533 QSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565
+L L+LSGN I ++E L +L
Sbjct: 82 VLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKL 112
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 26/98 (26%), Positives = 41/98 (41%), Gaps = 13/98 (13%)
Query: 115 NSFTQLESFDVSSNKITGEFPSAIVNISSLKSIR---LDNNSLSGSFPTDLCTRLPSLVQ 171
+ F +LE + +T +I N+ L ++ L +N +SG L + P+L
Sbjct: 39 DEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELSDNRVSGGLE-VLAEKCPNLTH 92
Query: 172 LRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209
L L GN I + + L NLK LDL +
Sbjct: 93 LNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.4 bits (127), Expect = 2e-07
Identities = 21/184 (11%), Positives = 50/184 (27%), Gaps = 23/184 (12%)
Query: 385 GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTS 444
+ VL + L L + L+ L ++S ++L +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL-EIISGGLPDSVVEDILGSDLPN 220
Query: 445 LRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS 504
L L + + + + L L + +
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSK---------------DRFPNLKWLGIVDAEEQ 265
Query: 505 GYIPSSIGN---LKNLDWLALARNAFQG----PIPQSFGSLISLQSLDLSGNNISGEIPK 557
+ L L+ + ++ + + L+ +++ N +S E+ K
Sbjct: 266 NVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKK 325
Query: 558 SLEK 561
L+K
Sbjct: 326 ELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 5e-05
Identities = 25/205 (12%), Positives = 61/205 (29%), Gaps = 16/205 (7%)
Query: 241 YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNL-FSGLVPNTFGNCRQLQILSLG 299
+ E LF + I + +L+ L + + + +L
Sbjct: 137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK 196
Query: 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS--------TSLEN 351
++ +G + + L LVL + +L+
Sbjct: 197 SLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKW 256
Query: 352 FYAGSSQLSGGIPVGFGN---LSNLLVLSLVNNEL----AGAIPTVLGKLQKLQGLDLNS 404
++ + F L L + + L A + + K++ L+ +++
Sbjct: 257 LGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316
Query: 405 NKLKGFIPTDLCKLEKLNTLLSNNN 429
N L + +L K + +S++
Sbjct: 317 NYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 2e-04
Identities = 25/162 (15%), Positives = 54/162 (33%), Gaps = 16/162 (9%)
Query: 59 GTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSF- 117
L P + + L +L I G + L LK ++ S L S+ D+ S
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 118 ---TQLESFDVSSNKITGEFPSAIVNI------SSLKSIRLDNNSLSGSFPTDLCT--RL 166
+L + + + + +LK + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI 208
P L + + +T R + + + + +LK +++ N +
Sbjct: 279 PQLETMDISAGVLTDE-GARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 7e-04
Identities = 21/111 (18%), Positives = 37/111 (33%), Gaps = 8/111 (7%)
Query: 70 FLVSLNISGNSFYDTLPNELWHMR--RLKIIDFSSNSLSGSLPGDMCNS--FTQLESFDV 125
++ + + + R LK + + S QLE+ D+
Sbjct: 227 YVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDI 286
Query: 126 SSNKITGE----FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQL 172
S+ +T E + I LK I + N LS +L LP + +
Sbjct: 287 SAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 47/280 (16%), Positives = 99/280 (35%), Gaps = 35/280 (12%)
Query: 89 LWHMRRLKIIDFSSNSLSGS----LPGDMCNSFTQLESFDVSSNKITGEFPSAI-----V 139
+ +D S N+L L N+ + S ++S N + + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPS----LVQLRLLGNNITGRIPNREIPNEIGNL 195
+++ S+ L N LS +L L + + L L N+ + + E NL
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSS-SEFKQAFSNL 136
Query: 196 H-NLKILDLGGNNI-----AGLIPSMIFNNSNMVAILLYGNHLS----GHLPSSIYLPN- 244
++ L+L GN++ LI + +N+ ++ L GN+L+ L +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 245 -LENLFLWKNNLSGIIPDSICNASEA-----TILELSSNLFSG----LVPNTFGNCRQLQ 294
+ +L L N L + + L L N G + + + LQ
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
+ L + + S Q + ++ + + ++ + +
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 60/370 (16%), Positives = 101/370 (27%), Gaps = 81/370 (21%)
Query: 136 SAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP----SLVQLRLLGNNITGRIPNREIPNE 191
+ S+ L N+L +L S+ L L GN++ + E+
Sbjct: 16 EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNS-DELVQI 74
Query: 192 IGNLH-NLKILDLGGNNI-----AGLIPSMIFNNSNMVAILLYGNHLSG----HLPSSIY 241
+ + N+ L+L GN + L+ ++ + + L N S +
Sbjct: 75 LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS 134
Query: 242 LPN--LENLFLWKNNLSGIIPDSICNASEA-----TILELSSN---------LFSGLVPN 285
+ +L L N+L D + A L L N L L
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA-- 192
Query: 286 TFGNCRQLQILSLGDNQLT-TGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGN 344
+ L L N L + IF S + L L N L G
Sbjct: 193 --SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH---VVSLNLCLNCLHG-------- 239
Query: 345 LSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL-------AGAIPTVLGKLQKL 397
L +L +L + L + + A+ +QK+
Sbjct: 240 ---------PSLENLKLLKD----SLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 398 QGLDLNSNK--------LKGFIPTDLCKLEKLNTLLSNNNAL----QGQIPTCLANLTSL 445
+D N + + I K + + L N + L L
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPS--LLNQCLIFAQKHQTNIEDLNIPDEL 344
Query: 446 RHLDFRSNSL 455
R L
Sbjct: 345 RESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 52/317 (16%), Positives = 92/317 (29%), Gaps = 69/317 (21%)
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKC-RYLRVLVLDTNPLKGVIPNSIGNLST 347
+ L+L N L LA + L L N L S L
Sbjct: 49 TPASVTSLNLSGNSLG---FKNSDELVQILAAIPANVTSLNLSGNFLS---YKSSDELVK 102
Query: 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL----AGAIPTVLGKL-QKLQGLDL 402
+L + VL L N+ + L + L+L
Sbjct: 103 TLAA-----------------IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNL 145
Query: 403 NSNKLKGFIPTDLCK-LEKLNTLLS----NNNALQ----GQIPTCLANL-TSLRHLDFRS 452
N L +L + L + ++ N L ++ LA++ S+ LD +
Sbjct: 146 RGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSA 205
Query: 453 NSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG----YIP 508
N L S L+ ++ +L NL N L G +
Sbjct: 206 NLLG----------------LKSYAELAYIFSSIPNHVVSL---NLCLNCLHGPSLENLK 246
Query: 509 SSIGNLKNLDWLALARNAFQGP-------IPQSFGSLISLQSLDLSGNNISGEIPKSLEK 561
+LK+L + L + + + +F ++ + +D +G I +
Sbjct: 247 LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISN 306
Query: 562 LSRLVDFNVSFNGLEGE 578
L R + L +
Sbjct: 307 LIRELSGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 48/300 (16%), Positives = 93/300 (31%), Gaps = 63/300 (21%)
Query: 71 LVSLNISGNSFYDT----LPNELWHM-RRLKIIDFSSNSLSGS----LPGDMCNSFTQLE 121
+ SLN+SGN L L + + ++D N S N +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 122 SFDVSSNKITGEFPSAIVNI-----SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
S ++ N + + ++ I +++ S+ L N+L+ +L L S+
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA----- 196
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNI----AGLIPSMIFNNSNMVAIL-LYGNH 231
++ LDL N + + + + N V L L N
Sbjct: 197 --------------------SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236
Query: 232 LSGHLPSSI-----YLPNLENLFLWKNNLSGIIPDSICNASEA-------TILELSSNLF 279
L G ++ L +L+ ++L + + + + A +++ +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
Query: 280 SGLVPNTFGN-----CRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
N + + SL + L Q I L LR + PL
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNI--EDLNIPDELRESIQTCKPL 354
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 23/93 (24%), Positives = 34/93 (36%), Gaps = 8/93 (8%)
Query: 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301
NLE L L L + ++ + LELS N G + L L+L N
Sbjct: 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105
Query: 302 QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
+L S+ + L K L+ L L +
Sbjct: 106 KLKDISTLE------PLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 26/116 (22%), Positives = 45/116 (38%), Gaps = 9/116 (7%)
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLK 199
++++ + LDN + L +L L L+ + + N + L LK
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN------LPKLPKLK 74
Query: 200 ILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS--GHLPSSIYLPNLENLFLWKN 253
L+L N I G + + N+ + L GN L L L L++L L+
Sbjct: 75 KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 31/139 (22%), Positives = 51/139 (36%), Gaps = 27/139 (19%)
Query: 414 DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473
+ +L L N + G+I A +L L + L S S L + ++
Sbjct: 22 TPAAVRELV--LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLE 77
Query: 474 FSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ 533
S N + G L + L L LNL+GN+ + ++ L+ L
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEPLK------------ 117
Query: 534 SFGSLISLQSLDLSGNNIS 552
L L+SLDL ++
Sbjct: 118 ---KLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 35/156 (22%), Positives = 56/156 (35%), Gaps = 29/156 (18%)
Query: 369 NLSNLLVLSLVNNELA-GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSN 427
+ + L L N + G I + + L+ L L + L ++L KL KL L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 428 NNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI 487
N + G + L +L HL+ N L +++L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK------------------DISTLE-----PL 116
Query: 488 GNLEALGGLNLTGN---QLSGYIPSSIGNLKNLDWL 520
LE L L+L L+ Y S L L +L
Sbjct: 117 KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 27/97 (27%), Positives = 36/97 (37%), Gaps = 8/97 (8%)
Query: 366 GFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL- 424
L L L L N + G + + KL L L+L+ NKLK + L L+KL L
Sbjct: 66 NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLK 123
Query: 425 ---LSNN--NALQGQIPTCLANLTSLRHLDFRSNSLN 456
L N L + L L +LD
Sbjct: 124 SLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 26/139 (18%), Positives = 45/139 (32%), Gaps = 10/139 (7%)
Query: 67 NLSFLVSLNISGNSFYDT-LPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDV 125
+ + L + D + L+ + + L S+ +L+ ++
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN--LPKLPKLKKLEL 78
Query: 126 SSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC--TRLPSLVQLRLLGNNITGRI 183
S N+I G + +L + L N L + L +L L L L +T
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVTNLN 136
Query: 184 PNREIPNEIGNLHNLKILD 202
RE L L LD
Sbjct: 137 DYRESV--FKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 22/80 (27%), Positives = 32/80 (40%), Gaps = 4/80 (5%)
Query: 486 NIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLD 545
L L+L L S++ L L L L+ N G + L +L L+
Sbjct: 44 LTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 546 LSGNNISGEIPKSLEKLSRL 565
LSGN + +LE L +L
Sbjct: 102 LSGNKLKD--ISTLEPLKKL 119
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 22/118 (18%), Positives = 43/118 (36%), Gaps = 13/118 (11%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIR---LDN 151
++ + + + + F LE + + + ++ N+ L ++ L
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKLELSE 80
Query: 152 NSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209
N + G L +LP+L L L GN + + + L LK LDL +
Sbjct: 81 NRIFGGLD-MLAEKLPNLTHLNLSGNKLK----DISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 65/225 (28%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSF----DTECEVMRRIR------ 734
+L+G GSF V KA VA+K+ + K+F E ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 735 ------------HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLD 781
RN + +V F+ L +L L + N+ +++
Sbjct: 115 KYYIVHLKRHFMFRNHLCLV-------FEMLSY------NLYDLLRNTNFRGVSLNLTRK 161
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQT 839
+ +AL +L + IIHCDLKP N+LL + + + DFG + L Q
Sbjct: 162 FAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG------QR 214
Query: 840 MT--LATIGYMAPE------YGSEGIVSISGDVYSFGILMMETFT 876
+ + + Y +PE Y +I D++S G +++E T
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYDL----AI--DMWSLGCILVEMHT 253
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 37/167 (22%), Positives = 59/167 (35%), Gaps = 42/167 (25%)
Query: 169 LVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY 228
V+L + I ++ + L K L L NNI +
Sbjct: 27 KVELHGMIPPIE------KMDATLSTLKACKHLALSTNNIEKI----------------- 63
Query: 229 GNHLSGHLPSSIYLPNLENLFLWKNNLSGIIP-DSICNASEATILELSSNLFSGLVPNTF 287
+ LSG + NL L L +N + I D++ + E L +S N + L
Sbjct: 64 -SSLSG-------MENLRILSLGRNLIKKIENLDAVADTLE--ELWISYNQIASLSG--I 111
Query: 288 GNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
L++L + +N++T LA L L+L NPL
Sbjct: 112 EKLVNLRVLYMSNNKITNWGE------IDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 5/94 (5%)
Query: 483 LPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQ 542
+ + L+A L L+ N + I SS+ ++NL L+L RN + I +L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLE 96
Query: 543 SLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
L +S N I+ + +EKL L +S N +
Sbjct: 97 ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 31/203 (15%)
Query: 252 KNNLSGIIPDSICNASEATILELSSNLFSGL--VPNTFGNCRQLQILSLGDNQLTTGSSA 309
K+ + A+EA +EL + + + T + + L+L N +
Sbjct: 8 KDAIRIFEERKSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIEK---- 62
Query: 310 QGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGN 369
I SSL+ LR+L L N +K + ++ ++ +LE + +Q++ + G
Sbjct: 63 ---I--SSLSGMENLRILSLGRNLIKKI--ENLDAVADTLEELWISYNQIAS-LS-GIEK 113
Query: 370 LSNLLVLSLVNNELAGAIP-TVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428
L NL VL + NN++ L L KL+ L L N L N
Sbjct: 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN--------------PLYNDYKEN 159
Query: 429 NALQGQIPTCLANLTSLRHLDFR 451
NA + L +L+ LD
Sbjct: 160 NATSEYRIEVVKRLPNLKKLDGM 182
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 79/514 (15%), Positives = 156/514 (30%), Gaps = 75/514 (14%)
Query: 72 VSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGD-----------MCNSFTQL 120
V++ + + D L ++R LK+ ++ +P + + N+ QL
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114
Query: 121 ESFDVSSNKITGEFPSAIVNI--SSLKSIRLDN-NSLSGSFPTDLCTRLPSLVQLRLLGN 177
+S ++ + L++++LD + + + T + L + +
Sbjct: 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES 174
Query: 178 NITGRIPN--REIPNEIGNLHNLKILDLGGNNI--AGLIPSMIFNNSNMVAILLYGNHLS 233
+ + + E+ +L L I L ++ N ++V++ + +
Sbjct: 175 SFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLE-TIARNCRSLVSVKVGDFEIL 233
Query: 234 GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELS--SNLFSGLVPNTFGNCR 291
+ NLE N +P+ N L S + +P F
Sbjct: 234 ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAA 293
Query: 292 QLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVL-DTNPLKGVIPNSIGNLSTSLE 350
Q++ L L L T + KC L VL + +G+ + L+
Sbjct: 294 QIRKLDLLYALLETEDHCT------LIQKCPNLEVLETRNVIGDRGLE--VLAQYCKQLK 345
Query: 351 NFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKL--K 408
G+ G +S +++L Q+L+ + + + + +
Sbjct: 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQG------------CQELEYMAVYVSDITNE 393
Query: 409 GF--IPTDLCKLEKLNTLLSNNNALQGQIPTC------LANLTSLRHLDFRSNSLNSTIP 460
I T L L +L + +P L LR F T
Sbjct: 394 SLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLT-- 451
Query: 461 STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGY-IPSSIGNLKNLDW 519
D L+ + P N+ + L S + NL
Sbjct: 452 ------------DLGLSYIGQYSP----NVRWM---LLGYVGESDEGLMEFSRGCPNLQK 492
Query: 520 LALARNAFQGP-IPQSFGSLISLQSLDLSGNNIS 552
L + F I + L SL+ L + G S
Sbjct: 493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 59/448 (13%), Positives = 126/448 (28%), Gaps = 113/448 (25%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRL----------LGNNITGRIPNREIPNE 191
+ + + + + P L R P+L L+L L G +
Sbjct: 50 ETREHVTMAL--CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEI 107
Query: 192 IGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLW 251
NL LK + + ++ ++ + + +LE L
Sbjct: 108 SNNLRQLKSVHFRRMIV---------SDLDLDRL------------AKARADDLETL--- 143
Query: 252 KNNLSGIIPDSICNA-SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQ 310
L C+ + +L + ++ CR+++ L + ++ +
Sbjct: 144 --KLDK------CSGFTTDGLLSIVTH------------CRKIKTLLMEESSFSEKD--- 180
Query: 311 GQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNL 370
G+ + L VL + P + ++ N
Sbjct: 181 GKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR---------------------NC 219
Query: 371 SNLLVLSLVNNELA--GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428
+L+ + + + E+ L++ G LN + +L KL L +
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL-CRLGLS 278
Query: 429 NALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIG 488
++P +R LD L + ++ +L L +
Sbjct: 279 YMGPNEMPILFPFAAQIRKLDLLYALLETE------DHCTLIQKCPNLEVLETRNVIGDR 332
Query: 489 NLEALGG-------LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISL 541
LE L L + + G + +ALA+ L
Sbjct: 333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG------------CQEL 380
Query: 542 QSLDLSGNNISGE----IPKSLEKLSRL 565
+ + + ++I+ E I L+ L
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDF 408
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 58/446 (13%), Positives = 128/446 (28%), Gaps = 35/446 (7%)
Query: 46 RVAALSLPNLSLGGTLPPHV----GNLSFLVSLNISGNSFYDTLPNELW--HMRRLKIID 99
R A +L + GG + P V NL L S++ D + L L+ +
Sbjct: 85 RAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144
Query: 100 FSS-NSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNIS----SLKSIRLDNNSL 154
+ + + ++++ + + + + + ++ SL+ +
Sbjct: 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEF 204
Query: 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPS 214
+ P DL T + L + + NL L +
Sbjct: 205 AKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYM 264
Query: 215 MIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFL-WKNNLSGIIPDSICNASEATILE 273
+ + + L + + + L L + + I +LE
Sbjct: 265 NLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLE 324
Query: 274 LSSNLFSGLVPNTFGNCRQLQILSL-GDNQLTTGSSAQGQIFYSSLAK----CRYLRVLV 328
+ + + C+QL+ L + +G + L C+ L +
Sbjct: 325 TRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMA 384
Query: 329 LDTNPLKGVIPNSIGNLSTSLENF---------YAGSSQLSGGIPVGFGNLSNLLVLSLV 379
+ + + SIG +L +F L G+ L +
Sbjct: 385 VYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFY 444
Query: 380 NNELA---GAIPTVLGKLQKLQGLDLNSNKL--KGFIP--TDLCKLEKLNTLLSNNNALQ 432
+ + + ++ + L +G + L+KL + +
Sbjct: 445 LRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLE--MRGCCFSE 502
Query: 433 GQIPTCLANLTSLRHLDFRSNSLNST 458
I + L SLR+L + + T
Sbjct: 503 RAIAAAVTKLPSLRYLWVQGYRASMT 528
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 46/155 (29%)
Query: 687 LLGSGSFDNVYKA--TLANGVSVAVKVFNLQEDRALKSF----DTECEVMRRIR------ 734
LG G+F V + VA+K+ R + + E V+++I+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 735 ------------HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLD 781
+ I F+ L + ++L +N+ +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIA-------FELLGK------NTFEFLKENNFQPYPLPHVRH 127
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816
+ + AL +LH + H DLKP N+L +
Sbjct: 128 MAYQLCHALRFLHE---NQLTHTDLKPENILFVNS 159
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 46/155 (29%)
Query: 687 LLGSGSFDNVYKA--TLANGVSVAVKVFNLQEDRALKSF----DTECEVMRRIR------ 734
LG G+F V + A G VAVK+ + + + +E +V+ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 735 ------------HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLD 781
H I IV F+ L + S ++ + + +
Sbjct: 76 TFRCVQMLEWFEHHGHICIV-------FELLGL------STYDFIKENGFLPFRLDHIRK 122
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816
+ + ++ +LH S + H DLKP N+L
Sbjct: 123 MAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 72/526 (13%), Positives = 164/526 (31%), Gaps = 79/526 (15%)
Query: 88 ELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSI 147
E W R++ I + + S P + F ++ S ++ + + +
Sbjct: 41 ERWCRRKVFIGNCYAVS-----PATVIRRFPKVRSVELKGKP----------HFADFNLV 85
Query: 148 RLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGG-N 206
+ + + L ++RL +T + + + N K+L L
Sbjct: 86 PDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVT----DDCLELIAKSFKNFKVLVLSSCE 141
Query: 207 NI--AGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-----YLPNLENLFLWKNNLSGII 259
GL ++ N+ + L + + + +L +L N+S +
Sbjct: 142 GFSTDGLA-AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL-----NISCL- 194
Query: 260 PDSICNASEATILELSSNL----FSGLVPNT-----FGNCRQLQILSLGDNQLTTGSSAQ 310
+ ++ ++ NL + VP QL+ L G
Sbjct: 195 ASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVY 254
Query: 311 GQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSG-GIPVGFGN 369
+ +L+ C+ LR L + + +P ++ ++ + L + + +
Sbjct: 255 SGLS-VALSGCKELRCLSGFWDAVPAYLP-AVYSVCSRLTTLNLSYATVQSYDLVKLLCQ 312
Query: 370 LSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIP----TD------LCKLE 419
L L +++ + + + L+ L + ++ P T+
Sbjct: 313 CPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCP 372
Query: 420 KLNTLLSNNNALQGQIPTCLA-NLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478
KL ++L + +A N ++ + T L D +
Sbjct: 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL------DIGFGA 426
Query: 479 LSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIG-NLKNLDWLALARNAFQGP-IPQSFG 536
+ +L L +L+G L+ + IG K ++ L++A +
Sbjct: 427 IVEHCK----DLRRL---SLSGL-LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS 478
Query: 537 SLISLQSLDLSGNNISGE----IPKSLEKLSRL--VDFNVSFNGLE 576
SL+ L++ + LE + L +VSF +
Sbjct: 479 GCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACK 524
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 48/371 (12%), Positives = 111/371 (29%), Gaps = 36/371 (9%)
Query: 67 NLSFLVSLNISGNSFYDT----LPNELWHMRRLKIIDFS--SNSLSGSLPGDMCNSFTQL 120
L L++ + D L + L ++ S ++ +S S + L
Sbjct: 154 TCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNL 213
Query: 121 ESFDVSSNKITGEFPSAIVNISSLKSIRLD--NNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
+S ++ + + + L+ + + + L L +LR L +
Sbjct: 214 KSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL--S 271
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNI--AGLIPSMIFNNSNMVAILLYGN-HLSGH 235
+P L L+L + L+ ++ + + + +G
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV-KLLCQCPKLQRLWVLDYIEDAGL 330
Query: 236 LPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSN------LFSGLVPNT--- 286
+ +L L + + + +E ++ +S + T
Sbjct: 331 EVLASTCKDLRELRV--FPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAA 388
Query: 287 ----FGNCRQLQILSLGDNQLTTGSSAQGQI----FYSSLAKCRYLRVLVLDTNPLKGVI 338
N + L + + F + + C+ LR L L L +
Sbjct: 389 LITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL-LTDKV 447
Query: 339 PNSIGNLSTSLENFYAGSSQLSG-GIPVGFGNLSNLLVLSLVNNELAG-AIPTVLGKLQK 396
IG + +E + S G+ +L L + + A+ KL+
Sbjct: 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLET 507
Query: 397 LQGLDLNSNKL 407
++ L ++S +
Sbjct: 508 MRSLWMSSCSV 518
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 28/110 (25%), Positives = 46/110 (41%), Gaps = 13/110 (11%)
Query: 325 RVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNEL 383
L LD N ++P + N L ++++S + F N++ LL L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNY-KHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRL 90
Query: 384 AGAIPT-VLGKLQKLQGLDLNSNKLKGFIPT---DLCKLEKLNTL-LSNN 428
IP L+ L+ L L+ N + +P + L L+ L + N
Sbjct: 91 R-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN--DLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305
L+L N + ++P + N T+++LS+N S L +F N QL L L N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 306 GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGS 356
+ F L LR+L L N + V+P N ++L + G+
Sbjct: 92 --CIPPRTF-DGLKS---LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 32/141 (22%), Positives = 53/141 (37%), Gaps = 35/141 (24%)
Query: 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYIL 470
IP D+ +L + N +P L+N L +D +N +++ +F
Sbjct: 29 IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF------- 74
Query: 471 AVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI-GNLKNLDWLALARNAFQG 529
N+ L L L+ N+L IP LK+L L+L N
Sbjct: 75 -----------------SNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDISV 116
Query: 530 PIPQ-SFGSLISLQSLDLSGN 549
+P+ +F L +L L + N
Sbjct: 117 -VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 3/105 (2%)
Query: 73 SLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITG 132
L + GN F +P EL + + L +ID S+N +S +L ++ TQL + +S N++
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 133 EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
P + SL+ + L N +S P L +L L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 2/87 (2%)
Query: 496 LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI 555
L L GNQ + +P + N K+L + L+ N QSF ++ L +L LS N +
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94
Query: 556 PKSLEKLSRLVDFNVSFNGLEGEIPSG 582
P++ + L L ++ N + +P G
Sbjct: 95 PRTFDGLKSLRLLSLHGNDIS-VVPEG 120
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 35/147 (23%), Positives = 61/147 (41%), Gaps = 32/147 (21%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G F V+ + + VA+KV + ++ E +++ +R+ + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDP-------N 96
Query: 747 NPGFKALIMQYM-------PQG------------SLEKWLYSHNY-SLTIRQRLDIMIDV 786
+P + +++Q + G L KW+ NY L + I+ V
Sbjct: 97 DPN-REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLL 813
L+YLH IIH D+KP N+LL
Sbjct: 156 LQGLDYLHTKCR--IIHTDIKPENILL 180
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 46/301 (15%), Positives = 88/301 (29%), Gaps = 56/301 (18%)
Query: 68 LSFLVSLNISGNSFYD----TLPNELWH-MRRLKIIDFSSNSLSGSLPGDMCNSFTQLES 122
LS L LN++G + L L ++ +S L + + F +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 123 FDVSSNKITGEFPSAI-----VNISSLKSIRLDNNSLSGSFPTDLCTRL---PSLVQLRL 174
+ N + E + + + ++RL NN L+ + L L S+ L L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 175 LGNNITGR---------IPNREIPNEIGNLHNLKILDLGGNNI----AGLIPSMIFNNSN 221
L + NR L+ L++ N A + + +
Sbjct: 191 LHTGLGDEGLELLAAQLDRNR----------QLQELNVAYNGAGDTAALALARAAREHPS 240
Query: 222 MVAILLYGNH--------LSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILE 273
+ + LY N L ++ + +S + E
Sbjct: 241 LELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS--------EYWSVILSE 292
Query: 274 LSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNP 333
+ NL S + +L + L D++ T + L +R L+
Sbjct: 293 VQRNLNSWDRARVQRHL-ELLLRDLEDSRGATLNP---WRKAQLLRVEGEVRALLEQLGS 348
Query: 334 L 334
Sbjct: 349 S 349
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 11/91 (12%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPT-VLGKLQKLQGLD 401
+ T+ + Y +Q++ + G F L+ L L L NN+L +P V KL +L L
Sbjct: 27 GIPTTTQVLYLYDNQITK-LEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLS 84
Query: 402 LNSNKLKGFIPT---DLCKLEKLNTL-LSNN 428
LN N+LK IP D L+ L + L NN
Sbjct: 85 LNDNQLKS-IPRGAFD--NLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPT-VLGKLQKLQGLD 401
+ T + + ++Q++ + G F +L NL L +N+L AIPT V KL +L LD
Sbjct: 30 GIPTDKQRLWLNNNQITK-LEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLD 87
Query: 402 LNSNKLKGFIPT---DLCKLEKLNTL-LSNN 428
LN N LK IP D L+ L + L NN
Sbjct: 88 LNDNHLKS-IPRGAFD--NLKSLTHIYLYNN 115
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 973 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.96 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.8 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.78 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.27 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.14 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.66 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.54 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.41 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.25 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.14 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.47 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.49 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.43 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-81 Score=775.40 Aligned_cols=588 Identities=31% Similarity=0.490 Sum_probs=439.4
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCcceEEEEEeeCCCCcEEEEecCCCCCCCc---CC---------------
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGT---LP--------------- 62 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~---~~--------------- 62 (973)
|||+||++++ ||. .+++ |+. ++|||+|.||+|+ ++||++|||++.++.|. +|
T Consensus 16 all~~k~~~~-~~~-~l~~-W~~-----~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~ 85 (768)
T 3rgz_A 16 QLISFKDVLP-DKN-LLPD-WSS-----NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85 (768)
T ss_dssp HHHHHHTTCS-CTT-SSTT-CCT-----TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECT
T ss_pred HHHHHHhhCC-Ccc-cccC-CCC-----CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCc
Confidence 7999999997 887 7775 864 5799999999998 69999999999999997 44
Q ss_pred --------CCCCCCCCCcEEEecCCCCCCCCCc--ccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCC
Q 048430 63 --------PHVGNLSFLVSLNISGNSFYDTLPN--ELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITG 132 (973)
Q Consensus 63 --------~~l~~l~~L~~L~L~~n~~~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 132 (973)
+.++.+++|++|+|++|.+.|.+|. .++++++|++|||++|.+.+.+|..++..+++|++|||++|++++
T Consensus 86 ~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 165 (768)
T 3rgz_A 86 NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165 (768)
T ss_dssp TSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEE
T ss_pred CCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCC
Confidence 5788889999999999999888888 899999999999999999988888777788999999999999988
Q ss_pred CCCcc---ccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc
Q 048430 133 EFPSA---IVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209 (973)
Q Consensus 133 ~~p~~---~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~ 209 (973)
..|.. +.++++|++|++++|.+++.+|. ..+++|++|+|++|++++. +|. ++++++|++|+|++|+++
T Consensus 166 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~-----~~~-l~~l~~L~~L~Ls~n~l~ 236 (768)
T 3rgz_A 166 ANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTG-----IPF-LGDCSALQHLDISGNKLS 236 (768)
T ss_dssp ETHHHHHHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSC-----CCB-CTTCCSCCEEECCSSCCC
T ss_pred cCChhhhhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCC-----Ccc-cccCCCCCEEECcCCcCC
Confidence 77766 77788888888888888765553 5677788888888887753 333 777777888888888777
Q ss_pred CccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhccc-CcccEEEeccccccccCCCccc
Q 048430 210 GLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNA-SEATILELSSNLFSGLVPNTFG 288 (973)
Q Consensus 210 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~L~L~~N~i~~~~~~~~~ 288 (973)
+.+|..+..+++|+.|++++|.+++.+|.. .+++|++|+|++|++++.+|..+... ++|++|+|++|.+++.+|..|+
T Consensus 237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~ 315 (768)
T 3rgz_A 237 GDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315 (768)
T ss_dssp SCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG
T ss_pred CcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh
Confidence 777777777777777777777776655543 44555555555555554444444443 4455555555555444444444
Q ss_pred cc-------------------------ccceEEEccCCcCCC-CCCCcchhh-----------------hhhhcc--CCc
Q 048430 289 NC-------------------------RQLQILSLGDNQLTT-GSSAQGQIF-----------------YSSLAK--CRY 323 (973)
Q Consensus 289 ~l-------------------------~~L~~L~L~~N~l~~-~~~~~~~~~-----------------~~~l~~--l~~ 323 (973)
++ ++|++|++++|++++ .+....... +..+.. +++
T Consensus 316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~ 395 (768)
T 3rgz_A 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395 (768)
T ss_dssp GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence 44 445555555554442 111100000 000111 333
Q ss_pred CcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEcc
Q 048430 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403 (973)
Q Consensus 324 L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls 403 (973)
|+.|++++|.+.+.+|..+..+ ..|+.|++++|.+++.+|..|+.+++|++|++++|.+.+.+|..+..+++|++|+|+
T Consensus 396 L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 396 LQELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCEEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred ccEEECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 4444444444444444444443 345666666666666666666666666666666666666666667777777777777
Q ss_pred CCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCc
Q 048430 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSL 483 (973)
Q Consensus 404 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 483 (973)
+|++++.+|..+.++++|++|++++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|+.||+++|+++|.+
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence 77777777777777777777777777777777777777777777777777777777777777888888888888777666
Q ss_pred CcCc----------------------------------------------------------------------cCCCCC
Q 048430 484 PLNI----------------------------------------------------------------------GNLEAL 493 (973)
Q Consensus 484 p~~~----------------------------------------------------------------------~~l~~L 493 (973)
|..+ +.+++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 6433 335678
Q ss_pred CeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCC
Q 048430 494 GGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 494 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
+.|+|++|+++|.+|..|+.++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++||+++|
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccCccccccCcccccCCccCCCCccC
Q 048430 574 GLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPCKT 612 (973)
Q Consensus 574 ~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~c~~ 612 (973)
+|+|.||..+++.+++..+|.||+++||.|+ ++|..
T Consensus 715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~ 750 (768)
T 3rgz_A 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDP 750 (768)
T ss_dssp EEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCS
T ss_pred cccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCC
Confidence 9999999999999999999999999999884 36754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-63 Score=615.21 Aligned_cols=515 Identities=34% Similarity=0.460 Sum_probs=420.3
Q ss_pred CcEEEEecCCCCCCCcCCCCC-CCCCCCcEEEecCCCCCCCCCcc---ccc----------------------ccCCcEE
Q 048430 45 GRVAALSLPNLSLGGTLPPHV-GNLSFLVSLNISGNSFYDTLPNE---LWH----------------------MRRLKII 98 (973)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~l-~~l~~L~~L~L~~n~~~~~~p~~---~~~----------------------l~~L~~L 98 (973)
.+.+.|+++++.+.|.+|..+ +.+++|++|+|++|++.+..|.. +++ +++|++|
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L 205 (768)
T 3rgz_A 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL 205 (768)
T ss_dssp TTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEE
T ss_pred CCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEE
Confidence 468888888888888888765 77778888888877776666554 444 4555555
Q ss_pred EccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEccccc
Q 048430 99 DFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178 (973)
Q Consensus 99 ~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~ 178 (973)
+|++|.+.+.+|. ++.+++|++|+|++|++++.+|..|+++++|++|+|++|+++|.+|.. .+++|++|+|++|+
T Consensus 206 ~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~ 280 (768)
T 3rgz_A 206 DVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENK 280 (768)
T ss_dssp ECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSE
T ss_pred ECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCc
Confidence 5555555544443 455556666666666665555555666666666666666665555443 45566666666666
Q ss_pred ccccCCCCCCCccccCC-CCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCC--CCccccceeeeccccc
Q 048430 179 ITGRIPNREIPNEIGNL-HNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS--IYLPNLENLFLWKNNL 255 (973)
Q Consensus 179 l~~~~~~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~--~~l~~L~~L~L~~N~l 255 (973)
++| .+|..+..+ ++|++|+|++|++++.+|..+..+++|+.|++++|.+++.+|.. ..+++|++|++++|++
T Consensus 281 l~~-----~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l 355 (768)
T 3rgz_A 281 FTG-----EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355 (768)
T ss_dssp EEE-----SCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEE
T ss_pred cCC-----ccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCcc
Confidence 654 345566554 88888888888888888888888888888888888888777743 3578888888888888
Q ss_pred cccCcchhcccC-cccEEEeccccccccCCCcccc--cccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCC
Q 048430 256 SGIIPDSICNAS-EATILELSSNLFSGLVPNTFGN--CRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTN 332 (973)
Q Consensus 256 ~~~~~~~l~~l~-~L~~L~L~~N~i~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 332 (973)
++.+|..+..++ +|++|++++|++++.+|..+.. +++|++|++++|++++ ..+..+.++++|+.|++++|
T Consensus 356 ~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-------~~p~~l~~l~~L~~L~Ls~N 428 (768)
T 3rgz_A 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG-------KIPPTLSNCSELVSLHLSFN 428 (768)
T ss_dssp EECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEE-------ECCGGGGGCTTCCEEECCSS
T ss_pred CccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccc-------ccCHHHhcCCCCCEEECcCC
Confidence 888888888887 8888888888888777777766 7788888888888874 23456889999999999999
Q ss_pred CCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCc
Q 048430 333 PLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIP 412 (973)
Q Consensus 333 ~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 412 (973)
++++.+|..+..+ ..|+.|++.+|.+++.+|..+..+++|++|++++|++++.+|..+..+++|++|+|++|++++.+|
T Consensus 429 ~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 507 (768)
T 3rgz_A 429 YLSGTIPSSLGSL-SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507 (768)
T ss_dssp EEESCCCGGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred cccCcccHHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCC
Confidence 9999999998887 579999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccc-----------------------------
Q 048430 413 TDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF----------------------------- 463 (973)
Q Consensus 413 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~----------------------------- 463 (973)
.+++.+++|+.|++++|++++.+|..+.++++|+.|++++|+++|.+|..+
T Consensus 508 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (768)
T 3rgz_A 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 587 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTC
T ss_pred hHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccc
Confidence 999999999999999999999999999999999999999999988777644
Q ss_pred -----------------------------------------cccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCc
Q 048430 464 -----------------------------------------WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQ 502 (973)
Q Consensus 464 -----------------------------------------~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 502 (973)
..+++|+.||+++|+++|.+|.+++++++|+.|+|++|+
T Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~ 667 (768)
T 3rgz_A 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667 (768)
T ss_dssp CSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCc
Confidence 335678999999999999999999999999999999999
Q ss_pred CcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCc-cccc
Q 048430 503 LSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNG-LEGE 578 (973)
Q Consensus 503 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~-l~~~ 578 (973)
++|.+|..|+.+++|+.|||++|+++|.+|..|+.+++|++|||++|+++|.+|.. ..+..+....+.+|+ |+|.
T Consensus 668 l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred cCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 99999999999999999999999999999999999999999999999999999965 456667777788885 7774
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=572.16 Aligned_cols=564 Identities=23% Similarity=0.234 Sum_probs=474.3
Q ss_pred ceEEEEEeeCC---------CCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCC
Q 048430 33 CNWVGVTCSIR---------HGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSN 103 (973)
Q Consensus 33 c~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n 103 (973)
|.++-|.|+.. ..+++.|+++++.+++..+..++++++|++|+|++|.+.+..|..++++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 45556777542 358999999999999877778999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccC
Q 048430 104 SLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRI 183 (973)
Q Consensus 104 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~ 183 (973)
.++ .+|...|..+++|++|+|++|++++..|..|+++++|++|+|++|.+++ ++...+..+++|++|+|++|++++..
T Consensus 84 ~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 84 ELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSC-CCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred ccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccc-cCchhhcccccCCEEEccCCcccccC
Confidence 998 7888878999999999999999998777899999999999999999994 45555678999999999999997532
Q ss_pred CCCCCCccc--cCCCCccEEEecCCcccCccccccccC---------------------------CcceeEEeecccccc
Q 048430 184 PNREIPNEI--GNLHNLKILDLGGNNIAGLIPSMIFNN---------------------------SNMVAILLYGNHLSG 234 (973)
Q Consensus 184 ~~~~~p~~l--~~l~~L~~L~L~~N~l~~~~~~~~~~~---------------------------~~L~~L~l~~n~l~~ 234 (973)
+..+ ..+++|++|++++|++++..|..+..+ ++|+.|++++|.+++
T Consensus 162 -----~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~ 236 (680)
T 1ziw_A 162 -----SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236 (680)
T ss_dssp -----HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCE
T ss_pred -----HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccc
Confidence 3334 356899999999999999888877665 456677777777777
Q ss_pred cCCCCC-Cc--cccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCC--C
Q 048430 235 HLPSSI-YL--PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSS--A 309 (973)
Q Consensus 235 ~~~~~~-~l--~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~ 309 (973)
..|..+ .+ ++|++|+|++|++++..|..|+.+++|++|++++|++.+..|..|.++++|+.|++++|....... .
T Consensus 237 ~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~ 316 (680)
T 1ziw_A 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316 (680)
T ss_dssp ECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------
T ss_pred cChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccc
Confidence 766554 34 348888888888888888888888888888888888888888888888888888888775442110 0
Q ss_pred cchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCcccc--CCCCCCCC--CcccEEEeecCcccc
Q 048430 310 QGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG--IPVGFGNL--SNLLVLSLVNNELAG 385 (973)
Q Consensus 310 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~--~p~~~~~l--~~L~~L~Ls~n~l~~ 385 (973)
.+.+....+..+++|+.|++++|.+.+..|..+..+ ..|+.+++++|.+... .+..|..+ ++|+.|++++|++++
T Consensus 317 lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~ 395 (680)
T 1ziw_A 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395 (680)
T ss_dssp CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC-TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCE
T ss_pred ccccChhhcccCCCCCEEECCCCccCCCChhHhccc-cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCe
Confidence 011112257788999999999999998888777765 5789999998875432 22334433 589999999999998
Q ss_pred ccCcccCCCCCCCEEEccCCcCCCCCc-hhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCC--CCCccc
Q 048430 386 AIPTVLGKLQKLQGLDLNSNKLKGFIP-TDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN--STIPST 462 (973)
Q Consensus 386 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~ 462 (973)
..|..|..+++|++|+|++|++.+.+| ..+.++++|++|++++|++.+..+..|..+++|+.|++++|.+. +..|..
T Consensus 396 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~ 475 (680)
T 1ziw_A 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCT
T ss_pred EChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcc
Confidence 889999999999999999999987665 68999999999999999999999999999999999999999986 578999
Q ss_pred ccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCC--------cccccCCcCCEEEcccCccccCCCCC
Q 048430 463 FWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP--------SSIGNLKNLDWLALARNAFQGPIPQS 534 (973)
Q Consensus 463 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~ 534 (973)
|..+++|+.|++++|++++..+..|.++++|+.|+|++|++++..+ ..|+++++|+.|+|++|+++...+..
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~ 555 (680)
T 1ziw_A 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred cccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHH
Confidence 9999999999999999998888889999999999999999986422 24789999999999999999555567
Q ss_pred cccccccccccccccccCCCCCccccccccccccccCCCcccccCCCC-C-CCCccCccccccCcccccCCc
Q 048430 535 FGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG-G-PFVNFTADSFKQNYALCGSSR 604 (973)
Q Consensus 535 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~-~~~~~~~~~~~~n~~~c~~~~ 604 (973)
|.++++|+.|+|++|+|++..+..|..+++|+.|++++|++++.+|.. + .+.++....+.+|++.|+|..
T Consensus 556 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 999999999999999999887788899999999999999999877753 1 356677778899999999874
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=548.42 Aligned_cols=508 Identities=21% Similarity=0.225 Sum_probs=371.5
Q ss_pred CCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCC
Q 048430 53 PNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITG 132 (973)
Q Consensus 53 ~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 132 (973)
++.+++ .+|..+.. .+++|+|++|++.+..|..|+++++|++|+|++|++.+ +++..|.++++|++|+|++|++++
T Consensus 20 ~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~ 95 (606)
T 3t6q_A 20 ENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPLIF 95 (606)
T ss_dssp TTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCSE
T ss_pred CCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccce-eChhhccCccccCeeeCCCCcccc
Confidence 333443 44444432 45666666666666556666666666666666666663 333344566666666666666666
Q ss_pred CCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCcc
Q 048430 133 EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLI 212 (973)
Q Consensus 133 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 212 (973)
..|.+|+++++|++|+|++|+++ .++...+..+++|++|+|++|++++. .+|. +..+++|++|+|++|++++..
T Consensus 96 ~~~~~~~~l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~----~~~~-~~~l~~L~~L~L~~n~l~~~~ 169 (606)
T 3t6q_A 96 MAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSI----KLPK-GFPTEKLKVLDFQNNAIHYLS 169 (606)
T ss_dssp ECTTTTSSCTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCC----CCCT-TCCCTTCCEEECCSSCCCEEC
T ss_pred cChhhhcccccccEeeccccCcc-cCCcchhccCCcccEEECCCCccccc----Cccc-ccCCcccCEEEcccCcccccC
Confidence 66666666666666666666666 44434455666666666666666532 1122 333666666666666666666
Q ss_pred ccccccCCcce--eEEeecccccccCCCCCCccccceeeeccccc--------------------------cccCcchhc
Q 048430 213 PSMIFNNSNMV--AILLYGNHLSGHLPSSIYLPNLENLFLWKNNL--------------------------SGIIPDSIC 264 (973)
Q Consensus 213 ~~~~~~~~~L~--~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l--------------------------~~~~~~~l~ 264 (973)
|..+..+++|+ .|++++|.+++..|..+...+|++|++++|.. ..+.+..+.
T Consensus 170 ~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~ 249 (606)
T 3t6q_A 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249 (606)
T ss_dssp HHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred hhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence 66666666666 66666666666666555556666666665531 112223333
Q ss_pred ccC--cccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcc
Q 048430 265 NAS--EATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI 342 (973)
Q Consensus 265 ~l~--~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 342 (973)
.+. +|+.|++++|.++++.+..|+.+++|++|++++|+++.++. .+..+++|++|++++|++.+..|..+
T Consensus 250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~--------~l~~l~~L~~L~l~~n~l~~~~~~~~ 321 (606)
T 3t6q_A 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS--------GLVGLSTLKKLVLSANKFENLCQISA 321 (606)
T ss_dssp GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS--------SCCSCTTCCEEECTTCCCSBGGGGCG
T ss_pred hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh--------hhcccccCCEEECccCCcCcCchhhh
Confidence 333 68888888888888888888888888888888888876443 46778888888888888887777777
Q ss_pred cccccccceeecccCCccccCCCC-CCCCCcccEEEeecCcccccc--CcccCCCCCCCEEEccCCcCCCCCchhhhccC
Q 048430 343 GNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAI--PTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLE 419 (973)
Q Consensus 343 ~~l~~~l~~l~l~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 419 (973)
..+ +.|+.+++++|.+.+.+|.. +..+++|++|++++|.+++.. +..+..+++|++|++++|++.+..|..+..++
T Consensus 322 ~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 400 (606)
T 3t6q_A 322 SNF-PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400 (606)
T ss_dssp GGC-TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCT
T ss_pred hcc-CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCc
Confidence 666 56888888888888766654 888888888888888888665 77888888888888888888877788888888
Q ss_pred cCCeeecCCccccCcCccc-ccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCC---cCcCccCCCCCCe
Q 048430 420 KLNTLLSNNNALQGQIPTC-LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGS---LPLNIGNLEALGG 495 (973)
Q Consensus 420 ~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~---~p~~~~~l~~L~~ 495 (973)
+|+.|++++|.+.+..+.. +.++++|++|++++|.+.+..|..+..+++|+.|++++|++++. .+..+..+++|+.
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~ 480 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCE
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccE
Confidence 8888888888888776544 78888888888888888888888888888888888888888762 2356788888888
Q ss_pred EEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcc
Q 048430 496 LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGL 575 (973)
Q Consensus 496 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l 575 (973)
|+|++|++++..|..|+.+++|+.|+|++|++++.+|..|..+++| .|+|++|++++.+|..+..+++|+.+++++|++
T Consensus 481 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 559 (606)
T 3t6q_A 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559 (606)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCE
T ss_pred EECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCc
Confidence 8888888888778888888888888888888888888888888888 888888888888888888888888888888888
Q ss_pred cccCC
Q 048430 576 EGEIP 580 (973)
Q Consensus 576 ~~~~p 580 (973)
.+..+
T Consensus 560 ~c~c~ 564 (606)
T 3t6q_A 560 DCTCS 564 (606)
T ss_dssp ECSGG
T ss_pred cccCC
Confidence 87665
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-59 Score=562.37 Aligned_cols=498 Identities=21% Similarity=0.313 Sum_probs=310.9
Q ss_pred ChHHHHhhhccCCCcccCCCCCCC--------CCCCCCCcceE---EEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCC
Q 048430 1 ALVQLKARISLDPHNFFANNWNLS--------PTNTSASVCNW---VGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLS 69 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~--------~~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~ 69 (973)
||++||+++..+. |... .|..+++||.| .||+|+.. +||++|+|+++++.|.+|++++.|+
T Consensus 34 aL~~~~~~~~~~~-------w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 34 ALKEIWDALNGKN-------WSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHTTGGG-------CCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHcCCCC-------cccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence 7999999985433 5422 25567999999 99999865 8999999999999999999999999
Q ss_pred CCcEEEecCCCC------CC------CCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCcc
Q 048430 70 FLVSLNISGNSF------YD------TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSA 137 (973)
Q Consensus 70 ~L~~L~L~~n~~------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 137 (973)
+|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.+|..+...+..+..+++....+..
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~----- 177 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK----- 177 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC-----
T ss_pred cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc-----
Confidence 999999999976 34 566655 67777 88898888887776554323333333333222110
Q ss_pred ccCCCCCCeEEcc--CccccccCCccccCCCCCccEEEccccccccc-CCCC-----------CCCcccc--CCCCccEE
Q 048430 138 IVNISSLKSIRLD--NNSLSGSFPTDLCTRLPSLVQLRLLGNNITGR-IPNR-----------EIPNEIG--NLHNLKIL 201 (973)
Q Consensus 138 ~~~l~~L~~L~L~--~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~~~~-----------~~p~~l~--~l~~L~~L 201 (973)
.....++.+.+. +|+++| ||..+ +++++|++|+|++|+++|. ++.. .+|..++ ++++|++|
T Consensus 178 -~~~~~l~~l~l~~~~n~l~~-ip~~l-~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L 254 (636)
T 4eco_A 178 -SSRITLKDTQIGQLSNNITF-VSKAV-MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254 (636)
T ss_dssp -CCCCCCCTTTTTCCSCEEEE-ECGGG-GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred -ccccchhhhhhccccCCCcc-CCHHH-hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence 011112222222 344443 44432 3444444444444444431 0000 0445555 55555555
Q ss_pred EecCCcccCccccccccCCcceeEEeeccc-ccc-cCCCCC-C------ccccceeeeccccccccCcc--hhcccCccc
Q 048430 202 DLGGNNIAGLIPSMIFNNSNMVAILLYGNH-LSG-HLPSSI-Y------LPNLENLFLWKNNLSGIIPD--SICNASEAT 270 (973)
Q Consensus 202 ~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~-l~~-~~~~~~-~------l~~L~~L~L~~N~l~~~~~~--~l~~l~~L~ 270 (973)
+|++|++.+.+|..+.++++|+.|++++|+ +++ .+|... . +++|++|+|++|+++ .+|. .++.+++|+
T Consensus 255 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~ 333 (636)
T 4eco_A 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLG 333 (636)
T ss_dssp EEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCC
T ss_pred EecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCC
Confidence 555555555555555555555555555554 444 333222 1 378888888888888 6777 788888888
Q ss_pred EEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCc-CcEEEccCCCCCCCCCCccccccccc
Q 048430 271 ILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY-LRVLVLDTNPLKGVIPNSIGNLSTSL 349 (973)
Q Consensus 271 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~~l 349 (973)
+|++++|++++.+| .|+.+++|++|++++|+++.++ ..+..+++ |+.|++++|+++ .+|..
T Consensus 334 ~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp--------~~l~~l~~~L~~L~Ls~N~l~-~lp~~-------- 395 (636)
T 4eco_A 334 MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP--------ANFCGFTEQVENLSFAHNKLK-YIPNI-------- 395 (636)
T ss_dssp EEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECC--------TTSEEECTTCCEEECCSSCCS-SCCSC--------
T ss_pred EEeCcCCcCccchh-hhCCCCCCCEEECCCCcccccc--------HhhhhhcccCcEEEccCCcCc-ccchh--------
Confidence 88888888887777 7888888888888888876432 33556666 666776666666 33333
Q ss_pred ceeecccCCccccCCCCCCC--CCcccEEEeecCccccccCcccC-------CCCCCCEEEccCCcCCCCCchhhhccCc
Q 048430 350 ENFYAGSSQLSGGIPVGFGN--LSNLLVLSLVNNELAGAIPTVLG-------KLQKLQGLDLNSNKLKGFIPTDLCKLEK 420 (973)
Q Consensus 350 ~~l~l~~n~l~~~~p~~~~~--l~~L~~L~Ls~n~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 420 (973)
+.. +++|++|++++|.+++..|..|. .+++|++|+|++|+++...+..+..+++
T Consensus 396 -----------------~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~ 458 (636)
T 4eco_A 396 -----------------FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458 (636)
T ss_dssp -----------------CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCC
T ss_pred -----------------hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCC
Confidence 333 34677888888888777777776 6667777777777777433334445677
Q ss_pred CCeeecCCccccCcCcc-cccCcC-------CCCeeeccCCCCCCCCccccc--ccccccEEEecCCcccCCcCcCccCC
Q 048430 421 LNTLLSNNNALQGQIPT-CLANLT-------SLRHLDFRSNSLNSTIPSTFW--SLKYILAVDFSLNSLSGSLPLNIGNL 490 (973)
Q Consensus 421 L~~L~l~~N~l~~~~~~-~~~~l~-------~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~l 490 (973)
|+.|++++|+++ .+|. .+.... +|++|+|++|+++ .+|..+. .+++|+.|++++|++++ +|..+..+
T Consensus 459 L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l 535 (636)
T 4eco_A 459 LSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535 (636)
T ss_dssp CSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC
T ss_pred CCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcC
Confidence 777777777766 3333 222221 4555555555554 3444443 44444444444444443 44444444
Q ss_pred CCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCcccccccccccccc
Q 048430 491 EALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNV 570 (973)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l 570 (973)
++|+.|+|++|+ ++++|++.+.+|..|+.+++|++|+|++|+| +.+|..+. ++|+.||+
T Consensus 536 ~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~L 594 (636)
T 4eco_A 536 STLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDI 594 (636)
T ss_dssp SSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEEC
T ss_pred CCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEEC
Confidence 444444443322 2256777777777777777888888888877 46776655 67788888
Q ss_pred CCCcccc
Q 048430 571 SFNGLEG 577 (973)
Q Consensus 571 s~N~l~~ 577 (973)
++|++..
T Consensus 595 s~N~l~~ 601 (636)
T 4eco_A 595 KDNPNIS 601 (636)
T ss_dssp CSCTTCE
T ss_pred cCCCCcc
Confidence 8887664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-56 Score=542.62 Aligned_cols=523 Identities=20% Similarity=0.233 Sum_probs=459.2
Q ss_pred CcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEE
Q 048430 45 GRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFD 124 (973)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~ 124 (973)
.+++.|+++++.+++..|..++++++|++|+|++|++.+..+..|+++++|++|+|++|++. .+|+..|+.+++|++|+
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~ 127 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLD 127 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEE
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccC-ccChhHccccCCCCEEE
Confidence 57999999999999988989999999999999999997655557999999999999999998 67766778999999999
Q ss_pred eeCcccCCCCCccccCCCCCCeEEccCccccccCCccccC--CCCCccEEEcccccccccCCCCCCCccccCC-------
Q 048430 125 VSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCT--RLPSLVQLRLLGNNITGRIPNREIPNEIGNL------- 195 (973)
Q Consensus 125 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l------- 195 (973)
|++|.+++..|..++++++|++|++++|.+++ ++...+. .+++|++|++++|++++.. |..+..+
T Consensus 128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~~~~~L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~ 201 (680)
T 1ziw_A 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSSNQIKEFS-----PGCFHAIGRLFGLF 201 (680)
T ss_dssp CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC-BCHHHHGGGTTCEESEEECTTCCCCCBC-----TTGGGGSSEECEEE
T ss_pred CCCCcccccCchhhcccccCCEEEccCCcccc-cCHHHhhccccccccEEECCCCcccccC-----hhhhhhhhhhhhhh
Confidence 99999999999999999999999999999984 4444332 5689999999999998643 3334332
Q ss_pred --------------------CCccEEEecCCcccCccccccccCCc--ceeEEeecccccccCCCCC-Cccccceeeecc
Q 048430 196 --------------------HNLKILDLGGNNIAGLIPSMIFNNSN--MVAILLYGNHLSGHLPSSI-YLPNLENLFLWK 252 (973)
Q Consensus 196 --------------------~~L~~L~L~~N~l~~~~~~~~~~~~~--L~~L~l~~n~l~~~~~~~~-~l~~L~~L~L~~ 252 (973)
++|+.|++++|++++..|..+.+++. |+.|++++|++++..+..+ .+++|++|++++
T Consensus 202 l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (680)
T 1ziw_A 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281 (680)
T ss_dssp CTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCC
Confidence 67889999999999999999988865 9999999999998887655 699999999999
Q ss_pred ccccccCcchhcccCcccEEEeccccccc---------cCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCc
Q 048430 253 NNLSGIIPDSICNASEATILELSSNLFSG---------LVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY 323 (973)
Q Consensus 253 N~l~~~~~~~l~~l~~L~~L~L~~N~i~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 323 (973)
|++.+..|..|..+++|+.|++++|...+ +....|..+++|++|++++|++++.+ +..+..+++
T Consensus 282 n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~-------~~~~~~l~~ 354 (680)
T 1ziw_A 282 NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK-------SNMFTGLIN 354 (680)
T ss_dssp CCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCC-------TTTTTTCTT
T ss_pred CccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCC-------hhHhccccC
Confidence 99999999999999999999999886553 22237889999999999999998754 345788999
Q ss_pred CcEEEccCCCCCCC--CCCcccccc-cccceeecccCCccccCCCCCCCCCcccEEEeecCccccccC-cccCCCCCCCE
Q 048430 324 LRVLVLDTNPLKGV--IPNSIGNLS-TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIP-TVLGKLQKLQG 399 (973)
Q Consensus 324 L~~L~L~~N~l~~~--~p~~~~~l~-~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~ 399 (973)
|+.|++++|.+... .+..+..+. ..++.+++++|++++..|..|..+++|++|++++|.+.+.+| ..|..+++|++
T Consensus 355 L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 434 (680)
T 1ziw_A 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434 (680)
T ss_dssp CCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCE
T ss_pred CcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccE
Confidence 99999999986433 223333332 579999999999999999999999999999999999987665 78999999999
Q ss_pred EEccCCcCCCCCchhhhccCcCCeeecCCcccc--CcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCC
Q 048430 400 LDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQ--GQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLN 477 (973)
Q Consensus 400 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 477 (973)
|++++|++.+..+..|..+++|+.|++++|.+. +..|..+.++++|+.|++++|++++..+..|..+++|+.|++++|
T Consensus 435 L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N 514 (680)
T 1ziw_A 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514 (680)
T ss_dssp EECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCC
Confidence 999999999888999999999999999999987 578899999999999999999999988889999999999999999
Q ss_pred cccCCcC--------cCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccccc
Q 048430 478 SLSGSLP--------LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549 (973)
Q Consensus 478 ~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (973)
++++..+ ..+.++++|+.|+|++|+++...+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus 515 ~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp CCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 9986422 23789999999999999999555557999999999999999999877888999999999999999
Q ss_pred ccCCCCCcccc-ccccccccccCCCcccccCCC
Q 048430 550 NISGEIPKSLE-KLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 550 ~l~~~~p~~~~-~l~~L~~l~ls~N~l~~~~p~ 581 (973)
+|++..|..+. .+++|+.+++++|++.+..+.
T Consensus 595 ~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 595 LITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99998888888 899999999999999998774
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=538.08 Aligned_cols=529 Identities=20% Similarity=0.198 Sum_probs=341.5
Q ss_pred EEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCc
Q 048430 49 ALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSN 128 (973)
Q Consensus 49 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N 128 (973)
.++.++++++ .+|..+. ++|++|+|++|++.+..|..|.++++|++|+|++|.++ .+++..|.++++|++|+|++|
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccc-ccCHHHhhchhhcCEeECCCC
Confidence 3566667776 6776554 78888899988888777778888888999999988888 455555678888999999988
Q ss_pred ccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcc
Q 048430 129 KITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI 208 (973)
Q Consensus 129 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l 208 (973)
++++..|.+|+++++|++|+|++|+++ .++...+..+++|++|+|++|++++. .+|..|+++++|++|+|++|++
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~lp~~~~~l~~L~~L~Ls~n~l 165 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSC----KLPAYFSNLTNLVHVDLSYNYI 165 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCC----CCCGGGGTCTTCCEEECCSSCC
T ss_pred cccccChhhcCCcccCCEEEccCCccc-cccccccCCCCCCCEEeCCCCcccce----echHhHhhcCCCCEEEccCCcc
Confidence 888777888888888999999998888 56655578888899999998888642 4678888888999999999988
Q ss_pred cCccccccccCCcce----eEEeecccccccCCCCCCccccceeeecccccc-ccCcchhcccCcccEEEeccccccc--
Q 048430 209 AGLIPSMIFNNSNMV----AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLS-GIIPDSICNASEATILELSSNLFSG-- 281 (973)
Q Consensus 209 ~~~~~~~~~~~~~L~----~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~i~~-- 281 (973)
++..|..+..+++|+ .|++++|.+++..+..+...+|++|++++|.+. +..|..+.+++.|+.+++..+.+..
T Consensus 166 ~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~ 245 (606)
T 3vq2_A 166 QTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245 (606)
T ss_dssp CEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC
T ss_pred eecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCC
Confidence 888787777776665 788888888877777666668888999888886 4567778888888877775443321
Q ss_pred ----cCCCcccccc--cceEEEc-cCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeec
Q 048430 282 ----LVPNTFGNCR--QLQILSL-GDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYA 354 (973)
Q Consensus 282 ----~~~~~~~~l~--~L~~L~L-~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l 354 (973)
..+..+.++. .++.+++ ..|.+.+. .+ .+..+++|+.|++++|.+.. +| .+..+ ..++.+++
T Consensus 246 ~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~-------~~-~~~~l~~L~~L~l~~~~~~~-l~-~l~~~-~~L~~L~l 314 (606)
T 3vq2_A 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD-------IV-KFHCLANVSAMSLAGVSIKY-LE-DVPKH-FKWQSLSI 314 (606)
T ss_dssp CCSCCCGGGGTTGGGSEEEEEEECCCTTCCGG-------GG-SCGGGTTCSEEEEESCCCCC-CC-CCCTT-CCCSEEEE
T ss_pred cccccChHHhhhhhhccHhheecccccccccc-------cc-ccccCCCCCEEEecCccchh-hh-hcccc-ccCCEEEc
Confidence 1111222221 2333444 33333321 11 14455555555555555542 23 33322 34555555
Q ss_pred ccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCC--CchhhhccCcCCeeecCCcccc
Q 048430 355 GSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGF--IPTDLCKLEKLNTLLSNNNALQ 432 (973)
Q Consensus 355 ~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~ 432 (973)
.+|.+ +.+| .+ .+++|++|++++|...+.. .+..+++|++|++++|++++. .|..+..+++|+.|++++|.++
T Consensus 315 ~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 389 (606)
T 3vq2_A 315 IRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389 (606)
T ss_dssp ESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE
T ss_pred ccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc
Confidence 55555 4455 33 5666666666666443222 445566666666666666544 2555666666666666666655
Q ss_pred CcCcccccCcCCCCeeeccCCCCCCCCc-ccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcc-cCCcc
Q 048430 433 GQIPTCLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG-YIPSS 510 (973)
Q Consensus 433 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~ 510 (973)
+ +|..+..+++|+.|++++|++.+..| ..|..+++|+.|++++|++++..|..++++++|+.|++++|++++ .+|..
T Consensus 390 ~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 468 (606)
T 3vq2_A 390 I-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468 (606)
T ss_dssp E-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred c-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHh
Confidence 3 33555666666666666666655555 455666666666666666665566666666666666666666664 25556
Q ss_pred cccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCC-CCCC-cc
Q 048430 511 IGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG-GPFV-NF 588 (973)
Q Consensus 511 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~-~~ 588 (973)
|+.+++|+.|+|++|++++.+|..|+.+++|++|+|++|++++.+|..|..+++|+.|++++|+++. +|.. ..+. ++
T Consensus 469 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L 547 (606)
T 3vq2_A 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSL 547 (606)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTC
T ss_pred hccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccC
Confidence 6666666666666666666556666666666666666666666556666666666666666666653 3322 2222 23
Q ss_pred CccccccCcccccCCc
Q 048430 589 TADSFKQNYALCGSSR 604 (973)
Q Consensus 589 ~~~~~~~n~~~c~~~~ 604 (973)
....+.+|++.|+++.
T Consensus 548 ~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 548 AFFNLTNNSVACICEH 563 (606)
T ss_dssp CEEECCSCCCCCSSTT
T ss_pred cEEEccCCCcccCCcc
Confidence 4445556666665543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=530.79 Aligned_cols=505 Identities=19% Similarity=0.180 Sum_probs=444.2
Q ss_pred EEEEEeeCC---------CCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCC
Q 048430 35 WVGVTCSIR---------HGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSL 105 (973)
Q Consensus 35 w~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l 105 (973)
+.-|.|... +..++.|+++++.+++..|..++++++|++|+|++|++.+..|..|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 345888652 35799999999999988888999999999999999999998899999999999999999999
Q ss_pred CCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCC
Q 048430 106 SGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN 185 (973)
Q Consensus 106 ~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~ 185 (973)
.+..| ..++.+++|++|+|++|++++..|..|+++++|++|+|++|+++ .++...+..+++|++|+|++|++++.
T Consensus 94 ~~~~~-~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~--- 168 (606)
T 3t6q_A 94 IFMAE-TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYL--- 168 (606)
T ss_dssp SEECT-TTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCC-CCCCCTTCCCTTCCEEECCSSCCCEE---
T ss_pred cccCh-hhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccc-ccCcccccCCcccCEEEcccCccccc---
Confidence 95444 45689999999999999999877889999999999999999999 44333333599999999999999853
Q ss_pred CCCCccccCCCCcc--EEEecCCcccCccccccccCCcceeEEeecccccc-------------------------cCCC
Q 048430 186 REIPNEIGNLHNLK--ILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG-------------------------HLPS 238 (973)
Q Consensus 186 ~~~p~~l~~l~~L~--~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~-------------------------~~~~ 238 (973)
.|..++.+++|+ .|++++|++++..|..+. ..+|+.|++++|.... .++.
T Consensus 169 --~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~ 245 (606)
T 3t6q_A 169 --SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245 (606)
T ss_dssp --CHHHHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCG
T ss_pred --ChhhhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccccCh
Confidence 356799999999 999999999987776654 4689999998875110 0000
Q ss_pred CC--Cc--cccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhh
Q 048430 239 SI--YL--PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIF 314 (973)
Q Consensus 239 ~~--~l--~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 314 (973)
.. .+ .+|++|++++|+++++.+..|+.+++|++|++++|.++. +|..+.++++|++|++++|+++.. .
T Consensus 246 ~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-lp~~l~~l~~L~~L~l~~n~l~~~-------~ 317 (606)
T 3t6q_A 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENL-------C 317 (606)
T ss_dssp GGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSC-CCSSCCSCTTCCEEECTTCCCSBG-------G
T ss_pred hHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCC-CChhhcccccCCEEECccCCcCcC-------c
Confidence 00 11 279999999999999988899999999999999999994 567799999999999999999863 3
Q ss_pred hhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccC--CCCCCCCCcccEEEeecCccccccCcccC
Q 048430 315 YSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI--PVGFGNLSNLLVLSLVNNELAGAIPTVLG 392 (973)
Q Consensus 315 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~--p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 392 (973)
+..+..+++|+.|++++|.+.+.+|.....-...|+.+++++|.+++.. |..+..+++|++|++++|++.+..|..|.
T Consensus 318 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 397 (606)
T 3t6q_A 318 QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397 (606)
T ss_dssp GGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTT
T ss_pred hhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhc
Confidence 4568899999999999999998887764444578999999999999876 88899999999999999999989999999
Q ss_pred CCCCCCEEEccCCcCCCCCch-hhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCC---Cccccccccc
Q 048430 393 KLQKLQGLDLNSNKLKGFIPT-DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNST---IPSTFWSLKY 468 (973)
Q Consensus 393 ~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~ 468 (973)
.+++|++|++++|++.+..+. .+..+++|+.|++++|.+.+..|..+..+++|++|++++|++++. .+..+..+++
T Consensus 398 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~ 477 (606)
T 3t6q_A 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477 (606)
T ss_dssp TCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTT
T ss_pred CCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCC
Confidence 999999999999999977665 489999999999999999999999999999999999999999862 3467999999
Q ss_pred ccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccc
Q 048430 469 ILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSG 548 (973)
Q Consensus 469 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 548 (973)
|+.|++++|++++..|..|+++++|+.|+|++|++++..|..+..++.| .|+|++|++++.+|..|..+++|+.|+|++
T Consensus 478 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 556 (606)
T 3t6q_A 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQ 556 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTT
T ss_pred ccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCC
Confidence 9999999999998889999999999999999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCC
Q 048430 549 NNISGEIP 556 (973)
Q Consensus 549 N~l~~~~p 556 (973)
|++++..+
T Consensus 557 N~~~c~c~ 564 (606)
T 3t6q_A 557 NPLDCTCS 564 (606)
T ss_dssp CCEECSGG
T ss_pred CCccccCC
Confidence 99997655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=543.32 Aligned_cols=523 Identities=21% Similarity=0.204 Sum_probs=255.4
Q ss_pred ecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCccc
Q 048430 51 SLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130 (973)
Q Consensus 51 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l 130 (973)
|.++++++ .+|. ..++|++|+|++|.+.+..|..|.++++|++|||++|.+.+.++++.|.++++|++|+|++|.+
T Consensus 10 dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l 85 (844)
T 3j0a_A 10 FYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85 (844)
T ss_dssp EESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCC
T ss_pred EccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcC
Confidence 34444554 3443 3355666666666665555666666666666666666554455555556666666666666666
Q ss_pred CCCCCccccCCCCCCeEEccCccccccCCc-cccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc
Q 048430 131 TGEFPSAIVNISSLKSIRLDNNSLSGSFPT-DLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209 (973)
Q Consensus 131 ~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~ 209 (973)
++..|.+|+++++|++|+|++|.+++.+|. ..+..+++|++|+|++|.+++.. .+..|+++++|++|+|++|.++
T Consensus 86 ~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~----~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY----LHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp CEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCC----CCGGGGTCSSCCEEEEESSCCC
T ss_pred cccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccc----cchhHhhCCCCCEEECCCCcCC
Confidence 655566666666666666666666544443 23455666666666666665321 2345566666666666666666
Q ss_pred CccccccccC--CcceeEEeecccccccCCCCC-Ccc------ccceeeeccccccccCcchhccc---CcccEEEecc-
Q 048430 210 GLIPSMIFNN--SNMVAILLYGNHLSGHLPSSI-YLP------NLENLFLWKNNLSGIIPDSICNA---SEATILELSS- 276 (973)
Q Consensus 210 ~~~~~~~~~~--~~L~~L~l~~n~l~~~~~~~~-~l~------~L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~L~~- 276 (973)
+..+..+..+ ++|+.|++++|.+.+..|... .++ +|++|++++|.+++..+..+... ++++.|.+++
T Consensus 162 ~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~ 241 (844)
T 3j0a_A 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241 (844)
T ss_dssp CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred eeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence 5555555555 566666666666655444322 122 26666666666655555444432 3344444431
Q ss_pred --------ccccccCCCccccc--ccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccc
Q 048430 277 --------NLFSGLVPNTFGNC--RQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346 (973)
Q Consensus 277 --------N~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 346 (973)
|.+.+..+..|.++ ++|+.|++++|.+.... +..+..+++|+.|+|++|++.+..|..+..+
T Consensus 242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~-------~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l- 313 (844)
T 3j0a_A 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN-------SRVFETLKDLKVLNLAYNKINKIADEAFYGL- 313 (844)
T ss_dssp CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEEC-------SCCSSSCCCCCEEEEESCCCCEECTTTTTTC-
T ss_pred cccccccccccCCCChhhhhccccCCccEEECCCCcccccC-------hhhhhcCCCCCEEECCCCcCCCCChHHhcCC-
Confidence 22222222333332 34444444444444321 1223444444444444444444444444333
Q ss_pred cccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeec
Q 048430 347 TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426 (973)
Q Consensus 347 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 426 (973)
..|+.|++++|.+++..|..|..+++|+.|++++|.+.+..+..|..+++|++|+|++|.+++. + .+++|+.|++
T Consensus 314 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l 388 (844)
T 3j0a_A 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFL 388 (844)
T ss_dssp SSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEE
T ss_pred CCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhcc
Confidence 2444444444444444444455555555555555555444444445555555555555554421 1 1444455555
Q ss_pred CCccccCcCcccccCcCCCCeeeccCCCCCCCC-cccccccccccEEEecCCcccCCcCc-CccCCCCCCeEEccCCcCc
Q 048430 427 NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTI-PSTFWSLKYILAVDFSLNSLSGSLPL-NIGNLEALGGLNLTGNQLS 504 (973)
Q Consensus 427 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~ 504 (973)
++|+++ .+|.. ..+++.|++++|++++.. +..+..+++|+.|++++|++++..+. .+..+++|+.|+|++|.++
T Consensus 389 ~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~ 464 (844)
T 3j0a_A 389 SGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464 (844)
T ss_dssp ESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCS
T ss_pred CCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccc
Confidence 555544 22221 234445555555544321 11233444555555555555432221 2333444555555555543
Q ss_pred -----ccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccC
Q 048430 505 -----GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579 (973)
Q Consensus 505 -----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 579 (973)
+..+..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+
T Consensus 465 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~ 542 (844)
T 3j0a_A 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPN 542 (844)
T ss_dssp SSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCC
T ss_pred cccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCC
Confidence 22233344445555555555555544444455555555555555555544443333 44555555555555444
Q ss_pred CCCCCCCccCccccccCcccccC
Q 048430 580 PSGGPFVNFTADSFKQNYALCGS 602 (973)
Q Consensus 580 p~~~~~~~~~~~~~~~n~~~c~~ 602 (973)
|. .+.++....+.+|++.|+|
T Consensus 543 ~~--~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 543 PD--VFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp SC--CCSSCCEEEEEEECCCCSS
T ss_pred hh--HhCCcCEEEecCCCccccc
Confidence 43 2233344444445544444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=543.23 Aligned_cols=481 Identities=20% Similarity=0.234 Sum_probs=320.1
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCc--ceE------------EEEEeeCCCCcEEEEecCCCCCCCcCCCCCC
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASV--CNW------------VGVTCSIRHGRVAALSLPNLSLGGTLPPHVG 66 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~ 66 (973)
||++||+++. || +|+.+.+|+..+| |+| .||+|+. .+||++|+|+++++.|.+|++++
T Consensus 273 ALl~~k~~l~-~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~~l~ 344 (876)
T 4ecn_A 273 ALKAIWEALD-GK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIG 344 (876)
T ss_dssp HHHHHHHHTT-GG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECGGGG
T ss_pred HHHHHHHHcC-CC------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCchHHh
Confidence 7999999994 66 4987765555565 999 9999987 68999999999999999999999
Q ss_pred CCCCCcEEEe-cCCCCCCCCCccc---------------------------------------------------ccccC
Q 048430 67 NLSFLVSLNI-SGNSFYDTLPNEL---------------------------------------------------WHMRR 94 (973)
Q Consensus 67 ~l~~L~~L~L-~~n~~~~~~p~~~---------------------------------------------------~~l~~ 94 (973)
+|++|++|+| ++|.+.|..|-.. .....
T Consensus 345 ~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~ 424 (876)
T 4ecn_A 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424 (876)
T ss_dssp GCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCC
T ss_pred ccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccc
Confidence 9999999999 8898776644221 11122
Q ss_pred CcEEEcc--CCCCCCCCCccccCCCCCccEEEeeCcccCC-----------------CCCcccc--CCCCCCeEEccCcc
Q 048430 95 LKIIDFS--SNSLSGSLPGDMCNSFTQLESFDVSSNKITG-----------------EFPSAIV--NISSLKSIRLDNNS 153 (973)
Q Consensus 95 L~~L~Ls--~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~N~ 153 (973)
++.+.++ +|+++| +|..+ +++++|++|+|++|+|++ .+|+.++ ++++|++|+|++|.
T Consensus 425 l~~l~l~~~~N~L~~-IP~~l-~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~ 502 (876)
T 4ecn_A 425 LKDTQIGNLTNRITF-ISKAI-QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502 (876)
T ss_dssp CCTTTTTCCSCEEEE-ECGGG-GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT
T ss_pred hhhceeccccCcccc-hhHHH-hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC
Confidence 3333333 378886 88764 789999999999999998 3899988 99999999999999
Q ss_pred ccccCCccccCCCCCccEEEccccc-ccc-cCCCCCCCccccCCC-------CccEEEecCCcccCcccc--ccccCCcc
Q 048430 154 LSGSFPTDLCTRLPSLVQLRLLGNN-ITG-RIPNREIPNEIGNLH-------NLKILDLGGNNIAGLIPS--MIFNNSNM 222 (973)
Q Consensus 154 l~~~ip~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~p~~l~~l~-------~L~~L~L~~N~l~~~~~~--~~~~~~~L 222 (973)
+.|.+|..+ ..+++|++|+|++|+ ++| . +|..+++++ +|++|+|++|+++ .+|. .+.++++|
T Consensus 503 l~~~iP~~l-~~L~~L~~L~Ls~N~~lsg~~-----iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 503 NMTQLPDFL-YDLPELQSLNIACNRGISAAQ-----LKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp TCCSCCGGG-GGCSSCCEEECTTCTTSCHHH-----HHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred CCccChHHH-hCCCCCCEEECcCCCCccccc-----chHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 999999554 689999999999998 876 3 355565555 9999999999999 7787 88886555
Q ss_pred eeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCc-ccEEEeccccccccCCCcccccccceEEEccCC
Q 048430 223 VAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASE-ATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301 (973)
Q Consensus 223 ~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 301 (973)
+.|++++|.++ .+|....+++|++|+|++|+++ .+|..+..+++ |+.|+|++|.++ .+|..+..+..
T Consensus 576 ~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~--------- 643 (876)
T 4ecn_A 576 GLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV--------- 643 (876)
T ss_dssp CEEECTTSCCC-BCCCCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS---------
T ss_pred CEEECCCCCcc-cchhhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcccc---------
Confidence 55555555555 4443334555555555555555 44444555554 555555555554 23333333322
Q ss_pred cCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCC--CCCcccEEEee
Q 048430 302 QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFG--NLSNLLVLSLV 379 (973)
Q Consensus 302 ~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~--~l~~L~~L~Ls 379 (973)
++|+.|++++|++.+.+|.. |..+. .+++|+.|+|+
T Consensus 644 --------------------~~L~~L~Ls~N~l~g~ip~l----------------------~~~l~~~~~~~L~~L~Ls 681 (876)
T 4ecn_A 644 --------------------YVMGSVDFSYNKIGSEGRNI----------------------SCSMDDYKGINASTVTLS 681 (876)
T ss_dssp --------------------SCEEEEECCSSCTTTTSSSC----------------------SSCTTTCCCCCEEEEECC
T ss_pred --------------------CCCCEEECcCCcCCCccccc----------------------hhhhccccCCCcCEEEcc
Confidence 22444444444444433321 11111 33467777888
Q ss_pred cCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhcc--------CcCCeeecCCccccCcCccccc--CcCCCCeee
Q 048430 380 NNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKL--------EKLNTLLSNNNALQGQIPTCLA--NLTSLRHLD 449 (973)
Q Consensus 380 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~ 449 (973)
+|.++...+..+..+++|+.|+|++|+++ .+|..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+
T Consensus 682 ~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~ 759 (876)
T 4ecn_A 682 YNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMD 759 (876)
T ss_dssp SSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEE
T ss_pred CCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEE
Confidence 87777333334457777778888877777 455443322 24555555555555 3444443 455555555
Q ss_pred ccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcccc
Q 048430 450 FRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529 (973)
Q Consensus 450 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (973)
|++|++++ +|..+..+++|+.|++++|+ ++++|++.+.+|..|+.+++|+.|+|++|+| +
T Consensus 760 Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~ 819 (876)
T 4ecn_A 760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-R 819 (876)
T ss_dssp CCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-C
T ss_pred eCCCCCCc-cchhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-C
Confidence 55555544 34444455555555554443 3345777777777777777777777777777 4
Q ss_pred CCCCCcccccccccccccccccCCCCCccccccccccccccCCCccc
Q 048430 530 PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576 (973)
Q Consensus 530 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 576 (973)
.+|..+. ++|+.|||++|++....+..+.....+..+.|++|++.
T Consensus 820 ~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 820 KVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp BCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred ccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 7776655 47777777777777666666666666666666666543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-55 Score=542.34 Aligned_cols=519 Identities=19% Similarity=0.169 Sum_probs=447.3
Q ss_pred ceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCC-CcccccccCCcEEEccCCCCCCCCCc
Q 048430 33 CNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTL-PNELWHMRRLKIIDFSSNSLSGSLPG 111 (973)
Q Consensus 33 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p~ 111 (973)
|+|..|.+ .+.+++.|||++|.+++..|..++++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+.+..|
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p- 90 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP- 90 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT-
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH-
Confidence 56777877 5678999999999999988999999999999999999776777 7889999999999999999995445
Q ss_pred cccCCCCCccEEEeeCcccCCCCCcc--ccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCC
Q 048430 112 DMCNSFTQLESFDVSSNKITGEFPSA--IVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIP 189 (973)
Q Consensus 112 ~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p 189 (973)
+.|..+++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+...|.++++|++|+|++|.+++ ..|
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~-----~~~ 165 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL-----VCE 165 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC-----CCS
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe-----eCH
Confidence 55689999999999999999877765 99999999999999999966666678899999999999999985 346
Q ss_pred ccccCC--CCccEEEecCCcccCccccccccCCc------ceeEEeecccccccCCCCC----Cccccceeeecc-----
Q 048430 190 NEIGNL--HNLKILDLGGNNIAGLIPSMIFNNSN------MVAILLYGNHLSGHLPSSI----YLPNLENLFLWK----- 252 (973)
Q Consensus 190 ~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~------L~~L~l~~n~l~~~~~~~~----~l~~L~~L~L~~----- 252 (973)
..++.+ ++|+.|+|++|.+.+..|..+..+.+ |+.|++++|.+++..+... ...+++.|.+++
T Consensus 166 ~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~ 245 (844)
T 3j0a_A 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245 (844)
T ss_dssp GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBC
T ss_pred HHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccc
Confidence 778877 89999999999999988887776665 9999999999988776544 246788888773
Q ss_pred ----ccccccCcchhccc--CcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcE
Q 048430 253 ----NNLSGIIPDSICNA--SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRV 326 (973)
Q Consensus 253 ----N~l~~~~~~~l~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~ 326 (973)
|.+.+..+..|..+ ++|+.|+|++|.+.+..+..|..+++|+.|+|++|+++... +..+..+++|+.
T Consensus 246 ~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-------~~~~~~l~~L~~ 318 (844)
T 3j0a_A 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA-------DEAFYGLDNLQV 318 (844)
T ss_dssp SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC-------TTTTTTCSSCCE
T ss_pred cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC-------hHHhcCCCCCCE
Confidence 34444445556555 78999999999999999999999999999999999998643 346788999999
Q ss_pred EEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCc
Q 048430 327 LVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK 406 (973)
Q Consensus 327 L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 406 (973)
|+|++|.+.+..|..+..+ ..|+.|++++|++++..+..|..+++|++|+|++|.+++. ..+++|+.|++++|+
T Consensus 319 L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~ 392 (844)
T 3j0a_A 319 LNLSYNLLGELYSSNFYGL-PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNK 392 (844)
T ss_dssp EEEESCCCSCCCSCSCSSC-TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCC
T ss_pred EECCCCCCCccCHHHhcCC-CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCC
Confidence 9999999998888888877 5799999999999988888999999999999999999843 238899999999999
Q ss_pred CCCCCchhhhccCcCCeeecCCccccCcCc-ccccCcCCCCeeeccCCCCCCCCcc-cccccccccEEEecCCccc----
Q 048430 407 LKGFIPTDLCKLEKLNTLLSNNNALQGQIP-TCLANLTSLRHLDFRSNSLNSTIPS-TFWSLKYILAVDFSLNSLS---- 480 (973)
Q Consensus 407 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~---- 480 (973)
++ .+|.. ..+++.|++++|++++... ..+.++++|+.|+|++|++++..+. .+..+++|+.|++++|.++
T Consensus 393 l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~ 468 (844)
T 3j0a_A 393 LV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468 (844)
T ss_dssp CC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCC
T ss_pred cc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccc
Confidence 99 45543 5679999999999997533 3456899999999999999875543 4667899999999999997
Q ss_pred -CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccc
Q 048430 481 -GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559 (973)
Q Consensus 481 -~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 559 (973)
+..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..|
T Consensus 469 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~ 546 (844)
T 3j0a_A 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF 546 (844)
T ss_dssp SCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC
T ss_pred cccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh
Confidence 44456789999999999999999998899999999999999999999987777776 899999999999999999876
Q ss_pred cccccccccccCCCcccccCCC
Q 048430 560 EKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 560 ~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
. +|+.+++++|++.+.++-
T Consensus 547 ~---~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 547 V---SLSVLDITHNKFICECEL 565 (844)
T ss_dssp S---SCCEEEEEEECCCCSSSC
T ss_pred C---CcCEEEecCCCccccccc
Confidence 4 788999999999987764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=511.54 Aligned_cols=505 Identities=21% Similarity=0.200 Sum_probs=430.5
Q ss_pred CcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEcc
Q 048430 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLD 150 (973)
Q Consensus 71 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 150 (973)
..+++.+++++ ..+|..+. ++|++|+|++|.++ .++...|.++++|++|+|++|++++..|.+|+++++|++|+|+
T Consensus 13 ~~~~~c~~~~l-~~ip~~~~--~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls 88 (606)
T 3vq2_A 13 NITYQCMDQKL-SKVPDDIP--SSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88 (606)
T ss_dssp TTEEECTTSCC-SSCCTTSC--TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCceEccCCCc-ccCCCCCC--CCcCEEECCCCCcC-EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECC
Confidence 36799999999 57888765 89999999999998 5666667899999999999999998889999999999999999
Q ss_pred CccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccC-ccccccccCCcceeEEeec
Q 048430 151 NNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG-LIPSMIFNNSNMVAILLYG 229 (973)
Q Consensus 151 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~l~~ 229 (973)
+|+++ .++...|..+++|++|+|++|++++. .|..++++++|++|+|++|++++ .+|..+.++++|+.|++++
T Consensus 89 ~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 89 GNPIQ-SFSPGSFSGLTSLENLVAVETKLASL-----ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp TCCCC-CCCTTSSTTCTTCCEEECTTSCCCCS-----SSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred CCccc-ccChhhcCCcccCCEEEccCCccccc-----cccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 99999 55555668999999999999999743 23679999999999999999986 5699999999999999999
Q ss_pred ccccccCCCCC-Ccccc----ceeeeccccccccCcchhcccCcccEEEecccccc-ccCCCcccccccceEEEccCCcC
Q 048430 230 NHLSGHLPSSI-YLPNL----ENLFLWKNNLSGIIPDSICNASEATILELSSNLFS-GLVPNTFGNCRQLQILSLGDNQL 303 (973)
Q Consensus 230 n~l~~~~~~~~-~l~~L----~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l 303 (973)
|++++..+..+ .+.+| .+|++++|.++++.+..+... +|+.|++++|.++ +..|..+.++++|+.+++..+.+
T Consensus 163 n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~ 241 (606)
T 3vq2_A 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241 (606)
T ss_dssp SCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECC
T ss_pred CcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccc
Confidence 99998877655 45555 489999999998777776655 8999999999987 56677889999999999876665
Q ss_pred CCCCCC--cchhhhhhhccCCcCcEEEc-cCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeec
Q 048430 304 TTGSSA--QGQIFYSSLAKCRYLRVLVL-DTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN 380 (973)
Q Consensus 304 ~~~~~~--~~~~~~~~l~~l~~L~~L~L-~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~ 380 (973)
.....- .....+..+..+ .++.+++ ..|.+.+.+|. +. ....++.+.+.+|.+.. +| .+..+++|+.|++++
T Consensus 242 ~~~~~l~~~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~-~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~ 316 (606)
T 3vq2_A 242 KDERNLEIFEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FH-CLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIR 316 (606)
T ss_dssp TTSCCCSCCCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CG-GGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEES
T ss_pred ccCCcccccChHHhhhhhhc-cHhheeccccccccccccc-cc-cCCCCCEEEecCccchh-hh-hccccccCCEEEccc
Confidence 432111 111122333333 5677777 78888888887 44 44789999999999964 56 899999999999999
Q ss_pred CccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCc--CcccccCcCCCCeeeccCCCCCCC
Q 048430 381 NELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQ--IPTCLANLTSLRHLDFRSNSLNST 458 (973)
Q Consensus 381 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~ 458 (973)
|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|+.|++++|.+++. .+..+..+++|++|++++|.+++
T Consensus 317 n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~- 390 (606)
T 3vq2_A 317 CQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII- 390 (606)
T ss_dssp CCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-
T ss_pred ccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-
Confidence 999 4778 45 9999999999999766443 677999999999999999976 37889999999999999999985
Q ss_pred CcccccccccccEEEecCCcccCCcC-cCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcccc-CCCCCcc
Q 048430 459 IPSTFWSLKYILAVDFSLNSLSGSLP-LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG-PIPQSFG 536 (973)
Q Consensus 459 ~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~ 536 (973)
+|..|..+++|+.|++++|++++..| ..+..+++|+.|++++|++++..|..++.+++|+.|+|++|++++ .+|..|+
T Consensus 391 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 470 (606)
T 3vq2_A 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470 (606)
T ss_dssp ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhc
Confidence 66899999999999999999998877 689999999999999999999999999999999999999999998 4799999
Q ss_pred cccccccccccccccCCCCCccccccccccccccCCCcccccCCCC-CCCCccCccccccCc
Q 048430 537 SLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG-GPFVNFTADSFKQNY 597 (973)
Q Consensus 537 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~ 597 (973)
.+++|++|+|++|++++.+|..|..+++|+.|++++|++++.+|.. ..+.++....+.+|.
T Consensus 471 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 532 (606)
T 3vq2_A 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532 (606)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred cCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence 9999999999999999999999999999999999999999987753 455666666677774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=488.84 Aligned_cols=508 Identities=20% Similarity=0.230 Sum_probs=422.6
Q ss_pred EecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcc
Q 048430 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNK 129 (973)
Q Consensus 50 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~ 129 (973)
++.++.+++ ++|..+. +.+++|+|++|++.+..|..|.++++|++|||++|++. .++...|.++++|++|+|++|+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~ 87 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCcCCc
Confidence 334444555 5665443 57899999999998877888999999999999999998 5666777889999999999999
Q ss_pred cCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc
Q 048430 130 ITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209 (973)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~ 209 (973)
+++..|.+|+++++|++|++++|+++ .+|...+..+++|++|+|++|.+++. .+|..|+++++|++|++++|+++
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~----~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSF----KLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCC----CCCGGGGGCTTCCEEECTTSCCC
T ss_pred CCccCHhhhcCccccccccccccccc-cCCCccccccccccEEecCCCcccee----cChhhhcccCCCCEEeCcCCccc
Confidence 99877789999999999999999998 67766678899999999999998742 46888999999999999999999
Q ss_pred CccccccccCCcc----eeEEeecccccccCCCCCCccccceeeeccccccc-cCcchhcccCcccEEEeccccc-----
Q 048430 210 GLIPSMIFNNSNM----VAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSG-IIPDSICNASEATILELSSNLF----- 279 (973)
Q Consensus 210 ~~~~~~~~~~~~L----~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~i----- 279 (973)
+..+..+..+++| +.+++++|.+++..+..+...+|++|++++|.... .++..+..+++++.+.+..+.+
T Consensus 163 ~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~ 242 (570)
T 2z63_A 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242 (570)
T ss_dssp EECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS
T ss_pred eecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchh
Confidence 8888888888888 88999999999888877766689999999885432 3455667777777666654322
Q ss_pred -cccCCCccccccc--ceEEEccCC-cCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecc
Q 048430 280 -SGLVPNTFGNCRQ--LQILSLGDN-QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAG 355 (973)
Q Consensus 280 -~~~~~~~~~~l~~--L~~L~L~~N-~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~ 355 (973)
..+....|.++.+ ++.+++++| .+... .+..+..+++|+.|++++|.+. .+|..+..+ .++.+++.
T Consensus 243 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~-------~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~ 312 (570)
T 2z63_A 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDD-------IIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELV 312 (570)
T ss_dssp CEECCTTTTGGGGGSEEEEEEEEETTEEESC-------STTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEE
T ss_pred hhhcchhhhccccccchhhhhhhcchhhhhh-------chhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeec
Confidence 2333444555443 456666665 33321 2345677788888888888877 467666666 78888888
Q ss_pred cCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCC--chhhhccCcCCeeecCCccccC
Q 048430 356 SSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFI--PTDLCKLEKLNTLLSNNNALQG 433 (973)
Q Consensus 356 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~ 433 (973)
+|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+..+++|+.|++++|.+.+
T Consensus 313 ~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 387 (570)
T 2z63_A 313 NCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387 (570)
T ss_dssp SCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE
T ss_pred cCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc
Confidence 88887 4554 4788999999999999866655 78899999999999999654 7889999999999999999996
Q ss_pred cCcccccCcCCCCeeeccCCCCCCCCc-ccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCc-ccCCccc
Q 048430 434 QIPTCLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS-GYIPSSI 511 (973)
Q Consensus 434 ~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~ 511 (973)
..+. +..+++|++|++++|.+.+..| ..|..+++|+.|++++|++++..|..+.++++|+.|+|++|+++ +.+|..+
T Consensus 388 ~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~ 466 (570)
T 2z63_A 388 MSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466 (570)
T ss_dssp EEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC
T ss_pred cccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhh
Confidence 6555 9999999999999999988766 57899999999999999999999999999999999999999998 6799999
Q ss_pred ccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCC
Q 048430 512 GNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582 (973)
Q Consensus 512 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 582 (973)
+.+++|+.|+|++|++++..|..|..+++|++|+|++|++++.+|..|..+++|+.|++++|+++|.+|..
T Consensus 467 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999999999999988999999999999999999999998889999999999999999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=487.32 Aligned_cols=499 Identities=18% Similarity=0.206 Sum_probs=358.9
Q ss_pred cceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCc
Q 048430 32 VCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPG 111 (973)
Q Consensus 32 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 111 (973)
.|.|.|| |+.. +++++ .+|+.+. ++|++|+|++|++.+..|..|+++++|++|+|++|++. .+++
T Consensus 3 ~C~~~~~-c~~~----------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~ 67 (549)
T 2z81_A 3 SCDASGV-CDGR----------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67 (549)
T ss_dssp EECTTSE-EECT----------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCC-EECT
T ss_pred cCCCCce-EECC----------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcC-ccCh
Confidence 4999999 9643 34444 5666553 67777777777777666777777777777777777777 3444
Q ss_pred cccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCcc
Q 048430 112 DMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNE 191 (973)
Q Consensus 112 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~ 191 (973)
+.|..+++|++|||++|++++..|..|+++++|++|+|++|++++.-....+..+++|++|++++|++.+.+| +..
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~----~~~ 143 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR----RID 143 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC----TTT
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccC----Hhh
Confidence 4556777777777777777766666677777777777777777632112345677777777777777433222 246
Q ss_pred ccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCC-CccccceeeeccccccccC--c-chhcccC
Q 048430 192 IGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGII--P-DSICNAS 267 (973)
Q Consensus 192 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~-~l~~L~~L~L~~N~l~~~~--~-~~l~~l~ 267 (973)
|+++++|++|++++|++++.+|..+..+++|+.|++++|.+....+... .+++|++|++++|++++.. | .....++
T Consensus 144 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~ 223 (549)
T 2z81_A 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223 (549)
T ss_dssp TTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCC
T ss_pred hhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhh
Confidence 7777777777777777777777777777777777777777653322221 3677888888888777642 1 2234467
Q ss_pred cccEEEeccccccccCC----CcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCccc
Q 048430 268 EATILELSSNLFSGLVP----NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG 343 (973)
Q Consensus 268 ~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 343 (973)
+|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+...-. ......+..+.+|+.|++.++.+..... +.
T Consensus 224 ~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~-~~~~~~~~~l~~L~~L~l~~~~i~~~~~--~~ 300 (549)
T 2z81_A 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN-PSESDVVSELGKVETVTIRRLHIPQFYL--FY 300 (549)
T ss_dssp CCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCC-CCTTTCCCCCTTCCEEEEESCBCSCGGG--SC
T ss_pred cccceeccccccchhHHHHHHHHhhhhcccccccccccccccccccc-ccchhhhhhhcccccccccccccchhhh--cc
Confidence 77888888887765433 33456677888888888776532211 1112345667778888887776543210 00
Q ss_pred ccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCccc-CCCCCCCEEEccCCcCCCCCch---hhhccC
Q 048430 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL-GKLQKLQGLDLNSNKLKGFIPT---DLCKLE 419 (973)
Q Consensus 344 ~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~ 419 (973)
.++..+....+|+.|++++|.+. .+|..+ ..+++|++|+|++|++.+.+|. .+..++
T Consensus 301 ------------------~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~ 361 (549)
T 2z81_A 301 ------------------DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361 (549)
T ss_dssp ------------------CCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSST
T ss_pred ------------------cchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccc
Confidence 11111233467889999999987 566554 5788999999999999876643 367888
Q ss_pred cCCeeecCCccccCcCc--ccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEE
Q 048430 420 KLNTLLSNNNALQGQIP--TCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLN 497 (973)
Q Consensus 420 ~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 497 (973)
+|+.|++++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|..+ .++|+.|+
T Consensus 362 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~ 437 (549)
T 2z81_A 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLD 437 (549)
T ss_dssp TCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEE
T ss_pred cCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEE
Confidence 99999999999886543 45888899999999999998 57888888899999999999988 455443 26899999
Q ss_pred ccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccc
Q 048430 498 LTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 498 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
|++|++++.+ ..+++|+.|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..+..+++|+.|++++|++.|
T Consensus 438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 511 (549)
T 2z81_A 438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511 (549)
T ss_dssp CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred CCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence 9999998643 57889999999999998 6776 5788999999999999999888889999999999999999988
Q ss_pred cCCC
Q 048430 578 EIPS 581 (973)
Q Consensus 578 ~~p~ 581 (973)
.+|.
T Consensus 512 ~~~~ 515 (549)
T 2z81_A 512 SCPR 515 (549)
T ss_dssp CHHH
T ss_pred CCcc
Confidence 8773
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=449.07 Aligned_cols=263 Identities=27% Similarity=0.463 Sum_probs=217.2
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667789999999999999863 478899999987766677899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEE
Q 048430 754 IMQYMPQGSLEKWLYSHN------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHL 821 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 821 (973)
|||||++|+|.++++..+ ..+++.++..|+.|||+||+||| +++||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999998642 46999999999999999999999 799999999999999999999999
Q ss_pred eecccccccCCCCCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhC
Q 048430 822 GDFGIAKLLDGVDPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 822 ~Dfgla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
+|||+|+.....+... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||...... .+...+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~-- 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQ-- 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHH--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence 9999998764433222 233569999999999999999999999999999999999 89999753221 11111111
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQAL 969 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~ 969 (973)
+ .. ...+..|++++.+++.+||+.||++||||+|+.+.|+.+.+.-+...
T Consensus 246 -~--------~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~l 295 (299)
T 4asz_A 246 -G--------RV-----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYL 295 (299)
T ss_dssp -T--------CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCS
T ss_pred -C--------CC-----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCccc
Confidence 0 00 01123467789999999999999999999999999999887654443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=451.07 Aligned_cols=261 Identities=24% Similarity=0.434 Sum_probs=209.3
Q ss_pred CCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
+|...++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4556688999999999999864 4789999999876666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 755 MQYMPQGSLEKWLYSHN--------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
||||++|+|.++++... ..+++.++..|+.|||+||+||| +++||||||||+|||+++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEE
Confidence 99999999999997642 35899999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhh
Q 048430 821 LGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 898 (973)
|+|||+|+.....+.. ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+...+...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~g 276 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQG 276 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHHT
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence 9999999876443322 2344579999999999999999999999999999999999 89999753221 111111110
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
. +...+..|++++.+++.+||+.||++||||+||+++|+.+.+..+.+
T Consensus 277 ~----------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~ 324 (329)
T 4aoj_A 277 R----------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVY 324 (329)
T ss_dssp C----------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC--
T ss_pred C----------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCccc
Confidence 0 01122346778999999999999999999999999999998754443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=440.93 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=207.5
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.+++...++||+|+||+||+|+++. .||||+++... ....+.|.+|++++++++|||||+++|+|.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567778999999999999999763 59999986442 3456789999999999999999999999865 56899999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP- 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 835 (973)
||++|+|.++++.....+++.++..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+.......
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999887778999999999999999999999 78999999999999999999999999999987643222
Q ss_pred cccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 VTQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
......+||+.|||||++. .+.++.++|||||||++|||+||+.||.+..... .+...+.... ..+.+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~-------~~p~~~ 260 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGY-------ASPDLS 260 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTC-------CCCCST
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCC-------CCCCcc
Confidence 2234457999999999874 4468999999999999999999999997532211 1111111110 000000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
..+..|++++.+++.+||+.||++||||+||+++|+.++..+
T Consensus 261 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 261 -----------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp -----------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred -----------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 112346778999999999999999999999999999886543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=442.83 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=208.8
Q ss_pred CCCCccccccCceEEEEEEeC------CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 682 FGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++..+.||+|+||+||+|++. +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445688999999999999862 578999999875433 3457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 755 MQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
||||++|+|.+++.... ..+++.++..|+.|||+||+||| +++||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence 99999999999997532 35899999999999999999999 7999999999999999999999
Q ss_pred EEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHh
Q 048430 820 HLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 897 (973)
||+|||+|+.....+.. ......||++|||||.+.++.++.++|||||||++|||+| |+.||.+.... .+...+..
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i~~ 262 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIRN 262 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHHHT
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc
Confidence 99999999876433322 2344579999999999999999999999999999999999 89998753221 12221111
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
+. ..+.+..|+.++.+++.+||+.||++||||+||+++|+.+
T Consensus 263 ---~~-------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 263 ---RQ-------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---TC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---CC-------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00 0112235677899999999999999999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=467.23 Aligned_cols=490 Identities=19% Similarity=0.154 Sum_probs=395.2
Q ss_pred CCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEE
Q 048430 44 HGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESF 123 (973)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L 123 (973)
..+++.|+++++.+++..+..+.++++|++|+|++|++.+..|..|+++++|++|+|++|++. .+|+..|..+++|++|
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L 105 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKL 105 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC-ccCHhhhcCccccccc
Confidence 357999999999999888889999999999999999998888889999999999999999998 5676777999999999
Q ss_pred EeeCcccCCCCCccccCCCCCCeEEccCccccc-cCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCc----
Q 048430 124 DVSSNKITGEFPSAIVNISSLKSIRLDNNSLSG-SFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNL---- 198 (973)
Q Consensus 124 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L---- 198 (973)
++++|++++..+..|+++++|++|+|++|.+++ .+|.. +.++++|++|++++|++++. .|..++.+++|
T Consensus 106 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~-~~~l~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~~~ 179 (570)
T 2z63_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSI-----YCTDLRVLHQMPLLN 179 (570)
T ss_dssp ECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGG-GGGCTTCCEEECTTSCCCEE-----CGGGGHHHHTCTTCC
T ss_pred cccccccccCCCccccccccccEEecCCCccceecChhh-hcccCCCCEEeCcCCcccee-----cHHHccchhccchhh
Confidence 999999997666689999999999999999984 35655 47899999999999999853 35678888888
Q ss_pred cEEEecCCcccCccccccccCCcceeEEeeccccccc-CCC-CCCccccceeeeccccc------cccCcchhcccC--c
Q 048430 199 KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGH-LPS-SIYLPNLENLFLWKNNL------SGIIPDSICNAS--E 268 (973)
Q Consensus 199 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~-~~~l~~L~~L~L~~N~l------~~~~~~~l~~l~--~ 268 (973)
+.|++++|.+++..|..+... +|+.|++++|..... ++. ...+++++.+.+..+.+ .......+..+. .
T Consensus 180 ~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~ 258 (570)
T 2z63_A 180 LSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258 (570)
T ss_dssp CEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSE
T ss_pred hhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccc
Confidence 899999999998888777665 899999999854321 111 11244444444432221 112222333332 2
Q ss_pred ccEEEeccc-cccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCccccccc
Q 048430 269 ATILELSSN-LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLST 347 (973)
Q Consensus 269 L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 347 (973)
++.+++++| .+.+..+..|..+++|++|++++|.++.++. .+..+ +|+.|++++|.+. .+|.. ...
T Consensus 259 l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~--------~~~~~-~L~~L~l~~n~~~-~l~~~---~l~ 325 (570)
T 2z63_A 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--------FSYNF-GWQHLELVNCKFG-QFPTL---KLK 325 (570)
T ss_dssp EEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCB--------CCSCC-CCSEEEEESCBCS-SCCBC---BCS
T ss_pred hhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhh--------hhccC-CccEEeeccCccc-ccCcc---ccc
Confidence 455666666 5666666666666667777776666665332 23444 6666777766666 33331 224
Q ss_pred ccceeecccCCccccCCCCCCCCCcccEEEeecCcccccc--CcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeee
Q 048430 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAI--PTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLL 425 (973)
Q Consensus 348 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 425 (973)
.++.+++.+|.+.+..+. ..+++|++|++++|.+++.. |..+..+++|++|++++|.+.+..+ .+..+++|+.|+
T Consensus 326 ~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~ 402 (570)
T 2z63_A 326 SLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLD 402 (570)
T ss_dssp SCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEE
T ss_pred ccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEE
Confidence 566677777766655554 67899999999999998654 7789999999999999999996544 499999999999
Q ss_pred cCCccccCcCc-ccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCccc-CCcCcCccCCCCCCeEEccCCcC
Q 048430 426 SNNNALQGQIP-TCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS-GSLPLNIGNLEALGGLNLTGNQL 503 (973)
Q Consensus 426 l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l 503 (973)
+++|.+.+..+ ..+.++++|++|++++|.+.+..|..|..+++|+.|++++|+++ +.+|..+..+++|+.|+|++|++
T Consensus 403 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l 482 (570)
T 2z63_A 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482 (570)
T ss_dssp CTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred ccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcc
Confidence 99999998776 57889999999999999999999999999999999999999998 57899999999999999999999
Q ss_pred cccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCc
Q 048430 504 SGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK 557 (973)
Q Consensus 504 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 557 (973)
++..|..|+.+++|+.|+|++|++++.+|..|..+++|+.|+|++|++++..|.
T Consensus 483 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 988899999999999999999999998889999999999999999999988774
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=462.17 Aligned_cols=489 Identities=19% Similarity=0.208 Sum_probs=402.0
Q ss_pred EEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCc
Q 048430 73 SLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152 (973)
Q Consensus 73 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 152 (973)
..+.++|++ ..+|..+. ++|++|||++|++++ ++...|..+++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus 9 ~c~~~~~~l-~~ip~~~~--~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 9 VCDGRSRSF-TSIPSGLT--AAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp EEECTTSCC-SSCCSCCC--TTCCEEECCSSCCCE-ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred eEECCCCcc-ccccccCC--CCccEEECcCCccCc-cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 457888888 57888775 799999999999984 44455689999999999999999888899999999999999999
Q ss_pred cccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCcc-ccccccCCcceeEEeeccc
Q 048430 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLI-PSMIFNNSNMVAILLYGNH 231 (973)
Q Consensus 153 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~~~~L~~L~l~~n~ 231 (973)
+++ .+|...+..+++|++|+|++|++++. .+|..++++++|++|++++|++.+.+ +..+.++++|+.|++++|.
T Consensus 85 ~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~ 159 (549)
T 2z81_A 85 HLS-SLSSSWFGPLSSLKYLNLMGNPYQTL----GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159 (549)
T ss_dssp CCC-SCCHHHHTTCTTCCEEECTTCCCSSS----CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ccC-ccCHHHhccCCCCcEEECCCCccccc----chhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence 999 67777678999999999999999742 34678999999999999999954444 4789999999999999999
Q ss_pred ccccCCCCC-CccccceeeeccccccccCcchhcccCcccEEEeccccccccC---CCcccccccceEEEccCCcCCCCC
Q 048430 232 LSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV---PNTFGNCRQLQILSLGDNQLTTGS 307 (973)
Q Consensus 232 l~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~---~~~~~~l~~L~~L~L~~N~l~~~~ 307 (973)
+++..|... .+++|++|++++|.+.......+..+++|++|++++|++++.. ......+++|+.|++++|.++...
T Consensus 160 l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred ccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 999877665 5899999999999987543334567899999999999998763 233456789999999999886421
Q ss_pred CCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccc-
Q 048430 308 SAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGA- 386 (973)
Q Consensus 308 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~- 386 (973)
.......+..+++|+.+++++|.+.+...-. ......+..+.+|+.|++.++.+...
T Consensus 240 ---~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~-------------------~~~~~~~~~l~~L~~L~l~~~~i~~~~ 297 (549)
T 2z81_A 240 ---FNELLKLLRYILELSEVEFDDCTLNGLGDFN-------------------PSESDVVSELGKVETVTIRRLHIPQFY 297 (549)
T ss_dssp ---HHHHHGGGGGCTTCCEEEEESCEEECCSCCC-------------------CCTTTCCCCCTTCCEEEEESCBCSCGG
T ss_pred ---HHHHHHHhhhhcccccccccccccccccccc-------------------ccchhhhhhhcccccccccccccchhh
Confidence 1223445677889999999999887642110 01122356788999999999987632
Q ss_pred ----cCcccCCCCCCCEEEccCCcCCCCCchhh-hccCcCCeeecCCccccCcCc---ccccCcCCCCeeeccCCCCCCC
Q 048430 387 ----IPTVLGKLQKLQGLDLNSNKLKGFIPTDL-CKLEKLNTLLSNNNALQGQIP---TCLANLTSLRHLDFRSNSLNST 458 (973)
Q Consensus 387 ----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~ 458 (973)
.+..+...++|++|++++|.+. .+|..+ ..+++|+.|++++|++++.+| ..++.+++|++|++++|++++.
T Consensus 298 ~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 376 (549)
T 2z81_A 298 LFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376 (549)
T ss_dssp GSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCH
T ss_pred hcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccccc
Confidence 1222344578999999999998 667666 579999999999999998764 3478899999999999999875
Q ss_pred Cc--ccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcc
Q 048430 459 IP--STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFG 536 (973)
Q Consensus 459 ~p--~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 536 (973)
.+ ..+..+++|+.||+++|+++ .+|..+..+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++.+ .
T Consensus 377 ~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~ 448 (549)
T 2z81_A 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----L 448 (549)
T ss_dssp HHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----C
T ss_pred ccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----c
Confidence 43 56899999999999999999 78999999999999999999998 4555442 68999999999999643 5
Q ss_pred cccccccccccccccCCCCCccccccccccccccCCCcccccCCC-CCCCCccCccccccCcccccCC
Q 048430 537 SLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS-GGPFVNFTADSFKQNYALCGSS 603 (973)
Q Consensus 537 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~ 603 (973)
.+++|++|+|++|+|+ .+|. ...+++|+.|++++|++++.+|. ...+.++....+.+|++.|+++
T Consensus 449 ~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 449 FLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 7899999999999999 6776 57899999999999999998886 3566677778899999998876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=430.28 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=210.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
..|...++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4588889999999999999996 479999999998765555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++|+|.+++... .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...... ...
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 999999999875 5999999999999999999999 8999999999999999999999999999998765332 233
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...+||+.|||||.+....|+.++||||+||++|||++|+.||..... ......+....+. .+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~--------~~------- 290 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP--------RL------- 290 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCC--------CC-------
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC--------CC-------
Confidence 456899999999999999999999999999999999999999965221 1111111111100 00
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|||++|+++|
T Consensus 291 -----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 -----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112346678999999999999999999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=463.20 Aligned_cols=531 Identities=20% Similarity=0.204 Sum_probs=403.0
Q ss_pred ecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCccc
Q 048430 51 SLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130 (973)
Q Consensus 51 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l 130 (973)
+-++.+|+ ++|+.+- +.+++|||++|+|++..|.+|.++++|++|||++|+|+ .+|++.|.++++|++|+|++|+|
T Consensus 37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCC
T ss_pred ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcC
Confidence 44555666 6776442 47899999999998777788999999999999999998 68888889999999999999999
Q ss_pred CCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccC
Q 048430 131 TGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG 210 (973)
Q Consensus 131 ~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~ 210 (973)
++..|.+|.++++|++|+|++|+|+ .+|...|+++++|++|+|++|+|++. .+|..++.+++|++|+|++|+|++
T Consensus 113 ~~l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~----~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 113 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSF----KLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp CEECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCC----CCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccC----CCchhhccchhhhhhcccCccccc
Confidence 9777778999999999999999998 78888889999999999999999743 467889999999999999999998
Q ss_pred ccccccccCCcce----eEEeecccccccCCCCCCccccceeeeccccccc-cCcchhcccCcccEEEecccc------c
Q 048430 211 LIPSMIFNNSNMV----AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSG-IIPDSICNASEATILELSSNL------F 279 (973)
Q Consensus 211 ~~~~~~~~~~~L~----~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~------i 279 (973)
..+..+..+.+++ .++++.|.+....+.......++.|++++|.... ..+..+..+..++...+..+. +
T Consensus 188 ~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l 267 (635)
T 4g8a_A 188 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 267 (635)
T ss_dssp ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCC
T ss_pred cccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccc
Confidence 8888887765543 6788999998877777767778889999886653 334567777777777765433 3
Q ss_pred cccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCc
Q 048430 280 SGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQL 359 (973)
Q Consensus 280 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l 359 (973)
.......+..+..+..+.+..+........ ....+..+.+++.+.+.+|.+....+.. ....++.+.+.+|.+
T Consensus 268 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~~~~~~~~~~~---~~~~L~~L~l~~~~~ 340 (635)
T 4g8a_A 268 EKFDKSALEGLCNLTIEEFRLAYLDYYLDG----IIDLFNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKF 340 (635)
T ss_dssp SCCCTTTTGGGGGSEEEEEEEECCCSCEEE----CTTTTGGGTTCSEEEEESCEEEECGGGG---SCCCCSEEEEESCEE
T ss_pred ccccccccccccchhhhhhhhhhhcccccc----hhhhhhhhcccccccccccccccccccc---cchhhhhhhcccccc
Confidence 334445566667777776666554322111 1233455667777777777766443221 124567777777777
Q ss_pred cccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCC--CCchhhhccCcCCeeecCCccccCcCcc
Q 048430 360 SGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKG--FIPTDLCKLEKLNTLLSNNNALQGQIPT 437 (973)
Q Consensus 360 ~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 437 (973)
.+..+ ..+..|+.+++++|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.+++..|.+.. .+.
T Consensus 341 ~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~ 414 (635)
T 4g8a_A 341 GQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSS 414 (635)
T ss_dssp SSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECS
T ss_pred cCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccc
Confidence 65443 3456777888888877633 234567888888888888753 345667778888888888888774 445
Q ss_pred cccCcCCCCeeeccCCCCCCCCc-ccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCc-ccCCcccccCC
Q 048430 438 CLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS-GYIPSSIGNLK 515 (973)
Q Consensus 438 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~ 515 (973)
.+..+++|+.+++++|......+ ..|..+++++.++++.|.+++..+..+..+++|+.|+|++|++. +..|..|..++
T Consensus 415 ~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~ 494 (635)
T 4g8a_A 415 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 494 (635)
T ss_dssp CCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred cccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhcc
Confidence 57778888888888877654443 56777888888888888888878888888888888888888743 45777888888
Q ss_pred cCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCC-CCC-CccCcccc
Q 048430 516 NLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSG-GPF-VNFTADSF 593 (973)
Q Consensus 516 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~-~~~~~~~~ 593 (973)
+|+.|+|++|+|++.+|..|+++++|++|+|++|+|++..|..|..+++|+.|||++|+|++.+|.. ..+ .++....+
T Consensus 495 ~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L 574 (635)
T 4g8a_A 495 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 574 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEEC
T ss_pred ccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEe
Confidence 8888888888888888888888888888888888888888888888888888888888888887764 223 35566677
Q ss_pred ccCcccccCC
Q 048430 594 KQNYALCGSS 603 (973)
Q Consensus 594 ~~n~~~c~~~ 603 (973)
.+|++.|+|.
T Consensus 575 ~~Np~~C~C~ 584 (635)
T 4g8a_A 575 TQNDFACTCE 584 (635)
T ss_dssp TTCCBCCSGG
T ss_pred eCCCCcccCC
Confidence 8888888875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=435.51 Aligned_cols=269 Identities=23% Similarity=0.368 Sum_probs=219.1
Q ss_pred CHHHHHHHhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccC-CceeEEE
Q 048430 671 SYHELQQATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRH-RNLIKIV 742 (973)
Q Consensus 671 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~ 742 (973)
+..+++...++|...+.||+|+||.||+|++. .++.||||+++... ....+.|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 33455566788999999999999999999853 24689999997654 3445789999999999965 8999999
Q ss_pred eeeecC-CeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC
Q 048430 743 SSCSNP-GFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806 (973)
Q Consensus 743 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl 806 (973)
|+|.++ +..++|||||++|+|.++++... ..+++.++..|+.|||+||+||| +++||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence 999764 56899999999999999997632 35899999999999999999999 899999999
Q ss_pred CCCcEEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 048430 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEM 884 (973)
Q Consensus 807 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~ 884 (973)
||+|||+++++.+||+|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543332 3445679999999999999999999999999999999998 89999764
Q ss_pred ccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 885 FTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
...+ .+...+.... +...+..+++++.+++.+||+.||++||||+|++++|+.+.+.
T Consensus 292 ~~~~-~~~~~i~~g~----------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KIDE-EFCRRLKEGT----------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSH-HHHHHHHHTC----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH-HHHHHHHcCC----------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 3222 1222111110 0111234567799999999999999999999999999998765
Q ss_pred H
Q 048430 965 L 965 (973)
Q Consensus 965 ~ 965 (973)
-
T Consensus 349 ~ 349 (353)
T 4ase_A 349 N 349 (353)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=429.65 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=203.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36799999999999999999985 579999999997552 344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||++|+|.+++...+ ..+++.+++.|+.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999999997654 45789999999999999999999 899999999999999999999999999999876421
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......+||+.|||||.+.+..++.++||||+||++|||++|+.||.... ..+.+.....+. ...
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~--------~~~- 244 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISGS--------FPP- 244 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTC--------CCC-
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCC--------CCC-
Confidence 112344579999999999999999999999999999999999999996532 111111111110 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..+++++.+++.+||+.||++|||++|+++|
T Consensus 245 ----------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 ----------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011345678999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=427.89 Aligned_cols=256 Identities=22% Similarity=0.257 Sum_probs=209.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+.|...++||+|+||.||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577778999999999999995 5799999999975432 247999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecccccccCCCCCc-
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPV- 836 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~- 836 (973)
++|+|.++++..+ .+++.++..++.||+.||+||| +++||||||||+|||++.++ .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999999998765 7999999999999999999999 89999999999999999987 6999999999876532211
Q ss_pred ---ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 837 ---TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 837 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.....+||+.|||||.+.+..++.++|||||||++|||++|+.||......+. ........ + ..
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~-~-~~---------- 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP-P-PI---------- 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC-C-GG----------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC-C-Cc----------
Confidence 12335799999999999999999999999999999999999999976443322 11111110 0 00
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
...+..+++++.+++.+||+.||++|||+.|++++|....+...
T Consensus 276 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 276 ---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 01123456778999999999999999999999999988776543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=458.84 Aligned_cols=461 Identities=20% Similarity=0.238 Sum_probs=345.2
Q ss_pred cEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccC
Q 048430 72 VSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDN 151 (973)
Q Consensus 72 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 151 (973)
++||+++|+++ .+|..+. ++|++|||++|.+. .++...|..+++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 57899999996 6888776 89999999999998 45555568899999999999999987788999999999999999
Q ss_pred ccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcc--eeEEeec
Q 048430 152 NSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNM--VAILLYG 229 (973)
Q Consensus 152 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L--~~L~l~~ 229 (973)
|+|+ .+|.. .+++|++|+|++|++++. .+|..|+++++|++|+|++|++++ ..+..+++| +.|++++
T Consensus 79 N~l~-~lp~~---~l~~L~~L~L~~N~l~~~----~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~ 147 (520)
T 2z7x_B 79 NKLV-KISCH---PTVNLKHLDLSFNAFDAL----PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVL 147 (520)
T ss_dssp SCCC-EEECC---CCCCCSEEECCSSCCSSC----CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEE
T ss_pred Ccee-ecCcc---ccCCccEEeccCCccccc----cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeec
Confidence 9998 78876 688999999999998742 357889999999999999999875 345555555 6666666
Q ss_pred ccc--cccCCCCC-Ccc-ccceeeeccccccccCcc-hhcccCcccEEEecccc-------ccccCCCcccccccceEEE
Q 048430 230 NHL--SGHLPSSI-YLP-NLENLFLWKNNLSGIIPD-SICNASEATILELSSNL-------FSGLVPNTFGNCRQLQILS 297 (973)
Q Consensus 230 n~l--~~~~~~~~-~l~-~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~-------i~~~~~~~~~~l~~L~~L~ 297 (973)
|.+ .+..|... .+. +...+++++|++.+.+++ .+..+++|+.|++++|. +.+.+| .|+.+++|+.|+
T Consensus 148 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~ 226 (520)
T 2z7x_B 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLT 226 (520)
T ss_dssp CTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEE
T ss_pred ccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcc
Confidence 666 44444332 111 233455566655543332 45556666666666665 444444 455566666666
Q ss_pred ccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEE
Q 048430 298 LGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLS 377 (973)
Q Consensus 298 L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~ 377 (973)
+++|.++.... ..... ...+++|+.|++++|++.+.+|..+... ....+++|+.++
T Consensus 227 l~~~~l~~~~~---~~~~~-~~~~~~L~~L~l~~n~l~~~~p~~~~~~--------------------~~~~l~~L~~l~ 282 (520)
T 2z7x_B 227 LNNIETTWNSF---IRILQ-LVWHTTVWYFSISNVKLQGQLDFRDFDY--------------------SGTSLKALSIHQ 282 (520)
T ss_dssp EEEEEEEHHHH---HHHHH-HHHTSSCSEEEEEEEEEESCCCCCCCCC--------------------CSCCCCEEEEEE
T ss_pred ccccccCHHHH---HHHHH-HhhhCcccEEEeecccccCccccchhhc--------------------ccccCceeEecc
Confidence 66655542100 00000 0112355555555555554444332111 017889999999
Q ss_pred eecCccccccC-cccCCC---CCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCC
Q 048430 378 LVNNELAGAIP-TVLGKL---QKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453 (973)
Q Consensus 378 Ls~n~l~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 453 (973)
+++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|+.|++++|++++..|..++++++|++|++++|
T Consensus 283 l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 358 (520)
T 2z7x_B 283 VVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358 (520)
T ss_dssp EEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSS
T ss_pred ccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCC
Confidence 999999 344 455444 67999999999987432 1267899999999999999989999999999999999999
Q ss_pred CCCC--CCcccccccccccEEEecCCcccCCcCcC-ccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccC
Q 048430 454 SLNS--TIPSTFWSLKYILAVDFSLNSLSGSLPLN-IGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGP 530 (973)
Q Consensus 454 ~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 530 (973)
++++ .+|..+..+++|+.|++++|++++.+|.. +..+++|+.|+|++|++++..|..+. ++|+.|+|++|+++ .
T Consensus 359 ~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ 435 (520)
T 2z7x_B 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-S 435 (520)
T ss_dssp CCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-C
T ss_pred ccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-c
Confidence 9986 56678999999999999999999756654 88899999999999999888887765 79999999999999 8
Q ss_pred CCCCcccccccccccccccccCCCCCcc-ccccccccccccCCCcccccCC
Q 048430 531 IPQSFGSLISLQSLDLSGNNISGEIPKS-LEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 531 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~~~~p 580 (973)
+|..+..+++|++|+|++|+|++ +|.. +..+++|+.|++++|++++.++
T Consensus 436 ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 436 IPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence 88888899999999999999995 5554 8999999999999999998765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=420.03 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=201.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----eeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG----FKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 755 (973)
++|...++||+|+||+||+|++. |+.||||+++..... ...+..|+..+.+++|||||+++++|.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 34566789999999999999984 899999998654322 223345666667889999999999997653 579999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG-----YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
|||++|+|.++++.. .+++..+.+++.|+|+||+|||+. ..++||||||||+|||++.++.+||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999876 599999999999999999999932 1238999999999999999999999999999876
Q ss_pred CCCCCc---ccccccccccccCccCCCCC------CCCcchhHHHHHHHHHHHHhCCCCCCccccCcc----------cH
Q 048430 831 DGVDPV---TQTMTLATIGYMAPEYGSEG------IVSISGDVYSFGILMMETFTRRKPTNEMFTGEM----------SL 891 (973)
Q Consensus 831 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~----------~~ 891 (973)
...... .....+||+.|||||++.+. .++.++|||||||++|||+||+.||........ ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 12345799999999987654 467899999999999999999887654322211 11
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
..+.... .+..+.. ..+.......+++.+.+++.+||+.||++||||+||++.|+++.++
T Consensus 239 ~~~~~~~--------~~~~~rp-----~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVV--------CEQKLRP-----NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHH--------TTSCCCC-----CCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHH--------hcccCCC-----CCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111111 1111100 0011112234677899999999999999999999999999988754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=470.73 Aligned_cols=450 Identities=18% Similarity=0.232 Sum_probs=270.6
Q ss_pred CCCcEEEecCCCCCCCCCcccccccCCcEEEc-cCCCCCCCCCccccCCCCCccE-----EE---------e-eCcccC-
Q 048430 69 SFLVSLNISGNSFYDTLPNELWHMRRLKIIDF-SSNSLSGSLPGDMCNSFTQLES-----FD---------V-SSNKIT- 131 (973)
Q Consensus 69 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~~~~l~~L~~-----L~---------L-s~N~l~- 131 (973)
.+++.|+|++|++.|.+|++|++|++|++||| ++|.++|..|-........+.. +. . ....+.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 9998887654321110000000 00 0 000000
Q ss_pred ----------CCCCccccCCCCCCeEEccC--ccccccCCccccCCCCCccEEEccccccccc-CCCC-----------C
Q 048430 132 ----------GEFPSAIVNISSLKSIRLDN--NSLSGSFPTDLCTRLPSLVQLRLLGNNITGR-IPNR-----------E 187 (973)
Q Consensus 132 ----------~~~p~~~~~l~~L~~L~L~~--N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~~~~-----------~ 187 (973)
...+........++.+.+.. |+++| ||..+ .++++|++|+|++|+|+|. ++.. .
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l-~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~ 480 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAI-QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGG-GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHH-hcCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence 00011111222333333333 55554 55442 4455555555555555541 0000 1
Q ss_pred CCcccc--CCCCccEEEecCCcccCccccccccCCcceeEEeeccc-ccc-cCCCC--------CCccccceeeeccccc
Q 048430 188 IPNEIG--NLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNH-LSG-HLPSS--------IYLPNLENLFLWKNNL 255 (973)
Q Consensus 188 ~p~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~-l~~-~~~~~--------~~l~~L~~L~L~~N~l 255 (973)
+|..++ ++++|++|+|++|++.+.+|..+.++++|+.|++++|+ +++ .+|.. ..+++|++|+|++|++
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 456666 77777777777777777777777776666666666665 554 33321 1244777777777777
Q ss_pred cccCcc--hhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCc-CcEEEccCC
Q 048430 256 SGIIPD--SICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY-LRVLVLDTN 332 (973)
Q Consensus 256 ~~~~~~--~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~-L~~L~L~~N 332 (973)
+ .+|. .++.+++|+.|+|++|+++ .+| .|+.+++|+.|+|++|+++.++ ..+..+++ |+.|+|++|
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp--------~~l~~l~~~L~~L~Ls~N 629 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIP--------EDFCAFTDQVEGLGFSHN 629 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCC--------TTSCEECTTCCEEECCSS
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccch--------HHHhhccccCCEEECcCC
Confidence 7 5666 7777777777777777777 445 6777777777777777776432 23455555 666666666
Q ss_pred CCCCCCCCcccccccccceeecccCCccccCCCCCCCC--CcccEEEeecCccccccCccc---C--CCCCCCEEEccCC
Q 048430 333 PLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNL--SNLLVLSLVNNELAGAIPTVL---G--KLQKLQGLDLNSN 405 (973)
Q Consensus 333 ~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~p~~~---~--~l~~L~~L~Ls~N 405 (973)
++. .+|. .+..+ ++|+.|+|++|++.+.+|... . .+++|+.|+|++|
T Consensus 630 ~L~-~lp~-------------------------~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N 683 (876)
T 4ecn_A 630 KLK-YIPN-------------------------IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683 (876)
T ss_dssp CCC-SCCS-------------------------CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSS
T ss_pred CCC-cCch-------------------------hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCC
Confidence 655 3333 23333 337777777777766554322 1 2336667777777
Q ss_pred cCCCCCchh-hhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcC
Q 048430 406 KLKGFIPTD-LCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP 484 (973)
Q Consensus 406 ~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 484 (973)
+++ .+|.. +..+++|+.|+|++|+++ .+|..+.... +..+..+++|+.|++++|+++ .+|
T Consensus 684 ~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~----------------~~~l~nl~~L~~L~Ls~N~L~-~lp 744 (876)
T 4ecn_A 684 EIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK----------------DGNYKNTYLLTTIDLRFNKLT-SLS 744 (876)
T ss_dssp CCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT----------------TSCCTTGGGCCEEECCSSCCC-CCC
T ss_pred cCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccc----------------cccccccCCccEEECCCCCCc-cch
Confidence 766 33433 335666666666666666 3333222111 000011224455555555554 444
Q ss_pred cCcc--CCCCCCeEEccCCcCcccCCcccccCCcCCEEEc------ccCccccCCCCCcccccccccccccccccCCCCC
Q 048430 485 LNIG--NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL------ARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIP 556 (973)
Q Consensus 485 ~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 556 (973)
..+. .+++|+.|+|++|+|++ +|..++.+++|+.|+| ++|++.+.+|..|..+++|+.|+|++|+| +.+|
T Consensus 745 ~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip 822 (876)
T 4ecn_A 745 DDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVD 822 (876)
T ss_dssp GGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCC
T ss_pred HHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccC
Confidence 4444 55555555555555553 4555555555555555 55899999999999999999999999999 6899
Q ss_pred ccccccccccccccCCCcccccCC
Q 048430 557 KSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 557 ~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
..+. ++|+.|||++|++...-+
T Consensus 823 ~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 823 EKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp SCCC--SSSCEEECCSCTTCEEEC
T ss_pred Hhhc--CCCCEEECCCCCCCccCh
Confidence 8876 699999999999876544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=414.11 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=197.8
Q ss_pred CCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec----CCeeEEEE
Q 048430 683 GESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN----PGFKALIM 755 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 755 (973)
...+.||+|+||+||+|.. .+++.||+|++.... ....+.|.+|++++++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456799999999999985 468999999987542 3445789999999999999999999999854 35689999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeCC-CCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~ 832 (973)
|||++|+|.+++.... .+++..+..++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998765 7999999999999999999999 666 999999999999974 78999999999986432
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
......+||+.|||||.+.+ .++.++|||||||++|||+||+.||.... ...........+....
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~~~~~~------- 249 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVKPA------- 249 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCCCG-------
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHcCCCCC-------
Confidence 22345679999999998764 69999999999999999999999996422 1222222111110000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|||++|+++|
T Consensus 250 -----------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 -----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111234568899999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=431.71 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=210.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+.|...+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5688899999999999999996 479999999998766555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++|+|.+++... .+++.++..|+.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+...... ...
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 999999999865 5999999999999999999999 8999999999999999999999999999998765432 233
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...+||+.|||||.+....|+.++|||||||++|||++|+.||..... ......+....+ +.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~--------~~~------- 367 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLP--------PRL------- 367 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCC--------CCC-------
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCC--------CCC-------
Confidence 456899999999999999999999999999999999999999965221 111111111110 001
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+|+.+||+.||++|||++|+++|
T Consensus 368 -----~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 -----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -----SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0112245678999999999999999999999986
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=469.58 Aligned_cols=459 Identities=18% Similarity=0.244 Sum_probs=291.0
Q ss_pred CCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCC------CC------CCCccccCCCCCccEEEeeCcccCCCCCc
Q 048430 69 SFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSL------SG------SLPGDMCNSFTQLESFDVSSNKITGEFPS 136 (973)
Q Consensus 69 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l------~~------~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~ 136 (973)
.+++.|+|++|++.|.+|+++++|++|++|||++|.+ .| .+|... +..|+ +++++|.+.+.+|.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~---~~~l~-l~l~~~~l~~~~~~ 156 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ---KQKMR-MHYQKTFVDYDPRE 156 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH---HHHHH-THHHHHHTCCCGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH---HHHHH-hhHHHhhhccCchh
Confidence 4789999999999999999999999999999999987 33 455544 45677 88888988888887
Q ss_pred cccC-CCCCCeEEccCccccccCCccccCCCCCccEEEcc--cccccccCCCCCCCccccCCCCccEEEecCCcccCc--
Q 048430 137 AIVN-ISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL--GNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGL-- 211 (973)
Q Consensus 137 ~~~~-l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~--~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~-- 211 (973)
.+.. +..+..+++....+.. .....++.+.+. .|+++| +|..|+++++|++|+|++|++++.
T Consensus 157 ~~~~~~~~l~~~~l~~~~~~~-------~~~~~l~~l~l~~~~n~l~~------ip~~l~~l~~L~~L~Ls~n~l~~~~~ 223 (636)
T 4eco_A 157 DFSDLIKDCINSDPQQKSIKK-------SSRITLKDTQIGQLSNNITF------VSKAVMRLTKLRQFYMGNSPFVAENI 223 (636)
T ss_dssp GSCHHHHHHHHHCTTSCCCCC-------CCCCCCCTTTTTCCSCEEEE------ECGGGGGCTTCCEEEEESCCCCGGGB
T ss_pred hHHHHHHHHhhcCcccccccc-------ccccchhhhhhccccCCCcc------CCHHHhcccCCCEEECcCCccccccc
Confidence 7663 2234444444433331 122334444443 588885 467899999999999999999985
Q ss_pred ---------------cccccc--cCCcceeEEeecccccccCCCCC-Cccccceeeecccc-ccc-cCcchhcccCcccE
Q 048430 212 ---------------IPSMIF--NNSNMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNN-LSG-IIPDSICNASEATI 271 (973)
Q Consensus 212 ---------------~~~~~~--~~~~L~~L~l~~n~l~~~~~~~~-~l~~L~~L~L~~N~-l~~-~~~~~l~~l~~L~~ 271 (973)
+|..+. ++++|+.|++++|.+.+.+|..+ .+++|++|+|++|+ +++ .+|..++.+.
T Consensus 224 ~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~---- 299 (636)
T 4eco_A 224 CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA---- 299 (636)
T ss_dssp SSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHH----
T ss_pred cccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhh----
Confidence 777777 75555555555555555544333 35555555555554 554 4454444430
Q ss_pred EEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccce
Q 048430 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLEN 351 (973)
Q Consensus 272 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~ 351 (973)
.+..+++|++|++++|+++.++. ...+.++++|+.|++++|++.|.+| .
T Consensus 300 --------------~~~~l~~L~~L~L~~n~l~~ip~------~~~l~~l~~L~~L~L~~N~l~g~ip-~---------- 348 (636)
T 4eco_A 300 --------------DAPVGEKIQIIYIGYNNLKTFPV------ETSLQKMKKLGMLECLYNQLEGKLP-A---------- 348 (636)
T ss_dssp --------------HSGGGGTCCEEECCSSCCSSCCC------HHHHTTCTTCCEEECCSCCCEEECC-C----------
T ss_pred --------------ccccCCCCCEEECCCCcCCccCc------hhhhccCCCCCEEeCcCCcCccchh-h----------
Confidence 00001445555555554443211 0134444455555555554444333 2
Q ss_pred eecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCC-CCEEEccCCcCCCCCchhhhccC--cCCeeecCC
Q 048430 352 FYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK-LQGLDLNSNKLKGFIPTDLCKLE--KLNTLLSNN 428 (973)
Q Consensus 352 l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~l~~ 428 (973)
|..+++|++|++++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..+. +|+.|++++
T Consensus 349 ---------------~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~ 411 (636)
T 4eco_A 349 ---------------FGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411 (636)
T ss_dssp ---------------CEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCS
T ss_pred ---------------hCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcC
Confidence 334445555555555555 45555555555 555555555555 4454444433 555555555
Q ss_pred ccccCcCccccc-------CcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccC--------CCCC
Q 048430 429 NALQGQIPTCLA-------NLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGN--------LEAL 493 (973)
Q Consensus 429 N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~--------l~~L 493 (973)
|.+++.+|..+. .+++|++|++++|++++..+..+..+++|+.|++++|+++ .+|..+.. +++|
T Consensus 412 N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L 490 (636)
T 4eco_A 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLL 490 (636)
T ss_dssp SCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGC
T ss_pred CcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCc
Confidence 555555555555 5556666666666666433333444666666666666666 44433222 2277
Q ss_pred CeEEccCCcCcccCCcccc--cCCcCCEEEcccCccccCCCCCcccccccccccc------cccccCCCCCccccccccc
Q 048430 494 GGLNLTGNQLSGYIPSSIG--NLKNLDWLALARNAFQGPIPQSFGSLISLQSLDL------SGNNISGEIPKSLEKLSRL 565 (973)
Q Consensus 494 ~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L 565 (973)
+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|
T Consensus 491 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L 568 (636)
T 4eco_A 491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568 (636)
T ss_dssp CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence 77777777777 5666665 77777777777777775 6777777777777777 6788999999999999999
Q ss_pred cccccCCCcccccCCCCCCCCccCccccccCccccc
Q 048430 566 VDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCG 601 (973)
Q Consensus 566 ~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 601 (973)
+.|+|++|++ +.+|..- ..++....+.+|+..|-
T Consensus 569 ~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 569 TQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNISI 602 (636)
T ss_dssp CEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCEE
T ss_pred CEEECCCCcC-CccCHhH-hCcCCEEECcCCCCccc
Confidence 9999999999 7888752 25677777888887763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=415.69 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=208.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999985 579999999997542 334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|||++|+|.+++...+ .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.......
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998765 7999999999999999999999 89999999999999999999999999999998754332
Q ss_pred -cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 -VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......+||+.|||||.+.+..++.++||||+||++|||++|+.||..... .........+ .+.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~--------~~~-- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKIIKL--------EYD-- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHT--------CCC--
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC--------CCC--
Confidence 233456899999999999999999999999999999999999999965221 1111111100 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..+++++.+++.+|++.||++|||++|++.+
T Consensus 253 ----------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 ----------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ----------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ----------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 011235668899999999999999999987544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=447.94 Aligned_cols=459 Identities=19% Similarity=0.185 Sum_probs=377.6
Q ss_pred EEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeC
Q 048430 48 AALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSS 127 (973)
Q Consensus 48 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~ 127 (973)
+.||+++++++ .+|..+. ++|++|+|++|++.+..|..|.++++|++|+|++|++++ ++++.|..+++|++|||++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCE-EEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCC-cChHHhhcccCCCEEecCC
Confidence 46899999999 6998877 899999999999988888899999999999999999994 5445568999999999999
Q ss_pred cccCCCCCccccCCCCCCeEEccCccccc-cCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCc--cEEEec
Q 048430 128 NKITGEFPSAIVNISSLKSIRLDNNSLSG-SFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNL--KILDLG 204 (973)
Q Consensus 128 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L--~~L~L~ 204 (973)
|+++ .+|.. .+++|++|+|++|++++ .+|. .+..+++|++|+|++|+|++ ..++.+++| ++|+++
T Consensus 79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~L~~n~l~~--------~~~~~l~~L~L~~L~l~ 146 (520)
T 2z7x_B 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICK-EFGNMSQLKFLGLSTTHLEK--------SSVLPIAHLNISKVLLV 146 (520)
T ss_dssp SCCC-EEECC--CCCCCSEEECCSSCCSSCCCCG-GGGGCTTCCEEEEEESSCCG--------GGGGGGTTSCEEEEEEE
T ss_pred Ccee-ecCcc--ccCCccEEeccCCccccccchh-hhccCCcceEEEecCcccch--------hhccccccceeeEEEee
Confidence 9999 67766 89999999999999984 3444 45789999999999999974 357778888 999999
Q ss_pred CCcc--cCccccccccCC-cceeEEeecccccccCCCCC--Cccccceeeecccc-------ccccCcchhcccCcccEE
Q 048430 205 GNNI--AGLIPSMIFNNS-NMVAILLYGNHLSGHLPSSI--YLPNLENLFLWKNN-------LSGIIPDSICNASEATIL 272 (973)
Q Consensus 205 ~N~l--~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~--~l~~L~~L~L~~N~-------l~~~~~~~l~~l~~L~~L 272 (973)
+|++ .+..|..+..+. +...+++++|.+.+.++... .+++|+.|++++|. +.+.+| .++.+++|+.|
T Consensus 147 ~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L 225 (520)
T 2z7x_B 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNL 225 (520)
T ss_dssp ECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEE
T ss_pred cccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhc
Confidence 9999 888888888776 45577889999888776544 48999999999998 777666 78999999999
Q ss_pred EeccccccccCCCccc---ccccceEEEccCCcCCC-CCCCcchhhhhhhccCCcCcEEEccCCCCCCCCC-Cccccccc
Q 048430 273 ELSSNLFSGLVPNTFG---NCRQLQILSLGDNQLTT-GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIP-NSIGNLST 347 (973)
Q Consensus 273 ~L~~N~i~~~~~~~~~---~l~~L~~L~L~~N~l~~-~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~ 347 (973)
++++|.+++..+..+. ..++|++|++++|++++ ++... +.....++++|+.+++++|.+ .+| ..+..+
T Consensus 226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~---~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~-- 298 (520)
T 2z7x_B 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD---FDYSGTSLKALSIHQVVSDVF--GFPQSYIYEI-- 298 (520)
T ss_dssp EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCC---CCCCSCCCCEEEEEEEEECCC--CSCTHHHHHH--
T ss_pred cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccch---hhcccccCceeEeccccccce--ecchhhhhcc--
Confidence 9999998754322211 24589999999999984 33221 111127899999999999988 444 332221
Q ss_pred ccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecC
Q 048430 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSN 427 (973)
Q Consensus 348 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 427 (973)
....+|+.|++++|.+.... .+..+++|++|++++|++++.+|..+..+++|+.|+++
T Consensus 299 --------------------~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 356 (520)
T 2z7x_B 299 --------------------FSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356 (520)
T ss_dssp --------------------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECC
T ss_pred --------------------cccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEcc
Confidence 01146888889888876332 13678889999999999998888888899999999999
Q ss_pred CccccC--cCcccccCcCCCCeeeccCCCCCCCCcc-cccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCc
Q 048430 428 NNALQG--QIPTCLANLTSLRHLDFRSNSLNSTIPS-TFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS 504 (973)
Q Consensus 428 ~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 504 (973)
+|++++ .+|..+..+++|++|++++|++++.+|. .+..+++|+.|++++|++++..|..+. ++|+.|+|++|+++
T Consensus 357 ~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp SSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred CCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 999986 5567788999999999999999885555 488889999999999999888877665 79999999999999
Q ss_pred ccCCcccccCCcCCEEEcccCccccCCCCC-cccccccccccccccccCCCCC
Q 048430 505 GYIPSSIGNLKNLDWLALARNAFQGPIPQS-FGSLISLQSLDLSGNNISGEIP 556 (973)
Q Consensus 505 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 556 (973)
.+|..+..+++|+.|+|++|+|+ .+|.. |..+++|++|+|++|++++..+
T Consensus 435 -~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 435 -SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp -CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred -ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 88888889999999999999999 56654 9999999999999999997654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=404.78 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=192.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999985 579999999997542 233567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+ +|+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence 999 679999998765 7999999999999999999999 899999999999999999999999999999876432
Q ss_pred cccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......+||+.|||||.+.+..+ +.++||||+||++|||++|+.||.... ..........+. .
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~~--------~--- 229 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNGV--------Y--- 229 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC--------C---
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCC--------C---
Confidence 22344679999999999887765 689999999999999999999996521 122221111000 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|||++|+++|
T Consensus 230 ---------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ---------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011245668899999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=410.30 Aligned_cols=248 Identities=26% Similarity=0.298 Sum_probs=197.8
Q ss_pred cCCCCCccccccCceEEEEEEe----CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++|...+.||+|+||+||+|+. .+++.||||+++... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688999999999999999985 257899999986542 2223468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|||||++|+|.+++...+ .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999998765 7999999999999999999999 899999999999999999999999999999865432
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
. ......+||+.|||||.+.+..++.++||||+||++|||+||+.||.+.... .+...+.. ...
T Consensus 180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~-----------~~~-- 243 (304)
T 3ubd_A 180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMILK-----------AKL-- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-----------CCC--
T ss_pred C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHHHc-----------CCC--
Confidence 2 2234467999999999999999999999999999999999999999653211 11111111 000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV-----KDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~-----~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|||+ +|+++|
T Consensus 244 ----------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 ----------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ----------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0112345678999999999999999984 677765
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=440.32 Aligned_cols=463 Identities=18% Similarity=0.196 Sum_probs=300.3
Q ss_pred EEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeC
Q 048430 48 AALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSS 127 (973)
Q Consensus 48 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~ 127 (973)
+.+|++++++++ +|..+. ++|++|+|++|.+.+..|..|.++++|++|+|++|+++ .++++.|..+++|++|||++
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCC-cCCHHHhCCCCCCCEEECCC
Confidence 566777777763 665543 56666666666665555556666666666666666665 23333345555566666666
Q ss_pred cccCCCCCccccCCCCCCeEEccCccccccCCc-cccCCCCCccEEEcccccccccCCCCCCCccccCCCCc--cEEEec
Q 048430 128 NKITGEFPSAIVNISSLKSIRLDNNSLSGSFPT-DLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNL--KILDLG 204 (973)
Q Consensus 128 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L--~~L~L~ 204 (973)
|+++ .+|.. .+++|++|+|++|+++ .+|. ..|.++++|++|+|++|+|++ ..+..+++| ++|+|+
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~-~l~~p~~~~~l~~L~~L~L~~n~l~~--------~~~~~l~~L~L~~L~L~ 177 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ--------LDLLPVAHLHLSCILLD 177 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCS-BCCCCGGGGGCTTCCEEEEECSBCCT--------TTTGGGTTSCEEEEEEE
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCcc-ccCchHhhcccCcccEEecCCCcccc--------CchhhhhhceeeEEEee
Confidence 6555 34443 4555555555555555 3331 233445555555555555542 122233333 555555
Q ss_pred CCcc--cCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcc-hhcccCcccEEEecccc---
Q 048430 205 GNNI--AGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPD-SICNASEATILELSSNL--- 278 (973)
Q Consensus 205 ~N~l--~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~--- 278 (973)
+|++ ++..|..+..+. ...+ .+++++|.+.+.+++ .+..+++|+.|++++|+
T Consensus 178 ~n~l~~~~~~~~~l~~l~---------------------~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 235 (562)
T 3a79_B 178 LVSYHIKGGETESLQIPN---------------------TTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235 (562)
T ss_dssp ESSCCCCSSSCCEEEECC---------------------EEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTH
T ss_pred cccccccccCcccccccC---------------------cceE-EEEecCccchhhhhhhcccccceEEEeccccccccc
Confidence 5555 444444333211 1112 456677777664443 45566777777777774
Q ss_pred --ccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeeccc
Q 048430 279 --FSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGS 356 (973)
Q Consensus 279 --i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~ 356 (973)
+.+. ...|..+++|+.|+++++.+..... ...+. ....++|++|++++|.+.+.+|..+...
T Consensus 236 ~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~---~~~~~-~~~~~~L~~L~l~~n~l~~~ip~~~~~~----------- 299 (562)
T 3a79_B 236 QRLMTF-LSELTRGPTLLNVTLQHIETTWKCS---VKLFQ-FFWPRPVEYLNIYNLTITERIDREEFTY----------- 299 (562)
T ss_dssp HHHHHH-HHHHHSCSSCEEEEEEEEEECHHHH---HHHHH-HHTTSSEEEEEEEEEEECSCCCCCCCCC-----------
T ss_pred chHHHH-HHHHhccCcceEEEecCCcCcHHHH---HHHHH-hhhcccccEEEEeccEeeccccchhhhc-----------
Confidence 2222 1245566677777776666543100 00011 1123366666666666665555443211
Q ss_pred CCccccCCCCCCCCCcccEEEeecCccccccC-cccCC---CCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCcccc
Q 048430 357 SQLSGGIPVGFGNLSNLLVLSLVNNELAGAIP-TVLGK---LQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQ 432 (973)
Q Consensus 357 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 432 (973)
....++.|+.++++.|.+ .+| ..+.. ..+|++|++++|.+.... ....+++|+.|++++|+++
T Consensus 300 ---------~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~ 366 (562)
T 3a79_B 300 ---------SETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFT 366 (562)
T ss_dssp ---------CSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCC
T ss_pred ---------ccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccc
Confidence 016677778888888877 333 23222 257999999999887432 1267889999999999999
Q ss_pred CcCcccccCcCCCCeeeccCCCCCCC--CcccccccccccEEEecCCcccCCcCc-CccCCCCCCeEEccCCcCcccCCc
Q 048430 433 GQIPTCLANLTSLRHLDFRSNSLNST--IPSTFWSLKYILAVDFSLNSLSGSLPL-NIGNLEALGGLNLTGNQLSGYIPS 509 (973)
Q Consensus 433 ~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~ 509 (973)
+..|..+.++++|++|++++|++++. +|..|..+++|+.|++++|++++.+|. .+..+++|+.|+|++|++++.+|.
T Consensus 367 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 446 (562)
T 3a79_B 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446 (562)
T ss_dssp TTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGS
T ss_pred cchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhh
Confidence 88888999999999999999999863 356788999999999999999975555 488889999999999999877777
Q ss_pred ccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCcc-ccccccccccccCCCcccccCCC
Q 048430 510 SIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKS-LEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 510 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
.+. ++|+.|+|++|+++ .+|..+..+++|++|+|++|+|++ +|.. +..+++|+.|++++|+++|.+|.
T Consensus 447 ~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 447 CLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred hhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 665 78999999999998 788777799999999999999994 5555 89999999999999999887763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=402.40 Aligned_cols=249 Identities=21% Similarity=0.354 Sum_probs=189.2
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC--------
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG-------- 749 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 749 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... +...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4588899999999999999985 479999999987554 344578999999999999999999999986433
Q ss_pred ----eeEEEEEecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEee
Q 048430 750 ----FKALIMQYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823 (973)
Q Consensus 750 ----~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 823 (973)
..|+|||||++|+|.+++.... ...++..++.++.||+.||+||| +++||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 3689999999999999998754 23566778899999999999999 79999999999999999999999999
Q ss_pred cccccccCCCCCc-----------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH
Q 048430 824 FGIAKLLDGVDPV-----------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892 (973)
Q Consensus 824 fgla~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~ 892 (973)
||+|+........ ..+..+||+.|||||.+.+..++.++|||||||++|||++ ||..... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HHH
Confidence 9999876432211 1234579999999999999999999999999999999996 7643111 111
Q ss_pred HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. +...... ... +......+...+++.+||+.||++|||+.|+++|
T Consensus 236 ~-~~~~~~~-------------~~p------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 T-LTDVRNL-------------KFP------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H-HHHHHTT-------------CCC------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H-HHHHhcC-------------CCC------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1110000 000 1112334557789999999999999999999985
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=429.68 Aligned_cols=526 Identities=20% Similarity=0.164 Sum_probs=428.7
Q ss_pred cceEE----EEEeeCC---------CCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEE
Q 048430 32 VCNWV----GVTCSIR---------HGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKII 98 (973)
Q Consensus 32 ~c~w~----gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 98 (973)
.|.|. -|.|... +..++.|||++|.+++..|.+++++++|++|+|++|+|.+..|.+|+++++|++|
T Consensus 26 ~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L 105 (635)
T 4g8a_A 26 PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 105 (635)
T ss_dssp CSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred CccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEE
Confidence 46555 4788642 2479999999999997666789999999999999999987778889999999999
Q ss_pred EccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEccccc
Q 048430 99 DFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178 (973)
Q Consensus 99 ~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~ 178 (973)
+|++|+|+ .+|.+.|.++++|++|+|++|++++..+..|+++++|++|+|++|++++.-....+..+++|++|+|++|+
T Consensus 106 ~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 106 ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp ECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred EccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence 99999998 78888899999999999999999987777899999999999999999843234556789999999999999
Q ss_pred ccccCCCCCCCccccCCCCc----cEEEecCCcccCccccccccCCcceeEEeecccccccCCCC--CCccccceeeecc
Q 048430 179 ITGRIPNREIPNEIGNLHNL----KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS--IYLPNLENLFLWK 252 (973)
Q Consensus 179 l~~~~~~~~~p~~l~~l~~L----~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~--~~l~~L~~L~L~~ 252 (973)
|++.. |..|..+.++ ..++++.|.++...+. ......+..+++.+|......... ..+..++...+..
T Consensus 185 l~~~~-----~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~ 258 (635)
T 4g8a_A 185 IQSIY-----CTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 258 (635)
T ss_dssp CCEEC-----GGGGHHHHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEE
T ss_pred ccccc-----cccccchhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhcccccccccchhhcCCcccccccccc
Confidence 98643 4556655554 4789999999865554 445567788999988665432211 1356666665543
Q ss_pred cc------ccccCcchhcccCcccEEEecccccc---ccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCc
Q 048430 253 NN------LSGIIPDSICNASEATILELSSNLFS---GLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY 323 (973)
Q Consensus 253 N~------l~~~~~~~l~~l~~L~~L~L~~N~i~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 323 (973)
+. +.......+..+..+..+++..+... ...+..+..+.+++.+.+.+|.+... ..+.....
T Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~---------~~~~~~~~ 329 (635)
T 4g8a_A 259 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV---------KDFSYNFG 329 (635)
T ss_dssp ECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC---------GGGGSCCC
T ss_pred cccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc---------cccccchh
Confidence 32 33334455666777777777665543 22345567778889999988887642 23566778
Q ss_pred CcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccc--ccCcccCCCCCCCEEE
Q 048430 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAG--AIPTVLGKLQKLQGLD 401 (973)
Q Consensus 324 L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~ 401 (973)
|+.|++.+|.+.+..+..+ ..++.+.+..|..... ..+..+++|+.|++++|.+.. ..+..+..+.+|+.|+
T Consensus 330 L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~ 403 (635)
T 4g8a_A 330 WQHLELVNCKFGQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLD 403 (635)
T ss_dssp CSEEEEESCEESSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEE
T ss_pred hhhhhcccccccCcCcccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhh
Confidence 8999999998886655443 4566777777776543 345678999999999999863 4566778889999999
Q ss_pred ccCCcCCCCCchhhhccCcCCeeecCCccccCcCc-ccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCccc
Q 048430 402 LNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIP-TCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480 (973)
Q Consensus 402 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 480 (973)
++.|.+. ..+..+..+++|+.+++..|......+ ..+..+++++.++++.|.+.+..+..+..++.++.|++++|++.
T Consensus 404 ~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~ 482 (635)
T 4g8a_A 404 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 482 (635)
T ss_dssp CCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEG
T ss_pred ccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccc
Confidence 9999988 456678899999999999988876654 46788999999999999999999999999999999999999854
Q ss_pred -CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccc
Q 048430 481 -GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559 (973)
Q Consensus 481 -~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 559 (973)
+..|..|..+++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|..+++|++|||++|+|++.+|..+
T Consensus 483 ~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 562 (635)
T 4g8a_A 483 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 562 (635)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCT
T ss_pred cccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHH
Confidence 4578899999999999999999999899999999999999999999999889999999999999999999999999999
Q ss_pred ccc-ccccccccCCCcccccCC
Q 048430 560 EKL-SRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 560 ~~l-~~L~~l~ls~N~l~~~~p 580 (973)
..+ ++|+.|+|++|++.+...
T Consensus 563 ~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 563 QHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCCCTTCCEEECTTCCBCCSGG
T ss_pred HhhhCcCCEEEeeCCCCcccCC
Confidence 998 689999999999998654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=415.25 Aligned_cols=437 Identities=20% Similarity=0.177 Sum_probs=311.2
Q ss_pred CcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEE
Q 048430 45 GRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFD 124 (973)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~ 124 (973)
.+++.|+++++.+++..|..++++++|++|+|++|++.+..|..|+++++|++|||++|+++ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC---CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc---ccccCCEEE
Confidence 57999999999999877789999999999999999999888999999999999999999998 78876 799999999
Q ss_pred eeCcccCC-CCCccccCCCCCCeEEccCccccccCCccccCCCCCc--cEEEcccccc--cccCCCCCCCccccCCC--C
Q 048430 125 VSSNKITG-EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL--VQLRLLGNNI--TGRIPNREIPNEIGNLH--N 197 (973)
Q Consensus 125 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~p~~l~~l~--~ 197 (973)
|++|++++ .+|..|+++++|++|+|++|++++ . .+..+++| ++|+|++|++ ++ ..|..+..+. .
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~-~---~~~~l~~L~L~~L~L~~n~l~~~~-----~~~~~l~~l~~~~ 198 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-L---DLLPVAHLHLSCILLDLVSYHIKG-----GETESLQIPNTTV 198 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT-T---TTGGGTTSCEEEEEEEESSCCCCS-----SSCCEEEECCEEE
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcccc-C---chhhhhhceeeEEEeecccccccc-----cCcccccccCcce
Confidence 99999997 456899999999999999999984 2 23455566 9999999999 64 3456777654 3
Q ss_pred ccEEEecCCcccCcccc-ccccCCcceeEEeeccc-----ccccCCCCCCccccceeeeccccccccC----cchhcccC
Q 048430 198 LKILDLGGNNIAGLIPS-MIFNNSNMVAILLYGNH-----LSGHLPSSIYLPNLENLFLWKNNLSGII----PDSICNAS 267 (973)
Q Consensus 198 L~~L~L~~N~l~~~~~~-~~~~~~~L~~L~l~~n~-----l~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~l~~l~ 267 (973)
| .+++++|.+.+.++. .+..+++|+.+++++|. +.+.++....+++|+.|+++++.+.+.. +..+ ..+
T Consensus 199 l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~ 276 (562)
T 3a79_B 199 L-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPR 276 (562)
T ss_dssp E-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTS
T ss_pred E-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcc
Confidence 3 668899999876554 45567888888888884 3333333345677888888777765421 1111 234
Q ss_pred cccEEEeccccccccCCCcc-----cccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcc
Q 048430 268 EATILELSSNLFSGLVPNTF-----GNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI 342 (973)
Q Consensus 268 ~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 342 (973)
+|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .++. .....+....+|+.|+
T Consensus 277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~----~~~~~~~~~~~L~~L~-------------- 337 (562)
T 3a79_B 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSK----EALYSVFAEMNIKMLS-------------- 337 (562)
T ss_dssp SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCH----HHHHHHHHTCCCSEEE--------------
T ss_pred cccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecCh----hhhhhhhccCcceEEE--------------
Confidence 78888888888887777665 6666666666666655 2211 0111111123344444
Q ss_pred cccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCC
Q 048430 343 GNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLN 422 (973)
Q Consensus 343 ~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 422 (973)
+++|.+.... .+..+++|++|++++|++++.+|..+.++++|+
T Consensus 338 -----------------------------------l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 380 (562)
T 3a79_B 338 -----------------------------------ISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380 (562)
T ss_dssp -----------------------------------EESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCC
T ss_pred -----------------------------------ccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCC
Confidence 4444443111 113444555555555555544555555555555
Q ss_pred eeecCCccccCc--CcccccCcCCCCeeeccCCCCCCCCc-ccccccccccEEEecCCcccCCcCcCccCCCCCCeEEcc
Q 048430 423 TLLSNNNALQGQ--IPTCLANLTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLT 499 (973)
Q Consensus 423 ~L~l~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 499 (973)
.|++++|++++. +|..+.++++|++|++++|++++.+| ..+..+++|+.|++++|++++..|..+. ++|+.|+|+
T Consensus 381 ~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~ 458 (562)
T 3a79_B 381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLH 458 (562)
T ss_dssp EEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECC
T ss_pred EEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECC
Confidence 555555555542 23455666666677777776665333 3466667777777777777766665554 688899999
Q ss_pred CCcCcccCCcccccCCcCCEEEcccCccccCCCCC-cccccccccccccccccCCCCC
Q 048430 500 GNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQS-FGSLISLQSLDLSGNNISGEIP 556 (973)
Q Consensus 500 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 556 (973)
+|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. |..+++|+.|+|++|++++..|
T Consensus 459 ~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 459 NNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp SSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 99998 67777778999999999999999 45555 8999999999999999987655
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=399.83 Aligned_cols=272 Identities=23% Similarity=0.241 Sum_probs=203.1
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec------CCe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN------PGF 750 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 750 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788999999999999999985 579999999996542 2345678899999999999999999998753 467
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.|+|||||+ |+|.+++...+ .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 68999998765 7999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCC---CcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchh
Q 048430 831 DGVD---PVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVT 904 (973)
Q Consensus 831 ~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 904 (973)
.... .......+||+.|||||.+.+. .++.++||||+||++|||++|+.||.+....+ .+........ +....
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHHh
Confidence 4321 1223456899999999987664 57999999999999999999999996532111 1111111111 11000
Q ss_pred hhccc-----ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVDA-----NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d~-----~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.. ....................++++.+|+.+||+.||++|||++|+++|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000000000000000111245678999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=395.37 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=201.7
Q ss_pred HHHhcCCCCCccccccCceEEEEEEe----CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCe
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 750 (973)
....++|...++||+|+||+||+|+. .+++.||||.+..... ...+.+|+++++.+ +||||+++++++.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34567899999999999999999974 3578999998865433 35688999999998 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeecccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKL 829 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~ 829 (973)
.|+||||+++|+|.+++. .+++.+++.++.|++.||+||| +++||||||||+|||++.+ +.+||+|||+|+.
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999999984 4899999999999999999999 8999999999999999877 7999999999986
Q ss_pred cCCCCC---------------------------cccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 048430 830 LDGVDP---------------------------VTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPT 881 (973)
Q Consensus 830 ~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~ 881 (973)
...... ......+||+.|||||.+.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 533211 112234799999999987765 5899999999999999999999998
Q ss_pred CccccCcccHHHHHHhhCCc----------------------chhhhcccccCCCCc---------hhhhhhHHhHHHHH
Q 048430 882 NEMFTGEMSLKQWVAESLPG----------------------AVTEVVDANLLSRED---------EEDADDFATKKTCI 930 (973)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~d~~l~~~~~---------~~~~~~~~~~~~~~ 930 (973)
.........+.......... ......+. +..... .............+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER-LRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHH-HC----------------------CTTCC
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHh-hccccccccccccccccccccccccccCC
Confidence 54322211122211110000 00000000 000000 00000001112345
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 931 SYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 931 ~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+++.+|+.+|++.||++|||++|+++|
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 678999999999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=403.12 Aligned_cols=392 Identities=20% Similarity=0.198 Sum_probs=293.1
Q ss_pred cEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcc
Q 048430 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL 175 (973)
Q Consensus 96 ~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~ 175 (973)
+.++.+++.+. .+|. + .++|++|||++|.+++..|..|+++++|++|+|++|.+.+.++...|..+++|++|+|+
T Consensus 13 ~~~~c~~~~l~-~lp~-l---~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp TEEECCSSCCS-SCCC-C---CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred cccCcCCCCcc-cCCC-C---CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 45677777776 6775 2 36788888888888877788888888888888888888777877777888888888888
Q ss_pred cccccccCCCCCCCccccCCCCccEEEecCCcccCccccc--cccCCcceeEEeecccccccCCCCCCccccceeeeccc
Q 048430 176 GNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSM--IFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253 (973)
Q Consensus 176 ~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N 253 (973)
+|++++. .|..|+++++|++|+|++|++++.++.. +.. +++|++|+|++|
T Consensus 88 ~n~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~-----------------------l~~L~~L~L~~n 139 (455)
T 3v47_A 88 YNQFLQL-----ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP-----------------------LTSLEMLVLRDN 139 (455)
T ss_dssp TCTTCEE-----CTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTT-----------------------CTTCCEEECCSS
T ss_pred CCccCcc-----ChhhccCcccCCEEeCCCCCCCccccCcccccC-----------------------cccCCEEECCCC
Confidence 8888743 3567888888888888888887644433 443 677777777778
Q ss_pred cccccCcch-hcccCcccEEEeccccccccCCCccccc--ccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEcc
Q 048430 254 NLSGIIPDS-ICNASEATILELSSNLFSGLVPNTFGNC--RQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330 (973)
Q Consensus 254 ~l~~~~~~~-l~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~ 330 (973)
++++..|.. +..+++|++|++++|.+++..+..+..+ .+|+.|++++|.+...+...
T Consensus 140 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~-------------------- 199 (455)
T 3v47_A 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW-------------------- 199 (455)
T ss_dssp BCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTC--------------------
T ss_pred ccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhh--------------------
Confidence 777776665 7778888888888888887777777665 56777777777766533211
Q ss_pred CCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCC---CCCCEEEccCCcC
Q 048430 331 TNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKL---QKLQGLDLNSNKL 407 (973)
Q Consensus 331 ~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l---~~L~~L~Ls~N~l 407 (973)
+. ......+..+++|++|++++|++++..|..+... ++|+.|++++|.+
T Consensus 200 -----------~~-----------------~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~ 251 (455)
T 3v47_A 200 -----------LG-----------------WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251 (455)
T ss_dssp -----------TT-----------------HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTT
T ss_pred -----------cc-----------------ccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccc
Confidence 00 0011123345667777777777766666555433 6777777777766
Q ss_pred CCCCchhhhccCcCCeeecCCccccCcCcccccC--cCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCc
Q 048430 408 KGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLAN--LTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPL 485 (973)
Q Consensus 408 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 485 (973)
.+... ..+.+....+..+.. .++|+.|++++|++++..|..|..+++|+.|++++|++++..|.
T Consensus 252 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 317 (455)
T 3v47_A 252 MGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN 317 (455)
T ss_dssp TSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred ccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChh
Confidence 53211 112222222223332 36788888888888888888888888888888888888877788
Q ss_pred CccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccc
Q 048430 486 NIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565 (973)
Q Consensus 486 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 565 (973)
.|+++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|
T Consensus 318 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 397 (455)
T 3v47_A 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSL 397 (455)
T ss_dssp TTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred HhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcc
Confidence 88889999999999999987778888999999999999999998888899999999999999999998777778899999
Q ss_pred cccccCCCcccccCCCC
Q 048430 566 VDFNVSFNGLEGEIPSG 582 (973)
Q Consensus 566 ~~l~ls~N~l~~~~p~~ 582 (973)
+.|++++|+++|.+|..
T Consensus 398 ~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 398 QKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CEEECCSSCBCCCTTTT
T ss_pred cEEEccCCCcccCCCcc
Confidence 99999999999988854
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=397.97 Aligned_cols=392 Identities=19% Similarity=0.222 Sum_probs=261.4
Q ss_pred CCcceEEE--EEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCC
Q 048430 30 ASVCNWVG--VTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSG 107 (973)
Q Consensus 30 ~~~c~w~g--v~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 107 (973)
.+.|.|.| |.|+. .+++ .+|. + .++|++|+|++|.+.+..|..|+++++|++|+|++|.+.+
T Consensus 5 ~~~c~~~~~~~~c~~------------~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~ 68 (455)
T 3v47_A 5 TSECSVIGYNAICIN------------RGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL 68 (455)
T ss_dssp --CCEEETTEEECCS------------SCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTC
T ss_pred cceeEEEccccCcCC------------CCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccc
Confidence 45577776 77754 2333 5555 2 2789999999999988889999999999999999999988
Q ss_pred CCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCC-ccccCCCCCccEEEcccccccccCCCC
Q 048430 108 SLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFP-TDLCTRLPSLVQLRLLGNNITGRIPNR 186 (973)
Q Consensus 108 ~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip-~~~~~~l~~L~~L~L~~N~l~~~~~~~ 186 (973)
.+|...|..+++|++|+|++|++++..|..|+++++|++|+|++|++++.+| ...+..+++|++|+|++|++++.
T Consensus 69 ~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---- 144 (455)
T 3v47_A 69 VIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI---- 144 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC----
T ss_pred eECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc----
Confidence 8888888999999999999999998889999999999999999999986554 34567888999999999998743
Q ss_pred CCCcc-ccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcch---
Q 048430 187 EIPNE-IGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS--- 262 (973)
Q Consensus 187 ~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--- 262 (973)
.|.. ++++++|++|+|++|++++..+..+..+. ..+|+.|++++|.+.+..+..
T Consensus 145 -~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~---------------------~~~L~~L~l~~n~l~~~~~~~~~~ 202 (455)
T 3v47_A 145 -QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ---------------------GKHFTLLRLSSITLQDMNEYWLGW 202 (455)
T ss_dssp -CCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGT---------------------TCEEEEEECTTCBCTTCSTTCTTH
T ss_pred -CcccccCCCCcccEEeCCCCcccccChhhhhccc---------------------cccccccccccCcccccchhhccc
Confidence 2444 78888899999999988887777665531 134555555555555433222
Q ss_pred -----hcccCcccEEEeccccccccCCCccccc---ccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCC
Q 048430 263 -----ICNASEATILELSSNLFSGLVPNTFGNC---RQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334 (973)
Q Consensus 263 -----l~~l~~L~~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 334 (973)
+..+++|++|++++|++++..|..+... ++|+.|++++|.+..
T Consensus 203 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~----------------------------- 253 (455)
T 3v47_A 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG----------------------------- 253 (455)
T ss_dssp HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS-----------------------------
T ss_pred cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc-----------------------------
Confidence 1233445555555555544444333322 444444444444322
Q ss_pred CCCCCCcccccccccceeecccCCccccCCCCCCC--CCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCc
Q 048430 335 KGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGN--LSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIP 412 (973)
Q Consensus 335 ~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~--l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 412 (973)
.... .+.+.+..+..+.. .++|+.|++++|.+++..|..|
T Consensus 254 --~~~~---------------~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~--------------------- 295 (455)
T 3v47_A 254 --SSFG---------------HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF--------------------- 295 (455)
T ss_dssp --CCTT---------------CCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTT---------------------
T ss_pred --cccc---------------hhhhccCcccccccccccCceEEEecCccccccchhhc---------------------
Confidence 1000 00111111111111 2344455555555444444444
Q ss_pred hhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCC
Q 048430 413 TDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEA 492 (973)
Q Consensus 413 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 492 (973)
..+++|+.|++++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|++++|++++..|..+..+++
T Consensus 296 ---~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 372 (455)
T 3v47_A 296 ---SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372 (455)
T ss_dssp ---TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred ---ccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccccc
Confidence 44444555555555554444555555666666666666666555666666666667777777776666777888888
Q ss_pred CCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCC
Q 048430 493 LGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ 533 (973)
Q Consensus 493 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 533 (973)
|+.|+|++|++++..+..|..+++|+.|+|++|++++..|.
T Consensus 373 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 373 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 88888888888876666778889999999999999877763
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=400.43 Aligned_cols=388 Identities=24% Similarity=0.281 Sum_probs=165.7
Q ss_pred CCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCC-------------ccEEEeeCcccCCCC
Q 048430 68 LSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQ-------------LESFDVSSNKITGEF 134 (973)
Q Consensus 68 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~-------------L~~L~Ls~N~l~~~~ 134 (973)
.++|++|++++|++ |.+|++++++++|++|++++|.+.|.+|..+ +.+++ |++|++++|.+++ +
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~-~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l 86 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGN-GEQREMAVSRLRDCLDRQAHELELNNLGLSS-L 86 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTS-CCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCccc-ccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence 34455555555555 4555555555555555555555544444433 33443 4666666666663 3
Q ss_pred CccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCcccc
Q 048430 135 PSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPS 214 (973)
Q Consensus 135 p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 214 (973)
|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +|
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~------l~~~---~~~L~~L~L~~n~l~~-lp- 147 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA------LSDL---PPLLEYLGVSNNQLEK-LP- 147 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC------CCSC---CTTCCEEECCSSCCSS-CC-
T ss_pred CCC---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc------ccCC---CCCCCEEECcCCCCCC-Cc-
Confidence 331 2456666666666663 5532 3566666666666652 1211 1466666666666664 44
Q ss_pred ccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccce
Q 048430 215 MIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294 (973)
Q Consensus 215 ~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 294 (973)
.+.++++|+.|++++|++++ +|.. .++|++|++++|++++ +| .++.+++|++|++++|.+++++ .. .++|+
T Consensus 148 ~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~-~~---~~~L~ 218 (454)
T 1jl5_A 148 ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLP-DL---PLSLE 218 (454)
T ss_dssp CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCC-CC---CTTCC
T ss_pred ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCC-CC---cCccc
Confidence 35555555555555555543 2211 2344444444444443 22 2444444444444444444321 11 12344
Q ss_pred EEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCccc
Q 048430 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLL 374 (973)
Q Consensus 295 ~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~ 374 (973)
+|++++|+++. +| .++.+++|+
T Consensus 219 ~L~l~~n~l~~---------------------------------------------------------lp-~~~~l~~L~ 240 (454)
T 1jl5_A 219 SIVAGNNILEE---------------------------------------------------------LP-ELQNLPFLT 240 (454)
T ss_dssp EEECCSSCCSS---------------------------------------------------------CC-CCTTCTTCC
T ss_pred EEECcCCcCCc---------------------------------------------------------cc-ccCCCCCCC
Confidence 44444444432 22 144455555
Q ss_pred EEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCC
Q 048430 375 VLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNS 454 (973)
Q Consensus 375 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 454 (973)
+|++++|++++ +|.. +++|++|++++|++++ +|.. .++|+.|++++|++++. +.. .++|+.|++++|+
T Consensus 241 ~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~ 308 (454)
T 1jl5_A 241 TIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNE 308 (454)
T ss_dssp EEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSC
T ss_pred EEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCc
Confidence 55555555553 2321 2455555555555553 3322 24555555555555531 110 1456666666666
Q ss_pred CCCCCccccccc-ccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcccc--CC
Q 048430 455 LNSTIPSTFWSL-KYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG--PI 531 (973)
Q Consensus 455 l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~ 531 (973)
+++ ++ .+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|++++|++++ .+
T Consensus 309 l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~i 375 (454)
T 1jl5_A 309 IRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDI 375 (454)
T ss_dssp CSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCC
T ss_pred CCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCC
Confidence 553 11 12 356666666666663 4432 356666666666666 3444 35666666666666665 45
Q ss_pred CCCcccccccccccccccccCCCCCccccccccccccccCCCcccc--cCC
Q 048430 532 PQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG--EIP 580 (973)
Q Consensus 532 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~--~~p 580 (973)
|.+++.+ +.|++.|.+|.. +++|+.|++++|+++| .+|
T Consensus 376 p~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 376 PESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp CTTCCEE--------ECCC--------------------------------
T ss_pred hHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 5554433 234455555542 3455666666666665 444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=392.96 Aligned_cols=407 Identities=24% Similarity=0.308 Sum_probs=251.0
Q ss_pred CcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCC-------------cEEEccCCCCCCCCCc
Q 048430 45 GRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRL-------------KIIDFSSNSLSGSLPG 111 (973)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L-------------~~L~Ls~n~l~~~~p~ 111 (973)
.+++.|+++++++ |.+|+++++|++|++|++++|++.|.+|.+++++++| ++|++++|.++ .+|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCC
Confidence 5688999999999 8999999999999999999999999999999999875 99999999998 5775
Q ss_pred cccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCcc
Q 048430 112 DMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNE 191 (973)
Q Consensus 112 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~ 191 (973)
-.++|++|++++|.+++ +|.. +++|++|++++|+++ .+|.. .++|++|++++|+++ .+| .
T Consensus 89 ----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~------~lp-~ 148 (454)
T 1jl5_A 89 ----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLE------KLP-E 148 (454)
T ss_dssp ----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCS------SCC-C
T ss_pred ----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCC------CCc-c
Confidence 24799999999999996 7754 488999999999998 55532 279999999999997 456 5
Q ss_pred ccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccE
Q 048430 192 IGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATI 271 (973)
Q Consensus 192 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 271 (973)
|+++++|++|++++|++++ +|..+ .+|+.|++++|++++ +|....+++|++|++++|++++ +|... ++|++
T Consensus 149 ~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~ 219 (454)
T 1jl5_A 149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLKK-LPDLP---LSLES 219 (454)
T ss_dssp CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSS-CCCCC---TTCCE
T ss_pred cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECCCCcCCc-CCCCc---CcccE
Confidence 9999999999999999996 56543 589999999999998 5666679999999999999996 44432 58999
Q ss_pred EEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccce
Q 048430 272 LELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLEN 351 (973)
Q Consensus 272 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~ 351 (973)
|++++|.++.+ | .|+.+++|++|++++|++++++. ..++|+.|++++|++.+ +|.
T Consensus 220 L~l~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~l~~-----------~~~~L~~L~l~~N~l~~-l~~----------- 274 (454)
T 1jl5_A 220 IVAGNNILEEL-P-ELQNLPFLTTIYADNNLLKTLPD-----------LPPSLEALNVRDNYLTD-LPE----------- 274 (454)
T ss_dssp EECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSCCS-----------CCTTCCEEECCSSCCSC-CCC-----------
T ss_pred EECcCCcCCcc-c-ccCCCCCCCEEECCCCcCCcccc-----------cccccCEEECCCCcccc-cCc-----------
Confidence 99999999954 5 48999999999999999986432 12456666666666553 121
Q ss_pred eecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccc
Q 048430 352 FYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNAL 431 (973)
Q Consensus 352 l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 431 (973)
. +++|++|++++|.+++. |.. .++|++|++++|++++. + .+
T Consensus 275 --------------~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~----~~------------- 315 (454)
T 1jl5_A 275 --------------L---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-C----DL------------- 315 (454)
T ss_dssp --------------C---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-C----CC-------------
T ss_pred --------------c---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-c----CC-------------
Confidence 0 14556666666666531 211 13455555555555421 1 11
Q ss_pred cCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcc--cCCc
Q 048430 432 QGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG--YIPS 509 (973)
Q Consensus 432 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~ 509 (973)
.++|++|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|++++|++++ .+|.
T Consensus 316 ----------~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~ 377 (454)
T 1jl5_A 316 ----------PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE 377 (454)
T ss_dssp ----------CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred ----------cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChH
Confidence 1356666666666664 3433 466777777777777 4555 36788888888888886 5666
Q ss_pred ccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCC--CCCccccccccccccccCCCcccccCCC
Q 048430 510 SIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG--EIPKSLEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 510 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
.++. |+.|.+.+.+|.. +++|+.|++++|++++ .+|.+ ++.|.+++|.+.+.+|.
T Consensus 378 ~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 378 SVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp TCCE--------EECCC---------------------------------------------------------
T ss_pred HHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence 5543 3457777777763 5788899999999987 66654 45566788888887775
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=407.19 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=211.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.+|+.++||||++++++|.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36799999999999999999985 57999999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC--CcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD--MVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~~ 835 (973)
|++|+|.+++......+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 9999999999876667999999999999999999999 8999999999999999854 89999999999987532
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......+||+.|||||.+.+..++.++||||+||++|||++|+.||.+.... .....+.. .. .. .
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~---~~--------~~--~ 375 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKS---CD--------WN--M 375 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHT---TC--------CC--C
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHh---CC--------CC--C
Confidence 2334457999999999999999999999999999999999999999653211 11111111 00 00 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. .....+++++.+|+.+||+.||++||+++|+++|
T Consensus 376 ~~------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DD------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CS------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cc------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0112345678899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=401.33 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=201.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHH---HHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTE---CEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...++||+|+||.||+|+. .+|+.||||+++... ......+.+| +.+++.++|||||+++++|.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36788999999999999999995 479999999997542 1222333444 5566677899999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
|+|||||+||+|.+++...+ .+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+...
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999998765 7999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.. .....+||+.|||||.+.. ..|+.++||||+||++|||++|+.||......+ ......... ...
T Consensus 344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~--------~~~ 410 (689)
T 3v5w_A 344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTL--------TMA 410 (689)
T ss_dssp SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHH--------HCC
T ss_pred CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhc--------CCC
Confidence 32 2234689999999998865 579999999999999999999999997533222 111111100 000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
. ..+..+++++.+++.+||+.||++|++ ++||++|
T Consensus 411 ~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 V------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred C------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0 011234567899999999999999998 6888765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=378.30 Aligned_cols=287 Identities=34% Similarity=0.546 Sum_probs=234.5
Q ss_pred ccccCCCCHHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEE
Q 048430 664 LATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIV 742 (973)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~ 742 (973)
......+++.+++.+.++|...+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345667899999999999999999999999999999988899999999875432 2234689999999999999999999
Q ss_pred eeeecCCeeEEEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 743 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
+++..++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999998654 349999999999999999999994222399999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc---ccCcccHHHHHH
Q 048430 820 HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM---FTGEMSLKQWVA 896 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~---~~~~~~~~~~~~ 896 (973)
||+|||+++..............||+.|+|||.+....++.++|||||||++|||++|+.||+.. .........|+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999999877544444445566999999999988888999999999999999999999999642 223344555655
Q ss_pred hhCCcc-hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 897 ESLPGA-VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 897 ~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...... .....+..... ..+..++..+.+++.+||+.||++|||++|++++|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQG----------NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTT----------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhcc----------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 433322 23333322221 1223567789999999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=375.27 Aligned_cols=280 Identities=34% Similarity=0.584 Sum_probs=230.7
Q ss_pred CHHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 671 SYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 671 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
++.++..++++|...+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34455567889999999999999999999988899999999877666667889999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999997653 35899999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc-ccHHHHHHhh-CCcchh
Q 048430 828 KLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE-MSLKQWVAES-LPGAVT 904 (973)
Q Consensus 828 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~~~~ 904 (973)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .....|.... ..+...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 86543222 22234468999999999888889999999999999999999999997654332 3344443322 222233
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
..+++.+.. ..+..++..+.+++.+||+.||++||+++|++++|+.+.+
T Consensus 267 ~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 267 QIVDPNLAD----------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSSCTT----------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcChhhcc----------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 333332221 1224567889999999999999999999999999998875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=373.94 Aligned_cols=285 Identities=27% Similarity=0.500 Sum_probs=261.3
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCcce--EEEEEeeCCC--CcEEEEecCCCCCCC--cCCCCCCCCCCCcEE
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCN--WVGVTCSIRH--GRVAALSLPNLSLGG--TLPPHVGNLSFLVSL 74 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L 74 (973)
||++||+++. ||. .+++ |+. +.+||. |.||+|+..+ ++|+.|++++++++| .+|+.++.+++|++|
T Consensus 10 aL~~~k~~~~-~~~-~l~~-W~~-----~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 10 ALLQIKKDLG-NPT-TLSS-WLP-----TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp HHHHHHHHTT-CCG-GGTT-CCT-----TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred HHHHHHHhcC-Ccc-cccC-CCC-----CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 7999999995 775 5664 754 578998 9999998765 899999999999999 999999999999999
Q ss_pred EecC-CCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCcc
Q 048430 75 NISG-NSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNS 153 (973)
Q Consensus 75 ~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 153 (973)
+|++ |++.+.+|..|+++++|++|+|++|++++.+|..+ ..+++|++|+|++|.+++.+|..|.++++|++|+|++|+
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL-SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGG-GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHH-hCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 9995 99999999999999999999999999998888765 789999999999999999999999999999999999999
Q ss_pred ccccCCccccCCCC-CccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccc
Q 048430 154 LSGSFPTDLCTRLP-SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHL 232 (973)
Q Consensus 154 l~~~ip~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l 232 (973)
++|.+|..++ .++ +|++|+|++|++++. +|..++.++ |++|+|++|++++.+|..+..+++|+.|++++|.+
T Consensus 161 l~~~~p~~l~-~l~~~L~~L~L~~N~l~~~-----~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 233 (313)
T 1ogq_A 161 ISGAIPDSYG-SFSKLFTSMTISRNRLTGK-----IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp CEEECCGGGG-CCCTTCCEEECCSSEEEEE-----CCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred ccCcCCHHHh-hhhhcCcEEECcCCeeecc-----CChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCce
Confidence 9999998775 565 999999999999864 567888887 99999999999999999999999999999999999
Q ss_pred cccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCc
Q 048430 233 SGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302 (973)
Q Consensus 233 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 302 (973)
++.++....+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 234 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 234 AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred eeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 988888777899999999999999999999999999999999999999888876 888999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=369.77 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=218.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
++|...++||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5677889999999999999996 468999999987666667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc-
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT- 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 837 (973)
++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999986668999999999999999999999 7999999999999999999999999999998764322211
Q ss_pred ------------cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 838 ------------QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 838 ------------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
.....||+.|+|||.+.+..++.++|||||||++|||++|..||........... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~~~~~ 238 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------LNVRG 238 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------BCHHH
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------hhhhc
Confidence 1145699999999999999999999999999999999999999865332211100 00000
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
..+ ...+..+++.+.+++.+||+.||++||+++|+++.|+++++.+...
T Consensus 239 ~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 239 FLD--------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp HHH--------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred ccc--------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 000 0111234566889999999999999999999999999999887643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=361.20 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=209.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999984 67999999999876655667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++|+|.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence 9999999999876 5899999999999999999999 7899999999999999999999999999998765332 23
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........+ .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~---------~------- 235 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP---------E------- 235 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC---------C-------
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC---------C-------
Confidence 344579999999999988899999999999999999999999986532111 01111000000 0
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+..++..+.+++.+||+.||++|||++|+++|
T Consensus 236 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 -----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -----CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00112345668899999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=370.15 Aligned_cols=276 Identities=21% Similarity=0.320 Sum_probs=210.8
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----eeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG----FKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 754 (973)
.++|...++||+|+||.||+|+.. ++.||||++..... ....+.+|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357888899999999999999876 89999999965433 3345667999999999999999999997643 46999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC----------CeEEccCCCCcEEeCCCCcEEEeec
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST----------PIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
|||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999875 4999999999999999999999 77 9999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc-cHHHHHHh
Q 048430 825 GIAKLLDGVDPV-TQTMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM-SLKQWVAE 897 (973)
Q Consensus 825 gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~ 897 (973)
|+++........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 2233579999999998776 3566789999999999999999999976433221 11111000
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.....+..+..... ..............+++++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 256 --~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 --HPSLEDMQEVVVHK-KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp --SCCHHHHHHHHTTS-CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCchhhhhhhhhcc-cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00011111100000 00011111122234677899999999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=373.91 Aligned_cols=262 Identities=27% Similarity=0.482 Sum_probs=214.8
Q ss_pred hcCCCCCccccccCceEEEEEEe--------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL--------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
.++|...+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+.+++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35788889999999999999985 245789999997553 34467899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+..++||||+++|+|.+++.... ..+++.++..++.||+.||+||| +.+|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999998753 24899999999999999999999 7899999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 99999999999999876543322 2233457889999999988899999999999999999999 99998653221 11
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
...+..... ...+..++.++.+++.+||+.+|++||++.|++++|+++.....+
T Consensus 315 ~~~~~~~~~----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 315 FKLLKEGHR----------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHHHTTCC----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHhcCCC----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 111111000 001123566789999999999999999999999999999876654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=371.96 Aligned_cols=362 Identities=20% Similarity=0.185 Sum_probs=212.6
Q ss_pred CCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCcc
Q 048430 58 GGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSA 137 (973)
Q Consensus 58 ~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 137 (973)
.+..+..++.+++|++|+|++|++.+ +| .++.+++|++|+|++|++++ +| ++.+++|++|+|++|++++. |
T Consensus 31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~---~~~l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 31 QATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD---LSQNTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp CTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSCC-C--
T ss_pred CcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec---cccCCCCCEEECcCCCCcee-e--
Confidence 33334445566666666666666644 24 45666666666666666653 33 35556666666666666542 2
Q ss_pred ccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccc
Q 048430 138 IVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIF 217 (973)
Q Consensus 138 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 217 (973)
++++++|++|+|++|+++ .+| +..+++|++|++++|++++ ++ ++++++|++|++++|+..+.+ .+.
T Consensus 102 ~~~l~~L~~L~L~~N~l~-~l~---~~~l~~L~~L~l~~N~l~~------l~--l~~l~~L~~L~l~~n~~~~~~--~~~ 167 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLT-KLD---VSQNPLLTYLNCARNTLTE------ID--VSHNTQLTELDCHLNKKITKL--DVT 167 (457)
T ss_dssp CTTCTTCCEEECCSSCCS-CCC---CTTCTTCCEEECTTSCCSC------CC--CTTCTTCCEEECTTCSCCCCC--CCT
T ss_pred cCCCCcCCEEECCCCcCC-eec---CCCCCcCCEEECCCCccce------ec--cccCCcCCEEECCCCCccccc--ccc
Confidence 555555666666555555 233 3445555555555555542 11 444455555555555332222 111
Q ss_pred cCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEE
Q 048430 218 NNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILS 297 (973)
Q Consensus 218 ~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 297 (973)
.+++|++|++++|+++++ | +..+++|+.|++++|+++++ .++.+++|++|+
T Consensus 168 -----------------------~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~ 218 (457)
T 3bz5_A 168 -----------------------PQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLD 218 (457)
T ss_dssp -----------------------TCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEE
T ss_pred -----------------------cCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEE
Confidence 244455555555555442 2 44444455555555544443 134444444444
Q ss_pred ccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEE
Q 048430 298 LGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLS 377 (973)
Q Consensus 298 L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~ 377 (973)
+++|+++++ | +..+++|+.|+
T Consensus 219 Ls~N~l~~i---------------------------------------------------------p--~~~l~~L~~L~ 239 (457)
T 3bz5_A 219 CSSNKLTEI---------------------------------------------------------D--VTPLTQLTYFD 239 (457)
T ss_dssp CCSSCCSCC---------------------------------------------------------C--CTTCTTCSEEE
T ss_pred CcCCccccc---------------------------------------------------------C--ccccCCCCEEE
Confidence 444444321 1 33455566666
Q ss_pred eecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCC
Q 048430 378 LVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS 457 (973)
Q Consensus 378 Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 457 (973)
+++|++++.. ++.+++|+.|++++| +|+.|++++|.+.+.+| ++.+++|+.|++++|...+
T Consensus 240 l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 240 CSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp CCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCC
T ss_pred eeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccc
Confidence 6666666432 344556666666654 34456666676665555 4567778888888887766
Q ss_pred CCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccc
Q 048430 458 TIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGS 537 (973)
Q Consensus 458 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 537 (973)
.+|. ...+|+.|++++ +++|+.|+|++|+|++ ++ ++.+++|+.|++++|+|++
T Consensus 301 ~l~~---~~~~L~~L~l~~-------------~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~-------- 353 (457)
T 3bz5_A 301 LLDC---QAAGITELDLSQ-------------NPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-------- 353 (457)
T ss_dssp EEEC---TTCCCSCCCCTT-------------CTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------
T ss_pred eecc---CCCcceEechhh-------------cccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------
Confidence 6653 234444444443 3688899999999986 33 8889999999999999985
Q ss_pred ccccccccccccccCCCCCccccccccccccccCCCcccccCCC
Q 048430 538 LISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 538 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
++.|..|++++|+++|. ..+..|..+++++|+++|.+|.
T Consensus 354 l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 354 FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 35678889999999876 3567788899999999999996
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=359.04 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=213.0
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56778899999999999999998899999999975432 23679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999887767999999999999999999999 799999999999999999999999999999876433222333
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...+|+.|+|||......++.++||||+|+++|||++ |+.||...... ........+ ...
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~~~---------~~~----- 226 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTG---------FRL----- 226 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTT---------CCC-----
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHhcC---------ccC-----
Confidence 4457788999999988889999999999999999999 99998653211 111111000 000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
..+..++.++.+++.+||+.+|++||+++|++++|+++.+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 -----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0011234568899999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=353.91 Aligned_cols=281 Identities=28% Similarity=0.454 Sum_probs=227.3
Q ss_pred ccCCCCHHHHHHHhcCCCCC------ccccccCceEEEEEEeCCCeEEEEEEEecc----chhhHHHHHHHHHHHHhccC
Q 048430 666 TLSRISYHELQQATNGFGES------NLLGSGSFDNVYKATLANGVSVAVKVFNLQ----EDRALKSFDTECEVMRRIRH 735 (973)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h 735 (973)
....+++.++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678999999999999887 8999999999999987 5889999998643 23346789999999999999
Q ss_pred CceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 736 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
|||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 99999999999999999999999999999999743 246899999999999999999999 7899999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~ 892 (973)
+.++.+||+|||++......... ......|++.|+|||...+ .++.++|||||||++|||++|+.||....... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence 99999999999999876432222 2234568999999997654 58899999999999999999999997644332 122
Q ss_pred HHHHhh--CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 893 QWVAES--LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 893 ~~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.+.... ....+.+.+++.+.. .+..+++.+.+++.+||+.+|++||+++|++++|+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMND-----------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSC-----------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccccc-----------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 222211 112233333332211 123467789999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=363.68 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=205.6
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 674 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
++....++|...+.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3334456788899999999999999987 48899999986543 34457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999998754 23899999999999999999999 788 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 187 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~------- 256 (309)
T 3p86_A 187 RLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKCK------- 256 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSCC-------
T ss_pred cccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCC-------
Confidence 765322 222334579999999999999999999999999999999999999996532211 1111110000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
. ...+..+++++.+++.+||+.+|++||+++|+++.|+.+.+...
T Consensus 257 -----~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 257 -----R---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp -----C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred -----C---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 0 00112345678999999999999999999999999999887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=359.90 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=215.3
Q ss_pred CCCCHHHHHHHhcC----------CCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCC
Q 048430 668 SRISYHELQQATNG----------FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHR 736 (973)
Q Consensus 668 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 736 (973)
..++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888887764 556679999999999999965 7999999999876655667899999999999999
Q ss_pred ceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC
Q 048430 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816 (973)
Q Consensus 737 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~ 816 (973)
||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998754 5999999999999999999999 7899999999999999999
Q ss_pred CcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHH
Q 048430 817 MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA 896 (973)
Q Consensus 817 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 896 (973)
+.+||+|||++....... .......||+.|+|||...+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 178 ~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 254 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLR 254 (321)
T ss_dssp CCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHH
T ss_pred CcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence 999999999998764322 223445799999999999988999999999999999999999999864321 11111111
Q ss_pred hhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 897 ESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 897 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... +.+ .....+++++.+++.+||+.||++||+++|+++|
T Consensus 255 ~~~~--------~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 255 DSPP--------PKL------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HSSC--------CCC------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCC--------CCc------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 000 0111245668899999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.43 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=210.3
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46777899999999999999963 4567999999765 334457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999877668999999999999999999999 7999999999999999999999999999998764332
Q ss_pred Cc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 835 PV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 835 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
.. ......+|+.|+|||.+....++.++|||||||++|||++ |+.||......+ ....+... .
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~------------~ 271 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEG------------Y 271 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT------------C
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcC------------C
Confidence 22 2223346788999999988889999999999999999999 999986532211 11111110 0
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
. ...+..++.++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 272 ~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 R----------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C----------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0 001123566789999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=358.93 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=213.8
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|...+.||+|+||.||+|+..++..||||+++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457888899999999999999999899999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+...........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999999887667999999999999999999999 78999999999999999999999999999987654443333
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....+|+.|+|||......++.++||||||+++|||++ |+.||+.....+ .......+. ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~---------~~---- 224 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQGH---------RL---- 224 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHTTC---------CC----
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHHHcCC---------CC----
Confidence 44557788999999888889999999999999999999 999986532211 111100000 00
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
..+..+++.+.+++.+||+.+|++|||++|++++|+.+++.
T Consensus 225 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 ------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 00112345688999999999999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=378.68 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=212.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 456778899999999999999975 78999999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999876667999999999999999999999 799999999999999999999999999999865322111
Q ss_pred c-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 837 T-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 837 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
. .....+++.|+|||.+....++.++|||||||++|||++ |+.||...... .....+... .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~------------~--- 332 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKG------------G--- 332 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTT------------C---
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------------C---
Confidence 1 112245788999999888889999999999999999998 99998653221 111111110 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
+...+..+++++.+++.+||+.||++|||++|+++.|+++++.
T Consensus 333 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 -------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0011223567789999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=363.92 Aligned_cols=275 Identities=24% Similarity=0.425 Sum_probs=211.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-----CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 751 (973)
.++|...+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35678889999999999999984 3689999999987666667889999999999999999999999854 4568
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999887667999999999999999999999 7999999999999999999999999999998764
Q ss_pred CCCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc-hh-hhc
Q 048430 832 GVDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA-VT-EVV 907 (973)
Q Consensus 832 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~~ 907 (973)
..... ......++..|+|||.+.+..++.++|||||||++|||++|..|+...... ............ .. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence 32221 223345778899999998889999999999999999999999997642110 111111000000 00 000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
+ .+... .....+..+++++.+++.+||+.||++|||++|+++.|+++++.++
T Consensus 243 ~-~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 243 E-LLKNN------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp H-HHHTT------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred H-HHhcc------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0 00000 0111123466789999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=364.73 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=207.4
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456789999999999999999996 689999999997542 34457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++...+ .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 99999999999998765 6999999999999999999999 789999999999999999999999999999876432
Q ss_pred CcccccccccccccCccCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVS-ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.......||+.|+|||.+.+..++ .++||||+||++|||++|+.||.... ......... ....
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~--------~~~~-- 231 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVL--------RGKY-- 231 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH--------HCCC--
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHH--------hCCC--
Confidence 233456799999999988877764 89999999999999999999996532 111111110 0000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++.++.+++.+||+.||++|||++|+++|
T Consensus 232 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011235668899999999999999999999876
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=366.21 Aligned_cols=346 Identities=28% Similarity=0.409 Sum_probs=178.3
Q ss_pred CCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCe
Q 048430 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKS 146 (973)
Q Consensus 67 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 146 (973)
.+++|+.|++++|.+. .+| .+..+++|++|||++|.+. .+|. +..+++|++|++++|++++..| ++++++|++
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccC-Cchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 3455666666666653 344 2555666666666666665 3333 4556666666666666654332 555666666
Q ss_pred EEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEE
Q 048430 147 IRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL 226 (973)
Q Consensus 147 L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~ 226 (973)
|+|++|.++ .++. +..+++|++|++++|.+++ +| .++.+++|++|+++ |.+.+..+ +.
T Consensus 117 L~L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~------~~-~~~~l~~L~~L~l~-~~~~~~~~--~~--------- 174 (466)
T 1o6v_A 117 LTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISD------IS-ALSGLTSLQQLSFG-NQVTDLKP--LA--------- 174 (466)
T ss_dssp EECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECC------CG-GGTTCTTCSEEEEE-ESCCCCGG--GT---------
T ss_pred EECCCCCCC-CChH--HcCCCCCCEEECCCCccCC------Ch-hhccCCcccEeecC-CcccCchh--hc---------
Confidence 666666555 3332 3455555555555555542 22 24555555555553 23322211 22
Q ss_pred eecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCC
Q 048430 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTG 306 (973)
Q Consensus 227 l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 306 (973)
.+++|++|++++|++++. ..+..+++|++|++++|.+.+..| ++.+++|++|++++|+++..
T Consensus 175 --------------~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 236 (466)
T 1o6v_A 175 --------------NLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 236 (466)
T ss_dssp --------------TCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred --------------cCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc
Confidence 255666666666666543 235666666666666666665544 55566666666666665431
Q ss_pred CCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccc
Q 048430 307 SSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGA 386 (973)
Q Consensus 307 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 386 (973)
..+..+++ |+.|++++|.+++.
T Consensus 237 ---------~~l~~l~~-------------------------------------------------L~~L~l~~n~l~~~ 258 (466)
T 1o6v_A 237 ---------GTLASLTN-------------------------------------------------LTDLDLANNQISNL 258 (466)
T ss_dssp ---------GGGGGCTT-------------------------------------------------CSEEECCSSCCCCC
T ss_pred ---------hhhhcCCC-------------------------------------------------CCEEECCCCccccc
Confidence 12333444 44444444444432
Q ss_pred cCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCccccccc
Q 048430 387 IPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSL 466 (973)
Q Consensus 387 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 466 (973)
.+ +..+++|++|++++|++++..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|++++..| +..+
T Consensus 259 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l 330 (466)
T 1o6v_A 259 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSL 330 (466)
T ss_dssp GG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred hh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccC
Confidence 22 4444444555555554443222 4444444444444444443322 4445555555555555554433 4445
Q ss_pred ccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcccc
Q 048430 467 KYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529 (973)
Q Consensus 467 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (973)
++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|.+++
T Consensus 331 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 331 TKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 5555555555555532 245555666666666666655444 5556666666666666653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.25 Aligned_cols=274 Identities=21% Similarity=0.262 Sum_probs=209.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
..++|...+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457788999999999999999999889999999986543 223567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 99975 899988877767999999999999999999999 7899999999999999999999999999998764322
Q ss_pred cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhhcccc-
Q 048430 836 VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEVVDAN- 910 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~- 910 (973)
.......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+........ +..+....+..
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccch
Confidence 22334568999999998765 568999999999999999999999997643332 2333222211 11111110000
Q ss_pred --cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 --LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 --l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
-.................+++++.+++.+||+.||++|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000001111122355678999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=357.47 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=210.9
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..++|...+.||+|+||.||+|+..++..||||+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3457888899999999999999999899999999975432 236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999999875567999999999999999999999 7899999999999999999999999999998764322222
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....+|+.|+|||......++.++||||+|+++|||++ |+.||...... .....+... ....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~------------~~~~-- 241 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQG------------LRLY-- 241 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTT------------CCCC--
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcc------------cCCC--
Confidence 333457788999999888889999999999999999998 99998653221 111111110 0000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.+..+++.+.+++.+||+.+|++||+++|++++|+++.+.
T Consensus 242 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 --------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0112345688999999999999999999999999988753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=371.21 Aligned_cols=259 Identities=22% Similarity=0.418 Sum_probs=202.0
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999864 57789999987653 34457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++......+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999887768999999999999999999999 7899999999999999999999999999998764322
Q ss_pred Ccc--cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 835 PVT--QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 835 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... .....+++.|+|||.+....++.++|||||||++|||++ |+.||...... .....+. ...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~------------~~~ 267 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVD------------EGY 267 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHH------------TTE
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH------------cCC
Confidence 211 122245778999999988899999999999999999998 99998653211 1111111 100
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
. ...+..++.++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 268 ~----------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 268 R----------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp E----------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred C----------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 0011234567899999999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.14 Aligned_cols=264 Identities=24% Similarity=0.347 Sum_probs=206.3
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHh--ccCCceeEEEeeeec----CCeeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR--IRHRNLIKIVSSCSN----PGFKA 752 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~ 752 (973)
.++|...+.||+|+||.||+|+. +++.||||++.... .+.+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788899999999999999988 58999999986443 3456677777776 789999999998643 35689
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY-----STPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
+||||+++|+|.++++.. .+++..+..++.|++.||+|||... +++|+||||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999999999999654 6999999999999999999999321 578999999999999999999999999999
Q ss_pred cccCCCCCcc---cccccccccccCccCCCCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCccccCc
Q 048430 828 KLLDGVDPVT---QTMTLATIGYMAPEYGSEG------IVSISGDVYSFGILMMETFTR----------RKPTNEMFTGE 888 (973)
Q Consensus 828 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~sDvws~Gvvl~elltg----------~~p~~~~~~~~ 888 (973)
+......... .....||+.|+|||.+... .++.++|||||||++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8664333221 2234799999999987766 455799999999999999999 78876655444
Q ss_pred ccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
................ ...........++.++.+++.+||+.||++|||++|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQR-------------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCC-------------CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCC-------------CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4443332221111000 00001112234678899999999999999999999999999886
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=356.07 Aligned_cols=260 Identities=22% Similarity=0.389 Sum_probs=206.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35788899999999999999985 47899999998643 234457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999998765 6999999999999999999999 7899999999999999999999999999998765433
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||....... ....... .....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~~~~~~~-~~~~~--------- 231 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----IAIKHIQ-DSVPN--------- 231 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH----HHHHHHS-SCCCC---------
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHhh-ccCCC---------
Confidence 333444579999999999988889999999999999999999999996532111 1111110 00000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-NVKDALADLKKIK 962 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~evl~~L~~~~ 962 (973)
.....+..+++.+.+++.+|++.||++|| +++++.+.|+.+.
T Consensus 232 ------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 ------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 00011123467789999999999999999 8888988887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=353.98 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=202.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
..++|...+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3467888899999999999999864 35679999986543 344578999999999999999999999985 45789
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999999887667999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
..........+++.|+|||......++.++|||||||++|||++ |+.||......+ ....+.....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~~----------- 235 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGER----------- 235 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC-----------
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCCC-----------
Confidence 33333344457889999999888889999999999999999997 999987543221 1111111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
...+..+++++.+++.+||+.||++||++.|++++|+++.+.-..
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 280 (281)
T 1mp8_A 236 -----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280 (281)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 001123466789999999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=374.48 Aligned_cols=263 Identities=18% Similarity=0.234 Sum_probs=210.9
Q ss_pred HHHHHHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeec
Q 048430 672 YHELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747 (973)
Q Consensus 672 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 747 (973)
+.++....++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556789999999999999999999965 58999999997532 1223458899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
.+..++|||||++|+|.+++......+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999886568999999999999999999999 799999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..........
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~ 297 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHK 297 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTHH
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----HHHHhhhhcc
Confidence 876544444444567999999999876 567899999999999999999999999653211 1111100000
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE--RINVKDALAD 957 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~evl~~ 957 (973)
... .+... ...+++++.+++.+|++.+|++ ||+++|+++|
T Consensus 298 -~~~---~~p~~-----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 -ERF---QFPTQ-----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HHC---CCCSS-----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -ccc---cCCcc-----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000 00000 0113566889999999988888 9999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=367.32 Aligned_cols=270 Identities=24% Similarity=0.374 Sum_probs=217.4
Q ss_pred CCHHHHHHHhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEE
Q 048430 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKI 741 (973)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l 741 (973)
.+..+++...++|...+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44556666778999999999999999999973 356899999997643 33457799999999999 79999999
Q ss_pred EeeeecCC-eeEEEEEecCCCCHHHHhhhCCC------------------------------------------------
Q 048430 742 VSSCSNPG-FKALIMQYMPQGSLEKWLYSHNY------------------------------------------------ 772 (973)
Q Consensus 742 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 772 (973)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99987754 48999999999999999986532
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 773 -----------------SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 773 -----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
.+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1899999999999999999999 78999999999999999999999999999986543222
Q ss_pred -cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 836 -VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 836 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .....+......
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~------------ 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRM------------ 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCC------------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCC------------
Confidence 23344568899999999888899999999999999999998 999986533222 111111111000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
..+..+++++.+++.+||+.||++||+++|++++|+++.+..
T Consensus 316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 001123566889999999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.91 Aligned_cols=253 Identities=19% Similarity=0.278 Sum_probs=209.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999864 68999999987543 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC--CCcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD--DMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~ 835 (973)
+++|+|.+++......+++.++..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999877667999999999999999999999 789999999999999987 7899999999998765322
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.. .... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~-----------~~~~--~ 222 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMN-----------AEYT--F 222 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH-----------TCCC--C
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHc-----------CCCC--C
Confidence 234457999999999998888999999999999999999999999653211 11111111 0000 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.......++.++.+++.+||+.||++|||+.|+++|=
T Consensus 223 ------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 223 ------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp ------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 0011123466789999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=359.01 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=207.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchh------hHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.+.|...+.||+|+||.||+|+.. +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467888999999999999999964 6899999999755321 346889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC----cEEEeecccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM----VAHLGDFGIA 827 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla 827 (973)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999997654 7999999999999999999999 78999999999999998877 7999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
...... .......||+.|+|||.+....++.++||||+||++|||++|+.||..... ...........
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~~i~~~~----- 234 (361)
T 2yab_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITAVS----- 234 (361)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTC-----
T ss_pred eEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcC-----
Confidence 876532 223345799999999999888999999999999999999999999965321 11111110000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ... ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus 235 ---~--~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 ---Y--DFD------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ---C--CCC------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---C--CCC------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000 01112345678999999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=354.76 Aligned_cols=249 Identities=24% Similarity=0.284 Sum_probs=206.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999964 69999999997542 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999998754 7899999999999999999999 7899999999999999999999999999998643222
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......+||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+...+.. ....
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~-----------~~~~-- 223 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM-----------EEIR-- 223 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-----------CCCC--
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHc-----------CCCC--
Confidence 223445799999999999999999999999999999999999999865221 111111110 0000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
.+..+++++.+++.+||+.||++|| +++|+++|
T Consensus 224 ----------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 ----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0112456688999999999999999 89999887
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=353.51 Aligned_cols=276 Identities=23% Similarity=0.315 Sum_probs=211.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC--eeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG--FKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 755 (973)
++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888899999999999999965 58999999987543 233577889999999999999999999987654 789999
Q ss_pred EecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe----CCCCcEEEeecccccc
Q 048430 756 QYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL----DDDMVAHLGDFGIAKL 829 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~ 829 (973)
||+++++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999998654 23899999999999999999999 7899999999999999 7888899999999987
Q ss_pred cCCCCCcccccccccccccCccCCC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH---HHHHhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGS--------EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK---QWVAES 898 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~---~~~~~~ 898 (973)
..... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||........... ......
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 65332 223456999999999764 57789999999999999999999999965433222222 222222
Q ss_pred CCcchhhhcccccCCCCc--hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 899 LPGAVTEVVDANLLSRED--EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
.+..+..+... ...... ............++..+.+++.+||+.||++||+++|+++|....
T Consensus 244 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKA-ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECS-TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred Ccccchhhhcc-cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111111100 000000 000011122345678899999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.69 Aligned_cols=272 Identities=24% Similarity=0.348 Sum_probs=209.2
Q ss_pred HHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc--cCCceeEEEeeeecC-
Q 048430 672 YHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSCSNP- 748 (973)
Q Consensus 672 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~- 748 (973)
...-....++|...+.||+|+||.||+|+.. ++.||||++..... ..+.+|.+++... +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3334445678999999999999999999986 89999999864432 3455566666554 899999999998776
Q ss_pred ---CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC--------CeEEccCCCCcEEeCCCC
Q 048430 749 ---GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST--------PIIHCDLKPNNVLLDDDM 817 (973)
Q Consensus 749 ---~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~ivH~dlk~~Nill~~~~ 817 (973)
...++||||+++|+|.+++... .+++..+..++.|++.||+||| +. +|+||||||+||+++.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCC
Confidence 7889999999999999999875 5999999999999999999999 66 999999999999999999
Q ss_pred cEEEeecccccccCCCCCcc---cccccccccccCccCCCCCCCCcc------hhHHHHHHHHHHHHhC----------C
Q 048430 818 VAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEGIVSIS------GDVYSFGILMMETFTR----------R 878 (973)
Q Consensus 818 ~~kl~Dfgla~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------sDvws~Gvvl~elltg----------~ 878 (973)
.+||+|||+++......... .....||+.|+|||.+.....+.+ +|||||||++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997664322221 124579999999998877666554 9999999999999999 5
Q ss_pred CCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 879 KPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 879 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.||............+........ .. ...........+++++.+++.+||+.||++||+++|++++|
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~--------~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKK--------LR-----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSC--------CC-----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhc--------cC-----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 565544433333333222111110 00 00111122346788899999999999999999999999999
Q ss_pred HHHHHHH
Q 048430 959 KKIKKIL 965 (973)
Q Consensus 959 ~~~~~~~ 965 (973)
+++.+..
T Consensus 327 ~~l~~~~ 333 (337)
T 3mdy_A 327 AKMSESQ 333 (337)
T ss_dssp HHHHHTT
T ss_pred HHHHhhc
Confidence 9988753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=345.45 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=212.2
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56778899999999999999998899999999975533 23678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++............
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999987667999999999999999999999 789999999999999999999999999999876432222223
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...++..|+|||......++.++||||||+++|||++ |+.||..... .........+ ...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~~~---------~~~----- 224 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTG---------FRL----- 224 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTT---------CCC-----
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHhcC---------CcC-----
Confidence 3457789999999888889999999999999999999 8999865321 1111111000 000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
..+..++..+.+++.+||+.+|++||+++|++++|+++.+
T Consensus 225 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 -----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011234568899999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.69 Aligned_cols=265 Identities=14% Similarity=0.113 Sum_probs=214.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35788899999999999999995 6799999999864432 35688999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc-----EEEeecccccccC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV-----AHLGDFGIAKLLD 831 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~~~~ 831 (973)
|+ +++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999987667999999999999999999999 899999999999999987776 9999999998765
Q ss_pred CCCCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 832 GVDPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 832 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
..... ......||+.|+|||...+..++.++|||||||++|||++|+.||........ ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~--- 237 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGEKK--- 237 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHHHH---
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHHHHHhhc---
Confidence 43221 23445699999999999988999999999999999999999999976432211 11111000000
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
. ..........+++++.+++.+||+.||++||+++++++.|+++.+...
T Consensus 238 -----~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 238 -----Q-------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp -----H-------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -----c-------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0 000000112356779999999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=371.78 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=207.3
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC-eeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG-FKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456778899999999999999986 7899999997543 4578999999999999999999999987654 78999999
Q ss_pred cCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHNY-SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++|+|.+++..... .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999987653 4799999999999999999999 789999999999999999999999999999854321
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....+++.|+|||.+....++.++|||||||++|||++ |+.||......+ ....+... .
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~------------~---- 403 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG------------Y---- 403 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTT------------C----
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC------------C----
Confidence 122357889999999988999999999999999999998 999987543221 11111110 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
+...+..+++++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 404 ------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 404 ------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011123456789999999999999999999999999988764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=356.49 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=205.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999865 789999999875532 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP- 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 835 (973)
|+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999997654 6999999999999999999999 79999999999999999999999999999986532221
Q ss_pred cccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||............+.......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------- 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-------------
Confidence 12234579999999998877665 7899999999999999999999976433322222222110000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....++.++.+++.+||+.||++|||++|++++
T Consensus 229 ---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0012245668899999999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=354.47 Aligned_cols=263 Identities=16% Similarity=0.146 Sum_probs=211.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788899999999999999995 6799999999875433 24688999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc-----EEEeecccccccC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV-----AHLGDFGIAKLLD 831 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~~~~ 831 (973)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 89999999976668999999999999999999999 789999999999999999887 9999999998764
Q ss_pred CCCCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 832 GVDPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 832 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~~~~- 238 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQKIGDTKRA- 238 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHHHHHHHHH-
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHHHHhhhcc-
Confidence 33221 1234579999999999999999999999999999999999999997643221 11111110000000
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
. ........++ ++.+++..||+.+|.+||+++++.+.|+++.+..
T Consensus 239 ~--------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 T--------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp S--------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C--------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 0000001134 7999999999999999999999999999887654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.49 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=205.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCe----EEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGV----SVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++|...++||+|+||.||+|+.. +++ +||+|.++... ....+.+.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56788899999999999999853 444 45788775432 234578999999999999999999999998754 789
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999987778999999999999999999999 789999999999999999999999999999876543
Q ss_pred CCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+.....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~----------- 237 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER----------- 237 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC-----------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCC-----------
Confidence 322 2233457889999999999999999999999999999999 99999754322 22222211100
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
. ..+..++.++.+++.+||+.+|++||++.|++++|+.+.+...+
T Consensus 238 -~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 282 (327)
T 3poz_A 238 -L----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 282 (327)
T ss_dssp -C----------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred -C----------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhh
Confidence 0 01122456688999999999999999999999999998865543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=360.12 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=208.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457888999999999999999864 7899999999766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC--CCcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD--DMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~ 835 (973)
+++|+|.+++......+++.++..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999877667999999999999999999999 789999999999999974 5789999999998765322
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......||+.|+|||.+....++.++|||||||++|||++|+.||..... ......+...... .+..
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~-----~~~~----- 272 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWE-----FDED----- 272 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCC-----CCSS-----
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC-----CCcc-----
Confidence 23345799999999999988999999999999999999999999865321 1111111110000 0000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++.++.+++.+||+.||++|||+.|+++|
T Consensus 273 ---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 ---------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 001245678899999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=363.85 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=213.1
Q ss_pred hcCCCCCccccccCceEEEEEEe--------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL--------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
.++|...+.||+|+||.||+|+. ..+..||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 45788889999999999999984 234689999997653 34457899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999998754 35899999999999999999999 7899999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987654332 22333457889999999988999999999999999999999 99998643211 11
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
...+.... .. ..+..++.++.+++.+||+.||++||+++|++++|+++....
T Consensus 303 ~~~~~~~~------------~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 303 FKLLKEGH------------RM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHTTC------------CC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHcCC------------CC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11111100 00 001124567899999999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=379.35 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=210.8
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 446677889999999999999999889999999997543 34578999999999999999999999987 5678999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 99999999998542 35889999999999999999999 789999999999999999999999999999876432222
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......+|..|+|||.+....++.++|||||||++|||++ |+.||...... .....+... ..
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~------------~~--- 403 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERG------------YR--- 403 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHT------------CC---
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------------CC---
Confidence 2233456789999999988899999999999999999999 99998653211 111111110 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
...+..+++++.+++.+||+.||++|||++++++.|+.+..
T Consensus 404 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 -------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 01122456779999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=358.25 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=204.0
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788899999999999999995 678999999987542 22246789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+ +|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 9999 679999887765 6999999999999999999999 789999999999999999999999999999876432
Q ss_pred CcccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+....... ...+....
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------------~~~i~~~~-- 224 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------------FKKVNSCV-- 224 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------------BCCCCSSC--
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------------HHHHHcCC--
Confidence 22344579999999999887765 7899999999999999999999965321110 00000000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
...+..+++++.+++.+||+.||++|||++|+++|=
T Consensus 225 ---------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 225 ---------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp ---------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred ---------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 001122456788999999999999999999999873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.29 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=205.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchh------hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
+.|...+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888899999999999999964 6899999998754321 3578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC----cEEEeeccccc
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM----VAHLGDFGIAK 828 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~ 828 (973)
+||||+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999997654 7999999999999999999999 79999999999999999887 89999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
...... ......||+.|+|||.+....++.++|||||||++|||++|+.||......+ ....+......
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~------- 235 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSAVNYE------- 235 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHTCCC-------
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHHhcCCC-------
Confidence 764322 2234569999999999988899999999999999999999999986532111 11111100000
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ......++..+.+++.+||+.||++|||+.|+++|
T Consensus 236 ------~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 ------FE------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ------CC------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------cC------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 01112345678899999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=361.49 Aligned_cols=346 Identities=29% Similarity=0.459 Sum_probs=202.9
Q ss_pred cccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCcc
Q 048430 91 HMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLV 170 (973)
Q Consensus 91 ~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~ 170 (973)
.+++|+.|++++|.+. .+|. +..+++|++|||++|.+++. |. +.++++|++|++++|+++ .++. +..+++|+
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~~--~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~ 115 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP--LANLTNLT 115 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCC
T ss_pred HhccccEEecCCCCCc-cCcc--hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccc-cChh--hcCCCCCC
Confidence 3555666666666655 4443 34455566666666655533 22 555555555555555555 2222 33444444
Q ss_pred EEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeee
Q 048430 171 QLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFL 250 (973)
Q Consensus 171 ~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L 250 (973)
+|+|++|++++ +|. ++++++|++|++++|+++
T Consensus 116 ~L~L~~n~l~~------~~~-~~~l~~L~~L~l~~n~l~----------------------------------------- 147 (466)
T 1o6v_A 116 GLTLFNNQITD------IDP-LKNLTNLNRLELSSNTIS----------------------------------------- 147 (466)
T ss_dssp EEECCSSCCCC------CGG-GTTCTTCSEEEEEEEEEC-----------------------------------------
T ss_pred EEECCCCCCCC------ChH-HcCCCCCCEEECCCCccC-----------------------------------------
Confidence 44444444431 111 344444444444444443
Q ss_pred ccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEcc
Q 048430 251 WKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330 (973)
Q Consensus 251 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~ 330 (973)
+. + .+..+++|+.|+++ |.+.+..+ +.++++|++|++++|+++.. ..+..+++|+.|+++
T Consensus 148 ------~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~---------~~l~~l~~L~~L~l~ 207 (466)
T 1o6v_A 148 ------DI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI---------SVLAKLTNLESLIAT 207 (466)
T ss_dssp ------CC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC---------GGGGGCTTCSEEECC
T ss_pred ------CC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCC---------hhhccCCCCCEEEec
Confidence 21 1 23344444444443 22322221 44555555555555555431 124445555555555
Q ss_pred CCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCC
Q 048430 331 TNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGF 410 (973)
Q Consensus 331 ~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 410 (973)
+|.+.+..| ++.+++|++|++++|++++. ..+..+++|++|++++|++.+.
T Consensus 208 ~n~l~~~~~---------------------------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 258 (466)
T 1o6v_A 208 NNQISDITP---------------------------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL 258 (466)
T ss_dssp SSCCCCCGG---------------------------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCccccccc---------------------------ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccc
Confidence 555543221 33456777777777777643 3567788888888888888865
Q ss_pred CchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCC
Q 048430 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNL 490 (973)
Q Consensus 411 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 490 (973)
.+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|++++..| +..+
T Consensus 259 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l 330 (466)
T 1o6v_A 259 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSL 330 (466)
T ss_dssp GG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred hh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccC
Confidence 44 7777888888888888776544 6777778888888887776444 6677777777777777776554 5667
Q ss_pred CCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCC
Q 048430 491 EALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 331 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 331 TKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 7777777777777643 356677777777777777776665 6677777777777777765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=365.22 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=209.8
Q ss_pred cCCCCCccccccCceEEEEEEeC------CCeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
++|...+.||+|+||.||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788899999999999999843 4678999998654 2344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC---cEEEee
Q 048430 753 LIMQYMPQGSLEKWLYSHN------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---VAHLGD 823 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 823 (973)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+||| +.+|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999998643 45899999999999999999999 79999999999999999555 599999
Q ss_pred cccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCc
Q 048430 824 FGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPG 901 (973)
Q Consensus 824 fgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 901 (973)
||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...+.....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~~- 304 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR- 304 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC-
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-
Confidence 999975432111 22234568899999999888899999999999999999998 9999865321 111111111000
Q ss_pred chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 902 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
...+..++..+.+++.+||+.+|++||+++|++++|+.+.+...
T Consensus 305 ---------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 305 ---------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 00112345668899999999999999999999999999876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=361.58 Aligned_cols=270 Identities=17% Similarity=0.167 Sum_probs=209.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeCC------CeEEEEEEEeccchhh-----------HHHHHHHHHHHHhccCCceeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRA-----------LKSFDTECEVMRRIRHRNLIK 740 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 740 (973)
..++|...+.||+|+||.||+|.... ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578889999999999999998754 4789999987553211 123345566677778999999
Q ss_pred EEeeeecC----CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC--
Q 048430 741 IVSSCSNP----GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-- 814 (973)
Q Consensus 741 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-- 814 (973)
+++++... ...++||||+ +++|.+++......+++.++..++.||+.||+||| +.+|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998654 5589999999 99999999887668999999999999999999999 78999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc
Q 048430 815 DDMVAHLGDFGIAKLLDGVDPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888 (973)
Q Consensus 815 ~~~~~kl~Dfgla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~ 888 (973)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876432111 1133459999999999999899999999999999999999999997533222
Q ss_pred ccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
...............++.++.+. ...++.++.+++..||+.+|++||+++++++.|+++.+..
T Consensus 269 -~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 -KYVRDSKIRYRENIASLMDKCFP-------------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp -HHHHHHHHHHHHCHHHHHHHHSC-------------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHHHHHHHHhhhhHHHHHHHhcc-------------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 12222222111222222222111 0234677999999999999999999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=364.38 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=206.0
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
..++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456788999999999999999985 579999999987553 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC---CCCcEEEeecccccccC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~ 831 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++ .++.+||+|||++....
T Consensus 89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999998765 6999999999999999999999 78999999999999998 56789999999998765
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... .......||+.|+|||.+....++.++||||+||++|+|++|+.||..... ......+......
T Consensus 165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~---------- 231 (444)
T 3soa_A 165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYD---------- 231 (444)
T ss_dssp TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCC----------
T ss_pred CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCC----------
Confidence 322 223345799999999999988999999999999999999999999865221 1111111110000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. .. .....+++++.+++.+||+.||++|||++|+++|
T Consensus 232 -~-~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 -F-PS-------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -C-CT-------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -C-Cc-------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 00 0011245678899999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=362.77 Aligned_cols=265 Identities=23% Similarity=0.380 Sum_probs=212.6
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG 749 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 749 (973)
...++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578889999999999999999864 45899999997653 344578999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN-----------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl 806 (973)
..++||||+++|+|.+++.... ..+++.+++.++.||++||.||| +.+|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 9999999999999999998742 46899999999999999999999 789999999
Q ss_pred CCCcEEeCCCCcEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 048430 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEM 884 (973)
Q Consensus 807 k~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~ 884 (973)
||+||+++.++.+||+|||+++....... .......+|+.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986543221 12234468899999999888889999999999999999999 99998653
Q ss_pred ccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 885 FTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.. .........+. ... .+..++.++.+++.+||+.||++||++.|++++|+++.+.
T Consensus 281 ~~-----~~~~~~~~~~~--------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 281 AH-----EEVIYYVRDGN--------ILA-----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CH-----HHHHHHHHTTC--------CCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred Ch-----HHHHHHHhCCC--------cCC-----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 21 11111111110 000 1123456789999999999999999999999999998876
Q ss_pred HHhh
Q 048430 965 LTQA 968 (973)
Q Consensus 965 ~~~~ 968 (973)
....
T Consensus 337 ~~~~ 340 (343)
T 1luf_A 337 AEGT 340 (343)
T ss_dssp ----
T ss_pred hhhh
Confidence 6543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=347.86 Aligned_cols=273 Identities=19% Similarity=0.233 Sum_probs=206.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999964 68999999997543 3345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++ ++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9975 777777765568999999999999999999999 789999999999999999999999999999876432 22
Q ss_pred ccccccccccccCccCCCCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cchhhhccc-cc
Q 048430 837 TQTMTLATIGYMAPEYGSEGI-VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAVTEVVDA-NL 911 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~-~l 911 (973)
......+|+.|+|||.+.+.. ++.++|||||||++|||++|+.||.........+......... ..+....+. ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 334457899999999877655 8999999999999999999998864332222222222222111 111110000 00
Q ss_pred CCCC-chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSRE-DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .............++.++.+++.+|++.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000000001112345678899999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=378.39 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=212.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..+|...+.||+|+||.||+|+.. ++..||||+++... ...+.|.+|+.++++++||||++++++|...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 356777899999999999999976 48999999987543 2357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 99999999998743 46899999999999999999999 799999999999999999999999999999876543333
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......++..|+|||.+....++.++|||||||++|||++ |+.||...... .+...+.. ...
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~------------~~~--- 437 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK------------DYR--- 437 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT------------TCC---
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc------------CCC---
Confidence 3334457789999999888889999999999999999999 99998653221 12221111 110
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
...+..+++++.+++.+||+.||++||++.|+++.|+.+.
T Consensus 438 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 -------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 0112245677999999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=348.63 Aligned_cols=269 Identities=21% Similarity=0.263 Sum_probs=204.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 56888999999999999999998899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 975 999999877668999999999999999999999 7899999999999999999999999999998764321 22
Q ss_pred cccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cchhhh-----cc
Q 048430 838 QTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAVTEV-----VD 908 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~d 908 (973)
.....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+......... ..+... .+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccccc
Confidence 334568999999998765 458999999999999999999999997532211 12222221111 001100 01
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+...... ..........+++++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYE---PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCC---CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccc---CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1110000 000000112345678899999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=359.19 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=199.9
Q ss_pred CccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 685 SNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
.+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999985 57899999999876655667899999999999999999999999999999999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe--CCCCcEEEeecccccccCCCCCcccccc
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL--DDDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
.+++......+++.++..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++...... .....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence 9999876667999999999999999999999 7899999999999999 677899999999998765332 22345
Q ss_pred cccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhh
Q 048430 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921 (973)
Q Consensus 842 ~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 921 (973)
.||+.|+|||.+....++.++|||||||++|||++|+.||...... ..+......... . . .
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~------------~-~-~---- 309 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD------------L-E-D---- 309 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC------------S-C-S----
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC------------C-C-h----
Confidence 6999999999998889999999999999999999999998653211 111111111000 0 0 0
Q ss_pred hHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 922 DFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 922 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....+++++.+++.+||+.||++||+++|+++|
T Consensus 310 --~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 310 --EEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011245678999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=356.99 Aligned_cols=267 Identities=25% Similarity=0.353 Sum_probs=210.9
Q ss_pred HHhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
...++|...+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457888899999999999999985 246789999987543 33457899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCC----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccC
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNY----------------------SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl 806 (973)
+..++||||+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 999999999999999999987542 3789999999999999999999 799999999
Q ss_pred CCCcEEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 048430 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEM 884 (973)
Q Consensus 807 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~ 884 (973)
||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866433222 2334567889999999888889999999999999999998 99998664
Q ss_pred ccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 885 FTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
... ......+..... . ..+..+++++.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 279 ~~~-~~~~~~~~~~~~------------~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVD-ANFYKLIQNGFK------------M----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCS-HHHHHHHHTTCC------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcH-HHHHHHHhcCCC------------C----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 322 112222211100 0 00112356789999999999999999999999999999887
Q ss_pred HHhhc
Q 048430 965 LTQAL 969 (973)
Q Consensus 965 ~~~~~ 969 (973)
..++.
T Consensus 336 ~~~~~ 340 (344)
T 1rjb_A 336 AEEAM 340 (344)
T ss_dssp -----
T ss_pred HHHHH
Confidence 66543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.96 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=206.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
..++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467889999999999999999864 68999999997543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC---cEEEeecccccccC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---VAHLGDFGIAKLLD 831 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~ 831 (973)
|||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999998654 7899999999999999999999 78999999999999998654 59999999998765
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+...+.... .
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~-----------~ 247 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGA-----------Y 247 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC-----------C
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCC-----------C
Confidence 322 23345799999999999888999999999999999999999999865221 11111111100 0
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. . . .....+++++.+++.+||+.||++||++.|+++|
T Consensus 248 ~~-~-~------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 DY-P-S------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-C-T------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-C-c------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 0 0012345678999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.14 Aligned_cols=253 Identities=24% Similarity=0.422 Sum_probs=204.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchh-------hHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDR-------ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
.++|...+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35788889999999999999996 57899999998654321 1267899999999999999999999997665
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeCCCCc-----EEEee
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLDDDMV-----AHLGD 823 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~D 823 (973)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+ |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999999999877778999999999999999999999 788 999999999999988776 99999
Q ss_pred cccccccCCCCCcccccccccccccCccCC--CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc
Q 048430 824 FGIAKLLDGVDPVTQTMTLATIGYMAPEYG--SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901 (973)
Q Consensus 824 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 901 (973)
||+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||.............+....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 246 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG-- 246 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC--
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC--
Confidence 999975432 23345689999999987 4556789999999999999999999999764333222222211110
Q ss_pred chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 902 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
... ..+..+++++.+++.+||+.||++||+++|+++.|+++
T Consensus 247 ---------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 ---------LRP----------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------CCC----------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000 01123456789999999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.71 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=215.2
Q ss_pred HhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQED-RALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG 749 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 749 (973)
..++|...+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788889999999999999984 3578999999975543 3457899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCCC-----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEE
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNY-----------------SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 812 (973)
..++||||+++|+|.+++..... .+++.++..++.|++.||+||| +.+|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence 99999999999999999987542 4899999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCccc
Q 048430 813 LDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMS 890 (973)
Q Consensus 813 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~ 890 (973)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-K 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-H
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-H
Confidence 999999999999999876543322 2234457889999999888899999999999999999999 999986543221 1
Q ss_pred HHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
....+..... .. .+..++.++.+++.+||+.||++||++.|++++|+++.....
T Consensus 257 ~~~~~~~~~~------------~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 FYKMIKEGFR------------ML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHTCC------------CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHhccCCC------------CC----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 2221111110 00 011235668999999999999999999999999999887543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=346.76 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=208.9
Q ss_pred HhcCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
..++|...+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 3467888899999999999999853 23469999987653 34467899999999999999999999998754 568
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999877667999999999999999999999 79999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
..........+++.|+|||......++.++||||||+++|||++ |+.||...... .....+......
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~~---------- 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDRL---------- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCCC----------
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCCC----------
Confidence 33333344567889999999888889999999999999999998 99998653222 122211111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
..+..+++.+.+++.+||+.||++||++.|++++|+.+.+.-.
T Consensus 234 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 234 ------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 0011245668899999999999999999999999999877543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=367.05 Aligned_cols=213 Identities=21% Similarity=0.199 Sum_probs=108.7
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
|..+++|++|++++|.+.+..+..|..+++|++|+|++|++++..+..+.++++|+.|++++|.+.+..+..|..+++|+
T Consensus 124 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 203 (477)
T 2id5_A 124 FQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203 (477)
T ss_dssp TTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCC
T ss_pred ccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccc
Confidence 33344444444444444444444444444444444444444443334444444455555555544444444455555555
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
.|++++|.+.+.+|.......+|+.|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 204 ~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (477)
T 2id5_A 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283 (477)
T ss_dssp EEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSC
T ss_pred eeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCc
Confidence 55555554444444444444455555555555553332345555555555555555554444455555555555555555
Q ss_pred cccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccC
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 579 (973)
+++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..
T Consensus 284 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred cceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 55555555555555555555555555544445555555555555555555443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=362.04 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=203.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 753 (973)
.++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467888999999999999999964 68899999997552 23345688899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|..++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999998765 7999999999999999999999 799999999999999999999999999999863322
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCccc---HHHHHHhhCCcchhhhcccc
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS---LKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~d~~ 910 (973)
.......+||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ....+.. .+....
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~-------~i~~~~ 278 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------VILEKQ 278 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH-------HHHHCC
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH-------HHhccc
Confidence 22334567999999999999999999999999999999999999999653221110 0000000 000000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV------KDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~------~evl~~ 957 (973)
. ..+..++.++.+++.+||+.||++||++ +|+++|
T Consensus 279 ~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 I------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred c------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0 0112245678899999999999999985 677665
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.82 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=201.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc---chhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ---EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (973)
..++|...++||+|+||.||+|+.. +++.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999964 6899999999754 233456788999999988 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++|+|.+++...+ .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999998765 6999999999999999999999 78999999999999999999999999999985432
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
........+||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ...... ......
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~i--------~~~~~~ 242 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAI--------LNDEVV 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH--------HHCCCC
T ss_pred -CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HHHHHH--------HcCCCC
Confidence 222334457999999999988888999999999999999999999999653211 111111 111000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV------KDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~------~evl~~ 957 (973)
.+..++.++.+++.+|++.||++||++ +|+++|
T Consensus 243 ------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 ------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 011234568899999999999999998 778765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=348.48 Aligned_cols=261 Identities=27% Similarity=0.456 Sum_probs=197.8
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
..++|...++||+|+||.||+|+... .||||+++... ....+.+.+|+.++++++||||+++++++. ....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 34678889999999999999998653 59999987543 344578999999999999999999999764 55689999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC-
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD- 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 834 (973)
||+++++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999877778999999999999999999999 7899999999999999999999999999997654321
Q ss_pred CcccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 835 PVTQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
........||+.|+|||.+. ...++.++|||||||++|||++|+.||......+ .....+...... +..
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~-------~~~ 247 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLS-------PDL 247 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCC-------CCT
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccC-------cch
Confidence 22223456899999999775 6678999999999999999999999996533221 122222111100 000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.. ....+++++.+++.+||+.+|++||+++|+++.|+++.+
T Consensus 248 ~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SK-----------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TS-----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hh-----------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 012345679999999999999999999999999998753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=356.97 Aligned_cols=356 Identities=19% Similarity=0.226 Sum_probs=249.8
Q ss_pred CCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEE
Q 048430 44 HGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESF 123 (973)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L 123 (973)
-.+++.|+++++.+++. | .++.+++|++|+|++|++.+ +| ++.+++|++|+|++|++++ +| ++.+++|++|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~---~~~l~~L~~L 111 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD---VTPLTKLTYL 111 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC---CTTCTTCCEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee---cCCCCcCCEE
Confidence 35799999999999974 5 79999999999999999976 44 9999999999999999995 55 6889999999
Q ss_pred EeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEe
Q 048430 124 DVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDL 203 (973)
Q Consensus 124 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L 203 (973)
++++|++++ +| ++++++|++|++++|++++ ++ +..+++|++|++++|+..+. + .++.+++|++|++
T Consensus 112 ~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~-----~--~~~~l~~L~~L~l 177 (457)
T 3bz5_A 112 NCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITK-----L--DVTPQTQLTTLDC 177 (457)
T ss_dssp ECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCC-----C--CCTTCTTCCEEEC
T ss_pred ECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCcccc-----c--ccccCCcCCEEEC
Confidence 999999996 55 8999999999999999994 54 56899999999999965543 2 3788999999999
Q ss_pred cCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccC
Q 048430 204 GGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLV 283 (973)
Q Consensus 204 ~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~ 283 (973)
++|++++. | +.. +++|++|++++|++++. .++.+++|+.|++++|+++++
T Consensus 178 s~n~l~~l-~--l~~-----------------------l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i- 227 (457)
T 3bz5_A 178 SFNKITEL-D--VSQ-----------------------NKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI- 227 (457)
T ss_dssp CSSCCCCC-C--CTT-----------------------CTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-
T ss_pred CCCcccee-c--ccc-----------------------CCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-
Confidence 99999964 3 444 45666666666666654 266677777777777777764
Q ss_pred CCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccC
Q 048430 284 PNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI 363 (973)
Q Consensus 284 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~ 363 (973)
| ++.+++|+.|++++|++++.+ +..+++|+.|+++.|
T Consensus 228 p--~~~l~~L~~L~l~~N~l~~~~----------~~~l~~L~~L~l~~n------------------------------- 264 (457)
T 3bz5_A 228 D--VTPLTQLTYFDCSVNPLTELD----------VSTLSKLTTLHCIQT------------------------------- 264 (457)
T ss_dssp C--CTTCTTCSEEECCSSCCSCCC----------CTTCTTCCEEECTTC-------------------------------
T ss_pred C--ccccCCCCEEEeeCCcCCCcC----------HHHCCCCCEEeccCC-------------------------------
Confidence 3 667777777777777776522 122333333333322
Q ss_pred CCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcC
Q 048430 364 PVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLT 443 (973)
Q Consensus 364 p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 443 (973)
+|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. ...
T Consensus 265 --------------------------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~ 307 (457)
T 3bz5_A 265 --------------------------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAA 307 (457)
T ss_dssp --------------------------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTC
T ss_pred --------------------------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCC
Confidence 22333344444333333 23344444444444444444332 223
Q ss_pred CCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcc
Q 048430 444 SLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALA 523 (973)
Q Consensus 444 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 523 (973)
+|+.|++++| ++|+.|++++|++++ ++ ++++++|+.|++++|+|++ ++.|..|+++
T Consensus 308 ~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~ 363 (457)
T 3bz5_A 308 GITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPAL 363 (457)
T ss_dssp CCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGG
T ss_pred cceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------cccccccccc
Confidence 4555555444 356666666666665 32 6777777777777777774 2345566777
Q ss_pred cCccccCCCCCcccccccccccccccccCCCCCccccc
Q 048430 524 RNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEK 561 (973)
Q Consensus 524 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 561 (973)
+|.++|. ..+..|+.++|++|+++|.+|..+..
T Consensus 364 ~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 364 NNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp GTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred CCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 7877765 45667788888888888888766543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.01 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=204.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-----hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35688899999999999999985 4789999999865421 13577999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc---EEEeeccc
Q 048430 753 LIMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV---AHLGDFGI 826 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl 826 (973)
+||||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998888643 235899999999999999999999 789999999999999987654 99999999
Q ss_pred ccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 827 AKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 827 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+....... .......||+.|+|||.+....++.++|||||||++|||++|+.||.... ......+..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~i~~--------- 246 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFEGIIK--------- 246 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHHHHHH---------
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHHHHHc---------
Confidence 98765322 22334579999999999998899999999999999999999999996521 111111100
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..... . ......++.++.+++.+||+.||++||++.|+++|
T Consensus 247 --~~~~~--~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 247 --GKYKM--N------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --TCCCC--C------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCCCC--C------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0 00112345678999999999999999999999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=352.13 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=213.1
Q ss_pred HhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
..++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 346788889999999999999985 345899999987543 3445789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCC
Q 048430 751 KALIMQYMPQGSLEKWLYSHN-----------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 807 (973)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 999999999999999998753 23899999999999999999999 7899999999
Q ss_pred CCcEEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 048430 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMF 885 (973)
Q Consensus 808 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~ 885 (973)
|+||+++.++.+||+|||+++........ ......+|+.|+|||...+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876433322 2233457889999999888889999999999999999999 999986533
Q ss_pred cCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 886 TGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.. .+...+...... ..+..+++++.+++.+||+.||++||+++|++++|+++.+.
T Consensus 258 ~~--~~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PE--RLFNLLKTGHRM----------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG--GHHHHHHTTCCC----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH--HHHHHhhcCCcC----------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 122221111000 01123456789999999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=365.69 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=208.9
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
++.....++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 444455688999999999999999999964 79999999997532 22345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
+..|+||||+++|+|.+++...+..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999876557999999999999999999999 7999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGS-------EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 901 (973)
.............+||+.|+|||.+. ...++.++|||||||++|||++|+.||...... .........
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~ 285 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-----ETYGKIVHY 285 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTH
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----HHHHHHHhc
Confidence 76543333334567999999999876 456899999999999999999999999653211 111110000
Q ss_pred chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 048430 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER---INVKDALAD 957 (973)
Q Consensus 902 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---pt~~evl~~ 957 (973)
. ..+.. . .....++.++.+++.+||+ +|++| |+++|+++|
T Consensus 286 ~------~~~~~-p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 K------EHLSL-P--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp H------HHCCC-C------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred c------cCcCC-C--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 00000 0 0012346678999999999 99998 589999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=350.10 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=217.7
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
...++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567888899999999999999965 58899999987543 34578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999998743 46999999999999999999999 7899999999999999999999999999998776544
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
........+++.|+|||......++.++||||||+++|||++ |..||...... .....+.... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~------------~~ 231 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY------------RM 231 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC------------CC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccC------------CC
Confidence 444445567889999999888889999999999999999999 99998653221 1222111110 00
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
..+..+++.+.+++.+|++.||++||+++|+++.|+.+.+...
T Consensus 232 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 232 ----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0112345678999999999999999999999999999887643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=354.05 Aligned_cols=249 Identities=25% Similarity=0.321 Sum_probs=203.4
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999854 68899999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+.+|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 9999999999998764 7999999999999999999999 799999999999999999999999999999876432
Q ss_pred cccccccccccccCccCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 VTQTMTLATIGYMAPEYGSE---GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... .....+.... ....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~---------~~~~ 237 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFE---------TTVV 237 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHH---------HCCC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHh---------hccc
Confidence 23345679999999998764 45899999999999999999999999653222 1122111100 0000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-VKDALA 956 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~evl~ 956 (973)
..+..++.++.+++.+||+.||++||+ ++++.+
T Consensus 238 -----------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011124567899999999999999998 666665
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=374.09 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=204.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..++|...+.||+|+||.||+|....+..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 345677889999999999999999888899999987543 234689999999999999999999999976 678999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++|+|.+++.... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 99999999997532 46899999999999999999999 799999999999999999999999999999876533322
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......++..|+|||.+....++.++|||||||++|||++ |+.||......+ ....+.. + .
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~---~---------~---- 398 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER---G---------Y---- 398 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT---T---------C----
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc---C---------C----
Confidence 3334457889999999888899999999999999999999 999986532211 1111110 0 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
+...+..+++.+.+++.+||+.||++|||++++++.|+.+..
T Consensus 399 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 001122456779999999999999999999999999987653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.47 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=190.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
..++|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567888999999999999999965 58899999987543 33678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccccccCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~ 833 (973)
|+++|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999999998764 6899999999999999999999 789999999999999975 889999999999865432
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. ... ...
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~----~~~--------~~~ 270 (349)
T 2w4o_A 205 --VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----NCE--------YYF 270 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH----TTC--------CCC
T ss_pred --cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH----hCC--------Ccc
Confidence 222345689999999999988999999999999999999999999865322211111111 000 000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. .....++.++.+++.+||+.||++||++.|+++|
T Consensus 271 ~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 IS--------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC--------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0011245668899999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=367.57 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=208.3
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
.++....++|...++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999965 68999999987532 12234588999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
+..++||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999875 5899999999999999999999 7999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGI----VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
.............+||+.|+|||.+.... ++.++|||||||++|||++|+.||..... ............
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~- 290 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHKN- 290 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTHHH-
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHHHHHHhccc-
Confidence 76543333344568999999999876554 78999999999999999999999965221 111111100000
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEE--RINVKDALAD 957 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rpt~~evl~~ 957 (973)
. +. ++....++.++.+++.+|++.+|++ ||+++|+++|
T Consensus 291 ~-----~~----------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 S-----LT----------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H-----CC----------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c-----cc----------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 00 0000123566889999999999998 9999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.50 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=193.8
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccch----hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED----RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|... ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999976 89999999865432 23567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC---eEEccCCCCcEEeCC--------CCcEEEeec
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP---IIHCDLKPNNVLLDD--------DMVAHLGDF 824 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~dlk~~Nill~~--------~~~~kl~Df 824 (973)
||+++++|.+++... .+++..+..++.|++.||+||| +.+ |+||||||+||+++. ++.+||+||
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999654 6999999999999999999999 566 999999999999986 778999999
Q ss_pred ccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 825 GIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 825 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
|.+...... ......|++.|+|||...+..++.++||||||+++|||++|+.||....... ....+. .
T Consensus 161 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~--~----- 228 (271)
T 3dtc_A 161 GLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--VAYGVA--M----- 228 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHH--T-----
T ss_pred Ccccccccc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHhhh--c-----
Confidence 999865432 2224568999999999888889999999999999999999999986532111 000000 0
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
..... ..+..+++.+.+++.+||+.||++||++.|++++|+++
T Consensus 229 ----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 ----NKLAL----------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----SCCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----CCCCC----------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00000 01123456789999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=350.55 Aligned_cols=267 Identities=24% Similarity=0.420 Sum_probs=208.3
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecC--Cee
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFK 751 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 751 (973)
+.|...+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477789999999999999983 468999999987543 23457889999999999999999999999776 678
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999776667999999999999999999999 7999999999999999999999999999998765
Q ss_pred CCCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccc--hhh
Q 048430 832 GVDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGA--VTE 905 (973)
Q Consensus 832 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~--~~~ 905 (973)
..... ......+|..|+|||.+.+..++.++||||+||++|||++|+.|+.... ..+..... .+. ...
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCHHH
Confidence 43321 2234568888999999888889999999999999999999999854321 11111100 000 000
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
... .+... .....+..+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 252 ~~~-~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVN-TLKEG------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHH-HHHTT------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH-HHhcc------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 00000 001112245677999999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.24 Aligned_cols=246 Identities=26% Similarity=0.309 Sum_probs=205.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 356888999999999999999964 79999999997542 23356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 99999999999998765 6999999999999999999999 89999999999999999999999999999987542
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ...... +......
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~--------i~~~~~~-- 221 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEK--------ILNAELR-- 221 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--------HHHCCCC--
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HHhCCCC--
Confidence 12345799999999999988999999999999999999999999965221 111111 1111100
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
.+..++.++.+++.+|++.||++|| +++|+++|
T Consensus 222 ----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 ----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0112356688999999999999999 88999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.16 Aligned_cols=260 Identities=21% Similarity=0.357 Sum_probs=212.0
Q ss_pred CCCCCc-cccccCceEEEEEEeC---CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESN-LLGSGSFDNVYKATLA---NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
+|...+ .||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 444555 8999999999999853 68899999997653 34567899999999999999999999999 456689999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999876667999999999999999999999 78999999999999999999999999999987653332
Q ss_pred cc--cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 VT--QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. .....+|+.|+|||......++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~------------ 231 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR------------ 231 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC------------
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCc------------
Confidence 21 223356889999999888889999999999999999998 99998653221 11121111000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
...+..+++++.+++.+||+.+|++||++.|++++|+++.......
T Consensus 232 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 ----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ----------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 0011234667999999999999999999999999999998876654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=356.67 Aligned_cols=275 Identities=18% Similarity=0.247 Sum_probs=205.8
Q ss_pred hcCCCCCcccccc--CceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSG--SFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.++|...++||+| +||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4568889999999 99999999965 79999999997653 3445778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 754 IMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998752 46999999999999999999999 79999999999999999999999999998865421
Q ss_pred CC------CcccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc--
Q 048430 833 VD------PVTQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA-- 902 (973)
Q Consensus 833 ~~------~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 902 (973)
.. ........||+.|+|||.+.. ..++.++|||||||++|||++|+.||......... ........+..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcCCCCcccc
Confidence 11 111223468999999998877 57899999999999999999999999764332211 11111000000
Q ss_pred --------hhh-----h----cccccCCCC---chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 --------VTE-----V----VDANLLSRE---DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 --------~~~-----~----~d~~l~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... . ......... ..........+..+++++.+++.+||+.||++|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0 000000000 000001112234467789999999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.26 Aligned_cols=273 Identities=23% Similarity=0.315 Sum_probs=193.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46788899999999999999985 4689999999875532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 757 YMPQGSLEKWLYSHN-----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
|++ |+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999987532 35899999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhhcc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEVVD 908 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d 908 (973)
... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+........ .......+.
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhhh
Confidence 322 22334568999999998765 46899999999999999999999999753221 11222222111 111110000
Q ss_pred ------cccCCCCch--hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ------ANLLSREDE--EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ------~~l~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+........ ...........++.++.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000 0000001112345679999999999999999999999876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.63 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=197.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--------------------------hhHHHHHHHHHHHH
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--------------------------RALKSFDTECEVMR 731 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 731 (973)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46788899999999999999985 5789999999865421 12356889999999
Q ss_pred hccCCceeEEEeeeec--CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCC
Q 048430 732 RIRHRNLIKIVSSCSN--PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPN 809 (973)
Q Consensus 732 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~ 809 (973)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++.++..++.|++.||+||| +.+|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999976 56889999999999998866543 6999999999999999999999 789999999999
Q ss_pred cEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 048430 810 NVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI---VSISGDVYSFGILMMETFTRRKPTNEMFT 886 (973)
Q Consensus 810 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~Gvvl~elltg~~p~~~~~~ 886 (973)
||+++.++.+||+|||+++...... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~- 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-
Confidence 9999999999999999998765332 2233457999999999887654 4789999999999999999999986421
Q ss_pred CcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 887 GEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+...... ..... . ....+++++.+++.+||+.||++||+++|+++|
T Consensus 245 ----~~~~~~~~~~--------~~~~~-~---------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 ----IMCLHSKIKS--------QALEF-P---------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ----HHHHHHHHHH--------CCCCC-C---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ----HHHHHHHHhc--------ccCCC-C---------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1111111000 00000 0 001235668899999999999999999999876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.52 Aligned_cols=265 Identities=27% Similarity=0.470 Sum_probs=212.8
Q ss_pred HhcCCCCCccccccCceEEEEEEe--------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeec
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL--------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSN 747 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 747 (973)
..++|...+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 346788899999999999999985 357789999987553 34467899999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEE
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil 812 (973)
.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 999999999999999999998654 24899999999999999999999 789999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCccc
Q 048430 813 LDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMS 890 (973)
Q Consensus 813 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~ 890 (973)
++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--H
Confidence 999999999999999876543322 2233457889999999888889999999999999999999 99998653211 1
Q ss_pred HHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 048430 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQAL 969 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~ 969 (973)
+...+..... . ..+..++.++.+++.+||+.+|++||++.|++++|+++.+....+.
T Consensus 268 ~~~~~~~~~~------------~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~ 324 (334)
T 2pvf_A 268 LFKLLKEGHR------------M----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324 (334)
T ss_dssp HHHHHHHTCC------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHhcCCC------------C----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence 1111111000 0 0011345678999999999999999999999999999988765443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.70 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=205.1
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCe
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 750 (973)
....++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999964 68999999997542 23456788899999887 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++||||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999998754 6999999999999999999999 789999999999999999999999999999864
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.... ......+||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ..+...+.... ..
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~---------~~ 236 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDN---------PF 236 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC---------CC
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCC---------CC
Confidence 3222 223456799999999999988999999999999999999999999965321 11111111100 00
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK-DALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-evl~~ 957 (973)
.+..++.++.+++.+||+.||++||++. |+++|
T Consensus 237 --------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 237 --------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0112356688999999999999999997 77654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.14 Aligned_cols=271 Identities=24% Similarity=0.376 Sum_probs=217.6
Q ss_pred CCHHHHHHHhcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhc-cCCceeEE
Q 048430 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQED-RALKSFDTECEVMRRI-RHRNLIKI 741 (973)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l 741 (973)
....++....++|...+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455556678899999999999999999974 3578999999976533 3456789999999999 79999999
Q ss_pred EeeeecCC-eeEEEEEecCCCCHHHHhhhCCCC---------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEcc
Q 048430 742 VSSCSNPG-FKALIMQYMPQGSLEKWLYSHNYS---------------LTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805 (973)
Q Consensus 742 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~d 805 (973)
++++...+ ..++||||+++|+|.+++...... +++..+..++.|++.||.||| +.+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99987654 589999999999999999876422 889999999999999999999 78999999
Q ss_pred CCCCcEEeCCCCcEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 048430 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNE 883 (973)
Q Consensus 806 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~ 883 (973)
|||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987643322 22334567899999999888899999999999999999998 9999865
Q ss_pred cccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 884 MFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
....+ .....+...... ..+..+++++.+++.+||+.||++||++.|++++|+.+.+
T Consensus 254 ~~~~~-~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 254 VKIDE-EFCRRLKEGTRM----------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCCSH-HHHHHHHHTCCC----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhH-HHHHHhccCccC----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 33222 111111111000 0011234568899999999999999999999999999987
Q ss_pred HHH
Q 048430 964 ILT 966 (973)
Q Consensus 964 ~~~ 966 (973)
...
T Consensus 311 ~~~ 313 (316)
T 2xir_A 311 ANA 313 (316)
T ss_dssp HHC
T ss_pred hhc
Confidence 643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.60 Aligned_cols=275 Identities=21% Similarity=0.331 Sum_probs=216.0
Q ss_pred CHHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHh--ccCCceeEEEeeeecC
Q 048430 671 SYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR--IRHRNLIKIVSSCSNP 748 (973)
Q Consensus 671 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~ 748 (973)
+...-....++|...+.||+|+||.||+|+.. ++.||||++.... ...+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 33344455678999999999999999999984 8999999986432 3567889999888 6899999999999876
Q ss_pred C----eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeEEccCCCCcEEeCCCCcE
Q 048430 749 G----FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY-----STPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 749 ~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~ 819 (973)
. ..++||||+++|+|.+++... .+++.+++.++.|++.||+|||... +.+|+||||||+||+++.++.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 5 789999999999999999875 5899999999999999999999311 4789999999999999999999
Q ss_pred EEeecccccccCCCCCc---ccccccccccccCccCCCCC------CCCcchhHHHHHHHHHHHHhC----------CCC
Q 048430 820 HLGDFGIAKLLDGVDPV---TQTMTLATIGYMAPEYGSEG------IVSISGDVYSFGILMMETFTR----------RKP 880 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDvws~Gvvl~elltg----------~~p 880 (973)
||+|||++......... ......||+.|+|||.+... .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876543322 22345699999999987765 234789999999999999999 678
Q ss_pred CCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 881 TNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 881 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
|............+.......... +.+ ........++..+.+++.+||+.||++||+++|++++|++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLR----PNI---------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCC----CCC---------CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHHHHHhC----CCC---------cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 766544444444433322111110 000 0011123567789999999999999999999999999999
Q ss_pred HHHH
Q 048430 961 IKKI 964 (973)
Q Consensus 961 ~~~~ 964 (973)
+.++
T Consensus 334 i~~~ 337 (342)
T 1b6c_B 334 LSQQ 337 (342)
T ss_dssp HHHT
T ss_pred HHHH
Confidence 8765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.04 Aligned_cols=256 Identities=27% Similarity=0.369 Sum_probs=200.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46777899999999999999986 789999998643 345789999999999999999999999874 4789999999
Q ss_pred CCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc-EEEeecccccccCCCCCc
Q 048430 760 QGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV-AHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 760 ~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~~ 836 (973)
+|+|.+++.... ..+++..+..++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999998654 24789999999999999999999322289999999999999998886 799999999765321
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....||+.|+|||...+..++.++|||||||++|||++|+.||.............+..... +.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~------ 224 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--------PP------ 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--------CC------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--------CC------
Confidence 223468999999999988899999999999999999999999997533221111111110000 00
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
.+..++..+.+++.+||+.||++||+++|++++|+.+.+.++
T Consensus 225 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 225 --------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp --------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred --------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 011245668899999999999999999999999999876553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.13 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=204.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999964 68999999997542 33456788999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999998754 6999999999999999999999 7899999999999999999999999999998643222
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc----cHHHHHHhhCCcchhhhcccc
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM----SLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~d~~ 910 (973)
......+||+.|+|||.+.+..++.++||||+||++|||++|+.||........ ....... .+....
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i~~~~ 235 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VILEKQ 235 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HHHHCC
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HHHcCC
Confidence 223445799999999999988999999999999999999999999965322110 0000000 000100
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV------KDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~------~evl~~ 957 (973)
. ..+..++.++.+++.+||+.||++||++ +|+++|
T Consensus 236 ~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 I------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred C------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0 0111245668899999999999999995 677665
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=344.97 Aligned_cols=245 Identities=23% Similarity=0.234 Sum_probs=196.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...++||+|+||+||+|+.. +++.||||++.... ......+..|+..+.++ +||||++++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999975 79999999886432 23334555666666655 8999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 999 67999999887767999999999999999999999 789999999999999999999999999999876432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......||+.|+|||.+.+ .++.++|||||||++|||++|..|+... ...... ..+. .
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~----~~~~------------~ 269 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQL----RQGY------------L 269 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHH----TTTC------------C
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHH----hccC------------C
Confidence 22334569999999998765 7899999999999999999997765431 111110 0000 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 270 ------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 ------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 001122356779999999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=353.04 Aligned_cols=271 Identities=25% Similarity=0.437 Sum_probs=215.1
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC--eeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG--FKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 752 (973)
++|...+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4677889999999999999984 468999999998766666788999999999999999999999986543 789
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999987767999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCcc--cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc-----hhh
Q 048430 833 VDPVT--QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA-----VTE 905 (973)
Q Consensus 833 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~ 905 (973)
..... .....++..|+|||...+..++.++|||||||++|||++|+.|+..... ............. +.+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTCCTHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhccccchhhhHHHHHH
Confidence 33221 2234577889999998888899999999999999999999998753210 0111100000000 001
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
.+.... ....+..++.++.+++.+||+.||++||++.|+++.|+++++++.
T Consensus 275 ~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 275 LLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HhhcCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111100 001123456779999999999999999999999999999998865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=356.40 Aligned_cols=277 Identities=23% Similarity=0.341 Sum_probs=200.2
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHH--HHhccCCceeEEEeeee-----cCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEV--MRRIRHRNLIKIVSSCS-----NPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~-----~~~~~ 751 (973)
.++|...+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++++. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999987 589999999975432 334444444 44589999999997542 33467
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC---------CeEEccCCCCcEEeCCCCcEEEe
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST---------PIIHCDLKPNNVLLDDDMVAHLG 822 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~ivH~dlk~~Nill~~~~~~kl~ 822 (973)
++||||+++|+|.+++.... .++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 89999999999999998764 689999999999999999999 67 99999999999999999999999
Q ss_pred ecccccccCCCC-------CcccccccccccccCccCCCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCccccCc
Q 048430 823 DFGIAKLLDGVD-------PVTQTMTLATIGYMAPEYGSE-------GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888 (973)
Q Consensus 823 Dfgla~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~ 888 (973)
|||+++...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998764321 112234469999999998776 456789999999999999999988764322211
Q ss_pred ccHHHHHHhhCCcc----hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGA----VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 889 ~~~~~~~~~~~~~~----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.....+........ ....+..... .............+++++.+++.+||+.||++|||++|+++.|+++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQ---RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCC---CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchHHHHHhhhccccc---CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10000000000000 0000000000 0000011111234677899999999999999999999999999999865
Q ss_pred HHh
Q 048430 965 LTQ 967 (973)
Q Consensus 965 ~~~ 967 (973)
+.+
T Consensus 320 ~~~ 322 (336)
T 3g2f_A 320 WER 322 (336)
T ss_dssp CCC
T ss_pred HHh
Confidence 433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=348.76 Aligned_cols=251 Identities=20% Similarity=0.333 Sum_probs=204.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CC-------eEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NG-------VSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
++|...+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|+.++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56778899999999999999854 23 57999999776666678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc--------EEEee
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV--------AHLGD 823 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~D 823 (973)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999999987666999999999999999999999 799999999999999998887 99999
Q ss_pred cccccccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc
Q 048430 824 FGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 824 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
||.+..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..|+........ ........ .
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~--~- 235 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR--H- 235 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT--C-
T ss_pred CcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc--C-
Confidence 999875432 223458899999998876 6789999999999999999996655432211111 11111100 0
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
... ..++.++.+++.+||+.||++|||++|++++|+++..
T Consensus 236 -------~~~--------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 -------QLP--------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -------CCC--------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -------CCC--------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000 0113347789999999999999999999999988754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.58 Aligned_cols=263 Identities=25% Similarity=0.434 Sum_probs=206.3
Q ss_pred cCCCCCccccccCceEEEEEEeCC-----CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN-----GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++|...+.||+|+||.||+|.... +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 345567899999999999998542 3469999987553 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999887668999999999999999999999 789999999999999999999999999999876432
Q ss_pred CCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 834 DPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 834 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
... ......+|+.|+|||.+....++.++|||||||++|||++ |+.||...... .....+.. +
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~---~--------- 266 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIND---G--------- 266 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT---T---------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHC---C---------
Confidence 211 1222346788999999888899999999999999999999 99998653211 11111111 0
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQAL 969 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~ 969 (973)
.. ...+..++.++.+++.+||+.+|++||++.|++++|+++.+......
T Consensus 267 ~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 267 FR----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp CC----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred Cc----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 00 00111345678999999999999999999999999999887655443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=353.33 Aligned_cols=253 Identities=21% Similarity=0.230 Sum_probs=195.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457888999999999999999965 789999999875432 236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc--EEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV--AHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~~~~~~~ 835 (973)
+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++.... .
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--H 171 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--c
Confidence 99999999997654 6999999999999999999999 799999999999999987765 99999999875322 1
Q ss_pred cccccccccccccCccCCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSIS-GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......||+.|+|||.+.+..++.+ +||||+||++|||++|+.||....... .....+....... ...
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~--------~~~- 241 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVK--------YSI- 241 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTC--------CCC-
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCC--------CCC-
Confidence 22334569999999998877776655 899999999999999999997643322 2222222111100 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+....+++++.+++.+||+.||++|||+.|+++|
T Consensus 242 ---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 ---------PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0001234568899999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=352.09 Aligned_cols=269 Identities=25% Similarity=0.375 Sum_probs=216.5
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeC-C-----CeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeee
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATLA-N-----GVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCS 746 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 746 (973)
++...++|...+.||+|+||.||+|... + ...||+|+++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678888999999999999999853 2 3479999987553 33457899999999999 8999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhhhC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 747 NPGFKALIMQYMPQGSLEKWLYSH-------------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 747 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 999999999999999999999753 235799999999999999999999 7899999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
+.++.+||+|||+++....... .......+|+.|+|||...+..++.++|||||||++|||++ |..||....... ..
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KF 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HH
Confidence 9999999999999986543222 22334457889999999888889999999999999999999 889986533221 11
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQAL 969 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~ 969 (973)
...+...... ..+..+++.+.+++.+||+.||++||+++|++++|+++.+...++.
T Consensus 277 ~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~r 332 (333)
T 2i1m_A 277 YKLVKDGYQM----------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332 (333)
T ss_dssp HHHHHHTCCC----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHhcCCCC----------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhccC
Confidence 2222111100 0011234568899999999999999999999999999988766553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.48 Aligned_cols=261 Identities=25% Similarity=0.444 Sum_probs=196.4
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCC-C---eEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLAN-G---VSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
...++|...+.||+|+||.||+|+... + ..||||+++.. .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345678999999999999999998643 3 27999998754 34456789999999999999999999999977665
Q ss_pred e------EEEEEecCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 751 K------ALIMQYMPQGSLEKWLYSHN-----YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 751 ~------~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
. ++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999996532 25899999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHh
Q 048430 820 HLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 897 (973)
||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ....+..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNYLIG 254 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHHHhc
Confidence 99999999876433222 2233457889999999988899999999999999999999 899987533221 1111111
Q ss_pred hCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 898 SLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 898 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.. .. ..+..+++++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 255 ~~-----------~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 255 GN-----------RL-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TC-----------CC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-----------CC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 00 00112456789999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.12 Aligned_cols=267 Identities=25% Similarity=0.395 Sum_probs=211.9
Q ss_pred CCCCccccccCceEEEEEEeC-----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeEE
Q 048430 682 FGESNLLGSGSFDNVYKATLA-----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKAL 753 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 753 (973)
|...+.||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377899999999999998642 68999999997653 3446789999999999999999999999976 467899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999876 4899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc------chhh
Q 048430 834 DPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG------AVTE 905 (973)
Q Consensus 834 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~ 905 (973)
... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||....... ..+. .... ...+
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~--~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LELI--GIAQGQMTVLRLTE 262 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHH--CSCCHHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhhh--cccccchhHHHHHH
Confidence 321 2233457888999999988889999999999999999999999986422110 0000 0000 0111
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
.++.... ...+..++.++.+++.+||+.||++||+++|+++.|+++.+.++.+
T Consensus 263 ~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 263 LLERGER----------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHhcccC----------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1111110 0112235677999999999999999999999999999999988754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=356.22 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=212.6
Q ss_pred cCCCCCccccccCceEEEEEEe-----CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeee--cCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-----ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS--NPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 752 (973)
++|...+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5678889999999999999984 468999999998776666778999999999999999999999886 456789
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999876557999999999999999999999 79999999999999999999999999999987653
Q ss_pred CCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC----Ccc---h
Q 048430 833 VDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGA---V 903 (973)
Q Consensus 833 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~---~ 903 (973)
.... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||..... ....... ... .
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA------EFLRMMGCERDVPALSRL 253 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHCC----CCHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc------hhhhhcccccccccHHHH
Confidence 3322 22334688889999998888899999999999999999999999754211 1111000 000 0
Q ss_pred hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
.+.+..... ...+..+++++.+++.+||+.||++||+++|++++|+.+.....
T Consensus 254 ~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 111111100 01123456779999999999999999999999999998875543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.29 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=204.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecC--CeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+.. ++.||||+++... ....+.+.+|+.++++++||||+++++++.++ +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999986 8999999997653 34457899999999999999999999999876 7889999
Q ss_pred EecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNY-SLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||+++|+|.+++..... .+++.++..++.|++.||+||| +.+ |+||||||+||+++.++.++++|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987653 5899999999999999999999 778 99999999999999999999999998764321
Q ss_pred CCCcccccccccccccCccCCCCCCCC---cchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVS---ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
....+|+.|+|||.+.+..++ .++|||||||++|||++|+.||......+. ........
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~----------- 227 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEG----------- 227 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSC-----------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcC-----------
Confidence 234689999999987765444 489999999999999999999865322111 00100000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
... ..+..++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 228 -~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 -LRP----------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 000 0012345678999999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.77 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=211.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..++|...+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 3467888899999999999999998889999999875432 34689999999999999999999999864 468999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999997542 25899999999999999999999 799999999999999999999999999999876543333
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......++..|+|||......++.++||||||+++|||++ |+.||...... .....+.. + ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~---~---------~~~-- 229 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLER---G---------YRM-- 229 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT---T---------CCC--
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhc---c---------cCC--
Confidence 3334457889999999888889999999999999999999 89998653211 11111111 0 000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
..+..+++++.+++.+||+.+|++||+++++++.|+++.....
T Consensus 230 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 230 --------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 0011345678999999999999999999999999999876643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=353.49 Aligned_cols=284 Identities=23% Similarity=0.253 Sum_probs=214.5
Q ss_pred cccccCCCCHHHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-----CC
Q 048430 663 NLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-----HR 736 (973)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ 736 (973)
.......+++.+.....++|...++||+|+||.||+|+. .+++.||||+++.. ......+..|+.+++.++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 344556667777777788999999999999999999996 57899999998643 334467788999999986 99
Q ss_pred ceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC
Q 048430 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815 (973)
Q Consensus 737 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~ 815 (973)
||+++++++...+..++||||+ +++|.+++.... ..+++.++..++.||+.||+||| +.+|+||||||+||+++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDD 172 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcc
Confidence 9999999999999999999999 889999998764 35899999999999999999999 799999999999999975
Q ss_pred -------------------------CCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHH
Q 048430 816 -------------------------DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGIL 870 (973)
Q Consensus 816 -------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvv 870 (973)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999865422 234568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCccccCcccHHHHHHhhC---Ccch---------hhhcccccCCCCchhhhhhH-----------HhHH
Q 048430 871 MMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAV---------TEVVDANLLSREDEEDADDF-----------ATKK 927 (973)
Q Consensus 871 l~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~---------~~~~d~~l~~~~~~~~~~~~-----------~~~~ 927 (973)
+|||++|+.||...... .....+.... +... ...++............... ....
T Consensus 249 l~ell~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHM--EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHSSCSCCCSSHH--HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHCCCCCCCCcHH--HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 99999999999753211 1111111111 1000 00000000000000000000 0001
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 928 TCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 928 ~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+.+.+++.+||+.||++|||++|+++|
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 123668899999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=353.22 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=197.8
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccC--CceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRH--RNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35688899999999999999998889999999987543 3445788999999999976 9999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|| +.+++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||+++......
T Consensus 88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 99 45789999998865 7999999999999999999999 78999999999999997 5789999999998764332
Q ss_pred Cc-ccccccccccccCccCCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc
Q 048430 835 PV-TQTMTLATIGYMAPEYGSE-----------GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 835 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
.. ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.........+..
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--------- 232 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA--------- 232 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH---------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH---------
Confidence 22 2334579999999997643 67899999999999999999999999653221111111
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+++...... +..++.++.+++.+||+.||++|||+.|+++|-
T Consensus 233 ---~~~~~~~~~~----------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 233 ---IIDPNHEIEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ---HHCTTSCCCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---HhcCCcccCC----------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111110000 011234588999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.19 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=207.7
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeee-ecCCeeEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC-SNPGFKALIM 755 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 755 (973)
..++|...+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 6799999998764432 24588899999999987766666554 6778889999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe---CCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~ 832 (973)
||+ +++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 89999999876667999999999999999999999 7899999999999999 7889999999999987654
Q ss_pred CCCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc--cHHHHHHhhCCcchh
Q 048430 833 VDPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM--SLKQWVAESLPGAVT 904 (973)
Q Consensus 833 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 904 (973)
.... ......||+.|+|||...+..++.++|||||||++|||++|+.||........ .+...........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence 3221 22345799999999999998999999999999999999999999976432221 1111111100000
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
.......+++++.+++.+||+.||++||+++|+++.|+++.+...
T Consensus 239 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 -----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000112246779999999999999999999999999999887654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.66 Aligned_cols=263 Identities=19% Similarity=0.230 Sum_probs=210.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeee-ecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC-SNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|+. .+++.||||++...... +.+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788899999999999999995 67999999998655332 4688999999999988766655554 66788899999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe---CCCCcEEEeecccccccCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+ +++|.+++......+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 89999999866668999999999999999999999 7899999999999999 48889999999999876543
Q ss_pred CCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc--ccHHHHHHhhCCcchhh
Q 048430 834 DPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE--MSLKQWVAESLPGAVTE 905 (973)
Q Consensus 834 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 905 (973)
... ......||+.|+|||...+..++.++|||||||++|||++|+.||....... ..+...........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 321 1234579999999999999899999999999999999999999997643221 11111111100000
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
.......+++++.+++.+||+.||++||+++|+++.|+++.+...
T Consensus 239 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 239 ----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 000112346779999999999999999999999999999877643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.69 Aligned_cols=245 Identities=22% Similarity=0.251 Sum_probs=205.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888899999999999999964 78999999997543 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999998765 6999999999999999999999 799999999999999999999999999999876432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... ......
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i--------~~~~~~--- 256 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKI--------VSGKVR--- 256 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH--------HHCCCC---
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHHHH--------HcCCCC---
Confidence 2345799999999999888999999999999999999999999865321 1111111 000000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
.+..++.++.+++.+||+.||++||+ ++|+++|
T Consensus 257 ---------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 ---------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 01124566889999999999999998 8888876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=360.27 Aligned_cols=260 Identities=23% Similarity=0.399 Sum_probs=199.5
Q ss_pred CCCCccccccCceEEEEEEeC--CC--eEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeec-CCeeEEEE
Q 048430 682 FGESNLLGSGSFDNVYKATLA--NG--VSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGFKALIM 755 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 755 (973)
|...+.||+|+||.||+|+.. ++ ..||||.++... ....+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 455689999999999999853 32 468999886443 3456789999999999999999999998754 56789999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++......+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999887767999999999999999999999 78999999999999999999999999999986543221
Q ss_pred c---ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 836 V---TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 836 ~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
. ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .....+.....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~----------- 314 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRR----------- 314 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCC-----------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCC-----------
Confidence 1 1233457889999999988899999999999999999999 66676543222 22222111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
...+..++..+.+++.+||+.||++||+++|++++|+++...+..+
T Consensus 315 -----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 315 -----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 0011234567899999999999999999999999999998765543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=345.78 Aligned_cols=270 Identities=23% Similarity=0.296 Sum_probs=202.9
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-----hhHHHHHHHHHHHHhcc---CCceeEEEeeeecC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIR---HRNLIKIVSSCSNP 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 748 (973)
..++|...+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 5789999999864321 12346777888877765 99999999999765
Q ss_pred C-----eeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEe
Q 048430 749 G-----FKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822 (973)
Q Consensus 749 ~-----~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 822 (973)
. ..++||||+. ++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5799999997 59999998765 34999999999999999999999 7899999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc-
Q 048430 823 DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG- 901 (973)
Q Consensus 823 Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 901 (973)
|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+..........
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 99999866432 22344578999999999988889999999999999999999999996532211 122222211110
Q ss_pred --chhhh---cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 902 --AVTEV---VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 902 --~~~~~---~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+... ....+... ...........+++++.+++.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPR---GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCC---CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCC---CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 00000000 0000111112356778999999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.76 Aligned_cols=250 Identities=22% Similarity=0.390 Sum_probs=186.6
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch---hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45788899999999999999986 5799999999975432 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++......+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999887667999999999999999999999 7899999999999999999999999999998764322
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
. ......+++.|+|||...+..++.++||||||+++|||++|+.||......+. .. .......
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~--------~~~~~~~--- 229 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LN--------KVVLADY--- 229 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCC---
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HH--------HHhhccc---
Confidence 1 22335689999999999888899999999999999999999999865322110 00 0000000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++.++.+++.+||+.||++||+++|+++|
T Consensus 230 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 ---------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0011235668899999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=345.59 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=182.6
Q ss_pred CccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 685 SNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6899999998643 3356789999999997 9999999999999999999999999999
Q ss_pred HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC---cEEEeecccccccCCCCCcccc
Q 048430 763 LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---VAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 763 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++...... ....
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 999998865 7999999999999999999999 79999999999999997765 89999999998654322 2234
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc--ccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE--MSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
...+|+.|+|||.+.+..++.++|||||||++|||++|+.||....... ............+. .. .
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------~~----~ 235 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------FS----F 235 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------CC----C
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------CC----C
Confidence 4568999999999999999999999999999999999999997533211 11111111111110 00 0
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......+++++.+++.+||+.||++||+++|+++|
T Consensus 236 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 ----EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ----CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ----CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001123456779999999999999999999998855
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=348.10 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=198.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC-------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG------- 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 749 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999975 79999999997543 335678999999999999999999999885433
Q ss_pred --------------------------------------------------eeEEEEEecCCCCHHHHhhhCC--CCCCHH
Q 048430 750 --------------------------------------------------FKALIMQYMPQGSLEKWLYSHN--YSLTIR 777 (973)
Q Consensus 750 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~l~~~ 777 (973)
..++||||+++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3799999999999999998754 345677
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-----------ccccccccccc
Q 048430 778 QRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-----------VTQTMTLATIG 846 (973)
Q Consensus 778 ~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~~~~~ 846 (973)
.+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999 79999999999999999999999999999987654321 12234569999
Q ss_pred ccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhH
Q 048430 847 YMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATK 926 (973)
Q Consensus 847 y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 926 (973)
|+|||.+.+..++.++|||||||++|||++|..|+... .......... .. ....
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~~~~------------~~-------~~~~ 295 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDVRNL------------KF-------PLLF 295 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHHHTT------------CC-------CHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHhhcc------------CC-------Cccc
Confidence 99999998889999999999999999999987663210 0111100000 00 0112
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 927 KTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 927 ~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...++++.+++.+||+.||++||+++|+++|
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 2345667899999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=343.10 Aligned_cols=263 Identities=23% Similarity=0.350 Sum_probs=201.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999985 57999999998753 2345678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||+++++|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999875 3356899999999999999999999 78999999999999999999999999999886543
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. .......+++.|+|||......++.++||||||+++|||++|+.||...... ............... .
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-----~- 258 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCDYPP-----L- 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHHHTTCSCC-----C-
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHhhcccCCC-----C-
Confidence 22 2223346899999999998889999999999999999999999998653221 112211111100000 0
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
....++.++.+++.+||+.||++||++.|+++.|+++....+.
T Consensus 259 ------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 ------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0012456789999999999999999999999999999877543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=346.19 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=195.3
Q ss_pred hcCCCCCccccccCceEEEEEEe----CCCeEEEEEEEeccc----hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQE----DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 750 (973)
.++|...+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999986 478999999987542 2334567899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999998754 6899999999999999999999 789999999999999999999999999998754
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.... .......||+.|+|||.+....++.++|||||||++|||++|+.||...... ..+.. +....
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~--------i~~~~ 237 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----KTIDK--------ILKCK 237 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHH--------HHHTC
T ss_pred ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----HHHHH--------HHhCC
Confidence 3221 2223456999999999998888999999999999999999999999653211 11111 00000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
.. .+..++.++.+++.+||+.||++|| ++.|+++|
T Consensus 238 ~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 00 0112356688999999999999999 78888876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=337.74 Aligned_cols=251 Identities=23% Similarity=0.269 Sum_probs=206.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456888999999999999999864 5789999999776555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe---CCCCcEEEeecccccccCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999999988765 6899999999999999999999 7899999999999999 788999999999998764322
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......+|+.|+|||...+ .++.++||||||+++|||++|+.||......+ ....+.... . .
T Consensus 164 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~-----------~-~- 225 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VMLKIREGT-----------F-T- 225 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCC-----------C-C-
T ss_pred --chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhCC-----------C-C-
Confidence 2334569999999998765 48999999999999999999999986532211 111111100 0 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. . ......+++++.+++.+|++.||++||++.|+++|
T Consensus 226 ~-~-----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 226 F-P-----EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp C-C-----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred C-C-----chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 00011345678999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=344.03 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=201.5
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999964 78999999986542 2335778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999998764 6999999999999999999999 789999999999999999999999999999876543
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.........+++.|+|||...+..++.++||||||+++|||++|+.||...... .....+....+.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~------------ 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR------------ 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC------------
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC------------
Confidence 333334557899999999999889999999999999999999999998653211 111111110000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-NVKDALADLKKIKKILT 966 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~evl~~L~~~~~~~~ 966 (973)
....+..++.++.+++.+||+.||++|| +++++++.|+++.+...
T Consensus 254 --------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 --------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0001123456688999999999999999 99999999988765543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=348.80 Aligned_cols=250 Identities=23% Similarity=0.240 Sum_probs=204.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (973)
..++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999965 58899999997542 23456788999999887 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++|+|.+++...+ .+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999998754 6999999999999999999999 78999999999999999999999999999986432
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
. .......+||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.+. .....
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~-----------~~~~~ 239 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIM-----------EHNVA 239 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH-----------HCCCC
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHH-----------hCCCC
Confidence 1 2223445799999999999988999999999999999999999999965221 11111111 11000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
.+..++.++.+++.+||+.||++||+ ++|+++|
T Consensus 240 ------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 ------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01124567889999999999999995 5777765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.30 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=205.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999864 68999999987553 334577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc---EEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV---AHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~~~~ 832 (973)
||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||.+.....
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999887764 6999999999999999999999 789999999999999987655 99999999987643
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
. .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+.......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~---------- 226 (284)
T 3kk8_A 161 S--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYDY---------- 226 (284)
T ss_dssp S--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC----------
T ss_pred C--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhccccC----------
Confidence 2 2233457999999999999989999999999999999999999998653211 1111111100000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. .....+++++.+++.+||+.||++||+++|+++|
T Consensus 227 --~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 --PS-------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --CT-------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --Cc-------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0001235668899999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.13 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=205.5
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeE----EEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVS----VAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
++|...+.||+|+||.||+|+.. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999853 4443 7788775332 223456788999999999999999999986 456889
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999876667999999999999999999999 789999999999999999999999999999876543
Q ss_pred CCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... ......+|..|+|||.+....++.++|||||||++|||++ |+.||...... .....+......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~---------- 236 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERL---------- 236 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBC----------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC----------
Confidence 322 2344567889999999988899999999999999999999 99999753222 122222111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
..+..++.++.+++.+||+.||++||+++|++++|+++.+...+
T Consensus 237 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~ 280 (325)
T 3kex_A 237 ------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280 (325)
T ss_dssp ------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHH
T ss_pred ------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 00111344577899999999999999999999999998765543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=357.80 Aligned_cols=278 Identities=22% Similarity=0.293 Sum_probs=212.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC--eeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG--FKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 755 (973)
++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888899999999999999965 58999999997543 233567889999999999999999999987654 779999
Q ss_pred EecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe----CCCCcEEEeecccccc
Q 048430 756 QYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL----DDDMVAHLGDFGIAKL 829 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~ 829 (973)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999998643 23899999999999999999999 7899999999999999 7788899999999987
Q ss_pred cCCCCCcccccccccccccCccCCCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHH---Hhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE--------GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV---AES 898 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~~ 898 (973)
.... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.............. ...
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 6432 22334569999999997654 4678899999999999999999999975433332222221 111
Q ss_pred CCcchhhhcccccCCCCc--hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 899 LPGAVTEVVDANLLSRED--EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
.+..+..... ....... ............++..+.+++.+||+.||++||+++|+++.++.+..
T Consensus 244 p~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQK-AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEEC-STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred Ccccchhhee-ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111111100 0000000 00000111224567889999999999999999999999999887754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.42 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=203.8
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--------hhHHHHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--------RALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
..++|...+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999984 5789999999875421 1234677899999999999999999999999
Q ss_pred CeeEEEEEecCCC-CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 749 GFKALIMQYMPQG-SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 749 ~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 9999998765 6999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
+...... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 8765322 2334569999999998887776 88999999999999999999998642110
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...... .+..+++++.+++.+||+.||++||+++|+++|
T Consensus 237 ~~~~~~------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIH------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccC------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011135668899999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=354.76 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=198.2
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhcc--CCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIR--HRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 755 (973)
.+|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588899999999999999998889999999987543 344678999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
| +.+++|.+++.... .+++.++..++.||+.||.||| +.+|+||||||+||+++ ++.+||+|||+++.......
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 56789999998765 7899999999999999999999 89999999999999995 57999999999987643222
Q ss_pred c-ccccccccccccCccCCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcch
Q 048430 836 V-TQTMTLATIGYMAPEYGSE-----------GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV 903 (973)
Q Consensus 836 ~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 903 (973)
. .....+||+.|+|||.+.. ..++.++|||||||++|||++|+.||....... ..+.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~------- 278 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLH------- 278 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHH-------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHH-------
Confidence 1 2344579999999997654 468999999999999999999999996532211 1111
Q ss_pred hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 904 TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 904 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+.+....... +..++.++.+++.+||+.||++||++.|+++|-
T Consensus 279 -~~~~~~~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 279 -AIIDPNHEIEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -HHHCTTSCCCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHhCccccCCC----------CccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11111111000 001234688999999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=345.69 Aligned_cols=261 Identities=23% Similarity=0.249 Sum_probs=207.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeee----cCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS----NPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l 753 (973)
.++|...+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45788899999999999999996 679999999987666666788999999999999999999999986 3457899
Q ss_pred EEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 754 IMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
||||+++|+|.+++.. ....+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999986 3457999999999999999999999 789999999999999999999999999998764
Q ss_pred CCCCCc--------ccccccccccccCccCCCCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 831 DGVDPV--------TQTMTLATIGYMAPEYGSEGI---VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 831 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
...... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||.............+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~- 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ- 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-
Confidence 321110 012235799999999876544 68999999999999999999999865332222222211110
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
... .....++.++.+++.+||+.||++||+++|++++|+.+...
T Consensus 264 -----------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 264 -----------LSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -------------C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -----------CCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 000 00112456789999999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=358.51 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=205.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999965 79999999997542 223567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 9999999999998654 7999999999999999999999 8999999999999999999999999999998764322
Q ss_pred cccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+.... .........+ ...
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~--------~~~-- 234 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFKKICDG--------IFY-- 234 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHHHHHTT--------CCC--
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcC--------CcC--
Confidence 2334579999999998887765 7899999999999999999999975321 1111111110 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..+++++.+++.+||+.||++|||++|+++|
T Consensus 235 ----------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 ----------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 011234568899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=349.32 Aligned_cols=247 Identities=27% Similarity=0.367 Sum_probs=201.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
+.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477889999999999999985 679999999987542 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+. |++.+++......+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 6898888766668999999999999999999999 789999999999999999999999999999865422
Q ss_pred cccccccccccccCccCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 VTQTMTLATIGYMAPEYG---SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
....||+.|+|||.+ ....++.++|||||||++|||++|+.||....... .+....... .+...
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~---------~~~~~ 274 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE---------SPALQ 274 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC---------CCCCC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcC---------CCCCC
Confidence 235699999999976 35678999999999999999999999986432111 011111100 00000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
...+++.+.+++.+||+.||++|||++|+++|-
T Consensus 275 -------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 275 -------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 012355688999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.47 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=206.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchh------hHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999964 6899999998754321 357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC----cEEEeecccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM----VAHLGDFGIA 827 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla 827 (973)
++||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999998754 7899999999999999999999 78999999999999999888 7999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
....... ......||+.|+|||......++.++|||||||++|||++|+.||..... ...........
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~----- 234 (321)
T 2a2a_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLANITSVS----- 234 (321)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHHHTTC-----
T ss_pred eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcc-----
Confidence 8764322 22345689999999999888999999999999999999999999865321 11111110000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. . .. ......++..+.+++.+||+.||++|||++|+++|
T Consensus 235 ---~-~-~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 ---Y-D-FD------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---C-C-CC------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---c-c-cC------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 00 00112345678999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=351.78 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=196.0
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----e
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG----F 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 750 (973)
.++|...+.||+|+||.||+|+. .+++.||||+++... ......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788899999999999999995 679999999997542 234567899999999999999999999986544 3
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++||||+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 499999999999999998765 6999999999999999999999 789999999999999999999999999999866
Q ss_pred CCCCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 831 DGVDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 831 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ....... .
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~---~------- 235 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRE---D------- 235 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHC---C-------
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcC---C-------
Confidence 432221 22335689999999999888999999999999999999999999965322110 0111100 0
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ........++.++.+++.+||+.||++||++.+++++
T Consensus 236 ------~~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 236 ------PI----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp ------CC----CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------CC----CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00 0001112356778999999999999999987766654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=345.92 Aligned_cols=264 Identities=23% Similarity=0.411 Sum_probs=201.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC-
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG- 749 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 749 (973)
...++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888899999999999999753 45689999987542 344578999999999999999999999997654
Q ss_pred ----eeEEEEEecCCCCHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 750 ----FKALIMQYMPQGSLEKWLYSH-----NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 750 ----~~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
..++||||+++|+|.+++... ...+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence 359999999999999998532 246999999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhh
Q 048430 821 LGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 898 (973)
|+|||++......... ......+++.|+|||...+..++.++|||||||++|||++ |+.||...... .....+...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~ 265 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLLHG 265 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHHcC
Confidence 9999999866432221 2233457889999999988899999999999999999999 88888653221 111111110
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
... ..+..++.++.+++.+||+.||++||++.|++++|+++.+.+++
T Consensus 266 ~~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 266 HRL----------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp CCC----------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCC----------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 000 01123456789999999999999999999999999999887653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.60 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=204.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeE----EEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVS----VAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
.++|...++||+|+||.||+|+.. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357888999999999999999853 4443 577766433 2334678999999999999999999999998764 78
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+|+||+.+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999987778999999999999999999999 78999999999999999999999999999987643
Q ss_pred CCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 833 VDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 833 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+.....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~---------- 237 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER---------- 237 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC----------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC----------
Confidence 2222 2233456889999999988899999999999999999999 99999764322 12222211100
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
...+..++.++.+++.+||+.||++||++.|+++.|+++.+...+.
T Consensus 238 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 283 (327)
T 3lzb_A 238 ------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY 283 (327)
T ss_dssp ------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred ------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCce
Confidence 0011224566889999999999999999999999999998655443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=376.86 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=204.0
Q ss_pred cccccCceEEEEEEeC---CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 687 LLGSGSFDNVYKATLA---NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999853 56789999997643 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc--cccc
Q 048430 763 LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTM 840 (973)
Q Consensus 763 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 840 (973)
|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999877667999999999999999999999 789999999999999999999999999999876432221 1122
Q ss_pred ccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 841 ~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
..+|+.|+|||.+....++.++|||||||++|||++ |+.||...... .+...+... .
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~------------~-------- 556 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG------------K-------- 556 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTT------------C--------
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC------------C--------
Confidence 345689999999988899999999999999999998 99999753321 112211110 0
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
+...+..++.++.+++.+||+.+|++||++.++++.|+.+.....
T Consensus 557 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 001122456789999999999999999999999999999877653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.41 Aligned_cols=259 Identities=21% Similarity=0.369 Sum_probs=207.3
Q ss_pred CCCCccccccCceEEEEEEeC-C---CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee-EEEE
Q 048430 682 FGESNLLGSGSFDNVYKATLA-N---GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK-ALIM 755 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~ 755 (973)
|...++||+|+||.||+|+.. + +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445688999999999999842 2 3479999986543 34467899999999999999999999999766554 9999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC-
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD- 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~- 834 (973)
||+.+|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999886668999999999999999999999 7899999999999999999999999999998654321
Q ss_pred --CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 835 --PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 835 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
........+|+.|+|||...+..++.++|||||||++|||++|+.|+...... ......+......
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~----------- 247 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRL----------- 247 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCC-----------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCCC-----------
Confidence 11223446789999999999989999999999999999999966664332221 2222222211100
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
..+..+++.+.+++.+||+.||++|||++|+++.|+++.+.+.
T Consensus 248 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 248 -----------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -----------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0011235668899999999999999999999999999988754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=341.92 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=205.6
Q ss_pred cCCCCCccccccCceEEEEEEeCC----CeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeee-ecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSC-SNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 753 (973)
..|...++||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++ ...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998532 3468999886543 34467899999999999999999999986 45668899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999877667999999999999999999999 789999999999999999999999999999866432
Q ss_pred CC---cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 834 DP---VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRR-KPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 834 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.. .......+|+.|+|||...+..++.++||||+|+++|||++|. .||...... .....+......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~-------- 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRL-------- 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHTTCCC--------
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhcCCCC--------
Confidence 21 1223345788999999998889999999999999999999954 455432211 111111110000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
..+..++..+.+++.+||+.+|++||+++|+++.|+++.+.+.
T Consensus 252 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 252 --------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred --------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0011235568899999999999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.58 Aligned_cols=274 Identities=21% Similarity=0.275 Sum_probs=195.6
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhcc-CCceeEEEeeeecC--Ce
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNP--GF 750 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~ 750 (973)
...++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 57899999998543 2344567889999999997 99999999999654 47
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.|+|||||+ ++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999997 5999999875 6899999999999999999999 799999999999999999999999999999865
Q ss_pred CCCC--------------------CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc
Q 048430 831 DGVD--------------------PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM 889 (973)
Q Consensus 831 ~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~ 889 (973)
.... .......+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 3211 112234579999999998776 67899999999999999999999999653221 1
Q ss_pred cHHHHHHhhC-Ccc--hhhhccc-----------c----cCCCCchhh-----hhhHHhHHHHHHHHHHHHHhccccCCC
Q 048430 890 SLKQWVAESL-PGA--VTEVVDA-----------N----LLSREDEED-----ADDFATKKTCISYIMSLALKCSAEIPE 946 (973)
Q Consensus 890 ~~~~~~~~~~-~~~--~~~~~d~-----------~----l~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~~P~ 946 (973)
.+...+.... +.. +..+..+ . ......... ......+..+++++.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 1122211111 100 0000000 0 000000000 000001113467899999999999999
Q ss_pred CCCCHHHHHHH
Q 048430 947 ERINVKDALAD 957 (973)
Q Consensus 947 ~Rpt~~evl~~ 957 (973)
+|||++|+++|
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.28 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=202.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
+.++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567888999999999999999854 67899999986542 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 999999999999998754 6899999999999999999999 89999999999999999999999999999865432
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+.... .
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~-----------~-- 224 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISRVE-----------F-- 224 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTC-----------C--
T ss_pred --ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HHHHHHhCC-----------C--
Confidence 22234568999999999988899999999999999999999999986422111 111111000 0
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
..+..++..+.+++.+||+.||++||+++|+++|-
T Consensus 225 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 225 ----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00112345688999999999999999999999983
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=349.41 Aligned_cols=272 Identities=19% Similarity=0.238 Sum_probs=200.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchh-hHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999965 7899999998654322 122456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++ |+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKT 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccc
Confidence 97 5999999887777999999999999999999999 799999999999999999999999999999865422 222
Q ss_pred cccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC---Ccchhhhcccc-c-
Q 048430 838 QTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL---PGAVTEVVDAN-L- 911 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~-l- 911 (973)
.....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .......... +..+....... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhhc
Confidence 334568999999998765 568999999999999999999999997632211 1122111111 11111111100 0
Q ss_pred -CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 -LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 -~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.................++.++.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000111223456778999999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=343.64 Aligned_cols=264 Identities=19% Similarity=0.235 Sum_probs=199.3
Q ss_pred cCCCCC-ccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGES-NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 756 (973)
+.|... +.||+|+||.||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 7899999999999984 57999999999766555567899999999985 79999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc---EEEeecccccccCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV---AHLGDFGIAKLLDGV 833 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~~~~~ 833 (973)
|+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 999999999998764 6899999999999999999999 789999999999999998776 999999998765321
Q ss_pred CC------cccccccccccccCccCCCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC--
Q 048430 834 DP------VTQTMTLATIGYMAPEYGSE-----GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP-- 900 (973)
Q Consensus 834 ~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 900 (973)
.. .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||......+..... ....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~ 244 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACPA 244 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccchh
Confidence 11 11223469999999998764 45789999999999999999999999764332211000 0000
Q ss_pred --cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 --GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 --~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+.+........ ......++.++.+++.+||+.||++||+++|+++|
T Consensus 245 ~~~~~~~~i~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCCCC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcccC-------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000000000000 00112346678999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=348.85 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=202.0
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-----hhhHHHHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-----DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
+....++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999986 568899999986542 34457899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 048430 749 GFKALIMQYMPQGSLEKWLYSH---------------------------------------NYSLTIRQRLDIMIDVASA 789 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~ 789 (973)
+..++||||+++|+|.+++... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521 1123577788999999999
Q ss_pred HHHhhhcCCCCeEEccCCCCcEEeCCCC--cEEEeecccccccCCCC---CcccccccccccccCccCCCC--CCCCcch
Q 048430 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDM--VAHLGDFGIAKLLDGVD---PVTQTMTLATIGYMAPEYGSE--GIVSISG 862 (973)
Q Consensus 790 L~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~s 862 (973)
|+||| +.+|+||||||+||+++.++ .+||+|||+++...... ........||+.|+|||.+.. ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 78999999999999998776 89999999998653222 112345579999999998764 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccc
Q 048430 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSA 942 (973)
Q Consensus 863 Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 942 (973)
|||||||++|||++|+.||......+ ....... ....... .....+++++.+++.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~------------~~~~~~~--------~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLN------------KKLCFEN--------PNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH------------CCCCTTS--------GGGGGSCHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHh------------cccccCC--------cccccCCHHHHHHHHHHcC
Confidence 99999999999999999986532211 1111111 1000000 0111245678999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 048430 943 EIPEERINVKDALAD 957 (973)
Q Consensus 943 ~~P~~Rpt~~evl~~ 957 (973)
.||++||++.|+++|
T Consensus 317 ~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 317 RNVDERFDAMRALQH 331 (345)
T ss_dssp SCTTTSCCHHHHHHS
T ss_pred CChhHCCCHHHHhcC
Confidence 999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=376.71 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=209.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
..++|...+.||+|+||.||+|.+..+..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 345677889999999999999999888899999997543 234689999999999999999999999976 678999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++|+|.+++.... ..+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 99999999997532 45899999999999999999999 799999999999999999999999999999865432111
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......++..|+|||.+....++.++|||||||++|||++ |+.||......+ ....+.. + ..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~---~---------~~--- 482 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER---G---------YR--- 482 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHT---T---------CC---
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc---C---------CC---
Confidence 2233456789999999888899999999999999999999 899986532111 1111110 0 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
...+..++..+.+++.+||+.||++||+++++++.|+.+.
T Consensus 483 -------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0111245677899999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.88 Aligned_cols=272 Identities=21% Similarity=0.236 Sum_probs=201.7
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999964 589999998865432 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+....... .
T Consensus 83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-D 157 (311)
T ss_dssp CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-c
Confidence 999999999887654 6999999999999999999999 7899999999999999999999999999998765322 2
Q ss_pred ccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhhcc-cccC
Q 048430 837 TQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEVVD-ANLL 912 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d-~~l~ 912 (973)
......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .......... ......... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhccccccccccccccccc
Confidence 2334568999999998765 678999999999999999999999996533221 1111111100 000000000 0000
Q ss_pred CC-C--ch-hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SR-E--DE-EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~-~--~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. . .. ...........++.++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0 00 0000001112356778999999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.38 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=208.9
Q ss_pred hcCCCCCc-cccccCceEEEEEEe---CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 679 TNGFGESN-LLGSGSFDNVYKATL---ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 679 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
.++|...+ .||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34566666 999999999999963 357899999987543 23357899999999999999999999999 566789
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 9999999999999998765 6999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCcc--cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 833 VDPVT--QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 833 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
..... .....+++.|+|||......++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--------- 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER--------- 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC---------
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence 33222 222346789999999888889999999999999999999 99998653221 11111111000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
...+..++.++.+++.+||+.||++||++.|+++.|+++....+.+
T Consensus 239 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 239 -------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 0011234567899999999999999999999999999998876654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.02 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=192.7
Q ss_pred cCCCCC-ccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHh-ccCCceeEEEeeeec----CCeeE
Q 048430 680 NGFGES-NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRR-IRHRNLIKIVSSCSN----PGFKA 752 (973)
Q Consensus 680 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~ 752 (973)
++|... ++||+|+||.||+|... +++.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 68999999999999864 6899999998632 456788888754 589999999998864 56789
Q ss_pred EEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeeccccc
Q 048430 753 LIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAK 828 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~ 828 (973)
+||||+++|+|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+||+++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998754 46999999999999999999999 789999999999999998 7899999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc--cHHHHHHhhCCcchhhh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM--SLKQWVAESLPGAVTEV 906 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 906 (973)
..... .......||+.|+|||++....++.++|||||||++|||++|+.||........ .....+....
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~------- 283 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------- 283 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC-------
T ss_pred ccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc-------
Confidence 65422 223445789999999999999999999999999999999999999976432221 1112111100
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
... .. .....++.++.+++.+||+.||++|||+.|+++|-
T Consensus 284 ----~~~-~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 284 ----YEF-PN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ----CCC-CT-------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ----ccC-CC-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000 00 00113456789999999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.15 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=207.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888999999999999999965 78999999987553 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP- 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 835 (973)
|+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999987654 6899999999999999999999 78999999999999999999999999999976532221
Q ss_pred cccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......|++.|+|||......+ +.++||||||+++|||++|+.||............+......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 227 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------------
Confidence 12234568999999998877665 789999999999999999999997643332222222211000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......++..+.+++.+||+.||++|||++|+++|
T Consensus 228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 --------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00011245668899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.66 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=196.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--------hhHHHHHHHHHHHHhccCCceeEEEeeeec
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--------RALKSFDTECEVMRRIRHRNLIKIVSSCSN 747 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 747 (973)
...++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999985 4689999999875421 122357899999999999999999999864
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC---CcEEEeec
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD---MVAHLGDF 824 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Df 824 (973)
+..++||||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.+ +.+||+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 45799999999999999887654 7999999999999999999999 7899999999999999754 45999999
Q ss_pred ccccccCCCCCcccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc
Q 048430 825 GIAKLLDGVDPVTQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901 (973)
Q Consensus 825 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 901 (973)
|+++.... ........||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+...+......
T Consensus 287 G~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 287 GHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGKYN 363 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHHHTTCCC
T ss_pred ccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHHhcCCCC
Confidence 99987643 22233457999999999875 366889999999999999999999999753322 2222222211100
Q ss_pred chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 902 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ......+++++.+++.+||+.||++||+++|+++|
T Consensus 364 ~~-------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 FI-------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CC-------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 01112346678999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=351.17 Aligned_cols=263 Identities=17% Similarity=0.182 Sum_probs=199.9
Q ss_pred cCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccchh-----------hHHHHHHHHHHHHhccCCceeEEEee
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQEDR-----------ALKSFDTECEVMRRIRHRNLIKIVSS 744 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~ 744 (973)
++|...+.||+|+||.||+|... ++..||||+....... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999965 5788999998755321 12346678889999999999999999
Q ss_pred eec----CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC--c
Q 048430 745 CSN----PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM--V 818 (973)
Q Consensus 745 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~--~ 818 (973)
+.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+||| +.+|+||||||+||+++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 877 77899999999 999999998765 7999999999999999999999 78999999999999999887 9
Q ss_pred EEEeecccccccCCCCC------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH
Q 048430 819 AHLGDFGIAKLLDGVDP------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892 (973)
Q Consensus 819 ~kl~Dfgla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~ 892 (973)
+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999987632211 112345799999999999888899999999999999999999999964322222111
Q ss_pred HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
....... ........ .......+++++.+++.+||+.||++||+++|+++.|+.+
T Consensus 272 ~~~~~~~-~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 272 TAKTNLL-DELPQSVL-------------KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHH-HTTTHHHH-------------HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHhhc-ccccHHHH-------------hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111100 00000000 0000013566799999999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=362.30 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=207.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...++||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999964 79999999997542 23356788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 755 MQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+||||||||+||+++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999998654 35999999999999999999999 789999999999999999999999999999876432
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcc--cHHHHHHhhCCcchhhhccccc
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM--SLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l 911 (973)
. .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+...+... +. .
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~--------~- 407 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PE--------E- 407 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CC--------C-
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cc--------c-
Confidence 2 22345799999999999888899999999999999999999999976432211 111111110 00 0
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
.+..++.++.+++.+||+.||++|| +++|+++|
T Consensus 408 -------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 -------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0112356789999999999999999 78999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=349.23 Aligned_cols=264 Identities=24% Similarity=0.412 Sum_probs=212.7
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeee
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSC 745 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 745 (973)
++++...++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556778999999999999999999854 47889999987543 23456789999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC
Q 048430 746 SNPGFKALIMQYMPQGSLEKWLYSHN---------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816 (973)
Q Consensus 746 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~ 816 (973)
.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence 99999999999999999999997532 35789999999999999999999 7899999999999999999
Q ss_pred CcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHH
Q 048430 817 MVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQW 894 (973)
Q Consensus 817 ~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 894 (973)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~ 249 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQV 249 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----HHH
Confidence 99999999999865432221 2233457889999999888889999999999999999999 8888865321 111
Q ss_pred HHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 895 VAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 895 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
......+. ... .+..++..+.+++.+||+.||++||++.|++++|+++.+
T Consensus 250 ~~~~~~~~--------~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVMEGG--------LLD-----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTTC--------CCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHcCC--------cCC-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111110 000 011345678999999999999999999999999987644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=346.21 Aligned_cols=274 Identities=22% Similarity=0.270 Sum_probs=198.2
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
...++|...+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999984 5799999999865432 234567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe-----CCCCcEEEeeccccc
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL-----DDDMVAHLGDFGIAK 828 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfgla~ 828 (973)
||||+++ +|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 111 v~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999975 9999998765 6999999999999999999999 7899999999999999 455569999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Cc-c-hh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PG-A-VT 904 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~-~~ 904 (973)
..... ........+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+ .+........ +. . +.
T Consensus 186 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTST
T ss_pred ccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhhhh
Confidence 76432 2223345689999999987764 58999999999999999999999986532211 1222222111 11 0 00
Q ss_pred hhcc-cccCCCC--chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVD-ANLLSRE--DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d-~~l~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... +...... ..........+..+++++.+++.+||+.||++|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 0000000 000001111122356778999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=348.28 Aligned_cols=276 Identities=23% Similarity=0.280 Sum_probs=202.2
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-----hhHHHHHHHHHHHHhccCCceeEEEeeeecCC
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIKIVSSCSNPG 749 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 749 (973)
....++|...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345578999999999999999999964 689999999865322 11346889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++||||+++ +|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999986 899999887667999999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cchhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAVTE 905 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 905 (973)
..... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+......... ..+.+
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhh
Confidence 64322 22344578999999998765 45899999999999999999999998653221 112222221111 11111
Q ss_pred hcc-cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVD-ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d-~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... +...................++.++.+++.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000000000000001112345779999999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=362.28 Aligned_cols=249 Identities=24% Similarity=0.273 Sum_probs=196.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...++||+|+||.||+|+. .+++.||||+++.. .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46788899999999999999985 57899999999754 223346678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|||+++|+|.+++.... .+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999998765 7999999999999999999999 6 89999999999999999999999999999864322
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.. ....
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~-----------~~~~- 367 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM-----------EEIR- 367 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-----------CCCC-
T ss_pred -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHh-----------CCCC-
Confidence 2223446799999999999888999999999999999999999999865321 111111110 0000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
.+..+++++.+++.+||+.||++|| +++|+++|
T Consensus 368 -----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0112356688999999999999999 99999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=373.52 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=201.8
Q ss_pred ccccccCceEEEEEEe---CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
+.||+|+||.||+|.+ ..++.||||+++... ....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 356889999997543 2345789999999999999999999999965 457899999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc--cc
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQ 838 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~ 838 (973)
|+|.+++.... .+++.++..++.||+.||+||| +.+||||||||+||+++.++.+||+|||+++........ ..
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999998765 7999999999999999999999 789999999999999999999999999999876433221 22
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....+|+.|+|||.+....++.++|||||||++|||++ |+.||...... .+...+... ..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~------------~~----- 590 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKG------------ER----- 590 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT------------CC-----
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------------CC-----
Confidence 33457789999999988899999999999999999998 99998653221 111111110 00
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
...+..++.++.+++.+||+.||++||+++++++.|+++...+
T Consensus 591 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 591 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0111235677999999999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=344.70 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=207.6
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--------hhhHHHHHHHHHHHHhc-cCCceeEEE
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--------DRALKSFDTECEVMRRI-RHRNLIKIV 742 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~ 742 (973)
.......++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344455678999999999999999999975 79999999987543 12246788999999999 799999999
Q ss_pred eeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEe
Q 048430 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822 (973)
Q Consensus 743 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 822 (973)
+++...+..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999998654 6999999999999999999999 7899999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccccccCccCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHH
Q 048430 823 DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS------EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA 896 (973)
Q Consensus 823 Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 896 (973)
|||++....... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~ 318 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMIM 318 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHH
Confidence 999998765322 233457999999999764 34688999999999999999999999865211 11111111
Q ss_pred hhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 897 ESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 897 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... .. . .......++..+.+++.+||+.||++||+++|+++|
T Consensus 319 ~~~-----------~~--~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 EGQ-----------YQ--F------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HTC-----------CC--C------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hCC-----------CC--C------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 100 00 0 001111245668999999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=359.09 Aligned_cols=269 Identities=22% Similarity=0.200 Sum_probs=198.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------C
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------G 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 749 (973)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788999999999999999985 46899999999754 334467888999999999999999999998654 4
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 67999999976 57776653 4899999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--------
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG-------- 901 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 901 (973)
.... ......+||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... ..+...+......
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHTTS
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHc
Confidence 6432 2334567999999999999999999999999999999999999999653211 1111111111100
Q ss_pred --chhhhccccc--CCCCchhh------hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 902 --AVTEVVDANL--LSREDEED------ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 902 --~~~~~~d~~l--~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....++... ........ ...........+++.+++.+||+.||++|||++|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00000000 00011122346779999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=333.66 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=202.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch------hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED------RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
++|...+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999965 689999999875421 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC----cEEEeeccccc
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM----VAHLGDFGIAK 828 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~ 828 (973)
+||||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||.+.
T Consensus 85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999997654 6899999999999999999999 78999999999999998877 89999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
...... ......+++.|+|||......++.++||||||+++|||++|+.||...... ..........
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~------ 227 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----ETLTNISAVN------ 227 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTC------
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----HHHHHhHhcc------
Confidence 764322 223456899999999998889999999999999999999999998653211 1111100000
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ... ......++..+.+++.+||+.||++||++.|+++|
T Consensus 228 --~--~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 --Y--DFD------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --C--CCC------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --c--CCc------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 000 01112345678999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=351.11 Aligned_cols=264 Identities=13% Similarity=0.116 Sum_probs=206.6
Q ss_pred cCCCCCccccccCceEEEEEEeC---------CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeE----------
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA---------NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK---------- 740 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------- 740 (973)
++|...+.||+|+||.||+|+.. +++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57888999999999999999965 3789999998744 46789999999999999987
Q ss_pred -----EEeeeec-CCeeEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 741 -----IVSSCSN-PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 741 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+++++.. .+..++||||+ +++|.+++... ...+++.++..++.||+.||+||| +.+|+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence 5666654 78889999999 99999999875 247999999999999999999999 7899999999999999
Q ss_pred CCCC--cEEEeecccccccCCCCC------cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 048430 814 DDDM--VAHLGDFGIAKLLDGVDP------VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMF 885 (973)
Q Consensus 814 ~~~~--~~kl~Dfgla~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~ 885 (973)
+.++ .+||+|||+++....... .......||+.|+|||...+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 999999999986543211 11233479999999999998899999999999999999999999997643
Q ss_pred cCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 886 TGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
.....+........ .......+.. .....++.++.+++.+||+.||++||+++|+++.|+++.+..
T Consensus 273 ~~~~~~~~~~~~~~-~~~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 273 PNTEDIMKQKQKFV-DKPGPFVGPC-------------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TCHHHHHHHHHHHH-HSCCCEECTT-------------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCHHHHHHHHHhcc-CChhhhhhhc-------------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 23222222221110 0000000000 000123566899999999999999999999999999988764
Q ss_pred H
Q 048430 966 T 966 (973)
Q Consensus 966 ~ 966 (973)
.
T Consensus 339 ~ 339 (352)
T 2jii_A 339 R 339 (352)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.51 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=197.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688889999999999999986 4689999999876542 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe---CCCCcEEEeecccccccC
Q 048430 758 MPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 758 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~ 831 (973)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 247999999999999999999999 7899999999999999 556889999999998654
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
.. .......+++.|+|||.+. ..++.++|||||||++|||++|+.||...... ..........+. .
T Consensus 179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~---------~ 244 (285)
T 3is5_A 179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEPN---------Y 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC---------C
T ss_pred Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccCCcc---------c
Confidence 32 2233456899999999875 56899999999999999999999998653211 111111110000 0
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ...+++++.+++.+||+.||++||+++|+++|
T Consensus 245 ~~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 245 AVE-----------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CC-------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccc-----------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00124568899999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.45 Aligned_cols=266 Identities=20% Similarity=0.280 Sum_probs=203.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeec--CCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSN--PGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+++.||||+++... .+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999985 578999999986433 367899999999997 9999999999987 67789999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 834 (973)
||+++++|.+++. .+++.++..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999999986 3789999999999999999999 79999999999999999776 89999999998764322
Q ss_pred CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||.........+.............+.++..-..
T Consensus 186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2334568999999998776 6789999999999999999999999854332222222222111111111111110000
Q ss_pred -------------CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 -------------REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 -------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
............+..+++++.+++.+||+.||++|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000111122356789999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.53 Aligned_cols=274 Identities=23% Similarity=0.319 Sum_probs=205.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeec--------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSN-------- 747 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 747 (973)
.++|...+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35788899999999999999996 5789999998865432 234678899999999999999999999876
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
.+..++||||+++ ++.+.+......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999975 888888876667999999999999999999999 789999999999999999999999999999
Q ss_pred cccCCCC---CcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh--CCc
Q 048430 828 KLLDGVD---PVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES--LPG 901 (973)
Q Consensus 828 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--~~~ 901 (973)
+...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ......... .+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh
Confidence 8764222 122344578999999997765 558999999999999999999999987632211 111111111 111
Q ss_pred c-hhhhcccccCCC-----CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 902 A-VTEVVDANLLSR-----EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 902 ~-~~~~~d~~l~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. +....+...... ...............++++.+++.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1 111111111000 0000111111112235678999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.00 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=205.2
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec---------
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN--------- 747 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 747 (973)
...+|...+.||+|+||.||+|+.. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888999999999999999975 79999999987553 356789999999999999999998753
Q ss_pred -------CCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 748 -------PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 748 -------~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
....++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 445799999999999999997643 47999999999999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 820 HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
||+|||++....... ......+++.|+|||...+..++.++|||||||++|||++|..|+... ..+....
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~~- 231 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTDL- 231 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHHH-
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHHh-
Confidence 999999998765322 223446899999999988888999999999999999999999886321 1111110
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhccc
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQALHL 971 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~~~ 971 (973)
.+..+. ..++..+.+++.+||+.||++||++.|++++|+.+.+......+.
T Consensus 232 -------~~~~~~--------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~~ 282 (284)
T 2a19_B 232 -------RDGIIS--------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282 (284)
T ss_dssp -------HTTCCC--------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--------
T ss_pred -------hccccc--------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccccc
Confidence 000000 113455789999999999999999999999999998876665543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.03 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=203.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456888999999999999999964 7899999999866544456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe---CCCCcEEEeecccccccCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~~ 834 (973)
+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 99999999997654 6899999999999999999999 7899999999999999 7889999999999875432
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......|++.|+|||...+..++.++||||+||++|||++|+.||...... .....+.... . ..
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~-----------~-~~ 226 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGY-----------Y-EF 226 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCC-----------C-CC
T ss_pred -CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCC-----------C-CC
Confidence 2223446899999999999999999999999999999999999998653211 1111111100 0 00
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. .....++.++.+++.+||+.||++||+++|+++|
T Consensus 227 ~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 ES-------PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CT-------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred Cc-------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 0011245678999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=348.29 Aligned_cols=276 Identities=20% Similarity=0.216 Sum_probs=205.4
Q ss_pred HHHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc-----------hhhHHHHHHHHHHHHhccCCceeE
Q 048430 672 YHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE-----------DRALKSFDTECEVMRRIRHRNLIK 740 (973)
Q Consensus 672 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~ 740 (973)
..++....++|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 467788889999999999999999999998889999999885432 122478999999999999999999
Q ss_pred EEeeee-----cCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC
Q 048430 741 IVSSCS-----NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815 (973)
Q Consensus 741 l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~ 815 (973)
+++++. .....++||||++ |+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 999983 3446899999997 6999999877668999999999999999999999 789999999999999999
Q ss_pred CCcEEEeecccccccCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHH
Q 048430 816 DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894 (973)
Q Consensus 816 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~ 894 (973)
++.+||+|||+++.... ........+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i 246 (362)
T 3pg1_A 170 NNDITICDFNLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLNKI 246 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred CCCEEEEecCccccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 99999999999975432 222344578999999998766 67899999999999999999999999753211 111222
Q ss_pred HHhhCCcch-----------hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 895 VAESLPGAV-----------TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 895 ~~~~~~~~~-----------~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+........ .+.......... ..........+++.+.+++.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP---ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC---CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCC---hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 211111111 111111111100 001111222346778999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.17 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=198.4
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec----CCeeEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN----PGFKAL 753 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 753 (973)
.|...+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 356677899999999999985 568899999987543 3446788999999999999999999998754 456899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeC-CCCcEEEeeccccccc
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLD-DDMVAHLGDFGIAKLL 830 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~ 830 (973)
||||+++++|.+++.... .+++..+..++.|++.||.||| +.+ |+||||||+||+++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999998754 6899999999999999999999 777 99999999999997 7899999999999765
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
... ......|++.|+|||.+. +.++.++||||+||++|||++|+.||..... ..........+....
T Consensus 183 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~----- 249 (290)
T 1t4h_A 183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVKPA----- 249 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCCCG-----
T ss_pred ccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHHHHHhccCCcc-----
Confidence 322 223456899999999776 4589999999999999999999999865322 222222111111000
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++||+++|+++|
T Consensus 250 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0011224568899999999999999999999976
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=354.16 Aligned_cols=164 Identities=20% Similarity=0.221 Sum_probs=98.5
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
|..+++|+.|++++|.+.+..+..|..+++|++|++++|.+.+.+|.. +....+|+
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~------------------------~~~~~~L~ 227 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN------------------------CLYGLNLT 227 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTT------------------------TTTTCCCS
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcc------------------------cccCcccc
Confidence 334455555555555555555555555555555555555544444433 33334555
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
+|++++|++++..+..|..+++|+.|++++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 228 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 307 (477)
T 2id5_A 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307 (477)
T ss_dssp EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence 55565555554444455556666666666666665555556666666777777777766666666667777777777777
Q ss_pred cccCCCCCcccccccccccccccccCCC
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNISGE 554 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (973)
|++..+..|..+++|+.|+|++|.+++.
T Consensus 308 l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 308 LTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp CSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred CceeCHhHcCCCcccCEEEccCCCccCc
Confidence 7655555666677777777777776643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=350.32 Aligned_cols=255 Identities=23% Similarity=0.278 Sum_probs=204.0
Q ss_pred hcCCCCCccccccCceEEEEEEe----CCCeEEEEEEEeccc----hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQE----DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPG 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 749 (973)
.++|...++||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999986 478999999986432 22345677899999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999998754 6999999999999999999999 78999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~------ 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS------ 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc------
Confidence 64333333344579999999998775 357899999999999999999999996532221 122221111000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALADL 958 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~L 958 (973)
.+ ..+..++..+.+++.+||+.||++|| +++|+++|.
T Consensus 282 ~~--------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EP--------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CC--------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CC--------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00 00112345688999999999999999 999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.89 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=199.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
++|....+||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455567999999999999995 578899999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeecccccccCCCCC
Q 048430 759 PQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 759 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~ 835 (973)
++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||.+........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999998753 34678899999999999999999 789999999999999987 89999999999987643221
Q ss_pred cccccccccccccCccCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEG--IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
......|++.|+|||..... .++.++||||||+++|||++|+.||................. ..+.
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~--- 246 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--------VHPE--- 246 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--------CCCC---
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--------cccc---
Confidence 22345689999999987654 378999999999999999999999864322111110000000 0000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..++.++.+++.+||+.||++||+++|+++|
T Consensus 247 -----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 -----------IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -----------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -----------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011245668899999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=345.70 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=204.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEE--EEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSV--AVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||.||+|+. .++..+ |+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5678889999999999999985 456654 999886532 33456789999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 755 MQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
|||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999998653 36899999999999999999999 7999999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhh
Q 048430 820 HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 898 (973)
||+|||+++.... ........+++.|+|||......++.++|||||||++|||++ |+.||..... .......
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~ 254 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL 254 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHG
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHHHHh
Confidence 9999999874321 112233457889999999888889999999999999999998 9999865321 1111111
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
..+ ... ..+..+++++.+++.+||+.+|++||+++|++++|+++.+..
T Consensus 255 ~~~---------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 255 PQG---------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GGT---------CCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hcC---------CCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 100 000 011134567899999999999999999999999999987654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.42 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=206.7
Q ss_pred hcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...+.||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788899999999999999983 35778999998644 234456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEe
Q 048430 752 ALIMQYMPQGSLEKWLYSHN------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLG 822 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 822 (973)
++||||+++++|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998754 35899999999999999999999 789999999999999984 4569999
Q ss_pred ecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCC
Q 048430 823 DFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 823 Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
|||++........ .......+++.|+|||.+....++.++|||||||++|||++ |+.||..... ......+.....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~ 263 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR 263 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCCC
Confidence 9999976533222 12234567899999999888889999999999999999998 8899865321 111111111000
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
. ..+..++..+.+++.+||+.||++||++.|++++|+.+.+...
T Consensus 264 ------------~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 264 ------------M----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ------------C----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 0 0011345678899999999999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.66 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=201.6
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 755 (973)
..++|...+.||+|+||.||+|... +++.||||+++.... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467888999999999999999864 689999999975532 245688888887 7999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC----CcEEEeecccccccC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKLLD 831 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~~~ 831 (973)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||++..+ +.+||+|||+++...
T Consensus 96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999998765 6999999999999999999999 7899999999999998543 359999999998764
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............+. .
T Consensus 172 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~--------~ 240 (342)
T 2qr7_A 172 AEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSGK--------F 240 (342)
T ss_dssp CTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHHHCC--------C
T ss_pred CCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHccCC--------c
Confidence 332 223345789999999988877789999999999999999999999975321 12222211111000 0
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.... ..+..+++++.+++.+||+.||++||++.|+++|=
T Consensus 241 ~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 241 SLSG--------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp CCCS--------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ccCc--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0000 00112456788999999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=337.98 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=199.0
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec-CCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|+.. ++.||||+++... ..+.+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 457888899999999999999875 8999999986543 44779999999999999999999998754 4578999999
Q ss_pred cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999998653 23789999999999999999999 789999999999999999999999999998765322
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....+++.|+|||...+..++.++||||||+++|||++ |+.||...... .....+. .+ ..
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~---~~---------~~--- 232 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE---KG---------YK--- 232 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHT---TT---------CC---
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh---cC---------CC---
Confidence 123357889999999888889999999999999999998 99998653221 1111110 00 00
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
...+..+++.+.+++.+||+.||++||++.|+++.|++++..
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 -------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 001123456789999999999999999999999999988753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=352.64 Aligned_cols=199 Identities=24% Similarity=0.313 Sum_probs=168.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----Ce
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 750 (973)
.++|...+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46788999999999999999985 46899999999653 234457889999999999999999999998765 57
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.|+||||++ |+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999996 59999998754 6999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCc---------------------ccccccccccccCccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 048430 831 DGVDPV---------------------TQTMTLATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRRKPTN 882 (973)
Q Consensus 831 ~~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~sDvws~Gvvl~elltg~~p~~ 882 (973)
...... .....+||+.|+|||.+ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 432211 12456799999999974 56679999999999999999998766654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=347.82 Aligned_cols=253 Identities=17% Similarity=0.136 Sum_probs=205.0
Q ss_pred HhcCCCCCccccccCceEEEEEE------eCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc---CCceeEEEeeeecC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKAT------LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR---HRNLIKIVSSCSNP 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 748 (973)
..++|...+.||+|+||.||+|. ..+++.||||+++... ...+.+|++++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678888999999999999994 4568999999986543 356788888888886 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---------
Q 048430 749 GFKALIMQYMPQGSLEKWLYS----HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD--------- 815 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--------- 815 (973)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||+||| +.+||||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975 2346999999999999999999999 899999999999999998
Q ss_pred --CCcEEEeecccccccCCC-CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH
Q 048430 816 --DMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892 (973)
Q Consensus 816 --~~~~kl~Dfgla~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~ 892 (973)
++.+||+|||+|+..... .........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+...
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 899999999999765321 222344567999999999999989999999999999999999999998543221110
Q ss_pred HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHHHHHHHH
Q 048430 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER-INVKDALADLKKIKKIL 965 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-pt~~evl~~L~~~~~~~ 965 (973)
.+..+... ...+.+.+++..|++.+|.+| |+++++.+.|+++.+..
T Consensus 295 --------------~~~~~~~~-------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 --------------PEGLFRRL-------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --------------ECSCCTTC-------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------------echhcccc-------------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00001000 013456789999999999998 57888888888877653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.26 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=206.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888899999999999999965 68899999987542 34457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++.... .+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999987754 6899999999999999999999 7899999999999999999999999999998764322
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......|++.|+|||...+..++.++||||||+++|||++|+.||...... ......... ...
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~--------~~~-- 233 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKKN--------EYS-- 233 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTT--------CCC--
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhhc--------cCC--
Confidence 2233456899999999998888999999999999999999999998653211 111110000 000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.+..++..+.+++.+||+.||++||+++|++++-
T Consensus 234 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 234 ----------IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----------CccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0112345688999999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.73 Aligned_cols=273 Identities=23% Similarity=0.282 Sum_probs=202.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356888899999999999999965 58999999986543 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999988888766544 6999999999999999999999 7899999999999999999999999999998654322
Q ss_pred cccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhhcccc--
Q 048430 836 VTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEVVDAN-- 910 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~-- 910 (973)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .+........ ...........
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhccc
Confidence 223345689999999987765 78999999999999999999999986532211 1111111110 00000000000
Q ss_pred ---cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 ---LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 ---l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..................+++++.+++.+||+.||++|||++|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000001111122457789999999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=357.95 Aligned_cols=194 Identities=23% Similarity=0.322 Sum_probs=154.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeec-----CCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSN-----PGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 750 (973)
.++|...++||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36789999999999999999985 47899999998643 23445788999999999999999999999843 367
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.|+||||+ +++|.+++.... .+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 469999998754 7999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCC--------------------------cccccccccccccCccCC-CCCCCCcchhHHHHHHHHHHHHhC
Q 048430 831 DGVDP--------------------------VTQTMTLATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTR 877 (973)
Q Consensus 831 ~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvws~Gvvl~elltg 877 (973)
..... ......+||+.|+|||.+ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 42211 122345789999999965 566799999999999999999994
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=352.42 Aligned_cols=263 Identities=19% Similarity=0.212 Sum_probs=210.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC-CceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH-RNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...++||+|+||.||+|+. .+++.||||++...... ..+.+|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999995 57999999988755432 457899999999986 566667777788889999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe---CCCCcEEEeecccccccCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+ +++|.+++......+++.+++.|+.||+.||+||| +.+||||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 89999999876668999999999999999999999 7899999999999999 68899999999999876543
Q ss_pred CCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 834 DPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 834 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .+.+...........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~i~~~~~~~~- 236 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEKISEKKVATS- 236 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHHHHHHHHHSC-
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHHHhhcccccc-
Confidence 321 12245799999999999999999999999999999999999999976433221 111111000000000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.......++.++.+++..||+.+|++||+++++++.|+++.+.
T Consensus 237 --------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 237 --------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp --------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0011123567899999999999999999999999999988764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.04 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=190.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeee--------cC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCS--------NP 748 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~ 748 (973)
..+|...++||+|+||.||+|+. .+++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34788889999999999999995 478999999987666666778999999999996 999999999983 34
Q ss_pred CeeEEEEEecCCCCHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeCCCCcEEEeec
Q 048430 749 GFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
...++||||+. |+|.+++.. ....+++.++..++.|++.||+||| +.+ |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 56799999996 699998875 3346999999999999999999999 777 999999999999999999999999
Q ss_pred ccccccCCCCCcc-----------cccccccccccCccCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCccc
Q 048430 825 GIAKLLDGVDPVT-----------QTMTLATIGYMAPEYG---SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS 890 (973)
Q Consensus 825 gla~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~ 890 (973)
|+++......... .....+|+.|+|||.+ ....++.++|||||||++|||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998765322211 1134589999999987 5667899999999999999999999998642111
Q ss_pred HHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
.... ....... ...++..+.+++.+||+.||++||+++|++++|+.+.+..
T Consensus 260 --~~~~------------~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 --RIVN------------GKYSIPP----------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------CCCCT----------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --Hhhc------------CcccCCc----------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0000 0000000 0112234778999999999999999999999999988653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=360.37 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=205.8
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788899999999999999964 69999999997543 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997643 46999999999999999999999 79999999999999999999999999999987643
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
... .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .......... .....
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~--------~~~~~ 411 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVL--------EQAVT 411 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHH--------HCCCC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHh--------hcccC
Confidence 222 2234579999999999999899999999999999999999999997643211 1112111110 00000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV-----KDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~-----~evl~~ 957 (973)
.+..++.++.+++.+||+.||++||++ +|+++|
T Consensus 412 ------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 ------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 012245678899999999999999965 677654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.28 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=205.0
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888899999999999999864 68899999986542 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 99999999999998765 6899999999999999999999 899999999999999999999999999998765422
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......|++.|+|||...+..++.++||||||+++|||++|+.||...... ...... ......
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~--------~~~~~~-- 230 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRI--------VNVDLK-- 230 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH--------HTTCCC--
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHH--------hccccC--
Confidence 223456899999999999889999999999999999999999998653211 111110 000000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..++.++.+++.+|++.||++||+++|+++|
T Consensus 231 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 ----------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 011234568899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.72 Aligned_cols=251 Identities=25% Similarity=0.291 Sum_probs=188.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||.||+|+. .+++.||||+++... ....+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999996 579999999987542 222344455556678889999999999999999999999
Q ss_pred EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 756 QYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYST-PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 756 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
||+++ +|.+++.. ....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99974 88887764 3457999999999999999999999 66 99999999999999999999999999998664
Q ss_pred CCCCcccccccccccccCccCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYG----SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.. .......||+.|+|||.+ ....++.++|||||||++|||++|+.||.........+...+....+..
T Consensus 162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 234 (290)
T 3fme_A 162 DD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL----- 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC-----
T ss_pred cc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc-----
Confidence 32 223334689999999984 5667899999999999999999999999753222222222211111000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....++.++.+++.+||+.||++|||++|+++|
T Consensus 235 -----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 -----------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -----------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -----------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 001235668899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.19 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=205.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999965 78999999987653 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST-PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
+++++|.+++.... .+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++..... .
T Consensus 113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 185 (360)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---H
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---c
Confidence 99999999998765 6899999999999999999999 54 899999999999999999999999999875422 1
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc---------------
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--------------- 901 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------------- 901 (973)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+.....+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC--------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccCCCCCCCcccCCCc
Confidence 2233568999999999999899999999999999999999999996532211 11110000000
Q ss_pred ------------chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 902 ------------AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 902 ------------~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
...+..+....... .......++.++.+++.+||+.||++|||++|+++|-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPP------PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCC------CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ccccccCCCCcccchhhhhHHhccCC------CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00000000000000 0000112456799999999999999999999999883
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.04 Aligned_cols=245 Identities=25% Similarity=0.284 Sum_probs=191.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHH-HHhccCCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEV-MRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888999999999999999964 68899999997553 2234556677776 567899999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999998754 6899999999999999999999 799999999999999999999999999999864322
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
. ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... +....+..
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~--------i~~~~~~~ 258 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN--------ILNKPLQL 258 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHH--------HHHSCCCC
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH--------HHhcccCC
Confidence 2 233446799999999999998999999999999999999999999965321 111111 11110000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKD 953 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~e 953 (973)
+..++.++.+++.+||+.||++||++.+
T Consensus 259 ------------~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 259 ------------KPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------------CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------------CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0123456889999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.97 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=202.1
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
...++|...+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567889999999999999999865 58999999987543 2467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 999999999999865557999999999999999999999 7999999999999999999999999999998764322
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......+++.|+|||......++.++||||||+++|||++|+.||....... ....+..... ...
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------~~~---- 245 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPP--------PTF---- 245 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC--------CCC----
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCC--------ccc----
Confidence 22334568999999999988889999999999999999999999986532111 0000000000 000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..++..+.+++.+||+.||++||++.|+++|
T Consensus 246 --------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 --------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp --------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0112245678999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=343.10 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=201.1
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
..++|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467888999999999999999965 689999999876655566889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 99999999999876667999999999999999999999 789999999999999999999999999987543210 11
Q ss_pred ccccccccccccCccCC-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 837 TQTMTLATIGYMAPEYG-----SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~-----~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
......|++.|+|||.. ....++.++|||||||++|||++|+.||....... ..........+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----------- 240 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPP----------- 240 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC-----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCc-----------
Confidence 12234689999999976 46778999999999999999999999986532211 01111110000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ...+..++.++.+++.+||+.||++|||+.|+++|
T Consensus 241 -~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 -T---------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -C---------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -c---------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00112345678999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=355.63 Aligned_cols=252 Identities=19% Similarity=0.225 Sum_probs=194.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc---chhhHHHHHHHHH---HHHhccCCceeEEE-------ee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ---EDRALKSFDTECE---VMRRIRHRNLIKIV-------SS 744 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~l~-------~~ 744 (973)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+. .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45677889999999999999995 57999999998743 3345678999995 55555899999998 55
Q ss_pred eecCC-----------------eeEEEEEecCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 048430 745 CSNPG-----------------FKALIMQYMPQGSLEKWLYSHN------YSLTIRQRLDIMIDVASALEYLHHGYSTPI 801 (973)
Q Consensus 745 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 801 (973)
+..++ ..++||||+ +|+|.+++.... ..+++..+..|+.||+.||+||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 54443 378999999 679999998643 12335888899999999999999 7899
Q ss_pred EEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCCCCC-----------CCCcchhHHHHHHH
Q 048430 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG-----------IVSISGDVYSFGIL 870 (973)
Q Consensus 802 vH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDvws~Gvv 870 (973)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||.+... .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334457 999999988877 79999999999999
Q ss_pred HHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC
Q 048430 871 MMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN 950 (973)
Q Consensus 871 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 950 (973)
+|||++|+.||........ ...+.. . ...+++++.+++.+||+.||++||+
T Consensus 303 l~elltg~~Pf~~~~~~~~-------------~~~~~~-~---------------~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG-------------SEWIFR-S---------------CKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHHHSSCCC------CC-------------SGGGGS-S---------------CCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHHHHHCCCCCcccccccc-------------hhhhhh-h---------------ccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999999864321110 000100 0 0123566889999999999999999
Q ss_pred HHHHHHH--HHHHHHHHHhh
Q 048430 951 VKDALAD--LKKIKKILTQA 968 (973)
Q Consensus 951 ~~evl~~--L~~~~~~~~~~ 968 (973)
+.|+++| ++++.+.....
T Consensus 354 ~~e~l~hp~f~~~~~~~~~~ 373 (377)
T 3byv_A 354 PLQAMETPEYEQLRTELSAA 373 (377)
T ss_dssp HHHHHTSHHHHHHHHHHHHH
T ss_pred HHHHhhChHHHHHHHHHHHh
Confidence 9999984 55555555443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.47 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=205.8
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888899999999999999964 58899999987542 34467789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999987754 6999999999999999999999 7899999999999999999999999999998764322
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ...... ......
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~--------~~~~~~-- 259 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRI--------KKNEYS-- 259 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH--------HHTCCC--
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHH--------hcCCCC--
Confidence 2234456899999999988888999999999999999999999998653211 111100 000000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..++..+.+++.+||+.||++||+++|+++|
T Consensus 260 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 ----------IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011234568899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=333.82 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=207.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.+.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688889999999999999985 578999999997553 3446789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+....... .
T Consensus 101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 99999999999764 6899999999999999999999 7899999999999999999999999999998764322 2
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
......|++.|+|||...+..++.++||||||+++|||++|+.||...... .....+..... +.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~----- 239 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNP--------PTL----- 239 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC--------CCC-----
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCC--------CCC-----
Confidence 233456899999999999889999999999999999999999998653211 11111111000 000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
+..++..+.+++.+||+.||++||++.|++++.
T Consensus 240 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 ---------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 012345688999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=346.91 Aligned_cols=271 Identities=23% Similarity=0.247 Sum_probs=199.3
Q ss_pred HHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec-------
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN------- 747 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 747 (973)
+...++|...+.||+|+||.||+|+. .+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 5799999999865432 23479999999999999999999843
Q ss_pred -------------------------------CCeeEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHh
Q 048430 748 -------------------------------PGFKALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYL 793 (973)
Q Consensus 748 -------------------------------~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~L 793 (973)
....++||||++ |+|.+.+.. ....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999998 488777753 335799999999999999999999
Q ss_pred hhcCCCCeEEccCCCCcEEeC-CCCcEEEeecccccccCCCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHH
Q 048430 794 HHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILM 871 (973)
Q Consensus 794 H~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl 871 (973)
| +.+|+||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9 89999999999999997 68899999999998764322 23345689999999987664 589999999999999
Q ss_pred HHHHhCCCCCCccccCcccHHHHHHhhCCcchhh--hcccccCCCCc---hhhhhhHHhHHHHHHHHHHHHHhccccCCC
Q 048430 872 METFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE--VVDANLLSRED---EEDADDFATKKTCISYIMSLALKCSAEIPE 946 (973)
Q Consensus 872 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~d~~l~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~ 946 (973)
|||++|+.||...... ..+...+.......... ..++....... ....-....+..++.++.+++.+||+.||+
T Consensus 233 ~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999753221 12222222211111111 11111111000 000011112233567799999999999999
Q ss_pred CCCCHHHHHHH
Q 048430 947 ERINVKDALAD 957 (973)
Q Consensus 947 ~Rpt~~evl~~ 957 (973)
+|||+.|+++|
T Consensus 312 ~R~t~~e~l~h 322 (383)
T 3eb0_A 312 LRINPYEAMAH 322 (383)
T ss_dssp GSCCHHHHHTS
T ss_pred hCCCHHHHhcC
Confidence 99999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=355.81 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=203.1
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888999999999999999964 78999999986442 234578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC---CCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~~ 832 (973)
||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999887764 6999999999999999999999 78999999999999995 566899999999987643
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
. .......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||...... .....+... ...
T Consensus 177 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~-----------~~~ 240 (486)
T 3mwu_A 177 N--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETG-----------KYA 240 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT-----------CCC
T ss_pred C--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------CCC
Confidence 2 22334579999999998765 5899999999999999999999998653211 111111110 000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ..+....+++++.+++.+||+.||++|||+.|+++|
T Consensus 241 ~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 F--------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S--------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C--------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 001112345678999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=339.49 Aligned_cols=262 Identities=19% Similarity=0.251 Sum_probs=205.6
Q ss_pred CCHHHHHHHhcCCCCC-ccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhcc-CCceeEEEee
Q 048430 670 ISYHELQQATNGFGES-NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIR-HRNLIKIVSS 744 (973)
Q Consensus 670 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~ 744 (973)
+.+...+...++|... +.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344445555667776 88999999999999864 689999999875432 33578899999999995 6999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEE
Q 048430 745 CSNPGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAH 820 (973)
Q Consensus 745 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~k 820 (973)
+.+.+..++||||+++|+|.+++... ...+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998654 257999999999999999999999 789999999999999998 78999
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
|+|||+++...... ......||+.|+|||.+....++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~ 250 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQVNV 250 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCC
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhccc
Confidence 99999998764322 2234579999999999998999999999999999999999999986532211 1111111000
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. .. .....++..+.+++.+||+.||++|||++|+++|
T Consensus 251 ~~-------------~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DY-------------SE------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CC-------------CT------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cc-------------Cc------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 00 0011245668899999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.44 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=196.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999965 79999999987543 22356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||+++++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999998765 6899999999999999999999 7899999999999999999999999999998764322
Q ss_pred CcccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
......+++.|+|||...+..+ +.++||||||+++|||++|+.||...... .....+... ...
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~------------~~~ 229 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGG------------VFY 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC------------CCC
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcC------------ccc
Confidence 2234468999999998887665 68999999999999999999998652211 111111110 000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..++..+.+++.+||+.||++||++.|+++|
T Consensus 230 -----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 -----------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011234568899999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.86 Aligned_cols=253 Identities=13% Similarity=0.137 Sum_probs=183.9
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch---hhHHHHHHHHHHHHhc--cCCceeEEE-------eeee
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED---RALKSFDTECEVMRRI--RHRNLIKIV-------SSCS 746 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~ 746 (973)
..|...+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4577889999999999999995 4799999999986532 3456778886655555 599988865 3332
Q ss_pred cC-----------------CeeEEEEEecCCCCHHHHhhhCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCCeEE
Q 048430 747 NP-----------------GFKALIMQYMPQGSLEKWLYSHNYSLTIRQR------LDIMIDVASALEYLHHGYSTPIIH 803 (973)
Q Consensus 747 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ivH 803 (973)
.+ ...++||||++ |+|.+++......+.+..+ ..++.||+.||+||| +.+|+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence 22 34799999998 8999999875434566666 788899999999999 799999
Q ss_pred ccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 048430 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPT 881 (973)
Q Consensus 804 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~ 881 (973)
|||||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986542 1213457799999999877 67999999999999999999999999
Q ss_pred CccccCcccHHHHHHhhCCcc-hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 882 NEMFTGEMSLKQWVAESLPGA-VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......... .... ......... .......+++.+.+++.+||+.||++||+++|+++|
T Consensus 294 ~~~~~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIKGS-------WKRPSLRVPGTDSL----------AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCTTC-------CCBCCTTSCCCCSC----------CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCcccccc-------hhhhhhhhcccccc----------chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 7643221100 0000 000000000 001112346778999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=369.94 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=208.4
Q ss_pred HhcCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
..++|...+.||+|+||.||+|... .+..||||+++... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 3467888899999999999999863 35689999986543 3445789999999999999999999999854 5689
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999987667999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
..........+|+.|+|||.+....++.++|||||||++|||++ |..||...... .....+.....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~----------- 610 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER----------- 610 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCC-----------
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCC-----------
Confidence 33333344557889999999888899999999999999999997 99998653221 11111111000
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
...+..+++.+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 611 -----------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 611 -----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0011234667899999999999999999999999999987654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=337.30 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=199.5
Q ss_pred HhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--------hhhHHHHHHHHHHHHhccCCceeEEEeeeecC
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--------DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP 748 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 748 (973)
..++|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346788999999999999999986 468999999986432 12234588999999999999999999998765
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc---EEEeecc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV---AHLGDFG 825 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 825 (973)
. .++||||+++++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 899999999999999997654 7999999999999999999999 789999999999999987664 9999999
Q ss_pred cccccCCCCCcccccccccccccCccCC---CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYG---SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
+++.... ........||+.|+|||.+ ....++.++|||||||++|||++|+.||....... .+...+.......
T Consensus 163 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 163 HSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKYNF 239 (322)
T ss_dssp TCEECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCCCC
T ss_pred cceeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCcccc
Confidence 9987642 2222345689999999975 35678999999999999999999999997543222 2222222111000
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ......++.++.+++.+||+.||++||+++|+++|
T Consensus 240 ~-------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 240 I-------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp C-------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C-------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0 00112345678999999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=337.93 Aligned_cols=345 Identities=19% Similarity=0.208 Sum_probs=222.2
Q ss_pred CCCCCCcc-eEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCc-ccccccCCcEEEccCC
Q 048430 26 TNTSASVC-NWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPN-ELWHMRRLKIIDFSSN 103 (973)
Q Consensus 26 ~~~~~~~c-~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~L~Ls~n 103 (973)
|..+.+|| .|.+..|.....+| ............-..+.+++.|++++|.+. .+|. .+..+++|++|+|++|
T Consensus 6 ~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n 79 (390)
T 3o6n_A 6 RQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79 (390)
T ss_dssp -CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTS
T ss_pred CCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCC
Confidence 33356666 45555554322222 222222233333456789999999999985 4554 4788999999999999
Q ss_pred CCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccC
Q 048430 104 SLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRI 183 (973)
Q Consensus 104 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~ 183 (973)
.+. .+|...+..+++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|..+|..+++|++|+|++|++++.
T Consensus 80 ~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~- 156 (390)
T 3o6n_A 80 QIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERI- 156 (390)
T ss_dssp CCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBC-
T ss_pred ccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCcc-
Confidence 998 566666788999999999999999888888999999999999999998 88888888899999999999998742
Q ss_pred CCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchh
Q 048430 184 PNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSI 263 (973)
Q Consensus 184 ~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 263 (973)
.|..++++++|++|++++|++++.. +.. +++|++|++++|.+++.
T Consensus 157 ----~~~~~~~l~~L~~L~l~~n~l~~~~---~~~-----------------------l~~L~~L~l~~n~l~~~----- 201 (390)
T 3o6n_A 157 ----EDDTFQATTSLQNLQLSSNRLTHVD---LSL-----------------------IPSLFHANVSYNLLSTL----- 201 (390)
T ss_dssp ----CTTTTSSCTTCCEEECCSSCCSBCC---GGG-----------------------CTTCSEEECCSSCCSEE-----
T ss_pred ----ChhhccCCCCCCEEECCCCcCCccc---ccc-----------------------ccccceeeccccccccc-----
Confidence 3456888889999999999888542 333 45555566666555432
Q ss_pred cccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCccc
Q 048430 264 CNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG 343 (973)
Q Consensus 264 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 343 (973)
...++|+.|++++|.+...... ..++|+.|++++|+++.. ..+..+++|+.|++++|.+.+..
T Consensus 202 ~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~---------~~l~~l~~L~~L~Ls~n~l~~~~----- 264 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT---------AWLLNYPGLVEVDLSYNELEKIM----- 264 (390)
T ss_dssp ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC---------GGGGGCTTCSEEECCSSCCCEEE-----
T ss_pred CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc---------HHHcCCCCccEEECCCCcCCCcC-----
Confidence 2234566666666666554322 235666666666666541 23445555555555555554332
Q ss_pred ccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCe
Q 048430 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNT 423 (973)
Q Consensus 344 ~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 423 (973)
|..|..+++|++|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.
T Consensus 265 --------------------~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~ 322 (390)
T 3o6n_A 265 --------------------YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322 (390)
T ss_dssp --------------------SGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred --------------------hhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence 2234555666666666666663 4445556666666666666666 34555566666666
Q ss_pred eecCCccccCcCcccccCcCCCCeeeccCCCCC
Q 048430 424 LLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456 (973)
Q Consensus 424 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 456 (973)
|++++|.++... +..+++|+.|++++|++.
T Consensus 323 L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 323 LYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp EECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred EECCCCccceeC---chhhccCCEEEcCCCCcc
Confidence 666666665331 445555666666666554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=334.62 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=198.3
Q ss_pred cCCCCCccccccCceEEEEEEeC--CC--eEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA--NG--VSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
++|...+.||+|+||.||+|++. ++ ..||||+++.. .....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999852 33 36899988654 2345678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+|+||+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999876557999999999999999999999 78999999999999999999999999999987654
Q ss_pred CCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 833 VDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 833 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.... ......+|..|+|||......++.++||||||+++|||++ |+.||..... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~------- 241 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEG------- 241 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSC-------
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHHHccC-------
Confidence 3322 1233457889999999888889999999999999999999 9999865321 11111110000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
.. ...+..++.++.+++.+||+.||++||++.|++++|+++...
T Consensus 242 -~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 -ER----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -CC----------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00 001123456789999999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=357.07 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=199.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 446888999999999999999964 78999999987543 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~ 832 (973)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999887654 6999999999999999999999 789999999999999976 45599999999987653
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
. .......||+.|+|||.+. ..++.++||||+||++|+|++|+.||...... .+...+.... ..
T Consensus 192 ~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~-----------~~ 255 (494)
T 3lij_A 192 Q--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGK-----------YT 255 (494)
T ss_dssp T--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC-----------CC
T ss_pred C--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-----------CC
Confidence 2 2234457999999999876 56899999999999999999999999653221 1111111100 00
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. . ......+++.+.+++.+||+.||++|||+.|+++|
T Consensus 256 ~-~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 F-D-------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C-C-------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-C-------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 0 00112345678899999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=339.17 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=187.1
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
...++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999985 478999999886543 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhh-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 755 MQYMPQGSLEKWLYS-------HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
|||+++++|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999974 2346899999999999999999999 789999999999999999999999999998
Q ss_pred cccCCCCC----cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc
Q 048430 828 KLLDGVDP----VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 828 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
........ .......||+.|+|||.... ..++.++|||||||++|||++|+.||........ . ..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-L-MLTLQNDPPS 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H-HHHHTSSCCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-H-HHHhccCCCc
Confidence 76543211 11234468999999998765 5689999999999999999999999976432211 1 1111100000
Q ss_pred h-hhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 V-TEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 ~-~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ....+... ...++.++.+++.+||+.||++||++.|+++|
T Consensus 247 ~~~~~~~~~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEM--------------LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CC--------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchh--------------hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 00000000 11234568899999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=331.75 Aligned_cols=244 Identities=17% Similarity=0.252 Sum_probs=198.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888999999999999999965 79999999987542 33456788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC---------------
Q 048430 755 MQYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD--------------- 816 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--------------- 816 (973)
|||+++++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999998642 46899999999999999999999 7899999999999999844
Q ss_pred ----CcEEEeecccccccCCCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccH
Q 048430 817 ----MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891 (973)
Q Consensus 817 ----~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~ 891 (973)
..+||+|||.+....... ...||+.|+|||.+... .++.++|||||||++|||++|..|+... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQW 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHH
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHH
Confidence 479999999998764322 23589999999987765 5678999999999999999998775321 111
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... .. ..... .+..++.++.+++.+||+.||++||++.|+++|
T Consensus 238 ~~~-~~-----------~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 HEI-RQ-----------GRLPR-----------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH-HT-----------TCCCC-----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH-Hc-----------CCCCC-----------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 10 00000 011235668999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.88 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=202.6
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeee--cCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCS--NPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l 753 (973)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999864 78999999997543 344578999999999999999999999874 4678999
Q ss_pred EEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCC-----eEEccCCCCcEEeCCCCcEEEeecc
Q 048430 754 IMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMIDVASALEYLHHGYSTP-----IIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997532 35999999999999999999999 566 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
.++...... .......+++.|+|||...+..++.++||||||+++|||++|+.||..... ..+...+....
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~------ 232 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGK------ 232 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC------
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcc------
Confidence 998764322 222344689999999998888899999999999999999999999875321 11111111100
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~ 959 (973)
... .+..++.++.+++.+||+.||++||+++|++++++
T Consensus 233 -----~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 -----FRR-----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----ccc-----------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 000 01124567899999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.00 Aligned_cols=267 Identities=23% Similarity=0.221 Sum_probs=195.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCC------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG------ 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 749 (973)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36788899999999999999985 47899999998753 2344567889999999999999999999987654
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++||||+++ +|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999975 78888863 5899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhh--CCcc-----
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES--LPGA----- 902 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~----- 902 (973)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.... ....
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCHHHH
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHH
Confidence 5422 223345789999999999888899999999999999999999999865321 11111110 0000
Q ss_pred ------hhhhccc--ccCCCCchh------hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 903 ------VTEVVDA--NLLSREDEE------DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 903 ------~~~~~d~--~l~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.....+. ......... ...........+.++.+++.+||+.||++|||++|+++|=
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000000 000000000 0001112234577899999999999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=344.24 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=196.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------C
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------G 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 749 (973)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 45788899999999999999996 57999999998543 233457789999999999999999999998765 3
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++||||+ +++|.+++... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 78999999874 5899999999999999999999 79999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEV 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 906 (973)
.... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... ..+........ +......
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHT
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHH
Confidence 5421 234578999999998766 67999999999999999999999998653211 11111111111 1000000
Q ss_pred cc--------cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VD--------ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d--------~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+. ..+....... .......+++++.+++.+|++.||++|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKD---FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCC---GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCC---HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 0000000000 000112345678999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=358.25 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=202.7
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch-------------hhHHHHHHHHHHHHhccCCceeEEEe
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-------------RALKSFDTECEVMRRIRHRNLIKIVS 743 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 743 (973)
..++|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4568999999999999999999964 688999999865421 23467899999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC---cEE
Q 048430 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM---VAH 820 (973)
Q Consensus 744 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k 820 (973)
++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999997754 6999999999999999999999 78999999999999998776 699
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
|+|||++...... .......||+.|+|||.+. +.++.++||||+||++|+|++|+.||...... .+...+..
T Consensus 190 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~--- 261 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEK--- 261 (504)
T ss_dssp ECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH---
T ss_pred EEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc---
Confidence 9999999876532 2234457999999999876 46899999999999999999999999653211 11111111
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+ ... . .......++.++.+++.+||+.||++|||++|+++|
T Consensus 262 ~--------~~~--~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 G--------KYY--F------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp C--------CCC--C------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--------CCC--C------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 000 0 011112346778999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=358.16 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=205.7
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999965 78999999986542 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe---CCCCcEEEeecccccccC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~ 831 (973)
|||+.+|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999998765 7999999999999999999999 7899999999999999 567899999999998765
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||..... ......+.... .
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~-----------~ 244 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGK-----------Y 244 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-----------C
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCC-----------C
Confidence 332 2334579999999998765 689999999999999999999999965321 11111111100 0
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. ..+....+++++.+++.+||+.+|++|||+.|+++|
T Consensus 245 ~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TF--------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CC--------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC--------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 001112346678999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.05 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=204.8
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---------hhhHHHHHHHHHHHHhcc-CCceeEEEeee
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---------DRALKSFDTECEVMRRIR-HRNLIKIVSSC 745 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 745 (973)
...++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578889999999999999999964 68999999997542 123467889999999996 99999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
...+..++||||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999998754 6899999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGS------EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
.+....... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||..... ......+...
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~- 244 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSG- 244 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT-
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHHhcC-
Confidence 998764322 233456899999999763 55689999999999999999999999865321 1111111110
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..... . .....++.++.+++.+||+.||++||+++|+++|
T Consensus 245 ----------~~~~~--~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 245 ----------NYQFG--S------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ----------CCCCC--T------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----------CcccC--c------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 00000 0 0112345678999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=341.77 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=206.1
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhh-----------------HHHHHHHHHHHHhccCCceeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRA-----------------LKSFDTECEVMRRIRHRNLIKI 741 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 741 (973)
.++|...+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788899999999999999999 89999999987543211 1789999999999999999999
Q ss_pred EeeeecCCeeEEEEEecCCCCHHHH------hhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeEEccCCCCcEEe
Q 048430 742 VSSCSNPGFKALIMQYMPQGSLEKW------LYSH-NYSLTIRQRLDIMIDVASALEYLHHGYS-TPIIHCDLKPNNVLL 813 (973)
Q Consensus 742 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill 813 (973)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||.||| + .+|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999998 6542 357999999999999999999999 6 999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCcccccccccccccCccCCCCC-CCCc-chhHHHHHHHHHHHHhCCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG-IVSI-SGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDvws~Gvvl~elltg~~p~~~~~~~~~~~ 891 (973)
+.++.+||+|||.+...... ......+++.|+|||...+. .++. ++|||||||++|||++|+.||....... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-EL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH
Confidence 99999999999999875432 33445789999999988877 5665 9999999999999999999997533211 11
Q ss_pred HHHHHhhCCcchhhhccc-ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDA-NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
...+ ..+......+. ...... ...........++.++.+++.+||+.||++||+++|+++|
T Consensus 262 ~~~i---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNI---RTKNIEYPLDRNHFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHH---TSCCCCCCCSSSSSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHH---hccCcCCccchhhhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 11110000000 000000 0000011113456779999999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.07 Aligned_cols=270 Identities=20% Similarity=0.256 Sum_probs=203.3
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc--------CCceeEEEeeee---
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR--------HRNLIKIVSSCS--- 746 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 746 (973)
.++|...++||+|+||.||+|+. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36788999999999999999985 56899999999644 334567889999999986 788999999987
Q ss_pred -cCCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCcEEeCCCC------
Q 048430 747 -NPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYST-PIIHCDLKPNNVLLDDDM------ 817 (973)
Q Consensus 747 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~------ 817 (973)
.....++||||+ ++++.+++.... ..+++..++.++.||+.||+||| ++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence 567889999999 556666665543 57999999999999999999999 67 999999999999999775
Q ss_pred -------------------------------------------cEEEeecccccccCCCCCcccccccccccccCccCCC
Q 048430 818 -------------------------------------------VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854 (973)
Q Consensus 818 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~ 854 (973)
.+||+|||.++..... .....||+.|+|||.+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999875422 23456899999999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCccc-----HHHHHHhhC--Ccch-------hhhccc--ccCCCCc--
Q 048430 855 EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS-----LKQWVAESL--PGAV-------TEVVDA--NLLSRED-- 916 (973)
Q Consensus 855 ~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~-----~~~~~~~~~--~~~~-------~~~~d~--~l~~~~~-- 916 (973)
+..++.++|||||||++|||++|+.||......+.. +........ +... ...+.. .+.....
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 888999999999999999999999999764332221 111111111 0000 000000 0000000
Q ss_pred -----hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 917 -----EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 917 -----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.........+...+.++.+++.+||+.||++|||++|+++|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00001112234567889999999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=347.24 Aligned_cols=197 Identities=21% Similarity=0.283 Sum_probs=171.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc------cCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI------RHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 751 (973)
..+|...++||+|+||.||+|.. .+++.||||+++... .....+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45788899999999999999985 468999999997542 3346778899988887 467999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc--EEEeeccccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV--AHLGDFGIAK 828 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~ 828 (973)
++||||+. ++|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 69999998765 45999999999999999999999 789999999999999999987 9999999997
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~ 884 (973)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 64321 23357899999999998888999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=364.13 Aligned_cols=250 Identities=22% Similarity=0.250 Sum_probs=205.8
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEecc---chhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQ---EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 752 (973)
..++|...++||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568899999999999999999954 6889999999754 233456788899999887 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++|+|.+++...+ .+++..++.++.||+.||+||| +.+||||||||+|||++.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999998765 6999999999999999999999 78999999999999999999999999999986432
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.. .......||+.|+|||++....++.++|||||||++|||++|+.||..... ......... ..+.
T Consensus 495 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~--------~~~~ 560 (674)
T 3pfq_A 495 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIME--------HNVA 560 (674)
T ss_dssp TT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHS--------SCCC
T ss_pred CC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHh--------CCCC
Confidence 22 233456799999999999999999999999999999999999999965321 111111111 1000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV-----KDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~-----~evl~~ 957 (973)
.+..++.++.+++.+||+.||++||++ +||++|
T Consensus 561 ------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 ------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 011245678999999999999999997 777654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=338.39 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=200.0
Q ss_pred CCHHHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeec
Q 048430 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSN 747 (973)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 747 (973)
+++.++....++|...+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34445555678899999999999999999996 5789999999875433 346788999999999 79999999999865
Q ss_pred ------CCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEE
Q 048430 748 ------PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAH 820 (973)
Q Consensus 748 ------~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 820 (973)
.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence 568899999999999999998753 46899999999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHH
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 895 (973)
|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|||++|+.||....... ....+
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~ 246 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFLI 246 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHh
Confidence 99999988654321 2233456899999999876 5678999999999999999999999986532111 11111
Q ss_pred HhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 896 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .+... ...++..+.+++.+||+.||++||+++|+++|
T Consensus 247 ~~~~--------~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 PRNP--------APRLK-------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHSC--------CCCCS-------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcCc--------cccCC-------------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1000 00000 01234568899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=338.89 Aligned_cols=272 Identities=25% Similarity=0.271 Sum_probs=203.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----Cee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 751 (973)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45788999999999999999985 478999999987543 33457889999999999999999999998654 468
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||++ |+|.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99999997 5999999875 5999999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCc--ccccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc---hhh
Q 048430 832 GVDPV--TQTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA---VTE 905 (973)
Q Consensus 832 ~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 905 (973)
..... ......||+.|+|||.+. ...++.++||||+||++|||++|+.||......+ .+........... +..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHH
Confidence 32211 123457999999999754 4558999999999999999999999997543221 2222221111110 000
Q ss_pred hcccc----cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVDAN----LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d~~----l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.. ..................++.++.+++.+||+.||++|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000001112345678999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.39 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=197.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeee-----------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS----------- 746 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 746 (973)
.++|...+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357888999999999999999965 58999999998776666788999999999999999999998873
Q ss_pred ---cCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC-CCCcEEEe
Q 048430 747 ---NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLG 822 (973)
Q Consensus 747 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 822 (973)
+....++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 5999999754 5899999999999999999999 78999999999999997 56799999
Q ss_pred ecccccccCCCCC--cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 823 DFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 823 Dfgla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
|||+++....... .......++..|+|||.... ..++.++|||||||++|||++|+.||......+ ....... ..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~-~~ 241 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILE-SI 241 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-HS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hc
Confidence 9999987643211 12233457899999997654 678999999999999999999999997532211 1111111 11
Q ss_pred Ccc----hhhhc-------ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 900 PGA----VTEVV-------DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 900 ~~~----~~~~~-------d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.. ..+.. ........ .........++.++.+++.+||+.||++||+++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPH----KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCC----CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhhhcCcccccccccCCC----CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 110 00000 00000000 00001112356789999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=343.47 Aligned_cols=265 Identities=24% Similarity=0.267 Sum_probs=185.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecC------C
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNP------G 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 749 (973)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788899999999999999984 57999999998643 233457788999999999999999999998654 5
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
..++|+|++ +++|.+++... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 67999998763 6999999999999999999999 79999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Cc-c-hhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PG-A-VTE 905 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~-~~~ 905 (973)
... ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... ..+........ +. . +..
T Consensus 182 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 182 TAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHTT
T ss_pred ccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHH
Confidence 532 1234578999999998776 67899999999999999999999999653211 11111111111 10 0 000
Q ss_pred hcc-------cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVD-------ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d-------~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.. ..+...... ........+++++.+++.+||+.||++|||++|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKM---NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCC---CHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCC---CHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 000000000 0000111245678999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=335.08 Aligned_cols=270 Identities=24% Similarity=0.327 Sum_probs=203.5
Q ss_pred HhcCCCCCccccccCceEEEEEEe--CCCeEEEEEEEeccch--hhHHHHHHHHHHHHhc---cCCceeEEEeeee----
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATL--ANGVSVAVKVFNLQED--RALKSFDTECEVMRRI---RHRNLIKIVSSCS---- 746 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 746 (973)
+.++|...+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999996 4689999999865432 2234566788777766 8999999999986
Q ss_pred -cCCeeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 747 -NPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 747 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678899999997 59999998754 35899999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Ccc-
Q 048430 825 GIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PGA- 902 (973)
Q Consensus 825 gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~- 902 (973)
|+++.... ........+++.|+|||...+..++.++|||||||++|||++|+.||...... ..+...+.... +..
T Consensus 165 g~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 165 GLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred cccccccC--CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCcc
Confidence 99986542 12233456899999999998889999999999999999999999998753221 11122221111 100
Q ss_pred -hhhhc---ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 -VTEVV---DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 -~~~~~---d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.... ........ ... .......++..+.+++.+||+.||++||++.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKS-AQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GSCTTCSSCGGGSCCCC-CCC--GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccccchhhhcccC-cch--hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 00000000 000 001112356778999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=342.81 Aligned_cols=267 Identities=22% Similarity=0.278 Sum_probs=195.9
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC------eeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG------FKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 753 (973)
.+|...++||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888899999999999999987777799998764432 2237999999999999999999985433 3789
Q ss_pred EEEecCCCCHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC-CCCcEEEeecccccc
Q 048430 754 IMQYMPQGSLEKWLY---SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKL 829 (973)
Q Consensus 754 v~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~ 829 (973)
||||++++ +.+.+. .....+++..+..++.||++||+||| +.+|+||||||+||+++ .++.+||+|||+++.
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999874 443332 22357999999999999999999999 79999999999999999 799999999999987
Q ss_pred cCCCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--chhhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--AVTEV 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 906 (973)
..... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.... ..+...+...... .....
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 64322 23345789999999987654 5899999999999999999999999753221 1222222221111 11111
Q ss_pred cccccCCCCchh---hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEE---DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.++......... .......+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 111111110000 000011112356789999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.91 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=198.1
Q ss_pred HHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhcc--CCceeEEEeeeecCCeeE
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIR--HRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~ 752 (973)
...++|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3456788899999999999999998889999999987543 345678999999999997 599999999999999999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||| +.+++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||++++ +.+||+|||++.....
T Consensus 105 lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 9999 56789999998765 7899999999999999999999 789999999999999965 8999999999987643
Q ss_pred CCCc-ccccccccccccCccCCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC
Q 048430 833 VDPV-TQTMTLATIGYMAPEYGSE-----------GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 833 ~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
.... ......|++.|+|||.... ..++.++|||||||++|||++|+.||............
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~------- 251 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA------- 251 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-------
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH-------
Confidence 2221 2234568999999998764 47889999999999999999999998653322111111
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
..+....... +..++.++.+++.+||+.||++||+++|++++-
T Consensus 252 -----~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 252 -----IIDPNHEIEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp -----HHCTTSCCCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----HHhcccccCC----------cccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1111110000 011245688999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=343.84 Aligned_cols=267 Identities=23% Similarity=0.272 Sum_probs=195.6
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec------CCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN------PGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~ 752 (973)
.+|...+.||+|+||.||+|+.. +++.||||++..... ...+|++++++++||||++++++|.. ....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999974 699999999865432 23479999999999999999998843 12367
Q ss_pred EEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-CcEEEeeccccc
Q 048430 753 LIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAK 828 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~ 828 (973)
+||||+++ ++.+.+.. ....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999976 66666542 3457999999999999999999999 8999999999999999965 578999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcch--hh
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAV--TE 905 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 905 (973)
...... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...+...+........ ..
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence 764322 22345789999999987654 789999999999999999999999975321 1222233322111110 01
Q ss_pred hcccccCCCCchhh-hh--hHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 906 VVDANLLSREDEED-AD--DFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 906 ~~d~~l~~~~~~~~-~~--~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..++.......... .. ....+...+.++.+|+.+||+.||++||++.|+++|
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11111111100000 00 000112345779999999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=344.35 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=183.7
Q ss_pred CCC-CccccccCceEEEEEEeC---CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeee--ecCCeeEEEE
Q 048430 682 FGE-SNLLGSGSFDNVYKATLA---NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC--SNPGFKALIM 755 (973)
Q Consensus 682 ~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~~lv~ 755 (973)
|.. .++||+|+||.||+|+.. +++.||||++..... ...+.+|+.++++++||||+++++++ ......++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 458999999999999965 578999999864432 35688999999999999999999999 4477899999
Q ss_pred EecCCCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe----CCCCcEEEee
Q 048430 756 QYMPQGSLEKWLYSHN--------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL----DDDMVAHLGD 823 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D 823 (973)
||+++ +|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+||++ +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99964 8888876321 24899999999999999999999 7899999999999999 7788999999
Q ss_pred cccccccCCCCC--cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCc--------ccHH
Q 048430 824 FGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE--------MSLK 892 (973)
Q Consensus 824 fgla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~--------~~~~ 892 (973)
||+++....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987643221 22334578999999998776 458999999999999999999999996533210 1112
Q ss_pred HHHHhhC-Cc--chhhhcc--------cccCCCC-chhhhhhH--HhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 893 QWVAESL-PG--AVTEVVD--------ANLLSRE-DEEDADDF--ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 893 ~~~~~~~-~~--~~~~~~d--------~~l~~~~-~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+.... +. .+..+.. ..+.... ........ ......+.++.+|+.+||+.||++|||++|+++|
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 2221111 00 0100000 0000000 00000000 0000114568899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.39 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=198.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc----hhhHHHHHHHHHHHHhccCCceeEEEeee--ecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE----DRALKSFDTECEVMRRIRHRNLIKIVSSC--SNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~ 751 (973)
.++|...+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999996 478999999997543 23457899999999999999999999998 445688
Q ss_pred EEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 752 ALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
++||||++++ +.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 77777653 346999999999999999999999 789999999999999999999999999999876
Q ss_pred CCCC-CcccccccccccccCccCCCCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 831 DGVD-PVTQTMTLATIGYMAPEYGSEGI--VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 831 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.... ........|++.|+|||...... ++.++|||||||++|||++|+.||.... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~-------- 226 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIG-------- 226 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHH--------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHh--------
Confidence 4322 22233456899999999876543 4789999999999999999999986521 111111100
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... ..+..++..+.+++.+||+.||++||+++|+++|
T Consensus 227 ~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 KGSY------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HCCC------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCCC------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0011245668899999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=336.94 Aligned_cols=272 Identities=23% Similarity=0.239 Sum_probs=201.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecC-----Cee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP-----GFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 751 (973)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999964 78999999986443 33456788999999999999999999987653 678
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
++||||+. ++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 5999999874 5999999999999999999999 7899999999999999999999999999998764
Q ss_pred CCCCc---------ccccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-C
Q 048430 832 GVDPV---------TQTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-P 900 (973)
Q Consensus 832 ~~~~~---------~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~ 900 (973)
..... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||......+ .+........ +
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence 32211 112346899999999754 4678999999999999999999999997532111 1111111110 0
Q ss_pred c--c-hhhhcccc----cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 G--A-VTEVVDAN----LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~--~-~~~~~d~~----l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. . ........ ..................++.++.+++.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0 00000000 00000000000001112456788999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=337.81 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=201.3
Q ss_pred HHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 676 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
....++|...+.||+|+||.||+|+... .||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3345778889999999999999999764 49999986542 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++++|.+++...+..+++.++..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999999887667999999999999999999999 78999999999999998 679999999998764321
Q ss_pred C----CcccccccccccccCccCCCC---------CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC
Q 048430 834 D----PVTQTMTLATIGYMAPEYGSE---------GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 834 ~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
. ........|++.|+|||.... ..++.++|||||||++|||++|+.||...... ........
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMGT 257 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHHHHT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcc
Confidence 1 112233458999999997653 45799999999999999999999998653211 11111111
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
+. .+.... ..++.++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 258 ~~-----~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GM-----KPNLSQ-------------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TC-----CCCCCC-------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CC-----CCCCCc-------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 10 000000 012345889999999999999999999999999887654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.88 Aligned_cols=269 Identities=21% Similarity=0.282 Sum_probs=204.4
Q ss_pred hcCCCCCccccccCceEEEEEEe--CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCc------eeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL--ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRN------LIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 750 (973)
.++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788899999999999999986 36899999998644 334567889999999987654 9999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC--------------
Q 048430 751 KALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-------------- 815 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------------- 815 (973)
.++||||+ +++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999998765 36899999999999999999999 789999999999999987
Q ss_pred -----CCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCccc
Q 048430 816 -----DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS 890 (973)
Q Consensus 816 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~ 890 (973)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-H 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-H
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-H
Confidence 668999999999865322 234568999999999988899999999999999999999999996532211 1
Q ss_pred HHHHHHhh--CCcchhhhcc-------cccCCCCchhh-----------hhhHHhHHHHHHHHHHHHHhccccCCCCCCC
Q 048430 891 LKQWVAES--LPGAVTEVVD-------ANLLSREDEED-----------ADDFATKKTCISYIMSLALKCSAEIPEERIN 950 (973)
Q Consensus 891 ~~~~~~~~--~~~~~~~~~d-------~~l~~~~~~~~-----------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 950 (973)
........ .+..+..... ....-...... .........+++++.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 11111111 1111100000 00000000000 0000112245678999999999999999999
Q ss_pred HHHHHHH
Q 048430 951 VKDALAD 957 (973)
Q Consensus 951 ~~evl~~ 957 (973)
++|+++|
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=339.30 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=198.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee----
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK---- 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 751 (973)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46788889999999999999985 479999999987542 33457888999999999999999999999876654
Q ss_pred --EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 752 --ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 752 --~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
++||||+. ++|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 589888743 4899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-C-cchhhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-P-GAVTEV 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~ 906 (973)
... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+........ + ......
T Consensus 194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTT
T ss_pred ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHHHH
Confidence 542 2234568999999998776 67899999999999999999999999753211 11122211111 0 000000
Q ss_pred cc--------cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VD--------ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d--------~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
++ ..+..... .........+++++.+++.+||+.||++|||++|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPR---KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCC---CCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcc---hhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000000 00011112346789999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=323.02 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=203.3
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999965 78999999987543 23457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC---CcEEEeecccccccC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD---MVAHLGDFGIAKLLD 831 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~ 831 (973)
|||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.+ +.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999887654 6899999999999999999999 7899999999999999764 479999999998764
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... ......+++.|+|||...+ .++.++||||||+++|+|++|+.||...... .....+.... .
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~-----------~ 239 (287)
T 2wei_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGK-----------Y 239 (287)
T ss_dssp CCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-----------C
T ss_pred CCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC-----------C
Confidence 322 2233458999999998765 4899999999999999999999998653211 1111111100 0
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ......++.++.+++.+||+.||++||+++|++++
T Consensus 240 ~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 AFD--------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCC--------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCC--------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000 00112345678999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=328.18 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=193.3
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec----------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN---------- 747 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 747 (973)
.++|...+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45688899999999999999996 47999999998643 3445788999999999999999999998754
Q ss_pred ---CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeec
Q 048430 748 ---PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824 (973)
Q Consensus 748 ---~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 824 (973)
.+..++||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 45779999999999999999987767889999999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCC-------------CcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCccc
Q 048430 825 GIAKLLDGVD-------------PVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS 890 (973)
Q Consensus 825 gla~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~ 890 (973)
|.+....... ........|++.|+|||.+.+. .++.++|||||||++|||++ ||......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--- 234 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--- 234 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---
Confidence 9998654221 1122345689999999987754 78999999999999999998 54321111
Q ss_pred HHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......... ....... .+..++..+.+++.+||+.||++|||++|+++|
T Consensus 235 -~~~~~~~~~~------~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 -VNILKKLRSV------SIEFPPD----------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHHHST------TCCCCTT----------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHHHhcccc------ccccCcc----------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111110000 0000000 011234568899999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=348.49 Aligned_cols=311 Identities=19% Similarity=0.204 Sum_probs=200.2
Q ss_pred CCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCC
Q 048430 66 GNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLK 145 (973)
Q Consensus 66 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 145 (973)
..+.+++.|++++|.+.+..+..++.+++|++|+|++|.+. .+|...|..+++|++|+|++|.+++..|..|+++++|+
T Consensus 48 l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 126 (597)
T 3oja_B 48 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126 (597)
T ss_dssp GGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred ccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC-CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCC
Confidence 45678889999998885544445788888899999888888 45555567888888888888888887777888888888
Q ss_pred eEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeE
Q 048430 146 SIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAI 225 (973)
Q Consensus 146 ~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L 225 (973)
+|+|++|.|+ .+|..+|..+++|++|+|++|.|++. .|..|+++++|++|+|++|.+++.. +..
T Consensus 127 ~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~---~~~------- 190 (597)
T 3oja_B 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERI-----EDDTFQATTSLQNLQLSSNRLTHVD---LSL------- 190 (597)
T ss_dssp EEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBC-----CTTTTTTCTTCCEEECTTSCCSBCC---GGG-------
T ss_pred EEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCC-----ChhhhhcCCcCcEEECcCCCCCCcC---hhh-------
Confidence 8888888888 77877777888888888888888743 3456778888888888888877542 222
Q ss_pred EeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCC
Q 048430 226 LLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305 (973)
Q Consensus 226 ~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 305 (973)
+++|++|++++|.+++. ....+|+.|++++|.+..+.+..+ ++|+.|+|++|.+++
T Consensus 191 ----------------l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~ 246 (597)
T 3oja_B 191 ----------------IPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTD 246 (597)
T ss_dssp ----------------CTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCC
T ss_pred ----------------hhhhhhhhcccCccccc-----cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCC
Confidence 45566666666665532 233456666666666654433222 456666666665543
Q ss_pred CCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccc
Q 048430 306 GSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAG 385 (973)
Q Consensus 306 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 385 (973)
. .. +..+++|+.|+|++|.+++
T Consensus 247 ~---------~~-------------------------------------------------l~~l~~L~~L~Ls~N~l~~ 268 (597)
T 3oja_B 247 T---------AW-------------------------------------------------LLNYPGLVEVDLSYNELEK 268 (597)
T ss_dssp C---------GG-------------------------------------------------GGGCTTCSEEECCSSCCCE
T ss_pred C---------hh-------------------------------------------------hccCCCCCEEECCCCccCC
Confidence 1 12 3334445555555555554
Q ss_pred ccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccc
Q 048430 386 AIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWS 465 (973)
Q Consensus 386 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 465 (973)
..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++.. +..
T Consensus 269 ~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~ 343 (597)
T 3oja_B 269 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LST 343 (597)
T ss_dssp EESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCT
T ss_pred CCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhh
Confidence 555555555555555555555553 3444444555555555555555 34444555556666666666655431 445
Q ss_pred cccccEEEecCCccc
Q 048430 466 LKYILAVDFSLNSLS 480 (973)
Q Consensus 466 l~~L~~L~ls~N~l~ 480 (973)
+++|+.|++++|.++
T Consensus 344 ~~~L~~L~l~~N~~~ 358 (597)
T 3oja_B 344 HHTLKNLTLSHNDWD 358 (597)
T ss_dssp TCCCSEEECCSSCEE
T ss_pred cCCCCEEEeeCCCCC
Confidence 566666666666665
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.70 Aligned_cols=279 Identities=20% Similarity=0.216 Sum_probs=193.4
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe-
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF- 750 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 750 (973)
.+.....++|...+.||+|+||.||+|+. .+++.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45667788999999999999999999996 468999999886543 223456778888899999999999999865332
Q ss_pred ------eEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEE
Q 048430 751 ------KALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAH 820 (973)
Q Consensus 751 ------~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~k 820 (973)
.++||||+++ ++.+.+.. ....+++..+..++.|++.|+.|||.. +.+|+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 55554432 334789999999999999999999932 588999999999999997 89999
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
|+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+...+....
T Consensus 173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHcC
Confidence 99999998765322 23345689999999987654 4899999999999999999999999763221 12222222211
Q ss_pred --CcchhhhcccccCCC-----Cchh-hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 900 --PGAVTEVVDANLLSR-----EDEE-DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 900 --~~~~~~~~d~~l~~~-----~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.......++..... .... ..........++.++.+++.+||+.||++|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111111111000 0000 000000111246789999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=332.40 Aligned_cols=201 Identities=22% Similarity=0.297 Sum_probs=172.0
Q ss_pred HHhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CC-----ceeEEEeeeecCC
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HR-----NLIKIVSSCSNPG 749 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~ 749 (973)
...++|...+.||+|+||.||+|+.. +++.||||+++.. ......+..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999854 6899999999744 233567788999988885 44 4999999999999
Q ss_pred eeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC--CCCcEEEeeccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD--DDMVAHLGDFGI 826 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl 826 (973)
..++||||++ |+|.+++.... ..+++..+..++.|++.||.|||.. ..+||||||||+||+++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 59999998764 4689999999999999999999931 46899999999999995 478899999999
Q ss_pred ccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 048430 827 AKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884 (973)
Q Consensus 827 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~ 884 (973)
++..... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 23457899999999999889999999999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=342.73 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=186.8
Q ss_pred CCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
|...++||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+.+..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 44467899999999987777789999999986542 35678999999886 89999999999999999999999996
Q ss_pred CCHHHHhhhCCCC------CCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC-------------CcEEE
Q 048430 761 GSLEKWLYSHNYS------LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-------------MVAHL 821 (973)
Q Consensus 761 gsL~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~kl 821 (973)
|+|.+++...... .++..+..++.||+.||+||| +.+|+||||||+||+++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999875411 123345789999999999999 7899999999999999754 48999
Q ss_pred eecccccccCCCCCc---ccccccccccccCccCCCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccCccc
Q 048430 822 GDFGIAKLLDGVDPV---TQTMTLATIGYMAPEYGSE-------GIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMS 890 (973)
Q Consensus 822 ~Dfgla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~ 890 (973)
+|||+++........ ......||+.|+|||.+.+ ..++.++|||||||++|||++ |+.||+.....+
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 999999876543221 1234579999999998754 678999999999999999999 999986532221
Q ss_pred HHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 891 LKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 891 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........... .. .......++.++.+++.+||+.||++||++.|+++|
T Consensus 248 -~~i~~~~~~~~-------~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 -SNIIRGIFSLD-------EM----------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -HHHHHTCCCCC-------CC----------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHhcCCCCcc-------cc----------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11111110000 00 000123456789999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=332.57 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=179.1
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHH-HHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECE-VMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||.||+|.. .+++.||||+++... ......+..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36788889999999999999996 479999999997653 233445566665 677789999999999999999999999
Q ss_pred EecCCCCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 756 QYMPQGSLEKWLYS----HNYSLTIRQRLDIMIDVASALEYLHHGYST-PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 756 e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
||+++ +|.+++.. ....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 88887763 2347899999999999999999999 66 9999999999999999999999999999865
Q ss_pred CCCCCcccccccccccccCccCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYG----SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
... .......|++.|+|||.+ ....++.++|||||||++|||++|+.||....... ..+.....+..
T Consensus 177 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~--- 247 (327)
T 3aln_A 177 VDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGDP--- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCC---
T ss_pred ccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCCC---
Confidence 432 222334689999999987 45678999999999999999999999986532110 00000000000
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.+... ....++.++.+++.+||+.||++||++.|++++
T Consensus 248 --~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 --PQLSNS----------EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --CCCCCC----------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --CCCCCc----------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000000 001245678999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.13 Aligned_cols=243 Identities=21% Similarity=0.280 Sum_probs=200.1
Q ss_pred HHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchh------hHHHHHHHHHHHHhcc--CCceeEEEeeeec
Q 048430 677 QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIR--HRNLIKIVSSCSN 747 (973)
Q Consensus 677 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~ 747 (973)
...++|...+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3456788999999999999999985 57899999998755321 2245678999999996 5999999999999
Q ss_pred CCeeEEEEEecCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC-CCCcEEEeecc
Q 048430 748 PGFKALIMQYMPQ-GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFG 825 (973)
Q Consensus 748 ~~~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg 825 (973)
++..++|+|++.+ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999976 89999998754 6899999999999999999999 79999999999999999 78999999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchh
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVT 904 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 904 (973)
+++..... ......||+.|+|||.+....+ +.++|||||||++|||++|+.||.... .....
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~------- 258 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG------- 258 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC-------
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcc-------
Confidence 99876432 2234568999999998776665 788999999999999999999986421 11110
Q ss_pred hhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 905 EVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 905 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... +..+++++.+++.+||+.||++||+++|++++
T Consensus 259 -----~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 -----QVFF------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----CCCC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----cccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01234568899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.69 Aligned_cols=252 Identities=23% Similarity=0.261 Sum_probs=182.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccch--hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456888899999999999999964 789999999976532 22334455556788889999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST-PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||+ ++.+..+.......+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 999 55666666554557999999999999999999999 64 9999999999999999999999999999765432
Q ss_pred CcccccccccccccCccCCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 835 PVTQTMTLATIGYMAPEYGS-----EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.......+++.|+|||.+. ...++.++|||||||++|||++|+.||..................+
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 248 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP--------- 248 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC---------
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC---------
Confidence 2223456899999999874 5568899999999999999999999986532211111111111000
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... ....++.++.+++.+||+.||++||+++|+++|
T Consensus 249 ~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LLP------------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCC------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCC------------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 001235568899999999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.02 Aligned_cols=334 Identities=20% Similarity=0.206 Sum_probs=198.5
Q ss_pred CCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCC-CCccccceeeeccccccccCcchhcccCcccEEE
Q 048430 195 LHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSS-IYLPNLENLFLWKNNLSGIIPDSICNASEATILE 273 (973)
Q Consensus 195 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 273 (973)
++++++|++++|.++...+..+..+++|+.|++++|.+++..+.. ..+++|++|+|++|++++..|+.|+.+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 345555555555555433333344222222222222222222211 1245555555555555555555555555555555
Q ss_pred eccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceee
Q 048430 274 LSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFY 353 (973)
Q Consensus 274 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~ 353 (973)
|++|.++.+++..|+++++|++|++++|+++.. .
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~-------------------------------~--------------- 157 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI-------------------------------E--------------- 157 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC-------------------------------C---------------
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCcc-------------------------------C---------------
Confidence 555555555444455555555555555555432 1
Q ss_pred cccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccC
Q 048430 354 AGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQG 433 (973)
Q Consensus 354 l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 433 (973)
|..|..+++|++|++++|++++. .+..+++|+.|++++|.+++. ...++|+.|++++|.+..
T Consensus 158 ----------~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 158 ----------DDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINV 219 (390)
T ss_dssp ----------TTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCE
T ss_pred ----------hhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeee
Confidence 22244455566666666655533 234455566666666665531 223456666666666654
Q ss_pred cCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCccccc
Q 048430 434 QIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGN 513 (973)
Q Consensus 434 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 513 (973)
. |.. ..++|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|+++ .+|..+..
T Consensus 220 ~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~ 293 (390)
T 3o6n_A 220 V-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 293 (390)
T ss_dssp E-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSC
T ss_pred c-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCC
Confidence 3 221 235677777777777653 46777777888888888877777777888888888888888887 45666677
Q ss_pred CCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCCCCCCccCcccc
Q 048430 514 LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSF 593 (973)
Q Consensus 514 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~ 593 (973)
+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|+.. | +..+++|+.|++++|++++.... ..+..+....+
T Consensus 294 l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~ 368 (390)
T 3o6n_A 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAV 368 (390)
T ss_dssp CTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTB
T ss_pred CCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcc
Confidence 888888888888887 5666778888888888888888754 3 66778888888888888774322 12233444455
Q ss_pred ccCcccccCC
Q 048430 594 KQNYALCGSS 603 (973)
Q Consensus 594 ~~n~~~c~~~ 603 (973)
.++...|+++
T Consensus 369 ~~~~~~c~~~ 378 (390)
T 3o6n_A 369 DDADQHCKID 378 (390)
T ss_dssp CCCCSCCCTT
T ss_pred cccCceeccc
Confidence 6676777654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.87 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=191.9
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch------hhHHHHHHHHHHHHhc----cCCceeEEE
Q 048430 674 ELQQATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED------RALKSFDTECEVMRRI----RHRNLIKIV 742 (973)
Q Consensus 674 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~ 742 (973)
+.+...++|...+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3344567899999999999999999985 5789999999865432 1223456799999998 899999999
Q ss_pred eeeecCCeeEEEEEe-cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC-CCCcEE
Q 048430 743 SSCSNPGFKALIMQY-MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAH 820 (973)
Q Consensus 743 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k 820 (973)
+++...+..++|+|+ +.+++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence 999999999999999 78999999998755 6999999999999999999999 78999999999999999 889999
Q ss_pred EeecccccccCCCCCcccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC
Q 048430 821 LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899 (973)
Q Consensus 821 l~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 899 (973)
|+|||++...... ......|+..|+|||......+ +.++|||||||++|||++|+.||.... ....
T Consensus 181 l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~--- 247 (312)
T 2iwi_A 181 LIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILE--- 247 (312)
T ss_dssp ECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH---
T ss_pred EEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhh---
Confidence 9999999876432 2234568999999998776655 458999999999999999999986421 1111
Q ss_pred CcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 900 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .+..++.++.+++.+||+.||++||+++|+++|
T Consensus 248 ---------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 ---------AELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------TCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------hccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011234568899999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.39 Aligned_cols=254 Identities=22% Similarity=0.237 Sum_probs=174.0
Q ss_pred HhcCCCCCc-cccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec----CCee
Q 048430 678 ATNGFGESN-LLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN----PGFK 751 (973)
Q Consensus 678 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 751 (973)
..++|...+ +||+|+||.||+|... +++.||||++..... ...+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346777754 6999999999999965 799999999864321 12223334566799999999999865 4558
Q ss_pred EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIA 827 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla 827 (973)
++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999998754 46999999999999999999999 789999999999999976 455999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+..... ......+|+.|+|||.+....++.++|||||||++|||++|+.||.......... .... .+.
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~--------~~~ 246 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-GMKR--------RIR 246 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-hHHH--------hhh
Confidence 865422 2234568999999999988889999999999999999999999986533221100 0000 000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADL 958 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L 958 (973)
.... ... ......++.++.+++.+||+.||++|||++|+++|-
T Consensus 247 ~~~~-~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 247 LGQY-GFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -----CCC-------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cccc-ccC-------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0000 000 000123456789999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=336.35 Aligned_cols=269 Identities=18% Similarity=0.229 Sum_probs=200.6
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-----------CCceeEEEeeeec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-----------HRNLIKIVSSCSN 747 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 747 (973)
++|...+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788899999999999999995 579999999987432 33467889999999886 8999999999875
Q ss_pred CC----eeEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEEccCCCCcEEeC------C
Q 048430 748 PG----FKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYST-PIIHCDLKPNNVLLD------D 815 (973)
Q Consensus 748 ~~----~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~------~ 815 (973)
.+ ..++||||+ +++|.+++.... ..+++..+..++.||+.||+||| ++ +|+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence 43 789999999 889999998743 45999999999999999999999 66 999999999999994 4
Q ss_pred CCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc-----cc
Q 048430 816 DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE-----MS 890 (973)
Q Consensus 816 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~-----~~ 890 (973)
.+.+||+|||++...... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999876432 233468999999999988889999999999999999999999997543211 11
Q ss_pred HHHHHHhhC--Ccchh-------hhcccc--cC---CCCc----hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 048430 891 LKQWVAESL--PGAVT-------EVVDAN--LL---SRED----EEDADDFATKKTCISYIMSLALKCSAEIPEERINVK 952 (973)
Q Consensus 891 ~~~~~~~~~--~~~~~-------~~~d~~--l~---~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 952 (973)
+.+.+.... +..+. ..++.. +. .... .........+..++.++.+++.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 112111111 00000 000000 00 0000 000111123356788899999999999999999999
Q ss_pred HHHHH
Q 048430 953 DALAD 957 (973)
Q Consensus 953 evl~~ 957 (973)
|+++|
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=328.84 Aligned_cols=269 Identities=20% Similarity=0.273 Sum_probs=201.3
Q ss_pred hcCCCCCccccccCceEEEEEEeC-CC-eEEEEEEEeccchhhHHHHHHHHHHHHhccCCc------eeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA-NG-VSVAVKVFNLQEDRALKSFDTECEVMRRIRHRN------LIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 750 (973)
.++|...+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467889999999999999999864 34 78999998643 334567889999999998766 9999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe----------------
Q 048430 751 KALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---------------- 813 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---------------- 813 (973)
.++||||+ ++++.+++.... ..+++.++..++.||+.||+||| +.+|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 567777776654 56999999999999999999999 8999999999999999
Q ss_pred ---CCCCcEEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCccc
Q 048430 814 ---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS 890 (973)
Q Consensus 814 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~ 890 (973)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-H 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 56789999999999864322 234568999999999988899999999999999999999999997532211 1
Q ss_pred HHHHHHhh--CCcchhhhc-------ccccCCCCchhhhh-----------hHHhHHHHHHHHHHHHHhccccCCCCCCC
Q 048430 891 LKQWVAES--LPGAVTEVV-------DANLLSREDEEDAD-----------DFATKKTCISYIMSLALKCSAEIPEERIN 950 (973)
Q Consensus 891 ~~~~~~~~--~~~~~~~~~-------d~~l~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt 950 (973)
+....... .+..+.... .....-........ ........+.++.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 11111111 111110000 00000000000000 00011234567999999999999999999
Q ss_pred HHHHHHH
Q 048430 951 VKDALAD 957 (973)
Q Consensus 951 ~~evl~~ 957 (973)
++|+++|
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=341.53 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=188.6
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.+|...++||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45777899999999997766667799999999864322 2356899999999 7999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-----CCcEEEeecccccccCCC
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-----DMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~~~~ 833 (973)
. |+|.+++........+.++..++.||+.||+||| +.+|+||||||+||+++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 5999999877655666677899999999999999 789999999999999953 336889999999876432
Q ss_pred CC--cccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 834 DP--VTQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 834 ~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.. .......||+.|+|||.+. ...++.++|||||||++|||++ |+.||...... .... ......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~~---~~~~~~---- 246 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QANI---LLGACS---- 246 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHHH---HTTCCC----
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHHH---HhccCC----
Confidence 21 2233457999999999887 4567889999999999999999 89998542211 1110 000000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .........+.+++.+||+.||++||+++|+++|
T Consensus 247 ----~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 ----LDCL--------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ----CTTS--------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cccc--------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 0011235567899999999999999999999965
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.23 Aligned_cols=264 Identities=22% Similarity=0.252 Sum_probs=196.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe-----
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF----- 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 750 (973)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788889999999999999986 479999999986542 3345778999999999999999999999976653
Q ss_pred -eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 751 -KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 751 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
.++||||++ ++|.+++.. .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 588887753 5899999999999999999999 78999999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-C-cchhhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-P-GAVTEV 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~ 906 (973)
.... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+........ + ......
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHHTT
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHH
Confidence 5321 234568999999998766 67899999999999999999999998653211 11111111110 0 000000
Q ss_pred ccc--------ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 VDA--------NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ~d~--------~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
+.. .+...... ........++.++.+++.+|++.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRK---DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSC---CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCc---cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000000 0000112346779999999999999999999999976
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=346.29 Aligned_cols=334 Identities=19% Similarity=0.217 Sum_probs=205.6
Q ss_pred CCCccEEEcccccccccCCCCCCCc-cccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccc
Q 048430 166 LPSLVQLRLLGNNITGRIPNREIPN-EIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPN 244 (973)
Q Consensus 166 l~~L~~L~L~~N~l~~~~~~~~~p~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~ 244 (973)
+++++.|++++|.++. +|. .++++++|++|+|++|.|++..|..|.. +++
T Consensus 50 l~~l~~l~l~~~~l~~------lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-----------------------l~~ 100 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRK------LPAALLDSFRQVELLNLNDLQIEEIDTYAFAY-----------------------AHT 100 (597)
T ss_dssp GCCCSEEEESSCEESE------ECTHHHHHCCCCSEEECTTSCCCEECTTTTTT-----------------------CTT
T ss_pred CCCceEEEeeCCCCCC------cCHHHHccCCCCcEEECCCCCCCCCChHHhcC-----------------------CCC
Confidence 5667777777777752 333 3566777777777777777665555555 455
Q ss_pred cceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcC
Q 048430 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYL 324 (973)
Q Consensus 245 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L 324 (973)
|++|+|++|.+++..|..|+.+++|++|+|++|.++++++..|+++++|++|+|++|.++..+
T Consensus 101 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~----------------- 163 (597)
T 3oja_B 101 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE----------------- 163 (597)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC-----------------
T ss_pred CCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCC-----------------
Confidence 555555555555555555555555555555555555555555555555555555555554321
Q ss_pred cEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccC
Q 048430 325 RVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNS 404 (973)
Q Consensus 325 ~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 404 (973)
|..|..+++|++|++++|.+++.. +..+++|+.|++++
T Consensus 164 ---------------------------------------~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~ 201 (597)
T 3oja_B 164 ---------------------------------------DDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSY 201 (597)
T ss_dssp ---------------------------------------TTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCS
T ss_pred ---------------------------------------hhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhccc
Confidence 112333333444444444433221 22233444444444
Q ss_pred CcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcC
Q 048430 405 NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP 484 (973)
Q Consensus 405 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 484 (973)
|.+++. ...++|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..+++|+.|++++|.+++..|
T Consensus 202 n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~ 271 (597)
T 3oja_B 202 NLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMY 271 (597)
T ss_dssp SCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEES
T ss_pred Cccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCH
Confidence 444321 12234455555555544322211 2467777777777765 3567777777777777777777777
Q ss_pred cCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCcccccccc
Q 048430 485 LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSR 564 (973)
Q Consensus 485 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 564 (973)
..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|+|++|+|++. | +..+++
T Consensus 272 ~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~ 346 (597)
T 3oja_B 272 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHT 346 (597)
T ss_dssp GGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCC
T ss_pred HHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCC
Confidence 778888888888888888874 5667777888888888888888 6777788888888888888888754 2 667788
Q ss_pred ccccccCCCcccccCCCCCCCCccCccccccCcccccCC
Q 048430 565 LVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSS 603 (973)
Q Consensus 565 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 603 (973)
|+.|++++|+++|..+. ..+..+....+.++...|+.+
T Consensus 347 L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 347 LKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred CCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 88899999988876432 233445555677888888864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=321.00 Aligned_cols=254 Identities=33% Similarity=0.526 Sum_probs=233.9
Q ss_pred cceeecccCCccc--cCCCCCCCCCcccEEEeec-CccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeee
Q 048430 349 LENFYAGSSQLSG--GIPVGFGNLSNLLVLSLVN-NELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLL 425 (973)
Q Consensus 349 l~~l~l~~n~l~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 425 (973)
++.+++.+|.+++ .+|..|..+++|++|++++ |.+.+.+|..|..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 131 (313)
T 1ogq_A 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEe
Confidence 4444444444444 5666678889999999995 999999999999999999999999999999999999999999999
Q ss_pred cCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccc-cccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCc
Q 048430 426 SNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK-YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS 504 (973)
Q Consensus 426 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 504 (973)
+++|.+++.+|..+..+++|++|++++|++++.+|..+..++ +|+.|++++|++++.+|..+..+. |+.|+|++|+++
T Consensus 132 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~ 210 (313)
T 1ogq_A 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE
T ss_pred CCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc
Confidence 999999999999999999999999999999999999999998 999999999999999999999997 999999999999
Q ss_pred ccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCCCC
Q 048430 505 GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGP 584 (973)
Q Consensus 505 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~ 584 (973)
+.+|..|+.+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..+..+++|+.|++++|+++|.+|..+.
T Consensus 211 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~ 289 (313)
T 1ogq_A 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred CcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcc
Confidence 99999999999999999999999977776 88999999999999999999999999999999999999999999999888
Q ss_pred CCccCccccccCcccccCCc
Q 048430 585 FVNFTADSFKQNYALCGSSR 604 (973)
Q Consensus 585 ~~~~~~~~~~~n~~~c~~~~ 604 (973)
+.++....+.+|+++||.|.
T Consensus 290 l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 290 LQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTS
T ss_pred ccccChHHhcCCCCccCCCC
Confidence 88999999999999999874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=320.88 Aligned_cols=268 Identities=19% Similarity=0.308 Sum_probs=201.9
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCcceEEEEEeeC--------CCCcEEEEecCCCCCCCcCCCCCCCCCCCc
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCSI--------RHGRVAALSLPNLSLGGTLPPHVGNLSFLV 72 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~c~w~gv~C~~--------~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~ 72 (973)
||++||++++.||.+++++ |... .....++|.|.||+|+. ...+|+.|++++++++ .+|+.++.+++|+
T Consensus 31 aLl~~k~~~~~~~~~~~~~-w~~~-~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~ 107 (328)
T 4fcg_A 31 VLSQWQRHYNADRNRWHSA-WRQA-NSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQ 107 (328)
T ss_dssp HHHHHHHHHHHCCTTHHHH-HHHH-TTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCS
T ss_pred HHHHHHHhccCCchhhhhh-hccc-ccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCC
Confidence 6999999998899887775 8411 12357899999999953 4578999999999998 8899999999999
Q ss_pred EEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccC---------CCC
Q 048430 73 SLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVN---------ISS 143 (973)
Q Consensus 73 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---------l~~ 143 (973)
+|+|++|.+. .+|..++++++|++|+|++|.++ .+|..+ ..+++|++|+|++|++.+.+|..+.. +++
T Consensus 108 ~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l-~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~ 184 (328)
T 4fcg_A 108 HMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASI-ASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184 (328)
T ss_dssp EEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGG-GGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTT
T ss_pred EEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHH-hcCcCCCEEECCCCCCccccChhHhhccchhhhccCCC
Confidence 9999999996 88999999999999999999998 788764 77899999999998888888887654 555
Q ss_pred CCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcce
Q 048430 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMV 223 (973)
Q Consensus 144 L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~ 223 (973)
|++|+|++|+++ .+|.. +..+++|++|+|++|+++ .+|..++.+++|++|+|++|.+.+.+|..+..
T Consensus 185 L~~L~L~~n~l~-~lp~~-l~~l~~L~~L~L~~N~l~------~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~----- 251 (328)
T 4fcg_A 185 LQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNSPLS------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG----- 251 (328)
T ss_dssp CCEEEEEEECCC-CCCGG-GGGCTTCCEEEEESSCCC------CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTC-----
T ss_pred CCEEECcCCCcC-cchHh-hcCCCCCCEEEccCCCCC------cCchhhccCCCCCEEECcCCcchhhhHHHhcC-----
Confidence 555555555555 55544 244555555555555554 23444555555555555555555554544443
Q ss_pred eEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcC
Q 048430 224 AILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303 (973)
Q Consensus 224 ~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 303 (973)
+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..++++++|+.+++..|.+
T Consensus 252 ------------------l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 252 ------------------RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp ------------------CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred ------------------CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 77788888888888878888888888888888888888888888888888888888887766
Q ss_pred CC
Q 048430 304 TT 305 (973)
Q Consensus 304 ~~ 305 (973)
..
T Consensus 314 ~~ 315 (328)
T 4fcg_A 314 AQ 315 (328)
T ss_dssp CC
T ss_pred HH
Confidence 54
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=347.81 Aligned_cols=268 Identities=24% Similarity=0.294 Sum_probs=199.2
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeec------CCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSN------PGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 750 (973)
.++|...+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999985 56899999998654 33446789999999999999999999998765 677
Q ss_pred eEEEEEecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCc---EEEeecc
Q 048430 751 KALIMQYMPQGSLEKWLYSHN--YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV---AHLGDFG 825 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 825 (973)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998754 35889999999999999999999 789999999999999997664 9999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhh
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (973)
.+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....|...........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC------
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccchh
Confidence 998764322 2334579999999999999999999999999999999999999986532 1122211111100000
Q ss_pred -hcccccCCCC--chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 048430 906 -VVDANLLSRE--DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDAL 955 (973)
Q Consensus 906 -~~d~~l~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl 955 (973)
.......... .............+++.+.+++.+||+.||++|||++|++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000000000 0000000011223577899999999999999999999855
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=309.06 Aligned_cols=307 Identities=23% Similarity=0.376 Sum_probs=189.1
Q ss_pred CCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCC
Q 048430 65 VGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSL 144 (973)
Q Consensus 65 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 144 (973)
+..+++|++|++++|.+. .+| .+..+++|++|++++|++. .+|. +..+++|++|++++|.+++ +| .+.++++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTC
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcC
Confidence 346677777777777774 344 3777777777777777776 4554 5677777777777777774 33 57777777
Q ss_pred CeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCccee
Q 048430 145 KSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVA 224 (973)
Q Consensus 145 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~ 224 (973)
++|++++|.++ .++. +..+++|++|++++|.... .+..+..+++|++|++++|.+.+..+ +..
T Consensus 113 ~~L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~~------~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~------ 175 (347)
T 4fmz_A 113 RELYLNEDNIS-DISP--LANLTKMYSLNLGANHNLS------DLSPLSNMTGLNYLTVTESKVKDVTP--IAN------ 175 (347)
T ss_dssp SEEECTTSCCC-CCGG--GTTCTTCCEEECTTCTTCC------CCGGGTTCTTCCEEECCSSCCCCCGG--GGG------
T ss_pred CEEECcCCccc-Cchh--hccCCceeEEECCCCCCcc------cccchhhCCCCcEEEecCCCcCCchh--hcc------
Confidence 77777777776 4444 4567777777777775432 22346777777777777777764433 334
Q ss_pred EEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCC
Q 048430 225 ILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304 (973)
Q Consensus 225 L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 304 (973)
+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|+++
T Consensus 176 -----------------l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~ 234 (347)
T 4fmz_A 176 -----------------LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234 (347)
T ss_dssp -----------------CTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred -----------------CCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC
Confidence 5666667777776664322 6667777777777777776544 667777777777777776
Q ss_pred CCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccc
Q 048430 305 TGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELA 384 (973)
Q Consensus 305 ~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 384 (973)
..+ .+..+++|+.|++++|.+++. ..+..+++|++|++++|+++
T Consensus 235 ~~~---------~~~~l~~L~~L~l~~n~l~~~---------------------------~~~~~l~~L~~L~l~~n~l~ 278 (347)
T 4fmz_A 235 DLS---------PLANLSQLTWLEIGTNQISDI---------------------------NAVKDLTKLKMLNVGSNQIS 278 (347)
T ss_dssp CCG---------GGTTCTTCCEEECCSSCCCCC---------------------------GGGTTCTTCCEEECCSSCCC
T ss_pred CCc---------chhcCCCCCEEECCCCccCCC---------------------------hhHhcCCCcCEEEccCCccC
Confidence 421 144555555555555555421 11344555666666666665
Q ss_pred cccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCC
Q 048430 385 GAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456 (973)
Q Consensus 385 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 456 (973)
+. ..+..+++|++|++++|++++..+..+..+++|+.|++++|++++..| +..+++|++|++++|.|+
T Consensus 279 ~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 279 DI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 32 235555666666666666655555555555555555555555554444 455555555555555543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=310.98 Aligned_cols=174 Identities=21% Similarity=0.353 Sum_probs=90.0
Q ss_pred ccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCC
Q 048430 88 ELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP 167 (973)
Q Consensus 88 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~ 167 (973)
.+..+++|+.|++++|.+. .+|. +..+++|++|++++|++++ +|. +.++++|++|++++|.++ .+| .+..++
T Consensus 39 ~~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~-~~~--~~~~l~ 110 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKIT-DIS--ALQNLT 110 (347)
T ss_dssp CHHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG--GGTTCT
T ss_pred cchhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCccc-Cch--HHcCCC
Confidence 3455666666666666665 4443 3556666666666666663 332 556666666666666655 333 234455
Q ss_pred CccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccce
Q 048430 168 SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLEN 247 (973)
Q Consensus 168 ~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~ 247 (973)
+|++|+|++|+++ .+|. +..+++|++|++++|.....++ ....+++|++
T Consensus 111 ~L~~L~l~~n~i~------~~~~-~~~l~~L~~L~l~~n~~~~~~~------------------------~~~~l~~L~~ 159 (347)
T 4fmz_A 111 NLRELYLNEDNIS------DISP-LANLTKMYSLNLGANHNLSDLS------------------------PLSNMTGLNY 159 (347)
T ss_dssp TCSEEECTTSCCC------CCGG-GTTCTTCCEEECTTCTTCCCCG------------------------GGTTCTTCCE
T ss_pred cCCEEECcCCccc------Cchh-hccCCceeEEECCCCCCccccc------------------------chhhCCCCcE
Confidence 5555555555554 1222 4444455555555443322211 1122555666
Q ss_pred eeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCC
Q 048430 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304 (973)
Q Consensus 248 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 304 (973)
|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.++
T Consensus 160 L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 212 (347)
T 4fmz_A 160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQIT 212 (347)
T ss_dssp EECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred EEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCC
Confidence 6666666554322 5555556666666555554433 445555555555555444
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=307.67 Aligned_cols=235 Identities=13% Similarity=0.088 Sum_probs=186.1
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888999999999999999965 58999999997543 334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++++|.+++... ....++..++.|++.||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999653 466678999999999999999 7999999999999999999999998543
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
|++ .++.++|||||||++|||++|+.||......+. +.. ........
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-------------~~~-~~~~~~~~- 221 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-------------LAP-AERDTAGQ- 221 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-------------SEE-CCBCTTSC-
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-------------hHH-HHHHhccC-
Confidence 333 268999999999999999999999976332210 000 00000000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
..........+++++.+++.+||+.||++| |+.|+++.|+++.....+
T Consensus 222 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 222 ---PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp ---BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred ---CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 000011122456779999999999999999 999999999998765443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=347.46 Aligned_cols=242 Identities=19% Similarity=0.292 Sum_probs=195.8
Q ss_pred cCCCCCccccccCceEEEEEEeC--CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCe-----e
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA--NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF-----K 751 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~ 751 (973)
++|...++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999965 68999999886443 3445678999999999999999999999976555 6
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
|+||||+++++|.+++.. .+++.+++.++.||+.||.||| +.+||||||||+||+++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999988764 6899999999999999999999 7899999999999999986 89999999998764
Q ss_pred CCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
.. ....||+.|+|||.+.+.. +.++|||||||++|||++|..||........
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------- 284 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------- 284 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------------
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------------
Confidence 32 3456999999999876654 8999999999999999999888754221110
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-VKDALADLKKIKKIL 965 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-~~evl~~L~~~~~~~ 965 (973)
.. .......++.+.+++.+||+.||++||+ ++++.+.|.++.+..
T Consensus 285 ~~---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 PE---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp CT---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred cc---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 00 0011123466889999999999999995 667777777766543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.73 Aligned_cols=231 Identities=21% Similarity=0.293 Sum_probs=180.4
Q ss_pred hcCCCCC-ccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHH-HhccCCceeEEEeeeec----CCee
Q 048430 679 TNGFGES-NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVM-RRIRHRNLIKIVSSCSN----PGFK 751 (973)
Q Consensus 679 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 751 (973)
.++|... +.||+|+||.||+|.. .+++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456666 7899999999999986 57899999998633 4567888888 55689999999999876 6778
Q ss_pred EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIA 827 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla 827 (973)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998754 46999999999999999999999 799999999999999998 789999999998
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.... +..++.++|||||||++|||++|+.||........ ....
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------~~~~----- 210 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------SPGM----- 210 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCS-----
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------hHHH-----
Confidence 7542 13467899999999999999999999865321110 0000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......... ........++.++.+++.+||+.||++||+++|+++|
T Consensus 211 ~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 211 KTRIRMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSSCTTCCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000000 0011112356789999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.71 Aligned_cols=250 Identities=19% Similarity=0.214 Sum_probs=186.2
Q ss_pred cCCCCCccccccCceEEEEEE-eCCCeEEEEEEEeccch---hhHHHHHHHHHHHHhccC-Ccee---------------
Q 048430 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRH-RNLI--------------- 739 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv--------------- 739 (973)
..|...++||+|+||.||+|+ ..+|+.||||+++.... ...+.+.+|+.+++.++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 346667899999999999999 45799999999874322 235789999999999976 2211
Q ss_pred ------EEEeeeec-----CCeeEEEEEecCCCCHHHHhh------hCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 048430 740 ------KIVSSCSN-----PGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802 (973)
Q Consensus 740 ------~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 802 (973)
.++.++.. ....+++|+++ +++|.+++. .....+++..+..++.|+++||+||| +++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 11111111 22456777765 679999884 22345788899999999999999999 79999
Q ss_pred EccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCC----------CCCCCCcchhHHHHHHHHH
Q 048430 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYG----------SEGIVSISGDVYSFGILMM 872 (973)
Q Consensus 803 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDvws~Gvvl~ 872 (973)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||.+ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865321 334467 999999987 5667899999999999999
Q ss_pred HHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHH
Q 048430 873 ETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK 952 (973)
Q Consensus 873 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~ 952 (973)
||++|+.||......+. .+..+... ..+++++.+++.+||+.||++||++.
T Consensus 309 elltg~~Pf~~~~~~~~-----------------~~~~~~~~------------~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-----------------SEWIFRSC------------KNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-----------------SGGGGSSC------------CCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHCCCCCCCcchhhh-----------------HHHHHhhc------------ccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999965322110 00001100 02346689999999999999999999
Q ss_pred HHHHH--HHHHHHHHHh
Q 048430 953 DALAD--LKKIKKILTQ 967 (973)
Q Consensus 953 evl~~--L~~~~~~~~~ 967 (973)
|++++ ++++.+.+..
T Consensus 360 ~~l~~~~~~~~~~~~~~ 376 (413)
T 3dzo_A 360 QAMETPEYEQLRTELSA 376 (413)
T ss_dssp HHTTSHHHHHHHHHHHH
T ss_pred HHHhCHHHHHHHHHHHH
Confidence 99887 6666655543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=302.73 Aligned_cols=268 Identities=22% Similarity=0.276 Sum_probs=152.4
Q ss_pred cccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCC
Q 048430 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322 (973)
Q Consensus 243 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 322 (973)
++|++|++++|++++..++.|..+++|++|+|++|.++++.|..|+++++|++|++++|+++.++... . +
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~--------~--~ 123 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNL--------P--S 123 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSC--------C--T
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCccc--------c--c
Confidence 56777777777777766677777777777777777777777777777777777777777776533221 0 3
Q ss_pred cCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccc--cccCcccCCCCCCCEE
Q 048430 323 YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELA--GAIPTVLGKLQKLQGL 400 (973)
Q Consensus 323 ~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~--~~~p~~~~~l~~L~~L 400 (973)
+|++|++++|++.+.. +..|..+++|++|++++|.++ +..+..+..+ +|++|
T Consensus 124 ~L~~L~l~~n~i~~~~-------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L 177 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVP-------------------------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL 177 (332)
T ss_dssp TCCEEECCSSCCCCCC-------------------------SGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCC
T ss_pred cCCEEECCCCccCccC-------------------------HhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEE
Confidence 3444444444443211 112444555555555555553 2344444444 55555
Q ss_pred EccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCccc
Q 048430 401 DLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480 (973)
Q Consensus 401 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 480 (973)
++++|++++ +|..+ . ++|++|++++|++++..+..|..+++|+.|++++|+++
T Consensus 178 ~l~~n~l~~-l~~~~------------------------~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (332)
T 2ft3_A 178 RISEAKLTG-IPKDL------------------------P--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230 (332)
T ss_dssp BCCSSBCSS-CCSSS------------------------C--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC
T ss_pred ECcCCCCCc-cCccc------------------------c--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 555555553 23222 1 34555555555555544455555555555555555555
Q ss_pred CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccc------cccccccccccccC--
Q 048430 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL------ISLQSLDLSGNNIS-- 552 (973)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~-- 552 (973)
+..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..+..|..+ .+|+.|++++|.+.
T Consensus 231 ~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp CCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred cCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 444445555556666666666665 555556666666666666666665555555432 45666777777665
Q ss_pred CCCCccccccccccccccCCCc
Q 048430 553 GEIPKSLEKLSRLVDFNVSFNG 574 (973)
Q Consensus 553 ~~~p~~~~~l~~L~~l~ls~N~ 574 (973)
+..|..|..+++|+.+++++|+
T Consensus 310 ~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 310 EVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp GSCGGGGTTBCCSTTEEC----
T ss_pred ccCcccccccchhhhhhccccc
Confidence 4556666677777777776663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-32 Score=300.50 Aligned_cols=269 Identities=21% Similarity=0.258 Sum_probs=178.5
Q ss_pred cccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCC
Q 048430 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322 (973)
Q Consensus 243 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 322 (973)
++|++|+|++|+++++.+..|..+++|++|+|++|.++++.|..|+++++|++|++++|+++.++..
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~------------- 118 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK------------- 118 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS-------------
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChh-------------
Confidence 5677778888877777666777788888888888888777777777777777777777777643321
Q ss_pred cCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEc
Q 048430 323 YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402 (973)
Q Consensus 323 ~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 402 (973)
+. ++|++|++++|.+++..+..|..+++|++|++
T Consensus 119 --------------------------------------------~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 152 (330)
T 1xku_A 119 --------------------------------------------MP--KTLQELRVHENEITKVRKSVFNGLNQMIVVEL 152 (330)
T ss_dssp --------------------------------------------CC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC
T ss_pred --------------------------------------------hc--ccccEEECCCCcccccCHhHhcCCccccEEEC
Confidence 11 34555555555555555555556666666666
Q ss_pred cCCcCCC--CCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCccc
Q 048430 403 NSNKLKG--FIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480 (973)
Q Consensus 403 s~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 480 (973)
++|.+.. ..+..+.++++|+.|++++|.++. +|..+. ++|++|++++|++++..|..|..+++|+.|++++|+++
T Consensus 153 ~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 229 (330)
T 1xku_A 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229 (330)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred CCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence 6666542 445555666666666666666653 333322 56777777777776666666777777777777777777
Q ss_pred CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccc------cccccccccccccCC-
Q 048430 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL------ISLQSLDLSGNNISG- 553 (973)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~- 553 (973)
+..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|... ..|+.|++++|.+..
T Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~ 308 (330)
T 1xku_A 230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308 (330)
T ss_dssp EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred eeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence 655666777777777777777777 667777777777777777777776666666433 667778888887753
Q ss_pred -CCCccccccccccccccCCCc
Q 048430 554 -EIPKSLEKLSRLVDFNVSFNG 574 (973)
Q Consensus 554 -~~p~~~~~l~~L~~l~ls~N~ 574 (973)
..|..|..+..++.++|++|+
T Consensus 309 ~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 309 EIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp GSCGGGGTTCCCGGGEEC----
T ss_pred ccCccccccccceeEEEecccC
Confidence 556777778888888888774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=301.10 Aligned_cols=296 Identities=23% Similarity=0.325 Sum_probs=165.9
Q ss_pred CCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcc
Q 048430 143 SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNM 222 (973)
Q Consensus 143 ~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L 222 (973)
+|+.+++++|.++ .+|..++ ++|++|+|++|+|++. .|..|+++++|++|+|++|++++..|..|.+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~-----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---- 100 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISEL-----RKDDFKGLQHLYALVLVNNKISKIHEKAFSP---- 100 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEE-----CTTTTTTCTTCCEEECCSSCCCEECGGGSTT----
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCcc-----CHhHhhCCCCCcEEECCCCccCccCHhHhhC----
Confidence 4555555555555 5554432 3455555555555421 1234444555555555555544443443333
Q ss_pred eeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCc
Q 048430 223 VAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302 (973)
Q Consensus 223 ~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 302 (973)
+++|++|+|++|+++. +|..+. ++|++|++++|+++++.+..|.++++|++|++++|+
T Consensus 101 -------------------l~~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 158 (332)
T 2ft3_A 101 -------------------LRKLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158 (332)
T ss_dssp -------------------CTTCCEEECCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCC
T ss_pred -------------------cCCCCEEECCCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCc
Confidence 4555555555555552 333222 455555555555555544455555555555555554
Q ss_pred CCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCc
Q 048430 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNE 382 (973)
Q Consensus 303 l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~ 382 (973)
++. . +..|..|..+ +|++|++++|+
T Consensus 159 l~~-------------------------------~-----------------------~~~~~~~~~l-~L~~L~l~~n~ 183 (332)
T 2ft3_A 159 LEN-------------------------------S-----------------------GFEPGAFDGL-KLNYLRISEAK 183 (332)
T ss_dssp CBG-------------------------------G-----------------------GSCTTSSCSC-CCSCCBCCSSB
T ss_pred ccc-------------------------------C-----------------------CCCcccccCC-ccCEEECcCCC
Confidence 431 0 1223446666 89999999999
Q ss_pred cccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCccc
Q 048430 383 LAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPST 462 (973)
Q Consensus 383 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 462 (973)
+++ +|..+. ++|++|+|++|.+++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|+++ .+|..
T Consensus 184 l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 184 LTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp CSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred CCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 995 565544 68999999999998776677777777777777777777666666666666666666666665 44444
Q ss_pred ccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc--cCCCCCcccccc
Q 048430 463 FWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ--GPIPQSFGSLIS 540 (973)
Q Consensus 463 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~ 540 (973)
+..+++|+.|++++|++++..+..|..... -.....|+.|++++|.+. +..|..|..+++
T Consensus 260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~ 321 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCC
T ss_pred hhcCccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccch
Confidence 555555555555555554333333322100 001245666667766665 455666777777
Q ss_pred cccccccccc
Q 048430 541 LQSLDLSGNN 550 (973)
Q Consensus 541 L~~L~Ls~N~ 550 (973)
|+.|+|++|+
T Consensus 322 L~~l~l~~n~ 331 (332)
T 2ft3_A 322 RLAIQFGNYK 331 (332)
T ss_dssp STTEEC----
T ss_pred hhhhhccccc
Confidence 7777777664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-31 Score=295.10 Aligned_cols=231 Identities=20% Similarity=0.327 Sum_probs=136.9
Q ss_pred CCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEE
Q 048430 69 SFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIR 148 (973)
Q Consensus 69 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 148 (973)
+.|++|+|++|++.+..+..|+++++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+. ++|++|+
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~ 127 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELR 127 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEE
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCH-HHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEE
Confidence 455666666666655444456666666666666666653223 23345555555555555555 3444332 4555555
Q ss_pred ccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEee
Q 048430 149 LDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY 228 (973)
Q Consensus 149 L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~ 228 (973)
+++|+++ .++...+..+++|++|++++|.++.. ...+..+.++++|++|++++|+++
T Consensus 128 l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~~~~~~l~~L~~L~l~~n~l~------------------- 184 (330)
T 1xku_A 128 VHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSS---GIENGAFQGMKKLSYIRIADTNIT------------------- 184 (330)
T ss_dssp CCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGG---GBCTTGGGGCTTCCEEECCSSCCC-------------------
T ss_pred CCCCccc-ccCHhHhcCCccccEEECCCCcCCcc---CcChhhccCCCCcCEEECCCCccc-------------------
Confidence 5555555 44444444555555555555555311 012334444555555555555544
Q ss_pred cccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCC
Q 048430 229 GNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSS 308 (973)
Q Consensus 229 ~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 308 (973)
.. |... .++|++|++++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|++|++++|+++.++.
T Consensus 185 -----~l-~~~~-~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~ 257 (330)
T 1xku_A 185 -----TI-PQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 257 (330)
T ss_dssp -----SC-CSSC-CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT
T ss_pred -----cC-Cccc-cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCCh
Confidence 22 1111 3678888888888888778888888888888888888888877778888888888888888775332
Q ss_pred CcchhhhhhhccCCcCcEEEccCCCCCCCCCCc
Q 048430 309 AQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNS 341 (973)
Q Consensus 309 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 341 (973)
.+..+++|++|++++|++++..+..
T Consensus 258 --------~l~~l~~L~~L~l~~N~i~~~~~~~ 282 (330)
T 1xku_A 258 --------GLADHKYIQVVYLHNNNISAIGSND 282 (330)
T ss_dssp --------TTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred --------hhccCCCcCEEECCCCcCCccChhh
Confidence 3455566666666666666444433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.1e-34 Score=315.21 Aligned_cols=245 Identities=13% Similarity=0.172 Sum_probs=185.2
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--------hhhHHHHHHHHHHHHhcc---------CCceeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--------DRALKSFDTECEVMRRIR---------HRNLIKI 741 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l 741 (973)
.++|...+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999998 68999999997552 223477899999999886 6666666
Q ss_pred Eeee-----------------ec-------------CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 048430 742 VSSC-----------------SN-------------PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791 (973)
Q Consensus 742 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~ 791 (973)
.+++ .+ .+..++||||+++|++.+.+.. ..+++.+++.++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 6543 22 6889999999999977666644 36899999999999999999
Q ss_pred HhhhcCCCCeEEccCCCCcEEeCCCC--------------------cEEEeecccccccCCCCCcccccccccccccCcc
Q 048430 792 YLHHGYSTPIIHCDLKPNNVLLDDDM--------------------VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851 (973)
Q Consensus 792 ~LH~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE 851 (973)
|||+ +.+|+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSG
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChh
Confidence 9993 37899999999999999887 899999999987642 2347999999999
Q ss_pred CCCCCCCCcchhHHHHHHH-HHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHH
Q 048430 852 YGSEGIVSISGDVYSFGIL-MMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCI 930 (973)
Q Consensus 852 ~~~~~~~~~~sDvws~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~ 930 (973)
.+.+.. +.++||||+|++ .+++++|..||... .|..... ..+.+....... .....+..++
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~----~~~~~~~~~~~~-----~~~~~~~~~s 309 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT----DKMLKQMTFKTK-----CNTPAMKQIK 309 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH----HHHHHTCCCSSC-----CCSHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH----HhhhhhhccCcc-----cchhhhhhcC
Confidence 887665 899999998777 77888899887321 1111100 000100000000 0112334678
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHH-HH
Q 048430 931 SYIMSLALKCSAEIPEERINVKDAL-AD 957 (973)
Q Consensus 931 ~~l~~l~~~cl~~~P~~Rpt~~evl-~~ 957 (973)
+++.+++.+||+.| |++|++ +|
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHHhccC-----CHHHHHhcC
Confidence 88999999999976 999998 65
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-35 Score=344.51 Aligned_cols=371 Identities=19% Similarity=0.152 Sum_probs=196.9
Q ss_pred cCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCC----CCCccccCCCCCCeEEccCccccccCCccccCCCC-
Q 048430 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITG----EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP- 167 (973)
Q Consensus 93 ~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~- 167 (973)
++|++|||++|+++......++..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+.+..+..++..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 3455566665555422222334556666666666666653 34556667777777777777776444444444454
Q ss_pred ---CccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccc
Q 048430 168 ---SLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPN 244 (973)
Q Consensus 168 ---~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~ 244 (973)
+|++|+|++|+|+..- ...+|..+..+++|++|+|++|++++..+..+... + ....++
T Consensus 83 ~~~~L~~L~L~~n~i~~~~-~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~----------------l--~~~~~~ 143 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAG-CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG----------------L--LDPQCR 143 (461)
T ss_dssp TTCCCCEEECTTSCCBGGG-HHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH----------------H--TSTTCC
T ss_pred CCCceeEEEccCCCCCHHH-HHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH----------------H--hcCCCc
Confidence 5777777777775210 01235667777778888888877764433333220 0 001346
Q ss_pred cceeeeccccccccC----cchhcccCcccEEEeccccccccCCCcccc-----cccceEEEccCCcCCCCCCCcchhhh
Q 048430 245 LENLFLWKNNLSGII----PDSICNASEATILELSSNLFSGLVPNTFGN-----CRQLQILSLGDNQLTTGSSAQGQIFY 315 (973)
Q Consensus 245 L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~~~~ 315 (973)
|++|+|++|++++.. +..+..+++|++|++++|.+++..+..+.. .++|++|++++|.++... ...++
T Consensus 144 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~---~~~l~ 220 (461)
T 1z7x_W 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN---CRDLC 220 (461)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH---HHHHH
T ss_pred ceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH---HHHHH
Confidence 777777777776533 445556677777777777766543333322 346666666666665311 01123
Q ss_pred hhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCC
Q 048430 316 SSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQ 395 (973)
Q Consensus 316 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 395 (973)
..+..+++|+.|++++|++.+..... ..+..+..++
T Consensus 221 ~~l~~~~~L~~L~Ls~n~l~~~~~~~--------------------------------------------l~~~~~~~~~ 256 (461)
T 1z7x_W 221 GIVASKASLRELALGSNKLGDVGMAE--------------------------------------------LCPGLLHPSS 256 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHH--------------------------------------------HHHHHTSTTC
T ss_pred HHHHhCCCccEEeccCCcCChHHHHH--------------------------------------------HHHHHhcCCC
Confidence 33444555555555555443211000 0011222344
Q ss_pred CCCEEEccCCcCCCC----CchhhhccCcCCeeecCCccccCcCcccccC-----cCCCCeeeccCCCCCCC----Cccc
Q 048430 396 KLQGLDLNSNKLKGF----IPTDLCKLEKLNTLLSNNNALQGQIPTCLAN-----LTSLRHLDFRSNSLNST----IPST 462 (973)
Q Consensus 396 ~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~p~~ 462 (973)
+|++|+|++|+++.. ++..+..+++|+.|++++|.+++..+..+.. .++|++|++++|.+++. ++..
T Consensus 257 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 336 (461)
T 1z7x_W 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336 (461)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHH
Confidence 455555555544432 2334444455555555555444333222221 24566666666665543 3344
Q ss_pred ccccccccEEEecCCcccCCcCcCccC-----CCCCCeEEccCCcCcc----cCCcccccCCcCCEEEcccCcccc
Q 048430 463 FWSLKYILAVDFSLNSLSGSLPLNIGN-----LEALGGLNLTGNQLSG----YIPSSIGNLKNLDWLALARNAFQG 529 (973)
Q Consensus 463 ~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (973)
+..+++|+.|++++|++++..+..+.. .++|+.|+|++|++++ .+|..+..+++|++|+|++|++++
T Consensus 337 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 444555666666666555433333321 4566677777776664 556666666677777777776654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-35 Score=344.97 Aligned_cols=287 Identities=20% Similarity=0.183 Sum_probs=190.8
Q ss_pred ccceeeeccccccc----cCcchhcccCcccEEEeccccccccCCCccc-----ccccceEEEccCCcCCCCCCCcchhh
Q 048430 244 NLENLFLWKNNLSG----IIPDSICNASEATILELSSNLFSGLVPNTFG-----NCRQLQILSLGDNQLTTGSSAQGQIF 314 (973)
Q Consensus 244 ~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~ 314 (973)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|++++|+++... ...+
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~---~~~l 162 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS---CEPL 162 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG---HHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH---HHHH
Confidence 46666666666653 3355666666666666666666543333222 2446777777777765421 1223
Q ss_pred hhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCC-CCCCcccEEEeecCccccc----cCc
Q 048430 315 YSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGF-GNLSNLLVLSLVNNELAGA----IPT 389 (973)
Q Consensus 315 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~-~~l~~L~~L~Ls~n~l~~~----~p~ 389 (973)
...+..+++|+.|++++|.+....+..+.. .+ ...++|++|++++|.+++. ++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~---------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 221 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQ---------------------GLKDSPCQLEALKLESCGVTSDNCRDLCG 221 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHH---------------------HHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHH---------------------HHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence 455666777777777777765432222111 01 1245788888888888753 466
Q ss_pred ccCCCCCCCEEEccCCcCCCCC-----chhhhccCcCCeeecCCccccCc----CcccccCcCCCCeeeccCCCCCCCCc
Q 048430 390 VLGKLQKLQGLDLNSNKLKGFI-----PTDLCKLEKLNTLLSNNNALQGQ----IPTCLANLTSLRHLDFRSNSLNSTIP 460 (973)
Q Consensus 390 ~~~~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p 460 (973)
.+..+++|++|+|++|++++.. +..+..+++|+.|++++|.++.. ++..+.++++|++|++++|.+.+..+
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 301 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence 7777888888888888887532 22223578888888888888864 56667778888888888888865444
Q ss_pred cccccc-----ccccEEEecCCcccCC----cCcCccCCCCCCeEEccCCcCcccCCccccc-----CCcCCEEEcccCc
Q 048430 461 STFWSL-----KYILAVDFSLNSLSGS----LPLNIGNLEALGGLNLTGNQLSGYIPSSIGN-----LKNLDWLALARNA 526 (973)
Q Consensus 461 ~~~~~l-----~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~ 526 (973)
..+... ++|+.|++++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|+.|+|++|+
T Consensus 302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 444432 5788888888888764 4555667788888888888887655554443 5688888888888
Q ss_pred ccc----CCCCCcccccccccccccccccCCC
Q 048430 527 FQG----PIPQSFGSLISLQSLDLSGNNISGE 554 (973)
Q Consensus 527 l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (973)
+++ .+|..+..+++|++|+|++|++++.
T Consensus 382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 875 6777777788888888888888754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=281.97 Aligned_cols=285 Identities=20% Similarity=0.245 Sum_probs=188.7
Q ss_pred CCCCCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCC
Q 048430 27 NTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS 106 (973)
Q Consensus 27 ~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~ 106 (973)
+....+|.|.|+ |+. ++++++ .+|..+. ++|++|+|++|++.+..+..+.++++|++|+|++|+++
T Consensus 24 ~~~~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (353)
T 2z80_A 24 NQASLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN 89 (353)
T ss_dssp ---CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred CccCCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC
Confidence 345677999998 854 344444 5565443 46777777777776555556777777777777777777
Q ss_pred CCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCc-cccCCCCCccEEEccccc-ccccCC
Q 048430 107 GSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPT-DLCTRLPSLVQLRLLGNN-ITGRIP 184 (973)
Q Consensus 107 ~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~L~L~~N~-l~~~~~ 184 (973)
.++...|..+++|++|+|++|++++..+..|+++++|++|+|++|+++ .+|. ..+..+++|++|++++|+ +++
T Consensus 90 -~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~--- 164 (353)
T 2z80_A 90 -TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTK--- 164 (353)
T ss_dssp -EECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCE---
T ss_pred -ccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccc---
Confidence 344444567777777777777777544444777777777777777777 6665 566777777777777774 442
Q ss_pred CCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCC-CccccceeeeccccccccCcchh
Q 048430 185 NREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-YLPNLENLFLWKNNLSGIIPDSI 263 (973)
Q Consensus 185 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~l 263 (973)
..|..|+++++|++|++++|++++..|..+..+++|+.|++++|.+....+... .+++|++|++++|++++..+..+
T Consensus 165 --~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l 242 (353)
T 2z80_A 165 --IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242 (353)
T ss_dssp --ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--
T ss_pred --cCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccc
Confidence 124567777777777777777777777777777777777777777754333222 26777777777777776554433
Q ss_pred c---ccCcccEEEeccccccc----cCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCC
Q 048430 264 C---NASEATILELSSNLFSG----LVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKG 336 (973)
Q Consensus 264 ~---~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 336 (973)
. ....++.++|++|.+++ .+|..+..+++|++|++++|+++.++.. .+..+++|+.|++++|++.+
T Consensus 243 ~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~-------~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDG-------IFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTT-------TTTTCTTCCEEECCSSCBCC
T ss_pred ccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHH-------HHhcCCCCCEEEeeCCCccC
Confidence 3 34556777777777664 2455667777777778877777754432 24667777788888887776
Q ss_pred CCC
Q 048430 337 VIP 339 (973)
Q Consensus 337 ~~p 339 (973)
..|
T Consensus 316 ~~~ 318 (353)
T 2z80_A 316 SCP 318 (353)
T ss_dssp CHH
T ss_pred cCC
Confidence 543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-31 Score=321.64 Aligned_cols=433 Identities=13% Similarity=0.023 Sum_probs=252.6
Q ss_pred CCCcccccccCCcEEEccCCCC---CCCCCcccc-----------CCCCCccEEEeeCcccCCCCCccccCC--CCCCeE
Q 048430 84 TLPNELWHMRRLKIIDFSSNSL---SGSLPGDMC-----------NSFTQLESFDVSSNKITGEFPSAIVNI--SSLKSI 147 (973)
Q Consensus 84 ~~p~~~~~l~~L~~L~Ls~n~l---~~~~p~~~~-----------~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L 147 (973)
..+..+..+++|++|+|+++.. .+.+|.... ..+++|++|+|++|.+++..+..+... .+|++|
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L 143 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence 3445567888999999988543 134443221 156777777777777766555555543 337777
Q ss_pred EccCcc-ccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccC----ccccccccCCcc
Q 048430 148 RLDNNS-LSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG----LIPSMIFNNSNM 222 (973)
Q Consensus 148 ~L~~N~-l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~~~~L 222 (973)
+|++|. ++..--..+...+++|++|+|++|.+++.-. ..++..+..+++|++|+|++|.+++ .++..+.+
T Consensus 144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~-~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~---- 218 (592)
T 3ogk_B 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDG-KWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN---- 218 (592)
T ss_dssp EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCS-HHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH----
T ss_pred ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcch-hHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh----
Confidence 777765 2110011122356667777777776653210 0022334556666666666666652 22222333
Q ss_pred eeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEecccccc---ccCCCcccccccceEEEcc
Q 048430 223 VAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFS---GLVPNTFGNCRQLQILSLG 299 (973)
Q Consensus 223 ~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~---~~~~~~~~~l~~L~~L~L~ 299 (973)
+++|++|++++|.+.+ ++..+..+++|+.|+++++... ...+..+..+++|+.|+++
T Consensus 219 -------------------~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~ 278 (592)
T 3ogk_B 219 -------------------CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLS 278 (592)
T ss_dssp -------------------CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEET
T ss_pred -------------------CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcc
Confidence 4566666666666664 4556666666666666643222 2223445566666666666
Q ss_pred CCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEee
Q 048430 300 DNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLV 379 (973)
Q Consensus 300 ~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls 379 (973)
++.... .+..+..+++|+.|++++|.+.+... +..+..+++|++|+++
T Consensus 279 ~~~~~~--------l~~~~~~~~~L~~L~Ls~~~l~~~~~------------------------~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 279 YMGPNE--------MPILFPFAAQIRKLDLLYALLETEDH------------------------CTLIQKCPNLEVLETR 326 (592)
T ss_dssp TCCTTT--------GGGGGGGGGGCCEEEETTCCCCHHHH------------------------HHHHTTCTTCCEEEEE
T ss_pred ccchhH--------HHHHHhhcCCCcEEecCCCcCCHHHH------------------------HHHHHhCcCCCEEecc
Confidence 543221 23345556666666666666442211 1113556777777777
Q ss_pred cCccccccCcccCCCCCCCEEEccC-----------CcCCCCC-chhhhccCcCCeeecCCccccCcCcccccC-cCCCC
Q 048430 380 NNELAGAIPTVLGKLQKLQGLDLNS-----------NKLKGFI-PTDLCKLEKLNTLLSNNNALQGQIPTCLAN-LTSLR 446 (973)
Q Consensus 380 ~n~l~~~~p~~~~~l~~L~~L~Ls~-----------N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~ 446 (973)
++-..+.++..+..+++|++|+|++ |.+++.. +..+..+++|+.|+++.|.+++..+..++. +++|+
T Consensus 327 ~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~ 406 (592)
T 3ogk_B 327 NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLC 406 (592)
T ss_dssp GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCC
T ss_pred CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCc
Confidence 3332333444445677777777773 4555332 222345777888877777777666666654 77788
Q ss_pred eeecc----CCCCCCC-----CcccccccccccEEEecCCc--ccCCcCcCcc-CCCCCCeEEccCCcCcc-cCCccccc
Q 048430 447 HLDFR----SNSLNST-----IPSTFWSLKYILAVDFSLNS--LSGSLPLNIG-NLEALGGLNLTGNQLSG-YIPSSIGN 513 (973)
Q Consensus 447 ~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~ls~N~--l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~ 513 (973)
.|+++ .|.+++. ++..+.++++|+.|+++++. +++..+..+. .+++|+.|+|++|++++ .++..+..
T Consensus 407 ~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 486 (592)
T 3ogk_B 407 DFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486 (592)
T ss_dssp EEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTC
T ss_pred EEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhc
Confidence 88885 6666653 33446667788888886433 5544444443 36778888888888875 34555677
Q ss_pred CCcCCEEEcccCccccC-CCCCcccccccccccccccccCCCCCcccc-ccccccccccCCC
Q 048430 514 LKNLDWLALARNAFQGP-IPQSFGSLISLQSLDLSGNNISGEIPKSLE-KLSRLVDFNVSFN 573 (973)
Q Consensus 514 l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~l~ls~N 573 (973)
+++|+.|+|++|.+++. ++..+..+++|++|+|++|+++..-...+. .++.+....+..+
T Consensus 487 ~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 78888888888887644 344446678888888888888765333332 4555555444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-31 Score=320.45 Aligned_cols=463 Identities=14% Similarity=0.117 Sum_probs=264.7
Q ss_pred CcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCC---CCCCCcccc------------cccCC
Q 048430 31 SVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSF---YDTLPNELW------------HMRRL 95 (973)
Q Consensus 31 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~---~~~~p~~~~------------~l~~L 95 (973)
-|++|.++.+... + .+.+.. ......+..+..+++|++|+|+++.. .+.+|..++ .+++|
T Consensus 40 vck~W~~~~~~~~--~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 40 VCRRWFKIDSETR--E--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp SCHHHHHHHHHHC--C--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HhHHHHHhhhccc--c--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 4458999965321 1 222222 12223334456788999999988532 255555444 78999
Q ss_pred cEEEccCCCCCCCCCccccCCCCC-ccEEEeeCcc-cCC-CCCccccCCCCCCeEEccCccccccCC---ccccCCCCCc
Q 048430 96 KIIDFSSNSLSGSLPGDMCNSFTQ-LESFDVSSNK-ITG-EFPSAIVNISSLKSIRLDNNSLSGSFP---TDLCTRLPSL 169 (973)
Q Consensus 96 ~~L~Ls~n~l~~~~p~~~~~~l~~-L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~ip---~~~~~~l~~L 169 (973)
++|+|++|.+++..+..+...++. |++|+|++|. ++. .++..+.++++|++|+|++|.+++.-. ..+...+++|
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 999999998875544444332445 9999999987 221 122334578999999999999874421 1234578999
Q ss_pred cEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccc---c-CCCCCCcccc
Q 048430 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG---H-LPSSIYLPNL 245 (973)
Q Consensus 170 ~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~---~-~~~~~~l~~L 245 (973)
++|+|++|.+++.. ...++..+.++++|++|+|++|.+.+ +|..+..+++|+.|+++...... . ......+++|
T Consensus 195 ~~L~L~~n~~~~~~-~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L 272 (592)
T 3ogk_B 195 EVLNFYMTEFAKIS-PKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL 272 (592)
T ss_dssp CEEECTTCCCSSCC-HHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTC
T ss_pred cEEEeeccCCCccC-HHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccc
Confidence 99999999996321 12345567789999999999999986 67888888888888887533221 1 1122235666
Q ss_pred ceeeeccccccccCcchhcccCcccEEEeccccccccCC-CcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcC
Q 048430 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP-NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYL 324 (973)
Q Consensus 246 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L 324 (973)
+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ |.+.. .........+++|
T Consensus 273 ~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~------~~l~~~~~~~~~L 344 (592)
T 3ogk_B 273 CRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGD------RGLEVLAQYCKQL 344 (592)
T ss_dssp CEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHH------HHHHHHHHHCTTC
T ss_pred cccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCH------HHHHHHHHhCCCC
Confidence 66666664333 445555666666666666666543322 224555666666665 33221 1111222344455
Q ss_pred cEEEccC---CCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccc-cCcccCCCCCCCEE
Q 048430 325 RVLVLDT---NPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGA-IPTVLGKLQKLQGL 400 (973)
Q Consensus 325 ~~L~L~~---N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L 400 (973)
++|++++ ++.... . .|.+++. ++..+..+++|++|
T Consensus 345 ~~L~L~~g~~~~~~~~-----------------~------------------------~~~~~~~~~~~l~~~~~~L~~L 383 (592)
T 3ogk_B 345 KRLRIERGADEQGMED-----------------E------------------------EGLVSQRGLIALAQGCQELEYM 383 (592)
T ss_dssp CEEEEECCCCSSTTSS-----------------T------------------------TCCCCHHHHHHHHHHCTTCSEE
T ss_pred CEEEeecCcccccccc-----------------c------------------------cCccCHHHHHHHHhhCccCeEE
Confidence 5555541 000000 0 1233221 11112334455555
Q ss_pred EccCCcCCCCCchhhhc-cCcCCeeecC----CccccCc-----CcccccCcCCCCeeeccCCC--CCCCCcccccc-cc
Q 048430 401 DLNSNKLKGFIPTDLCK-LEKLNTLLSN----NNALQGQ-----IPTCLANLTSLRHLDFRSNS--LNSTIPSTFWS-LK 467 (973)
Q Consensus 401 ~Ls~N~l~~~~~~~~~~-l~~L~~L~l~----~N~l~~~-----~~~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~-l~ 467 (973)
+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+.++++|++|++++|. +++..+..+.. ++
T Consensus 384 ~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~ 463 (592)
T 3ogk_B 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463 (592)
T ss_dssp EEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCT
T ss_pred EeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCc
Confidence 55555554443444433 4555555553 4444432 22234455666666665432 44333333332 56
Q ss_pred cccEEEecCCcccC-CcCcCccCCCCCCeEEccCCcCccc-CCcccccCCcCCEEEcccCccccCCCCCc-ccccccccc
Q 048430 468 YILAVDFSLNSLSG-SLPLNIGNLEALGGLNLTGNQLSGY-IPSSIGNLKNLDWLALARNAFQGPIPQSF-GSLISLQSL 544 (973)
Q Consensus 468 ~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 544 (973)
+|+.|++++|++++ .++..+.++++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++.....+ ..++.+...
T Consensus 464 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~ 543 (592)
T 3ogk_B 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIE 543 (592)
T ss_dssp TCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEE
T ss_pred cceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEE
Confidence 66667777666654 2344456677888888888887644 34445567888888888888775433333 234555555
Q ss_pred ccccc
Q 048430 545 DLSGN 549 (973)
Q Consensus 545 ~Ls~N 549 (973)
.+..+
T Consensus 544 ~~~~~ 548 (592)
T 3ogk_B 544 LIPSR 548 (592)
T ss_dssp EECCC
T ss_pred EecCc
Confidence 44443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=274.00 Aligned_cols=276 Identities=21% Similarity=0.250 Sum_probs=135.2
Q ss_pred cCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEE
Q 048430 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQL 172 (973)
Q Consensus 93 ~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L 172 (973)
+.....|+++|.++ .+|.++. ++|++|++++|++++..+..|.++++|++|+|++|+++ .++...|..+++|++|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEE
T ss_pred CCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC-ccCHhhcCCCCCCCEE
Confidence 33344555555555 4554432 35555555555555443345555555555555555555 3333344455555555
Q ss_pred EcccccccccCCCCCCCcc-ccCCCCccEEEecCCcccCccc-cccccCCcceeEEeecccccccCCCCCCccccceeee
Q 048430 173 RLLGNNITGRIPNREIPNE-IGNLHNLKILDLGGNNIAGLIP-SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFL 250 (973)
Q Consensus 173 ~L~~N~l~~~~~~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L 250 (973)
+|++|+|+ .+|.. |+++++|++|+|++|++++..+ ..+.. +++|++|++
T Consensus 106 ~Ls~n~l~------~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~-----------------------l~~L~~L~l 156 (353)
T 2z80_A 106 DLSYNYLS------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSH-----------------------LTKLQILRV 156 (353)
T ss_dssp ECCSSCCS------SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTT-----------------------CTTCCEEEE
T ss_pred ECCCCcCC------cCCHhHhCCCccCCEEECCCCCCcccCchhhhcc-----------------------CCCCcEEEC
Confidence 55555554 22332 5555556666666555553322 23333 444555555
Q ss_pred ccc-cccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEc
Q 048430 251 WKN-NLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVL 329 (973)
Q Consensus 251 ~~N-~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L 329 (973)
++| .+.++.+..+..+++|++|++++|.+++..|..|..+++|++|++++|+++.. ....+..+++|+.|++
T Consensus 157 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~-------~~~~~~~~~~L~~L~L 229 (353)
T 2z80_A 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL-------LEIFVDVTSSVECLEL 229 (353)
T ss_dssp EESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTH-------HHHHHHHTTTEEEEEE
T ss_pred CCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccc-------hhhhhhhcccccEEEC
Confidence 554 24444445555555555555555555555555566666666666666655431 1122334555566666
Q ss_pred cCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccc----ccCcccCCCCCCCEEEccCC
Q 048430 330 DTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAG----AIPTVLGKLQKLQGLDLNSN 405 (973)
Q Consensus 330 ~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N 405 (973)
++|.+++..+..+.. ......++.++++++.+.+ .+|..+..+++|++|+|++|
T Consensus 230 ~~n~l~~~~~~~l~~----------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N 287 (353)
T 2z80_A 230 RDTDLDTFHFSELST----------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287 (353)
T ss_dssp ESCBCTTCCCC----------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSS
T ss_pred CCCcccccccccccc----------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCC
Confidence 666555443322211 1223445555665555543 23444555555555555555
Q ss_pred cCCCCCchh-hhccCcCCeeecCCcccc
Q 048430 406 KLKGFIPTD-LCKLEKLNTLLSNNNALQ 432 (973)
Q Consensus 406 ~l~~~~~~~-~~~l~~L~~L~l~~N~l~ 432 (973)
+++. +|.. |..+++|+.|++++|.+.
T Consensus 288 ~l~~-i~~~~~~~l~~L~~L~L~~N~~~ 314 (353)
T 2z80_A 288 QLKS-VPDGIFDRLTSLQKIWLHTNPWD 314 (353)
T ss_dssp CCCC-CCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCc-cCHHHHhcCCCCCEEEeeCCCcc
Confidence 5552 2322 244444444444444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=294.41 Aligned_cols=285 Identities=26% Similarity=0.295 Sum_probs=184.3
Q ss_pred CCCcceEEEEEee------CCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccC
Q 048430 29 SASVCNWVGVTCS------IRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSS 102 (973)
Q Consensus 29 ~~~~c~w~gv~C~------~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~ 102 (973)
+.+||.|+|..|. .....++.|++++++++ .+|..+. ++|++|+|++|++. .+|. .+++|++|+|++
T Consensus 18 ~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~ 90 (622)
T 3g06_A 18 AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSG 90 (622)
T ss_dssp TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCC
Confidence 5789999775332 12345888899988888 8887776 78888888888885 5665 567888888888
Q ss_pred CCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEccccccccc
Q 048430 103 NSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGR 182 (973)
Q Consensus 103 n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~ 182 (973)
|+++ .+|. .+++|++|+|++|++++ +|. .+++|+.|++++|+|+ .+|.. +++|++|+|++|+|++
T Consensus 91 N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~----l~~L~~L~Ls~N~l~~- 155 (622)
T 3g06_A 91 NQLT-SLPV----LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLAS- 155 (622)
T ss_dssp CCCS-CCCC----CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSC-
T ss_pred CcCC-cCCC----CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC----CCCCCEEECcCCcCCC-
Confidence 8887 6775 56888888888888884 554 4677888888888887 56642 4777777777777763
Q ss_pred CCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcch
Q 048430 183 IPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS 262 (973)
Q Consensus 183 ~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 262 (973)
+|. .+++|+.|++++|+|++. | . .+++|+.|++++|++++ +|..
T Consensus 156 -----l~~---~~~~L~~L~L~~N~l~~l-~---~-----------------------~~~~L~~L~Ls~N~l~~-l~~~ 199 (622)
T 3g06_A 156 -----LPA---LPSELCKLWAYNNQLTSL-P---M-----------------------LPSGLQELSVSDNQLAS-LPTL 199 (622)
T ss_dssp -----CCC---CCTTCCEEECCSSCCSCC-C---C-----------------------CCTTCCEEECCSSCCSC-CCCC
T ss_pred -----cCC---ccCCCCEEECCCCCCCCC-c---c-----------------------cCCCCcEEECCCCCCCC-CCCc
Confidence 332 235677777777777642 3 1 14667777777777764 3322
Q ss_pred hcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcc
Q 048430 263 ICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSI 342 (973)
Q Consensus 263 l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 342 (973)
+++|+.|++++|.++.+.. .+++|+.|++++|+|+.++
T Consensus 200 ---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~lp----------------------------------- 237 (622)
T 3g06_A 200 ---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTSLP----------------------------------- 237 (622)
T ss_dssp ---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCCC-----------------------------------
T ss_pred ---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCcCC-----------------------------------
Confidence 3566667777776664432 2355666666666555322
Q ss_pred cccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCC
Q 048430 343 GNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLN 422 (973)
Q Consensus 343 ~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 422 (973)
..+++|+.|++++|.++ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+
T Consensus 238 -------------------------~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~ 287 (622)
T 3g06_A 238 -------------------------VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSET 287 (622)
T ss_dssp -------------------------CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTC
T ss_pred -------------------------CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccC
Confidence 11234555555555555 2333 3455666666666666 4555666666666
Q ss_pred eeecCCccccCcCcccccCcC
Q 048430 423 TLLSNNNALQGQIPTCLANLT 443 (973)
Q Consensus 423 ~L~l~~N~l~~~~~~~~~~l~ 443 (973)
.|++++|.+++..|..+..++
T Consensus 288 ~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 288 TVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp EEECCSCCCCHHHHHHHHHHH
T ss_pred EEEecCCCCCCcCHHHHHhcc
Confidence 666666666666665555444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=271.81 Aligned_cols=278 Identities=24% Similarity=0.254 Sum_probs=174.2
Q ss_pred ceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCc
Q 048430 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLR 325 (973)
Q Consensus 246 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~ 325 (973)
+.++++++.++. +|..+. ++|++|+|++|+++.+++..|.++++|++|++++|+++.... .+..
T Consensus 10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~-------- 73 (306)
T 2z66_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC-----CSQS-------- 73 (306)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE-----EEHH--------
T ss_pred CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC-----cccc--------
Confidence 456666666663 343332 567777777777776666667777777777777776653100 0111
Q ss_pred EEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCC
Q 048430 326 VLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405 (973)
Q Consensus 326 ~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 405 (973)
+..+++|++|++++|.+. .+|..+..+++|++|++++|
T Consensus 74 -----------------------------------------~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n 111 (306)
T 2z66_A 74 -----------------------------------------DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111 (306)
T ss_dssp -----------------------------------------HHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTS
T ss_pred -----------------------------------------cccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCC
Confidence 223445555555555555 34444555566666666666
Q ss_pred cCCCCCc-hhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCC-CCcccccccccccEEEecCCcccCCc
Q 048430 406 KLKGFIP-TDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS-TIPSTFWSLKYILAVDFSLNSLSGSL 483 (973)
Q Consensus 406 ~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~ 483 (973)
++++..+ ..+..+++|+.|++++|.+.+..+..+..+++|++|++++|.+++ ..|..+..+++|+.|++++|++++..
T Consensus 112 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 191 (306)
T 2z66_A 112 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 191 (306)
T ss_dssp EEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred cccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcC
Confidence 6554433 355556666666666666665556666666666666666666654 45666666667777777777776666
Q ss_pred CcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccc-ccccccccccccCCCCC--cccc
Q 048430 484 PLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI-SLQSLDLSGNNISGEIP--KSLE 560 (973)
Q Consensus 484 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~ 560 (973)
|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..+ ....
T Consensus 192 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~ 271 (306)
T 2z66_A 192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 271 (306)
T ss_dssp TTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHH
T ss_pred HHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHH
Confidence 66777777777777777777766666677777788888888888777777777774 78888888888776432 1122
Q ss_pred ccccccccccCCCcccccCCC
Q 048430 561 KLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 561 ~l~~L~~l~ls~N~l~~~~p~ 581 (973)
-+...+.+.+..+.+.+..|+
T Consensus 272 ~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 272 WIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp HHHHTGGGBSCGGGCBEEESG
T ss_pred HHHhhhhhhccccccccCCch
Confidence 344455666667777777765
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=294.79 Aligned_cols=192 Identities=17% Similarity=0.195 Sum_probs=132.8
Q ss_pred CCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCe
Q 048430 368 GNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRH 447 (973)
Q Consensus 368 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 447 (973)
..+++|++|+|++|.+++..+ .++|++|+|++|.+++..+. .+++|+.|++++|.+++..|..++++++|+.
T Consensus 77 ~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 148 (487)
T 3oja_A 77 ESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148 (487)
T ss_dssp TTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEE
T ss_pred ccCCCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCE
Confidence 334445555555555543221 14556666666666544332 2355666666666666666666666666777
Q ss_pred eeccCCCCCCCCccccc-ccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 448 LDFRSNSLNSTIPSTFW-SLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 448 L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
|+|++|.+++..|..+. .+++|+.|++++|.|++. |. +..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.
T Consensus 149 L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~ 225 (487)
T 3oja_A 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225 (487)
T ss_dssp EECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSC
T ss_pred EECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCc
Confidence 77777776666666654 567777777777777644 22 3457889999999999985 55558888999999999999
Q ss_pred cccCCCCCcccccccccccccccccC-CCCCccccccccccccccC
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNIS-GEIPKSLEKLSRLVDFNVS 571 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~l~ls 571 (973)
|++ +|..+..+++|+.|+|++|.++ +.+|..+..++.|+.++++
T Consensus 226 l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred Ccc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 984 7778888999999999999998 6778888888888888886
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=268.12 Aligned_cols=226 Identities=23% Similarity=0.280 Sum_probs=198.5
Q ss_pred CCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEE
Q 048430 321 CRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGL 400 (973)
Q Consensus 321 l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 400 (973)
.++++.|+|++|.+. . +|..+..+++|++|+|++|.++ .+|..++.+++|++|
T Consensus 80 ~~~l~~L~L~~n~l~-~-------------------------lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L 132 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-Q-------------------------FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETL 132 (328)
T ss_dssp STTCCEEEEESSCCS-S-------------------------CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEE
T ss_pred ccceeEEEccCCCch-h-------------------------cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEE
Confidence 356777777777776 3 3444566788888888888888 778888888888888
Q ss_pred EccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccC---------cCCCCeeeccCCCCCCCCcccccccccccE
Q 048430 401 DLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLAN---------LTSLRHLDFRSNSLNSTIPSTFWSLKYILA 471 (973)
Q Consensus 401 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 471 (973)
+|++|+++ .+|..+.++++|+.|++++|++.+.+|..+.. +++|++|++++|+++ .+|..+..+++|+.
T Consensus 133 ~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~ 210 (328)
T 4fcg_A 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210 (328)
T ss_dssp EEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCE
T ss_pred ECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCE
Confidence 88888888 67888888888888888888888888877654 999999999999998 78888999999999
Q ss_pred EEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccccccc
Q 048430 472 VDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNI 551 (973)
Q Consensus 472 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 551 (973)
|++++|+++ .+|..++.+++|+.|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..|+.+++|++|+|++|++
T Consensus 211 L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp EEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred EEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 999999999 4777899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCccccccccccccccCCCccc
Q 048430 552 SGEIPKSLEKLSRLVDFNVSFNGLE 576 (973)
Q Consensus 552 ~~~~p~~~~~l~~L~~l~ls~N~l~ 576 (973)
.+.+|..+.++++|+.++++.|.+.
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999999977654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=266.35 Aligned_cols=251 Identities=24% Similarity=0.221 Sum_probs=213.2
Q ss_pred eEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcc
Q 048430 294 QILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNL 373 (973)
Q Consensus 294 ~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L 373 (973)
+.++++++.++.+|... .++|++|++++|.++. ..+..|..+++|
T Consensus 10 ~~l~c~~~~l~~ip~~~----------~~~l~~L~L~~n~l~~-------------------------i~~~~~~~l~~L 54 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGI----------PSSATRLELESNKLQS-------------------------LPHGVFDKLTQL 54 (306)
T ss_dssp TEEECCSSCCSSCCSCC----------CTTCCEEECCSSCCCC-------------------------CCTTTTTTCTTC
T ss_pred CEEEcCCCCcccCCCCC----------CCCCCEEECCCCccCc-------------------------cCHhHhhccccC
Confidence 46677777776654321 1355666666665552 223347889999
Q ss_pred cEEEeecCccccc--cCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCc-ccccCcCCCCeeec
Q 048430 374 LVLSLVNNELAGA--IPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIP-TCLANLTSLRHLDF 450 (973)
Q Consensus 374 ~~L~Ls~n~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L 450 (973)
++|++++|.++.. .+..+..+++|++|+|++|.+. .+|..+..+++|+.|++++|.+++..+ ..+..+++|++|++
T Consensus 55 ~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 133 (306)
T 2z66_A 55 TKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 133 (306)
T ss_dssp SEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEEC
T ss_pred CEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEEC
Confidence 9999999999833 3677778999999999999998 567779999999999999999997765 67889999999999
Q ss_pred cCCCCCCCCcccccccccccEEEecCCcccC-CcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcccc
Q 048430 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSG-SLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529 (973)
Q Consensus 451 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (973)
++|.+.+..+..|..+++|+.|++++|.+++ .+|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++
T Consensus 134 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp TTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 9999998889999999999999999999987 588899999999999999999998888999999999999999999998
Q ss_pred CCCCCcccccccccccccccccCCCCCccccccc-cccccccCCCcccccCC
Q 048430 530 PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLS-RLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 530 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~ls~N~l~~~~p 580 (973)
..+..|..+++|++|+|++|++++..|..+..++ +|+.|++++|++++..+
T Consensus 214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 7777899999999999999999999999999985 89999999999987654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=278.00 Aligned_cols=242 Identities=26% Similarity=0.333 Sum_probs=186.6
Q ss_pred CCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCC
Q 048430 53 PNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITG 132 (973)
Q Consensus 53 ~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~ 132 (973)
.+.+++ .+|..+. ++|++|+|++|++.+..|..|.++++|++|+|++|+++ .++...|..+++|++|+|++|++++
T Consensus 62 ~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~ 137 (452)
T 3zyi_A 62 TRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV 137 (452)
T ss_dssp CSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCSB
T ss_pred CCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEECCCCcCCc
Confidence 344454 5665543 68899999999998888899999999999999999998 5666667889999999999999997
Q ss_pred CCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCcc
Q 048430 133 EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLI 212 (973)
Q Consensus 133 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 212 (973)
..+..|.++++|++|+|++|+|+ .+|...|..+++|++|+|++|+..+.++ +..|.++++|++|+|++|++++.
T Consensus 138 ~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~----~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 138 IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYIS----EGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp CCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEEC----TTTTTTCTTCCEEECTTSCCSSC-
T ss_pred cChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccC----hhhccCCCCCCEEECCCCccccc-
Confidence 77777999999999999999998 8888888999999999999954433322 34688999999999999999854
Q ss_pred ccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCccccccc
Q 048430 213 PSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQ 292 (973)
Q Consensus 213 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 292 (973)
| .+.. +++|++|+|++|+++++.|..|..+++|+.|+|++|+++++.+..|.++++
T Consensus 212 ~-~~~~-----------------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 267 (452)
T 3zyi_A 212 P-NLTP-----------------------LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267 (452)
T ss_dssp C-CCTT-----------------------CTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred c-cccc-----------------------cccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence 3 2333 566777777777777666777777777777777777777777777777777
Q ss_pred ceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCC
Q 048430 293 LQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLK 335 (973)
Q Consensus 293 L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 335 (973)
|+.|+|++|+++.++. ..+..+++|+.|+|++|++.
T Consensus 268 L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 268 LVELNLAHNNLSSLPH-------DLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CCEEECCSSCCSCCCT-------TSSTTCTTCCEEECCSSCEE
T ss_pred CCEEECCCCcCCccCh-------HHhccccCCCEEEccCCCcC
Confidence 7777777777765443 23556677777777777765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=260.11 Aligned_cols=193 Identities=25% Similarity=0.290 Sum_probs=104.0
Q ss_pred CCCCCcccEEEeecCc-cccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCC
Q 048430 367 FGNLSNLLVLSLVNNE-LAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 445 (973)
|..+++|++|++++|. +....|..|..+++|++|+|++|++++..|..+.++++|++|++++|.+++..+..+..+++|
T Consensus 76 ~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 155 (285)
T 1ozn_A 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155 (285)
T ss_dssp TTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred cCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCc
Confidence 3444455555555554 443344555555555555555555554444455555555555555555554444445555556
Q ss_pred CeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccC
Q 048430 446 RHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARN 525 (973)
Q Consensus 446 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 525 (973)
++|++++|++++..+..|..+++|+.|++++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|
T Consensus 156 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 235 (285)
T 1ozn_A 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235 (285)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred cEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCC
Confidence 66666666555444444555555555555555555555555666666666666666666544445666666666666666
Q ss_pred ccccCCCCCcccccccccccccccccCCCCCcccc
Q 048430 526 AFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLE 560 (973)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 560 (973)
.+.+..+. ..-+..++.+..+.|.+.+..|..+.
T Consensus 236 ~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 236 PWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred CccCCCCc-HHHHHHHHhcccccCccccCCchHhC
Confidence 66543321 12223345555555555555555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=274.49 Aligned_cols=229 Identities=24% Similarity=0.279 Sum_probs=198.6
Q ss_pred cceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCC
Q 048430 349 LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428 (973)
Q Consensus 349 l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 428 (973)
++.|++++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+++...+..|..+++|+.|++++
T Consensus 66 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 145 (440)
T 3zyj_A 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN 145 (440)
T ss_dssp CSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCS
T ss_pred CcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCC
Confidence 34444444444445556688899999999999999988888999999999999999999977777899999999999999
Q ss_pred ccccCcCcccccCcCCCCeeeccCC-CCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccC
Q 048430 429 NALQGQIPTCLANLTSLRHLDFRSN-SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYI 507 (973)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (973)
|.++...+..|.++++|++|++++| .+....+..|..+++|+.|++++|+++ .+| .+..+++|+.|+|++|++++..
T Consensus 146 N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~ 223 (440)
T 3zyj_A 146 NPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIR 223 (440)
T ss_dssp CCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEEC
T ss_pred CcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccC
Confidence 9999888888999999999999995 455445567899999999999999998 556 4888999999999999999888
Q ss_pred CcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccC
Q 048430 508 PSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579 (973)
Q Consensus 508 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 579 (973)
|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 224 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp TTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred hhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 999999999999999999999988999999999999999999999888888999999999999999987643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-30 Score=281.61 Aligned_cols=260 Identities=15% Similarity=0.177 Sum_probs=130.8
Q ss_pred CcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCC-CCCCCcccc-------cccCCcEEEccC
Q 048430 31 SVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSF-YDTLPNELW-------HMRRLKIIDFSS 102 (973)
Q Consensus 31 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~-~~~~p~~~~-------~l~~L~~L~Ls~ 102 (973)
.|+.|.++.......+++.|+++++.+ .+|..+... |+.|+|++|.+ .+.+|..+. ++++|++|+|++
T Consensus 29 ~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~ 104 (312)
T 1wwl_A 29 NCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104 (312)
T ss_dssp GSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEE
T ss_pred hhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccC
Confidence 344444333222233455556666666 555544433 66666666666 334555544 566666666666
Q ss_pred CCCCCCCCcccc-CCCCCccEEEeeCcccCCCCCccccCC-----CCCCeEEccCccccccCCccccCCCCCccEEEccc
Q 048430 103 NSLSGSLPGDMC-NSFTQLESFDVSSNKITGEFPSAIVNI-----SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176 (973)
Q Consensus 103 n~l~~~~p~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~ 176 (973)
|++++.+|..++ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|+++ .++...+..+++|++|+|++
T Consensus 105 n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~ 182 (312)
T 1wwl_A 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSD 182 (312)
T ss_dssp EBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCC-CCCTTTCCCCSSCCEEECCS
T ss_pred CcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCc-cchHHHhccCCCCCEEECCC
Confidence 666656665543 5566666666666666654 5555555 56666666666665 44444445566666666666
Q ss_pred ccccccCCCCCCCccc--cCCCCccEEEecCCcccCc---cccccccCCcceeEEeecccccccCCC--CCCccccceee
Q 048430 177 NNITGRIPNREIPNEI--GNLHNLKILDLGGNNIAGL---IPSMIFNNSNMVAILLYGNHLSGHLPS--SIYLPNLENLF 249 (973)
Q Consensus 177 N~l~~~~~~~~~p~~l--~~l~~L~~L~L~~N~l~~~---~~~~~~~~~~L~~L~l~~n~l~~~~~~--~~~l~~L~~L~ 249 (973)
|++.+.++ +|..+ +.+++|++|+|++|+|++. ....+..+++|+.|++++|++++.+|. ...+++|++|+
T Consensus 183 N~l~~~~~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 259 (312)
T 1wwl_A 183 NPELGERG---LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259 (312)
T ss_dssp CTTCHHHH---HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEE
T ss_pred CCcCcchH---HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEE
Confidence 66543210 12222 5556666666666666521 112223444455555555544443321 11244444444
Q ss_pred eccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCC
Q 048430 250 LWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304 (973)
Q Consensus 250 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 304 (973)
|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|++|++++|+++
T Consensus 260 Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 260 LSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 4444444 3333333 4444444444444444 22 444444444444444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=274.71 Aligned_cols=231 Identities=22% Similarity=0.244 Sum_probs=197.3
Q ss_pred ccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecC
Q 048430 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSN 427 (973)
Q Consensus 348 ~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 427 (973)
.++.|++++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+++
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 34444444444555556668888999999999999998888899999999999999999997777778899999999999
Q ss_pred CccccCcCcccccCcCCCCeeeccCC-CCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCccc
Q 048430 428 NNALQGQIPTCLANLTSLRHLDFRSN-SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGY 506 (973)
Q Consensus 428 ~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 506 (973)
+|.++...+..|.++++|++|++++| .+....+..|..+++|+.|++++|++++ +| .+..+++|+.|+|++|++++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCccc
Confidence 99999877778999999999999984 5554445578899999999999999985 44 588899999999999999988
Q ss_pred CCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCC
Q 048430 507 IPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 507 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
.|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 89999999999999999999998889999999999999999999998888888999999999999999876543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=261.95 Aligned_cols=210 Identities=24% Similarity=0.222 Sum_probs=137.5
Q ss_pred CcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCcc-ccCcCcccccCcCCCCeee
Q 048430 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNA-LQGQIPTCLANLTSLRHLD 449 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~ 449 (973)
++|++|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|++++|. +....+..+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 456666666666665555566666666666666666665556666666666666666665 5555566666666666666
Q ss_pred ccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcccc
Q 048430 450 FRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529 (973)
Q Consensus 450 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (973)
+++|++++..|..|..+++|+.|++++|++++..+..++.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 66666666666666666666666666666665555556666677777777777765455556666777777777777766
Q ss_pred CCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCC
Q 048430 530 PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 530 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++.+..+
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 666667777777777777777766555566667777777777777665544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=274.66 Aligned_cols=266 Identities=18% Similarity=0.201 Sum_probs=172.3
Q ss_pred ceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCc
Q 048430 246 ENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLR 325 (973)
Q Consensus 246 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~ 325 (973)
+.++++++.+.......+..+++|++|+|++|.++++.|..|..+++|++|++++|++++.+ .+.
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~---------~~~------ 77 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL---------DLE------ 77 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE---------EET------
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch---------hhh------
Confidence 44455666665544455555566666666666666666666666666666666666654310 123
Q ss_pred EEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCC
Q 048430 326 VLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405 (973)
Q Consensus 326 ~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 405 (973)
.+++|++|++++|++++.. ..++|++|++++|
T Consensus 78 -------------------------------------------~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n 109 (317)
T 3o53_A 78 -------------------------------------------SLSTLRTLDLNNNYVQELL-----VGPSIETLHAANN 109 (317)
T ss_dssp -------------------------------------------TCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSS
T ss_pred -------------------------------------------hcCCCCEEECcCCcccccc-----CCCCcCEEECCCC
Confidence 3344444444444444221 1244555555555
Q ss_pred cCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCccccc-ccccccEEEecCCcccCCcC
Q 048430 406 KLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFW-SLKYILAVDFSLNSLSGSLP 484 (973)
Q Consensus 406 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p 484 (973)
++++..+. .+++|+.|++++|++++..+..+..+++|++|++++|++++..+..+. .+++|+.|++++|++++. +
T Consensus 110 ~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~ 185 (317)
T 3o53_A 110 NISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185 (317)
T ss_dssp CCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred ccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c
Confidence 55533222 234455555555555555555555566666666666666655555443 466666666666666643 3
Q ss_pred cCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccC-CCCCccccccc
Q 048430 485 LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS-GEIPKSLEKLS 563 (973)
Q Consensus 485 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~ 563 (973)
. ...+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..++
T Consensus 186 ~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~ 262 (317)
T 3o53_A 186 G-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262 (317)
T ss_dssp C-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCH
T ss_pred c-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccc
Confidence 2 3347889999999999984 5556889999999999999998 57888999999999999999998 77888999999
Q ss_pred cccccccC-CCcccccCCC
Q 048430 564 RLVDFNVS-FNGLEGEIPS 581 (973)
Q Consensus 564 ~L~~l~ls-~N~l~~~~p~ 581 (973)
+|+.++++ .+.+.|..|.
T Consensus 263 ~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 263 RVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp HHHHHHHHHHHHHHSSSSC
T ss_pred cceEEECCCchhccCCchh
Confidence 99999998 5567777665
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=273.93 Aligned_cols=245 Identities=26% Similarity=0.319 Sum_probs=186.6
Q ss_pred EecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcc
Q 048430 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNK 129 (973)
Q Consensus 50 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~ 129 (973)
++..+.+++ .+|..+. +.++.|+|++|++.+..+..|.++++|++|+|++|.+. .++...|.++++|++|+|++|+
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCSSCCEEECCSSC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCccCCEEECCCCc
Confidence 444555565 6777654 68999999999998888899999999999999999998 6777778899999999999999
Q ss_pred cCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc
Q 048430 130 ITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209 (973)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~ 209 (973)
+++..+..|.++++|++|+|++|+|+ .+|...|..+++|++|+|++|+..+.++ +..|.++++|++|+|++|+++
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~----~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYIS----EGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEEC----TTTTTTCSSCCEEECTTSCCS
T ss_pred CCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeC----cchhhcccccCeecCCCCcCc
Confidence 99776778999999999999999998 8888888999999999999955433322 346889999999999999998
Q ss_pred CccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccc
Q 048430 210 GLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGN 289 (973)
Q Consensus 210 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~ 289 (973)
.. |. +.. +++|++|+|++|+++++.|..|..+++|+.|+|++|+++++.+..|.+
T Consensus 199 ~~-~~-~~~-----------------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 253 (440)
T 3zyj_A 199 EI-PN-LTP-----------------------LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253 (440)
T ss_dssp SC-CC-CTT-----------------------CSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTT
T ss_pred cc-cc-cCC-----------------------CcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcC
Confidence 43 42 444 556666666666666666666666666666666666666666666666
Q ss_pred cccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCC
Q 048430 290 CRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLK 335 (973)
Q Consensus 290 l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 335 (973)
+++|++|+|++|+++.++. ..+..+++|+.|+|++|++.
T Consensus 254 l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 254 LQSLVEINLAHNNLTLLPH-------DLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTCCEEECTTSCCCCCCT-------TTTSSCTTCCEEECCSSCEE
T ss_pred CCCCCEEECCCCCCCccCh-------hHhccccCCCEEEcCCCCcc
Confidence 6666666666666665432 23455666666666666665
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-29 Score=274.78 Aligned_cols=247 Identities=19% Similarity=0.194 Sum_probs=169.4
Q ss_pred ccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccC
Q 048430 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKC 321 (973)
Q Consensus 242 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l 321 (973)
+++|++|+|++|++++..|+.|..+++|++|+|++|.+++..+ |..+++|++|++++|+++++ ...
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l------------~~~ 98 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL------------LVG 98 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE------------EEC
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc------------cCC
Confidence 6789999999999998888899999999999999999988765 88999999999999988642 223
Q ss_pred CcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEE
Q 048430 322 RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLD 401 (973)
Q Consensus 322 ~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 401 (973)
++|+.|++++|++++ ..+.. +++|++|+
T Consensus 99 ~~L~~L~l~~n~l~~-------------------------------------------------~~~~~---~~~L~~L~ 126 (317)
T 3o53_A 99 PSIETLHAANNNISR-------------------------------------------------VSCSR---GQGKKNIY 126 (317)
T ss_dssp TTCCEEECCSSCCSE-------------------------------------------------EEECC---CSSCEEEE
T ss_pred CCcCEEECCCCccCC-------------------------------------------------cCccc---cCCCCEEE
Confidence 455555555555542 22221 23344444
Q ss_pred ccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccc-cCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCccc
Q 048430 402 LNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCL-ANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480 (973)
Q Consensus 402 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 480 (973)
+++|++++..+..+..+++|+.|++++|.+++..+..+ ..+++|++|++++|++++. + ....+++|+.|++++|+++
T Consensus 127 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp CCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC
T ss_pred CCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC
Confidence 44444444434444444555555555555544444443 2455666666666666543 2 1223666777777777776
Q ss_pred CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc-cCCCCCccccccccccccc-ccccCCCCCcc
Q 048430 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ-GPIPQSFGSLISLQSLDLS-GNNISGEIPKS 558 (973)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~ 558 (973)
.+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus 205 -~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp -EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred -cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 34555778888888888888888 57777888888888899888888 7778888888999999998 44667665544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=274.45 Aligned_cols=268 Identities=26% Similarity=0.364 Sum_probs=163.9
Q ss_pred CCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEc
Q 048430 70 FLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRL 149 (973)
Q Consensus 70 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 149 (973)
.++.|++++|++. .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 3566666666663 5555544 55666666666665 4553 2455666666666655 3443 4455555555
Q ss_pred cCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeec
Q 048430 150 DNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYG 229 (973)
Q Consensus 150 ~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~ 229 (973)
++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. +++|++|+|++|++++. |.
T Consensus 109 s~N~l~-~l~~----~l~~L~~L~L~~N~l~------~lp~~---l~~L~~L~Ls~N~l~~l-~~--------------- 158 (622)
T 3g06_A 109 FSNPLT-HLPA----LPSGLCKLWIFGNQLT------SLPVL---PPGLQELSVSDNQLASL-PA--------------- 158 (622)
T ss_dssp CSCCCC-CCCC----CCTTCCEEECCSSCCS------CCCCC---CTTCCEEECCSSCCSCC-CC---------------
T ss_pred cCCcCC-CCCC----CCCCcCEEECCCCCCC------cCCCC---CCCCCEEECcCCcCCCc-CC---------------
Confidence 555555 3443 2344555555555544 22221 23444444444444421 11
Q ss_pred ccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCC
Q 048430 230 NHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSA 309 (973)
Q Consensus 230 n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 309 (973)
.+++|+.|++++|++++ +| ..+++|+.|++++|.|+++++ .+
T Consensus 159 -----------~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----~~------------------- 200 (622)
T 3g06_A 159 -----------LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----LP------------------- 200 (622)
T ss_dssp -----------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CC-------------------
T ss_pred -----------ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----cc-------------------
Confidence 13455556666665554 22 233455555555555544221 12
Q ss_pred cchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCc
Q 048430 310 QGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPT 389 (973)
Q Consensus 310 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 389 (973)
++|+.|++++|.++. +| . .+++|+.|++++|++++ +|
T Consensus 201 ------------~~L~~L~L~~N~l~~-l~-------------------------~---~~~~L~~L~Ls~N~L~~-lp- 237 (622)
T 3g06_A 201 ------------SELYKLWAYNNRLTS-LP-------------------------A---LPSGLKELIVSGNRLTS-LP- 237 (622)
T ss_dssp ------------TTCCEEECCSSCCSS-CC-------------------------C---CCTTCCEEECCSSCCSC-CC-
T ss_pred ------------chhhEEECcCCcccc-cC-------------------------C---CCCCCCEEEccCCccCc-CC-
Confidence 344555555555442 11 1 13679999999999995 55
Q ss_pred ccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccc
Q 048430 390 VLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLK 467 (973)
Q Consensus 390 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 467 (973)
..+++|++|+|++|+|+. +|. .+++|+.|++++|+|+ .+|..+.++++|+.|+|++|.+++..|..+..++
T Consensus 238 --~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 238 --VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp --CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred --CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 556899999999999994 565 6789999999999999 6788899999999999999999998888887765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=273.25 Aligned_cols=203 Identities=20% Similarity=0.211 Sum_probs=174.5
Q ss_pred CCCcccEEEeecCccccccCccc--CCCCCCCEEEccCCcCCCCCchhhhcc-----CcCCeeecCCccccCcCcccccC
Q 048430 369 NLSNLLVLSLVNNELAGAIPTVL--GKLQKLQGLDLNSNKLKGFIPTDLCKL-----EKLNTLLSNNNALQGQIPTCLAN 441 (973)
Q Consensus 369 ~l~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~ 441 (973)
++++|++|++++|++++..|..+ ..+++|++|+|++|++++. |..+..+ ++|++|++++|++++..+..+++
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 67899999999999998888876 8899999999999999976 8888877 89999999999999888899999
Q ss_pred cCCCCeeeccCCCCCCC--Ccccc--cccccccEEEecCCcccC--CcC-cCccCCCCCCeEEccCCcCcccCC-ccccc
Q 048430 442 LTSLRHLDFRSNSLNST--IPSTF--WSLKYILAVDFSLNSLSG--SLP-LNIGNLEALGGLNLTGNQLSGYIP-SSIGN 513 (973)
Q Consensus 442 l~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~ls~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~ 513 (973)
+++|++|++++|++.+. .|..+ ..+++|+.|++++|++++ .++ ..+.++++|+.|+|++|++++..| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 99999999999998765 33344 788999999999999983 122 334577899999999999997775 45677
Q ss_pred CCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccc
Q 048430 514 LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 514 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
+++|+.|+|++|+|+ .+|..+. ++|++|||++|+|++. |. +..+++|+.|++++|++++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 899999999999999 7888777 8999999999999976 66 8999999999999999976
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=247.63 Aligned_cols=171 Identities=22% Similarity=0.351 Sum_probs=116.1
Q ss_pred CCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCC
Q 048430 30 ASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109 (973)
Q Consensus 30 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 109 (973)
.++|.|.|+.|+.. +.++.+++++++++ .+|..+. +.|++|+|++|++.+..+..|+++++|++|+|++|.++ .+
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i 76 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TL 76 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-ee
Confidence 47899999999753 35667889988888 5776554 57888888888887666667888888888888888887 67
Q ss_pred CccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCC
Q 048430 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIP 189 (973)
Q Consensus 110 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p 189 (973)
|..+|..+++|++|+|++|++++..+..|.++++|++|+|++|+++ .++...|..+++|++|+|++|+|++. .+
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~-----~~ 150 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSL-----PK 150 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCC-----CT
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCcc-----CH
Confidence 7777777777777777777777655566677777777777777776 45555555555555555555555421 11
Q ss_pred ccccCCCCccEEEecCCcccCc
Q 048430 190 NEIGNLHNLKILDLGGNNIAGL 211 (973)
Q Consensus 190 ~~l~~l~~L~~L~L~~N~l~~~ 211 (973)
..|+.+++|++|+|++|++++.
T Consensus 151 ~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 151 GVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCC
T ss_pred hHccCCcccceeEecCCcCcEe
Confidence 2244455555555555555433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-30 Score=307.59 Aligned_cols=207 Identities=15% Similarity=0.094 Sum_probs=126.0
Q ss_pred CCCCcccEEEeecCcccc-ccCcccCCCCCCCEEEccC---------CcCCCCCchhhh-ccCcCCeeecCCccccCcCc
Q 048430 368 GNLSNLLVLSLVNNELAG-AIPTVLGKLQKLQGLDLNS---------NKLKGFIPTDLC-KLEKLNTLLSNNNALQGQIP 436 (973)
Q Consensus 368 ~~l~~L~~L~Ls~n~l~~-~~p~~~~~l~~L~~L~Ls~---------N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~ 436 (973)
..+++|+.|++++| +.. .++.....+++|++|+|++ +.+++.....+. .+++|+.|.++.|.+++...
T Consensus 311 ~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~ 389 (594)
T 2p1m_B 311 CQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL 389 (594)
T ss_dssp TTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHH
T ss_pred hcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHH
Confidence 34566666666666 332 1222233466677776632 344433222333 36777777777777766555
Q ss_pred cccc-CcCCCCeeecc--C----CCCCCC-----CcccccccccccEEEecCCcccCCcCcCccC-CCCCCeEEccCCcC
Q 048430 437 TCLA-NLTSLRHLDFR--S----NSLNST-----IPSTFWSLKYILAVDFSLNSLSGSLPLNIGN-LEALGGLNLTGNQL 503 (973)
Q Consensus 437 ~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l 503 (973)
..+. .+++|+.|+++ + |.++.. ++..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+
T Consensus 390 ~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i 468 (594)
T 2p1m_B 390 ITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGD 468 (594)
T ss_dssp HHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred HHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCC
Confidence 5554 46778888887 3 455422 122255677888888866 565544444544 77888888888888
Q ss_pred cccCCccc-ccCCcCCEEEcccCccccCCCC-CcccccccccccccccccCCCCCccc-cccccccccccCCCccc
Q 048430 504 SGYIPSSI-GNLKNLDWLALARNAFQGPIPQ-SFGSLISLQSLDLSGNNISGEIPKSL-EKLSRLVDFNVSFNGLE 576 (973)
Q Consensus 504 ~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~l~ls~N~l~ 576 (973)
++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|+|++|+++......+ ..+++|+...+..+.-.
T Consensus 469 ~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp SHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred cHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 75555444 5678888888888888644433 44557888888888888854333333 44566665555555433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-30 Score=308.70 Aligned_cols=466 Identities=13% Similarity=0.114 Sum_probs=230.4
Q ss_pred CcceEEEEEeeCCCCcEEEEecCCCCCCCcCCC-CCCCCCCCcEEEecCCCCC---CCCCc------------ccccccC
Q 048430 31 SVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPP-HVGNLSFLVSLNISGNSFY---DTLPN------------ELWHMRR 94 (973)
Q Consensus 31 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~-~l~~l~~L~~L~L~~n~~~---~~~p~------------~~~~l~~ 94 (973)
-|++|.++.. .....+++.... +..|. .+..+++|++|+|+++... +..|. ....+++
T Consensus 33 vck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~ 106 (594)
T 2p1m_B 33 VCKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTW 106 (594)
T ss_dssp SCHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCC
Confidence 4557998822 223455554432 22222 3456788999999987532 22222 1246778
Q ss_pred CcEEEccCCCCCCCCCccccCCCCCccEEEeeCc-ccCCC-CCccccCCCCCCeEEccCccccccCCc---cccCCCCCc
Q 048430 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSN-KITGE-FPSAIVNISSLKSIRLDNNSLSGSFPT---DLCTRLPSL 169 (973)
Q Consensus 95 L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~ip~---~~~~~l~~L 169 (973)
|++|+|++|.+++..+..+...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+. .+...+++|
T Consensus 107 L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L 186 (594)
T 2p1m_B 107 LEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186 (594)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCC
T ss_pred CCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcC
Confidence 8888888888775555444445788888888888 44432 344445788888888888887643322 223356688
Q ss_pred cEEEcccccccccCCCCCCCccccCCCCccEEEecCC-cccCccccccccCCcceeEEeecc-------cccccCCCCCC
Q 048430 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGN-NIAGLIPSMIFNNSNMVAILLYGN-------HLSGHLPSSIY 241 (973)
Q Consensus 170 ~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~L~~L~l~~n-------~l~~~~~~~~~ 241 (973)
++|+|++|. +.+....++..+.++++|++|+|++| .+.+ ++..+..+++|+.|++..+ .+.+..+....
T Consensus 187 ~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 187 VSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred cEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 888888876 11111112222345678888888887 4443 6677777777777774433 33333322223
Q ss_pred cccccee-eeccccccccCcchhcccCcccEEEeccccccccCC-CcccccccceEEEccCCcCCCCCCCcchhhhhhhc
Q 048430 242 LPNLENL-FLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP-NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLA 319 (973)
Q Consensus 242 l~~L~~L-~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~ 319 (973)
+++|+.| .+.+... +.++..+..+++|++|+|++|.+++... ..+..+++|++|++++| ++. ..+.....
T Consensus 264 ~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~------~~l~~l~~ 335 (594)
T 2p1m_B 264 CKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IED------AGLEVLAS 335 (594)
T ss_dssp CTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHH------HHHHHHHH
T ss_pred CCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCH------HHHHHHHH
Confidence 5555555 3332222 1233344455566666666665443221 12345556666666655 221 11111122
Q ss_pred cCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCC-CCCCcccEEEeecCccccccCcccC-CCCCC
Q 048430 320 KCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGF-GNLSNLLVLSLVNNELAGAIPTVLG-KLQKL 397 (973)
Q Consensus 320 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~-~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L 397 (973)
.+++|+.|++.++.-.|. ...+.+++.....+ ..+++|+.|.++.|.+++..+..+. .+++|
T Consensus 336 ~~~~L~~L~L~~~~~~g~----------------~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L 399 (594)
T 2p1m_B 336 TCKDLRELRVFPSEPFVM----------------EPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM 399 (594)
T ss_dssp HCTTCCEEEEECSCTTCS----------------SCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTC
T ss_pred hCCCCCEEEEecCccccc----------------ccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCc
Confidence 355555555533210000 00011111000011 1245555555555555544333333 35555
Q ss_pred CEEEcc--C----CcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccc-ccccc
Q 048430 398 QGLDLN--S----NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWS-LKYIL 470 (973)
Q Consensus 398 ~~L~Ls--~----N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~ 470 (973)
+.|+|+ + |.++....+. .++..+..+++|+.|++++ .+++..+..+.. +++|+
T Consensus 400 ~~L~L~~~~~~~~~~l~~~~~~~-------------------~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~ 459 (594)
T 2p1m_B 400 TRFRLCIIEPKAPDYLTLEPLDI-------------------GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKME 459 (594)
T ss_dssp CEEEEEESSTTCCCTTTCCCTHH-------------------HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCC
T ss_pred ceeEeecccCCCcccccCCchhh-------------------HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhcc
Confidence 555555 2 3333110000 0111133444555555544 333332333332 45555
Q ss_pred EEEecCCcccCCcCcCc-cCCCCCCeEEccCCcCcccCCc-ccccCCcCCEEEcccCccccCCCCCc-cccccccccccc
Q 048430 471 AVDFSLNSLSGSLPLNI-GNLEALGGLNLTGNQLSGYIPS-SIGNLKNLDWLALARNAFQGPIPQSF-GSLISLQSLDLS 547 (973)
Q Consensus 471 ~L~ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls 547 (973)
.|++++|.+++..+..+ ..+++|+.|+|++|.+++.... .+..+++|+.|++++|+++......+ ..+++|+...+.
T Consensus 460 ~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~ 539 (594)
T 2p1m_B 460 MLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVID 539 (594)
T ss_dssp EEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEEC
T ss_pred EeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEec
Confidence 55555555543333333 4456666666666666433222 23346666666666666643222222 334455444444
Q ss_pred cc
Q 048430 548 GN 549 (973)
Q Consensus 548 ~N 549 (973)
.+
T Consensus 540 ~~ 541 (594)
T 2p1m_B 540 ER 541 (594)
T ss_dssp SS
T ss_pred CC
Confidence 44
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=278.96 Aligned_cols=185 Identities=17% Similarity=0.091 Sum_probs=131.7
Q ss_pred cccccCceEEEEEE-eCCCeEEEEEEEeccc----------hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEE
Q 048430 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQE----------DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 687 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 754 (973)
..+.|++|.+..++ ...|+.||||++.... +...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666666654 4458889999986541 22346799999999999 699999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
|||++|++|.+++...+ .++.. +|+.||+.||+|+| ++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999998765 56654 48999999999999 8999999999999999999999999999998764322
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p 880 (973)
......+||++|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 23345679999999998765 567789999999998887666544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=268.80 Aligned_cols=237 Identities=20% Similarity=0.194 Sum_probs=161.8
Q ss_pred ccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccC
Q 048430 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKC 321 (973)
Q Consensus 242 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l 321 (973)
+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.+| |..+++|++|+|++|+|++++ ..
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~------------~~ 98 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL------------VG 98 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE------------EC
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC------------CC
Confidence 5678888888888887777788888888888888888877665 777778888888777775411 12
Q ss_pred CcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEE
Q 048430 322 RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLD 401 (973)
Q Consensus 322 ~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 401 (973)
++ |++|++++|.+++..+. .+++|+.|+
T Consensus 99 ~~-------------------------------------------------L~~L~L~~N~l~~~~~~---~l~~L~~L~ 126 (487)
T 3oja_A 99 PS-------------------------------------------------IETLHAANNNISRVSCS---RGQGKKNIY 126 (487)
T ss_dssp TT-------------------------------------------------CCEEECCSSCCCCEEEC---CCSSCEEEE
T ss_pred CC-------------------------------------------------cCEEECcCCcCCCCCcc---ccCCCCEEE
Confidence 34 44444445544433332 234555555
Q ss_pred ccCCcCCCCCchhhhccCcCCeeecCCccccCcCccccc-CcCCCCeeeccCCCCCCCCcccccccccccEEEecCCccc
Q 048430 402 LNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA-NLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480 (973)
Q Consensus 402 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 480 (973)
|++|.+++..|..++.+++|+.|++++|.+++..|..+. .+++|+.|+|++|.+++..+ +..+++|+.|++++|.++
T Consensus 127 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~ 204 (487)
T 3oja_A 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLA 204 (487)
T ss_dssp CCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCC
Confidence 555555555555555555555566666655555555554 56666666666666664422 224667777777777777
Q ss_pred CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc-cCCCCCcccccccccccccc
Q 048430 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ-GPIPQSFGSLISLQSLDLSG 548 (973)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~ 548 (973)
+ +|..+..+++|+.|+|++|+|+ .+|..++.+++|+.|++++|.+. +.+|..+..++.|+.|+++.
T Consensus 205 ~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 205 F-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp E-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred C-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence 4 4445778888888888888888 47777888889999999999888 67778888889999988863
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=239.53 Aligned_cols=210 Identities=22% Similarity=0.235 Sum_probs=178.9
Q ss_pred CcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeec
Q 048430 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 450 (973)
++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++|.+++..+..+.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46888888888888777778888888888888888888777778888888899999998888887788888899999999
Q ss_pred cCCCCCCCCcccccccccccEEEecCCcccCC-cCcCccCCCCCCeEEccCCcCcccCCcccccCCcCC----EEEcccC
Q 048430 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSGS-LPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLD----WLALARN 525 (973)
Q Consensus 451 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N 525 (973)
++|.+.+..+..+..+++|+.|++++|++++. +|..++++++|+.|+|++|++++..+..+..+.+|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99998887777888889999999999998863 588899999999999999999977777888777777 8999999
Q ss_pred ccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCC
Q 048430 526 AFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
++++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|++++|++++..|.
T Consensus 188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred cccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 999666655554 4899999999999987777789999999999999999987775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-25 Score=235.83 Aligned_cols=217 Identities=22% Similarity=0.252 Sum_probs=167.0
Q ss_pred cCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCcccc
Q 048430 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIV 139 (973)
Q Consensus 60 ~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 139 (973)
.+|..+. +.|++|+|++|++.+..+..|.++++|++|+|++|++. .++...+..+++|++|+|++|.+++..|..|.
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhhhc
Confidence 4565443 57899999999998777778999999999999999998 67766778899999999999999988888899
Q ss_pred CCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccC
Q 048430 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNN 219 (973)
Q Consensus 140 ~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 219 (973)
++++|++|++++|.++ .++...+..+++|++|+|++|++++. .+|..++++++|++|+|++|++++..+..+..+
T Consensus 98 ~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~----~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 172 (276)
T 2z62_A 98 GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSF----KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172 (276)
T ss_dssp TCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCC----CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred CCccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCcccee----cCchhhccCCCCCEEECCCCCCCcCCHHHhhhh
Confidence 9999999999999998 66666678899999999999999742 367889999999999999999998777777664
Q ss_pred CcceeEEeecccccccCCCCCCccccc-eeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEc
Q 048430 220 SNMVAILLYGNHLSGHLPSSIYLPNLE-NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSL 298 (973)
Q Consensus 220 ~~L~~L~l~~n~l~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 298 (973)
.+|+ .|. +|++++|+++++.+..+.. .+|+.|+|++|+++++++..|..+++|+.|++
T Consensus 173 ~~L~--------------------~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 231 (276)
T 2z62_A 173 HQMP--------------------LLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231 (276)
T ss_dssp HTCT--------------------TCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEEC
T ss_pred hhcc--------------------ccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEc
Confidence 4443 111 5566666666544444333 35666666666666666666666666777777
Q ss_pred cCCcCCC
Q 048430 299 GDNQLTT 305 (973)
Q Consensus 299 ~~N~l~~ 305 (973)
++|+++.
T Consensus 232 ~~N~~~c 238 (276)
T 2z62_A 232 HTNPWDC 238 (276)
T ss_dssp CSSCBCC
T ss_pred cCCcccc
Confidence 7766654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=230.56 Aligned_cols=206 Identities=24% Similarity=0.272 Sum_probs=160.6
Q ss_pred cccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeecc
Q 048430 372 NLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFR 451 (973)
Q Consensus 372 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 451 (973)
+.+.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|++++|.++...+..|.++++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4667778877777 4555443 567888888888876666677778888888888888876666667778888888888
Q ss_pred CCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCC
Q 048430 452 SNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPI 531 (973)
Q Consensus 452 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 531 (973)
+|++++..+..|..+++|+.|++++|++++..+..|+.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 88887777777788888888888888888777777788888888888888888666666788888888888888888776
Q ss_pred CCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCC
Q 048430 532 PQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 532 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++.+..+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 7778888888888888888887666678888888888888888776554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=232.97 Aligned_cols=200 Identities=23% Similarity=0.237 Sum_probs=119.1
Q ss_pred CcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeec
Q 048430 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 450 (973)
++|+.|++++|.++. + ..+..+++|++|+|++|.+++. ..+..+++|++|++++|.+++..+..+.++++|++|++
T Consensus 41 ~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 344444444444431 1 1244445555555555555431 24445555555555555555444445555556666666
Q ss_pred cCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccC
Q 048430 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGP 530 (973)
Q Consensus 451 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 530 (973)
++|++++..+..|..+++|+.|++++|++++..+..++.+++|+.|+|++|++++..+..|+.+++|+.|+|++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 66666555555556666666666666666655555566667777777777777765555666777777777777777766
Q ss_pred CCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCC
Q 048430 531 IPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 531 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
.|..|..+++|+.|+|++|.+.+. ++.|+.++++.|.++|.+|.
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred CHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 666667777777777777776644 33567777777777777775
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-24 Score=229.87 Aligned_cols=205 Identities=24% Similarity=0.231 Sum_probs=168.0
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
+.++++++++++++|+++ .+|..+. ++++.|+|++|++++..+..|.++++|+.|++++|.+++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 556788888999998888 4555443 5788899999998877778888888999999999988865433 6788899
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
+|++++|+++ .+|..+..+++|+.|++++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999887 567788888888888888888887767788888888888888888887777778888888888888888
Q ss_pred cccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCccccc
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGE 578 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 578 (973)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.++|++|++.+.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 88666667788888888888888888 6777788888888888888887653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=228.61 Aligned_cols=207 Identities=26% Similarity=0.280 Sum_probs=171.9
Q ss_pred cccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeec
Q 048430 347 TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS 426 (973)
Q Consensus 347 ~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 426 (973)
..++.+++.+|.++. ...+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++..+..+..+++|++|++
T Consensus 41 ~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 567888888888774 23578888899999999888853 47888888999999999888777777888888999999
Q ss_pred CCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCccc
Q 048430 427 NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGY 506 (973)
Q Consensus 427 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 506 (973)
++|++++..+..+..+++|++|++++|++++..+..|..+++|+.|++++|++++..+..++.+++|+.|+|++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 99998887777788888899999999988877777788888899999999998877777778888899999999999877
Q ss_pred CCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCcccccccc
Q 048430 507 IPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSR 564 (973)
Q Consensus 507 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 564 (973)
.|..++.+++|+.|+|++|.+.+.. ++|+.|+++.|+++|.+|.+++.+..
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~~~-------~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDCTC-------PGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCT-------TTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CHHHHhCCcCCCEEEccCCCccccC-------cHHHHHHHHHHhCCCcccCcccccCC
Confidence 7777888889999999999887544 46888888889998888888777654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=227.44 Aligned_cols=208 Identities=23% Similarity=0.186 Sum_probs=184.9
Q ss_pred ccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccc
Q 048430 390 VLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI 469 (973)
Q Consensus 390 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 469 (973)
.+.++++++++++++|.++ .+|..+. ++++.|++++|.+++..+..|..+++|++|+|++|.+++..+. ..+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 4678899999999999999 5666554 6899999999999998899999999999999999999865443 789999
Q ss_pred cEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccccc
Q 048430 470 LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549 (973)
Q Consensus 470 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (973)
+.|++++|+++ .+|..+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999999 78889999999999999999999877789999999999999999999888888999999999999999
Q ss_pred ccCCCCCccccccccccccccCCCcccccCCCCCCCCccCccccccCcccccCC
Q 048430 550 NISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSS 603 (973)
Q Consensus 550 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 603 (973)
+|++..+..|..+++|+.|+|++|+++..++.......+....+.+|++.|++.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence 999777778899999999999999999544444555566777789999999874
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=224.97 Aligned_cols=193 Identities=19% Similarity=0.321 Sum_probs=163.1
Q ss_pred CCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCC
Q 048430 30 ASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109 (973)
Q Consensus 30 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 109 (973)
.+||.|.|.+|... .+.+++++++++ .+|+.+. +.|+.|+|++|++.+..|..|.++++|++|+|++|.++ .+
T Consensus 2 ~~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~ 74 (251)
T 3m19_A 2 KTCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TL 74 (251)
T ss_dssp --CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CC
T ss_pred ccCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC-cc
Confidence 36899999999642 446899999998 7887665 68999999999999888889999999999999999998 46
Q ss_pred CccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCC
Q 048430 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIP 189 (973)
Q Consensus 110 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p 189 (973)
+...+..+++|++|+|++|++++..+..|.++++|++|+|++|+|+ .+|...|..+++|++|+|++|+|++. .+
T Consensus 75 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~~ 148 (251)
T 3m19_A 75 SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSI-----PA 148 (251)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCC-----CT
T ss_pred CHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCcc-----CH
Confidence 6667788999999999999999877788999999999999999998 78888888999999999999999732 23
Q ss_pred ccccCCCCccEEEecCCcccCccccccccCCcceeEEeeccccccc
Q 048430 190 NEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGH 235 (973)
Q Consensus 190 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 235 (973)
..|+.+++|++|+|++|++++..+..+..+++|+.|++++|.++..
T Consensus 149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 4688999999999999999988777888866677666666666544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.4e-25 Score=255.65 Aligned_cols=186 Identities=17% Similarity=0.161 Sum_probs=145.3
Q ss_pred CCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--------hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--------DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
+...++||+|+||.||+|.. .++.+|+|...... ....+.+.+|++++++++||||+++..++...+..++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34467899999999999954 47889999764321 1124568999999999999999966666666777899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++++|.+++.. +..++.|+++||+||| +++|+||||||+|||++. .+||+|||+++.....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999999976 4689999999999999 799999999999999999 9999999999977532
Q ss_pred CCcc------cccccccccccCccCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 048430 834 DPVT------QTMTLATIGYMAPEYGSE--GIVSISGDVYSFGILMMETFTRRKPTN 882 (973)
Q Consensus 834 ~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~Gvvl~elltg~~p~~ 882 (973)
.... .....||+.|||||.+.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111 134579999999998776 557888999999999999888877763
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=218.85 Aligned_cols=203 Identities=19% Similarity=0.234 Sum_probs=116.9
Q ss_pred cCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCC-CCCCCCccccCCCCCccEEEeeC-cccCCCCCcc
Q 048430 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNS-LSGSLPGDMCNSFTQLESFDVSS-NKITGEFPSA 137 (973)
Q Consensus 60 ~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~~l~~L~~L~Ls~-N~l~~~~p~~ 137 (973)
.+|. +. ..|++|+|++|++.+..+..|+.+++|++|++++|. +. .+|...|..+++|++|++++ |++++..+..
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~ 100 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDA 100 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTS
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHH
Confidence 4555 32 267778888877765555567777777777777775 55 55555556666666666666 6666544455
Q ss_pred ccCCCCCCeEEccCccccccCCccccCCCCCcc---EEEcccc-cccccCCCCCCCccccCCCCcc-EEEecCCcccCcc
Q 048430 138 IVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLV---QLRLLGN-NITGRIPNREIPNEIGNLHNLK-ILDLGGNNIAGLI 212 (973)
Q Consensus 138 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~p~~l~~l~~L~-~L~L~~N~l~~~~ 212 (973)
|.++++|++|++++|+++ .+|. +..+++|+ +|++++| ++++.. +..|.++++|+ +|++++|+++
T Consensus 101 f~~l~~L~~L~l~~n~l~-~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~-----~~~~~~l~~L~~~L~l~~n~l~--- 169 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLK-MFPD--LTKVYSTDIFFILEITDNPYMTSIP-----VNAFQGLCNETLTLKLYNNGFT--- 169 (239)
T ss_dssp EECCTTCCEEEEEEECCC-SCCC--CTTCCBCCSEEEEEEESCTTCCEEC-----TTTTTTTBSSEEEEECCSCCCC---
T ss_pred hCCCCCCCEEeCCCCCCc-cccc--cccccccccccEEECCCCcchhhcC-----cccccchhcceeEEEcCCCCCc---
Confidence 666666666666666665 3443 34444444 5555554 443211 12344444444 4444444444
Q ss_pred ccccccCCcceeEEeecccccccCCCCCCccccceeeecccc-ccccCcchhccc-CcccEEEeccccccccCCCccccc
Q 048430 213 PSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNN-LSGIIPDSICNA-SEATILELSSNLFSGLVPNTFGNC 290 (973)
Q Consensus 213 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l-~~L~~L~L~~N~i~~~~~~~~~~l 290 (973)
...+..+..++|++|+|++|+ ++++.+..|..+ ++|+.|++++|+++++++. .+
T Consensus 170 ---------------------~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~ 225 (239)
T 2xwt_C 170 ---------------------SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GL 225 (239)
T ss_dssp ---------------------EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TC
T ss_pred ---------------------ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---Hh
Confidence 222222223566777777773 666666666666 6777777777777655443 44
Q ss_pred ccceEEEccCC
Q 048430 291 RQLQILSLGDN 301 (973)
Q Consensus 291 ~~L~~L~L~~N 301 (973)
++|+.|+++++
T Consensus 226 ~~L~~L~l~~~ 236 (239)
T 2xwt_C 226 EHLKELIARNT 236 (239)
T ss_dssp TTCSEEECTTC
T ss_pred ccCceeeccCc
Confidence 56666666554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-24 Score=240.01 Aligned_cols=265 Identities=18% Similarity=0.176 Sum_probs=127.7
Q ss_pred EEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCc----chhcccC-cccEEEec
Q 048430 201 LDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIP----DSICNAS-EATILELS 275 (973)
Q Consensus 201 L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~l~~l~-~L~~L~L~ 275 (973)
++|++|.+++.+|..+.. .++|++|+|++|.+++..+ +.+..++ +|++|+|+
T Consensus 3 ~~ls~n~~~~~~~~~~~~-----------------------~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls 59 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSI-----------------------PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLS 59 (362)
T ss_dssp EECCCCTTCCHHHHHHTS-----------------------CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECC
T ss_pred cccccccchHHHHHHHhC-----------------------CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECc
Confidence 456666666666655544 2335555555555555444 4455555 56666666
Q ss_pred cccccccCCCccccc-----ccceEEEccCCcCCCCCCCcchhhhhhhccC-CcCcEEEccCCCCCCCCCCccccccccc
Q 048430 276 SNLFSGLVPNTFGNC-----RQLQILSLGDNQLTTGSSAQGQIFYSSLAKC-RYLRVLVLDTNPLKGVIPNSIGNLSTSL 349 (973)
Q Consensus 276 ~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~~l 349 (973)
+|.+++..+..|..+ ++|++|+|++|+++.... ..+...+..+ ++|++|++++|++++..+..+...
T Consensus 60 ~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~---~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~---- 132 (362)
T 3goz_A 60 GNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSS---DELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA---- 132 (362)
T ss_dssp SSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCH---HHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH----
T ss_pred CCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHH---HHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH----
Confidence 666655555444443 555566665555543211 1122223333 455555555555543332222111
Q ss_pred ceeecccCCccccCCCCCCC-CCcccEEEeecCcccccc----CcccCCCC-CCCEEEccCCcCCCCCchhhhc----c-
Q 048430 350 ENFYAGSSQLSGGIPVGFGN-LSNLLVLSLVNNELAGAI----PTVLGKLQ-KLQGLDLNSNKLKGFIPTDLCK----L- 418 (973)
Q Consensus 350 ~~l~l~~n~l~~~~p~~~~~-l~~L~~L~Ls~n~l~~~~----p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~----l- 418 (973)
+.. .++|++|+|++|.+++.. +..+..++ +|++|+|++|++++..+..+.. +
T Consensus 133 -----------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~ 195 (362)
T 3goz_A 133 -----------------FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP 195 (362)
T ss_dssp -----------------HTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSC
T ss_pred -----------------HHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCC
Confidence 222 135555555555555322 22233333 5666666666555444433332 2
Q ss_pred CcCCeeecCCccccCc----CcccccC-cCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCC
Q 048430 419 EKLNTLLSNNNALQGQ----IPTCLAN-LTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEAL 493 (973)
Q Consensus 419 ~~L~~L~l~~N~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 493 (973)
++|+.|+|++|.+++. ++..+.. .++|++|+|++|++++..+..+ ...+..+++|
T Consensus 196 ~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--------------------~~~~~~l~~L 255 (362)
T 3goz_A 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENL--------------------KLLKDSLKHL 255 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHH--------------------HHTTTTTTTC
T ss_pred CCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHH--------------------HHHHhcCCCc
Confidence 3555555555555432 2222222 2345555555555543322111 1223444555
Q ss_pred CeEEccCCcCcc-------cCCcccccCCcCCEEEcccCccccCCC
Q 048430 494 GGLNLTGNQLSG-------YIPSSIGNLKNLDWLALARNAFQGPIP 532 (973)
Q Consensus 494 ~~L~Ls~N~l~~-------~~p~~~~~l~~L~~L~Ls~N~l~~~~p 532 (973)
+.|+|++|++++ .++..+..+++|+.|+|++|++.+..+
T Consensus 256 ~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp SEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 555555555332 123345566667777777777665433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-25 Score=250.62 Aligned_cols=265 Identities=17% Similarity=0.211 Sum_probs=163.0
Q ss_pred cceeeeccccccccCcchhcccCcccEEEeccccccccCC----CcccccccceEEEccCCcCCCCCCCcchhhhhhhcc
Q 048430 245 LENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP----NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAK 320 (973)
Q Consensus 245 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~ 320 (973)
|+...+....+. .++..+..+++|++|+|++|.++...+ ..|..+++|++|+|++|.+..
T Consensus 11 L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~--------------- 74 (386)
T 2ca6_A 11 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR--------------- 74 (386)
T ss_dssp CEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTS---------------
T ss_pred cccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCc---------------
Confidence 333334444444 455667777777888888777775533 235566666666666655432
Q ss_pred CCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccc----ccCcccCCCCC
Q 048430 321 CRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAG----AIPTVLGKLQK 396 (973)
Q Consensus 321 l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~ 396 (973)
+.+.+|..+.. +...|..+++|++|+|++|.+++ .+|..+..+++
T Consensus 75 -------------l~~~~~~~~~~------------------l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~ 123 (386)
T 2ca6_A 75 -------------VKDEIPEALRL------------------LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123 (386)
T ss_dssp -------------CGGGSHHHHHH------------------HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTT
T ss_pred -------------cccchhHHHHH------------------HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCC
Confidence 11222222211 11223556777777777777765 36667777777
Q ss_pred CCEEEccCCcCCCCCchhhhc----c---------CcCCeeecCCcccc-CcCc---ccccCcCCCCeeeccCCCCC--C
Q 048430 397 LQGLDLNSNKLKGFIPTDLCK----L---------EKLNTLLSNNNALQ-GQIP---TCLANLTSLRHLDFRSNSLN--S 457 (973)
Q Consensus 397 L~~L~Ls~N~l~~~~~~~~~~----l---------~~L~~L~l~~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~ 457 (973)
|++|+|++|.++...+..+.. + ++|+.|++++|+++ ..++ ..+..+++|++|++++|+++ +
T Consensus 124 L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g 203 (386)
T 2ca6_A 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203 (386)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHH
T ss_pred CCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhH
Confidence 888888888776443333333 3 67777777777776 2333 34556677777777777775 2
Q ss_pred ---CCcccccccccccEEEecCCccc----CCcCcCccCCCCCCeEEccCCcCccc----CCccc--ccCCcCCEEEccc
Q 048430 458 ---TIPSTFWSLKYILAVDFSLNSLS----GSLPLNIGNLEALGGLNLTGNQLSGY----IPSSI--GNLKNLDWLALAR 524 (973)
Q Consensus 458 ---~~p~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~ 524 (973)
..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++. +|..+ +.+++|+.|+|++
T Consensus 204 ~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~ 283 (386)
T 2ca6_A 204 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283 (386)
T ss_dssp HHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCS
T ss_pred HHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcC
Confidence 23336666777777777777774 45666667777777777777777654 44555 3367777777777
Q ss_pred Ccccc----CCCCCc-ccccccccccccccccCCCCC
Q 048430 525 NAFQG----PIPQSF-GSLISLQSLDLSGNNISGEIP 556 (973)
Q Consensus 525 N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p 556 (973)
|.+++ .+|..+ .++++|++|+|++|++++..+
T Consensus 284 n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp SCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 77775 366555 556777777777777776553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=225.95 Aligned_cols=200 Identities=17% Similarity=0.162 Sum_probs=134.8
Q ss_pred CcccEEEeecCccccccCccc--CCCCCCCEEEccCCcCCCCCc----hhhhccCcCCeeecCCccccCcCcccccCcCC
Q 048430 371 SNLLVLSLVNNELAGAIPTVL--GKLQKLQGLDLNSNKLKGFIP----TDLCKLEKLNTLLSNNNALQGQIPTCLANLTS 444 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 444 (973)
++|++|++++|.+.+..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|++++|.+.+..+..++.+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 456777777777776666666 667777777777777765443 33445667777777777777666667777777
Q ss_pred CCeeeccCCCCCCC--C--cccccccccccEEEecCCcccCCcCc----CccCCCCCCeEEccCCcCcccCCcccccC--
Q 048430 445 LRHLDFRSNSLNST--I--PSTFWSLKYILAVDFSLNSLSGSLPL----NIGNLEALGGLNLTGNQLSGYIPSSIGNL-- 514 (973)
Q Consensus 445 L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-- 514 (973)
|++|+|++|++.+. + +..+..+++|++|++++|+++ .++. .++.+++|++|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 77777777776532 1 122356667777777777775 2332 24566777777777777776667666665
Q ss_pred -CcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCccc
Q 048430 515 -KNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576 (973)
Q Consensus 515 -~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 576 (973)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|++++|+++
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 57778888888877 5666664 6788888888888753 33 567777888888888775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.8e-25 Score=248.21 Aligned_cols=246 Identities=22% Similarity=0.252 Sum_probs=196.9
Q ss_pred hhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecC---ccccccCcc
Q 048430 314 FYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNN---ELAGAIPTV 390 (973)
Q Consensus 314 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~ 390 (973)
+...+..+++|+.|+|++|.+....+.. ++..|..+++|++|+|++| ++++.+|..
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~---------------------l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~ 82 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARW---------------------LSENIASKKDLEIAEFSDIFTGRVKDEIPEA 82 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHH---------------------HHHTTTTCTTCCEEECCSCCTTSCGGGSHHH
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHH---------------------HHHHHHhCCCccEEeCcccccCccccchhHH
Confidence 3445666677777777777666433322 2233667788888888885 444455554
Q ss_pred c-------CCCCCCCEEEccCCcCCC----CCchhhhccCcCCeeecCCccccCcCcccccC----c---------CCCC
Q 048430 391 L-------GKLQKLQGLDLNSNKLKG----FIPTDLCKLEKLNTLLSNNNALQGQIPTCLAN----L---------TSLR 446 (973)
Q Consensus 391 ~-------~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~----l---------~~L~ 446 (973)
+ ..+++|++|+|++|.+++ .+|..+..+++|+.|+|++|.++...+..+.. + ++|+
T Consensus 83 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~ 162 (386)
T 2ca6_A 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 162 (386)
T ss_dssp HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred HHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence 4 789999999999999997 47788999999999999999998655544443 3 8999
Q ss_pred eeeccCCCCC-CCCc---ccccccccccEEEecCCcccC-----CcCcCccCCCCCCeEEccCCcCc----ccCCccccc
Q 048430 447 HLDFRSNSLN-STIP---STFWSLKYILAVDFSLNSLSG-----SLPLNIGNLEALGGLNLTGNQLS----GYIPSSIGN 513 (973)
Q Consensus 447 ~L~L~~N~l~-~~~p---~~~~~l~~L~~L~ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~ 513 (973)
+|++++|+++ +.++ ..+..+++|+.|++++|+++. ..|..+..+++|+.|+|++|+++ +.+|..+..
T Consensus 163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~ 242 (386)
T 2ca6_A 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242 (386)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence 9999999997 4455 467789999999999999983 34547889999999999999996 578889999
Q ss_pred CCcCCEEEcccCccccC----CCCCc--ccccccccccccccccCC----CCCccc-cccccccccccCCCcccccCC
Q 048430 514 LKNLDWLALARNAFQGP----IPQSF--GSLISLQSLDLSGNNISG----EIPKSL-EKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 514 l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~l~ls~N~l~~~~p 580 (973)
+++|+.|+|++|.+++. +|..+ +.+++|++|+|++|+|++ .+|..+ .++++|+.|++++|++++..|
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 99999999999999876 56666 348999999999999997 488887 668999999999999986554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-23 Score=214.88 Aligned_cols=196 Identities=17% Similarity=0.194 Sum_probs=149.6
Q ss_pred cccEEEeecCccccccCcccCCCCCCCEEEccCCc-CCCCCchhhhccCcCCeeecCC-ccccCcCcccccCcCCCCeee
Q 048430 372 NLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK-LKGFIPTDLCKLEKLNTLLSNN-NALQGQIPTCLANLTSLRHLD 449 (973)
Q Consensus 372 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~ 449 (973)
+|++|++++|++++..+..|..+++|++|++++|+ ++...+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 68888888888887767788888888888888886 7766566778888888888887 888877777788888888888
Q ss_pred ccCCCCCCCCccccccccccc---EEEecCC-cccCCcCcCccCCCCCC-eEEccCCcCcccCCcccccCCcCCEEEccc
Q 048430 450 FRSNSLNSTIPSTFWSLKYIL---AVDFSLN-SLSGSLPLNIGNLEALG-GLNLTGNQLSGYIPSSIGNLKNLDWLALAR 524 (973)
Q Consensus 450 L~~N~l~~~~p~~~~~l~~L~---~L~ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 524 (973)
+++|++++ +|. |..+++|+ .|++++| ++++..+..|.++++|+ .|++++|+++ .+|......++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 88888876 555 77777777 8888888 88766666688888888 8888888888 4444333337888888888
Q ss_pred Cc-cccCCCCCcccc-cccccccccccccCCCCCccccccccccccccCCC
Q 048430 525 NA-FQGPIPQSFGSL-ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 525 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
|+ +++..+..|..+ ++|+.|+|++|+|++. |.. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 84 886667778888 8888888888888754 433 5667777777765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-22 Score=212.37 Aligned_cols=181 Identities=25% Similarity=0.256 Sum_probs=135.9
Q ss_pred CcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeec
Q 048430 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 450 (973)
.+.++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|++++|.+++..+..|.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45678888888888 5565554 57888888888888777777888888888888888888777777788888888888
Q ss_pred cCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccC
Q 048430 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGP 530 (973)
Q Consensus 451 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 530 (973)
++|++++..+..|..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|++..+..|+.+++|+.|+|++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 88888776667777777777777777777755555567777777777777777755555677777777777777777766
Q ss_pred CCCCcccccccccccccccccCCC
Q 048430 531 IPQSFGSLISLQSLDLSGNNISGE 554 (973)
Q Consensus 531 ~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (973)
.+..|..+++|+.|+|++|++++.
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHHhCCCCCCEEEeeCCceeCC
Confidence 666777777777777777777654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-24 Score=239.68 Aligned_cols=262 Identities=21% Similarity=0.193 Sum_probs=157.7
Q ss_pred eeeeccccccccCcchhcccCcccEEEeccccccccCC----Ccccccc-cceEEEccCCcCCCCCCCcchhhhhhhccC
Q 048430 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP----NTFGNCR-QLQILSLGDNQLTTGSSAQGQIFYSSLAKC 321 (973)
Q Consensus 247 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l 321 (973)
++.+++|.+++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|+++.... ..+...+...
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~---~~l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNS---DELVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCH---HHHHHHHHTS
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHH---HHHHHHHhcc
Confidence 35677788887777777666678888888888777666 5666666 67777777777654221 1111222222
Q ss_pred -CcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCC-CCCCE
Q 048430 322 -RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKL-QKLQG 399 (973)
Q Consensus 322 -~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~ 399 (973)
++|++|+|++|++++..+..+.. .+..+ ++|++
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~---------------------------------------------~l~~~~~~L~~ 113 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVK---------------------------------------------TLAAIPFTITV 113 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHH---------------------------------------------HHHTSCTTCCE
T ss_pred CCCccEEECcCCcCChHHHHHHHH---------------------------------------------HHHhCCCCccE
Confidence 45555555555544333322211 12222 44555
Q ss_pred EEccCCcCCCCCchhhhc-----cCcCCeeecCCccccCcCc----ccccCcC-CCCeeeccCCCCCCCCccccccc---
Q 048430 400 LDLNSNKLKGFIPTDLCK-----LEKLNTLLSNNNALQGQIP----TCLANLT-SLRHLDFRSNSLNSTIPSTFWSL--- 466 (973)
Q Consensus 400 L~Ls~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l--- 466 (973)
|+|++|++++..+..+.. .++|++|++++|.+++... ..+..++ +|++|+|++|++++..+..+...
T Consensus 114 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 193 (362)
T 3goz_A 114 LDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193 (362)
T ss_dssp EECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHT
T ss_pred EECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHh
Confidence 555555554443333322 1355555555555553222 2223333 66666666666665555444332
Q ss_pred --ccccEEEecCCcccCC----cCcCccC-CCCCCeEEccCCcCcccCC----cccccCCcCCEEEcccCccccC-----
Q 048430 467 --KYILAVDFSLNSLSGS----LPLNIGN-LEALGGLNLTGNQLSGYIP----SSIGNLKNLDWLALARNAFQGP----- 530 (973)
Q Consensus 467 --~~L~~L~ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~----- 530 (973)
++|+.||+++|.+++. ++..+.. .++|+.|+|++|++++..+ ..+..+++|+.|+|++|.+.+.
T Consensus 194 ~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~ 273 (362)
T 3goz_A 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC 273 (362)
T ss_dssp SCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHH
T ss_pred CCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHH
Confidence 4677777777777642 4444555 3589999999999986544 3457789999999999995533
Q ss_pred --CCCCcccccccccccccccccCCCCC
Q 048430 531 --IPQSFGSLISLQSLDLSGNNISGEIP 556 (973)
Q Consensus 531 --~p~~~~~l~~L~~L~Ls~N~l~~~~p 556 (973)
++..+..+++|+.|||++|++....+
T Consensus 274 ~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 274 KALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHhccCCceEEEecCCCcCCCcch
Confidence 34578889999999999999986644
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=220.29 Aligned_cols=173 Identities=25% Similarity=0.350 Sum_probs=113.7
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
+..+++|++|++++|.+++..+ +..+++|++|+|++|++++. + .+..+++|+.|++++|++++.. .+..+++|+
T Consensus 59 ~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~ 132 (308)
T 1h6u_A 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQ 132 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCC
T ss_pred hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCCch--hhcCCCCCC
Confidence 3445566666666666664333 66666666666666666642 2 4666666666666666666432 266667777
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
+|++++|++++..+ +..+++|+.|++++|++++. +. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|+
T Consensus 133 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred EEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence 77777777765433 66677777777777777643 33 6777777777777777774332 6777777777777777
Q ss_pred cccCCCCCcccccccccccccccccCC
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
+++..| +..+++|+.|+|++|++++
T Consensus 207 l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 207 ISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cCcccc--ccCCCCCCEEEccCCeeec
Confidence 775443 7777777888888887774
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-22 Score=220.80 Aligned_cols=245 Identities=21% Similarity=0.201 Sum_probs=160.0
Q ss_pred CcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCC
Q 048430 31 SVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLP 110 (973)
Q Consensus 31 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 110 (973)
+.|.|..|.|+. ++|+ ++|..+ .+++++|+|++|+|...-+..|.++++|++|+|++|++.+.+|
T Consensus 7 C~C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~ 71 (350)
T 4ay9_X 7 CHCSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71 (350)
T ss_dssp SEEETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred cEeeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence 347788888854 3444 567655 3578888999888864444568888888888888888876788
Q ss_pred ccccCCCCCccE-EEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEccc-ccccccCCCCCC
Q 048430 111 GDMCNSFTQLES-FDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG-NNITGRIPNREI 188 (973)
Q Consensus 111 ~~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~ 188 (973)
.+.|.++++|.+ ++++.|+++...|..|.++++|++|++++|+|+ .+|...+....++..|++.+ |++....
T Consensus 72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~----- 145 (350)
T 4ay9_X 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE----- 145 (350)
T ss_dssp TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEEC-----
T ss_pred hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccc-cCCchhhcccchhhhhhhcccccccccc-----
Confidence 877888877664 666778888766778888888888888888887 66665555566667777654 4454211
Q ss_pred CccccCCC-CccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeec-cccccccCcchhccc
Q 048430 189 PNEIGNLH-NLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLW-KNNLSGIIPDSICNA 266 (973)
Q Consensus 189 p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~l~~l 266 (973)
+..|..+. .+++|+|++|+|+.+ |...+. ..+|++|+++ +|.++.+.++.|..+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~-----------------------~~~L~~l~l~~~n~l~~i~~~~f~~l 201 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQEI-HNSAFN-----------------------GTQLDELNLSDNNNLEELPNDVFHGA 201 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEE-CTTSST-----------------------TEEEEEEECTTCTTCCCCCTTTTTTE
T ss_pred ccchhhcchhhhhhccccccccCC-Chhhcc-----------------------ccchhHHhhccCCcccCCCHHHhccC
Confidence 12344443 466667777766633 333323 4566667765 355665555567777
Q ss_pred CcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccC
Q 048430 267 SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDT 331 (973)
Q Consensus 267 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~ 331 (973)
++|++|+|++|+|+.+++..|.++++|+.+++ +.++.+| .+.++++|+.+++.+
T Consensus 202 ~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~lP---------~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 202 SGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP---------TLEKLVALMEASLTY 255 (350)
T ss_dssp ECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCCC---------CTTTCCSCCEEECSC
T ss_pred cccchhhcCCCCcCccChhhhccchHhhhccC--CCcCcCC---------CchhCcChhhCcCCC
Confidence 77777777777777776666665555555443 3333322 255667777777654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=222.02 Aligned_cols=230 Identities=20% Similarity=0.210 Sum_probs=175.9
Q ss_pred ccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCC
Q 048430 291 RQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNL 370 (973)
Q Consensus 291 ~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l 370 (973)
..++.|.+.++.++... ......+..+++|++|++++|.+.+..|..+.. ..+
T Consensus 64 ~~l~~l~l~~~~~~~~~----~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-----------------------~~~ 116 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQL----LVGALRVLAYSRLKELTLEDLKITGTMPPLPLE-----------------------ATG 116 (310)
T ss_dssp CCCCEEEECSCCCBHHH----HHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSS-----------------------CCC
T ss_pred cceeEEEEeCCcCCHHH----HHHHHHhcccCceeEEEeeCCEeccchhhhhhh-----------------------ccC
Confidence 34677888877765310 001112233466888888888777665544210 677
Q ss_pred CcccEEEeecCccccccC----cccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCc--C--cccccCc
Q 048430 371 SNLLVLSLVNNELAGAIP----TVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQ--I--PTCLANL 442 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--~~~~~~l 442 (973)
++|++|++++|.+++..+ ..+..+++|++|+|++|++.+..+..+..+++|++|++++|++.+. + +..+..+
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 888999999999886544 3456788999999999999888788888999999999999987652 2 2345788
Q ss_pred CCCCeeeccCCCCCCCCcc----cccccccccEEEecCCcccCCcCcCccCC---CCCCeEEccCCcCcccCCcccccCC
Q 048430 443 TSLRHLDFRSNSLNSTIPS----TFWSLKYILAVDFSLNSLSGSLPLNIGNL---EALGGLNLTGNQLSGYIPSSIGNLK 515 (973)
Q Consensus 443 ~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~ 515 (973)
++|++|+|++|+++. ++. .+..+++|+.||+++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+. +
T Consensus 197 ~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~ 272 (310)
T 4glp_A 197 PAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--A 272 (310)
T ss_dssp CCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--S
T ss_pred CCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--C
Confidence 999999999999973 333 35678999999999999998878888777 69999999999999 6787775 7
Q ss_pred cCCEEEcccCccccCCCCCcccccccccccccccccCC
Q 048430 516 NLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 516 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
+|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 273 ~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 273 KLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 999999999999954 44 7888999999999999974
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-23 Score=230.48 Aligned_cols=252 Identities=18% Similarity=0.214 Sum_probs=119.6
Q ss_pred cceeeeccccccccCcchhccc--CcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCC
Q 048430 245 LENLFLWKNNLSGIIPDSICNA--SEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322 (973)
Q Consensus 245 L~~L~L~~N~l~~~~~~~l~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 322 (973)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.++. ...+..
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~------~~~~~~----- 113 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV------STLHGI----- 113 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH------HHHHHH-----
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH------HHHHHH-----
Confidence 556666666655 3455555 6666666666666665544 3345556666665555432 001111
Q ss_pred cCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEc
Q 048430 323 YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402 (973)
Q Consensus 323 ~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 402 (973)
+..+++|++|++++|.+++..+..+..+++|++|+|
T Consensus 114 --------------------------------------------~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 114 --------------------------------------------LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp --------------------------------------------HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred --------------------------------------------HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 233444444444444444444444555555555555
Q ss_pred cCC-cCCCC-CchhhhccCcCCeeecCCc-cccCc-CcccccCcC-CCCeeeccCCCCCCCCcccccccccccEEEecCC
Q 048430 403 NSN-KLKGF-IPTDLCKLEKLNTLLSNNN-ALQGQ-IPTCLANLT-SLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLN 477 (973)
Q Consensus 403 s~N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 477 (973)
++| .+++. ++..+.++++|+.|++++| .+++. ++..+..++ +|++|++++|.+
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~---------------------- 207 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK---------------------- 207 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG----------------------
T ss_pred CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcc----------------------
Confidence 555 34421 3333444444555555444 44432 233344444 555555555421
Q ss_pred ccc-CCcCcCccCCCCCCeEEccCCc-CcccCCcccccCCcCCEEEcccCc-cccCCCCCcccccccccccccccccCCC
Q 048430 478 SLS-GSLPLNIGNLEALGGLNLTGNQ-LSGYIPSSIGNLKNLDWLALARNA-FQGPIPQSFGSLISLQSLDLSGNNISGE 554 (973)
Q Consensus 478 ~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (973)
.++ +.+|..+..+++|+.|++++|. +++..+..++.+++|+.|+|++|. +.......++.+++|+.|+|++| ++
T Consensus 208 ~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~-- 284 (336)
T 2ast_B 208 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP-- 284 (336)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC--
T ss_pred cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC--
Confidence 122 1233333444455555555554 443444445555555555555553 11111113455555555555555 22
Q ss_pred CCcccccc-ccccccccCCCcccccCCC
Q 048430 555 IPKSLEKL-SRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 555 ~p~~~~~l-~~L~~l~ls~N~l~~~~p~ 581 (973)
...+..+ ..+..|++++|++++..|.
T Consensus 285 -~~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 285 -DGTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp -TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred -HHHHHHHHhhCcceEEecccCccccCC
Confidence 1233333 2355555666666666654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-22 Score=203.35 Aligned_cols=188 Identities=23% Similarity=0.343 Sum_probs=137.2
Q ss_pred CCCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCC
Q 048430 29 SASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGS 108 (973)
Q Consensus 29 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 108 (973)
....|.|.+|.|+.. +++ .+|..+ .++|++|+|++|++.+..+..++.+++|++|+|++|++. .
T Consensus 3 ~~C~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~ 66 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-S 66 (208)
T ss_dssp TTCEEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-C
T ss_pred CCCEECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-c
Confidence 345689999999753 222 345433 357888999999887666666788888888888888887 6
Q ss_pred CCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCC
Q 048430 109 LPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREI 188 (973)
Q Consensus 109 ~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 188 (973)
+|...|..+++|++|+|++|++++..+..|.++++|++|+|++|+|+ .+|...|..+++|++|+|++|++++. .
T Consensus 67 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~-----~ 140 (208)
T 2o6s_A 67 LPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSV-----P 140 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCC-----C
T ss_pred cChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCcccee-----C
Confidence 77777778888888888888888666666788888888888888887 66666666777777777777777632 1
Q ss_pred CccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCc
Q 048430 189 PNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASE 268 (973)
Q Consensus 189 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 268 (973)
+..+..+++|++|+|++|.+.+. +++|++|+++.|+++|.+|+.++.++.
T Consensus 141 ~~~~~~l~~L~~L~l~~N~~~~~------------------------------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 141 DGVFDRLTSLQYIWLHDNPWDCT------------------------------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCC------------------------------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred HHHhccCCCccEEEecCCCeecC------------------------------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 23466677777777777765532 567788888888888888887776654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-23 Score=229.86 Aligned_cols=179 Identities=21% Similarity=0.248 Sum_probs=124.2
Q ss_pred CCCCCCEEEccCCcCCCC-CchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCC-CCCC-CCcccccccccc
Q 048430 393 KLQKLQGLDLNSNKLKGF-IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN-SLNS-TIPSTFWSLKYI 469 (973)
Q Consensus 393 ~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L 469 (973)
.+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++..+..++.+++|++|++++| .+++ .++..+..+++|
T Consensus 91 ~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L 170 (336)
T 2ast_B 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 170 (336)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCC
Confidence 344444444444444432 3444444555555555555544444555555556666666666 4443 244555666666
Q ss_pred cEEEecCC-cccCC-cCcCccCCC-CCCeEEccCC--cCc-ccCCcccccCCcCCEEEcccCc-cccCCCCCcccccccc
Q 048430 470 LAVDFSLN-SLSGS-LPLNIGNLE-ALGGLNLTGN--QLS-GYIPSSIGNLKNLDWLALARNA-FQGPIPQSFGSLISLQ 542 (973)
Q Consensus 470 ~~L~ls~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~ 542 (973)
+.|++++| .+++. ++..+..++ +|+.|+|++| .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|+
T Consensus 171 ~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~ 250 (336)
T 2ast_B 171 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 250 (336)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred CEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCC
Confidence 66666666 66643 566678888 9999999999 565 4677888899999999999999 7778888999999999
Q ss_pred cccccccccCCCCCc---cccccccccccccCCC
Q 048430 543 SLDLSGNNISGEIPK---SLEKLSRLVDFNVSFN 573 (973)
Q Consensus 543 ~L~Ls~N~l~~~~p~---~~~~l~~L~~l~ls~N 573 (973)
+|+|++|. +..+. .+.++++|+.|++++|
T Consensus 251 ~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 251 HLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp EEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence 99999996 23344 6889999999999998
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-22 Score=216.36 Aligned_cols=196 Identities=25% Similarity=0.377 Sum_probs=173.0
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
+..+++|++|++++|.+.. ++ .+..+++|++|+|++|++++..+ +..+++|+.|++++|.+++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 3457899999999999984 45 68899999999999999996544 99999999999999999864 3689999999
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
+|++++|++++. + .+..+++|+.|++++|++++..+ ++.+++|+.|+|++|++++ ++. +..+++|+.|+|++|+
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCc
Confidence 999999999874 3 38999999999999999996544 8899999999999999995 444 9999999999999999
Q ss_pred cccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCccccc
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGE 578 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 578 (973)
+++..+ +..+++|++|+|++|++++..| +..+++|+.|++++|++++.
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 996554 8999999999999999996653 89999999999999999863
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-21 Score=213.78 Aligned_cols=241 Identities=19% Similarity=0.187 Sum_probs=156.6
Q ss_pred cEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccE-EEc
Q 048430 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQ-LRL 174 (973)
Q Consensus 96 ~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~-L~L 174 (973)
+.++.++++++ .||.++ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|.++|.++++|++ +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 45566666666 566554 3466777777777764434466777777777777777665667666677766654 455
Q ss_pred ccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeec-ccccccCCCCC-C-ccccceeeec
Q 048430 175 LGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYG-NHLSGHLPSSI-Y-LPNLENLFLW 251 (973)
Q Consensus 175 ~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~-~-l~~L~~L~L~ 251 (973)
+.|+|+.. .|..|..+++|++|++++|+|++..+..+....++..+++.+ |++....+..+ . ...+++|+|+
T Consensus 88 ~~N~l~~l-----~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~ 162 (350)
T 4ay9_X 88 KANNLLYI-----NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162 (350)
T ss_dssp EETTCCEE-----CTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cCCccccc-----CchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccc
Confidence 56666532 245667777777777777777766666666666666666654 34444433332 2 3468889999
Q ss_pred cccccccCcchhcccCcccEEEec-cccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEcc
Q 048430 252 KNNLSGIIPDSICNASEATILELS-SNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330 (973)
Q Consensus 252 ~N~l~~~~~~~l~~l~~L~~L~L~-~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~ 330 (973)
+|+|+.+.+..| ...+|+.|+++ +|.++.++++.|.++++|++|++++|+|+.++.. .+.+|+.|.+.
T Consensus 163 ~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~----------~~~~L~~L~~l 231 (350)
T 4ay9_X 163 KNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY----------GLENLKKLRAR 231 (350)
T ss_dssp SSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS----------SCTTCCEEECT
T ss_pred cccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh----------hhccchHhhhc
Confidence 999986555444 55678899987 4777777778889999999999999999876543 13445555544
Q ss_pred CCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCc
Q 048430 331 TNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNE 382 (973)
Q Consensus 331 ~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~ 382 (973)
++.-.. .+| .+..+++|+.++++++.
T Consensus 232 ~~~~l~-------------------------~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 232 STYNLK-------------------------KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TCTTCC-------------------------CCC-CTTTCCSCCEEECSCHH
T ss_pred cCCCcC-------------------------cCC-CchhCcChhhCcCCCCc
Confidence 432221 233 26677888888887654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-22 Score=234.26 Aligned_cols=210 Identities=25% Similarity=0.332 Sum_probs=155.4
Q ss_pred CCCcc-----eEEEE-EeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccC
Q 048430 29 SASVC-----NWVGV-TCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSS 102 (973)
Q Consensus 29 ~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~ 102 (973)
+.++| .|.|+ .|.. ++++.|+++++++++ +|+.+. ++|++|+|++|+|. .+| ..+++|++|+|++
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~ 109 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACD 109 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCS
T ss_pred cCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccC
Confidence 34556 79999 7864 479999999999987 888774 88999999999996 678 5578999999999
Q ss_pred CCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEccccccccc
Q 048430 103 NSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGR 182 (973)
Q Consensus 103 n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~ 182 (973)
|+|++ +|. + .. +|++|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|. .+++|++|+|++|+|++
T Consensus 110 N~l~~-ip~-l-~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~L~~- 174 (571)
T 3cvr_A 110 NRLST-LPE-L-PA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLT-MLPE----LPTSLEVLSVRNNQLTF- 174 (571)
T ss_dssp SCCSC-CCC-C-CT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-
T ss_pred CCCCC-cch-h-hc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccC-cCCC----cCCCcCEEECCCCCCCC-
Confidence 99985 887 4 33 89999999999996 676 6889999999999998 5776 47889999999999874
Q ss_pred CCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcch
Q 048430 183 IPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS 262 (973)
Q Consensus 183 ~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 262 (973)
+|. |. ++|++|+|++|+|+ .+|. +.. +| ....+.|++|+|++|+|+ .+|..
T Consensus 175 -----lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L----------------~~~~~~L~~L~Ls~N~l~-~lp~~ 225 (571)
T 3cvr_A 175 -----LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN----------------HHSEETEIFFRCRENRIT-HIPEN 225 (571)
T ss_dssp -----CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------------------------CCEEEECCSSCCC-CCCGG
T ss_pred -----cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh----------------hcccccceEEecCCCcce-ecCHH
Confidence 455 55 78999999999988 4454 432 33 000233466666666666 35555
Q ss_pred hcccCcccEEEeccccccccCCCcccccc
Q 048430 263 ICNASEATILELSSNLFSGLVPNTFGNCR 291 (973)
Q Consensus 263 l~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 291 (973)
+..+++|+.|+|++|++++.+|..|..+.
T Consensus 226 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 226 ILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp GGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred HhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 66666677777777776666666555543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.71 Aligned_cols=181 Identities=23% Similarity=0.235 Sum_probs=118.7
Q ss_pred cEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCC
Q 048430 374 LVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453 (973)
Q Consensus 374 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 453 (973)
+.++.+++.++ .+|..+ .++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 45666777776 344333 346777777777777655556667777777777777777665556667777777777777
Q ss_pred CCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCC
Q 048430 454 SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ 533 (973)
Q Consensus 454 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 533 (973)
++++..+..|..+++|+.|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--- 163 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--- 163 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC---
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC---
Confidence 77765555566666677777777766655555566667777777777777655555566667777777777766532
Q ss_pred CcccccccccccccccccCCCCCcccccccc
Q 048430 534 SFGSLISLQSLDLSGNNISGEIPKSLEKLSR 564 (973)
Q Consensus 534 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 564 (973)
+++|+.|+++.|+++|.+|.+++.++.
T Consensus 164 ----~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 ----CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCHHHHHHHHHhCCceeeccCccccC
Confidence 335666666666666666666655543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=209.31 Aligned_cols=150 Identities=15% Similarity=0.141 Sum_probs=118.8
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccch------------------hhHHHHHHHHHHHHhccCC
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED------------------RALKSFDTECEVMRRIRHR 736 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~ 736 (973)
+......|...+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 3334455666799999999999999998899999999864321 134678999999999984
Q ss_pred ceeEEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC
Q 048430 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816 (973)
Q Consensus 737 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~ 816 (973)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||++ +
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-T
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-C
Confidence 555554433 45699999999999998 432 224579999999999999 89999999999999999 9
Q ss_pred CcEEEeecccccccCCCCCcccccccccccccCccCCC
Q 048430 817 MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854 (973)
Q Consensus 817 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~ 854 (973)
+.+||+|||+|+.. ..|+|||++.
T Consensus 229 ~~vkl~DFG~a~~~--------------~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVEV--------------GEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred CcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence 99999999998743 3467888653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-20 Score=217.37 Aligned_cols=189 Identities=22% Similarity=0.318 Sum_probs=112.4
Q ss_pred CCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEE
Q 048430 94 RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173 (973)
Q Consensus 94 ~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~ 173 (973)
+|+.|+|++|.+++ +|..+ +++|++|+|++|+|+ .+| ..+++|++|+|++|+|+ .+|. + .. +|++|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l---~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~-~ip~-l-~~--~L~~L~ 126 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL---PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLS-TLPE-L-PA--SLKHLD 126 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC---CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC-C-CT--TCCEEE
T ss_pred CccEEEeCCCCCCc-cCHhH---cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCC-Ccch-h-hc--CCCEEE
Confidence 55555555555552 55443 245555555555555 344 23455555555555555 2554 2 11 555555
Q ss_pred cccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccc
Q 048430 174 LLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253 (973)
Q Consensus 174 L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N 253 (973)
|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|++++|++++ +|. +. ++|++|+|++|
T Consensus 127 Ls~N~l~~------lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~-~~L~~L~Ls~N 190 (571)
T 3cvr_A 127 VDNNQLTM------LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP-ESLEALDVSTN 190 (571)
T ss_dssp CCSSCCSC------CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC-TTCCEEECCSS
T ss_pred CCCCcCCC------CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh-CCCCEEECcCC
Confidence 55555542 233 34555666666666554 333 34556666666666655 333 22 78888888888
Q ss_pred cccccCcchhcccCcc-------cEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCc
Q 048430 254 NLSGIIPDSICNASEA-------TILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY 323 (973)
Q Consensus 254 ~l~~~~~~~l~~l~~L-------~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~ 323 (973)
+|+ .+|. +.. +| +.|+|++|+|+.+ |..+..+++|+.|+|++|++++ ..+..+..++.
T Consensus 191 ~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~l-p~~l~~l~~L~~L~L~~N~l~~-------~~p~~l~~l~~ 255 (571)
T 3cvr_A 191 LLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSS-------RIRESLSQQTA 255 (571)
T ss_dssp CCS-SCCC-CC----------CCEEEECCSSCCCCC-CGGGGGSCTTEEEECCSSSCCH-------HHHHHHHHHHH
T ss_pred CCC-chhh-HHH--hhhcccccceEEecCCCcceec-CHHHhcCCCCCEEEeeCCcCCC-------cCHHHHHHhhc
Confidence 888 4555 544 66 9999999999965 6667779999999999999985 34555555444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=6e-20 Score=190.86 Aligned_cols=163 Identities=23% Similarity=0.288 Sum_probs=122.8
Q ss_pred CCCCCCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCC
Q 048430 26 TNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSL 105 (973)
Q Consensus 26 ~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l 105 (973)
|+.+.+.|+|.+|.|+.. +++ .+|..+. ++|++|+|++|++.+..|..|..+++|++|+|++|++
T Consensus 12 ~~~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l 76 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL 76 (229)
T ss_dssp CCCTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence 445788999999999642 232 5665443 7889999999999888888899999999999999998
Q ss_pred CCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCC
Q 048430 106 SGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPN 185 (973)
Q Consensus 106 ~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~ 185 (973)
. .+|...|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+ ..+++|++|+|++|+|++.
T Consensus 77 ~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~--- 150 (229)
T 3e6j_A 77 G-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI-ERLTHLTHLALDQNQLKSI--- 150 (229)
T ss_dssp C-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTG-GGCTTCSEEECCSSCCCCC---
T ss_pred C-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCccc-ccCCCCCEEECCCCcCCcc---
Confidence 6 777777788888888888888888766666788888888888888887 677655 5667777777777777632
Q ss_pred CCCCccccCCCCccEEEecCCcccCc
Q 048430 186 REIPNEIGNLHNLKILDLGGNNIAGL 211 (973)
Q Consensus 186 ~~~p~~l~~l~~L~~L~L~~N~l~~~ 211 (973)
.+..|..+++|++|+|++|.+...
T Consensus 151 --~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 151 --PHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp --CTTTTTTCTTCCEEECTTSCBCTT
T ss_pred --CHHHHhCCCCCCEEEeeCCCccCC
Confidence 123466667777777777766643
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.1e-21 Score=231.70 Aligned_cols=205 Identities=20% Similarity=0.238 Sum_probs=116.2
Q ss_pred CCCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcE-----EEecCCCCCCCCCcccccccCCcEEEccCC
Q 048430 29 SASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVS-----LNISGNSFYDTLPNELWHMRRLKIIDFSSN 103 (973)
Q Consensus 29 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~-----L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n 103 (973)
.+..+.|.+++++. .+++.|+|.++++.+ ++..+.....|.. ++++.|.+. ..|..+..++.|+.|+|++|
T Consensus 159 ~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n 234 (727)
T 4b8c_D 159 STPSGTATNSAVST--PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNL 234 (727)
T ss_dssp -------------------------------------------------------------------CCCCCCEEECTTS
T ss_pred CCccccCCCceecC--CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCC
Confidence 45667899999964 789999999999886 3444332222222 223334442 45788999999999999999
Q ss_pred CCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccC
Q 048430 104 SLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRI 183 (973)
Q Consensus 104 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~ 183 (973)
.+. .+|..++ .+++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .+|..+ ..+++|++|+|++|.|+
T Consensus 235 ~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~--- 306 (727)
T 4b8c_D 235 QIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAEL-GSCFQLKYFYFFDNMVT--- 306 (727)
T ss_dssp CCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSG-GGGTTCSEEECCSSCCC---
T ss_pred CCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhh-cCCCCCCEEECCCCCCC---
Confidence 998 8998886 7999999999999999 88999999999999999999998 888775 67999999999999996
Q ss_pred CCCCCCccccCCCCccEEEecCCcccCccccccccCCc-ceeEEeecccccccCCCCCCccccceeeeccc
Q 048430 184 PNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSN-MVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253 (973)
Q Consensus 184 ~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N 253 (973)
.+|..|+++++|++|+|++|.|++.+|..+..+.. +..++|++|.+++.+| ..|+.|++++|
T Consensus 307 ---~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p-----~~l~~l~l~~n 369 (727)
T 4b8c_D 307 ---TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP-----HERRFIEINTD 369 (727)
T ss_dssp ---CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC-----CC---------
T ss_pred ---ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc-----cccceeEeecc
Confidence 67888999999999999999999988888766422 2235666666666554 34555556555
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.1e-20 Score=190.72 Aligned_cols=136 Identities=21% Similarity=0.224 Sum_probs=74.5
Q ss_pred CCeeeccCCCCCCCCc-ccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcc
Q 048430 445 LRHLDFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALA 523 (973)
Q Consensus 445 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 523 (973)
+++|+|++|++++..+ ..|..+++|+.|++++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 3444444444443322 234445555555555555554444455555555555555555555445555555666666666
Q ss_pred cCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCC
Q 048430 524 RNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 524 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
+|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|++++|++++..+
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 666655555556666666666666666665555556666666666666666655443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=201.65 Aligned_cols=177 Identities=24% Similarity=0.228 Sum_probs=133.3
Q ss_pred cEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhh-ccCcCCeeecCCccccCcCcccccCcCCCCeeeccC
Q 048430 374 LVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLC-KLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRS 452 (973)
Q Consensus 374 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 452 (973)
+.+++++++++ .+|..+. +.++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 68899999888 5665554 3588899999998877777776 888888888888888877777888888888888888
Q ss_pred CCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCccc---ccCCcCCEEEcccCcccc
Q 048430 453 NSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSI---GNLKNLDWLALARNAFQG 529 (973)
Q Consensus 453 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 529 (973)
|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 88887767777788888888888888877667777778888888888888874333334 457777777777777775
Q ss_pred CCCCCcccccc--cccccccccccCC
Q 048430 530 PIPQSFGSLIS--LQSLDLSGNNISG 553 (973)
Q Consensus 530 ~~p~~~~~l~~--L~~L~Ls~N~l~~ 553 (973)
..+..|..++. |+.|+|++|.+..
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 55566666665 3677777777764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.7e-19 Score=183.55 Aligned_cols=152 Identities=22% Similarity=0.301 Sum_probs=80.1
Q ss_pred CEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCC
Q 048430 398 QGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLN 477 (973)
Q Consensus 398 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 477 (973)
+.+++++|.++ .+|..+. ++|+.|++++|.|++..+..|..+++|++|+|++|++++..|..|.++++|+.|++++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666666666 3444332 45566666666665555555555555555555555555554555555555555555555
Q ss_pred cccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccC
Q 048430 478 SLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 478 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (973)
+|+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 555333333444555555555555555444444555555555555555555444444444555555555555444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-19 Score=191.54 Aligned_cols=172 Identities=23% Similarity=0.357 Sum_probs=119.0
Q ss_pred CCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCe
Q 048430 368 GNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRH 447 (973)
Q Consensus 368 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 447 (973)
..+++|+.|++++|.+... + .+..+++|++|+|++|++++..+ +..+++|+.|++++|.+++. ..+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCE
Confidence 3466778888888877743 3 36777888888888888875433 77777788888888877752 23777777777
Q ss_pred eeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcc
Q 048430 448 LDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAF 527 (973)
Q Consensus 448 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 527 (973)
|++++|++++. ..+..+++|+.|++++|++++. ..++.+++|+.|+|++|++++..| +..+++|+.|+|++|++
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 77777777653 3566677777777777777643 456677777777777777764433 66777777777777777
Q ss_pred ccCCCCCcccccccccccccccccCC
Q 048430 528 QGPIPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 528 ~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
++ +| .+..+++|+.|+|++|+++.
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CC-Ch-hhccCCCCCEEECcCCcccC
Confidence 64 33 36667777777777777764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.1e-19 Score=191.04 Aligned_cols=172 Identities=25% Similarity=0.363 Sum_probs=88.0
Q ss_pred ccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCc
Q 048430 90 WHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169 (973)
Q Consensus 90 ~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L 169 (973)
..+++|+.|++++|.+. .+|. +..+++|++|+|++|++++..| +.++++|++|+|++|+++ .+|. +..+++|
T Consensus 43 ~~l~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L 114 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS--LKDLKKL 114 (291)
T ss_dssp HHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGGG--GTTCTTC
T ss_pred hhcCcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC-CChh--hccCCCC
Confidence 45555555555555554 3432 3445555555555555554322 555555555555555555 3332 3455555
Q ss_pred cEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceee
Q 048430 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLF 249 (973)
Q Consensus 170 ~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~ 249 (973)
++|+|++|+|++ + ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..+ ...+++|++|+
T Consensus 115 ~~L~L~~n~i~~------~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~ 184 (291)
T 1h6t_A 115 KSLSLEHNGISD------I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLY 184 (291)
T ss_dssp CEEECTTSCCCC------C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred CEEECCCCcCCC------C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEE
Confidence 566666555542 2 2455556666666666666543 334444444444444443333222 22355555555
Q ss_pred eccccccccCcchhcccCcccEEEeccccccc
Q 048430 250 LWKNNLSGIIPDSICNASEATILELSSNLFSG 281 (973)
Q Consensus 250 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~ 281 (973)
+++|++++. + .+..+++|+.|++++|+++.
T Consensus 185 L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 185 LSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 555555542 2 25555556666666655554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-19 Score=213.41 Aligned_cols=178 Identities=25% Similarity=0.336 Sum_probs=83.1
Q ss_pred ccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCc
Q 048430 90 WHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169 (973)
Q Consensus 90 ~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L 169 (973)
..|++|+.|+|++|.+. .+|. +..+++|+.|+|++|++++..| +..+++|+.|+|++|.|+ .+| .+..+++|
T Consensus 40 ~~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~--~l~~l~~L 111 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS--SLKDLKKL 111 (605)
T ss_dssp HHHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC-CCT--TSTTCTTC
T ss_pred hcCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC-CCh--hhccCCCC
Confidence 34444444444444444 3332 2344444444444444443222 444444444444444444 232 12344445
Q ss_pred cEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceee
Q 048430 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLF 249 (973)
Q Consensus 170 ~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~ 249 (973)
++|+|++|+|++ + ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+++..| ...+++|++|+
T Consensus 112 ~~L~Ls~N~l~~------l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~ 181 (605)
T 1m9s_A 112 KSLSLEHNGISD------I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLY 181 (605)
T ss_dssp CEEECTTSCCCC------C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEE
T ss_pred CEEEecCCCCCC------C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEE
Confidence 555555554431 1 2344455555555555555433 233343333333333333333322 22356666666
Q ss_pred eccccccccCcchhcccCcccEEEeccccccccCCCcc
Q 048430 250 LWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTF 287 (973)
Q Consensus 250 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~ 287 (973)
|++|+|+++ ..+..+++|+.|+|++|++.+.+...+
T Consensus 182 Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~ 217 (605)
T 1m9s_A 182 LSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQ 217 (605)
T ss_dssp CCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCC
T ss_pred CcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccccc
Confidence 666666643 245666666666666666665444333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.7e-19 Score=181.61 Aligned_cols=157 Identities=24% Similarity=0.277 Sum_probs=93.1
Q ss_pred cEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCC
Q 048430 374 LVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453 (973)
Q Consensus 374 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 453 (973)
+.+++++|.++ .+|..+. ..+++|+|++|++++..+. ..|..+++|++|+|++|
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~-----------------------~~~~~l~~L~~L~L~~N 67 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEAT-----------------------GIFKKLPQLRKINFSNN 67 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCC-----------------------CCGGGCTTCCEEECCSS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCch-----------------------hhhccCCCCCEEECCCC
Confidence 46666666666 3444332 2345666666666644332 22344444555555555
Q ss_pred CCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCC
Q 048430 454 SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQ 533 (973)
Q Consensus 454 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 533 (973)
+|++..+..|..+++|+.|++++|++++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|.
T Consensus 68 ~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 68 KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred cCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 55444444555555555555555555545555566666666666666666666666667777777777777777766677
Q ss_pred CcccccccccccccccccCCCCC
Q 048430 534 SFGSLISLQSLDLSGNNISGEIP 556 (973)
Q Consensus 534 ~~~~l~~L~~L~Ls~N~l~~~~p 556 (973)
.|..+++|+.|+|++|.+++..+
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECSGG
T ss_pred HhcCCCCCCEEEecCcCCcCCCc
Confidence 77777777777777777765443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=180.87 Aligned_cols=153 Identities=25% Similarity=0.283 Sum_probs=83.5
Q ss_pred CCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecC
Q 048430 397 LQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSL 476 (973)
Q Consensus 397 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 476 (973)
-+.++.+++.++ .+|..+. ++|+.|++++|.+++..+..|.++++|++|+|++|+|.+..+..|..+++|+.|++++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345666666666 4444332 5566666666666655555566666666666666666544444455555555555555
Q ss_pred CcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCC
Q 048430 477 NSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 477 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 5555444444455555555555555555 445555555555555555555554444445555555555555555543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=9.8e-19 Score=180.36 Aligned_cols=152 Identities=22% Similarity=0.278 Sum_probs=91.3
Q ss_pred cEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCC
Q 048430 374 LVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453 (973)
Q Consensus 374 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 453 (973)
+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45566666665 3444333 45666666666666555555666666666666666666555666666666666666666
Q ss_pred CCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc
Q 048430 454 SLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528 (973)
Q Consensus 454 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (973)
+|++..+..|..+++|+.|++++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666555555566666666666666666555556666666666666666666555555666666666666666665
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.5e-19 Score=197.99 Aligned_cols=175 Identities=21% Similarity=0.194 Sum_probs=85.0
Q ss_pred eeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccC-CCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCc
Q 048430 351 NFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLG-KLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNN 429 (973)
Q Consensus 351 ~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 429 (973)
.++..++.++. +|..+. ..++.|+|++|++++..+..|. .+++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 44444444442 333332 2345555555555544444444 5555555555555555444444555555555555555
Q ss_pred cccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCc---cCCCCCCeEEccCCcCccc
Q 048430 430 ALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNI---GNLEALGGLNLTGNQLSGY 506 (973)
Q Consensus 430 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~ 506 (973)
+++...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 5554444445555555555555555554445555555555555555555553222222 3445555555555555533
Q ss_pred CCcccccCCc--CCEEEcccCccc
Q 048430 507 IPSSIGNLKN--LDWLALARNAFQ 528 (973)
Q Consensus 507 ~p~~~~~l~~--L~~L~Ls~N~l~ 528 (973)
.+..+..++. |+.|+|++|.+.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CHHHhhhccHhhcceEEecCCCcc
Confidence 3344444444 244555555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-19 Score=208.09 Aligned_cols=186 Identities=22% Similarity=0.308 Sum_probs=133.7
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
+..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|++.+..+ +..+++|+.|+|++|.+.+. ..+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCC
Confidence 3456677778888888773 33 47777888888888888875544 77788888888888887752 2577778888
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCc
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNA 526 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 526 (973)
.|+|++|++.+. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+
T Consensus 113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 888888887753 3577778888888888888754 457777888888888888876555 7778888888888888
Q ss_pred cccCCCCCcccccccccccccccccCCCCCcccccccccc
Q 048430 527 FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLV 566 (973)
Q Consensus 527 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 566 (973)
|++. | .+..+++|+.|+|++|++++.....+..+..+.
T Consensus 187 i~~l-~-~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~ 224 (605)
T 1m9s_A 187 ISDL-R-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224 (605)
T ss_dssp CCBC-G-GGTTCTTCSEEECCSEEEECCCCCCCSSCEEEC
T ss_pred CCCC-h-HHccCCCCCEEEccCCcCcCCcccccccEEecc
Confidence 8753 3 577788888888888888765444444443333
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-20 Score=220.33 Aligned_cols=191 Identities=21% Similarity=0.200 Sum_probs=119.0
Q ss_pred CCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCc-------------CCCCCchhhhccCcCCeee-cCCccccC
Q 048430 368 GNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK-------------LKGFIPTDLCKLEKLNTLL-SNNNALQG 433 (973)
Q Consensus 368 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~~~~l~~L~~L~-l~~N~l~~ 433 (973)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..+..+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45667777777777776 667777777777777776654 4445566666666666666 4544332
Q ss_pred cCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCccccc
Q 048430 434 QIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGN 513 (973)
Q Consensus 434 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 513 (973)
+|+.+.+++|.+++..+ ..|+.|++++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..|+.
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 22333333343332111 135666666666664 454 666666666666666666 56666666
Q ss_pred CCcCCEEEcccCccccCCCCCcccccccccccccccccCCCC-CccccccccccccccCCCcccccCCC
Q 048430 514 LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI-PKSLEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 514 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
+++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.+ |..+..+++|+.|+|++|++++.+|.
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 6666777777766664 45 5666666777777777666655 66666666677777777766666554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-20 Score=219.03 Aligned_cols=36 Identities=14% Similarity=0.050 Sum_probs=27.1
Q ss_pred ccccceeeeccccccccCcchhcccCcccEEEecccc
Q 048430 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNL 278 (973)
Q Consensus 242 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 278 (973)
.++|+.|+|++|+++ .+|+.++.+++|+.|++++|.
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~ 383 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKW 383 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHH
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccch
Confidence 677788888888887 567777777777777776654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.5e-19 Score=212.48 Aligned_cols=191 Identities=23% Similarity=0.258 Sum_probs=94.0
Q ss_pred EEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCC
Q 048430 376 LSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSL 455 (973)
Q Consensus 376 L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 455 (973)
++++.|.+. ..++.|..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|+++++|++|+|++|+|
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 344445555 55666777777777777777777 55666667777777777777776 5666677777777777777777
Q ss_pred CCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCc-CCEEEcccCccccCCCCC
Q 048430 456 NSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKN-LDWLALARNAFQGPIPQS 534 (973)
Q Consensus 456 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~ 534 (973)
+ .+|..|..+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 6 55666667777777777777666 56666667777777777777776666666654322 223566666666666653
Q ss_pred ccccccccccccccc--------ccCCCCCccccccccccccccCCCcccc
Q 048430 535 FGSLISLQSLDLSGN--------NISGEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 535 ~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
|+.|++++| .|.+..+..+..+..+....+++|-+++
T Consensus 361 ------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 361 ------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp -----------------------------------------------CCCG
T ss_pred ------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 344455555 3333333344445555555555555543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=183.82 Aligned_cols=170 Identities=20% Similarity=0.252 Sum_probs=112.6
Q ss_pred CCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCe
Q 048430 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKS 146 (973)
Q Consensus 67 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 146 (973)
.+..+..++++.|.+.+ ++ .+..+++|+.|++++|.+. .+| . +..+++|++|+|++|++++.. . +.++++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~-l~~l~~L~~L~L~~N~i~~~~-~-l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-G-MQFFTNLKELHLSHNQISDLS-P-LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCG-G-GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-H-HhhCCCCCEEECCCCccCCCh-h-hccCCCCCE
Confidence 45666777777777753 33 5777888888888888887 566 2 467788888888888888543 3 778888888
Q ss_pred EEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEE
Q 048430 147 IRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL 226 (973)
Q Consensus 147 L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~ 226 (973)
|+|++|+++ .+|.... ++|++|+|++|+|++ ++ .++.+++|++|+|++|+|++. + .+..+++|+.|+
T Consensus 90 L~L~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~------~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~ 156 (263)
T 1xeu_A 90 LSVNRNRLK-NLNGIPS---ACLSRLFLDNNELRD------TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLD 156 (263)
T ss_dssp EECCSSCCS-CCTTCCC---SSCCEEECCSSCCSB------SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEE
T ss_pred EECCCCccC-CcCcccc---CcccEEEccCCccCC------Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEE
Confidence 888888887 5554332 778888888888863 22 477788888888888888754 2 455555555555
Q ss_pred eecccccccCCCCCCccccceeeeccccccc
Q 048430 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSG 257 (973)
Q Consensus 227 l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~ 257 (973)
+++|++++. +....+++|++|++++|.+.+
T Consensus 157 L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 157 LHGNEITNT-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CTTSCCCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred CCCCcCcch-HHhccCCCCCEEeCCCCcccC
Confidence 555555443 222334555555555555543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=183.86 Aligned_cols=171 Identities=21% Similarity=0.289 Sum_probs=111.8
Q ss_pred CCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCee
Q 048430 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHL 448 (973)
Q Consensus 369 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 448 (973)
.+.++..+++++|.+++. + .+..+++|++|++++|.++. ++ .+..+++|+.|++++|++++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 345566667777777633 2 46667777777777777773 34 56677777777777777775544 6677777777
Q ss_pred eccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc
Q 048430 449 DFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528 (973)
Q Consensus 449 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (973)
++++|++++. |... . ++|+.|++++|++++ ++ .+..+++|+.|+|++|++++ ++ .++.+++|+.|+|++|+++
T Consensus 91 ~L~~N~l~~l-~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCc
Confidence 7777777653 2221 2 667777777777764 22 46667777777777777764 33 5666777777777777776
Q ss_pred cCCCCCcccccccccccccccccCCC
Q 048430 529 GPIPQSFGSLISLQSLDLSGNNISGE 554 (973)
Q Consensus 529 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ 554 (973)
+. ..+..+++|+.|+|++|++++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 54 5566677777777777777654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.2e-18 Score=170.40 Aligned_cols=151 Identities=13% Similarity=0.187 Sum_probs=83.6
Q ss_pred cCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEE
Q 048430 418 LEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLN 497 (973)
Q Consensus 418 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 497 (973)
+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|+.|++++|++++..|..++.+++|+.|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 344444444444444 222 3444455555555555443 223455555555555555555555555566666666666
Q ss_pred ccCCcCcccCCcccccCCcCCEEEcccCc-cccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCccc
Q 048430 498 LTGNQLSGYIPSSIGNLKNLDWLALARNA-FQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576 (973)
Q Consensus 498 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 576 (973)
|++|++++..|..++.+++|+.|+|++|+ ++ .+| .+..+++|+.|+|++|++++ ++ .+..+++|+.|++++|++.
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 66666665556666666666666666666 43 444 46666666666666666664 23 5666666666666666654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.5e-18 Score=171.17 Aligned_cols=151 Identities=17% Similarity=0.197 Sum_probs=81.9
Q ss_pred CCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEe
Q 048430 395 QKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDF 474 (973)
Q Consensus 395 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 474 (973)
++|++|++++|.++ .+| .+..+++|+.|++++|.++ .+..+..+++|++|++++|++++..+..+..+++|+.|++
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 33444444444444 222 2344444444444444332 1123444555555555555555445555555555555566
Q ss_pred cCCcccCCcCcCccCCCCCCeEEccCCc-CcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCC
Q 048430 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQ-LSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 475 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
++|++++..|..++.+++|+.|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|+|.+
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 6666655555566666666777777766 44 444 56667777777777777764 33 56777777777777777653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=5.2e-17 Score=163.60 Aligned_cols=113 Identities=24% Similarity=0.279 Sum_probs=71.4
Q ss_pred CCCeeeccCCCCCCCCcc-cccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEc
Q 048430 444 SLRHLDFRSNSLNSTIPS-TFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522 (973)
Q Consensus 444 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 522 (973)
+|++|++++|++++..+. .|..+++|+.|++++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 555566666665544443 3555666666666666666555666666666666666666666655666666666666666
Q ss_pred ccCccccCCCCCcccccccccccccccccCCCCC
Q 048430 523 ARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIP 556 (973)
Q Consensus 523 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 556 (973)
++|+|++.+|..|..+++|++|+|++|.+++..+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 6666666666666666666677777776665544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=6.5e-17 Score=162.86 Aligned_cols=153 Identities=23% Similarity=0.262 Sum_probs=95.6
Q ss_pred cCCeeecCCccccCcCcc-cccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEc
Q 048430 420 KLNTLLSNNNALQGQIPT-CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNL 498 (973)
Q Consensus 420 ~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 498 (973)
+|+.|++++|.+++..+. .|..+++|++|+|++|+|++..|..|..+++|+.|++++|+|++..+..|.++++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 444445555554444332 3556666666666666666666666666667777777777777666666778888888888
Q ss_pred cCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccc-cccccccccccccCCCCCccccccccccccccCCCcccc
Q 048430 499 TGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL-ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 499 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
++|+|++..|..|..+++|+.|+|++|.+++..+- ..+ ..++...+..+......|..+.. ....+++.+.+..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l--~~~~~~l~~~~~~~~~~~C~~P~~l~~---~~l~~l~~~~~~C 184 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL--AWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFKC 184 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG--HHHHHHHHHHCCSGGGCBBCSSTTTTT---SBGGGSCTTTCCC
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc--hHHHHHHHHcCCCCCCCCCCCChHHcC---CChhhCcHhhcCc
Confidence 88888877788888888888888888888865542 111 12333344445444444544333 3344555555543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.1e-17 Score=174.77 Aligned_cols=137 Identities=20% Similarity=0.274 Sum_probs=107.1
Q ss_pred CCCCccccccCceEEEEEEe-CCCeE--EEEEEEeccch------------------------hhHHHHHHHHHHHHhcc
Q 048430 682 FGESNLLGSGSFDNVYKATL-ANGVS--VAVKVFNLQED------------------------RALKSFDTECEVMRRIR 734 (973)
Q Consensus 682 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~ 734 (973)
|...+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999997 68999 99998754311 11236889999999998
Q ss_pred CCce--eEEEeeeecCCeeEEEEEecCC-C----CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCC
Q 048430 735 HRNL--IKIVSSCSNPGFKALIMQYMPQ-G----SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807 (973)
Q Consensus 735 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk 807 (973)
|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.|||+ +.+|+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 8754 334432 356899999942 3 77776543 2344677899999999999995 4799999999
Q ss_pred CCcEEeCCCCcEEEeeccccccc
Q 048430 808 PNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 808 ~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-17 Score=180.94 Aligned_cols=39 Identities=15% Similarity=0.263 Sum_probs=25.4
Q ss_pred cCcccEEEeccccccccCCCcccccccceEEEccCCcCCC
Q 048430 266 ASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305 (973)
Q Consensus 266 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 305 (973)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++.
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~ 138 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPN 138 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCE
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccc
Confidence 66677777766 6666666666666666666666666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.1e-17 Score=179.71 Aligned_cols=199 Identities=13% Similarity=0.069 Sum_probs=115.4
Q ss_pred CCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCc----CCCCCchhhhccCcCC-eeecCCccccCcCcccc-
Q 048430 366 GFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK----LKGFIPTDLCKLEKLN-TLLSNNNALQGQIPTCL- 439 (973)
Q Consensus 366 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~----l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~- 439 (973)
+|.++++|+.|++++|.+..+.+.+|..+.++..+.+..+. ........|.++..|+ .+.+.... .++..+
T Consensus 119 aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~ 195 (329)
T 3sb4_A 119 AFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIM 195 (329)
T ss_dssp TTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHH
T ss_pred HhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHh
Confidence 35566666666666666655555666665555555544421 1222233344444444 22222211 111111
Q ss_pred ---cCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCc
Q 048430 440 ---ANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKN 516 (973)
Q Consensus 440 ---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 516 (973)
....+++.+.+.++-...........+++|+.+++++|+++...+..|.++.+|+.|+|++| ++...+..|.++++
T Consensus 196 ~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~ 274 (329)
T 3sb4_A 196 KAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGR 274 (329)
T ss_dssp HTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred hcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChh
Confidence 12344555555544211111111112567777777777777555566777777777777777 66555667777777
Q ss_pred CC-EEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccc
Q 048430 517 LD-WLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFN 569 (973)
Q Consensus 517 L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ 569 (973)
|+ .|++.+ .++.+.+.+|.++++|+.|++++|+++...+..|..+++|+.++
T Consensus 275 L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 275 LAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred ccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 87 777777 66656667788888888888877777766666777777777765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.8e-16 Score=153.32 Aligned_cols=135 Identities=23% Similarity=0.364 Sum_probs=92.8
Q ss_pred CCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCC
Q 048430 30 ASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109 (973)
Q Consensus 30 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 109 (973)
...|.|.+|.|+.. +++ .+|..+ .++|++|+|++|++.+..+..++.+++|++|+|++|+++ .+
T Consensus 4 ~C~C~~~~l~~~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~ 67 (177)
T 2o6r_A 4 RCSCSGTEIRCNSK------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SL 67 (177)
T ss_dssp TCEEETTEEECCSS------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CC
T ss_pred CCEeCCCEEEecCC------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-Ee
Confidence 44588999988643 333 345433 257888888888887665666777888888888888887 56
Q ss_pred CccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccc
Q 048430 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITG 181 (973)
Q Consensus 110 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~ 181 (973)
|...+..+++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|...+..+++|++|+|++|.+++
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeec
Confidence 6666677777777777777777665556677777777777777776 5665555555666666666665543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.9e-16 Score=154.50 Aligned_cols=133 Identities=20% Similarity=0.169 Sum_probs=97.7
Q ss_pred CCCCeeeccCCCCC-CCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEE
Q 048430 443 TSLRHLDFRSNSLN-STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLA 521 (973)
Q Consensus 443 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 521 (973)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 56666677777777777777777754 5677777888888888888766777777788888888
Q ss_pred cccCccccCC-CCCcccccccccccccccccCCCCC---ccccccccccccccCCCcccc
Q 048430 522 LARNAFQGPI-PQSFGSLISLQSLDLSGNNISGEIP---KSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 522 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~ls~N~l~~ 577 (973)
|++|++++.. +..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 8888887432 2677778888888888888876554 477778888888888887753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-15 Score=152.88 Aligned_cols=125 Identities=27% Similarity=0.409 Sum_probs=95.2
Q ss_pred EecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcc
Q 048430 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNK 129 (973)
Q Consensus 50 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~ 129 (973)
+++++++++ .+|..+. +.|++|+|++|++. .+|..|.++++|+.|+|++|.++ .++...|..+++|++|+|++|+
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCC-EeCHhHccCCCCCCEEECCCCc
Confidence 344455555 5666543 57888888888884 77888888888888888888888 5666667788888888888888
Q ss_pred cCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEccccccc
Q 048430 130 ITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180 (973)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~ 180 (973)
|++..|..|.++++|+.|+|++|+|+ .+|...|..+++|+.|+|++|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCee
Confidence 88777777888888888888888887 677766667777777777777665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=8.6e-16 Score=154.55 Aligned_cols=109 Identities=27% Similarity=0.331 Sum_probs=62.3
Q ss_pred cccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccc
Q 048430 468 YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547 (973)
Q Consensus 468 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (973)
+|+.|++++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4455555555554 444555555555555555555555445555556666666666666665555556666666666666
Q ss_pred ccccCCCCCccccccccccccccCCCcccc
Q 048430 548 GNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 548 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
+|+|++..+..|..+++|+.|++++|++.+
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 666654444455556666666666665554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.3e-16 Score=150.89 Aligned_cols=132 Identities=21% Similarity=0.177 Sum_probs=61.2
Q ss_pred CCCCEEEccCCcCC-CCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEE
Q 048430 395 QKLQGLDLNSNKLK-GFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473 (973)
Q Consensus 395 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 473 (973)
++|++|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34555555555544 33444444444444444444444433 3444555555555555555544444444444444444
Q ss_pred ecCCcccCCc-CcCccCCCCCCeEEccCCcCcccCC---cccccCCcCCEEEcccCccc
Q 048430 474 FSLNSLSGSL-PLNIGNLEALGGLNLTGNQLSGYIP---SSIGNLKNLDWLALARNAFQ 528 (973)
Q Consensus 474 ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 528 (973)
+++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 4444444321 1344444444555555554443222 24444444444444444444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-16 Score=150.77 Aligned_cols=127 Identities=19% Similarity=0.203 Sum_probs=83.9
Q ss_pred CCCCeeeccCCCCC-CCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEE
Q 048430 443 TSLRHLDFRSNSLN-STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLA 521 (973)
Q Consensus 443 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 521 (973)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..++.+++|+.|+|++|++++.+|..++.+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45566666666655 45555555666666666666666543 5566677777777777777755666666677777777
Q ss_pred cccCccccC-CCCCcccccccccccccccccCCCCC---ccccccccccccccC
Q 048430 522 LARNAFQGP-IPQSFGSLISLQSLDLSGNNISGEIP---KSLEKLSRLVDFNVS 571 (973)
Q Consensus 522 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~ls 571 (973)
+++|++++. .|..++.+++|++|++++|++++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777777642 23667777777777777777776554 467777777777765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=150.47 Aligned_cols=113 Identities=21% Similarity=0.235 Sum_probs=61.1
Q ss_pred cccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccc
Q 048430 468 YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547 (973)
Q Consensus 468 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (973)
+|+.|++++|++++..+..++.+++|+.|+|++|++++..+..|+.+++|+.|+|++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 44455555555554334444555555555555555554444445555555555555555554444455555555555555
Q ss_pred ccccCCCCCccccccccccccccCCCcccccCC
Q 048430 548 GNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 548 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
+|+|++..+..+..+++|+.|++++|++++.+|
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 555554444445555556666666665555444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-15 Score=147.21 Aligned_cols=126 Identities=23% Similarity=0.262 Sum_probs=65.7
Q ss_pred cCCeeecCCcccc-CcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEc
Q 048430 420 KLNTLLSNNNALQ-GQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNL 498 (973)
Q Consensus 420 ~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 498 (973)
+|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|+.|++++|++++.+|..++.+++|+.|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3444444444444 33444444444455555555544433 34444555555555555555444544555555666666
Q ss_pred cCCcCccc-CCcccccCCcCCEEEcccCccccCCC---CCccccccccccccc
Q 048430 499 TGNQLSGY-IPSSIGNLKNLDWLALARNAFQGPIP---QSFGSLISLQSLDLS 547 (973)
Q Consensus 499 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls 547 (973)
++|++++. .+..++.+++|+.|++++|.+++..+ ..+..+++|+.||++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 66666532 23556666666666666666664433 356666666666665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.2e-14 Score=158.88 Aligned_cols=172 Identities=16% Similarity=0.198 Sum_probs=86.1
Q ss_pred cCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEE
Q 048430 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQL 172 (973)
Q Consensus 93 ~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L 172 (973)
..++.+.+.++ +. .|+...|.+. +|+.+++.+| ++..-..+|.+. +|+.+.+.+ .++ .|+...|.++++|+.+
T Consensus 113 ~~l~~i~ip~~-i~-~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 113 KGYNEIILPNS-VK-SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKA 185 (401)
T ss_dssp SSCSEEECCTT-CC-EECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEE
T ss_pred CCccEEEECCc-cC-EehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCee
Confidence 34444444332 22 3444444432 4555554444 333333344442 355555443 333 4444444444444444
Q ss_pred EcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeecc
Q 048430 173 RLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWK 252 (973)
Q Consensus 173 ~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~ 252 (973)
+|.+|+++ .+|......++|+.+.|..+ ++.+...+|.+ +++|+.+++..
T Consensus 186 ~l~~n~l~------~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~-----------------------~~~L~~l~l~~ 235 (401)
T 4fdw_A 186 DLSKTKIT------KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLK-----------------------TSQLKTIEIPE 235 (401)
T ss_dssp ECTTSCCS------EECTTTTTTCCCSEEECCTT-CCEECTTTTTT-----------------------CTTCCCEECCT
T ss_pred ecCCCcce------EechhhEeecccCEEEeCCc-hheehhhHhhC-----------------------CCCCCEEecCC
Confidence 44444443 22222112344444444422 33333333333 55666666655
Q ss_pred ccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCC
Q 048430 253 NNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLT 304 (973)
Q Consensus 253 N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 304 (973)
| ++.+...+|.+ ++|+.+.+ .|.++.+...+|.++++|+.+.+.+|.+.
T Consensus 236 ~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 236 N-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp T-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred C-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 3 44455566666 67777777 45566677777888888888877777654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.8e-14 Score=161.90 Aligned_cols=201 Identities=11% Similarity=0.137 Sum_probs=105.9
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
|.++++|+.+++++|+++.....+|. ..+|+.+.|..+ ++.+....|.++++|+.+.+..| ++.....+|.+ .+|+
T Consensus 176 F~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~ 251 (401)
T 4fdw_A 176 FYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGIT 251 (401)
T ss_dssp TTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCS
T ss_pred hhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCcc
Confidence 34444444444444444433333333 244444444422 33333334444444444444432 33233334444 4455
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCccc-----CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEE
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS-----GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLA 521 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 521 (973)
.+.+ .|.++.....+|.++++|+.+++.+|.+. ...+..|.++++|+.++|. +.++......|.++.+|+.++
T Consensus 252 ~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~ 329 (401)
T 4fdw_A 252 TVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLT 329 (401)
T ss_dssp EEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEE
T ss_pred EEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEE
Confidence 5555 23344344445555555555555555443 2344566777777777777 346545556677777777777
Q ss_pred cccCccccCCCCCcccccccccccccccccCCCCCccccccc-cccccccCCCcc
Q 048430 522 LARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLS-RLVDFNVSFNGL 575 (973)
Q Consensus 522 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~ls~N~l 575 (973)
|..| ++.+-+.+|.++ +|+.+++++|.+....+..|..++ .+..+++..|.+
T Consensus 330 lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 330 IPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp ECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred ECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 7544 554556677777 777777777777655556666663 455666655543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-15 Score=166.54 Aligned_cols=137 Identities=13% Similarity=0.189 Sum_probs=101.6
Q ss_pred CCCCCccccccCceEEEEEEeCCCeEEEEEEEeccch--------------h--------hHHHHHHHHHHHHhccCCce
Q 048430 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQED--------------R--------ALKSFDTECEVMRRIRHRNL 738 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~--------~~~~~~~e~~~l~~l~h~ni 738 (973)
-|.+.++||+|+||.||+|...+|+.||||+++.... . ......+|...+.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3778899999999999999998999999998753210 0 01123456777777755443
Q ss_pred e--EEEeeeecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC
Q 048430 739 I--KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD 816 (973)
Q Consensus 739 v--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~ 816 (973)
. ..+++ ...++||||+++++|.++... .....++.|++.+|.||| ..+||||||||.|||++++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCC
Confidence 2 22222 123799999999888765432 234568899999999999 7899999999999999887
Q ss_pred C----------cEEEeecccccccC
Q 048430 817 M----------VAHLGDFGIAKLLD 831 (973)
Q Consensus 817 ~----------~~kl~Dfgla~~~~ 831 (973)
+ .+.|+||+-+....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38999999876543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.1e-14 Score=157.40 Aligned_cols=144 Identities=12% Similarity=0.128 Sum_probs=58.5
Q ss_pred CcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeec
Q 048430 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDF 450 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 450 (973)
.+|+.+.+..+ ++......|..+..|+.+.+..+... .....|..+..++.+....+.+ ....|..+.+|+.+.+
T Consensus 230 ~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l 304 (394)
T 4fs7_A 230 TGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKL 304 (394)
T ss_dssp CCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEE
T ss_pred CCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---cccccccccccccccc
Confidence 34444444332 22233444555555555555544333 3334444444554444443322 1223444555555555
Q ss_pred cCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEc
Q 048430 451 RSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522 (973)
Q Consensus 451 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 522 (973)
..+ ++.+-..+|.++.+|+.+++..+ ++.....+|.++.+|+.+++..| ++..-...|.++.+|+.+++
T Consensus 305 ~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 305 LDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred ccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence 433 33222333333344444433322 22222333444444444444333 33222333444444444444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=5.5e-15 Score=146.48 Aligned_cols=134 Identities=21% Similarity=0.178 Sum_probs=101.3
Q ss_pred cccCcCCCCeeeccCCCCCCCCcccccccc-cccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCc
Q 048430 438 CLANLTSLRHLDFRSNSLNSTIPSTFWSLK-YILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKN 516 (973)
Q Consensus 438 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 516 (973)
.+.++.+|++|++++|+++. +|. +..+. +|+.|++++|.+++. ..++.+++|+.|+|++|+|++..+..|+.+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 34566777777777777774 343 44443 788888888888753 56788888888888888888554455688888
Q ss_pred CCEEEcccCccccCCCC--CcccccccccccccccccCCCCCcc----ccccccccccccCCCcccc
Q 048430 517 LDWLALARNAFQGPIPQ--SFGSLISLQSLDLSGNNISGEIPKS----LEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 517 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~l~ls~N~l~~ 577 (973)
|+.|+|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|.. +..+++|+.||+++|....
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 888888888886 5665 7888888888888888887 45654 8888889999998887653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-13 Score=152.95 Aligned_cols=145 Identities=14% Similarity=0.141 Sum_probs=87.2
Q ss_pred CCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCC
Q 048430 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446 (973)
Q Consensus 367 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 446 (973)
|.++..|+.+.+..+... .....|..+..++.+.+..+.+. ...|..+.+|+.+.+.++ +..+...+|.++++|+
T Consensus 249 f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~ 323 (394)
T 4fs7_A 249 FYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLV 323 (394)
T ss_dssp TTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCC
Confidence 555566666666555433 44556666666666666554332 234556666666666544 4444555666677777
Q ss_pred eeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEE
Q 048430 447 HLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWL 520 (973)
Q Consensus 447 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 520 (973)
.++|..+ ++.+-..+|.++.+|+.+++..| ++.....+|.++.+|+.+++..+ ++ .+...|.++++|+.+
T Consensus 324 ~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 324 SIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp EECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred EEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 7777543 55455566777777777777665 55455567777788888877654 33 344567667666654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=9.4e-17 Score=162.70 Aligned_cols=134 Identities=22% Similarity=0.305 Sum_probs=64.4
Q ss_pred CCCCCCCEEEccCCcCCCCCch------hhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccc
Q 048430 392 GKLQKLQGLDLNSNKLKGFIPT------DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWS 465 (973)
Q Consensus 392 ~~l~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 465 (973)
.....++.++++.|.+.+..|. .+..+++|++|++++|.+++ +| .+..+++|++|++++|+++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3344555555555555555444 55555555555555555554 33 4555555555555555554 34444444
Q ss_pred cccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCC-cccccCCcCCEEEcccCccccC
Q 048430 466 LKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIP-SSIGNLKNLDWLALARNAFQGP 530 (973)
Q Consensus 466 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 530 (973)
+++|+.|++++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+++.
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 4455555555555442 22 34444444444444444442111 2344444444444444444433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-16 Score=160.15 Aligned_cols=155 Identities=19% Similarity=0.285 Sum_probs=100.7
Q ss_pred hhccCcCCeeecCCccccCcCcc------cccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCcc
Q 048430 415 LCKLEKLNTLLSNNNALQGQIPT------CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIG 488 (973)
Q Consensus 415 ~~~l~~L~~L~l~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 488 (973)
+.....++.++++.+.+.+..|. .+..+++|++|++++|++++ +| .+..+++|+.|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44455666666777777666665 66667777777777777765 44 6666777777777777776 5566566
Q ss_pred CCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCC-CCcccccccccccccccccCCCCCcc---------
Q 048430 489 NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIP-QSFGSLISLQSLDLSGNNISGEIPKS--------- 558 (973)
Q Consensus 489 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~--------- 558 (973)
.+++|+.|+|++|++++ +| .++.+++|+.|+|++|++++..+ ..+..+++|++|++++|++++.+|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 66677777777777764 44 46667777777777777763222 35666777777777777776555542
Q ss_pred -ccccccccccccCCCccc
Q 048430 559 -LEKLSRLVDFNVSFNGLE 576 (973)
Q Consensus 559 -~~~l~~L~~l~ls~N~l~ 576 (973)
+..+++|+.|| +|.++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 56667777665 55544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.9e-14 Score=141.28 Aligned_cols=132 Identities=20% Similarity=0.215 Sum_probs=62.6
Q ss_pred cCCCCCCCEEEccCCcCCCCCchhhhccC-cCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccc
Q 048430 391 LGKLQKLQGLDLNSNKLKGFIPTDLCKLE-KLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI 469 (973)
Q Consensus 391 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 469 (973)
+..+.+|++|++++|+++. +|. +..+. +|+.|++++|.+++. ..+..+++|++|++++|++++..+..|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~------ 84 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLD------ 84 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHH------
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchh------
Confidence 3444555555555555552 232 22222 455555555544432 334445555555555555543322333
Q ss_pred cEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCc--ccccCCcCCEEEcccCccccCCCCC----ccccccccc
Q 048430 470 LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPS--SIGNLKNLDWLALARNAFQGPIPQS----FGSLISLQS 543 (973)
Q Consensus 470 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~ 543 (973)
..+++|+.|+|++|+|+ .+|. .++.+++|+.|++++|.++ .+|.. +..+++|+.
T Consensus 85 ------------------~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~ 144 (176)
T 1a9n_A 85 ------------------QALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 144 (176)
T ss_dssp ------------------HHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred ------------------hcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccce
Confidence 44444444444444443 2333 4455555555555555554 33432 555555555
Q ss_pred ccccccccC
Q 048430 544 LDLSGNNIS 552 (973)
Q Consensus 544 L~Ls~N~l~ 552 (973)
||+++|.+.
T Consensus 145 Ld~~~n~~~ 153 (176)
T 1a9n_A 145 LDFQKVKLK 153 (176)
T ss_dssp ETTEECCHH
T ss_pred eCCCcCCHH
Confidence 555555543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=4.9e-14 Score=138.52 Aligned_cols=89 Identities=21% Similarity=0.229 Sum_probs=42.9
Q ss_pred CCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCcccccccccccccc
Q 048430 491 EALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNV 570 (973)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l 570 (973)
++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 44444444444444444444444455555555555554444444444555555555555554444444444555555555
Q ss_pred CCCcccccC
Q 048430 571 SFNGLEGEI 579 (973)
Q Consensus 571 s~N~l~~~~ 579 (973)
++|++++..
T Consensus 110 ~~N~~~c~c 118 (170)
T 3g39_A 110 LNNPWDCAC 118 (170)
T ss_dssp CSSCBCTTB
T ss_pred CCCCCCCCc
Confidence 555444433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=136.23 Aligned_cols=104 Identities=19% Similarity=0.195 Sum_probs=53.8
Q ss_pred CeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccC
Q 048430 446 RHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARN 525 (973)
Q Consensus 446 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 525 (973)
+.+++++|+++ .+|..+. ++|+.|++++|+|++..|..|+++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666664 3343332 45555555555555444555555555555555555555433334455555555555555
Q ss_pred ccccCCCCCcccccccccccccccccC
Q 048430 526 AFQGPIPQSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (973)
+|++..+..|..+++|++|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555433334555555555555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=5e-13 Score=131.29 Aligned_cols=108 Identities=23% Similarity=0.218 Sum_probs=85.3
Q ss_pred CCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEccc
Q 048430 445 LRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALAR 524 (973)
Q Consensus 445 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 524 (973)
.+.+++++|+++. +|..+ .++|+.|++++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4677777777764 45444 26777888888888877777888888888888888888876666778888888888888
Q ss_pred CccccCCCCCcccccccccccccccccCCCC
Q 048430 525 NAFQGPIPQSFGSLISLQSLDLSGNNISGEI 555 (973)
Q Consensus 525 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 555 (973)
|+|++..+..|..+++|++|+|++|.+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 8888777777888888999999999888653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=1e-12 Score=129.46 Aligned_cols=104 Identities=25% Similarity=0.363 Sum_probs=77.1
Q ss_pred EEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeC
Q 048430 48 AALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSS 127 (973)
Q Consensus 48 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~ 127 (973)
+.+++++++++ .+|..+. +.|++|+|++|++.+..|..|+++++|++|+|++|+|+ .+|..+|..+++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECCC
Confidence 35677777774 6777664 77888888888887777777888888888888888887 56766667777777777777
Q ss_pred cccCCCCCccccCCCCCCeEEccCcccc
Q 048430 128 NKITGEFPSAIVNISSLKSIRLDNNSLS 155 (973)
Q Consensus 128 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 155 (973)
|+|++..+..|.++++|++|+|++|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 7777555455777777777777777776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.1e-10 Score=129.33 Aligned_cols=131 Identities=11% Similarity=0.174 Sum_probs=56.0
Q ss_pred CCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCC
Q 048430 366 GFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSL 445 (973)
Q Consensus 366 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 445 (973)
+|.++..|+.+.+.++-.. +...+|.++++|+.+.+. +.++.+....|.++.+|+.+.+..+ ++.+...+|.++++|
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 4555555555555444332 444455555555555554 2333233334444445554444432 332333344444444
Q ss_pred CeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccC
Q 048430 446 RHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARN 525 (973)
Q Consensus 446 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 525 (973)
+ .+.+..+ ++.....+|.++.+|+.+++.+|.... ..+....+|+.+.+..|
T Consensus 337 ~------------------------~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 337 E------------------------RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp C------------------------EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred C------------------------EEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence 4 4444332 332333445555555555555554331 23444555555555544
Q ss_pred cc
Q 048430 526 AF 527 (973)
Q Consensus 526 ~l 527 (973)
.+
T Consensus 389 ~~ 390 (394)
T 4gt6_A 389 SI 390 (394)
T ss_dssp --
T ss_pred CE
Confidence 43
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.2e-14 Score=155.46 Aligned_cols=66 Identities=20% Similarity=0.188 Sum_probs=32.7
Q ss_pred cCCCCCCeEEccCCcCccc----CCcccccCCcCCEEEcccCccccC----CCCCcccccccccccccccccCC
Q 048430 488 GNLEALGGLNLTGNQLSGY----IPSSIGNLKNLDWLALARNAFQGP----IPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 488 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
..+++|++|+|++|+|++. ++..+...++|+.|+|++|.|+.. ++..+...++|++|||++|.|+.
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 4445555555555555422 233444455555566665555432 22223334555666666665553
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.3e-14 Score=155.38 Aligned_cols=166 Identities=18% Similarity=0.147 Sum_probs=124.2
Q ss_pred CCcccEEEeecCccccccCcccCC-----CCCCCEEEccCCcCCCCCchhhh-ccCcCCeeecCCccccCcCccccc---
Q 048430 370 LSNLLVLSLVNNELAGAIPTVLGK-----LQKLQGLDLNSNKLKGFIPTDLC-KLEKLNTLLSNNNALQGQIPTCLA--- 440 (973)
Q Consensus 370 l~~L~~L~Ls~n~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~--- 440 (973)
++.|+.|+|++|.++......+.. .++|++|+|++|.++......+. .+++|+.|+|++|.++......+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 357889999999988544433332 26899999999998754333333 467899999999999865555442
Q ss_pred --CcCCCCeeeccCCCCCC----CCcccccccccccEEEecCCcccCC----cCcCccCCCCCCeEEccCCcCccc----
Q 048430 441 --NLTSLRHLDFRSNSLNS----TIPSTFWSLKYILAVDFSLNSLSGS----LPLNIGNLEALGGLNLTGNQLSGY---- 506 (973)
Q Consensus 441 --~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~---- 506 (973)
..++|++|+|++|.|+. .++..+...++|++|||++|.|++. ++..+...++|+.|+|++|.|++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 45789999999999864 2444557788999999999999853 255667788999999999999853
Q ss_pred CCcccccCCcCCEEEcccCccccCCCCCc
Q 048430 507 IPSSIGNLKNLDWLALARNAFQGPIPQSF 535 (973)
Q Consensus 507 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 535 (973)
++..+...+.|+.|+|++|.|+......+
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 34455667999999999999985444333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=8.4e-12 Score=138.33 Aligned_cols=133 Identities=19% Similarity=0.129 Sum_probs=99.0
Q ss_pred CeeeccCC-CCCCCCcccccccccccEEEecC-CcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcc
Q 048430 446 RHLDFRSN-SLNSTIPSTFWSLKYILAVDFSL-NSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALA 523 (973)
Q Consensus 446 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 523 (973)
..++++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|+++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45688887 7874 666 88888899999986 88887777788889999999999999988888888889999999999
Q ss_pred cCccccCCCCCcccccccccccccccccCCCCC-ccccccccccccccCCCcccccCCC
Q 048430 524 RNAFQGPIPQSFGSLISLQSLDLSGNNISGEIP-KSLEKLSRLVDFNVSFNGLEGEIPS 581 (973)
Q Consensus 524 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~~~p~ 581 (973)
+|+|++..+..|..+. |+.|+|++|++...-. .+|..+.+.....+..+.+.+.-|.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 9999866666676665 8899999998875432 2333333333344444555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.6e-10 Score=127.40 Aligned_cols=334 Identities=11% Similarity=0.159 Sum_probs=169.3
Q ss_pred CccccCCC-CCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCC-CccccCCCCccEEEecCCcccCcc
Q 048430 135 PSAIVNIS-SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREI-PNEIGNLHNLKILDLGGNNIAGLI 212 (973)
Q Consensus 135 p~~~~~l~-~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-p~~l~~l~~L~~L~L~~N~l~~~~ 212 (973)
..+|.++. .|+.+.+..+ ++ .|...+|.++.+|+.+.+..|.-+.. ..+ ..+|.++.+|+.+.+..+ ++...
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l---~~Ig~~aF~~c~~L~~i~~~~~-~~~I~ 129 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCV---KKIGRQAFMFCSELTDIPILDS-VTEID 129 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCC---CEECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred HhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCee---eEechhhchhcccceeeccCCc-cceeh
Confidence 45676664 5888888654 55 77777777778888887776642110 011 234666666666665543 33333
Q ss_pred ccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCccccccc
Q 048430 213 PSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQ 292 (973)
Q Consensus 213 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 292 (973)
..+|..+. +|+.+.+..+ +..+....|..+..|+.+.+..+ +..+...+|.+ .+
T Consensus 130 ~~aF~~c~-----------------------~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~ 183 (394)
T 4gt6_A 130 SEAFHHCE-----------------------ELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TA 183 (394)
T ss_dssp TTTTTTCT-----------------------TCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CC
T ss_pred hhhhhhhc-----------------------ccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cc
Confidence 44455544 4444444322 22233445555555555555433 33344444543 34
Q ss_pred ceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCc
Q 048430 293 LQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSN 372 (973)
Q Consensus 293 L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~ 372 (973)
|+.+.+..+-.. +....+..+..++......+..... ...+... +.........+.....
T Consensus 184 l~~i~ip~~~~~--------i~~~af~~c~~l~~~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~ 243 (394)
T 4gt6_A 184 LTQIHIPAKVTR--------IGTNAFSECFALSTITSDSESYPAI-DNVLYEK-----------SANGDYALIRYPSQRE 243 (394)
T ss_dssp CSEEEECTTCCE--------ECTTTTTTCTTCCEEEECCSSSCBS-SSCEEEE-----------CTTSCEEEEECCTTCC
T ss_pred eeEEEECCcccc--------cccchhhhccccceecccccccccc-cceeecc-----------cccccccccccccccc
Confidence 555555433221 1123344555555555444333211 1110000 0000000000111122
Q ss_pred ccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccC
Q 048430 373 LLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRS 452 (973)
Q Consensus 373 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 452 (973)
+..+.+. +.++.....+|..+.+|+.+.+ .++... ....+|.++++|+.+.+.
T Consensus 244 ~~~~~ip-~~v~~i~~~aF~~c~~L~~i~l------------------------p~~~~~-I~~~aF~~c~~L~~i~l~- 296 (394)
T 4gt6_A 244 DPAFKIP-NGVARIETHAFDSCAYLASVKM------------------------PDSVVS-IGTGAFMNCPALQDIEFS- 296 (394)
T ss_dssp CSEEECC-TTEEEECTTTTTTCSSCCEEEC------------------------CTTCCE-ECTTTTTTCTTCCEEECC-
T ss_pred cceEEcC-CcceEcccceeeecccccEEec------------------------ccccce-ecCcccccccccccccCC-
Confidence 2222222 1222233344444444544444 433222 334455556666666664
Q ss_pred CCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCC
Q 048430 453 NSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIP 532 (973)
Q Consensus 453 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 532 (973)
+.++.....+|.++.+|+.+++..+ ++.....+|.++.+|+.+.|..+ ++..-...|.++++|+.+++.+|....
T Consensus 297 ~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--- 371 (394)
T 4gt6_A 297 SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW--- 371 (394)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---
T ss_pred CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---
Confidence 3344444556666667777776654 44455678999999999999765 664556789999999999999987652
Q ss_pred CCcccccccccccccccccC
Q 048430 533 QSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 533 ~~~~~l~~L~~L~Ls~N~l~ 552 (973)
..|....+|+.+.+..|.+.
T Consensus 372 ~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 372 NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp HTCBCCCCC-----------
T ss_pred hhhhccCCCCEEEeCCCCEE
Confidence 46788889999999887654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.4e-11 Score=136.66 Aligned_cols=132 Identities=16% Similarity=0.099 Sum_probs=84.3
Q ss_pred eeecCCc-cccCcCcccccCcCCCCeeeccC-CCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccC
Q 048430 423 TLLSNNN-ALQGQIPTCLANLTSLRHLDFRS-NSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTG 500 (973)
Q Consensus 423 ~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 500 (973)
.++++++ .++. +|. +..+++|++|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 6663 555 77777777777775 777766667777777777777777777776677777777777777777
Q ss_pred CcCcccCCcccccCCcCCEEEcccCccccCCC-CCcccccccccccccccccCCCCCc
Q 048430 501 NQLSGYIPSSIGNLKNLDWLALARNAFQGPIP-QSFGSLISLQSLDLSGNNISGEIPK 557 (973)
Q Consensus 501 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~ 557 (973)
|+|++..+..|..++ |+.|+|++|.+...-. .+|..+.......+..++++...|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 777755555555555 7777777777764322 1222222233334444555554444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=123.77 Aligned_cols=148 Identities=16% Similarity=0.132 Sum_probs=116.0
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeE
Q 048430 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 674 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 752 (973)
.+.....+|......+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..+
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34455677888888898999999999865 6899999986532222346889999999985 677888999998888999
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG------------------------------------ 796 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------ 796 (973)
+||||++|.++.+.+.. ......++.+++++++.||.-
T Consensus 87 lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999876421 122347889999999999951
Q ss_pred --------------------CCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 797 --------------------YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 797 --------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01448999999999999877667899999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=5e-10 Score=118.52 Aligned_cols=137 Identities=16% Similarity=0.151 Sum_probs=101.2
Q ss_pred CCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCc--eeEEEeeeecCCeeEEEEEec
Q 048430 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRN--LIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 758 (973)
++....+.+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44433333455669999998877888999987543 2246788999999986544 556888888778889999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY----------------------------------------- 797 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 797 (973)
+|.++. ... .+ ...++.++++.+..||...
T Consensus 98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998884 211 12 2367888888899998421
Q ss_pred --------------CCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 798 --------------STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 798 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998876678999998763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.2e-08 Score=109.82 Aligned_cols=45 Identities=11% Similarity=0.153 Sum_probs=19.5
Q ss_pred CCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCC
Q 048430 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTR 165 (973)
Q Consensus 118 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~ 165 (973)
.+|+.+.+... ++..-..+|.++.+|+.+.|..+ ++ .|+..+|.+
T Consensus 46 ~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~ 90 (379)
T 4h09_A 46 DRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFAD 90 (379)
T ss_dssp GGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTT
T ss_pred cCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcC
Confidence 44555554432 33233344555555555555432 33 444444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.93 E-value=7.5e-08 Score=107.77 Aligned_cols=285 Identities=9% Similarity=0.027 Sum_probs=122.6
Q ss_pred ccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccC
Q 048430 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKC 321 (973)
Q Consensus 242 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l 321 (973)
..+|+.+.+.. .++.+...+|.++++|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++.+. ...+..+
T Consensus 45 ~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~-------~~aF~~~ 113 (379)
T 4h09_A 45 RDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFG-------DYVFQGT 113 (379)
T ss_dssp GGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEEC-------TTTTTTC
T ss_pred ccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEec-------cceeccC
Confidence 34566666643 355555666777777777777543 666666677666 5666665433 33221 1223333
Q ss_pred CcCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCcccc------------ccCc
Q 048430 322 RYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAG------------AIPT 389 (973)
Q Consensus 322 ~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~------------~~p~ 389 (973)
+|+.+.+..+- .......+.+. .+....+- ..++..-...|..+.+++.+.+..+.... ....
T Consensus 114 -~L~~i~lp~~~-~~i~~~~F~~~--~l~~~~~~-~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (379)
T 4h09_A 114 -DLDDFEFPGAT-TEIGNYIFYNS--SVKRIVIP-KSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILE 188 (379)
T ss_dssp -CCSEEECCTTC-CEECTTTTTTC--CCCEEEEC-TTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEE
T ss_pred -CcccccCCCcc-ccccccccccc--eeeeeecc-ceeeccccchhcccccccccccccccceeecccceecccccceec
Confidence 56666665432 21112222111 12222211 11222233345555555555554433221 1111
Q ss_pred ccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccc
Q 048430 390 VLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI 469 (973)
Q Consensus 390 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 469 (973)
.+.....+..+.+..+... .....+....+|+.+.+..+ +......+|.++..|+.+.+..+ ++..-...|.....|
T Consensus 189 ~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l 265 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL 265 (379)
T ss_dssp ECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred cccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehh
Confidence 2223333333333332221 22333444444444444333 22233334444455555554433 333333444444444
Q ss_pred cEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCccccccccccccc
Q 048430 470 LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLS 547 (973)
Q Consensus 470 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 547 (973)
+.+.+..+ ++......|.++.+|+.+.+.++.++......|.++.+|+.+.|..+ ++.+-..+|.++.+|+.+.+.
T Consensus 266 ~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 266 KTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 44444332 22222333444444444444444444333334444444444444332 332333444444444444443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.91 E-value=7.5e-10 Score=121.82 Aligned_cols=58 Identities=21% Similarity=0.316 Sum_probs=26.8
Q ss_pred CCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCcccc-CCCCCccEEEcc
Q 048430 115 NSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC-TRLPSLVQLRLL 175 (973)
Q Consensus 115 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~-~~l~~L~~L~L~ 175 (973)
..+|+|+.|+|++|.-. .+|. +. +++|++|+|..|.+.......+. ..+|+|++|+|+
T Consensus 169 ~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 169 DAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred hcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 44556666666555211 1222 22 55666666665555422111111 245555555553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=6e-10 Score=122.59 Aligned_cols=159 Identities=15% Similarity=0.172 Sum_probs=94.8
Q ss_pred CchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCccccc--ccccccEEEecC--CcccCC----
Q 048430 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFW--SLKYILAVDFSL--NSLSGS---- 482 (973)
Q Consensus 411 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~--N~l~~~---- 482 (973)
+...+..+++|+.|.+++|.-. .++. +. +++|+.|+|..+.+.......+. .+++|+.|+|+. |...+.
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~ 240 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence 3445556667777777665211 1222 22 56777777777766433222333 567777777653 221111
Q ss_pred -cCcCc--cCCCCCCeEEccCCcCcccCCcccc---cCCcCCEEEcccCccccC----CCCCcccccccccccccccccC
Q 048430 483 -LPLNI--GNLEALGGLNLTGNQLSGYIPSSIG---NLKNLDWLALARNAFQGP----IPQSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 483 -~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 552 (973)
+...+ ..+++|+.|+|++|.+++..+..+. .+++|+.|+|+.|.+++. ++..+..+++|+.|+|++|.|+
T Consensus 241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 11112 2468899999988888754433332 478899999999988763 4555567788999999999887
Q ss_pred CCCCccccc-cccccccccCCCc
Q 048430 553 GEIPKSLEK-LSRLVDFNVSFNG 574 (973)
Q Consensus 553 ~~~p~~~~~-l~~L~~l~ls~N~ 574 (973)
...-..+.. + ...+++++|+
T Consensus 321 d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 321 DEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHHHHHc--CCEEEecCCc
Confidence 433333332 2 2457787776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.80 E-value=1e-08 Score=113.93 Aligned_cols=142 Identities=15% Similarity=0.218 Sum_probs=107.0
Q ss_pred CCccccccCceEEEEEEeCCCeEEEEEEEe--ccc-hhhHHHHHHHHHHHHhcc--CCceeEEEeeeecC---CeeEEEE
Q 048430 684 ESNLLGSGSFDNVYKATLANGVSVAVKVFN--LQE-DRALKSFDTECEVMRRIR--HRNLIKIVSSCSNP---GFKALIM 755 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 755 (973)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45789999999999998764 578888765 222 122356888999999997 45678888888766 4589999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY-------------------------------------- 797 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 797 (973)
||++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999997774421 124678888999999999999999510
Q ss_pred -----------------CCCeEEccCCCCcEEeCCCCc--EEEeecccccc
Q 048430 798 -----------------STPIIHCDLKPNNVLLDDDMV--AHLGDFGIAKL 829 (973)
Q Consensus 798 -----------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~ 829 (973)
...++|+|+++.||+++.++. +.++||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256899999999999997753 68999998875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.78 E-value=8.6e-11 Score=122.41 Aligned_cols=168 Identities=20% Similarity=0.198 Sum_probs=95.5
Q ss_pred CcceEEEEEeeCCCCcEEEEecCC---CCCCCcCCCC-CCCCCCCcEEEecCCCCCCCCCc-ccccccCCcE--EEccCC
Q 048430 31 SVCNWVGVTCSIRHGRVAALSLPN---LSLGGTLPPH-VGNLSFLVSLNISGNSFYDTLPN-ELWHMRRLKI--IDFSSN 103 (973)
Q Consensus 31 ~~c~w~gv~C~~~~~~v~~l~l~~---~~l~g~~~~~-l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~--L~Ls~n 103 (973)
..|+|.|+.|+....+|+.+...+ ..+.|.++++ +..|+. .|....|...+.++- .+...+.|+. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 348999999998777887776655 3444555432 222221 111222222222221 1444445554 566666
Q ss_pred CCCCCCCc---cccCCCCCccEEEeeCcccCC--CCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEccccc
Q 048430 104 SLSGSLPG---DMCNSFTQLESFDVSSNKITG--EFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178 (973)
Q Consensus 104 ~l~~~~p~---~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~ 178 (973)
... .++. -+...+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-..+.+..+ +|++|+|++|.
T Consensus 154 ~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Np 231 (267)
T 3rw6_A 154 RRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNS 231 (267)
T ss_dssp SHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTST
T ss_pred HHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCc
Confidence 433 2221 112457788888888888876 4456667788888888888888743122222333 78888888888
Q ss_pred ccccCCCC--CCCccccCCCCccEEE
Q 048430 179 ITGRIPNR--EIPNEIGNLHNLKILD 202 (973)
Q Consensus 179 l~~~~~~~--~~p~~l~~l~~L~~L~ 202 (973)
+++.+|.. .....+..+++|+.||
T Consensus 232 l~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 232 LCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CccccCcchhHHHHHHHHCcccCeEC
Confidence 87543310 0012366778888775
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=5e-09 Score=113.41 Aligned_cols=186 Identities=18% Similarity=0.190 Sum_probs=123.7
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCc--eeEEEeeeecCC---eeEEEEEec
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRN--LIKIVSSCSNPG---FKALIMQYM 758 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 758 (973)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999863 46888986432 33567889999998883 322 445555543332 457899999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG------------------------------------------ 796 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------ 796 (973)
+|.++.+.... .++..++..++.++++.++.||..
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888754332 467888888999999999999841
Q ss_pred -------------CCCCeEEccCCCCcEEeCC--CCcEEEeecccccccCCCCCccccc-------------cccccccc
Q 048430 797 -------------YSTPIIHCDLKPNNVLLDD--DMVAHLGDFGIAKLLDGVDPVTQTM-------------TLATIGYM 848 (973)
Q Consensus 797 -------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~-------------~~~~~~y~ 848 (973)
....++|+|+++.||++++ +..+.++||+.+...++........ .....++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 0134799999999999998 5568899999987643211100000 00000111
Q ss_pred C-ccCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 048430 849 A-PEYGSEGIVSISGDVYSFGILMMETFTRRKPT 881 (973)
Q Consensus 849 a-PE~~~~~~~~~~sDvws~Gvvl~elltg~~p~ 881 (973)
. |+... ......+.|++|.++|++.+|..+|
T Consensus 256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 22111 0122368999999999999998764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-08 Score=106.31 Aligned_cols=80 Identities=25% Similarity=0.394 Sum_probs=47.3
Q ss_pred cCCCCCCeEEccCCcCcc--cCCcccccCCcCCEEEcccCccccCCCCCccccc--ccccccccccccCCCCCc------
Q 048430 488 GNLEALGGLNLTGNQLSG--YIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI--SLQSLDLSGNNISGEIPK------ 557 (973)
Q Consensus 488 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~------ 557 (973)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 345666666666666665 3345556666666777776666643 2234444 666667777766655542
Q ss_pred -cccccccccccc
Q 048430 558 -SLEKLSRLVDFN 569 (973)
Q Consensus 558 -~~~~l~~L~~l~ 569 (973)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 355566666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=1.5e-07 Score=93.17 Aligned_cols=47 Identities=9% Similarity=0.039 Sum_probs=25.2
Q ss_pred ccCcccCCCCCCCEEEccCC-cCCCCC----chhhhccCcCCeeecCCcccc
Q 048430 386 AIPTVLGKLQKLQGLDLNSN-KLKGFI----PTDLCKLEKLNTLLSNNNALQ 432 (973)
Q Consensus 386 ~~p~~~~~l~~L~~L~Ls~N-~l~~~~----~~~~~~l~~L~~L~l~~N~l~ 432 (973)
.+...+...++|++|+|++| .+.... ...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 34455666777777777777 666321 222333344555555555444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.26 E-value=1.9e-07 Score=92.43 Aligned_cols=91 Identities=20% Similarity=0.169 Sum_probs=65.7
Q ss_pred CCCCCCcccEEEeecC-cccc----ccCcccCCCCCCCEEEccCCcCCCCC----chhhhccCcCCeeecCCccccCc--
Q 048430 366 GFGNLSNLLVLSLVNN-ELAG----AIPTVLGKLQKLQGLDLNSNKLKGFI----PTDLCKLEKLNTLLSNNNALQGQ-- 434 (973)
Q Consensus 366 ~~~~l~~L~~L~Ls~n-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~-- 434 (973)
.+...+.|++|+|++| .+.. .+...+...++|++|+|++|+|...- ...+...++|++|+|++|.|...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3567889999999999 8874 34566777899999999999998432 33444557788888888877754
Q ss_pred --CcccccCcCCCCeeec--cCCCCC
Q 048430 435 --IPTCLANLTSLRHLDF--RSNSLN 456 (973)
Q Consensus 435 --~~~~~~~l~~L~~L~L--~~N~l~ 456 (973)
+...+...++|++|+| ++|.|.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2444555566777777 667665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=7.9e-06 Score=88.03 Aligned_cols=136 Identities=16% Similarity=0.161 Sum_probs=97.7
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCC---ceeEEEeeee-cCCeeEEEEEecCC
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHR---NLIKIVSSCS-NPGFKALIMQYMPQ 760 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 760 (973)
.+.++.|....||+. +..+++|+.. .......+.+|+++++.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899988 5678888853 223456789999999999642 3556666663 45667899999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG-------------------------------------------- 796 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------- 796 (973)
.++.+.... .++..++..++.++++.|+.||.-
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 888763221 245566666677777776666631
Q ss_pred -------------CCCCeEEccCCCCcEEeCC---CCc-EEEeecccccc
Q 048430 797 -------------YSTPIIHCDLKPNNVLLDD---DMV-AHLGDFGIAKL 829 (973)
Q Consensus 797 -------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgla~~ 829 (973)
....++|+|+.+.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1234699999999999987 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.4e-05 Score=84.61 Aligned_cols=135 Identities=16% Similarity=0.110 Sum_probs=99.1
Q ss_pred cccccCce-EEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 687 LLGSGSFD-NVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 687 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
.+..|..+ .||+.... ++..+++|+-... ....+.+|+..++.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987754 4677899986532 3456888999998884 33467888888888999999999999888
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------------
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG----------------------------------------------- 796 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------------- 796 (973)
.+..... ......++.+++..+..||.-
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7765432 123445677777777777730
Q ss_pred --------CCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 797 --------YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 797 --------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
....++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012278999999999999887778999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1.2e-05 Score=88.81 Aligned_cols=79 Identities=14% Similarity=0.076 Sum_probs=55.7
Q ss_pred ccc-cccCceEEEEEEeC-------CCeEEEEEEEeccc---hhhHHHHHHHHHHHHhcc-C--CceeEEEeeeecC---
Q 048430 686 NLL-GSGSFDNVYKATLA-------NGVSVAVKVFNLQE---DRALKSFDTECEVMRRIR-H--RNLIKIVSSCSNP--- 748 (973)
Q Consensus 686 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 748 (973)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88889999988754 26788999765332 001245778999988884 3 3567788877654
Q ss_pred CeeEEEEEecCCCCHH
Q 048430 749 GFKALIMQYMPQGSLE 764 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~ 764 (973)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.66 E-value=2.6e-05 Score=75.02 Aligned_cols=92 Identities=11% Similarity=0.082 Sum_probs=67.5
Q ss_pred CCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCc-CCCCCchhhhcc----CcCCeeecCCcc-ccCcCc
Q 048430 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNK-LKGFIPTDLCKL----EKLNTLLSNNNA-LQGQIP 436 (973)
Q Consensus 363 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~~ 436 (973)
+|.....-..|+.||++++.++..--..+..+++|++|+|++|. |+..--..++.+ ++|+.|++++|. ++...-
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 34444344579999999999887666677889999999999985 664444455554 368888888874 776555
Q ss_pred ccccCcCCCCeeeccCCC
Q 048430 437 TCLANLTSLRHLDFRSNS 454 (973)
Q Consensus 437 ~~~~~l~~L~~L~L~~N~ 454 (973)
..+..+++|++|+++++.
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 667778888888888875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00032 Score=76.72 Aligned_cols=138 Identities=15% Similarity=0.149 Sum_probs=79.8
Q ss_pred ccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC--CceeEEEe------eeecCCeeEEEEEe
Q 048430 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH--RNLIKIVS------SCSNPGFKALIMQY 757 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 757 (973)
+.++.|..+.||+....+| .+++|+..... ..+..|+.+++.+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 58899886421 233455565555531 12333333 11245678899999
Q ss_pred cCCCCHH--------------HHhhh--CCC-----------CCCHHHH-------------------------------
Q 048430 758 MPQGSLE--------------KWLYS--HNY-----------SLTIRQR------------------------------- 779 (973)
Q Consensus 758 ~~~gsL~--------------~~l~~--~~~-----------~l~~~~~------------------------------- 779 (973)
++|..+. ..++. ... ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 11111 100 0122110
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 780 LDIMIDVASALEYLHH----------GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 780 ~~i~~~i~~~L~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
..+...+.+++.+|+. .....++|+|+.+.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224445666652 125789999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00026 Score=79.31 Aligned_cols=75 Identities=11% Similarity=0.124 Sum_probs=49.5
Q ss_pred CccccccCceEEEEEEeC-CCeEEEEEEEeccch-------hhHHHHHHHHHHHHhccC--C-ceeEEEeeeecCCeeEE
Q 048430 685 SNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQED-------RALKSFDTECEVMRRIRH--R-NLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 753 (973)
.+.+|.|..+.||++... +++.|+||....... .....+..|+++++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 467999999999999754 468899997643211 123456789999888742 3 344555543 345689
Q ss_pred EEEecCCC
Q 048430 754 IMQYMPQG 761 (973)
Q Consensus 754 v~e~~~~g 761 (973)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.50 E-value=1.6e-05 Score=76.51 Aligned_cols=84 Identities=13% Similarity=0.033 Sum_probs=51.3
Q ss_pred ccccEEEecCCcccCCcCcCccCCCCCCeEEccCCc-CcccCCcccccC----CcCCEEEcccCc-cccCCCCCcccccc
Q 048430 467 KYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQ-LSGYIPSSIGNL----KNLDWLALARNA-FQGPIPQSFGSLIS 540 (973)
Q Consensus 467 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 540 (973)
.+|+.||++++.++..--..+.++++|+.|+|++|. +++.--..++.+ ++|++|+|++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666776666665544556677777777777774 554333344443 357777777764 65433344566677
Q ss_pred cccccccccc
Q 048430 541 LQSLDLSGNN 550 (973)
Q Consensus 541 L~~L~Ls~N~ 550 (973)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777663
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00017 Score=81.33 Aligned_cols=80 Identities=13% Similarity=0.071 Sum_probs=50.9
Q ss_pred CCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccccccccccCccCCCCC---CCCcchhHHHHHHHHHHH
Q 048430 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG---IVSISGDVYSFGILMMET 874 (973)
Q Consensus 798 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvws~Gvvl~el 874 (973)
...++|+|+++.|||++.++ ++++||+.+..-.+..........-...|++|+..... ......++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 67799999999999999876 99999999875431111000000012346666654321 223345667888888888
Q ss_pred HhCC
Q 048430 875 FTRR 878 (973)
Q Consensus 875 ltg~ 878 (973)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0011 Score=70.97 Aligned_cols=137 Identities=15% Similarity=0.134 Sum_probs=91.5
Q ss_pred CCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc---CCceeEEEeeeecCCeeEEEEEecCC
Q 048430 684 ESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR---HRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
..+.|+.|....+|+.... +..+++|+.... ....+.+|++.++.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3467899999999999864 678889987533 2467889999998884 35688888888878889999999998
Q ss_pred CCHH--------H---HhhhCCC---------------------CCCHHHHH---HHH----------------HHHH-H
Q 048430 761 GSLE--------K---WLYSHNY---------------------SLTIRQRL---DIM----------------IDVA-S 788 (973)
Q Consensus 761 gsL~--------~---~l~~~~~---------------------~l~~~~~~---~i~----------------~~i~-~ 788 (973)
..+. + .++.... .-+|.... ++. ..++ +
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7541 1 1222110 01343321 111 1111 1
Q ss_pred HHHHhh-hcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 789 ALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 789 ~L~~LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
....|. ......+||+|+.+.|++++.++ +.+.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 122342 12246799999999999999887 8898974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0013 Score=69.98 Aligned_cols=78 Identities=14% Similarity=0.150 Sum_probs=56.8
Q ss_pred CCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC---CceeEEEeeeecCCeeEEEEEe
Q 048430 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH---RNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.....+.+|.|..+.||+.+..+|+.|++|+...........|.+|++.|+.+.- --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3445678999999999999999999999998654433333568899999998842 1344555542 24789999
Q ss_pred cCCCC
Q 048430 758 MPQGS 762 (973)
Q Consensus 758 ~~~gs 762 (973)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00013 Score=71.61 Aligned_cols=92 Identities=9% Similarity=0.085 Sum_probs=52.0
Q ss_pred cccceeeecccccccc----CcchhcccCcccEEEeccccccccC----CCcccccccceEEEccCCcCCCCCCCcchhh
Q 048430 243 PNLENLFLWKNNLSGI----IPDSICNASEATILELSSNLFSGLV----PNTFGNCRQLQILSLGDNQLTTGSSAQGQIF 314 (973)
Q Consensus 243 ~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 314 (973)
..|+.|+|++|+|... +.+.+..-+.|++|+|++|.|+... ..++..-+.|++|+|++|....+.......+
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 4555666666665532 2233444566777777777766321 2234455668888887653312222222345
Q ss_pred hhhhccCCcCcEEEccCCCC
Q 048430 315 YSSLAKCRYLRVLVLDTNPL 334 (973)
Q Consensus 315 ~~~l~~l~~L~~L~L~~N~l 334 (973)
...+..-+.|+.|+++.|.+
T Consensus 150 a~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCcCeEeccCCCc
Confidence 55677778888888876654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00013 Score=71.49 Aligned_cols=17 Identities=6% Similarity=0.091 Sum_probs=8.4
Q ss_pred cccCcccEEEeccc-ccc
Q 048430 264 CNASEATILELSSN-LFS 280 (973)
Q Consensus 264 ~~l~~L~~L~L~~N-~i~ 280 (973)
.+-+.|+.|+|++| +|.
T Consensus 38 ~~n~~L~~L~L~~nn~ig 55 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVS 55 (197)
T ss_dssp TTCSSCCEEECTTCCSSC
T ss_pred hcCCCccEEECCCCCCCC
Confidence 33445555555553 443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0033 Score=67.82 Aligned_cols=158 Identities=15% Similarity=0.196 Sum_probs=90.0
Q ss_pred CCCCHHHHHHHhcCCCC-----CccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCc--eeE
Q 048430 668 SRISYHELQQATNGFGE-----SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRN--LIK 740 (973)
Q Consensus 668 ~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~ 740 (973)
..++.+++......|.. .+.|+.|....+|+....+| .+++|+..... ..+.+..|+.+++.+.... +.+
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 34566777777776764 24566788899999987755 67889876421 1234566777777764222 233
Q ss_pred EEee------eecCCeeEEEEEecCCCCHHH--------------HhhhC--C--CC----C---CHHHHHH--------
Q 048430 741 IVSS------CSNPGFKALIMQYMPQGSLEK--------------WLYSH--N--YS----L---TIRQRLD-------- 781 (973)
Q Consensus 741 l~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~--~~----l---~~~~~~~-------- 781 (973)
++.. ....+..++|++|++|..+.. .++.. . .. . .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 112356789999998754310 01110 0 00 1 1221100
Q ss_pred ----HHHHHHHHHHHhhh----cCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 782 ----IMIDVASALEYLHH----GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 782 ----i~~~i~~~L~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
+...+.+.++++++ .....++|+|+.+.||+++.+..+.++||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01123444555542 123568999999999999987666899999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0033 Score=67.16 Aligned_cols=129 Identities=14% Similarity=0.170 Sum_probs=75.3
Q ss_pred CccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCce-eEEEeeeecCCeeEEEEEec-CCCC
Q 048430 685 SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL-IKIVSSCSNPGFKALIMQYM-PQGS 762 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 762 (973)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+ .++++++ ++.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678989999999998 46888887543211 1223568888877742222 4555544 33346899999 5544
Q ss_pred HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------------
Q 048430 763 LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH----------------------------------------------- 795 (973)
Q Consensus 763 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~----------------------------------------------- 795 (973)
+...-... +..++.++++.|+-||.
T Consensus 95 l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 95 MSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp CCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred CCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 32100000 00012222222222221
Q ss_pred ---cCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 796 ---GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 796 ---~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.....++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 11344799999999999 55667899999988643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0032 Score=57.56 Aligned_cols=55 Identities=25% Similarity=0.382 Sum_probs=28.8
Q ss_pred EEEeeCcccC-CCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccc
Q 048430 122 SFDVSSNKIT-GEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNI 179 (973)
Q Consensus 122 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l 179 (973)
.++.+++.++ ..+|..+. ++|++|+|++|+|+ .+|.++|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 3444444443 23343321 24556666666665 56655555566666666666554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0044 Score=68.10 Aligned_cols=140 Identities=13% Similarity=0.168 Sum_probs=82.5
Q ss_pred CccccccCceEEEEEEeC--------CCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEE
Q 048430 685 SNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 755 (973)
.+.+..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888899998864 3578999986322 122456678999998885 3333566766653 2899
Q ss_pred EecCCCCHHH--------------H---hhhCC----CCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 048430 756 QYMPQGSLEK--------------W---LYSHN----YSLT--IRQRLDIMIDVAS-------------------ALEYL 793 (973)
Q Consensus 756 e~~~~gsL~~--------------~---l~~~~----~~l~--~~~~~~i~~~i~~-------------------~L~~L 793 (973)
||++|..+.. . ++... .... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998754421 0 11111 1122 3444444443322 23333
Q ss_pred h----h-cCCCCeEEccCCCCcEEeCCC----CcEEEeecccccc
Q 048430 794 H----H-GYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKL 829 (973)
Q Consensus 794 H----~-~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~ 829 (973)
. . .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 123458899999999999876 7899999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.48 E-value=0.015 Score=62.72 Aligned_cols=158 Identities=12% Similarity=0.154 Sum_probs=89.9
Q ss_pred CCCCHHHHHHHhcCCCC-----CccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCC--ceeE
Q 048430 668 SRISYHELQQATNGFGE-----SNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHR--NLIK 740 (973)
Q Consensus 668 ~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~ 740 (973)
...+.+++..+...|.. ...++ |....||+....+|+.+++|...... .....+..|..+++.+... .+.+
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 34455556555554432 34566 88889999887778789999986331 1234667788888777422 2334
Q ss_pred EEee-----eecCCeeEEEEEecCCCCHH-----H------H---hhh----C----CCCCCHHHH----HHH-------
Q 048430 741 IVSS-----CSNPGFKALIMQYMPQGSLE-----K------W---LYS----H----NYSLTIRQR----LDI------- 782 (973)
Q Consensus 741 l~~~-----~~~~~~~~lv~e~~~~gsL~-----~------~---l~~----~----~~~l~~~~~----~~i------- 782 (973)
++.. ....+..++||||++|..+. . . ++. . ...+++... ..+
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 4432 12245667899999875321 1 0 111 0 011222211 001
Q ss_pred --------HHHHHHHHHHhhh----cCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 783 --------MIDVASALEYLHH----GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 783 --------~~~i~~~L~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
...+...++.+.. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111122233321 1245688999999999999 5 899999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0042 Score=56.77 Aligned_cols=55 Identities=15% Similarity=0.277 Sum_probs=25.4
Q ss_pred EEEecCCCCC-CCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCccc
Q 048430 73 SLNISGNSFY-DTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130 (973)
Q Consensus 73 ~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l 130 (973)
.++.++++++ ..+|..+. .+|++|+|++|+|+ .+|.++|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 4555555552 14443322 23445555555554 44444444444444444444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0037 Score=70.32 Aligned_cols=72 Identities=15% Similarity=0.223 Sum_probs=49.1
Q ss_pred CccccccCceEEEEEEeCC--------CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCc-eeEEEeeeecCCeeEEEE
Q 048430 685 SNLLGSGSFDNVYKATLAN--------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRN-LIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 755 (973)
.+.|+.|....||+....+ ++.+++|+...... .+.+.+|..+++.+...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999998653 57899998843211 144557999988885333 3566766542 3899
Q ss_pred EecCCCC
Q 048430 756 QYMPQGS 762 (973)
Q Consensus 756 e~~~~gs 762 (973)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.014 Score=63.14 Aligned_cols=140 Identities=12% Similarity=0.106 Sum_probs=74.1
Q ss_pred ccccccCceE-EEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC--CceeEEEeeeecCCeeEEEEEecCCCC
Q 048430 686 NLLGSGSFDN-VYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH--RNLIKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 686 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
+.++.|+... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565555544 6677654467777776543211 234556777766642 23456666644443 68999997766
Q ss_pred HHHHhhhCC-------------------------CCCCHHHHHH--------H------------HHHHHHHHHHhh---
Q 048430 763 LEKWLYSHN-------------------------YSLTIRQRLD--------I------------MIDVASALEYLH--- 794 (973)
Q Consensus 763 L~~~l~~~~-------------------------~~l~~~~~~~--------i------------~~~i~~~L~~LH--- 794 (973)
+.+++.... ..++...... + ...+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654443210 0122111000 0 011112222221
Q ss_pred hcCCCCeEEccCCCCcEEeCCC----CcEEEeeccccccc
Q 048430 795 HGYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKLL 830 (973)
Q Consensus 795 ~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~~ 830 (973)
......++|||+.+.||+++.+ +.+.++||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124579999999999999875 68999999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.012 Score=66.58 Aligned_cols=73 Identities=12% Similarity=0.188 Sum_probs=47.5
Q ss_pred CccccccCceEEEEEEeCC-CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCce-eEEEeeeecCCeeEEEEEecCCCC
Q 048430 685 SNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL-IKIVSSCSNPGFKALIMQYMPQGS 762 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 762 (973)
.+.|+.|-...+|+....+ +..+++|+....... .....+|..+++.+...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998765 578899987432211 1123588899988864444 56777663 2 25999998744
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.99 E-value=0.06 Score=52.91 Aligned_cols=119 Identities=17% Similarity=0.113 Sum_probs=76.9
Q ss_pred CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccccc
Q 048430 762 SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841 (973)
Q Consensus 762 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 841 (973)
+|.+++...+.++++++++.++.|.+++|.-+-.+ ... ..+=+.|..|++..+|.|...+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-------------
Confidence 89999999888999999999999999998877211 011 1233457889999999988764 1111
Q ss_pred cccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh
Q 048430 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897 (973)
Q Consensus 842 ~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 897 (973)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-+....-...+.+.+..
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~ 152 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDH 152 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHH
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHH
Confidence 0122456888653 456788999999999999988666644332223344444443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.037 Score=60.02 Aligned_cols=33 Identities=21% Similarity=0.312 Sum_probs=28.5
Q ss_pred CCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 798 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
...++|+|+.+.||+++.++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 356899999999999998888999999887643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.012 Score=64.93 Aligned_cols=72 Identities=14% Similarity=0.245 Sum_probs=43.8
Q ss_pred ccccccCceEEEEEEeCC---------CeEEEEEEEeccchhhHHHHHHHHHHHHhccCCc-eeEEEeeeecCCeeEEEE
Q 048430 686 NLLGSGSFDNVYKATLAN---------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRN-LIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 755 (973)
+.++.|....+|+....+ ++.+++|+....... ......|.++++.+.... +.++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 467778888999998654 268889987543221 123467888888775333 345665442 26899
Q ss_pred EecCCCC
Q 048430 756 QYMPQGS 762 (973)
Q Consensus 756 e~~~~gs 762 (973)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.49 E-value=0.092 Score=58.40 Aligned_cols=73 Identities=11% Similarity=0.208 Sum_probs=47.7
Q ss_pred CccccccCceEEEEEEeCC--------CeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEE
Q 048430 685 SNLLGSGSFDNVYKATLAN--------GVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 755 (973)
.+.+..|-...+|+....+ ++.+++|+..... ....+..+|.++++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999998753 5789999864332 11223467888888875 332345555442 26899
Q ss_pred EecCCCC
Q 048430 756 QYMPQGS 762 (973)
Q Consensus 756 e~~~~gs 762 (973)
||++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.43 E-value=1 Score=49.75 Aligned_cols=29 Identities=28% Similarity=0.380 Sum_probs=24.9
Q ss_pred eEEccCCCCcEEe------CCCCcEEEeecccccc
Q 048430 801 IIHCDLKPNNVLL------DDDMVAHLGDFGIAKL 829 (973)
Q Consensus 801 ivH~dlk~~Nill------~~~~~~kl~Dfgla~~ 829 (973)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 973 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-62
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 27/286 (9%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK V+V + + L++F E V+R+ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH IIH D
Sbjct: 74 TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEY---GSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921
DVY+FGI++ E T + P + + + + L +++V
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS------------- 236
Query: 922 DFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967
C + L +C + +ER LA ++ + + L +
Sbjct: 237 ------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 4e-54
Identities = 62/311 (19%), Positives = 123/311 (39%), Gaps = 44/311 (14%)
Query: 671 SYHELQQATNGFGES---------NLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE- 716
++ + +A F + ++G+G F V L + VA+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 717 DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTI 776
++ + F +E +M + H N+I + + +I ++M GSL+ +L ++ T+
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-DGVDP 835
Q + ++ +A+ ++YL +H DL N+L++ ++V + DFG+++ L D
Sbjct: 128 IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 836 VTQTMTL---ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
T T L I + APE + + DV+S+GI+M E + + T
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT------ 238
Query: 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK 952
V ++ + + C S + L L C + R
Sbjct: 239 -------NQDVINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFG 281
Query: 953 DALADLKKIKK 963
+ L K+ +
Sbjct: 282 QIVNTLDKMIR 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-54
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 29/277 (10%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ +I +YM GSL +L + LTI + LD+ +A + ++ IH
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFA 924
+SFGIL+ E T + T ++ + + R D
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQN------------LERGYRMVRPDN------- 234
Query: 925 TKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961
C + L C E PE+R + L+
Sbjct: 235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 27/278 (9%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSG F V+ N VA+K + + + F E EVM ++ H L+++ C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
L+ ++M G L +L + L + +DV + YL +IH D
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRD 126
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L N L+ ++ V + DFG+ + + + T T + + +PE S S DV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 866 SFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFAT 925
SFG+LM E F+ K E + + + ++ + L S
Sbjct: 187 SFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGF-----RLYKPRLASTH---------- 230
Query: 926 KKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
+ + C E PE+R L L +I +
Sbjct: 231 -------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 27/276 (9%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG+G F V VA+K+ + + F E +VM + H L+++ C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ +I +YM G L +L + +Q L++ DV A+EYL +H D
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 125
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L N L++D V + DFG+++ + + + + + + PE S D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 866 SFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFAT 925
+FG+LM E ++ K E FT + + + L R
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEH------------IAQGLRLYRPHLASEK---- 229
Query: 926 KKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961
+ ++ C E +ER K L+++ +
Sbjct: 230 -------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-53
Identities = 63/312 (20%), Positives = 123/312 (39%), Gaps = 29/312 (9%)
Query: 675 LQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKS-FDTECEVMRR 732
++ + F + + LG+G+ V+K + +G+ +A K+ +L+ A+++ E +V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++ + + G ++ M++M GSL++ L + + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
L I+H D+KP+N+L++ L DFG++ L D + + T YM+PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPER 174
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL--KQWVAESLPGAVTEVVDAN 910
S+ D++S G+ ++E R P E+ L V
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 911 LLSREDEEDADDFATKKTCISYIM-----------------SLALKCSAEIPEERINVKD 953
D+ + YI+ KC + P ER ++K
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 954 ALAD--LKKIKK 963
+ +K+
Sbjct: 295 LMVHAFIKRSDA 306
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 8e-53
Identities = 74/280 (26%), Positives = 111/280 (39%), Gaps = 35/280 (12%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G F +V G VAVK ++ D ++F E VM ++RH NL++++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 746 -SNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
G ++ +YM +GSL +L S S L L +DV A+EYL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL NVL+ +D VA + DFG+ K TQ + + APE E S D
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923
V+SFGIL+ E ++ + + LK V G + D
Sbjct: 183 VWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPD--------------- 223
Query: 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
C + + C R + L+ IK
Sbjct: 224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-52
Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 25/294 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
+G G F V++ G VAVK+F+ +E+R+ + E +RH N++ +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 748 PGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY-----S 798
L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT---LATIGYMAPEYGSE 855
I H DLK N+L+ + + D G+A D + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 856 GI------VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909
I D+Y+ G++ E R ++ V +V E+
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKV 244
Query: 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
+ + + + + + + + +C R+ L ++ +
Sbjct: 245 VCEQKLRPNIPNRWQSCE-ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 52/280 (18%), Positives = 106/280 (37%), Gaps = 33/280 (11%)
Query: 688 LGSGSFDNVYKATLA---NGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVS 743
LG G+F +V + + VA+KV ++A + E ++M ++ + +++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
C L+M+ G L K+L + + +++ V+ ++YL +H
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA--TIGYMAPEYGSEGIVSIS 861
DL NVLL + A + DFG++K L D + + + APE + S
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921
DV+S+G+ M E + + + P + + + E +
Sbjct: 193 SDVWSYGVTMWEALSYGQKP------------YKKMKGPEVMAFIEQGKRMECPPECPPE 240
Query: 922 DFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961
+ +L C E+R + ++
Sbjct: 241 -----------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-51
Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 29/277 (10%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F V+ T VA+K + ++F E +VM+++RH L+++ +
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLT-IRQRLDIMIDVASALEYLHHGYSTPIIHC 804
S ++ +YM +GSL +L + Q +D+ +AS + Y+ +H
Sbjct: 82 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 137
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFA 924
+SFGIL+ E T+ + V + V+ E +
Sbjct: 198 WSFGILLTELTTKGRVPYPGMV-------------NREVLDQVERGYRMPCPPECPESLH 244
Query: 925 TKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961
L +C + PEER + A L+
Sbjct: 245 ----------DLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (448), Expect = 3e-50
Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 29/280 (10%)
Query: 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+ LG G + VY+ ++VAVK ++ ++ F E VM+ I+H NL++++
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
C+ +I ++M G+L +L N ++ L + ++SA+EYL IH
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DL N L+ ++ + + DFG+++L+ G I + APE + SI D
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923
V++FG+L+ E T + L Q V E+++ + E +
Sbjct: 199 VWAFGVLLWEIATYGMS----PYPGIDLSQ---------VYELLEKDYRMERPEGCPEKV 245
Query: 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
L C P +R + + + + +
Sbjct: 246 Y----------ELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-50
Identities = 61/296 (20%), Positives = 105/296 (35%), Gaps = 39/296 (13%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F VYKA V A KV + + + L+ + E +++ H N++K++ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+++++ G+++ + LT Q + AL YLH IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY-----GSEGIVS 859
DLK N+L D L DFG++ + T +MAPE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 193
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919
DV+S GI ++E P +L + + +
Sbjct: 194 YKADVWSLGITLIEMAEIEPP----HHELN------------------PMRVLLKIAKSE 231
Query: 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD-------LKKIKKILTQA 968
A S KC + + R L K I++++ +A
Sbjct: 232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEA 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 66/290 (22%), Positives = 123/290 (42%), Gaps = 34/290 (11%)
Query: 682 FGESNLLGSGSFDNVYKATLANG-----VSVAVKVFNLQE-DRALKSFDTECEVMRRIRH 735
++G+G F VYK L V VA+K ++ F E +M + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
N+I++ S +I +YM G+L+K+L + ++ Q + ++ +A+ ++YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA--TIGYMAPEYG 853
+ +H DL N+L++ ++V + DFG++++L+ T T + I + APE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
S + + DV+SFGI+M E T + E V + ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAINDGFRL 232
Query: 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
+ C S I L ++C + R D ++ L K+ +
Sbjct: 233 PTPMD----------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-48
Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 36/295 (12%)
Query: 684 ESNLLGSGSFDNVYKATLAN---GVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNL 738
E LGSG+F V K +VAVK+ + + E VM+++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L + + + + ++++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA--TIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + + T + + APE +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916
S DV+SFG+LM E F+ + + G VT +++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK---PYRGMK----------GSEVTAMLEKGERMGCP 232
Query: 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI-KKILTQALH 970
+ L C E R L+ ++ + H
Sbjct: 233 AGCPREMY----------DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 2e-48
Identities = 67/281 (23%), Positives = 102/281 (36%), Gaps = 39/281 (13%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNL---QEDRALKSFDTECEVMRRIRHRN 737
F + +G GSF VY A + N VA+K + Q + + E ++++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
I+ L+M+Y + + H L + + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY---GS 854
S +IH D+K N+LL + + LGDFG A ++ + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMD 187
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914
EG DV+S GI +E R+ P M L P L S
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESP---------ALQSG 237
Query: 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDAL 955
E + C +IP++R + L
Sbjct: 238 HWSEYFRN-------------FVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-48
Identities = 60/288 (20%), Positives = 118/288 (40%), Gaps = 35/288 (12%)
Query: 685 SNLLGSGSFDNVYKATLAN----GVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLI 739
+ ++G G F VY TL + + AVK N D + F TE +M+ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 740 KIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSE 855
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915
+ DV+SFG+L+ E TR P +++ ++ L +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITV--------YLLQGRRLLQP 256
Query: 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
+ C + + LKC E R + + ++ + I
Sbjct: 257 EY-----------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-48
Identities = 63/279 (22%), Positives = 109/279 (39%), Gaps = 38/279 (13%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G GSF VYK V VA ++ + F E E+++ ++H N+++ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 745 C----SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
L+ + M G+L+ +L + I+ + L++LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPP 134
Query: 801 IIHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGSEGIV 858
IIH DLK +N+ + +GD G+A L + + T +MAPE E
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEEK-Y 189
Query: 859 SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918
S DVY+FG+ M+E T P +E ++ + P + +V +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV------- 242
Query: 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
+ C + +ER ++KD L
Sbjct: 243 ---------------KEIIEGCIRQNKDERYSIKDLLNH 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-48
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 35/282 (12%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIV 742
+G+GS+ K ++G + K + + + +E ++R ++H N+++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 743 SSCSNPGFKAL--IMQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLH--H 795
+ L +M+Y G L + L L +M + AL+ H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
++H DLKP NV LD LGDFG+A++L+ + T YM+PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNR 188
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915
+ D++S G L+ E P + A S ++ +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP-------------FTAFSQKELAGKIREGKFRRIP 235
Query: 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
+ + + + R +V++ L +
Sbjct: 236 YRYSDE-----------LNEIITRMLNLKDYHRPSVEEILEN 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 2e-47
Identities = 61/321 (19%), Positives = 121/321 (37%), Gaps = 57/321 (17%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVFNLQED-RALKSFDTE 726
L+ N +G G+F V++A VAVK+ + F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 727 CEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS------------- 773
+M + N++K++ C+ L+ +YM G L ++L S +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 774 ----------LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823
L+ ++L I VA+ + YL +H DL N L+ ++MV + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIAD 183
Query: 824 FGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTN 882
FG+++ + D A I +M PE + DV+++G+++ E F+
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP- 242
Query: 883 EMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSA 942
+ + + V D N+L+ + + + +L C +
Sbjct: 243 -----------YYGMAHEEVIYYVRDGNILACPENCPLE-----------LYNLMRLCWS 280
Query: 943 EIPEERINVKDALADLKKIKK 963
++P +R + L+++ +
Sbjct: 281 KLPADRPSFCSIHRILQRMCE 301
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 32/282 (11%)
Query: 687 LLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIKI 741
+G G F +V++ + ++VA+K N D + F E MR+ H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ + +IM+ G L +L YSL + + +++AL YL S
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+H D+ NVL+ + LGDFG+++ ++ + I +MAPE + + +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921
DV+ FG+ M E + + + E+ +
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----------------------ENGE 226
Query: 922 DFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
C + SL KC A P R + A L I +
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-46
Identities = 63/273 (23%), Positives = 103/273 (37%), Gaps = 29/273 (10%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
++M+Y+ GSL + Q + + ALE+LH S +IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
D+K +N+LL D L DFG + TM T +MAPE + D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFA 924
+S GI+ +E P + E L+ L +
Sbjct: 200 WSLGIMAIEMIEGEPP----YLNENPLRA------------------LYLIATNGTPELQ 237
Query: 925 TKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
+ + +C E+R + K+ L
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 71/284 (25%), Positives = 103/284 (36%), Gaps = 35/284 (12%)
Query: 688 LGSGSFDNVYKATL----ANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIK 740
LG GSF V + VSVAVK L + A+ F E M + HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ P K ++ + P GSL L H + + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+LL + +GDFG+ + L D V Q + APE
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 859 SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918
S + D + FG+ + E FT + G L + E
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------------------ 233
Query: 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962
+ C I ++ ++C A PE+R L + +
Sbjct: 234 ----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 60/277 (21%), Positives = 107/277 (38%), Gaps = 38/277 (13%)
Query: 686 NLLGSGSFDNVYKATL-ANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G F NVY A + +A+KV L++ E E+ +RH N++++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ LI++Y P G++ + L + ++ + ++A+AL Y H S +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRV 127
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGSEGIVSI 860
IH D+KP N+LL + DFG + ++ TL T+ Y+ PE +
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920
D++S G+L E + P F + + +SR +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPP----FEANTYQETY---------------KRISRVEFTFP 224
Query: 921 DDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
D L + P +R +++ L
Sbjct: 225 DFVTEG------ARDLISRLLKHNPSQRPMLREVLEH 255
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-46
Identities = 60/297 (20%), Positives = 113/297 (38%), Gaps = 34/297 (11%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-----GVSVAVKVFNLQED-RALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK + VA+K +A K E VM + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914
I + DV+S+G+ + E T + ++ +++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------------ASEISSILEKGERLP 233
Query: 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQALHL 971
+ D + +KC + R ++ + + K+ + + L +
Sbjct: 234 QPPICTIDVY----------MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-46
Identities = 66/315 (20%), Positives = 129/315 (40%), Gaps = 55/315 (17%)
Query: 669 RISYHELQQATNGFGESNLLGSGSFDNVYKATLANG---VSVAVKVFNLQEDR-ALKSFD 724
+ +++++ +++G G+F V KA + + A+K + + F
Sbjct: 6 VLDWNDIK-------FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 725 TECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNY----------- 772
E EV+ ++ H N+I ++ +C + G+ L ++Y P G+L +L
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 773 ----SLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828
+L+ +Q L DVA ++YL IH DL N+L+ ++ VA + DFG+++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ V +TM + +MA E + + + + DV+S+G+L+ E +
Sbjct: 176 GQE--VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----G 229
Query: 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
M+ + L E + C + L +C E P ER
Sbjct: 230 MTCAELY-------------EKLPQGYRLEKPLN------CDDEVYDLMRQCWREKPYER 270
Query: 949 INVKDALADLKKIKK 963
+ L L ++ +
Sbjct: 271 PSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-46
Identities = 64/304 (21%), Positives = 113/304 (37%), Gaps = 56/304 (18%)
Query: 687 LLGSGSFDNVYKATL------ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRI-RHRNL 738
+LGSG+F V AT + VAVK+ + D + ++ +E ++M ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN----------------------YSLTI 776
+ ++ +C+ G LI +Y G L +L S LT
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
L VA +E+L +H DL NVL+ V + DFG+A+ +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 837 TQTMTLA-TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
+ +MAPE EGI +I DV+S+GIL+ E F+ +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------PYP 268
Query: 896 AESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDAL 955
+ +++ + ++ + C A +R + +
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIY----------IIMQSCWAFDSRKRPSFPNLT 318
Query: 956 ADLK 959
+ L
Sbjct: 319 SFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-46
Identities = 55/276 (19%), Positives = 99/276 (35%), Gaps = 30/276 (10%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVS 743
LG G++ V A +VAVK+ +++ ++ E + + + H N++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ L ++Y G L + + + + + YLH I H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITH 126
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEY-GSEGIVSIS 861
D+KP N+LLD+ + DFG+A + + + T+ Y+APE +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDAD 921
DV+S GI++ P ++ W + + +D+ L
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--------- 237
Query: 922 DFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
+L K E P RI + D D
Sbjct: 238 -------------ALLHKILVENPSARITIPDIKKD 260
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 60/302 (19%), Positives = 108/302 (35%), Gaps = 51/302 (16%)
Query: 686 NLLGSGSFDNVYKATLA------NGVSVAVKVFNLQEDRA-LKSFDTECEVMRRI-RHRN 737
LG+G+F V +AT ++VAVK+ ++ +E +V+ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-----------------LTIRQRL 780
++ ++ +C+ G +I +Y G L +L S L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQT 839
VA + +L S IH DL N+LL + + DFG+A+ + V +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899
+ +MAPE + + DV+S+GI + E F+ + + + E
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959
E A + + C P +R K + ++
Sbjct: 266 RMLSPEHAPAEMY----------------------DIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 960 KI 961
K
Sbjct: 304 KQ 305
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 165 bits (418), Expect = 2e-45
Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 31/275 (11%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG+G+F V++ T A G + A K + ++ E + M +RH L+ + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ +I ++M G L + + + ++ + ++ M V L ++H +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 806 LKPNNVLL--DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
LKP N++ L DFG+ LD + +T T + APE V D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 207
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA-ESLPGAVTEVVDANLLSREDEEDADD 922
++S G+L + P F GE + +S + + + + ED D
Sbjct: 208 MWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDWNMDDSAFSGI-----SEDGKD 258
Query: 923 FATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
F K P R+ + AL
Sbjct: 259 FIR-------------KLLLADPNTRMTIHQALEH 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (414), Expect = 7e-45
Identities = 64/288 (22%), Positives = 112/288 (38%), Gaps = 31/288 (10%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LGSG+F V++ A G K N + E +M ++ H LI + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ LI++++ G L + + +Y ++ + ++ M L+++H I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 806 LKPNNVLLD--DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
+KP N++ + + DFG+A L+ +T AT + APE V D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923
+++ G+L + P F GE L+ N+ + E D D F
Sbjct: 211 MWAIGVLGYVLLSGLSP----FAGEDDLETL--------------QNVKRCDWEFDEDAF 252
Query: 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALAD--LKKIKKILTQAL 969
+ + P +R+ V DAL LK LT +
Sbjct: 253 ---SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 9/200 (4%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKI 741
+LG GSF V A LA A+K+ + ++ + E +VM R+ H +K+
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ + + Y G L K++ S ++ SALEYLH I
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGI 129
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGSEGIVSI 860
IH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 861 SGDVYSFGILMMETFTRRKP 880
S D+++ G ++ + P
Sbjct: 190 SSDLWALGCIIYQLVAGLPP 209
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 61/295 (20%), Positives = 121/295 (41%), Gaps = 43/295 (14%)
Query: 686 NLLGSGSFDNVYKATL------ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNL 738
LG GSF VY+ VA+K N R F E VM+ ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS---------LTIRQRLDIMIDVASA 789
++++ S +IM+ M +G L+ +L S + ++ + + + ++A
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYM 848
+ YL+ + +H DL N ++ +D +GDFG+ + + D + L + +M
Sbjct: 146 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
+PE +G+ + DV+SFG+++ E T + + + E L+ V++
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VME 250
Query: 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963
LL + D C + L C P+ R + + ++ +K+ +
Sbjct: 251 GGLLDKPDN-----------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 71/302 (23%), Positives = 124/302 (41%), Gaps = 52/302 (17%)
Query: 686 NLLGSGSFDNVYKATL--------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RH 735
LG G+F V A VAVK+ ++ L +E E+M+ I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L + L+ + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 841 TLA-TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL 899
+ +MAPE + I + DV+SFG+L+ E FT E K
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL------ 249
Query: 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLK 959
+ + + + + C + + + C +P +R K + DL
Sbjct: 250 ------LKEGHRMDKPSN-----------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 960 KI 961
+I
Sbjct: 293 RI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-41
Identities = 58/293 (19%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F V++ ++ + K ++ E ++ RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ +I +++ + + + + + L R+ + + V AL++LH S I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 806 LKPNNVLLDDDMVAH--LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
++P N++ + + +FG A+ L D T Y APE +VS + D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVVSTATD 185
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923
++S G L+ + P F E + + N+++ E D + F
Sbjct: 186 MWSLGTLVYVLLSGINP----FLAETNQQII--------------ENIMNAEYTFDEEAF 227
Query: 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALAD---LKKIKKILTQALHLTK 973
K M + + + R+ +AL +KI+++ T+ + K
Sbjct: 228 ---KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLK 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (370), Expect = 6e-40
Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 36/286 (12%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L VAVKV ++ F E + + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 743 SSCSNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ ++M+Y+ +L +++ +T ++ ++++ D AL + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---Q 129
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-DGVDPVTQTMTLA-TIGYMAPEYGSEG 856
IIH D+KP N+++ + DFGIA+ + D + VTQT + T Y++PE
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916
V DVYS G ++ E T P FTG+ + + LS +
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSARHEGLSAD- 244
Query: 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERI-NVKDALADLKKI 961
+ ++ LK A+ PE R + ADL ++
Sbjct: 245 ----------------LDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 1e-39
Identities = 60/274 (21%), Positives = 103/274 (37%), Gaps = 26/274 (9%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVS 743
++LG+G+F V A VA+K + + S + E V+ +I+H N++ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ G LIMQ + G L + + T R ++ V A++YLH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
LD+D + DFG++K+ D ++ T GY+APE ++ S + D
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQKPYSKAVD 191
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDF 923
+S G++ P F E K + +L E E D+ +
Sbjct: 192 CWSIGVIAYILLCGYPP----FYDENDAKLF--------------EQILKAEYEFDSPYW 233
Query: 924 ATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
+ PE+R + AL
Sbjct: 234 ---DDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-39
Identities = 68/285 (23%), Positives = 110/285 (38%), Gaps = 16/285 (5%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVS 743
+ +G G++ V A N V VA+K + E + + E +++ R RH N+I I
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
P + + Y+ + LY L+ + + L+Y+H S +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIVS 859
+H DLKP+N+LL+ + DFG+A++ D T +AT Y APE
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 860 I-SGDVYSFGILMMETFTRRKPTNEMFTGEM------SLKQWVAESLPGAVTEVVDANLL 912
S D++S G ++ E + R + L E L + LL
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
S + S + L K P +RI V+ ALA
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-39
Identities = 72/286 (25%), Positives = 113/286 (39%), Gaps = 23/286 (8%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-----EDRALKSFDTECEVMRRIRHRNLI 739
+ LG G F VYKA VA+K L +D ++ E ++++ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ + + +L+ +M LE + ++ LT M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-YGSEGIV 858
I+H DLKPNN+LLD++ V L DFG+AK T + T Y APE +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 859 SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA-ESLPGAVTEVVDANLLSREDE 917
+ D+++ G ++ E R G+ L Q G TE ++ S D
Sbjct: 179 GVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 918 EDADDFATKKTCISY------IMSLALKCSAEIPEERINVKDALAD 957
F + ++ L P RI AL
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (359), Expect = 2e-38
Identities = 46/278 (16%), Positives = 96/278 (34%), Gaps = 10/278 (3%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNL--QEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G G++ VYKA G + A+K L +++ + E +++ ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
L+ +++ L+K L L ++ + + + Y H ++H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DLKP N+L++ + + DFG+A+ + S + D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 864 VYSFGILMMETFTRRKP---TNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDA 920
++S G + E +E + + +
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 921 DDFATKKTCIS-YIMSLALKCSAEIPEERINVKDALAD 957
+ + + + L K P +RI K AL
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (360), Expect = 5e-38
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 12/211 (5%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG+GSF V+ NG A+KV + + ++ + E ++ + H +I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ + +IM Y+ G L + +V ALEYLH S I
Sbjct: 70 WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
I+ DLKP N+LLD + + DFG AK + T Y+APE S + S
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
D +SFGIL+ E P + T + K
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 69/297 (23%), Positives = 117/297 (39%), Gaps = 24/297 (8%)
Query: 686 NLLGSGSFDNVYKAT--LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRI---RHRNL 738
+G G++ V+KA G VA+K +Q E+ S E V+R + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 739 IKIVSSCSNPGFKA-----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
+++ C+ L+ +++ Q + D+M + L++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYG 853
H S ++H DLKP N+L+ L DFG+A++ +T + T+ Y APE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVL 187
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
+ + D++S G + E F R+ + K LPG D L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 914 REDEEDADDFATK--KTCISYIMSLALKCSAEIPEERINVKDALA-----DLKKIKK 963
+ + K L LKC P +RI+ AL+ DL++ K+
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (353), Expect = 1e-37
Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 44/289 (15%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNL---------QEDRALKSFDTECEVMRRIR- 734
+LG G V + AVK+ ++ + ++ E +++R++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H N+I++ + F L+ M +G L +L +L+ ++ IM + + LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH 127
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
I+H DLKP N+LLDDDM L DFG + LD + + + T Y+APE
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG--TPSYLAPEIIE 182
Query: 855 EGIVSISG------DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
+ D++S G++M P F +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLML-------------- 224
Query: 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957
++S + + ++ + L + P++R ++ALA
Sbjct: 225 RMIMSGNYQFGSPEW---DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 15/296 (5%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNL--QEDRALKSFDTECEVMRRIRHRNLIKIV 742
+G G++ VYKA G VA+K L + + + E +++ + H N++K++
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
L+ +++ Q + S + + + + L + H S ++
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVL 124
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-YGSEGIVSIS 861
H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE S +
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 862 GDVYSFGILMMETFTRRKP---TNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918
D++S G + E TRR +E+ + + +
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 919 DADDFATKKTCISY-IMSLALKCSAEIPEERINVKDALAD--LKKIKKILTQALHL 971
DF+ + SL + P +RI+ K ALA + + K + L L
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH-LRL 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 60/303 (19%), Positives = 112/303 (36%), Gaps = 50/303 (16%)
Query: 686 NLLGSGSFDNVYKAT------LANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNL 738
LG G+F V +A A +VAVK+ + ++ +E +++ I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 739 I-KIVSSCSNPGFK-ALIMQYMPQGSLEKWLYSHNYS---------------LTIRQRLD 781
+ ++ +C+ PG +I+++ G+L +L S LT+ +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
VA +E+L S IH DL N+LL + V + DFG+A+ + +
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 842 LA-TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
+ +MAPE + + +I DV+SFG+L+ E F+ + + + E
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 255
Query: 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960
+ + L C P +R + + L
Sbjct: 256 MRAPDYTTPEMY----------------------QTMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 961 IKK 963
+ +
Sbjct: 294 LLQ 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 7e-37
Identities = 66/295 (22%), Positives = 111/295 (37%), Gaps = 39/295 (13%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRR-IRHRNLIK 740
+LG GSF V+ A A+K + D ++ E V+ H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + +M+Y+ G L + S + + + ++ L++LH S
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKG 123
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
I++ DLK +N+LLD D + DFG+ K D T Y+APE +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNH 182
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGE--MSLKQWVAESLPGAVTEVVDANLLSREDEE 918
S D +SFG+L+ E + P F G+ L + P R E+
Sbjct: 183 SVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMDNP----------FYPRWLEK 228
Query: 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQALHLTK 973
+A D L +K PE+R+ V+ + ++I + L +
Sbjct: 229 EAKD-------------LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKE 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 3e-36
Identities = 48/285 (16%), Positives = 100/285 (35%), Gaps = 32/285 (11%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF ++Y T +A G VA+K+ ++ E ++ + ++ I + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
G +++ + SLE + +++ L + + S +EY+H S IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 806 LKPNNVL---LDDDMVAHLGDFGIAKLLDGVDPVTQTMT------LATIGYMAPEYGSEG 856
+KP+N L + ++ DFG+AK T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916
S D+ S G ++M G + + A + + + + + +
Sbjct: 189 EQSRRDDLESLGYVLM----------YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961
S + C + +++ + + +
Sbjct: 239 VLCKG-------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 49/227 (21%), Positives = 86/227 (37%), Gaps = 20/227 (8%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQ------EDRALKSFDTECEVMRRIR--HRN 737
LLGSG F +VY +++ + VA+K E E +++++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+I+++ P LI++ + +L V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 798 STPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY-GSE 855
+ ++H D+K N+L+D + L DFG LL T T Y PE+
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 856 GIVSISGDVYSFGILMMETFTRRKP---TNEMFTGEMSLKQWVAESL 899
S V+S GIL+ + P E+ G++ +Q V+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-36
Identities = 60/299 (20%), Positives = 107/299 (35%), Gaps = 39/299 (13%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSS 744
+LG G V + A+K+ + E E+ R + ++++IV
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 745 CSNPGFKA----LIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYST 799
N ++M+ + G L + + + T R+ +IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 800 PIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H D+KP N+L + + L DFG AK + +T T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916
S D++S G++M P F L + + N E
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD--LKKIKKILTQALHLTK 973
E+ L P +R+ + + + + + K+ LH ++
Sbjct: 245 SEEVKM-------------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 64/298 (21%), Positives = 121/298 (40%), Gaps = 42/298 (14%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNL------QEDRALKSFDTECEVMRRIRHRNLI 739
LGSG F V K + G+ A K + + + + E +++ I+H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ N LI++ + G L +L SLT + + + + + + YLH S
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SL 132
Query: 800 PIIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEIVNY 190
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915
+ + D++S G++ + P F G+ + AN+ +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP----FLGDTKQETL--------------ANVSAVN 232
Query: 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD--LKKI--KKILTQAL 969
E + + F + + + P++R+ ++D+L +K ++ L+ A
Sbjct: 233 YEFEDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAW 287
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (343), Expect = 2e-35
Identities = 46/209 (22%), Positives = 81/209 (38%), Gaps = 15/209 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNL------QEDRALKSFDTECEVMRR 732
N F ++G G F VY G A+K + Q + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++ + + P + I+ M G L L H + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
+H + +++ DLKP N+LLD+ + D G+A P ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176
Query: 853 GSEGI-VSISGDVYSFGILMMETFTRRKP 880
+G+ S D +S G ++ + P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 50/283 (17%), Positives = 104/283 (36%), Gaps = 18/283 (6%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIV 742
+G G++ V+KA VA+K L +D S E +++ ++H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ L+ ++ Q + + + + + L + H ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLKP N+L++ + L +FG+A+ + + S S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA-ESLPGAVTEVVDANLLSREDEEDAD 921
D++S G + E +P +F G Q L G TE ++ D +
Sbjct: 184 DMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 922 DFATKKTCISYI-------MSLALKCSAEIPEERINVKDALAD 957
+ + ++ + L P +RI+ ++AL
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-34
Identities = 64/306 (20%), Positives = 120/306 (39%), Gaps = 32/306 (10%)
Query: 682 FGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L +G VA+K + + + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPG------FKALIMQYMPQGSLEKWLY--SHNYSLTIRQRLDIMIDVASALEY 792
+ + G + L++ Y+P+ + +L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
+H S I H D+KP N+LLD D V L DFG AK L +P + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAPEL 193
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA-ESLPGAVTEVVDAN 910
+ S DV+S G ++ E + F G+ + Q V + G T
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 911 LLSREDEEDADDFATKKTCISYI-------MSLALKCSAEIPEERINVKDALAD--LKKI 961
+ E + ++L + P R+ +A A ++
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 962 KKILTQ 967
+ +
Sbjct: 310 RDPNVK 315
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 63/298 (21%), Positives = 112/298 (37%), Gaps = 34/298 (11%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIV 742
+G G+F V+KA G VA+K ++ ++ + E ++++ ++H N++ ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 743 SSCSNPGFKA--------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
C L+ + T+ + +M + L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQML---LNGLY 131
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP---VTQTMTLATIGYMAPE 851
+ + I+H D+K NVL+ D V L DFG+A+ T + T+ Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 852 -YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA-ESLPGAVTEVVDA 909
E D++ G +M E +TR G Q L G++T V
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALISQLCGSITPEVWP 247
Query: 910 NLLSREDEEDADDFATKKTCISYIMS----------LALKCSAEIPEERINVKDALAD 957
N+ + E E + +K + + L K P +RI+ DAL
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 4e-34
Identities = 41/287 (14%), Positives = 85/287 (29%), Gaps = 34/287 (11%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G GSF +++ T L N VA+K + D E + + I V
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
G +++ + SLE L +++ + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 806 LKPNNVLLDDDMVAH-----LGDFGIAKLLD------GVDPVTQTMTLATIGYMAPEYGS 854
+KP+N L+ + + DFG+ K + + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914
S D+ + G + M G + + A + + + +
Sbjct: 187 GREQSRRDDLEALGHVFM----------YFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236
Query: 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961
E A + + K+
Sbjct: 237 LRELCAG-------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-32
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 26/287 (9%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+GSG++ V A G VA+K Q + K E +++ +RH N+I ++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 744 SCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ L+M +M G+ L H L + ++ + L Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIH--- 138
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-YGSEG 856
+ IIH DLKP N+ +++D + DFG+A+ D T + T Y APE +
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWM 194
Query: 857 IVSISGDVYSFGILMMETFTRRKP-----TNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911
+ + D++S G +M E T + + M + + N
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 912 LSREDEEDADDFATKKTCIS-YIMSLALKCSAEIPEERINVKDALAD 957
+ E + DFA+ T S ++L K E+R+ +ALA
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 2e-32
Identities = 45/211 (21%), Positives = 85/211 (40%), Gaps = 16/211 (7%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG+GSF V +G A+K+ + + + + ++ E +++ + L+K+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
S + ++M+Y+ G + L + + EYLH S +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIY 164
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DLKP N+L+D + DFG AK T +APE + + D
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
++ G+L+ E P F + ++ +
Sbjct: 221 WWALGVLIYEMAAGYPP----FFADQPIQIY 247
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 53/199 (26%), Positives = 82/199 (41%), Gaps = 9/199 (4%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKI 741
LLG G+F V A G A+K+ + + TE V++ RH L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ +M+Y G L L S T + ++ SALEYLH S +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
++ D+K N++LD D + DFG+ K +T T Y+APE + +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 185
Query: 862 GDVYSFGILMMETFTRRKP 880
D + G++M E R P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-30
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHR- 736
+LG+G++ V+ G A+KV +Q+ + + TE +V+ IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG 796
L+ + + LI+ Y+ G L L ++ I V + L H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGS 854
+ II+ D+K N+LLD + L DFG++K + TI YMAP+ G
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ + D +S G+LM E T P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-29
Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 22/286 (7%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
+ +GSG++ +V A G+ VAVK + Q K E +++ ++H N+I ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 743 SSCSNPGFKA-----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ ++ ++ L LT ++ + L+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
S IIH DLKP+N+ +++D + DFG+A+ D +
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMH 195
Query: 858 VSISGDVYSFGILMMETFTRRKP---TNEMFTGEMSLKQWVA--ESLPGAVTEVVDANLL 912
+ + D++S G +M E T R T+ + ++ L+ L ++ N +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 913 SREDEEDADDFATKKTCIS-YIMSLALKCSAEIPEERINVKDALAD 957
+ +FA + + L K ++RI ALA
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (292), Expect = 5e-29
Identities = 55/312 (17%), Positives = 116/312 (37%), Gaps = 37/312 (11%)
Query: 671 SYHELQQATNGFGESN------LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSF 723
Y + + +G + LG G + V++A + N V VK+ + K
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKI 76
Query: 724 DTECEVMRRIR-HRNLIKIVSSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRL 780
E +++ +R N+I + +P + AL+ +++ ++ + LT
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIR 132
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQT 839
M ++ AL+Y H S I+H D+KP+NV++D + L D+G+A+
Sbjct: 133 FYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYN 187
Query: 840 MTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKP-------------TNEMF 885
+ +A+ + PE + + S D++S G ++ R++P ++
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 886 TGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIP 945
E ++ SR+ E + + K
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307
Query: 946 EERINVKDALAD 957
+ R+ ++A+
Sbjct: 308 QSRLTAREAMEH 319
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-28
Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 22/217 (10%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+GSG+ V A +VA+K + Q K E +M+ + H+N+I +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 744 SCSNPGFK------ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ L+M+ M + + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAG 139
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
IIH DLKP+N+++ D + DFG+A+ T + T Y APE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMG 194
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
+ D++S G +M E + F G + QW
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQW 227
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 2e-26
Identities = 51/312 (16%), Positives = 98/312 (31%), Gaps = 44/312 (14%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F V+ A + N VA+K+ + ++ + E ++++R+ + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 746 SNPGFK---------------ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL 790
+N K ++ + + + L + + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDGVDPVTQTMTLATI-GYM 848
+Y+H IIH D+KP NVL++ D +L IA L + Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKP------------TNEMFTGEMSLKQWVA 896
+PE D++S L+ E T + + L + +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 897 ESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEI-----------P 945
L N F + ++ + + EI P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 946 EERINVKDALAD 957
+R + +
Sbjct: 317 RKRADAGGLVNH 328
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 106 bits (264), Expect = 1e-25
Identities = 73/311 (23%), Positives = 122/311 (39%), Gaps = 17/311 (5%)
Query: 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVCNWVGVTCS--IRHGRVAALSLPNLSLG 58
AL+Q+K + +P ++W T W+GV C + RV L L L+L
Sbjct: 10 ALLQIKKDLG-NPTTL--SSWL---PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 59 G--TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
+P + NL +L L I G + + +++ D +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 117 FTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLG 176
L + D S N ++G P +I ++ +L I D N +SG+ P + + +
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 177 NNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHL 236
N +TG+IP NL +DL N + G + ++ N I L N L+ L
Sbjct: 184 NRLTGKIPPTFAN------LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 237 PSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQIL 296
NL L L N + G +P + L +S N G +P GN ++ +
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVS 296
Query: 297 SLGDNQLTTGS 307
+ +N+ GS
Sbjct: 297 AYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.0 bits (198), Expect = 5e-17
Identities = 76/269 (28%), Positives = 112/269 (41%), Gaps = 29/269 (10%)
Query: 368 GNLSNLLVLSLVNNELAGA--IPTVLGKLQKLQGLDLNSN-KLKGFIPTDLCKLEKLNTL 424
+ L L L IP+ L L L L + L G IP + KL +L+ L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 425 LSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP 484
+ + G IP L+ + +L LDF N+L+ T+P + SL ++ + F N +SG++P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 485 LNIGNLEALGG-LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI---- 539
+ G+ L + ++ N+L+G IP + NL
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 540 ------------------SLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
+L LDL N I G +P+ L +L L NVSFN L GEIP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 582 GGPFVNFTADSFKQNYALCGSSRLQVPPC 610
GG F ++ N LCGS +P C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS---PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 2e-08
Identities = 20/75 (26%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 90 WHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRL 149
+ L +D +N + G+LP + L S +VS N + GE P N+
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAY 298
Query: 150 DNNSLSGSFPTDLCT 164
NN P CT
Sbjct: 299 ANNKCLCGSPLPACT 313
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.9 bits (245), Expect = 1e-22
Identities = 78/385 (20%), Positives = 135/385 (35%), Gaps = 26/385 (6%)
Query: 194 NLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253
L LG N+ + + + + + + YL NL + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQ--VTTLQADRLGIK-SIDGVEYLNNLTQINFSNN 76
Query: 254 NLSGIIPDSICNASEATILELSSNLFSGLVP-----NTFGNCRQLQILSLGDNQLTTGSS 308
L+ I P + N ++ + +++N + + P N G ++ D +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 309 AQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFG 368
+ ++ ++++ L L G + L+ S
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428
L+NL L NN+++ P + L L LN N+LK L L L L N
Sbjct: 195 KLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 429 NALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIG 488
N + P L+ LT L L +N +++ P L + ++ + N L I
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPIS 304
Query: 489 NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSG 548
NL+ L L L N +S P + +L L L A N S +L ++ L
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGH 360
Query: 549 NNISGEIPKSLEKLSRLVDFNVSFN 573
N IS P L L+R+ ++
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.9 bits (245), Expect = 1e-22
Identities = 76/406 (18%), Positives = 138/406 (33%), Gaps = 55/406 (13%)
Query: 151 NNSLSGSFPTDLCTR--LPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI 208
L + TD ++ L + L+ I I + L+NL ++ N +
Sbjct: 26 KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK------SIDG-VEYLNNLTQINFSNNQL 78
Query: 209 AGLIP-----SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSI 263
+ P ++ N I + + + L N + + +
Sbjct: 79 TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138
Query: 264 CNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY 323
+++ + + S L S + L+ L+ S+ S LAK
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198
Query: 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL 383
L L+ N + + P I T+L+ +QL +L+NL L L NN++
Sbjct: 199 LESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 384 AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLT 443
+ P L L KL L L +N++ P L N + + ++NL
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL----EDISPISNLK 307
Query: 444 SLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQL 503
+L +L N+++ P + +L L L N++
Sbjct: 308 NLTYLTLYFNNISDISP--------------------------VSSLTKLQRLFFANNKV 341
Query: 504 SGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGN 549
S SS+ NL N++WL+ N P +L + L L+
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.1 bits (209), Expect = 5e-18
Identities = 67/358 (18%), Positives = 136/358 (37%), Gaps = 35/358 (9%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
+L + +L + + ++ L I+FS+N L+ P + T+L ++
Sbjct: 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMN 96
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
+N+I P A + + ++ + + L + + + +
Sbjct: 97 NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL 156
Query: 187 EIP------NEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
+ ++ L NL L+ + + + + L+ N+ +
Sbjct: 157 QQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG 216
Query: 241 YLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
L NL+ L L N L I ++ + + T L+L++N S L P +L L LG
Sbjct: 217 ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 301 NQLTTGSSAQG-------------QIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLST 347
NQ++ S G S ++ + L L L N + + P + +L T
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL-T 329
Query: 348 SLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSN 405
L+ + ++++S NL+N+ LS +N+++ P L L ++ L LN
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 1e-17
Identities = 74/391 (18%), Positives = 126/391 (32%), Gaps = 57/391 (14%)
Query: 92 MRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDN 151
+ +++ ++ + T L I + +++L I N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTL---QADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 152 NSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGL 211
N L+ P L LV + + N I P + N G +
Sbjct: 76 NQLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 212 IPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFL---------WKNNLSGIIPDS 262
+ + +SN ++ + + L+ S + L ++
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 263 ICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322
+ + L ++N S + P L LSL NQL +LA
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD---------IGTLASLT 241
Query: 323 YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPV----------------- 365
L L L N + + P + L T L G++Q+S P+
Sbjct: 242 NLTDLDLANNQISNLAP--LSGL-TKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298
Query: 366 ---GFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLN 422
NL NL L+L N ++ P + L KLQ L +NK+ + L L +N
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 423 TLLSNNNALQGQIPTCLANLTSLRHLDFRSN 453
L + +N + P LANLT + L
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.9 bits (154), Expect = 3e-11
Identities = 39/181 (21%), Positives = 69/181 (38%), Gaps = 19/181 (10%)
Query: 33 CNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHM 92
+T + LSL L + +L+ L L+++ N + P L +
Sbjct: 207 NQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGL 262
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152
+L + +N +S P + T + N+ E S I N+ +L + L N
Sbjct: 263 TKLTELKLGANQISNISPLAGLTALTN-----LELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLI 212
++S P + L L +L N ++ + + NL N+ L G N I+ L
Sbjct: 318 NISDISP---VSSLTKLQRLFFANNKVSD-------VSSLANLTNINWLSAGHNQISDLT 367
Query: 213 P 213
P
Sbjct: 368 P 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 3e-05
Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 43/247 (17%)
Query: 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIP-TDLCKLEKL------ 421
+L + L + + L L ++ ++N+L P +L KL +
Sbjct: 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQ 99
Query: 422 -----------NTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYIL 470
N Q L NLT+L L+ SN+++ + + L
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 471 AVDFSLNSLSGSLPL-----------------NIGNLEALGGLNLTGNQLSGYIPSSIGN 513
+ + L L + L L L T NQ+S P I
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL- 218
Query: 514 LKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573
NLD L+L N + + SL +L LDL+ N IS P L L++L + + N
Sbjct: 219 -TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273
Query: 574 GLEGEIP 580
+ P
Sbjct: 274 QISNISP 280
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 4e-21
Identities = 24/156 (15%), Positives = 47/156 (30%), Gaps = 18/156 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNL----------QEDRALKSFDTECEVMRRIRH 735
L+G G V+ VK + + D F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
R L K+ + +E Y + + +++ + + +H
Sbjct: 66 RALQKL----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
I+H DL NVL+ ++ + + DF + +
Sbjct: 122 RG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.7 bits (221), Expect = 5e-20
Identities = 60/277 (21%), Positives = 95/277 (34%), Gaps = 22/277 (7%)
Query: 235 HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294
+P + P+ L L N ++ I N L L +N S + P F +L+
Sbjct: 24 KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS-TSLENFY 353
L L NQL + L+ L + N + V + L+ +
Sbjct: 83 RLYLSKNQLKELPEKM----------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132
Query: 354 AGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPT 413
+ SG F + L + + + + IP G L L L+ NK+
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAA 189
Query: 414 DLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473
L L L L + N++ LAN LR L +N L +P KYI V
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248
Query: 474 FSLNSLSG------SLPLNIGNLEALGGLNLTGNQLS 504
N++S P + G++L N +
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.5 bits (210), Expect = 1e-18
Identities = 47/294 (15%), Positives = 98/294 (33%), Gaps = 33/294 (11%)
Query: 259 IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318
+P + + +L+L +N + + F N + L L L +N+++ I +
Sbjct: 25 VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-------ISPGAF 75
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
A L L L N LK +P + L +++ + N ++ L
Sbjct: 76 APLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVF-NGLNQMIVVELGT 133
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
+ +G ++KL + + + L +L+ L N +
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH--LDGNK-ITKVDAAS 190
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNL 498
L L +L L NS+++ + + ++ + + N L P + + + + + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYL 249
Query: 499 TGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
N +S + N F P S + L N +
Sbjct: 250 HNNNISA----------------IGSNDFCPP--GYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 2e-18
Identities = 66/335 (19%), Positives = 110/335 (32%), Gaps = 45/335 (13%)
Query: 143 SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILD 202
L+ ++ + L P DL P L L N IT + NL NL L
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITE-----IKDGDFKNLKNLHTLI 61
Query: 203 LGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS 262
L N I+ + P + + L N L LP + + L + +N ++ +
Sbjct: 62 LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTL-QELRVHENEITKVRKSV 119
Query: 263 ICNASEATILELSS--NLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAK 320
++ ++EL + SG+ F ++L + + D +TT
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL---------- 169
Query: 321 CRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN 380
L L LD N + V S+ L+ + S + G + L +N
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL--SFNSISAVDNGSLANTPHLRELHLN 227
Query: 381 NELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA 440
N +P L + +Q + L++N + D C P
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFC------------------PPGYNT 269
Query: 441 NLTSLRHLDFRSNSLNST--IPSTFWSLKYILAVD 473
S + SN + PSTF + AV
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 4e-18
Identities = 48/262 (18%), Positives = 95/262 (36%), Gaps = 33/262 (12%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+L +++++ F NL NL L L+NN+++ P L KL+ L L+
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF 463
N+LK L++L + ++ + L + + L + F
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAF 146
Query: 464 WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALA 523
+K + + + +++ + G +L L+L GN+++ +S+ L NL L L+
Sbjct: 147 QGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 524 RNAFQG-----------------------PIPQSFGSLISLQSLDLSGNNISG------E 554
N+ +P +Q + L NNIS
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 555 IPKSLEKLSRLVDFNVSFNGLE 576
P K + ++ N ++
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.1 bits (196), Expect = 7e-17
Identities = 63/306 (20%), Positives = 105/306 (34%), Gaps = 50/306 (16%)
Query: 33 CNWVGVTCSIRH---------GRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYD 83
C+ V CS A L L N + NL L +L + N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 84 TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI------------- 130
P + +L+ + S N L LP M + +L + K+
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 131 ----------TGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNIT 180
+G A + L IR+ + +++ + P L PSL +L L GN IT
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKIT 184
Query: 181 GRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI 240
+ L+NL L L N+I+ + + N ++ + L N L
Sbjct: 185 KV-----DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLA 239
Query: 241 YLPNLENLFLWKNNLSGIIPDSICNASEA------TILELSSN--LFSGLVPNTFGNCRQ 292
++ ++L NN+S I + C + + L SN + + P+TF
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299
Query: 293 LQILSL 298
+ L
Sbjct: 300 RAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 48/204 (23%), Positives = 74/204 (36%), Gaps = 4/204 (1%)
Query: 397 LQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
LDL +NK+ D L+ L+TL+ NN + P A L L L N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 457 STIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKN 516
+L+ + + + + S+ N N + L + SG + +K
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 517 LDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLE 576
L ++ +A IPQ SL L L GN I+ SL+ L+ L +SFN +
Sbjct: 152 LSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 577 GEIPSGGPFVNFTADSFKQNYALC 600
+ N L
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 3e-08
Identities = 26/108 (24%), Positives = 40/108 (37%), Gaps = 3/108 (2%)
Query: 472 VDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPI 531
V S L +P ++ L+L N+++ NLKNL L L N
Sbjct: 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 532 PQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579
P +F L+ L+ L LS N + K + L L + +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 22/153 (14%), Positives = 46/153 (30%), Gaps = 3/153 (1%)
Query: 444 SLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQL 503
LR + L + D N ++ + NL+ L L L N++
Sbjct: 11 HLRVVQCSDLGLEKVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 504 SGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLS 563
S P + L L+ L L++N + + +L L+ + + + L ++
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 564 RLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQN 596
+ E + +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (193), Expect = 1e-16
Identities = 59/287 (20%), Positives = 90/287 (31%), Gaps = 13/287 (4%)
Query: 264 CNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRY 323
C + Q + L N+++ + +S CR
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAA---SQRIFLHGNRISH-------VPAASFRACRN 57
Query: 324 LRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNEL 383
L +L L +N L + + L+ + + ++QL P F L L L L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 384 AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLT 443
P + L LQ L L N L+ L L L + N + L
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 444 SLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQL 503
SL L N + P F L ++ + N+LS + L AL L L N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
Query: 504 SGYIPSSIGNLKNLDWLALARNAFQGPIPQSFG--SLISLQSLDLSG 548
+ L + + +PQ L L + DL G
Sbjct: 238 VC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 3e-13
Identities = 56/255 (21%), Positives = 98/255 (38%), Gaps = 5/255 (1%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+ + + + +++S F NL +L L +N LA L L+ LDL+
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 404 SNKLKGFI-PTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPST 462
N + P L +L+TL + LQ P L +L++L + N+L + T
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 463 FWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522
F L + + N +S L +L L L N+++ P + +L L L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 523 ARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS- 581
N ++ L +LQ L L+ N + + + L F S + + +P
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR 267
Query: 582 --GGPFVNFTADSFK 594
G A+ +
Sbjct: 268 LAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (156), Expect = 7e-12
Identities = 50/307 (16%), Positives = 87/307 (28%), Gaps = 54/307 (17%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
L ++P + + + N+I+ ++ +L + L +N L+
Sbjct: 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSM 215
+ P L L L L + L P +
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLR-----SVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 216 IFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELS 275
L+ L+L N L + D+ + T L L
Sbjct: 125 FRGL-----------------------AALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161
Query: 276 SNLFSGLVPNTFGNCRQLQILSLGDNQLTT-----------------GSSAQGQIFYSSL 318
N S + F L L L N++ ++ + +L
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
A R L+ L L+ NP L L+ F SS++ +P L+ + L
Sbjct: 222 APLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRL 276
Query: 379 VNNELAG 385
N+L G
Sbjct: 277 AANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 1e-10
Identities = 48/208 (23%), Positives = 72/208 (34%), Gaps = 9/208 (4%)
Query: 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTL-L 425
+++ L ++ L A+P L K L L+ N L F L +L L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 426 SNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPL 485
+ Q+ L L +L + SL + D S N L+
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL----DVSFNRLTSLPLG 118
Query: 486 NIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLD 545
+ L L L L GN+L P + L+ L+LA N L +L +L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 546 LSGNNISGEIPKSLEKLSRLVDFNVSFN 573
L N++ IPK L + N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 8e-10
Identities = 42/221 (19%), Positives = 63/221 (28%), Gaps = 19/221 (8%)
Query: 114 CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173
+ + +T P + + L N L L L QL
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLM-PYTRLTQLN 61
Query: 174 LLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS 233
L +T + L L LDL N + L + V + + S
Sbjct: 62 LDRAELTKLQVDG-------TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS 114
Query: 234 GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQL 293
L + L L+ L+L N L + P + + L L++N + L L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 294 QILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPL 334
L L +N L T L L NP
Sbjct: 175 DTLLLQENSLYT--------IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 46/187 (24%), Positives = 65/187 (34%), Gaps = 6/187 (3%)
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLN 422
+P + +L L N L L +L L+L+ + L L
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQVDGTLPVLG 80
Query: 423 TLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGS 482
TL ++N LQ L +L LD N L S L + + N L
Sbjct: 81 TLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 483 LPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQ 542
P + L L+L N L+ + L+NLD L L N+ IP+ F L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 543 SLDLSGN 549
L GN
Sbjct: 199 FAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 7e-07
Identities = 41/185 (22%), Positives = 61/185 (32%), Gaps = 4/185 (2%)
Query: 344 NLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+L + + L + L L+L E V G L L LDL+
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLGTLDLS 85
Query: 404 SNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTF 463
N+L+ L L L + N L L L L+ L + N L + P
Sbjct: 86 HNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144
Query: 464 WSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALA 523
+ + + N+L+ + LE L L L N L IP L + L
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 524 RNAFQ 528
N +
Sbjct: 204 GNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 49/217 (22%), Positives = 70/217 (32%), Gaps = 19/217 (8%)
Query: 242 LPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301
+ + + K NL+ + P + + TIL LS NL T +L L+L
Sbjct: 9 VASHLEVNCDKRNLTAL-PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 302 QLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLK-GVIPNSIGNLSTSLENFYAGSSQLS 360
+ + L L VL +G +L ++L+
Sbjct: 66 E------------LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT 113
Query: 361 GGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEK 420
L L L L NEL P +L KL+ L L +N L L LE
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 421 LNTL-LSNNNALQGQIPTCLANLTSLRHLDFRSNSLN 456
L+TL L N+ IP L N
Sbjct: 174 LDTLLLQENSLY--TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 6e-04
Identities = 30/185 (16%), Positives = 52/185 (28%), Gaps = 17/185 (9%)
Query: 60 TLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSN------------SLSG 107
LPP + L++S N Y L RL ++ L
Sbjct: 24 ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 108 SLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLP 167
L + + + + + ++ L +L T P
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 168 SLVQLRLLGNNITGRIPNRE--IPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAI 225
L+ ++ N + L NL L L N++ IP F + +
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFA 200
Query: 226 LLYGN 230
L+GN
Sbjct: 201 FLHGN 205
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 10/103 (9%)
Query: 462 TFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLA 521
F L + + LN+ S + +L LN++ N+L +P+ L+ L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI--- 310
Query: 522 LARNAFQGPIPQSFGSLISLQSLDLSGNNISG--EIPKSLEKL 562
+ N +P+ +L+ L + N + +IP+S+E L
Sbjct: 311 ASFNHLAE-VPELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 9/91 (9%)
Query: 427 NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLN 486
NA +I + SL L+ +N L +P+ L+ + S N L+ +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERL---IASFNHLA-EVPEL 322
Query: 487 IGNLEALGGLNLTGNQLSGYIPSSIGNLKNL 517
NL+ L++ N L P ++++L
Sbjct: 323 PQNLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 49/332 (14%), Positives = 101/332 (30%), Gaps = 24/332 (7%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKIL 201
+ L+N L + L P L L N++T E+P +L +L +
Sbjct: 38 RQAHELELNNLGL-----SSLPELPPHLESLVASCNSLT------ELPELPQSLKSLLVD 86
Query: 202 DLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE----NLFLWKNNLSG 257
+ ++ L P + + + + + I + N
Sbjct: 87 NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA 146
Query: 258 IIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSS 317
+ + E L + +++ L + S+ + Q
Sbjct: 147 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206
Query: 318 LAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLS 377
+L + + ++ + + S F LS L
Sbjct: 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266
Query: 378 LVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPT 437
N + I ++ L+ L++++NKL +P +LE+L S N+ ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI--ASFNHL--AEVPE 321
Query: 438 CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYI 469
N L+ L N L P S++ +
Sbjct: 322 LPQN---LKQLHVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 20/111 (18%), Positives = 43/111 (38%), Gaps = 15/111 (13%)
Query: 90 WHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRL 149
+ + + S + +C+ LE +VS+NK+ E P+ L+ +
Sbjct: 256 FSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIA 311
Query: 150 DNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKI 200
N L ++ +L QL + N + E P+ ++ +L++
Sbjct: 312 SFNHL-----AEVPELPQNLKQLHVEYNPLR------EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 62/354 (17%), Positives = 114/354 (32%), Gaps = 41/354 (11%)
Query: 93 RRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNN 152
R+ ++ ++ LS SLP LES S N +T E P SLKS+ +DNN
Sbjct: 38 RQAHELELNNLGLS-SLP----ELPPHLESLVASCNSLT-ELPE---LPQSLKSLLVDNN 88
Query: 153 SLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLI 212
+L L L + + ++ L N L + + L
Sbjct: 89 NLKA---------------LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK 133
Query: 213 PSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATIL 272
S LP L+NL + ++
Sbjct: 134 KLPDLPPSLEFIAAGNNQL--------EELPELQNLPFLTAIYADNNSLKKLPDLPLSLE 185
Query: 273 ELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTN 332
+ + N L + +N L T + ++ + L +
Sbjct: 186 SIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQS 245
Query: 333 PLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLG 392
+ +I + + L + S I +L L++ NN+L +P +
Sbjct: 246 LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP 304
Query: 393 KLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446
+L++ L + N L +P L++L+ + N L+ + P ++ LR
Sbjct: 305 RLER---LIASFNHLAE-VPELPQNLKQLH--VEYNP-LR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 21/81 (25%), Positives = 36/81 (44%), Gaps = 9/81 (11%)
Query: 501 NQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLE 560
N S I S +L+ L ++ N +P L + L S N+++ E+P+ +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQ 324
Query: 561 KLSRLVDFNVSFNGLEGEIPS 581
L +L +V +N L E P
Sbjct: 325 NLKQL---HVEYNPLR-EFPD 341
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 18/88 (20%), Positives = 33/88 (37%), Gaps = 16/88 (18%)
Query: 163 CTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNM 222
C PSL +L + N + E+P L + L N++A + N+
Sbjct: 280 CDLPPSLEELNVSNNKLI------ELPALPPRL---ERLIASFNHLAEVPELP----QNL 326
Query: 223 VAILLYGNHLSGHLPSSIYLPNLENLFL 250
+ + N L P ++E+L +
Sbjct: 327 KQLHVEYNPLRE-FPDIP--ESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 8e-04
Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 8/90 (8%)
Query: 206 NNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICN 265
N + I S+ ++ + + N L LP+ P LE L N+L+ +P+ N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP--PRLERLIASFNHLAE-VPELPQN 325
Query: 266 ASEATILELSSNLFSGLVPNTFGNCRQLQI 295
+ L + N P+ + L++
Sbjct: 326 LKQ---LHVEYNPLREF-PDIPESVEDLRM 351
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 33/217 (15%), Positives = 56/217 (25%), Gaps = 22/217 (10%)
Query: 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428
L+N + ++ + + + L + L + + L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 429 NALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS--------------TFWSLKYILAVDF 474
N + P + L S I T + L+
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 475 SLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQS 534
L + L+ + + NL L L N P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 535 FGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVS 571
SL +L + L N IS P L S L ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 30/217 (13%), Positives = 66/217 (30%), Gaps = 15/217 (6%)
Query: 194 NLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253
L N + G +N+ + + + + +G ++ + YL NL L L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73
Query: 254 NLSGIIPDS-------ICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTG 306
++ + P + + + + + + + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 307 SSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG 366
+ + L + + N + L A +++S P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLAN-LSKLTTLKADDNKISDISP-- 190
Query: 367 FGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLN 403
+L NL+ + L NN+++ P L L + L
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 37/217 (17%), Positives = 71/217 (32%), Gaps = 14/217 (6%)
Query: 218 NNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSN 277
+N + I ++++ + + L + L + ++ I + + + LEL N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA-DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 278 LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGV 337
+ L P LS + + + I L + V L V
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 338 I------PNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL 391
+ +I L+ Y NLS L L +N+++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 392 GKLQKLQGLDLNSNKLKGFIP-TDLCKLEKLNTLLSN 427
L L + L +N++ P + L + L+N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLANTSNLFIVT--LTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 33/217 (15%), Positives = 70/217 (32%), Gaps = 16/217 (7%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
L+ + + ++ DT+ + + + ++ ++ G L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELK 71
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQ--------LRLLGNN 178
N+IT P + + + + + + L L L N
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPS 238
+ +I N + L N + + N S + + N +S +
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISP 190
Query: 239 SIYLPNLENLFLWKNNLSGIIPDSICNASEATILELS 275
LPNL + L N +S + P + N S I+ L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 32/224 (14%), Positives = 66/224 (29%), Gaps = 26/224 (11%)
Query: 116 SFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL 175
+ + +T A ++ + ++ ++ + L +L+ L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELK 71
Query: 176 GNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGH 235
N IT P + + + L + S + + LS
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 236 LPSSIYLPNLENLFLWKNNLSGIIPDS----------ICNASEATILELSSNLFSGLVPN 285
+ L + N+ + + N S+ T L+ N S + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 286 TFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVL 329
+ L + L +NQ++ S LA L ++ L
Sbjct: 191 -LASLPNLIEVHLKNNQISD---------VSPLANTSNLFIVTL 224
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 5e-07
Identities = 25/117 (21%), Positives = 42/117 (35%), Gaps = 5/117 (4%)
Query: 199 KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGI 258
++L L ++ L + + + L N L P+ L LE L N L +
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 259 IPDSICNASEATILELSSNLFSGL-VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIF 314
D + N L L +N +C +L +L+L N L Q ++
Sbjct: 59 --DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 20/116 (17%), Positives = 45/116 (38%), Gaps = 11/116 (9%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
+++ + L+ L + D+S N++ P+ +++L+ + + S +
Sbjct: 1 RVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDN 53
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGL 211
D LP L +L L N + + + L +L+L GN++
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQSAA----IQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 2e-05
Identities = 31/128 (24%), Positives = 45/128 (35%), Gaps = 12/128 (9%)
Query: 446 RHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSG 505
R L L T+ L + +D S N L P + L L L + N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55
Query: 506 YIPSSIGNLKNLDWLALARNAFQG-PIPQSFGSLISLQSLDLSGNNISGE------IPKS 558
+ NL L L L N Q Q S L L+L GN++ E + +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 559 LEKLSRLV 566
L +S ++
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 25/114 (21%), Positives = 37/114 (32%), Gaps = 8/114 (7%)
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLN 422
+ L + L L +N L P L L+ L+ L + N +
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA-LENVDGVANLPRLQE 69
Query: 423 TLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLN------STIPSTFWSLKYIL 470
LL NN Q L + L L+ + NSL + S+ IL
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 15/128 (11%)
Query: 271 ILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLD 330
+L L+ + L + L L N+L +LA R L VL
Sbjct: 2 VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRA--------LPPALAALRCLEVLQAS 51
Query: 331 TNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPT 389
N L+ V + L +++L + + L++L+L N L
Sbjct: 52 DNALENVDGVANLPRLQEL---LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEG 107
Query: 390 VLGKLQKL 397
+ +L ++
Sbjct: 108 IQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 19/105 (18%), Positives = 35/105 (33%), Gaps = 23/105 (21%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPN---------------------E 88
L L + L T+ H+ L + L++S N P
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 89 LWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGE 133
+ ++ RL+ + +N L S S +L ++ N + E
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 7e-07
Identities = 19/130 (14%), Positives = 44/130 (33%), Gaps = 6/130 (4%)
Query: 143 SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILD 202
++S+ + LS + +L L +RL +T ++I + + L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC-KDISSALRVNPALAELN 61
Query: 203 LGGNNI-----AGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSG 257
L N + ++ + + + + L L+G + L + +LS
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 121
Query: 258 IIPDSICNAS 267
+
Sbjct: 122 NLLGDAGLQL 131
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 9/76 (11%)
Query: 496 LNLTGNQLSG----YIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLI-----SLQSLDL 546
L L +S + +++ +L L L+ N + L+ L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 547 SGNNISGEIPKSLEKL 562
S E+ L+ L
Sbjct: 434 YDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 14/95 (14%), Positives = 30/95 (31%), Gaps = 8/95 (8%)
Query: 89 LWHMRRLKIIDFSSNSLSGSLPGDMCNSF---TQLESFDVSSNKITGEFPSAIV-----N 140
L+++ + +S S + + L D+S+N + +V
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 141 ISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL 175
L+ + L + S L LR++
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 8e-06
Identities = 10/69 (14%), Positives = 21/69 (30%), Gaps = 5/69 (7%)
Query: 496 LNLTGNQLS-GYIPSSIGNLKNLDWLALARNAFQG----PIPQSFGSLISLQSLDLSGNN 550
L++ +LS + L+ + L I + +L L+L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 551 ISGEIPKSL 559
+ +
Sbjct: 67 LGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 9e-06
Identities = 14/90 (15%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 71 LVSLNISGNSFYDTLPNELW-HMRRLKIIDFSSNSLSGSLPGDMCNSF---TQLESFDVS 126
+ SL+I D EL +++ +++ L+ + D+ ++ L ++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSG 156
SN++ ++ S ++ SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 14/92 (15%), Positives = 30/92 (32%), Gaps = 8/92 (8%)
Query: 95 LKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGE----FPSAIVNISSLKSIRLD 150
++ +D LS + ++ Q + + +T SA+ +L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 151 NNSLSGSFPTDLCTRL----PSLVQLRLLGNN 178
+N L + L + +L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 20/151 (13%), Positives = 42/151 (27%), Gaps = 14/151 (9%)
Query: 13 PHNFFANNWNLSPTNTSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLV 72
+ + + + +++ L + + S L
Sbjct: 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 372
Query: 73 SLNISGNSFYDT----LPNELWHMRRLKIIDFSSNSLSGS----LPGDMCNSFTQLESFD 124
L ++ D+ L L L+ +D S+N L + L + LE
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 125 VSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
+ + E L+++ D SL
Sbjct: 433 LYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 17/85 (20%), Positives = 30/85 (35%), Gaps = 9/85 (10%)
Query: 367 FGNLSNLLVLSLVNNEL----AGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCK----- 417
S L VL L + ++ ++ L L+ LDL++N L L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 418 LEKLNTLLSNNNALQGQIPTCLANL 442
L L+ + ++ L L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 15/72 (20%), Positives = 27/72 (37%), Gaps = 5/72 (6%)
Query: 397 LQGLDLNSNKLKGFIPTDLCK-LEKLNTLLSNNNALQGQ----IPTCLANLTSLRHLDFR 451
+Q LD+ +L +L L++ + ++ L I + L +L L+ R
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 452 SNSLNSTIPSTF 463
SN L
Sbjct: 64 SNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 14/80 (17%), Positives = 28/80 (35%), Gaps = 3/80 (3%)
Query: 140 NISSLKSIRLDNNSLSGSFPTDLC---TRLPSLVQLRLLGNNITGRIPNREIPNEIGNLH 196
S L+ + L + +S S + L SL +L L N + + + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 197 NLKILDLGGNNIAGLIPSMI 216
L+ L L + + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 18/95 (18%), Positives = 35/95 (36%), Gaps = 11/95 (11%)
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNI-----AGLIPSMIFNNSN 221
L L L +++ + + H+L+ LDL N + L+ S+
Sbjct: 369 SVLRVLWLADCDVSDSSC-SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 222 MVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLS 256
+ ++LY + S + L+ L K +L
Sbjct: 428 LEQLVLYDIYWSEEMEDR-----LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 346 STSLENFYAGSSQLS-GGIPVGFGNLSNLLVLSLVNNEL----AGAIPTVLGKLQKLQGL 400
S +++ +LS L V+ L + L I + L L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 401 DLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQ 432
+L SN+L + + L + + +Q
Sbjct: 61 NLRSNELGDVGVHCVLQG-----LQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 9e-04
Identities = 14/78 (17%), Positives = 22/78 (28%), Gaps = 9/78 (11%)
Query: 513 NLKNLDWLALARNAFQG----PIPQSFGSLISLQSLDLSGNNISGEIPKSL-----EKLS 563
L L LA + + + SL+ LDLS N + L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 564 RLVDFNVSFNGLEGEIPS 581
L + E+
Sbjct: 427 LLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 20/110 (18%), Positives = 32/110 (29%), Gaps = 23/110 (20%)
Query: 287 FGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
L++L L D ++ + ++L LR L L N L I L
Sbjct: 365 GQPGSVLRVLWLADCDVS---DSSCSSLAATLLANHSLRELDLSNNCLG---DAGILQLV 418
Query: 347 TSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQK 396
S+ L L L + + + L L+K
Sbjct: 419 ESVRQ-----------------PGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 7e-07
Identities = 25/249 (10%), Positives = 69/249 (27%), Gaps = 15/249 (6%)
Query: 159 PTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFN 218
+C + + + +T EIP+++ N L + +
Sbjct: 2 HHRICHCSNRVFLCQ--ESKVT------EIPSDL--PRNAIELRFVLTKLRVIQKGAFSG 51
Query: 219 NSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNL 278
++ I + N + + + ++ + + + ++ + L+
Sbjct: 52 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 111
Query: 279 FSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVI 338
+G+ + L + + ++L N
Sbjct: 112 NTGIKHLPDVHKIHSLQ----KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167
Query: 339 PNSIGNLSTSLENFYAGSSQLSGGIPVG-FGNLSNLLVLSLVNNELAGAIPTVLGKLQKL 397
++ T L+ + +P F S ++L + + L L+KL
Sbjct: 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 227
Query: 398 QGLDLNSNK 406
+ + K
Sbjct: 228 RARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 32/223 (14%), Positives = 61/223 (27%), Gaps = 9/223 (4%)
Query: 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLN 422
IP N + L V +L L+ ++++ N + I D+
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 423 TLLS----NNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNS 478
+ NN + + K +L + ++N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 479 LSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSL 538
+ +G L L N + + + + N + F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 539 ISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
LD+S I LE L +L S L+ ++P+
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 32/240 (13%), Positives = 78/240 (32%), Gaps = 12/240 (5%)
Query: 143 SLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILD 202
S + + ++ P+DL + ++LR + + I +L+ ++
Sbjct: 9 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRV-IQ----KGAFSGFGDLEKIE 59
Query: 203 LGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDS 262
+ N++ +I + +F+N + + + + NL NL + +GI
Sbjct: 60 ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI--KH 117
Query: 263 ICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322
+ + + L+ + LS L + +I + +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 323 YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNE 382
+ + D N L+ + + + +++ G NL L S N +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGA-SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 33/226 (14%), Positives = 58/226 (25%), Gaps = 9/226 (3%)
Query: 259 IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318
IP + A L + F L+ + + N + A L
Sbjct: 23 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
+ R + L + + + L
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI----QD 136
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
N + +G + L LN N ++ + LS+NN L+
Sbjct: 137 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDV 196
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLP 484
+ LD ++S +LK + A S +L LP
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 27/233 (11%), Positives = 59/233 (25%), Gaps = 9/233 (3%)
Query: 229 GNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG 288
+ ++ +PS + N L L I + + +E+S N ++
Sbjct: 17 ESKVT-EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTS 348
+ + + + + P I + L
Sbjct: 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134
Query: 349 LENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLK 408
+N + + G ++L L N + Q + ++N L+
Sbjct: 135 QDNINIHTIE----RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190
Query: 409 GFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS 461
L + + L NL LR + +P+
Sbjct: 191 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---LKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 15/80 (18%), Positives = 33/80 (41%), Gaps = 11/80 (13%)
Query: 90 WHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRL 149
++ +L ++ S N+ LP D+ + + D+S +I + N+ L++
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--R 230
Query: 150 DNNSLSGSFPTDLCTRLPSL 169
+L +LP+L
Sbjct: 231 STYNL---------KKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 33/240 (13%), Positives = 72/240 (30%), Gaps = 14/240 (5%)
Query: 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLS 155
++ + ++ +P D+ + +L K+ A L+ I + N +
Sbjct: 11 RVFLCQESKVT-EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66
Query: 156 GSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSM 215
D+ + LP L ++R+ N I N + L +
Sbjct: 67 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126
Query: 216 IFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELS 275
+ + + + + + + L+L KN + I + +
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLS-FESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 276 SNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLK 335
+N L + F IL + ++ + + L + LR T LK
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHS-------LPSYGLENLKKLR--ARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 17/81 (20%), Positives = 24/81 (29%), Gaps = 2/81 (2%)
Query: 225 ILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVP 284
L H + E NNL + D AS IL++S L
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 285 NTFGNCRQLQILSLGDNQLTT 305
N ++L+ S L
Sbjct: 219 YGLENLKKLRARST--YNLKK 237
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 8e-07
Identities = 37/291 (12%), Positives = 86/291 (29%), Gaps = 29/291 (9%)
Query: 201 LDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGI-I 259
LDL G N+ + + + ++A + + L ++++ L + + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 260 PDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ-LTTGSSAQGQIFYSSL 318
+ S+ L L S + NT L L+L + + S L
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSL 378
+ ++ + + ++ + Y + Q S + + + +
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 379 VNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
+ L +L LQ L L S + +
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSL-----------------------SRCYDIIPETLLE 220
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGN 489
L + +L+ L + T+ +L ++ + + + IGN
Sbjct: 221 LGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 7/89 (7%)
Query: 496 LNLTGNQLSGYIPSSIGNL--KNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG 553
L+LTG L P G L + + R+ P+ + F S +Q +DLS + I
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 554 E-IPKSLEKLSRLVDFNVSFNGLEGEIPS 581
+ L + S+L + ++ L I +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 28/251 (11%), Positives = 76/251 (30%), Gaps = 7/251 (2%)
Query: 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSL 109
L L +L + + + +++ + L R++ +D S++ + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62
Query: 110 PGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSI-RLDNNSLSGSFPTDLCTRLPS 168
+ + ++L++ + +++ + + S+L + + S L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 169 LVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLY 228
L +L L + + L N+ S + + L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 229 GNHLSGHLPSSIYL---PNLENLFLWK-NNLSGIIPDSICNASEATILELSSNLFSGLVP 284
+ + L++L L + ++ + L++ + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 285 NTFGNCRQLQI 295
LQI
Sbjct: 243 LLKEALPHLQI 253
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 8e-06
Identities = 46/300 (15%), Positives = 89/300 (29%), Gaps = 37/300 (12%)
Query: 145 KSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLG 204
+++ L +L L ++ ++ R + + + E + ++ +DL
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLA------EHFSPFRVQHMDLS 54
Query: 205 GNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSIC 264
+ I I + L+NL L LS I +++
Sbjct: 55 NSVIEVSTLHGILSQ----------------------CSKLQNLSLEGLRLSDPIVNTLA 92
Query: 265 NASEATILELSS--NLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322
S L LS + +C +L L+L T Q + + S +
Sbjct: 93 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ 152
Query: 323 YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVN-N 381
+ N K + + + + S L F L+ L LSL
Sbjct: 153 L-NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211
Query: 382 ELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLAN 441
++ LG++ L+ L + G + L L N + + N
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 4e-05
Identities = 35/229 (15%), Positives = 67/229 (29%), Gaps = 36/229 (15%)
Query: 372 NLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKG-FIPTDLCKLEKLNTLLSNNNA 430
++ + + + ++Q +DL+++ ++ + L + KL L
Sbjct: 24 GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 431 LQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNL 490
L I LA ++L L+ S S + +L+ ++
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 491 EALGGLNLTGNQLSGY---------------------------------IPSSIGNLKNL 517
A +T LSGY L L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 518 DWLALAR-NAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565
L+L+R G + +L++L + G G + E L L
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 251
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 3e-06
Identities = 39/169 (23%), Positives = 61/169 (36%), Gaps = 9/169 (5%)
Query: 398 QGLDLNSNKLKGF---IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNS 454
+D LK IP +L LL++N + L L L+ + N
Sbjct: 11 TTVDCTGRGLKEIPRDIPLHTTEL-----LLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 455 LNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNL 514
L P+ F +I + N + L L LNL NQ+S +P S +L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 515 KNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLS 563
+L L LA N F ++ + L+ L+G P + +
Sbjct: 126 NSLTSLNLASNPFNCNCHLAWFAE-WLRKKSLNGGAARCGAPSKVRDVQ 173
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 4e-05
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 3/101 (2%)
Query: 188 IPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLEN 247
LH LK L+L N I+ ++P + +++ ++ L N + + + + L
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRK 153
Query: 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFG 288
L P + + I +L + F N+ G
Sbjct: 154 KSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 0.002
Identities = 25/163 (15%), Positives = 51/163 (31%), Gaps = 12/163 (7%)
Query: 186 REIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMV--AILLYGNHLSGHLPSSIYLP 243
+EIP +I + L L N + + +F + L +
Sbjct: 21 KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 244 NLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303
+++ L L +N + I + L L N S ++P +F + L
Sbjct: 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-------- 130
Query: 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLS 346
+S +LR L+ + P+ + ++
Sbjct: 131 LNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ 173
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 40/333 (12%), Positives = 89/333 (26%), Gaps = 28/333 (8%)
Query: 120 LESFDVSSNKITGE----FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL 175
+E + + IT E + ++ S+K I L N++ L + S L +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 176 --GNNITGRIPNREIPNEIGNLHNL--KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNH 231
+ TGR+ + EIP + L K L ++ + + +
Sbjct: 65 EFSDIFTGRVKD-EIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 232 LSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCR 291
+L ++ P + + +I+ + L +G + +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 292 QLQILSLGDNQLTTGSSAQGQIFYSSL----------AKCRYLRVLVLDTNPLKGVIPNS 341
++L + + + +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 342 IGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVL-----GKLQK 396
+ + + L L L NE+ L K+
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 397 LQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNN 429
L L+LN N+ ++++ + S
Sbjct: 304 LLFLELNGNRFSEEDDV----VDEIREVFSTRG 332
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 8e-04
Identities = 13/98 (13%), Positives = 30/98 (30%), Gaps = 12/98 (12%)
Query: 90 WHMRRLKIIDFSSNSLSGSLPGDMCN-----SFTQLESFDVSSNKITGEFPSAIV----- 139
L+ + + LS + + L++ + N+I + +
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299
Query: 140 NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN 177
+ L + L+ N S D+ + + R G
Sbjct: 300 KMPDLLFLELNGNRFSEE--DDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 13/90 (14%), Positives = 27/90 (30%), Gaps = 5/90 (5%)
Query: 515 KNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGE----IPKSLEKLSRLVDFNV 570
K+L A+ + + S++ + LSGN I E + +++ L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 571 SFNGLEGEIPSGGPFVNFTADSFKQNYALC 600
S + + + L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 3e-05
Identities = 37/203 (18%), Positives = 65/203 (32%), Gaps = 16/203 (7%)
Query: 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428
+ + +L + A+ +L + + N++ +K + L + L N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 429 NALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIG 488
N L LANL +L L N + L+++ + S L
Sbjct: 78 NKLTDIK--PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 489 NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSG 548
G N + + + L D +P L LQ+L LS
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDN------QISDIVP--LAGLTKLQNLYLSK 187
Query: 549 NNISGEIPKSLEKLSRLVDFNVS 571
N+IS ++L L L +
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 44/215 (20%), Positives = 80/215 (37%), Gaps = 28/215 (13%)
Query: 115 NSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRL 174
++F + ++ +T ++S+ I +N+ + LP++ +L L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFL 75
Query: 175 LGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG 234
GN +T L NLK L + + + + L ++
Sbjct: 76 NGNKLTDIK----------PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 235 HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQ 294
+ ++LP LE+L+L N ++ I S + L L N S +VP +LQ
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLT--KLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 295 ILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVL 329
L L N ++ +LA + L VL L
Sbjct: 182 NLYLSKNHISD---------LRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 26/210 (12%), Positives = 66/210 (31%), Gaps = 22/210 (10%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
+ + N+ S D + + + I +++ + + ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG---IQYLPNVTKLFLN 76
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
NK+T +++LK++ + +
Sbjct: 77 GNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKD----------LKKLKSLSLEH 121
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE 246
++I L +L L+ + + + + L ++ + L L+
Sbjct: 122 NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQ 181
Query: 247 NLFLWKNNLSGIIPDSICNASEATILELSS 276
NL+L KN++S + ++ +LEL S
Sbjct: 182 NLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 9e-05
Identities = 32/140 (22%), Positives = 53/140 (37%), Gaps = 6/140 (4%)
Query: 63 PHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLES 122
N L++ G + N + + IDFS N + D +L++
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 67
Query: 123 FDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGR 182
V++N+I + L + L NNSL D L SL L +L N +T +
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 183 IPNREIPNEIGNLHNLKILD 202
R I + +++LD
Sbjct: 128 KHYR--LYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 19/135 (14%), Positives = 34/135 (25%), Gaps = 11/135 (8%)
Query: 166 LPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAI 225
+L L G I I N L +D N I + +
Sbjct: 17 AVRDRELDLRGYKIP------VIENLGATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLL 69
Query: 226 LLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPN 285
+ LP+L L L N+L + + ++ +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 286 ----TFGNCRQLQIL 296
Q+++L
Sbjct: 130 YRLYVIYKVPQVRVL 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 9e-05
Identities = 27/143 (18%), Positives = 44/143 (30%), Gaps = 12/143 (8%)
Query: 387 IPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLR 446
+ ++ K L+ L+ DL L ++ + N+ L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 447 HLDFRSNSL--NSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS 504
L+ +N L + S + ++ S N L L+ L L L GN LS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 505 -------GYIPSSIGNLKNLDWL 520
YI + L L
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRL 151
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 26/125 (20%), Positives = 46/125 (36%), Gaps = 5/125 (4%)
Query: 434 QIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEAL 493
Q+ ++ L S + I V +S++ +L + N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRSD---PDLVAQNIDVVLNRRSSMAATLRIIEENIPEL 67
Query: 494 GGLNLTGNQLSGY--IPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNI 551
LNL+ N+L + S + NL L L+ N + + L+ L L GN++
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 552 SGEIP 556
S
Sbjct: 128 SDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 23/138 (16%), Positives = 44/138 (31%), Gaps = 17/138 (12%)
Query: 119 QLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNN 178
++ D+ + +V + + ++ + + +P L+ L L N
Sbjct: 23 SQQALDLKGLR----SDPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPELLSLNLSNNR 76
Query: 179 ITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPS 238
+ + + + NLKIL+L GN + + + L GN LS
Sbjct: 77 LYRLDD---MSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
Query: 239 SI--------YLPNLENL 248
P L L
Sbjct: 134 QSTYISAIRERFPKLLRL 151
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 29/197 (14%), Positives = 58/197 (29%), Gaps = 16/197 (8%)
Query: 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNN 428
L+ + L + + L ++ L + +K + L L + +N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 429 NALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIG 488
N L P ++ + + + + L + + N+
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 489 NLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSG 548
L S I L ++ Q + +L +L+ LD+S
Sbjct: 132 RL----------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISS 181
Query: 549 NNISGEIPKSLEKLSRL 565
N +S L KL+ L
Sbjct: 182 NKVSD--ISVLAKLTNL 196
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 973 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.39 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.31 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.54 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.93 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.75 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.6 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.58 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=422.27 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=203.8
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677789999999999999999889999999987543 334689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|+|.+++......+++..+..++.|||+||+||| +++|+||||||+||+++.++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999887778999999999999999999999 799999999999999999999999999999877544444444
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchhh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEED 919 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 919 (973)
...||+.|+|||.+....++.++|||||||++|||+|++.|+..... ...+...+.....
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~------------------- 220 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFR------------------- 220 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHHTCC-------------------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHhcCC-------------------
Confidence 56789999999999999999999999999999999996555432111 1111111111100
Q ss_pred hhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 920 ADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 920 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
...+..+++++.+++.+||+.||++||||+|++++|+++.+.
T Consensus 221 ---~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 ---LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 001123456789999999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=421.83 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=208.8
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||+||+|+.+. .||||+++.. .....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678889999999999999998753 5999998654 34456789999999999999999999999865 46799999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP- 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~- 835 (973)
||++|+|.+++...+..+++.++..|+.|||+||+||| +++||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877768999999999999999999999 78999999999999999999999999999987643322
Q ss_pred cccccccccccccCccCCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 VTQTMTLATIGYMAPEYGSE---GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.......||+.|||||.+.. ..++.++|||||||++|||+||+.||....... .+...+...... +..
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~-------p~~- 231 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLS-------PDL- 231 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCC-------CCG-
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC-------Ccc-
Confidence 23344579999999998753 458999999999999999999999997532221 111111111100 000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
...+..+++++.+++.+||+.||++||||+|++++|+.+.+.++
T Consensus 232 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 ----------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ----------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 01122456789999999999999999999999999999987543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=410.05 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=215.1
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMP 759 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 759 (973)
++|...++||+|+||+||+|+.++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999999899999999976543 34689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcccc
Q 048430 760 QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839 (973)
Q Consensus 760 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 839 (973)
+|+|..++......+++..+.+++.|+|+||+||| +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999998877778999999999999999999999 789999999999999999999999999999876554444444
Q ss_pred cccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 840 ~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...+|+.|+|||.+....++.++|||||||++|||+| |+.||......+ +...+.. + ..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~---~---------~~------ 219 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQ---G---------LR------ 219 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHT---T---------CC------
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHh---C---------CC------
Confidence 5679999999999999999999999999999999998 798986543211 1111111 0 00
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
...+..+++++.+++.+||+.||++|||++|++++|.+
T Consensus 220 ----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 ----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01112345679999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=420.39 Aligned_cols=257 Identities=22% Similarity=0.397 Sum_probs=200.7
Q ss_pred CCCCCccccccCceEEEEEEeC-C---CeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATLA-N---GVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
+|...++||+|+||+||+|+.. + ...||||.+... .....+.|.+|++++++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3445689999999999999864 2 336899987654 3345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|||++|+|.+++......+++.++..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999999999999887768999999999999999999999 79999999999999999999999999999987643222
Q ss_pred c----ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 836 V----TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 836 ~----~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
. ......+|+.|||||.+.++.++.++|||||||++|||+| |+.||...... .+...+...
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~------------ 249 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQD------------ 249 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT------------
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------------
Confidence 1 1122457899999999999999999999999999999998 89998653221 111111110
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
. +.+.+..+++++.+++.+||+.||++||||+|+++.|+++.+.
T Consensus 250 ~----------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 Y----------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C----------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 0 0011224567799999999999999999999999999988653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=413.55 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=210.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999985 579999999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++|+|.+++... .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...... ...
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999999988765 5999999999999999999999 7999999999999999999999999999998765432 233
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCchh
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEE 918 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 918 (973)
...+||+.|+|||.+.+..++.++||||+||++|||++|+.||......+ .+........+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~------------------ 234 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP------------------ 234 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC------------------
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC------------------
Confidence 45579999999999999999999999999999999999999996432111 11111111000
Q ss_pred hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 919 DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 919 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 235 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ---ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001122346678999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=413.42 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=210.0
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|...+.||+|+||.||+|++++++.||||+++... ...+.|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 45677889999999999999999889999999997543 334689999999999999999999998865 5678999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++|+|.+++.... ..+++.++..|+.||++||.||| +++|+||||||+|||+++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999999876543 35899999999999999999999 7999999999999999999999999999999876544444
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....||+.|+|||.+.++.++.++|||||||++|||+||+.|+...... ....+.+....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~------------------ 227 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGY------------------ 227 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTC------------------
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcC------------------
Confidence 45567899999999998889999999999999999999976665432211 11111111100
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
+...+..+++++.+++.+||+.||++||||+|+++.|+.+-
T Consensus 228 ----~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 00111235667899999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=409.64 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=205.1
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5688899999999999999996 5799999999876532 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC-c
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-V 836 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-~ 836 (973)
+++|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999997654 7999999999999999999999 79999999999999999999999999999987643322 2
Q ss_pred ccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 TQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....+||+.|||||.+.+..+ +.++||||+||++|||++|+.||............+......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------------- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Confidence 2345679999999998877765 678999999999999999999997543332222221110000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......+++++.+++.+||+.||++|||++|+++|
T Consensus 226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00112245668899999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=409.73 Aligned_cols=260 Identities=21% Similarity=0.360 Sum_probs=212.5
Q ss_pred CCCCCc-cccccCceEEEEEEeC---CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 681 GFGESN-LLGSGSFDNVYKATLA---NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 681 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
+|...+ +||+|+||+||+|... ++..||||+++... ....+.|.+|++++++++|||||+++|+|.. +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 344455 4999999999999753 46689999997553 3446789999999999999999999999975 4679999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|||++|+|.+++...+..+++.++..++.|||+||+||| +++|+||||||+||+++.++.+||+|||+|+.......
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999999998877668999999999999999999999 79999999999999999999999999999987754333
Q ss_pred c--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 836 V--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 836 ~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
. ......||+.|+|||.+..+.++.++|||||||++|||+| |+.||...... .+...+....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~------------- 229 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK------------- 229 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTC-------------
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-------------
Confidence 2 2234468999999999988899999999999999999998 89999753221 1222221100
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
+...+..+++++.+++.+||+.+|++||||.+|++.|+.+...+...
T Consensus 230 ---------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 230 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 00112345678999999999999999999999999999887665543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=406.70 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=207.1
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688889999999999999996 478999999987442 334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|||++|+|.+++.... .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 9999999999998765 6999999999999999999999 799999999999999999999999999999865432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......||+.|||||.+.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~--------~---- 221 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVE--------F---- 221 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTC--------C----
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC--------C----
Confidence 23345799999999999999999999999999999999999999965221 11111111100 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|||++|+++|
T Consensus 222 --------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 --------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0112245678899999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-48 Score=413.15 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=214.0
Q ss_pred HhcCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 678 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
..++|...+.||+|+||+||+|+.. +++.||||+++... ...++|.+|++++++++|||||+++++|.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3457888899999999999999965 68999999986543 335789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 757 YMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 757 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||++|+|.+++... ...+++..+..++.|||+||+||| +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999999764 357899999999999999999999 78999999999999999999999999999997765444
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+...+.. ...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~------------~~~--- 234 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEK------------DYR--- 234 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHT------------TCC---
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhc------------CCC---
Confidence 4445556899999999999999999999999999999999987776432111 111111111 110
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
...+..+++++.+++.+||+.||++|||++|+++.|+.+.
T Consensus 235 -------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 -------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0111235677999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=413.43 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=208.6
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
+.|+..+.||+|+||+||+|+. .+++.||||+++.......+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4578889999999999999996 578999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
++|+|.+++......+++.++..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+..... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC-cccc
Confidence 999999998776557999999999999999999999 799999999999999999999999999999764321 1123
Q ss_pred ccccccccccCccCC-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 839 TMTLATIGYMAPEYG-----SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~-----~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
....||+.|+|||.+ ....++.++|||||||++|||++|+.||......+ .+........+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~------------- 233 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPP------------- 233 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCC-------------
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCC-------------
Confidence 346799999999976 34568999999999999999999999997543221 11111111000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 234 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 --------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001122356778999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=408.62 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=205.9
Q ss_pred cCCCCCccccccCceEEEEEEeCCC-----eEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANG-----VSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
+.|...++||+|+||.||+|.++.. ..||||+++... ....+.|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999986532 479999987543 3345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+.+|++.+++......+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999887778999999999999999999999 799999999999999999999999999999876433
Q ss_pred CCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
... ......||+.|+|||.+..+.++.++|||||||++|||++|+.|+....... .+...+.. ..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~------------~~ 230 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIND------------GF 230 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT------------TC
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhc------------cC
Confidence 222 2233468999999999999999999999999999999999777654322111 11111111 10
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILT 966 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~ 966 (973)
. .+.+..++.++.+++.+||+.||++||+|.||++.|+++.+.-.
T Consensus 231 ~----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 231 R----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp C----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred C----------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 0 01112356678999999999999999999999999999887543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=405.60 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=205.3
Q ss_pred ccccccCceEEEEEEeC---CCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEecCC
Q 048430 686 NLLGSGSFDNVYKATLA---NGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQ 760 (973)
Q Consensus 686 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 760 (973)
++||+|+||+||+|.+. .++.||||+++.. .....+.|.+|++++++++||||++++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999853 3578999998643 23345789999999999999999999999965 457899999999
Q ss_pred CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc--c
Q 048430 761 GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT--Q 838 (973)
Q Consensus 761 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~ 838 (973)
|+|.+++.... .+++.++..++.||++||+||| +++||||||||+||+++.++.+||+|||+++......... .
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999998765 7999999999999999999999 7899999999999999999999999999998765433322 2
Q ss_pred ccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 839 TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.... .+...+.. +.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~---~~--------------- 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEK---GE--------------- 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT---TC---------------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHc---CC---------------
Confidence 33468999999999988999999999999999999998 89998753211 11111111 00
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhhc
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQAL 969 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~~ 969 (973)
+...+..+++++.+++.+||+.||++|||++||++.|+.+-.+.-++.
T Consensus 228 ----~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e~ 275 (277)
T d1xbba_ 228 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275 (277)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCCC
Confidence 011123456789999999999999999999999999988766554443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=402.82 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=193.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec--CCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN--PGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 754 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... +...+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788899999999999999985 578999999987553 3445778999999999999999999999864 4568999
Q ss_pred EEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 755 MQYMPQGSLEKWLYSH---NYSLTIRQRLDIMIDVASALEYLHHGY--STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
||||++|+|.+++... ...+++..++.++.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 347999999999999999999999421 13499999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||..... ..+...+.. .
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~-----------~ 229 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIRE-----------G 229 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH-----------T
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHc-----------C
Confidence 65322 223446799999999999999999999999999999999999999965321 111111111 0
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .+..+++++.+++.+||+.||++|||++|+++|
T Consensus 230 ~~~~-----------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 KFRR-----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC-----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000 012345678999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=395.91 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=196.9
Q ss_pred CCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec----CCeeEEEE
Q 048430 683 GESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN----PGFKALIM 755 (973)
Q Consensus 683 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 755 (973)
+..++||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4456899999999999996 468899999987543 3445789999999999999999999999854 45679999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEEccCCCCcEEeC-CCCcEEEeecccccccCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP--IIHCDLKPNNVLLD-DDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~ 832 (973)
||+++|+|.+++.... .+++.++..++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999998764 7999999999999999999999 666 99999999999996 578999999999986432
Q ss_pred CCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 833 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
......+||+.|||||.+.+ .++.++|||||||++|||++|+.||..... ..........+....
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i~~~~~~~------- 232 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVKPA------- 232 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCCCG-------
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHHHcCCCCc-------
Confidence 22334579999999998765 699999999999999999999999964321 112111111110000
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|||++|+++|
T Consensus 233 -----------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 -----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0112235568899999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=413.56 Aligned_cols=271 Identities=22% Similarity=0.294 Sum_probs=206.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.++|...+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788999999999999999995 579999999997653 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
||++|+|.+++...+ .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+|+.... .
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 158 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---H
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---C
Confidence 999999999998765 69999999999999999999993 24899999999999999999999999999986532 1
Q ss_pred ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh------cccc
Q 048430 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV------VDAN 910 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~d~~ 910 (973)
.....+||+.|+|||.+.+..++.++||||+||++|||++|+.||......+.. ........+..... ....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH--HHC---------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhcCCcccCCccccccccc
Confidence 223458999999999999999999999999999999999999999653221110 00000000000000 0000
Q ss_pred -----cCCCCchhhhhhHH----------hHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 911 -----LLSREDEEDADDFA----------TKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 911 -----l~~~~~~~~~~~~~----------~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.............. ....++.++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000000000 001135678999999999999999999999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=410.18 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=207.1
Q ss_pred hcCCCCCccccccCceEEEEEEeCC------CeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 750 (973)
.++|...++||+|+||+||+|+... ...||||.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578888999999999999998532 2469999886543 33456899999999998 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCC
Q 048430 751 KALIMQYMPQGSLEKWLYSHN----------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~ 808 (973)
.++|||||++|+|.++++... ..+++..++.++.||++||+||| +++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 999999999999999997653 24889999999999999999999 78999999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 048430 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFT 886 (973)
Q Consensus 809 ~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~ 886 (973)
+||+++.++.+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543332 2334568999999999999999999999999999999998 8999875332
Q ss_pred CcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 048430 887 GEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKK 960 (973)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~ 960 (973)
. ..+...+.... +...+..+++++.+++.+||+.||++||||+||+++|..
T Consensus 273 ~-~~~~~~~~~~~----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 D-ANFYKLIQNGF----------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp S-HHHHHHHHTTC----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HHHHHHHhcCC----------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 2 12222222110 001123456779999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=398.84 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=202.2
Q ss_pred hcCCCCCccccccCceEEEEEEeC----CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA----NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.++|...+.||+|+||.||+|+.. .+..||||.++... +...+.|.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 356788899999999999999854 24578899886443 344678999999999999999999999996 467899
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
||||+++|++.+++......+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998887778999999999999999999999 899999999999999999999999999999876544
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 912 (973)
.........||+.|+|||.+....++.++|||||||++|||++ |+.||...... .+...+.....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~------------ 227 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER------------ 227 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC------------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence 4444455678999999999999999999999999999999998 88888654322 22222211100
Q ss_pred CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 913 SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
.+.+..+++++.+++.+||+.||++|||++|++++|+.+.+.-
T Consensus 228 ----------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 228 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0112245677999999999999999999999999999987653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-46 Score=405.17 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=191.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.+.|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46688899999999999999996 478999999987553 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC---CCCcEEEeecccccccCCC
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~~~ 833 (973)
||++|+|.+++...+ .+++.++..++.||+.||+||| +++||||||||+||++. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999998754 7999999999999999999999 79999999999999994 5789999999999866432
Q ss_pred CCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 834 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
. .....+||+.|||||.+.+..++.++||||+||++|||++|+.||.+.... .....+.. +. ...
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~---~~--------~~~ 228 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILK---AE--------YEF 228 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHT---TC--------CCC
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhc---cC--------CCC
Confidence 2 233457999999999999999999999999999999999999999653211 11111111 00 000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ......+++++.+++.+||+.||++|||++|+++|
T Consensus 229 ~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 D--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C--------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 00112345678999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-45 Score=405.85 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=210.6
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999999985 57999999999776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC--CCcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD--DMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~ 835 (973)
|++|+|.+++......+++.++..++.||+.||+||| +++||||||||+|||++. ++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 9999999999766667999999999999999999999 899999999999999964 578999999999876532
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......||+.|||||.+.+..++.++||||+||++|||++|+.||.+... ........ ......
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~--------~~~~~~-- 244 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNVK--------SCDWNM-- 244 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH--------HTCCCS--
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHH--------hCCCCC--
Confidence 233446799999999999999999999999999999999999999965321 11111110 000000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.. .....+++++.+++.+||+.||++|||++|+++|
T Consensus 245 ~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DD------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CC------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred Cc------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0111245678999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=402.91 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=204.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688899999999999999996 579999999987542 334577999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++||||||||+|||+++++.+||+|||+|+.......
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999988765 7999999999999999999999 89999999999999999999999999999987653322
Q ss_pred -cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 836 -VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 836 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......+||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .........+. .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~--------~--- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIKLE--------Y--- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHTTC--------C---
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHHHHcCC--------C---
Confidence 233445799999999999999999999999999999999999999965211 11111111110 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|||++|++++
T Consensus 228 ---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ---------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0011245668899999999999999999998665
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=397.83 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=202.6
Q ss_pred hcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++|+..+.||+|+||.||+|+.++++.||||+++... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35788899999999999999999888899999986543 334789999999999999999999999865 5678999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++|+|..++.... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999999887543 46999999999999999999999 7899999999999999999999999999998765444444
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCch
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDE 917 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 917 (973)
.....||+.|+|||++..+.++.++|||||||++|||++|+.|+...... .....++.....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~----------------- 232 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYR----------------- 232 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC-----------------
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC-----------------
Confidence 45567999999999999999999999999999999999987775432211 111121111100
Q ss_pred hhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 048430 918 EDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIK 962 (973)
Q Consensus 918 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~ 962 (973)
.+.+..+++++.+++.+||+.||++||+|++|++.|+.+.
T Consensus 233 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 0111235667899999999999999999999998887643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-46 Score=400.50 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=201.4
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
.|...+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488889999999999999985 578999999987543 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
||++|++..++.... .+++.++..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 999999987766554 7999999999999999999999 79999999999999999999999999999986532
Q ss_pred ccccccccccccCccCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCC
Q 048430 837 TQTMTLATIGYMAPEYGS---EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 913 (973)
.....||+.|||||.+. .+.++.++|||||||++|||++|+.||..... ...+.... ... .+..
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~~~~~i~-~~~-----~~~~-- 234 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIA-QNE-----SPAL-- 234 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH-HSC-----CCCC--
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-hCC-----CCCC--
Confidence 23457999999999764 35689999999999999999999999865321 11111100 000 0000
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+..+++++.+++.+||+.||++|||++|+++|
T Consensus 235 -----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 -----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 011245678999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-45 Score=404.71 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=210.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35688999999999999999995 57999999999876655567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeC--CCCcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD--DDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|++|+|.+++......+++.+++.|+.||+.||+||| +++||||||||+|||++ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999999998877767999999999999999999999 79999999999999997 6789999999999887542
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... .....+...... ...
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~---------~~~-- 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWE---------FDE-- 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCCC---------CCS--
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC---------CCc--
Confidence 2334457999999999999999999999999999999999999999653211 111111110000 000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....+++++.+++.+||+.||++|||++|+++|
T Consensus 250 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 --------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011245678999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=401.22 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=208.2
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCe----EEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGV----SVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 753 (973)
.+|+..++||+|+||+||+|+.. +|+ +||+|.++... ....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999854 443 68888876443 34467899999999999999999999999865 5678
Q ss_pred EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCC
Q 048430 754 IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833 (973)
Q Consensus 754 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 833 (973)
|+||+.+|+|.+++......+++..+..++.|||+||+||| +++||||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999988778999999999999999999999 789999999999999999999999999999876543
Q ss_pred CCcc-cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccccc
Q 048430 834 DPVT-QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANL 911 (973)
Q Consensus 834 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 911 (973)
.... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||+..... .+...+....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~------------ 230 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE------------ 230 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTC------------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC------------
Confidence 3322 233468999999999999999999999999999999999 78888653322 2222222110
Q ss_pred CCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHh
Q 048430 912 LSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQ 967 (973)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~ 967 (973)
+...+..+++++.+++.+||+.||++|||++|++++|+.+.+...+
T Consensus 231 ----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~ 276 (317)
T d1xkka_ 231 ----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276 (317)
T ss_dssp ----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHH
T ss_pred ----------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHh
Confidence 0011234567799999999999999999999999999998765443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=391.94 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=207.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc------hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE------DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35788999999999999999996 579999999986432 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC----cEEEeecccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM----VAHLGDFGIA 827 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla 827 (973)
++|||||++|+|.+++...+ .+++.+++.++.|++.||+||| +.+||||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999998765 7999999999999999999999 89999999999999998876 4999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... +.........
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~~~----- 232 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANVSAVN----- 232 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHTTC-----
T ss_pred hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcC-----
Confidence 8764322 234457899999999999999999999999999999999999999653211 1111110000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. .. ....+..++.++.+++.+||+.||++|||++|+++|
T Consensus 233 ---~--~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 ---Y--EF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---C--CC------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---C--CC------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 011122356778999999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=399.29 Aligned_cols=262 Identities=24% Similarity=0.408 Sum_probs=212.4
Q ss_pred HHHHHhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccch-hhHHHHHHHHHHHHhccCCceeEEEeeee
Q 048430 674 ELQQATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKIVSSCS 746 (973)
Q Consensus 674 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 746 (973)
+++...++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44445678999999999999999999853 467899999875533 34578999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEE
Q 048430 747 NPGFKALIMQYMPQGSLEKWLYSHN-----------------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803 (973)
Q Consensus 747 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 803 (973)
..+..++||||+++|+|.++++... ..+++..+..|+.|++.||+||| +++|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 9999999999999999999997532 24889999999999999999999 899999
Q ss_pred ccCCCCcEEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCC-CC
Q 048430 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRK-PT 881 (973)
Q Consensus 804 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~-p~ 881 (973)
|||||+||+++.++.+||+|||+|+........ ......+++.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999866432222 2334568899999999999999999999999999999999964 56
Q ss_pred CccccCcccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 882 NEMFTGEMSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
...... .+...+.. +. . ...+..+++++.+++.+||+.+|++||||.||++.|++|
T Consensus 244 ~~~~~~--e~~~~v~~---~~--------~-----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHE--EVIYYVRD---GN--------I-----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHH--HHHHHHHT---TC--------C-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHH--HHHHHHHc---CC--------C-----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 542211 11111111 10 0 011224566789999999999999999999999999987
Q ss_pred H
Q 048430 962 K 962 (973)
Q Consensus 962 ~ 962 (973)
.
T Consensus 300 ~ 300 (301)
T d1lufa_ 300 C 300 (301)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=389.64 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=198.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec-CCeeEEEEEec
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGFKALIMQYM 758 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 758 (973)
++|...+.||+|+||.||+|+.+ |+.||||+++.+ ...+.+.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45667889999999999999985 889999998644 344789999999999999999999999855 56789999999
Q ss_pred CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 759 PQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 759 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
++|+|.+++.... ..+++..+++++.||+.||.||| +.+|+||||||+||+++.++.+|++|||+++.... .
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----~ 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----T 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC----C
Confidence 9999999997643 35899999999999999999999 78999999999999999999999999999986542 2
Q ss_pred cccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCCc
Q 048430 838 QTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRED 916 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 916 (973)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.||..... ..+..++.....
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~~---------------- 218 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYK---------------- 218 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCC----------------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCC----------------
Confidence 233468899999999988999999999999999999998 6777654322 122222211000
Q ss_pred hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 917 EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 917 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
...+..+++++.+++.+||+.||++||||.|++++|++++.
T Consensus 219 ------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 ------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 01112345678999999999999999999999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=394.85 Aligned_cols=258 Identities=23% Similarity=0.403 Sum_probs=208.7
Q ss_pred CccccccCceEEEEEEeCC----CeEEEEEEEecc-chhhHHHHHHHHHHHHhccCCceeEEEeeeec-CCeeEEEEEec
Q 048430 685 SNLLGSGSFDNVYKATLAN----GVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSSCSN-PGFKALIMQYM 758 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 758 (973)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998643 236899998643 44556889999999999999999999999865 56889999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc--
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-- 836 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-- 836 (973)
++|+|.+++.......++..+..++.|+|+||.|+| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999987778889999999999999999999 799999999999999999999999999999876433222
Q ss_pred -ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 837 -TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 837 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
......||+.|+|||....+.++.++|||||||++|||+||+.||....... .+..++.....
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~--------------- 252 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR--------------- 252 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC---------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC---------------
Confidence 2233568999999999999999999999999999999999888876433221 11121111000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHHHhh
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKILTQA 968 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~~~~ 968 (973)
...+..+++++.+++.+||+.||++||+|.||+++|+++.+.+..+
T Consensus 253 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 253 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 0011234567899999999999999999999999999998765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=391.81 Aligned_cols=278 Identities=21% Similarity=0.280 Sum_probs=201.3
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----eeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG----FKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. +|+.||||+++..... ...+..|+..+.+++||||++++++|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3566678999999999999997 4899999998644321 122334555556789999999999997543 678999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG-----YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
|||++|+|.++++.. .+++.++.+++.|+|.||+|+|.. ..++||||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999876 599999999999999999999942 1369999999999999999999999999999876
Q ss_pred CCCCCc---ccccccccccccCccCCCCCC------CCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc
Q 048430 831 DGVDPV---TQTMTLATIGYMAPEYGSEGI------VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901 (973)
Q Consensus 831 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 901 (973)
...... ......||+.|+|||++.... ++.++|||||||++|||+||..||............... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~--~~~ 236 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP--SDP 236 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC--SSC
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc--ccc
Confidence 543322 223457999999999876542 678999999999999999999887543222111100000 000
Q ss_pred chhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 902 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
......+....... ............+...+.+++.+||+.||++||||.||+++|+++.++
T Consensus 237 ~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00000000000000 001111122334667799999999999999999999999999988864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=396.73 Aligned_cols=249 Identities=24% Similarity=0.286 Sum_probs=208.6
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 754 (973)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35788999999999999999995 579999999997542 33457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||||++|+|.+++...+ .+++..++.++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999998765 7899999999999999999999 8999999999999999999999999999998654322
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
......+||+.|+|||.+.+..++.++||||+||++|||++|+.||.+... ..+...+.. +. .
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~i~~---~~--------~--- 222 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM---EE--------I--- 222 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---CC--------C---
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHHHHhc---CC--------C---
Confidence 233446799999999999999999999999999999999999999865321 111111111 00 0
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++||+ ++|+++|
T Consensus 223 ---------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ---------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 011234567889999999999999995 8888876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=390.74 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=201.9
Q ss_pred HHHHhcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeee
Q 048430 675 LQQATNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCS 746 (973)
Q Consensus 675 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 746 (973)
++...++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3334467888999999999999999853 35789999987543 34456788888888877 6899999999876
Q ss_pred c-CCeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCc
Q 048430 747 N-PGFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNN 810 (973)
Q Consensus 747 ~-~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N 810 (973)
+ ....++|||||++|+|.++++... ..+++.++..++.||++||+||| +++||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence 5 456899999999999999997542 35899999999999999999999 7999999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCccccCc
Q 048430 811 VLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRR-KPTNEMFTGE 888 (973)
Q Consensus 811 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~-~p~~~~~~~~ 888 (973)
||++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||..... .
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~ 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-D 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-S
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-H
Confidence 99999999999999999876433322 334457999999999999999999999999999999999975 46654322 1
Q ss_pred ccHHHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 889 MSLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
..+...+..... ...+..+++++.+++.+||+.||++|||++|+++||+.+.+.
T Consensus 244 ~~~~~~~~~~~~----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 244 EEFCRRLKEGTR----------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHTCC----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCC----------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 222222221110 001123456789999999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=389.52 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=197.7
Q ss_pred cCCCCCccccccCceEEEEEEeC--C--CeEEEEEEEecc---chhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA--N--GVSVAVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKA 752 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 752 (973)
++|+..+.||+|+||.||+|+.. + ...||||+++.. .+...+.|.+|+.++++++||||++++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 46788899999999999999853 2 347899988643 234467899999999999999999999999764 678
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
+||||+++|++.+++......+++..+..++.|||+||.||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999988876667999999999999999999999 79999999999999999999999999999998754
Q ss_pred CCCc--ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccHHHHHHhhCCcchhhhccc
Q 048430 833 VDPV--TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909 (973)
Q Consensus 833 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 909 (973)
.... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||.+.... ....++.. +
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~---~-------- 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDK---E-------- 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT---S--------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHh---C--------
Confidence 3322 2234468889999999999999999999999999999998 89998643211 11111111 0
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKI 961 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~ 961 (973)
... .+.+..++.++.+++.+||+.||++||||+||.+.|++.
T Consensus 231 ~~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GER----------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 000 011123456789999999999999999999999888764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.7e-44 Score=378.58 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=205.5
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---------hhhHHHHHHHHHHHHhcc-CCceeEEEeeeecC
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---------DRALKSFDTECEVMRRIR-HRNLIKIVSSCSNP 748 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 748 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999985 579999999987542 122456889999999997 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
+..|+|||||++|+|.+++.... .+++.+++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999998765 7999999999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCccCCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcc
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGS------EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 902 (973)
...... ......||+.|+|||.+. ...++.++||||+||++|||++|+.||.+.... .....+...
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~~~~~i~~~---- 230 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMSG---- 230 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT----
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--HHHHHHHhC----
Confidence 765422 234457999999999653 345789999999999999999999999753211 111111110
Q ss_pred hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 903 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .......+++++.+++.+||++||++||+++||++|
T Consensus 231 -------~~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 -------NYQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -------CCCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -------CCCC--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 000112356779999999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-44 Score=389.76 Aligned_cols=245 Identities=27% Similarity=0.315 Sum_probs=206.0
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688899999999999999996 579999999997542 334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
|||++|++..++.... .+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999988765 7889999999999999999999 899999999999999999999999999999876432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
....+||+.|||||.+.+..++.++||||+||++|||++|+.||..... ........ ....
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~--------~~~~---- 218 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKIL--------NAEL---- 218 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH--------HCCC----
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHHH--------cCCC----
Confidence 2345799999999999999999999999999999999999999965221 11111110 0000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..+++++.+++.+|++.||++|+ +++|+++|
T Consensus 219 --------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 00112356688999999999999996 89999886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-44 Score=384.40 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=202.5
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----e
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG----F 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 750 (973)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36788999999999999999985 579999999997542 344567999999999999999999999986543 4
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.|+||||+++|+|.+++...+ .+++.++..++.||+.||+||| +.+||||||||+||+++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 789999999999999988765 7999999999999999999999 799999999999999999999999999998765
Q ss_pred CCCCC--cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 831 DGVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 831 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
..... ......+||+.|+|||.+.+..++.++||||+||++|||+||+.||......+ .....+.. ....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~---~~~~---- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVRE---DPIP---- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHC---CCCC----
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhc---CCCC----
Confidence 33222 23344579999999999998899999999999999999999999996532111 11111110 0000
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-NVKDALADLKKIK 962 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-t~~evl~~L~~~~ 962 (973)
.......+++++.+++.+||+.||++|| +++|+++.|.+++
T Consensus 234 -------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0001123456789999999999999999 8999999888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=386.78 Aligned_cols=252 Identities=19% Similarity=0.284 Sum_probs=207.9
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
.++|...+.||+|+||+||+|+. .+++.||||+++.... ....+.+|++++++++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 46788999999999999999986 4789999999976543 335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCC--CcEEEeecccccccCCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD--MVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~~ 835 (973)
|++|+|.+++...+..+++.++..++.||+.||+||| +.+|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999999999877667999999999999999999999 7999999999999999854 58999999999876432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.......+|+.|+|||...+..++.++||||+||++|||++|+.||...... ..+.. +...... .
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~--------i~~~~~~--~ 222 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIEN--------IMNAEYT--F 222 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH--------HHHTCCC--C
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHH--------HHhCCCC--C
Confidence 2234457899999999999999999999999999999999999999653211 11111 0000000 0
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......+++++.+++.+|++.||++|||++|+++|
T Consensus 223 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 ------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112346678999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=385.36 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=213.0
Q ss_pred hcCCCCCccccccCceEEEEEEe------CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL------ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 750 (973)
.++|...++||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||+++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35777789999999999999985 356789999997653 34456799999999999 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 751 KALIMQYMPQGSLEKWLYSHN-----------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
.++|||||++|+|.++++... ..+++..+..++.||++||+||| +++||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 999999999999999997643 35899999999999999999999 7999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCC-cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~ 892 (973)
+.++.+|++|||.++....... .......||+.|+|||.+.++.++.++|||||||++|||+|++.|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654333 233456789999999999999999999999999999999996555433333322233
Q ss_pred HHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHH
Q 048430 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKI 964 (973)
Q Consensus 893 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~ 964 (973)
..+..... . ..+..+++++.+|+.+||+.||++||||+|+++.|+++...
T Consensus 259 ~~i~~~~~------------~----------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGFR------------M----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTCC------------C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCC------------C----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 33322111 0 01122456789999999999999999999999999877543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=390.32 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=203.9
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCe--EEEEEEEecc-chhhHHHHHHHHHHHHhc-cCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGV--SVAVKVFNLQ-EDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...++||+|+||.||+|++. ++. .||||.++.. .....+.|.+|+++++++ +||||++++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56777899999999999999864 444 4777877543 233456899999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcE
Q 048430 755 MQYMPQGSLEKWLYSH---------------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA 819 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 819 (973)
|||+++|+|.++++.. ...+++.++..++.|||.||.|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999754 257999999999999999999999 7999999999999999999999
Q ss_pred EEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCccccCcccHHHHHHhh
Q 048430 820 HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRK-PTNEMFTGEMSLKQWVAES 898 (973)
Q Consensus 820 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~ 898 (973)
||+|||+|+..... .......||..|+|||.+..+.++.++|||||||++|||++|.. ||... ...+.....
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHG
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Confidence 99999999865321 12233468999999999999999999999999999999999765 55432 112221111
Q ss_pred CCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 899 LPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 899 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
..+ . +...+..+++++.+++.+||+.||++||||+||+++|+++.+..
T Consensus 240 ~~~---------~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 PQG---------Y----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGT---------C----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred Hhc---------C----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 100 0 01112235677999999999999999999999999999987643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-43 Score=390.60 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=200.7
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHH---HHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTE---CEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...++||+|+||.||+|+. .+|+.||||++.... ......+.+| +.+++.++||||+++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36788999999999999999996 479999999986432 1122334444 5666677899999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccC
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 831 (973)
|+||||+++|+|.+++.... .+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999998765 6899999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccc
Q 048430 832 GVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDAN 910 (973)
Q Consensus 832 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 910 (973)
.. ......||+.|+|||.+.. ..++.++|||||||++|||+||+.||......+ .............
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~~------- 226 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAV------- 226 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCCC-------
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcccCCC-------
Confidence 32 2334579999999998764 568999999999999999999999997643222 1111111111100
Q ss_pred cCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 048430 911 LLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERIN-----VKDALAD 957 (973)
Q Consensus 911 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt-----~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++||| ++|+++|
T Consensus 227 -------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 -------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 001124567899999999999999999 6888876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=385.14 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=205.5
Q ss_pred hcCCCCCccccccCceEEEEEEeC--------CCeEEEEEEEeccch-hhHHHHHHHHHHHHhc-cCCceeEEEeeeecC
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQED-RALKSFDTECEVMRRI-RHRNLIKIVSSCSNP 748 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 748 (973)
.++|...+.||+|+||.||+|+.. ++..||||+++.... .....+.+|+..+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 356777899999999999999842 235799999876543 4457889999999888 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEe
Q 048430 749 GFKALIMQYMPQGSLEKWLYSHN---------------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL 813 (973)
Q Consensus 749 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill 813 (973)
+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+||| +.+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999997653 35899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccCcccH
Q 048430 814 DDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSL 891 (973)
Q Consensus 814 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~ellt-g~~p~~~~~~~~~~~ 891 (973)
+.++.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||...... .+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence 99999999999999876543322 2344568999999999999999999999999999999998 67777542211 11
Q ss_pred HHHHHhhCCcchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 892 KQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 892 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
...+... .. ...+..+++++.+++.+||+.||++||||.||++.|+++.+
T Consensus 247 ~~~i~~~------------~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKLLKEG------------HR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTT------------CC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcC------------CC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111110 00 01112345679999999999999999999999999998864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=386.81 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=199.6
Q ss_pred hcCCCCCc-cccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhc-cCCceeEEEeeeec----CCee
Q 048430 679 TNGFGESN-LLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSN----PGFK 751 (973)
Q Consensus 679 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 751 (973)
.++|.+.. +||+|+||.||+|+. .+++.||||+++.. +.+.+|+.++.++ +||||++++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 45787764 699999999999985 57999999998633 4577899987655 89999999999864 4678
Q ss_pred EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccc
Q 048430 752 ALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIA 827 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla 827 (973)
|+|||||++|+|.+++.... ..+++.+++.++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 99999999999999998753 46999999999999999999999 899999999999999985 567999999999
Q ss_pred cccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 828 KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
+...... ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.+..... ........
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~~---------- 228 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTR---------- 228 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------C----------
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHHH----------
Confidence 8765332 2344679999999999999999999999999999999999999996532211 11111000
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........ .......+++++.+++.+||+.||++|||+.|+++|
T Consensus 229 ---i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 ---IRMGQYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCSCSSSC---CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HhcCCCCC---CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000000 001223467789999999999999999999999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-43 Score=387.08 Aligned_cols=245 Identities=22% Similarity=0.249 Sum_probs=206.1
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 755 (973)
++|...+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5788899999999999999986 579999999986542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 835 (973)
||+.+|+|.+++...+ .+++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999998765 7999999999999999999999 899999999999999999999999999999876432
Q ss_pred cccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCCC
Q 048430 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSRE 915 (973)
Q Consensus 836 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 915 (973)
.....||+.|||||.+.+..++.++|||||||++|||+||+.||.+.. ......... ....
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~--------~~~~---- 255 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIV--------SGKV---- 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHH--------HCCC----
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHHh--------cCCC----
Confidence 234579999999999999999999999999999999999999996521 111111110 0000
Q ss_pred chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 916 DEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 916 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
..+..+++++.+++.+||+.||++|+ +++|+++|
T Consensus 256 --------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 --------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 00112456788999999999999994 89999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=384.19 Aligned_cols=248 Identities=24% Similarity=0.287 Sum_probs=203.8
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc---hhhHHHHHHHHHHHH-hccCCceeEEEeeeecCCeeEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE---DRALKSFDTECEVMR-RIRHRNLIKIVSSCSNPGFKALI 754 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 754 (973)
++|...+.||+|+||+||+|+. .+++.||||+++... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788899999999999999986 479999999997542 333456777777765 68999999999999999999999
Q ss_pred EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCC
Q 048430 755 MQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 755 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 834 (973)
||||++|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence 99999999999998765 6899999999999999999999 789999999999999999999999999999865432
Q ss_pred CcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcccccCCC
Q 048430 835 PVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLSR 914 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 914 (973)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||.+... ..+...+....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~-------------- 220 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNP-------------- 220 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC--------------
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCC--------------
Confidence 2333446799999999999999999999999999999999999999965321 111111111000
Q ss_pred CchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 048430 915 EDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVK-DALAD 957 (973)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~-evl~~ 957 (973)
..+..+++++.+++.+||+.||++||++. |+++|
T Consensus 221 ---------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 ---------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 01122456789999999999999999995 77653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=381.47 Aligned_cols=273 Identities=23% Similarity=0.256 Sum_probs=203.7
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++... +...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999995 679999999986543 2235789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
|+.++.+..........+++.++..++.||+.||+||| +++||||||||+|||++.++.+||+|||.|+..... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VR 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SB
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC-cc
Confidence 99764444443444567999999999999999999999 799999999999999999999999999999876432 23
Q ss_pred ccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC-Cc-chhhhccc--cc
Q 048430 837 TQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL-PG-AVTEVVDA--NL 911 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~~~d~--~l 911 (973)
......||+.|+|||..... .++.++||||+||++|||++|+.||.+....+ .+........ +. ........ ..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhcccccccccc
Confidence 34445799999999976554 46899999999999999999999997532211 1222222111 11 11110000 00
Q ss_pred CCCC-chhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 912 LSRE-DEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 912 ~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.... .............+++++.+++.+|++.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 000001111112345778999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=381.93 Aligned_cols=267 Identities=23% Similarity=0.250 Sum_probs=196.9
Q ss_pred CccccccCceEEEEEEe-CCCeEEEEEEEeccch-----hhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEec
Q 048430 685 SNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED-----RALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYM 758 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 758 (973)
.++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999995 5799999999865432 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCccc
Q 048430 759 PQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838 (973)
Q Consensus 759 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 838 (973)
.++++..+.. ....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAY 157 (299)
T ss_dssp SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCC
T ss_pred cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc-ccc
Confidence 8876666554 3447999999999999999999999 8999999999999999999999999999998765332 223
Q ss_pred ccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cchhhhccccc-CC
Q 048430 839 TMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAVTEVVDANL-LS 913 (973)
Q Consensus 839 ~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~l-~~ 913 (973)
...+||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+ .+......... ..+........ ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchhhh
Confidence 34579999999998764 467999999999999999999999986532211 11111111110 00000000000 00
Q ss_pred CCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 914 REDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
................++++.+++.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000011112345779999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=384.26 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=209.4
Q ss_pred hcCCCCCccccccCceEEEEEEeC------CCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCee
Q 048430 679 TNGFGESNLLGSGSFDNVYKATLA------NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 751 (973)
.++|...+.||+|+||.||+|.+. +++.||||+++... ......|.+|+.++++++||||++++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 356777899999999999999853 36789999997543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEe
Q 048430 752 ALIMQYMPQGSLEKWLYSHN---------YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 822 (973)
++||||+++|+|.+++.... ..+++..+.+++.|+|+||.||| +++|+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999987532 35789999999999999999999 7899999999999999999999999
Q ss_pred ecccccccCCCCCc-ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCccccCcccHHHHHHhhCC
Q 048430 823 DFGIAKLLDGVDPV-TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRR-KPTNEMFTGEMSLKQWVAESLP 900 (973)
Q Consensus 823 Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 900 (973)
|||+|+........ ......+|+.|+|||.+.+..++.++|||||||++|||+||+ .||... ...++......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~~i~~ 250 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRFVME 250 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHHHHT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHh
Confidence 99999876433222 233346899999999999999999999999999999999985 555432 22222221111
Q ss_pred cchhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
+. . ...+..+++.+.+++.+||+.+|++||||.||+++|++..+
T Consensus 251 ~~--------~-----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GG--------L-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TC--------C-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CC--------C-----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 0 01112356679999999999999999999999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-43 Score=375.22 Aligned_cols=272 Identities=19% Similarity=0.219 Sum_probs=203.4
Q ss_pred cCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...++||+|+||+||+|+.++|+.||||+++... +...+.+.+|+.++++++||||+++++++..++..++|+|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999996543 23357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCcc
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 837 (973)
+.++.+..+... ...+++..+..++.||+.||+||| +.+||||||||+|||++.++.+|++|||.+....... ..
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 987666555544 458999999999999999999999 7899999999999999999999999999998765322 22
Q ss_pred cccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cchhhhccc-ccC
Q 048430 838 QTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAVTEVVDA-NLL 912 (973)
Q Consensus 838 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~-~l~ 912 (973)
.....+++.|+|||.+.. ..++.++||||+||++|||++|+.||......+ .+......... ..+...... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhhcc
Confidence 344568999999997765 457999999999999999999999997532211 11221111111 001111000 000
Q ss_pred -CCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 913 -SREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 913 -~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.................++++.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000011111112345678999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=376.59 Aligned_cols=240 Identities=21% Similarity=0.277 Sum_probs=197.3
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccch------hhHHHHHHHHHHHHhcc--CCceeEEEeeeecCCe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED------RALKSFDTECEVMRRIR--HRNLIKIVSSCSNPGF 750 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 750 (973)
++|...+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788899999999999999995 5799999999875421 12234678999999996 8999999999999999
Q ss_pred eEEEEEecCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-CCcEEEeeccccc
Q 048430 751 KALIMQYMPQ-GSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-DMVAHLGDFGIAK 828 (973)
Q Consensus 751 ~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~ 828 (973)
.++||||+.+ +++.+++.... .+++.+++.++.||+.||+||| +++|+||||||+||+++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 68888887654 7999999999999999999999 899999999999999985 4799999999998
Q ss_pred ccCCCCCcccccccccccccCccCCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhc
Q 048430 829 LLDGVDPVTQTMTLATIGYMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVV 907 (973)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (973)
.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .....
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~---------- 219 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG---------- 219 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC----------
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhc----------
Confidence 6542 23344679999999998876655 677999999999999999999986421 11110
Q ss_pred ccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
... .+..+++++.+++.+||+.||++|||++|+++|
T Consensus 220 --~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 --QVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --ccC------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 001235678999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=377.26 Aligned_cols=270 Identities=23% Similarity=0.286 Sum_probs=202.4
Q ss_pred hcCCCCCccccccCceEEEEEEe-CC-CeEEEEEEEeccc--hhhHHHHHHHHHHHHhc---cCCceeEEEeeee-----
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-AN-GVSVAVKVFNLQE--DRALKSFDTECEVMRRI---RHRNLIKIVSSCS----- 746 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----- 746 (973)
.++|...+.||+|+||+||+|+. ++ ++.||||+++... +.....+.+|+.+++.+ +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 6789999986542 22234566788877766 7999999999984
Q ss_pred cCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccc
Q 048430 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGI 826 (973)
Q Consensus 747 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 826 (973)
.....+++|||++++++..........+++..++.++.|++.||+||| +++||||||||+|||++.++.+||+|||.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 335789999999988776666666667999999999999999999999 79999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhh
Q 048430 827 AKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906 (973)
Q Consensus 827 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (973)
++.... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+...............
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGGS
T ss_pred hhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchhcc
Confidence 876432 22344567999999999999999999999999999999999999999753221 112222221111000000
Q ss_pred ------cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 ------VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 ------~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
......... .. .........++.+.+|+.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~-~~--~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKS-AQ--PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCC-CC--CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhcccc-cc--chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00 0011112345678899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=366.64 Aligned_cols=273 Identities=22% Similarity=0.299 Sum_probs=198.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec--------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN-------- 747 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 747 (973)
.++|...+.||+|+||+||+|+. .+|+.||||++.... +...+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36788999999999999999996 579999999986542 3345778999999999999999999998754
Q ss_pred CCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccc
Q 048430 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827 (973)
Q Consensus 748 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 827 (973)
.+..++||||+.++.+..+. .....++...++.+++|++.||.||| +.+|+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 35689999999876655444 44457999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHh-h--CC
Q 048430 828 KLLDGVDPV---TQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-S--LP 900 (973)
Q Consensus 828 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-~--~~ 900 (973)
+........ .....+||+.|+|||.+... .++.++||||+||++|||++|+.||..... ......+.. . ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSIT 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhcCCCC
Confidence 766432221 22335799999999987654 689999999999999999999999965321 111111111 1 11
Q ss_pred cchhhhcc-cccC----CCCc-hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 GAVTEVVD-ANLL----SRED-EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~~~~~~~d-~~l~----~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......+ .... .... ..............+++.+|+.+||++||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11111111 0000 0000 00111111222345678899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-40 Score=354.81 Aligned_cols=262 Identities=15% Similarity=0.140 Sum_probs=209.6
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC-CceeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH-RNLIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 757 (973)
++|.+.+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|++.++.++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5788899999999999999995 4799999998865432 2457789999999975 8999999999999999999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC-----CCcEEEeecccccccCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD-----DMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~~~ 832 (973)
+ +++|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+|+....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 67999999887778999999999999999999999 899999999999999974 57899999999987643
Q ss_pred CCCc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHH-HHHHhhCCcchhh
Q 048430 833 VDPV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK-QWVAESLPGAVTE 905 (973)
Q Consensus 833 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 905 (973)
.... .....+||+.|||||.+.+..++.++|||||||++|||++|+.||........... ..+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-----~ 233 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-----Q 233 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-----H
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-----C
Confidence 2211 22345799999999999999999999999999999999999999975432221110 0010000 0
Q ss_pred hcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHHHH
Q 048430 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKKIL 965 (973)
Q Consensus 906 ~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~~~ 965 (973)
..........+++++.+++..|++.+|++||+++.+.+.|+++.++.
T Consensus 234 -------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 -------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000111235677999999999999999999999998888876543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-40 Score=358.89 Aligned_cols=259 Identities=19% Similarity=0.217 Sum_probs=202.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCc-eeEEEeeeecCCeeEEEEEe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRN-LIKIVSSCSNPGFKALIMQY 757 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 757 (973)
++|...+.||+|+||.||+|+. .+|+.||||++...... +.+..|++++++++|+| |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688899999999999999985 57899999998755332 45789999999998766 55556666788899999999
Q ss_pred cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCC---CCcEEEeecccccccCCCC
Q 048430 758 MPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 758 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~~ 834 (973)
+ ++++.+.+......+++..+..++.|++.||+||| +++||||||||+||+++. +..+|++|||+|+......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 55787777776668999999999999999999999 899999999999999864 5579999999998765332
Q ss_pred Cc------ccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCccc--HHHHHHhhCCcchhhh
Q 048430 835 PV------TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS--LKQWVAESLPGAVTEV 906 (973)
Q Consensus 835 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 906 (973)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----- 235 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----- 235 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-----
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-----
Confidence 21 223457999999999999989999999999999999999999999764332211 11111000000
Q ss_pred cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHH
Q 048430 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALADLKKIKK 963 (973)
Q Consensus 907 ~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~L~~~~~ 963 (973)
........+++++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 236 --------------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 --------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --------------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred --------------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0001112456789999999999999999999999988887654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9.9e-41 Score=364.27 Aligned_cols=287 Identities=27% Similarity=0.479 Sum_probs=256.0
Q ss_pred ChHHHHhhhccCCCcccCCCCCCCCCCCCCCcc--eEEEEEeeCCC--CcEEEEecCCCCCCC--cCCCCCCCCCCCcEE
Q 048430 1 ALVQLKARISLDPHNFFANNWNLSPTNTSASVC--NWVGVTCSIRH--GRVAALSLPNLSLGG--TLPPHVGNLSFLVSL 74 (973)
Q Consensus 1 al~~~k~~~~~~~~~~~~~~w~~~~~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L 74 (973)
||++||++|+ || ..+++ |.. ++||| .|+||+|+..+ +||++|||+++++.| .+|+++++|++|++|
T Consensus 10 aLl~~k~~~~-~~-~~l~s-W~~-----~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 10 ALLQIKKDLG-NP-TTLSS-WLP-----TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp HHHHHHHHTT-CC-GGGTT-CCT-----TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred HHHHHHHHCC-CC-CcCCC-CCC-----CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 7999999997 55 35775 764 68999 49999998754 499999999999999 589999999999999
Q ss_pred EecC-CCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCcc
Q 048430 75 NISG-NSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNS 153 (973)
Q Consensus 75 ~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 153 (973)
+|++ |++.|.+|++|++|++|++|+|++|++.+..| ..+..+..|+++++++|.+.+.+|..|+++++|+.+++++|.
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP-DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC-GGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccccccccccchhhhcccccccccc-ccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 9997 89999999999999999999999999996544 556889999999999999999999999999999999999999
Q ss_pred ccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeeccccc
Q 048430 154 LSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS 233 (973)
Q Consensus 154 l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~ 233 (973)
+.|.+|..++.....++.+++++|+++|. .|..++++.. ..+++++|...+.+|..+..+++++.+++++|.+.
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~-----~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGK-----IPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEE-----CCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred ccccccccccccccccccccccccccccc-----cccccccccc-ccccccccccccccccccccccccccccccccccc
Confidence 99999988764444459999999999975 4567777754 47999999999999999999999999999999999
Q ss_pred ccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcC
Q 048430 234 GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303 (973)
Q Consensus 234 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 303 (973)
+.++....+++|++|+|++|+++|.+|+.|+.+++|++|+|++|+|+|.+|. ++++++|+.+++++|+.
T Consensus 235 ~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303 (313)
T ss_dssp CBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSE
T ss_pred ccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCcc
Confidence 9888877899999999999999999999999999999999999999988874 67889999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=359.04 Aligned_cols=272 Identities=18% Similarity=0.222 Sum_probs=207.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeecCCeeEEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQ 756 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 756 (973)
++|+..+.||+|+||+||+|+. .+++.||||+++... +...+.+.+|+.+++.++||||+++++++.++...++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788999999999999999995 578999999986543 3446789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCCCCCc
Q 048430 757 YMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836 (973)
Q Consensus 757 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 836 (973)
++.++++..++...+ .+++..+..++.|++.||+||| +++||||||||+|||++.++.+||+|||.|+...... .
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-S
T ss_pred ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC-c
Confidence 999988888777654 7899999999999999999999 7999999999999999999999999999998765332 2
Q ss_pred ccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC---cch---hhhccc
Q 048430 837 TQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---GAV---TEVVDA 909 (973)
Q Consensus 837 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~---~~~~d~ 909 (973)
......+++.|+|||.+... .++.++||||+||++|||++|+.||................... ... ....+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 33344678899999977655 46999999999999999999999974322211112211111111 000 011110
Q ss_pred ccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 910 NLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 910 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.-... ..............++++.+++.+|++.||++|||++|+++|
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPM-YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCC-CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccc-ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000001111122345678899999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=367.11 Aligned_cols=273 Identities=24% Similarity=0.254 Sum_probs=197.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc-hhhHHHHHHHHHHHHhccCCceeEEEeeeecCC----eeE
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG----FKA 752 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 752 (973)
.++|...++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999985 589999999996543 344678999999999999999999999986543 234
Q ss_pred EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccccCC
Q 048430 753 LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG 832 (973)
Q Consensus 753 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 832 (973)
++++++.+|+|.+++... .+++..++.++.|++.||+||| +++||||||||+|||++.++.+||+|||+|.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 555667799999999875 5999999999999999999999 79999999999999999999999999999986543
Q ss_pred CCC--cccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc-
Q 048430 833 VDP--VTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD- 908 (973)
Q Consensus 833 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d- 908 (973)
... ......+||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+. ..................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhhh
Confidence 221 12344579999999998744 5678999999999999999999999965332211 111111111000000000
Q ss_pred ------cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 909 ------ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 909 ------~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.....................+.++.+++.+|++.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000000111234578999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=365.06 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=204.1
Q ss_pred cCCCCCccccccCceEEEEEEe----CCCeEEEEEEEecc----chhhHHHHHHHHHHHHhccC-CceeEEEeeeecCCe
Q 048430 680 NGFGESNLLGSGSFDNVYKATL----ANGVSVAVKVFNLQ----EDRALKSFDTECEVMRRIRH-RNLIKIVSSCSNPGF 750 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 750 (973)
++|...++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688999999999999999984 25899999998543 22335678899999999976 899999999999999
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++||||+.+|+|.+++...+ .+++..+..++.|++.|++|+| +.+||||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999998776 6788999999999999999999 799999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCccCCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCcchhhhcc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEG--IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 908 (973)
............|++.|+|||..... .++.++||||+||++|||++|+.||......+. ......... .
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~--------~ 250 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRIL--------K 250 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHH--------H
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcc--------c
Confidence 54444444556799999999977543 478899999999999999999999976433322 111111110 0
Q ss_pred cccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 048430 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERI-----NVKDALAD 957 (973)
Q Consensus 909 ~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----t~~evl~~ 957 (973)
... ..+..+++++.+++.+||++||++|| |++|+++|
T Consensus 251 ~~~------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 SEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCC------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 000 01123567799999999999999999 58899875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=364.91 Aligned_cols=267 Identities=23% Similarity=0.255 Sum_probs=193.7
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCceeEEEeeeec------CCeeEE
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN------PGFKAL 753 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~l 753 (973)
+|...++||+|+||+||+|+. .+|+.||||+++.... ...+|++++++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 577788999999999999996 4799999999875432 23479999999999999999999843 345789
Q ss_pred EEEecCCCCHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeeccccccc
Q 048430 754 IMQYMPQGSLEKWLY--SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLL 830 (973)
Q Consensus 754 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~ 830 (973)
|||||+++.+..+.. .....+++.+++.++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998754333322 23457999999999999999999999 89999999999999999775 8999999999876
Q ss_pred CCCCCcccccccccccccCccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCCc--chhhhc
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGS-EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG--AVTEVV 907 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 907 (973)
.... ......|++.|+|||.+. ...++.++||||+||++|||++|+.||...... ..+...+...... ......
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhhh
Confidence 4322 233457999999999765 457899999999999999999999999653221 1122222111110 000000
Q ss_pred ccccCCCCchh---hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 908 DANLLSREDEE---DADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 908 d~~l~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.+......... ...........++++.+|+.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11100000000 000000112345678999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-40 Score=360.00 Aligned_cols=264 Identities=19% Similarity=0.279 Sum_probs=198.4
Q ss_pred cCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeec--CCeeEEEE
Q 048430 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSN--PGFKALIM 755 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 755 (973)
++|...++||+|+||+||+|+. .+|+.||||+++... .+.+.+|+.+|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999995 579999999986443 367889999999995 9999999999864 46789999
Q ss_pred EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC-cEEEeecccccccCCCC
Q 048430 756 QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVD 834 (973)
Q Consensus 756 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 834 (973)
||+.+++|..+.+ .+++.+++.++.||+.||+||| +++||||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999977643 5899999999999999999999 89999999999999998655 69999999998765322
Q ss_pred CcccccccccccccCccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHH------------hhCCc
Q 048430 835 PVTQTMTLATIGYMAPEYGSEG-IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA------------ESLPG 901 (973)
Q Consensus 835 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~------------~~~~~ 901 (973)
......+|+.|+|||..... .++.++||||+||++|||++|+.||............... .....
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23445789999999986654 5799999999999999999999998653221111111110 00000
Q ss_pred c---hhhhcccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 902 A---VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 902 ~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
. ......... ...............+++++.+|+.+|++.||++|||++|+++|
T Consensus 263 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 263 LDPRFNDILGRHS--RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCGGGGGTCCCCC--CCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCcccchhccccc--ccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000000 00000011111222356778999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-40 Score=361.76 Aligned_cols=265 Identities=23% Similarity=0.275 Sum_probs=196.3
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEecc--chhhHHHHHHHHHHHHhccCCceeEEEeeeecCC------
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG------ 749 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 749 (973)
.++|...+.||+|+||+||+|+. .+|+.||||+++.. .+...+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46788899999999999999995 57999999998753 2344578899999999999999999999997654
Q ss_pred eeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 750 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
+.|+||||+ +.+|..+.+.. .+++..++.++.||+.||+||| +++||||||||+|||++.++.+|++|||.|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 579999999 56888887664 5999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhC--Ccchhhh
Q 048430 830 LDGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL--PGAVTEV 906 (973)
Q Consensus 830 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 906 (973)
... ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+........ +......
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHT
T ss_pred cCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHHhh
Confidence 643 2244579999999998765 4679999999999999999999999865321 111111111111 1000000
Q ss_pred --------cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 --------VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 --------~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
....+........ .......++++.+|+.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDF---ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCG---GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcchhhhhhhccCCcccccch---HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000100000000 00112345678899999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=358.23 Aligned_cols=268 Identities=23% Similarity=0.189 Sum_probs=193.0
Q ss_pred cCCCCCccccccCceEEEEEEeC-CCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec------CCe
Q 048430 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN------PGF 750 (973)
Q Consensus 680 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 750 (973)
++|.+.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||++++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67889999999999999999964 79999999997542 3445678999999999999999999999853 468
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.|+||||+.++ +.+.+.. .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 89999999765 4444432 5899999999999999999999 799999999999999999999999999998865
Q ss_pred CCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC----------
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP---------- 900 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 900 (973)
.. ........+|+.|+|||.+.+..++.++||||+||+++||++|+.||.+.... ......+.....
T Consensus 170 ~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTTSC
T ss_pred cc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHHhh
Confidence 42 22334557899999999999999999999999999999999999998643211 111111111110
Q ss_pred cchhhhcccccCCCCc--------hhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 901 GAVTEVVDANLLSRED--------EEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 901 ~~~~~~~d~~l~~~~~--------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
.......+........ .............++++.+|+.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011111111000000 00011112234567889999999999999999999999977
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=356.41 Aligned_cols=266 Identities=23% Similarity=0.228 Sum_probs=196.8
Q ss_pred hcCCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccc--hhhHHHHHHHHHHHHhccCCceeEEEeeeec-----CCe
Q 048430 679 TNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSN-----PGF 750 (973)
Q Consensus 679 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 750 (973)
.++|...++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999985 579999999987542 3345678899999999999999999999853 334
Q ss_pred eEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeeccccccc
Q 048430 751 KALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830 (973)
Q Consensus 751 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 830 (973)
.++|+||+.+|+|.+++... .+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+|++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 46777888899999999764 5999999999999999999999 799999999999999999999999999998754
Q ss_pred CCCCCcccccccccccccCccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccCcccHHHHHHhhCC--cchhhh-
Q 048430 831 DGVDPVTQTMTLATIGYMAPEYGSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP--GAVTEV- 906 (973)
Q Consensus 831 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~- 906 (973)
. .......|++.|+|||.... ..++.++||||+||++|||++|+.||.+..... ........... ......
T Consensus 172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTTC
T ss_pred C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhhc
Confidence 3 23344578999999997555 457899999999999999999999996532111 11111111110 000000
Q ss_pred -------cccccCCCCchhhhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 048430 907 -------VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINVKDALAD 957 (973)
Q Consensus 907 -------~d~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl~~ 957 (973)
........... .........++++.+|+.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKM---NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCC---CHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCc---chhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000 0001112345678999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-34 Score=321.91 Aligned_cols=270 Identities=18% Similarity=0.198 Sum_probs=191.1
Q ss_pred CCCCCccccccCceEEEEEEe-CCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-----------CCceeEEEeeeec-
Q 048430 681 GFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-----------HRNLIKIVSSCSN- 747 (973)
Q Consensus 681 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~- 747 (973)
+|...++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999995 579999999997543 23467788999888875 5789999988754
Q ss_pred -CCeeEEEEEecCCCCH-HHH-hhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCC------c
Q 048430 748 -PGFKALIMQYMPQGSL-EKW-LYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM------V 818 (973)
Q Consensus 748 -~~~~~lv~e~~~~gsL-~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~------~ 818 (973)
....++|++++..+.. ... .......+++..+..++.||+.|++|||+ ..+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 4566677777655432 222 22333578999999999999999999994 48899999999999998665 3
Q ss_pred EEEeecccccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCccccCc-----ccHHH
Q 048430 819 AHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE-----MSLKQ 893 (973)
Q Consensus 819 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl~elltg~~p~~~~~~~~-----~~~~~ 893 (973)
++++|||.+..... .....+||+.|+|||......++.++||||+||+++||++|+.||....... ..+..
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999876432 2234579999999999888899999999999999999999999986532211 11111
Q ss_pred HHHhhC--Ccch-------hhhcccc-----cCCCCchh----hhhhHHhHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 048430 894 WVAESL--PGAV-------TEVVDAN-----LLSREDEE----DADDFATKKTCISYIMSLALKCSAEIPEERINVKDAL 955 (973)
Q Consensus 894 ~~~~~~--~~~~-------~~~~d~~-----l~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rpt~~evl 955 (973)
.+.... +... ....+.. ........ ...........++++.+|+.+|++.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 111111 1100 0011100 00000000 0011122345678899999999999999999999999
Q ss_pred HH
Q 048430 956 AD 957 (973)
Q Consensus 956 ~~ 957 (973)
+|
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 86
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.9e-32 Score=298.11 Aligned_cols=244 Identities=34% Similarity=0.558 Sum_probs=227.6
Q ss_pred cCCCCCCCCCcccEEEeec-CccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCccccc
Q 048430 362 GIPVGFGNLSNLLVLSLVN-NELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLA 440 (973)
Q Consensus 362 ~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 440 (973)
.+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+.
T Consensus 67 ~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~ 146 (313)
T d1ogqa_ 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146 (313)
T ss_dssp ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred CCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhc
Confidence 3677788999999999997 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCeeeccCCCCCCCCcccccccccc-cEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCE
Q 048430 441 NLTSLRHLDFRSNSLNSTIPSTFWSLKYI-LAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDW 519 (973)
Q Consensus 441 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 519 (973)
+++.|+.+++++|.+.+.+|..+..+..+ +.++++.|++++..|..+..+..+ .+++++|.+.+.+|..++.+++|+.
T Consensus 147 ~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~ 225 (313)
T d1ogqa_ 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQK 225 (313)
T ss_dssp GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSE
T ss_pred cCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccc
Confidence 99999999999999999999999998886 889999999999999888887655 7999999999999999999999999
Q ss_pred EEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCCCCCCCCccCccccccCccc
Q 048430 520 LALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYAL 599 (973)
Q Consensus 520 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 599 (973)
|++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|..|+++++|++|||++|+|+|.+|+.+.+.++....+.+|+.+
T Consensus 226 l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l 304 (313)
T d1ogqa_ 226 IHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304 (313)
T ss_dssp EECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEE
T ss_pred ccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccc
Confidence 9999999997765 689999999999999999999999999999999999999999999999888999999999999999
Q ss_pred ccCCccCCCCc
Q 048430 600 CGSSRLQVPPC 610 (973)
Q Consensus 600 c~~~~~~~~~c 610 (973)
||.| .|+|
T Consensus 305 ~g~p---lp~c 312 (313)
T d1ogqa_ 305 CGSP---LPAC 312 (313)
T ss_dssp ESTT---SSCC
T ss_pred cCCC---CCCC
Confidence 9987 3566
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.4e-28 Score=275.88 Aligned_cols=123 Identities=25% Similarity=0.363 Sum_probs=59.8
Q ss_pred CcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEE
Q 048430 441 NLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWL 520 (973)
Q Consensus 441 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 520 (973)
.+++|+.|++++|++++.. .+..+..++.++++.|++++ + ..+..+++++.|++++|++++.. .+..+++|+.|
T Consensus 261 ~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L 334 (384)
T d2omza2 261 GLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRL 334 (384)
T ss_dssp TCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEE
T ss_pred ccccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCCc--ccccCCCCCEE
Confidence 3344444444444443321 13344444444444444442 1 12444555555555555555322 24555555555
Q ss_pred EcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCC
Q 048430 521 ALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 521 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
+|++|+|++ ++ .|+++++|++|+|++|+|++.+| +.++++|+.|++++|
T Consensus 335 ~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 335 FFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 555555552 22 35555555555555555554433 555555666665555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1e-28 Score=277.04 Aligned_cols=357 Identities=26% Similarity=0.385 Sum_probs=265.0
Q ss_pred EEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEE
Q 048430 123 FDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILD 202 (973)
Q Consensus 123 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~ 202 (973)
.+++.+.+++.++ ...+.+|++|++++|.|+ .++ + ++.+++|++|+|++|+|+ .+| .++++++|++|+
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l~-g-l~~L~nL~~L~Ls~N~l~------~l~-~l~~L~~L~~L~ 94 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-G-VEYLNNLTQINFSNNQLT------DIT-PLKNLTKLVDIL 94 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CCT-T-GGGCTTCCEEECCSSCCC------CCG-GGTTCTTCCEEE
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Ccc-c-cccCCCCCEEeCcCCcCC------CCc-cccCCccccccc
Confidence 4566777776544 356778999999999988 553 3 357889999999999987 344 388899999999
Q ss_pred ecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEecccccccc
Q 048430 203 LGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGL 282 (973)
Q Consensus 203 L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~ 282 (973)
+++|++.+..+ +..+++|+.|++++|.+++..+ ......+..+....|.+....+..................+
T Consensus 95 L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--- 168 (384)
T d2omza2 95 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL--- 168 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC---
T ss_pred ccccccccccc--cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccchh---
Confidence 99999986533 7777888888888887775443 23355667777777777654433333333333333322222
Q ss_pred CCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCcccccccccceeecccCCcccc
Q 048430 283 VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362 (973)
Q Consensus 283 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~ 362 (973)
..+.............|.... ......+++++.+++++|.+++..|
T Consensus 169 --~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~~~~l~l~~n~i~~~~~----------------------- 214 (384)
T d2omza2 169 --KPLANLTTLERLDISSNKVSD---------ISVLAKLTNLESLIATNNQISDITP----------------------- 214 (384)
T ss_dssp --GGGTTCTTCCEEECCSSCCCC---------CGGGGGCTTCSEEECCSSCCCCCGG-----------------------
T ss_pred --hhhcccccccccccccccccc---------ccccccccccceeeccCCccCCCCc-----------------------
Confidence 234445555556666665542 3345667777888888777765432
Q ss_pred CCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCc
Q 048430 363 IPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANL 442 (973)
Q Consensus 363 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 442 (973)
+...++|+.|++++|.++. + ..+..+++|+.|++++|.+++.. .+..+++|+.|++++|++++.. .+..+
T Consensus 215 ----~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~ 284 (384)
T d2omza2 215 ----LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGL 284 (384)
T ss_dssp ----GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTC
T ss_pred ----ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccc
Confidence 3345789999999999984 3 46788999999999999999654 3788999999999999998654 36788
Q ss_pred CCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEc
Q 048430 443 TSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLAL 522 (973)
Q Consensus 443 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 522 (973)
+.++.++++.|.+.+ ...+..++.++.|++++|++++.. .+..+++|+.|++++|+|++ ++ .++++++|++|+|
T Consensus 285 ~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l 358 (384)
T d2omza2 285 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSA 358 (384)
T ss_dssp TTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEEC
T ss_pred ccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEEC
Confidence 899999999999875 345788899999999999999653 37889999999999999984 44 6899999999999
Q ss_pred ccCccccCCCCCccccccccccccccc
Q 048430 523 ARNAFQGPIPQSFGSLISLQSLDLSGN 549 (973)
Q Consensus 523 s~N~l~~~~p~~~~~l~~L~~L~Ls~N 549 (973)
++|+|++..| +.++++|+.|+|++|
T Consensus 359 ~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 359 GHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCcCCCChh--hccCCCCCEeeCCCC
Confidence 9999997665 899999999999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=4.5e-26 Score=246.43 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=181.4
Q ss_pred CCCCcceEEEEEeeCCCCcEEEEecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCC
Q 048430 28 TSASVCNWVGVTCSIRHGRVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSG 107 (973)
Q Consensus 28 ~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 107 (973)
+..+-|.|.+|.|+. .+|+ ++|+.+. +.+++|+|++|++....+..|.++++|++|++++|.+.
T Consensus 5 p~~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~- 68 (305)
T d1xkua_ 5 PFRCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 68 (305)
T ss_dssp CTTCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-
T ss_pred CCCCEecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc-
Confidence 345558899999964 3455 6777653 57888888888886544457888888888888888888
Q ss_pred CCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCC
Q 048430 108 SLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNRE 187 (973)
Q Consensus 108 ~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 187 (973)
.+++..|..+++|++|++++|+++ .+|..+ ...|+.|++.+|.+. .++...+.....+..++...|...... .
T Consensus 69 ~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~---~ 141 (305)
T d1xkua_ 69 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSG---I 141 (305)
T ss_dssp CBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGG---B
T ss_pred ccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchh-hhhhhhhhccccccccccccccccccC---C
Confidence 566666778888888888888888 455543 357788888888887 667666677777777777777543221 2
Q ss_pred CCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccC
Q 048430 188 IPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNAS 267 (973)
Q Consensus 188 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 267 (973)
.+..+..+++|+++++++|.++. +|..+ +++|++|++++|.+.+..+..+..++
T Consensus 142 ~~~~~~~l~~L~~l~l~~n~l~~-l~~~~-------------------------~~~L~~L~l~~n~~~~~~~~~~~~~~ 195 (305)
T d1xkua_ 142 ENGAFQGMKKLSYIRIADTNITT-IPQGL-------------------------PPSLTELHLDGNKITKVDAASLKGLN 195 (305)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCS-CCSSC-------------------------CTTCSEEECTTSCCCEECTGGGTTCT
T ss_pred CccccccccccCccccccCCccc-cCccc-------------------------CCccCEEECCCCcCCCCChhHhhccc
Confidence 34566777777777777777663 23221 56778888888888877777888888
Q ss_pred cccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCC
Q 048430 268 EATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGV 337 (973)
Q Consensus 268 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 337 (973)
.+++|++++|.+.++.+..|.++++|++|+|++|+|++++ ..+.++++|++|+|++|+|+.+
T Consensus 196 ~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp--------~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP--------GGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC--------TTTTTCSSCCEEECCSSCCCCC
T ss_pred cccccccccccccccccccccccccceeeecccccccccc--------cccccccCCCEEECCCCccCcc
Confidence 8888888888888887888888888888888888877643 2355666666666666666643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=2.1e-25 Score=241.05 Aligned_cols=223 Identities=23% Similarity=0.295 Sum_probs=115.4
Q ss_pred cccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCC
Q 048430 243 PNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCR 322 (973)
Q Consensus 243 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~ 322 (973)
+++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|..|.++++|+.|++++|+++.++.. .
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~----------~-- 98 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK----------M-- 98 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS----------C--
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccc----------h--
Confidence 5677777777777766556777777777777777777777777777777777777777777653321 0
Q ss_pred cCcEEEccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCcccCCCCCCCEEEc
Q 048430 323 YLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDL 402 (973)
Q Consensus 323 ~L~~L~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 402 (973)
...+..|++++|.+.+..+..+.....+..++.
T Consensus 99 -----------------------------------------------~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~ 131 (305)
T d1xkua_ 99 -----------------------------------------------PKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131 (305)
T ss_dssp -----------------------------------------------CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC
T ss_pred -----------------------------------------------hhhhhhhhccccchhhhhhhhhhcccccccccc
Confidence 123444444444444333334444444455555
Q ss_pred cCCcCC--CCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCccc
Q 048430 403 NSNKLK--GFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLS 480 (973)
Q Consensus 403 s~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 480 (973)
..|... ...+..+..+++|+.+.+++|.+.. ++.. .+++|+.|++++|.+++..+..|..++.++.|++++|.++
T Consensus 132 ~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~ 208 (305)
T d1xkua_ 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208 (305)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred ccccccccCCCccccccccccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhcccccccccccccccc
Confidence 444332 1122334444444444444444432 2221 1234455555555444444444444444444444444444
Q ss_pred CCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc
Q 048430 481 GSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528 (973)
Q Consensus 481 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (973)
+..+..+.++++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+
T Consensus 209 ~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 333444444444444444444444 33444444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.2e-25 Score=236.76 Aligned_cols=267 Identities=25% Similarity=0.279 Sum_probs=175.2
Q ss_pred eeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEE
Q 048430 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVL 327 (973)
Q Consensus 248 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L 327 (973)
++.++++++ .+|..+. +.+++|+|++|+|+.+++..|.++++|++|++++|++..++.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~------------------- 73 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA------------------- 73 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECT-------------------
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccc-------------------
Confidence 455555565 3444332 456677777777776666667777777777776666654221
Q ss_pred EccCCCCCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEee-cCccccccCcccCCCCCCCEEEccCCc
Q 048430 328 VLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLV-NNELAGAIPTVLGKLQKLQGLDLNSNK 406 (973)
Q Consensus 328 ~L~~N~l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls-~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 406 (973)
..+..+..++.+... .|.++...+..|.++++|++|++++|.
T Consensus 74 -------------------------------------~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~ 116 (284)
T d1ozna_ 74 -------------------------------------AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116 (284)
T ss_dssp -------------------------------------TTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred -------------------------------------ccccccccccccccccccccccccchhhcccccCCEEecCCcc
Confidence 113333444444433 344444445566666666666666666
Q ss_pred CCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcC
Q 048430 407 LKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLN 486 (973)
Q Consensus 407 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 486 (973)
+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..
T Consensus 117 ~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~ 196 (284)
T d1ozna_ 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhH
Confidence 66555555666666666666666666555666667777777777777777666777777777777777777777777778
Q ss_pred ccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCcccccccccc
Q 048430 487 IGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLV 566 (973)
Q Consensus 487 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 566 (973)
|.++++|++|++++|++++..|..|+.+++|+.|+|++|.+.+.-+ .-.-...++.+....+++....|..+.+ +.
T Consensus 197 f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~ 272 (284)
T d1ozna_ 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RD 272 (284)
T ss_dssp TTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CB
T ss_pred hhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---Cc
Confidence 8888888888888888887777788888888888888888875433 1222345777777788887777776654 34
Q ss_pred ccccCCCcccc
Q 048430 567 DFNVSFNGLEG 577 (973)
Q Consensus 567 ~l~ls~N~l~~ 577 (973)
..+++.+.|+|
T Consensus 273 l~~l~~~~l~g 283 (284)
T d1ozna_ 273 LKRLAANDLQG 283 (284)
T ss_dssp GGGSCGGGSCC
T ss_pred cccCCHHHCCC
Confidence 55667776665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.1e-25 Score=235.20 Aligned_cols=210 Identities=23% Similarity=0.216 Sum_probs=167.4
Q ss_pred CcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeec-CCccccCcCcccccCcCCCCeee
Q 048430 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLS-NNNALQGQIPTCLANLTSLRHLD 449 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l-~~N~l~~~~~~~~~~l~~L~~L~ 449 (973)
+++++|+|++|+|+...+..|.++++|++|++++|++..+.+..+..+..+..+.. ..|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 45778888888887666667888888888888888888777777777777777754 45666666677788888888888
Q ss_pred ccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCcccc
Q 048430 450 FRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQG 529 (973)
Q Consensus 450 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 529 (973)
+++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 88888877777777778888888888888886666778888888888888888887777788888888888888888888
Q ss_pred CCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccCC
Q 048430 530 PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580 (973)
Q Consensus 530 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 580 (973)
..|..|..+++|++||+++|++++..|..|..+++|++|++++|++.+..+
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 888888888888888888888888777888888888888888888877654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=4e-23 Score=217.79 Aligned_cols=202 Identities=25% Similarity=0.232 Sum_probs=153.1
Q ss_pred CCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCee
Q 048430 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHL 448 (973)
Q Consensus 369 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 448 (973)
....+.+++.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence 3455666777778877 4565543 4678888888888766566777888888888888887733 3 34677888888
Q ss_pred eccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc
Q 048430 449 DFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528 (973)
Q Consensus 449 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (973)
+|++|++++ .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..++.|+.|++++|+|+
T Consensus 83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 888888764 4667777888888888888887777777777888888888888888666667777888888888888888
Q ss_pred cCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccc
Q 048430 529 GPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEG 577 (973)
Q Consensus 529 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 577 (973)
+..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 777777888888888888888887 677777788888888888776654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.5e-22 Score=213.38 Aligned_cols=200 Identities=22% Similarity=0.264 Sum_probs=125.3
Q ss_pred ccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCc
Q 048430 90 WHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSL 169 (973)
Q Consensus 90 ~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L 169 (973)
.+.+.+...|.+++.++ .+|.++. ++|++|||++|+|++..+.+|.++++|++|+|++|+|+ .+|. +..+++|
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--~~~l~~L 79 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVL 79 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--CSCCTTC
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--ccccccc
Confidence 44556666778887777 6776552 56788888888888655567888888888888888887 6654 3467888
Q ss_pred cEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccccCCCCC-Ccccccee
Q 048430 170 VQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSI-YLPNLENL 248 (973)
Q Consensus 170 ~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~-~l~~L~~L 248 (973)
++|+|++|+++ ..+..+.++++|++|++++|.+.+..+..+..+.+++.|++++|.++...+... .+++|+.|
T Consensus 80 ~~L~Ls~N~l~------~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l 153 (266)
T d1p9ag_ 80 GTLDLSHNQLQ------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (266)
T ss_dssp CEEECCSSCCS------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccccccccc------ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhc
Confidence 88888888886 445677788888888888888877666666664444444444444443333322 24455555
Q ss_pred eeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEccCCcC
Q 048430 249 FLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQL 303 (973)
Q Consensus 249 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 303 (973)
++++|+++++.++.|..+++|++|+|++|+|+. +|..+..+++|+.|+|++|.+
T Consensus 154 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~-lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCB
T ss_pred ccccccccccCccccccccccceeecccCCCcc-cChhHCCCCCCCEEEecCCCC
Confidence 555555554444445555555555555555552 233333444555555555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=3.2e-20 Score=204.32 Aligned_cols=96 Identities=34% Similarity=0.495 Sum_probs=60.5
Q ss_pred CCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEE
Q 048430 94 RLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLR 173 (973)
Q Consensus 94 ~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~ 173 (973)
+++.|||++|.++ .+|+ .+++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++. + .+.|++|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l---p~~L~~L~ 104 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L---PPLLEYLG 104 (353)
T ss_dssp TCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C---CTTCCEEE
T ss_pred CCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h---cccccccc
Confidence 4666777777766 5663 2456777777777776 556543 45677777777776 5542 1 23577777
Q ss_pred cccccccccCCCCCCCccccCCCCccEEEecCCcccC
Q 048430 174 LLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG 210 (973)
Q Consensus 174 L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~ 210 (973)
+++|.|+ .+|. ++.+++|++|++++|.+..
T Consensus 105 L~~n~l~------~lp~-~~~l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 105 VSNNQLE------KLPE-LQNSSFLKIIDVDNNSLKK 134 (353)
T ss_dssp CCSSCCS------SCCC-CTTCTTCCEEECCSSCCSC
T ss_pred ccccccc------cccc-hhhhccceeeccccccccc
Confidence 7777765 3443 5667777777777776653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=1e-19 Score=200.27 Aligned_cols=59 Identities=25% Similarity=0.376 Sum_probs=33.3
Q ss_pred CCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCc
Q 048430 490 LEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK 557 (973)
Q Consensus 490 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 557 (973)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +.+|++|+|++|+|+ .+|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 355666666666665 44432 345666666666665 45532 345666666666665 4444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.2e-21 Score=193.03 Aligned_cols=168 Identities=15% Similarity=0.156 Sum_probs=120.2
Q ss_pred CCccccccCceEEEEEEeCCCeEEEEEEEeccc------------------hhhHHHHHHHHHHHHhccCCceeEEEeee
Q 048430 684 ESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE------------------DRALKSFDTECEVMRRIRHRNLIKIVSSC 745 (973)
Q Consensus 684 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 745 (973)
..++||+|+||+||+|+..+|+.||||+++... ........+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 457899999999999998899999999875321 01123456788999999999999888664
Q ss_pred ecCCeeEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEEccCCCCcEEeCCCCcEEEeecc
Q 048430 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825 (973)
Q Consensus 746 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 825 (973)
. .++||||+++..+.+ ++......++.|+++|++||| ..+|+||||||+|||++++ .++++|||
T Consensus 84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred C----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECC
Confidence 2 379999998865433 334456789999999999999 7999999999999999976 58999999
Q ss_pred cccccCCCCCcccccccccccccCccCCCCCCCCcchhHHHHHHHH
Q 048430 826 IAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILM 871 (973)
Q Consensus 826 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~Gvvl 871 (973)
.|.......... ........ -.++ ..+.++.++||||..--+
T Consensus 148 ~a~~~~~~~~~~--~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWRE--ILERDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHH--HHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHH--HHHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 997654221110 00000000 0011 135577889999975433
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=6.7e-19 Score=182.49 Aligned_cols=213 Identities=17% Similarity=0.195 Sum_probs=125.9
Q ss_pred CCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeC-cccCCC
Q 048430 55 LSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSS-NKITGE 133 (973)
Q Consensus 55 ~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~-N~l~~~ 133 (973)
.+++ ++|+.+- +++++|+|++|++....+..|.++++|++|+|++|.+...+|...|..++++++|++.. |.+...
T Consensus 18 ~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~ 94 (242)
T d1xwdc1 18 SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 94 (242)
T ss_dssp CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEE
T ss_pred CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccc
Confidence 4455 6665542 46777888877775433345777777777777777776556666666677777776653 556555
Q ss_pred CCccccCCCCCCeEEccCccccccCCc-cccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCcc
Q 048430 134 FPSAIVNISSLKSIRLDNNSLSGSFPT-DLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLI 212 (973)
Q Consensus 134 ~p~~~~~l~~L~~L~L~~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 212 (973)
.+..|.++++|++|++++|.+. .++. ..+..+..+..+...++.+ ....
T Consensus 95 ~~~~~~~l~~L~~l~l~~~~l~-~~~~~~~~~~l~~l~~~~~~n~~l-----------------------------~~i~ 144 (242)
T d1xwdc1 95 NPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINI-----------------------------HTIE 144 (242)
T ss_dssp CTTSEECCTTCCEEEEESCCCC-SCCCCTTTCBSSCEEEEEESCTTC-----------------------------CEEC
T ss_pred ccccccccccccccccchhhhc-cccccccccccccccccccccccc-----------------------------cccc
Confidence 5566666677777777776665 3322 2222333344444444444 3333
Q ss_pred ccccccCC-cceeEEeecccccccCCCCCCcccccee-eeccccccccCcchhcccCcccEEEeccccccccCCCccccc
Q 048430 213 PSMIFNNS-NMVAILLYGNHLSGHLPSSIYLPNLENL-FLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNC 290 (973)
Q Consensus 213 ~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l 290 (973)
+..+.+++ .++.|++++|+++...+..+..++++++ ++++|+++.+.++.|..+++|++|+|++|+|+.+++..|.++
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred ccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 33333321 3334444444444333333334454444 457777776656667888888888888888887777777777
Q ss_pred ccceEEEccC
Q 048430 291 RQLQILSLGD 300 (973)
Q Consensus 291 ~~L~~L~L~~ 300 (973)
++|+.|++.+
T Consensus 225 ~~L~~l~~~~ 234 (242)
T d1xwdc1 225 KKLRARSTYN 234 (242)
T ss_dssp CEEESSSEES
T ss_pred cccccCcCCC
Confidence 7777776643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=6.5e-22 Score=226.44 Aligned_cols=160 Identities=19% Similarity=0.115 Sum_probs=79.4
Q ss_pred CCcccEEEeecCccccc----cCcccCCCCCCCEEEccCCcCCCCCchhhh-----ccCcCCeeecCCccccCcCcccc-
Q 048430 370 LSNLLVLSLVNNELAGA----IPTVLGKLQKLQGLDLNSNKLKGFIPTDLC-----KLEKLNTLLSNNNALQGQIPTCL- 439 (973)
Q Consensus 370 l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~~~~~~- 439 (973)
...++.|++++|.+... ....+...+.++.+++++|.++......+. ....|+.+++++|.++......+
T Consensus 254 ~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~ 333 (460)
T d1z7xw1 254 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 333 (460)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcc
Confidence 34455555555555421 122233455555566665555422111111 12345566666665554332222
Q ss_pred ---cCcCCCCeeeccCCCCCCC----Cccccc-ccccccEEEecCCcccCC----cCcCccCCCCCCeEEccCCcCcccC
Q 048430 440 ---ANLTSLRHLDFRSNSLNST----IPSTFW-SLKYILAVDFSLNSLSGS----LPLNIGNLEALGGLNLTGNQLSGYI 507 (973)
Q Consensus 440 ---~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 507 (973)
....+|++|+|++|+++.. ++..+. ..+.|++|++++|.|+.. ++..+..+++|++|+|++|+|+...
T Consensus 334 ~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g 413 (460)
T d1z7xw1 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413 (460)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHH
T ss_pred cccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHH
Confidence 2334566666666665421 122222 234566666666666532 3334455567777777777776432
Q ss_pred Cccc----c-cCCcCCEEEcccCcccc
Q 048430 508 PSSI----G-NLKNLDWLALARNAFQG 529 (973)
Q Consensus 508 p~~~----~-~l~~L~~L~Ls~N~l~~ 529 (973)
...+ . +...|+.|++++|.+..
T Consensus 414 ~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 414 ILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 2222 1 23357777777777664
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=5.3e-22 Score=227.22 Aligned_cols=186 Identities=21% Similarity=0.129 Sum_probs=107.1
Q ss_pred CCCCcccEEEeecCcccc-----ccCcccCCCCCCCEEEccCCcCCCCC----chhhhccCcCCeeecCCccccCcCccc
Q 048430 368 GNLSNLLVLSLVNNELAG-----AIPTVLGKLQKLQGLDLNSNKLKGFI----PTDLCKLEKLNTLLSNNNALQGQIPTC 438 (973)
Q Consensus 368 ~~l~~L~~L~Ls~n~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~ 438 (973)
...+.++.+++++|.+.. ..+..+.....++.+++++|.+.... ...+...+.++.+++++|.++......
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 345677888888887642 23344555677888888888876332 233455677888888888776433222
Q ss_pred c-----cCcCCCCeeeccCCCCCCCCccc----ccccccccEEEecCCcccCC----cCcCcc-CCCCCCeEEccCCcCc
Q 048430 439 L-----ANLTSLRHLDFRSNSLNSTIPST----FWSLKYILAVDFSLNSLSGS----LPLNIG-NLEALGGLNLTGNQLS 504 (973)
Q Consensus 439 ~-----~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~ 504 (973)
+ .....|+.+++++|.++...... +...++|+.|||++|++++. ++..+. ..+.|+.|+|++|+|+
T Consensus 303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence 2 12346778888887776432222 23345677777777776532 222222 3455677777777775
Q ss_pred cc----CCcccccCCcCCEEEcccCccccCCCCCcc-----cccccccccccccccCC
Q 048430 505 GY----IPSSIGNLKNLDWLALARNAFQGPIPQSFG-----SLISLQSLDLSGNNISG 553 (973)
Q Consensus 505 ~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~ 553 (973)
.. ++..+..+++|++|+|++|+|+......|. ....|+.|++++|.+..
T Consensus 383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 32 334455566677777777766532222221 12246666666666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=9.8e-19 Score=179.12 Aligned_cols=202 Identities=21% Similarity=0.315 Sum_probs=90.4
Q ss_pred EEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCcc
Q 048430 74 LNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNS 153 (973)
Q Consensus 74 L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 153 (973)
++++.+++.+.+ .+..+.+|+.|++++|.++ .++. ++.+++|++|++++|++++..| +.++++|+.+++++|.
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cchh--HhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 344444444322 3344555555555555555 3432 3445555555555555553322 5555555555555555
Q ss_pred ccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeeccccc
Q 048430 154 LSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLS 233 (973)
Q Consensus 154 l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~ 233 (973)
++ .++. +.++++|+.|+++++...+. ..+...+.++.+.++.+.+.... .+...++|+.|++++|.++
T Consensus 97 ~~-~i~~--l~~l~~L~~l~l~~~~~~~~-------~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 97 LK-NVSA--IAGLQSIKTLDLTSTQITDV-------TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp CS-CCGG--GTTCTTCCEEECTTSCCCCC-------GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCC
T ss_pred cc-cccc--cccccccccccccccccccc-------chhccccchhhhhchhhhhchhh--hhccccccccccccccccc
Confidence 54 3331 23455555555555554321 12344455555555555554321 1333333333333333322
Q ss_pred ccCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEcc
Q 048430 234 GHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299 (973)
Q Consensus 234 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 299 (973)
+..+ ...+++|++|+|++|+++++ + .++.+++|++|+|++|+++++.| ++++++|++|+++
T Consensus 165 ~~~~-l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 165 DLTP-LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CCGG-GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred cchh-hcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 1111 11244455555555554432 1 24444455555555555444322 4444444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=4.1e-18 Score=176.42 Aligned_cols=202 Identities=18% Similarity=0.121 Sum_probs=154.4
Q ss_pred CcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCC-chhhhccCcCCeeecC-CccccCcCcccccCcCCCCee
Q 048430 371 SNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFI-PTDLCKLEKLNTLLSN-NNALQGQIPTCLANLTSLRHL 448 (973)
Q Consensus 371 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~-~N~l~~~~~~~~~~l~~L~~L 448 (973)
+++++|++++|.++...+..|.++++|++|+|++|.+...+ +..|.++++++.+.+. .|.+....+..|.++++|+++
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 46888899999888666667888899999999998887544 4467788888888765 467777777888889999999
Q ss_pred eccCCCCCCCCc-ccccccccccEEEecCCcccCCcCcCccCCC-CCCeEEccCCcCcccCCcccccCCcCC-EEEcccC
Q 048430 449 DFRSNSLNSTIP-STFWSLKYILAVDFSLNSLSGSLPLNIGNLE-ALGGLNLTGNQLSGYIPSSIGNLKNLD-WLALARN 525 (973)
Q Consensus 449 ~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N 525 (973)
++++|++....+ ..+..+..+..+..+++.+....+..+.+++ .++.|++++|+++...+..| ...++. .+++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhcccccccc
Confidence 999998875433 2345567777778888888765566676664 78889999999985444444 445544 4467888
Q ss_pred ccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCC
Q 048430 526 AFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFN 573 (973)
Q Consensus 526 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 573 (973)
+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+.
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l 235 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence 898555667899999999999999999666677899999998887643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=2.1e-18 Score=171.40 Aligned_cols=157 Identities=22% Similarity=0.227 Sum_probs=92.7
Q ss_pred cCCeeecCCccccC-cCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEc
Q 048430 420 KLNTLLSNNNALQG-QIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNL 498 (973)
Q Consensus 420 ~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 498 (973)
++++|+|++|+|++ ..+..|.++++|++|+|++|.+.+..+..|..+++|+.|++++|+|++..|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 34444444444433 22334455555666666666655555555555556666666666666555556666777777777
Q ss_pred cCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCccccc
Q 048430 499 TGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGE 578 (973)
Q Consensus 499 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 578 (973)
++|+|++..|..|..+++|++|+|++|.+....+ ...-...++.+.+..|.++...|..+ ..++.++|+.|.|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCC
T ss_pred CCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCC
Confidence 7777776666667777777777777777764332 22223346667777777776666544 3455667777777644
Q ss_pred CC
Q 048430 579 IP 580 (973)
Q Consensus 579 ~p 580 (973)
.+
T Consensus 186 ~~ 187 (192)
T d1w8aa_ 186 SE 187 (192)
T ss_dssp CC
T ss_pred CC
Confidence 33
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.4e-18 Score=176.14 Aligned_cols=148 Identities=27% Similarity=0.372 Sum_probs=57.5
Q ss_pred CCCcccEEEeecCccccccCcccCCCCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCee
Q 048430 369 NLSNLLVLSLVNNELAGAIPTVLGKLQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHL 448 (973)
Q Consensus 369 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 448 (973)
.+++|++|++++|.+++..| +..+++|+++++++|.++. ++ .+.++++|+.+.++++...+. ..+...+.++.+
T Consensus 61 ~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l 134 (227)
T d1h6ua2 61 YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVL 134 (227)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEE
T ss_pred cCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccccccccccccccc--chhccccchhhh
Confidence 34444444444444443222 4444444444444444442 11 233444444444444433321 112333444444
Q ss_pred eccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccc
Q 048430 449 DFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQ 528 (973)
Q Consensus 449 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 528 (973)
.++.+.+... ..+...++|+.|++++|.+++.. .++++++|+.|+|++|++++ ++ .++.+++|++|+|++|+++
T Consensus 135 ~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 135 YLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp ECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCC
T ss_pred hchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCC
Confidence 4444443321 11233333334444333333211 13344444444444444442 21 1344444444444444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=8.2e-18 Score=166.96 Aligned_cols=177 Identities=20% Similarity=0.223 Sum_probs=144.4
Q ss_pred CCeeecCCccccCcCcccccCcCCCCeeeccCCCCCC-CCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEcc
Q 048430 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNS-TIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLT 499 (973)
Q Consensus 421 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 499 (973)
.++++.++++++ .+|..+. +++++|+|++|+|++ ..+..|..+++|+.|++++|++++..+..+..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 346777777777 4555543 689999999999986 446788999999999999999999999999999999999999
Q ss_pred CCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCccccccccccccccCCCcccccC
Q 048430 500 GNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEI 579 (973)
Q Consensus 500 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 579 (973)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+..+ -...++.+.+..|.+.+..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCC
Confidence 999998888899999999999999999998889999999999999999999986543322 2334677888889998877
Q ss_pred CCCCCCCccCccccccCcccccCC
Q 048430 580 PSGGPFVNFTADSFKQNYALCGSS 603 (973)
Q Consensus 580 p~~~~~~~~~~~~~~~n~~~c~~~ 603 (973)
|. .+....-..+..|..-|.++
T Consensus 166 p~--~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PS--KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp ST--TTTTSBGGGSCTTTCCCCCC
T ss_pred Ch--hhcCCEeeecCHhhCcCCCC
Confidence 75 34444444556666566544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.3e-17 Score=166.14 Aligned_cols=179 Identities=25% Similarity=0.362 Sum_probs=88.7
Q ss_pred EecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccc
Q 048430 75 NISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154 (973)
Q Consensus 75 ~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 154 (973)
++..+.+.+.++. ..+.+|++|++++|.+. .++. ++.+++|++|+|++|+|++. + .++++++|++|++++|+|
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccc
Confidence 3444444333322 24555566666666555 3332 24455666666666665532 2 245555666666666655
Q ss_pred cccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccccccccCCcceeEEeecccccc
Q 048430 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSG 234 (973)
Q Consensus 155 ~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~ 234 (973)
+ .+|. +..+++|+.|++++|.+. .+ ..+..+++|+.+++++|.+++. ..+..
T Consensus 103 ~-~l~~--l~~l~~L~~L~l~~~~~~------~~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~---------------- 154 (210)
T d1h6ta2 103 K-DLSS--LKDLKKLKSLSLEHNGIS------DI-NGLVHLPQLESLYLGNNKITDI--TVLSR---------------- 154 (210)
T ss_dssp C-CGGG--GTTCTTCCEEECTTSCCC------CC-GGGGGCTTCCEEECCSSCCCCC--GGGGG----------------
T ss_pred c-cccc--cccccccccccccccccc------cc-cccccccccccccccccccccc--ccccc----------------
Confidence 5 3432 334555555555555543 11 2345555555555555555422 11222
Q ss_pred cCCCCCCccccceeeeccccccccCcchhcccCcccEEEeccccccccCCCcccccccceEEEcc
Q 048430 235 HLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLG 299 (973)
Q Consensus 235 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 299 (973)
+++|+++++++|+++++ + .++++++|+.|+|++|+|+.+ + .|.++++|++|+|+
T Consensus 155 -------l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 155 -------LTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF 208 (210)
T ss_dssp -------CTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred -------ccccccccccccccccc-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence 45555555555555532 1 255555555555555555543 1 35555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4.4e-17 Score=162.61 Aligned_cols=118 Identities=25% Similarity=0.410 Sum_probs=58.8
Q ss_pred EecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccc
Q 048430 75 NISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSL 154 (973)
Q Consensus 75 ~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 154 (973)
.++.+.+.+.+ ....+.++++|++++|.+. .++. ++.+++|++|+|++|++++..| ++++++|++|++++|.+
T Consensus 24 ~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 24 VLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HTTCSSTTSEE--CHHHHTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HhCCCCCCCcc--CHHHhcCCCEEECCCCCCC-Cccc--cccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 34444444332 2234555556666666555 3432 2445566666666666553221 55556666666666555
Q ss_pred cccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc
Q 048430 155 SGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209 (973)
Q Consensus 155 ~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~ 209 (973)
. .++. +..++.|+.|++++|.+.. ...+..+++|+.|++++|++.
T Consensus 97 ~-~~~~--l~~l~~L~~L~l~~~~~~~-------~~~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 97 A-DITP--LANLTNLTGLTLFNNQITD-------IDPLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp C-CCGG--GTTCTTCSEEECCSSCCCC-------CGGGTTCTTCSEEECCSSCCC
T ss_pred c-cccc--ccccccccccccccccccc-------ccccchhhhhHHhhhhhhhhc
Confidence 4 3332 3445555555555555431 122444555555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4.9e-17 Score=163.77 Aligned_cols=181 Identities=23% Similarity=0.356 Sum_probs=140.3
Q ss_pred EecCCCCCCCcCCCCCCCCCCCcEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcc
Q 048430 50 LSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNK 129 (973)
Q Consensus 50 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~ 129 (973)
.++....+++.++. ..|..|++|++++|.+.+ ++ .+..+++|++|+|++|+++ .++. ++.+++|++|++++|+
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~-~l~~--~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLFLDENK 101 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCcccc-Cccc--cccCcccccccccccc
Confidence 45666666666553 467889999999999964 33 4889999999999999998 4654 4789999999999999
Q ss_pred cCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCccc
Q 048430 130 ITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIA 209 (973)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~ 209 (973)
+++ +| .+.++++|+.|++++|.+. .++ .+..+++|+.+++++|.+++ +..+..+++|+++++++|+++
T Consensus 102 i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~--~l~~l~~l~~l~~~~n~l~~-------~~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 102 VKD-LS-SLKDLKKLKSLSLEHNGIS-DIN--GLVHLPQLESLYLGNNKITD-------ITVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCC-CCG--GGGGCTTCCEEECCSSCCCC-------CGGGGGCTTCSEEECCSSCCC
T ss_pred ccc-cc-ccccccccccccccccccc-ccc--cccccccccccccccccccc-------ccccccccccccccccccccc
Confidence 984 55 5899999999999999987 554 34678999999999999963 345788999999999999998
Q ss_pred CccccccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCcchhcccCcccEEEecc
Q 048430 210 GLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSS 276 (973)
Q Consensus 210 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 276 (973)
+..+ +.+ +++|++|+|++|+|+.+ + .+..+++|++|+|++
T Consensus 170 ~i~~--l~~-----------------------l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 170 DIVP--LAG-----------------------LTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCGG--GTT-----------------------CTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred cccc--ccC-----------------------CCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence 6432 555 56666666666666643 3 466677777777653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=9.6e-17 Score=160.15 Aligned_cols=161 Identities=26% Similarity=0.377 Sum_probs=86.1
Q ss_pred CCCCCEEEccCCcCCCCCchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEE
Q 048430 394 LQKLQGLDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVD 473 (973)
Q Consensus 394 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 473 (973)
+.++++|++++|.+.. + +.+..+++|++|++++|++++..+ ++++++|++|++++|.+... + .+..++.|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-cccccccccccc
Confidence 3445555555555542 1 124445555555555555543322 44555555555555555422 1 244555555555
Q ss_pred ecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCC
Q 048430 474 FSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISG 553 (973)
Q Consensus 474 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 553 (973)
+++|.+... ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++. + .|+++++|++|+|++|+++.
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC
Confidence 555555432 22555666666666666665 222 456666666666666666643 2 26666677777777776663
Q ss_pred CCCcccccccccccc
Q 048430 554 EIPKSLEKLSRLVDF 568 (973)
Q Consensus 554 ~~p~~~~~l~~L~~l 568 (973)
++ .++++++|+.|
T Consensus 187 -i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 -IS-VLAKLTNLESL 199 (199)
T ss_dssp -CG-GGGGCTTCSEE
T ss_pred -Cc-cccCCCCCCcC
Confidence 33 35566665543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.2e-16 Score=164.74 Aligned_cols=211 Identities=17% Similarity=0.181 Sum_probs=103.9
Q ss_pred CCccEEEeeCcccCCC-CCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccc-cccccCCCCCCCccccCC
Q 048430 118 TQLESFDVSSNKITGE-FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGN-NITGRIPNREIPNEIGNL 195 (973)
Q Consensus 118 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~p~~l~~l 195 (973)
.+|++|||++|.+++. ++..+.++++|++|+|++|.+++..+..+ ..+++|++|+|+++ .++.. .+..-...+
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l-~~~~~L~~L~Ls~c~~itd~----~l~~l~~~~ 120 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL-AKNSNLVRLNLSGCSGFSEF----ALQTLLSSC 120 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHH-TTCTTCSEEECTTCBSCCHH----HHHHHHHHC
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHH-hcCCCCcCcccccccccccc----ccchhhHHH
Confidence 3455555555544421 22234445555555555555443333222 33455555555552 33210 011112345
Q ss_pred CCccEEEecCC-cccCc-ccccccc-CCcceeEEeeccc--ccc-cCCCC-CCccccceeeeccc-cccccCcchhcccC
Q 048430 196 HNLKILDLGGN-NIAGL-IPSMIFN-NSNMVAILLYGNH--LSG-HLPSS-IYLPNLENLFLWKN-NLSGIIPDSICNAS 267 (973)
Q Consensus 196 ~~L~~L~L~~N-~l~~~-~~~~~~~-~~~L~~L~l~~n~--l~~-~~~~~-~~l~~L~~L~L~~N-~l~~~~~~~l~~l~ 267 (973)
++|++|+++++ .++.. +...+.. .++|+.|+++++. ++. .+... ..+++|++|++++| .+++.....+..++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 55666666554 23211 1111222 2345555554431 211 11111 12677888888775 46666666777778
Q ss_pred cccEEEeccc-cccccCCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCCCCccc
Q 048430 268 EATILELSSN-LFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG 343 (973)
Q Consensus 268 ~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 343 (973)
+|++|+|++| .+++.....++++++|+.|+++++ ++. .. .......+++|+ +..+.++...++.++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d---~~---l~~l~~~lp~L~---i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GT---LQLLKEALPHLQ---INCSHFTTIARPTIG 267 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TC---HHHHHHHSTTSE---ESCCCSCCTTCSSCS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH---HH---HHHHHHhCcccc---ccCccCCCCCCCccC
Confidence 8888888874 566655566777788888888776 322 10 111123345544 456666665555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6e-15 Score=140.80 Aligned_cols=125 Identities=18% Similarity=0.314 Sum_probs=59.3
Q ss_pred cccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCcc
Q 048430 91 HMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLV 170 (973)
Q Consensus 91 ~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~ 170 (973)
+..+|+.|||++|+|+ .+| .++..+++|++|||++|+|+. ++ .|..+++|++|++++|+++ .+|..++..+++|+
T Consensus 16 n~~~lr~L~L~~n~I~-~i~-~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT 90 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCC-CGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred CcCcCcEEECCCCCCC-ccC-ccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhccccccc-CCCccccccccccc
Confidence 4444455555555554 343 223344555555555555542 22 3445555555555555554 44444444455555
Q ss_pred EEEcccccccccCCCCCCC--ccccCCCCccEEEecCCcccCcc---ccccccCCcceeEE
Q 048430 171 QLRLLGNNITGRIPNREIP--NEIGNLHNLKILDLGGNNIAGLI---PSMIFNNSNMVAIL 226 (973)
Q Consensus 171 ~L~L~~N~l~~~~~~~~~p--~~l~~l~~L~~L~L~~N~l~~~~---~~~~~~~~~L~~L~ 226 (973)
+|++++|+|+. ++ ..+..+++|++|++++|.++... +..+..+++|+.|+
T Consensus 91 ~L~L~~N~i~~------~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVE------LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCC------GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccc------cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 55555555531 12 23455555555555555554321 12344455555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=5.4e-15 Score=156.03 Aligned_cols=183 Identities=17% Similarity=0.154 Sum_probs=97.6
Q ss_pred Cccccceeeecccccccc-CcchhcccCcccEEEeccccccccCCCcccccccceEEEccCC-cCCCCCCCcchhhhhhh
Q 048430 241 YLPNLENLFLWKNNLSGI-IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN-QLTTGSSAQGQIFYSSL 318 (973)
Q Consensus 241 ~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~l 318 (973)
...+|++|++++|.+... +...+..+++|++|+|++|.+++..+..++.+++|++|+++++ .++. .-....+
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd------~~l~~l~ 117 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE------FALQTLL 117 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH------HHHHHHH
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccc------cccchhh
Confidence 356777888887777543 3345666777788888777777666666777777777777774 3432 1111223
Q ss_pred ccCCcCcEEEccCCC-CCCC-CCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecC--cccc-ccCcccCC
Q 048430 319 AKCRYLRVLVLDTNP-LKGV-IPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNN--ELAG-AIPTVLGK 393 (973)
Q Consensus 319 ~~l~~L~~L~L~~N~-l~~~-~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n--~l~~-~~p~~~~~ 393 (973)
..+++|++|+++++. ++.. +...+ ....++|+.|+++++ .++. .+...+..
T Consensus 118 ~~~~~L~~L~ls~c~~~~~~~~~~~~------------------------~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~ 173 (284)
T d2astb2 118 SSCSRLDELNLSWCFDFTEKHVQVAV------------------------AHVSETITQLNLSGYRKNLQKSDLSTLVRR 173 (284)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHH------------------------HHSCTTCCEEECCSCGGGSCHHHHHHHHHH
T ss_pred HHHHhccccccccccccccccchhhh------------------------cccccccchhhhcccccccccccccccccc
Confidence 456677777776642 2210 00000 011245566666543 2221 12222344
Q ss_pred CCCCCEEEccCCc-CCCCCchhhhccCcCCeeecCCc-cccCcCcccccCcCCCCeeeccCC
Q 048430 394 LQKLQGLDLNSNK-LKGFIPTDLCKLEKLNTLLSNNN-ALQGQIPTCLANLTSLRHLDFRSN 453 (973)
Q Consensus 394 l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~N 453 (973)
+++|++|++++|. +++.....+.++++|++|++++| .+++.....++++++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 5566666666543 44444445555555555555553 344444444555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=6e-14 Score=127.05 Aligned_cols=102 Identities=25% Similarity=0.373 Sum_probs=58.3
Q ss_pred cEEEecCCCCCCCCCcccccccCCcEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccC
Q 048430 72 VSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDN 151 (973)
Q Consensus 72 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 151 (973)
+.|+|++|+++ .+| .+.++++|++||+++|+++ .+|+.+ +.+++|++|++++|+|++ +| .++++++|++|++++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~-~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPAL-AALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGG-GGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhh-hhhhcccccccccccccc-cC-ccccccccCeEECCC
Confidence 35666666664 333 3566666666666666665 555443 456666666666666663 33 356666666666666
Q ss_pred ccccccCCc-cccCCCCCccEEEccccccc
Q 048430 152 NSLSGSFPT-DLCTRLPSLVQLRLLGNNIT 180 (973)
Q Consensus 152 N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~ 180 (973)
|+|+ .+|. ..+..+++|++|++++|.++
T Consensus 75 N~i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 75 NRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SCCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 6665 3432 33445555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.8e-14 Score=127.66 Aligned_cols=104 Identities=20% Similarity=0.392 Sum_probs=83.2
Q ss_pred cEEEccCCCCCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcc
Q 048430 96 KIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL 175 (973)
Q Consensus 96 ~~L~Ls~n~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~ 175 (973)
|.|||++|+++ .+|. ++.+++|++||+++|+|+ .+|+.|+.+++|+.|++++|+|+ .+|. +..+++|++|+++
T Consensus 1 R~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~ 73 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLC 73 (124)
T ss_dssp SEEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECC
T ss_pred CEEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc--cccccccCeEECC
Confidence 57899999998 6764 578899999999999998 57878888999999999999998 6653 5678888888888
Q ss_pred cccccccCCCCCCCccccCCCCccEEEecCCcccC
Q 048430 176 GNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAG 210 (973)
Q Consensus 176 ~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~ 210 (973)
+|+|+... ....++.+++|++|++++|.++.
T Consensus 74 ~N~i~~~~----~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 74 NNRLQQSA----AIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp SSCCCSSS----TTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCccCCCC----CchhhcCCCCCCEEECCCCcCCc
Confidence 88886321 12457888888888888888863
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.3e-14 Score=138.41 Aligned_cols=127 Identities=23% Similarity=0.228 Sum_probs=94.6
Q ss_pred ccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCcccCCcccccCCcCC
Q 048430 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLD 518 (973)
Q Consensus 439 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 518 (973)
+.+..+|++|+|++|+|+. ++..+..+++|+.||+++|+|+ .++ .+..+++|+.|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 4566678888888888874 4666677788888888888887 443 477888888888888888855555567788888
Q ss_pred EEEcccCccccCCC--CCcccccccccccccccccCCCCCc----ccccccccccccc
Q 048430 519 WLALARNAFQGPIP--QSFGSLISLQSLDLSGNNISGEIPK----SLEKLSRLVDFNV 570 (973)
Q Consensus 519 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~l~l 570 (973)
.|+|++|+|+. ++ ..+..+++|++|++++|.++. .|. .+..+++|++||-
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred cceeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence 88888888873 33 457788888888888888873 342 4677888888774
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=6.9e-16 Score=168.50 Aligned_cols=252 Identities=16% Similarity=0.180 Sum_probs=119.8
Q ss_pred CcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCCCCC---CCcccccccccceeecccCCccc
Q 048430 285 NTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVI---PNSIGNLSTSLENFYAGSSQLSG 361 (973)
Q Consensus 285 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~~l~~l~l~~n~l~~ 361 (973)
..+.....|++|+|++|.+... ....+...+...++|+.++++++...... |..+.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~---~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~------------------ 83 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTE---AARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR------------------ 83 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHH---HHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH------------------
T ss_pred HHHhhCCCCCEEECcCCcCCHH---HHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH------------------
Confidence 4456677788888888877531 11223345666777888887776554221 11111
Q ss_pred cCCCCCCCCCcccEEEeecCccccc----cCcccCCCCCCCEEEccCCcCCCCCchhh-------------hccCcCCee
Q 048430 362 GIPVGFGNLSNLLVLSLVNNELAGA----IPTVLGKLQKLQGLDLNSNKLKGFIPTDL-------------CKLEKLNTL 424 (973)
Q Consensus 362 ~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------~~l~~L~~L 424 (973)
.+...+...++|++|+|++|.++.. +...+...++|++|++++|.+.......+ ...+.|+.+
T Consensus 84 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l 163 (344)
T d2ca6a1 84 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 163 (344)
T ss_dssp HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred HHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCccccee
Confidence 1112244556677777777776543 23334456677777777776642111111 123344555
Q ss_pred ecCCccccCcC----cccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccC
Q 048430 425 LSNNNALQGQI----PTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTG 500 (973)
Q Consensus 425 ~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 500 (973)
.+++|.++... ...+...+.|++|+|++|++...-. ...+...+..+++|+.|+|++
T Consensus 164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~-------------------~~~l~~~l~~~~~L~~L~Ls~ 224 (344)
T d2ca6a1 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI-------------------EHLLLEGLAYCQELKVLDLQD 224 (344)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHH-------------------HHHHHTTGGGCTTCCEEECCS
T ss_pred ecccccccccccccccchhhhhhhhccccccccccccccc-------------------ccchhhhhcchhhhccccccc
Confidence 55555443221 1122334445555555554431100 001122344445555555555
Q ss_pred CcCccc----CCcccccCCcCCEEEcccCccccCCCCCc----c--cccccccccccccccCCC----CCcccc-ccccc
Q 048430 501 NQLSGY----IPSSIGNLKNLDWLALARNAFQGPIPQSF----G--SLISLQSLDLSGNNISGE----IPKSLE-KLSRL 565 (973)
Q Consensus 501 N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L 565 (973)
|.++.. +...+..+++|++|+|++|.|++.....+ . ....|++|||++|+|+.. +...+. ++++|
T Consensus 225 N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L 304 (344)
T d2ca6a1 225 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304 (344)
T ss_dssp SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTC
T ss_pred ccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCC
Confidence 555421 22334455555555555555543211111 1 123455666666655432 122222 34556
Q ss_pred cccccCCCccc
Q 048430 566 VDFNVSFNGLE 576 (973)
Q Consensus 566 ~~l~ls~N~l~ 576 (973)
+.|++++|.+.
T Consensus 305 ~~L~l~~N~~~ 315 (344)
T d2ca6a1 305 LFLELNGNRFS 315 (344)
T ss_dssp CEEECTTSBSC
T ss_pred CEEECCCCcCC
Confidence 66666666553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=2.9e-15 Score=163.39 Aligned_cols=199 Identities=17% Similarity=0.157 Sum_probs=106.2
Q ss_pred chhcccCcccEEEecccccccc----CCCcccccccceEEEccCCcCCCCCCCc---chhhhhhhccCCcCcEEEccCCC
Q 048430 261 DSICNASEATILELSSNLFSGL----VPNTFGNCRQLQILSLGDNQLTTGSSAQ---GQIFYSSLAKCRYLRVLVLDTNP 333 (973)
Q Consensus 261 ~~l~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~~~~~l~~l~~L~~L~L~~N~ 333 (973)
..+.....|+.|+|++|.|... +...+...++|+.|+++++......... ...+...+..+++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 4455556666666666665422 1223455566666666666544322111 12234445566777777777776
Q ss_pred CCCCCCCcccccccccceeecccCCccccCCCCCCCCCcccEEEeecCccccccCc-------------ccCCCCCCCEE
Q 048430 334 LKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGNLSNLLVLSLVNNELAGAIPT-------------VLGKLQKLQGL 400 (973)
Q Consensus 334 l~~~~p~~~~~l~~~l~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~-------------~~~~l~~L~~L 400 (973)
+.......+. ..+...++|++|++++|.+...... .....+.|+.+
T Consensus 105 i~~~~~~~l~---------------------~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l 163 (344)
T d2ca6a1 105 FGPTAQEPLI---------------------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 163 (344)
T ss_dssp CCTTTHHHHH---------------------HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred cccccccchh---------------------hhhcccccchheecccccccccccccccccccccccccccccCccccee
Confidence 6543111111 1123345667777777665421110 11345667777
Q ss_pred EccCCcCCCCC----chhhhccCcCCeeecCCccccCc-----CcccccCcCCCCeeeccCCCCCCC----Ccccccccc
Q 048430 401 DLNSNKLKGFI----PTDLCKLEKLNTLLSNNNALQGQ-----IPTCLANLTSLRHLDFRSNSLNST----IPSTFWSLK 467 (973)
Q Consensus 401 ~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~ 467 (973)
++++|++.... ...+...+.|+.|++++|.+... +...+..+++|+.|+|++|.++.. +...+...+
T Consensus 164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~ 243 (344)
T d2ca6a1 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243 (344)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred ecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccc
Confidence 77777776332 23344567788888888877642 233456667777777777776421 222334444
Q ss_pred cccEEEecCCccc
Q 048430 468 YILAVDFSLNSLS 480 (973)
Q Consensus 468 ~L~~L~ls~N~l~ 480 (973)
+|++|++++|.|+
T Consensus 244 ~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 244 NLRELGLNDCLLS 256 (344)
T ss_dssp TCCEEECTTCCCC
T ss_pred cchhhhhhcCccC
Confidence 5555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=3.4e-14 Score=140.56 Aligned_cols=114 Identities=23% Similarity=0.246 Sum_probs=53.5
Q ss_pred CCccccCCCCCCeEEccCccccccCCccccCCCCCccEEEcccccccccCCCCCCCccccCCCCccEEEecCCcccCccc
Q 048430 134 FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIP 213 (973)
Q Consensus 134 ~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 213 (973)
+|.++..+++|++|+|++|+|+ .++. +..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.. +
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~------~i~~~~~~~~~L~~L~l~~N~i~~l-~ 109 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIK------KIENLDAVADTLEELWISYNQIASL-S 109 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEEC------SCSSHHHHHHHCCEEECSEEECCCH-H
T ss_pred hhhHHhcccccceeECcccCCC-Cccc--ccCCccccChhhcccccc------ccccccccccccccccccccccccc-c
Confidence 3445555555555555555555 3431 234445555555555543 2333333334455555555554421 1
Q ss_pred cccccCCcceeEEeecccccccCCCCCCccccceeeeccccccccCc-chhcccCcccEEEeccccccc
Q 048430 214 SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIP-DSICNASEATILELSSNLFSG 281 (973)
Q Consensus 214 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~i~~ 281 (973)
.+.. +++|++|++++|+|+.... +.+..+++|+.|+|++|++..
T Consensus 110 -~~~~-----------------------l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 110 -GIEK-----------------------LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp -HHHH-----------------------HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred -cccc-----------------------cccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 1222 4455555555555543211 234555555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=7.4e-14 Score=138.08 Aligned_cols=114 Identities=21% Similarity=0.276 Sum_probs=62.2
Q ss_pred CchhhhccCcCCeeecCCccccCcCcccccCcCCCCeeeccCCCCCCCCcccccccccccEEEecCCcccCCcCcCccCC
Q 048430 411 IPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFSLNSLSGSLPLNIGNL 490 (973)
Q Consensus 411 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 490 (973)
++..+..+++|+.|+|++|+|+.. + .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. ++ .+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccc
Confidence 344555556666666666665532 2 3555666666666666654 234444444555566666665552 22 24555
Q ss_pred CCCCeEEccCCcCcccCC-cccccCCcCCEEEcccCcccc
Q 048430 491 EALGGLNLTGNQLSGYIP-SSIGNLKNLDWLALARNAFQG 529 (973)
Q Consensus 491 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 529 (973)
++|+.|+|++|+|+.... ..+..+++|+.|+|++|.+..
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 666666666666652211 345566666666666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=8.8e-12 Score=117.61 Aligned_cols=92 Identities=21% Similarity=0.193 Sum_probs=56.2
Q ss_pred CCcccccccCCcEEEccCCC-CCCCCCccccCCCCCccEEEeeCcccCCCCCccccCCCCCCeEEccCccccccCCcccc
Q 048430 85 LPNELWHMRRLKIIDFSSNS-LSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLC 163 (973)
Q Consensus 85 ~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~ 163 (973)
+|..+..+++|+.|++++|+ ++ .++.+.|.++++|+.|+|++|+|+...|.+|.++++|++|+|++|+|+ .+|.++|
T Consensus 23 ~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~ 100 (156)
T d2ifga3 23 SLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTV 100 (156)
T ss_dssp TTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTT
T ss_pred CcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhh
Confidence 34445555556666665443 44 566555666666666666666666555666667777777777777776 6666665
Q ss_pred CCCCCccEEEcccccc
Q 048430 164 TRLPSLVQLRLLGNNI 179 (973)
Q Consensus 164 ~~l~~L~~L~L~~N~l 179 (973)
..+ +|++|+|++|.+
T Consensus 101 ~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 101 QGL-SLQELVLSGNPL 115 (156)
T ss_dssp CSC-CCCEEECCSSCC
T ss_pred ccc-cccccccCCCcc
Confidence 433 456666666655
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=7.8e-12 Score=117.98 Aligned_cols=67 Identities=27% Similarity=0.296 Sum_probs=30.6
Q ss_pred cCccCCCCCCeEEccCCcCcccCCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccC
Q 048430 485 LNIGNLEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552 (973)
Q Consensus 485 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 552 (973)
..|.++++|+.|+|++|+|+...|..|..+++|+.|+|++|+|+...+..|.. .+|+.|+|++|.+.
T Consensus 50 ~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 50 RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred hhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 33444444444555555544444444445555555555555554222222322 24555555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=7.7e-09 Score=97.72 Aligned_cols=83 Identities=25% Similarity=0.317 Sum_probs=49.1
Q ss_pred ccCCCCCCeEEccCCcCccc--CCcccccCCcCCEEEcccCccccCCCCCcccccccccccccccccCCCCCc-------
Q 048430 487 IGNLEALGGLNLTGNQLSGY--IPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK------- 557 (973)
Q Consensus 487 ~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------- 557 (973)
+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+...+-.+....+|+.|+|++|.++.....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 34566677777777777632 233455667777777777777633222333344567777777777654442
Q ss_pred cccccccccccc
Q 048430 558 SLEKLSRLVDFN 569 (973)
Q Consensus 558 ~~~~l~~L~~l~ 569 (973)
.+..+|+|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 245567777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=3.7e-08 Score=92.90 Aligned_cols=67 Identities=25% Similarity=0.185 Sum_probs=29.0
Q ss_pred cccCcCCCCeeeccCCCCCCCC--cccccccccccEEEecCCcccCCcCcCccCCCCCCeEEccCCcCc
Q 048430 438 CLANLTSLRHLDFRSNSLNSTI--PSTFWSLKYILAVDFSLNSLSGSLPLNIGNLEALGGLNLTGNQLS 504 (973)
Q Consensus 438 ~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 504 (973)
.+.++++|++|+|++|+|+... +..+..+++|+.||+++|+|+...+..+.....|+.|++++|.++
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3345566666666666665421 223333444444444444444211111112223444455555444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=1.9e-06 Score=88.19 Aligned_cols=150 Identities=16% Similarity=0.128 Sum_probs=105.0
Q ss_pred HHHHHHhcCCCCCccccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCee
Q 048430 673 HELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFK 751 (973)
Q Consensus 673 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 751 (973)
.++....+.|...+..+-++.+.||+.... ++.+++|+...........+.+|...+..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 356666677776655444445789988754 5667788876554444456788888888774 43466778888888899
Q ss_pred EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------
Q 048430 752 ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG----------------------------------- 796 (973)
Q Consensus 752 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------- 796 (973)
++||+++++.++.+...... ....++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999988766543221 2334566677777777731
Q ss_pred ---------------------CCCCeEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 797 ---------------------YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 797 ---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
....++|+|+.|.||++++++.+-++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112378999999999999877777999998763
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.57 E-value=1.7e-05 Score=74.35 Aligned_cols=69 Identities=6% Similarity=0.033 Sum_probs=40.0
Q ss_pred ccCcccEEEecccccccc----CCCcccccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCC
Q 048430 265 NASEATILELSSNLFSGL----VPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNP 333 (973)
Q Consensus 265 ~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~ 333 (973)
..+.|+.|+|++|.|+.. +..++...++|++|++++|++..+.......+...+...+.|+.|+++.+.
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 344555555555555422 122345556677777777766554333334456667777888888876654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.54 E-value=0.00011 Score=74.19 Aligned_cols=130 Identities=16% Similarity=0.166 Sum_probs=86.7
Q ss_pred cccccCc-eEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccC--CceeEEEeeeecCCeeEEEEEecCCCCH
Q 048430 687 LLGSGSF-DNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH--RNLIKIVSSCSNPGFKALIMQYMPQGSL 763 (973)
Q Consensus 687 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 763 (973)
.+..|.. +.||+....++..+++|...... ...+..|+..++.+.. -.+.++++++.+++..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 67999998888889999865432 2346778888877742 3366778888888889999999987654
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhh------------------------------------------------
Q 048430 764 EKWLYSHNYSLTIRQRLDIMIDVASALEYLHH------------------------------------------------ 795 (973)
Q Consensus 764 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~------------------------------------------------ 795 (973)
.+. ..+. ...+.++++.++-||.
T Consensus 94 ~~~------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSS------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTS------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 321 0111 1122333334444441
Q ss_pred -------cCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 796 -------GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 796 -------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
.....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 012237999999999999988777899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.49 E-value=3.7e-05 Score=72.02 Aligned_cols=88 Identities=9% Similarity=0.083 Sum_probs=56.2
Q ss_pred CCCcccEEEeecC-ccccc----cCcccCCCCCCCEEEccCCcCCCC----CchhhhccCcCCeeecCCccccCcC----
Q 048430 369 NLSNLLVLSLVNN-ELAGA----IPTVLGKLQKLQGLDLNSNKLKGF----IPTDLCKLEKLNTLLSNNNALQGQI---- 435 (973)
Q Consensus 369 ~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~---- 435 (973)
+.+.|++|+|+++ .++.. +...+...+.|++|+|++|.+... +...+...+.|+.|++++|.++...
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4577888888864 45432 334566777888888888887632 2233445567777777777776532
Q ss_pred cccccCcCCCCeeeccCCCCC
Q 048430 436 PTCLANLTSLRHLDFRSNSLN 456 (973)
Q Consensus 436 ~~~~~~l~~L~~L~L~~N~l~ 456 (973)
...+...++|++|++++|++.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 223455566777777777654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.93 E-value=0.001 Score=71.41 Aligned_cols=76 Identities=12% Similarity=0.148 Sum_probs=48.9
Q ss_pred CccccccCceEEEEEEeC-CCeEEEEEEEeccc-------hhhHHHHHHHHHHHHhcc-C--CceeEEEeeeecCCeeEE
Q 048430 685 SNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-------DRALKSFDTECEVMRRIR-H--RNLIKIVSSCSNPGFKAL 753 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 753 (973)
.+.||.|....||+.... +++.|+||.-.... .........|++.++.+. + ..+.+++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 457899999999999864 46789999653211 112334567888887763 2 3455666554 445678
Q ss_pred EEEecCCCC
Q 048430 754 IMQYMPQGS 762 (973)
Q Consensus 754 v~e~~~~gs 762 (973)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.75 E-value=4.2e-05 Score=71.61 Aligned_cols=44 Identities=11% Similarity=0.076 Sum_probs=18.7
Q ss_pred ccccceEEEccCCcCCCCCCCcchhhhhhhccCCcCcEEEccCCCCC
Q 048430 289 NCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLK 335 (973)
Q Consensus 289 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 335 (973)
..++|++|++++|.++.. ....+...+...+.++.+++++|.+.
T Consensus 44 ~n~~L~~L~Ls~n~l~~~---~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDP---VAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCCSCCEEECTTSCCCHH---HHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCccCeeeccCCcccHH---HHHHHHHHHhhcccchhhhhcccccc
Confidence 344455555555544321 11122233444455555555554443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.60 E-value=0.00014 Score=67.87 Aligned_cols=11 Identities=18% Similarity=0.277 Sum_probs=5.1
Q ss_pred cccceEEEccC
Q 048430 290 CRQLQILSLGD 300 (973)
Q Consensus 290 l~~L~~L~L~~ 300 (973)
.++|++|+|++
T Consensus 16 ~~~L~~L~L~~ 26 (166)
T d1io0a_ 16 DPDLEEVNLNN 26 (166)
T ss_dssp CTTCCEEECTT
T ss_pred CCCCcEEEcCC
Confidence 34444444443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.55 E-value=0.0021 Score=66.87 Aligned_cols=134 Identities=11% Similarity=0.133 Sum_probs=77.9
Q ss_pred ceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCce--eEEEe-----eeecCCeeEEEEEecCCCCH--
Q 048430 693 FDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL--IKIVS-----SCSNPGFKALIMQYMPQGSL-- 763 (973)
Q Consensus 693 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL-- 763 (973)
--.||++..++|+.|++|+.+... ...+++..|...+..+....+ +..+. .+...+..+.|+++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 358999999999999999986542 234667888888888752222 11111 12345677889999876421
Q ss_pred ----------------HHHhhhC----CCCCC-------------------HHHHHHHHHHHHHHHHHhh----hcCCCC
Q 048430 764 ----------------EKWLYSH----NYSLT-------------------IRQRLDIMIDVASALEYLH----HGYSTP 800 (973)
Q Consensus 764 ----------------~~~l~~~----~~~l~-------------------~~~~~~i~~~i~~~L~~LH----~~~~~~ 800 (973)
+...... +...+ ...+..+...+.+.++.+. +....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1111100 01111 1111112222222333332 223456
Q ss_pred eEEccCCCCcEEeCCCCcEEEeecccccc
Q 048430 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829 (973)
Q Consensus 801 ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 829 (973)
+||+|+.+.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.0083 Score=61.86 Aligned_cols=157 Identities=14% Similarity=0.142 Sum_probs=85.1
Q ss_pred CCCHHHHHHHhcCCCCCcc-----ccccCceEEEEEEeCCCeEEEEEEEeccchhhHHHHHHHHHHHHhccCCce--eEE
Q 048430 669 RISYHELQQATNGFGESNL-----LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL--IKI 741 (973)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l 741 (973)
..+.++++....+|...+. |..|---+.|+.+..+|+ +++|++....+ .++...|+.++..+...++ ...
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccc
Confidence 3566788888888876543 345666788999887664 88998854322 2345556667766642221 111
Q ss_pred Ee------eeecCCeeEEEEEecCCCCHH--------------HHhhh----CC----CC------------------CC
Q 048430 742 VS------SCSNPGFKALIMQYMPQGSLE--------------KWLYS----HN----YS------------------LT 775 (973)
Q Consensus 742 ~~------~~~~~~~~~lv~e~~~~gsL~--------------~~l~~----~~----~~------------------l~ 775 (973)
+. +....+....++.+..+.... ..++. .. .. ..
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 112234556677776654211 00000 00 00 00
Q ss_pred HHHHHHHHHHHHHHHHHhh-hcCCCCeEEccCCCCcEEeCCCCcEEEeeccccc
Q 048430 776 IRQRLDIMIDVASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK 828 (973)
Q Consensus 776 ~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 828 (973)
.......+..+...+.-.+ .....++||+|+.+.||+++.+...-++||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111112222222222222 2345779999999999999998877899999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.58 E-value=0.013 Score=62.58 Aligned_cols=72 Identities=13% Similarity=0.196 Sum_probs=49.2
Q ss_pred CccccccCceEEEEEEeCC--------CeEEEEEEEeccchhhHHHHHHHHHHHHhcc-CCceeEEEeeeecCCeeEEEE
Q 048430 685 SNLLGSGSFDNVYKATLAN--------GVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSCSNPGFKALIM 755 (973)
Q Consensus 685 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 755 (973)
.+.|+.|-.-.+|+....+ .+.|.+++.. .... .....+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568888889999998653 3567777764 2222 245668999998885 4334577777753 5899
Q ss_pred EecCCCC
Q 048430 756 QYMPQGS 762 (973)
Q Consensus 756 e~~~~gs 762 (973)
||+++..
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998643
|